data_1ezb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ezb _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 105.863 -1.902 . . . . 1.5700000000000001 105.863 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -105.44 120.33 41.33 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.794 -1.188 . . . . 1.4399999999999999 107.794 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.493 ' H ' ' ND2' ' A' ' 225' ' ' ASN . . . -104.13 -159.28 24.3 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.686 -1.766 . . . . 1.01 108.686 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 90.8 mt -96.35 1.68 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.29 -1.124 . . . . 1.6299999999999999 112.687 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tp 49.91 97.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.846 -1.158 . . . . 1.5800000000000001 112.213 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.5 -46.84 12.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 1.3400000000000001 111.234 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -149.16 150.15 31.27 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.994 -1.113 . . . . 1.8600000000000001 107.994 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.59 150.0 44.81 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.024 2.483 . . . . 1.01 111.803 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.09 121.39 1.36 Allowed Glycine 0 N--CA 1.508 3.453 0 C-N-CA 120.133 -1.032 . . . . 0.81000000000000005 110.708 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -88.59 135.07 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.839 -1.389 . . . . 1.3700000000000001 109.061 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.05 153.86 48.13 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.789 -0.819 . . . . 1.1399999999999999 108.789 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -125.02 140.59 52.77 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.221 -0.924 . . . . 0.87 109.077 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.09 170.15 41.76 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 118.672 -1.728 . . . . 0.56999999999999995 110.207 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -79.46 158.82 27.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.654 -0.91 . . . . 2.3500000000000001 109.126 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -83.25 126.86 33.12 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.666 -1.235 . . . . 1.21 107.666 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.0 tp -109.91 103.38 12.15 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 105.04 -2.207 . . . . 1.3999999999999999 105.04 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.6 tp -88.0 140.02 29.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.011 . . . . 1.4399999999999999 108.906 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.7 mt -99.04 112.31 24.47 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.414 -1.698 . . . . 1.45 106.414 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -110.18 131.97 54.58 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.816 -1.179 . . . . 2.5 107.816 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -126.91 140.07 52.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.192 -0.942 . . . . 2.6600000000000001 108.949 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -80.61 137.83 36.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.236 -1.024 . . . . 2.3199999999999998 108.236 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -62.06 150.54 37.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.236 -0.915 . . . . 2.1099999999999999 109.953 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.5 mt -90.23 134.85 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.077 -1.014 . . . . 1.29 108.52 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -108.9 131.37 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.463 -0.94 . . . . 1.4099999999999999 108.463 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.9 mt -94.32 140.35 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.936 -0.764 . . . . 1.3100000000000001 108.936 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -91.33 123.03 34.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.116 -0.99 . . . . 1.3400000000000001 108.503 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -100.02 18.34 18.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.457 -0.777 . . . . 3.48 112.046 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -70.43 145.31 51.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.812 -1.18 . . . . 2.52 109.488 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -88.15 129.96 35.17 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.759 -1.2 . . . . 2.6299999999999999 107.759 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 pt -95.96 167.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.405 -0.809 . . . . 1.3100000000000001 110.474 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.4 p -95.81 167.7 11.1 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.345 0.593 . . . . 1.24 109.997 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.25 -21.44 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.454 -0.779 . . . . 1.49 111.728 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -69.64 -41.24 75.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 2.2799999999999998 110.743 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -84.13 -7.39 59.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.029 -1.045 . . . . 2.0499999999999998 112.204 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.1 t -58.5 -39.77 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.32 -0.863 . . . . 1.3400000000000001 110.299 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -58.54 -40.19 82.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.008 -1.058 . . . . 1.54 110.208 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -61.81 -40.43 95.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.699 -0.625 . . . . 2.8500000000000001 110.885 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -59.73 -43.97 93.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.064 -1.022 . . . . 1.3100000000000001 111.004 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.48 -41.77 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.986 -1.071 . . . . 1.3799999999999999 110.674 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -60.28 -49.21 78.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.177 -0.952 . . . . 1.5 110.044 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.441 ' HG2' HH11 ' A' ' 42' ' ' ARG . 45.6 mtt-85 -60.25 -38.01 82.18 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.534 -0.729 . . . . 2.7799999999999998 109.857 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -71.85 -59.44 2.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.596 -0.69 . . . . 1.0600000000000001 110.232 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.15 -45.45 90.95 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.218 -0.993 . . . . 1.3999999999999999 110.0 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -67.76 -38.81 83.95 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.505 -0.747 . . . . 1.3200000000000001 110.137 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.08 -41.23 94.46 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.579 -1.409 . . . . 0.69999999999999996 109.579 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.513 HH22 ' CD ' ' A' ' 86' ' ' GLU . 32.8 ttm180 -59.8 -31.23 69.51 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.469 -1.018 . . . . 3.4399999999999999 109.206 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.33 86.9 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.548 0.69 . . . . 1.3600000000000001 109.765 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -80.61 -44.08 19.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.81 . . . . 2.8300000000000001 111.007 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.12 -42.41 94.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 1.23 110.163 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.1 t -59.86 -38.93 83.55 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.053 -1.029 . . . . 1.9199999999999999 109.081 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.08 -50.05 44.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.682 -0.69 . . . . 1.25 110.94 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.34 -49.44 77.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.602 -1.311 . . . . 1.97 110.66 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.21 -40.42 93.9 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.396 -0.815 . . . . 2.1800000000000002 109.381 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.86 -40.5 93.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.602 -0.686 . . . . 1.1899999999999999 110.25 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 m -66.28 -45.42 80.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.998 -1.064 . . . . 1.3400000000000001 109.798 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 57' ' ' ILE . 95.3 mt -60.02 -38.33 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.519 -0.738 . . . . 1.23 110.387 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -51.26 -42.42 61.04 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.794 -0.762 . . . . 1.5600000000000001 110.328 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -70.28 -35.3 73.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.27 -0.894 . . . . 1.3 110.03 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -61.83 -39.92 93.5 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.179 -1.008 . . . . 2.3199999999999998 109.074 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.85 -34.74 76.51 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.769 -0.773 . . . . 1.1399999999999999 109.76 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.27 -36.65 20.29 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.643 -1.265 . . . . 0.68999999999999995 110.884 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -81.71 -20.26 39.78 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.847 -1.384 . . . . 1.48 111.126 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -88.61 -51.93 5.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.414 -0.804 . . . . 1.52 110.839 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -107.31 -21.05 13.08 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.538 -0.726 . . . . 1.3100000000000001 112.865 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.03 164.24 12.49 Favored Glycine 0 N--CA 1.504 3.167 0 O-C-N 121.51 -0.744 . . . . 0.84999999999999998 112.075 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -52.85 -24.85 9.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.692 -0.887 . . . . 3.8599999999999999 112.288 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.23 -39.56 79.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.838 -1.164 . . . . 2.3500000000000001 111.137 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -87.13 -22.06 25.59 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.981 -1.074 . . . . 2.2599999999999998 111.8 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -60.76 -37.62 82.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 1.45 110.754 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.69 -33.75 73.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.251 -0.905 . . . . 1.25 111.299 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.9 mt -65.88 -43.46 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.64 -1.287 . . . . 1.26 110.533 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -69.43 -32.15 70.93 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.319 -0.863 . . . . 0.82999999999999996 110.706 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -61.56 -38.48 87.65 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.215 -0.928 . . . . 1.1899999999999999 110.087 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.39 -41.9 99.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.817 -0.913 . . . . 0.57999999999999996 110.817 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -59.28 -40.46 86.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.246 . . . . 2.0499999999999998 110.535 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.82 -38.57 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.123 -0.985 . . . . 1.21 110.724 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.2 ttp -58.14 -39.68 79.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.356 -0.84 . . . . 2.29 110.639 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.72 -48.77 80.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.412 -0.805 . . . . 1.21 110.11 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.09 -41.33 92.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.562 -0.711 . . . . 1.1399999999999999 110.641 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -86.54 9.86 17.12 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 112.984 0.735 . . . . 1.4199999999999999 112.984 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -68.37 122.29 18.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 1.27 108.258 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.55 -16.35 64.09 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.779 0.799 . . . . 1.3500000000000001 110.789 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -74.75 -51.18 14.86 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.71 0.766 . . . . 2.2200000000000002 110.115 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.68 -34.43 77.09 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.771 -0.771 . . . . 1.22 110.313 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.513 ' CD ' HH22 ' A' ' 47' ' ' ARG . 88.9 tt0 -59.98 -47.16 86.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.541 -0.724 . . . . 1.29 110.93 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -63.22 -37.91 89.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.991 -1.068 . . . . 2.1699999999999999 110.995 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -68.24 -49.46 60.51 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.124 -0.985 . . . . 1.3 110.756 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.1 mt -58.42 -43.94 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 1.1699999999999999 110.551 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.0 mt -62.91 -43.78 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 1.3999999999999999 110.47 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.71 -40.59 95.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.325 -0.859 . . . . 1.3300000000000001 111.113 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.57 -42.78 97.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.978 -1.076 . . . . 1.48 110.437 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.15 -50.33 79.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.951 -1.093 . . . . 1.28 110.176 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -78.48 -34.97 47.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.369 -0.832 . . . . 2.6000000000000001 111.774 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 91' ' ' ALA . 54.7 t0 -79.08 -46.85 17.25 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.573 -1.329 . . . . 1.51 111.444 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -100.49 8.09 43.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.08 -1.013 . . . . 2.48 111.857 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.6 m170 49.78 48.92 21.01 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.219 -0.993 . . . . 1.6100000000000001 111.528 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.2 mtt -103.64 156.84 17.49 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.678 0.752 . . . . 1.8999999999999999 109.923 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.679 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 59.3 p -73.09 159.19 33.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.519 -0.738 . . . . 1.3200000000000001 109.296 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.16 79.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.088 -1.007 . . . . 1.1499999999999999 110.376 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -68.75 -39.82 80.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.942 -1.099 . . . . 2.25 110.135 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.679 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -69.38 -51.06 40.28 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.446 -0.784 . . . . 1.22 111.44 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.72 94.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.555 -0.716 . . . . 1.1899999999999999 110.636 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.89 -44.91 96.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.569 -0.707 . . . . 1.2 111.332 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -60.31 -39.57 87.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 2.1000000000000001 110.959 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -55.83 -49.46 73.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.86 -1.15 . . . . 1.3 110.969 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.07 -45.49 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.677 -1.264 . . . . 1.27 109.85 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.42 -30.76 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.626 0.727 . . . . 1.1899999999999999 110.117 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -59.16 -40.36 85.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.126 -0.984 . . . . 2.1099999999999999 110.775 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.37 -32.18 20.31 Favored Glycine 0 N--CA 1.5 2.904 0 C-N-CA 119.193 -1.479 . . . . 0.88 112.601 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -60.44 -40.73 92.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.545 -1.562 . . . . 1.99 110.096 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.16 -47.77 48.44 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.608 0.718 . . . . 1.28 110.307 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 m -60.97 -38.08 84.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 2.2200000000000002 110.545 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.56 97.82 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.186 -0.946 . . . . 1.45 110.854 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.2 mt -65.69 -28.04 68.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 1.47 111.288 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -67.39 -24.27 65.65 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.176 -0.952 . . . . 2.04 111.18 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.17 -11.65 60.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.119 -0.988 . . . . 1.73 111.42 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.3 mt -89.51 138.03 31.81 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.818 -1.179 . . . . 1.79 107.818 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 14.9 t70 -97.56 47.77 1.02 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.277 -0.889 . . . . 2.8799999999999999 111.772 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -119.92 139.84 51.8 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.416 -0.802 . . . . 1.5800000000000001 109.023 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -59.98 -39.09 84.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.446 -0.783 . . . . 3.04 110.762 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -70.53 -57.19 5.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 1.29 110.23 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.9 mt -61.01 -41.51 96.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 1.6000000000000001 110.498 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -61.46 -49.54 76.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.854 -1.154 . . . . 2.7599999999999998 109.8 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -59.94 -30.97 69.43 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.054 -1.058 . . . . 2.1499999999999999 109.545 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -63.39 -29.18 70.52 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.532 -0.867 . . . . 2.8100000000000001 109.499 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.41 73.29 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.779 0.799 . . . . 1.3899999999999999 109.92 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.99 -44.53 80.16 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.768 -0.773 . . . . 1.4099999999999999 110.134 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -63.02 -34.84 78.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.357 -0.839 . . . . 1.3899999999999999 110.569 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.2 t -67.96 -40.81 83.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.905 -1.122 . . . . 1.1899999999999999 109.586 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -59.28 -37.39 77.56 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.09 -1.044 . . . . 3.6299999999999999 109.23 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -59.77 -38.21 81.2 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.212 0.529 . . . . 1.28 110.067 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.7 mt -60.1 -40.24 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.972 . . . . 1.1799999999999999 110.006 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.89 -43.03 94.59 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.089 -1.204 . . . . 0.51000000000000001 110.089 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -58.6 -40.1 82.29 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.493 -1.004 . . . . 3.1699999999999999 110.589 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.402 HH11 ' HG2' ' A' ' 136' ' ' ARG . 51.9 mtt-85 -62.34 -42.43 99.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 2.8500000000000001 110.031 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.6 tp -63.28 -44.41 95.16 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.594 0.711 . . . . 1.6499999999999999 110.036 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.55 -45.2 95.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.635 0.731 . . . . 1.2 110.345 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.405 HH21 ' HA ' ' A' ' 146' ' ' ILE . 53.2 mtp180 -62.06 -34.5 76.38 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.623 -0.673 . . . . 2.7999999999999998 110.945 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -76.02 -43.23 45.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.927 -1.108 . . . . 2.1499999999999999 111.005 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.437 HD11 HG22 ' A' ' 141' ' ' ILE . 96.2 mt -61.58 -37.14 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.922 -1.111 . . . . 1.21 110.823 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.7 mt -88.03 -5.96 58.22 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.013 -1.055 . . . . 1.3400000000000001 112.372 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.14 27.28 73.13 Favored Glycine 0 N--CA 1.481 1.664 0 C-N-CA 119.869 -1.157 . . . . 0.91000000000000003 112.844 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.1 tp -62.3 147.37 48.38 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.643 0.735 . . . . 1.51 109.66 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.41 140.21 58.61 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.562 -0.903 . . . . 2.8799999999999999 108.562 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.405 ' HA ' HH21 ' A' ' 139' ' ' ARG . 54.1 mt -101.34 137.88 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.098 -1.001 . . . . 1.6200000000000001 108.518 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.493 ' H ' ' CD1' ' A' ' 147' ' ' ILE . 3.0 mp -82.44 123.76 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.869 -1.16 . . . . 2.1099999999999999 107.869 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -99.67 97.54 8.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.854 -1.536 . . . . 1.6200000000000001 106.854 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.1 -17.87 61.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.586 -0.696 . . . . 1.3999999999999999 111.382 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.8 t -81.58 2.02 31.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.874 . . . . 2.0499999999999998 112.097 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.91 21.09 14.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.559 -0.713 . . . . 1.3500000000000001 111.928 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.2 mt -74.3 134.51 29.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.266 -0.896 . . . . 1.4199999999999999 108.913 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.35 -15.8 13.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.487 -0.758 . . . . 2.9900000000000002 113.003 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -111.49 130.6 55.67 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.165 -1.421 . . . . 1.54 107.165 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -72.27 123.86 23.86 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.535 -0.913 . . . . 1.3799999999999999 108.535 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 25.3 m -145.69 179.56 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.482 -0.762 . . . . 1.28 109.462 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.7 mt -89.66 140.23 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.714 -0.847 . . . . 1.1599999999999999 108.714 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.83 124.88 40.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.973 -1.079 . . . . 1.3100000000000001 108.54 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.42 130.67 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.258 -1.016 . . . . 1.25 108.258 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.72 150.86 17.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 1.26 109.002 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.491 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.13 -37.86 84.33 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.915 -1.115 . . . . 1.6000000000000001 109.544 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 46.9 t0 -171.23 150.28 2.94 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.391 -0.818 . . . . 2.4199999999999999 108.83 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.465 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 48.2 mt -119.55 141.05 49.59 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.882 -0.784 . . . . 1.3500000000000001 108.882 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.1 p -87.37 150.91 50.13 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.893 -1.129 . . . . 1.3200000000000001 108.646 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -43.12 -41.63 9.53 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.787 1.658 . . . . 0.69999999999999996 113.414 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.6 m -61.95 -49.02 77.81 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.144 -1.022 . . . . 1.1200000000000001 110.14 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -62.84 -40.14 96.52 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.447 -0.783 . . . . 1.21 110.478 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.624 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 71.5 p -69.73 -39.0 77.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.236 -0.915 . . . . 1.1899999999999999 110.271 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.49 -33.4 73.71 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.469 -0.769 . . . . 1.24 110.503 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -96.06 -2.09 47.42 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.198 -0.939 . . . . 1.6899999999999999 112.51 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.72 147.73 41.25 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.306 -0.998 . . . . 1.3400000000000001 108.306 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.59 113.79 25.48 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.993 -1.484 . . . . 2.77 106.993 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.18 -17.27 61.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.778 -0.576 . . . . 2.0899999999999999 111.431 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -80.69 -24.04 39.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.814 . . . . 2.6699999999999999 111.902 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -100.84 -6.13 25.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.264 -0.898 . . . . 2.5800000000000001 113.216 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 65.4 t -107.61 129.65 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.182 -1.044 . . . . 1.1799999999999999 108.182 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 55.1 tp -85.79 -11.21 54.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.261 -0.9 . . . . 2.1800000000000002 112.35 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.92 178.66 44.96 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.072 -1.611 . . . . 0.48999999999999999 109.072 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -132.13 132.84 43.62 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.557 -1.275 . . . . 0.64000000000000001 107.557 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 66.8 mt -137.85 107.04 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 106.076 -1.824 . . . . 1.21 106.076 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 203' ' ' VAL . 60.1 p -128.57 169.22 14.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.11 -0.994 . . . . 1.3799999999999999 109.041 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 12.8 p-10 -98.14 42.74 1.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.288 -0.882 . . . . 2.3700000000000001 111.223 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.216 0 O-C-N 121.547 -0.721 . . . . 1.52 109.804 -179.697 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.877 -0.786 . . . . 2.1099999999999999 108.877 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.624 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 39.5 t60 -60.16 -36.53 77.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.463 -0.773 . . . . 1.24 111.019 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.2 p -56.09 -41.79 75.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.324 -0.86 . . . . 2.1499999999999999 110.237 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.7 t -60.02 -38.53 82.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.44 -0.787 . . . . 2.02 110.179 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.89 -39.48 80.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.669 -0.644 . . . . 2.1200000000000001 110.913 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.7 mtp -60.39 -44.14 95.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.911 -1.118 . . . . 1.3600000000000001 109.539 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.07 -47.42 86.44 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.711 -0.677 . . . . 1.29 111.205 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.37 -46.17 90.91 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.762 -1.211 . . . . 3.5600000000000001 111.351 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.4 m -69.77 -39.78 76.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.987 . . . . 1.1799999999999999 110.644 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.9 mt -91.98 -9.89 41.34 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.069 0.766 . . . . 1.3400000000000001 113.069 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.6 mt-10 53.66 12.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.637 0.977 . . . . 1.45 113.637 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.1 mt -71.82 148.91 92.6 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.198 -1.038 . . . . 1.25 108.198 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.67 135.56 62.4 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 121.36 1.373 . . . . 0.78000000000000003 109.916 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.0 167.61 24.18 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 117.642 -1.623 . . . . 1.2 109.791 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 84.5 mt -148.44 156.09 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.202 -1.407 . . . . 1.25 107.202 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.407 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.1 m -138.71 -25.98 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 120.825 -1.172 . . . . 1.3899999999999999 112.098 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.98 45.17 3.47 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.432 -0.889 . . . . 0.96999999999999997 111.832 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.3 p -64.84 -14.55 59.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.453 -1.028 . . . . 1.3500000000000001 111.034 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.82 -94.26 0.97 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.273 -1.131 . . . . 1.0700000000000001 110.273 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 71.9 m -129.38 27.7 5.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.621 -0.929 . . . . 1.9199999999999999 112.697 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.59 -36.26 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.358 -1.464 . . . . 1.3300000000000001 110.775 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.2 p -57.51 -25.93 60.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.994 -1.066 . . . . 1.4199999999999999 111.235 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 36.8 p -93.1 3.81 55.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.605 -0.684 . . . . 2.1200000000000001 111.733 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -126.26 -9.19 6.42 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.33 0.863 . . . . 2.6899999999999999 113.33 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 51.5 t -119.59 156.33 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.97 -0.752 . . . . 1.29 108.97 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.413 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 6.2 mmmm -125.99 158.85 34.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.817 -1.179 . . . . 2.6899999999999999 107.817 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 52.7 p-10 -52.43 149.16 5.94 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 120.75 -1.219 . . . . 2.79 110.459 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.1 t70 80.72 -2.69 1.84 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 114.11 1.152 . . . . 2.3500000000000001 114.11 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 16' ' ' ALA . 54.8 t0 -66.69 146.47 54.43 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.737 -1.227 . . . . 1.97 108.489 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.459 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 43.3 t80 -88.49 122.16 31.66 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.442 -1.318 . . . . 2.9700000000000002 107.442 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 85.2 mt -127.3 146.38 50.46 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -0.841 . . . . 1.25 109.674 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.5 mt -115.71 128.78 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.418 -1.697 . . . . 1.22 106.418 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.9 tp -98.5 117.96 34.1 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 106.025 -1.843 . . . . 1.24 106.025 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 223' ' ' VAL . 32.0 t0 -87.0 -26.75 23.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.736 -1.227 . . . . 2.0499999999999998 112.066 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 39.54 20.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.842 . . . . 1.25 113.139 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.5 t -119.5 -63.22 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-O 121.769 0.795 . . . . 1.4299999999999999 109.711 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -99.32 14.34 29.98 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.496 0.665 . . . . 3.0299999999999998 111.256 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.493 ' ND2' ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 60.22 54.74 3.89 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.376 0.607 . . . . 2.25 112.233 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.514 ' OE1' ' CZ ' ' A' ' 228' ' ' TYR . 15.7 tt0 -145.72 143.59 29.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.035 -1.041 . . . . 2.52 109.568 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.65 139.26 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.438 -1.319 . . . . 1.29 107.438 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.514 ' CZ ' ' OE1' ' A' ' 226' ' ' GLN . 86.8 m-85 -103.93 134.43 47.22 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.832 -1.168 . . . . 1.3400000000000001 108.956 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.25 130.59 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.9 -1.148 . . . . 1.3400000000000001 107.9 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 1.0 OUTLIER 54.52 49.91 6.01 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.185 -0.947 . . . . 2.1800000000000002 112.95 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 44.8 Cg_endo -68.88 149.38 72.34 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.906 2.404 . . . . 0.93999999999999995 111.459 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.5 m -78.34 157.64 29.07 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.668 0.747 . . . . 2.3999999999999999 109.765 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -55.68 -40.59 72.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.447 -0.783 . . . . 3.3300000000000001 110.627 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.05 -39.65 86.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.574 -0.704 . . . . 3.1699999999999999 110.62 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.67 -37.92 71.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.301 -0.874 . . . . 1.6899999999999999 110.204 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.9 -43.0 91.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.454 -0.779 . . . . 1.6000000000000001 110.369 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -59.18 -40.35 85.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -0.871 . . . . 2.7000000000000002 110.462 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -61.4 -46.1 91.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 2.96 110.982 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.1 mtp -72.3 -35.91 68.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.066 -1.021 . . . . 1.6299999999999999 111.148 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 . . . . . 0 C--N 1.301 -1.518 0 O-C-N 121.09 -1.006 . . . . 3.27 110.774 -179.821 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.0 mt . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 106.233 -1.766 . . . . 1.5700000000000001 106.233 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.3 m -104.57 127.33 52.27 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.387 -0.968 . . . . 1.4399999999999999 108.387 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.57 -141.24 11.99 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.494 -1.042 . . . . 1.01 110.494 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.45 ' CG2' ' O ' ' A' ' 5' ' ' ILE . 56.6 mt -100.51 1.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.241 -1.152 . . . . 1.6299999999999999 112.467 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tp 49.45 96.73 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.863 -1.148 . . . . 1.5800000000000001 112.162 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.5 -45.79 10.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.072 -1.017 . . . . 1.3400000000000001 111.419 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t -147.11 145.9 23.75 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.686 -1.227 . . . . 1.8600000000000001 107.686 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.71 151.8 46.85 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.565 2.176 . . . . 1.01 112.254 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 146.53 123.7 1.51 Allowed Glycine 0 N--CA 1.508 3.491 0 N-CA-C 110.94 -0.864 . . . . 0.81000000000000005 110.94 177.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.7 mt -92.37 131.41 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.767 -1.431 . . . . 1.3700000000000001 109.348 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.89 140.73 42.54 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.355 -0.98 . . . . 1.1399999999999999 108.355 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 12.4 m-85 -108.59 136.83 47.53 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.971 -1.122 . . . . 0.87 107.971 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.76 169.05 42.09 Favored Glycine 0 N--CA 1.498 2.81 0 C-N-CA 118.276 -1.916 . . . . 0.56999999999999995 110.461 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -77.7 159.39 29.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.756 -0.849 . . . . 2.3500000000000001 108.795 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.83 131.24 34.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.999 -1.063 . . . . 1.21 109.234 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.4 tp -109.8 103.47 12.28 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.175 -2.157 . . . . 1.3999999999999999 105.175 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 tp -89.46 132.31 35.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.981 -1.075 . . . . 1.4399999999999999 108.615 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.3 mt -100.01 121.26 41.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.515 -1.291 . . . . 1.45 107.515 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -110.65 129.4 55.83 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.763 -1.199 . . . . 2.5 107.763 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -111.33 141.54 44.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.398 -0.814 . . . . 2.6600000000000001 109.22 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.18 127.03 33.25 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.436 -1.32 . . . . 2.3199999999999998 107.436 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.21 147.04 54.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.046 -1.034 . . . . 2.1099999999999999 109.156 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.5 mt -95.32 133.35 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.498 -0.927 . . . . 1.29 108.498 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -105.74 129.75 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.969 -1.123 . . . . 1.4099999999999999 107.969 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 73.5 mt -98.33 137.27 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.152 -0.967 . . . . 1.3100000000000001 108.671 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -92.31 120.61 33.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.161 -1.052 . . . . 1.3400000000000001 108.161 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.401 HH11 ' HG3' ' A' ' 28' ' ' ARG . 22.6 mmm-85 -94.96 13.78 23.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.206 -0.934 . . . . 3.48 112.217 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -72.13 143.03 49.13 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.494 -0.754 . . . . 2.52 109.239 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' CB ' ' HZ1' ' A' ' 30' ' ' LYS . 8.8 mtpm? -85.74 140.29 30.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.379 -0.826 . . . . 2.6299999999999999 109.482 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.26 165.59 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 121.629 0.728 . . . . 1.3100000000000001 110.41 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.7 p -93.56 167.78 11.46 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.311 0.577 . . . . 1.24 109.801 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.97 -18.66 14.41 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.015 -1.053 . . . . 1.49 112.713 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -68.99 -38.14 79.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.885 . . . . 2.2799999999999998 110.877 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -92.27 -5.88 51.49 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.548 -1.345 . . . . 2.0499999999999998 113.086 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.72 -42.89 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.097 -1.002 . . . . 1.3400000000000001 110.69 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.1 -40.33 85.01 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.841 -1.162 . . . . 1.54 110.527 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.52 -39.42 93.51 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.292 -0.88 . . . . 2.8500000000000001 111.063 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -59.76 -40.83 89.48 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.893 -1.129 . . . . 1.3100000000000001 111.148 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.1 -45.0 96.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 120.937 -1.102 . . . . 1.3799999999999999 110.725 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -61.43 -45.88 92.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.823 -1.173 . . . . 1.5 110.648 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -60.77 -41.35 95.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 2.7799999999999998 110.176 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -75.09 -55.44 5.73 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.155 -0.966 . . . . 1.0600000000000001 110.184 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.9 tp -57.38 -47.14 82.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.409 -0.916 . . . . 1.3999999999999999 110.125 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.5 t -70.22 -38.9 75.35 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.051 0.929 . . . . 1.3200000000000001 109.785 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.53 -44.9 97.22 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.488 -1.445 . . . . 0.69999999999999996 109.488 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 43.9 ttp180 -57.49 -31.72 66.28 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.853 -0.793 . . . . 3.4399999999999999 109.342 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.34 -41.49 80.13 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.774 0.797 . . . . 1.3600000000000001 109.906 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -77.46 -40.94 41.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.633 -0.667 . . . . 2.8300000000000001 110.236 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.66 92.15 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.588 -0.845 . . . . 1.23 109.874 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.4 t -60.26 -39.85 88.26 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.041 0.925 . . . . 1.9199999999999999 109.392 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.2 75.47 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.819 -0.628 . . . . 1.25 110.597 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -66.55 -50.1 64.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.055 -1.028 . . . . 1.97 111.032 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.09 -38.43 91.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 2.1800000000000002 110.229 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -59.76 -41.0 90.04 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.233 -0.917 . . . . 1.1899999999999999 110.449 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.1 m -65.59 -43.39 89.84 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.241 -0.912 . . . . 1.3400000000000001 109.882 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 57' ' ' ILE . 96.6 mt -60.08 -31.9 49.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.379 -0.826 . . . . 1.23 110.691 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -51.78 -46.64 64.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.745 -1.222 . . . . 1.5600000000000001 110.477 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -68.63 -34.21 75.36 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.953 -1.092 . . . . 1.3 109.805 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.442 ' O ' ' OG1' ' A' ' 64' ' ' THR . 65.6 mttm -63.13 -39.95 96.17 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.356 -1.338 . . . . 2.3199999999999998 109.136 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.7 75.89 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.832 -0.747 . . . . 1.1399999999999999 109.548 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.18 -35.74 29.41 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.375 -1.393 . . . . 0.68999999999999995 110.688 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -80.75 -22.53 40.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.107 -1.231 . . . . 1.48 111.016 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 13.6 m -84.56 -48.9 9.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.428 -0.795 . . . . 1.52 110.714 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -106.81 -22.62 12.65 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.409 -0.807 . . . . 1.3100000000000001 112.93 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.37 169.29 14.89 Favored Glycine 0 N--CA 1.501 3.002 0 CA-C-O 121.967 0.76 . . . . 0.84999999999999998 112.036 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.22 -24.17 40.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.912 -0.758 . . . . 3.8599999999999999 112.501 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.96 -38.27 78.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.091 -1.006 . . . . 2.3500000000000001 111.634 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -84.62 -15.84 44.12 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.321 -1.487 . . . . 2.2599999999999998 113.347 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -60.07 -34.66 73.73 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.1 -1.0 . . . . 1.45 110.69 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.59 86.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 1.25 111.308 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 mt -65.54 -43.8 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.822 -1.174 . . . . 1.26 110.44 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -70.05 -30.68 68.01 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.225 -0.922 . . . . 0.82999999999999996 110.583 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.49 -38.95 82.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.248 -0.907 . . . . 1.1899999999999999 110.511 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.48 -38.73 79.87 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.734 -1.222 . . . . 0.57999999999999996 110.616 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -58.05 -42.62 85.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.782 -1.422 . . . . 2.0499999999999998 110.873 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.9 mt -60.4 -41.49 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 1.21 110.375 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.5 ttt -60.38 -39.15 86.22 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.221 -0.924 . . . . 2.29 110.397 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 tp -59.64 -48.43 81.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.796 -1.19 . . . . 1.21 110.729 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.61 -41.64 95.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.355 -0.841 . . . . 1.1399999999999999 110.247 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -87.09 9.99 18.05 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.376 0.608 . . . . 1.4199999999999999 112.213 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.99 122.17 16.37 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.858 -1.151 . . . . 1.27 108.624 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.86 -17.69 65.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.512 -0.743 . . . . 1.3500000000000001 111.07 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -76.46 -53.65 7.82 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.664 0.745 . . . . 2.2200000000000002 110.365 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.89 -39.52 85.62 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.593 -0.843 . . . . 1.22 110.389 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.521 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 86.3 tt0 -59.9 -45.87 91.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.718 -1.239 . . . . 1.29 110.965 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -60.58 -39.98 90.0 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.966 -1.084 . . . . 2.1699999999999999 110.839 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.42 -48.49 77.56 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.335 -0.853 . . . . 1.3 110.111 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.8 mt -58.61 -43.27 87.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 118.974 -1.09 . . . . 1.1699999999999999 109.61 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.4 mt -61.35 -45.08 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.535 -0.728 . . . . 1.3999999999999999 110.316 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.36 -44.93 96.33 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.271 0.558 . . . . 1.3300000000000001 110.929 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.91 -43.34 94.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.574 -1.329 . . . . 1.48 110.337 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.2 mt -62.33 -49.99 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.137 -0.977 . . . . 1.28 110.723 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -78.79 -36.32 42.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.609 -0.682 . . . . 2.6000000000000001 111.563 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -79.93 -46.11 17.34 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 120.789 -1.194 . . . . 1.51 111.838 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -102.24 10.66 39.11 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.097 -1.002 . . . . 2.48 112.066 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.3 m80 51.26 51.5 16.8 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.306 -0.871 . . . . 1.6100000000000001 112.452 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.6 mtp -104.32 158.27 16.57 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 120.91 -1.119 . . . . 1.8999999999999999 109.289 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 66.7 p -72.83 158.43 35.56 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.282 -0.886 . . . . 1.3200000000000001 109.466 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.11 -42.04 84.86 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.224 -0.922 . . . . 1.1499999999999999 110.17 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -68.78 -38.82 80.29 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.976 -1.078 . . . . 2.25 110.207 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.91 -48.59 57.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.5 -0.88 . . . . 1.22 111.536 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.32 -47.58 84.86 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.221 -0.924 . . . . 1.1899999999999999 110.967 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.59 95.78 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.475 -0.766 . . . . 1.2 110.82 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -61.49 -37.67 84.51 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.558 -0.714 . . . . 2.1000000000000001 110.718 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.09 -49.3 78.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.859 -1.151 . . . . 1.3 111.399 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.36 -46.25 95.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.622 -1.299 . . . . 1.27 110.097 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.43 -33.78 58.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.451 0.643 . . . . 1.1899999999999999 110.437 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -57.53 -41.59 81.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -0.828 . . . . 2.1099999999999999 110.786 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.65 -28.01 27.97 Favored Glycine 0 N--CA 1.5 2.94 0 C-N-CA 119.176 -1.487 . . . . 0.88 113.084 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -62.38 -39.58 93.67 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.253 -1.734 . . . . 1.99 109.747 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.13 -53.63 12.16 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.57 0.7 . . . . 1.28 111.425 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.7 p -60.41 -39.6 88.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 2.2200000000000002 110.502 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.59 97.5 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.112 -0.993 . . . . 1.45 110.622 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.33 -29.0 69.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.966 -1.084 . . . . 1.47 111.202 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -68.22 -20.26 64.82 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.458 -0.776 . . . . 2.04 111.346 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -73.06 -12.34 60.88 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.331 -0.947 . . . . 1.73 110.766 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 20.1 mt -85.91 147.3 26.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.566 -0.708 . . . . 1.79 109.098 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -103.12 39.14 1.61 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.149 -0.969 . . . . 2.8799999999999999 111.826 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -113.54 139.21 49.17 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 108.733 -0.839 . . . . 1.5800000000000001 108.733 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.8 -37.74 79.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.795 -1.191 . . . . 3.04 110.812 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -72.42 -46.19 56.23 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.539 -1.351 . . . . 1.29 110.667 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.7 mt -64.33 -40.86 96.73 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.014 -1.054 . . . . 1.6000000000000001 109.823 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -61.17 -46.66 89.59 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.164 -0.96 . . . . 2.7599999999999998 110.256 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.0 -31.93 71.52 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.177 -0.952 . . . . 2.1499999999999999 109.641 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.78 -29.19 70.52 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.854 -1.138 . . . . 2.8100000000000001 109.722 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.37 -49.14 78.75 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.857 0.837 . . . . 1.3899999999999999 109.852 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.53 -44.65 70.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.62 0.724 . . . . 1.4099999999999999 110.663 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -63.52 -33.76 76.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.422 -0.799 . . . . 1.3899999999999999 110.875 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.3 t -69.74 -42.24 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.224 -0.99 . . . . 1.1899999999999999 110.203 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -59.21 -38.29 79.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.96 -1.088 . . . . 3.6299999999999999 109.456 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -59.52 -39.59 84.39 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.707 -0.621 . . . . 1.28 110.213 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.04 -40.71 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.081 -1.012 . . . . 1.1799999999999999 110.322 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.83 -39.93 85.28 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.948 -1.261 . . . . 0.51000000000000001 109.948 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.33 -45.39 91.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.714 -0.874 . . . . 3.1699999999999999 109.968 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.411 HH11 ' HG2' ' A' ' 136' ' ' ARG . 51.5 mtt-85 -62.77 -42.68 99.8 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.49 -0.884 . . . . 2.8500000000000001 109.875 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.02 -41.3 91.87 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.673 -0.642 . . . . 1.6499999999999999 109.954 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.2 mt -60.36 -42.06 94.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.81 . . . . 1.2 110.226 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.9 mtt-85 -61.08 -32.13 71.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 2.7999999999999998 110.53 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -75.99 -41.55 50.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.244 -0.91 . . . . 2.1499999999999999 110.933 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 141' ' ' ILE . 91.9 mt -60.17 -39.18 79.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.961 -1.087 . . . . 1.21 110.274 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.1 mt -86.72 -7.61 58.14 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.348 -0.845 . . . . 1.3400000000000001 112.666 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.82 20.04 77.26 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.11 -1.519 . . . . 0.91000000000000003 112.724 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.94 149.1 50.75 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.957 -0.731 . . . . 1.51 109.709 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -66.84 149.37 50.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.262 -0.899 . . . . 2.8799999999999999 109.753 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.0 mt -107.64 141.03 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.229 -1.026 . . . . 1.6200000000000001 108.229 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.0 mp -78.98 123.88 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.601 -0.888 . . . . 2.1099999999999999 108.601 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -96.84 95.67 8.02 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.796 -1.557 . . . . 1.6200000000000001 106.796 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.42 -15.8 59.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.439 -0.788 . . . . 1.3999999999999999 111.683 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.6 m -80.76 1.72 29.17 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.244 -0.91 . . . . 2.0499999999999998 112.514 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.86 19.03 14.48 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 112.774 0.657 . . . . 1.3500000000000001 112.774 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.8 mt -74.1 139.47 19.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.266 -0.896 . . . . 1.4199999999999999 109.353 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -122.24 -8.78 8.68 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.458 0.646 . . . . 2.9900000000000002 112.199 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -111.07 138.49 47.43 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.885 -1.154 . . . . 1.54 107.885 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.88 116.39 20.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.09 -1.078 . . . . 1.3799999999999999 108.09 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.3 176.7 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.992 -0.744 . . . . 1.28 108.992 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.2 mt -84.21 140.29 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.364 -0.976 . . . . 1.1599999999999999 108.364 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 27.9 tp -96.53 128.32 43.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.486 -0.931 . . . . 1.3100000000000001 108.486 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.2 130.12 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.075 -1.083 . . . . 1.25 108.075 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.57 159.68 30.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.234 -0.916 . . . . 1.26 108.92 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -62.43 -41.14 98.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.316 -1.49 . . . . 1.6000000000000001 109.717 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -174.21 150.94 1.58 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.755 -0.832 . . . . 2.4199999999999999 108.755 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.13 140.8 48.92 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.176 -0.675 . . . . 1.3500000000000001 109.176 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.7 p -90.98 151.18 43.02 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.675 -1.266 . . . . 1.3200000000000001 108.471 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -39.67 -37.77 1.51 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.077 1.851 . . . . 0.69999999999999996 113.512 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.4 m -63.6 -51.4 65.45 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.154 -0.966 . . . . 1.1200000000000001 109.916 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.95 -39.24 94.03 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.539 -0.726 . . . . 1.21 110.237 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 32.1 p -68.16 -40.28 82.39 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.348 0.595 . . . . 1.1899999999999999 110.442 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.68 81.56 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.177 -0.952 . . . . 1.24 110.4 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -94.04 -1.61 54.18 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.94 -1.1 . . . . 1.6899999999999999 112.855 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.26 149.22 33.98 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.697 -0.853 . . . . 1.3400000000000001 108.697 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -96.48 114.26 25.91 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.885 -1.524 . . . . 2.77 106.885 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 82.4 mt -72.05 -17.02 62.05 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.173 0.511 . . . . 2.0899999999999999 111.55 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -84.72 -22.19 29.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.654 -0.654 . . . . 2.6699999999999999 112.034 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -99.51 -4.22 31.75 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.24 -0.913 . . . . 2.5800000000000001 112.923 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.92 129.86 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 107.599 -1.26 . . . . 1.1799999999999999 107.599 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.2 tp -89.1 -8.53 53.66 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.899 -1.126 . . . . 2.1800000000000002 111.827 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.22 171.21 39.03 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.995 -1.642 . . . . 0.48999999999999999 108.995 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.0 136.2 49.15 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.283 -1.127 . . . . 0.64000000000000001 108.147 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 86.2 mt -135.54 115.75 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 106.358 -1.719 . . . . 1.21 106.358 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 81.6 p -131.0 169.5 15.75 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.784 -1.198 . . . . 1.3799999999999999 109.897 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 39.0 p-10 -103.24 43.62 1.07 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.586 -0.696 . . . . 2.3700000000000001 110.721 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 2.263 0 O-C-N 120.866 -1.146 . . . . 1.52 110.068 179.641 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.9 p . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 107.967 -1.124 . . . . 2.1099999999999999 107.967 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -61.07 -38.53 86.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.688 -0.633 . . . . 1.24 110.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.1 p -51.99 -43.66 63.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.056 -1.028 . . . . 2.1499999999999999 110.405 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.9 m -60.12 -37.81 81.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.767 0.794 . . . . 2.02 110.405 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.7 mm -59.52 -38.58 76.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.525 -0.735 . . . . 2.1200000000000001 110.8 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 77.2 mtp -63.17 -43.0 99.49 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.226 1.012 . . . . 1.3600000000000001 108.883 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.79 -48.99 78.15 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.598 -0.728 . . . . 1.29 111.335 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.28 -46.78 88.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.014 -1.054 . . . . 3.5600000000000001 111.146 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 42.7 m -69.85 -41.36 74.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.178 -0.951 . . . . 1.1799999999999999 110.294 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.27 -1.6 57.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.415 -0.803 . . . . 1.3400000000000001 111.991 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 194' ' ' ALA . 54.9 mt-10 54.04 9.75 0.24 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.723 1.009 . . . . 1.45 113.723 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.19 164.94 52.78 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.984 -1.072 . . . . 1.25 108.304 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -82.06 144.04 13.18 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.851 1.701 . . . . 0.78000000000000003 110.397 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.48 168.28 25.44 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 117.733 -1.587 . . . . 1.2 109.499 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.4 mt -148.85 145.9 17.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.159 -1.423 . . . . 1.25 107.159 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.98 -25.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 120.899 -1.125 . . . . 1.3899999999999999 113.523 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.14 46.16 3.57 Favored Glycine 0 N--CA 1.492 2.403 0 O-C-N 120.99 -1.069 . . . . 0.96999999999999997 111.644 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.5 p -67.59 -12.48 60.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.375 -1.073 . . . . 1.3500000000000001 111.803 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.48 -95.54 0.98 Allowed Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.301 -1.12 . . . . 1.0700000000000001 110.301 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.9 p -128.41 29.28 5.34 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.389 -1.065 . . . . 1.9199999999999999 112.344 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 72.4 t -58.49 -38.03 67.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.567 -1.333 . . . . 1.3300000000000001 110.707 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.7 p -55.48 -24.94 34.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 1.4199999999999999 111.58 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.4 t -94.34 3.93 54.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.875 . . . . 2.1200000000000001 111.988 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -127.66 1.13 6.14 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.675 0.621 . . . . 2.6899999999999999 112.675 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 16.1 t -116.23 150.2 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.889 0.852 . . . . 1.29 109.611 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -116.07 167.16 11.23 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.939 -0.763 . . . . 2.6899999999999999 108.939 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 68.5 m-80 -68.05 140.33 56.29 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.74 -1.184 . . . . 2.79 108.814 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.0 m-20 78.0 4.71 2.84 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.171 1.175 . . . . 2.3500000000000001 114.171 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -63.38 147.88 49.97 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.075 -1.083 . . . . 1.97 108.075 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -89.01 120.16 30.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.588 -1.32 . . . . 2.9700000000000002 107.484 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 80.2 mt -127.9 146.99 50.46 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.664 0.745 . . . . 1.25 109.697 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 60.2 mt -119.08 128.2 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.08 -1.452 . . . . 1.22 107.08 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 48.8 tp -100.98 119.96 39.49 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 106.329 -1.73 . . . . 1.24 106.329 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 223' ' ' VAL . 40.2 t0 -87.28 -25.65 23.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.955 -1.091 . . . . 2.0499999999999998 112.176 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.409 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 38.8 16.84 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 113.652 0.982 . . . . 1.25 113.652 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 221' ' ' ASP . 43.1 t -120.38 -63.31 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.178 -0.951 . . . . 1.4299999999999999 109.621 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -90.81 7.84 37.8 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.059 0.933 . . . . 3.0299999999999998 111.175 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 62.3 55.34 2.38 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.692 0.758 . . . . 2.25 112.148 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -147.31 145.17 29.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.353 -0.842 . . . . 2.52 109.562 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 29.9 t -115.95 138.34 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.775 -1.194 . . . . 1.29 107.775 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -105.76 132.7 51.56 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.925 -1.11 . . . . 1.3400000000000001 108.483 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.94 130.56 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 108.532 -0.914 . . . . 1.3400000000000001 108.532 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.425 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 41.6 t-20 50.72 51.34 10.38 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 113.462 0.912 . . . . 2.1800000000000002 113.462 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 36.4 Cg_endo -67.86 150.27 78.41 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.53 2.153 . . . . 0.93999999999999995 110.507 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.5 p -74.05 159.99 31.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.994 -1.066 . . . . 2.3999999999999999 109.7 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -61.57 -35.76 78.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.284 -0.885 . . . . 3.3300000000000001 110.334 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.35 -39.74 84.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.961 -1.087 . . . . 3.1699999999999999 110.43 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.91 -36.73 70.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.491 -0.756 . . . . 1.6899999999999999 110.017 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.01 -43.78 93.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.261 -0.9 . . . . 1.6000000000000001 110.543 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.22 -41.2 88.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.955 -1.091 . . . . 2.7000000000000002 110.252 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -63.61 -40.03 95.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.447 -0.783 . . . . 2.96 110.502 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 73.2 mtp -70.73 -36.99 73.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.925 . . . . 1.6299999999999999 110.936 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 120.8 -1.188 . . . . 3.27 110.127 179.877 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 106.568 -1.642 . . . . 1.5700000000000001 106.568 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.3 m -104.01 122.31 44.98 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.281 -1.007 . . . . 1.4399999999999999 108.281 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.57 -159.22 18.21 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 108.641 -1.784 . . . . 1.01 108.641 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 93.4 mt -97.07 1.06 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.253 -1.145 . . . . 1.6299999999999999 112.646 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tp 51.42 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.049 . . . . 1.5800000000000001 112.345 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.62 -45.0 13.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.993 -1.067 . . . . 1.3400000000000001 111.496 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -146.06 146.48 28.43 Favored Pre-proline 0 N--CA 1.5 2.064 0 N-CA-C 107.447 -1.316 . . . . 1.8600000000000001 107.447 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.15 146.17 28.43 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.644 2.229 . . . . 1.01 112.144 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 153.71 176.43 26.11 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 108.828 -1.709 . . . . 0.81000000000000005 108.828 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.4 mt -138.05 136.69 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 107.712 -1.218 . . . . 1.3700000000000001 107.712 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.25 152.85 44.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.392 -0.818 . . . . 1.1399999999999999 109.19 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -122.16 145.11 48.5 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.354 -0.98 . . . . 0.87 108.354 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.78 167.58 34.3 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.584 -1.769 . . . . 0.56999999999999995 109.886 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.579 ' CB ' ' HZ1' ' A' ' 15' ' ' LYS . 8.8 mtpm? -76.89 159.16 30.25 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.788 -0.831 . . . . 2.3500000000000001 108.802 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.92 126.94 33.49 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.866 -1.161 . . . . 1.21 107.866 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.89 107.89 19.14 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 104.965 -2.235 . . . . 1.3999999999999999 104.965 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.37 138.67 32.06 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.162 -1.051 . . . . 1.4399999999999999 108.162 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.7 mt -100.69 118.03 36.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 106.768 -1.567 . . . . 1.45 106.768 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -109.96 136.06 49.84 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.043 -1.466 . . . . 2.5 107.043 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -123.94 140.1 53.31 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.847 -1.158 . . . . 2.6600000000000001 108.34 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -82.91 136.26 34.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.464 -1.31 . . . . 2.3199999999999998 107.464 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.32 150.03 44.32 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.671 -0.812 . . . . 2.1099999999999999 109.516 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.3 mt -91.77 134.64 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.314 -0.866 . . . . 1.29 108.752 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.4 t -106.31 130.03 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.496 -1.298 . . . . 1.4099999999999999 107.496 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.4 mt -96.34 132.26 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.643 -0.873 . . . . 1.3100000000000001 108.643 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -91.81 121.62 33.6 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.316 -0.994 . . . . 1.3400000000000001 108.316 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -100.03 22.01 11.92 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.15 -0.969 . . . . 3.48 112.139 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -65.78 143.65 57.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.889 -1.132 . . . . 2.52 109.073 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -89.32 131.39 35.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.077 -1.082 . . . . 2.6299999999999999 108.077 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 pt -97.63 167.74 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 1.3100000000000001 109.996 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.3 p -97.62 163.68 12.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.531 -0.731 . . . . 1.24 110.109 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.87 -24.09 14.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 1.49 111.861 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -67.37 -35.97 80.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.953 . . . . 2.2799999999999998 110.715 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -94.78 -12.81 26.41 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.993 -1.067 . . . . 2.0499999999999998 112.802 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.19 -46.42 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.895 . . . . 1.3400000000000001 110.537 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -58.12 -39.38 78.54 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.102 -0.999 . . . . 1.54 110.701 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -62.41 -43.25 99.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.418 -0.801 . . . . 2.8500000000000001 110.876 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.46 -36.55 78.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.079 -1.013 . . . . 1.3100000000000001 110.935 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.46 -42.4 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.784 -1.198 . . . . 1.3799999999999999 110.091 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -61.89 -41.03 97.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.097 -1.002 . . . . 1.5 110.091 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -63.14 -40.95 99.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.512 -0.743 . . . . 2.7799999999999998 110.168 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -71.94 -56.72 5.17 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.27 -0.894 . . . . 1.0600000000000001 110.349 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.9 tp -58.92 -47.04 86.45 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.377 -0.929 . . . . 1.3999999999999999 109.754 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.0 t -70.27 -42.18 72.45 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.263 -0.975 . . . . 1.3200000000000001 109.426 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.24 -38.85 88.58 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.145 -1.582 . . . . 0.69999999999999996 109.145 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -59.79 -33.37 71.63 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 122.103 0.954 . . . . 3.4399999999999999 108.973 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.35 -42.14 81.44 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.604 0.716 . . . . 1.3600000000000001 109.642 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -79.46 -43.34 23.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -0.821 . . . . 2.8300000000000001 110.527 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.78 87.88 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.335 -0.853 . . . . 1.23 109.814 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 m -60.77 -39.81 90.21 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.798 0.808 . . . . 1.9199999999999999 109.546 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.86 86.98 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.243 0.544 . . . . 1.25 110.475 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.02 -48.77 78.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 1.97 110.575 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.96 -38.56 88.89 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.012 -1.055 . . . . 2.1800000000000002 109.783 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -60.19 -40.04 88.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.83 -0.544 . . . . 1.1899999999999999 110.789 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.7 m -61.8 -42.81 99.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.759 -1.213 . . . . 1.3400000000000001 109.931 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.49 -37.64 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.298 -0.876 . . . . 1.23 110.493 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -50.1 -44.29 51.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.403 -0.811 . . . . 1.5600000000000001 111.118 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.407 ' H ' ' HG1' ' A' ' 59' ' ' THR . 2.7 m -70.25 -37.38 74.91 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.123 -0.986 . . . . 1.3 110.109 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -61.68 -38.55 88.21 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.905 -1.118 . . . . 2.3199999999999998 109.545 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.47 -33.59 76.24 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.918 -0.713 . . . . 1.1399999999999999 109.621 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.37 -36.82 13.41 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.957 -1.116 . . . . 0.68999999999999995 111.123 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -81.36 -23.08 37.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.966 -1.314 . . . . 1.48 111.023 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 m -91.4 -51.29 5.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.484 -0.76 . . . . 1.52 110.971 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.12 -8.17 17.59 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.001 1.112 . . . . 1.3100000000000001 114.001 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.36 170.69 30.63 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.257 -0.902 . . . . 0.84999999999999998 111.75 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -58.21 -21.98 50.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.98 -0.717 . . . . 3.8599999999999999 112.15 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -54.34 -41.61 69.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.06 -1.025 . . . . 2.3500000000000001 110.861 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -89.24 -24.0 22.21 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.161 -0.962 . . . . 2.2599999999999998 112.031 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -60.01 -39.57 86.27 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.604 -0.685 . . . . 1.45 111.167 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.36 87.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.357 -0.839 . . . . 1.25 111.523 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 mt -65.95 -45.56 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.541 -1.35 . . . . 1.26 110.131 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -68.43 -33.22 73.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.066 -1.021 . . . . 0.82999999999999996 110.623 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -60.15 -36.13 76.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.233 -0.917 . . . . 1.1899999999999999 110.321 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.87 -39.66 85.3 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.941 -1.123 . . . . 0.57999999999999996 110.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -58.98 -42.88 91.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.102 -1.234 . . . . 2.0499999999999998 110.525 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.9 mt -60.36 -37.54 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 1.21 110.34 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.5 ttt -59.45 -39.9 85.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.257 -0.902 . . . . 2.29 110.517 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.03 -46.36 88.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.334 -0.854 . . . . 1.21 109.866 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.3 -38.78 88.04 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.817 0.818 . . . . 1.1399999999999999 110.139 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.86 9.7 18.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.515 -0.74 . . . . 1.4199999999999999 112.735 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -67.11 121.76 16.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.182 -0.949 . . . . 1.27 108.849 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.75 -15.55 62.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.536 -0.728 . . . . 1.3500000000000001 111.065 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -76.86 -49.63 15.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.678 0.751 . . . . 2.2200000000000002 110.431 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.36 -37.26 86.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.755 0.788 . . . . 1.22 110.192 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.91 -47.46 85.66 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.35 -0.844 . . . . 1.29 110.744 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.82 -37.79 85.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.215 -0.928 . . . . 2.1699999999999999 110.473 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -65.41 -47.72 75.29 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.092 -1.043 . . . . 1.3 110.646 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.35 -44.55 88.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.138 -1.025 . . . . 1.1699999999999999 110.07 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.87 -39.83 83.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.653 -0.655 . . . . 1.3999999999999999 110.245 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.05 90.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.531 -0.73 . . . . 1.3300000000000001 110.878 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.0 -41.74 92.74 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.028 -1.045 . . . . 1.48 110.272 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.5 mt -64.94 -50.01 77.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.776 -0.769 . . . . 1.28 110.494 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -74.77 -38.54 62.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 2.6000000000000001 111.778 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -78.82 -45.76 20.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.665 -1.272 . . . . 1.51 111.279 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -101.47 8.84 41.89 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.983 -1.073 . . . . 2.48 112.569 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.2 m80 50.25 49.97 19.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.707 -1.246 . . . . 1.6100000000000001 111.632 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.6 mtt -102.8 154.97 18.66 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.831 0.824 . . . . 1.8999999999999999 109.716 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 20.7 p -70.96 161.44 31.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.604 -0.685 . . . . 1.3200000000000001 109.582 177.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.87 91.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 1.1499999999999999 111.042 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 28.6 p-10 -69.13 -39.05 79.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.798 -1.189 . . . . 2.25 110.53 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.419 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -69.7 -50.36 44.48 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.432 -0.907 . . . . 1.22 111.46 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.11 90.94 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.948 -1.095 . . . . 1.1899999999999999 110.472 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.44 90.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.254 -0.904 . . . . 1.2 110.868 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -61.06 -38.75 87.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.737 -1.227 . . . . 2.1000000000000001 111.003 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -57.68 -49.81 75.28 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.053 -1.029 . . . . 1.3 110.791 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.2 -47.23 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.831 -1.168 . . . . 1.27 110.144 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -62.0 -32.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.358 -0.839 . . . . 1.1899999999999999 110.497 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -57.78 -40.05 78.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 2.1099999999999999 110.856 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.06 -33.2 15.47 Favored Glycine 0 N--CA 1.501 3.029 0 C-N-CA 119.152 -1.499 . . . . 0.88 112.452 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -61.66 -42.26 98.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.434 -1.627 . . . . 1.99 110.2 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.9 -53.3 15.57 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.494 0.664 . . . . 1.28 110.821 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.6 m -61.42 -39.92 92.5 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.021 -1.049 . . . . 2.2200000000000002 111.083 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.43 97.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.993 -1.067 . . . . 1.45 111.318 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 43.9 mt -62.21 -29.99 70.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.953 -1.092 . . . . 1.47 110.613 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.27 -19.67 64.73 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.971 -1.081 . . . . 2.04 111.073 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -74.65 -9.38 58.52 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.965 0.888 . . . . 1.73 110.898 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 69.2 mt -87.37 149.57 24.4 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.039 -0.726 . . . . 1.79 109.039 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -104.12 38.77 1.77 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.105 -0.997 . . . . 2.8799999999999999 111.586 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -116.43 138.58 51.25 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.23 -0.919 . . . . 1.5800000000000001 108.981 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.79 -39.54 85.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.693 -0.629 . . . . 3.04 110.957 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -71.68 -48.12 49.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.64 -1.287 . . . . 1.29 110.38 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.1 -39.57 94.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 1.6000000000000001 110.021 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.492 ' CB ' ' HZ1' ' A' ' 124' ' ' LYS . 3.5 ttmp? -60.28 -47.98 83.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.906 -1.121 . . . . 2.7599999999999998 109.518 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.32 -31.28 70.13 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.716 -0.794 . . . . 2.1499999999999999 109.57 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 126' ' ' ARG . 19.2 ttt-85 -60.5 -31.11 70.17 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.136 -1.026 . . . . 2.8100000000000001 108.397 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.96 -48.85 78.51 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.459 -0.896 . . . . 1.3899999999999999 109.332 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.01 -46.11 79.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.388 -0.82 . . . . 1.4099999999999999 110.408 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.38 -34.45 77.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.48 -0.763 . . . . 1.3899999999999999 110.656 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.4 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 25.0 t -68.23 -39.5 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 1.1899999999999999 110.275 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -57.37 -39.69 76.57 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.139 -0.976 . . . . 3.6299999999999999 110.115 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -61.28 -39.38 90.22 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.624 0.726 . . . . 1.28 110.591 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.27 -39.79 83.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.381 -0.825 . . . . 1.1799999999999999 110.293 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.92 -48.4 48.55 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.394 -0.908 . . . . 0.51000000000000001 111.456 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -58.26 -40.64 82.38 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.73 -1.453 . . . . 3.1699999999999999 110.811 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -61.79 -45.86 92.04 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.677 -1.264 . . . . 2.8500000000000001 110.326 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.96 -43.78 98.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.486 -0.759 . . . . 1.6499999999999999 110.376 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.93 -45.53 92.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.831 . . . . 1.2 110.44 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -60.54 -35.99 77.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.571 -0.706 . . . . 2.7999999999999998 110.987 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -74.71 -40.35 61.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 2.1499999999999999 110.66 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.34 -39.17 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.448 -0.901 . . . . 1.21 110.407 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.28 -7.05 58.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.086 -1.009 . . . . 1.3400000000000001 112.33 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.85 19.49 77.57 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.812 -1.185 . . . . 0.91000000000000003 112.478 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.38 147.91 39.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.639 -0.918 . . . . 1.51 109.302 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -67.24 142.92 56.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.401 -0.812 . . . . 2.8799999999999999 109.185 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.6 mt -108.7 137.72 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.167 -1.049 . . . . 1.6200000000000001 108.167 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 mp -79.45 130.36 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.015 . . . . 2.1099999999999999 108.546 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -93.95 96.2 9.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.507 -1.664 . . . . 1.6200000000000001 106.507 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.5 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 57.3 mt -74.61 -10.56 59.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 1.3999999999999999 111.951 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 172' ' ' ASN . 27.5 t -89.5 0.74 56.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.909 -1.119 . . . . 2.0499999999999998 112.424 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -102.43 33.75 3.02 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.102 -0.999 . . . . 1.3500000000000001 112.884 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.5 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 1.9 mp -66.29 140.63 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.197 -1.564 . . . . 1.4199999999999999 108.827 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -109.29 -20.77 12.83 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.08 0.943 . . . . 2.9900000000000002 111.346 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.437 ' O ' ' CG2' ' A' ' 152' ' ' ILE . 95.7 m-20 -118.89 140.17 50.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.875 -1.157 . . . . 1.54 107.875 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -74.49 124.94 27.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.056 -1.091 . . . . 1.3799999999999999 108.056 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.6 m -146.88 175.7 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.564 -0.71 . . . . 1.28 109.513 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.1 mt -88.7 141.83 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.951 -0.759 . . . . 1.1599999999999999 108.951 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.6 tp -96.67 121.39 38.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 1.3100000000000001 108.297 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.78 131.56 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.373 -0.973 . . . . 1.25 108.373 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.37 158.2 31.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 1.26 109.088 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.56 82.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.692 -1.255 . . . . 1.6000000000000001 109.713 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -171.81 151.07 2.74 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.889 -0.782 . . . . 2.4199999999999999 108.889 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.0 mt -115.76 142.9 46.14 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.504 -0.747 . . . . 1.3500000000000001 109.248 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 54.3 p -92.4 148.86 37.28 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 120.984 -1.073 . . . . 1.3200000000000001 108.878 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -41.28 -41.84 4.98 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.052 1.835 . . . . 0.69999999999999996 113.354 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.9 m -60.51 -50.37 73.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.938 -1.101 . . . . 1.1200000000000001 110.235 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -60.68 -40.14 91.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.416 -0.802 . . . . 1.21 109.779 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 48.6 p -66.73 -38.47 86.73 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.568 -0.708 . . . . 1.1899999999999999 110.278 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.28 82.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 1.24 111.122 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -96.93 1.05 49.95 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.31 -0.869 . . . . 1.6899999999999999 113.136 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.27 150.03 36.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.2 -0.938 . . . . 1.3400000000000001 109.601 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 150' ' ' SER . 6.1 m120 -94.83 116.14 28.36 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 106.877 -1.527 . . . . 2.77 106.877 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.6 mm? -75.06 -19.43 60.0 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.482 -0.761 . . . . 2.0899999999999999 111.81 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -85.9 -21.23 28.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 2.6699999999999999 112.266 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -98.95 -2.86 36.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.126 -0.983 . . . . 2.5800000000000001 112.598 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.08 129.32 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 107.979 -1.119 . . . . 1.1799999999999999 107.979 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.2 tp -86.26 -6.2 59.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.518 -0.739 . . . . 2.1800000000000002 111.833 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 167.29 172.74 34.8 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 108.822 -1.711 . . . . 0.48999999999999999 108.822 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -127.18 131.12 50.75 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.206 -1.173 . . . . 0.64000000000000001 108.15 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.1 mt -135.97 116.07 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 106.164 -1.791 . . . . 1.21 106.164 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 203' ' ' VAL . 62.8 p -138.79 174.99 9.94 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.282 -1.511 . . . . 1.3799999999999999 110.543 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.48 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 44.2 m-20 -97.62 61.73 1.63 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 115.455 -0.793 . . . . 2.3700000000000001 109.674 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 108.72 -0.845 . . . . 1.52 108.72 -179.837 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.802 -0.814 . . . . 2.1099999999999999 108.802 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -60.04 -35.49 75.22 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.181 0.515 . . . . 1.24 111.012 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.498 ' HG1' ' N ' ' A' ' 191' ' ' SER . 77.9 p -57.67 -41.24 81.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.77 -1.206 . . . . 2.1499999999999999 110.464 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.498 ' N ' ' HG1' ' A' ' 190' ' ' THR . 50.6 m -60.07 -35.95 76.31 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.016 -1.053 . . . . 2.02 110.172 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.1 mm -59.97 -39.95 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.893 -0.504 . . . . 2.1200000000000001 111.029 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.5 mtp -61.13 -45.14 95.91 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.009 -1.057 . . . . 1.3600000000000001 109.62 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -57.91 -48.2 80.57 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.678 -0.692 . . . . 1.29 111.061 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.418 ' HG2' HH11 ' A' ' 195' ' ' ARG . 41.6 mtt-85 -61.87 -41.01 97.33 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.132 -0.98 . . . . 3.5600000000000001 110.605 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.5 m -69.62 -41.36 75.79 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.288 -0.883 . . . . 1.1799999999999999 110.185 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.22 -8.12 49.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 112.574 0.583 . . . . 1.3400000000000001 112.574 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.1 mt-10 52.97 10.66 0.17 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.085 1.143 . . . . 1.45 114.085 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.405 ' O ' ' OG ' ' A' ' 8' ' ' SER . 82.7 mt -71.95 149.7 92.52 Favored Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 108.188 -1.041 . . . . 1.25 108.188 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -54.09 132.81 52.18 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.236 1.29 . . . . 0.78000000000000003 109.903 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -158.75 162.71 37.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.294 -1.504 . . . . 1.2 109.468 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 202' ' ' ILE . 81.2 mt -148.23 154.5 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.686 -1.228 . . . . 1.25 107.686 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.9 m -137.22 -28.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 121.077 -1.014 . . . . 1.3899999999999999 112.244 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.75 32.93 0.72 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.822 -1.18 . . . . 0.96999999999999997 113.5 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.48 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 39.4 p -60.8 -25.27 66.44 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.31 -1.112 . . . . 1.3500000000000001 110.453 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 76.27 -93.44 0.99 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.818 -1.182 . . . . 1.0700000000000001 110.541 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.0 p -127.3 32.6 5.02 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.215 -1.168 . . . . 1.9199999999999999 112.325 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.26 -36.24 67.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 120.682 -1.261 . . . . 1.3300000000000001 109.911 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.5 p -57.48 -20.19 29.36 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.282 -0.886 . . . . 1.4199999999999999 111.74 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.4 t -91.16 -3.57 56.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 2.1200000000000001 111.732 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -122.62 -8.2 8.52 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 112.923 0.712 . . . . 2.6899999999999999 112.923 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 68.9 t -112.32 148.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.427 0.632 . . . . 1.29 109.649 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -120.09 159.46 24.76 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.012 -1.107 . . . . 2.6899999999999999 108.012 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.2 p30 -57.61 149.0 22.54 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.409 -1.432 . . . . 2.79 110.507 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 9.0 t0 81.69 -2.44 1.6 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 114.644 1.35 . . . . 2.3500000000000001 114.644 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -67.61 147.97 52.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.743 -1.223 . . . . 1.97 108.328 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -90.18 122.96 33.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.757 -1.201 . . . . 2.9700000000000002 107.757 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.0 mt -124.88 143.88 50.61 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.9 0.857 . . . . 1.25 110.199 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.61 122.93 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.125 -1.805 . . . . 1.22 106.125 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.1 tp -98.92 117.77 34.17 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.409 -1.7 . . . . 1.24 106.409 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 223' ' ' VAL . 30.9 t0 -92.76 -26.0 17.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.933 -1.104 . . . . 2.0499999999999998 112.96 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.436 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 38.59 18.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.863 0.69 . . . . 1.25 112.863 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.2 t -113.49 -60.72 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.956 0.884 . . . . 1.4299999999999999 109.386 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -95.54 10.55 36.2 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.721 0.772 . . . . 3.0299999999999998 110.764 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 62.21 50.25 3.99 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.446 0.641 . . . . 2.25 111.74 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -147.17 146.6 29.93 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.414 1.102 . . . . 2.52 109.563 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.11 140.25 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.691 -0.855 . . . . 1.29 108.691 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -100.28 132.16 45.81 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.909 -1.119 . . . . 1.3400000000000001 108.542 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.1 t -110.15 130.18 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.411 -0.959 . . . . 1.3400000000000001 108.411 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.7 t30 53.12 52.84 10.97 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 114.124 1.157 . . . . 2.1800000000000002 114.124 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.38 149.6 69.53 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.149 1.899 . . . . 0.93999999999999995 110.717 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 65.7 p -75.72 157.94 32.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 2.3999999999999999 109.245 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -60.84 -38.56 85.91 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.788 -0.765 . . . . 3.3300000000000001 110.24 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 234' ' ' GLU . 55.8 mp0 -60.28 -39.34 86.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.636 -0.665 . . . . 3.1699999999999999 110.732 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.48 -40.83 77.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.864 -1.134 . . . . 1.6899999999999999 110.142 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.4 -43.87 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.437 -0.789 . . . . 1.6000000000000001 110.082 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -59.72 -41.42 90.8 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.104 -0.997 . . . . 2.7000000000000002 110.385 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -63.61 -40.58 97.27 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.474 -0.89 . . . . 2.96 110.342 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 84.0 mtp -69.85 -41.01 75.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 1.6299999999999999 110.648 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 . . . . . 0 C--N 1.3 -1.578 0 O-C-N 120.327 -1.483 . . . . 3.27 110.276 179.806 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.2 mt . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 112.321 0.489 . . . . 1.5700000000000001 112.321 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 m -93.07 118.22 30.95 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.09 -1.448 . . . . 1.4399999999999999 107.09 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.4 -146.8 16.69 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.48 -1.048 . . . . 1.01 110.48 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 96.8 mt -94.95 -2.88 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.34 -1.094 . . . . 1.6299999999999999 113.036 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tp 50.8 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.867 -1.146 . . . . 1.5800000000000001 112.607 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.8 -43.79 13.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 1.3400000000000001 110.741 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -147.96 142.42 16.54 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 107.797 -1.186 . . . . 1.8600000000000001 107.797 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.97 149.39 36.79 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.716 2.277 . . . . 1.01 112.454 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 155.43 162.61 11.43 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.143 -1.583 . . . . 0.81000000000000005 109.143 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -121.9 135.08 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 O-C-N 121.089 -1.242 . . . . 1.3700000000000001 108.271 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.11 155.5 46.97 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.456 -0.778 . . . . 1.1399999999999999 109.269 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -127.44 139.58 52.73 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.89 -1.152 . . . . 0.87 107.89 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.46 168.98 35.98 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 118.69 -1.719 . . . . 0.56999999999999995 110.063 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -80.03 161.15 25.57 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.451 -1.029 . . . . 2.3500000000000001 110.216 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -84.85 131.68 34.49 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.391 -0.966 . . . . 1.21 108.391 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 tp -109.78 101.77 10.61 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 105.405 -2.072 . . . . 1.3999999999999999 105.405 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.53 133.15 35.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.911 -1.144 . . . . 1.4399999999999999 107.911 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.7 117.93 35.8 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.394 -1.706 . . . . 1.45 106.394 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -109.32 133.38 53.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.943 -1.132 . . . . 2.5 107.943 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -123.59 140.24 53.19 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.305 -0.872 . . . . 2.6600000000000001 108.666 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -80.46 136.99 36.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.073 -1.017 . . . . 2.3199999999999998 108.256 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.2 146.12 51.62 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.281 -0.887 . . . . 2.1099999999999999 108.955 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.0 mt -93.39 128.84 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.237 -1.023 . . . . 1.29 108.237 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -108.83 130.49 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.726 -1.213 . . . . 1.4099999999999999 107.726 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.5 mt -95.7 132.14 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.341 -0.85 . . . . 1.3100000000000001 108.943 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -89.94 120.8 31.47 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.61 -1.256 . . . . 1.3400000000000001 107.61 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -96.65 17.74 15.79 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.431 -0.793 . . . . 3.48 112.417 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -67.45 146.29 54.14 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.203 -0.935 . . . . 2.52 108.979 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -87.82 134.83 33.61 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.103 -1.073 . . . . 2.6299999999999999 108.103 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 pt -96.82 165.69 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.458 -0.776 . . . . 1.3100000000000001 110.329 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -94.27 168.47 10.89 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 1.24 109.541 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.11 -18.97 28.75 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.959 -1.088 . . . . 1.49 112.879 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.09 -35.85 76.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.746 -1.221 . . . . 2.2799999999999998 110.825 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -94.5 -8.83 37.23 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.969 -1.082 . . . . 2.0499999999999998 113.221 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.9 -43.79 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.164 -0.96 . . . . 1.3400000000000001 110.156 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.52 -40.09 81.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.954 -1.091 . . . . 1.54 110.4 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -62.1 -38.09 87.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.683 . . . . 2.8500000000000001 110.656 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.77 -39.49 85.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 1.3100000000000001 110.883 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.49 -43.68 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.131 -0.98 . . . . 1.3799999999999999 110.769 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -62.13 -43.8 98.04 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.113 -0.992 . . . . 1.5 110.461 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -62.7 -38.78 91.79 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.247 -0.908 . . . . 2.7799999999999998 110.592 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -76.09 -55.56 5.48 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.123 -0.986 . . . . 1.0600000000000001 110.532 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.68 -48.28 81.62 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.295 -0.962 . . . . 1.3999999999999999 110.59 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.9 t -69.84 -40.78 75.62 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.74 -0.784 . . . . 1.3200000000000001 110.435 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.15 -45.73 87.05 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.24 -1.457 . . . . 0.69999999999999996 109.691 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -58.39 -30.06 66.53 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.036 0.922 . . . . 3.4399999999999999 109.995 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.66 -46.19 87.73 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.672 0.748 . . . . 1.3600000000000001 110.018 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -78.95 -41.81 28.42 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 2.8300000000000001 110.311 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.48 86.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.4 -0.813 . . . . 1.23 109.74 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -60.45 -40.38 90.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.118 -0.989 . . . . 1.9199999999999999 109.288 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.91 -47.17 69.52 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.926 -0.579 . . . . 1.25 110.894 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.52 -51.38 65.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.084 . . . . 1.97 110.7 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 54' ' ' LEU . 3.0 mm? -61.41 -40.11 93.19 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.563 -0.855 . . . . 2.1800000000000002 110.023 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -59.7 -41.59 91.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 1.1899999999999999 110.354 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -66.05 -42.74 89.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.134 -0.979 . . . . 1.3400000000000001 110.457 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 57' ' ' ILE . 98.8 mt -59.89 -39.76 80.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.352 -0.843 . . . . 1.23 110.705 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -49.93 -41.92 47.29 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.09 -1.006 . . . . 1.5600000000000001 110.87 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -70.21 -38.17 75.23 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.143 -0.973 . . . . 1.3 110.039 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.4 -38.88 88.66 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.721 -1.192 . . . . 2.3199999999999998 108.945 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.16 72.24 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.52 0.676 . . . . 1.1399999999999999 109.609 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.24 -33.37 20.46 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.103 -1.046 . . . . 0.68999999999999995 111.055 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -80.6 -26.83 37.59 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.083 -1.245 . . . . 1.48 111.202 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 m -85.71 -48.61 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.579 -0.701 . . . . 1.52 110.856 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -107.48 -17.99 13.97 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 113.229 0.826 . . . . 1.3100000000000001 113.229 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.13 155.72 11.48 Favored Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.329 -0.857 . . . . 0.84999999999999998 112.325 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -50.65 -22.56 2.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.882 -0.776 . . . . 3.8599999999999999 112.305 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.61 -36.18 71.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 2.3500000000000001 111.349 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -80.98 -22.39 39.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.853 -1.154 . . . . 2.2599999999999998 111.935 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -58.87 -33.53 70.58 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.957 -1.09 . . . . 1.45 111.2 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.95 -41.71 83.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 1.25 110.816 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.1 mt -66.65 -44.75 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.86 -1.15 . . . . 1.26 110.125 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -70.24 -31.11 68.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 0.82999999999999996 110.382 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -61.04 -39.76 91.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.316 -0.865 . . . . 1.1899999999999999 109.754 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.04 -39.95 96.72 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 120.177 -1.011 . . . . 0.57999999999999996 110.611 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -59.73 -45.39 92.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -1.092 . . . . 2.0499999999999998 110.621 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 77' ' ' ILE . 92.0 mt -60.45 -39.03 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.411 -0.806 . . . . 1.21 110.545 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.9 ttt -59.61 -39.37 84.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 2.29 110.503 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.14 -49.65 77.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.035 -1.04 . . . . 1.21 109.801 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.86 -39.82 95.1 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.571 0.701 . . . . 1.1399999999999999 110.687 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -85.31 6.91 24.24 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.074 0.768 . . . . 1.4199999999999999 113.074 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -69.28 118.1 11.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.697 -1.252 . . . . 1.27 109.074 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.35 -16.9 64.07 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.627 0.727 . . . . 1.3500000000000001 110.901 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.36 -46.33 41.25 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.358 -0.937 . . . . 2.2200000000000002 109.966 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -66.2 -38.52 88.19 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.664 -0.815 . . . . 1.22 110.273 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -58.8 -46.1 88.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.5 -0.75 . . . . 1.29 110.903 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -62.73 -37.84 88.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.909 . . . . 2.1699999999999999 110.545 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.51 -48.65 66.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.013 -1.055 . . . . 1.3 110.653 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.8 mt -57.5 -43.05 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.218 -0.926 . . . . 1.1699999999999999 110.402 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.9 mt -60.62 -43.31 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.737 -0.602 . . . . 1.3999999999999999 110.389 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.45 -42.69 99.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.326 -0.859 . . . . 1.3300000000000001 110.67 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.57 -42.5 98.93 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.16 -0.963 . . . . 1.48 110.537 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 93' ' ' ILE . 96.5 mt -64.43 -44.62 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 1.28 110.537 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -84.41 -35.16 23.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.398 -0.814 . . . . 2.6000000000000001 111.713 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 91' ' ' ALA . 51.4 t0 -80.97 -45.39 16.73 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.134 -0.979 . . . . 1.51 111.79 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -101.03 9.55 42.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.245 -0.909 . . . . 2.48 112.45 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.5 m80 49.79 51.67 16.09 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.27 -0.894 . . . . 1.6100000000000001 112.023 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 85.4 mtp -104.11 154.76 19.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.0 -0.741 . . . . 1.8999999999999999 109.0 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.42 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 46.4 p -72.6 160.39 32.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 1.3200000000000001 110.208 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.46 91.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 1.1499999999999999 110.81 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 23.5 p-10 -69.86 -43.64 71.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.9 -1.125 . . . . 2.25 110.427 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.4 -47.6 72.76 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.498 -0.881 . . . . 1.22 111.172 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.12 91.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.359 -0.838 . . . . 1.1899999999999999 110.075 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.74 96.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.556 -0.715 . . . . 1.2 110.482 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -61.49 -37.72 84.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.191 -0.943 . . . . 2.1000000000000001 110.892 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -56.92 -49.77 74.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.79 . . . . 1.3 110.788 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.8 t -60.28 -44.48 95.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.922 -1.111 . . . . 1.27 110.33 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.14 -34.53 60.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.562 -0.711 . . . . 1.1899999999999999 110.37 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -58.5 -40.28 82.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.979 -1.076 . . . . 2.1099999999999999 110.875 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.87 -34.42 13.23 Favored Glycine 0 N--CA 1.498 2.775 0 C-N-CA 119.236 -1.459 . . . . 0.88 112.174 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -62.2 -41.25 98.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.711 -1.464 . . . . 1.99 109.879 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.94 -51.39 22.3 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.529 -0.732 . . . . 1.28 110.547 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.9 m -60.55 -37.51 81.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 2.2200000000000002 110.76 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.25 97.67 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.552 -0.718 . . . . 1.45 110.523 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.85 -29.81 70.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.908 -1.12 . . . . 1.47 111.156 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -65.94 -21.02 66.4 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.286 -0.884 . . . . 2.04 111.121 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -71.94 -15.01 62.07 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.167 -0.958 . . . . 1.73 111.012 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 55.1 mt -84.6 147.16 27.14 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.193 -0.669 . . . . 1.79 109.193 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 6.6 t0 -100.66 38.41 1.53 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.132 -0.98 . . . . 2.8799999999999999 112.083 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -113.03 140.08 48.13 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.173 -0.954 . . . . 1.5800000000000001 108.75 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 27.8 mp0 -58.28 -39.37 79.1 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.358 -0.839 . . . . 3.04 110.92 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -71.82 -52.51 17.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.534 -1.354 . . . . 1.29 110.631 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.9 mt -60.94 -41.7 96.76 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 1.6000000000000001 110.658 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -63.42 -49.64 72.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.818 -1.176 . . . . 2.7599999999999998 109.582 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.82 -30.26 69.98 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.328 -0.949 . . . . 2.1499999999999999 109.446 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.577 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -61.09 -30.1 70.15 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.924 0.868 . . . . 2.8100000000000001 108.732 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.44 -50.41 72.9 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.78 0.8 . . . . 1.3899999999999999 109.432 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.01 -43.89 81.74 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.714 0.769 . . . . 1.4099999999999999 110.093 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -63.72 -34.0 76.9 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.475 0.655 . . . . 1.3899999999999999 110.255 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.1 t -69.01 -41.75 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 1.1899999999999999 109.91 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -58.51 -37.34 75.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.886 -1.133 . . . . 3.6299999999999999 109.584 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -58.79 -39.81 82.19 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.418 0.628 . . . . 1.28 110.464 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.19 -40.11 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.994 -1.066 . . . . 1.1799999999999999 109.778 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.85 -47.56 89.42 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.343 -1.103 . . . . 0.51000000000000001 110.343 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -58.27 -40.58 82.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -1.14 . . . . 3.1699999999999999 110.26 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -64.88 -43.66 92.19 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.403 -0.919 . . . . 2.8500000000000001 109.359 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.0 tp -59.66 -43.58 93.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.571 -0.705 . . . . 1.6499999999999999 109.64 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 20.7 mt -60.09 -38.66 83.61 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.322 -0.861 . . . . 1.2 110.576 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -39.84 84.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.063 . . . . 2.7999999999999998 110.776 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -75.77 -40.64 54.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.794 . . . . 2.1499999999999999 110.536 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.17 -40.36 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 1.21 109.572 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.45 -8.96 49.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.393 -0.817 . . . . 1.3400000000000001 112.224 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.04 18.62 76.42 Favored Glycine 0 N--CA 1.482 1.713 0 C-N-CA 119.689 -1.243 . . . . 0.91000000000000003 112.617 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.73 144.43 57.25 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.594 -0.945 . . . . 1.51 109.08 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -66.35 149.86 49.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.75 . . . . 2.8799999999999999 109.818 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.44 145.88 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.678 -0.86 . . . . 1.6200000000000001 108.678 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 147' ' ' ILE . 13.1 mm -76.93 118.84 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.942 -1.099 . . . . 2.1099999999999999 108.555 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -97.8 98.12 9.56 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.487 -1.672 . . . . 1.6200000000000001 106.487 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.5 mt -77.13 -17.6 58.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.324 -0.86 . . . . 1.3999999999999999 111.726 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -80.31 1.11 30.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 2.0499999999999998 112.476 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.75 28.31 4.81 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.364 -0.835 . . . . 1.3500000000000001 112.284 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 7.9 mt -73.49 140.08 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 1.4199999999999999 109.745 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -111.45 -21.67 11.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.605 0.717 . . . . 2.9900000000000002 112.231 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -118.14 139.96 50.49 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.369 -0.975 . . . . 1.54 108.369 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.46 125.97 28.44 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.361 -0.977 . . . . 1.3799999999999999 108.361 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.07 173.94 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 1.28 109.258 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.4 mt -87.96 145.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.683 -0.858 . . . . 1.1599999999999999 108.683 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.7 tp -95.44 123.81 39.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.916 -1.115 . . . . 1.3100000000000001 108.736 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.6 t -125.04 128.69 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.279 -1.378 . . . . 1.25 107.279 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.67 154.84 18.7 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.941 -1.1 . . . . 1.26 108.537 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.08 81.93 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.409 -1.432 . . . . 1.6000000000000001 109.375 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.1 t0 -171.01 153.42 3.8 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.511 -0.922 . . . . 2.4199999999999999 108.511 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 34.8 mt -114.69 144.59 43.21 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.298 -0.876 . . . . 1.3500000000000001 109.343 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.9 p -91.03 149.62 40.35 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.741 -1.224 . . . . 1.3200000000000001 108.826 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.58 -43.27 14.33 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.469 1.446 . . . . 0.69999999999999996 113.527 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.7 m -61.88 -45.76 92.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.926 -1.109 . . . . 1.1200000000000001 110.132 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.88 -41.66 97.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.472 -0.768 . . . . 1.21 110.385 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.467 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 82.7 p -67.22 -38.41 85.21 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.453 0.644 . . . . 1.1899999999999999 110.48 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.95 -37.25 86.3 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.467 -0.771 . . . . 1.24 110.606 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -93.73 -1.97 54.42 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.122 -0.986 . . . . 1.6899999999999999 112.683 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.55 149.62 34.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.621 -0.881 . . . . 1.3400000000000001 108.621 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -94.86 109.81 21.76 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.772 -1.566 . . . . 2.77 106.772 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.39 -22.01 64.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.93 -0.481 . . . . 2.0899999999999999 111.745 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -83.72 -17.34 41.63 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.299 -0.876 . . . . 2.6699999999999999 112.797 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -101.19 -5.65 25.3 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.196 -0.94 . . . . 2.5800000000000001 113.229 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.3 129.99 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.92 -1.141 . . . . 1.1799999999999999 107.92 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.5 tp -86.28 -3.78 59.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.146 -0.971 . . . . 2.1800000000000002 111.964 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.27 166.61 28.59 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.947 -1.661 . . . . 0.48999999999999999 108.947 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.73 130.01 53.13 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.748 -1.204 . . . . 0.64000000000000001 107.748 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 92.0 mt -131.07 124.84 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.305 -1.739 . . . . 1.21 106.305 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 203' ' ' VAL . 41.7 p -140.92 170.66 15.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.786 -1.196 . . . . 1.3799999999999999 110.595 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 48.8 t0 -108.38 66.73 0.65 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.743 -0.662 . . . . 2.3700000000000001 109.375 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.025 0 O-C-N 121.363 -0.835 . . . . 1.52 109.045 179.793 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.7 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 107.46 -1.311 . . . . 2.1099999999999999 107.46 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.467 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 58.0 t60 -62.7 -36.34 82.65 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.411 -0.806 . . . . 1.24 109.604 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 59.0 m -58.65 -38.94 79.21 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.571 -0.706 . . . . 2.1499999999999999 110.144 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 64.7 p -58.24 -37.98 75.98 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.196 -0.94 . . . . 2.02 109.73 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.8 mm -60.15 -40.0 82.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.479 -0.763 . . . . 2.1200000000000001 110.287 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 64.5 mtp -63.82 -42.37 97.67 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.084 -1.01 . . . . 1.3600000000000001 109.578 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.47 -48.45 81.59 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.574 -0.739 . . . . 1.29 110.92 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -61.89 -44.11 97.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 3.5600000000000001 110.608 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.0 m -68.62 -40.81 80.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 1.1799999999999999 110.165 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.38 -8.53 47.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.456 -0.778 . . . . 1.3400000000000001 112.526 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.0 mt-10 55.25 13.79 0.93 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.067 1.136 . . . . 1.45 114.067 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 50.2 mt -71.09 164.46 56.63 Favored Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 108.497 -0.927 . . . . 1.25 108.497 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.87 140.46 38.54 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 121.598 1.532 . . . . 0.78000000000000003 110.468 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.08 168.34 24.57 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.019 -1.675 . . . . 1.2 109.998 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.5 mt -147.7 152.55 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.866 -1.161 . . . . 1.25 107.866 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.6 m -135.12 -27.63 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 120.968 -1.082 . . . . 1.3899999999999999 111.409 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.22 46.54 3.22 Favored Glycine 0 N--CA 1.489 2.207 0 O-C-N 120.944 -1.098 . . . . 0.96999999999999997 111.75 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.3 p -62.9 -16.42 58.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.359 -1.083 . . . . 1.3500000000000001 111.702 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.459 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 76.03 -94.9 1.02 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.948 -1.261 . . . . 1.0700000000000001 109.948 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.2 m -129.97 27.6 5.14 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.478 -1.013 . . . . 1.9199999999999999 112.38 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.2 t -57.96 -40.23 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.536 -1.353 . . . . 1.3300000000000001 110.536 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.1 p -58.68 -18.88 34.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.923 -1.111 . . . . 1.4199999999999999 111.77 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.8 t -94.96 -0.59 53.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.412 -0.805 . . . . 2.1200000000000001 112.227 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -129.86 0.44 4.82 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.698 0.629 . . . . 2.6899999999999999 112.698 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t -120.09 150.54 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.934 0.873 . . . . 1.29 109.806 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.67 154.74 36.43 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.222 -1.029 . . . . 2.6899999999999999 108.222 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.9 p-10 -51.38 145.6 8.21 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.103 -0.998 . . . . 2.79 110.172 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.9 t0 81.73 -7.0 1.45 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.264 1.209 . . . . 2.3500000000000001 114.264 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 16' ' ' ALA . 19.7 t0 -60.47 145.24 49.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.773 -1.205 . . . . 1.97 108.478 177.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.438 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 14.2 t80 -88.32 123.07 32.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.939 -1.134 . . . . 2.9700000000000002 107.939 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 49.6 mt -128.26 149.86 50.3 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.553 -0.717 . . . . 1.25 109.607 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.13 123.0 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.309 -1.737 . . . . 1.22 106.309 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.0 tp -100.86 112.79 25.29 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.927 -1.879 . . . . 1.24 105.927 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 223' ' ' VAL . 41.6 p30 -93.35 -22.85 18.7 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.881 -1.137 . . . . 2.0499999999999998 112.314 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 37.91 16.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.996 0.739 . . . . 1.25 112.996 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.598 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.1 t -106.94 -57.75 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.057 -1.027 . . . . 1.4299999999999999 109.359 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -93.62 9.08 38.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.421 1.105 . . . . 3.0299999999999998 110.41 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.78 52.56 3.45 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.89 -1.05 . . . . 2.25 112.177 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.443 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 89.6 mt-30 -146.79 150.16 34.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.357 1.075 . . . . 2.52 109.827 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -115.63 139.86 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.864 -1.161 . . . . 1.29 107.864 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -104.21 131.67 51.27 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 108.145 -1.057 . . . . 1.3400000000000001 108.145 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.1 t -110.31 130.38 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.898 -0.778 . . . . 1.3400000000000001 108.898 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.458 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 8.9 t-20 53.95 48.12 4.47 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 113.393 0.886 . . . . 2.1800000000000002 113.393 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 56.2 Cg_endo -68.99 148.51 70.24 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.128 1.886 . . . . 0.93999999999999995 111.216 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 43.2 p -74.61 162.84 28.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.807 -1.183 . . . . 2.3999999999999999 110.172 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -59.8 -36.78 77.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 3.3300000000000001 110.66 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -59.9 -39.42 85.32 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.28 -0.888 . . . . 3.1699999999999999 110.952 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 87.4 t -70.02 -38.46 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 1.6899999999999999 110.075 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.518 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 96.1 mt -59.69 -47.5 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.552 -0.717 . . . . 1.6000000000000001 110.377 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -60.01 -39.64 86.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 2.7000000000000002 110.792 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -63.06 -45.99 89.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.363 -0.836 . . . . 2.96 110.74 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 72.7 mtp -70.99 -35.69 72.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 1.6299999999999999 110.647 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.537 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.899 . . . . 3.27 110.377 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.4 mt . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.237 0.542 . . . . 1.5700000000000001 112.116 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -96.39 111.98 23.88 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.829 -1.545 . . . . 1.4399999999999999 106.829 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.92 -154.13 29.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.66 -1.376 . . . . 1.01 109.66 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 82.2 mt -95.03 -0.62 10.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.321 -1.105 . . . . 1.6299999999999999 112.273 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 49.63 100.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.939 -1.101 . . . . 1.5800000000000001 112.511 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.18 -42.19 12.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.144 -0.972 . . . . 1.3400000000000001 111.983 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 m -145.0 142.78 18.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.875 -1.141 . . . . 1.8600000000000001 108.007 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.53 148.48 26.25 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.198 1.932 . . . . 1.01 112.357 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 151.38 173.22 21.04 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.053 -1.619 . . . . 0.81000000000000005 109.053 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.0 mt -129.52 137.07 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -1.222 . . . . 1.3700000000000001 108.272 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.95 154.65 46.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 1.1399999999999999 109.173 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.0 m-85 -121.03 140.46 51.9 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.437 -0.949 . . . . 0.87 108.437 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.45 162.56 28.33 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.311 -1.9 . . . . 0.56999999999999995 110.32 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -78.45 158.77 28.57 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.527 -0.916 . . . . 2.3500000000000001 108.527 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.72 127.45 34.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.003 -1.061 . . . . 1.21 108.539 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.1 tp -103.77 103.5 13.4 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 104.976 -2.231 . . . . 1.3999999999999999 104.976 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.1 tp -91.46 129.9 37.38 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.335 -1.357 . . . . 1.4399999999999999 107.335 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.07 119.88 39.39 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.443 -1.317 . . . . 1.45 107.443 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -110.17 132.34 54.26 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.503 -1.295 . . . . 2.5 107.503 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -128.96 155.24 45.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.336 -0.852 . . . . 2.6600000000000001 109.529 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -85.15 137.76 32.82 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.816 -1.179 . . . . 2.3199999999999998 107.816 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.2 149.71 49.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.033 -1.042 . . . . 2.1099999999999999 108.991 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -92.42 128.88 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.293 -1.003 . . . . 1.29 108.293 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.75 130.42 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.941 -1.133 . . . . 1.4099999999999999 107.941 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.9 mt -96.45 139.35 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.545 -0.909 . . . . 1.3100000000000001 108.545 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.25 120.6 32.3 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.298 -1.371 . . . . 1.3400000000000001 107.298 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -96.3 16.84 17.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.811 . . . . 3.48 112.485 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -67.74 143.67 55.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.862 -1.149 . . . . 2.52 108.88 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -88.87 132.28 34.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.134 -1.062 . . . . 2.6299999999999999 108.134 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.1 pt -98.97 167.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.399 -0.813 . . . . 1.3100000000000001 110.342 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.9 p -93.1 162.44 14.03 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.641 0.734 . . . . 1.24 109.766 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.87 -17.31 6.1 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.111 -0.993 . . . . 1.49 112.722 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -69.89 -32.65 71.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.012 . . . . 2.2799999999999998 111.094 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -86.27 0.95 52.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.989 -1.069 . . . . 2.0499999999999998 112.431 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 t -56.27 -44.6 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.466 -0.771 . . . . 1.3400000000000001 110.46 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -58.08 -40.77 81.9 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.205 -0.935 . . . . 1.54 110.327 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -64.14 -45.0 90.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.653 -0.655 . . . . 2.8500000000000001 111.604 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.7 -42.8 99.43 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.812 -1.18 . . . . 1.3100000000000001 111.068 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.27 -41.88 88.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.162 -0.961 . . . . 1.3799999999999999 110.228 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -63.13 -45.88 89.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.042 -1.036 . . . . 1.5 110.119 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -61.92 -42.3 98.92 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.456 -0.897 . . . . 2.7799999999999998 109.957 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -71.45 -52.86 16.15 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.4 -0.92 . . . . 1.0600000000000001 110.165 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.44 -49.28 78.21 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.241 -0.984 . . . . 1.3999999999999999 110.647 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.1 t -69.97 -45.1 68.09 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.552 0.692 . . . . 1.3200000000000001 110.346 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.98 -45.71 86.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.295 -1.522 . . . . 0.69999999999999996 109.295 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -57.37 -31.44 65.78 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.855 0.836 . . . . 3.4399999999999999 109.775 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.11 -42.57 86.02 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.542 0.687 . . . . 1.3600000000000001 110.097 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -75.82 -38.61 57.97 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.268 -0.895 . . . . 2.8300000000000001 110.067 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.76 -38.69 82.51 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.148 -0.97 . . . . 1.23 109.946 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 t -61.02 -38.88 87.64 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.897 0.856 . . . . 1.9199999999999999 109.422 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.64 -47.57 75.13 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.959 -0.564 . . . . 1.25 110.289 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.9 -49.76 74.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.878 -1.139 . . . . 1.97 110.208 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.66 -39.32 90.96 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.258 -0.901 . . . . 2.1800000000000002 110.016 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -59.66 -41.26 90.21 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.218 -0.593 . . . . 1.1899999999999999 110.311 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.9 m -67.05 -44.21 80.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.225 -0.922 . . . . 1.3400000000000001 110.297 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -59.8 -34.82 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.652 -0.655 . . . . 1.23 110.873 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -51.57 -44.64 62.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.92 -1.112 . . . . 1.5600000000000001 110.713 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -68.97 -34.63 75.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.042 -1.036 . . . . 1.3 110.124 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -63.76 -39.74 95.01 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.812 -1.155 . . . . 2.3199999999999998 109.241 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.83 -31.12 72.2 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.163 -0.615 . . . . 1.1399999999999999 109.88 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.1 -36.27 13.4 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.784 -1.198 . . . . 0.68999999999999995 110.81 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.31 -24.26 42.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.945 -1.327 . . . . 1.48 110.242 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.8 m -84.55 -51.14 7.1 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.339 -0.85 . . . . 1.52 110.995 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -106.68 -19.93 13.51 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.102 -0.998 . . . . 1.3100000000000001 113.286 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.61 165.55 14.05 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 121.277 -0.889 . . . . 0.84999999999999998 112.211 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -53.74 -24.03 13.65 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 112.583 0.586 . . . . 3.8599999999999999 112.583 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.86 -36.74 70.4 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.017 -1.052 . . . . 2.3500000000000001 111.653 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -84.92 -15.35 44.77 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.301 -1.499 . . . . 2.2599999999999998 112.913 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.88 -35.62 77.1 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.047 -1.033 . . . . 1.45 110.811 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.51 -39.24 87.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.357 -0.839 . . . . 1.25 111.222 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.9 mt -66.6 -48.96 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.971 -1.081 . . . . 1.26 110.564 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -69.91 -30.37 67.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.451 -0.781 . . . . 0.82999999999999996 110.411 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.86 -38.23 87.48 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.604 -0.839 . . . . 1.1899999999999999 109.823 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.21 -38.66 92.08 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 110.592 -1.003 . . . . 0.57999999999999996 110.592 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -60.13 -40.39 89.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 2.0499999999999998 110.797 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.85 -44.74 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.93 -1.106 . . . . 1.21 110.118 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.4 ttp -60.08 -38.16 82.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -0.891 . . . . 2.29 110.11 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 tp -60.31 -49.94 75.6 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.362 -0.836 . . . . 1.21 110.686 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.38 -40.08 89.58 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.923 -0.711 . . . . 1.1399999999999999 110.333 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -86.21 5.47 34.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.373 -0.829 . . . . 1.4199999999999999 112.386 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.18 119.7 11.34 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.856 -1.152 . . . . 1.27 108.924 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.03 -15.65 63.22 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.645 0.736 . . . . 1.3500000000000001 110.977 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -71.68 -49.55 38.69 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.018 -1.073 . . . . 2.2200000000000002 110.037 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.84 -38.62 88.9 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.169 -1.012 . . . . 1.22 110.097 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.7 -46.18 89.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 1.29 110.777 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -60.05 -39.54 86.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.082 -1.011 . . . . 2.1699999999999999 110.578 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -65.63 -47.9 74.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.954 -1.092 . . . . 1.3 110.19 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.2 mt -57.9 -43.06 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.558 -0.714 . . . . 1.1699999999999999 110.158 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 90' ' ' ILE . 77.6 mt -59.68 -40.89 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.162 0.506 . . . . 1.3999999999999999 110.547 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.72 -40.59 88.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 1.3300000000000001 110.387 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.52 -45.5 90.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 1.48 110.097 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.0 mt -62.57 -43.42 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.365 -0.834 . . . . 1.28 110.193 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' CB ' ' HZ1' ' A' ' 94' ' ' LYS . 7.3 mtpm? -82.64 -38.4 23.57 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.37 -0.831 . . . . 2.6000000000000001 111.932 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 91' ' ' ALA . 49.4 t0 -80.83 -43.28 20.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.909 -1.119 . . . . 1.51 111.882 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.55 8.1 35.35 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.374 -0.829 . . . . 2.48 112.777 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.0 m170 52.46 51.43 16.18 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.868 -1.145 . . . . 1.6100000000000001 111.58 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.2 mtt -105.12 152.17 23.12 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.37 -0.831 . . . . 1.8999999999999999 109.265 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.658 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 71.4 p -71.3 161.68 30.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.374 -0.829 . . . . 1.3200000000000001 110.121 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.18 88.92 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.241 -0.912 . . . . 1.1499999999999999 110.254 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -68.08 -41.1 82.39 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.212 -0.93 . . . . 2.25 110.34 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.658 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -69.66 -49.83 49.91 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.158 -0.964 . . . . 1.22 111.21 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.38 92.22 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.383 -0.823 . . . . 1.1899999999999999 110.407 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.77 95.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.65 -0.656 . . . . 1.2 110.894 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -61.49 -40.05 93.16 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.396 -0.815 . . . . 2.1000000000000001 110.835 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -57.84 -49.57 76.24 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.669 -1.27 . . . . 1.3 111.347 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.7 t -61.11 -44.82 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.95 -1.094 . . . . 1.27 110.161 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 mm -62.78 -33.52 60.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.765 0.793 . . . . 1.1899999999999999 109.958 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -55.46 -40.89 72.18 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.519 -0.738 . . . . 2.1099999999999999 110.87 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.29 -32.49 16.59 Favored Glycine 0 N--CA 1.498 2.825 0 C-N-CA 118.98 -1.581 . . . . 0.88 112.571 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -60.34 -41.59 93.92 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.302 -1.705 . . . . 1.99 110.204 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.92 -51.62 17.82 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.328 -0.857 . . . . 1.28 110.966 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.8 p -62.41 -39.4 93.13 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.265 -0.897 . . . . 2.2200000000000002 110.709 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.72 96.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.404 -0.81 . . . . 1.45 110.913 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 43.8 mt -65.29 -30.89 71.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.891 -1.131 . . . . 1.47 110.5 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.14 -22.33 66.37 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.928 -1.108 . . . . 2.04 111.205 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -71.34 -12.47 61.45 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.765 0.793 . . . . 1.73 110.956 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.85 146.06 27.5 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.874 -0.787 . . . . 1.79 108.874 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -100.3 35.36 2.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.15 -0.969 . . . . 2.8799999999999999 112.112 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -112.58 139.59 48.04 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 108.269 -1.011 . . . . 1.5800000000000001 108.269 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.01 -37.64 80.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.429 -0.794 . . . . 3.04 110.772 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -73.22 -49.0 30.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.794 -1.191 . . . . 1.29 110.215 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.2 mt -63.2 -40.67 98.14 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.616 -1.234 . . . . 1.6000000000000001 109.738 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -60.96 -47.63 85.55 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.788 -1.195 . . . . 2.7599999999999998 110.097 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.27 -31.4 70.19 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.759 -0.777 . . . . 2.1499999999999999 109.556 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.479 HH11 ' HG2' ' A' ' 126' ' ' ARG . 9.2 ttt-85 -62.14 -29.67 70.5 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.008 0.908 . . . . 2.8100000000000001 108.975 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.63 -49.83 75.93 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.054 0.93 . . . . 1.3899999999999999 109.592 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -41.41 78.83 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.59 0.71 . . . . 1.4099999999999999 110.415 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.87 -38.49 91.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.559 -0.713 . . . . 1.3899999999999999 110.25 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.6 -39.77 78.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.522 -0.736 . . . . 1.1899999999999999 110.648 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -58.68 -39.77 81.64 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.3 -1.36 . . . . 3.6299999999999999 110.029 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -59.67 -39.75 85.5 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.166 0.508 . . . . 1.28 110.823 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.99 -39.18 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.336 -0.852 . . . . 1.1799999999999999 110.625 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -64.71 -44.26 95.12 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.791 -1.195 . . . . 0.51000000000000001 110.909 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -58.14 -40.61 81.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.271 . . . . 3.1699999999999999 110.575 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -61.36 -42.68 99.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.312 -0.867 . . . . 2.8500000000000001 110.111 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 31.3 tp -60.29 -43.33 96.35 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.439 -0.904 . . . . 1.6499999999999999 109.506 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.25 -45.92 91.6 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.46 0.648 . . . . 1.2 110.197 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -60.98 -34.86 75.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.461 -0.774 . . . . 2.7999999999999998 111.08 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -75.81 -41.73 51.92 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.074 -1.016 . . . . 2.1499999999999999 110.978 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.46 -39.02 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.789 -1.194 . . . . 1.21 110.594 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 61.5 mt -84.64 -8.95 58.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.339 -0.851 . . . . 1.3400000000000001 111.65 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.55 25.62 67.39 Favored Glycine 0 N--CA 1.479 1.557 0 C-N-CA 119.772 -1.204 . . . . 0.91000000000000003 113.237 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.74 142.04 58.57 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.727 -0.866 . . . . 1.51 109.33 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -67.94 147.74 52.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 2.8799999999999999 108.907 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 72.9 mt -107.03 138.13 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.219 -1.03 . . . . 1.6200000000000001 108.219 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 147' ' ' ILE . 18.2 mm -78.76 133.98 28.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.25 -0.906 . . . . 2.1099999999999999 108.862 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -94.51 94.74 8.39 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.657 -1.608 . . . . 1.6200000000000001 106.657 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 67.1 mt -73.53 -24.35 60.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.574 -0.704 . . . . 1.3999999999999999 110.865 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.9 m -81.48 7.17 12.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.406 -0.809 . . . . 2.0499999999999998 112.304 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.42 18.05 17.45 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.792 . . . . 1.3500000000000001 112.151 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.409 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 18.5 mt -74.73 140.23 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 1.4199999999999999 109.807 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -118.97 -12.34 9.56 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.946 0.879 . . . . 2.9900000000000002 112.427 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -112.7 147.74 36.18 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.728 -0.841 . . . . 1.54 108.728 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -78.27 124.13 27.73 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.188 -1.041 . . . . 1.3799999999999999 108.188 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.8 m -147.64 172.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.55 -0.719 . . . . 1.28 109.3 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.6 mt -90.74 146.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.535 -0.913 . . . . 1.1599999999999999 108.535 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.2 tp -95.9 123.79 39.64 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.093 0.949 . . . . 1.3100000000000001 108.788 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.5 t -124.64 129.96 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.892 -1.151 . . . . 1.25 107.892 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.99 152.87 19.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.006 -1.059 . . . . 1.26 108.835 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.92 -33.76 73.64 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.561 -1.337 . . . . 1.6000000000000001 109.476 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -171.8 144.74 1.83 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.301 -0.629 . . . . 2.4199999999999999 109.301 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 75.8 mt -118.39 135.94 54.04 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.057 -1.09 . . . . 1.3500000000000001 108.057 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.0 p -92.9 150.09 38.81 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.931 -1.105 . . . . 1.3200000000000001 108.529 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -39.18 -45.37 2.87 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 122.252 1.968 . . . . 0.69999999999999996 113.781 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 61.2 m -58.46 -47.56 83.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 1.1200000000000001 110.409 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.18 -38.4 90.9 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.076 -1.015 . . . . 1.21 110.515 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.66 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 39.3 p -69.3 -39.64 78.17 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.545 -0.722 . . . . 1.1899999999999999 110.5 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.83 -37.58 79.63 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.262 -0.575 . . . . 1.24 110.66 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -91.42 -0.16 57.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.05 -1.031 . . . . 1.6899999999999999 112.271 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.6 tp -63.88 150.33 45.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.751 -0.593 . . . . 1.3400000000000001 109.787 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -95.16 113.79 25.52 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.22 -1.4 . . . . 2.77 107.22 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 36.7 mt -71.79 -17.96 62.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.696 -0.627 . . . . 2.0899999999999999 111.778 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.91 -21.31 31.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 2.6699999999999999 112.381 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 152' ' ' ILE . 29.7 mmtp -101.32 -4.99 26.03 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.907 -1.12 . . . . 2.5800000000000001 113.436 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.7 t -114.2 128.91 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 107.533 -1.284 . . . . 1.1799999999999999 107.533 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.2 tp -93.69 -4.89 49.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.507 -0.745 . . . . 2.1800000000000002 112.609 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -175.49 170.04 42.95 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.021 -1.632 . . . . 0.48999999999999999 109.021 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -128.11 128.88 45.68 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.484 -1.302 . . . . 0.64000000000000001 107.484 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 79.3 mt -131.68 125.13 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 106.413 -1.699 . . . . 1.21 106.413 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 205' ' ' THR . 20.6 p -140.63 172.05 13.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.86 -1.15 . . . . 1.3799999999999999 110.213 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -98.1 39.33 1.24 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.378 0.608 . . . . 2.3700000000000001 111.497 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.033 0 O-C-N 121.192 -0.942 . . . . 1.52 109.676 179.596 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 83.6 p . . . . . 0 N--CA 1.492 1.675 0 N-CA-C 107.739 -1.208 . . . . 2.1099999999999999 107.739 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.66 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 50.9 t60 -60.46 -31.43 70.44 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.07 -1.019 . . . . 1.24 110.608 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.3 p -57.21 -40.61 77.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 2.1499999999999999 110.391 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.6 t -60.18 -37.25 79.62 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.123 -0.986 . . . . 2.02 109.948 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.4 mt -59.51 -40.13 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.287 -0.965 . . . . 2.1200000000000001 110.497 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 38.5 mtp -64.56 -44.83 89.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.932 -1.105 . . . . 1.3600000000000001 109.244 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.17 -44.7 94.83 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.554 -0.748 . . . . 1.29 111.212 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -61.23 -45.07 96.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.778 -1.202 . . . . 3.5600000000000001 110.664 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.8 m -69.87 -38.98 76.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.036 -1.04 . . . . 1.1799999999999999 110.766 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -91.75 -8.15 47.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.554 -0.716 . . . . 1.3400000000000001 112.66 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.8 mt-10 54.14 9.31 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.937 1.088 . . . . 1.45 113.937 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.3 mt -70.08 150.19 96.18 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.621 -0.881 . . . . 1.25 108.621 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.8 144.06 94.27 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 121.146 1.231 . . . . 0.78000000000000003 109.491 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -158.79 159.78 35.53 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.175 -1.41 . . . . 1.2 110.214 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.5 mt -147.46 150.2 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.071 -1.085 . . . . 1.25 108.071 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.0 m -135.02 -25.72 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.932 -1.105 . . . . 1.3899999999999999 111.724 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.22 33.35 2.23 Favored Glycine 0 N--CA 1.488 2.151 0 O-C-N 121.022 -1.049 . . . . 0.96999999999999997 113.306 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 181' ' ' THR . 2.7 p -60.63 -28.31 68.46 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.95 -1.323 . . . . 1.3500000000000001 111.037 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.04 -90.67 1.3 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.96 -1.114 . . . . 1.0700000000000001 110.621 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 27.8 m -123.5 27.13 7.55 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.147 -1.208 . . . . 1.9199999999999999 112.984 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 68.2 t -57.41 -34.47 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.172 -1.58 . . . . 1.3300000000000001 110.144 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.2 p -57.61 -23.46 51.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 1.4199999999999999 111.964 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.2 p -92.88 2.77 56.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.968 -1.082 . . . . 2.1200000000000001 111.928 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -128.32 1.88 5.71 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.808 0.67 . . . . 2.6899999999999999 112.808 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.75 151.26 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 109.112 -0.699 . . . . 1.29 109.112 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -120.97 150.13 41.58 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.857 -0.794 . . . . 2.6899999999999999 108.857 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 42.1 p-10 -52.16 143.59 14.06 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.008 -1.077 . . . . 2.79 110.278 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.4 m-20 78.3 -1.17 2.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.525 1.305 . . . . 2.3500000000000001 114.525 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.53 144.03 52.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.861 -1.149 . . . . 1.97 108.307 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -89.31 112.96 24.16 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.331 -1.359 . . . . 2.9700000000000002 107.331 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 48.7 mt -124.22 143.44 50.52 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.322 0.582 . . . . 1.25 109.645 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.3 mt -109.81 126.76 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 106.58 -1.637 . . . . 1.22 106.58 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 52.3 tp -100.64 119.4 38.51 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.118 -1.808 . . . . 1.24 106.118 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 223' ' ' VAL . 36.9 p-10 -93.67 -20.93 19.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.081 -1.012 . . . . 2.0499999999999998 112.682 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 10' ' ' GLY . . . 39.73 13.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.477 0.547 . . . . 1.25 112.477 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.624 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.1 t -109.89 -58.75 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.273 -0.892 . . . . 1.4299999999999999 109.521 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -91.63 8.33 37.27 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.541 1.163 . . . . 3.0299999999999998 110.852 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.0 t30 60.87 49.31 6.09 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.108 -0.951 . . . . 2.25 111.786 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -148.45 154.58 40.06 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.226 1.012 . . . . 2.52 109.746 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.4 t -116.45 141.04 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.576 -0.738 . . . . 1.29 109.181 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -101.16 134.94 43.43 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.327 -0.99 . . . . 1.3400000000000001 108.327 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.28 130.77 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.614 -0.884 . . . . 1.3400000000000001 108.614 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 51.23 58.31 16.6 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.31 -0.869 . . . . 2.1800000000000002 112.867 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.93 150.19 60.65 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.387 2.058 . . . . 0.93999999999999995 110.626 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.7 p -76.23 158.59 31.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.105 -0.997 . . . . 2.3999999999999999 109.608 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -60.79 -39.35 88.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 3.3300000000000001 110.993 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.39 -41.47 80.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.067 -1.021 . . . . 3.1699999999999999 110.696 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.05 -39.31 77.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.806 -1.184 . . . . 1.6899999999999999 110.075 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 71.0 mt -60.03 -49.45 83.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.387 -0.821 . . . . 1.6000000000000001 110.883 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.92 -41.53 91.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.097 -1.002 . . . . 2.7000000000000002 110.543 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -64.41 -44.35 91.52 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.717 -0.793 . . . . 2.96 110.285 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 84.6 mtp -72.4 -37.05 68.78 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.301 -0.874 . . . . 1.6299999999999999 110.743 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.9 mmm-85 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 120.827 -1.17 . . . . 3.27 110.472 179.817 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 79.2 mt . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 107.219 -1.4 . . . . 1.5700000000000001 107.219 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 m -106.01 119.91 40.41 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.202 -1.407 . . . . 1.4399999999999999 107.202 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.97 -153.85 24.45 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.414 -1.874 . . . . 1.01 108.414 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 96.9 mt -97.64 0.98 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -1.168 . . . . 1.6299999999999999 112.38 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 49.89 93.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.985 -1.072 . . . . 1.5800000000000001 111.985 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.38 -30.93 18.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 1.3400000000000001 111.663 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -150.8 138.25 12.0 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.216 -0.927 . . . . 1.8600000000000001 108.54 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.18 145.0 21.38 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.341 2.027 . . . . 1.01 112.533 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 151.42 177.92 25.69 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 109.084 -1.606 . . . . 0.81000000000000005 109.084 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.5 mt -132.0 138.66 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.058 -1.26 . . . . 1.3700000000000001 108.238 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.37 155.5 46.74 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.233 -0.917 . . . . 1.1399999999999999 109.09 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.537 ' CD2' ' NH1' ' A' ' 240' ' ' ARG . 25.4 m-85 -129.08 141.26 51.26 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.521 -0.918 . . . . 0.87 108.521 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.81 168.42 34.78 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 118.27 -1.919 . . . . 0.56999999999999995 110.198 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -77.01 160.3 29.23 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.901 . . . . 2.3500000000000001 109.846 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -81.84 121.49 26.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.691 -1.225 . . . . 1.21 107.691 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.401 HD13 HD22 ' A' ' 214' ' ' ASN . 31.4 tp -100.14 98.51 9.21 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.069 -1.826 . . . . 1.3999999999999999 106.069 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 tp -90.74 134.71 34.22 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.662 -1.236 . . . . 1.4399999999999999 107.662 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.0 mt -99.77 111.1 23.45 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.752 -1.573 . . . . 1.45 106.752 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -104.31 127.54 51.97 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.989 -1.486 . . . . 2.5 106.989 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.474 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 81.6 tt0 -129.41 144.21 51.15 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.941 -0.762 . . . . 2.6600000000000001 108.941 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -80.89 136.01 36.0 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.823 -1.177 . . . . 2.3199999999999998 107.823 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -65.81 149.83 49.54 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.516 -0.74 . . . . 2.1099999999999999 109.264 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -92.21 130.87 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.843 -1.169 . . . . 1.29 107.843 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.65 129.81 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.153 -1.055 . . . . 1.4099999999999999 108.153 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.2 mt -95.53 139.74 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.424 -0.798 . . . . 1.3100000000000001 108.927 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -87.58 123.62 32.65 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.125 -1.065 . . . . 1.3400000000000001 108.125 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -94.74 14.67 20.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.656 -0.652 . . . . 3.48 112.38 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -77.55 140.58 39.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.281 -0.887 . . . . 2.52 109.275 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -84.69 140.27 31.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.103 -0.998 . . . . 2.6299999999999999 109.744 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -95.75 175.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 1.3100000000000001 109.776 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -98.09 164.33 12.38 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.887 -0.597 . . . . 1.24 109.544 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.14 -23.41 21.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.268 -0.895 . . . . 1.49 112.029 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -68.88 -40.05 79.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.812 -1.18 . . . . 2.2799999999999998 110.946 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -86.39 -6.2 58.99 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.289 -1.507 . . . . 2.0499999999999998 112.189 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.19 -41.81 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.968 -1.083 . . . . 1.3400000000000001 110.456 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -58.24 -39.42 79.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.003 -1.061 . . . . 1.54 110.936 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.2 -39.87 95.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.02 . . . . 2.8500000000000001 110.967 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -58.96 -40.33 84.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.875 . . . . 1.3100000000000001 110.724 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.25 -41.71 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 1.3799999999999999 110.127 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.57 -44.58 93.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 1.5 109.58 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -62.43 -40.45 96.61 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.401 -0.92 . . . . 2.7799999999999998 109.925 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.39 -52.84 12.37 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.801 0.81 . . . . 1.0600000000000001 109.871 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.07 -48.84 80.06 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.255 -0.903 . . . . 1.3999999999999999 109.96 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.2 t -68.21 -41.05 81.88 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.659 0.743 . . . . 1.3200000000000001 109.831 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.95 -42.08 85.82 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.34 -1.504 . . . . 0.69999999999999996 109.34 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.404 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 51.7 ttt180 -58.38 -32.77 68.91 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.689 0.756 . . . . 3.4399999999999999 109.772 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.61 -50.21 72.66 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.375 0.607 . . . . 1.3600000000000001 110.819 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -78.05 -38.64 43.99 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.306 -0.872 . . . . 2.8300000000000001 110.44 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.16 87.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.395 -0.816 . . . . 1.23 110.209 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.5 m -60.45 -40.14 90.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.869 0.843 . . . . 1.9199999999999999 109.497 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.41 78.1 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.15 -0.62 . . . . 1.25 110.072 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.16 -50.58 72.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 1.97 110.577 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.83 -39.17 93.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.019 . . . . 2.1800000000000002 110.105 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -59.86 -40.93 90.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.807 -0.558 . . . . 1.1899999999999999 110.958 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.8 m -64.27 -45.31 88.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.822 -1.174 . . . . 1.3400000000000001 110.356 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 57' ' ' ILE . 96.4 mt -60.12 -34.64 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 1.23 110.984 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -52.97 -45.76 67.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.26 -0.9 . . . . 1.5600000000000001 111.084 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.14 -37.71 81.36 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.148 -0.97 . . . . 1.3 110.182 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -61.35 -39.81 91.95 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.577 -1.249 . . . . 2.3199999999999998 109.617 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.98 -32.3 73.45 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.625 -0.672 . . . . 1.1399999999999999 110.558 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.04 -34.58 14.43 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.832 -1.175 . . . . 0.68999999999999995 111.405 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -81.85 -25.75 34.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.567 -1.549 . . . . 1.48 111.373 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.4 m -86.69 -49.99 7.1 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.408 -0.807 . . . . 1.52 111.125 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.9 -5.25 19.83 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 113.909 1.078 . . . . 1.3100000000000001 113.909 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.83 161.47 27.75 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.401 -0.904 . . . . 0.84999999999999998 112.733 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -55.79 -18.88 9.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -1.065 . . . . 3.8599999999999999 112.82 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -59.07 -40.66 85.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -0.973 . . . . 2.3500000000000001 110.518 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -85.9 -23.9 26.83 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.213 -0.929 . . . . 2.2599999999999998 111.465 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.65 -35.44 76.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.638 -0.664 . . . . 1.45 111.356 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.02 83.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.388 -0.82 . . . . 1.25 111.334 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.5 mt -62.02 -40.91 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 1.26 110.324 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -71.04 -30.29 66.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.302 -0.874 . . . . 0.82999999999999996 110.546 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -60.91 -39.07 87.96 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.187 -0.945 . . . . 1.1899999999999999 109.732 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.98 -39.58 93.25 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 110.098 -1.201 . . . . 0.57999999999999996 110.098 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -59.82 -45.0 93.74 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.433 -1.04 . . . . 2.0499999999999998 110.355 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.61 -40.91 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 1.21 110.401 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 26.3 ttt -60.14 -39.4 86.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.325 -0.859 . . . . 2.29 110.384 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.5 tp -57.84 -48.25 80.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.151 -0.968 . . . . 1.21 110.221 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.98 -41.76 92.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.239 -0.913 . . . . 1.1399999999999999 110.413 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -88.13 10.4 19.44 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 112.899 0.703 . . . . 1.4199999999999999 112.899 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.63 126.32 27.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.891 -1.131 . . . . 1.27 108.818 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.22 -18.72 65.35 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.871 0.843 . . . . 1.3500000000000001 110.639 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -74.45 -54.99 6.48 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.491 0.662 . . . . 2.2200000000000002 110.178 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.9 mt -61.1 -37.49 82.95 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.663 -0.648 . . . . 1.22 111.058 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.404 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 30.5 tt0 -60.05 -45.18 93.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 1.29 110.559 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.97 -38.46 91.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 2.1699999999999999 110.685 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -68.26 -47.87 66.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.035 -1.041 . . . . 1.3 110.922 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.11 -42.48 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.093 -1.004 . . . . 1.1699999999999999 110.04 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.4 mt -63.51 -43.0 98.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.485 -0.76 . . . . 1.3999999999999999 110.505 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.29 -42.83 99.69 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.3 -0.875 . . . . 1.3300000000000001 110.928 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.62 -45.63 93.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.974 -1.079 . . . . 1.48 110.544 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 93' ' ' ILE . 94.8 mt -61.88 -43.65 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.041 -1.037 . . . . 1.28 110.339 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -84.75 -31.26 24.09 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.277 -0.89 . . . . 2.6000000000000001 111.724 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 91' ' ' ALA . 60.6 t0 -82.47 -45.57 14.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.64 -1.287 . . . . 1.51 111.527 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -100.76 4.82 43.33 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.227 -0.92 . . . . 2.48 112.617 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 53.2 50.64 17.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 1.6100000000000001 111.466 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.33 159.02 15.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.385 -0.822 . . . . 1.8999999999999999 109.207 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.668 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 30.2 p -71.5 161.02 31.69 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.772 -0.58 . . . . 1.3200000000000001 109.832 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.28 -45.04 92.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.033 -1.042 . . . . 1.1499999999999999 110.56 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -68.12 -37.04 80.67 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.226 -0.922 . . . . 2.25 110.121 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.668 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -68.54 -51.71 40.0 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.757 -0.777 . . . . 1.22 111.429 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.63 94.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.117 -0.989 . . . . 1.1899999999999999 110.408 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.31 95.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.653 -0.654 . . . . 1.2 110.793 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -61.69 -37.87 85.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.124 -0.985 . . . . 2.1000000000000001 111.496 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -59.23 -49.59 77.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.883 -1.136 . . . . 1.3 111.077 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.68 -45.72 97.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.437 -1.414 . . . . 1.27 110.214 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.1 mm -61.12 -34.76 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.638 -0.664 . . . . 1.1899999999999999 110.403 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -58.44 -39.16 79.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.095 -1.003 . . . . 2.1099999999999999 111.226 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.69 -41.3 7.8 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.947 -1.597 . . . . 0.88 112.853 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -60.57 -41.07 93.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.599 -1.53 . . . . 1.99 109.891 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.43 -52.65 20.75 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.399 0.619 . . . . 1.28 110.559 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.0 p -62.53 -36.44 82.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.462 -0.774 . . . . 2.2200000000000002 110.453 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.3 97.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 1.45 110.722 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.19 -30.11 70.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.938 . . . . 1.47 110.855 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.58 -21.75 65.41 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.011 -1.056 . . . . 2.04 110.989 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -71.37 -14.3 62.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 1.73 111.462 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.2 mt -86.85 146.4 26.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.434 -0.791 . . . . 1.79 109.574 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -99.2 36.08 1.79 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.233 -0.917 . . . . 2.8799999999999999 112.285 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -113.09 139.6 48.57 Favored 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 108.437 -0.949 . . . . 1.5800000000000001 108.437 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -60.23 -38.46 83.47 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.329 -0.857 . . . . 3.04 110.89 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -70.23 -53.33 17.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.684 -1.26 . . . . 1.29 109.909 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.1 mt -62.79 -40.31 96.94 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.228 -0.92 . . . . 1.6000000000000001 109.627 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.64 -50.49 66.88 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.828 0.823 . . . . 2.7599999999999998 109.918 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.78 -29.11 70.46 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.753 -1.217 . . . . 2.1499999999999999 109.921 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -61.66 -31.4 71.51 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.368 -0.933 . . . . 2.8100000000000001 109.111 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.15 78.86 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.643 0.735 . . . . 1.3899999999999999 109.815 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.61 -43.65 79.94 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.416 -0.914 . . . . 1.4099999999999999 109.958 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -60.97 -38.6 86.52 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.485 0.659 . . . . 1.3899999999999999 110.829 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.5 -39.07 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.574 -0.704 . . . . 1.1899999999999999 110.262 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.414 ' NH1' ' HG3' ' A' ' 131' ' ' ARG . 40.4 ttm-85 -59.04 -40.07 83.91 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.143 -0.973 . . . . 3.6299999999999999 109.856 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -60.21 -38.75 84.29 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.356 0.598 . . . . 1.28 110.405 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.67 -39.76 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.254 -0.904 . . . . 1.1799999999999999 110.444 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.86 -47.36 67.04 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.424 -1.07 . . . . 0.51000000000000001 110.424 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -58.24 -42.1 85.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.21 -1.171 . . . . 3.1699999999999999 110.078 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 60.1 mtt-85 -61.67 -43.23 99.26 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.14 -1.024 . . . . 2.8500000000000001 110.372 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.31 -43.02 96.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.371 -0.831 . . . . 1.6499999999999999 109.843 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -41.53 91.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.78 -0.575 . . . . 1.2 110.833 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.474 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 99.5 mtt180 -60.08 -35.58 75.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 2.7999999999999998 111.329 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -73.56 -41.32 63.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.025 -1.047 . . . . 2.1499999999999999 110.645 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.3 mt -60.4 -39.26 80.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.092 -1.005 . . . . 1.21 110.228 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.6 -8.54 54.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.474 -0.766 . . . . 1.3400000000000001 112.039 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.34 25.32 70.93 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 120.363 -0.923 . . . . 0.91000000000000003 113.59 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.5 tp -70.13 148.62 48.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.634 -0.921 . . . . 1.51 109.956 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -65.46 151.72 45.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.483 -0.761 . . . . 2.8799999999999999 110.803 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.8 mt -103.32 140.6 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.125 -1.065 . . . . 1.6200000000000001 108.125 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.6 mm -82.37 120.36 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.817 -1.177 . . . . 2.1099999999999999 108.138 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -99.36 95.89 7.35 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.165 -1.791 . . . . 1.6200000000000001 106.165 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.82 -18.38 61.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.504 -0.748 . . . . 1.3999999999999999 112.053 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.0 m -81.72 8.74 9.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 2.0499999999999998 112.208 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.04 24.63 9.09 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.239 -0.913 . . . . 1.3500000000000001 111.655 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.1 mt -74.35 147.24 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.371 -0.83 . . . . 1.4199999999999999 110.146 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -115.26 -20.12 10.49 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.58 -0.7 . . . . 2.9900000000000002 112.596 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -119.55 139.92 51.36 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.812 -1.181 . . . . 1.54 107.812 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.71 128.57 36.52 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.602 -0.888 . . . . 1.3799999999999999 108.602 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -146.28 178.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.477 -0.764 . . . . 1.28 109.426 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 81.3 mt -91.42 144.75 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.504 -0.925 . . . . 1.1599999999999999 108.504 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.71 123.65 39.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.889 -1.132 . . . . 1.3100000000000001 108.366 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.74 130.09 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.156 -1.053 . . . . 1.25 108.156 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.34 154.77 21.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.099 -1.001 . . . . 1.26 108.93 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.7 -31.2 70.48 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.653 -1.28 . . . . 1.6000000000000001 109.626 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 29.0 p-10 -173.35 150.8 1.91 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.708 -0.849 . . . . 2.4199999999999999 108.708 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.3 mt -119.39 138.78 52.86 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.332 -0.988 . . . . 1.3500000000000001 108.332 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.0 p -95.61 152.61 39.29 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 108.507 -0.923 . . . . 1.3200000000000001 108.507 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -43.68 -39.57 10.23 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.367 1.378 . . . . 0.69999999999999996 113.367 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.0 m -59.85 -48.88 79.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.923 -1.111 . . . . 1.1200000000000001 110.042 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.99 -40.33 97.43 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.338 -0.851 . . . . 1.21 109.961 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.648 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 31.5 p -68.17 -40.0 82.41 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.857 -0.737 . . . . 1.1899999999999999 110.055 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.36 78.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.581 -0.7 . . . . 1.24 110.779 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -97.03 -1.43 45.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.207 -0.933 . . . . 1.6899999999999999 112.881 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.82 150.39 41.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.476 -0.765 . . . . 1.3400000000000001 109.571 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -96.03 111.04 23.17 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.773 -1.566 . . . . 2.77 106.773 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 31.9 mt -74.57 -15.19 60.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.636 -0.665 . . . . 2.0899999999999999 111.486 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -81.32 -25.58 36.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 2.6699999999999999 111.832 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -102.72 -1.96 29.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.27 -0.894 . . . . 2.5800000000000001 113.325 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.05 127.26 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 107.394 -1.335 . . . . 1.1799999999999999 107.394 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 45.1 tp -88.58 -10.84 47.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.104 -0.998 . . . . 2.1800000000000002 112.244 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.96 174.32 46.72 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.049 -1.621 . . . . 0.48999999999999999 109.049 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -130.02 131.19 45.76 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.506 -1.294 . . . . 0.64000000000000001 107.506 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 84.6 mt -131.32 129.79 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.156 -1.424 . . . . 1.21 107.156 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 203' ' ' VAL . 82.7 p -140.57 170.55 15.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.886 -1.133 . . . . 1.3799999999999999 109.702 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.447 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 1.4 m-20 -105.04 44.72 1.01 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.817 -0.552 . . . . 2.3700000000000001 110.777 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.05 0 O-C-N 121.086 -1.009 . . . . 1.52 109.637 179.317 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 107.296 -1.372 . . . . 2.1099999999999999 107.296 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.648 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 44.1 t60 -59.55 -34.39 72.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.475 -0.765 . . . . 1.24 110.107 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 15.2 t -59.67 -39.44 84.48 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.537 -0.727 . . . . 2.1499999999999999 110.603 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.8 t -57.24 -39.99 76.67 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.16 -0.962 . . . . 2.02 110.072 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.3 -39.62 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.44 -0.787 . . . . 2.1200000000000001 109.937 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 45.5 mtp -66.27 -40.93 90.44 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.395 1.093 . . . . 1.3600000000000001 109.414 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.73 -42.22 88.26 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.464 -0.789 . . . . 1.29 110.709 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -60.84 -44.95 96.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.912 -1.118 . . . . 3.5600000000000001 110.317 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.8 m -70.21 -40.1 74.77 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.199 -0.938 . . . . 1.1799999999999999 110.225 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.4 mt -91.7 -6.92 51.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.529 -0.732 . . . . 1.3400000000000001 112.64 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.0 mt-10 52.54 13.45 0.32 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.749 1.018 . . . . 1.45 113.749 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.71 148.11 89.7 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.942 -1.132 . . . . 1.25 107.942 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -54.35 140.5 73.18 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.905 1.737 . . . . 0.78000000000000003 109.985 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -158.84 160.5 36.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.249 -1.532 . . . . 1.2 109.86 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 29.6 mt -148.65 151.49 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.676 -1.231 . . . . 1.25 107.676 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.7 m -135.5 -27.58 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 120.956 -1.09 . . . . 1.3899999999999999 112.014 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.92 42.06 2.8 Favored Glycine 0 N--CA 1.492 2.41 0 O-C-N 121.081 -1.012 . . . . 0.96999999999999997 112.02 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 74.7 p -65.4 -13.11 57.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.899 -1.353 . . . . 1.3500000000000001 111.151 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.65 -95.88 1.38 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 110.565 -1.014 . . . . 1.0700000000000001 110.565 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -129.08 30.96 4.96 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.659 -0.907 . . . . 1.9199999999999999 112.322 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.2 -36.33 45.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.571 -1.331 . . . . 1.3300000000000001 110.819 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.1 p -57.77 -24.58 57.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.792 -1.193 . . . . 1.4199999999999999 111.544 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 18.2 t -92.15 -2.05 56.8 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.797 0.808 . . . . 2.1200000000000001 111.483 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -122.46 -5.29 8.77 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.561 0.949 . . . . 2.6899999999999999 113.561 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 34.8 t -120.05 149.07 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.357 -0.839 . . . . 1.29 109.594 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.0 156.9 27.75 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.973 -1.121 . . . . 2.6899999999999999 107.973 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.506 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 22.2 t-20 -51.47 142.84 13.01 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.075 -1.016 . . . . 2.79 110.216 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 83.35 -7.62 1.14 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.109 1.151 . . . . 2.3500000000000001 114.109 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.4 t0 -58.57 142.15 50.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.507 -1.37 . . . . 1.97 108.91 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -88.74 119.82 29.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.671 -1.268 . . . . 2.9700000000000002 108.072 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.69 148.85 47.76 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.465 0.65 . . . . 1.25 109.653 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.79 124.89 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.226 -1.768 . . . . 1.22 106.226 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 53.6 tp -102.24 116.78 33.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.215 -1.772 . . . . 1.24 106.215 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.3 p-10 -93.15 -22.12 19.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.934 -1.104 . . . . 2.0499999999999998 112.709 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.519 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.17 15.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 112.663 0.616 . . . . 1.25 112.663 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.633 ' N ' ' O ' ' A' ' 221' ' ' ASP . 20.6 t -109.73 -59.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.112 -0.993 . . . . 1.4299999999999999 109.86 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -93.79 9.91 35.22 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.27 1.033 . . . . 3.0299999999999998 110.891 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.33 53.1 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.983 -1.008 . . . . 2.25 112.304 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -148.84 148.54 30.02 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.811 -1.181 . . . . 2.52 110.084 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.97 139.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 108.136 -1.061 . . . . 1.29 108.136 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -102.74 133.88 47.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.181 -0.95 . . . . 1.3400000000000001 108.669 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 53.4 t -110.86 130.8 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.214 -1.032 . . . . 1.3400000000000001 108.214 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.488 ' C ' HD21 ' A' ' 230' ' ' ASN . 0.6 OUTLIER 55.63 47.9 3.53 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 113.384 0.883 . . . . 2.1800000000000002 113.384 178.489 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 62.3 Cg_endo -69.82 153.12 69.04 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.559 2.172 . . . . 0.93999999999999995 110.901 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.6 m -74.19 159.38 32.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 2.3999999999999999 108.866 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -59.47 -34.01 72.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.114 -0.991 . . . . 3.3300000000000001 110.691 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -59.96 -41.05 91.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.407 -0.808 . . . . 3.1699999999999999 110.56 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.96 -39.97 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.288 -0.883 . . . . 1.6899999999999999 110.192 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 236' ' ' ILE . 92.4 mt -60.0 -49.97 81.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.168 -0.957 . . . . 1.6000000000000001 111.043 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -59.52 -40.66 87.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.98 . . . . 2.7000000000000002 110.644 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.71 -47.91 84.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.853 . . . . 2.96 110.195 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 66.1 mtp -70.63 -38.39 73.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 1.6299999999999999 110.871 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.537 ' NH1' ' CD2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.147 -0.97 . . . . 3.27 110.245 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.3 mt . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 106.386 -1.709 . . . . 1.5700000000000001 106.386 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m -105.88 125.23 50.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.048 -1.093 . . . . 1.4399999999999999 108.048 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.46 -154.96 17.46 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.333 -1.907 . . . . 1.01 108.333 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.472 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 80.3 mt -95.78 1.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.309 -1.113 . . . . 1.6299999999999999 112.185 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 5' ' ' ILE . 3.8 tp 50.82 101.16 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.085 -1.01 . . . . 1.5800000000000001 112.357 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.38 -47.44 10.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.118 -0.989 . . . . 1.3400000000000001 111.11 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m -144.58 146.95 34.26 Favored Pre-proline 0 N--CA 1.501 2.093 0 N-CA-C 107.855 -1.165 . . . . 1.8600000000000001 107.855 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.49 147.71 32.52 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.575 2.183 . . . . 1.01 112.088 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 155.08 163.34 11.97 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.343 -1.503 . . . . 0.81000000000000005 109.343 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.3 mt -125.37 130.53 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.159 -1.2 . . . . 1.3700000000000001 108.095 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.11 148.92 43.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.242 -0.911 . . . . 1.1399999999999999 109.016 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 5.8 m-85 -117.49 140.17 49.96 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 108.827 -0.805 . . . . 0.87 108.827 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.77 167.27 35.64 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 118.004 -2.046 . . . . 0.56999999999999995 110.39 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -77.48 160.36 28.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.827 -0.808 . . . . 2.3500000000000001 109.669 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.46 126.46 34.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.835 -1.166 . . . . 1.21 108.152 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.9 tp -104.6 98.93 8.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.081 -1.822 . . . . 1.3999999999999999 106.081 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.0 tp -90.55 130.83 36.55 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.753 -1.203 . . . . 1.4399999999999999 107.753 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.5 mt -101.77 117.06 34.09 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.861 -1.533 . . . . 1.45 106.861 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -109.5 136.04 49.54 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.993 -1.484 . . . . 2.5 106.993 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -119.69 149.18 42.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.083 -1.011 . . . . 2.6600000000000001 109.452 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -82.67 134.62 35.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.858 -1.164 . . . . 2.3199999999999998 107.858 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.19 148.35 50.24 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.671 -0.863 . . . . 2.1099999999999999 108.671 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.87 130.3 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.282 -1.007 . . . . 1.29 108.282 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -105.35 131.11 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.033 -1.099 . . . . 1.4099999999999999 108.033 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 77.1 mt -97.86 135.55 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.526 -0.916 . . . . 1.3100000000000001 108.526 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -91.12 123.02 34.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.858 -1.164 . . . . 1.3400000000000001 107.858 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -95.06 13.04 26.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.223 -0.923 . . . . 3.48 112.135 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -67.25 149.66 50.11 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.282 -0.886 . . . . 2.52 109.244 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -86.43 140.0 30.39 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.179 -1.045 . . . . 2.6299999999999999 108.179 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -93.31 171.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.079 -1.013 . . . . 1.3100000000000001 109.418 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.6 p -108.53 158.62 17.39 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.935 -0.765 . . . . 1.24 108.935 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.82 -26.23 1.56 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.108 -0.995 . . . . 1.49 112.672 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -69.84 -39.87 76.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.161 -0.962 . . . . 2.2799999999999998 110.167 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -86.47 -11.3 52.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.426 -0.796 . . . . 2.0499999999999998 111.813 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.15 -47.19 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.438 -0.789 . . . . 1.3400000000000001 110.472 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.12 -40.08 84.3 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.098 -1.001 . . . . 1.54 110.687 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.46 -44.77 95.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.42 -0.8 . . . . 2.8500000000000001 110.999 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.05 -39.74 87.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.919 -1.113 . . . . 1.3100000000000001 111.02 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.04 -41.77 87.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.92 -1.112 . . . . 1.3799999999999999 110.656 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -61.93 -45.89 91.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.008 -1.057 . . . . 1.5 110.279 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -62.48 -39.67 94.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.308 -0.87 . . . . 2.7799999999999998 110.165 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -76.22 -54.42 6.83 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.562 -0.711 . . . . 1.0600000000000001 110.315 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -58.32 -47.78 82.64 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.382 -0.927 . . . . 1.3999999999999999 109.772 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -68.39 -36.74 79.59 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.738 -0.785 . . . . 1.3200000000000001 109.891 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.68 -44.09 94.17 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.218 -1.468 . . . . 0.69999999999999996 109.57 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.425 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.4 ttt-85 -60.32 -29.48 68.89 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.194 -1.18 . . . . 3.4399999999999999 110.328 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.31 -50.24 73.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 1.3600000000000001 110.929 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -81.44 -36.07 29.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.909 -1.12 . . . . 2.8300000000000001 110.341 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.49 89.7 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.268 -0.895 . . . . 1.23 109.683 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 87.4 p -60.77 -39.28 88.24 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.219 1.009 . . . . 1.9199999999999999 109.055 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -45.3 75.64 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.711 -0.677 . . . . 1.25 110.595 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.29 -48.6 72.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.672 -1.268 . . . . 1.97 110.658 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.05 -35.95 81.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.994 -1.066 . . . . 2.1800000000000002 109.888 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -60.06 -40.24 88.81 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.574 -0.704 . . . . 1.1899999999999999 110.256 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -62.11 -43.45 98.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.139 -0.976 . . . . 1.3400000000000001 110.457 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.1 mt -59.94 -35.21 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.438 -0.789 . . . . 1.23 110.726 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -52.64 -41.63 63.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.15 -0.969 . . . . 1.5600000000000001 110.878 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.76 -36.92 76.19 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.996 -1.065 . . . . 1.3 110.318 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -61.58 -36.81 81.72 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.926 -1.109 . . . . 2.3199999999999998 109.552 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.12 79.01 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.618 -0.677 . . . . 1.1399999999999999 110.43 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.24 -36.21 13.22 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.637 -1.268 . . . . 0.68999999999999995 111.502 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.54 -22.66 43.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.668 -1.489 . . . . 1.48 110.736 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.2 m -90.42 -49.93 6.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.253 -0.904 . . . . 1.52 111.52 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.27 -7.17 16.83 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 113.918 1.081 . . . . 1.3100000000000001 113.918 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.08 163.46 24.79 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.719 -0.753 . . . . 0.84999999999999998 112.349 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -54.17 -23.89 16.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.565 -0.962 . . . . 3.8599999999999999 112.779 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.3 -40.08 70.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.823 -1.173 . . . . 2.3500000000000001 110.993 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -86.02 -22.99 26.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.674 -1.266 . . . . 2.2599999999999998 111.488 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -60.56 -40.3 91.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 1.45 111.031 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.25 86.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.486 -0.759 . . . . 1.25 111.443 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -65.82 -44.0 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.754 -1.216 . . . . 1.26 110.921 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -69.95 -32.91 71.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.686 -1.259 . . . . 0.82999999999999996 110.22 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.2 -38.85 88.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -0.881 . . . . 1.1899999999999999 110.23 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.13 96.96 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.591 -0.814 . . . . 0.57999999999999996 111.097 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -58.11 -40.92 82.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.669 -1.489 . . . . 2.0499999999999998 110.777 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.93 -40.05 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.118 -0.989 . . . . 1.21 110.987 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.8 ttm -58.76 -40.28 83.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.983 -1.073 . . . . 2.29 110.377 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 tp -59.85 -48.6 81.05 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.185 -0.947 . . . . 1.21 110.023 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.97 -39.8 86.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.207 -0.933 . . . . 1.1399999999999999 110.284 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -84.3 6.78 21.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.216 0.821 . . . . 1.4199999999999999 113.216 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -66.41 125.33 25.31 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.664 -1.273 . . . . 1.27 108.26 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.97 -16.54 64.1 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.263 -0.898 . . . . 1.3500000000000001 111.121 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -75.03 -50.29 16.98 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.674 -0.81 . . . . 2.2200000000000002 110.34 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.8 -36.76 84.21 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.739 -0.784 . . . . 1.22 110.392 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -59.93 -48.8 80.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.367 -0.833 . . . . 1.29 110.705 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -61.85 -38.42 88.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 2.1699999999999999 110.546 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.23 -47.38 79.88 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.025 -1.047 . . . . 1.3 110.499 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.61 -45.03 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.34 -0.85 . . . . 1.1699999999999999 110.198 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.34 -40.12 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.683 0.754 . . . . 1.3999999999999999 110.465 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.43 98.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.152 -0.968 . . . . 1.3300000000000001 110.965 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.18 -39.16 85.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.015 -1.053 . . . . 1.48 110.612 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.26 -51.52 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 1.28 110.757 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -75.87 -35.31 59.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.756 . . . . 2.6000000000000001 111.446 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.43 -46.24 14.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 1.51 111.948 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -100.13 7.84 44.31 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.342 -0.849 . . . . 2.48 112.861 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.9 m80 49.9 48.61 21.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.74 -1.225 . . . . 1.6100000000000001 111.427 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.9 mtt -109.97 152.02 26.39 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.778 0.799 . . . . 1.8999999999999999 109.552 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.9 p -70.1 160.27 32.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.515 -0.741 . . . . 1.3200000000000001 110.018 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.18 92.98 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.46 -0.775 . . . . 1.1499999999999999 110.419 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -65.86 -43.45 88.38 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.962 -1.086 . . . . 2.25 109.361 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.18 -49.31 51.64 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.921 -0.711 . . . . 1.22 110.862 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.71 -44.47 93.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 1.1899999999999999 110.637 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.22 -41.07 87.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 1.2 110.483 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.3 -38.28 90.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 2.1000000000000001 111.48 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.62 -49.76 76.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.387 -1.446 . . . . 1.3 111.29 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.68 -46.81 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.918 -1.114 . . . . 1.27 110.112 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.8 mm -62.0 -29.43 46.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.921 0.867 . . . . 1.1899999999999999 110.681 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.51 -40.33 82.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.551 -0.718 . . . . 2.1099999999999999 110.996 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.55 -32.04 17.07 Favored Glycine 0 N--CA 1.501 3.004 0 C-N-CA 119.384 -1.389 . . . . 0.88 112.535 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -63.03 -37.54 87.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.363 -1.669 . . . . 1.99 110.169 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.63 -51.21 15.08 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.533 -0.73 . . . . 1.28 111.201 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.9 m -58.32 -38.73 77.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.388 -0.82 . . . . 2.2200000000000002 111.142 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.09 99.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.303 -0.873 . . . . 1.45 111.025 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.75 -28.81 69.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.967 . . . . 1.47 111.269 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -68.11 -22.27 64.9 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.209 -0.932 . . . . 2.04 111.055 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -73.08 -13.64 61.24 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.963 0.887 . . . . 1.73 111.029 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.4 mt -91.18 140.53 29.72 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.503 -0.925 . . . . 1.79 108.503 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -99.71 43.55 1.05 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.028 -1.045 . . . . 2.8799999999999999 112.082 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -112.87 140.51 47.6 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.134 -0.979 . . . . 1.5800000000000001 108.808 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.24 -40.47 77.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 3.04 111.008 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -73.22 -54.04 9.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.864 -1.148 . . . . 1.29 110.95 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.7 mt -59.81 -41.3 90.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.897 -1.127 . . . . 1.6000000000000001 110.475 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -63.65 -50.09 70.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.116 -0.99 . . . . 2.7599999999999998 109.951 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.44 -31.83 70.8 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.978 -1.076 . . . . 2.1499999999999999 109.292 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.506 ' HG2' HH11 ' A' ' 126' ' ' ARG . 11.3 ttt-85 -61.32 -29.32 69.81 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.59 -0.844 . . . . 2.8100000000000001 109.49 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.12 74.81 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.815 0.817 . . . . 1.3899999999999999 109.448 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.5 -45.72 78.66 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.101 -0.64 . . . . 1.4099999999999999 110.125 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -62.05 -33.93 75.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.543 -0.723 . . . . 1.3899999999999999 110.574 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.437 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 25.1 t -68.12 -41.91 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 1.1899999999999999 110.272 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.416 ' HG2' HH11 ' A' ' 131' ' ' ARG . 28.1 ttt-85 -59.77 -39.49 85.04 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.006 -1.077 . . . . 3.6299999999999999 109.311 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.482 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 56.8 t0 -58.29 -36.22 72.98 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.734 -0.604 . . . . 1.28 109.896 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.2 mt -60.63 -39.35 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.158 -0.964 . . . . 1.1799999999999999 110.152 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.75 -44.85 30.21 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.253 -0.975 . . . . 0.51000000000000001 111.007 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -56.68 -45.27 81.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.316 -1.108 . . . . 3.1699999999999999 110.401 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.482 ' NH2' ' OD2' ' A' ' 132' ' ' ASP . 42.1 mtt-85 -62.46 -40.76 97.67 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.096 -1.042 . . . . 2.8500000000000001 109.643 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -43.21 99.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.703 -0.623 . . . . 1.6499999999999999 110.057 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.23 -44.5 92.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.204 -0.935 . . . . 1.2 110.317 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.1 mtp180 -60.02 -32.63 71.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 2.7999999999999998 110.723 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -74.09 -41.08 62.23 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.254 -0.903 . . . . 2.1499999999999999 110.704 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 141' ' ' ILE . 98.5 mt -60.63 -37.52 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.42 -0.8 . . . . 1.21 110.142 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.9 mt -87.06 -7.41 58.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.504 -0.748 . . . . 1.3400000000000001 112.169 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.1 19.4 78.46 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.808 -1.187 . . . . 0.91000000000000003 112.613 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.6 tp -61.33 143.29 55.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.94 -0.741 . . . . 1.51 109.63 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -66.44 146.6 54.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 2.8799999999999999 108.966 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.55 142.24 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.214 -1.032 . . . . 1.6200000000000001 108.214 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 147' ' ' ILE . 15.4 mm -75.73 129.93 36.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.04 -1.096 . . . . 2.1099999999999999 108.04 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.27 94.67 9.28 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.914 -1.513 . . . . 1.6200000000000001 106.914 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 54.5 mt -74.19 -23.68 59.25 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.73 0.776 . . . . 1.3999999999999999 110.515 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.5 m -82.88 6.96 16.69 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.882 0.848 . . . . 2.0499999999999998 112.019 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.73 23.08 9.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.627 -0.671 . . . . 1.3500000000000001 112.634 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.7 mt -73.68 138.49 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.32 -0.862 . . . . 1.4199999999999999 109.148 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -118.02 -18.44 9.43 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.778 0.799 . . . . 2.9900000000000002 112.725 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -115.36 140.72 48.87 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.432 -0.951 . . . . 1.54 108.432 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -70.98 120.83 17.12 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.041 -1.037 . . . . 1.3799999999999999 108.483 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.13 175.01 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.568 -0.707 . . . . 1.28 109.305 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 mt -87.49 144.43 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.322 -0.861 . . . . 1.1599999999999999 108.935 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.8 tp -97.66 126.97 43.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.996 -1.065 . . . . 1.3100000000000001 108.24 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.0 131.06 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.268 -1.012 . . . . 1.25 108.268 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.04 147.59 11.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.058 -1.027 . . . . 1.26 109.087 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.06 -32.18 71.82 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.544 -1.347 . . . . 1.6000000000000001 109.741 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 50.6 p-10 -172.53 150.82 2.31 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.434 -0.95 . . . . 2.4199999999999999 108.434 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 46.4 mt -118.53 143.07 47.01 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.373 -0.829 . . . . 1.3500000000000001 109.247 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.0 p -92.19 141.83 25.53 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.112 -0.992 . . . . 1.3200000000000001 108.673 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.57 -40.28 2.15 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 121.871 1.714 . . . . 0.69999999999999996 113.706 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.8 m -60.72 -49.99 75.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.1 -1.04 . . . . 1.1200000000000001 109.704 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.31 -39.91 94.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.504 -0.747 . . . . 1.21 110.168 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 34.5 p -66.87 -38.54 86.51 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.449 0.642 . . . . 1.1899999999999999 110.561 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.39 88.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.632 -0.668 . . . . 1.24 110.427 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -93.23 0.07 56.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.077 -1.015 . . . . 1.6899999999999999 112.694 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.46 148.06 43.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.979 -1.076 . . . . 1.3400000000000001 108.515 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -97.65 119.71 36.71 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.13 -1.434 . . . . 2.77 107.13 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 45.5 mt -78.14 -12.34 59.99 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.929 -0.482 . . . . 2.0899999999999999 111.601 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -83.0 -23.75 33.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.974 -1.079 . . . . 2.6699999999999999 111.825 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -101.96 -4.95 25.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.232 -0.917 . . . . 2.5800000000000001 113.092 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.23 125.95 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.76 -1.2 . . . . 1.1799999999999999 107.76 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 37.8 tp -90.96 -8.52 49.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.905 . . . . 2.1800000000000002 112.197 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 177.4 169.64 38.76 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.978 -1.649 . . . . 0.48999999999999999 108.978 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -127.82 133.86 49.42 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.005 -1.109 . . . . 0.64000000000000001 108.005 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 76.9 mt -132.09 109.62 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 106.133 -1.803 . . . . 1.21 106.133 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 203' ' ' VAL . 66.5 p -131.26 172.28 12.33 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.917 -1.114 . . . . 1.3799999999999999 110.347 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.402 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 26.9 t0 -101.53 61.7 0.92 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.563 -0.71 . . . . 2.3700000000000001 109.958 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.143 0 O-C-N 121.233 -0.917 . . . . 1.52 108.809 -179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 108.041 -1.096 . . . . 2.1099999999999999 108.041 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -62.68 -37.86 88.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.303 -0.873 . . . . 1.24 110.888 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 87.0 m -59.68 -40.12 86.75 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.405 -0.918 . . . . 2.1499999999999999 110.586 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.6 t -58.54 -39.73 81.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.231 -0.918 . . . . 2.02 110.049 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.9 mm -60.04 -35.84 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 2.1200000000000001 110.96 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 65.9 mtp -62.94 -41.2 99.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.02 -1.05 . . . . 1.3600000000000001 109.951 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.17 -47.2 84.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.997 -0.547 . . . . 1.29 110.588 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' A' ' 195' ' ' ARG . 29.0 mtt-85 -60.14 -42.16 94.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 3.5600000000000001 110.349 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.7 m -69.47 -41.59 75.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.017 -1.052 . . . . 1.1799999999999999 109.835 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.5 mt -91.0 -8.3 49.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.619 -0.675 . . . . 1.3400000000000001 112.094 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 48.62 14.54 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.739 1.015 . . . . 1.45 113.739 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.4 mt -74.1 149.18 87.14 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.053 -1.03 . . . . 1.25 108.267 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.07 136.64 53.49 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 121.146 1.231 . . . . 0.78000000000000003 109.691 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.28 159.32 37.46 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 118.133 -1.427 . . . . 1.2 110.148 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 77.0 mt -144.65 144.87 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.64 -1.245 . . . . 1.25 107.64 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 181' ' ' THR . 6.6 m -124.54 -33.94 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 113.608 0.966 . . . . 1.3899999999999999 113.608 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.76 40.72 1.17 Allowed Glycine 0 N--CA 1.484 1.858 0 C-N-CA 120.308 -0.949 . . . . 0.96999999999999997 111.792 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 44.3 p -58.21 -22.54 52.33 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.186 -1.185 . . . . 1.3500000000000001 111.279 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.402 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 72.31 -89.82 0.52 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.505 -1.038 . . . . 1.0700000000000001 110.505 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.42 ' OG ' ' OG ' ' A' ' 210' ' ' SER . 44.9 t -129.43 28.47 5.2 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.604 -0.939 . . . . 1.9199999999999999 112.784 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.12 -37.42 61.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.665 -1.272 . . . . 1.3300000000000001 110.165 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 39.6 p -52.02 -26.25 10.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 1.4199999999999999 111.256 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.42 ' OG ' ' OG ' ' A' ' 207' ' ' SER . 59.3 p -93.2 3.9 54.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 2.1200000000000001 111.603 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -126.92 -3.62 6.44 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.924 0.713 . . . . 2.6899999999999999 112.924 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 22.7 t -120.59 149.42 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.682 0.753 . . . . 1.29 109.185 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -124.96 156.97 37.2 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.476 -0.935 . . . . 2.6899999999999999 108.476 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 9.8 t-20 -56.48 141.13 43.75 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.83 -1.169 . . . . 2.79 110.674 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.6 m-20 80.24 2.51 1.95 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.472 1.286 . . . . 2.3500000000000001 114.472 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.38 145.45 55.69 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.812 -1.18 . . . . 1.97 108.455 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -88.46 116.12 26.46 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.041 -1.466 . . . . 2.9700000000000002 107.041 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 88.6 mt -127.32 142.05 51.55 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.463 -0.773 . . . . 1.25 109.695 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.2 mt -109.65 128.34 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.99 -1.485 . . . . 1.22 106.99 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.8 tp -102.75 115.93 31.56 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.292 -1.744 . . . . 1.24 106.292 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 223' ' ' VAL . 21.6 p-10 -94.38 -22.81 18.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.94 -1.1 . . . . 2.0499999999999998 112.599 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.447 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.23 17.85 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 112.859 0.689 . . . . 1.25 112.859 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.3 t -108.92 -59.57 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.122 -0.986 . . . . 1.4299999999999999 108.959 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.32 11.03 34.04 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.654 0.74 . . . . 3.0299999999999998 111.157 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 60.71 54.67 3.54 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.417 0.627 . . . . 2.25 112.063 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -150.2 149.52 30.32 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.091 0.948 . . . . 2.52 109.942 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.9 t -116.12 141.23 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 109.175 -0.676 . . . . 1.29 109.175 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.43 130.61 49.26 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.855 -1.153 . . . . 1.3400000000000001 108.264 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.5 t -109.81 129.35 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.217 -0.927 . . . . 1.3400000000000001 108.695 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.439 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 10.2 t-20 54.82 50.29 6.2 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 113.701 1.0 . . . . 2.1800000000000002 113.701 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.0 Cg_endo -68.91 151.92 73.69 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.962 2.441 . . . . 0.93999999999999995 110.594 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 65.3 p -76.35 161.45 28.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.241 -0.912 . . . . 2.3999999999999999 110.333 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -60.95 -38.08 84.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.792 -1.192 . . . . 3.3300000000000001 110.191 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -60.4 -41.38 93.76 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.458 0.647 . . . . 3.1699999999999999 110.573 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.82 -40.18 78.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.083 -1.011 . . . . 1.6899999999999999 110.241 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.02 -43.58 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 1.6000000000000001 110.545 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -57.87 -41.52 82.63 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.181 -0.95 . . . . 2.7000000000000002 110.418 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.35 -42.33 98.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.547 -0.721 . . . . 2.96 111.057 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.7 mtp -70.24 -42.53 72.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 1.6299999999999999 110.874 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.075 -1.016 . . . . 3.27 109.593 -178.826 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.2 mt . . . . . 0 N--CA 1.499 1.982 0 N-CA-C 106.119 -1.808 . . . . 1.5700000000000001 106.119 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -105.9 120.97 43.1 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 107.665 -1.235 . . . . 1.4399999999999999 107.665 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.4 -159.03 18.39 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.715 -1.754 . . . . 1.01 108.715 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 83.5 mt -94.84 1.11 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -1.189 . . . . 1.6299999999999999 112.409 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tp 49.02 98.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 1.5800000000000001 112.012 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.98 -45.71 12.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.728 -1.233 . . . . 1.3400000000000001 111.577 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -145.89 145.21 24.24 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.796 -1.187 . . . . 1.8600000000000001 107.796 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.37 143.84 22.43 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.868 2.378 . . . . 1.01 112.276 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.95 174.19 25.46 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 108.908 -1.677 . . . . 0.81000000000000005 108.908 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 11' ' ' ILE . 98.2 mt -131.31 133.09 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.316 -1.108 . . . . 1.3700000000000001 108.054 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.62 155.2 48.53 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.503 -0.748 . . . . 1.1399999999999999 109.629 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.5 m-85 -125.56 140.36 52.81 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.732 -0.84 . . . . 0.87 108.732 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.42 164.41 30.43 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 118.813 -1.66 . . . . 0.56999999999999995 109.626 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -75.05 159.1 32.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.579 -0.953 . . . . 2.3500000000000001 108.773 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -89.06 126.23 35.35 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.975 -1.12 . . . . 1.21 107.975 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.9 tp -103.85 105.91 16.26 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.022 -2.214 . . . . 1.3999999999999999 105.022 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.5 tp -90.32 133.63 34.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 1.4399999999999999 108.188 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.6 mt -99.93 120.03 39.16 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.925 -1.509 . . . . 1.45 106.925 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -109.86 142.33 41.32 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.717 -0.846 . . . . 2.5 108.717 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -121.57 141.74 50.79 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.907 -1.12 . . . . 2.6600000000000001 109.225 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.25 137.28 34.9 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.87 -1.144 . . . . 2.3199999999999998 108.018 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -62.38 149.19 43.07 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.252 -0.648 . . . . 2.1099999999999999 109.252 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -93.84 131.91 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.359 -0.978 . . . . 1.29 108.359 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t -106.04 130.35 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.297 -1.001 . . . . 1.4099999999999999 108.297 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.3 mt -96.24 138.22 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.846 -0.798 . . . . 1.3100000000000001 108.846 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -90.1 122.86 33.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.206 -1.035 . . . . 1.3400000000000001 108.206 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.1 mmt-85 -95.35 14.47 22.34 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.283 -0.886 . . . . 3.48 112.478 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -75.3 140.47 43.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.917 -1.114 . . . . 2.52 109.198 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.55 136.35 32.98 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.875 -1.157 . . . . 2.6299999999999999 107.875 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 pt -94.93 168.84 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.885 . . . . 1.3100000000000001 110.482 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.4 p -97.77 165.82 11.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.675 -0.641 . . . . 1.24 109.845 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.03 -27.24 61.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.874 -1.141 . . . . 1.49 111.579 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -68.17 -34.62 76.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.939 -1.1 . . . . 2.2799999999999998 110.453 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -90.13 -9.48 48.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.978 -1.076 . . . . 2.0499999999999998 112.492 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.3 t -58.55 -42.14 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.856 -1.152 . . . . 1.3400000000000001 110.622 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.17 -38.25 79.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 1.54 110.926 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -63.17 -45.0 93.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.909 . . . . 2.8500000000000001 111.268 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.52 -37.05 82.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.547 -1.346 . . . . 1.3100000000000001 110.991 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.6 t -60.8 -40.17 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.074 -1.016 . . . . 1.3799999999999999 110.193 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.64 -39.63 92.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.948 -1.095 . . . . 1.5 110.096 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.71 -40.23 91.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.885 . . . . 2.7799999999999998 109.893 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -74.03 -58.37 3.34 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.295 -0.878 . . . . 1.0600000000000001 109.703 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.0 -48.38 75.99 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.05 -1.06 . . . . 1.3999999999999999 110.204 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 t -70.65 -44.55 66.89 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.293 -0.963 . . . . 1.3200000000000001 110.153 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.09 -46.17 85.7 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.55 -1.31 . . . . 0.69999999999999996 110.035 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -57.91 -30.25 65.76 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.698 -0.883 . . . . 3.4399999999999999 109.595 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.52 -46.75 80.4 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.676 0.75 . . . . 1.3600000000000001 109.629 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.594 ' HZ1' ' NE2' ' A' ' 53' ' ' GLN . 25.4 ttpp -79.89 -40.65 27.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.467 -0.771 . . . . 2.8300000000000001 110.293 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.85 93.13 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 1.23 110.056 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.8 m -60.13 -37.6 80.54 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.017 0.913 . . . . 1.9199999999999999 109.334 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.37 -46.66 69.46 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.776 -0.647 . . . . 1.25 110.179 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.594 ' NE2' ' HZ1' ' A' ' 49' ' ' LYS . 45.5 mt-30 -61.4 -48.56 80.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.855 -1.153 . . . . 1.97 110.13 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.09 -41.36 96.51 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.845 0.831 . . . . 2.1800000000000002 109.596 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -60.56 -41.22 94.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.468 0.652 . . . . 1.1899999999999999 109.855 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.1 m -64.35 -41.89 96.51 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.387 -0.821 . . . . 1.3400000000000001 110.429 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.02 -32.81 55.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.191 -0.943 . . . . 1.23 110.573 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -53.18 -46.56 69.02 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.329 -0.857 . . . . 1.5600000000000001 110.733 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -68.74 -38.92 80.48 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.202 -0.937 . . . . 1.3 109.48 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -62.9 -40.31 97.15 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.53 -1.268 . . . . 2.3199999999999998 108.952 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.62 72.82 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.714 -0.794 . . . . 1.1399999999999999 109.234 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.09 -33.23 26.98 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.155 -1.178 . . . . 0.68999999999999995 110.155 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -82.1 -24.67 35.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.107 -1.231 . . . . 1.48 111.138 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.1 m -86.29 -46.74 10.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.506 -0.746 . . . . 1.52 110.74 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -105.71 -19.04 13.88 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.373 -0.829 . . . . 1.3100000000000001 112.657 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.82 152.73 9.09 Favored Glycine 0 N--CA 1.504 3.225 0 O-C-N 121.247 -0.908 . . . . 0.84999999999999998 111.816 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -52.58 -21.77 4.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.48 -1.012 . . . . 3.8599999999999999 112.66 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.31 -32.63 71.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.193 -0.942 . . . . 2.3500000000000001 111.456 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -82.79 -13.73 55.72 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.655 -1.278 . . . . 2.2599999999999998 112.579 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.41 -32.49 71.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.046 -1.034 . . . . 1.45 111.209 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.56 96.16 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.025 -1.047 . . . . 1.25 111.322 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.7 mt -65.45 -42.52 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.652 -1.28 . . . . 1.26 110.638 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.6 -28.74 66.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.113 -0.992 . . . . 0.82999999999999996 110.554 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.35 -37.59 81.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.259 -0.901 . . . . 1.1899999999999999 110.403 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.83 -41.09 74.37 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.26 -0.971 . . . . 0.57999999999999996 110.899 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -58.63 -43.02 89.59 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.967 -1.313 . . . . 2.0499999999999998 110.223 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 77' ' ' ILE . 87.2 mt -60.59 -39.97 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.19 -0.944 . . . . 1.21 109.934 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.1 ttp -59.61 -39.56 84.61 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.055 -0.658 . . . . 2.29 110.585 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.33 -49.41 77.93 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.035 -1.041 . . . . 1.21 110.837 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.0 -45.1 93.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 1.1399999999999999 110.423 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -85.93 14.13 6.53 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.01 -1.056 . . . . 1.4199999999999999 112.718 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -65.58 127.51 32.17 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.759 -1.213 . . . . 1.27 108.503 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -68.21 -17.18 64.25 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.235 1.017 . . . . 1.3500000000000001 110.704 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -75.24 -52.83 9.94 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.799 0.809 . . . . 2.2200000000000002 110.544 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.08 -37.85 84.15 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.794 -0.763 . . . . 1.22 110.225 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -59.21 -49.33 78.26 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.487 -0.758 . . . . 1.29 110.716 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -60.75 -38.7 86.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.422 -0.798 . . . . 2.1699999999999999 110.781 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.85 -48.55 73.9 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.479 -0.888 . . . . 1.3 110.142 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.06 -45.57 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.411 -0.916 . . . . 1.1699999999999999 109.661 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.8 mt -60.7 -43.65 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.144 0.497 . . . . 1.3999999999999999 110.453 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -60.21 -44.43 95.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.964 -1.085 . . . . 1.3300000000000001 111.058 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.65 -44.06 97.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.011 . . . . 1.48 110.151 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.31 -48.94 86.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.276 -0.89 . . . . 1.28 110.292 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -77.83 -33.41 52.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.373 -0.829 . . . . 2.6000000000000001 111.44 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 91' ' ' ALA . 55.1 t0 -82.74 -47.48 11.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.663 -1.273 . . . . 1.51 112.386 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -102.55 10.72 38.63 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.362 -0.836 . . . . 2.48 112.456 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.8 m80 51.49 49.18 21.49 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.988 -1.07 . . . . 1.6100000000000001 111.303 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 59.0 mtt -104.57 150.79 24.33 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.387 -0.821 . . . . 1.8999999999999999 109.701 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.4 p -74.11 165.66 24.76 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.405 -0.809 . . . . 1.3200000000000001 109.988 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.81 -40.6 80.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.647 -0.658 . . . . 1.1499999999999999 110.711 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -68.1 -42.93 79.56 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.52 -0.738 . . . . 2.25 110.07 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -52.09 28.2 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.111 -0.635 . . . . 1.22 111.225 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.16 -44.24 95.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.874 -1.141 . . . . 1.1899999999999999 110.905 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.56 88.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.724 -0.61 . . . . 1.2 111.078 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -59.75 -37.26 78.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.614 -1.304 . . . . 2.1000000000000001 110.562 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -59.28 -48.28 82.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.922 -1.111 . . . . 1.3 110.636 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.4 t -60.89 -47.04 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.788 -1.195 . . . . 1.27 110.875 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.17 -34.06 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.605 0.717 . . . . 1.1899999999999999 109.833 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -57.55 -42.56 83.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.761 . . . . 2.1099999999999999 110.803 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.09 -32.34 17.62 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.521 -1.323 . . . . 0.88 112.735 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -62.07 -42.63 99.4 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.167 -1.784 . . . . 1.99 109.828 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.7 -53.31 16.16 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.749 0.785 . . . . 1.28 110.771 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 64.7 m -60.95 -36.04 78.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.702 -0.624 . . . . 2.2200000000000002 110.659 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.55 -42.15 99.36 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.379 -0.826 . . . . 1.45 110.184 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.2 mt -65.3 -29.66 70.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.793 -1.192 . . . . 1.47 110.967 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.98 -20.01 66.27 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.322 -0.861 . . . . 2.04 110.76 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.74 -12.54 61.05 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.779 0.8 . . . . 1.73 110.82 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 24.7 mt -90.6 139.58 30.57 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.964 -1.124 . . . . 1.79 107.964 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -101.83 43.71 1.05 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.46 -0.775 . . . . 2.8799999999999999 111.618 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -115.87 142.37 46.86 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.296 -0.878 . . . . 1.5800000000000001 109.069 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -56.81 -41.53 77.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 3.04 110.101 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -71.9 -55.13 8.06 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.911 -1.118 . . . . 1.29 110.577 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.1 mt -60.13 -40.01 88.26 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.141 -0.974 . . . . 1.6000000000000001 110.63 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -63.09 -48.71 77.45 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.231 -0.918 . . . . 2.7599999999999998 109.812 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -60.63 -31.45 70.65 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.896 -0.722 . . . . 2.1499999999999999 109.922 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.504 ' HG2' HH11 ' A' ' 126' ' ' ARG . 1.5 ttt-85 -61.2 -30.5 70.46 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.275 1.036 . . . . 2.8100000000000001 108.769 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.08 -49.8 75.86 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.839 0.828 . . . . 1.3899999999999999 110.097 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.24 -44.29 79.81 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.737 0.779 . . . . 1.4099999999999999 110.281 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.6 -35.71 81.39 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.293 -0.88 . . . . 1.3899999999999999 110.803 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 49.8 t -69.14 -38.74 78.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 120.975 -1.078 . . . . 1.1899999999999999 110.823 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.481 ' HG2' HH11 ' A' ' 131' ' ' ARG . 1.8 ttt-85 -55.31 -39.97 70.55 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.494 -1.282 . . . . 3.6299999999999999 109.53 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -61.32 -36.99 81.65 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.577 0.703 . . . . 1.28 110.088 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.51 -39.91 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.915 -1.116 . . . . 1.1799999999999999 109.941 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.03 -44.07 98.65 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.567 -1.301 . . . . 0.51000000000000001 109.899 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.36 -40.12 85.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.403 -1.057 . . . . 3.1699999999999999 110.744 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.43 ' HG2' HH11 ' A' ' 136' ' ' ARG . 53.3 mtt-85 -59.46 -43.11 93.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.118 -0.989 . . . . 2.8500000000000001 110.328 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.6 tp -65.4 -45.42 84.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.433 -0.792 . . . . 1.6499999999999999 110.154 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.23 -42.91 99.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.317 -0.864 . . . . 1.2 110.419 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -59.68 -34.84 73.38 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.657 -0.652 . . . . 2.7999999999999998 110.688 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -74.97 -42.38 57.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 2.1499999999999999 110.832 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.401 HG22 HD11 ' A' ' 141' ' ' ILE . 96.3 mt -62.99 -38.81 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.461 -0.774 . . . . 1.21 110.337 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 43.8 mt -87.15 -6.09 58.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.998 -1.064 . . . . 1.3400000000000001 112.178 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.6 23.87 77.49 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 119.445 -1.36 . . . . 0.91000000000000003 113.057 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.83 150.35 33.07 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.864 -0.786 . . . . 1.51 109.901 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -67.79 150.46 48.6 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.545 -0.862 . . . . 2.8799999999999999 110.043 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.5 mt -105.32 141.83 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.423 -0.798 . . . . 1.6200000000000001 109.083 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 147' ' ' ILE . 17.8 mm -76.21 122.03 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 107.75 -1.204 . . . . 2.1099999999999999 107.75 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -92.98 94.6 8.99 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.481 -1.674 . . . . 1.6200000000000001 106.481 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.38 -28.17 59.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.594 -0.692 . . . . 1.3999999999999999 111.18 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 t -81.21 3.32 24.18 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.868 0.842 . . . . 2.0499999999999998 111.979 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.08 14.62 21.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.443 -0.786 . . . . 1.3500000000000001 112.755 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.4 mt -72.89 136.69 24.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.069 -1.02 . . . . 1.4199999999999999 108.715 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -117.27 -15.31 10.42 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.148 0.975 . . . . 2.9900000000000002 112.297 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -115.41 140.34 49.22 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.747 0.784 . . . . 1.54 109.092 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -70.62 119.53 14.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.461 -0.774 . . . . 1.3799999999999999 109.029 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.06 174.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.281 -0.887 . . . . 1.28 109.174 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mt -89.25 145.55 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 1.1599999999999999 108.843 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.6 tp -98.1 121.55 40.16 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.062 -1.024 . . . . 1.3100000000000001 108.37 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.1 130.21 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 108.146 -1.057 . . . . 1.25 108.146 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.98 157.92 27.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.808 -1.182 . . . . 1.26 108.654 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.84 -36.88 82.49 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.386 -1.446 . . . . 1.6000000000000001 109.829 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -172.96 149.7 1.92 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.404 -0.591 . . . . 2.4199999999999999 109.404 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.8 mt -117.64 141.24 48.6 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.405 -0.809 . . . . 1.3500000000000001 109.009 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.6 p -94.03 151.23 39.54 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.741 -1.224 . . . . 1.3200000000000001 108.88 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -41.57 -46.22 6.17 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.251 1.968 . . . . 0.69999999999999996 113.838 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.0 m -58.88 -49.91 76.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.761 -1.212 . . . . 1.1200000000000001 110.45 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.26 -38.71 87.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.915 0.864 . . . . 1.21 110.225 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.2 p -70.0 -39.9 75.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 1.1899999999999999 110.416 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.84 74.32 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.712 -0.618 . . . . 1.24 110.656 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -93.09 -3.56 53.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 1.6899999999999999 112.767 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.0 tp -64.62 150.99 45.95 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.291 -0.633 . . . . 1.3400000000000001 109.291 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -93.95 112.43 24.27 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.636 -1.616 . . . . 2.77 106.636 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.0 mt -70.3 -22.23 62.86 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.769 -0.582 . . . . 2.0899999999999999 111.704 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -83.35 -15.83 48.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.479 -0.763 . . . . 2.6699999999999999 112.919 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -102.79 -4.04 25.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.206 -0.934 . . . . 2.5800000000000001 113.446 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 64.3 t -111.14 129.93 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.197 -1.038 . . . . 1.1799999999999999 108.197 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.5 tp -83.99 -10.04 58.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.327 -0.858 . . . . 2.1800000000000002 112.263 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.5 166.98 35.59 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.796 -1.721 . . . . 0.48999999999999999 108.796 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -126.37 127.49 45.57 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.51 -1.293 . . . . 0.64000000000000001 107.51 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 61.0 mt -125.34 127.91 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 106.702 -1.592 . . . . 1.21 106.702 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 203' ' ' VAL . 30.2 p -138.57 174.61 10.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.005 -1.06 . . . . 1.3799999999999999 109.704 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 52.8 t0 -106.32 34.71 3.24 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.375 0.607 . . . . 2.3700000000000001 110.712 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.222 0 N-CA-C 107.262 -1.384 . . . . 1.52 107.262 178.302 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 108.834 -0.802 . . . . 2.1099999999999999 108.834 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -58.45 -38.08 76.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 1.24 111.208 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.498 ' HG1' ' N ' ' A' ' 191' ' ' SER . 3.8 p -56.66 -43.28 80.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.31 -1.494 . . . . 2.1499999999999999 110.199 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.498 ' N ' ' HG1' ' A' ' 190' ' ' THR . 77.1 p -61.97 -36.17 80.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.3 -0.875 . . . . 2.02 110.316 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.3 mt -61.46 -36.79 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.142 -0.974 . . . . 2.1200000000000001 110.759 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 85.3 mtp -62.08 -46.94 86.89 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.653 1.216 . . . . 1.3600000000000001 109.48 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.5 -51.77 67.26 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.016 -0.993 . . . . 1.29 110.748 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -63.15 -44.88 94.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.277 -0.89 . . . . 3.5600000000000001 110.759 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.4 m -66.9 -38.13 85.68 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.768 -1.207 . . . . 1.1799999999999999 110.288 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 25.3 mt -91.45 -0.42 57.62 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.723 0.638 . . . . 1.3400000000000001 112.723 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 56.23 5.52 0.19 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 114.444 1.275 . . . . 1.45 114.444 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.6 mt -72.26 143.05 85.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.919 -1.113 . . . . 1.25 108.396 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.56 137.07 75.39 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.298 1.332 . . . . 0.78000000000000003 110.292 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.29 169.39 20.72 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 117.762 -1.575 . . . . 1.2 109.803 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 58.2 mt -145.72 156.85 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.808 -1.182 . . . . 1.25 107.808 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 181' ' ' THR . 25.5 m -140.47 -29.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.268 -0.895 . . . . 1.3899999999999999 112.893 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.62 38.44 3.11 Favored Glycine 0 N--CA 1.486 2.025 0 O-C-N 121.293 -0.879 . . . . 0.96999999999999997 112.058 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.3 p -53.25 -26.55 18.46 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.506 -0.997 . . . . 1.3500000000000001 111.622 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 88.56 -88.98 1.56 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.82 -0.912 . . . . 1.0700000000000001 110.82 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 39.7 t -128.45 30.43 5.16 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.189 -1.183 . . . . 1.9199999999999999 112.285 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 44.7 t -62.01 -38.45 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.435 -1.416 . . . . 1.3300000000000001 109.991 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.8 p -53.19 -21.37 5.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 1.4199999999999999 111.308 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.3 t -95.02 0.73 54.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.222 -0.924 . . . . 2.1200000000000001 111.581 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -126.31 -6.36 6.51 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 113.345 0.869 . . . . 2.6899999999999999 113.345 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 10.2 t -117.31 145.59 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 122.014 0.911 . . . . 1.29 109.434 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -118.94 155.07 31.97 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.026 -1.102 . . . . 2.6899999999999999 108.026 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 35.5 p-10 -54.58 140.69 34.12 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.844 -1.16 . . . . 2.79 110.724 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 m-20 78.81 5.89 2.34 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.484 1.29 . . . . 2.3500000000000001 114.484 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.0 149.23 47.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.746 -1.221 . . . . 1.97 108.388 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -88.86 117.63 27.99 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.29 -1.374 . . . . 2.9700000000000002 107.29 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 84.1 mt -128.58 149.62 50.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.763 0.792 . . . . 1.25 109.498 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.3 mt -115.12 129.86 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.77 -1.567 . . . . 1.22 106.77 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 64.4 tp -101.02 117.06 34.28 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.41 -2.07 . . . . 1.24 105.41 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.577 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.8 t0 -90.63 -24.36 20.53 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.078 -1.049 . . . . 2.0499999999999998 112.574 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 39.13 17.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 112.735 0.643 . . . . 1.25 112.735 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' A' ' 221' ' ' ASP . 26.0 t -114.42 -64.59 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.959 0.885 . . . . 1.4299999999999999 109.135 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -89.73 9.41 27.29 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.139 0.971 . . . . 3.0299999999999998 110.582 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 52.2 t30 60.34 49.81 6.68 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.67 0.748 . . . . 2.25 111.589 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -147.53 153.03 38.97 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.193 0.996 . . . . 2.52 109.669 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 76.5 t -118.43 140.03 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.507 -0.923 . . . . 1.29 108.507 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.25 132.79 42.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.86 -1.15 . . . . 1.3400000000000001 107.984 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 44.1 t -109.8 129.68 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 108.474 -0.936 . . . . 1.3400000000000001 108.474 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.408 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 58.5 t30 47.28 54.57 15.64 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 113.577 0.955 . . . . 2.1800000000000002 113.577 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 40.5 Cg_endo -67.88 151.89 77.78 Favored 'Trans proline' 0 C--N 1.297 -2.177 0 C-N-CA 122.462 2.108 . . . . 0.93999999999999995 110.033 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.5 m -74.17 155.32 38.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.823 -0.806 . . . . 2.3999999999999999 108.823 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -57.58 -39.52 76.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.151 -0.968 . . . . 3.3300000000000001 110.468 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.45 -38.28 89.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.349 -0.845 . . . . 3.1699999999999999 110.208 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.44 -37.53 75.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.497 -0.752 . . . . 1.6899999999999999 110.523 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.26 -44.39 95.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.783 -0.767 . . . . 1.6000000000000001 110.498 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -58.9 -39.4 81.35 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.482 -0.761 . . . . 2.7000000000000002 110.034 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -60.53 -40.45 91.55 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.46 -0.775 . . . . 2.96 110.239 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 83.8 mtp -74.74 -41.51 60.0 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.016 -1.053 . . . . 1.6299999999999999 110.537 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 . . . . . 0 C--N 1.307 -1.264 0 C-N-CA 119.513 -0.875 . . . . 3.27 109.689 -178.908 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.3 mt . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 106.737 -1.579 . . . . 1.5700000000000001 106.737 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.5 m -105.24 122.0 45.02 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.629 -1.249 . . . . 1.4399999999999999 107.629 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.41 -157.4 13.37 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.643 -1.783 . . . . 1.01 108.643 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 85.1 mt -92.69 -1.46 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.327 -1.102 . . . . 1.6299999999999999 112.552 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 tp 49.83 102.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 1.5800000000000001 112.227 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.14 -44.44 11.5 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.138 -0.976 . . . . 1.3400000000000001 111.589 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 m -144.32 143.81 23.43 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 107.971 -1.122 . . . . 1.8600000000000001 107.971 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.78 143.01 23.21 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.996 2.464 . . . . 1.01 112.344 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 222' ' ' ALA . . . 152.67 168.09 16.28 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 109.236 -1.546 . . . . 0.81000000000000005 109.236 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.8 mt -124.35 137.51 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.034 -1.274 . . . . 1.3700000000000001 107.845 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.17 148.36 43.08 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.323 -0.861 . . . . 1.1399999999999999 109.081 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.3 m-85 -118.0 139.87 50.56 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 108.378 -0.971 . . . . 0.87 108.378 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.2 167.77 35.45 Favored Glycine 0 N--CA 1.499 2.862 0 C-N-CA 118.806 -1.664 . . . . 0.56999999999999995 110.05 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -78.84 159.83 27.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -1.126 . . . . 2.3500000000000001 109.494 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.93 126.69 34.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.705 -1.247 . . . . 1.21 107.994 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.8 tp -103.53 105.25 15.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.569 -2.011 . . . . 1.3999999999999999 105.569 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.1 tp -92.14 134.47 34.82 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.866 -1.161 . . . . 1.4399999999999999 107.866 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.1 mt -102.21 116.45 32.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.081 -1.452 . . . . 1.45 107.081 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -109.46 131.54 54.97 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.537 -1.282 . . . . 2.5 107.537 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -126.89 152.64 46.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.381 -0.824 . . . . 2.6600000000000001 109.664 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -83.47 134.41 34.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.131 -1.063 . . . . 2.3199999999999998 108.131 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.87 148.84 50.62 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.752 -0.833 . . . . 2.1099999999999999 108.752 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.69 132.28 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.306 -0.998 . . . . 1.29 108.306 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.6 t -108.76 129.94 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.857 -1.164 . . . . 1.4099999999999999 107.857 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.3 133.4 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.391 -0.966 . . . . 1.3100000000000001 108.391 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -93.24 128.97 39.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.096 -1.002 . . . . 1.3400000000000001 108.325 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -97.31 18.95 14.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.277 -0.889 . . . . 3.48 112.004 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -71.19 149.01 46.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 2.52 109.783 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -92.37 138.05 31.85 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.413 -0.958 . . . . 2.6299999999999999 108.413 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 pt -97.44 168.41 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.77 . . . . 1.3100000000000001 109.932 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.4 p -97.71 167.32 11.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.688 -0.632 . . . . 1.24 109.939 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.77 -24.72 58.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.005 -1.059 . . . . 1.49 111.858 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -68.72 -37.97 79.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 2.2799999999999998 110.905 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -84.98 -7.26 59.22 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.72 -1.237 . . . . 2.0499999999999998 112.354 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -58.59 -45.01 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.114 -0.991 . . . . 1.3400000000000001 110.137 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -57.95 -39.78 78.91 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.967 -1.083 . . . . 1.54 110.588 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -63.08 -45.42 92.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.162 -0.961 . . . . 2.8500000000000001 111.037 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -59.88 -40.33 88.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.928 -1.108 . . . . 1.3100000000000001 110.777 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.1 t -59.93 -41.24 85.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.22 -0.925 . . . . 1.3799999999999999 110.689 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -60.1 -47.23 86.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.917 -1.114 . . . . 1.5 110.078 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -61.36 -40.9 96.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.774 -0.771 . . . . 2.7799999999999998 110.247 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -75.29 -56.12 5.03 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.572 -0.705 . . . . 1.0600000000000001 110.307 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 tp -58.01 -45.62 86.57 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.548 -0.861 . . . . 1.3999999999999999 110.375 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 t -66.36 -37.08 84.5 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.159 -0.963 . . . . 1.3200000000000001 109.749 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.66 -41.77 93.9 Favored Glycine 0 N--CA 1.483 1.819 0 C-N-CA 119.582 -1.294 . . . . 0.69999999999999996 109.937 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -59.81 -29.77 68.47 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.172 -1.193 . . . . 3.4399999999999999 109.924 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.35 -49.16 76.67 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.607 0.718 . . . . 1.3600000000000001 110.493 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' CB ' ' HZ1' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -82.4 -38.79 23.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.954 -1.092 . . . . 2.8300000000000001 110.684 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.38 93.31 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.105 -0.997 . . . . 1.23 110.074 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.7 p -63.55 -40.8 97.95 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.046 -1.034 . . . . 1.9199999999999999 109.439 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.59 -48.5 66.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.537 -0.465 . . . . 1.25 110.477 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.77 -49.17 76.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.925 -1.109 . . . . 1.97 110.724 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.15 -39.13 88.94 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.858 -1.151 . . . . 2.1800000000000002 109.971 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -59.84 -41.0 90.44 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.216 -0.594 . . . . 1.1899999999999999 110.319 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.7 m -68.49 -45.12 73.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.142 -0.974 . . . . 1.3400000000000001 110.246 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.8 mt -58.34 -33.95 48.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.338 -0.851 . . . . 1.23 110.815 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -53.07 -42.82 66.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.178 -0.952 . . . . 1.5600000000000001 110.844 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.58 -36.34 76.17 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.021 -1.049 . . . . 1.3 110.051 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.67 -39.62 94.5 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.75 -1.18 . . . . 2.3199999999999998 109.447 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.13 -33.97 77.28 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.75 -0.78 . . . . 1.1399999999999999 109.983 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.15 -36.72 17.18 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.878 -1.153 . . . . 0.68999999999999995 111.132 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -81.65 -25.41 35.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.06 -1.259 . . . . 1.48 111.189 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.8 m -86.48 -48.33 8.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.557 -0.714 . . . . 1.52 111.042 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -107.94 -9.33 15.71 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.031 1.123 . . . . 1.3100000000000001 114.031 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.71 166.45 23.45 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.423 -0.894 . . . . 0.84999999999999998 112.749 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.1 -28.15 50.39 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.702 -0.881 . . . . 3.8599999999999999 112.409 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -54.44 -40.19 68.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.94 -1.1 . . . . 2.3500000000000001 110.73 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -85.24 -25.99 26.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.902 -1.124 . . . . 2.2599999999999998 111.926 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.37 -39.9 84.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.469 -0.769 . . . . 1.45 110.631 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.64 90.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.852 . . . . 1.25 110.89 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.94 -45.68 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.009 -1.057 . . . . 1.26 110.315 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -71.31 -31.0 66.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.82999999999999996 110.441 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.31 -40.12 89.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.012 -1.055 . . . . 1.1899999999999999 109.68 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.7 -38.85 93.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.208 -1.157 . . . . 0.57999999999999996 110.208 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -58.28 -42.07 85.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.227 -1.161 . . . . 2.0499999999999998 110.489 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 77' ' ' ILE . 96.3 mt -60.37 -39.34 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 1.21 110.195 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.3 ttp -59.04 -39.36 81.77 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.178 -0.951 . . . . 2.29 110.491 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.39 -51.39 70.03 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.195 -1.002 . . . . 1.21 110.796 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.76 -38.15 90.03 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.376 -0.827 . . . . 1.1399999999999999 109.994 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -84.67 4.72 31.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.287 0.847 . . . . 1.4199999999999999 113.287 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -66.75 123.48 20.24 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.576 -1.328 . . . . 1.27 108.169 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -65.71 -20.19 66.19 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.778 0.799 . . . . 1.3500000000000001 110.811 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -75.24 -49.46 19.26 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.426 -0.909 . . . . 2.2200000000000002 110.737 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.2 -40.04 95.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.056 -1.027 . . . . 1.22 110.629 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -60.45 -48.22 82.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.002 -1.061 . . . . 1.29 110.602 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.33 -39.97 92.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.385 -0.822 . . . . 2.1699999999999999 110.771 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -63.73 -46.5 85.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.022 -1.071 . . . . 1.3 110.256 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.5 mt -58.36 -43.66 86.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.23 -0.919 . . . . 1.1699999999999999 110.067 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.24 -44.07 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.467 -0.771 . . . . 1.3999999999999999 110.61 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.53 -41.28 97.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 1.3300000000000001 111.146 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.11 -44.85 96.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.054 -1.028 . . . . 1.48 110.736 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.02 -45.1 99.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.16 -0.963 . . . . 1.28 110.305 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -83.2 -37.57 23.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 2.6000000000000001 111.665 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 91' ' ' ALA . 56.1 t0 -79.16 -45.33 20.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.821 -1.174 . . . . 1.51 111.453 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -101.55 8.02 42.07 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.187 -0.945 . . . . 2.48 112.272 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 51.85 49.77 20.04 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.329 -0.857 . . . . 1.6100000000000001 112.097 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.8 mtp -106.78 156.8 18.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.264 -0.897 . . . . 1.8999999999999999 108.838 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.482 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 36.8 p -72.71 161.18 31.08 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.474 -0.766 . . . . 1.3200000000000001 110.361 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.62 93.65 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.459 -0.776 . . . . 1.1499999999999999 110.531 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -68.64 -39.46 80.71 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.069 -1.019 . . . . 2.25 110.392 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.482 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -69.89 -52.34 25.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.186 -1.005 . . . . 1.22 110.84 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.07 92.44 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.1 -1.0 . . . . 1.1899999999999999 110.519 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.46 96.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.339 -0.851 . . . . 1.2 110.565 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -60.64 -38.86 86.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.166 -0.959 . . . . 2.1000000000000001 110.738 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -54.95 -49.5 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 1.3 111.158 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.21 -47.28 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.844 -1.16 . . . . 1.27 109.987 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -61.93 -32.35 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.352 0.596 . . . . 1.1899999999999999 110.568 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -58.51 -40.76 83.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -0.877 . . . . 2.1099999999999999 111.189 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.41 -37.15 8.31 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.064 -1.541 . . . . 0.88 112.888 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -60.3 -38.89 85.06 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.586 -1.538 . . . . 1.99 110.095 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.61 -51.78 15.66 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.54 0.686 . . . . 1.28 110.89 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.6 p -63.49 -35.77 81.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 2.2200000000000002 110.606 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.44 96.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.795 . . . . 1.45 110.629 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.79 -29.99 70.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.053 -1.03 . . . . 1.47 110.655 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -67.16 -22.57 65.75 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.353 -0.842 . . . . 2.04 110.933 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -70.32 -16.12 62.96 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.593 -0.843 . . . . 1.73 111.131 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.8 mt -84.66 144.38 28.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.579 -0.7 . . . . 1.79 109.949 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -97.74 37.36 1.4 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.479 -0.763 . . . . 2.8799999999999999 111.987 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -113.56 139.22 49.18 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 108.377 -0.972 . . . . 1.5800000000000001 108.377 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -59.96 -40.64 89.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.484 -0.76 . . . . 3.04 110.775 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.34 -50.9 34.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.788 -1.195 . . . . 1.29 110.177 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.2 mt -63.23 -42.5 99.25 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.85 -1.14 . . . . 1.6000000000000001 110.022 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -63.35 -49.01 75.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.787 -1.196 . . . . 2.7599999999999998 109.266 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -59.94 -31.07 69.51 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.606 -0.838 . . . . 2.1499999999999999 109.386 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.56 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 17.7 ttt-85 -61.93 -30.44 70.9 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.992 0.901 . . . . 2.8100000000000001 108.82 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.86 -49.37 77.74 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.718 0.771 . . . . 1.3899999999999999 109.366 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.22 85.59 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.581 -0.848 . . . . 1.4099999999999999 110.258 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -63.32 -37.41 87.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.552 -0.717 . . . . 1.3899999999999999 110.417 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.56 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 39.9 t -69.18 -39.7 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 1.1899999999999999 109.936 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -58.58 -36.55 74.15 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.016 -1.052 . . . . 3.6299999999999999 109.734 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.402 ' OD2' ' OG1' ' A' ' 164' ' ' THR . 64.8 t0 -59.92 -39.74 86.48 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.455 0.645 . . . . 1.28 110.052 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.1 mt -61.97 -39.55 84.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.438 -0.789 . . . . 1.1799999999999999 109.509 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.97 -46.8 50.18 Favored Glycine 0 N--CA 1.483 1.773 0 C-N-CA 119.766 -1.207 . . . . 0.51000000000000001 110.517 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.74 -49.99 71.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -1.155 . . . . 3.1699999999999999 110.289 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.432 ' NH2' ' HG ' ' A' ' 166' ' ' SER . 67.3 mtm180 -62.64 -39.25 93.27 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.21 -0.996 . . . . 2.8500000000000001 109.87 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.33 -39.96 88.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.559 -0.713 . . . . 1.6499999999999999 110.02 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.47 -44.32 93.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.519 -0.738 . . . . 1.2 110.081 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -60.51 -35.4 75.86 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.102 -0.999 . . . . 2.7999999999999998 110.26 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -73.06 -40.21 65.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 2.1499999999999999 110.7 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 141' ' ' ILE . 96.7 mt -60.28 -40.01 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 1.21 109.942 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.0 mt -91.01 -3.45 57.23 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.209 -0.932 . . . . 1.3400000000000001 112.416 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.47 23.23 77.72 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.808 -1.187 . . . . 0.91000000000000003 113.13 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.9 tp -66.16 149.26 50.58 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.744 -0.856 . . . . 1.51 109.284 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -64.64 144.91 56.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 2.8799999999999999 109.433 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 53.8 mt -105.46 143.12 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.436 -0.949 . . . . 1.6200000000000001 108.436 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.427 ' H ' HD13 ' A' ' 147' ' ' ILE . 4.2 mp -77.8 125.03 37.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.09 -1.078 . . . . 2.1099999999999999 108.09 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -95.89 93.16 6.88 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.585 -1.635 . . . . 1.6200000000000001 106.585 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.9 mt -78.81 -16.53 57.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 1.3999999999999999 111.981 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.5 m -80.66 0.76 32.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.338 -0.851 . . . . 2.0499999999999998 112.572 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.03 19.75 14.58 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.24 -0.913 . . . . 1.3500000000000001 112.459 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.0 mt -74.86 136.72 24.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.515 0.674 . . . . 1.4199999999999999 109.3 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -125.17 -2.78 7.58 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.448 0.642 . . . . 2.9900000000000002 112.51 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -116.86 134.28 54.96 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.248 -1.019 . . . . 1.54 108.248 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.72 119.1 15.4 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.075 -0.713 . . . . 1.3799999999999999 109.075 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.8 m -147.38 172.27 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.518 -0.739 . . . . 1.28 109.286 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.1 mt -87.33 142.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 1.1599999999999999 109.093 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 25.6 tp -96.46 123.76 40.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.077 -1.014 . . . . 1.3100000000000001 108.432 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.68 129.74 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 107.594 -1.261 . . . . 1.25 107.594 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.14 152.53 19.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.033 -1.042 . . . . 1.26 108.95 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.68 -35.46 76.31 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.585 -1.322 . . . . 1.6000000000000001 109.424 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 64.2 t0 -172.54 147.26 1.83 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.268 -0.641 . . . . 2.4199999999999999 109.268 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.502 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 82.3 mt -116.23 141.61 47.92 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.179 -0.675 . . . . 1.3500000000000001 109.179 177.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.402 ' OG1' ' OD2' ' A' ' 132' ' ' ASP . 36.5 p -94.08 150.25 38.15 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.159 -0.963 . . . . 1.3200000000000001 109.152 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -42.02 -44.3 7.23 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.007 1.805 . . . . 0.69999999999999996 113.719 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.432 ' HG ' ' NH2' ' A' ' 136' ' ' ARG . 28.8 m -59.94 -48.25 82.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.883 -1.136 . . . . 1.1200000000000001 110.055 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.95 -40.69 95.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.225 -0.99 . . . . 1.21 110.126 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 70.7 p -70.22 -39.01 75.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 1.1899999999999999 110.401 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.04 -34.35 74.72 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.896 -0.722 . . . . 1.24 110.881 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -95.7 1.37 53.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.074 -1.017 . . . . 1.6899999999999999 112.521 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.51 152.02 31.3 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.384 -0.822 . . . . 1.3400000000000001 109.778 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.431 HD21 ' H ' ' A' ' 175' ' ' LYS . 0.4 OUTLIER -93.65 110.91 22.51 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.057 -1.831 . . . . 2.77 106.057 177.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.1 mt -72.26 -21.15 61.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.638 -0.664 . . . . 2.0899999999999999 112.318 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -82.53 -23.57 34.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.929 -1.107 . . . . 2.6699999999999999 112.386 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.431 ' H ' HD21 ' A' ' 172' ' ' ASN . 44.2 mmtm -97.15 -4.98 38.24 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.035 -1.041 . . . . 2.5800000000000001 113.094 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.2 t -108.34 128.78 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.566 -1.272 . . . . 1.1799999999999999 107.566 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.1 tp -88.5 -12.05 44.06 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.403 -0.811 . . . . 2.1800000000000002 112.241 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 179.26 167.72 37.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.639 -1.785 . . . . 0.48999999999999999 108.639 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -128.01 131.48 49.2 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.255 -1.144 . . . . 0.64000000000000001 108.458 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 76.8 mt -127.12 129.91 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.172 -1.418 . . . . 1.21 107.172 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 203' ' ' VAL . 37.8 p -138.96 169.95 16.86 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.593 -1.317 . . . . 1.3799999999999999 110.066 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.439 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 4.3 m-20 -101.07 35.5 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.875 -0.515 . . . . 2.3700000000000001 111.53 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.888 0 O-C-N 120.922 -1.112 . . . . 1.52 108.325 178.59 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.598 0.713 . . . . 2.1099999999999999 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -57.6 -39.66 77.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -0.875 . . . . 1.24 111.088 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 44.1 p -59.74 -41.4 90.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.068 -1.02 . . . . 2.1499999999999999 110.498 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 59.9 p -61.15 -35.49 77.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 2.02 110.367 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.03 -39.59 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 2.1200000000000001 110.852 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 66.0 mtp -62.89 -40.78 98.59 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.233 1.016 . . . . 1.3600000000000001 109.409 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.44 -48.95 79.67 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.739 -0.664 . . . . 1.29 110.297 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -61.16 -41.57 97.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.238 -0.914 . . . . 3.5600000000000001 110.938 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m -70.3 -40.57 74.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.963 -1.086 . . . . 1.1799999999999999 110.539 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.57 -9.1 48.34 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.043 0.757 . . . . 1.3400000000000001 113.043 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.5 mt-10 55.63 8.35 0.32 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.794 1.035 . . . . 1.45 113.794 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 56.8 mt -72.56 147.98 90.0 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 1.25 108.267 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.76 136.3 72.89 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 120.982 1.121 . . . . 0.78000000000000003 110.027 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.31 164.63 34.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.398 -1.439 . . . . 1.2 109.429 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 99.1 mt -144.1 160.19 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.335 -1.357 . . . . 1.25 107.335 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 181' ' ' THR . 15.7 m -139.09 -27.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 120.818 -1.176 . . . . 1.3899999999999999 112.023 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.75 41.03 3.04 Favored Glycine 0 N--CA 1.492 2.43 0 O-C-N 121.242 -0.911 . . . . 0.96999999999999997 111.841 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 46.9 p -62.69 -23.72 67.28 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.24 -1.153 . . . . 1.3500000000000001 111.007 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.04 -92.17 1.78 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.077 -1.059 . . . . 1.0700000000000001 110.668 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 86.0 p -128.35 30.61 5.16 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.178 -1.189 . . . . 1.9199999999999999 112.302 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.21 -33.68 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.264 -1.522 . . . . 1.3300000000000001 110.107 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 26.0 p -58.14 -26.76 63.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.987 -1.071 . . . . 1.4199999999999999 111.52 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.8 t -93.58 1.82 56.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.301 -0.875 . . . . 2.1200000000000001 111.999 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -123.95 -0.53 8.43 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 112.911 0.708 . . . . 2.6899999999999999 112.911 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 11.1 t -120.01 150.87 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.52 -0.737 . . . . 1.29 109.853 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -118.73 157.81 26.77 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.918 -1.142 . . . . 2.6899999999999999 107.918 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.602 HD21 ' N ' ' A' ' 215' ' ' ASP . 0.2 OUTLIER -59.26 141.2 54.96 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.978 -1.076 . . . . 2.79 110.492 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.602 ' N ' HD21 ' A' ' 214' ' ' ASN . 3.3 m-20 80.75 -1.5 1.85 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 114.525 1.306 . . . . 2.3500000000000001 114.525 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -62.33 148.85 43.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.34 -1.475 . . . . 1.97 108.176 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -88.57 120.84 30.32 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.311 -1.366 . . . . 2.9700000000000002 107.311 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.8 mt -128.48 146.38 50.83 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.664 0.745 . . . . 1.25 109.905 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.11 126.76 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.617 -1.623 . . . . 1.22 106.617 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 65.5 tp -100.52 119.64 38.81 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.355 -1.721 . . . . 1.24 106.355 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 53.3 t0 -92.25 -26.4 18.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.893 -1.13 . . . . 2.0499999999999998 112.518 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 10' ' ' GLY . . . 39.11 13.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.137 0.791 . . . . 1.25 113.137 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.2 t -108.27 -59.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.741 -1.224 . . . . 1.4299999999999999 109.695 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -92.68 10.12 32.01 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.018 0.913 . . . . 3.0299999999999998 110.561 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 62.15 53.58 2.89 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.659 -0.7 . . . . 2.25 112.242 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -147.0 149.06 32.4 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.371 1.081 . . . . 2.52 109.645 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.1 t -115.98 133.33 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.444 -1.317 . . . . 1.29 107.444 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.11 132.57 46.5 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.026 -1.047 . . . . 1.3400000000000001 108.468 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 60.4 t -110.48 129.94 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.365 -0.834 . . . . 1.3400000000000001 108.763 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.4 t30 54.34 55.2 11.73 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.15 -0.969 . . . . 2.1800000000000002 113.232 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.09 150.42 60.06 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.582 2.188 . . . . 0.93999999999999995 111.322 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.5 m -75.2 158.87 32.29 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.254 -0.904 . . . . 2.3999999999999999 109.313 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -58.75 -39.09 79.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 3.3300000000000001 110.688 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -58.82 -40.17 83.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -0.937 . . . . 3.1699999999999999 109.865 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.65 -39.09 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 1.6899999999999999 110.105 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.4 mt -57.35 -47.26 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.818 -0.753 . . . . 1.6000000000000001 110.715 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.92 -40.22 88.12 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.326 -0.859 . . . . 2.7000000000000002 110.557 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -61.17 -48.12 83.03 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.401 -0.812 . . . . 2.96 111.289 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 81.9 mtp -70.44 -33.1 70.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 1.6299999999999999 111.092 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 . . . . . 0 C--N 1.303 -1.428 0 O-C-N 120.983 -1.073 . . . . 3.27 110.076 179.295 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.1 mt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.557 0.694 . . . . 1.5700000000000001 111.962 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.0 m -97.38 116.67 30.02 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.576 -1.639 . . . . 1.4399999999999999 106.576 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.78 -153.47 30.29 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 120.441 -1.412 . . . . 1.01 109.912 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.472 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 74.6 mt -94.43 1.01 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.586 -0.949 . . . . 1.6299999999999999 112.552 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 tp 52.52 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.685 -1.26 . . . . 1.5800000000000001 112.444 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.54 -35.33 17.01 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.648 -1.283 . . . . 1.3400000000000001 110.744 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 1.2 p -148.67 140.96 14.85 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.711 -1.243 . . . . 1.8600000000000001 108.083 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.0 147.88 24.33 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.151 1.901 . . . . 1.01 112.347 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 152.56 163.64 11.79 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.265 -1.534 . . . . 0.81000000000000005 109.265 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.5 mt -121.05 134.33 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.057 -1.261 . . . . 1.3700000000000001 108.345 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.25 151.85 44.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.193 -0.942 . . . . 1.1399999999999999 109.416 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.9 m-85 -122.06 144.46 48.9 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.431 -0.951 . . . . 0.87 108.431 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.85 166.27 31.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.551 -1.785 . . . . 0.56999999999999995 110.092 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -77.88 159.68 28.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.329 -1.101 . . . . 2.3500000000000001 109.204 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.53 127.69 35.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.792 -1.188 . . . . 1.21 107.792 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.2 tp -106.11 109.53 21.49 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 105.468 -2.049 . . . . 1.3999999999999999 105.468 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.8 tp -95.58 136.27 36.17 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.414 -1.328 . . . . 1.4399999999999999 107.414 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.8 mt -99.8 118.82 37.09 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.062 -1.459 . . . . 1.45 107.062 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -112.05 136.19 51.72 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.65 -1.241 . . . . 2.5 107.65 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -130.33 151.96 50.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.251 -0.906 . . . . 2.6600000000000001 109.149 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -80.06 138.35 36.96 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.478 -0.934 . . . . 2.3199999999999998 108.478 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -63.79 149.33 47.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.454 -0.779 . . . . 2.1099999999999999 109.002 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.6 mt -92.69 129.97 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.915 -1.116 . . . . 1.29 108.651 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.9 t -105.36 130.01 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.529 -1.285 . . . . 1.4099999999999999 107.529 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.27 135.03 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.654 -0.869 . . . . 1.3100000000000001 108.654 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -90.91 122.1 33.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.075 -1.016 . . . . 1.3400000000000001 108.512 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -95.4 11.8 31.52 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.591 -0.693 . . . . 3.48 112.106 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' CB ' ' HZ1' ' A' ' 29' ' ' LYS . 9.8 mtmp? -66.97 141.54 57.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.88 -1.138 . . . . 2.52 108.885 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -88.9 134.16 34.05 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.138 -1.06 . . . . 2.6299999999999999 108.138 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -97.78 167.14 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.394 -0.816 . . . . 1.3100000000000001 110.477 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.6 p -94.67 160.95 14.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.686 -0.633 . . . . 1.24 109.53 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.41 -21.92 11.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.903 -1.123 . . . . 1.49 111.94 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -67.53 -37.24 82.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 2.2799999999999998 110.753 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -90.25 -8.5 50.85 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.649 -1.282 . . . . 2.0499999999999998 112.587 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.1 t -58.89 -39.82 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.446 -0.784 . . . . 1.3400000000000001 110.553 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -56.33 -40.24 74.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.929 -1.107 . . . . 1.54 110.187 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.29 -39.5 94.74 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.432 -0.793 . . . . 2.8500000000000001 111.045 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.46 -43.54 96.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.025 -1.047 . . . . 1.3100000000000001 110.707 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.24 -40.85 84.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.23 -0.918 . . . . 1.3799999999999999 110.501 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -60.58 -45.37 94.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.237 -0.914 . . . . 1.5 110.107 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -61.83 -40.57 95.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.582 -0.699 . . . . 2.7799999999999998 110.287 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -74.02 -52.84 11.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.094 -1.004 . . . . 1.0600000000000001 109.934 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.6 tp -61.77 -47.96 82.84 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.554 -0.859 . . . . 1.3999999999999999 110.09 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 t -69.92 -38.06 76.13 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.289 -0.882 . . . . 1.3200000000000001 109.703 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.89 -40.8 95.71 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.037 -1.625 . . . . 0.69999999999999996 109.037 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.545 HH22 ' CD ' ' A' ' 86' ' ' GLU . 17.2 ttm180 -59.2 -30.69 68.4 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.737 0.779 . . . . 3.4399999999999999 109.334 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.79 76.5 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.614 0.721 . . . . 1.3600000000000001 110.365 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -82.7 -38.33 23.51 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.297 -0.877 . . . . 2.8300000000000001 110.169 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.5 -44.85 95.54 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.84 -0.744 . . . . 1.23 109.905 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.8 t -60.13 -40.21 88.99 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.339 1.066 . . . . 1.9199999999999999 108.797 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.62 -45.93 88.04 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.648 -0.706 . . . . 1.25 109.771 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -61.46 -50.44 72.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.995 -1.065 . . . . 1.97 110.324 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.26 -39.83 91.81 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.321 -0.862 . . . . 2.1800000000000002 110.071 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -59.9 -43.11 95.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.887 -0.508 . . . . 1.1899999999999999 110.619 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 m -63.96 -42.36 97.3 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.789 -1.194 . . . . 1.3400000000000001 109.948 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.6 -35.2 61.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.68 -0.638 . . . . 1.23 110.337 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -53.03 -41.51 64.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.431 -0.793 . . . . 1.5600000000000001 110.442 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -70.34 -35.42 73.59 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.376 -0.828 . . . . 1.3 109.691 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.48 -40.9 92.93 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.221 -0.991 . . . . 2.3199999999999998 109.045 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.08 -36.01 82.18 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 120.178 -0.609 . . . . 1.1399999999999999 109.47 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.2 -35.07 27.92 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.588 -1.291 . . . . 0.68999999999999995 110.435 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.36 -16.98 50.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.318 -1.107 . . . . 1.48 111.209 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.6 m -91.24 -54.88 3.74 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.264 0.554 . . . . 1.52 110.381 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.544 ' C ' ' H ' ' A' ' 67' ' ' GLU . 61.5 m-85 -107.35 -30.48 8.67 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.11 0.782 . . . . 1.3100000000000001 113.11 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 61.48 -26.13 0.06 OUTLIER Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.536 -1.316 . . . . 0.84999999999999998 115.059 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 65' ' ' PHE . 52.5 mt-10 -54.84 -166.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.556 -0.967 . . . . 3.8599999999999999 109.844 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -66.57 7.29 0.36 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 112.953 0.723 . . . . 2.3500000000000001 112.953 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 67' ' ' GLU . 66.8 mmtt -68.6 -24.64 64.6 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.461 -0.774 . . . . 2.2599999999999998 111.375 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -58.65 -40.21 82.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.021 -1.049 . . . . 1.45 110.687 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.83 -36.56 84.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.869 . . . . 1.25 110.958 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.3 mt -64.8 -45.91 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 1.26 110.718 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -69.62 -33.96 73.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.863 -1.148 . . . . 0.82999999999999996 110.257 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.44 -39.23 90.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.302 -0.874 . . . . 1.1899999999999999 110.174 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.09 -37.74 95.01 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.664 -0.974 . . . . 0.57999999999999996 110.664 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -59.84 -41.98 92.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -1.114 . . . . 2.0499999999999998 110.343 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.8 mt -61.2 -40.96 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.09 . . . . 1.21 110.43 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.3 ttt -59.71 -39.65 85.35 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 120.97 -1.081 . . . . 2.29 110.523 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 tp -58.43 -49.98 75.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.114 -0.991 . . . . 1.21 110.199 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.5 tp -61.67 -42.08 98.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.099 -1.001 . . . . 1.1399999999999999 109.961 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -86.63 9.08 19.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.482 -0.762 . . . . 1.4199999999999999 112.564 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.05 121.45 14.19 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.12 -0.988 . . . . 1.27 108.505 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.63 -18.89 65.12 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.455 -0.778 . . . . 1.3500000000000001 111.067 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.61 -50.63 14.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.51 -0.876 . . . . 2.2200000000000002 110.41 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.28 -35.39 77.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.208 -0.597 . . . . 1.22 110.684 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.545 ' CD ' HH22 ' A' ' 47' ' ' ARG . 72.5 tt0 -59.77 -47.45 85.62 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.444 -0.785 . . . . 1.29 110.473 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -61.22 -37.48 83.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.35 -0.844 . . . . 2.1699999999999999 110.756 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -68.44 -48.83 63.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 1.3 110.673 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.5 mt -57.6 -43.51 83.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.179 -0.95 . . . . 1.1699999999999999 110.242 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.0 mt -60.09 -40.63 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.462 -0.774 . . . . 1.3999999999999999 110.411 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.42 95.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.563 -0.711 . . . . 1.3300000000000001 110.685 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.31 -45.61 92.78 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.96 -1.087 . . . . 1.48 110.313 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.28 -49.11 80.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.155 -0.966 . . . . 1.28 110.335 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -73.8 -36.44 65.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.916 -1.115 . . . . 2.6000000000000001 111.842 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -78.5 -47.77 16.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.833 -1.167 . . . . 1.51 111.469 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -101.48 7.43 42.45 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.422 -0.799 . . . . 2.48 112.846 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.4 m80 52.39 50.1 19.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.824 -1.173 . . . . 1.6100000000000001 111.661 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtt -102.98 158.1 16.52 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.843 0.83 . . . . 1.8999999999999999 109.16 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.457 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 66.9 p -74.87 161.9 29.13 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.817 -0.552 . . . . 1.3200000000000001 109.963 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.87 92.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.993 -1.067 . . . . 1.1499999999999999 110.395 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.457 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 16.7 p-10 -68.64 -39.83 80.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.018 -1.051 . . . . 2.25 110.26 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.26 -51.36 38.26 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.548 -0.861 . . . . 1.22 111.307 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.09 92.78 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.153 -1.019 . . . . 1.1899999999999999 110.838 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.37 85.23 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.27 -0.894 . . . . 1.2 110.965 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -61.64 -38.88 89.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.686 -1.259 . . . . 2.1000000000000001 111.499 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.83 -48.98 79.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.779 -1.201 . . . . 1.3 111.219 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.85 -45.99 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.912 -1.118 . . . . 1.27 110.248 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 mm -61.95 -31.13 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.814 . . . . 1.1899999999999999 109.91 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -59.8 -41.37 91.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 2.1099999999999999 110.892 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.59 -34.12 12.24 Favored Glycine 0 N--CA 1.498 2.828 0 C-N-CA 119.084 -1.532 . . . . 0.88 112.478 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -60.9 -39.89 91.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.529 -1.571 . . . . 1.99 110.215 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.49 55.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.378 0.609 . . . . 1.28 110.6 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.5 p -62.6 -40.48 97.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.437 -0.789 . . . . 2.2200000000000002 110.275 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.96 -41.26 96.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 1.45 111.087 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.6 mt -65.67 -30.67 71.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.772 -1.205 . . . . 1.47 111.084 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -66.66 -21.81 66.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.872 -1.143 . . . . 2.04 111.079 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -73.28 -14.18 61.27 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.192 -0.943 . . . . 1.73 111.57 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.1 mt -84.26 142.54 30.18 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.582 -0.699 . . . . 1.79 109.26 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -100.39 55.23 0.89 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 2.8799999999999999 110.737 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -129.98 137.86 50.53 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.211 -1.033 . . . . 1.5800000000000001 108.211 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -58.99 -36.61 75.16 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.134 -0.626 . . . . 3.04 110.816 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.457 ' HH ' ' NH1' ' A' ' 126' ' ' ARG . 17.7 t80 -73.9 -52.46 12.87 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.791 -1.193 . . . . 1.29 110.381 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 23.1 mt -64.07 -43.72 94.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.06 -1.025 . . . . 1.6000000000000001 110.27 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -61.14 -47.35 86.61 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.641 -1.287 . . . . 2.7599999999999998 109.857 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -61.77 -29.28 70.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.083 -1.011 . . . . 2.1499999999999999 110.014 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.457 ' NH1' ' HH ' ' A' ' 122' ' ' TYR . 56.0 ttt180 -65.15 -29.0 69.8 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.537 -0.865 . . . . 2.8100000000000001 109.365 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.55 -49.83 76.27 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.613 -0.835 . . . . 1.3899999999999999 109.698 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.23 85.02 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.007 -0.677 . . . . 1.4099999999999999 110.248 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.54 -38.26 90.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.226 -0.921 . . . . 1.3899999999999999 110.439 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.92 -40.18 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.913 -1.117 . . . . 1.1899999999999999 109.839 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -60.08 -37.8 80.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.892 -1.13 . . . . 3.6299999999999999 110.21 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.536 ' CG ' HH11 ' A' ' 136' ' ' ARG . 42.1 t0 -59.87 -39.23 84.56 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.209 -0.932 . . . . 1.28 110.535 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.31 -39.43 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.562 -0.711 . . . . 1.1799999999999999 110.1 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.06 -50.48 45.97 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.89 -1.147 . . . . 0.51000000000000001 110.603 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -59.42 -47.02 87.04 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.112 -1.228 . . . . 3.1699999999999999 110.534 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 132' ' ' ASP . 14.8 mtm-85 -64.58 -39.85 94.47 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.067 -1.053 . . . . 2.8500000000000001 109.883 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.1 tp -61.24 -39.91 92.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.6499999999999999 110.15 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 73.2 mt -59.34 -40.26 85.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 1.2 110.704 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -61.19 -34.52 75.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.128 -0.983 . . . . 2.7999999999999998 110.344 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -75.58 -40.73 56.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.021 -1.049 . . . . 2.1499999999999999 110.587 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 98.1 mt -60.04 -39.48 80.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 120.812 -1.18 . . . . 1.21 110.479 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.88 -7.93 58.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 1.3400000000000001 111.659 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.26 22.62 64.88 Favored Glycine 0 N--CA 1.483 1.807 0 C-N-CA 120.104 -1.046 . . . . 0.91000000000000003 113.367 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.41 145.92 55.14 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.744 -0.857 . . . . 1.51 109.418 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -64.5 148.57 50.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.418 -0.801 . . . . 2.8799999999999999 109.322 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.2 mt -108.61 140.11 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.47 -0.937 . . . . 1.6200000000000001 108.47 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 21.2 mm -79.77 129.55 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.972 -1.08 . . . . 2.1099999999999999 108.754 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -96.95 95.67 7.98 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.149 -1.797 . . . . 1.6200000000000001 106.149 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.43 -22.19 61.13 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.498 -0.751 . . . . 1.3999999999999999 111.088 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.462 ' OG ' ' OD1' ' A' ' 172' ' ' ASN . 32.5 t -78.13 -0.53 28.62 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.084 0.945 . . . . 2.0499999999999998 112.316 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.9 25.48 5.29 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.438 -0.789 . . . . 1.3500000000000001 112.236 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.8 mt -71.05 139.97 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.465 -0.772 . . . . 1.4199999999999999 109.566 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -115.17 -19.89 10.63 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 2.9900000000000002 112.949 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -117.27 139.61 50.59 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.885 -1.154 . . . . 1.54 107.885 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.6 126.69 30.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.449 -0.945 . . . . 1.3799999999999999 108.449 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.7 m -149.5 175.16 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.01 -1.056 . . . . 1.28 109.166 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.9 mt -89.09 142.35 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 1.1599999999999999 108.644 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 27.6 tp -96.79 124.02 40.65 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.459 -0.941 . . . . 1.3100000000000001 108.459 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.1 t -125.02 131.98 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.293 -1.003 . . . . 1.25 108.293 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.48 157.63 19.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 1.26 108.982 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -64.99 -35.35 80.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.686 -1.259 . . . . 1.6000000000000001 109.304 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.7 t0 -171.45 152.71 3.32 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.845 -0.798 . . . . 2.4199999999999999 108.845 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.472 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 66.3 mt -115.09 142.98 45.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.677 -0.86 . . . . 1.3500000000000001 108.677 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.8 p -92.95 147.18 33.43 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.462 -0.773 . . . . 1.3200000000000001 108.938 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -40.31 -42.04 3.55 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.511 1.474 . . . . 0.69999999999999996 113.587 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.1 m -61.6 -48.14 82.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.799 -1.188 . . . . 1.1200000000000001 110.278 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.13 -39.46 89.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.023 -1.048 . . . . 1.21 110.87 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -68.79 -40.51 79.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.344 -0.847 . . . . 1.1899999999999999 110.783 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.48 79.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -0.949 . . . . 1.24 110.464 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -93.65 -2.39 54.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.913 -1.117 . . . . 1.6899999999999999 112.396 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 42.6 tp -62.13 146.77 49.58 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.251 -1.018 . . . . 1.3400000000000001 108.251 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.462 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 17.6 m120 -95.33 116.96 29.48 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.727 -1.582 . . . . 2.77 106.727 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -73.52 -18.82 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.419 -0.801 . . . . 2.0899999999999999 111.41 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -82.78 -18.26 41.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.526 -0.734 . . . . 2.6699999999999999 112.293 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -104.15 -6.12 21.34 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.312 0.856 . . . . 2.5800000000000001 113.312 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 52.2 t -108.54 129.67 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.559 -1.275 . . . . 1.1799999999999999 107.559 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 29.7 tp -82.89 -8.77 59.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.054 -1.029 . . . . 2.1800000000000002 112.543 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 166.98 177.52 38.77 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.599 -1.8 . . . . 0.48999999999999999 108.599 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -129.28 135.84 49.3 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.975 -1.309 . . . . 0.64000000000000001 107.588 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 75.1 mt -138.01 105.15 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.145 -1.798 . . . . 1.21 106.145 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 203' ' ' VAL . 76.7 p -129.68 168.94 15.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.357 -0.84 . . . . 1.3799999999999999 109.416 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 26.1 p-10 -98.68 47.95 0.98 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.737 -0.602 . . . . 2.3700000000000001 110.93 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.395 -0.816 . . . . 1.52 110.416 -179.849 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 53.5 m . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 107.717 -1.216 . . . . 2.1099999999999999 107.717 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -60.63 -35.53 76.41 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.383 -0.823 . . . . 1.24 110.422 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.6 p -56.31 -39.7 73.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.167 -0.958 . . . . 2.1499999999999999 109.982 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.4 m -59.2 -37.29 77.07 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.934 -0.707 . . . . 2.02 110.098 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -59.9 -38.85 78.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.498 -0.751 . . . . 2.1200000000000001 110.309 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 69.9 mtp -64.1 -40.21 95.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.671 -1.268 . . . . 1.3600000000000001 109.457 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.8 -48.92 79.73 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.027 -0.533 . . . . 1.29 111.384 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -59.37 -43.95 92.81 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.19 -0.944 . . . . 3.5600000000000001 110.432 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.1 m -68.97 -40.18 79.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.339 -0.851 . . . . 1.1799999999999999 110.226 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.6 mt -91.78 -9.32 43.97 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.811 0.815 . . . . 1.3400000000000001 112.126 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.8 mt-10 47.46 14.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.472 0.916 . . . . 1.45 113.472 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.45 ' O ' ' OG ' ' A' ' 8' ' ' SER . 59.6 mt -75.41 150.27 84.73 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.953 -1.092 . . . . 1.25 108.538 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -51.49 140.51 44.2 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.393 1.396 . . . . 0.78000000000000003 109.302 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.442 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -159.05 163.61 36.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.209 -1.557 . . . . 1.2 109.829 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.5 mt -147.17 147.04 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.761 -1.2 . . . . 1.25 107.761 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 181' ' ' THR . 9.9 m -129.11 -29.19 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 113.251 0.834 . . . . 1.3899999999999999 113.251 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.61 46.35 3.66 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 120.344 -0.931 . . . . 0.96999999999999997 111.97 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 65.8 p -66.78 -12.88 60.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.965 -1.315 . . . . 1.3500000000000001 111.229 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.85 -94.42 0.68 Allowed Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.038 -1.077 . . . . 1.0700000000000001 110.49 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -129.52 31.21 4.82 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.522 -0.987 . . . . 1.9199999999999999 112.144 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.86 -33.34 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.617 -1.302 . . . . 1.3300000000000001 110.474 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 80.5 p -56.33 -28.22 58.24 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.076 -1.015 . . . . 1.4199999999999999 111.171 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 26.4 t -92.26 0.69 57.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.101 -1.0 . . . . 2.1200000000000001 112.214 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -120.33 -4.19 9.94 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.545 0.943 . . . . 2.6899999999999999 113.545 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.3 149.42 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.227 -0.92 . . . . 1.29 109.285 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -117.62 149.61 40.39 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.535 -0.913 . . . . 2.6899999999999999 108.535 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 38.4 p-10 -50.47 141.33 12.34 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.384 -0.926 . . . . 2.79 110.366 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 8.8 t0 81.49 4.06 1.41 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 114.219 1.192 . . . . 2.3500000000000001 114.219 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -66.7 145.62 55.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.883 -1.136 . . . . 1.97 108.252 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -88.13 119.53 28.6 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.328 -1.36 . . . . 2.9700000000000002 107.328 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 85.2 mt -128.66 150.3 50.3 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.506 0.669 . . . . 1.25 110.155 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 56.5 mt -115.09 122.17 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 106.675 -1.602 . . . . 1.22 106.675 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.0 tp -98.99 115.8 29.77 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 106.754 -1.572 . . . . 1.24 106.754 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 9.3 m-20 -95.47 -24.39 16.68 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.414 -0.914 . . . . 2.0499999999999998 112.606 -177.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.405 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 39.21 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.652 0.739 . . . . 1.25 112.176 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.7 t -111.38 -61.29 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.654 -0.869 . . . . 1.4299999999999999 108.654 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -91.13 9.55 30.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.145 0.974 . . . . 3.0299999999999998 110.159 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.93 51.35 3.77 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 114.921 -1.036 . . . . 2.25 111.986 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -153.17 152.79 31.64 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.798 1.285 . . . . 2.52 110.497 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.0 t -117.38 140.79 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.527 -0.916 . . . . 1.29 108.527 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -100.78 132.82 45.99 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.85 -1.156 . . . . 1.3400000000000001 108.56 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.1 t -109.79 129.55 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.419 -0.956 . . . . 1.3400000000000001 108.419 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.445 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER 56.38 48.17 3.35 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 113.734 1.013 . . . . 2.1800000000000002 113.734 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 58.7 Cg_endo -70.61 150.54 63.18 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.292 1.995 . . . . 0.93999999999999995 111.138 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.7 m -72.93 153.74 40.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.984 -1.073 . . . . 2.3999999999999999 109.027 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 31.6 p-10 -59.82 -33.38 71.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.93 . . . . 3.3300000000000001 110.441 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 97.7 mt-10 -60.12 -39.78 87.45 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.294 -0.879 . . . . 3.1699999999999999 110.161 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.86 -38.93 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.898 . . . . 1.6899999999999999 109.883 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.52 -45.04 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.897 -0.721 . . . . 1.6000000000000001 110.627 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -59.88 -42.08 92.97 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.022 -1.071 . . . . 2.7000000000000002 110.193 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -62.23 -41.15 98.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -0.922 . . . . 2.96 110.328 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.0 mtp -71.42 -40.27 70.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.256 -0.902 . . . . 1.6299999999999999 110.507 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 3.27 110.08 -178.813 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mt . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 112.904 0.705 . . . . 1.5700000000000001 112.904 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.0 m -100.01 119.13 37.78 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.832 -1.544 . . . . 1.4399999999999999 106.832 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.85 -141.35 9.92 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.615 -0.994 . . . . 1.01 110.615 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 94.3 mt -97.71 -1.91 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.558 -0.966 . . . . 1.6299999999999999 113.008 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp 52.06 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.846 -1.159 . . . . 1.5800000000000001 112.265 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.23 -46.95 12.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.245 -0.909 . . . . 1.3400000000000001 111.193 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -143.4 145.33 31.5 Favored Pre-proline 0 N--CA 1.5 2.048 0 N-CA-C 107.784 -1.191 . . . . 1.8600000000000001 107.784 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.82 150.22 26.96 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.26 1.973 . . . . 1.01 112.309 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 149.81 170.82 17.65 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 108.946 -1.662 . . . . 0.81000000000000005 108.946 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.4 mt -128.31 133.5 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 120.961 -1.317 . . . . 1.3700000000000001 107.828 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.08 145.16 47.66 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.663 -0.866 . . . . 1.1399999999999999 108.663 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.7 m-85 -117.39 141.04 48.81 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.302 -0.874 . . . . 0.87 109.051 177.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.21 168.17 36.01 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.474 -1.822 . . . . 0.56999999999999995 110.096 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -76.59 160.52 29.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.861 -0.788 . . . . 2.3500000000000001 109.943 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.98 126.23 31.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.077 -1.015 . . . . 1.21 108.38 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.1 tp -108.07 102.77 11.91 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 105.0 -2.222 . . . . 1.3999999999999999 105.0 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.5 tp -90.58 138.06 31.86 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.602 -1.258 . . . . 1.4399999999999999 107.602 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.9 mt -100.01 117.45 34.31 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.739 -1.578 . . . . 1.45 106.739 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -111.93 140.08 46.89 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.27 -1.011 . . . . 2.5 108.27 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.517 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 71.5 tt0 -123.82 139.82 53.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 2.6600000000000001 108.802 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.85 133.54 34.74 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.982 -1.118 . . . . 2.3199999999999998 107.982 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -62.19 143.01 57.34 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.633 -0.877 . . . . 2.1099999999999999 108.633 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.3 mt -95.23 135.44 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.121 -0.987 . . . . 1.29 108.363 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.71 129.93 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.349 -0.982 . . . . 1.4099999999999999 108.349 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.94 139.74 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.487 -0.931 . . . . 1.3100000000000001 108.487 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -91.26 119.04 30.99 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.333 -1.358 . . . . 1.3400000000000001 107.333 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.525 ' HG2' HH11 ' A' ' 28' ' ' ARG . 1.0 OUTLIER -95.89 11.72 32.79 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.94 -1.1 . . . . 3.48 112.369 -179.657 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.5 150.64 47.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 2.52 110.966 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -89.29 131.3 35.45 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.103 -1.073 . . . . 2.6299999999999999 108.103 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -94.29 165.4 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.04 . . . . 1.3100000000000001 110.278 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.9 p -92.56 166.08 12.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.584 -0.697 . . . . 1.24 109.724 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.84 -22.53 37.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 1.49 111.85 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -67.2 -36.24 81.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.004 -1.06 . . . . 2.2799999999999998 110.87 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -92.43 -9.36 41.89 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.048 -1.032 . . . . 2.0499999999999998 113.187 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.27 -43.72 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.936 -1.102 . . . . 1.3400000000000001 110.044 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -58.51 -39.97 81.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.096 -1.002 . . . . 1.54 110.574 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -61.37 -39.9 92.32 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.445 -0.784 . . . . 2.8500000000000001 110.028 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -61.06 -40.35 93.34 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 1.3100000000000001 110.373 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.5 t -60.71 -41.61 88.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.047 -1.033 . . . . 1.3799999999999999 110.024 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -60.72 -48.96 79.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.122 -0.986 . . . . 1.5 110.268 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -61.78 -43.21 99.3 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.552 -0.859 . . . . 2.7799999999999998 109.979 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -73.37 -53.21 11.31 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.508 -0.745 . . . . 1.0600000000000001 109.748 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 40' ' ' VAL . 44.8 tp -59.6 -47.2 86.49 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.477 -0.889 . . . . 1.3999999999999999 109.938 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.4 t -69.31 -34.41 74.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 1.3200000000000001 110.011 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.17 -41.82 92.96 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.177 -1.569 . . . . 0.69999999999999996 109.177 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 40.7 ttm-85 -58.73 -34.07 70.96 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.438 -0.905 . . . . 3.4399999999999999 109.053 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.34 -49.68 76.63 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.915 0.864 . . . . 1.3600000000000001 110.182 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.557 ' NZ ' ' OE1' ' A' ' 53' ' ' GLN . 26.9 ttpp -80.94 -42.37 21.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 2.8300000000000001 111.136 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.6 92.18 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.746 -0.781 . . . . 1.23 110.093 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.2 t -60.11 -41.4 92.51 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.206 -0.934 . . . . 1.9199999999999999 109.39 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 -48.4 62.52 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.554 -0.716 . . . . 1.25 110.63 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.557 ' OE1' ' NZ ' ' A' ' 49' ' ' LYS . 27.9 mt-30 -62.34 -49.29 76.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 1.97 110.593 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.86 -37.28 86.22 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.084 -1.01 . . . . 2.1800000000000002 109.766 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -59.25 -40.65 86.64 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.652 -0.655 . . . . 1.1899999999999999 110.648 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -62.4 -40.33 96.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.924 -1.11 . . . . 1.3400000000000001 110.058 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.67 -39.85 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 1.23 110.513 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -50.14 -42.99 51.75 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.348 -0.845 . . . . 1.5600000000000001 111.259 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.6 -36.12 78.25 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.03 -1.044 . . . . 1.3 110.276 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.448 ' O ' ' OG1' ' A' ' 64' ' ' THR . 43.7 mtpt -61.13 -37.91 84.48 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.945 -1.102 . . . . 2.3199999999999998 108.984 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.29 86.8 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.793 -0.763 . . . . 1.1399999999999999 109.613 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.17 -34.75 40.39 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.332 -1.413 . . . . 0.68999999999999995 110.398 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -82.32 -20.08 38.08 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.254 -1.145 . . . . 1.48 111.308 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 38.2 m -86.37 -51.33 6.29 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.356 -0.84 . . . . 1.52 110.428 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.96 -19.66 13.66 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.92 0.711 . . . . 1.3100000000000001 112.92 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.17 163.69 13.6 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 111.466 -0.653 . . . . 0.84999999999999998 111.466 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -56.32 -22.48 30.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.794 -0.827 . . . . 3.8599999999999999 112.603 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -58.21 -35.07 71.11 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.033 -1.042 . . . . 2.3500000000000001 111.631 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -86.61 -11.95 49.97 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.824 -1.172 . . . . 2.2599999999999998 113.07 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.75 -30.76 69.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.773 -1.204 . . . . 1.45 111.26 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.74 85.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.983 -1.073 . . . . 1.25 111.241 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 mt -68.02 -48.01 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.823 -1.173 . . . . 1.26 110.13 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -69.87 -32.47 70.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.375 -0.828 . . . . 0.82999999999999996 110.539 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.36 -37.44 80.71 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.054 -1.029 . . . . 1.1899999999999999 110.075 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.22 -38.32 91.77 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 120.281 -0.962 . . . . 0.57999999999999996 110.827 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -59.6 -45.89 90.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.902 -1.352 . . . . 2.0499999999999998 110.599 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 77' ' ' ILE . 94.1 mt -60.31 -38.84 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.863 -1.148 . . . . 1.21 110.488 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.2 ttt -59.55 -39.89 85.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.49 -0.756 . . . . 2.29 110.626 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 tp -59.19 -48.76 80.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.386 -0.926 . . . . 1.21 109.953 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.446 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 61.3 tp -60.91 -45.92 92.73 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.653 0.739 . . . . 1.1399999999999999 110.754 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.11 11.87 7.33 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.225 0.824 . . . . 1.4199999999999999 113.225 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -63.96 123.83 19.99 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.798 -0.816 . . . . 1.27 108.798 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -65.52 -18.09 65.06 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.742 0.782 . . . . 1.3500000000000001 110.819 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.71 -56.88 4.08 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.452 0.644 . . . . 2.2200000000000002 110.046 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.29 -40.18 89.56 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.006 -0.678 . . . . 1.22 110.64 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -58.55 -49.96 75.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.132 -0.98 . . . . 1.29 110.969 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -62.81 -38.03 89.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 2.1699999999999999 110.443 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -65.92 -48.92 69.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 1.3 110.458 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.9 mt -55.98 -42.93 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.058 -1.026 . . . . 1.1699999999999999 109.653 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.0 mt -61.73 -44.0 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.435 -0.79 . . . . 1.3999999999999999 110.316 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.8 -44.29 97.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 1.3300000000000001 110.942 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.01 -44.63 94.45 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.912 -1.117 . . . . 1.48 110.463 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.0 mt -60.61 -48.39 88.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.267 -0.895 . . . . 1.28 110.712 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -81.56 -33.55 31.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.407 -0.808 . . . . 2.6000000000000001 111.714 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 91' ' ' ALA . 54.2 t0 -82.93 -40.18 20.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.091 -1.006 . . . . 1.51 111.457 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -103.09 7.13 38.89 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.241 -0.912 . . . . 2.48 112.263 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.5 m80 51.3 44.62 28.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 1.6100000000000001 111.953 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.9 mtt -102.93 153.73 19.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.417 -0.802 . . . . 1.8999999999999999 109.425 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.414 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 43.2 p -70.54 160.71 31.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 1.3200000000000001 109.506 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.6 92.9 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.93 -1.106 . . . . 1.1499999999999999 110.874 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 24.2 p-10 -69.42 -38.27 77.8 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.985 -1.072 . . . . 2.25 110.024 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.74 -51.2 43.9 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.052 -1.059 . . . . 1.22 111.388 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.69 90.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 1.1899999999999999 111.049 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.32 -41.81 85.37 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.352 -0.842 . . . . 1.2 110.613 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.56 -38.74 85.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.414 -0.804 . . . . 2.1000000000000001 111.173 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -58.06 -48.42 80.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.881 -1.137 . . . . 1.3 111.087 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.04 -43.64 96.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.882 -1.136 . . . . 1.27 110.772 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 108' ' ' ILE . 39.8 mm -62.71 -35.26 69.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.605 -0.684 . . . . 1.1899999999999999 110.318 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -57.44 -39.81 77.07 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.876 -0.73 . . . . 2.1099999999999999 111.207 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.73 -35.61 11.39 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 118.842 -1.647 . . . . 0.88 112.693 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -61.12 -41.2 96.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.497 -1.59 . . . . 1.99 110.145 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.6 -50.91 22.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.932 0.872 . . . . 1.28 110.471 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.501 ' HG ' ' N ' ' A' ' 114' ' ' ALA . 55.9 p -62.34 -37.85 87.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.862 . . . . 2.2200000000000002 110.814 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.501 ' N ' ' HG ' ' A' ' 113' ' ' SER . . . -62.86 -40.77 98.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 1.45 110.943 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.59 -30.18 70.41 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.637 -1.289 . . . . 1.47 110.892 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -67.34 -22.09 65.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.83 -1.169 . . . . 2.04 110.93 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.5 -11.79 60.81 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.103 -1.039 . . . . 1.73 111.0 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 75.8 mt -87.16 144.91 26.63 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.282 -0.636 . . . . 1.79 109.282 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -100.19 39.73 1.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.344 -0.847 . . . . 2.8799999999999999 111.58 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -113.57 135.8 53.51 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 108.261 -1.014 . . . . 1.5800000000000001 108.261 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -57.67 -40.15 78.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.499 -0.75 . . . . 3.04 111.198 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -72.81 -51.14 20.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.731 -1.231 . . . . 1.29 110.714 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 23.9 mt -59.29 -41.28 88.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.26 -0.9 . . . . 1.6000000000000001 110.541 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -64.12 -46.7 83.01 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.209 -0.996 . . . . 2.7599999999999998 109.793 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -60.17 -33.45 72.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.49 -0.884 . . . . 2.1499999999999999 109.561 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.522 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 29.7 ttt-85 -60.79 -29.66 69.58 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.306 1.05 . . . . 2.8100000000000001 108.935 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.78 -49.47 77.6 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.825 0.821 . . . . 1.3899999999999999 109.396 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.19 -45.81 86.73 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.722 -0.791 . . . . 1.4099999999999999 109.774 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.02 -36.85 82.79 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.632 -0.668 . . . . 1.3899999999999999 110.168 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.522 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 48.3 t -69.41 -40.04 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 1.1899999999999999 110.037 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -57.9 -38.46 75.88 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.44 -0.904 . . . . 3.6299999999999999 110.041 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -59.95 -39.57 86.03 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.594 0.711 . . . . 1.28 109.87 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.6 -36.96 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.216 -0.928 . . . . 1.1799999999999999 109.937 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.81 -56.93 22.24 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 120.009 -1.091 . . . . 0.51000000000000001 111.353 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -59.07 -39.72 82.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.153 -1.204 . . . . 3.1699999999999999 110.256 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -60.12 -44.81 94.62 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.775 -1.17 . . . . 2.8500000000000001 109.57 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.98 -43.89 94.84 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.433 -0.792 . . . . 1.6499999999999999 110.176 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.63 -44.87 93.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.447 -0.783 . . . . 1.2 110.365 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.517 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 98.8 mtt180 -60.13 -33.19 71.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.893 . . . . 2.7999999999999998 111.071 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -76.38 -42.95 42.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.098 -1.001 . . . . 2.1499999999999999 110.725 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.72 -40.17 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 1.21 110.105 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.87 -11.27 45.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.076 -1.015 . . . . 1.3400000000000001 111.757 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.6 21.67 71.66 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.73 -1.224 . . . . 0.91000000000000003 112.91 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -62.73 147.41 49.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.806 -0.82 . . . . 1.51 109.139 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -67.0 147.05 53.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.303 -0.873 . . . . 2.8799999999999999 108.905 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.9 mt -105.74 149.16 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.419 -0.956 . . . . 1.6200000000000001 108.419 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.401 HD11 ' H ' ' A' ' 147' ' ' ILE . 4.4 mp -77.65 119.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.157 -0.964 . . . . 2.1099999999999999 108.727 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -99.51 96.5 7.71 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.66 -1.607 . . . . 1.6200000000000001 106.66 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.7 mt -77.36 -12.44 59.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.903 . . . . 1.3999999999999999 111.628 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.5 p -81.7 3.0 27.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.138 -0.977 . . . . 2.0499999999999998 112.072 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.68 18.46 14.27 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.67 -0.644 . . . . 1.3500000000000001 112.579 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.8 mt -71.97 138.95 20.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.52 -0.738 . . . . 1.4199999999999999 109.271 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -118.54 -15.79 9.55 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.834 0.826 . . . . 2.9900000000000002 112.629 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -114.33 138.66 50.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.974 -1.121 . . . . 1.54 107.974 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -72.66 121.98 20.69 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.33 -0.989 . . . . 1.3799999999999999 108.33 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.6 m -144.49 174.95 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.033 -0.728 . . . . 1.28 109.033 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.6 mt -89.45 142.15 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.793 -1.192 . . . . 1.1599999999999999 109.088 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 31.5 tp -94.49 123.05 37.67 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.29 -1.004 . . . . 1.3100000000000001 108.29 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.65 129.64 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.705 -1.22 . . . . 1.25 107.705 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.32 154.68 21.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.149 -0.97 . . . . 1.26 108.826 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.93 -37.31 86.53 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.541 -1.349 . . . . 1.6000000000000001 109.458 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -173.3 147.86 1.57 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.166 -0.679 . . . . 2.4199999999999999 109.166 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.1 mt -115.93 143.25 45.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.489 -0.757 . . . . 1.3500000000000001 109.21 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.7 p -89.45 147.43 38.04 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.162 -0.961 . . . . 1.3200000000000001 108.881 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -40.49 -42.48 3.91 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.892 1.728 . . . . 0.69999999999999996 113.673 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.8 m -61.32 -50.25 73.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.017 -1.052 . . . . 1.1200000000000001 110.295 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -61.42 -39.67 91.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 1.21 109.772 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.6 p -68.75 -39.69 80.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.608 -0.682 . . . . 1.1899999999999999 110.458 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.41 79.38 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.928 -0.709 . . . . 1.24 110.531 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -93.71 -1.03 55.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.902 . . . . 1.6899999999999999 112.727 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.84 148.6 38.81 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.262 -1.014 . . . . 1.3400000000000001 108.262 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -96.4 114.81 26.51 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.839 -1.541 . . . . 2.77 106.839 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 7.5 mp -73.37 -20.39 60.77 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.433 0.635 . . . . 2.0899999999999999 111.77 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -80.42 -21.85 41.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 2.6699999999999999 112.037 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -100.23 -6.08 26.6 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 113.198 0.814 . . . . 2.5800000000000001 113.198 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.26 129.52 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.616 -1.254 . . . . 1.1799999999999999 107.616 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.5 -6.29 54.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 2.1800000000000002 112.635 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.53 164.79 33.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.788 -1.725 . . . . 0.48999999999999999 108.788 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -122.72 127.48 49.28 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.402 -1.333 . . . . 0.64000000000000001 107.402 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.9 mt -127.36 127.64 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.802 -1.555 . . . . 1.21 106.802 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.5 p -140.43 166.27 25.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.865 -1.147 . . . . 1.3799999999999999 109.486 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.429 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 1.5 m-20 -104.4 43.25 1.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.746 -0.596 . . . . 2.3700000000000001 110.341 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.94 0 O-C-N 121.082 -1.011 . . . . 1.52 108.906 179.115 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.604 ' HG ' ' HG1' ' A' ' 190' ' ' THR . 41.1 t . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 108.14 -1.059 . . . . 2.1099999999999999 108.14 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -59.96 -39.14 84.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 1.24 110.651 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.604 ' HG1' ' HG ' ' A' ' 188' ' ' SER . 57.5 p -60.03 -40.34 88.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 2.1499999999999999 110.546 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.0 t -60.08 -36.86 78.3 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.167 -0.958 . . . . 2.02 110.12 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.2 mm -60.48 -38.87 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.735 -0.603 . . . . 2.1200000000000001 110.814 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 75.1 mtp -61.01 -45.36 95.12 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.616 1.198 . . . . 1.3600000000000001 109.157 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.02 -50.47 73.61 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.462 -0.79 . . . . 1.29 110.823 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -59.65 -44.84 93.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 3.5600000000000001 111.179 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.9 m -70.2 -40.85 74.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.863 . . . . 1.1799999999999999 110.543 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.3 mt -90.89 -7.0 53.41 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.071 0.939 . . . . 1.3400000000000001 112.242 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 194' ' ' ALA . 93.7 mt-10 53.67 9.71 0.2 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.929 1.085 . . . . 1.45 113.929 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.38 147.91 90.43 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 120.844 -1.16 . . . . 1.25 107.972 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.79 137.28 60.14 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.374 1.383 . . . . 0.78000000000000003 110.07 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.67 166.2 24.78 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.225 -1.39 . . . . 1.2 109.839 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 35.9 mt -148.16 151.07 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.872 -1.159 . . . . 1.25 107.872 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.7 m -134.82 -26.63 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.845 -1.159 . . . . 1.3899999999999999 112.027 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.19 42.4 2.85 Favored Glycine 0 N--CA 1.49 2.258 0 O-C-N 120.985 -1.072 . . . . 0.96999999999999997 111.432 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 69.8 p -64.04 -24.15 67.6 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.925 -1.338 . . . . 1.3500000000000001 111.233 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.86 -90.05 1.48 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 120.042 -1.075 . . . . 1.0700000000000001 110.596 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.7 t -130.83 32.3 4.37 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.291 -1.123 . . . . 1.9199999999999999 113.04 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.9 t -56.29 -32.76 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.255 -1.528 . . . . 1.3300000000000001 110.439 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.6 p -59.04 -25.42 63.69 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.058 -1.026 . . . . 1.4199999999999999 111.215 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.8 m -92.96 1.89 57.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 2.1200000000000001 112.063 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -125.66 -5.72 6.97 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.441 0.904 . . . . 2.6899999999999999 113.441 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.6 t -118.83 148.03 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.424 -0.798 . . . . 1.29 109.515 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -120.42 150.45 40.77 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.998 -1.112 . . . . 2.6899999999999999 107.998 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 26.2 t-20 -51.32 141.29 15.39 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.233 -0.917 . . . . 2.79 110.562 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 80.93 -3.81 1.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.028 1.121 . . . . 2.3500000000000001 114.028 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -61.68 146.01 50.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.814 -1.179 . . . . 1.97 108.284 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -87.32 118.18 26.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.529 -1.286 . . . . 2.9700000000000002 107.529 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.92 147.64 50.86 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.454 -0.779 . . . . 1.25 109.552 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 13.7 mt -119.14 130.06 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.186 -1.413 . . . . 1.22 107.186 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 54.1 tp -98.5 122.88 42.25 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.732 -1.211 . . . . 1.24 107.732 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 223' ' ' VAL . 43.8 t0 -94.03 -29.58 15.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.785 -1.197 . . . . 2.0499999999999998 112.385 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.412 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 38.62 18.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.92 0.711 . . . . 1.25 112.92 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -109.68 -60.49 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.059 -1.025 . . . . 1.4299999999999999 109.222 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -93.74 11.15 30.14 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.949 0.88 . . . . 3.0299999999999998 110.018 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 63.32 53.16 2.25 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.657 -0.702 . . . . 2.25 112.205 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -149.04 154.84 39.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.482 -0.761 . . . . 2.52 109.515 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.6 135.85 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.595 -1.261 . . . . 1.29 107.595 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -102.83 130.51 49.85 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.118 -0.988 . . . . 1.3400000000000001 108.97 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.14 127.81 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.682 -1.229 . . . . 1.3400000000000001 107.682 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 50.1 53.16 13.76 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 113.428 0.899 . . . . 2.1800000000000002 113.428 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 151.15 79.64 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 123.028 2.486 . . . . 0.93999999999999995 111.085 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 67.3 p -73.97 155.29 38.78 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.739 -0.837 . . . . 2.3999999999999999 108.739 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -60.26 -37.94 81.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 3.3300000000000001 110.714 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -50.83 -44.28 59.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.056 -1.027 . . . . 3.1699999999999999 110.445 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.24 -39.93 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.189 -0.944 . . . . 1.6899999999999999 110.64 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.76 -49.16 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.897 -0.721 . . . . 1.6000000000000001 110.962 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.41 -39.64 84.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.922 -1.111 . . . . 2.7000000000000002 110.777 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -61.1 -44.85 96.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 2.96 110.761 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 55.3 mtm -75.1 -37.8 61.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.819 -1.175 . . . . 1.6299999999999999 111.301 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 . . . . . 0 N--CA 1.497 1.9 0 O-C-N 120.962 -1.087 . . . . 3.27 111.161 -179.766 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mt . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 106.305 -1.739 . . . . 1.5700000000000001 106.305 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.4 m -101.11 123.45 45.28 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.663 -1.236 . . . . 1.4399999999999999 107.663 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.35 -159.4 11.76 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 108.708 -1.757 . . . . 1.01 108.708 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.461 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 95.0 mt -99.19 2.32 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.439 -1.036 . . . . 1.6299999999999999 112.744 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 48.61 94.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.636 -1.29 . . . . 1.5800000000000001 112.171 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.84 -40.48 17.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.471 -1.393 . . . . 1.3400000000000001 111.49 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -148.27 144.29 18.55 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 107.465 -1.309 . . . . 1.8600000000000001 107.465 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.11 142.31 27.36 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.574 2.183 . . . . 1.01 112.192 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.416 ' O ' ' CB ' ' A' ' 222' ' ' ALA . . . 157.55 171.31 23.39 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.36 -1.496 . . . . 0.81000000000000005 109.36 178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -134.21 133.7 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.819 -1.401 . . . . 1.3700000000000001 107.574 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.09 156.8 45.93 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.141 0.972 . . . . 1.1399999999999999 109.664 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.422 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 13.2 m-85 -120.99 140.21 52.22 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.93 -1.137 . . . . 0.87 107.93 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.21 166.62 36.22 Favored Glycine 0 N--CA 1.499 2.841 0 C-N-CA 119.044 -1.551 . . . . 0.56999999999999995 109.901 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -80.09 157.84 26.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.297 -1.12 . . . . 2.3500000000000001 109.668 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -85.76 128.68 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.149 -1.056 . . . . 1.21 108.149 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.5 tp -107.24 105.47 15.46 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 105.327 -2.101 . . . . 1.3999999999999999 105.327 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.6 tp -93.32 135.43 34.54 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.036 -1.098 . . . . 1.4399999999999999 108.036 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.9 mt -99.54 118.1 35.38 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.584 -1.635 . . . . 1.45 106.584 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -110.56 123.74 50.52 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.782 -1.562 . . . . 2.5 106.782 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -131.38 158.25 41.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.946 -1.096 . . . . 2.6600000000000001 108.701 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -84.95 138.79 32.27 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.782 -0.822 . . . . 2.3199999999999998 108.782 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.41 156.33 36.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.948 . . . . 2.1099999999999999 109.496 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.7 mt -86.24 133.91 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.035 -1.041 . . . . 1.29 108.444 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -110.38 130.71 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.815 -1.18 . . . . 1.4099999999999999 107.815 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.8 mt -94.66 134.34 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.647 -0.871 . . . . 1.3100000000000001 108.647 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -92.41 120.5 32.97 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.086 -1.079 . . . . 1.3400000000000001 108.086 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.523 ' HG2' HH11 ' A' ' 28' ' ' ARG . 1.7 mmt-85 -93.56 16.98 12.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.007 -1.058 . . . . 3.48 112.43 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -60.33 140.14 57.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.014 -1.054 . . . . 2.52 109.81 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -87.65 132.51 34.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.839 -1.163 . . . . 2.6299999999999999 108.004 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 pt -96.89 165.55 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 1.3100000000000001 110.584 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.7 p -97.91 170.45 8.95 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.241 -0.912 . . . . 1.24 109.507 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.1 66.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.394 -0.816 . . . . 1.49 111.454 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.64 -33.47 74.07 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.436 -0.79 . . . . 2.2799999999999998 110.648 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -90.95 -7.57 51.7 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.738 -1.226 . . . . 2.0499999999999998 112.502 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.48 -42.67 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 1.3400000000000001 110.183 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -58.11 -39.91 79.88 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.307 -0.871 . . . . 1.54 111.136 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -63.44 -43.92 96.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.734 -0.604 . . . . 2.8500000000000001 111.233 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -60.67 -40.15 91.03 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.803 -1.186 . . . . 1.3100000000000001 110.189 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.6 t -60.68 -40.83 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.108 -0.995 . . . . 1.3799999999999999 109.963 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -61.59 -44.86 96.24 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.447 -0.783 . . . . 1.5 110.223 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 42' ' ' ARG . 43.5 mtt-85 -62.11 -40.05 94.59 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.33 -0.856 . . . . 2.7799999999999998 110.152 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -70.53 -57.17 5.05 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.36 -0.837 . . . . 1.0600000000000001 110.235 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.79 -47.4 85.84 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.914 -1.115 . . . . 1.3999999999999999 109.582 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 t -69.33 -37.46 77.73 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.399 -0.92 . . . . 1.3200000000000001 109.814 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.05 -43.28 93.26 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.053 -1.546 . . . . 0.69999999999999996 109.681 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -59.87 -30.66 69.14 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.167 0.984 . . . . 3.4399999999999999 109.476 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.79 90.15 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.427 -0.796 . . . . 1.3600000000000001 110.348 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -80.22 -49.77 11.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.371 -0.932 . . . . 2.8300000000000001 110.699 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.91 76.8 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.468 -0.77 . . . . 1.23 110.279 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.4 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 94.7 p -60.09 -40.35 89.31 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.136 0.97 . . . . 1.9199999999999999 109.178 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -47.53 44.42 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.834 0.826 . . . . 1.25 110.733 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -64.5 -48.31 75.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.521 -1.362 . . . . 1.97 110.958 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.18 -37.98 89.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.726 -0.789 . . . . 2.1800000000000002 109.842 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 51' ' ' SER . 17.5 mm-40 -59.81 -40.33 88.04 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.275 -0.57 . . . . 1.1899999999999999 110.272 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.1 m -63.76 -42.24 97.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.234 -0.916 . . . . 1.3400000000000001 110.343 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 99.5 mt -59.97 -37.3 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.716 0.77 . . . . 1.23 110.268 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -50.4 -44.24 54.91 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.46 -0.775 . . . . 1.5600000000000001 110.753 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -69.12 -33.71 73.9 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.156 -0.965 . . . . 1.3 110.225 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.411 ' O ' ' OG1' ' A' ' 64' ' ' THR . 49.5 mttp -64.22 -40.28 95.72 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.185 -1.406 . . . . 2.3199999999999998 109.526 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.75 -30.16 71.16 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.856 -0.738 . . . . 1.1399999999999999 110.151 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.12 -34.18 18.5 Favored Glycine 0 N--CA 1.484 1.872 0 C-N-CA 119.559 -1.305 . . . . 0.68999999999999995 110.893 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -81.7 -20.41 39.49 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.358 -1.083 . . . . 1.48 111.199 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 19.5 m -90.16 -51.98 5.18 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 120.941 0.401 . . . . 1.52 110.842 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -107.83 -9.12 15.81 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 113.616 0.969 . . . . 1.3100000000000001 113.616 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.09 167.01 23.12 Favored Glycine 0 N--CA 1.502 3.09 0 O-C-N 121.24 -0.913 . . . . 0.84999999999999998 112.764 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.96 -21.94 59.34 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.785 -0.833 . . . . 3.8599999999999999 112.131 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -57.7 -40.05 78.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.959 -1.088 . . . . 2.3500000000000001 110.905 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -87.07 -25.48 24.15 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.43 -0.908 . . . . 2.2599999999999998 111.459 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -60.65 -38.0 83.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.904 -0.497 . . . . 1.45 111.405 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.12 90.35 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.242 -0.911 . . . . 1.25 112.055 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -64.77 -41.72 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.339 -1.476 . . . . 1.26 110.381 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -69.44 -32.09 70.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.603 -1.311 . . . . 0.82999999999999996 110.428 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -59.44 -39.73 84.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.783 -1.198 . . . . 1.1899999999999999 109.909 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.74 97.95 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.894 -0.883 . . . . 0.57999999999999996 110.894 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -59.77 -41.2 90.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.906 -1.349 . . . . 2.0499999999999998 110.633 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 77' ' ' ILE . 85.4 mt -60.29 -38.16 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.807 -1.183 . . . . 1.21 110.658 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.7 ttp -58.85 -39.78 82.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.917 . . . . 2.29 110.528 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.65 -48.26 81.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.917 -1.115 . . . . 1.21 110.629 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.2 tp -59.92 -40.92 90.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.493 -0.755 . . . . 1.1399999999999999 110.435 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -86.06 6.09 30.58 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.022 -0.671 . . . . 1.4199999999999999 112.508 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -60.33 121.82 12.98 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.917 -1.114 . . . . 1.27 109.348 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -68.0 -17.63 64.48 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 121.145 -0.972 . . . . 1.3500000000000001 110.792 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -74.14 -46.7 40.8 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.787 -1.165 . . . . 2.2200000000000002 110.419 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.0 -35.47 80.82 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.209 -0.996 . . . . 1.22 110.023 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -58.69 -45.09 90.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.166 -0.959 . . . . 1.29 110.798 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -63.98 -41.6 97.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.926 -1.109 . . . . 2.1699999999999999 110.78 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -67.98 -49.53 61.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.737 -1.227 . . . . 1.3 110.506 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.12 -43.49 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 118.978 -1.089 . . . . 1.1699999999999999 110.372 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.52 ' CG2' ' HZ3' ' A' ' 94' ' ' LYS . 52.2 mt -62.17 -43.85 98.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.107 -0.996 . . . . 1.3999999999999999 110.54 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -60.36 -41.13 93.07 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.251 -0.906 . . . . 1.3300000000000001 110.894 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.31 -44.28 95.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.162 -0.961 . . . . 1.48 110.606 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.71 -49.2 83.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.266 -0.896 . . . . 1.28 110.322 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.52 ' HZ3' ' CG2' ' A' ' 90' ' ' ILE . 20.5 mtmm -82.43 -28.59 31.25 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.603 -1.31 . . . . 2.6000000000000001 112.182 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 91' ' ' ALA . 47.9 t0 -79.16 -45.66 19.5 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 120.242 -1.536 . . . . 1.51 111.293 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -104.62 7.59 35.04 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.752 -1.218 . . . . 2.48 111.884 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.8 m80 54.26 50.15 17.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 1.6100000000000001 112.291 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 73.2 mtm -105.88 161.0 14.83 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.722 -1.236 . . . . 1.8999999999999999 109.502 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.1 p -72.75 158.89 34.71 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.846 0.832 . . . . 1.3200000000000001 109.368 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.68 87.99 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.148 -0.97 . . . . 1.1499999999999999 110.658 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -67.34 -40.75 85.88 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.805 -1.184 . . . . 2.25 110.069 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.43 39.8 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.207 -0.997 . . . . 1.22 110.816 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.13 96.52 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.661 0.743 . . . . 1.1899999999999999 110.338 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.43 93.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.648 -0.658 . . . . 1.2 111.08 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.75 -38.97 83.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.307 -0.871 . . . . 2.1000000000000001 111.335 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.14 -48.28 82.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.091 -1.006 . . . . 1.3 111.19 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.56 -43.22 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.658 -1.217 . . . . 1.27 110.225 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.61 -33.08 53.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.799 -0.563 . . . . 1.1899999999999999 110.697 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -59.53 -40.21 86.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.351 -0.54 . . . . 2.1099999999999999 110.745 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.92 -30.52 25.89 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.018 -1.563 . . . . 0.88 113.128 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -61.37 -40.43 94.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.216 -1.755 . . . . 1.99 109.69 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.23 -45.72 59.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.064 0.935 . . . . 1.28 109.718 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.2 m -60.36 -39.24 86.5 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.346 0.593 . . . . 2.2200000000000002 110.049 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.83 -46.51 89.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.416 -0.803 . . . . 1.45 110.866 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.03 -26.89 67.73 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.506 -1.371 . . . . 1.47 110.87 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -66.22 -26.45 67.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.875 . . . . 2.04 111.572 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -70.65 -13.48 62.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.943 -1.103 . . . . 1.73 111.48 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 78.8 mt -88.72 140.2 29.69 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.838 0.828 . . . . 1.79 109.383 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -94.85 41.44 1.09 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.816 -1.178 . . . . 2.8799999999999999 111.258 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -111.87 133.42 54.08 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.07 0.938 . . . . 1.5800000000000001 108.903 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.59 -29.2 69.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.708 -0.62 . . . . 3.04 111.348 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.03 -60.32 2.38 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.655 -1.278 . . . . 1.29 110.703 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.78 -38.2 90.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 1.6000000000000001 110.801 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -63.38 -50.88 68.15 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.779 -1.201 . . . . 2.7599999999999998 110.093 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.67 -32.17 71.38 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.094 -1.042 . . . . 2.1499999999999999 109.602 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -65.89 -26.97 67.86 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.778 0.799 . . . . 2.8100000000000001 109.485 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.88 -47.88 83.38 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.599 -0.84 . . . . 1.3899999999999999 108.998 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.81 -43.92 91.57 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.306 -0.957 . . . . 1.4099999999999999 110.017 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -64.29 -31.38 72.56 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.422 0.629 . . . . 1.3899999999999999 110.446 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.3 t -68.7 -39.19 79.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 C-N-CA 119.942 -0.703 . . . . 1.1899999999999999 109.961 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -59.32 -38.01 79.2 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.73 -1.188 . . . . 3.6299999999999999 109.285 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -59.92 -38.94 83.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.881 -0.512 . . . . 1.28 110.602 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.7 mt -60.33 -40.0 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.975 -1.078 . . . . 1.1799999999999999 110.148 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.12 -46.96 93.28 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.475 -1.05 . . . . 0.51000000000000001 110.475 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -59.99 -41.08 91.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.966 -1.314 . . . . 3.1699999999999999 110.658 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -60.07 -42.7 95.13 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.315 -0.865 . . . . 2.8500000000000001 110.18 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.41 -40.41 94.3 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.174 0.988 . . . . 1.6499999999999999 109.881 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.0 mt -61.66 -40.67 95.76 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.353 -0.842 . . . . 1.2 110.746 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -61.34 -38.2 86.05 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.509 -0.745 . . . . 2.7999999999999998 111.316 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -74.4 -42.6 58.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.954 -1.091 . . . . 2.1499999999999999 110.993 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.21 -38.95 79.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.013 -1.054 . . . . 1.21 110.553 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.35 -3.08 59.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.829 -1.169 . . . . 1.3400000000000001 111.793 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.83 23.03 78.64 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.613 -1.28 . . . . 0.91000000000000003 113.577 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.5 tp -61.97 150.04 38.99 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 122.053 -0.675 . . . . 1.51 109.746 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -66.93 157.27 33.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.503 -0.748 . . . . 2.8799999999999999 110.16 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.4 mt -101.18 139.5 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.46 -0.941 . . . . 1.6200000000000001 108.46 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.3 mp -79.49 120.51 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.797 -1.186 . . . . 2.1099999999999999 107.797 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -98.62 93.41 6.1 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.881 -1.525 . . . . 1.6200000000000001 106.881 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.6 mt -75.39 -21.29 58.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.898 . . . . 1.3999999999999999 111.599 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 150' ' ' SER . 2.5 t -82.77 10.24 8.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.169 -0.957 . . . . 2.0499999999999998 112.101 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.95 18.52 14.49 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.269 -0.894 . . . . 1.3500000000000001 112.435 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.542 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 23.8 mt -75.28 141.03 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.203 -0.935 . . . . 1.4199999999999999 110.015 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -117.62 -13.67 10.24 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.361 -0.837 . . . . 2.9900000000000002 112.795 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -117.03 141.95 47.59 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.612 -0.884 . . . . 1.54 108.612 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -77.04 122.83 25.49 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.271 -1.011 . . . . 1.3799999999999999 108.271 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.2 m -147.31 178.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.226 -0.657 . . . . 1.28 109.226 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.4 mt -87.4 143.92 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.683 -0.858 . . . . 1.1599999999999999 108.683 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 34.7 tp -97.57 126.1 42.67 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.912 -1.118 . . . . 1.3100000000000001 108.367 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.0 t -126.43 129.23 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.126 -1.065 . . . . 1.25 108.126 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.17 159.91 32.23 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.272 -0.893 . . . . 1.26 108.601 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.18 93.34 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.539 -1.264 . . . . 1.6000000000000001 109.97 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 46.8 p-10 -173.96 150.02 1.57 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.304 -0.628 . . . . 2.4199999999999999 109.304 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.2 mt -115.41 141.54 47.91 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.346 -0.846 . . . . 1.3500000000000001 109.276 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.9 p -93.92 150.7 38.98 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.162 -0.961 . . . . 1.3200000000000001 108.455 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -39.25 -44.97 2.91 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.772 1.648 . . . . 0.69999999999999996 113.243 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.3 m -59.58 -49.41 77.86 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.168 -0.957 . . . . 1.1200000000000001 110.306 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.34 -40.4 94.1 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.743 -0.783 . . . . 1.21 110.001 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.9 p -67.58 -37.12 82.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.815 0.817 . . . . 1.1899999999999999 110.222 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.18 -39.84 87.9 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.519 -0.738 . . . . 1.24 110.54 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -94.21 0.22 55.57 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.094 -1.004 . . . . 1.6899999999999999 113.105 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.89 149.21 41.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.738 -1.226 . . . . 1.3400000000000001 108.498 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -94.45 114.71 26.77 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 106.812 -1.551 . . . . 2.77 106.812 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 10.6 mp -80.79 -10.41 59.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.552 -0.718 . . . . 2.0899999999999999 112.435 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -83.45 -23.25 32.33 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.984 -1.073 . . . . 2.6699999999999999 111.954 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 152' ' ' ILE . 90.7 mttt -105.41 4.16 30.44 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.22 -0.925 . . . . 2.5800000000000001 112.777 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.9 t -108.85 128.63 64.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.929 -1.137 . . . . 1.1799999999999999 107.929 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.412 ' CD2' ' O ' ' A' ' 177' ' ' LEU . 2.0 tt -92.93 -6.31 48.83 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.208 1.004 . . . . 2.1800000000000002 111.53 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.39 168.28 37.51 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.746 -1.741 . . . . 0.48999999999999999 108.746 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -124.04 128.85 49.95 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.559 -1.274 . . . . 0.64000000000000001 107.559 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.9 mt -130.77 129.86 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.968 -1.864 . . . . 1.21 105.968 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.2 p -140.94 176.1 9.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.167 -0.958 . . . . 1.3799999999999999 109.981 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.447 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 2.8 m-20 -110.38 45.13 1.15 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.892 -0.505 . . . . 2.3700000000000001 110.757 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.005 0 O-C-N 121.164 -0.96 . . . . 1.52 108.924 179.227 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 112.946 0.721 . . . . 2.1099999999999999 112.946 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -49.49 -40.82 38.8 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.143 -1.023 . . . . 1.24 110.161 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.6 p -62.11 -40.8 97.12 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.366 -0.934 . . . . 2.1499999999999999 109.389 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.64 ' HG ' ' N ' ' A' ' 192' ' ' ILE . 27.9 p -60.87 -35.25 76.13 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 119.668 -0.813 . . . . 2.02 109.863 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.64 ' N ' ' HG ' ' A' ' 191' ' ' SER . 77.1 mt -58.79 -39.61 77.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.461 -0.895 . . . . 2.1200000000000001 109.934 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.8 mtp -60.93 -44.23 97.51 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.781 1.276 . . . . 1.3600000000000001 109.126 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.1 -43.97 95.19 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.966 -1.015 . . . . 1.29 110.532 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.444 ' HG2' HH11 ' A' ' 195' ' ' ARG . 28.7 mtt-85 -60.04 -44.2 94.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.995 -1.066 . . . . 3.5600000000000001 110.09 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 35.3 m -68.48 -39.07 81.49 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.099 0.952 . . . . 1.1799999999999999 109.646 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.77 -4.07 56.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.068 -1.02 . . . . 1.3400000000000001 112.659 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.0 mt-10 53.61 9.87 0.2 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.212 1.19 . . . . 1.45 114.212 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.489 ' O ' ' OG ' ' A' ' 8' ' ' SER . 32.7 mt -72.12 150.06 92.21 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 120.581 -1.324 . . . . 1.25 108.378 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.0 143.51 99.77 Favored 'Trans proline' 0 N--CA 1.511 2.554 0 C-N-CA 121.623 1.549 . . . . 0.78000000000000003 110.11 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.92 160.91 31.47 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 117.683 -1.607 . . . . 1.2 109.701 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.0 mt -148.32 149.72 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.088 -1.079 . . . . 1.25 108.088 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 181' ' ' THR . 19.7 m -133.93 -29.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 C-N-CA 119.281 -0.967 . . . . 1.3899999999999999 112.78 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.39 35.65 1.55 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.76 -1.209 . . . . 0.96999999999999997 113.907 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 35.2 p -56.98 -25.49 58.33 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.234 -1.157 . . . . 1.3500000000000001 111.227 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.45 -91.4 1.72 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.032 -1.227 . . . . 1.0700000000000001 110.032 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.8 p -129.31 29.97 5.05 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.295 -1.121 . . . . 1.9199999999999999 112.683 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.2 t -56.56 -35.09 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.246 -1.534 . . . . 1.3300000000000001 110.764 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 45.4 p -60.58 -21.43 62.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.038 . . . . 1.4199999999999999 111.491 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 67.5 m -97.2 1.74 50.14 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.568 0.699 . . . . 2.1200000000000001 111.997 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -126.08 -0.96 7.13 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.227 0.825 . . . . 2.6899999999999999 113.227 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 56.0 t -126.02 155.43 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.139 -0.975 . . . . 1.29 110.182 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -115.7 157.69 23.89 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.06 -1.089 . . . . 2.6899999999999999 108.06 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 32.2 p-10 -58.86 144.18 45.24 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.56 -1.256 . . . . 2.79 109.922 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER 81.39 -3.05 1.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.081 1.141 . . . . 2.3500000000000001 114.081 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 40.0 t0 -61.61 149.96 37.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.882 -1.136 . . . . 1.97 109.129 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.514 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 37.0 t80 -88.58 124.39 33.99 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.412 -1.329 . . . . 2.9700000000000002 107.412 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.5 mt -130.3 149.36 52.03 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.331 -0.856 . . . . 1.25 109.307 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.7 mt -112.75 123.4 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.064 -1.828 . . . . 1.22 106.064 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 49.2 tp -98.72 119.48 37.54 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.087 -1.82 . . . . 1.24 106.087 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 27.4 t0 -93.78 -25.18 17.51 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.086 -1.009 . . . . 2.0499999999999998 112.836 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 10' ' ' GLY . . . 38.64 14.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.153 0.797 . . . . 1.25 113.153 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 37.1 t -111.18 -62.31 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.119 -0.988 . . . . 1.4299999999999999 109.258 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -90.27 9.14 29.85 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.398 1.094 . . . . 3.0299999999999998 110.987 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.18 49.71 3.25 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.436 -0.802 . . . . 2.25 111.645 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -146.93 148.77 32.11 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.635 -1.29 . . . . 2.52 109.734 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.0 t -117.32 139.29 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.216 -1.031 . . . . 1.29 108.216 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -99.26 134.95 41.38 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.118 -1.067 . . . . 1.3400000000000001 108.118 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.71 129.93 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.755 -0.832 . . . . 1.3400000000000001 108.755 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.431 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 42.4 t-20 49.1 50.29 8.93 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.01 0.744 . . . . 2.1800000000000002 113.01 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.5 Cg_endo -62.26 149.95 88.75 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.342 2.028 . . . . 0.93999999999999995 110.883 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 6.0 m -74.53 156.06 37.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.252 -0.905 . . . . 2.3999999999999999 109.151 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -59.35 -38.42 80.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 3.3300000000000001 110.218 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -58.83 -41.05 85.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.231 -0.918 . . . . 3.1699999999999999 110.367 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.66 -41.09 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.13 0.967 . . . . 1.6899999999999999 109.892 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 85.1 mt -60.03 -47.99 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 1.6000000000000001 110.391 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -59.28 -42.52 91.46 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.458 -0.897 . . . . 2.7000000000000002 110.26 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -61.37 -41.54 97.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 2.96 110.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 81.6 mtp -71.48 -37.79 71.28 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.09 -1.006 . . . . 1.6299999999999999 111.201 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 120.635 -1.29 . . . . 3.27 110.321 179.517 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.9 mt . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 121.258 0.552 . . . . 1.5700000000000001 111.914 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 m -95.57 113.58 25.24 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.614 -1.624 . . . . 1.4399999999999999 106.614 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.66 -149.16 25.21 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.111 -1.196 . . . . 1.01 110.111 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 93.2 mt -96.65 -0.93 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -1.04 . . . . 1.6299999999999999 112.864 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 tp 49.49 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.064 -1.022 . . . . 1.5800000000000001 112.725 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.77 -43.51 12.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.072 -1.018 . . . . 1.3400000000000001 111.168 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 t -145.76 136.08 12.04 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.138 -1.06 . . . . 1.8600000000000001 108.138 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.43 149.79 45.24 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.38 2.053 . . . . 1.01 112.249 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.418 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 152.25 164.34 12.26 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.554 -1.819 . . . . 0.81000000000000005 108.554 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.0 mt -120.89 133.92 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.285 -1.127 . . . . 1.3700000000000001 108.273 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.23 149.99 43.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.318 -0.864 . . . . 1.1399999999999999 109.129 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.3 m-85 -121.25 140.39 52.11 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.179 -1.045 . . . . 0.87 108.179 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.2 166.99 35.96 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 118.998 -1.573 . . . . 0.56999999999999995 109.419 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -78.13 158.33 29.13 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.65 -0.912 . . . . 2.3500000000000001 108.98 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -82.75 131.9 35.19 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.886 -1.134 . . . . 1.21 109.206 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.8 tp -113.67 102.7 10.51 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 105.609 -1.997 . . . . 1.3999999999999999 105.609 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 tp -90.67 137.15 32.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.913 -1.117 . . . . 1.4399999999999999 108.116 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.3 mt -102.57 119.47 38.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.469 -1.678 . . . . 1.45 106.469 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -110.68 135.06 51.87 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.674 -1.232 . . . . 2.5 107.674 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -126.28 137.49 53.51 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.404 -0.962 . . . . 2.6600000000000001 108.404 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -82.73 135.47 34.99 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.794 -1.187 . . . . 2.3199999999999998 107.794 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -62.22 149.21 42.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.579 -0.701 . . . . 2.1099999999999999 109.186 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.94 134.78 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.72 -0.845 . . . . 1.29 108.72 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -107.48 129.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.626 -1.25 . . . . 1.4099999999999999 107.626 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.0 mt -93.78 140.29 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 1.3100000000000001 109.201 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -88.18 121.22 30.32 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.838 -1.171 . . . . 1.3400000000000001 107.838 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -95.02 16.16 16.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 3.48 112.213 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -65.14 142.68 58.27 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.071 -1.018 . . . . 2.52 109.027 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -88.88 134.85 33.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.886 -1.153 . . . . 2.6299999999999999 107.886 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 pt -98.15 165.02 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.3 -0.875 . . . . 1.3100000000000001 110.313 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.467 ' H ' ' HG ' ' A' ' 32' ' ' SER . 4.5 p -99.29 168.79 9.8 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.298 0.57 . . . . 1.24 109.702 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.89 -27.9 46.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.249 -0.907 . . . . 1.49 112.642 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 35' ' ' GLN . 37.1 p-10 -70.07 -31.84 69.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.222 -0.924 . . . . 2.2799999999999998 110.825 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.562 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 73.0 mt-30 -92.31 -7.9 46.64 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.612 -1.305 . . . . 2.0499999999999998 112.792 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.18 -43.15 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.892 . . . . 1.3400000000000001 110.833 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -57.94 -39.16 77.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.075 -1.016 . . . . 1.54 110.828 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.78 -43.29 99.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.987 -1.071 . . . . 2.8500000000000001 111.147 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.96 -39.6 92.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.778 -1.201 . . . . 1.3100000000000001 110.937 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.2 t -60.72 -42.43 92.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.192 -0.943 . . . . 1.3799999999999999 110.366 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -61.77 -45.15 95.13 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.585 -0.846 . . . . 1.5 109.962 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.2 mtt-85 -61.61 -42.01 98.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.875 -1.141 . . . . 2.7799999999999998 109.663 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -71.68 -55.71 7.18 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.507 -0.745 . . . . 1.0600000000000001 109.829 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.9 tp -58.09 -47.6 82.73 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.445 -0.902 . . . . 1.3999999999999999 109.643 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.4 t -68.13 -36.3 79.49 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.441 -0.787 . . . . 1.3200000000000001 109.702 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.66 -40.23 87.78 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.582 -1.407 . . . . 0.69999999999999996 109.582 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -58.86 -34.25 71.38 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 122.076 0.941 . . . . 3.4399999999999999 109.205 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.97 79.51 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.934 0.873 . . . . 1.3600000000000001 109.863 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -81.38 -45.62 15.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -0.822 . . . . 2.8300000000000001 110.949 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.67 86.04 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.644 -0.822 . . . . 1.23 110.397 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 t -59.94 -40.28 88.44 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.105 0.955 . . . . 1.9199999999999999 109.127 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.57 -44.78 81.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.953 -0.567 . . . . 1.25 110.219 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -62.41 -52.11 64.88 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.997 -1.081 . . . . 1.97 110.162 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.84 -40.87 94.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.171 -0.955 . . . . 2.1800000000000002 110.153 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -59.99 -40.0 87.65 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.685 -0.634 . . . . 1.1899999999999999 110.583 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -64.83 -41.8 95.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.9 -1.125 . . . . 1.3400000000000001 110.615 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.43 -38.89 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.227 -0.921 . . . . 1.23 110.798 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -51.42 -44.5 62.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.244 -0.91 . . . . 1.5600000000000001 110.538 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -68.96 -38.21 79.27 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.987 -1.071 . . . . 1.3 110.086 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -62.07 -38.95 90.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.314 -0.955 . . . . 2.3199999999999998 109.641 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.28 -31.47 70.01 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.206 0.527 . . . . 1.1399999999999999 109.748 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.93 -37.68 12.63 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.584 -1.293 . . . . 0.68999999999999995 111.017 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.51 -23.99 36.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.773 -1.427 . . . . 1.48 111.119 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.6 m -87.13 -50.58 6.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 1.52 110.68 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.04 -8.7 16.45 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.194 1.183 . . . . 1.3100000000000001 114.194 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.73 164.93 23.37 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 121.249 -0.907 . . . . 0.84999999999999998 112.734 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -55.11 -13.91 1.4 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.85 -0.794 . . . . 3.8599999999999999 112.925 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -58.75 -37.4 76.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.101 -1.0 . . . . 2.3500000000000001 111.236 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -85.34 -19.18 31.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.816 -1.177 . . . . 2.2599999999999998 112.693 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -59.61 -39.64 84.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.733 -1.229 . . . . 1.45 111.047 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.0 -41.23 91.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 1.25 110.945 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.92 -47.3 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.62 -1.3 . . . . 1.26 110.119 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -69.88 -31.97 70.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.82999999999999996 110.662 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -58.81 -38.61 79.02 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 1.1899999999999999 109.731 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.82 -36.03 73.8 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 110.261 -1.135 . . . . 0.57999999999999996 110.261 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -59.18 -46.49 88.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.167 -1.196 . . . . 2.0499999999999998 110.72 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.73 -39.77 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 1.21 109.956 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.0 ttp -59.13 -39.63 82.94 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.93 -0.708 . . . . 2.29 109.911 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 tp -57.57 -50.08 74.27 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.888 -1.125 . . . . 1.21 110.676 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.89 -40.47 93.2 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.715 0.769 . . . . 1.1399999999999999 109.953 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -86.65 7.42 26.6 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 112.445 0.535 . . . . 1.4199999999999999 112.445 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 57.7 t0 -60.87 120.7 10.68 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.875 -1.14 . . . . 1.27 108.502 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -64.86 -19.81 66.08 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.711 0.767 . . . . 1.3500000000000001 110.876 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.445 ' OE1' ' OD1' ' A' ' 82' ' ' ASP . 21.7 mp0 -77.63 -52.99 8.1 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.357 -0.839 . . . . 2.2200000000000002 110.327 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.87 -40.16 87.68 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.508 -0.877 . . . . 1.22 110.444 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -57.1 -49.48 75.76 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.279 -0.888 . . . . 1.29 110.597 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -62.33 -36.94 83.74 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.355 -0.841 . . . . 2.1699999999999999 110.589 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -67.83 -47.63 68.48 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.352 -0.939 . . . . 1.3 110.682 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.9 mt -57.45 -42.05 79.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.281 -0.887 . . . . 1.1699999999999999 110.044 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 90' ' ' ILE . 78.8 mt -62.48 -41.73 93.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 121.405 0.622 . . . . 1.3999999999999999 110.101 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.56 98.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.67 -0.644 . . . . 1.3300000000000001 111.226 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.69 -42.81 93.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.884 -1.135 . . . . 1.48 110.575 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.47 -50.33 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 1.28 110.351 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.56 -38.71 65.12 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.218 -0.926 . . . . 2.6000000000000001 111.862 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -81.67 -44.93 16.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.709 -1.244 . . . . 1.51 112.169 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -100.49 10.14 41.61 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.976 -1.078 . . . . 2.48 112.166 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.6 m80 49.14 50.59 17.71 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.728 -1.232 . . . . 1.6100000000000001 111.304 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -104.45 151.76 23.16 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.461 -0.774 . . . . 1.8999999999999999 109.747 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.9 p -72.82 167.56 20.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 1.3200000000000001 110.24 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.37 86.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 1.1499999999999999 110.334 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -67.12 -40.21 86.79 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.074 -1.016 . . . . 2.25 110.408 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.37 -49.72 58.19 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.232 -0.987 . . . . 1.22 111.128 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.71 98.22 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.265 -0.897 . . . . 1.1899999999999999 110.299 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.86 97.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.25 -0.906 . . . . 1.2 111.09 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -60.48 -40.08 89.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.015 . . . . 2.1000000000000001 111.272 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -59.91 -48.97 79.51 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.728 -1.233 . . . . 1.3 111.063 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.52 -46.53 96.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.004 -1.06 . . . . 1.27 110.13 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.16 -32.39 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.711 -0.618 . . . . 1.1899999999999999 110.316 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -55.99 -41.09 74.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.486 -0.758 . . . . 2.1099999999999999 110.77 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.38 -34.86 10.0 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.098 -1.525 . . . . 0.88 112.378 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -62.13 -44.34 96.86 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.701 -1.47 . . . . 1.99 110.179 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.29 -52.36 19.29 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.772 0.796 . . . . 1.28 110.695 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.8 p -60.07 -37.57 80.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.514 -0.741 . . . . 2.2200000000000002 110.48 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.51 -44.33 97.27 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.017 -0.673 . . . . 1.45 110.501 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.2 mt -61.75 -29.96 70.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.576 -1.327 . . . . 1.47 110.528 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -67.12 -22.4 65.8 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.339 -0.851 . . . . 2.04 111.411 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -73.18 -15.35 61.45 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.318 -0.864 . . . . 1.73 111.245 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.0 mt -84.54 141.59 30.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.431 -0.793 . . . . 1.79 108.896 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -94.92 39.46 1.1 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.077 -1.014 . . . . 2.8799999999999999 112.086 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -112.0 136.82 50.84 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.119 -1.067 . . . . 1.5800000000000001 108.119 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -59.77 -37.13 78.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.339 -0.851 . . . . 3.04 110.768 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -70.58 -57.84 4.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.79 -1.194 . . . . 1.29 110.188 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 23.1 mt -59.9 -39.9 86.94 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.16 -0.962 . . . . 1.6000000000000001 110.335 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -62.53 -51.17 68.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.997 -1.064 . . . . 2.7599999999999998 110.119 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.31 -30.59 71.7 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.751 -0.78 . . . . 2.1499999999999999 109.816 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -65.22 -28.91 69.7 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.026 -1.07 . . . . 2.8100000000000001 109.155 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.83 80.16 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.813 0.816 . . . . 1.3899999999999999 109.413 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.55 95.18 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.513 -0.875 . . . . 1.4099999999999999 109.692 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -64.95 -36.99 86.17 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.292 0.568 . . . . 1.3899999999999999 110.303 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.9 -40.49 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 1.1899999999999999 109.802 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -59.88 -38.08 81.18 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.894 0.854 . . . . 3.6299999999999999 109.552 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -59.48 -38.99 82.27 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.287 0.565 . . . . 1.28 110.274 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.9 mt -61.46 -40.27 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.271 -0.893 . . . . 1.1799999999999999 109.977 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.4 48.68 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.94 -1.124 . . . . 0.51000000000000001 110.341 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -59.1 -45.99 89.45 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 120.994 -1.297 . . . . 3.1699999999999999 110.087 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.432 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 58.6 mtm180 -62.32 -40.73 97.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.827 -1.17 . . . . 2.8500000000000001 109.998 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.61 -42.97 99.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 1.6499999999999999 110.153 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.27 -45.41 93.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 1.2 110.17 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -59.78 -33.93 72.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.556 -0.715 . . . . 2.7999999999999998 111.025 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -75.18 -40.45 59.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.207 -0.933 . . . . 2.1499999999999999 110.72 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.03 -39.96 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 1.21 110.292 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.3 mt -88.68 -6.18 57.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 1.3400000000000001 111.942 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.72 71.01 Favored Glycine 0 N--CA 1.479 1.544 0 C-N-CA 119.304 -1.427 . . . . 0.91000000000000003 112.932 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.2 tp -61.08 151.83 29.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 122.012 -0.699 . . . . 1.51 110.522 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -61.22 145.71 50.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.36 -0.837 . . . . 2.8799999999999999 109.1 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.9 mt -111.3 139.94 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.536 -0.913 . . . . 1.6200000000000001 108.536 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 147' ' ' ILE . 13.8 mm -79.53 121.85 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.223 -1.029 . . . . 2.1099999999999999 108.223 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -97.4 95.52 7.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.37 -1.715 . . . . 1.6200000000000001 106.37 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.46 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 76.8 mt -75.51 -23.26 56.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.629 -0.669 . . . . 1.3999999999999999 111.332 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.4 ' OG ' ' OD1' ' A' ' 172' ' ' ASN . 5.7 t -79.53 -0.68 34.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.176 -0.952 . . . . 2.0499999999999998 112.334 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.08 22.84 8.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.737 -0.602 . . . . 1.3500000000000001 112.46 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.46 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 11.3 mt -72.05 137.36 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.695 . . . . 1.4199999999999999 109.543 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -112.47 -19.43 12.14 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.714 0.769 . . . . 2.9900000000000002 112.828 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -117.44 138.95 51.5 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.53 -1.285 . . . . 1.54 107.53 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.35 122.02 21.37 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.001 -1.111 . . . . 1.3799999999999999 108.001 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.8 m -145.63 177.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.438 -0.788 . . . . 1.28 109.291 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.3 mt -88.26 140.97 14.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.517 -0.74 . . . . 1.1599999999999999 109.341 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.4 tp -94.12 124.17 37.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.969 -1.082 . . . . 1.3100000000000001 108.143 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.8 t -125.36 130.21 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.131 -1.063 . . . . 1.25 108.131 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.63 152.41 21.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.454 -0.779 . . . . 1.26 109.226 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.24 82.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.495 -1.378 . . . . 1.6000000000000001 109.738 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 49.6 t0 -172.72 146.48 1.64 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.03 -0.729 . . . . 2.4199999999999999 109.03 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.423 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 83.6 mt -119.35 141.27 49.18 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.406 -0.809 . . . . 1.3500000000000001 109.304 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 65.7 p -91.59 152.41 43.41 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 120.848 -1.158 . . . . 1.3200000000000001 108.364 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -41.6 -39.12 4.56 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.081 1.854 . . . . 0.69999999999999996 113.848 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.432 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 27.4 m -59.91 -47.06 87.29 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 1.1200000000000001 110.184 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -67.6 -40.52 84.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.793 . . . . 1.21 109.948 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.524 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 26.9 p -68.42 -37.91 80.74 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.917 -0.713 . . . . 1.1899999999999999 110.223 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.55 82.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.945 . . . . 1.24 110.526 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -93.18 -2.67 55.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.054 . . . . 1.6899999999999999 112.792 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.37 146.23 51.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.05 -1.031 . . . . 1.3400000000000001 108.434 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.4 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 5.1 m120 -96.42 118.86 33.82 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.786 -1.561 . . . . 2.77 106.786 177.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.3 mm? -76.85 -14.55 59.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.446 -0.784 . . . . 2.0899999999999999 111.451 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -80.05 -27.35 39.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.535 -0.728 . . . . 2.6699999999999999 111.807 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -100.83 1.19 39.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.149 -0.969 . . . . 2.5800000000000001 113.204 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.14 129.97 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.584 -0.895 . . . . 1.1799999999999999 108.584 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.26 -11.32 43.91 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.359 -0.838 . . . . 2.1800000000000002 112.455 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.57 177.1 42.54 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.141 -1.584 . . . . 0.48999999999999999 109.141 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -133.45 132.66 41.35 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 107.784 -1.191 . . . . 0.64000000000000001 107.784 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 77.5 mt -134.37 111.2 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 105.824 -1.917 . . . . 1.21 105.824 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 54.2 p -130.32 171.99 12.33 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.679 -1.263 . . . . 1.3799999999999999 110.292 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -101.17 52.1 0.85 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.973 -0.558 . . . . 2.3700000000000001 110.222 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 108.693 -0.854 . . . . 1.52 108.693 179.301 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.441 ' HG ' ' H ' ' A' ' 191' ' ' SER . 18.2 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 108.385 -0.968 . . . . 2.1099999999999999 108.385 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.524 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 49.2 t60 -59.87 -38.61 82.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.405 -0.81 . . . . 1.24 110.545 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.3 p -54.13 -40.37 67.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 2.1499999999999999 110.587 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.441 ' H ' ' HG ' ' A' ' 188' ' ' SER . 23.2 t -59.62 -39.6 84.82 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.034 -1.041 . . . . 2.02 109.71 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 33.6 mm -60.08 -39.22 79.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.583 -0.698 . . . . 2.1200000000000001 110.394 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.5 mtp -62.51 -40.08 95.59 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.403 1.097 . . . . 1.3600000000000001 109.786 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -56.2 -48.93 75.44 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.815 -0.63 . . . . 1.29 110.749 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -60.16 -42.55 95.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.011 -1.056 . . . . 3.5600000000000001 110.605 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 64.9 m -69.96 -40.03 75.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.932 -1.105 . . . . 1.1799999999999999 110.347 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 26.7 mt -91.12 -7.98 50.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 1.3400000000000001 112.448 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 194' ' ' ALA . 48.3 mt-10 53.33 7.99 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.804 1.038 . . . . 1.45 113.804 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.26 150.48 92.0 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.933 . . . . 1.25 108.646 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.04 144.17 90.61 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.285 1.323 . . . . 0.78000000000000003 109.263 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.73 162.26 34.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.119 -1.613 . . . . 1.2 110.075 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.2 mt -147.31 152.41 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.028 -1.101 . . . . 1.25 108.028 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.6 m -135.42 -32.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 121.288 -0.883 . . . . 1.3899999999999999 112.702 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.84 41.42 2.37 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 120.098 -1.049 . . . . 0.96999999999999997 111.399 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.472 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 43.2 p -64.14 -17.17 63.22 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.453 -1.028 . . . . 1.3500000000000001 111.508 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.69 -95.81 0.91 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.945 -1.122 . . . . 1.0700000000000001 110.345 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 88.8 p -127.25 30.8 5.34 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.849 -0.795 . . . . 1.9199999999999999 112.146 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 72.7 t -58.91 -33.15 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.389 -1.444 . . . . 1.3300000000000001 110.116 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 38.5 p -56.48 -24.04 43.35 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.71 -0.796 . . . . 1.4199999999999999 111.407 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.2 p -92.98 0.74 57.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.866 . . . . 2.1200000000000001 112.001 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -123.55 -7.74 8.03 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.562 0.696 . . . . 2.6899999999999999 112.218 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 15.3 t -114.12 140.91 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.068 -0.716 . . . . 1.29 109.068 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -115.96 150.0 37.87 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.331 -0.988 . . . . 2.6899999999999999 108.331 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.498 HD21 ' CG ' ' A' ' 215' ' ' ASP . 1.8 p-10 -52.1 141.08 19.22 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.28 -0.887 . . . . 2.79 110.279 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.498 ' CG ' HD21 ' A' ' 214' ' ' ASN . 1.2 m-20 80.27 -0.75 1.99 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.948 1.092 . . . . 2.3500000000000001 113.948 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -64.77 149.02 50.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.78 -1.2 . . . . 1.97 108.745 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -87.33 116.01 25.13 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.381 -1.34 . . . . 2.9700000000000002 107.381 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.2 mt -128.38 144.73 51.17 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.513 0.673 . . . . 1.25 109.714 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 20.1 mt -115.81 128.61 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.698 -1.593 . . . . 1.22 106.698 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 48.9 tp -99.3 119.67 38.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 106.725 -1.584 . . . . 1.24 106.725 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.6 t0 -94.46 -28.66 15.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.926 -1.109 . . . . 2.0499999999999998 112.333 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.418 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 38.61 17.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.005 0.743 . . . . 1.25 113.005 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' A' ' 221' ' ' ASP . 32.1 t -107.33 -58.54 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -0.929 . . . . 1.4299999999999999 108.948 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -92.15 11.23 26.22 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.888 0.851 . . . . 3.0299999999999998 110.545 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 62.51 50.79 3.47 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.616 -0.72 . . . . 2.25 112.504 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -153.41 159.24 42.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.025 . . . . 2.52 109.945 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.0 t -116.43 141.65 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.127 -0.694 . . . . 1.29 109.127 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -103.5 132.08 50.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.024 -1.047 . . . . 1.3400000000000001 108.758 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.63 129.63 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 107.717 -1.216 . . . . 1.3400000000000001 107.717 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.435 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 54.0 t30 48.9 50.67 9.54 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 2.1800000000000002 112.912 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 25.2 Cg_endo -64.13 154.26 71.64 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.42 2.08 . . . . 0.93999999999999995 110.541 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.6 m -74.55 156.51 36.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.074 -1.016 . . . . 2.3999999999999999 109.489 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -58.74 -35.76 73.22 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.018 . . . . 3.3300000000000001 110.774 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -59.57 -40.19 86.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 3.1699999999999999 110.015 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 96.8 t -69.64 -39.53 78.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.56 -0.713 . . . . 1.6899999999999999 110.236 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.3 mt -57.48 -43.93 83.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.64 -0.662 . . . . 1.6000000000000001 110.613 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.46 -43.31 93.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.873 -1.142 . . . . 2.7000000000000002 110.317 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -63.64 -44.36 94.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.101 -1.0 . . . . 2.96 111.126 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.9 mtp -68.75 -37.75 79.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.007 -1.058 . . . . 1.6299999999999999 110.874 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.471 -0.768 . . . . 3.27 110.917 179.343 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.1 mt . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 106.806 -1.553 . . . . 1.5700000000000001 106.806 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.6 m -104.71 125.46 50.83 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.989 -1.115 . . . . 1.4399999999999999 107.989 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.8 -154.57 18.45 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.252 -1.939 . . . . 1.01 108.252 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 73.0 mt -96.07 -2.08 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -1.003 . . . . 1.6299999999999999 112.808 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 tp 49.57 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 1.5800000000000001 112.583 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.96 -42.92 13.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.991 -1.068 . . . . 1.3400000000000001 111.242 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -145.7 141.3 16.65 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 107.893 -1.151 . . . . 1.8600000000000001 107.893 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.05 147.83 30.61 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.233 1.956 . . . . 1.01 112.333 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.94 166.74 15.67 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.818 -1.713 . . . . 0.81000000000000005 108.818 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -127.46 138.04 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.09 -1.241 . . . . 1.3700000000000001 108.004 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.48 160.06 40.93 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.964 0.888 . . . . 1.1399999999999999 109.466 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 11.9 m-85 -129.66 139.94 51.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.168 -1.419 . . . . 0.87 107.168 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.69 169.2 38.4 Favored Glycine 0 N--CA 1.5 2.903 0 C-N-CA 119.04 -1.552 . . . . 0.56999999999999995 110.077 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -77.31 158.42 30.19 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.606 -0.887 . . . . 2.3500000000000001 108.606 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.09 128.28 35.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.167 -0.958 . . . . 1.21 108.613 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 tp -108.43 105.68 15.45 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 105.124 -2.176 . . . . 1.3999999999999999 105.124 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.0 tp -94.73 132.6 39.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.107 -0.996 . . . . 1.4399999999999999 108.774 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.9 mt -101.78 118.16 36.36 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.161 -1.792 . . . . 1.45 106.161 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -107.27 130.22 54.78 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.961 -1.125 . . . . 2.5 107.961 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -128.46 140.71 51.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.453 -0.779 . . . . 2.6600000000000001 109.178 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.51 137.66 35.55 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.17 -1.048 . . . . 2.3199999999999998 108.17 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -65.57 150.8 47.81 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.208 -0.933 . . . . 2.1099999999999999 110.141 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.5 mt -89.11 134.05 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.89 -1.152 . . . . 1.29 107.89 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.22 130.23 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.928 -1.138 . . . . 1.4099999999999999 107.928 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 26' ' ' ILE . 67.9 mt -94.88 130.92 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.548 -0.908 . . . . 1.3100000000000001 108.548 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -92.74 127.01 38.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.232 -1.025 . . . . 1.3400000000000001 108.232 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.431 HH11 ' HG3' ' A' ' 28' ' ' ARG . 23.4 mmm-85 -99.31 17.39 20.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.529 -0.732 . . . . 3.48 112.277 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -61.95 144.49 54.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.783 -1.198 . . . . 2.52 109.467 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -90.66 131.93 36.07 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.606 -0.886 . . . . 2.6299999999999999 108.606 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 pt -99.24 168.05 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.315 -0.866 . . . . 1.3100000000000001 110.239 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.5 p -94.6 162.73 13.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.565 -0.71 . . . . 1.24 109.825 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.37 -21.11 22.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 1.49 111.667 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.76 -38.41 76.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.058 -1.026 . . . . 2.2799999999999998 110.597 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -88.4 -6.35 57.73 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.104 -0.997 . . . . 2.0499999999999998 111.932 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.07 -41.21 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.049 -1.032 . . . . 1.3400000000000001 110.59 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -57.58 -40.08 78.22 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.907 -1.121 . . . . 1.54 110.736 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -63.2 -40.84 98.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 2.8500000000000001 111.265 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.3 -39.76 88.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.779 -1.201 . . . . 1.3100000000000001 110.875 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.2 -41.72 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.94 . . . . 1.3799999999999999 110.43 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -61.75 -42.6 99.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.021 -1.049 . . . . 1.5 110.071 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.48 ' NH2' ' O ' ' A' ' 141' ' ' ILE . 55.4 mtp180 -61.82 -42.54 99.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 2.7799999999999998 110.371 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -73.11 -51.08 19.33 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.014 -1.054 . . . . 1.0600000000000001 110.162 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.45 -47.86 82.18 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.112 -1.435 . . . . 1.3999999999999999 110.238 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 t -69.63 -42.56 74.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.419 -0.8 . . . . 1.3200000000000001 110.469 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.81 -41.83 84.35 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.178 -1.487 . . . . 0.69999999999999996 109.395 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.53 HH22 ' CD ' ' A' ' 86' ' ' GLU . 17.7 ttm180 -57.45 -32.73 67.21 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.227 1.013 . . . . 3.4399999999999999 109.473 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.28 -42.43 81.64 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.806 0.813 . . . . 1.3600000000000001 109.669 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.664 ' HZ2' ' ND2' ' A' ' 140' ' ' ASN . 26.1 ttpp -79.75 -43.93 21.65 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.729 0.776 . . . . 2.8300000000000001 110.223 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.17 88.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.334 -0.854 . . . . 1.23 109.929 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 t -59.57 -41.76 90.94 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.068 0.937 . . . . 1.9199999999999999 109.289 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.48 -45.23 80.37 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.965 -0.562 . . . . 1.25 110.063 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -64.85 -50.2 67.58 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.052 -1.059 . . . . 1.97 110.181 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.67 -37.61 84.71 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.658 -0.817 . . . . 2.1800000000000002 110.2 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -60.19 -42.81 95.85 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.551 -0.718 . . . . 1.1899999999999999 110.822 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.5 m -65.01 -44.2 90.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.019 -1.051 . . . . 1.3400000000000001 110.42 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.15 -36.76 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.54 -0.725 . . . . 1.23 110.674 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -50.81 -44.94 59.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.155 -0.965 . . . . 1.5600000000000001 110.561 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -68.3 -37.49 80.69 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.135 -0.978 . . . . 1.3 110.16 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' O ' ' OG1' ' A' ' 64' ' ' THR . 24.7 mtpp -61.49 -39.02 89.43 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.427 -1.309 . . . . 2.3199999999999998 108.932 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.98 -38.76 87.11 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.799 -0.761 . . . . 1.1399999999999999 109.261 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.94 -40.04 58.01 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 119.692 -1.242 . . . . 0.68999999999999995 110.505 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -79.64 -20.15 47.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.427 -1.043 . . . . 1.48 110.437 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 87.9 m -82.74 -53.31 6.01 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 120.217 -0.593 . . . . 1.52 110.458 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -106.19 -16.06 14.69 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.289 -0.882 . . . . 1.3100000000000001 112.693 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.95 167.77 16.3 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 111.459 -0.656 . . . . 0.84999999999999998 111.459 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.3 -25.86 62.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.407 -1.054 . . . . 3.8599999999999999 112.23 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.07 -40.06 73.01 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.895 -1.128 . . . . 2.3500000000000001 111.182 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -89.36 -16.45 31.0 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.924 -1.11 . . . . 2.2599999999999998 112.3 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.62 -39.0 86.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 1.45 110.702 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.17 78.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.72 -0.613 . . . . 1.25 111.495 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.01 -41.52 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.847 -1.158 . . . . 1.26 110.521 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -70.26 -31.44 68.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.917 -1.115 . . . . 0.82999999999999996 110.498 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.43 -39.98 92.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.309 -0.87 . . . . 1.1899999999999999 110.021 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.44 96.25 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.799 -1.32 . . . . 0.57999999999999996 109.799 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -57.81 -40.13 79.21 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.367 -1.078 . . . . 2.0499999999999998 110.495 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.5 mt -61.44 -40.39 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 1.21 110.236 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.6 ttm -59.5 -41.12 89.14 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.259 -0.901 . . . . 2.29 110.381 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.3 tp -57.52 -49.1 77.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.81 . . . . 1.21 110.309 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.02 -45.12 93.85 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.86 0.838 . . . . 1.1399999999999999 110.175 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -87.46 8.03 26.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.464 -0.773 . . . . 1.4199999999999999 113.026 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 55.2 t0 -62.22 123.47 18.28 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.764 -1.21 . . . . 1.27 109.151 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -66.48 -18.54 65.42 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.406 -0.809 . . . . 1.3500000000000001 111.168 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' OE1' ' OD1' ' A' ' 82' ' ' ASP . 10.8 mp0 -77.68 -52.4 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.689 -0.804 . . . . 2.2200000000000002 110.099 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.5 mt -60.92 -35.2 76.07 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.101 -0.999 . . . . 1.22 110.287 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.53 ' CD ' HH22 ' A' ' 47' ' ' ARG . 80.8 tt0 -59.14 -47.6 84.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.821 . . . . 1.29 110.402 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -61.72 -35.54 78.34 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.629 -0.669 . . . . 2.1699999999999999 110.12 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.07 -49.09 71.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 1.3 110.313 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.3 mt -58.64 -43.93 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.06 -1.025 . . . . 1.1699999999999999 109.779 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.01 -40.9 87.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.65 -0.656 . . . . 1.3999999999999999 110.146 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.91 -42.32 93.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.33 -0.857 . . . . 1.3300000000000001 110.424 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.39 -44.03 97.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.285 -0.884 . . . . 1.48 110.013 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.8 mt -63.56 -49.21 83.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.363 -0.835 . . . . 1.28 110.039 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -78.12 -37.2 46.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.496 -0.752 . . . . 2.6000000000000001 111.658 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 91' ' ' ALA . 53.0 t0 -81.81 -40.96 21.79 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.573 -1.329 . . . . 1.51 111.996 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -105.58 7.76 32.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.457 -0.777 . . . . 2.48 112.687 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.7 m80 49.65 49.79 19.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.563 -1.336 . . . . 1.6100000000000001 111.504 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 67.1 mtt -104.45 156.75 17.67 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.049 0.928 . . . . 1.8999999999999999 109.967 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.439 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 81.3 p -72.59 161.75 30.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.783 -0.573 . . . . 1.3200000000000001 110.02 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.55 86.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 1.1499999999999999 110.302 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.28 -40.07 89.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.118 -0.989 . . . . 2.25 109.868 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.439 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -70.2 -48.83 55.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.559 -0.713 . . . . 1.22 111.08 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.93 92.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.167 -0.958 . . . . 1.1899999999999999 110.227 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.17 95.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.579 -0.701 . . . . 1.2 110.661 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -60.29 -39.87 88.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.204 -0.935 . . . . 2.1000000000000001 111.275 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -58.05 -48.92 78.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.729 -1.232 . . . . 1.3 110.912 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.77 -45.61 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.892 -1.13 . . . . 1.27 109.867 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.3 mm -62.22 -31.72 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.645 -0.659 . . . . 1.1899999999999999 110.348 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -57.33 -41.09 79.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 2.1099999999999999 110.572 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.16 -34.64 9.52 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.368 -1.396 . . . . 0.88 112.624 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -60.69 -42.37 97.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.261 -1.729 . . . . 1.99 110.153 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.07 -55.55 6.35 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.451 -0.781 . . . . 1.28 110.727 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.8 m -60.61 -37.95 83.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 2.2200000000000002 110.886 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.51 96.37 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.897 -1.127 . . . . 1.45 111.079 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.31 -30.22 70.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.873 -1.131 . . . . 1.47 110.918 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -66.53 -20.82 66.12 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.168 -1.013 . . . . 2.04 110.954 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -71.91 -15.18 62.09 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.838 0.827 . . . . 1.73 110.828 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 50.0 mt -86.74 145.16 26.76 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.246 -0.65 . . . . 1.79 109.246 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -103.02 39.7 1.51 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.337 -0.852 . . . . 2.8799999999999999 111.461 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -113.04 136.27 52.87 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.135 -1.061 . . . . 1.5800000000000001 108.135 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -56.63 -38.07 71.59 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.444 0.64 . . . . 3.04 110.796 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -72.16 -52.79 14.99 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.827 -1.171 . . . . 1.29 110.312 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 19.3 mt -63.58 -39.72 95.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.168 -0.958 . . . . 1.6000000000000001 110.497 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -65.65 -47.54 75.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.93 . . . . 2.7599999999999998 110.502 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -61.47 -31.34 71.3 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.407 -0.917 . . . . 2.1499999999999999 110.248 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -65.71 -27.7 68.52 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 118.995 -1.082 . . . . 2.8100000000000001 109.528 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.84 -49.16 78.77 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.786 0.803 . . . . 1.3899999999999999 109.589 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.23 91.22 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.57 -0.852 . . . . 1.4099999999999999 109.633 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 2.0 m-20 -62.97 -35.47 80.28 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.306 0.574 . . . . 1.3899999999999999 110.214 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.8 t -68.17 -40.47 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.518 -0.739 . . . . 1.1899999999999999 110.639 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -59.72 -38.13 80.81 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.509 -1.277 . . . . 3.6299999999999999 110.076 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.52 ' OD1' ' NE ' ' A' ' 136' ' ' ARG . 54.4 t0 -60.22 -40.05 88.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.608 -0.683 . . . . 1.28 110.186 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.19 -39.64 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.01 -1.056 . . . . 1.1799999999999999 110.399 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.08 -46.9 62.68 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.937 -1.125 . . . . 0.51000000000000001 110.696 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -59.94 -41.31 91.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.123 -1.222 . . . . 3.1699999999999999 110.368 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.52 ' NE ' ' OD1' ' A' ' 132' ' ' ASP . 40.5 mtt-85 -63.32 -42.11 98.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.06 -1.025 . . . . 2.8500000000000001 109.995 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.0 tt -61.06 -45.15 95.92 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.967 0.889 . . . . 1.6499999999999999 109.76 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.98 -42.05 97.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.89 . . . . 1.2 110.522 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.12 -31.71 70.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.933 . . . . 2.7999999999999998 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.664 ' ND2' ' HZ2' ' A' ' 49' ' ' LYS . 24.9 m120 -75.33 -41.67 56.18 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.945 -1.097 . . . . 2.1499999999999999 110.777 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.48 ' O ' ' NH2' ' A' ' 42' ' ' ARG . 98.0 mt -60.02 -37.92 74.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.144 -0.973 . . . . 1.21 110.607 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.0 mt -87.49 -9.18 55.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.378 -0.826 . . . . 1.3400000000000001 111.716 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.26 23.62 65.34 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 120.298 -0.953 . . . . 0.91000000000000003 113.457 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.1 tp -68.34 139.71 55.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.806 -0.82 . . . . 1.51 109.863 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -68.6 150.54 47.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.568 -0.707 . . . . 2.8799999999999999 109.907 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 39.7 mt -108.76 137.7 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.341 -0.985 . . . . 1.6200000000000001 108.341 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 147' ' ' ILE . 13.3 mm -78.31 130.35 36.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.875 -1.141 . . . . 2.1099999999999999 109.016 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -94.47 97.62 10.29 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.625 -1.62 . . . . 1.6200000000000001 106.625 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 51.0 mt -76.98 -15.66 59.58 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.39 0.614 . . . . 1.3999999999999999 111.563 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.4 t -80.97 2.39 27.06 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.59 0.71 . . . . 2.0499999999999998 112.156 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.69 22.7 10.57 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.713 0.768 . . . . 1.3500000000000001 112.069 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 12.5 mt -72.77 135.88 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.427 -0.953 . . . . 1.4199999999999999 108.427 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -121.15 -13.69 8.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 112.927 0.714 . . . . 2.9900000000000002 112.927 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -112.53 136.89 51.51 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.926 -1.138 . . . . 1.54 107.926 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.07 117.68 17.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.376 -0.828 . . . . 1.3799999999999999 109.009 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -148.01 179.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.21 -0.663 . . . . 1.28 109.21 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 49.0 mt -88.13 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.481 -0.933 . . . . 1.1599999999999999 108.481 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.3 tp -94.63 126.82 40.17 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.43 -0.952 . . . . 1.3100000000000001 108.43 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.48 130.66 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.038 -1.097 . . . . 1.25 108.038 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.34 159.51 31.3 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.009 -1.057 . . . . 1.26 108.67 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.14 92.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.692 -1.255 . . . . 1.6000000000000001 109.324 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 50.9 t0 -171.75 154.09 3.53 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.527 -0.916 . . . . 2.4199999999999999 108.527 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 49.6 mt -117.18 139.04 51.26 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.446 -0.946 . . . . 1.3500000000000001 108.446 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.7 p -92.06 146.29 32.49 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.158 -0.964 . . . . 1.3200000000000001 108.41 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -38.97 -44.63 2.51 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.169 1.913 . . . . 0.69999999999999996 113.812 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 16.2 m -60.34 -47.84 84.32 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.629 -1.294 . . . . 1.1200000000000001 109.954 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -63.17 -37.8 88.67 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.657 0.742 . . . . 1.21 110.167 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.651 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 46.0 p -67.87 -39.05 83.79 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.547 -0.721 . . . . 1.1899999999999999 110.192 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.19 86.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.533 -0.73 . . . . 1.24 110.744 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.79 -3.31 56.3 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.149 -0.97 . . . . 1.6899999999999999 113.046 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.37 156.35 26.15 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.402 -0.811 . . . . 1.3400000000000001 109.587 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -94.9 110.2 22.12 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.503 -1.666 . . . . 2.77 106.503 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.1 mt -71.33 -24.91 62.21 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.748 0.785 . . . . 2.0899999999999999 111.408 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -85.66 -18.66 32.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.492 -0.755 . . . . 2.6699999999999999 112.446 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -100.64 -2.73 31.97 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.297 -0.877 . . . . 2.5800000000000001 112.767 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.69 130.09 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.689 -1.226 . . . . 1.1799999999999999 107.689 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.419 ' CD2' ' O ' ' A' ' 177' ' ' LEU . 1.8 tt -85.61 -9.89 56.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.031 -1.043 . . . . 2.1800000000000002 111.702 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.37 173.41 38.98 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.485 -1.446 . . . . 0.48999999999999999 109.485 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.9 OUTLIER -130.64 131.31 44.83 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.622 -1.251 . . . . 0.64000000000000001 107.622 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 87.5 mt -134.49 109.11 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 106.093 -1.818 . . . . 1.21 106.093 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 203' ' ' VAL . 73.6 p -134.26 174.58 10.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.678 -1.264 . . . . 1.3799999999999999 110.415 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 206' ' ' GLY . 11.8 t0 -103.85 65.83 0.83 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.639 -0.71 . . . . 2.3700000000000001 109.375 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.027 0 O-C-N 121.195 -0.941 . . . . 1.52 109.053 179.882 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.402 ' OG ' ' OG ' ' A' ' 191' ' ' SER . 27.9 p . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 107.07 -1.455 . . . . 2.1099999999999999 107.07 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.651 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 46.6 t60 -59.98 -30.46 69.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.838 . . . . 1.24 110.528 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.0 m -56.45 -40.51 74.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.539 -0.726 . . . . 2.1499999999999999 110.039 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.402 ' OG ' ' OG ' ' A' ' 188' ' ' SER . 49.1 m -59.78 -39.98 86.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 2.02 109.948 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.504 ' CD1' ' N ' ' A' ' 192' ' ' ILE . 1.6 mp -60.23 -38.89 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.815 . . . . 2.1200000000000001 110.418 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 68.3 mtp -62.38 -42.96 99.82 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 122.062 0.934 . . . . 1.3600000000000001 109.529 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.5 -48.74 79.69 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.726 -0.67 . . . . 1.29 111.673 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 195' ' ' ARG . 30.2 mtt-85 -60.78 -44.4 96.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.14 . . . . 3.5600000000000001 110.653 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 28.8 m -69.45 -39.54 77.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.887 . . . . 1.1799999999999999 110.435 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.4 -4.9 53.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 1.3400000000000001 112.987 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 194' ' ' ALA . 75.3 mt-10 54.6 12.5 0.56 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.115 1.154 . . . . 1.45 114.115 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 72.9 mt -73.77 158.4 86.15 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.05 -1.032 . . . . 1.25 108.495 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -65.32 142.71 73.98 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.973 1.115 . . . . 0.78000000000000003 110.557 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.96 163.87 33.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 119.928 -1.733 . . . . 1.2 110.431 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.0 mt -149.88 149.74 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 107.465 -1.309 . . . . 1.25 107.465 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 5.5 m -135.82 -26.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.755 -1.216 . . . . 1.3899999999999999 112.54 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.15 35.04 1.49 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.309 -1.424 . . . . 0.96999999999999997 113.113 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 47.5 p -56.06 -27.62 54.19 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.421 -1.046 . . . . 1.3500000000000001 111.45 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 77.12 -90.78 1.0 Allowed Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.133 -1.032 . . . . 1.0700000000000001 110.815 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.2 p -125.06 27.6 6.64 Favored 'General case' 0 N--CA 1.512 2.652 0 O-C-N 121.341 -1.094 . . . . 1.9199999999999999 112.669 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.11 -34.76 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.232 -1.543 . . . . 1.3300000000000001 110.075 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.9 p -58.34 -17.97 23.96 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.26 -0.976 . . . . 1.4199999999999999 111.86 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.8 p -92.63 -0.98 57.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.137 -0.977 . . . . 2.1200000000000001 112.006 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -129.13 5.19 5.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 112.595 0.591 . . . . 2.6899999999999999 112.595 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.87 141.32 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.732 -0.605 . . . . 1.29 109.39 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -120.35 155.21 33.84 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.371 -0.974 . . . . 2.6899999999999999 108.371 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 16.6 p30 -53.8 142.79 22.77 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.083 -1.011 . . . . 2.79 110.547 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.6 t0 80.19 0.25 2.01 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.504 1.298 . . . . 2.3500000000000001 114.504 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.12 146.67 54.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.795 -1.191 . . . . 1.97 108.78 177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -88.74 120.7 30.38 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.458 -1.312 . . . . 2.9700000000000002 107.458 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 49.6 mt -128.94 149.04 50.96 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.404 -0.81 . . . . 1.25 110.018 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 57.4 mt -116.03 126.95 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.878 -1.527 . . . . 1.22 106.878 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 65.1 tp -99.22 120.11 38.98 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.306 -1.368 . . . . 1.24 107.306 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 223' ' ' VAL . 49.7 t0 -93.89 -28.97 15.54 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.012 -1.055 . . . . 2.0499999999999998 112.826 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 38.77 18.37 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.186 0.809 . . . . 1.25 113.186 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.8 t -111.45 -58.84 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-O 122.197 0.999 . . . . 1.4299999999999999 108.922 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -96.47 9.8 40.24 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.412 1.101 . . . . 3.0299999999999998 110.188 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 61.92 50.05 4.38 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.785 -1.098 . . . . 2.25 111.665 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -145.28 148.04 33.02 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.345 1.069 . . . . 2.52 109.749 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 80.9 t -117.2 140.77 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 115.503 -0.772 . . . . 1.29 109.285 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -100.03 130.59 46.21 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.171 -1.048 . . . . 1.3400000000000001 108.171 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.3 t -109.83 131.48 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.579 0.704 . . . . 1.3400000000000001 109.166 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.413 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 24.6 t30 52.96 51.65 9.47 Favored Pre-proline 0 N--CA 1.497 1.877 0 N-CA-C 113.345 0.869 . . . . 2.1800000000000002 113.345 177.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 61.9 Cg_endo -70.23 151.66 66.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.784 2.323 . . . . 0.93999999999999995 111.441 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.0 m -72.23 156.46 39.11 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.964 -1.085 . . . . 2.3999999999999999 108.747 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -59.8 -39.43 84.95 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.89 -1.131 . . . . 3.3300000000000001 109.935 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.65 -39.72 85.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.482 -0.761 . . . . 3.1699999999999999 110.278 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 87.9 t -69.71 -38.58 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.461 -0.775 . . . . 1.6899999999999999 110.216 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 236' ' ' ILE . 73.5 mt -59.29 -46.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.042 -1.036 . . . . 1.6000000000000001 110.15 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.03 -40.22 88.57 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.175 -0.953 . . . . 2.7000000000000002 110.208 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -62.17 -41.57 98.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 2.96 110.808 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 74.9 mtp -70.81 -31.39 68.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 1.6299999999999999 110.372 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 3.27 110.063 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 106.455 -1.683 . . . . 1.5700000000000001 106.455 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 m -104.38 128.45 52.23 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.097 -1.075 . . . . 1.4399999999999999 108.097 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.04 -160.45 16.79 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.904 -1.678 . . . . 1.01 108.904 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 96.6 mt -93.31 -1.11 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.292 -1.122 . . . . 1.6299999999999999 112.772 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 50.72 96.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.102 -0.999 . . . . 1.5800000000000001 112.688 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.92 -42.33 13.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 1.3400000000000001 111.547 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -145.35 144.85 24.37 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.046 -1.094 . . . . 1.8600000000000001 108.046 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.81 147.44 27.43 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.59 2.193 . . . . 1.01 112.218 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 151.29 167.77 15.16 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 109.261 -1.536 . . . . 0.81000000000000005 109.261 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 11' ' ' ILE . 83.7 mt -125.91 132.49 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.243 -1.151 . . . . 1.3700000000000001 107.909 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.53 151.59 46.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 1.1399999999999999 109.286 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.609 ' CE1' ' NH2' ' A' ' 240' ' ' ARG . 1.8 m-85 -122.24 144.52 48.93 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.259 -1.015 . . . . 0.87 108.259 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.92 167.45 34.22 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 118.362 -1.875 . . . . 0.56999999999999995 110.197 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -78.1 157.68 29.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.429 -1.042 . . . . 2.3500000000000001 108.938 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.96 124.64 31.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.975 -1.078 . . . . 1.21 108.151 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.3 tp -100.46 104.49 15.89 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.024 -2.213 . . . . 1.3999999999999999 105.024 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -91.02 135.78 33.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.215 -1.031 . . . . 1.4399999999999999 108.215 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.3 mt -97.27 120.1 37.01 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.438 -1.319 . . . . 1.45 107.438 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -109.11 134.67 51.4 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.249 -1.019 . . . . 2.5 108.249 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.563 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 37.2 tt0 -117.98 140.36 49.85 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.224 -0.658 . . . . 2.6600000000000001 109.224 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -81.98 131.28 35.25 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.718 -1.216 . . . . 2.3199999999999998 107.718 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.09 145.02 56.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 2.1099999999999999 108.74 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.67 135.19 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.91 -1.118 . . . . 1.29 108.636 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.6 t -103.44 129.8 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.967 -1.123 . . . . 1.4099999999999999 107.967 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -99.0 136.97 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.646 -0.872 . . . . 1.3100000000000001 108.646 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -90.62 122.46 33.43 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.828 -1.175 . . . . 1.3400000000000001 107.828 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' A' ' 28' ' ' ARG . 20.6 mmm-85 -93.52 15.72 15.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.315 -0.865 . . . . 3.48 112.319 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -71.47 143.25 50.1 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.408 -0.807 . . . . 2.52 109.527 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.75 141.7 31.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.649 -0.657 . . . . 2.6299999999999999 109.425 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.2 pt -98.3 168.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.197 -0.939 . . . . 1.3100000000000001 110.622 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.8 p -102.37 162.3 13.03 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.983 -0.747 . . . . 1.24 108.983 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.45 -18.55 1.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.086 -1.009 . . . . 1.49 112.379 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -69.85 -39.99 76.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 2.2799999999999998 110.754 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -93.13 -8.91 41.27 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.873 -1.142 . . . . 2.0499999999999998 112.949 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -56.29 -50.48 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.168 -0.957 . . . . 1.3400000000000001 110.781 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.85 -39.44 85.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.542 -0.724 . . . . 1.54 110.674 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -62.2 -41.29 98.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.831 . . . . 2.8500000000000001 110.896 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.53 -37.62 81.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.742 -1.224 . . . . 1.3100000000000001 110.449 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.41 -41.78 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.169 -0.957 . . . . 1.3799999999999999 110.028 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -62.13 -43.58 98.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 1.5 109.745 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.434 ' HG2' HH11 ' A' ' 42' ' ' ARG . 34.0 mtt-85 -61.8 -44.05 97.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.524 -0.735 . . . . 2.7799999999999998 110.063 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -70.78 -52.16 22.38 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.346 -0.846 . . . . 1.0600000000000001 109.896 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.08 -46.44 89.56 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.394 -0.922 . . . . 1.3999999999999999 109.846 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 t -69.19 -34.89 75.6 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.243 0.544 . . . . 1.3200000000000001 110.364 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.44 -47.95 87.79 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.685 -1.245 . . . . 0.69999999999999996 110.17 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -56.91 -32.02 65.5 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.363 -1.08 . . . . 3.4399999999999999 109.183 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.38 -42.06 69.93 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.522 0.677 . . . . 1.3600000000000001 109.968 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -78.49 -42.02 30.85 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.688 -0.805 . . . . 2.8300000000000001 110.14 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.77 95.95 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.669 0.747 . . . . 1.23 110.368 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.1 p -60.01 -39.81 87.06 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.994 0.902 . . . . 1.9199999999999999 109.666 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.57 67.97 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 120.073 -0.651 . . . . 1.25 110.31 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -61.18 -48.57 80.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.273 -0.892 . . . . 1.97 110.382 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.8 -40.37 96.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -0.92 . . . . 2.1800000000000002 109.821 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -60.55 -41.24 94.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.542 -0.724 . . . . 1.1899999999999999 110.428 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 m -65.65 -42.86 90.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.0 -1.062 . . . . 1.3400000000000001 110.409 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.2 -30.73 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.658 . . . . 1.23 110.611 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -52.61 -46.29 66.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.709 -0.619 . . . . 1.5600000000000001 110.619 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 m -68.82 -37.2 79.05 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.21 -0.931 . . . . 1.3 109.791 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -61.73 -38.35 87.58 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.427 -0.909 . . . . 2.3199999999999998 109.386 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.19 74.86 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.822 -0.751 . . . . 1.1399999999999999 109.977 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.97 -34.57 21.03 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.379 -1.391 . . . . 0.68999999999999995 110.917 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.44 -18.05 43.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.783 -1.422 . . . . 1.48 111.545 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.0 m -87.91 -52.57 5.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.912 -0.493 . . . . 1.52 110.344 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -107.27 -15.28 14.69 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.435 -0.791 . . . . 1.3100000000000001 112.97 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.91 164.88 14.71 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.537 -0.727 . . . . 0.84999999999999998 111.567 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -58.16 -17.94 22.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.629 -0.924 . . . . 3.8599999999999999 113.113 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.91 -39.43 85.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.995 -1.065 . . . . 2.3500000000000001 110.769 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -86.8 -23.63 25.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.953 -1.092 . . . . 2.2599999999999998 111.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -59.84 -39.98 86.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.725 -0.609 . . . . 1.45 111.598 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.44 -36.77 81.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.162 -0.961 . . . . 1.25 111.352 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 57.8 mt -63.38 -41.65 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.73 -1.232 . . . . 1.26 110.843 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -70.59 -30.94 67.75 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.933 -1.104 . . . . 0.82999999999999996 110.631 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.51 -38.73 85.32 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.195 -0.94 . . . . 1.1899999999999999 109.91 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.3 -44.67 90.22 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 120.298 -0.953 . . . . 0.57999999999999996 110.891 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -59.73 -40.79 89.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.874 -1.368 . . . . 2.0499999999999998 110.723 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.6 mt -59.83 -39.43 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.107 -0.995 . . . . 1.21 110.772 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.21 -39.77 83.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.111 -0.993 . . . . 2.29 110.633 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.5 tp -58.36 -45.89 87.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.14 -0.975 . . . . 1.21 110.235 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.51 -39.83 89.2 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.585 -0.846 . . . . 1.1399999999999999 110.248 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -86.93 11.02 14.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 1.4199999999999999 112.304 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -66.47 120.96 14.26 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.978 -1.076 . . . . 1.27 108.536 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.87 -16.8 64.17 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.367 -0.833 . . . . 1.3500000000000001 110.918 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -73.42 -47.89 38.13 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.548 -0.861 . . . . 2.2200000000000002 110.447 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.86 -37.29 86.83 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.429 -0.908 . . . . 1.22 110.229 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.74 -45.53 93.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.338 -0.851 . . . . 1.29 110.915 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.7 -36.98 85.62 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.014 -1.054 . . . . 2.1699999999999999 110.925 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.7 -48.48 63.77 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.735 -1.228 . . . . 1.3 110.404 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -57.44 -47.71 84.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.444 -0.902 . . . . 1.1699999999999999 110.243 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.87 -39.61 80.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.785 -0.572 . . . . 1.3999999999999999 110.415 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.53 91.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 1.3300000000000001 110.644 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.15 -43.68 98.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 1.48 110.284 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.1 mt -61.0 -45.95 97.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 1.28 110.648 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -82.31 -36.43 26.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -0.757 . . . . 2.6000000000000001 111.908 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -84.49 -39.36 18.97 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.62 -1.3 . . . . 1.51 111.627 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -105.26 10.37 33.65 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.969 -1.082 . . . . 2.48 111.939 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.4 m80 48.48 51.39 15.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 1.6100000000000001 111.588 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.2 mtt -109.5 154.34 22.81 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.703 0.763 . . . . 1.8999999999999999 109.722 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.1 p -71.81 158.64 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.132 -0.692 . . . . 1.3200000000000001 109.132 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.27 89.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.403 -0.811 . . . . 1.1499999999999999 110.754 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -67.42 -43.06 82.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.755 -1.215 . . . . 2.25 109.51 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.06 -48.31 58.4 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.656 0.741 . . . . 1.22 110.845 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.48 -46.85 87.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.138 -0.976 . . . . 1.1899999999999999 110.47 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.29 94.96 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.497 0.665 . . . . 1.2 110.411 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.85 -39.33 84.82 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.032 -1.043 . . . . 2.1000000000000001 110.334 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.42 -49.92 75.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.878 -1.139 . . . . 1.3 111.099 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.25 -49.0 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.059 . . . . 1.27 110.004 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.45 -30.82 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.676 -0.64 . . . . 1.1899999999999999 110.699 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -59.45 -40.37 86.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 2.1099999999999999 110.276 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.28 -28.0 31.74 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.204 -1.474 . . . . 0.88 113.108 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -60.29 -39.73 87.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.056 -1.85 . . . . 1.99 110.045 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.63 -46.69 52.82 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.554 -0.716 . . . . 1.28 110.299 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.3 p -62.83 -40.21 96.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.419 -0.801 . . . . 2.2200000000000002 110.433 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.39 -40.65 97.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 1.45 110.508 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.88 -29.61 70.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.04 -1.037 . . . . 1.47 111.111 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.09 -21.36 64.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.906 -1.121 . . . . 2.04 111.053 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -73.81 -12.48 60.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.215 -0.928 . . . . 1.73 110.788 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.6 mt -84.84 144.89 28.13 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.485 -0.759 . . . . 1.79 109.065 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -101.46 46.91 0.92 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.171 -0.956 . . . . 2.8799999999999999 111.591 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -122.28 138.75 54.39 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.057 -1.027 . . . . 1.5800000000000001 108.589 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.8 -38.67 82.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 3.04 110.973 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -71.93 -47.02 55.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.957 -1.089 . . . . 1.29 110.525 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.67 -36.76 84.89 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.46 -0.896 . . . . 1.6000000000000001 110.103 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -60.47 -46.53 89.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.819 -1.152 . . . . 2.7599999999999998 109.644 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -61.95 -30.84 71.19 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.367 -0.933 . . . . 2.1499999999999999 109.651 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -61.86 -30.12 70.64 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.291 -0.964 . . . . 2.8100000000000001 108.9 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.21 73.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.785 0.802 . . . . 1.3899999999999999 109.574 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.89 -43.36 71.95 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.622 0.725 . . . . 1.4099999999999999 110.319 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -64.5 -34.15 77.56 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.497 -0.752 . . . . 1.3899999999999999 110.528 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.01 -39.96 82.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.252 -0.905 . . . . 1.1899999999999999 110.033 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 131' ' ' ARG . 27.4 ttt-85 -56.18 -39.92 73.14 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.251 -1.379 . . . . 3.6299999999999999 109.469 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -60.05 -42.59 94.79 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.575 0.702 . . . . 1.28 110.235 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.32 -38.94 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 1.1799999999999999 110.166 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.59 -43.74 23.02 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.852 -1.166 . . . . 0.51000000000000001 110.832 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -58.33 -40.76 83.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.293 -1.122 . . . . 3.1699999999999999 110.592 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -62.33 -41.55 98.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.959 -1.088 . . . . 2.8500000000000001 109.969 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.64 -39.59 84.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.611 -0.681 . . . . 1.6499999999999999 109.964 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.3 mt -59.73 -40.09 86.86 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.453 -0.779 . . . . 1.2 110.473 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.563 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 63.1 mtt-85 -60.66 -38.6 85.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.016 -1.053 . . . . 2.7999999999999998 111.062 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -71.65 -41.81 68.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 2.1499999999999999 110.87 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.3 -39.62 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.016 -1.053 . . . . 1.21 110.216 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.2 -8.93 56.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.123 -0.986 . . . . 1.3400000000000001 112.199 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.27 21.29 78.07 Favored Glycine 0 N--CA 1.48 1.617 0 C-N-CA 119.703 -1.237 . . . . 0.91000000000000003 113.282 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 tp -69.2 149.94 48.02 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.78 -0.835 . . . . 1.51 110.543 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -67.85 150.92 47.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.369 -0.832 . . . . 2.8799999999999999 110.913 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.9 mt -101.74 139.96 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.368 -0.975 . . . . 1.6200000000000001 108.368 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.514 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.3 mp -78.56 124.42 36.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.297 -1.001 . . . . 2.1099999999999999 108.297 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -99.6 100.03 10.97 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.317 -1.735 . . . . 1.6200000000000001 106.317 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.518 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 71.6 mt -78.54 -4.99 51.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.545 -0.722 . . . . 1.3999999999999999 112.321 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.2 p -86.99 9.18 20.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.145 -0.972 . . . . 2.0499999999999998 112.366 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.66 18.42 14.33 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 114.151 1.167 . . . . 1.3500000000000001 114.151 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.518 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 3.1 mp -71.35 141.12 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 119.909 -1.744 . . . . 1.4199999999999999 109.498 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -118.84 -13.52 9.51 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.045 0.926 . . . . 2.9900000000000002 112.429 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -117.38 145.04 44.34 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.555 -0.906 . . . . 1.54 108.555 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -76.26 121.78 23.44 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.673 -0.862 . . . . 1.3799999999999999 108.673 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.4 m -147.48 176.31 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.434 -0.791 . . . . 1.28 108.973 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.9 mt -88.65 142.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.524 -0.735 . . . . 1.1599999999999999 109.339 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.5 tp -94.85 126.73 40.38 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.594 -0.891 . . . . 1.3100000000000001 108.594 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.89 131.02 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.648 -0.871 . . . . 1.25 108.648 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.98 154.56 19.87 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.646 -0.872 . . . . 1.26 108.646 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.22 -36.02 78.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.393 -1.442 . . . . 1.6000000000000001 109.477 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 55.9 t0 -172.75 151.22 2.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.43 -0.952 . . . . 2.4199999999999999 108.43 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 70.1 mt -113.06 140.22 48.04 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.371 -0.831 . . . . 1.3500000000000001 108.926 177.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.5 p -94.82 152.81 39.97 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.221 -0.925 . . . . 1.3200000000000001 108.754 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -42.91 -42.28 9.08 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.806 1.671 . . . . 0.69999999999999996 113.295 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.9 m -62.24 -50.44 71.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.987 -1.071 . . . . 1.1200000000000001 109.744 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.28 -40.5 90.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.503 -0.748 . . . . 1.21 110.25 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 78.3 p -67.86 -40.09 83.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.53 -0.731 . . . . 1.1899999999999999 110.754 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.13 86.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 1.24 110.743 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -95.32 1.1 54.28 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.204 -0.935 . . . . 1.6899999999999999 112.691 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.83 150.15 29.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.451 -0.781 . . . . 1.3400000000000001 109.902 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.595 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.6 OUTLIER -91.99 107.02 18.91 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.274 -1.75 . . . . 2.77 106.274 177.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.4 mt -81.15 -9.16 59.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.788 . . . . 2.0899999999999999 112.535 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -77.59 -35.51 52.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.039 -1.038 . . . . 2.6699999999999999 110.572 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -101.36 2.87 40.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.235 -0.915 . . . . 2.5800000000000001 113.01 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.0 t -101.0 120.01 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 106.807 -1.553 . . . . 1.1799999999999999 106.807 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.2 tp -90.93 -9.51 45.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.097 -1.002 . . . . 2.1800000000000002 112.04 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.66 169.26 40.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.035 -1.626 . . . . 0.48999999999999999 109.035 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.1 m-85 -128.02 129.79 47.28 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.384 -1.068 . . . . 0.64000000000000001 108.2 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.4 mt -128.85 108.75 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 105.857 -1.905 . . . . 1.21 105.857 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 203' ' ' VAL . 76.4 p -130.82 171.76 12.78 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.905 -1.122 . . . . 1.3799999999999999 110.153 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.445 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 33.3 t0 -102.54 59.15 0.8 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.724 -0.61 . . . . 2.3700000000000001 110.453 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 106.371 -1.715 . . . . 1.52 106.371 178.311 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 52.0 m . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.171 -0.678 . . . . 2.1099999999999999 109.171 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -59.84 -39.6 85.69 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.36 -0.838 . . . . 1.24 111.082 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.9 m -58.47 -40.99 84.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.633 -1.292 . . . . 2.1499999999999999 110.228 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.2 m -61.39 -37.04 81.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 2.02 110.447 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.73 -39.32 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.509 -0.745 . . . . 2.1200000000000001 110.666 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 68.8 mtp -62.92 -41.15 99.37 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.08 0.943 . . . . 1.3600000000000001 109.486 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.92 -45.43 94.67 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.931 -0.577 . . . . 1.29 111.091 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -60.37 -43.37 96.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.982 -1.074 . . . . 3.5600000000000001 110.674 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.2 m -69.45 -39.13 77.97 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.211 -0.93 . . . . 1.1799999999999999 110.187 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.45 -7.48 50.48 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.871 0.844 . . . . 1.3400000000000001 112.531 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 53.12 7.16 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.996 1.109 . . . . 1.45 113.996 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.91 149.67 92.61 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 120.959 -1.088 . . . . 1.25 108.385 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.13 144.95 88.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.534 1.49 . . . . 0.78000000000000003 109.738 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.62 161.41 35.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.366 -1.458 . . . . 1.2 109.673 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.6 mt -149.94 149.55 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.756 -1.202 . . . . 1.25 107.756 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.8 m -133.41 -25.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.123 -0.986 . . . . 1.3899999999999999 112.324 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.68 43.0 2.07 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 120.226 -0.987 . . . . 0.96999999999999997 111.837 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 43.8 p -63.08 -15.63 57.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.322 -1.105 . . . . 1.3500000000000001 111.573 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.445 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 72.12 -93.82 0.6 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.868 -1.293 . . . . 1.0700000000000001 109.868 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 85.2 p -129.95 33.4 4.4 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.35 -1.088 . . . . 1.9199999999999999 112.022 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.67 -35.79 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.023 -1.673 . . . . 1.3300000000000001 110.482 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.1 p -60.33 -24.76 65.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 1.4199999999999999 111.73 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.8 p -96.57 9.0 42.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 2.1200000000000001 112.149 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -132.59 -4.27 3.31 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.728 -0.607 . . . . 2.6899999999999999 112.409 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.06 157.59 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.275 -0.89 . . . . 1.29 109.854 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -122.25 160.25 25.64 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.069 -1.086 . . . . 2.6899999999999999 108.069 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 51.5 p-10 -57.03 142.12 43.23 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.093 -1.004 . . . . 2.79 110.53 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.0 OUTLIER 80.32 7.49 1.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.79 1.404 . . . . 2.3500000000000001 114.79 179.387 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.8 t0 -67.21 149.38 50.53 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.308 -0.997 . . . . 1.97 108.308 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.433 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.3 t80 -89.64 115.04 26.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.331 -1.359 . . . . 2.9700000000000002 107.331 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 78.5 mt -124.96 148.15 48.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -0.755 . . . . 1.25 109.365 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.3 mt -119.09 126.35 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.15 -1.796 . . . . 1.22 106.15 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 66.2 tp -100.91 119.04 38.13 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.425 -1.694 . . . . 1.24 106.425 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.0 p-10 -94.73 -21.33 18.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.027 -1.046 . . . . 2.0499999999999998 112.459 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.425 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 37.93 18.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.376 0.608 . . . . 1.25 112.477 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.601 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.4 t -112.26 -62.83 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 1.4299999999999999 109.389 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -89.68 7.25 37.64 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.314 1.054 . . . . 3.0299999999999998 110.226 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 39.6 t30 63.86 50.58 2.56 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.023 -0.989 . . . . 2.25 112.1 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 74.6 mt-30 -147.16 152.38 38.33 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.352 1.072 . . . . 2.52 110.187 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.9 t -115.65 139.92 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.989 -1.115 . . . . 1.29 107.989 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -104.98 133.17 50.21 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.164 -0.96 . . . . 1.3400000000000001 108.775 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.85 130.89 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.16 -1.052 . . . . 1.3400000000000001 108.16 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.461 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 57.7 t30 54.39 49.04 5.12 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 113.578 0.955 . . . . 2.1800000000000002 113.578 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 52.9 Cg_endo -68.95 149.67 72.25 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.607 2.204 . . . . 0.93999999999999995 110.994 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.1 p -78.33 165.47 23.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.035 -1.041 . . . . 2.3999999999999999 110.497 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -60.77 -36.34 78.7 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.946 -1.096 . . . . 3.3300000000000001 110.455 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.58 -39.91 85.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.004 -1.06 . . . . 3.1699999999999999 111.138 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.17 -40.37 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 1.6899999999999999 110.243 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 74.9 mt -59.42 -43.96 91.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.327 -0.858 . . . . 1.6000000000000001 110.916 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.02 -40.31 88.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.21 -0.931 . . . . 2.7000000000000002 110.573 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -62.49 -45.35 93.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.51 -0.744 . . . . 2.96 110.722 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 77.8 mtp -71.63 -39.46 70.41 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.364 -0.835 . . . . 1.6299999999999999 110.883 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.609 ' NH2' ' CE1' ' A' ' 13' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 3.27 110.634 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 106.495 -1.668 . . . . 1.5700000000000001 106.495 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.7 m -104.14 121.56 43.49 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.719 -1.215 . . . . 1.4399999999999999 107.719 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 225' ' ' ASN . . . -117.78 -164.17 13.1 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.868 -1.693 . . . . 1.01 108.868 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 96.1 mt -96.34 1.56 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 120.872 -1.37 . . . . 1.6299999999999999 112.708 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ILE . 18.9 tp 49.33 100.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.012 -1.075 . . . . 1.5800000000000001 111.678 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.33 -45.24 13.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.255 -1.528 . . . . 1.3400000000000001 111.249 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -148.57 149.04 30.18 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.275 -1.009 . . . . 1.8600000000000001 108.275 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.53 148.93 43.28 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 123.01 2.473 . . . . 1.01 112.104 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 147.89 119.68 1.1 Allowed Glycine 0 N--CA 1.507 3.413 0 N-CA-C 110.323 -1.111 . . . . 0.81000000000000005 110.323 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 53.3 mt -90.64 135.78 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.893 -1.357 . . . . 1.3700000000000001 108.818 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.74 157.64 45.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.854 -0.795 . . . . 1.1399999999999999 108.854 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -118.74 140.01 50.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.93 -1.137 . . . . 0.87 107.93 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.77 163.26 31.49 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 118.597 -1.763 . . . . 0.56999999999999995 110.057 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -78.8 157.74 28.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.67 -0.9 . . . . 2.3500000000000001 108.996 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.53 130.42 35.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.002 -1.061 . . . . 1.21 108.394 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -110.87 101.4 10.0 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.729 -1.952 . . . . 1.3999999999999999 105.729 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.4 tp -87.78 135.26 33.46 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.408 -1.33 . . . . 1.4399999999999999 107.408 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.0 mt -101.02 114.56 28.6 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 106.481 -1.674 . . . . 1.45 106.481 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -108.51 138.02 45.51 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.885 -1.154 . . . . 2.5 107.885 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 52.1 mp0 -123.09 149.35 44.58 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.462 -0.774 . . . . 2.6600000000000001 109.463 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -83.82 130.6 34.93 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.784 -1.191 . . . . 2.3199999999999998 107.784 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -63.22 146.88 52.46 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.149 -0.969 . . . . 2.1099999999999999 108.96 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.6 mt -92.16 135.41 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 108.115 -1.069 . . . . 1.29 108.115 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -106.43 127.94 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.099 -1.074 . . . . 1.4099999999999999 108.099 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -101.57 136.26 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.043 -1.095 . . . . 1.3100000000000001 108.043 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -89.47 125.24 35.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.73 -1.231 . . . . 1.3400000000000001 107.766 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.3 mmt-85 -93.54 11.15 29.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.998 -1.064 . . . . 3.48 112.358 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -67.53 143.7 56.01 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.058 -1.026 . . . . 2.52 108.991 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -88.86 136.95 32.74 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.08 -1.082 . . . . 2.6299999999999999 108.08 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.18 166.72 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.277 -0.89 . . . . 1.3100000000000001 110.303 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.7 p -93.89 163.69 13.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 1.24 109.666 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.83 -21.17 6.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.46 -0.775 . . . . 1.49 112.04 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -69.95 -41.92 73.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.063 -1.023 . . . . 2.2799999999999998 111.049 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -86.56 -2.68 58.69 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.438 -1.414 . . . . 2.0499999999999998 112.224 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -60.96 -45.39 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 1.3400000000000001 110.938 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.72 -39.66 85.4 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.644 -1.285 . . . . 1.54 110.528 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.539 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 10.4 mp0 -60.34 -41.07 92.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.106 -0.497 . . . . 2.8500000000000001 110.947 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.59 -38.47 84.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.575 -1.328 . . . . 1.3100000000000001 110.626 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.5 t -59.82 -41.64 86.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.939 -1.101 . . . . 1.3799999999999999 110.729 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -63.42 -49.81 72.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.719 -1.238 . . . . 1.5 110.206 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.37 -38.88 88.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.595 -0.691 . . . . 2.7799999999999998 110.329 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -75.5 -55.87 5.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.657 0.741 . . . . 1.0600000000000001 109.902 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.63 -46.99 85.89 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.693 -0.803 . . . . 1.3999999999999999 110.561 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.4 t -67.32 -41.88 84.57 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.19 -0.944 . . . . 1.3200000000000001 110.131 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.15 87.6 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 119.088 -1.53 . . . . 0.69999999999999996 109.965 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.6 ttt-85 -58.2 -31.35 67.22 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.744 -0.857 . . . . 3.4399999999999999 109.794 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.61 -40.89 80.14 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.881 0.848 . . . . 1.3600000000000001 109.792 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -78.12 -41.91 33.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 2.8300000000000001 110.112 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.21 93.16 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.272 -0.892 . . . . 1.23 109.939 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 p -60.5 -38.24 83.67 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.465 1.126 . . . . 1.9199999999999999 109.268 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.84 -47.04 64.21 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.68 -0.691 . . . . 1.25 110.419 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.04 -48.4 71.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.248 -0.908 . . . . 1.97 110.546 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.8 -39.18 90.8 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.343 -0.848 . . . . 2.1800000000000002 109.572 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -60.18 -41.56 93.17 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.686 -0.634 . . . . 1.1899999999999999 110.478 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.6 m -62.91 -40.63 98.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.026 -1.046 . . . . 1.3400000000000001 110.272 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.4 mt -60.6 -36.02 67.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.471 -0.768 . . . . 1.23 110.325 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -53.79 -42.92 68.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 1.5600000000000001 111.027 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -70.0 -33.39 71.98 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.835 -1.166 . . . . 1.3 110.557 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -64.89 -39.92 94.3 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.886 -1.125 . . . . 2.3199999999999998 109.515 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.39 80.96 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.756 -0.59 . . . . 1.1399999999999999 109.968 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.7 -36.1 34.1 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.651 -1.261 . . . . 0.68999999999999995 110.583 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -79.91 -28.18 39.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.876 -1.367 . . . . 1.48 110.984 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 79.6 m -86.77 -47.74 8.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.368 -0.832 . . . . 1.52 110.942 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -107.93 -11.16 15.39 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 113.343 0.868 . . . . 1.3100000000000001 113.343 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.67 159.63 24.79 Favored Glycine 0 N--CA 1.5 2.949 0 C-N-CA 120.658 -0.782 . . . . 0.84999999999999998 113.29 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -52.33 -18.87 1.77 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.743 -0.857 . . . . 3.8599999999999999 112.921 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.17 -38.57 76.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 2.3500000000000001 111.522 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -82.37 -21.63 35.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.903 -1.123 . . . . 2.2599999999999998 112.05 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -59.74 -31.47 69.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 1.45 111.098 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.79 88.82 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.13 -0.981 . . . . 1.25 110.519 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.0 mt -67.01 -44.71 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.633 -1.292 . . . . 1.26 110.145 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -70.85 -28.8 64.85 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.321 -0.862 . . . . 0.82999999999999996 110.925 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -61.87 -37.99 86.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.883 . . . . 1.1899999999999999 110.153 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.11 -38.98 73.34 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 119.693 -1.242 . . . . 0.57999999999999996 110.486 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -59.68 -42.55 93.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.094 -1.239 . . . . 2.0499999999999998 110.3 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.2 mt -62.44 -38.97 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.351 -0.843 . . . . 1.21 110.091 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.9 ttm -59.99 -39.99 87.62 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.549 -0.861 . . . . 2.29 110.263 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.66 -51.49 69.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.199 -0.938 . . . . 1.21 110.89 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.7 tp -60.52 -41.58 94.68 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.913 -0.715 . . . . 1.1399999999999999 110.057 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -87.24 1.17 53.98 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.086 0.773 . . . . 1.4199999999999999 113.086 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -60.28 123.53 17.52 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.426 -1.421 . . . . 1.27 108.577 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.18 -17.26 64.76 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.694 0.759 . . . . 1.3500000000000001 111.064 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -76.36 -54.19 7.1 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.875 -0.73 . . . . 2.2200000000000002 110.227 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.9 mt -62.27 -38.38 89.12 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.152 -0.619 . . . . 1.22 110.722 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.38 -49.91 75.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.075 -1.016 . . . . 1.29 111.213 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.25 -37.57 83.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.811 -1.181 . . . . 2.1699999999999999 110.577 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.2 -47.79 78.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.146 -0.971 . . . . 1.3 110.18 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.0 mt -57.68 -47.08 86.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 120.999 -1.063 . . . . 1.1699999999999999 110.015 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 90' ' ' ILE . 96.5 mt -62.26 -41.92 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.66 0.743 . . . . 1.3999999999999999 110.857 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.34 -42.44 91.52 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.226 -0.921 . . . . 1.3300000000000001 110.866 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.69 -42.42 97.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.972 -1.08 . . . . 1.48 110.161 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.44 -50.35 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 1.28 110.572 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -76.16 -35.15 59.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 2.6000000000000001 111.903 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -81.89 -43.78 17.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.733 -1.229 . . . . 1.51 112.043 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -102.08 7.11 41.23 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.233 -0.917 . . . . 2.48 112.862 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 50.72 49.59 20.63 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 1.6100000000000001 111.887 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.3 mtt -102.99 155.95 18.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.387 -0.821 . . . . 1.8999999999999999 109.34 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.8 p -72.17 159.53 33.96 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.76 0.79 . . . . 1.3200000000000001 109.6 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.89 88.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.937 -1.102 . . . . 1.1499999999999999 110.416 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -68.52 -39.17 81.3 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.176 -0.953 . . . . 2.25 110.618 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.8 -51.76 24.81 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.273 -0.892 . . . . 1.22 111.214 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.48 94.79 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.827 -1.171 . . . . 1.1899999999999999 110.994 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.15 98.94 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.379 -0.826 . . . . 1.2 110.9 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -60.42 -39.82 88.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.916 -1.115 . . . . 2.1000000000000001 111.003 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -59.03 -49.38 78.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.801 -1.187 . . . . 1.3 110.684 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.57 -41.89 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.252 -0.905 . . . . 1.27 110.231 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -63.29 -32.47 56.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.301 -0.874 . . . . 1.1899999999999999 110.03 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.85 -41.11 86.21 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.611 -0.68 . . . . 2.1099999999999999 110.927 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.21 -31.55 19.49 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.422 -1.371 . . . . 0.88 112.898 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -61.44 -40.45 94.5 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 119.421 1.61 . . . . 1.99 109.958 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.56 -50.6 24.48 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.938 0.875 . . . . 1.28 110.364 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 60.9 p -61.48 -37.22 82.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.394 -0.816 . . . . 2.2200000000000002 110.775 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.1 -45.22 93.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.379 -0.826 . . . . 1.45 110.92 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.22 -28.27 69.25 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.083 -1.011 . . . . 1.47 111.21 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -66.67 -22.27 66.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.856 . . . . 2.04 110.731 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -71.61 -15.72 62.26 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.378 -0.826 . . . . 1.73 111.245 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.7 mt -86.28 138.93 31.47 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.685 -1.228 . . . . 1.79 107.685 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -97.8 39.41 1.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.341 -0.849 . . . . 2.8799999999999999 111.617 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -112.23 137.18 50.7 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.557 -0.905 . . . . 1.5800000000000001 108.557 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.9 -36.72 72.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 3.04 111.167 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.15 -56.48 5.5 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.838 -1.164 . . . . 1.29 110.41 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.4 mt -62.29 -42.08 99.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 1.6000000000000001 110.785 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.03 -47.47 84.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.993 -1.067 . . . . 2.7599999999999998 110.456 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -60.28 -32.53 71.26 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.328 -0.949 . . . . 2.1499999999999999 109.968 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -64.76 -29.12 70.09 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.187 -1.005 . . . . 2.8100000000000001 109.552 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.93 87.02 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.763 0.792 . . . . 1.3899999999999999 109.829 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.41 -42.74 78.56 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.543 0.687 . . . . 1.4099999999999999 110.449 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.04 -33.34 75.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.577 -0.702 . . . . 1.3899999999999999 110.729 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 52.7 t -69.31 -38.56 77.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.439 -0.788 . . . . 1.1899999999999999 110.529 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 131' ' ' ARG . 34.3 ttt-85 -59.67 -40.21 87.04 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.864 -1.135 . . . . 3.6299999999999999 109.665 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -61.23 -35.24 76.7 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.649 0.738 . . . . 1.28 110.715 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.3 mt -61.73 -40.13 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.051 -1.031 . . . . 1.1799999999999999 110.47 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.55 -46.77 91.55 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.088 -1.053 . . . . 0.51000000000000001 110.745 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -58.32 -43.71 88.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.944 -1.327 . . . . 3.1699999999999999 110.59 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 51.6 mtt-85 -60.63 -44.1 96.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.929 -1.107 . . . . 2.8500000000000001 110.577 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.1 -44.21 97.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.067 -1.021 . . . . 1.6499999999999999 110.083 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.46 -41.13 96.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.876 . . . . 1.2 110.702 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -61.52 -34.76 76.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.907 . . . . 2.7999999999999998 110.563 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -73.97 -40.4 63.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 2.1499999999999999 110.989 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.67 -38.5 78.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.23 -0.919 . . . . 1.21 110.615 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.5 mt -87.95 -7.92 56.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.931 -1.105 . . . . 1.3400000000000001 112.587 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.16 18.88 79.06 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 120.077 -1.059 . . . . 0.91000000000000003 113.046 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -62.31 146.75 50.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.983 . . . . 1.51 109.406 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -67.22 147.88 52.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.974 -1.079 . . . . 2.8799999999999999 109.176 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.8 mt -109.63 136.22 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.097 -1.002 . . . . 1.6200000000000001 108.306 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.2 mp -78.0 130.09 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.48 -0.763 . . . . 2.1099999999999999 108.949 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -97.46 99.97 11.39 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.287 -1.745 . . . . 1.6200000000000001 106.287 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.8 mt -70.8 -21.08 62.52 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 116.145 -0.479 . . . . 1.3999999999999999 111.48 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.8 m -80.71 3.33 22.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.922 . . . . 2.0499999999999998 111.821 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.72 19.41 12.51 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.445 -0.784 . . . . 1.3500000000000001 112.507 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.5 mt -71.81 141.44 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 1.4199999999999999 109.689 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -117.54 -14.34 10.28 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.84 0.829 . . . . 2.9900000000000002 113.049 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -114.75 138.04 51.21 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.239 -1.022 . . . . 1.54 108.239 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.62 123.32 22.98 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.408 -0.96 . . . . 1.3799999999999999 108.408 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.1 m -145.95 176.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.391 -0.818 . . . . 1.28 109.273 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mt -87.27 140.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.758 -1.214 . . . . 1.1599999999999999 108.426 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.9 tp -95.3 121.06 36.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.869 -1.145 . . . . 1.3100000000000001 108.158 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.3 t -123.3 132.29 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 108.369 -0.975 . . . . 1.25 108.369 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.4 160.51 32.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 1.26 108.561 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.64 77.63 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.826 -1.171 . . . . 1.6000000000000001 109.208 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 p-10 -172.4 155.49 3.5 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.726 -0.842 . . . . 2.4199999999999999 108.726 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 75.1 mt -120.25 137.99 53.91 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.956 -1.127 . . . . 1.3500000000000001 107.956 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 p -96.42 150.9 37.65 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.188 -0.945 . . . . 1.3200000000000001 108.629 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -41.15 -42.74 5.0 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.869 1.713 . . . . 0.69999999999999996 113.102 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 54.7 m -60.59 -50.58 72.94 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.159 -0.963 . . . . 1.1200000000000001 109.892 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -61.97 -40.85 96.98 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.757 -1.177 . . . . 1.21 109.621 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.7 p -68.23 -37.78 81.18 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.49 -0.884 . . . . 1.1899999999999999 110.525 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.47 75.68 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.509 -0.744 . . . . 1.24 110.706 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -93.73 -3.46 52.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.009 -1.057 . . . . 1.6899999999999999 112.815 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.61 149.1 49.54 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.74 -0.837 . . . . 1.3400000000000001 108.74 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -96.83 118.48 33.35 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.721 -1.585 . . . . 2.77 106.721 177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.9 -12.99 60.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 2.0899999999999999 111.852 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -84.66 -26.16 28.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.391 -0.818 . . . . 2.6699999999999999 112.336 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -100.88 2.1 40.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.367 -0.833 . . . . 2.5800000000000001 112.271 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.9 t -111.18 131.21 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 N-CA-C 108.263 -1.014 . . . . 1.1799999999999999 108.263 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.38 -12.35 43.53 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.37 -0.831 . . . . 2.1800000000000002 112.016 -179.511 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.94 -179.42 44.4 Favored Glycine 0 N--CA 1.497 2.745 0 O-C-N 120.46 -1.4 . . . . 0.48999999999999999 109.768 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -130.1 134.01 47.06 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 107.408 -1.331 . . . . 0.64000000000000001 107.408 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 59.0 mt -137.54 106.22 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 105.783 -1.932 . . . . 1.21 105.783 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 203' ' ' VAL . 71.0 p -132.91 177.32 7.74 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.71 -1.244 . . . . 1.3799999999999999 110.844 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 16.4 m-20 -101.4 57.52 0.85 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.534 -0.757 . . . . 2.3700000000000001 109.405 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.113 0 O-C-N 121.417 -0.802 . . . . 1.52 109.656 179.746 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 108.591 -0.892 . . . . 2.1099999999999999 108.591 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -60.35 -39.34 86.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 1.24 110.727 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 35.2 p -58.36 -38.04 76.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 2.1499999999999999 110.54 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.7 m -60.58 -39.75 89.2 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.357 -0.839 . . . . 2.02 110.221 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.81 -39.72 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.126 -0.983 . . . . 2.1200000000000001 110.489 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 71.3 mtp -63.39 -42.58 98.82 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.503 1.145 . . . . 1.3600000000000001 109.341 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.12 -41.16 92.04 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.463 -0.79 . . . . 1.29 110.938 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.5 -44.92 96.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.837 -1.164 . . . . 3.5600000000000001 110.355 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 27.8 m -71.67 -39.54 70.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.9 . . . . 1.1799999999999999 110.416 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.9 mt -91.64 -11.2 37.75 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.818 0.818 . . . . 1.3400000000000001 112.22 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.5 mt-10 49.94 19.09 0.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.67 0.989 . . . . 1.45 113.67 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.67 166.85 32.35 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.064 -1.022 . . . . 1.25 108.435 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.64 140.57 21.26 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.865 1.71 . . . . 0.78000000000000003 110.38 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.23 168.06 23.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 119.915 -1.741 . . . . 1.2 109.859 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 202' ' ' ILE . 92.9 mt -144.01 156.89 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.36 -1.348 . . . . 1.25 107.36 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 181' ' ' THR . 10.2 m -138.15 -30.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 120.99 -1.069 . . . . 1.3899999999999999 112.744 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.79 30.84 0.9 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.014 -1.089 . . . . 0.96999999999999997 113.663 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.431 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 9.8 p -61.34 -27.51 68.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.649 -1.501 . . . . 1.3500000000000001 110.924 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.47 -91.04 0.38 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 120.221 -0.99 . . . . 1.0700000000000001 110.77 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.5 m -121.7 27.11 8.36 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.531 -0.982 . . . . 1.9199999999999999 112.594 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.1 t -58.5 -35.84 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.121 -1.612 . . . . 1.3300000000000001 110.22 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 56.2 p -52.91 -24.62 9.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 1.4199999999999999 111.625 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.2 p -90.96 0.41 57.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.36 -0.837 . . . . 2.1200000000000001 111.789 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -123.56 -3.52 8.31 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 113.079 0.77 . . . . 2.6899999999999999 113.079 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 38.7 t -116.8 149.08 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.574 0.702 . . . . 1.29 109.712 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.468 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 4.1 mptp? -119.41 150.09 40.77 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.123 -1.066 . . . . 2.6899999999999999 108.123 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.421 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.2 p-10 -56.67 143.85 34.61 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.02 -1.072 . . . . 2.79 110.355 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.1 m-20 79.89 -1.61 2.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.796 1.406 . . . . 2.3500000000000001 114.796 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.468 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 80.4 m-20 -63.31 150.72 42.61 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.709 -1.196 . . . . 1.97 109.036 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -89.5 117.36 28.35 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.455 -1.403 . . . . 2.9700000000000002 107.591 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 84.9 mt -126.67 149.8 49.34 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.596 0.713 . . . . 1.25 109.708 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.4 mt -119.21 129.94 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.394 -1.336 . . . . 1.22 107.394 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 49.6 tp -92.73 121.99 34.68 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.293 -1.373 . . . . 1.24 107.293 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 81.1 m-20 -88.33 -30.48 19.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.695 -1.253 . . . . 2.0499999999999998 111.661 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.402 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 40.41 19.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.448 -0.782 . . . . 1.25 112.552 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.1 t -121.84 -59.68 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.922 0.868 . . . . 1.4299999999999999 110.263 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -96.23 10.29 38.31 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.876 0.846 . . . . 3.0299999999999998 110.768 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 4' ' ' GLY . 6.5 t-20 60.82 50.34 5.43 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.579 -0.737 . . . . 2.25 112.021 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.529 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 12.9 pt20 -151.23 158.7 44.23 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.957 0.884 . . . . 2.52 109.638 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 28.0 t -116.37 140.3 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 109.017 -0.734 . . . . 1.29 109.017 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.529 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 47.4 m-85 -99.35 130.83 45.66 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.144 -0.973 . . . . 1.3400000000000001 108.466 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.2 t -109.84 130.02 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.434 -0.791 . . . . 1.3400000000000001 108.921 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.525 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 4.5 t-20 61.11 43.71 0.69 Allowed Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 113.792 1.034 . . . . 2.1800000000000002 113.792 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 33.4 Cg_endo -65.53 147.48 86.7 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.208 1.939 . . . . 0.93999999999999995 111.199 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 44.1 p -76.82 157.25 31.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.112 -0.992 . . . . 2.3999999999999999 108.985 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -59.92 -33.22 71.6 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.133 -0.98 . . . . 3.3300000000000001 110.523 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -57.62 -40.45 79.2 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.468 -0.77 . . . . 3.1699999999999999 110.218 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -71.0 -40.84 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.393 -0.817 . . . . 1.6899999999999999 110.064 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 56.4 mt -60.17 -47.54 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 1.6000000000000001 110.662 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -59.26 -40.39 85.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.674 -1.266 . . . . 2.7000000000000002 110.482 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -64.66 -42.12 95.63 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.826 -0.75 . . . . 2.96 110.357 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.1 mtp -70.88 -34.35 71.51 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.272 -0.893 . . . . 1.6299999999999999 110.975 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.198 -0.939 . . . . 3.27 110.389 -179.791 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 2' ' ' ILE . 67.2 mt . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 106.302 -1.74 . . . . 1.5700000000000001 106.302 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 m -105.38 124.87 50.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.259 -1.015 . . . . 1.4399999999999999 108.259 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.89 -152.02 16.8 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 108.141 -1.984 . . . . 1.01 108.141 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.9 mt -94.78 -4.87 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.249 -1.148 . . . . 1.6299999999999999 112.926 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 tp 49.7 99.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.086 -1.009 . . . . 1.5800000000000001 112.624 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.65 -53.74 5.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.007 -1.058 . . . . 1.3400000000000001 110.571 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.439 ' HG ' ' N ' ' A' ' 9' ' ' PRO . 0.9 OUTLIER -142.99 148.44 45.38 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 107.746 -1.205 . . . . 1.8600000000000001 107.746 -179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.439 ' N ' ' HG ' ' A' ' 8' ' ' SER . 85.2 Cg_endo -74.8 156.52 43.88 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.578 2.186 . . . . 1.01 112.272 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 147.17 122.21 1.33 Allowed Glycine 0 N--CA 1.507 3.418 0 N-CA-C 111.087 -0.805 . . . . 0.81000000000000005 111.087 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 11' ' ' ILE . 84.8 mt -89.64 132.05 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.777 -1.426 . . . . 1.3700000000000001 108.706 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.99 151.49 46.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.256 -0.902 . . . . 1.1399999999999999 108.638 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.7 m-85 -116.7 145.41 43.47 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.279 -0.888 . . . . 0.87 109.219 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.31 167.89 36.86 Favored Glycine 0 N--CA 1.5 2.906 0 C-N-CA 118.938 -1.601 . . . . 0.56999999999999995 110.053 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -78.08 158.89 28.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.752 -0.852 . . . . 2.3500000000000001 109.132 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.37 119.81 25.54 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.029 -1.1 . . . . 1.21 108.029 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -99.93 95.68 7.05 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 105.683 -1.969 . . . . 1.3999999999999999 105.683 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.5 tp -90.67 137.71 32.15 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.454 -1.313 . . . . 1.4399999999999999 107.454 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.5 mt -99.02 111.19 23.66 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.647 -1.612 . . . . 1.45 106.647 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -103.52 128.72 50.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.217 -1.401 . . . . 2.5 107.217 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -130.6 154.34 47.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.926 -0.768 . . . . 2.6600000000000001 108.926 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -80.65 139.39 36.23 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.695 -0.854 . . . . 2.3199999999999998 108.695 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.82 149.88 49.46 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.473 -1.392 . . . . 2.1099999999999999 109.046 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -93.22 131.01 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.602 -0.888 . . . . 1.29 108.602 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.9 t -108.93 130.13 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.272 -1.01 . . . . 1.4099999999999999 108.272 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.0 mt -94.67 133.51 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.456 -0.942 . . . . 1.3100000000000001 108.456 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -89.01 120.83 30.78 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.294 -1.372 . . . . 1.3400000000000001 107.294 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -96.54 15.8 20.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.132 -0.98 . . . . 3.48 112.403 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -70.42 149.89 46.8 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.542 -0.723 . . . . 2.52 109.838 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -90.76 130.35 36.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.669 -1.234 . . . . 2.6299999999999999 107.669 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.9 pt -94.76 164.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.988 . . . . 1.3100000000000001 110.347 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -94.95 166.02 12.16 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.486 -0.759 . . . . 1.24 109.681 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.23 -19.11 7.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 1.49 112.351 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.12 -37.86 81.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 2.2799999999999998 110.696 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -94.52 -6.14 44.42 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.563 -1.336 . . . . 2.0499999999999998 113.105 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.8 t -59.55 -42.12 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.217 -0.927 . . . . 1.3400000000000001 110.758 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -58.41 -39.19 79.05 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.128 -0.982 . . . . 1.54 110.58 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -64.99 -38.79 92.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.403 -0.811 . . . . 2.8500000000000001 111.131 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -59.37 -41.23 88.83 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.619 -1.3 . . . . 1.3100000000000001 110.783 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.17 -40.85 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.98 -1.075 . . . . 1.3799999999999999 110.789 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -62.83 -42.6 99.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.977 -1.077 . . . . 1.5 110.457 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.416 ' HG2' HH11 ' A' ' 42' ' ' ARG . 42.2 mtt-85 -61.36 -40.41 94.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -0.863 . . . . 2.7799999999999998 110.296 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 40.6 t80 -75.32 -55.34 5.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.298 -0.876 . . . . 1.0600000000000001 110.965 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.4 tp -58.07 -47.46 83.11 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.507 -0.877 . . . . 1.3999999999999999 110.459 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 t -68.79 -39.91 79.91 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.822 -0.751 . . . . 1.3200000000000001 109.918 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.29 -42.48 97.35 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.495 -1.442 . . . . 0.69999999999999996 109.495 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' CG ' HH11 ' A' ' 47' ' ' ARG . 2.2 ttt-85 -60.3 -28.76 68.36 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.235 -1.156 . . . . 3.4399999999999999 110.117 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.49 73.58 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.465 0.65 . . . . 1.3600000000000001 110.955 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -83.26 -38.07 22.68 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.134 -0.979 . . . . 2.8300000000000001 111.043 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.9 -42.82 85.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.162 -0.961 . . . . 1.23 109.664 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.4 t -60.47 -41.26 93.82 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.718 -0.845 . . . . 1.9199999999999999 108.718 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.78 -44.86 76.42 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.624 -0.831 . . . . 1.25 110.434 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -62.18 -51.51 67.53 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.366 -0.934 . . . . 1.97 110.668 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.69 -38.25 89.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.136 -0.977 . . . . 2.1800000000000002 109.988 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -59.12 -40.08 84.33 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.594 -0.691 . . . . 1.1899999999999999 110.331 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.6 m -62.26 -45.05 95.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.937 -1.102 . . . . 1.3400000000000001 110.266 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 57' ' ' ILE . 97.8 mt -60.25 -32.31 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.566 -0.709 . . . . 1.23 110.978 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -53.98 -44.58 70.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 1.5600000000000001 110.469 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -68.69 -36.49 78.57 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.276 -0.89 . . . . 1.3 109.709 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -62.27 -40.0 94.78 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.862 -1.135 . . . . 2.3199999999999998 108.853 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.32 75.41 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.06 -0.656 . . . . 1.1399999999999999 110.06 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.66 -34.05 26.09 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.106 -1.045 . . . . 0.68999999999999995 110.883 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.25 -18.05 43.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.007 -1.29 . . . . 1.48 111.321 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.6 m -90.96 -53.8 4.23 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.209 0.528 . . . . 1.52 111.184 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -106.86 -12.65 15.43 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 113.066 0.765 . . . . 1.3100000000000001 113.066 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.8 155.84 10.78 Favored Glycine 0 N--CA 1.501 3.022 0 O-C-N 121.434 -0.791 . . . . 0.84999999999999998 112.338 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -55.78 -20.56 15.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.65 -0.912 . . . . 3.8599999999999999 112.393 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.55 -34.26 66.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.415 -0.803 . . . . 2.3500000000000001 111.165 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -81.17 -19.22 43.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.567 -1.333 . . . . 2.2599999999999998 111.86 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.01 -31.81 70.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.187 -0.946 . . . . 1.45 111.022 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.8 95.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.874 -1.141 . . . . 1.25 110.379 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.1 -45.92 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.38 -0.928 . . . . 1.26 110.056 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -71.47 -31.63 67.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.838 . . . . 0.82999999999999996 110.417 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -60.32 -38.44 83.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 1.1899999999999999 109.847 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.32 -41.85 94.35 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.213 -1.155 . . . . 0.57999999999999996 110.213 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -58.25 -46.27 86.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -1.103 . . . . 2.0499999999999998 110.416 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.74 -39.61 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.976 -1.078 . . . . 1.21 110.179 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.4 ttt -59.85 -39.8 86.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.961 -1.087 . . . . 2.29 110.411 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.19 -49.07 79.27 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.595 0.712 . . . . 1.21 110.774 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.76 -43.64 94.22 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.702 0.763 . . . . 1.1399999999999999 110.241 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -86.25 9.39 17.83 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.338 -0.851 . . . . 1.4199999999999999 112.731 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -64.42 126.5 28.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.389 -0.819 . . . . 1.27 109.007 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.76 -14.18 62.74 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.056 0.932 . . . . 1.3500000000000001 110.647 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -75.8 -54.67 6.57 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.643 -0.66 . . . . 2.2200000000000002 110.137 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 mt -62.0 -40.31 95.24 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.759 -0.776 . . . . 1.22 110.686 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.6 -46.03 81.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.701 -1.25 . . . . 1.29 110.749 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.52 -39.59 91.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.78 . . . . 2.1699999999999999 110.891 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.23 -48.09 66.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.372 -1.455 . . . . 1.3 110.953 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -55.44 -43.05 70.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.112 -1.035 . . . . 1.1699999999999999 110.153 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.3 mt -62.43 -47.51 92.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.68 0.753 . . . . 1.3999999999999999 110.524 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.61 94.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.457 -0.777 . . . . 1.3300000000000001 110.879 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.7 -39.03 87.0 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.674 -1.266 . . . . 1.48 110.239 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.56 -52.77 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 1.28 110.347 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -72.36 -35.13 68.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.502 -0.749 . . . . 2.6000000000000001 112.067 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -80.94 -46.06 15.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.796 -1.19 . . . . 1.51 112.045 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -101.16 9.11 42.3 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.408 -0.807 . . . . 2.48 112.335 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.8 m80 50.54 49.68 20.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.051 -1.031 . . . . 1.6100000000000001 111.45 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.0 mtt -103.92 153.5 20.72 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.73 0.776 . . . . 1.8999999999999999 109.631 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.54 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 81.3 p -72.6 161.43 30.79 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.141 -0.975 . . . . 1.3200000000000001 109.508 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.83 -41.28 86.5 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.1 -1.0 . . . . 1.1499999999999999 110.932 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -67.98 -40.73 83.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -0.901 . . . . 2.25 109.866 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.54 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -69.38 -50.36 46.83 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.475 -0.89 . . . . 1.22 110.932 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.07 96.18 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.888 0.851 . . . . 1.1899999999999999 110.166 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.65 96.04 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.856 -0.611 . . . . 1.2 110.94 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -61.94 -38.88 90.14 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.125 -0.984 . . . . 2.1000000000000001 110.789 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.66 -48.62 80.95 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.677 -1.264 . . . . 1.3 111.462 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.02 -44.12 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.207 -0.933 . . . . 1.27 110.059 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.8 mm -61.58 -31.99 52.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.403 0.62 . . . . 1.1899999999999999 110.211 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -59.07 -41.18 87.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.671 . . . . 2.1099999999999999 110.529 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.36 -31.6 21.85 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.355 -1.403 . . . . 0.88 112.518 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -61.33 -39.38 90.32 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.484 1.642 . . . . 1.99 110.12 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.68 -48.2 27.44 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.893 0.854 . . . . 1.28 110.119 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.1 p -63.76 -36.0 82.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.355 -0.841 . . . . 2.2200000000000002 109.954 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.62 -43.61 98.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 1.45 110.535 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.18 -30.55 71.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.819 -1.176 . . . . 1.47 110.94 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.31 -22.72 66.87 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.29 -0.881 . . . . 2.04 111.038 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -74.44 -10.91 60.03 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.398 -0.921 . . . . 1.73 111.391 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.49 141.95 28.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.597 -0.69 . . . . 1.79 109.412 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -97.76 55.51 1.21 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.577 -0.702 . . . . 2.8799999999999999 111.078 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -131.89 134.11 45.35 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 107.382 -1.34 . . . . 1.5800000000000001 107.382 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -57.53 -39.83 77.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.281 -0.887 . . . . 3.04 110.922 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -70.79 -52.02 23.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.52 -1.363 . . . . 1.29 110.672 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -61.17 -41.03 96.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.021 -1.049 . . . . 1.6000000000000001 109.842 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -61.5 -49.21 77.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.798 -1.189 . . . . 2.7599999999999998 109.762 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -60.37 -31.67 70.56 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.898 0.856 . . . . 2.1499999999999999 110.047 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 ttp180 -66.85 -27.7 67.75 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 122.3 1.048 . . . . 2.8100000000000001 109.477 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.02 83.29 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.883 0.849 . . . . 1.3899999999999999 109.33 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.3 80.12 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.464 0.65 . . . . 1.4099999999999999 110.326 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.26 -35.74 79.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 1.3899999999999999 110.649 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.5 t -67.43 -38.34 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.229 -0.919 . . . . 1.1899999999999999 110.331 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -59.0 -39.68 82.57 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 118.923 -1.111 . . . . 3.6299999999999999 109.496 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.45 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 62.1 t0 -60.26 -37.69 81.22 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.44 0.638 . . . . 1.28 110.527 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.8 mt -60.43 -39.15 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.925 -1.109 . . . . 1.1799999999999999 110.113 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.92 -45.34 88.63 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 120.128 -1.034 . . . . 0.51000000000000001 110.702 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -59.81 -40.0 86.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.146 -1.208 . . . . 3.1699999999999999 110.095 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.45 ' NH2' ' OD2' ' A' ' 132' ' ' ASP . 39.7 mtt-85 -61.25 -42.04 97.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.097 -1.002 . . . . 2.8500000000000001 109.78 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 37.8 tp -60.43 -40.48 91.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.462 -0.773 . . . . 1.6499999999999999 110.129 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.58 -42.61 92.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.143 -0.973 . . . . 1.2 110.399 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.457 ' NH1' ' CD2' ' A' ' 144' ' ' LEU . 54.5 mtt-85 -59.87 -37.58 79.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 2.7999999999999998 110.762 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.4 -41.72 55.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.188 -0.945 . . . . 2.1499999999999999 110.893 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.36 -37.76 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.223 -0.923 . . . . 1.21 110.768 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.4 -7.35 58.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 1.3400000000000001 111.994 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.49 23.19 68.34 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 120.091 -1.052 . . . . 0.91000000000000003 113.227 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.457 ' CD2' ' NH1' ' A' ' 139' ' ' ARG . 5.7 tp -64.49 148.09 51.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.049 -0.723 . . . . 1.51 109.049 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -66.44 148.53 51.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.039 -0.726 . . . . 2.8799999999999999 109.039 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.4 mt -103.31 132.35 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.17 -1.048 . . . . 1.6200000000000001 108.17 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.486 ' H ' ' CD1' ' A' ' 147' ' ' ILE . 2.7 mp -84.02 122.82 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.497 -1.297 . . . . 2.1099999999999999 107.497 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -95.07 97.99 10.34 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 105.958 -1.867 . . . . 1.6200000000000001 105.958 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.4 mt -74.91 -15.05 60.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.931 . . . . 1.3999999999999999 112.005 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.8 m -79.94 -1.58 40.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.119 -0.988 . . . . 2.0499999999999998 112.177 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.5 29.04 4.22 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.661 0.743 . . . . 1.3500000000000001 111.954 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 7.3 mt -72.29 138.41 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.169 -0.957 . . . . 1.4199999999999999 109.006 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -113.81 -18.82 11.72 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.278 1.037 . . . . 2.9900000000000002 112.475 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -114.88 138.09 51.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.809 -1.182 . . . . 1.54 107.809 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.26 122.88 26.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.024 -1.102 . . . . 1.3799999999999999 108.024 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.47 179.98 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.11 -0.994 . . . . 1.28 108.847 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.8 mt -87.45 142.24 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.05 -1.031 . . . . 1.1599999999999999 108.785 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 45.2 tp -96.66 123.36 40.31 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.061 -1.089 . . . . 1.3100000000000001 108.061 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.19 129.64 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.281 -1.377 . . . . 1.25 107.281 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.78 157.12 23.72 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.893 -1.129 . . . . 1.26 108.872 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.32 83.11 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.801 -1.187 . . . . 1.6000000000000001 109.392 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -172.97 148.95 1.82 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.13 -0.693 . . . . 2.4199999999999999 109.13 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.0 mt -111.66 141.22 45.53 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.482 -0.761 . . . . 1.3500000000000001 109.223 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.8 p -92.78 147.86 34.89 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.914 -1.116 . . . . 1.3200000000000001 108.917 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.55 -43.31 6.07 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.824 1.683 . . . . 0.69999999999999996 113.119 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.2 m -60.49 -51.01 71.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.201 -0.937 . . . . 1.1200000000000001 110.251 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -61.56 -39.52 91.42 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.01 -1.056 . . . . 1.21 109.975 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.571 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 48.1 p -65.77 -36.92 84.9 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.852 0.834 . . . . 1.1899999999999999 109.965 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.81 88.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.494 -0.754 . . . . 1.24 111.127 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -94.27 -3.05 51.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -0.789 . . . . 1.6899999999999999 113.083 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.91 148.18 44.39 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.407 -0.96 . . . . 1.3400000000000001 108.407 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -93.75 114.79 27.14 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 106.884 -1.524 . . . . 2.77 106.884 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 3.3 mm? -70.75 -27.89 64.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.234 0.54 . . . . 2.0899999999999999 111.506 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -82.92 -16.89 45.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 2.6699999999999999 112.293 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -100.48 -2.82 32.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.015 -1.053 . . . . 2.5800000000000001 112.8 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.9 t -107.69 130.62 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.22 -1.03 . . . . 1.1799999999999999 108.22 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.14 -7.65 59.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 2.1800000000000002 112.133 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.59 172.64 37.13 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.184 -1.566 . . . . 0.48999999999999999 109.184 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -128.89 127.63 42.19 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 107.57 -1.27 . . . . 0.64000000000000001 107.57 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 56.4 mt -132.33 120.6 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.406 -1.701 . . . . 1.21 106.406 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 203' ' ' VAL . 67.7 p -138.88 169.83 17.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.828 -1.17 . . . . 1.3799999999999999 110.357 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.464 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 36.9 t0 -106.25 62.03 0.65 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.109 -0.7 . . . . 2.3700000000000001 109.109 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 108.804 -0.813 . . . . 1.52 108.804 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.9 p . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 106.675 -1.602 . . . . 2.1099999999999999 106.675 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.571 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 36.2 t60 -61.36 -32.49 72.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 1.24 110.365 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.3 t -56.3 -39.46 72.78 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.381 -0.824 . . . . 2.1499999999999999 110.18 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.4 p -59.74 -39.0 83.3 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.895 -1.122 . . . . 2.02 109.952 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.77 -40.0 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.647 -0.821 . . . . 2.1200000000000001 110.208 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 51.2 mtp -64.55 -44.92 89.26 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.522 1.153 . . . . 1.3600000000000001 109.119 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.81 -43.58 94.44 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.089 -0.96 . . . . 1.29 111.405 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -59.66 -45.68 91.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.894 -1.129 . . . . 3.5600000000000001 110.533 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.1 m -71.19 -39.3 71.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.881 . . . . 1.1799999999999999 110.327 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.5 mt -92.36 -6.64 49.75 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.155 0.798 . . . . 1.3400000000000001 113.155 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 53.92 13.6 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.745 1.017 . . . . 1.45 113.745 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.65 149.73 95.37 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.925 -1.109 . . . . 1.25 108.767 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.08 137.18 73.97 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.503 1.469 . . . . 0.78000000000000003 109.957 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.09 163.65 25.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.368 -1.458 . . . . 1.2 109.522 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 13.2 mt -149.12 145.46 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.998 -1.112 . . . . 1.25 107.998 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.9 m -125.84 -25.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 O-C-N 121.114 -0.991 . . . . 1.3899999999999999 113.24 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.66 50.46 4.25 Favored Glycine 0 N--CA 1.488 2.125 0 O-C-N 120.842 -1.161 . . . . 0.96999999999999997 111.004 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.9 p -68.05 -11.59 59.27 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.933 -1.334 . . . . 1.3500000000000001 112.219 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.464 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 73.88 -95.99 0.84 Allowed Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.756 -1.338 . . . . 1.0700000000000001 109.756 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 70.8 m -130.31 30.65 4.72 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.336 -1.097 . . . . 1.9199999999999999 112.296 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.72 -39.67 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.446 -1.409 . . . . 1.3300000000000001 110.7 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.7 p -60.68 -19.3 58.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 1.4199999999999999 111.986 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 27.7 t -94.93 -1.95 51.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.121 -0.987 . . . . 2.1200000000000001 112.107 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -128.77 6.85 5.6 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 112.529 0.566 . . . . 2.6899999999999999 112.529 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 35.0 t -118.62 148.15 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.567 0.699 . . . . 1.29 110.036 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -119.32 150.08 40.73 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.035 -1.098 . . . . 2.6899999999999999 108.035 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 45.0 p-10 -50.3 141.53 11.52 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.785 -1.197 . . . . 2.79 110.723 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 t70 80.44 1.81 1.9 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.455 1.28 . . . . 2.3500000000000001 114.455 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -65.2 147.99 52.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.882 -1.136 . . . . 1.97 108.732 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -88.22 120.21 29.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.012 -1.477 . . . . 2.9700000000000002 107.012 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 84.6 mt -129.48 152.59 48.84 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.786 0.803 . . . . 1.25 109.984 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 mt -129.31 134.81 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.607 -1.257 . . . . 1.22 107.607 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 36.0 tp -97.96 125.04 42.7 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.891 -1.151 . . . . 1.24 107.891 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.1 t0 -86.07 -31.2 22.05 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.797 -1.189 . . . . 2.0499999999999998 110.984 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.433 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 39.75 19.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.757 1.021 . . . . 1.25 113.757 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.5 t -115.91 -62.32 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-O 121.985 0.898 . . . . 1.4299999999999999 109.465 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -91.41 13.54 17.24 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.655 0.741 . . . . 3.0299999999999998 110.9 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 63.49 51.34 2.59 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.745 0.646 . . . . 2.25 112.745 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.59 ' NE2' ' CZ ' ' A' ' 228' ' ' TYR . 20.7 pt20 -150.24 161.38 42.53 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.544 1.164 . . . . 2.52 109.948 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.8 t -116.36 138.84 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 108.27 -1.011 . . . . 1.29 108.27 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.59 ' CZ ' ' NE2' ' A' ' 226' ' ' GLN . 51.0 m-85 -105.06 131.04 53.07 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.396 -0.964 . . . . 1.3400000000000001 108.396 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.69 129.26 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 107.577 -1.268 . . . . 1.3400000000000001 107.577 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 46.3 56.48 16.38 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.013 -1.054 . . . . 2.1800000000000002 113.132 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.4 150.93 70.98 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.656 2.237 . . . . 0.93999999999999995 110.901 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.4 p -75.12 163.5 27.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -0.849 . . . . 2.3999999999999999 110.321 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -61.27 -38.74 87.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.753 -1.217 . . . . 3.3300000000000001 110.605 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -59.84 -41.3 91.06 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.15 -0.969 . . . . 3.1699999999999999 110.361 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 84.3 t -70.83 -40.48 76.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.241 -0.912 . . . . 1.6899999999999999 110.237 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt -60.01 -43.85 93.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.151 -0.968 . . . . 1.6000000000000001 110.375 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -59.85 -38.75 82.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 2.7000000000000002 110.955 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -61.18 -47.98 83.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.215 -0.928 . . . . 2.96 111.164 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 24.4 mtm -73.79 -36.18 65.0 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.018 -1.051 . . . . 1.6299999999999999 111.172 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 . . . . . 0 C--N 1.298 -1.64 0 O-C-N 121.177 -0.952 . . . . 3.27 110.043 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 mmt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.236 0.541 . . . . 3.5299999999999998 109.576 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.6 mt -100.28 107.02 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 105.863 -1.902 . . . . 1.5700000000000001 105.863 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -105.44 120.33 41.33 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.794 -1.188 . . . . 1.4399999999999999 107.794 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.493 ' H ' ' ND2' ' A' ' 225' ' ' ASN . . . -104.13 -159.28 24.3 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.686 -1.766 . . . . 1.01 108.686 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 90.8 mt -96.35 1.68 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.29 -1.124 . . . . 1.6299999999999999 112.687 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tp 49.91 97.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.846 -1.158 . . . . 1.5800000000000001 112.213 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.5 -46.84 12.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 1.3400000000000001 111.234 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -149.16 150.15 31.27 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.994 -1.113 . . . . 1.8600000000000001 107.994 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.59 150.0 44.81 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.024 2.483 . . . . 1.01 111.803 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.09 121.39 1.36 Allowed Glycine 0 N--CA 1.508 3.453 0 C-N-CA 120.133 -1.032 . . . . 0.81000000000000005 110.708 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -88.59 135.07 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.839 -1.389 . . . . 1.3700000000000001 109.061 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.05 153.86 48.13 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.789 -0.819 . . . . 1.1399999999999999 108.789 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -125.02 140.59 52.77 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.221 -0.924 . . . . 0.87 109.077 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.09 170.15 41.76 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 118.672 -1.728 . . . . 0.56999999999999995 110.207 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -79.46 158.82 27.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.654 -0.91 . . . . 2.3500000000000001 109.126 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -83.25 126.86 33.12 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.666 -1.235 . . . . 1.21 107.666 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.0 tp -109.91 103.38 12.15 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 105.04 -2.207 . . . . 1.3999999999999999 105.04 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.6 tp -88.0 140.02 29.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.011 . . . . 1.4399999999999999 108.906 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.7 mt -99.04 112.31 24.47 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.414 -1.698 . . . . 1.45 106.414 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -110.18 131.97 54.58 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.816 -1.179 . . . . 2.5 107.816 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -126.91 140.07 52.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.192 -0.942 . . . . 2.6600000000000001 108.949 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -80.61 137.83 36.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.236 -1.024 . . . . 2.3199999999999998 108.236 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -62.06 150.54 37.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.236 -0.915 . . . . 2.1099999999999999 109.953 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.5 mt -90.23 134.85 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.077 -1.014 . . . . 1.29 108.52 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -108.9 131.37 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.463 -0.94 . . . . 1.4099999999999999 108.463 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.9 mt -94.32 140.35 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.936 -0.764 . . . . 1.3100000000000001 108.936 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -91.33 123.03 34.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.116 -0.99 . . . . 1.3400000000000001 108.503 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -100.02 18.34 18.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.457 -0.777 . . . . 3.48 112.046 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -70.43 145.31 51.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.812 -1.18 . . . . 2.52 109.488 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -88.15 129.96 35.17 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.759 -1.2 . . . . 2.6299999999999999 107.759 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 pt -95.96 167.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.405 -0.809 . . . . 1.3100000000000001 110.474 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.4 p -95.81 167.7 11.1 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.345 0.593 . . . . 1.24 109.997 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.25 -21.44 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.454 -0.779 . . . . 1.49 111.728 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -69.64 -41.24 75.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 2.2799999999999998 110.743 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -84.13 -7.39 59.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.029 -1.045 . . . . 2.0499999999999998 112.204 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.1 t -58.5 -39.77 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.32 -0.863 . . . . 1.3400000000000001 110.299 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -58.54 -40.19 82.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.008 -1.058 . . . . 1.54 110.208 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -61.81 -40.43 95.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.699 -0.625 . . . . 2.8500000000000001 110.885 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -59.73 -43.97 93.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.064 -1.022 . . . . 1.3100000000000001 111.004 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.48 -41.77 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.986 -1.071 . . . . 1.3799999999999999 110.674 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -60.28 -49.21 78.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.177 -0.952 . . . . 1.5 110.044 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.441 ' HG2' HH11 ' A' ' 42' ' ' ARG . 45.6 mtt-85 -60.25 -38.01 82.18 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.534 -0.729 . . . . 2.7799999999999998 109.857 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -71.85 -59.44 2.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.596 -0.69 . . . . 1.0600000000000001 110.232 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.15 -45.45 90.95 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.218 -0.993 . . . . 1.3999999999999999 110.0 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -67.76 -38.81 83.95 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.505 -0.747 . . . . 1.3200000000000001 110.137 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.08 -41.23 94.46 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.579 -1.409 . . . . 0.69999999999999996 109.579 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.513 HH22 ' CD ' ' A' ' 86' ' ' GLU . 32.8 ttm180 -59.8 -31.23 69.51 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.469 -1.018 . . . . 3.4399999999999999 109.206 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.33 86.9 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.548 0.69 . . . . 1.3600000000000001 109.765 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -80.61 -44.08 19.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.81 . . . . 2.8300000000000001 111.007 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.12 -42.41 94.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 1.23 110.163 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.1 t -59.86 -38.93 83.55 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.053 -1.029 . . . . 1.9199999999999999 109.081 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.08 -50.05 44.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.682 -0.69 . . . . 1.25 110.94 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.34 -49.44 77.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.602 -1.311 . . . . 1.97 110.66 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.21 -40.42 93.9 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.396 -0.815 . . . . 2.1800000000000002 109.381 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.86 -40.5 93.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.602 -0.686 . . . . 1.1899999999999999 110.25 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 m -66.28 -45.42 80.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.998 -1.064 . . . . 1.3400000000000001 109.798 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 57' ' ' ILE . 95.3 mt -60.02 -38.33 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.519 -0.738 . . . . 1.23 110.387 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -51.26 -42.42 61.04 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.794 -0.762 . . . . 1.5600000000000001 110.328 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -70.28 -35.3 73.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.27 -0.894 . . . . 1.3 110.03 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -61.83 -39.92 93.5 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.179 -1.008 . . . . 2.3199999999999998 109.074 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.85 -34.74 76.51 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.769 -0.773 . . . . 1.1399999999999999 109.76 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.27 -36.65 20.29 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.643 -1.265 . . . . 0.68999999999999995 110.884 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -81.71 -20.26 39.78 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.847 -1.384 . . . . 1.48 111.126 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -88.61 -51.93 5.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.414 -0.804 . . . . 1.52 110.839 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -107.31 -21.05 13.08 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.538 -0.726 . . . . 1.3100000000000001 112.865 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.03 164.24 12.49 Favored Glycine 0 N--CA 1.504 3.167 0 O-C-N 121.51 -0.744 . . . . 0.84999999999999998 112.075 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -52.85 -24.85 9.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.692 -0.887 . . . . 3.8599999999999999 112.288 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.23 -39.56 79.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.838 -1.164 . . . . 2.3500000000000001 111.137 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -87.13 -22.06 25.59 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.981 -1.074 . . . . 2.2599999999999998 111.8 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -60.76 -37.62 82.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 1.45 110.754 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.69 -33.75 73.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.251 -0.905 . . . . 1.25 111.299 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.9 mt -65.88 -43.46 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.64 -1.287 . . . . 1.26 110.533 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -69.43 -32.15 70.93 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.319 -0.863 . . . . 0.82999999999999996 110.706 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -61.56 -38.48 87.65 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.215 -0.928 . . . . 1.1899999999999999 110.087 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.39 -41.9 99.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.817 -0.913 . . . . 0.57999999999999996 110.817 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -59.28 -40.46 86.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.246 . . . . 2.0499999999999998 110.535 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.82 -38.57 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.123 -0.985 . . . . 1.21 110.724 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.2 ttp -58.14 -39.68 79.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.356 -0.84 . . . . 2.29 110.639 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.72 -48.77 80.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.412 -0.805 . . . . 1.21 110.11 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.09 -41.33 92.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.562 -0.711 . . . . 1.1399999999999999 110.641 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -86.54 9.86 17.12 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 112.984 0.735 . . . . 1.4199999999999999 112.984 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -68.37 122.29 18.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 1.27 108.258 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.55 -16.35 64.09 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.779 0.799 . . . . 1.3500000000000001 110.789 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -74.75 -51.18 14.86 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.71 0.766 . . . . 2.2200000000000002 110.115 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.68 -34.43 77.09 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.771 -0.771 . . . . 1.22 110.313 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.513 ' CD ' HH22 ' A' ' 47' ' ' ARG . 88.9 tt0 -59.98 -47.16 86.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.541 -0.724 . . . . 1.29 110.93 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -63.22 -37.91 89.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.991 -1.068 . . . . 2.1699999999999999 110.995 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -68.24 -49.46 60.51 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.124 -0.985 . . . . 1.3 110.756 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.1 mt -58.42 -43.94 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 1.1699999999999999 110.551 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.0 mt -62.91 -43.78 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 1.3999999999999999 110.47 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.71 -40.59 95.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.325 -0.859 . . . . 1.3300000000000001 111.113 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.57 -42.78 97.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.978 -1.076 . . . . 1.48 110.437 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.15 -50.33 79.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.951 -1.093 . . . . 1.28 110.176 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -78.48 -34.97 47.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.369 -0.832 . . . . 2.6000000000000001 111.774 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 91' ' ' ALA . 54.7 t0 -79.08 -46.85 17.25 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.573 -1.329 . . . . 1.51 111.444 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -100.49 8.09 43.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.08 -1.013 . . . . 2.48 111.857 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.6 m170 49.78 48.92 21.01 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.219 -0.993 . . . . 1.6100000000000001 111.528 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.2 mtt -103.64 156.84 17.49 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.678 0.752 . . . . 1.8999999999999999 109.923 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.679 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 59.3 p -73.09 159.19 33.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.519 -0.738 . . . . 1.3200000000000001 109.296 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.16 79.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.088 -1.007 . . . . 1.1499999999999999 110.376 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -68.75 -39.82 80.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.942 -1.099 . . . . 2.25 110.135 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.679 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -69.38 -51.06 40.28 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.446 -0.784 . . . . 1.22 111.44 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.72 94.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.555 -0.716 . . . . 1.1899999999999999 110.636 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.89 -44.91 96.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.569 -0.707 . . . . 1.2 111.332 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -60.31 -39.57 87.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 2.1000000000000001 110.959 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -55.83 -49.46 73.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.86 -1.15 . . . . 1.3 110.969 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.07 -45.49 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.677 -1.264 . . . . 1.27 109.85 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.42 -30.76 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.626 0.727 . . . . 1.1899999999999999 110.117 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -59.16 -40.36 85.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.126 -0.984 . . . . 2.1099999999999999 110.775 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.37 -32.18 20.31 Favored Glycine 0 N--CA 1.5 2.904 0 C-N-CA 119.193 -1.479 . . . . 0.88 112.601 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -60.44 -40.73 92.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.545 -1.562 . . . . 1.99 110.096 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.16 -47.77 48.44 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.608 0.718 . . . . 1.28 110.307 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 m -60.97 -38.08 84.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 2.2200000000000002 110.545 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.56 97.82 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.186 -0.946 . . . . 1.45 110.854 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.2 mt -65.69 -28.04 68.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 1.47 111.288 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -67.39 -24.27 65.65 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.176 -0.952 . . . . 2.04 111.18 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.17 -11.65 60.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.119 -0.988 . . . . 1.73 111.42 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.3 mt -89.51 138.03 31.81 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.818 -1.179 . . . . 1.79 107.818 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 14.9 t70 -97.56 47.77 1.02 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.277 -0.889 . . . . 2.8799999999999999 111.772 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -119.92 139.84 51.8 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.416 -0.802 . . . . 1.5800000000000001 109.023 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -59.98 -39.09 84.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.446 -0.783 . . . . 3.04 110.762 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -70.53 -57.19 5.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 1.29 110.23 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.9 mt -61.01 -41.51 96.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 1.6000000000000001 110.498 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -61.46 -49.54 76.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.854 -1.154 . . . . 2.7599999999999998 109.8 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -59.94 -30.97 69.43 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.054 -1.058 . . . . 2.1499999999999999 109.545 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -63.39 -29.18 70.52 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.532 -0.867 . . . . 2.8100000000000001 109.499 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.41 73.29 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.779 0.799 . . . . 1.3899999999999999 109.92 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.99 -44.53 80.16 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.768 -0.773 . . . . 1.4099999999999999 110.134 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -63.02 -34.84 78.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.357 -0.839 . . . . 1.3899999999999999 110.569 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.2 t -67.96 -40.81 83.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.905 -1.122 . . . . 1.1899999999999999 109.586 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -59.28 -37.39 77.56 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.09 -1.044 . . . . 3.6299999999999999 109.23 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -59.77 -38.21 81.2 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.212 0.529 . . . . 1.28 110.067 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.7 mt -60.1 -40.24 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.972 . . . . 1.1799999999999999 110.006 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.89 -43.03 94.59 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.089 -1.204 . . . . 0.51000000000000001 110.089 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -58.6 -40.1 82.29 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.493 -1.004 . . . . 3.1699999999999999 110.589 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.402 HH11 ' HG2' ' A' ' 136' ' ' ARG . 51.9 mtt-85 -62.34 -42.43 99.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 2.8500000000000001 110.031 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.6 tp -63.28 -44.41 95.16 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.594 0.711 . . . . 1.6499999999999999 110.036 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.55 -45.2 95.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.635 0.731 . . . . 1.2 110.345 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.405 HH21 ' HA ' ' A' ' 146' ' ' ILE . 53.2 mtp180 -62.06 -34.5 76.38 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.623 -0.673 . . . . 2.7999999999999998 110.945 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -76.02 -43.23 45.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.927 -1.108 . . . . 2.1499999999999999 111.005 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.437 HD11 HG22 ' A' ' 141' ' ' ILE . 96.2 mt -61.58 -37.14 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.922 -1.111 . . . . 1.21 110.823 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.7 mt -88.03 -5.96 58.22 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.013 -1.055 . . . . 1.3400000000000001 112.372 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.14 27.28 73.13 Favored Glycine 0 N--CA 1.481 1.664 0 C-N-CA 119.869 -1.157 . . . . 0.91000000000000003 112.844 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.1 tp -62.3 147.37 48.38 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.643 0.735 . . . . 1.51 109.66 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.41 140.21 58.61 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.562 -0.903 . . . . 2.8799999999999999 108.562 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.405 ' HA ' HH21 ' A' ' 139' ' ' ARG . 54.1 mt -101.34 137.88 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.098 -1.001 . . . . 1.6200000000000001 108.518 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.493 ' H ' ' CD1' ' A' ' 147' ' ' ILE . 3.0 mp -82.44 123.76 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.869 -1.16 . . . . 2.1099999999999999 107.869 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -99.67 97.54 8.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.854 -1.536 . . . . 1.6200000000000001 106.854 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.1 -17.87 61.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.586 -0.696 . . . . 1.3999999999999999 111.382 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.8 t -81.58 2.02 31.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.874 . . . . 2.0499999999999998 112.097 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.91 21.09 14.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.559 -0.713 . . . . 1.3500000000000001 111.928 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.2 mt -74.3 134.51 29.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.266 -0.896 . . . . 1.4199999999999999 108.913 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.35 -15.8 13.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.487 -0.758 . . . . 2.9900000000000002 113.003 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -111.49 130.6 55.67 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.165 -1.421 . . . . 1.54 107.165 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -72.27 123.86 23.86 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.535 -0.913 . . . . 1.3799999999999999 108.535 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 25.3 m -145.69 179.56 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.482 -0.762 . . . . 1.28 109.462 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.7 mt -89.66 140.23 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.714 -0.847 . . . . 1.1599999999999999 108.714 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.83 124.88 40.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.973 -1.079 . . . . 1.3100000000000001 108.54 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.42 130.67 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.258 -1.016 . . . . 1.25 108.258 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.72 150.86 17.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 1.26 109.002 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.491 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.13 -37.86 84.33 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.915 -1.115 . . . . 1.6000000000000001 109.544 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 46.9 t0 -171.23 150.28 2.94 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.391 -0.818 . . . . 2.4199999999999999 108.83 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.465 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 48.2 mt -119.55 141.05 49.59 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.882 -0.784 . . . . 1.3500000000000001 108.882 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.1 p -87.37 150.91 50.13 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.893 -1.129 . . . . 1.3200000000000001 108.646 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -43.12 -41.63 9.53 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.787 1.658 . . . . 0.69999999999999996 113.414 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.6 m -61.95 -49.02 77.81 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.144 -1.022 . . . . 1.1200000000000001 110.14 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -62.84 -40.14 96.52 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.447 -0.783 . . . . 1.21 110.478 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.624 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 71.5 p -69.73 -39.0 77.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.236 -0.915 . . . . 1.1899999999999999 110.271 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.49 -33.4 73.71 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.469 -0.769 . . . . 1.24 110.503 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -96.06 -2.09 47.42 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.198 -0.939 . . . . 1.6899999999999999 112.51 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.72 147.73 41.25 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.306 -0.998 . . . . 1.3400000000000001 108.306 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.59 113.79 25.48 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.993 -1.484 . . . . 2.77 106.993 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.18 -17.27 61.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.778 -0.576 . . . . 2.0899999999999999 111.431 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -80.69 -24.04 39.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.814 . . . . 2.6699999999999999 111.902 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -100.84 -6.13 25.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.264 -0.898 . . . . 2.5800000000000001 113.216 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 65.4 t -107.61 129.65 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.182 -1.044 . . . . 1.1799999999999999 108.182 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 55.1 tp -85.79 -11.21 54.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.261 -0.9 . . . . 2.1800000000000002 112.35 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.92 178.66 44.96 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.072 -1.611 . . . . 0.48999999999999999 109.072 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -132.13 132.84 43.62 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.557 -1.275 . . . . 0.64000000000000001 107.557 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 66.8 mt -137.85 107.04 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 106.076 -1.824 . . . . 1.21 106.076 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 203' ' ' VAL . 60.1 p -128.57 169.22 14.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.11 -0.994 . . . . 1.3799999999999999 109.041 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 12.8 p-10 -98.14 42.74 1.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.288 -0.882 . . . . 2.3700000000000001 111.223 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.22 66.68 0.79 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.547 -0.721 . . . . 1.52 109.804 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.15 95.39 1.29 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 107.676 -2.17 . . . . 1.8 107.676 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -160.97 145.07 10.52 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.234 -1.546 . . . . 2.04 109.234 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -58.43 -28.54 65.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.028 -1.278 . . . . 5.0 110.757 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.6 p -87.99 10.24 19.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.711 -0.618 . . . . 3.02 111.75 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.7 m -78.65 116.94 19.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 2.1099999999999999 108.877 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.624 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 39.5 t60 -60.16 -36.53 77.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.463 -0.773 . . . . 1.24 111.019 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.2 p -56.09 -41.79 75.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.324 -0.86 . . . . 2.1499999999999999 110.237 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.7 t -60.02 -38.53 82.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.44 -0.787 . . . . 2.02 110.179 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.89 -39.48 80.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.669 -0.644 . . . . 2.1200000000000001 110.913 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.7 mtp -60.39 -44.14 95.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.911 -1.118 . . . . 1.3600000000000001 109.539 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.07 -47.42 86.44 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.711 -0.677 . . . . 1.29 111.205 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.37 -46.17 90.91 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.762 -1.211 . . . . 3.5600000000000001 111.351 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.4 m -69.77 -39.78 76.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.987 . . . . 1.1799999999999999 110.644 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.9 mt -91.98 -9.89 41.34 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.069 0.766 . . . . 1.3400000000000001 113.069 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.6 mt-10 53.66 12.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.637 0.977 . . . . 1.45 113.637 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.1 mt -71.82 148.91 92.6 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.198 -1.038 . . . . 1.25 108.198 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.67 135.56 62.4 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 121.36 1.373 . . . . 0.78000000000000003 109.916 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.0 167.61 24.18 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 117.642 -1.623 . . . . 1.2 109.791 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 84.5 mt -148.44 156.09 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.202 -1.407 . . . . 1.25 107.202 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.407 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.1 m -138.71 -25.98 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 120.825 -1.172 . . . . 1.3899999999999999 112.098 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.98 45.17 3.47 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.432 -0.889 . . . . 0.96999999999999997 111.832 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.3 p -64.84 -14.55 59.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.453 -1.028 . . . . 1.3500000000000001 111.034 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.82 -94.26 0.97 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.273 -1.131 . . . . 1.0700000000000001 110.273 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 71.9 m -129.38 27.7 5.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.621 -0.929 . . . . 1.9199999999999999 112.697 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.59 -36.26 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.358 -1.464 . . . . 1.3300000000000001 110.775 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.2 p -57.51 -25.93 60.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.994 -1.066 . . . . 1.4199999999999999 111.235 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 36.8 p -93.1 3.81 55.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.605 -0.684 . . . . 2.1200000000000001 111.733 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -126.26 -9.19 6.42 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.33 0.863 . . . . 2.6899999999999999 113.33 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 51.5 t -119.59 156.33 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.97 -0.752 . . . . 1.29 108.97 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.413 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 6.2 mmmm -125.99 158.85 34.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.817 -1.179 . . . . 2.6899999999999999 107.817 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 52.7 p-10 -52.43 149.16 5.94 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 120.75 -1.219 . . . . 2.79 110.459 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.1 t70 80.72 -2.69 1.84 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 114.11 1.152 . . . . 2.3500000000000001 114.11 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 16' ' ' ALA . 54.8 t0 -66.69 146.47 54.43 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.737 -1.227 . . . . 1.97 108.489 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.459 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 43.3 t80 -88.49 122.16 31.66 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.442 -1.318 . . . . 2.9700000000000002 107.442 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 85.2 mt -127.3 146.38 50.46 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -0.841 . . . . 1.25 109.674 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.5 mt -115.71 128.78 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.418 -1.697 . . . . 1.22 106.418 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.9 tp -98.5 117.96 34.1 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 106.025 -1.843 . . . . 1.24 106.025 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 223' ' ' VAL . 32.0 t0 -87.0 -26.75 23.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.736 -1.227 . . . . 2.0499999999999998 112.066 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 39.54 20.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.842 . . . . 1.25 113.139 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.5 t -119.5 -63.22 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-O 121.769 0.795 . . . . 1.4299999999999999 109.711 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -99.32 14.34 29.98 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.496 0.665 . . . . 3.0299999999999998 111.256 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.493 ' ND2' ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 60.22 54.74 3.89 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.376 0.607 . . . . 2.25 112.233 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.514 ' OE1' ' CZ ' ' A' ' 228' ' ' TYR . 15.7 tt0 -145.72 143.59 29.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.035 -1.041 . . . . 2.52 109.568 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.65 139.26 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.438 -1.319 . . . . 1.29 107.438 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.514 ' CZ ' ' OE1' ' A' ' 226' ' ' GLN . 86.8 m-85 -103.93 134.43 47.22 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.832 -1.168 . . . . 1.3400000000000001 108.956 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.25 130.59 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.9 -1.148 . . . . 1.3400000000000001 107.9 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 1.0 OUTLIER 54.52 49.91 6.01 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.185 -0.947 . . . . 2.1800000000000002 112.95 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 44.8 Cg_endo -68.88 149.38 72.34 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.906 2.404 . . . . 0.93999999999999995 111.459 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.5 m -78.34 157.64 29.07 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.668 0.747 . . . . 2.3999999999999999 109.765 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -55.68 -40.59 72.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.447 -0.783 . . . . 3.3300000000000001 110.627 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.05 -39.65 86.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.574 -0.704 . . . . 3.1699999999999999 110.62 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.67 -37.92 71.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.301 -0.874 . . . . 1.6899999999999999 110.204 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.9 -43.0 91.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.454 -0.779 . . . . 1.6000000000000001 110.369 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -59.18 -40.35 85.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -0.871 . . . . 2.7000000000000002 110.462 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -61.4 -46.1 91.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 2.96 110.982 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.1 mtp -72.3 -35.91 68.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.066 -1.021 . . . . 1.6299999999999999 111.148 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -59.36 -39.21 82.52 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.09 -1.006 . . . . 3.27 110.774 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -69.47 -43.11 73.88 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.357 -0.839 . . . . 2.23 111.461 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 91.0 t -56.37 -53.21 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.667 -1.271 . . . . 2.79 112.46 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -62.81 -48.63 78.27 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.466 -1.396 . . . . 4.2599999999999998 109.953 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.38 -39.22 89.86 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.699 -0.625 . . . . 1.8799999999999999 111.207 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -60.76 -28.77 68.97 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.438 -1.414 . . . . 3.3799999999999999 110.63 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.51 -42.94 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.469 -0.769 . . . . 2.8799999999999999 110.66 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.69 89.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.274 -0.891 . . . . 2.75 110.39 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.3 t -69.16 -35.74 76.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.2 -0.937 . . . . 3.4199999999999999 110.594 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.37 -32.78 73.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.09 -1.006 . . . . 3.5699999999999998 110.756 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -63.03 -40.2 97.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.979 -1.076 . . . . 4.6100000000000003 110.572 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.02 83.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -0.958 . . . . 4.4500000000000002 110.484 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -69.03 -30.52 68.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.879 . . . . 5.9699999999999998 111.063 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.12 -32.09 71.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.06 -1.025 . . . . 6.4500000000000002 110.565 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -63.73 -32.1 73.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.089 . . . . 6.6600000000000001 110.773 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -83.36 -11.09 58.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.859 -1.151 . . . . 8.5399999999999991 112.739 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 93.1 mt -86.83 -0.97 57.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.279 -0.888 . . . . 8.0700000000000003 112.399 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -85.31 -11.04 55.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 9.7200000000000006 112.34 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -96.36 -8.37 32.73 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.366 -0.834 . . . . 10.119999999999999 113.098 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.973 -1.013 . . . . 11.9 108.692 -178.638 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.325 0.583 . . . . 3.5299999999999998 109.889 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.0 mt -142.79 110.9 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.233 -1.766 . . . . 1.5700000000000001 106.233 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.3 m -104.57 127.33 52.27 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.387 -0.968 . . . . 1.4399999999999999 108.387 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.57 -141.24 11.99 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.494 -1.042 . . . . 1.01 110.494 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.45 ' CG2' ' O ' ' A' ' 5' ' ' ILE . 56.6 mt -100.51 1.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.241 -1.152 . . . . 1.6299999999999999 112.467 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tp 49.45 96.73 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.863 -1.148 . . . . 1.5800000000000001 112.162 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.5 -45.79 10.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.072 -1.017 . . . . 1.3400000000000001 111.419 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t -147.11 145.9 23.75 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.686 -1.227 . . . . 1.8600000000000001 107.686 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.71 151.8 46.85 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.565 2.176 . . . . 1.01 112.254 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 146.53 123.7 1.51 Allowed Glycine 0 N--CA 1.508 3.491 0 N-CA-C 110.94 -0.864 . . . . 0.81000000000000005 110.94 177.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.7 mt -92.37 131.41 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.767 -1.431 . . . . 1.3700000000000001 109.348 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.89 140.73 42.54 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.355 -0.98 . . . . 1.1399999999999999 108.355 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 12.4 m-85 -108.59 136.83 47.53 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.971 -1.122 . . . . 0.87 107.971 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.76 169.05 42.09 Favored Glycine 0 N--CA 1.498 2.81 0 C-N-CA 118.276 -1.916 . . . . 0.56999999999999995 110.461 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -77.7 159.39 29.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.756 -0.849 . . . . 2.3500000000000001 108.795 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.83 131.24 34.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.999 -1.063 . . . . 1.21 109.234 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.4 tp -109.8 103.47 12.28 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.175 -2.157 . . . . 1.3999999999999999 105.175 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 tp -89.46 132.31 35.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.981 -1.075 . . . . 1.4399999999999999 108.615 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.3 mt -100.01 121.26 41.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.515 -1.291 . . . . 1.45 107.515 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -110.65 129.4 55.83 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.763 -1.199 . . . . 2.5 107.763 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -111.33 141.54 44.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.398 -0.814 . . . . 2.6600000000000001 109.22 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.18 127.03 33.25 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.436 -1.32 . . . . 2.3199999999999998 107.436 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.21 147.04 54.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.046 -1.034 . . . . 2.1099999999999999 109.156 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.5 mt -95.32 133.35 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.498 -0.927 . . . . 1.29 108.498 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -105.74 129.75 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.969 -1.123 . . . . 1.4099999999999999 107.969 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 73.5 mt -98.33 137.27 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.152 -0.967 . . . . 1.3100000000000001 108.671 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -92.31 120.61 33.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.161 -1.052 . . . . 1.3400000000000001 108.161 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.401 HH11 ' HG3' ' A' ' 28' ' ' ARG . 22.6 mmm-85 -94.96 13.78 23.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.206 -0.934 . . . . 3.48 112.217 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -72.13 143.03 49.13 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.494 -0.754 . . . . 2.52 109.239 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' CB ' ' HZ1' ' A' ' 30' ' ' LYS . 8.8 mtpm? -85.74 140.29 30.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.379 -0.826 . . . . 2.6299999999999999 109.482 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.26 165.59 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 121.629 0.728 . . . . 1.3100000000000001 110.41 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.7 p -93.56 167.78 11.46 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.311 0.577 . . . . 1.24 109.801 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.97 -18.66 14.41 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.015 -1.053 . . . . 1.49 112.713 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -68.99 -38.14 79.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.885 . . . . 2.2799999999999998 110.877 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -92.27 -5.88 51.49 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.548 -1.345 . . . . 2.0499999999999998 113.086 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.72 -42.89 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.097 -1.002 . . . . 1.3400000000000001 110.69 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.1 -40.33 85.01 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.841 -1.162 . . . . 1.54 110.527 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.52 -39.42 93.51 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.292 -0.88 . . . . 2.8500000000000001 111.063 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -59.76 -40.83 89.48 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.893 -1.129 . . . . 1.3100000000000001 111.148 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.1 -45.0 96.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 120.937 -1.102 . . . . 1.3799999999999999 110.725 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -61.43 -45.88 92.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.823 -1.173 . . . . 1.5 110.648 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -60.77 -41.35 95.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 2.7799999999999998 110.176 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -75.09 -55.44 5.73 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.155 -0.966 . . . . 1.0600000000000001 110.184 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.9 tp -57.38 -47.14 82.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.409 -0.916 . . . . 1.3999999999999999 110.125 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.5 t -70.22 -38.9 75.35 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.051 0.929 . . . . 1.3200000000000001 109.785 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.53 -44.9 97.22 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.488 -1.445 . . . . 0.69999999999999996 109.488 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 43.9 ttp180 -57.49 -31.72 66.28 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.853 -0.793 . . . . 3.4399999999999999 109.342 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.34 -41.49 80.13 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.774 0.797 . . . . 1.3600000000000001 109.906 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -77.46 -40.94 41.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.633 -0.667 . . . . 2.8300000000000001 110.236 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.66 92.15 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.588 -0.845 . . . . 1.23 109.874 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.4 t -60.26 -39.85 88.26 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.041 0.925 . . . . 1.9199999999999999 109.392 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.2 75.47 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.819 -0.628 . . . . 1.25 110.597 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -66.55 -50.1 64.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.055 -1.028 . . . . 1.97 111.032 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.09 -38.43 91.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 2.1800000000000002 110.229 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -59.76 -41.0 90.04 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.233 -0.917 . . . . 1.1899999999999999 110.449 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.1 m -65.59 -43.39 89.84 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.241 -0.912 . . . . 1.3400000000000001 109.882 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 57' ' ' ILE . 96.6 mt -60.08 -31.9 49.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.379 -0.826 . . . . 1.23 110.691 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -51.78 -46.64 64.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.745 -1.222 . . . . 1.5600000000000001 110.477 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -68.63 -34.21 75.36 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.953 -1.092 . . . . 1.3 109.805 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.442 ' O ' ' OG1' ' A' ' 64' ' ' THR . 65.6 mttm -63.13 -39.95 96.17 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.356 -1.338 . . . . 2.3199999999999998 109.136 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.7 75.89 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.832 -0.747 . . . . 1.1399999999999999 109.548 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.18 -35.74 29.41 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.375 -1.393 . . . . 0.68999999999999995 110.688 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -80.75 -22.53 40.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.107 -1.231 . . . . 1.48 111.016 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 13.6 m -84.56 -48.9 9.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.428 -0.795 . . . . 1.52 110.714 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -106.81 -22.62 12.65 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.409 -0.807 . . . . 1.3100000000000001 112.93 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.37 169.29 14.89 Favored Glycine 0 N--CA 1.501 3.002 0 CA-C-O 121.967 0.76 . . . . 0.84999999999999998 112.036 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.22 -24.17 40.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.912 -0.758 . . . . 3.8599999999999999 112.501 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.96 -38.27 78.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.091 -1.006 . . . . 2.3500000000000001 111.634 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -84.62 -15.84 44.12 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.321 -1.487 . . . . 2.2599999999999998 113.347 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -60.07 -34.66 73.73 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.1 -1.0 . . . . 1.45 110.69 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.59 86.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 1.25 111.308 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 mt -65.54 -43.8 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.822 -1.174 . . . . 1.26 110.44 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -70.05 -30.68 68.01 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.225 -0.922 . . . . 0.82999999999999996 110.583 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.49 -38.95 82.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.248 -0.907 . . . . 1.1899999999999999 110.511 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.48 -38.73 79.87 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.734 -1.222 . . . . 0.57999999999999996 110.616 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -58.05 -42.62 85.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.782 -1.422 . . . . 2.0499999999999998 110.873 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.9 mt -60.4 -41.49 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 1.21 110.375 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.5 ttt -60.38 -39.15 86.22 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.221 -0.924 . . . . 2.29 110.397 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 tp -59.64 -48.43 81.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.796 -1.19 . . . . 1.21 110.729 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.61 -41.64 95.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.355 -0.841 . . . . 1.1399999999999999 110.247 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -87.09 9.99 18.05 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.376 0.608 . . . . 1.4199999999999999 112.213 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.99 122.17 16.37 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.858 -1.151 . . . . 1.27 108.624 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.86 -17.69 65.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.512 -0.743 . . . . 1.3500000000000001 111.07 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -76.46 -53.65 7.82 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.664 0.745 . . . . 2.2200000000000002 110.365 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.89 -39.52 85.62 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.593 -0.843 . . . . 1.22 110.389 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.521 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 86.3 tt0 -59.9 -45.87 91.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.718 -1.239 . . . . 1.29 110.965 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -60.58 -39.98 90.0 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.966 -1.084 . . . . 2.1699999999999999 110.839 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.42 -48.49 77.56 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.335 -0.853 . . . . 1.3 110.111 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.8 mt -58.61 -43.27 87.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 118.974 -1.09 . . . . 1.1699999999999999 109.61 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.4 mt -61.35 -45.08 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.535 -0.728 . . . . 1.3999999999999999 110.316 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.36 -44.93 96.33 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.271 0.558 . . . . 1.3300000000000001 110.929 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.91 -43.34 94.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.574 -1.329 . . . . 1.48 110.337 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.2 mt -62.33 -49.99 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.137 -0.977 . . . . 1.28 110.723 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -78.79 -36.32 42.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.609 -0.682 . . . . 2.6000000000000001 111.563 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -79.93 -46.11 17.34 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 120.789 -1.194 . . . . 1.51 111.838 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -102.24 10.66 39.11 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.097 -1.002 . . . . 2.48 112.066 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.3 m80 51.26 51.5 16.8 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.306 -0.871 . . . . 1.6100000000000001 112.452 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.6 mtp -104.32 158.27 16.57 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 120.91 -1.119 . . . . 1.8999999999999999 109.289 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 66.7 p -72.83 158.43 35.56 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.282 -0.886 . . . . 1.3200000000000001 109.466 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.11 -42.04 84.86 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.224 -0.922 . . . . 1.1499999999999999 110.17 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -68.78 -38.82 80.29 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.976 -1.078 . . . . 2.25 110.207 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.91 -48.59 57.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.5 -0.88 . . . . 1.22 111.536 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.32 -47.58 84.86 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.221 -0.924 . . . . 1.1899999999999999 110.967 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.59 95.78 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.475 -0.766 . . . . 1.2 110.82 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -61.49 -37.67 84.51 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.558 -0.714 . . . . 2.1000000000000001 110.718 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.09 -49.3 78.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.859 -1.151 . . . . 1.3 111.399 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.36 -46.25 95.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.622 -1.299 . . . . 1.27 110.097 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.43 -33.78 58.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.451 0.643 . . . . 1.1899999999999999 110.437 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -57.53 -41.59 81.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -0.828 . . . . 2.1099999999999999 110.786 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.65 -28.01 27.97 Favored Glycine 0 N--CA 1.5 2.94 0 C-N-CA 119.176 -1.487 . . . . 0.88 113.084 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -62.38 -39.58 93.67 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.253 -1.734 . . . . 1.99 109.747 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.13 -53.63 12.16 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.57 0.7 . . . . 1.28 111.425 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.7 p -60.41 -39.6 88.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 2.2200000000000002 110.502 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.59 97.5 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.112 -0.993 . . . . 1.45 110.622 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.33 -29.0 69.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.966 -1.084 . . . . 1.47 111.202 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -68.22 -20.26 64.82 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.458 -0.776 . . . . 2.04 111.346 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -73.06 -12.34 60.88 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.331 -0.947 . . . . 1.73 110.766 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 20.1 mt -85.91 147.3 26.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.566 -0.708 . . . . 1.79 109.098 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -103.12 39.14 1.61 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.149 -0.969 . . . . 2.8799999999999999 111.826 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -113.54 139.21 49.17 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 108.733 -0.839 . . . . 1.5800000000000001 108.733 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.8 -37.74 79.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.795 -1.191 . . . . 3.04 110.812 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -72.42 -46.19 56.23 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.539 -1.351 . . . . 1.29 110.667 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.7 mt -64.33 -40.86 96.73 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.014 -1.054 . . . . 1.6000000000000001 109.823 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -61.17 -46.66 89.59 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.164 -0.96 . . . . 2.7599999999999998 110.256 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.0 -31.93 71.52 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.177 -0.952 . . . . 2.1499999999999999 109.641 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.78 -29.19 70.52 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.854 -1.138 . . . . 2.8100000000000001 109.722 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.37 -49.14 78.75 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.857 0.837 . . . . 1.3899999999999999 109.852 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.53 -44.65 70.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.62 0.724 . . . . 1.4099999999999999 110.663 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -63.52 -33.76 76.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.422 -0.799 . . . . 1.3899999999999999 110.875 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.3 t -69.74 -42.24 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.224 -0.99 . . . . 1.1899999999999999 110.203 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -59.21 -38.29 79.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.96 -1.088 . . . . 3.6299999999999999 109.456 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -59.52 -39.59 84.39 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.707 -0.621 . . . . 1.28 110.213 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.04 -40.71 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.081 -1.012 . . . . 1.1799999999999999 110.322 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.83 -39.93 85.28 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.948 -1.261 . . . . 0.51000000000000001 109.948 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.33 -45.39 91.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.714 -0.874 . . . . 3.1699999999999999 109.968 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.411 HH11 ' HG2' ' A' ' 136' ' ' ARG . 51.5 mtt-85 -62.77 -42.68 99.8 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.49 -0.884 . . . . 2.8500000000000001 109.875 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.02 -41.3 91.87 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.673 -0.642 . . . . 1.6499999999999999 109.954 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.2 mt -60.36 -42.06 94.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.81 . . . . 1.2 110.226 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.9 mtt-85 -61.08 -32.13 71.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 2.7999999999999998 110.53 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -75.99 -41.55 50.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.244 -0.91 . . . . 2.1499999999999999 110.933 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 141' ' ' ILE . 91.9 mt -60.17 -39.18 79.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.961 -1.087 . . . . 1.21 110.274 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.1 mt -86.72 -7.61 58.14 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.348 -0.845 . . . . 1.3400000000000001 112.666 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.82 20.04 77.26 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.11 -1.519 . . . . 0.91000000000000003 112.724 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.94 149.1 50.75 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.957 -0.731 . . . . 1.51 109.709 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -66.84 149.37 50.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.262 -0.899 . . . . 2.8799999999999999 109.753 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.0 mt -107.64 141.03 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.229 -1.026 . . . . 1.6200000000000001 108.229 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.0 mp -78.98 123.88 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.601 -0.888 . . . . 2.1099999999999999 108.601 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -96.84 95.67 8.02 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.796 -1.557 . . . . 1.6200000000000001 106.796 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.42 -15.8 59.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.439 -0.788 . . . . 1.3999999999999999 111.683 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.6 m -80.76 1.72 29.17 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.244 -0.91 . . . . 2.0499999999999998 112.514 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.86 19.03 14.48 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 112.774 0.657 . . . . 1.3500000000000001 112.774 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.8 mt -74.1 139.47 19.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.266 -0.896 . . . . 1.4199999999999999 109.353 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -122.24 -8.78 8.68 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.458 0.646 . . . . 2.9900000000000002 112.199 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -111.07 138.49 47.43 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.885 -1.154 . . . . 1.54 107.885 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.88 116.39 20.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.09 -1.078 . . . . 1.3799999999999999 108.09 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.3 176.7 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.992 -0.744 . . . . 1.28 108.992 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.2 mt -84.21 140.29 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.364 -0.976 . . . . 1.1599999999999999 108.364 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 27.9 tp -96.53 128.32 43.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.486 -0.931 . . . . 1.3100000000000001 108.486 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.2 130.12 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.075 -1.083 . . . . 1.25 108.075 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.57 159.68 30.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.234 -0.916 . . . . 1.26 108.92 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -62.43 -41.14 98.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.316 -1.49 . . . . 1.6000000000000001 109.717 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -174.21 150.94 1.58 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.755 -0.832 . . . . 2.4199999999999999 108.755 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.13 140.8 48.92 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.176 -0.675 . . . . 1.3500000000000001 109.176 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.7 p -90.98 151.18 43.02 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.675 -1.266 . . . . 1.3200000000000001 108.471 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -39.67 -37.77 1.51 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.077 1.851 . . . . 0.69999999999999996 113.512 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.4 m -63.6 -51.4 65.45 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.154 -0.966 . . . . 1.1200000000000001 109.916 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.95 -39.24 94.03 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.539 -0.726 . . . . 1.21 110.237 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 32.1 p -68.16 -40.28 82.39 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.348 0.595 . . . . 1.1899999999999999 110.442 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.68 81.56 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.177 -0.952 . . . . 1.24 110.4 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -94.04 -1.61 54.18 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.94 -1.1 . . . . 1.6899999999999999 112.855 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.26 149.22 33.98 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.697 -0.853 . . . . 1.3400000000000001 108.697 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -96.48 114.26 25.91 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.885 -1.524 . . . . 2.77 106.885 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 82.4 mt -72.05 -17.02 62.05 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.173 0.511 . . . . 2.0899999999999999 111.55 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -84.72 -22.19 29.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.654 -0.654 . . . . 2.6699999999999999 112.034 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -99.51 -4.22 31.75 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.24 -0.913 . . . . 2.5800000000000001 112.923 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.92 129.86 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 107.599 -1.26 . . . . 1.1799999999999999 107.599 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.2 tp -89.1 -8.53 53.66 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.899 -1.126 . . . . 2.1800000000000002 111.827 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.22 171.21 39.03 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.995 -1.642 . . . . 0.48999999999999999 108.995 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.0 136.2 49.15 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.283 -1.127 . . . . 0.64000000000000001 108.147 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 86.2 mt -135.54 115.75 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 106.358 -1.719 . . . . 1.21 106.358 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 81.6 p -131.0 169.5 15.75 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.784 -1.198 . . . . 1.3799999999999999 109.897 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 39.0 p-10 -103.24 43.62 1.07 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.586 -0.696 . . . . 2.3700000000000001 110.721 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -103.52 163.13 12.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.866 -1.146 . . . . 1.52 110.068 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 183' ' ' ALA . . . -47.73 -96.49 0.01 OUTLIER Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.699 -1.239 . . . . 1.8 111.522 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 153.81 -46.11 0.56 Allowed Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.828 -1.395 . . . . 2.04 112.895 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -56.66 -40.13 74.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.742 -1.446 . . . . 5.0 110.474 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.9 p -121.41 23.22 10.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.888 -0.507 . . . . 3.02 111.204 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.9 p -87.88 128.6 35.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.967 -1.124 . . . . 2.1099999999999999 107.967 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -61.07 -38.53 86.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.688 -0.633 . . . . 1.24 110.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.1 p -51.99 -43.66 63.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.056 -1.028 . . . . 2.1499999999999999 110.405 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.9 m -60.12 -37.81 81.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.767 0.794 . . . . 2.02 110.405 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.7 mm -59.52 -38.58 76.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.525 -0.735 . . . . 2.1200000000000001 110.8 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 77.2 mtp -63.17 -43.0 99.49 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.226 1.012 . . . . 1.3600000000000001 108.883 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.79 -48.99 78.15 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.598 -0.728 . . . . 1.29 111.335 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.28 -46.78 88.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.014 -1.054 . . . . 3.5600000000000001 111.146 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 42.7 m -69.85 -41.36 74.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.178 -0.951 . . . . 1.1799999999999999 110.294 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.27 -1.6 57.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.415 -0.803 . . . . 1.3400000000000001 111.991 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 194' ' ' ALA . 54.9 mt-10 54.04 9.75 0.24 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.723 1.009 . . . . 1.45 113.723 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.19 164.94 52.78 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.984 -1.072 . . . . 1.25 108.304 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -82.06 144.04 13.18 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.851 1.701 . . . . 0.78000000000000003 110.397 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.48 168.28 25.44 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 117.733 -1.587 . . . . 1.2 109.499 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.4 mt -148.85 145.9 17.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.159 -1.423 . . . . 1.25 107.159 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.98 -25.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 120.899 -1.125 . . . . 1.3899999999999999 113.523 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.14 46.16 3.57 Favored Glycine 0 N--CA 1.492 2.403 0 O-C-N 120.99 -1.069 . . . . 0.96999999999999997 111.644 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.5 p -67.59 -12.48 60.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.375 -1.073 . . . . 1.3500000000000001 111.803 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.48 -95.54 0.98 Allowed Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.301 -1.12 . . . . 1.0700000000000001 110.301 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.9 p -128.41 29.28 5.34 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.389 -1.065 . . . . 1.9199999999999999 112.344 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 72.4 t -58.49 -38.03 67.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.567 -1.333 . . . . 1.3300000000000001 110.707 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.7 p -55.48 -24.94 34.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 1.4199999999999999 111.58 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.4 t -94.34 3.93 54.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.875 . . . . 2.1200000000000001 111.988 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -127.66 1.13 6.14 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.675 0.621 . . . . 2.6899999999999999 112.675 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 16.1 t -116.23 150.2 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.889 0.852 . . . . 1.29 109.611 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -116.07 167.16 11.23 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.939 -0.763 . . . . 2.6899999999999999 108.939 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 68.5 m-80 -68.05 140.33 56.29 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.74 -1.184 . . . . 2.79 108.814 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.0 m-20 78.0 4.71 2.84 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.171 1.175 . . . . 2.3500000000000001 114.171 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -63.38 147.88 49.97 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.075 -1.083 . . . . 1.97 108.075 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -89.01 120.16 30.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.588 -1.32 . . . . 2.9700000000000002 107.484 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 80.2 mt -127.9 146.99 50.46 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.664 0.745 . . . . 1.25 109.697 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 60.2 mt -119.08 128.2 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.08 -1.452 . . . . 1.22 107.08 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 48.8 tp -100.98 119.96 39.49 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 106.329 -1.73 . . . . 1.24 106.329 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 223' ' ' VAL . 40.2 t0 -87.28 -25.65 23.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.955 -1.091 . . . . 2.0499999999999998 112.176 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.409 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 38.8 16.84 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 113.652 0.982 . . . . 1.25 113.652 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 221' ' ' ASP . 43.1 t -120.38 -63.31 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.178 -0.951 . . . . 1.4299999999999999 109.621 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -90.81 7.84 37.8 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.059 0.933 . . . . 3.0299999999999998 111.175 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 62.3 55.34 2.38 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.692 0.758 . . . . 2.25 112.148 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -147.31 145.17 29.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.353 -0.842 . . . . 2.52 109.562 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 29.9 t -115.95 138.34 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.775 -1.194 . . . . 1.29 107.775 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -105.76 132.7 51.56 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.925 -1.11 . . . . 1.3400000000000001 108.483 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.94 130.56 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 108.532 -0.914 . . . . 1.3400000000000001 108.532 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.425 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 41.6 t-20 50.72 51.34 10.38 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 113.462 0.912 . . . . 2.1800000000000002 113.462 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 36.4 Cg_endo -67.86 150.27 78.41 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.53 2.153 . . . . 0.93999999999999995 110.507 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.5 p -74.05 159.99 31.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.994 -1.066 . . . . 2.3999999999999999 109.7 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -61.57 -35.76 78.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.284 -0.885 . . . . 3.3300000000000001 110.334 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.35 -39.74 84.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.961 -1.087 . . . . 3.1699999999999999 110.43 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.91 -36.73 70.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.491 -0.756 . . . . 1.6899999999999999 110.017 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.01 -43.78 93.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.261 -0.9 . . . . 1.6000000000000001 110.543 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.22 -41.2 88.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.955 -1.091 . . . . 2.7000000000000002 110.252 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -63.61 -40.03 95.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.447 -0.783 . . . . 2.96 110.502 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 73.2 mtp -70.73 -36.99 73.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.925 . . . . 1.6299999999999999 110.936 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -57.56 -39.87 77.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.8 -1.188 . . . . 3.27 110.127 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.15 -56.91 5.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.239 -0.913 . . . . 2.23 110.077 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.78 -42.57 92.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.294 -0.879 . . . . 2.79 110.701 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -58.33 -51.98 67.5 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.901 -1.119 . . . . 4.2599999999999998 111.055 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.97 -30.95 71.97 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.366 -0.934 . . . . 1.8799999999999999 109.478 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -60.57 -30.69 69.96 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.298 -0.961 . . . . 3.3799999999999999 108.754 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 82.7 t -60.13 -41.82 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 122.312 1.053 . . . . 2.8799999999999999 108.676 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.04 -39.06 68.75 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.001 -1.079 . . . . 2.75 108.773 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 29.4 t -71.0 -19.44 62.52 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.513 0.673 . . . . 3.4199999999999999 110.569 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.48 -40.59 91.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.345 -0.847 . . . . 3.5699999999999998 109.283 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -64.72 -29.39 70.37 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.677 1.227 . . . . 4.6100000000000003 109.629 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.03 37.18 0.43 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.849 -1.069 . . . . 4.4500000000000002 111.886 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -58.35 -28.45 65.11 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.408 -0.917 . . . . 5.9699999999999998 111.124 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 253' ' ' LEU . 8.1 mp -66.02 -29.72 70.14 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.445 -0.902 . . . . 6.4500000000000002 110.367 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -73.66 -3.51 28.63 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.85 0.685 . . . . 6.6600000000000001 112.85 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.92 -3.14 43.35 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.859 -1.151 . . . . 8.5399999999999991 112.47 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.526 ' N ' ' CD2' ' A' ' 256' ' ' LEU . 3.5 mm? -80.39 -1.74 42.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.438 -0.789 . . . . 8.0700000000000003 111.741 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -94.27 19.64 9.18 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.887 -0.508 . . . . 9.7200000000000006 112.131 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.25 10.48 22.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.289 -0.882 . . . . 10.119999999999999 112.202 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 118.123 -0.941 . . . . 11.9 109.327 178.777 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.805 -0.443 . . . . 3.5299999999999998 109.805 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 80.9 mt -99.08 117.16 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 106.568 -1.642 . . . . 1.5700000000000001 106.568 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.3 m -104.01 122.31 44.98 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.281 -1.007 . . . . 1.4399999999999999 108.281 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.57 -159.22 18.21 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 108.641 -1.784 . . . . 1.01 108.641 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 93.4 mt -97.07 1.06 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.253 -1.145 . . . . 1.6299999999999999 112.646 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tp 51.42 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.049 . . . . 1.5800000000000001 112.345 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.62 -45.0 13.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.993 -1.067 . . . . 1.3400000000000001 111.496 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -146.06 146.48 28.43 Favored Pre-proline 0 N--CA 1.5 2.064 0 N-CA-C 107.447 -1.316 . . . . 1.8600000000000001 107.447 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.15 146.17 28.43 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.644 2.229 . . . . 1.01 112.144 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 153.71 176.43 26.11 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 108.828 -1.709 . . . . 0.81000000000000005 108.828 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.4 mt -138.05 136.69 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 107.712 -1.218 . . . . 1.3700000000000001 107.712 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.25 152.85 44.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.392 -0.818 . . . . 1.1399999999999999 109.19 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -122.16 145.11 48.5 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.354 -0.98 . . . . 0.87 108.354 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.78 167.58 34.3 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.584 -1.769 . . . . 0.56999999999999995 109.886 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.579 ' CB ' ' HZ1' ' A' ' 15' ' ' LYS . 8.8 mtpm? -76.89 159.16 30.25 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.788 -0.831 . . . . 2.3500000000000001 108.802 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.92 126.94 33.49 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.866 -1.161 . . . . 1.21 107.866 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.89 107.89 19.14 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 104.965 -2.235 . . . . 1.3999999999999999 104.965 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.37 138.67 32.06 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.162 -1.051 . . . . 1.4399999999999999 108.162 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.7 mt -100.69 118.03 36.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 106.768 -1.567 . . . . 1.45 106.768 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -109.96 136.06 49.84 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.043 -1.466 . . . . 2.5 107.043 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -123.94 140.1 53.31 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.847 -1.158 . . . . 2.6600000000000001 108.34 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -82.91 136.26 34.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.464 -1.31 . . . . 2.3199999999999998 107.464 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.32 150.03 44.32 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.671 -0.812 . . . . 2.1099999999999999 109.516 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.3 mt -91.77 134.64 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.314 -0.866 . . . . 1.29 108.752 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.4 t -106.31 130.03 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.496 -1.298 . . . . 1.4099999999999999 107.496 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.4 mt -96.34 132.26 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.643 -0.873 . . . . 1.3100000000000001 108.643 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -91.81 121.62 33.6 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.316 -0.994 . . . . 1.3400000000000001 108.316 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -100.03 22.01 11.92 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.15 -0.969 . . . . 3.48 112.139 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -65.78 143.65 57.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.889 -1.132 . . . . 2.52 109.073 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -89.32 131.39 35.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.077 -1.082 . . . . 2.6299999999999999 108.077 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 pt -97.63 167.74 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 1.3100000000000001 109.996 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.3 p -97.62 163.68 12.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.531 -0.731 . . . . 1.24 110.109 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.87 -24.09 14.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 1.49 111.861 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -67.37 -35.97 80.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.953 . . . . 2.2799999999999998 110.715 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -94.78 -12.81 26.41 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.993 -1.067 . . . . 2.0499999999999998 112.802 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.19 -46.42 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.895 . . . . 1.3400000000000001 110.537 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -58.12 -39.38 78.54 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.102 -0.999 . . . . 1.54 110.701 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -62.41 -43.25 99.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.418 -0.801 . . . . 2.8500000000000001 110.876 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.46 -36.55 78.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.079 -1.013 . . . . 1.3100000000000001 110.935 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.46 -42.4 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.784 -1.198 . . . . 1.3799999999999999 110.091 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -61.89 -41.03 97.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.097 -1.002 . . . . 1.5 110.091 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -63.14 -40.95 99.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.512 -0.743 . . . . 2.7799999999999998 110.168 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -71.94 -56.72 5.17 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.27 -0.894 . . . . 1.0600000000000001 110.349 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.9 tp -58.92 -47.04 86.45 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.377 -0.929 . . . . 1.3999999999999999 109.754 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.0 t -70.27 -42.18 72.45 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.263 -0.975 . . . . 1.3200000000000001 109.426 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.24 -38.85 88.58 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.145 -1.582 . . . . 0.69999999999999996 109.145 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -59.79 -33.37 71.63 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 122.103 0.954 . . . . 3.4399999999999999 108.973 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.35 -42.14 81.44 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.604 0.716 . . . . 1.3600000000000001 109.642 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -79.46 -43.34 23.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -0.821 . . . . 2.8300000000000001 110.527 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.78 87.88 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.335 -0.853 . . . . 1.23 109.814 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 m -60.77 -39.81 90.21 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.798 0.808 . . . . 1.9199999999999999 109.546 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.86 86.98 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.243 0.544 . . . . 1.25 110.475 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.02 -48.77 78.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 1.97 110.575 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.96 -38.56 88.89 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.012 -1.055 . . . . 2.1800000000000002 109.783 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -60.19 -40.04 88.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.83 -0.544 . . . . 1.1899999999999999 110.789 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.7 m -61.8 -42.81 99.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.759 -1.213 . . . . 1.3400000000000001 109.931 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.49 -37.64 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.298 -0.876 . . . . 1.23 110.493 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -50.1 -44.29 51.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.403 -0.811 . . . . 1.5600000000000001 111.118 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.407 ' H ' ' HG1' ' A' ' 59' ' ' THR . 2.7 m -70.25 -37.38 74.91 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.123 -0.986 . . . . 1.3 110.109 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -61.68 -38.55 88.21 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.905 -1.118 . . . . 2.3199999999999998 109.545 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.47 -33.59 76.24 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.918 -0.713 . . . . 1.1399999999999999 109.621 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.37 -36.82 13.41 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.957 -1.116 . . . . 0.68999999999999995 111.123 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -81.36 -23.08 37.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.966 -1.314 . . . . 1.48 111.023 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 m -91.4 -51.29 5.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.484 -0.76 . . . . 1.52 110.971 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.12 -8.17 17.59 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.001 1.112 . . . . 1.3100000000000001 114.001 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.36 170.69 30.63 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.257 -0.902 . . . . 0.84999999999999998 111.75 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -58.21 -21.98 50.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.98 -0.717 . . . . 3.8599999999999999 112.15 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -54.34 -41.61 69.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.06 -1.025 . . . . 2.3500000000000001 110.861 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -89.24 -24.0 22.21 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.161 -0.962 . . . . 2.2599999999999998 112.031 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -60.01 -39.57 86.27 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.604 -0.685 . . . . 1.45 111.167 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.36 87.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.357 -0.839 . . . . 1.25 111.523 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 mt -65.95 -45.56 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.541 -1.35 . . . . 1.26 110.131 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -68.43 -33.22 73.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.066 -1.021 . . . . 0.82999999999999996 110.623 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -60.15 -36.13 76.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.233 -0.917 . . . . 1.1899999999999999 110.321 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.87 -39.66 85.3 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.941 -1.123 . . . . 0.57999999999999996 110.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -58.98 -42.88 91.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.102 -1.234 . . . . 2.0499999999999998 110.525 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.9 mt -60.36 -37.54 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 1.21 110.34 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.5 ttt -59.45 -39.9 85.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.257 -0.902 . . . . 2.29 110.517 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.03 -46.36 88.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.334 -0.854 . . . . 1.21 109.866 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.3 -38.78 88.04 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.817 0.818 . . . . 1.1399999999999999 110.139 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.86 9.7 18.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.515 -0.74 . . . . 1.4199999999999999 112.735 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -67.11 121.76 16.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.182 -0.949 . . . . 1.27 108.849 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.75 -15.55 62.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.536 -0.728 . . . . 1.3500000000000001 111.065 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -76.86 -49.63 15.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.678 0.751 . . . . 2.2200000000000002 110.431 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.36 -37.26 86.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.755 0.788 . . . . 1.22 110.192 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.91 -47.46 85.66 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.35 -0.844 . . . . 1.29 110.744 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.82 -37.79 85.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.215 -0.928 . . . . 2.1699999999999999 110.473 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -65.41 -47.72 75.29 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.092 -1.043 . . . . 1.3 110.646 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.35 -44.55 88.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.138 -1.025 . . . . 1.1699999999999999 110.07 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.87 -39.83 83.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.653 -0.655 . . . . 1.3999999999999999 110.245 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.05 90.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.531 -0.73 . . . . 1.3300000000000001 110.878 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.0 -41.74 92.74 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.028 -1.045 . . . . 1.48 110.272 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.5 mt -64.94 -50.01 77.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.776 -0.769 . . . . 1.28 110.494 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -74.77 -38.54 62.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 2.6000000000000001 111.778 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -78.82 -45.76 20.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.665 -1.272 . . . . 1.51 111.279 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -101.47 8.84 41.89 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.983 -1.073 . . . . 2.48 112.569 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.2 m80 50.25 49.97 19.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.707 -1.246 . . . . 1.6100000000000001 111.632 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.6 mtt -102.8 154.97 18.66 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.831 0.824 . . . . 1.8999999999999999 109.716 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 20.7 p -70.96 161.44 31.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.604 -0.685 . . . . 1.3200000000000001 109.582 177.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.87 91.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 1.1499999999999999 111.042 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 28.6 p-10 -69.13 -39.05 79.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.798 -1.189 . . . . 2.25 110.53 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.419 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -69.7 -50.36 44.48 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.432 -0.907 . . . . 1.22 111.46 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.11 90.94 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.948 -1.095 . . . . 1.1899999999999999 110.472 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.44 90.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.254 -0.904 . . . . 1.2 110.868 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -61.06 -38.75 87.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.737 -1.227 . . . . 2.1000000000000001 111.003 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -57.68 -49.81 75.28 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.053 -1.029 . . . . 1.3 110.791 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.2 -47.23 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.831 -1.168 . . . . 1.27 110.144 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -62.0 -32.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.358 -0.839 . . . . 1.1899999999999999 110.497 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -57.78 -40.05 78.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 2.1099999999999999 110.856 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.06 -33.2 15.47 Favored Glycine 0 N--CA 1.501 3.029 0 C-N-CA 119.152 -1.499 . . . . 0.88 112.452 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -61.66 -42.26 98.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.434 -1.627 . . . . 1.99 110.2 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.9 -53.3 15.57 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.494 0.664 . . . . 1.28 110.821 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.6 m -61.42 -39.92 92.5 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.021 -1.049 . . . . 2.2200000000000002 111.083 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.43 97.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.993 -1.067 . . . . 1.45 111.318 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 43.9 mt -62.21 -29.99 70.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.953 -1.092 . . . . 1.47 110.613 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.27 -19.67 64.73 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.971 -1.081 . . . . 2.04 111.073 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -74.65 -9.38 58.52 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.965 0.888 . . . . 1.73 110.898 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 69.2 mt -87.37 149.57 24.4 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.039 -0.726 . . . . 1.79 109.039 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -104.12 38.77 1.77 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.105 -0.997 . . . . 2.8799999999999999 111.586 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -116.43 138.58 51.25 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.23 -0.919 . . . . 1.5800000000000001 108.981 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.79 -39.54 85.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.693 -0.629 . . . . 3.04 110.957 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -71.68 -48.12 49.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.64 -1.287 . . . . 1.29 110.38 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.1 -39.57 94.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 1.6000000000000001 110.021 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.492 ' CB ' ' HZ1' ' A' ' 124' ' ' LYS . 3.5 ttmp? -60.28 -47.98 83.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.906 -1.121 . . . . 2.7599999999999998 109.518 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.32 -31.28 70.13 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.716 -0.794 . . . . 2.1499999999999999 109.57 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 126' ' ' ARG . 19.2 ttt-85 -60.5 -31.11 70.17 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.136 -1.026 . . . . 2.8100000000000001 108.397 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.96 -48.85 78.51 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.459 -0.896 . . . . 1.3899999999999999 109.332 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.01 -46.11 79.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.388 -0.82 . . . . 1.4099999999999999 110.408 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.38 -34.45 77.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.48 -0.763 . . . . 1.3899999999999999 110.656 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.4 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 25.0 t -68.23 -39.5 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 1.1899999999999999 110.275 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -57.37 -39.69 76.57 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.139 -0.976 . . . . 3.6299999999999999 110.115 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -61.28 -39.38 90.22 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.624 0.726 . . . . 1.28 110.591 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.27 -39.79 83.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.381 -0.825 . . . . 1.1799999999999999 110.293 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.92 -48.4 48.55 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.394 -0.908 . . . . 0.51000000000000001 111.456 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -58.26 -40.64 82.38 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.73 -1.453 . . . . 3.1699999999999999 110.811 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -61.79 -45.86 92.04 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.677 -1.264 . . . . 2.8500000000000001 110.326 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.96 -43.78 98.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.486 -0.759 . . . . 1.6499999999999999 110.376 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.93 -45.53 92.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.831 . . . . 1.2 110.44 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -60.54 -35.99 77.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.571 -0.706 . . . . 2.7999999999999998 110.987 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -74.71 -40.35 61.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 2.1499999999999999 110.66 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.34 -39.17 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.448 -0.901 . . . . 1.21 110.407 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.28 -7.05 58.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.086 -1.009 . . . . 1.3400000000000001 112.33 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.85 19.49 77.57 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.812 -1.185 . . . . 0.91000000000000003 112.478 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.38 147.91 39.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.639 -0.918 . . . . 1.51 109.302 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -67.24 142.92 56.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.401 -0.812 . . . . 2.8799999999999999 109.185 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.6 mt -108.7 137.72 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.167 -1.049 . . . . 1.6200000000000001 108.167 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 mp -79.45 130.36 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.015 . . . . 2.1099999999999999 108.546 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -93.95 96.2 9.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.507 -1.664 . . . . 1.6200000000000001 106.507 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.5 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 57.3 mt -74.61 -10.56 59.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 1.3999999999999999 111.951 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 172' ' ' ASN . 27.5 t -89.5 0.74 56.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.909 -1.119 . . . . 2.0499999999999998 112.424 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -102.43 33.75 3.02 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.102 -0.999 . . . . 1.3500000000000001 112.884 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.5 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 1.9 mp -66.29 140.63 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.197 -1.564 . . . . 1.4199999999999999 108.827 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -109.29 -20.77 12.83 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.08 0.943 . . . . 2.9900000000000002 111.346 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.437 ' O ' ' CG2' ' A' ' 152' ' ' ILE . 95.7 m-20 -118.89 140.17 50.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.875 -1.157 . . . . 1.54 107.875 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -74.49 124.94 27.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.056 -1.091 . . . . 1.3799999999999999 108.056 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.6 m -146.88 175.7 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.564 -0.71 . . . . 1.28 109.513 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.1 mt -88.7 141.83 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.951 -0.759 . . . . 1.1599999999999999 108.951 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.6 tp -96.67 121.39 38.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 1.3100000000000001 108.297 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.78 131.56 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.373 -0.973 . . . . 1.25 108.373 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.37 158.2 31.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 1.26 109.088 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.56 82.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.692 -1.255 . . . . 1.6000000000000001 109.713 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -171.81 151.07 2.74 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.889 -0.782 . . . . 2.4199999999999999 108.889 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.0 mt -115.76 142.9 46.14 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.504 -0.747 . . . . 1.3500000000000001 109.248 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 54.3 p -92.4 148.86 37.28 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 120.984 -1.073 . . . . 1.3200000000000001 108.878 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -41.28 -41.84 4.98 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.052 1.835 . . . . 0.69999999999999996 113.354 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.9 m -60.51 -50.37 73.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.938 -1.101 . . . . 1.1200000000000001 110.235 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -60.68 -40.14 91.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.416 -0.802 . . . . 1.21 109.779 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 48.6 p -66.73 -38.47 86.73 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.568 -0.708 . . . . 1.1899999999999999 110.278 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.28 82.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 1.24 111.122 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -96.93 1.05 49.95 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.31 -0.869 . . . . 1.6899999999999999 113.136 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.27 150.03 36.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.2 -0.938 . . . . 1.3400000000000001 109.601 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 150' ' ' SER . 6.1 m120 -94.83 116.14 28.36 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 106.877 -1.527 . . . . 2.77 106.877 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.6 mm? -75.06 -19.43 60.0 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.482 -0.761 . . . . 2.0899999999999999 111.81 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -85.9 -21.23 28.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 2.6699999999999999 112.266 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -98.95 -2.86 36.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.126 -0.983 . . . . 2.5800000000000001 112.598 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.08 129.32 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 107.979 -1.119 . . . . 1.1799999999999999 107.979 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.2 tp -86.26 -6.2 59.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.518 -0.739 . . . . 2.1800000000000002 111.833 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 167.29 172.74 34.8 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 108.822 -1.711 . . . . 0.48999999999999999 108.822 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -127.18 131.12 50.75 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.206 -1.173 . . . . 0.64000000000000001 108.15 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.1 mt -135.97 116.07 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 106.164 -1.791 . . . . 1.21 106.164 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 203' ' ' VAL . 62.8 p -138.79 174.99 9.94 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.282 -1.511 . . . . 1.3799999999999999 110.543 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.48 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 44.2 m-20 -97.62 61.73 1.63 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 115.455 -0.793 . . . . 2.3700000000000001 109.674 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -106.88 141.66 37.74 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.72 -0.845 . . . . 1.52 108.72 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -58.58 -35.9 82.77 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.637 -1.268 . . . . 1.8 110.899 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 93.2 -12.78 69.12 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 121.066 -1.255 . . . . 2.04 113.717 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -61.44 -40.98 96.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.812 -1.404 . . . . 5.0 109.887 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 40.9 p -152.6 36.95 0.51 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 3.02 111.89 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 67.6 m -83.74 132.04 34.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 2.1099999999999999 108.802 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -60.04 -35.49 75.22 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.181 0.515 . . . . 1.24 111.012 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.498 ' HG1' ' N ' ' A' ' 191' ' ' SER . 77.9 p -57.67 -41.24 81.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.77 -1.206 . . . . 2.1499999999999999 110.464 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.498 ' N ' ' HG1' ' A' ' 190' ' ' THR . 50.6 m -60.07 -35.95 76.31 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.016 -1.053 . . . . 2.02 110.172 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.1 mm -59.97 -39.95 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.893 -0.504 . . . . 2.1200000000000001 111.029 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.5 mtp -61.13 -45.14 95.91 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.009 -1.057 . . . . 1.3600000000000001 109.62 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -57.91 -48.2 80.57 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.678 -0.692 . . . . 1.29 111.061 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.418 ' HG2' HH11 ' A' ' 195' ' ' ARG . 41.6 mtt-85 -61.87 -41.01 97.33 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.132 -0.98 . . . . 3.5600000000000001 110.605 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.5 m -69.62 -41.36 75.79 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.288 -0.883 . . . . 1.1799999999999999 110.185 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.22 -8.12 49.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 112.574 0.583 . . . . 1.3400000000000001 112.574 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.1 mt-10 52.97 10.66 0.17 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.085 1.143 . . . . 1.45 114.085 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.405 ' O ' ' OG ' ' A' ' 8' ' ' SER . 82.7 mt -71.95 149.7 92.52 Favored Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 108.188 -1.041 . . . . 1.25 108.188 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -54.09 132.81 52.18 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.236 1.29 . . . . 0.78000000000000003 109.903 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -158.75 162.71 37.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.294 -1.504 . . . . 1.2 109.468 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 202' ' ' ILE . 81.2 mt -148.23 154.5 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.686 -1.228 . . . . 1.25 107.686 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.9 m -137.22 -28.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 121.077 -1.014 . . . . 1.3899999999999999 112.244 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.75 32.93 0.72 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.822 -1.18 . . . . 0.96999999999999997 113.5 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.48 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 39.4 p -60.8 -25.27 66.44 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.31 -1.112 . . . . 1.3500000000000001 110.453 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 76.27 -93.44 0.99 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.818 -1.182 . . . . 1.0700000000000001 110.541 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.0 p -127.3 32.6 5.02 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.215 -1.168 . . . . 1.9199999999999999 112.325 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.26 -36.24 67.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 120.682 -1.261 . . . . 1.3300000000000001 109.911 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.5 p -57.48 -20.19 29.36 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.282 -0.886 . . . . 1.4199999999999999 111.74 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.4 t -91.16 -3.57 56.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 2.1200000000000001 111.732 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -122.62 -8.2 8.52 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 112.923 0.712 . . . . 2.6899999999999999 112.923 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 68.9 t -112.32 148.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.427 0.632 . . . . 1.29 109.649 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -120.09 159.46 24.76 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.012 -1.107 . . . . 2.6899999999999999 108.012 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.2 p30 -57.61 149.0 22.54 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.409 -1.432 . . . . 2.79 110.507 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 9.0 t0 81.69 -2.44 1.6 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 114.644 1.35 . . . . 2.3500000000000001 114.644 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -67.61 147.97 52.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.743 -1.223 . . . . 1.97 108.328 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -90.18 122.96 33.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.757 -1.201 . . . . 2.9700000000000002 107.757 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.0 mt -124.88 143.88 50.61 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.9 0.857 . . . . 1.25 110.199 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.61 122.93 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.125 -1.805 . . . . 1.22 106.125 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.1 tp -98.92 117.77 34.17 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.409 -1.7 . . . . 1.24 106.409 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 223' ' ' VAL . 30.9 t0 -92.76 -26.0 17.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.933 -1.104 . . . . 2.0499999999999998 112.96 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.436 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 38.59 18.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.863 0.69 . . . . 1.25 112.863 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.2 t -113.49 -60.72 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.956 0.884 . . . . 1.4299999999999999 109.386 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -95.54 10.55 36.2 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.721 0.772 . . . . 3.0299999999999998 110.764 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 62.21 50.25 3.99 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.446 0.641 . . . . 2.25 111.74 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -147.17 146.6 29.93 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.414 1.102 . . . . 2.52 109.563 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.11 140.25 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.691 -0.855 . . . . 1.29 108.691 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -100.28 132.16 45.81 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.909 -1.119 . . . . 1.3400000000000001 108.542 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.1 t -110.15 130.18 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.411 -0.959 . . . . 1.3400000000000001 108.411 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.7 t30 53.12 52.84 10.97 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 114.124 1.157 . . . . 2.1800000000000002 114.124 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.38 149.6 69.53 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.149 1.899 . . . . 0.93999999999999995 110.717 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 65.7 p -75.72 157.94 32.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 2.3999999999999999 109.245 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -60.84 -38.56 85.91 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.788 -0.765 . . . . 3.3300000000000001 110.24 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 234' ' ' GLU . 55.8 mp0 -60.28 -39.34 86.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.636 -0.665 . . . . 3.1699999999999999 110.732 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.48 -40.83 77.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.864 -1.134 . . . . 1.6899999999999999 110.142 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.4 -43.87 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.437 -0.789 . . . . 1.6000000000000001 110.082 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -59.72 -41.42 90.8 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.104 -0.997 . . . . 2.7000000000000002 110.385 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -63.61 -40.58 97.27 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.474 -0.89 . . . . 2.96 110.342 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.488 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 84.0 mtp -69.85 -41.01 75.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 1.6299999999999999 110.648 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -53.28 -44.68 68.47 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.327 -1.483 . . . . 3.27 110.276 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.84 -59.63 2.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 2.23 110.514 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.69 -46.01 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.276 -0.89 . . . . 2.79 111.921 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 239' ' ' MET . 4.2 tp60 -59.32 -43.24 92.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.712 -1.243 . . . . 4.2599999999999998 110.861 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -60.46 -35.87 76.91 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.489 -1.284 . . . . 1.8799999999999999 109.94 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -60.55 -28.74 68.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.776 -1.17 . . . . 3.3799999999999999 110.213 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 99.7 t -60.31 -41.66 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 118.981 -1.088 . . . . 2.8799999999999999 109.186 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.92 82.8 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.478 -0.889 . . . . 2.75 109.705 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 7.7 t -70.82 -27.56 63.97 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.577 0.703 . . . . 3.4199999999999999 110.887 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -59.78 -38.88 83.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.78 . . . . 3.5699999999999998 110.3 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.476 ' C ' ' H ' ' A' ' 252' ' ' GLU . 93.3 mttt -66.48 -29.32 69.4 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.898 0.856 . . . . 4.6100000000000003 110.674 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -74.52 28.55 0.08 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.763 0.792 . . . . 4.4500000000000002 111.88 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 250' ' ' LYS . 85.3 tt0 -59.88 -24.55 64.36 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.695 -0.628 . . . . 5.9699999999999998 111.388 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.27 -35.15 73.21 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.398 -0.921 . . . . 6.4500000000000002 109.592 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -74.94 -0.31 18.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.717 -0.614 . . . . 6.6600000000000001 112.466 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -76.1 -7.69 55.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.222 -0.924 . . . . 8.5399999999999991 112.529 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 47.9 mt -80.31 -4.24 52.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.994 -1.067 . . . . 8.0700000000000003 112.256 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -85.18 -3.85 58.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.133 -0.979 . . . . 9.7200000000000006 112.181 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -94.5 -59.09 2.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.985 -1.072 . . . . 10.119999999999999 111.049 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 118.205 -0.902 . . . . 11.9 109.985 -179.168 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 mmt . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.492 -0.558 . . . . 3.5299999999999998 109.492 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.2 mt 48.36 71.36 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.315 -0.866 . . . . 1.5700000000000001 112.321 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 m -93.07 118.22 30.95 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.09 -1.448 . . . . 1.4399999999999999 107.09 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.4 -146.8 16.69 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.48 -1.048 . . . . 1.01 110.48 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 96.8 mt -94.95 -2.88 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.34 -1.094 . . . . 1.6299999999999999 113.036 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tp 50.8 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.867 -1.146 . . . . 1.5800000000000001 112.607 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.8 -43.79 13.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 1.3400000000000001 110.741 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -147.96 142.42 16.54 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 107.797 -1.186 . . . . 1.8600000000000001 107.797 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.97 149.39 36.79 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.716 2.277 . . . . 1.01 112.454 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 155.43 162.61 11.43 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.143 -1.583 . . . . 0.81000000000000005 109.143 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -121.9 135.08 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 O-C-N 121.089 -1.242 . . . . 1.3700000000000001 108.271 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.11 155.5 46.97 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.456 -0.778 . . . . 1.1399999999999999 109.269 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -127.44 139.58 52.73 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.89 -1.152 . . . . 0.87 107.89 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.46 168.98 35.98 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 118.69 -1.719 . . . . 0.56999999999999995 110.063 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -80.03 161.15 25.57 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.451 -1.029 . . . . 2.3500000000000001 110.216 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -84.85 131.68 34.49 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.391 -0.966 . . . . 1.21 108.391 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 tp -109.78 101.77 10.61 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 105.405 -2.072 . . . . 1.3999999999999999 105.405 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.53 133.15 35.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.911 -1.144 . . . . 1.4399999999999999 107.911 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.7 117.93 35.8 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.394 -1.706 . . . . 1.45 106.394 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -109.32 133.38 53.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.943 -1.132 . . . . 2.5 107.943 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -123.59 140.24 53.19 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.305 -0.872 . . . . 2.6600000000000001 108.666 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -80.46 136.99 36.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.073 -1.017 . . . . 2.3199999999999998 108.256 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.2 146.12 51.62 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.281 -0.887 . . . . 2.1099999999999999 108.955 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.0 mt -93.39 128.84 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.237 -1.023 . . . . 1.29 108.237 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -108.83 130.49 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.726 -1.213 . . . . 1.4099999999999999 107.726 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.5 mt -95.7 132.14 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.341 -0.85 . . . . 1.3100000000000001 108.943 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -89.94 120.8 31.47 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.61 -1.256 . . . . 1.3400000000000001 107.61 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -96.65 17.74 15.79 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.431 -0.793 . . . . 3.48 112.417 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -67.45 146.29 54.14 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.203 -0.935 . . . . 2.52 108.979 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -87.82 134.83 33.61 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.103 -1.073 . . . . 2.6299999999999999 108.103 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 pt -96.82 165.69 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.458 -0.776 . . . . 1.3100000000000001 110.329 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -94.27 168.47 10.89 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 1.24 109.541 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.11 -18.97 28.75 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.959 -1.088 . . . . 1.49 112.879 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.09 -35.85 76.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.746 -1.221 . . . . 2.2799999999999998 110.825 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -94.5 -8.83 37.23 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.969 -1.082 . . . . 2.0499999999999998 113.221 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.9 -43.79 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.164 -0.96 . . . . 1.3400000000000001 110.156 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.52 -40.09 81.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.954 -1.091 . . . . 1.54 110.4 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -62.1 -38.09 87.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.683 . . . . 2.8500000000000001 110.656 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.77 -39.49 85.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 1.3100000000000001 110.883 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.49 -43.68 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.131 -0.98 . . . . 1.3799999999999999 110.769 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -62.13 -43.8 98.04 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.113 -0.992 . . . . 1.5 110.461 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -62.7 -38.78 91.79 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.247 -0.908 . . . . 2.7799999999999998 110.592 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -76.09 -55.56 5.48 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.123 -0.986 . . . . 1.0600000000000001 110.532 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.68 -48.28 81.62 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.295 -0.962 . . . . 1.3999999999999999 110.59 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.9 t -69.84 -40.78 75.62 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.74 -0.784 . . . . 1.3200000000000001 110.435 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.15 -45.73 87.05 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.24 -1.457 . . . . 0.69999999999999996 109.691 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -58.39 -30.06 66.53 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.036 0.922 . . . . 3.4399999999999999 109.995 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.66 -46.19 87.73 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.672 0.748 . . . . 1.3600000000000001 110.018 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -78.95 -41.81 28.42 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 2.8300000000000001 110.311 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.48 86.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.4 -0.813 . . . . 1.23 109.74 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -60.45 -40.38 90.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.118 -0.989 . . . . 1.9199999999999999 109.288 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.91 -47.17 69.52 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.926 -0.579 . . . . 1.25 110.894 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.52 -51.38 65.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.084 . . . . 1.97 110.7 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 54' ' ' LEU . 3.0 mm? -61.41 -40.11 93.19 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.563 -0.855 . . . . 2.1800000000000002 110.023 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -59.7 -41.59 91.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 1.1899999999999999 110.354 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -66.05 -42.74 89.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.134 -0.979 . . . . 1.3400000000000001 110.457 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 57' ' ' ILE . 98.8 mt -59.89 -39.76 80.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.352 -0.843 . . . . 1.23 110.705 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -49.93 -41.92 47.29 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.09 -1.006 . . . . 1.5600000000000001 110.87 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -70.21 -38.17 75.23 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.143 -0.973 . . . . 1.3 110.039 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.4 -38.88 88.66 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.721 -1.192 . . . . 2.3199999999999998 108.945 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.16 72.24 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.52 0.676 . . . . 1.1399999999999999 109.609 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.24 -33.37 20.46 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.103 -1.046 . . . . 0.68999999999999995 111.055 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -80.6 -26.83 37.59 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.083 -1.245 . . . . 1.48 111.202 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 m -85.71 -48.61 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.579 -0.701 . . . . 1.52 110.856 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -107.48 -17.99 13.97 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 113.229 0.826 . . . . 1.3100000000000001 113.229 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.13 155.72 11.48 Favored Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.329 -0.857 . . . . 0.84999999999999998 112.325 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -50.65 -22.56 2.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.882 -0.776 . . . . 3.8599999999999999 112.305 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.61 -36.18 71.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 2.3500000000000001 111.349 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -80.98 -22.39 39.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.853 -1.154 . . . . 2.2599999999999998 111.935 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -58.87 -33.53 70.58 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.957 -1.09 . . . . 1.45 111.2 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.95 -41.71 83.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 1.25 110.816 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.1 mt -66.65 -44.75 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.86 -1.15 . . . . 1.26 110.125 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -70.24 -31.11 68.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 0.82999999999999996 110.382 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -61.04 -39.76 91.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.316 -0.865 . . . . 1.1899999999999999 109.754 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.04 -39.95 96.72 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 120.177 -1.011 . . . . 0.57999999999999996 110.611 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -59.73 -45.39 92.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -1.092 . . . . 2.0499999999999998 110.621 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 77' ' ' ILE . 92.0 mt -60.45 -39.03 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.411 -0.806 . . . . 1.21 110.545 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.9 ttt -59.61 -39.37 84.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 2.29 110.503 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.14 -49.65 77.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.035 -1.04 . . . . 1.21 109.801 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.86 -39.82 95.1 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.571 0.701 . . . . 1.1399999999999999 110.687 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -85.31 6.91 24.24 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.074 0.768 . . . . 1.4199999999999999 113.074 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -69.28 118.1 11.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.697 -1.252 . . . . 1.27 109.074 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.35 -16.9 64.07 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.627 0.727 . . . . 1.3500000000000001 110.901 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.36 -46.33 41.25 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.358 -0.937 . . . . 2.2200000000000002 109.966 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -66.2 -38.52 88.19 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.664 -0.815 . . . . 1.22 110.273 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -58.8 -46.1 88.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.5 -0.75 . . . . 1.29 110.903 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -62.73 -37.84 88.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.909 . . . . 2.1699999999999999 110.545 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.51 -48.65 66.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.013 -1.055 . . . . 1.3 110.653 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.8 mt -57.5 -43.05 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.218 -0.926 . . . . 1.1699999999999999 110.402 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.9 mt -60.62 -43.31 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.737 -0.602 . . . . 1.3999999999999999 110.389 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.45 -42.69 99.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.326 -0.859 . . . . 1.3300000000000001 110.67 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.57 -42.5 98.93 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.16 -0.963 . . . . 1.48 110.537 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 93' ' ' ILE . 96.5 mt -64.43 -44.62 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 1.28 110.537 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -84.41 -35.16 23.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.398 -0.814 . . . . 2.6000000000000001 111.713 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 91' ' ' ALA . 51.4 t0 -80.97 -45.39 16.73 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.134 -0.979 . . . . 1.51 111.79 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -101.03 9.55 42.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.245 -0.909 . . . . 2.48 112.45 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.5 m80 49.79 51.67 16.09 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.27 -0.894 . . . . 1.6100000000000001 112.023 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 85.4 mtp -104.11 154.76 19.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.0 -0.741 . . . . 1.8999999999999999 109.0 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.42 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 46.4 p -72.6 160.39 32.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 1.3200000000000001 110.208 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.46 91.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 1.1499999999999999 110.81 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 23.5 p-10 -69.86 -43.64 71.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.9 -1.125 . . . . 2.25 110.427 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.4 -47.6 72.76 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.498 -0.881 . . . . 1.22 111.172 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.12 91.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.359 -0.838 . . . . 1.1899999999999999 110.075 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.74 96.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.556 -0.715 . . . . 1.2 110.482 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -61.49 -37.72 84.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.191 -0.943 . . . . 2.1000000000000001 110.892 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -56.92 -49.77 74.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.79 . . . . 1.3 110.788 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.8 t -60.28 -44.48 95.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.922 -1.111 . . . . 1.27 110.33 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.14 -34.53 60.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.562 -0.711 . . . . 1.1899999999999999 110.37 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -58.5 -40.28 82.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.979 -1.076 . . . . 2.1099999999999999 110.875 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.87 -34.42 13.23 Favored Glycine 0 N--CA 1.498 2.775 0 C-N-CA 119.236 -1.459 . . . . 0.88 112.174 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -62.2 -41.25 98.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.711 -1.464 . . . . 1.99 109.879 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.94 -51.39 22.3 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.529 -0.732 . . . . 1.28 110.547 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.9 m -60.55 -37.51 81.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 2.2200000000000002 110.76 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.25 97.67 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.552 -0.718 . . . . 1.45 110.523 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.85 -29.81 70.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.908 -1.12 . . . . 1.47 111.156 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -65.94 -21.02 66.4 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.286 -0.884 . . . . 2.04 111.121 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -71.94 -15.01 62.07 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.167 -0.958 . . . . 1.73 111.012 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 55.1 mt -84.6 147.16 27.14 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.193 -0.669 . . . . 1.79 109.193 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 6.6 t0 -100.66 38.41 1.53 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.132 -0.98 . . . . 2.8799999999999999 112.083 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -113.03 140.08 48.13 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.173 -0.954 . . . . 1.5800000000000001 108.75 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 27.8 mp0 -58.28 -39.37 79.1 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.358 -0.839 . . . . 3.04 110.92 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -71.82 -52.51 17.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.534 -1.354 . . . . 1.29 110.631 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.9 mt -60.94 -41.7 96.76 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 1.6000000000000001 110.658 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -63.42 -49.64 72.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.818 -1.176 . . . . 2.7599999999999998 109.582 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.82 -30.26 69.98 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.328 -0.949 . . . . 2.1499999999999999 109.446 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.577 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -61.09 -30.1 70.15 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.924 0.868 . . . . 2.8100000000000001 108.732 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.44 -50.41 72.9 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.78 0.8 . . . . 1.3899999999999999 109.432 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.01 -43.89 81.74 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.714 0.769 . . . . 1.4099999999999999 110.093 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -63.72 -34.0 76.9 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.475 0.655 . . . . 1.3899999999999999 110.255 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.1 t -69.01 -41.75 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 1.1899999999999999 109.91 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -58.51 -37.34 75.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.886 -1.133 . . . . 3.6299999999999999 109.584 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -58.79 -39.81 82.19 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.418 0.628 . . . . 1.28 110.464 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.19 -40.11 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.994 -1.066 . . . . 1.1799999999999999 109.778 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.85 -47.56 89.42 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.343 -1.103 . . . . 0.51000000000000001 110.343 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -58.27 -40.58 82.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -1.14 . . . . 3.1699999999999999 110.26 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -64.88 -43.66 92.19 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.403 -0.919 . . . . 2.8500000000000001 109.359 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.0 tp -59.66 -43.58 93.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.571 -0.705 . . . . 1.6499999999999999 109.64 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 20.7 mt -60.09 -38.66 83.61 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.322 -0.861 . . . . 1.2 110.576 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -39.84 84.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.063 . . . . 2.7999999999999998 110.776 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -75.77 -40.64 54.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.794 . . . . 2.1499999999999999 110.536 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.17 -40.36 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 1.21 109.572 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.45 -8.96 49.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.393 -0.817 . . . . 1.3400000000000001 112.224 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.04 18.62 76.42 Favored Glycine 0 N--CA 1.482 1.713 0 C-N-CA 119.689 -1.243 . . . . 0.91000000000000003 112.617 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.73 144.43 57.25 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.594 -0.945 . . . . 1.51 109.08 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -66.35 149.86 49.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.75 . . . . 2.8799999999999999 109.818 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.44 145.88 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.678 -0.86 . . . . 1.6200000000000001 108.678 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 147' ' ' ILE . 13.1 mm -76.93 118.84 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.942 -1.099 . . . . 2.1099999999999999 108.555 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -97.8 98.12 9.56 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.487 -1.672 . . . . 1.6200000000000001 106.487 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.5 mt -77.13 -17.6 58.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.324 -0.86 . . . . 1.3999999999999999 111.726 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -80.31 1.11 30.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 2.0499999999999998 112.476 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.75 28.31 4.81 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.364 -0.835 . . . . 1.3500000000000001 112.284 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 7.9 mt -73.49 140.08 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 1.4199999999999999 109.745 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -111.45 -21.67 11.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.605 0.717 . . . . 2.9900000000000002 112.231 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -118.14 139.96 50.49 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.369 -0.975 . . . . 1.54 108.369 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.46 125.97 28.44 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.361 -0.977 . . . . 1.3799999999999999 108.361 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.07 173.94 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 1.28 109.258 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.4 mt -87.96 145.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.683 -0.858 . . . . 1.1599999999999999 108.683 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.7 tp -95.44 123.81 39.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.916 -1.115 . . . . 1.3100000000000001 108.736 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.6 t -125.04 128.69 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.279 -1.378 . . . . 1.25 107.279 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.67 154.84 18.7 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.941 -1.1 . . . . 1.26 108.537 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.08 81.93 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.409 -1.432 . . . . 1.6000000000000001 109.375 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.1 t0 -171.01 153.42 3.8 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.511 -0.922 . . . . 2.4199999999999999 108.511 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 34.8 mt -114.69 144.59 43.21 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.298 -0.876 . . . . 1.3500000000000001 109.343 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.9 p -91.03 149.62 40.35 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.741 -1.224 . . . . 1.3200000000000001 108.826 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.58 -43.27 14.33 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.469 1.446 . . . . 0.69999999999999996 113.527 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.7 m -61.88 -45.76 92.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.926 -1.109 . . . . 1.1200000000000001 110.132 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.88 -41.66 97.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.472 -0.768 . . . . 1.21 110.385 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.467 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 82.7 p -67.22 -38.41 85.21 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.453 0.644 . . . . 1.1899999999999999 110.48 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.95 -37.25 86.3 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.467 -0.771 . . . . 1.24 110.606 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -93.73 -1.97 54.42 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.122 -0.986 . . . . 1.6899999999999999 112.683 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.55 149.62 34.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.621 -0.881 . . . . 1.3400000000000001 108.621 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -94.86 109.81 21.76 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.772 -1.566 . . . . 2.77 106.772 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.39 -22.01 64.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.93 -0.481 . . . . 2.0899999999999999 111.745 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -83.72 -17.34 41.63 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.299 -0.876 . . . . 2.6699999999999999 112.797 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -101.19 -5.65 25.3 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.196 -0.94 . . . . 2.5800000000000001 113.229 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.3 129.99 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.92 -1.141 . . . . 1.1799999999999999 107.92 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.5 tp -86.28 -3.78 59.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.146 -0.971 . . . . 2.1800000000000002 111.964 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.27 166.61 28.59 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.947 -1.661 . . . . 0.48999999999999999 108.947 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.73 130.01 53.13 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.748 -1.204 . . . . 0.64000000000000001 107.748 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 92.0 mt -131.07 124.84 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.305 -1.739 . . . . 1.21 106.305 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 203' ' ' VAL . 41.7 p -140.92 170.66 15.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.786 -1.196 . . . . 1.3799999999999999 110.595 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 48.8 t0 -108.38 66.73 0.65 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.743 -0.662 . . . . 2.3700000000000001 109.375 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.08 142.67 36.38 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.363 -0.835 . . . . 1.52 109.045 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.34 2.36 37.72 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.377 -0.916 . . . . 1.8 113.284 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 86.7 -20.02 25.97 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 120.988 -1.301 . . . . 2.04 114.864 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -58.94 -40.59 85.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.035 -1.274 . . . . 5.0 110.177 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.7 p -149.31 58.27 1.02 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.53 -0.731 . . . . 3.02 110.135 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.7 p -87.17 101.01 13.08 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.46 -1.311 . . . . 2.1099999999999999 107.46 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.467 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 58.0 t60 -62.7 -36.34 82.65 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.411 -0.806 . . . . 1.24 109.604 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 59.0 m -58.65 -38.94 79.21 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.571 -0.706 . . . . 2.1499999999999999 110.144 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 64.7 p -58.24 -37.98 75.98 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.196 -0.94 . . . . 2.02 109.73 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.8 mm -60.15 -40.0 82.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.479 -0.763 . . . . 2.1200000000000001 110.287 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 64.5 mtp -63.82 -42.37 97.67 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.084 -1.01 . . . . 1.3600000000000001 109.578 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.47 -48.45 81.59 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.574 -0.739 . . . . 1.29 110.92 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -61.89 -44.11 97.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 3.5600000000000001 110.608 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.0 m -68.62 -40.81 80.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 1.1799999999999999 110.165 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.38 -8.53 47.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.456 -0.778 . . . . 1.3400000000000001 112.526 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.0 mt-10 55.25 13.79 0.93 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.067 1.136 . . . . 1.45 114.067 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 50.2 mt -71.09 164.46 56.63 Favored Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 108.497 -0.927 . . . . 1.25 108.497 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.87 140.46 38.54 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 121.598 1.532 . . . . 0.78000000000000003 110.468 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.08 168.34 24.57 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.019 -1.675 . . . . 1.2 109.998 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.5 mt -147.7 152.55 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.866 -1.161 . . . . 1.25 107.866 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.6 m -135.12 -27.63 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 120.968 -1.082 . . . . 1.3899999999999999 111.409 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.22 46.54 3.22 Favored Glycine 0 N--CA 1.489 2.207 0 O-C-N 120.944 -1.098 . . . . 0.96999999999999997 111.75 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.3 p -62.9 -16.42 58.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.359 -1.083 . . . . 1.3500000000000001 111.702 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.459 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 76.03 -94.9 1.02 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.948 -1.261 . . . . 1.0700000000000001 109.948 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.2 m -129.97 27.6 5.14 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.478 -1.013 . . . . 1.9199999999999999 112.38 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.2 t -57.96 -40.23 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.536 -1.353 . . . . 1.3300000000000001 110.536 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.1 p -58.68 -18.88 34.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.923 -1.111 . . . . 1.4199999999999999 111.77 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.8 t -94.96 -0.59 53.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.412 -0.805 . . . . 2.1200000000000001 112.227 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -129.86 0.44 4.82 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.698 0.629 . . . . 2.6899999999999999 112.698 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t -120.09 150.54 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.934 0.873 . . . . 1.29 109.806 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.67 154.74 36.43 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.222 -1.029 . . . . 2.6899999999999999 108.222 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.9 p-10 -51.38 145.6 8.21 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.103 -0.998 . . . . 2.79 110.172 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.9 t0 81.73 -7.0 1.45 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.264 1.209 . . . . 2.3500000000000001 114.264 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 16' ' ' ALA . 19.7 t0 -60.47 145.24 49.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.773 -1.205 . . . . 1.97 108.478 177.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.438 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 14.2 t80 -88.32 123.07 32.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.939 -1.134 . . . . 2.9700000000000002 107.939 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 49.6 mt -128.26 149.86 50.3 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.553 -0.717 . . . . 1.25 109.607 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.13 123.0 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.309 -1.737 . . . . 1.22 106.309 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.0 tp -100.86 112.79 25.29 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.927 -1.879 . . . . 1.24 105.927 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 223' ' ' VAL . 41.6 p30 -93.35 -22.85 18.7 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.881 -1.137 . . . . 2.0499999999999998 112.314 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 37.91 16.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.996 0.739 . . . . 1.25 112.996 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.598 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.1 t -106.94 -57.75 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.057 -1.027 . . . . 1.4299999999999999 109.359 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -93.62 9.08 38.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.421 1.105 . . . . 3.0299999999999998 110.41 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.78 52.56 3.45 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.89 -1.05 . . . . 2.25 112.177 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.443 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 89.6 mt-30 -146.79 150.16 34.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.357 1.075 . . . . 2.52 109.827 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -115.63 139.86 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.864 -1.161 . . . . 1.29 107.864 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -104.21 131.67 51.27 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 108.145 -1.057 . . . . 1.3400000000000001 108.145 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.1 t -110.31 130.38 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.898 -0.778 . . . . 1.3400000000000001 108.898 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.458 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 8.9 t-20 53.95 48.12 4.47 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 113.393 0.886 . . . . 2.1800000000000002 113.393 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 56.2 Cg_endo -68.99 148.51 70.24 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.128 1.886 . . . . 0.93999999999999995 111.216 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 43.2 p -74.61 162.84 28.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.807 -1.183 . . . . 2.3999999999999999 110.172 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -59.8 -36.78 77.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 3.3300000000000001 110.66 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -59.9 -39.42 85.32 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.28 -0.888 . . . . 3.1699999999999999 110.952 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 87.4 t -70.02 -38.46 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 1.6899999999999999 110.075 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.518 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 96.1 mt -59.69 -47.5 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.552 -0.717 . . . . 1.6000000000000001 110.377 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -60.01 -39.64 86.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 2.7000000000000002 110.792 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -63.06 -45.99 89.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.363 -0.836 . . . . 2.96 110.74 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 72.7 mtp -70.99 -35.69 72.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 1.6299999999999999 110.647 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.537 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -57.1 -40.19 76.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.899 . . . . 3.27 110.377 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.29 -54.43 7.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.273 -0.892 . . . . 2.23 110.673 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 85.2 t -59.53 -42.13 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.351 -0.843 . . . . 2.79 111.092 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -59.17 -49.95 75.92 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.963 -1.086 . . . . 4.2599999999999998 111.103 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -66.78 -39.12 87.69 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.128 -0.982 . . . . 1.8799999999999999 110.868 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -61.04 -29.74 69.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.811 -1.181 . . . . 3.3799999999999999 110.377 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.13 -43.3 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.423 -0.911 . . . . 2.8799999999999999 109.488 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.62 92.85 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.426 -0.796 . . . . 2.75 110.132 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 p -69.95 -33.0 71.55 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.4 -0.812 . . . . 3.4199999999999999 110.477 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -62.68 -31.02 71.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 3.5699999999999998 110.396 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -60.14 -34.6 73.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.487 -0.758 . . . . 4.6100000000000003 110.47 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.03 -29.25 69.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.922 . . . . 4.4500000000000002 110.91 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -70.8 -10.25 59.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.203 -0.935 . . . . 5.9699999999999998 112.242 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 46.5 tp -63.55 -29.69 70.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.901 -1.125 . . . . 6.4500000000000002 110.865 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.459 ' O ' ' NZ ' ' A' ' 257' ' ' LYS . . . -68.78 -10.34 56.09 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 6.6600000000000001 111.947 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -83.11 9.9 9.37 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.575 -0.703 . . . . 8.5399999999999991 112.082 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 13.2 tp -79.67 -4.04 49.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.024 . . . . 8.0700000000000003 112.164 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 254' ' ' ALA . 31.7 mtmm -80.21 -0.52 36.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.16 -0.963 . . . . 9.7200000000000006 112.104 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -93.45 10.7 31.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.43 -0.794 . . . . 10.119999999999999 112.474 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 259' ' ' ARG . 27.2 ttt-85 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 11.9 109.222 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.072 -0.714 . . . . 3.5299999999999998 109.072 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.4 mt 41.85 69.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.203 -0.936 . . . . 1.5700000000000001 112.116 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -96.39 111.98 23.88 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.829 -1.545 . . . . 1.4399999999999999 106.829 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.92 -154.13 29.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.66 -1.376 . . . . 1.01 109.66 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 82.2 mt -95.03 -0.62 10.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.321 -1.105 . . . . 1.6299999999999999 112.273 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 49.63 100.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.939 -1.101 . . . . 1.5800000000000001 112.511 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.18 -42.19 12.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.144 -0.972 . . . . 1.3400000000000001 111.983 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 m -145.0 142.78 18.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.875 -1.141 . . . . 1.8600000000000001 108.007 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.53 148.48 26.25 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.198 1.932 . . . . 1.01 112.357 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 151.38 173.22 21.04 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.053 -1.619 . . . . 0.81000000000000005 109.053 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.0 mt -129.52 137.07 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -1.222 . . . . 1.3700000000000001 108.272 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.95 154.65 46.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 1.1399999999999999 109.173 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.0 m-85 -121.03 140.46 51.9 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.437 -0.949 . . . . 0.87 108.437 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.45 162.56 28.33 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.311 -1.9 . . . . 0.56999999999999995 110.32 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -78.45 158.77 28.57 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.527 -0.916 . . . . 2.3500000000000001 108.527 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.72 127.45 34.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.003 -1.061 . . . . 1.21 108.539 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.1 tp -103.77 103.5 13.4 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 104.976 -2.231 . . . . 1.3999999999999999 104.976 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.1 tp -91.46 129.9 37.38 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.335 -1.357 . . . . 1.4399999999999999 107.335 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.07 119.88 39.39 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.443 -1.317 . . . . 1.45 107.443 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -110.17 132.34 54.26 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.503 -1.295 . . . . 2.5 107.503 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -128.96 155.24 45.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.336 -0.852 . . . . 2.6600000000000001 109.529 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -85.15 137.76 32.82 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.816 -1.179 . . . . 2.3199999999999998 107.816 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.2 149.71 49.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.033 -1.042 . . . . 2.1099999999999999 108.991 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -92.42 128.88 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.293 -1.003 . . . . 1.29 108.293 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.75 130.42 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.941 -1.133 . . . . 1.4099999999999999 107.941 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.9 mt -96.45 139.35 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.545 -0.909 . . . . 1.3100000000000001 108.545 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.25 120.6 32.3 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.298 -1.371 . . . . 1.3400000000000001 107.298 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -96.3 16.84 17.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.811 . . . . 3.48 112.485 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -67.74 143.67 55.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.862 -1.149 . . . . 2.52 108.88 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -88.87 132.28 34.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.134 -1.062 . . . . 2.6299999999999999 108.134 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.1 pt -98.97 167.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.399 -0.813 . . . . 1.3100000000000001 110.342 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.9 p -93.1 162.44 14.03 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.641 0.734 . . . . 1.24 109.766 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.87 -17.31 6.1 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.111 -0.993 . . . . 1.49 112.722 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -69.89 -32.65 71.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.012 . . . . 2.2799999999999998 111.094 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -86.27 0.95 52.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.989 -1.069 . . . . 2.0499999999999998 112.431 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 t -56.27 -44.6 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.466 -0.771 . . . . 1.3400000000000001 110.46 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -58.08 -40.77 81.9 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.205 -0.935 . . . . 1.54 110.327 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -64.14 -45.0 90.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.653 -0.655 . . . . 2.8500000000000001 111.604 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.7 -42.8 99.43 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.812 -1.18 . . . . 1.3100000000000001 111.068 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.27 -41.88 88.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.162 -0.961 . . . . 1.3799999999999999 110.228 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -63.13 -45.88 89.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.042 -1.036 . . . . 1.5 110.119 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -61.92 -42.3 98.92 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.456 -0.897 . . . . 2.7799999999999998 109.957 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -71.45 -52.86 16.15 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.4 -0.92 . . . . 1.0600000000000001 110.165 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.44 -49.28 78.21 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.241 -0.984 . . . . 1.3999999999999999 110.647 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.1 t -69.97 -45.1 68.09 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.552 0.692 . . . . 1.3200000000000001 110.346 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.98 -45.71 86.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.295 -1.522 . . . . 0.69999999999999996 109.295 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -57.37 -31.44 65.78 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.855 0.836 . . . . 3.4399999999999999 109.775 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.11 -42.57 86.02 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.542 0.687 . . . . 1.3600000000000001 110.097 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -75.82 -38.61 57.97 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.268 -0.895 . . . . 2.8300000000000001 110.067 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.76 -38.69 82.51 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.148 -0.97 . . . . 1.23 109.946 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 t -61.02 -38.88 87.64 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.897 0.856 . . . . 1.9199999999999999 109.422 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.64 -47.57 75.13 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.959 -0.564 . . . . 1.25 110.289 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.9 -49.76 74.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.878 -1.139 . . . . 1.97 110.208 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.66 -39.32 90.96 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.258 -0.901 . . . . 2.1800000000000002 110.016 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -59.66 -41.26 90.21 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.218 -0.593 . . . . 1.1899999999999999 110.311 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.9 m -67.05 -44.21 80.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.225 -0.922 . . . . 1.3400000000000001 110.297 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -59.8 -34.82 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.652 -0.655 . . . . 1.23 110.873 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -51.57 -44.64 62.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.92 -1.112 . . . . 1.5600000000000001 110.713 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -68.97 -34.63 75.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.042 -1.036 . . . . 1.3 110.124 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -63.76 -39.74 95.01 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.812 -1.155 . . . . 2.3199999999999998 109.241 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.83 -31.12 72.2 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.163 -0.615 . . . . 1.1399999999999999 109.88 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.1 -36.27 13.4 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.784 -1.198 . . . . 0.68999999999999995 110.81 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.31 -24.26 42.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.945 -1.327 . . . . 1.48 110.242 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.8 m -84.55 -51.14 7.1 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.339 -0.85 . . . . 1.52 110.995 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -106.68 -19.93 13.51 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.102 -0.998 . . . . 1.3100000000000001 113.286 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.61 165.55 14.05 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 121.277 -0.889 . . . . 0.84999999999999998 112.211 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -53.74 -24.03 13.65 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 112.583 0.586 . . . . 3.8599999999999999 112.583 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.86 -36.74 70.4 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.017 -1.052 . . . . 2.3500000000000001 111.653 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -84.92 -15.35 44.77 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.301 -1.499 . . . . 2.2599999999999998 112.913 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.88 -35.62 77.1 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.047 -1.033 . . . . 1.45 110.811 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.51 -39.24 87.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.357 -0.839 . . . . 1.25 111.222 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.9 mt -66.6 -48.96 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.971 -1.081 . . . . 1.26 110.564 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -69.91 -30.37 67.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.451 -0.781 . . . . 0.82999999999999996 110.411 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.86 -38.23 87.48 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.604 -0.839 . . . . 1.1899999999999999 109.823 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.21 -38.66 92.08 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 110.592 -1.003 . . . . 0.57999999999999996 110.592 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -60.13 -40.39 89.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 2.0499999999999998 110.797 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.85 -44.74 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.93 -1.106 . . . . 1.21 110.118 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.4 ttp -60.08 -38.16 82.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -0.891 . . . . 2.29 110.11 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 tp -60.31 -49.94 75.6 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.362 -0.836 . . . . 1.21 110.686 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.38 -40.08 89.58 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.923 -0.711 . . . . 1.1399999999999999 110.333 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -86.21 5.47 34.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.373 -0.829 . . . . 1.4199999999999999 112.386 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.18 119.7 11.34 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.856 -1.152 . . . . 1.27 108.924 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.03 -15.65 63.22 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.645 0.736 . . . . 1.3500000000000001 110.977 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -71.68 -49.55 38.69 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.018 -1.073 . . . . 2.2200000000000002 110.037 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.84 -38.62 88.9 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.169 -1.012 . . . . 1.22 110.097 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.7 -46.18 89.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 1.29 110.777 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -60.05 -39.54 86.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.082 -1.011 . . . . 2.1699999999999999 110.578 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -65.63 -47.9 74.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.954 -1.092 . . . . 1.3 110.19 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.2 mt -57.9 -43.06 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.558 -0.714 . . . . 1.1699999999999999 110.158 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 90' ' ' ILE . 77.6 mt -59.68 -40.89 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.162 0.506 . . . . 1.3999999999999999 110.547 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.72 -40.59 88.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 1.3300000000000001 110.387 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.52 -45.5 90.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 1.48 110.097 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.0 mt -62.57 -43.42 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.365 -0.834 . . . . 1.28 110.193 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' HZ1' ' CB ' ' A' ' 94' ' ' LYS . 7.3 mtpm? -82.64 -38.4 23.57 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.37 -0.831 . . . . 2.6000000000000001 111.932 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 91' ' ' ALA . 49.4 t0 -80.83 -43.28 20.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.909 -1.119 . . . . 1.51 111.882 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.55 8.1 35.35 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.374 -0.829 . . . . 2.48 112.777 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.0 m170 52.46 51.43 16.18 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.868 -1.145 . . . . 1.6100000000000001 111.58 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.2 mtt -105.12 152.17 23.12 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.37 -0.831 . . . . 1.8999999999999999 109.265 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.658 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 71.4 p -71.3 161.68 30.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.374 -0.829 . . . . 1.3200000000000001 110.121 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.18 88.92 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.241 -0.912 . . . . 1.1499999999999999 110.254 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -68.08 -41.1 82.39 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.212 -0.93 . . . . 2.25 110.34 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.658 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -69.66 -49.83 49.91 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.158 -0.964 . . . . 1.22 111.21 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.38 92.22 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.383 -0.823 . . . . 1.1899999999999999 110.407 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.77 95.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.65 -0.656 . . . . 1.2 110.894 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -61.49 -40.05 93.16 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.396 -0.815 . . . . 2.1000000000000001 110.835 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -57.84 -49.57 76.24 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.669 -1.27 . . . . 1.3 111.347 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.7 t -61.11 -44.82 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.95 -1.094 . . . . 1.27 110.161 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 mm -62.78 -33.52 60.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.765 0.793 . . . . 1.1899999999999999 109.958 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -55.46 -40.89 72.18 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.519 -0.738 . . . . 2.1099999999999999 110.87 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.29 -32.49 16.59 Favored Glycine 0 N--CA 1.498 2.825 0 C-N-CA 118.98 -1.581 . . . . 0.88 112.571 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -60.34 -41.59 93.92 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.302 -1.705 . . . . 1.99 110.204 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.92 -51.62 17.82 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.328 -0.857 . . . . 1.28 110.966 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.8 p -62.41 -39.4 93.13 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.265 -0.897 . . . . 2.2200000000000002 110.709 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.72 96.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.404 -0.81 . . . . 1.45 110.913 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 43.8 mt -65.29 -30.89 71.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.891 -1.131 . . . . 1.47 110.5 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.14 -22.33 66.37 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.928 -1.108 . . . . 2.04 111.205 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -71.34 -12.47 61.45 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.765 0.793 . . . . 1.73 110.956 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.85 146.06 27.5 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.874 -0.787 . . . . 1.79 108.874 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -100.3 35.36 2.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.15 -0.969 . . . . 2.8799999999999999 112.112 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -112.58 139.59 48.04 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 108.269 -1.011 . . . . 1.5800000000000001 108.269 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.01 -37.64 80.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.429 -0.794 . . . . 3.04 110.772 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -73.22 -49.0 30.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.794 -1.191 . . . . 1.29 110.215 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.2 mt -63.2 -40.67 98.14 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.616 -1.234 . . . . 1.6000000000000001 109.738 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -60.96 -47.63 85.55 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.788 -1.195 . . . . 2.7599999999999998 110.097 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.27 -31.4 70.19 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.759 -0.777 . . . . 2.1499999999999999 109.556 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.479 ' HG2' HH11 ' A' ' 126' ' ' ARG . 9.2 ttt-85 -62.14 -29.67 70.5 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.008 0.908 . . . . 2.8100000000000001 108.975 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.63 -49.83 75.93 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.054 0.93 . . . . 1.3899999999999999 109.592 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -41.41 78.83 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.59 0.71 . . . . 1.4099999999999999 110.415 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.87 -38.49 91.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.559 -0.713 . . . . 1.3899999999999999 110.25 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.6 -39.77 78.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.522 -0.736 . . . . 1.1899999999999999 110.648 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -58.68 -39.77 81.64 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.3 -1.36 . . . . 3.6299999999999999 110.029 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -59.67 -39.75 85.5 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.166 0.508 . . . . 1.28 110.823 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.99 -39.18 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.336 -0.852 . . . . 1.1799999999999999 110.625 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -64.71 -44.26 95.12 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.791 -1.195 . . . . 0.51000000000000001 110.909 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -58.14 -40.61 81.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.271 . . . . 3.1699999999999999 110.575 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -61.36 -42.68 99.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.312 -0.867 . . . . 2.8500000000000001 110.111 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 31.3 tp -60.29 -43.33 96.35 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.439 -0.904 . . . . 1.6499999999999999 109.506 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.25 -45.92 91.6 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.46 0.648 . . . . 1.2 110.197 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -60.98 -34.86 75.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.461 -0.774 . . . . 2.7999999999999998 111.08 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -75.81 -41.73 51.92 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.074 -1.016 . . . . 2.1499999999999999 110.978 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.46 -39.02 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.789 -1.194 . . . . 1.21 110.594 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 61.5 mt -84.64 -8.95 58.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.339 -0.851 . . . . 1.3400000000000001 111.65 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.55 25.62 67.39 Favored Glycine 0 N--CA 1.479 1.557 0 C-N-CA 119.772 -1.204 . . . . 0.91000000000000003 113.237 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.74 142.04 58.57 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.727 -0.866 . . . . 1.51 109.33 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -67.94 147.74 52.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 2.8799999999999999 108.907 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 72.9 mt -107.03 138.13 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.219 -1.03 . . . . 1.6200000000000001 108.219 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 147' ' ' ILE . 18.2 mm -78.76 133.98 28.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.25 -0.906 . . . . 2.1099999999999999 108.862 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -94.51 94.74 8.39 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.657 -1.608 . . . . 1.6200000000000001 106.657 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 67.1 mt -73.53 -24.35 60.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.574 -0.704 . . . . 1.3999999999999999 110.865 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.9 m -81.48 7.17 12.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.406 -0.809 . . . . 2.0499999999999998 112.304 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.42 18.05 17.45 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.792 . . . . 1.3500000000000001 112.151 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.409 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 18.5 mt -74.73 140.23 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 1.4199999999999999 109.807 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -118.97 -12.34 9.56 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.946 0.879 . . . . 2.9900000000000002 112.427 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -112.7 147.74 36.18 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.728 -0.841 . . . . 1.54 108.728 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -78.27 124.13 27.73 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.188 -1.041 . . . . 1.3799999999999999 108.188 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.8 m -147.64 172.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.55 -0.719 . . . . 1.28 109.3 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.6 mt -90.74 146.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.535 -0.913 . . . . 1.1599999999999999 108.535 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.2 tp -95.9 123.79 39.64 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.093 0.949 . . . . 1.3100000000000001 108.788 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.5 t -124.64 129.96 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.892 -1.151 . . . . 1.25 107.892 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.99 152.87 19.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.006 -1.059 . . . . 1.26 108.835 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.92 -33.76 73.64 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.561 -1.337 . . . . 1.6000000000000001 109.476 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -171.8 144.74 1.83 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.301 -0.629 . . . . 2.4199999999999999 109.301 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 75.8 mt -118.39 135.94 54.04 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.057 -1.09 . . . . 1.3500000000000001 108.057 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.0 p -92.9 150.09 38.81 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.931 -1.105 . . . . 1.3200000000000001 108.529 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -39.18 -45.37 2.87 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 122.252 1.968 . . . . 0.69999999999999996 113.781 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 61.2 m -58.46 -47.56 83.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 1.1200000000000001 110.409 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.18 -38.4 90.9 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.076 -1.015 . . . . 1.21 110.515 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.66 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 39.3 p -69.3 -39.64 78.17 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.545 -0.722 . . . . 1.1899999999999999 110.5 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.83 -37.58 79.63 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.262 -0.575 . . . . 1.24 110.66 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -91.42 -0.16 57.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.05 -1.031 . . . . 1.6899999999999999 112.271 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.6 tp -63.88 150.33 45.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.751 -0.593 . . . . 1.3400000000000001 109.787 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -95.16 113.79 25.52 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.22 -1.4 . . . . 2.77 107.22 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 36.7 mt -71.79 -17.96 62.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.696 -0.627 . . . . 2.0899999999999999 111.778 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.91 -21.31 31.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 2.6699999999999999 112.381 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 152' ' ' ILE . 29.7 mmtp -101.32 -4.99 26.03 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.907 -1.12 . . . . 2.5800000000000001 113.436 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.7 t -114.2 128.91 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 107.533 -1.284 . . . . 1.1799999999999999 107.533 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.2 tp -93.69 -4.89 49.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.507 -0.745 . . . . 2.1800000000000002 112.609 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -175.49 170.04 42.95 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.021 -1.632 . . . . 0.48999999999999999 109.021 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -128.11 128.88 45.68 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.484 -1.302 . . . . 0.64000000000000001 107.484 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 79.3 mt -131.68 125.13 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 106.413 -1.699 . . . . 1.21 106.413 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 205' ' ' THR . 20.6 p -140.63 172.05 13.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.86 -1.15 . . . . 1.3799999999999999 110.213 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -98.1 39.33 1.24 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.378 0.608 . . . . 2.3700000000000001 111.497 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -95.59 141.49 29.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.192 -0.942 . . . . 1.52 109.676 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.79 2.33 25.16 Favored Glycine 0 N--CA 1.487 2.036 0 C-N-CA 120.052 -1.07 . . . . 1.8 113.473 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 88.97 -9.23 77.54 Favored Glycine 0 N--CA 1.491 2.341 0 O-C-N 121.148 -1.207 . . . . 2.04 114.036 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.444 ' O ' ' OG1' ' A' ' 187' ' ' THR . 46.2 ttp180 -77.25 116.71 18.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.902 -1.352 . . . . 5.0 107.841 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 16.6 p 48.66 40.29 15.39 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.97 -1.081 . . . . 3.02 111.601 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 83.6 p -85.21 115.05 22.77 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.739 -1.208 . . . . 2.1099999999999999 107.739 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.66 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 50.9 t60 -60.46 -31.43 70.44 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.07 -1.019 . . . . 1.24 110.608 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.3 p -57.21 -40.61 77.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 2.1499999999999999 110.391 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.6 t -60.18 -37.25 79.62 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.123 -0.986 . . . . 2.02 109.948 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.4 mt -59.51 -40.13 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.287 -0.965 . . . . 2.1200000000000001 110.497 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 38.5 mtp -64.56 -44.83 89.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.932 -1.105 . . . . 1.3600000000000001 109.244 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.17 -44.7 94.83 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.554 -0.748 . . . . 1.29 111.212 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -61.23 -45.07 96.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.778 -1.202 . . . . 3.5600000000000001 110.664 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.8 m -69.87 -38.98 76.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.036 -1.04 . . . . 1.1799999999999999 110.766 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -91.75 -8.15 47.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.554 -0.716 . . . . 1.3400000000000001 112.66 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.8 mt-10 54.14 9.31 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.937 1.088 . . . . 1.45 113.937 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.3 mt -70.08 150.19 96.18 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.621 -0.881 . . . . 1.25 108.621 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.8 144.06 94.27 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 121.146 1.231 . . . . 0.78000000000000003 109.491 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -158.79 159.78 35.53 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.175 -1.41 . . . . 1.2 110.214 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.5 mt -147.46 150.2 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.071 -1.085 . . . . 1.25 108.071 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.0 m -135.02 -25.72 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.932 -1.105 . . . . 1.3899999999999999 111.724 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.22 33.35 2.23 Favored Glycine 0 N--CA 1.488 2.151 0 O-C-N 121.022 -1.049 . . . . 0.96999999999999997 113.306 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 181' ' ' THR . 2.7 p -60.63 -28.31 68.46 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.95 -1.323 . . . . 1.3500000000000001 111.037 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.04 -90.67 1.3 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.96 -1.114 . . . . 1.0700000000000001 110.621 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 27.8 m -123.5 27.13 7.55 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.147 -1.208 . . . . 1.9199999999999999 112.984 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 68.2 t -57.41 -34.47 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.172 -1.58 . . . . 1.3300000000000001 110.144 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.2 p -57.61 -23.46 51.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 1.4199999999999999 111.964 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.2 p -92.88 2.77 56.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.968 -1.082 . . . . 2.1200000000000001 111.928 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -128.32 1.88 5.71 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.808 0.67 . . . . 2.6899999999999999 112.808 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.75 151.26 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 109.112 -0.699 . . . . 1.29 109.112 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -120.97 150.13 41.58 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.857 -0.794 . . . . 2.6899999999999999 108.857 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 42.1 p-10 -52.16 143.59 14.06 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.008 -1.077 . . . . 2.79 110.278 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.4 m-20 78.3 -1.17 2.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.525 1.305 . . . . 2.3500000000000001 114.525 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.53 144.03 52.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.861 -1.149 . . . . 1.97 108.307 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -89.31 112.96 24.16 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.331 -1.359 . . . . 2.9700000000000002 107.331 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 48.7 mt -124.22 143.44 50.52 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.322 0.582 . . . . 1.25 109.645 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.3 mt -109.81 126.76 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 106.58 -1.637 . . . . 1.22 106.58 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 52.3 tp -100.64 119.4 38.51 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.118 -1.808 . . . . 1.24 106.118 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 223' ' ' VAL . 36.9 p-10 -93.67 -20.93 19.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.081 -1.012 . . . . 2.0499999999999998 112.682 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 10' ' ' GLY . . . 39.73 13.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.477 0.547 . . . . 1.25 112.477 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.624 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.1 t -109.89 -58.75 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.273 -0.892 . . . . 1.4299999999999999 109.521 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -91.63 8.33 37.27 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.541 1.163 . . . . 3.0299999999999998 110.852 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.0 t30 60.87 49.31 6.09 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.108 -0.951 . . . . 2.25 111.786 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -148.45 154.58 40.06 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.226 1.012 . . . . 2.52 109.746 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.4 t -116.45 141.04 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.576 -0.738 . . . . 1.29 109.181 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -101.16 134.94 43.43 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.327 -0.99 . . . . 1.3400000000000001 108.327 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.28 130.77 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.614 -0.884 . . . . 1.3400000000000001 108.614 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 51.23 58.31 16.6 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.31 -0.869 . . . . 2.1800000000000002 112.867 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.93 150.19 60.65 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.387 2.058 . . . . 0.93999999999999995 110.626 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.7 p -76.23 158.59 31.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.105 -0.997 . . . . 2.3999999999999999 109.608 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -60.79 -39.35 88.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 3.3300000000000001 110.993 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.39 -41.47 80.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.067 -1.021 . . . . 3.1699999999999999 110.696 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.05 -39.31 77.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.806 -1.184 . . . . 1.6899999999999999 110.075 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 71.0 mt -60.03 -49.45 83.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.387 -0.821 . . . . 1.6000000000000001 110.883 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.92 -41.53 91.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.097 -1.002 . . . . 2.7000000000000002 110.543 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -64.41 -44.35 91.52 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.717 -0.793 . . . . 2.96 110.285 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 84.6 mtp -72.4 -37.05 68.78 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.301 -0.874 . . . . 1.6299999999999999 110.743 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.9 mmm-85 -57.57 -40.62 79.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.827 -1.17 . . . . 3.27 110.472 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.85 -56.11 5.36 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.267 -0.896 . . . . 2.23 110.634 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.27 -40.02 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.361 -0.837 . . . . 2.79 111.135 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.93 -50.17 74.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.67 -1.269 . . . . 4.2599999999999998 111.083 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -64.66 -33.43 75.92 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.696 -0.801 . . . . 1.8799999999999999 110.68 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -60.59 -31.24 70.4 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.348 -0.941 . . . . 3.3799999999999999 109.817 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.14 -41.85 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.854 0.835 . . . . 2.8799999999999999 109.835 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.37 89.73 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.679 0.752 . . . . 2.75 110.57 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.1 m -71.15 -34.32 70.87 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.628 -0.67 . . . . 3.4199999999999999 110.849 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -66.39 -46.26 77.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.875 -1.141 . . . . 3.5699999999999998 110.999 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -72.13 -28.92 63.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.005 -1.06 . . . . 4.6100000000000003 111.422 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.92 71.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.423 -0.798 . . . . 4.4500000000000002 111.236 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.58 -55.64 7.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.239 -0.913 . . . . 5.9699999999999998 110.62 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.89 -26.87 62.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 6.4500000000000002 111.793 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.71 -34.77 77.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.111 -0.993 . . . . 6.6600000000000001 111.359 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -84.77 -14.04 49.4 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.727 -1.233 . . . . 8.5399999999999991 113.003 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.2 0.27 56.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.85 -1.156 . . . . 8.0700000000000003 112.194 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -84.18 -4.49 58.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.065 -1.022 . . . . 9.7200000000000006 112.4 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -91.26 4.37 52.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.441 -0.787 . . . . 10.119999999999999 112.621 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 . . . . . 0 N--CA 1.496 1.825 0 N-CA-C 108.43 -0.952 . . . . 11.9 108.43 -179.184 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' H1 ' ' H ' ' A' ' 2' ' ' ILE . 50.2 mtt . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 108.949 -0.76 . . . . 3.5299999999999998 108.949 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.43 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 79.2 mt -99.11 111.21 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.219 -1.4 . . . . 1.5700000000000001 107.219 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 m -106.01 119.91 40.41 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.202 -1.407 . . . . 1.4399999999999999 107.202 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.97 -153.85 24.45 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.414 -1.874 . . . . 1.01 108.414 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 96.9 mt -97.64 0.98 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -1.168 . . . . 1.6299999999999999 112.38 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 49.89 93.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.985 -1.072 . . . . 1.5800000000000001 111.985 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.38 -30.93 18.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 1.3400000000000001 111.663 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -150.8 138.25 12.0 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.216 -0.927 . . . . 1.8600000000000001 108.54 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.18 145.0 21.38 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.341 2.027 . . . . 1.01 112.533 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 151.42 177.92 25.69 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 109.084 -1.606 . . . . 0.81000000000000005 109.084 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.5 mt -132.0 138.66 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.058 -1.26 . . . . 1.3700000000000001 108.238 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.37 155.5 46.74 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.233 -0.917 . . . . 1.1399999999999999 109.09 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.537 ' CD2' ' NH1' ' A' ' 240' ' ' ARG . 25.4 m-85 -129.08 141.26 51.26 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.521 -0.918 . . . . 0.87 108.521 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.81 168.42 34.78 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 118.27 -1.919 . . . . 0.56999999999999995 110.198 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -77.01 160.3 29.23 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.901 . . . . 2.3500000000000001 109.846 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -81.84 121.49 26.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.691 -1.225 . . . . 1.21 107.691 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.401 HD13 HD22 ' A' ' 214' ' ' ASN . 31.4 tp -100.14 98.51 9.21 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.069 -1.826 . . . . 1.3999999999999999 106.069 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 tp -90.74 134.71 34.22 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.662 -1.236 . . . . 1.4399999999999999 107.662 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.0 mt -99.77 111.1 23.45 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.752 -1.573 . . . . 1.45 106.752 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -104.31 127.54 51.97 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.989 -1.486 . . . . 2.5 106.989 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.474 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 81.6 tt0 -129.41 144.21 51.15 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.941 -0.762 . . . . 2.6600000000000001 108.941 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -80.89 136.01 36.0 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.823 -1.177 . . . . 2.3199999999999998 107.823 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -65.81 149.83 49.54 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.516 -0.74 . . . . 2.1099999999999999 109.264 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -92.21 130.87 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.843 -1.169 . . . . 1.29 107.843 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.65 129.81 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.153 -1.055 . . . . 1.4099999999999999 108.153 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.2 mt -95.53 139.74 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.424 -0.798 . . . . 1.3100000000000001 108.927 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -87.58 123.62 32.65 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.125 -1.065 . . . . 1.3400000000000001 108.125 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -94.74 14.67 20.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.656 -0.652 . . . . 3.48 112.38 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -77.55 140.58 39.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.281 -0.887 . . . . 2.52 109.275 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -84.69 140.27 31.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.103 -0.998 . . . . 2.6299999999999999 109.744 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -95.75 175.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 1.3100000000000001 109.776 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -98.09 164.33 12.38 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.887 -0.597 . . . . 1.24 109.544 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.14 -23.41 21.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.268 -0.895 . . . . 1.49 112.029 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -68.88 -40.05 79.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.812 -1.18 . . . . 2.2799999999999998 110.946 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -86.39 -6.2 58.99 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.289 -1.507 . . . . 2.0499999999999998 112.189 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.19 -41.81 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.968 -1.083 . . . . 1.3400000000000001 110.456 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -58.24 -39.42 79.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.003 -1.061 . . . . 1.54 110.936 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.2 -39.87 95.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.02 . . . . 2.8500000000000001 110.967 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -58.96 -40.33 84.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.875 . . . . 1.3100000000000001 110.724 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.25 -41.71 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 1.3799999999999999 110.127 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.57 -44.58 93.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 1.5 109.58 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -62.43 -40.45 96.61 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.401 -0.92 . . . . 2.7799999999999998 109.925 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.39 -52.84 12.37 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.801 0.81 . . . . 1.0600000000000001 109.871 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.07 -48.84 80.06 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.255 -0.903 . . . . 1.3999999999999999 109.96 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.2 t -68.21 -41.05 81.88 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.659 0.743 . . . . 1.3200000000000001 109.831 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.95 -42.08 85.82 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.34 -1.504 . . . . 0.69999999999999996 109.34 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.404 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 51.7 ttt180 -58.38 -32.77 68.91 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.689 0.756 . . . . 3.4399999999999999 109.772 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.61 -50.21 72.66 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.375 0.607 . . . . 1.3600000000000001 110.819 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -78.05 -38.64 43.99 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.306 -0.872 . . . . 2.8300000000000001 110.44 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.16 87.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.395 -0.816 . . . . 1.23 110.209 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.5 m -60.45 -40.14 90.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.869 0.843 . . . . 1.9199999999999999 109.497 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.41 78.1 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.15 -0.62 . . . . 1.25 110.072 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.16 -50.58 72.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 1.97 110.577 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.83 -39.17 93.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.019 . . . . 2.1800000000000002 110.105 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -59.86 -40.93 90.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.807 -0.558 . . . . 1.1899999999999999 110.958 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.8 m -64.27 -45.31 88.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.822 -1.174 . . . . 1.3400000000000001 110.356 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 57' ' ' ILE . 96.4 mt -60.12 -34.64 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 1.23 110.984 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -52.97 -45.76 67.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.26 -0.9 . . . . 1.5600000000000001 111.084 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.14 -37.71 81.36 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.148 -0.97 . . . . 1.3 110.182 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -61.35 -39.81 91.95 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.577 -1.249 . . . . 2.3199999999999998 109.617 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.98 -32.3 73.45 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.625 -0.672 . . . . 1.1399999999999999 110.558 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.04 -34.58 14.43 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.832 -1.175 . . . . 0.68999999999999995 111.405 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -81.85 -25.75 34.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.567 -1.549 . . . . 1.48 111.373 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.4 m -86.69 -49.99 7.1 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.408 -0.807 . . . . 1.52 111.125 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.9 -5.25 19.83 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 113.909 1.078 . . . . 1.3100000000000001 113.909 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.83 161.47 27.75 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.401 -0.904 . . . . 0.84999999999999998 112.733 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -55.79 -18.88 9.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -1.065 . . . . 3.8599999999999999 112.82 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -59.07 -40.66 85.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -0.973 . . . . 2.3500000000000001 110.518 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -85.9 -23.9 26.83 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.213 -0.929 . . . . 2.2599999999999998 111.465 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.65 -35.44 76.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.638 -0.664 . . . . 1.45 111.356 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.02 83.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.388 -0.82 . . . . 1.25 111.334 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.5 mt -62.02 -40.91 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 1.26 110.324 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -71.04 -30.29 66.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.302 -0.874 . . . . 0.82999999999999996 110.546 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -60.91 -39.07 87.96 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.187 -0.945 . . . . 1.1899999999999999 109.732 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.98 -39.58 93.25 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 110.098 -1.201 . . . . 0.57999999999999996 110.098 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -59.82 -45.0 93.74 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.433 -1.04 . . . . 2.0499999999999998 110.355 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.61 -40.91 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 1.21 110.401 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 26.3 ttt -60.14 -39.4 86.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.325 -0.859 . . . . 2.29 110.384 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.5 tp -57.84 -48.25 80.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.151 -0.968 . . . . 1.21 110.221 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.98 -41.76 92.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.239 -0.913 . . . . 1.1399999999999999 110.413 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -88.13 10.4 19.44 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 112.899 0.703 . . . . 1.4199999999999999 112.899 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.63 126.32 27.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.891 -1.131 . . . . 1.27 108.818 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.22 -18.72 65.35 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.871 0.843 . . . . 1.3500000000000001 110.639 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -74.45 -54.99 6.48 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.491 0.662 . . . . 2.2200000000000002 110.178 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.9 mt -61.1 -37.49 82.95 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.663 -0.648 . . . . 1.22 111.058 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.404 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 30.5 tt0 -60.05 -45.18 93.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 1.29 110.559 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.97 -38.46 91.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 2.1699999999999999 110.685 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -68.26 -47.87 66.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.035 -1.041 . . . . 1.3 110.922 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.11 -42.48 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.093 -1.004 . . . . 1.1699999999999999 110.04 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.4 mt -63.51 -43.0 98.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.485 -0.76 . . . . 1.3999999999999999 110.505 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.29 -42.83 99.69 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.3 -0.875 . . . . 1.3300000000000001 110.928 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.62 -45.63 93.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.974 -1.079 . . . . 1.48 110.544 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 93' ' ' ILE . 94.8 mt -61.88 -43.65 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.041 -1.037 . . . . 1.28 110.339 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -84.75 -31.26 24.09 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.277 -0.89 . . . . 2.6000000000000001 111.724 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 91' ' ' ALA . 60.6 t0 -82.47 -45.57 14.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.64 -1.287 . . . . 1.51 111.527 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -100.76 4.82 43.33 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.227 -0.92 . . . . 2.48 112.617 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 53.2 50.64 17.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 1.6100000000000001 111.466 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.33 159.02 15.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.385 -0.822 . . . . 1.8999999999999999 109.207 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.668 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 30.2 p -71.5 161.02 31.69 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.772 -0.58 . . . . 1.3200000000000001 109.832 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.28 -45.04 92.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.033 -1.042 . . . . 1.1499999999999999 110.56 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -68.12 -37.04 80.67 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.226 -0.922 . . . . 2.25 110.121 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.668 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -68.54 -51.71 40.0 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.757 -0.777 . . . . 1.22 111.429 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.63 94.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.117 -0.989 . . . . 1.1899999999999999 110.408 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.31 95.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.653 -0.654 . . . . 1.2 110.793 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -61.69 -37.87 85.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.124 -0.985 . . . . 2.1000000000000001 111.496 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -59.23 -49.59 77.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.883 -1.136 . . . . 1.3 111.077 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.68 -45.72 97.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.437 -1.414 . . . . 1.27 110.214 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.1 mm -61.12 -34.76 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.638 -0.664 . . . . 1.1899999999999999 110.403 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -58.44 -39.16 79.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.095 -1.003 . . . . 2.1099999999999999 111.226 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.69 -41.3 7.8 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.947 -1.597 . . . . 0.88 112.853 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -60.57 -41.07 93.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.599 -1.53 . . . . 1.99 109.891 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.43 -52.65 20.75 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.399 0.619 . . . . 1.28 110.559 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.0 p -62.53 -36.44 82.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.462 -0.774 . . . . 2.2200000000000002 110.453 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.3 97.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 1.45 110.722 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.19 -30.11 70.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.938 . . . . 1.47 110.855 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.58 -21.75 65.41 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.011 -1.056 . . . . 2.04 110.989 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -71.37 -14.3 62.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 1.73 111.462 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.2 mt -86.85 146.4 26.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.434 -0.791 . . . . 1.79 109.574 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -99.2 36.08 1.79 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.233 -0.917 . . . . 2.8799999999999999 112.285 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -113.09 139.6 48.57 Favored 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 108.437 -0.949 . . . . 1.5800000000000001 108.437 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -60.23 -38.46 83.47 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.329 -0.857 . . . . 3.04 110.89 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -70.23 -53.33 17.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.684 -1.26 . . . . 1.29 109.909 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.1 mt -62.79 -40.31 96.94 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.228 -0.92 . . . . 1.6000000000000001 109.627 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.64 -50.49 66.88 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.828 0.823 . . . . 2.7599999999999998 109.918 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.78 -29.11 70.46 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.753 -1.217 . . . . 2.1499999999999999 109.921 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -61.66 -31.4 71.51 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.368 -0.933 . . . . 2.8100000000000001 109.111 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.15 78.86 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.643 0.735 . . . . 1.3899999999999999 109.815 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.61 -43.65 79.94 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.416 -0.914 . . . . 1.4099999999999999 109.958 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -60.97 -38.6 86.52 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.485 0.659 . . . . 1.3899999999999999 110.829 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.5 -39.07 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.574 -0.704 . . . . 1.1899999999999999 110.262 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.414 ' NH1' ' HG3' ' A' ' 131' ' ' ARG . 40.4 ttm-85 -59.04 -40.07 83.91 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.143 -0.973 . . . . 3.6299999999999999 109.856 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -60.21 -38.75 84.29 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.356 0.598 . . . . 1.28 110.405 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.67 -39.76 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.254 -0.904 . . . . 1.1799999999999999 110.444 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.86 -47.36 67.04 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.424 -1.07 . . . . 0.51000000000000001 110.424 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -58.24 -42.1 85.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.21 -1.171 . . . . 3.1699999999999999 110.078 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 60.1 mtt-85 -61.67 -43.23 99.26 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.14 -1.024 . . . . 2.8500000000000001 110.372 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.31 -43.02 96.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.371 -0.831 . . . . 1.6499999999999999 109.843 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -41.53 91.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.78 -0.575 . . . . 1.2 110.833 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.474 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 99.5 mtt180 -60.08 -35.58 75.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 2.7999999999999998 111.329 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -73.56 -41.32 63.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.025 -1.047 . . . . 2.1499999999999999 110.645 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.3 mt -60.4 -39.26 80.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.092 -1.005 . . . . 1.21 110.228 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.6 -8.54 54.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.474 -0.766 . . . . 1.3400000000000001 112.039 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.34 25.32 70.93 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 120.363 -0.923 . . . . 0.91000000000000003 113.59 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.5 tp -70.13 148.62 48.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.634 -0.921 . . . . 1.51 109.956 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -65.46 151.72 45.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.483 -0.761 . . . . 2.8799999999999999 110.803 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.8 mt -103.32 140.6 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.125 -1.065 . . . . 1.6200000000000001 108.125 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.6 mm -82.37 120.36 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.817 -1.177 . . . . 2.1099999999999999 108.138 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -99.36 95.89 7.35 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.165 -1.791 . . . . 1.6200000000000001 106.165 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.82 -18.38 61.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.504 -0.748 . . . . 1.3999999999999999 112.053 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.0 m -81.72 8.74 9.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 2.0499999999999998 112.208 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.04 24.63 9.09 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.239 -0.913 . . . . 1.3500000000000001 111.655 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.1 mt -74.35 147.24 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.371 -0.83 . . . . 1.4199999999999999 110.146 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -115.26 -20.12 10.49 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.58 -0.7 . . . . 2.9900000000000002 112.596 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -119.55 139.92 51.36 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.812 -1.181 . . . . 1.54 107.812 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.71 128.57 36.52 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.602 -0.888 . . . . 1.3799999999999999 108.602 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -146.28 178.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.477 -0.764 . . . . 1.28 109.426 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 81.3 mt -91.42 144.75 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.504 -0.925 . . . . 1.1599999999999999 108.504 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.71 123.65 39.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.889 -1.132 . . . . 1.3100000000000001 108.366 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.74 130.09 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.156 -1.053 . . . . 1.25 108.156 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.34 154.77 21.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.099 -1.001 . . . . 1.26 108.93 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.7 -31.2 70.48 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.653 -1.28 . . . . 1.6000000000000001 109.626 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 29.0 p-10 -173.35 150.8 1.91 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.708 -0.849 . . . . 2.4199999999999999 108.708 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.3 mt -119.39 138.78 52.86 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.332 -0.988 . . . . 1.3500000000000001 108.332 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.0 p -95.61 152.61 39.29 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 108.507 -0.923 . . . . 1.3200000000000001 108.507 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -43.68 -39.57 10.23 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.367 1.378 . . . . 0.69999999999999996 113.367 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.0 m -59.85 -48.88 79.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.923 -1.111 . . . . 1.1200000000000001 110.042 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.99 -40.33 97.43 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.338 -0.851 . . . . 1.21 109.961 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.648 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 31.5 p -68.17 -40.0 82.41 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.857 -0.737 . . . . 1.1899999999999999 110.055 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.36 78.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.581 -0.7 . . . . 1.24 110.779 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -97.03 -1.43 45.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.207 -0.933 . . . . 1.6899999999999999 112.881 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.82 150.39 41.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.476 -0.765 . . . . 1.3400000000000001 109.571 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -96.03 111.04 23.17 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.773 -1.566 . . . . 2.77 106.773 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 31.9 mt -74.57 -15.19 60.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.636 -0.665 . . . . 2.0899999999999999 111.486 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -81.32 -25.58 36.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 2.6699999999999999 111.832 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -102.72 -1.96 29.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.27 -0.894 . . . . 2.5800000000000001 113.325 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.05 127.26 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 107.394 -1.335 . . . . 1.1799999999999999 107.394 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 45.1 tp -88.58 -10.84 47.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.104 -0.998 . . . . 2.1800000000000002 112.244 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.96 174.32 46.72 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.049 -1.621 . . . . 0.48999999999999999 109.049 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -130.02 131.19 45.76 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.506 -1.294 . . . . 0.64000000000000001 107.506 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 84.6 mt -131.32 129.79 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.156 -1.424 . . . . 1.21 107.156 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 203' ' ' VAL . 82.7 p -140.57 170.55 15.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.886 -1.133 . . . . 1.3799999999999999 109.702 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.447 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 1.4 m-20 -105.04 44.72 1.01 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.817 -0.552 . . . . 2.3700000000000001 110.777 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -104.39 155.0 19.15 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.086 -1.009 . . . . 1.52 109.637 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.22 -8.39 74.55 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.924 -1.131 . . . . 1.8 112.311 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.76 -18.43 56.9 Favored Glycine 0 N--CA 1.497 2.707 0 O-C-N 121.4 -1.059 . . . . 2.04 113.385 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -59.78 -39.86 86.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.059 -1.259 . . . . 5.0 110.526 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.0 p -129.59 31.19 4.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.805 -0.559 . . . . 3.02 111.023 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 90.7 p -83.16 98.64 9.46 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.296 -1.372 . . . . 2.1099999999999999 107.296 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.648 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 44.1 t60 -59.55 -34.39 72.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.475 -0.765 . . . . 1.24 110.107 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 15.2 t -59.67 -39.44 84.48 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.537 -0.727 . . . . 2.1499999999999999 110.603 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.8 t -57.24 -39.99 76.67 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.16 -0.962 . . . . 2.02 110.072 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.3 -39.62 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.44 -0.787 . . . . 2.1200000000000001 109.937 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 45.5 mtp -66.27 -40.93 90.44 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.395 1.093 . . . . 1.3600000000000001 109.414 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.73 -42.22 88.26 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.464 -0.789 . . . . 1.29 110.709 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -60.84 -44.95 96.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.912 -1.118 . . . . 3.5600000000000001 110.317 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.8 m -70.21 -40.1 74.77 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.199 -0.938 . . . . 1.1799999999999999 110.225 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.4 mt -91.7 -6.92 51.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.529 -0.732 . . . . 1.3400000000000001 112.64 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.0 mt-10 52.54 13.45 0.32 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.749 1.018 . . . . 1.45 113.749 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.71 148.11 89.7 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.942 -1.132 . . . . 1.25 107.942 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -54.35 140.5 73.18 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.905 1.737 . . . . 0.78000000000000003 109.985 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -158.84 160.5 36.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.249 -1.532 . . . . 1.2 109.86 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 29.6 mt -148.65 151.49 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.676 -1.231 . . . . 1.25 107.676 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.7 m -135.5 -27.58 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 120.956 -1.09 . . . . 1.3899999999999999 112.014 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.92 42.06 2.8 Favored Glycine 0 N--CA 1.492 2.41 0 O-C-N 121.081 -1.012 . . . . 0.96999999999999997 112.02 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 74.7 p -65.4 -13.11 57.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.899 -1.353 . . . . 1.3500000000000001 111.151 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.65 -95.88 1.38 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 110.565 -1.014 . . . . 1.0700000000000001 110.565 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -129.08 30.96 4.96 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.659 -0.907 . . . . 1.9199999999999999 112.322 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.2 -36.33 45.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.571 -1.331 . . . . 1.3300000000000001 110.819 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.1 p -57.77 -24.58 57.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.792 -1.193 . . . . 1.4199999999999999 111.544 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 18.2 t -92.15 -2.05 56.8 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.797 0.808 . . . . 2.1200000000000001 111.483 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -122.46 -5.29 8.77 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.561 0.949 . . . . 2.6899999999999999 113.561 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 34.8 t -120.05 149.07 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.357 -0.839 . . . . 1.29 109.594 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.0 156.9 27.75 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.973 -1.121 . . . . 2.6899999999999999 107.973 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.506 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 22.2 t-20 -51.47 142.84 13.01 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.075 -1.016 . . . . 2.79 110.216 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 83.35 -7.62 1.14 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.109 1.151 . . . . 2.3500000000000001 114.109 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.4 t0 -58.57 142.15 50.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.507 -1.37 . . . . 1.97 108.91 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -88.74 119.82 29.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.671 -1.268 . . . . 2.9700000000000002 108.072 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.69 148.85 47.76 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.465 0.65 . . . . 1.25 109.653 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.79 124.89 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.226 -1.768 . . . . 1.22 106.226 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 53.6 tp -102.24 116.78 33.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.215 -1.772 . . . . 1.24 106.215 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.3 p-10 -93.15 -22.12 19.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.934 -1.104 . . . . 2.0499999999999998 112.709 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.519 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.17 15.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 112.663 0.616 . . . . 1.25 112.663 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.633 ' N ' ' O ' ' A' ' 221' ' ' ASP . 20.6 t -109.73 -59.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.112 -0.993 . . . . 1.4299999999999999 109.86 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -93.79 9.91 35.22 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.27 1.033 . . . . 3.0299999999999998 110.891 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.33 53.1 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.983 -1.008 . . . . 2.25 112.304 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -148.84 148.54 30.02 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.811 -1.181 . . . . 2.52 110.084 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.97 139.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 108.136 -1.061 . . . . 1.29 108.136 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -102.74 133.88 47.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.181 -0.95 . . . . 1.3400000000000001 108.669 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 53.4 t -110.86 130.8 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.214 -1.032 . . . . 1.3400000000000001 108.214 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.488 ' C ' HD21 ' A' ' 230' ' ' ASN . 0.6 OUTLIER 55.63 47.9 3.53 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 113.384 0.883 . . . . 2.1800000000000002 113.384 178.489 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 62.3 Cg_endo -69.82 153.12 69.04 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.559 2.172 . . . . 0.93999999999999995 110.901 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.6 m -74.19 159.38 32.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 2.3999999999999999 108.866 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -59.47 -34.01 72.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.114 -0.991 . . . . 3.3300000000000001 110.691 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -59.96 -41.05 91.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.407 -0.808 . . . . 3.1699999999999999 110.56 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.96 -39.97 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.288 -0.883 . . . . 1.6899999999999999 110.192 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 236' ' ' ILE . 92.4 mt -60.0 -49.97 81.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.168 -0.957 . . . . 1.6000000000000001 111.043 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -59.52 -40.66 87.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.98 . . . . 2.7000000000000002 110.644 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.71 -47.91 84.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.853 . . . . 2.96 110.195 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 66.1 mtp -70.63 -38.39 73.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 1.6299999999999999 110.871 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.537 ' NH1' ' CD2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -56.2 -41.36 75.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.147 -0.97 . . . . 3.27 110.245 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.81 -42.99 69.53 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.288 -0.882 . . . . 2.23 111.194 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 95.3 t -59.54 -48.82 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.964 -1.085 . . . . 2.79 110.764 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -63.52 -49.91 71.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.424 -1.422 . . . . 4.2599999999999998 110.097 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.13 -37.84 86.7 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.756 -0.59 . . . . 1.8799999999999999 111.083 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -61.46 -30.07 70.36 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.839 -1.144 . . . . 3.3799999999999999 110.178 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.87 -47.3 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.196 -1.002 . . . . 2.8799999999999999 109.953 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.57 89.06 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.236 -0.986 . . . . 2.75 110.247 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.4 t -71.55 -44.46 64.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 3.4199999999999999 111.454 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.64 -36.18 82.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.313 -0.867 . . . . 3.5699999999999998 110.589 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -63.78 -36.78 85.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.519 -0.738 . . . . 4.6100000000000003 110.726 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.02 -49.37 58.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 4.4500000000000002 110.749 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -70.78 -33.03 70.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.541 -0.724 . . . . 5.9699999999999998 111.205 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 46.5 tp -67.89 -28.75 67.78 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.98 -1.075 . . . . 6.4500000000000002 111.675 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -72.84 -5.38 37.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.89 -1.132 . . . . 6.6600000000000001 112.944 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -85.53 34.82 0.59 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.965 -1.085 . . . . 8.5399999999999991 112.689 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 14.6 mt -80.16 -1.78 41.81 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.809 -1.182 . . . . 8.0700000000000003 112.233 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -87.27 0.75 54.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.202 -0.936 . . . . 9.7200000000000006 112.648 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.69 -3.87 58.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.931 . . . . 10.119999999999999 112.792 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 117.982 -1.008 . . . . 11.9 109.86 -178.012 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.337 0.589 . . . . 3.5299999999999998 110.098 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.3 mt -98.13 110.48 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.386 -1.709 . . . . 1.5700000000000001 106.386 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m -105.88 125.23 50.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.048 -1.093 . . . . 1.4399999999999999 108.048 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.46 -154.96 17.46 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.333 -1.907 . . . . 1.01 108.333 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.472 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 80.3 mt -95.78 1.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.309 -1.113 . . . . 1.6299999999999999 112.185 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 5' ' ' ILE . 3.8 tp 50.82 101.16 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.085 -1.01 . . . . 1.5800000000000001 112.357 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.38 -47.44 10.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.118 -0.989 . . . . 1.3400000000000001 111.11 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m -144.58 146.95 34.26 Favored Pre-proline 0 N--CA 1.501 2.093 0 N-CA-C 107.855 -1.165 . . . . 1.8600000000000001 107.855 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.49 147.71 32.52 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.575 2.183 . . . . 1.01 112.088 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 155.08 163.34 11.97 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.343 -1.503 . . . . 0.81000000000000005 109.343 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.3 mt -125.37 130.53 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.159 -1.2 . . . . 1.3700000000000001 108.095 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.11 148.92 43.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.242 -0.911 . . . . 1.1399999999999999 109.016 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 5.8 m-85 -117.49 140.17 49.96 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 108.827 -0.805 . . . . 0.87 108.827 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.77 167.27 35.64 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 118.004 -2.046 . . . . 0.56999999999999995 110.39 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -77.48 160.36 28.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.827 -0.808 . . . . 2.3500000000000001 109.669 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.46 126.46 34.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.835 -1.166 . . . . 1.21 108.152 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.9 tp -104.6 98.93 8.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.081 -1.822 . . . . 1.3999999999999999 106.081 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.0 tp -90.55 130.83 36.55 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.753 -1.203 . . . . 1.4399999999999999 107.753 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.5 mt -101.77 117.06 34.09 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.861 -1.533 . . . . 1.45 106.861 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -109.5 136.04 49.54 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.993 -1.484 . . . . 2.5 106.993 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -119.69 149.18 42.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.083 -1.011 . . . . 2.6600000000000001 109.452 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -82.67 134.62 35.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.858 -1.164 . . . . 2.3199999999999998 107.858 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.19 148.35 50.24 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.671 -0.863 . . . . 2.1099999999999999 108.671 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.87 130.3 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.282 -1.007 . . . . 1.29 108.282 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -105.35 131.11 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.033 -1.099 . . . . 1.4099999999999999 108.033 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 77.1 mt -97.86 135.55 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.526 -0.916 . . . . 1.3100000000000001 108.526 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -91.12 123.02 34.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.858 -1.164 . . . . 1.3400000000000001 107.858 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -95.06 13.04 26.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.223 -0.923 . . . . 3.48 112.135 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -67.25 149.66 50.11 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.282 -0.886 . . . . 2.52 109.244 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -86.43 140.0 30.39 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.179 -1.045 . . . . 2.6299999999999999 108.179 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -93.31 171.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.079 -1.013 . . . . 1.3100000000000001 109.418 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.6 p -108.53 158.62 17.39 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.935 -0.765 . . . . 1.24 108.935 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.82 -26.23 1.56 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.108 -0.995 . . . . 1.49 112.672 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -69.84 -39.87 76.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.161 -0.962 . . . . 2.2799999999999998 110.167 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -86.47 -11.3 52.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.426 -0.796 . . . . 2.0499999999999998 111.813 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.15 -47.19 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.438 -0.789 . . . . 1.3400000000000001 110.472 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.12 -40.08 84.3 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.098 -1.001 . . . . 1.54 110.687 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.46 -44.77 95.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.42 -0.8 . . . . 2.8500000000000001 110.999 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.05 -39.74 87.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.919 -1.113 . . . . 1.3100000000000001 111.02 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.04 -41.77 87.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.92 -1.112 . . . . 1.3799999999999999 110.656 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -61.93 -45.89 91.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.008 -1.057 . . . . 1.5 110.279 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -62.48 -39.67 94.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.308 -0.87 . . . . 2.7799999999999998 110.165 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -76.22 -54.42 6.83 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.562 -0.711 . . . . 1.0600000000000001 110.315 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -58.32 -47.78 82.64 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.382 -0.927 . . . . 1.3999999999999999 109.772 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -68.39 -36.74 79.59 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.738 -0.785 . . . . 1.3200000000000001 109.891 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.68 -44.09 94.17 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.218 -1.468 . . . . 0.69999999999999996 109.57 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.425 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.4 ttt-85 -60.32 -29.48 68.89 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.194 -1.18 . . . . 3.4399999999999999 110.328 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.31 -50.24 73.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 1.3600000000000001 110.929 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -81.44 -36.07 29.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.909 -1.12 . . . . 2.8300000000000001 110.341 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.49 89.7 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.268 -0.895 . . . . 1.23 109.683 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 87.4 p -60.77 -39.28 88.24 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.219 1.009 . . . . 1.9199999999999999 109.055 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -45.3 75.64 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.711 -0.677 . . . . 1.25 110.595 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.29 -48.6 72.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.672 -1.268 . . . . 1.97 110.658 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.05 -35.95 81.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.994 -1.066 . . . . 2.1800000000000002 109.888 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -60.06 -40.24 88.81 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.574 -0.704 . . . . 1.1899999999999999 110.256 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -62.11 -43.45 98.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.139 -0.976 . . . . 1.3400000000000001 110.457 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.1 mt -59.94 -35.21 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.438 -0.789 . . . . 1.23 110.726 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -52.64 -41.63 63.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.15 -0.969 . . . . 1.5600000000000001 110.878 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.76 -36.92 76.19 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.996 -1.065 . . . . 1.3 110.318 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -61.58 -36.81 81.72 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.926 -1.109 . . . . 2.3199999999999998 109.552 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.12 79.01 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.618 -0.677 . . . . 1.1399999999999999 110.43 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.24 -36.21 13.22 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.637 -1.268 . . . . 0.68999999999999995 111.502 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.54 -22.66 43.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.668 -1.489 . . . . 1.48 110.736 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.2 m -90.42 -49.93 6.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.253 -0.904 . . . . 1.52 111.52 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.27 -7.17 16.83 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 113.918 1.081 . . . . 1.3100000000000001 113.918 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.08 163.46 24.79 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.719 -0.753 . . . . 0.84999999999999998 112.349 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -54.17 -23.89 16.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.565 -0.962 . . . . 3.8599999999999999 112.779 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.3 -40.08 70.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.823 -1.173 . . . . 2.3500000000000001 110.993 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -86.02 -22.99 26.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.674 -1.266 . . . . 2.2599999999999998 111.488 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -60.56 -40.3 91.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 1.45 111.031 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.25 86.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.486 -0.759 . . . . 1.25 111.443 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -65.82 -44.0 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.754 -1.216 . . . . 1.26 110.921 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -69.95 -32.91 71.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.686 -1.259 . . . . 0.82999999999999996 110.22 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.2 -38.85 88.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -0.881 . . . . 1.1899999999999999 110.23 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.13 96.96 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.591 -0.814 . . . . 0.57999999999999996 111.097 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -58.11 -40.92 82.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.669 -1.489 . . . . 2.0499999999999998 110.777 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.93 -40.05 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.118 -0.989 . . . . 1.21 110.987 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.8 ttm -58.76 -40.28 83.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.983 -1.073 . . . . 2.29 110.377 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 tp -59.85 -48.6 81.05 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.185 -0.947 . . . . 1.21 110.023 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.97 -39.8 86.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.207 -0.933 . . . . 1.1399999999999999 110.284 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -84.3 6.78 21.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.216 0.821 . . . . 1.4199999999999999 113.216 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -66.41 125.33 25.31 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.664 -1.273 . . . . 1.27 108.26 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.97 -16.54 64.1 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.263 -0.898 . . . . 1.3500000000000001 111.121 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -75.03 -50.29 16.98 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.674 -0.81 . . . . 2.2200000000000002 110.34 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.8 -36.76 84.21 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.739 -0.784 . . . . 1.22 110.392 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -59.93 -48.8 80.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.367 -0.833 . . . . 1.29 110.705 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -61.85 -38.42 88.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 2.1699999999999999 110.546 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.23 -47.38 79.88 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.025 -1.047 . . . . 1.3 110.499 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.61 -45.03 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.34 -0.85 . . . . 1.1699999999999999 110.198 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.34 -40.12 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.683 0.754 . . . . 1.3999999999999999 110.465 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.43 98.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.152 -0.968 . . . . 1.3300000000000001 110.965 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.18 -39.16 85.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.015 -1.053 . . . . 1.48 110.612 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.26 -51.52 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 1.28 110.757 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -75.87 -35.31 59.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.756 . . . . 2.6000000000000001 111.446 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.43 -46.24 14.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 1.51 111.948 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -100.13 7.84 44.31 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.342 -0.849 . . . . 2.48 112.861 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.9 m80 49.9 48.61 21.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.74 -1.225 . . . . 1.6100000000000001 111.427 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.9 mtt -109.97 152.02 26.39 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.778 0.799 . . . . 1.8999999999999999 109.552 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.9 p -70.1 160.27 32.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.515 -0.741 . . . . 1.3200000000000001 110.018 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.18 92.98 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.46 -0.775 . . . . 1.1499999999999999 110.419 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -65.86 -43.45 88.38 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.962 -1.086 . . . . 2.25 109.361 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.18 -49.31 51.64 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.921 -0.711 . . . . 1.22 110.862 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.71 -44.47 93.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 1.1899999999999999 110.637 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.22 -41.07 87.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 1.2 110.483 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.3 -38.28 90.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 2.1000000000000001 111.48 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.62 -49.76 76.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.387 -1.446 . . . . 1.3 111.29 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.68 -46.81 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.918 -1.114 . . . . 1.27 110.112 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.8 mm -62.0 -29.43 46.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.921 0.867 . . . . 1.1899999999999999 110.681 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.51 -40.33 82.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.551 -0.718 . . . . 2.1099999999999999 110.996 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.55 -32.04 17.07 Favored Glycine 0 N--CA 1.501 3.004 0 C-N-CA 119.384 -1.389 . . . . 0.88 112.535 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -63.03 -37.54 87.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.363 -1.669 . . . . 1.99 110.169 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.63 -51.21 15.08 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.533 -0.73 . . . . 1.28 111.201 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.9 m -58.32 -38.73 77.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.388 -0.82 . . . . 2.2200000000000002 111.142 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.09 99.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.303 -0.873 . . . . 1.45 111.025 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.75 -28.81 69.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.967 . . . . 1.47 111.269 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -68.11 -22.27 64.9 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.209 -0.932 . . . . 2.04 111.055 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -73.08 -13.64 61.24 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.963 0.887 . . . . 1.73 111.029 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.4 mt -91.18 140.53 29.72 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.503 -0.925 . . . . 1.79 108.503 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -99.71 43.55 1.05 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.028 -1.045 . . . . 2.8799999999999999 112.082 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -112.87 140.51 47.6 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.134 -0.979 . . . . 1.5800000000000001 108.808 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.24 -40.47 77.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 3.04 111.008 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -73.22 -54.04 9.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.864 -1.148 . . . . 1.29 110.95 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.7 mt -59.81 -41.3 90.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.897 -1.127 . . . . 1.6000000000000001 110.475 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -63.65 -50.09 70.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.116 -0.99 . . . . 2.7599999999999998 109.951 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.44 -31.83 70.8 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.978 -1.076 . . . . 2.1499999999999999 109.292 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.506 ' HG2' HH11 ' A' ' 126' ' ' ARG . 11.3 ttt-85 -61.32 -29.32 69.81 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.59 -0.844 . . . . 2.8100000000000001 109.49 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.12 74.81 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.815 0.817 . . . . 1.3899999999999999 109.448 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.5 -45.72 78.66 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.101 -0.64 . . . . 1.4099999999999999 110.125 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -62.05 -33.93 75.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.543 -0.723 . . . . 1.3899999999999999 110.574 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.437 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 25.1 t -68.12 -41.91 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 1.1899999999999999 110.272 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.416 ' HG2' HH11 ' A' ' 131' ' ' ARG . 28.1 ttt-85 -59.77 -39.49 85.04 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.006 -1.077 . . . . 3.6299999999999999 109.311 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.482 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 56.8 t0 -58.29 -36.22 72.98 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.734 -0.604 . . . . 1.28 109.896 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.2 mt -60.63 -39.35 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.158 -0.964 . . . . 1.1799999999999999 110.152 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.75 -44.85 30.21 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.253 -0.975 . . . . 0.51000000000000001 111.007 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -56.68 -45.27 81.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.316 -1.108 . . . . 3.1699999999999999 110.401 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.482 ' NH2' ' OD2' ' A' ' 132' ' ' ASP . 42.1 mtt-85 -62.46 -40.76 97.67 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.096 -1.042 . . . . 2.8500000000000001 109.643 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -43.21 99.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.703 -0.623 . . . . 1.6499999999999999 110.057 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.23 -44.5 92.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.204 -0.935 . . . . 1.2 110.317 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.1 mtp180 -60.02 -32.63 71.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 2.7999999999999998 110.723 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -74.09 -41.08 62.23 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.254 -0.903 . . . . 2.1499999999999999 110.704 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 141' ' ' ILE . 98.5 mt -60.63 -37.52 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.42 -0.8 . . . . 1.21 110.142 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.9 mt -87.06 -7.41 58.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.504 -0.748 . . . . 1.3400000000000001 112.169 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.1 19.4 78.46 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.808 -1.187 . . . . 0.91000000000000003 112.613 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.6 tp -61.33 143.29 55.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.94 -0.741 . . . . 1.51 109.63 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -66.44 146.6 54.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 2.8799999999999999 108.966 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.55 142.24 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.214 -1.032 . . . . 1.6200000000000001 108.214 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 147' ' ' ILE . 15.4 mm -75.73 129.93 36.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.04 -1.096 . . . . 2.1099999999999999 108.04 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.27 94.67 9.28 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.914 -1.513 . . . . 1.6200000000000001 106.914 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 54.5 mt -74.19 -23.68 59.25 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.73 0.776 . . . . 1.3999999999999999 110.515 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.5 m -82.88 6.96 16.69 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.882 0.848 . . . . 2.0499999999999998 112.019 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.73 23.08 9.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.627 -0.671 . . . . 1.3500000000000001 112.634 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.7 mt -73.68 138.49 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.32 -0.862 . . . . 1.4199999999999999 109.148 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -118.02 -18.44 9.43 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.778 0.799 . . . . 2.9900000000000002 112.725 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -115.36 140.72 48.87 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.432 -0.951 . . . . 1.54 108.432 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -70.98 120.83 17.12 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.041 -1.037 . . . . 1.3799999999999999 108.483 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.13 175.01 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.568 -0.707 . . . . 1.28 109.305 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 mt -87.49 144.43 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.322 -0.861 . . . . 1.1599999999999999 108.935 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.8 tp -97.66 126.97 43.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.996 -1.065 . . . . 1.3100000000000001 108.24 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.0 131.06 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.268 -1.012 . . . . 1.25 108.268 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.04 147.59 11.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.058 -1.027 . . . . 1.26 109.087 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.06 -32.18 71.82 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.544 -1.347 . . . . 1.6000000000000001 109.741 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 50.6 p-10 -172.53 150.82 2.31 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.434 -0.95 . . . . 2.4199999999999999 108.434 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 46.4 mt -118.53 143.07 47.01 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.373 -0.829 . . . . 1.3500000000000001 109.247 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.0 p -92.19 141.83 25.53 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.112 -0.992 . . . . 1.3200000000000001 108.673 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.57 -40.28 2.15 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 121.871 1.714 . . . . 0.69999999999999996 113.706 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.8 m -60.72 -49.99 75.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.1 -1.04 . . . . 1.1200000000000001 109.704 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.31 -39.91 94.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.504 -0.747 . . . . 1.21 110.168 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 34.5 p -66.87 -38.54 86.51 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.449 0.642 . . . . 1.1899999999999999 110.561 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.39 88.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.632 -0.668 . . . . 1.24 110.427 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -93.23 0.07 56.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.077 -1.015 . . . . 1.6899999999999999 112.694 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.46 148.06 43.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.979 -1.076 . . . . 1.3400000000000001 108.515 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -97.65 119.71 36.71 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.13 -1.434 . . . . 2.77 107.13 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 45.5 mt -78.14 -12.34 59.99 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.929 -0.482 . . . . 2.0899999999999999 111.601 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -83.0 -23.75 33.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.974 -1.079 . . . . 2.6699999999999999 111.825 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -101.96 -4.95 25.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.232 -0.917 . . . . 2.5800000000000001 113.092 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.23 125.95 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.76 -1.2 . . . . 1.1799999999999999 107.76 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 37.8 tp -90.96 -8.52 49.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.905 . . . . 2.1800000000000002 112.197 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 177.4 169.64 38.76 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.978 -1.649 . . . . 0.48999999999999999 108.978 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -127.82 133.86 49.42 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.005 -1.109 . . . . 0.64000000000000001 108.005 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 76.9 mt -132.09 109.62 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 106.133 -1.803 . . . . 1.21 106.133 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 203' ' ' VAL . 66.5 p -131.26 172.28 12.33 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.917 -1.114 . . . . 1.3799999999999999 110.347 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.402 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 26.9 t0 -101.53 61.7 0.92 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.563 -0.71 . . . . 2.3700000000000001 109.958 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.55 139.66 37.85 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.233 -0.917 . . . . 1.52 108.809 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.47 0.3 26.72 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.921 -1.133 . . . . 1.8 112.857 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 81.01 -14.87 24.7 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.093 -1.239 . . . . 2.04 113.837 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.443 ' O ' ' OG1' ' A' ' 187' ' ' THR . 42.9 ttt-85 -76.09 113.15 13.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.022 -1.281 . . . . 5.0 108.168 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 73.5 p 49.53 40.23 18.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 3.02 111.753 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.8 t -85.13 114.34 22.18 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.041 -1.096 . . . . 2.1099999999999999 108.041 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -62.68 -37.86 88.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.303 -0.873 . . . . 1.24 110.888 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 87.0 m -59.68 -40.12 86.75 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.405 -0.918 . . . . 2.1499999999999999 110.586 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.6 t -58.54 -39.73 81.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.231 -0.918 . . . . 2.02 110.049 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.9 mm -60.04 -35.84 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 2.1200000000000001 110.96 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 65.9 mtp -62.94 -41.2 99.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.02 -1.05 . . . . 1.3600000000000001 109.951 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.17 -47.2 84.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.997 -0.547 . . . . 1.29 110.588 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' A' ' 195' ' ' ARG . 29.0 mtt-85 -60.14 -42.16 94.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 3.5600000000000001 110.349 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.7 m -69.47 -41.59 75.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.017 -1.052 . . . . 1.1799999999999999 109.835 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.5 mt -91.0 -8.3 49.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.619 -0.675 . . . . 1.3400000000000001 112.094 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 48.62 14.54 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.739 1.015 . . . . 1.45 113.739 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.4 mt -74.1 149.18 87.14 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.053 -1.03 . . . . 1.25 108.267 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.07 136.64 53.49 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 121.146 1.231 . . . . 0.78000000000000003 109.691 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.28 159.32 37.46 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 118.133 -1.427 . . . . 1.2 110.148 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 77.0 mt -144.65 144.87 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.64 -1.245 . . . . 1.25 107.64 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 181' ' ' THR . 6.6 m -124.54 -33.94 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 113.608 0.966 . . . . 1.3899999999999999 113.608 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.76 40.72 1.17 Allowed Glycine 0 N--CA 1.484 1.858 0 C-N-CA 120.308 -0.949 . . . . 0.96999999999999997 111.792 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 44.3 p -58.21 -22.54 52.33 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.186 -1.185 . . . . 1.3500000000000001 111.279 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.402 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 72.31 -89.82 0.52 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.505 -1.038 . . . . 1.0700000000000001 110.505 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.42 ' OG ' ' OG ' ' A' ' 210' ' ' SER . 44.9 t -129.43 28.47 5.2 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.604 -0.939 . . . . 1.9199999999999999 112.784 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.12 -37.42 61.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.665 -1.272 . . . . 1.3300000000000001 110.165 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 39.6 p -52.02 -26.25 10.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 1.4199999999999999 111.256 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.42 ' OG ' ' OG ' ' A' ' 207' ' ' SER . 59.3 p -93.2 3.9 54.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 2.1200000000000001 111.603 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -126.92 -3.62 6.44 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.924 0.713 . . . . 2.6899999999999999 112.924 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 22.7 t -120.59 149.42 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.682 0.753 . . . . 1.29 109.185 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -124.96 156.97 37.2 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.476 -0.935 . . . . 2.6899999999999999 108.476 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 9.8 t-20 -56.48 141.13 43.75 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.83 -1.169 . . . . 2.79 110.674 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.6 m-20 80.24 2.51 1.95 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.472 1.286 . . . . 2.3500000000000001 114.472 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.38 145.45 55.69 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.812 -1.18 . . . . 1.97 108.455 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -88.46 116.12 26.46 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.041 -1.466 . . . . 2.9700000000000002 107.041 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 88.6 mt -127.32 142.05 51.55 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.463 -0.773 . . . . 1.25 109.695 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.2 mt -109.65 128.34 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.99 -1.485 . . . . 1.22 106.99 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.8 tp -102.75 115.93 31.56 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.292 -1.744 . . . . 1.24 106.292 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 223' ' ' VAL . 21.6 p-10 -94.38 -22.81 18.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.94 -1.1 . . . . 2.0499999999999998 112.599 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.447 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.23 17.85 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 112.859 0.689 . . . . 1.25 112.859 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.3 t -108.92 -59.57 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.122 -0.986 . . . . 1.4299999999999999 108.959 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.32 11.03 34.04 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.654 0.74 . . . . 3.0299999999999998 111.157 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 60.71 54.67 3.54 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.417 0.627 . . . . 2.25 112.063 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -150.2 149.52 30.32 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.091 0.948 . . . . 2.52 109.942 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.9 t -116.12 141.23 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 109.175 -0.676 . . . . 1.29 109.175 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.43 130.61 49.26 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.855 -1.153 . . . . 1.3400000000000001 108.264 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.5 t -109.81 129.35 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.217 -0.927 . . . . 1.3400000000000001 108.695 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.439 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 10.2 t-20 54.82 50.29 6.2 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 113.701 1.0 . . . . 2.1800000000000002 113.701 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.0 Cg_endo -68.91 151.92 73.69 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.962 2.441 . . . . 0.93999999999999995 110.594 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 65.3 p -76.35 161.45 28.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.241 -0.912 . . . . 2.3999999999999999 110.333 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -60.95 -38.08 84.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.792 -1.192 . . . . 3.3300000000000001 110.191 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -60.4 -41.38 93.76 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.458 0.647 . . . . 3.1699999999999999 110.573 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.82 -40.18 78.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.083 -1.011 . . . . 1.6899999999999999 110.241 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.02 -43.58 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 1.6000000000000001 110.545 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -57.87 -41.52 82.63 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.181 -0.95 . . . . 2.7000000000000002 110.418 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.35 -42.33 98.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.547 -0.721 . . . . 2.96 111.057 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.7 mtp -70.24 -42.53 72.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 1.6299999999999999 110.874 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -57.83 -40.75 80.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.075 -1.016 . . . . 3.27 109.593 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.6 -56.66 4.73 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.633 -0.667 . . . . 2.23 110.821 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 67.6 t -59.77 -40.95 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 2.79 111.32 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.71 -49.64 76.96 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.739 -1.226 . . . . 4.2599999999999998 110.4 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.01 -33.87 76.71 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.604 -0.838 . . . . 1.8799999999999999 110.7 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.27 -30.32 69.37 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.25 -1.38 . . . . 3.3799999999999999 109.604 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.83 -48.9 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.358 -0.937 . . . . 2.8799999999999999 109.704 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.4 85.82 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.691 0.757 . . . . 2.75 110.123 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.9 t -69.23 -31.06 69.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.704 -0.623 . . . . 3.4199999999999999 110.4 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.449 ' OE2' ' OE1' ' A' ' 252' ' ' GLU . 49.3 tp10 -59.92 -39.21 84.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -0.82 . . . . 3.5699999999999998 110.64 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -62.18 -39.82 93.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.095 -1.003 . . . . 4.6100000000000003 110.413 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.91 2.43 17.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.339 -0.851 . . . . 4.4500000000000002 112.858 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.449 ' OE1' ' OE2' ' A' ' 249' ' ' GLU . 70.4 tt0 -70.17 -12.67 61.76 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 112.703 0.631 . . . . 5.9699999999999998 112.703 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.433 HD22 ' H ' ' A' ' 254' ' ' ALA . 1.8 pt? -63.67 -27.06 68.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.259 -1.525 . . . . 6.4500000000000002 111.512 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.433 ' H ' HD22 ' A' ' 253' ' ' LEU . . . -74.44 -8.05 55.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.383 -0.823 . . . . 6.6600000000000001 112.52 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -81.76 -1.95 49.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.535 -0.728 . . . . 8.5399999999999991 112.49 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 39.8 mt -80.22 -14.04 58.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.858 -1.151 . . . . 8.0700000000000003 111.995 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -92.2 -14.69 28.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 9.7200000000000006 112.758 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -105.97 56.39 0.67 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.535 -0.728 . . . . 10.119999999999999 110.063 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 117.948 -1.025 . . . . 11.9 109.422 179.823 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.793 -0.447 . . . . 3.5299999999999998 109.793 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.2 mt -97.78 107.6 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 106.119 -1.808 . . . . 1.5700000000000001 106.119 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -105.9 120.97 43.1 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 107.665 -1.235 . . . . 1.4399999999999999 107.665 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.4 -159.03 18.39 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.715 -1.754 . . . . 1.01 108.715 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 83.5 mt -94.84 1.11 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -1.189 . . . . 1.6299999999999999 112.409 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tp 49.02 98.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 1.5800000000000001 112.012 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.98 -45.71 12.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.728 -1.233 . . . . 1.3400000000000001 111.577 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -145.89 145.21 24.24 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.796 -1.187 . . . . 1.8600000000000001 107.796 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.37 143.84 22.43 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.868 2.378 . . . . 1.01 112.276 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.95 174.19 25.46 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 108.908 -1.677 . . . . 0.81000000000000005 108.908 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 11' ' ' ILE . 98.2 mt -131.31 133.09 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.316 -1.108 . . . . 1.3700000000000001 108.054 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.62 155.2 48.53 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.503 -0.748 . . . . 1.1399999999999999 109.629 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.5 m-85 -125.56 140.36 52.81 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.732 -0.84 . . . . 0.87 108.732 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.42 164.41 30.43 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 118.813 -1.66 . . . . 0.56999999999999995 109.626 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -75.05 159.1 32.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.579 -0.953 . . . . 2.3500000000000001 108.773 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -89.06 126.23 35.35 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.975 -1.12 . . . . 1.21 107.975 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.9 tp -103.85 105.91 16.26 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.022 -2.214 . . . . 1.3999999999999999 105.022 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.5 tp -90.32 133.63 34.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 1.4399999999999999 108.188 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.6 mt -99.93 120.03 39.16 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.925 -1.509 . . . . 1.45 106.925 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -109.86 142.33 41.32 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.717 -0.846 . . . . 2.5 108.717 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -121.57 141.74 50.79 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.907 -1.12 . . . . 2.6600000000000001 109.225 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.25 137.28 34.9 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.87 -1.144 . . . . 2.3199999999999998 108.018 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -62.38 149.19 43.07 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.252 -0.648 . . . . 2.1099999999999999 109.252 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -93.84 131.91 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.359 -0.978 . . . . 1.29 108.359 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t -106.04 130.35 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.297 -1.001 . . . . 1.4099999999999999 108.297 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.3 mt -96.24 138.22 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.846 -0.798 . . . . 1.3100000000000001 108.846 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -90.1 122.86 33.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.206 -1.035 . . . . 1.3400000000000001 108.206 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.1 mmt-85 -95.35 14.47 22.34 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.283 -0.886 . . . . 3.48 112.478 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -75.3 140.47 43.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.917 -1.114 . . . . 2.52 109.198 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.55 136.35 32.98 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.875 -1.157 . . . . 2.6299999999999999 107.875 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 pt -94.93 168.84 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.885 . . . . 1.3100000000000001 110.482 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.4 p -97.77 165.82 11.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.675 -0.641 . . . . 1.24 109.845 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.03 -27.24 61.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.874 -1.141 . . . . 1.49 111.579 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -68.17 -34.62 76.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.939 -1.1 . . . . 2.2799999999999998 110.453 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -90.13 -9.48 48.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.978 -1.076 . . . . 2.0499999999999998 112.492 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.3 t -58.55 -42.14 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.856 -1.152 . . . . 1.3400000000000001 110.622 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.17 -38.25 79.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 1.54 110.926 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -63.17 -45.0 93.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.909 . . . . 2.8500000000000001 111.268 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.52 -37.05 82.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.547 -1.346 . . . . 1.3100000000000001 110.991 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.6 t -60.8 -40.17 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.074 -1.016 . . . . 1.3799999999999999 110.193 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.64 -39.63 92.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.948 -1.095 . . . . 1.5 110.096 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.71 -40.23 91.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.885 . . . . 2.7799999999999998 109.893 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -74.03 -58.37 3.34 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.295 -0.878 . . . . 1.0600000000000001 109.703 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.0 -48.38 75.99 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.05 -1.06 . . . . 1.3999999999999999 110.204 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 t -70.65 -44.55 66.89 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.293 -0.963 . . . . 1.3200000000000001 110.153 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.09 -46.17 85.7 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.55 -1.31 . . . . 0.69999999999999996 110.035 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -57.91 -30.25 65.76 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.698 -0.883 . . . . 3.4399999999999999 109.595 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.52 -46.75 80.4 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.676 0.75 . . . . 1.3600000000000001 109.629 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.594 ' HZ1' ' NE2' ' A' ' 53' ' ' GLN . 25.4 ttpp -79.89 -40.65 27.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.467 -0.771 . . . . 2.8300000000000001 110.293 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.85 93.13 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 1.23 110.056 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.8 m -60.13 -37.6 80.54 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.017 0.913 . . . . 1.9199999999999999 109.334 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.37 -46.66 69.46 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.776 -0.647 . . . . 1.25 110.179 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.594 ' NE2' ' HZ1' ' A' ' 49' ' ' LYS . 45.5 mt-30 -61.4 -48.56 80.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.855 -1.153 . . . . 1.97 110.13 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.09 -41.36 96.51 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.845 0.831 . . . . 2.1800000000000002 109.596 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -60.56 -41.22 94.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.468 0.652 . . . . 1.1899999999999999 109.855 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.1 m -64.35 -41.89 96.51 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.387 -0.821 . . . . 1.3400000000000001 110.429 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.02 -32.81 55.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.191 -0.943 . . . . 1.23 110.573 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -53.18 -46.56 69.02 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.329 -0.857 . . . . 1.5600000000000001 110.733 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -68.74 -38.92 80.48 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.202 -0.937 . . . . 1.3 109.48 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -62.9 -40.31 97.15 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.53 -1.268 . . . . 2.3199999999999998 108.952 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.62 72.82 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.714 -0.794 . . . . 1.1399999999999999 109.234 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.09 -33.23 26.98 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.155 -1.178 . . . . 0.68999999999999995 110.155 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -82.1 -24.67 35.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.107 -1.231 . . . . 1.48 111.138 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.1 m -86.29 -46.74 10.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.506 -0.746 . . . . 1.52 110.74 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -105.71 -19.04 13.88 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.373 -0.829 . . . . 1.3100000000000001 112.657 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.82 152.73 9.09 Favored Glycine 0 N--CA 1.504 3.225 0 O-C-N 121.247 -0.908 . . . . 0.84999999999999998 111.816 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -52.58 -21.77 4.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.48 -1.012 . . . . 3.8599999999999999 112.66 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.31 -32.63 71.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.193 -0.942 . . . . 2.3500000000000001 111.456 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -82.79 -13.73 55.72 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.655 -1.278 . . . . 2.2599999999999998 112.579 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.41 -32.49 71.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.046 -1.034 . . . . 1.45 111.209 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.56 96.16 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.025 -1.047 . . . . 1.25 111.322 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.7 mt -65.45 -42.52 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.652 -1.28 . . . . 1.26 110.638 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.6 -28.74 66.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.113 -0.992 . . . . 0.82999999999999996 110.554 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.35 -37.59 81.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.259 -0.901 . . . . 1.1899999999999999 110.403 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.83 -41.09 74.37 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.26 -0.971 . . . . 0.57999999999999996 110.899 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -58.63 -43.02 89.59 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.967 -1.313 . . . . 2.0499999999999998 110.223 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 77' ' ' ILE . 87.2 mt -60.59 -39.97 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.19 -0.944 . . . . 1.21 109.934 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.1 ttp -59.61 -39.56 84.61 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.055 -0.658 . . . . 2.29 110.585 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.33 -49.41 77.93 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.035 -1.041 . . . . 1.21 110.837 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.0 -45.1 93.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 1.1399999999999999 110.423 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -85.93 14.13 6.53 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.01 -1.056 . . . . 1.4199999999999999 112.718 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -65.58 127.51 32.17 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.759 -1.213 . . . . 1.27 108.503 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -68.21 -17.18 64.25 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.235 1.017 . . . . 1.3500000000000001 110.704 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -75.24 -52.83 9.94 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.799 0.809 . . . . 2.2200000000000002 110.544 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.08 -37.85 84.15 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.794 -0.763 . . . . 1.22 110.225 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -59.21 -49.33 78.26 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.487 -0.758 . . . . 1.29 110.716 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -60.75 -38.7 86.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.422 -0.798 . . . . 2.1699999999999999 110.781 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.85 -48.55 73.9 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.479 -0.888 . . . . 1.3 110.142 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.06 -45.57 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.411 -0.916 . . . . 1.1699999999999999 109.661 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.8 mt -60.7 -43.65 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.144 0.497 . . . . 1.3999999999999999 110.453 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -60.21 -44.43 95.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.964 -1.085 . . . . 1.3300000000000001 111.058 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.65 -44.06 97.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.011 . . . . 1.48 110.151 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.31 -48.94 86.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.276 -0.89 . . . . 1.28 110.292 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -77.83 -33.41 52.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.373 -0.829 . . . . 2.6000000000000001 111.44 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 91' ' ' ALA . 55.1 t0 -82.74 -47.48 11.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.663 -1.273 . . . . 1.51 112.386 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -102.55 10.72 38.63 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.362 -0.836 . . . . 2.48 112.456 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.8 m80 51.49 49.18 21.49 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.988 -1.07 . . . . 1.6100000000000001 111.303 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 59.0 mtt -104.57 150.79 24.33 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.387 -0.821 . . . . 1.8999999999999999 109.701 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.4 p -74.11 165.66 24.76 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.405 -0.809 . . . . 1.3200000000000001 109.988 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.81 -40.6 80.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.647 -0.658 . . . . 1.1499999999999999 110.711 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -68.1 -42.93 79.56 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.52 -0.738 . . . . 2.25 110.07 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -52.09 28.2 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.111 -0.635 . . . . 1.22 111.225 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.16 -44.24 95.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.874 -1.141 . . . . 1.1899999999999999 110.905 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.56 88.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.724 -0.61 . . . . 1.2 111.078 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -59.75 -37.26 78.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.614 -1.304 . . . . 2.1000000000000001 110.562 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -59.28 -48.28 82.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.922 -1.111 . . . . 1.3 110.636 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.4 t -60.89 -47.04 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.788 -1.195 . . . . 1.27 110.875 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.17 -34.06 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.605 0.717 . . . . 1.1899999999999999 109.833 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -57.55 -42.56 83.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.761 . . . . 2.1099999999999999 110.803 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.09 -32.34 17.62 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.521 -1.323 . . . . 0.88 112.735 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -62.07 -42.63 99.4 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.167 -1.784 . . . . 1.99 109.828 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.7 -53.31 16.16 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.749 0.785 . . . . 1.28 110.771 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 64.7 m -60.95 -36.04 78.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.702 -0.624 . . . . 2.2200000000000002 110.659 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.55 -42.15 99.36 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.379 -0.826 . . . . 1.45 110.184 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.2 mt -65.3 -29.66 70.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.793 -1.192 . . . . 1.47 110.967 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.98 -20.01 66.27 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.322 -0.861 . . . . 2.04 110.76 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.74 -12.54 61.05 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.779 0.8 . . . . 1.73 110.82 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 24.7 mt -90.6 139.58 30.57 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.964 -1.124 . . . . 1.79 107.964 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -101.83 43.71 1.05 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.46 -0.775 . . . . 2.8799999999999999 111.618 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -115.87 142.37 46.86 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.296 -0.878 . . . . 1.5800000000000001 109.069 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -56.81 -41.53 77.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 3.04 110.101 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -71.9 -55.13 8.06 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.911 -1.118 . . . . 1.29 110.577 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.1 mt -60.13 -40.01 88.26 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.141 -0.974 . . . . 1.6000000000000001 110.63 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -63.09 -48.71 77.45 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.231 -0.918 . . . . 2.7599999999999998 109.812 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -60.63 -31.45 70.65 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.896 -0.722 . . . . 2.1499999999999999 109.922 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.504 ' HG2' HH11 ' A' ' 126' ' ' ARG . 1.5 ttt-85 -61.2 -30.5 70.46 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.275 1.036 . . . . 2.8100000000000001 108.769 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.08 -49.8 75.86 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.839 0.828 . . . . 1.3899999999999999 110.097 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.24 -44.29 79.81 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.737 0.779 . . . . 1.4099999999999999 110.281 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.6 -35.71 81.39 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.293 -0.88 . . . . 1.3899999999999999 110.803 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 49.8 t -69.14 -38.74 78.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 120.975 -1.078 . . . . 1.1899999999999999 110.823 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.481 ' HG2' HH11 ' A' ' 131' ' ' ARG . 1.8 ttt-85 -55.31 -39.97 70.55 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.494 -1.282 . . . . 3.6299999999999999 109.53 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -61.32 -36.99 81.65 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.577 0.703 . . . . 1.28 110.088 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.51 -39.91 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.915 -1.116 . . . . 1.1799999999999999 109.941 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.03 -44.07 98.65 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.567 -1.301 . . . . 0.51000000000000001 109.899 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.36 -40.12 85.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.403 -1.057 . . . . 3.1699999999999999 110.744 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.43 ' HG2' HH11 ' A' ' 136' ' ' ARG . 53.3 mtt-85 -59.46 -43.11 93.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.118 -0.989 . . . . 2.8500000000000001 110.328 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.6 tp -65.4 -45.42 84.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.433 -0.792 . . . . 1.6499999999999999 110.154 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.23 -42.91 99.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.317 -0.864 . . . . 1.2 110.419 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -59.68 -34.84 73.38 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.657 -0.652 . . . . 2.7999999999999998 110.688 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -74.97 -42.38 57.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 2.1499999999999999 110.832 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.401 HG22 HD11 ' A' ' 141' ' ' ILE . 96.3 mt -62.99 -38.81 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.461 -0.774 . . . . 1.21 110.337 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 43.8 mt -87.15 -6.09 58.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.998 -1.064 . . . . 1.3400000000000001 112.178 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.6 23.87 77.49 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 119.445 -1.36 . . . . 0.91000000000000003 113.057 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.83 150.35 33.07 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.864 -0.786 . . . . 1.51 109.901 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -67.79 150.46 48.6 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.545 -0.862 . . . . 2.8799999999999999 110.043 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.5 mt -105.32 141.83 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.423 -0.798 . . . . 1.6200000000000001 109.083 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 147' ' ' ILE . 17.8 mm -76.21 122.03 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 107.75 -1.204 . . . . 2.1099999999999999 107.75 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -92.98 94.6 8.99 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.481 -1.674 . . . . 1.6200000000000001 106.481 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.38 -28.17 59.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.594 -0.692 . . . . 1.3999999999999999 111.18 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 t -81.21 3.32 24.18 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.868 0.842 . . . . 2.0499999999999998 111.979 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.08 14.62 21.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.443 -0.786 . . . . 1.3500000000000001 112.755 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.4 mt -72.89 136.69 24.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.069 -1.02 . . . . 1.4199999999999999 108.715 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -117.27 -15.31 10.42 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.148 0.975 . . . . 2.9900000000000002 112.297 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -115.41 140.34 49.22 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.747 0.784 . . . . 1.54 109.092 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -70.62 119.53 14.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.461 -0.774 . . . . 1.3799999999999999 109.029 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.06 174.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.281 -0.887 . . . . 1.28 109.174 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mt -89.25 145.55 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 1.1599999999999999 108.843 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.6 tp -98.1 121.55 40.16 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.062 -1.024 . . . . 1.3100000000000001 108.37 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.1 130.21 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 108.146 -1.057 . . . . 1.25 108.146 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.98 157.92 27.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.808 -1.182 . . . . 1.26 108.654 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.84 -36.88 82.49 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.386 -1.446 . . . . 1.6000000000000001 109.829 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -172.96 149.7 1.92 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.404 -0.591 . . . . 2.4199999999999999 109.404 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.8 mt -117.64 141.24 48.6 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.405 -0.809 . . . . 1.3500000000000001 109.009 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.6 p -94.03 151.23 39.54 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.741 -1.224 . . . . 1.3200000000000001 108.88 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -41.57 -46.22 6.17 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.251 1.968 . . . . 0.69999999999999996 113.838 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.0 m -58.88 -49.91 76.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.761 -1.212 . . . . 1.1200000000000001 110.45 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.26 -38.71 87.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.915 0.864 . . . . 1.21 110.225 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.2 p -70.0 -39.9 75.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 1.1899999999999999 110.416 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.84 74.32 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.712 -0.618 . . . . 1.24 110.656 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -93.09 -3.56 53.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 1.6899999999999999 112.767 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.0 tp -64.62 150.99 45.95 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.291 -0.633 . . . . 1.3400000000000001 109.291 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -93.95 112.43 24.27 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.636 -1.616 . . . . 2.77 106.636 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.0 mt -70.3 -22.23 62.86 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.769 -0.582 . . . . 2.0899999999999999 111.704 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -83.35 -15.83 48.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.479 -0.763 . . . . 2.6699999999999999 112.919 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -102.79 -4.04 25.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.206 -0.934 . . . . 2.5800000000000001 113.446 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 64.3 t -111.14 129.93 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.197 -1.038 . . . . 1.1799999999999999 108.197 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.5 tp -83.99 -10.04 58.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.327 -0.858 . . . . 2.1800000000000002 112.263 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.5 166.98 35.59 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.796 -1.721 . . . . 0.48999999999999999 108.796 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -126.37 127.49 45.57 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.51 -1.293 . . . . 0.64000000000000001 107.51 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 61.0 mt -125.34 127.91 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 106.702 -1.592 . . . . 1.21 106.702 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 203' ' ' VAL . 30.2 p -138.57 174.61 10.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.005 -1.06 . . . . 1.3799999999999999 109.704 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 52.8 t0 -106.32 34.71 3.24 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.375 0.607 . . . . 2.3700000000000001 110.712 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -105.31 96.24 6.38 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 107.262 -1.384 . . . . 1.52 107.262 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -84.95 30.35 3.94 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 121.004 -1.06 . . . . 1.8 112.793 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.93 131.97 10.99 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.892 -1.683 . . . . 2.04 108.892 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -57.26 -31.96 66.11 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.467 -1.02 . . . . 5.0 109.78 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 60.2 p -97.29 28.75 3.5 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.565 0.58 . . . . 3.02 112.565 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.4 t -74.75 131.57 40.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.893 -1.13 . . . . 2.1099999999999999 108.834 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -58.45 -38.08 76.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 1.24 111.208 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.498 ' HG1' ' N ' ' A' ' 191' ' ' SER . 3.8 p -56.66 -43.28 80.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.31 -1.494 . . . . 2.1499999999999999 110.199 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.498 ' N ' ' HG1' ' A' ' 190' ' ' THR . 77.1 p -61.97 -36.17 80.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.3 -0.875 . . . . 2.02 110.316 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.3 mt -61.46 -36.79 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.142 -0.974 . . . . 2.1200000000000001 110.759 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 85.3 mtp -62.08 -46.94 86.89 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.653 1.216 . . . . 1.3600000000000001 109.48 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.5 -51.77 67.26 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.016 -0.993 . . . . 1.29 110.748 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -63.15 -44.88 94.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.277 -0.89 . . . . 3.5600000000000001 110.759 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.4 m -66.9 -38.13 85.68 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.768 -1.207 . . . . 1.1799999999999999 110.288 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 25.3 mt -91.45 -0.42 57.62 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.723 0.638 . . . . 1.3400000000000001 112.723 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 56.23 5.52 0.19 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 114.444 1.275 . . . . 1.45 114.444 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.6 mt -72.26 143.05 85.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.919 -1.113 . . . . 1.25 108.396 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.56 137.07 75.39 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.298 1.332 . . . . 0.78000000000000003 110.292 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.29 169.39 20.72 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 117.762 -1.575 . . . . 1.2 109.803 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 58.2 mt -145.72 156.85 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.808 -1.182 . . . . 1.25 107.808 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 181' ' ' THR . 25.5 m -140.47 -29.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.268 -0.895 . . . . 1.3899999999999999 112.893 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.62 38.44 3.11 Favored Glycine 0 N--CA 1.486 2.025 0 O-C-N 121.293 -0.879 . . . . 0.96999999999999997 112.058 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.3 p -53.25 -26.55 18.46 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.506 -0.997 . . . . 1.3500000000000001 111.622 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 88.56 -88.98 1.56 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.82 -0.912 . . . . 1.0700000000000001 110.82 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 39.7 t -128.45 30.43 5.16 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.189 -1.183 . . . . 1.9199999999999999 112.285 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 44.7 t -62.01 -38.45 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.435 -1.416 . . . . 1.3300000000000001 109.991 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.8 p -53.19 -21.37 5.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 1.4199999999999999 111.308 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.3 t -95.02 0.73 54.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.222 -0.924 . . . . 2.1200000000000001 111.581 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -126.31 -6.36 6.51 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 113.345 0.869 . . . . 2.6899999999999999 113.345 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 10.2 t -117.31 145.59 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 122.014 0.911 . . . . 1.29 109.434 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -118.94 155.07 31.97 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.026 -1.102 . . . . 2.6899999999999999 108.026 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 35.5 p-10 -54.58 140.69 34.12 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.844 -1.16 . . . . 2.79 110.724 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 m-20 78.81 5.89 2.34 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.484 1.29 . . . . 2.3500000000000001 114.484 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.0 149.23 47.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.746 -1.221 . . . . 1.97 108.388 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -88.86 117.63 27.99 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.29 -1.374 . . . . 2.9700000000000002 107.29 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 84.1 mt -128.58 149.62 50.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.763 0.792 . . . . 1.25 109.498 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.3 mt -115.12 129.86 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.77 -1.567 . . . . 1.22 106.77 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 64.4 tp -101.02 117.06 34.28 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.41 -2.07 . . . . 1.24 105.41 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.577 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.8 t0 -90.63 -24.36 20.53 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.078 -1.049 . . . . 2.0499999999999998 112.574 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 39.13 17.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 112.735 0.643 . . . . 1.25 112.735 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' A' ' 221' ' ' ASP . 26.0 t -114.42 -64.59 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.959 0.885 . . . . 1.4299999999999999 109.135 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -89.73 9.41 27.29 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.139 0.971 . . . . 3.0299999999999998 110.582 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 52.2 t30 60.34 49.81 6.68 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.67 0.748 . . . . 2.25 111.589 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -147.53 153.03 38.97 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.193 0.996 . . . . 2.52 109.669 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 76.5 t -118.43 140.03 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.507 -0.923 . . . . 1.29 108.507 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.25 132.79 42.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.86 -1.15 . . . . 1.3400000000000001 107.984 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 44.1 t -109.8 129.68 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 108.474 -0.936 . . . . 1.3400000000000001 108.474 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.408 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 58.5 t30 47.28 54.57 15.64 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 113.577 0.955 . . . . 2.1800000000000002 113.577 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 40.5 Cg_endo -67.88 151.89 77.78 Favored 'Trans proline' 0 C--N 1.297 -2.177 0 C-N-CA 122.462 2.108 . . . . 0.93999999999999995 110.033 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.5 m -74.17 155.32 38.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.823 -0.806 . . . . 2.3999999999999999 108.823 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -57.58 -39.52 76.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.151 -0.968 . . . . 3.3300000000000001 110.468 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.45 -38.28 89.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.349 -0.845 . . . . 3.1699999999999999 110.208 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.44 -37.53 75.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.497 -0.752 . . . . 1.6899999999999999 110.523 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.26 -44.39 95.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.783 -0.767 . . . . 1.6000000000000001 110.498 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -58.9 -39.4 81.35 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.482 -0.761 . . . . 2.7000000000000002 110.034 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -60.53 -40.45 91.55 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.46 -0.775 . . . . 2.96 110.239 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 83.8 mtp -74.74 -41.51 60.0 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.016 -1.053 . . . . 1.6299999999999999 110.537 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -58.27 -37.85 75.8 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.513 -0.875 . . . . 3.27 109.689 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.544 ' C ' HE21 ' A' ' 245' ' ' GLN . . . -72.22 -56.6 5.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 2.23 110.623 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.55 -43.2 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.057 -1.027 . . . . 2.79 110.99 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -51.82 64.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.649 -1.282 . . . . 4.2599999999999998 110.756 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.88 -32.23 73.63 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.56 -0.713 . . . . 1.8799999999999999 110.878 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.544 HE21 ' C ' ' A' ' 241' ' ' ALA . 37.5 mt-30 -61.54 -30.15 70.46 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.525 -1.27 . . . . 3.3799999999999999 109.471 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.77 -50.02 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 118.463 -1.295 . . . . 2.8799999999999999 109.129 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.15 90.03 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.813 -0.755 . . . . 2.75 110.2 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 18.1 t -65.56 -35.75 81.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.687 -0.633 . . . . 3.4199999999999999 110.835 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -61.12 -40.7 94.77 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.721 -1.237 . . . . 3.5699999999999998 110.132 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -67.51 -37.42 82.77 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.158 0.98 . . . . 4.6100000000000003 109.849 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.25 -6.96 38.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.624 -0.673 . . . . 4.4500000000000002 112.44 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -61.53 -30.45 70.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 5.9699999999999998 111.018 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 31.3 tp -60.41 -38.75 85.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.118 -0.989 . . . . 6.4500000000000002 110.264 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -71.34 -19.77 62.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.469 -0.769 . . . . 6.6600000000000001 111.872 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -86.5 9.1 19.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.414 -0.804 . . . . 8.5399999999999991 112.324 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.29 -20.07 57.68 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.325 -0.859 . . . . 8.0700000000000003 111.371 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -88.29 9.8 21.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.245 -0.91 . . . . 9.7200000000000006 112.196 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -97.26 24.45 6.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.071 -1.018 . . . . 10.119999999999999 112.283 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 118.0 -1.0 . . . . 11.9 109.9 -179.513 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.641 ' H3 ' ' NE2' ' A' ' 226' ' ' GLN . 68.6 mtm . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.883 -0.414 . . . . 3.5299999999999998 109.883 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.3 mt -98.57 114.72 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 106.737 -1.579 . . . . 1.5700000000000001 106.737 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.5 m -105.24 122.0 45.02 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.629 -1.249 . . . . 1.4399999999999999 107.629 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.41 -157.4 13.37 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.643 -1.783 . . . . 1.01 108.643 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 85.1 mt -92.69 -1.46 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.327 -1.102 . . . . 1.6299999999999999 112.552 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 tp 49.83 102.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 1.5800000000000001 112.227 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.14 -44.44 11.5 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.138 -0.976 . . . . 1.3400000000000001 111.589 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 m -144.32 143.81 23.43 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 107.971 -1.122 . . . . 1.8600000000000001 107.971 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.78 143.01 23.21 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.996 2.464 . . . . 1.01 112.344 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 222' ' ' ALA . . . 152.67 168.09 16.28 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 109.236 -1.546 . . . . 0.81000000000000005 109.236 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.8 mt -124.35 137.51 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.034 -1.274 . . . . 1.3700000000000001 107.845 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.17 148.36 43.08 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.323 -0.861 . . . . 1.1399999999999999 109.081 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.3 m-85 -118.0 139.87 50.56 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 108.378 -0.971 . . . . 0.87 108.378 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.2 167.77 35.45 Favored Glycine 0 N--CA 1.499 2.862 0 C-N-CA 118.806 -1.664 . . . . 0.56999999999999995 110.05 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -78.84 159.83 27.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -1.126 . . . . 2.3500000000000001 109.494 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.93 126.69 34.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.705 -1.247 . . . . 1.21 107.994 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.8 tp -103.53 105.25 15.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.569 -2.011 . . . . 1.3999999999999999 105.569 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.1 tp -92.14 134.47 34.82 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.866 -1.161 . . . . 1.4399999999999999 107.866 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.1 mt -102.21 116.45 32.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.081 -1.452 . . . . 1.45 107.081 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -109.46 131.54 54.97 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.537 -1.282 . . . . 2.5 107.537 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -126.89 152.64 46.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.381 -0.824 . . . . 2.6600000000000001 109.664 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -83.47 134.41 34.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.131 -1.063 . . . . 2.3199999999999998 108.131 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.87 148.84 50.62 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.752 -0.833 . . . . 2.1099999999999999 108.752 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.69 132.28 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.306 -0.998 . . . . 1.29 108.306 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.6 t -108.76 129.94 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.857 -1.164 . . . . 1.4099999999999999 107.857 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.3 133.4 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.391 -0.966 . . . . 1.3100000000000001 108.391 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -93.24 128.97 39.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.096 -1.002 . . . . 1.3400000000000001 108.325 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -97.31 18.95 14.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.277 -0.889 . . . . 3.48 112.004 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -71.19 149.01 46.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 2.52 109.783 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -92.37 138.05 31.85 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.413 -0.958 . . . . 2.6299999999999999 108.413 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 pt -97.44 168.41 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.77 . . . . 1.3100000000000001 109.932 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.4 p -97.71 167.32 11.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.688 -0.632 . . . . 1.24 109.939 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.77 -24.72 58.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.005 -1.059 . . . . 1.49 111.858 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -68.72 -37.97 79.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 2.2799999999999998 110.905 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -84.98 -7.26 59.22 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.72 -1.237 . . . . 2.0499999999999998 112.354 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -58.59 -45.01 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.114 -0.991 . . . . 1.3400000000000001 110.137 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -57.95 -39.78 78.91 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.967 -1.083 . . . . 1.54 110.588 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -63.08 -45.42 92.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.162 -0.961 . . . . 2.8500000000000001 111.037 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -59.88 -40.33 88.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.928 -1.108 . . . . 1.3100000000000001 110.777 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.1 t -59.93 -41.24 85.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.22 -0.925 . . . . 1.3799999999999999 110.689 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -60.1 -47.23 86.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.917 -1.114 . . . . 1.5 110.078 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -61.36 -40.9 96.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.774 -0.771 . . . . 2.7799999999999998 110.247 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -75.29 -56.12 5.03 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.572 -0.705 . . . . 1.0600000000000001 110.307 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 tp -58.01 -45.62 86.57 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.548 -0.861 . . . . 1.3999999999999999 110.375 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 t -66.36 -37.08 84.5 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.159 -0.963 . . . . 1.3200000000000001 109.749 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.66 -41.77 93.9 Favored Glycine 0 N--CA 1.483 1.819 0 C-N-CA 119.582 -1.294 . . . . 0.69999999999999996 109.937 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -59.81 -29.77 68.47 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.172 -1.193 . . . . 3.4399999999999999 109.924 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.35 -49.16 76.67 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.607 0.718 . . . . 1.3600000000000001 110.493 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' CB ' ' HZ1' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -82.4 -38.79 23.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.954 -1.092 . . . . 2.8300000000000001 110.684 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.38 93.31 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.105 -0.997 . . . . 1.23 110.074 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.7 p -63.55 -40.8 97.95 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.046 -1.034 . . . . 1.9199999999999999 109.439 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.59 -48.5 66.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.537 -0.465 . . . . 1.25 110.477 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.77 -49.17 76.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.925 -1.109 . . . . 1.97 110.724 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.15 -39.13 88.94 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.858 -1.151 . . . . 2.1800000000000002 109.971 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -59.84 -41.0 90.44 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.216 -0.594 . . . . 1.1899999999999999 110.319 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.7 m -68.49 -45.12 73.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.142 -0.974 . . . . 1.3400000000000001 110.246 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.8 mt -58.34 -33.95 48.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.338 -0.851 . . . . 1.23 110.815 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -53.07 -42.82 66.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.178 -0.952 . . . . 1.5600000000000001 110.844 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.58 -36.34 76.17 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.021 -1.049 . . . . 1.3 110.051 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.67 -39.62 94.5 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.75 -1.18 . . . . 2.3199999999999998 109.447 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.13 -33.97 77.28 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.75 -0.78 . . . . 1.1399999999999999 109.983 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.15 -36.72 17.18 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.878 -1.153 . . . . 0.68999999999999995 111.132 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -81.65 -25.41 35.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.06 -1.259 . . . . 1.48 111.189 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.8 m -86.48 -48.33 8.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.557 -0.714 . . . . 1.52 111.042 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -107.94 -9.33 15.71 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.031 1.123 . . . . 1.3100000000000001 114.031 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.71 166.45 23.45 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.423 -0.894 . . . . 0.84999999999999998 112.749 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.1 -28.15 50.39 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.702 -0.881 . . . . 3.8599999999999999 112.409 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -54.44 -40.19 68.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.94 -1.1 . . . . 2.3500000000000001 110.73 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -85.24 -25.99 26.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.902 -1.124 . . . . 2.2599999999999998 111.926 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.37 -39.9 84.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.469 -0.769 . . . . 1.45 110.631 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.64 90.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.852 . . . . 1.25 110.89 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.94 -45.68 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.009 -1.057 . . . . 1.26 110.315 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -71.31 -31.0 66.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.82999999999999996 110.441 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.31 -40.12 89.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.012 -1.055 . . . . 1.1899999999999999 109.68 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.7 -38.85 93.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.208 -1.157 . . . . 0.57999999999999996 110.208 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -58.28 -42.07 85.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.227 -1.161 . . . . 2.0499999999999998 110.489 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 77' ' ' ILE . 96.3 mt -60.37 -39.34 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 1.21 110.195 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.3 ttp -59.04 -39.36 81.77 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.178 -0.951 . . . . 2.29 110.491 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.39 -51.39 70.03 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.195 -1.002 . . . . 1.21 110.796 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.76 -38.15 90.03 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.376 -0.827 . . . . 1.1399999999999999 109.994 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -84.67 4.72 31.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.287 0.847 . . . . 1.4199999999999999 113.287 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -66.75 123.48 20.24 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.576 -1.328 . . . . 1.27 108.169 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -65.71 -20.19 66.19 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.778 0.799 . . . . 1.3500000000000001 110.811 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -75.24 -49.46 19.26 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.426 -0.909 . . . . 2.2200000000000002 110.737 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.2 -40.04 95.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.056 -1.027 . . . . 1.22 110.629 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -60.45 -48.22 82.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.002 -1.061 . . . . 1.29 110.602 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.33 -39.97 92.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.385 -0.822 . . . . 2.1699999999999999 110.771 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -63.73 -46.5 85.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.022 -1.071 . . . . 1.3 110.256 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.5 mt -58.36 -43.66 86.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.23 -0.919 . . . . 1.1699999999999999 110.067 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.24 -44.07 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.467 -0.771 . . . . 1.3999999999999999 110.61 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.53 -41.28 97.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 1.3300000000000001 111.146 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.11 -44.85 96.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.054 -1.028 . . . . 1.48 110.736 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.02 -45.1 99.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.16 -0.963 . . . . 1.28 110.305 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -83.2 -37.57 23.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 2.6000000000000001 111.665 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 91' ' ' ALA . 56.1 t0 -79.16 -45.33 20.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.821 -1.174 . . . . 1.51 111.453 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -101.55 8.02 42.07 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.187 -0.945 . . . . 2.48 112.272 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 51.85 49.77 20.04 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.329 -0.857 . . . . 1.6100000000000001 112.097 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.8 mtp -106.78 156.8 18.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.264 -0.897 . . . . 1.8999999999999999 108.838 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.482 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 36.8 p -72.71 161.18 31.08 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.474 -0.766 . . . . 1.3200000000000001 110.361 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.62 93.65 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.459 -0.776 . . . . 1.1499999999999999 110.531 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -68.64 -39.46 80.71 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.069 -1.019 . . . . 2.25 110.392 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.482 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -69.89 -52.34 25.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.186 -1.005 . . . . 1.22 110.84 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.07 92.44 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.1 -1.0 . . . . 1.1899999999999999 110.519 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.46 96.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.339 -0.851 . . . . 1.2 110.565 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -60.64 -38.86 86.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.166 -0.959 . . . . 2.1000000000000001 110.738 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -54.95 -49.5 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 1.3 111.158 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.21 -47.28 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.844 -1.16 . . . . 1.27 109.987 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -61.93 -32.35 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.352 0.596 . . . . 1.1899999999999999 110.568 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -58.51 -40.76 83.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -0.877 . . . . 2.1099999999999999 111.189 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.41 -37.15 8.31 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.064 -1.541 . . . . 0.88 112.888 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -60.3 -38.89 85.06 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.586 -1.538 . . . . 1.99 110.095 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.61 -51.78 15.66 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.54 0.686 . . . . 1.28 110.89 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.6 p -63.49 -35.77 81.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 2.2200000000000002 110.606 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.44 96.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.795 . . . . 1.45 110.629 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.79 -29.99 70.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.053 -1.03 . . . . 1.47 110.655 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -67.16 -22.57 65.75 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.353 -0.842 . . . . 2.04 110.933 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -70.32 -16.12 62.96 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.593 -0.843 . . . . 1.73 111.131 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.8 mt -84.66 144.38 28.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.579 -0.7 . . . . 1.79 109.949 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -97.74 37.36 1.4 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.479 -0.763 . . . . 2.8799999999999999 111.987 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -113.56 139.22 49.18 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 108.377 -0.972 . . . . 1.5800000000000001 108.377 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -59.96 -40.64 89.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.484 -0.76 . . . . 3.04 110.775 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.34 -50.9 34.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.788 -1.195 . . . . 1.29 110.177 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.2 mt -63.23 -42.5 99.25 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.85 -1.14 . . . . 1.6000000000000001 110.022 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -63.35 -49.01 75.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.787 -1.196 . . . . 2.7599999999999998 109.266 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -59.94 -31.07 69.51 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.606 -0.838 . . . . 2.1499999999999999 109.386 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.56 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 17.7 ttt-85 -61.93 -30.44 70.9 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.992 0.901 . . . . 2.8100000000000001 108.82 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.86 -49.37 77.74 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.718 0.771 . . . . 1.3899999999999999 109.366 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.22 85.59 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.581 -0.848 . . . . 1.4099999999999999 110.258 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -63.32 -37.41 87.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.552 -0.717 . . . . 1.3899999999999999 110.417 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.56 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 39.9 t -69.18 -39.7 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 1.1899999999999999 109.936 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -58.58 -36.55 74.15 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.016 -1.052 . . . . 3.6299999999999999 109.734 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.402 ' OD2' ' OG1' ' A' ' 164' ' ' THR . 64.8 t0 -59.92 -39.74 86.48 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.455 0.645 . . . . 1.28 110.052 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.1 mt -61.97 -39.55 84.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.438 -0.789 . . . . 1.1799999999999999 109.509 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.97 -46.8 50.18 Favored Glycine 0 N--CA 1.483 1.773 0 C-N-CA 119.766 -1.207 . . . . 0.51000000000000001 110.517 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.74 -49.99 71.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -1.155 . . . . 3.1699999999999999 110.289 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.432 ' NH2' ' HG ' ' A' ' 166' ' ' SER . 67.3 mtm180 -62.64 -39.25 93.27 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.21 -0.996 . . . . 2.8500000000000001 109.87 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.33 -39.96 88.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.559 -0.713 . . . . 1.6499999999999999 110.02 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.47 -44.32 93.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.519 -0.738 . . . . 1.2 110.081 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -60.51 -35.4 75.86 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.102 -0.999 . . . . 2.7999999999999998 110.26 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -73.06 -40.21 65.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 2.1499999999999999 110.7 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 141' ' ' ILE . 96.7 mt -60.28 -40.01 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 1.21 109.942 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.0 mt -91.01 -3.45 57.23 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.209 -0.932 . . . . 1.3400000000000001 112.416 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.47 23.23 77.72 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.808 -1.187 . . . . 0.91000000000000003 113.13 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.9 tp -66.16 149.26 50.58 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.744 -0.856 . . . . 1.51 109.284 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -64.64 144.91 56.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 2.8799999999999999 109.433 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 53.8 mt -105.46 143.12 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.436 -0.949 . . . . 1.6200000000000001 108.436 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.427 ' H ' HD13 ' A' ' 147' ' ' ILE . 4.2 mp -77.8 125.03 37.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.09 -1.078 . . . . 2.1099999999999999 108.09 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -95.89 93.16 6.88 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.585 -1.635 . . . . 1.6200000000000001 106.585 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.9 mt -78.81 -16.53 57.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 1.3999999999999999 111.981 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.5 m -80.66 0.76 32.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.338 -0.851 . . . . 2.0499999999999998 112.572 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.03 19.75 14.58 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.24 -0.913 . . . . 1.3500000000000001 112.459 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.0 mt -74.86 136.72 24.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.515 0.674 . . . . 1.4199999999999999 109.3 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -125.17 -2.78 7.58 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.448 0.642 . . . . 2.9900000000000002 112.51 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -116.86 134.28 54.96 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.248 -1.019 . . . . 1.54 108.248 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.72 119.1 15.4 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.075 -0.713 . . . . 1.3799999999999999 109.075 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.8 m -147.38 172.27 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.518 -0.739 . . . . 1.28 109.286 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.1 mt -87.33 142.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 1.1599999999999999 109.093 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 25.6 tp -96.46 123.76 40.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.077 -1.014 . . . . 1.3100000000000001 108.432 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.68 129.74 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 107.594 -1.261 . . . . 1.25 107.594 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.14 152.53 19.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.033 -1.042 . . . . 1.26 108.95 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.68 -35.46 76.31 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.585 -1.322 . . . . 1.6000000000000001 109.424 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 64.2 t0 -172.54 147.26 1.83 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.268 -0.641 . . . . 2.4199999999999999 109.268 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.502 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 82.3 mt -116.23 141.61 47.92 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.179 -0.675 . . . . 1.3500000000000001 109.179 177.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.402 ' OG1' ' OD2' ' A' ' 132' ' ' ASP . 36.5 p -94.08 150.25 38.15 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.159 -0.963 . . . . 1.3200000000000001 109.152 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -42.02 -44.3 7.23 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.007 1.805 . . . . 0.69999999999999996 113.719 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.432 ' HG ' ' NH2' ' A' ' 136' ' ' ARG . 28.8 m -59.94 -48.25 82.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.883 -1.136 . . . . 1.1200000000000001 110.055 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.95 -40.69 95.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.225 -0.99 . . . . 1.21 110.126 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 70.7 p -70.22 -39.01 75.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 1.1899999999999999 110.401 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.04 -34.35 74.72 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.896 -0.722 . . . . 1.24 110.881 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -95.7 1.37 53.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.074 -1.017 . . . . 1.6899999999999999 112.521 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.51 152.02 31.3 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.384 -0.822 . . . . 1.3400000000000001 109.778 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.431 HD21 ' H ' ' A' ' 175' ' ' LYS . 0.4 OUTLIER -93.65 110.91 22.51 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.057 -1.831 . . . . 2.77 106.057 177.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.1 mt -72.26 -21.15 61.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.638 -0.664 . . . . 2.0899999999999999 112.318 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -82.53 -23.57 34.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.929 -1.107 . . . . 2.6699999999999999 112.386 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.431 ' H ' HD21 ' A' ' 172' ' ' ASN . 44.2 mmtm -97.15 -4.98 38.24 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.035 -1.041 . . . . 2.5800000000000001 113.094 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.2 t -108.34 128.78 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.566 -1.272 . . . . 1.1799999999999999 107.566 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.1 tp -88.5 -12.05 44.06 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.403 -0.811 . . . . 2.1800000000000002 112.241 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 179.26 167.72 37.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.639 -1.785 . . . . 0.48999999999999999 108.639 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -128.01 131.48 49.2 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.255 -1.144 . . . . 0.64000000000000001 108.458 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 76.8 mt -127.12 129.91 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.172 -1.418 . . . . 1.21 107.172 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 203' ' ' VAL . 37.8 p -138.96 169.95 16.86 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.593 -1.317 . . . . 1.3799999999999999 110.066 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.439 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 4.3 m-20 -101.07 35.5 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.875 -0.515 . . . . 2.3700000000000001 111.53 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -99.88 121.71 41.73 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.922 -1.112 . . . . 1.52 108.325 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.38 19.42 43.76 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.255 -0.974 . . . . 1.8 112.189 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -82.54 118.78 4.7 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.148 -1.981 . . . . 2.04 108.148 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -57.98 -29.95 65.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.986 -1.302 . . . . 5.0 109.747 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 63.9 p -108.4 38.76 2.14 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.414 0.626 . . . . 3.02 110.195 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.6 t -70.22 150.69 46.17 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.598 0.713 . . . . 2.1099999999999999 109.416 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -57.6 -39.66 77.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -0.875 . . . . 1.24 111.088 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 44.1 p -59.74 -41.4 90.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.068 -1.02 . . . . 2.1499999999999999 110.498 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 59.9 p -61.15 -35.49 77.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 2.02 110.367 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.03 -39.59 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 2.1200000000000001 110.852 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 66.0 mtp -62.89 -40.78 98.59 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.233 1.016 . . . . 1.3600000000000001 109.409 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.44 -48.95 79.67 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.739 -0.664 . . . . 1.29 110.297 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -61.16 -41.57 97.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.238 -0.914 . . . . 3.5600000000000001 110.938 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m -70.3 -40.57 74.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.963 -1.086 . . . . 1.1799999999999999 110.539 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.57 -9.1 48.34 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.043 0.757 . . . . 1.3400000000000001 113.043 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.5 mt-10 55.63 8.35 0.32 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.794 1.035 . . . . 1.45 113.794 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 56.8 mt -72.56 147.98 90.0 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 1.25 108.267 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.76 136.3 72.89 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 120.982 1.121 . . . . 0.78000000000000003 110.027 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.31 164.63 34.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.398 -1.439 . . . . 1.2 109.429 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 99.1 mt -144.1 160.19 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.335 -1.357 . . . . 1.25 107.335 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 181' ' ' THR . 15.7 m -139.09 -27.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 120.818 -1.176 . . . . 1.3899999999999999 112.023 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.75 41.03 3.04 Favored Glycine 0 N--CA 1.492 2.43 0 O-C-N 121.242 -0.911 . . . . 0.96999999999999997 111.841 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 46.9 p -62.69 -23.72 67.28 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.24 -1.153 . . . . 1.3500000000000001 111.007 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.04 -92.17 1.78 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.077 -1.059 . . . . 1.0700000000000001 110.668 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 86.0 p -128.35 30.61 5.16 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.178 -1.189 . . . . 1.9199999999999999 112.302 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.21 -33.68 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.264 -1.522 . . . . 1.3300000000000001 110.107 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 26.0 p -58.14 -26.76 63.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.987 -1.071 . . . . 1.4199999999999999 111.52 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.8 t -93.58 1.82 56.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.301 -0.875 . . . . 2.1200000000000001 111.999 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -123.95 -0.53 8.43 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 112.911 0.708 . . . . 2.6899999999999999 112.911 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 11.1 t -120.01 150.87 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.52 -0.737 . . . . 1.29 109.853 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -118.73 157.81 26.77 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.918 -1.142 . . . . 2.6899999999999999 107.918 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.602 HD21 ' N ' ' A' ' 215' ' ' ASP . 0.2 OUTLIER -59.26 141.2 54.96 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.978 -1.076 . . . . 2.79 110.492 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.602 ' N ' HD21 ' A' ' 214' ' ' ASN . 3.3 m-20 80.75 -1.5 1.85 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 114.525 1.306 . . . . 2.3500000000000001 114.525 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -62.33 148.85 43.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.34 -1.475 . . . . 1.97 108.176 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -88.57 120.84 30.32 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.311 -1.366 . . . . 2.9700000000000002 107.311 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.8 mt -128.48 146.38 50.83 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.664 0.745 . . . . 1.25 109.905 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.11 126.76 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.617 -1.623 . . . . 1.22 106.617 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 65.5 tp -100.52 119.64 38.81 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.355 -1.721 . . . . 1.24 106.355 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 53.3 t0 -92.25 -26.4 18.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.893 -1.13 . . . . 2.0499999999999998 112.518 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 10' ' ' GLY . . . 39.11 13.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.137 0.791 . . . . 1.25 113.137 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.2 t -108.27 -59.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.741 -1.224 . . . . 1.4299999999999999 109.695 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -92.68 10.12 32.01 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.018 0.913 . . . . 3.0299999999999998 110.561 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 62.15 53.58 2.89 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.659 -0.7 . . . . 2.25 112.242 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.641 ' NE2' ' H3 ' ' A' ' 1' ' ' MET . 63.1 tt0 -147.0 149.06 32.4 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.371 1.081 . . . . 2.52 109.645 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.1 t -115.98 133.33 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.444 -1.317 . . . . 1.29 107.444 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.11 132.57 46.5 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.026 -1.047 . . . . 1.3400000000000001 108.468 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 60.4 t -110.48 129.94 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.365 -0.834 . . . . 1.3400000000000001 108.763 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.4 t30 54.34 55.2 11.73 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.15 -0.969 . . . . 2.1800000000000002 113.232 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.09 150.42 60.06 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.582 2.188 . . . . 0.93999999999999995 111.322 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.5 m -75.2 158.87 32.29 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.254 -0.904 . . . . 2.3999999999999999 109.313 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -58.75 -39.09 79.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 3.3300000000000001 110.688 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -58.82 -40.17 83.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -0.937 . . . . 3.1699999999999999 109.865 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.65 -39.09 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 1.6899999999999999 110.105 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.4 mt -57.35 -47.26 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.818 -0.753 . . . . 1.6000000000000001 110.715 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.92 -40.22 88.12 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.326 -0.859 . . . . 2.7000000000000002 110.557 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -61.17 -48.12 83.03 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.401 -0.812 . . . . 2.96 111.289 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 81.9 mtp -70.44 -33.1 70.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 1.6299999999999999 111.092 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -58.05 -40.4 80.83 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.983 -1.073 . . . . 3.27 110.076 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.11 -36.97 66.85 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.418 -0.801 . . . . 2.23 110.676 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 82.5 t -58.86 -49.7 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.206 -0.934 . . . . 2.79 111.097 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.427 ' OE1' ' N ' ' A' ' 244' ' ' GLU . 20.9 tm0? -61.58 -52.09 65.83 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.775 -1.203 . . . . 4.2599999999999998 110.362 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.427 ' N ' ' OE1' ' A' ' 243' ' ' GLN . 85.8 mt-10 -62.23 -34.42 76.48 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.715 -0.794 . . . . 1.8799999999999999 110.125 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -62.81 -30.02 71.16 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.373 -0.931 . . . . 3.3799999999999999 110.024 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.42 -44.92 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.251 -0.98 . . . . 2.8799999999999999 109.875 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.28 96.55 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.069 -1.052 . . . . 2.75 109.901 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.3 t -72.41 -30.42 64.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.586 -0.696 . . . . 3.4199999999999999 110.805 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.46 -40.0 89.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.055 -1.028 . . . . 3.5699999999999998 110.921 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -65.0 -39.81 94.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.843 -1.161 . . . . 4.6100000000000003 110.424 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.86 -26.3 63.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.201 -0.937 . . . . 4.4500000000000002 111.273 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -69.07 -48.86 61.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.113 -0.992 . . . . 5.9699999999999998 110.624 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 3.1 pp -71.08 -22.85 62.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.1 -1.0 . . . . 6.4500000000000002 111.622 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -70.37 -20.31 62.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 6.6600000000000001 111.707 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -77.64 -46.27 22.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.135 -0.978 . . . . 8.5399999999999991 110.981 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.3 56.75 2.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.997 -1.065 . . . . 8.0700000000000003 110.771 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -84.6 -8.95 58.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.942 -1.099 . . . . 9.7200000000000006 112.058 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -93.76 9.57 36.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.581 -0.699 . . . . 10.119999999999999 112.548 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 118.046 -0.978 . . . . 11.9 110.361 -179.389 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.671 -0.492 . . . . 3.5299999999999998 109.671 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 1' ' ' MET . 40.1 mt 41.2 68.17 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.837 . . . . 1.5700000000000001 111.962 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.0 m -97.38 116.67 30.02 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.576 -1.639 . . . . 1.4399999999999999 106.576 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.78 -153.47 30.29 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 120.441 -1.412 . . . . 1.01 109.912 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.472 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 74.6 mt -94.43 1.01 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.586 -0.949 . . . . 1.6299999999999999 112.552 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 tp 52.52 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.685 -1.26 . . . . 1.5800000000000001 112.444 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.54 -35.33 17.01 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.648 -1.283 . . . . 1.3400000000000001 110.744 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 1.2 p -148.67 140.96 14.85 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.711 -1.243 . . . . 1.8600000000000001 108.083 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.0 147.88 24.33 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.151 1.901 . . . . 1.01 112.347 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 152.56 163.64 11.79 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.265 -1.534 . . . . 0.81000000000000005 109.265 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.5 mt -121.05 134.33 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.057 -1.261 . . . . 1.3700000000000001 108.345 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.25 151.85 44.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.193 -0.942 . . . . 1.1399999999999999 109.416 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.9 m-85 -122.06 144.46 48.9 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.431 -0.951 . . . . 0.87 108.431 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.85 166.27 31.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.551 -1.785 . . . . 0.56999999999999995 110.092 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -77.88 159.68 28.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.329 -1.101 . . . . 2.3500000000000001 109.204 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.53 127.69 35.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.792 -1.188 . . . . 1.21 107.792 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.2 tp -106.11 109.53 21.49 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 105.468 -2.049 . . . . 1.3999999999999999 105.468 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.8 tp -95.58 136.27 36.17 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.414 -1.328 . . . . 1.4399999999999999 107.414 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.8 mt -99.8 118.82 37.09 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.062 -1.459 . . . . 1.45 107.062 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -112.05 136.19 51.72 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.65 -1.241 . . . . 2.5 107.65 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -130.33 151.96 50.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.251 -0.906 . . . . 2.6600000000000001 109.149 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -80.06 138.35 36.96 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.478 -0.934 . . . . 2.3199999999999998 108.478 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -63.79 149.33 47.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.454 -0.779 . . . . 2.1099999999999999 109.002 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.6 mt -92.69 129.97 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.915 -1.116 . . . . 1.29 108.651 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.9 t -105.36 130.01 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.529 -1.285 . . . . 1.4099999999999999 107.529 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.27 135.03 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.654 -0.869 . . . . 1.3100000000000001 108.654 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -90.91 122.1 33.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.075 -1.016 . . . . 1.3400000000000001 108.512 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -95.4 11.8 31.52 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.591 -0.693 . . . . 3.48 112.106 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' CB ' ' HZ1' ' A' ' 29' ' ' LYS . 9.8 mtmp? -66.97 141.54 57.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.88 -1.138 . . . . 2.52 108.885 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -88.9 134.16 34.05 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.138 -1.06 . . . . 2.6299999999999999 108.138 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -97.78 167.14 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.394 -0.816 . . . . 1.3100000000000001 110.477 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.6 p -94.67 160.95 14.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.686 -0.633 . . . . 1.24 109.53 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.41 -21.92 11.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.903 -1.123 . . . . 1.49 111.94 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -67.53 -37.24 82.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 2.2799999999999998 110.753 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -90.25 -8.5 50.85 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.649 -1.282 . . . . 2.0499999999999998 112.587 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.1 t -58.89 -39.82 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.446 -0.784 . . . . 1.3400000000000001 110.553 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -56.33 -40.24 74.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.929 -1.107 . . . . 1.54 110.187 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.29 -39.5 94.74 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.432 -0.793 . . . . 2.8500000000000001 111.045 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.46 -43.54 96.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.025 -1.047 . . . . 1.3100000000000001 110.707 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.24 -40.85 84.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.23 -0.918 . . . . 1.3799999999999999 110.501 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -60.58 -45.37 94.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.237 -0.914 . . . . 1.5 110.107 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -61.83 -40.57 95.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.582 -0.699 . . . . 2.7799999999999998 110.287 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -74.02 -52.84 11.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.094 -1.004 . . . . 1.0600000000000001 109.934 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.6 tp -61.77 -47.96 82.84 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.554 -0.859 . . . . 1.3999999999999999 110.09 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 t -69.92 -38.06 76.13 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.289 -0.882 . . . . 1.3200000000000001 109.703 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.89 -40.8 95.71 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.037 -1.625 . . . . 0.69999999999999996 109.037 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.545 HH22 ' CD ' ' A' ' 86' ' ' GLU . 17.2 ttm180 -59.2 -30.69 68.4 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.737 0.779 . . . . 3.4399999999999999 109.334 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.79 76.5 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.614 0.721 . . . . 1.3600000000000001 110.365 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -82.7 -38.33 23.51 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.297 -0.877 . . . . 2.8300000000000001 110.169 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.5 -44.85 95.54 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.84 -0.744 . . . . 1.23 109.905 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.8 t -60.13 -40.21 88.99 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.339 1.066 . . . . 1.9199999999999999 108.797 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.62 -45.93 88.04 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.648 -0.706 . . . . 1.25 109.771 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -61.46 -50.44 72.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.995 -1.065 . . . . 1.97 110.324 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.26 -39.83 91.81 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.321 -0.862 . . . . 2.1800000000000002 110.071 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -59.9 -43.11 95.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.887 -0.508 . . . . 1.1899999999999999 110.619 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 m -63.96 -42.36 97.3 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.789 -1.194 . . . . 1.3400000000000001 109.948 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.6 -35.2 61.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.68 -0.638 . . . . 1.23 110.337 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -53.03 -41.51 64.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.431 -0.793 . . . . 1.5600000000000001 110.442 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -70.34 -35.42 73.59 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.376 -0.828 . . . . 1.3 109.691 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.48 -40.9 92.93 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.221 -0.991 . . . . 2.3199999999999998 109.045 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.08 -36.01 82.18 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 120.178 -0.609 . . . . 1.1399999999999999 109.47 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.2 -35.07 27.92 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.588 -1.291 . . . . 0.68999999999999995 110.435 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.36 -16.98 50.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.318 -1.107 . . . . 1.48 111.209 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.6 m -91.24 -54.88 3.74 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.264 0.554 . . . . 1.52 110.381 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.544 ' C ' ' H ' ' A' ' 67' ' ' GLU . 61.5 m-85 -107.35 -30.48 8.67 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.11 0.782 . . . . 1.3100000000000001 113.11 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 61.48 -26.13 0.06 OUTLIER Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.536 -1.316 . . . . 0.84999999999999998 115.059 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 65' ' ' PHE . 52.5 mt-10 -54.84 -166.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.556 -0.967 . . . . 3.8599999999999999 109.844 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -66.57 7.29 0.36 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 112.953 0.723 . . . . 2.3500000000000001 112.953 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 67' ' ' GLU . 66.8 mmtt -68.6 -24.64 64.6 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.461 -0.774 . . . . 2.2599999999999998 111.375 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -58.65 -40.21 82.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.021 -1.049 . . . . 1.45 110.687 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.83 -36.56 84.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.869 . . . . 1.25 110.958 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.3 mt -64.8 -45.91 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 1.26 110.718 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -69.62 -33.96 73.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.863 -1.148 . . . . 0.82999999999999996 110.257 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.44 -39.23 90.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.302 -0.874 . . . . 1.1899999999999999 110.174 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.09 -37.74 95.01 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.664 -0.974 . . . . 0.57999999999999996 110.664 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -59.84 -41.98 92.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -1.114 . . . . 2.0499999999999998 110.343 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.8 mt -61.2 -40.96 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.09 . . . . 1.21 110.43 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.3 ttt -59.71 -39.65 85.35 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 120.97 -1.081 . . . . 2.29 110.523 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 tp -58.43 -49.98 75.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.114 -0.991 . . . . 1.21 110.199 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.5 tp -61.67 -42.08 98.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.099 -1.001 . . . . 1.1399999999999999 109.961 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -86.63 9.08 19.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.482 -0.762 . . . . 1.4199999999999999 112.564 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.05 121.45 14.19 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.12 -0.988 . . . . 1.27 108.505 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.63 -18.89 65.12 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.455 -0.778 . . . . 1.3500000000000001 111.067 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.61 -50.63 14.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.51 -0.876 . . . . 2.2200000000000002 110.41 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.28 -35.39 77.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.208 -0.597 . . . . 1.22 110.684 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.545 ' CD ' HH22 ' A' ' 47' ' ' ARG . 72.5 tt0 -59.77 -47.45 85.62 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.444 -0.785 . . . . 1.29 110.473 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -61.22 -37.48 83.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.35 -0.844 . . . . 2.1699999999999999 110.756 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -68.44 -48.83 63.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 1.3 110.673 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.5 mt -57.6 -43.51 83.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.179 -0.95 . . . . 1.1699999999999999 110.242 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.0 mt -60.09 -40.63 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.462 -0.774 . . . . 1.3999999999999999 110.411 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.42 95.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.563 -0.711 . . . . 1.3300000000000001 110.685 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.31 -45.61 92.78 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.96 -1.087 . . . . 1.48 110.313 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.28 -49.11 80.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.155 -0.966 . . . . 1.28 110.335 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -73.8 -36.44 65.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.916 -1.115 . . . . 2.6000000000000001 111.842 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -78.5 -47.77 16.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.833 -1.167 . . . . 1.51 111.469 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -101.48 7.43 42.45 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.422 -0.799 . . . . 2.48 112.846 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.4 m80 52.39 50.1 19.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.824 -1.173 . . . . 1.6100000000000001 111.661 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtt -102.98 158.1 16.52 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.843 0.83 . . . . 1.8999999999999999 109.16 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.457 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 66.9 p -74.87 161.9 29.13 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.817 -0.552 . . . . 1.3200000000000001 109.963 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.87 92.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.993 -1.067 . . . . 1.1499999999999999 110.395 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.457 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 16.7 p-10 -68.64 -39.83 80.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.018 -1.051 . . . . 2.25 110.26 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.26 -51.36 38.26 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.548 -0.861 . . . . 1.22 111.307 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.09 92.78 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.153 -1.019 . . . . 1.1899999999999999 110.838 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.37 85.23 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.27 -0.894 . . . . 1.2 110.965 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -61.64 -38.88 89.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.686 -1.259 . . . . 2.1000000000000001 111.499 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.83 -48.98 79.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.779 -1.201 . . . . 1.3 111.219 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.85 -45.99 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.912 -1.118 . . . . 1.27 110.248 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 mm -61.95 -31.13 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.814 . . . . 1.1899999999999999 109.91 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -59.8 -41.37 91.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 2.1099999999999999 110.892 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.59 -34.12 12.24 Favored Glycine 0 N--CA 1.498 2.828 0 C-N-CA 119.084 -1.532 . . . . 0.88 112.478 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -60.9 -39.89 91.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.529 -1.571 . . . . 1.99 110.215 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.49 55.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.378 0.609 . . . . 1.28 110.6 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.5 p -62.6 -40.48 97.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.437 -0.789 . . . . 2.2200000000000002 110.275 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.96 -41.26 96.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 1.45 111.087 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.6 mt -65.67 -30.67 71.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.772 -1.205 . . . . 1.47 111.084 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -66.66 -21.81 66.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.872 -1.143 . . . . 2.04 111.079 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -73.28 -14.18 61.27 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.192 -0.943 . . . . 1.73 111.57 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.1 mt -84.26 142.54 30.18 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.582 -0.699 . . . . 1.79 109.26 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -100.39 55.23 0.89 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 2.8799999999999999 110.737 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -129.98 137.86 50.53 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.211 -1.033 . . . . 1.5800000000000001 108.211 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -58.99 -36.61 75.16 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.134 -0.626 . . . . 3.04 110.816 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.457 ' HH ' ' NH1' ' A' ' 126' ' ' ARG . 17.7 t80 -73.9 -52.46 12.87 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.791 -1.193 . . . . 1.29 110.381 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 23.1 mt -64.07 -43.72 94.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.06 -1.025 . . . . 1.6000000000000001 110.27 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -61.14 -47.35 86.61 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.641 -1.287 . . . . 2.7599999999999998 109.857 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -61.77 -29.28 70.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.083 -1.011 . . . . 2.1499999999999999 110.014 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.457 ' NH1' ' HH ' ' A' ' 122' ' ' TYR . 56.0 ttt180 -65.15 -29.0 69.8 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.537 -0.865 . . . . 2.8100000000000001 109.365 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.55 -49.83 76.27 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.613 -0.835 . . . . 1.3899999999999999 109.698 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.23 85.02 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.007 -0.677 . . . . 1.4099999999999999 110.248 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.54 -38.26 90.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.226 -0.921 . . . . 1.3899999999999999 110.439 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.92 -40.18 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.913 -1.117 . . . . 1.1899999999999999 109.839 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -60.08 -37.8 80.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.892 -1.13 . . . . 3.6299999999999999 110.21 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.536 ' CG ' HH11 ' A' ' 136' ' ' ARG . 42.1 t0 -59.87 -39.23 84.56 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.209 -0.932 . . . . 1.28 110.535 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.31 -39.43 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.562 -0.711 . . . . 1.1799999999999999 110.1 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.06 -50.48 45.97 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.89 -1.147 . . . . 0.51000000000000001 110.603 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -59.42 -47.02 87.04 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.112 -1.228 . . . . 3.1699999999999999 110.534 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 132' ' ' ASP . 14.8 mtm-85 -64.58 -39.85 94.47 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.067 -1.053 . . . . 2.8500000000000001 109.883 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.1 tp -61.24 -39.91 92.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.6499999999999999 110.15 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 73.2 mt -59.34 -40.26 85.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 1.2 110.704 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -61.19 -34.52 75.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.128 -0.983 . . . . 2.7999999999999998 110.344 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -75.58 -40.73 56.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.021 -1.049 . . . . 2.1499999999999999 110.587 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 98.1 mt -60.04 -39.48 80.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 120.812 -1.18 . . . . 1.21 110.479 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.88 -7.93 58.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 1.3400000000000001 111.659 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.26 22.62 64.88 Favored Glycine 0 N--CA 1.483 1.807 0 C-N-CA 120.104 -1.046 . . . . 0.91000000000000003 113.367 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.41 145.92 55.14 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.744 -0.857 . . . . 1.51 109.418 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -64.5 148.57 50.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.418 -0.801 . . . . 2.8799999999999999 109.322 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.2 mt -108.61 140.11 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.47 -0.937 . . . . 1.6200000000000001 108.47 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 21.2 mm -79.77 129.55 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.972 -1.08 . . . . 2.1099999999999999 108.754 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -96.95 95.67 7.98 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.149 -1.797 . . . . 1.6200000000000001 106.149 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.43 -22.19 61.13 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.498 -0.751 . . . . 1.3999999999999999 111.088 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.462 ' OG ' ' OD1' ' A' ' 172' ' ' ASN . 32.5 t -78.13 -0.53 28.62 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.084 0.945 . . . . 2.0499999999999998 112.316 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.9 25.48 5.29 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.438 -0.789 . . . . 1.3500000000000001 112.236 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.8 mt -71.05 139.97 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.465 -0.772 . . . . 1.4199999999999999 109.566 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -115.17 -19.89 10.63 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 2.9900000000000002 112.949 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -117.27 139.61 50.59 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.885 -1.154 . . . . 1.54 107.885 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.6 126.69 30.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.449 -0.945 . . . . 1.3799999999999999 108.449 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.7 m -149.5 175.16 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.01 -1.056 . . . . 1.28 109.166 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.9 mt -89.09 142.35 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 1.1599999999999999 108.644 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 27.6 tp -96.79 124.02 40.65 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.459 -0.941 . . . . 1.3100000000000001 108.459 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.1 t -125.02 131.98 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.293 -1.003 . . . . 1.25 108.293 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.48 157.63 19.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 1.26 108.982 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -64.99 -35.35 80.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.686 -1.259 . . . . 1.6000000000000001 109.304 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.7 t0 -171.45 152.71 3.32 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.845 -0.798 . . . . 2.4199999999999999 108.845 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.472 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 66.3 mt -115.09 142.98 45.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.677 -0.86 . . . . 1.3500000000000001 108.677 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.8 p -92.95 147.18 33.43 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.462 -0.773 . . . . 1.3200000000000001 108.938 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -40.31 -42.04 3.55 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.511 1.474 . . . . 0.69999999999999996 113.587 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.1 m -61.6 -48.14 82.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.799 -1.188 . . . . 1.1200000000000001 110.278 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.13 -39.46 89.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.023 -1.048 . . . . 1.21 110.87 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -68.79 -40.51 79.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.344 -0.847 . . . . 1.1899999999999999 110.783 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.48 79.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -0.949 . . . . 1.24 110.464 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -93.65 -2.39 54.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.913 -1.117 . . . . 1.6899999999999999 112.396 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 42.6 tp -62.13 146.77 49.58 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.251 -1.018 . . . . 1.3400000000000001 108.251 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.462 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 17.6 m120 -95.33 116.96 29.48 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.727 -1.582 . . . . 2.77 106.727 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -73.52 -18.82 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.419 -0.801 . . . . 2.0899999999999999 111.41 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -82.78 -18.26 41.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.526 -0.734 . . . . 2.6699999999999999 112.293 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -104.15 -6.12 21.34 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.312 0.856 . . . . 2.5800000000000001 113.312 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 52.2 t -108.54 129.67 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.559 -1.275 . . . . 1.1799999999999999 107.559 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 29.7 tp -82.89 -8.77 59.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.054 -1.029 . . . . 2.1800000000000002 112.543 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 166.98 177.52 38.77 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.599 -1.8 . . . . 0.48999999999999999 108.599 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -129.28 135.84 49.3 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.975 -1.309 . . . . 0.64000000000000001 107.588 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 75.1 mt -138.01 105.15 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.145 -1.798 . . . . 1.21 106.145 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 203' ' ' VAL . 76.7 p -129.68 168.94 15.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.357 -0.84 . . . . 1.3799999999999999 109.416 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 26.1 p-10 -98.68 47.95 0.98 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.737 -0.602 . . . . 2.3700000000000001 110.93 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.403 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -99.34 164.54 12.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.395 -0.816 . . . . 1.52 110.416 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 183' ' ' ALA . . . -54.23 -100.6 0.01 OUTLIER Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.298 -1.521 . . . . 1.8 109.298 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 164.93 -58.87 0.25 Allowed Glycine 0 N--CA 1.492 2.427 0 O-C-N 121.095 -1.238 . . . . 2.04 112.596 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -57.51 -45.43 84.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -1.094 . . . . 5.0 110.231 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.3 p -109.22 17.78 21.21 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.529 -0.732 . . . . 3.02 112.238 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 53.5 m -88.03 126.83 35.3 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.717 -1.216 . . . . 2.1099999999999999 107.717 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -60.63 -35.53 76.41 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.383 -0.823 . . . . 1.24 110.422 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.6 p -56.31 -39.7 73.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.167 -0.958 . . . . 2.1499999999999999 109.982 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.4 m -59.2 -37.29 77.07 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.934 -0.707 . . . . 2.02 110.098 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -59.9 -38.85 78.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.498 -0.751 . . . . 2.1200000000000001 110.309 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 69.9 mtp -64.1 -40.21 95.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.671 -1.268 . . . . 1.3600000000000001 109.457 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.8 -48.92 79.73 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.027 -0.533 . . . . 1.29 111.384 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -59.37 -43.95 92.81 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.19 -0.944 . . . . 3.5600000000000001 110.432 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.1 m -68.97 -40.18 79.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.339 -0.851 . . . . 1.1799999999999999 110.226 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.6 mt -91.78 -9.32 43.97 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.811 0.815 . . . . 1.3400000000000001 112.126 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.8 mt-10 47.46 14.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.472 0.916 . . . . 1.45 113.472 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.45 ' O ' ' OG ' ' A' ' 8' ' ' SER . 59.6 mt -75.41 150.27 84.73 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.953 -1.092 . . . . 1.25 108.538 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -51.49 140.51 44.2 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.393 1.396 . . . . 0.78000000000000003 109.302 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.442 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -159.05 163.61 36.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.209 -1.557 . . . . 1.2 109.829 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.5 mt -147.17 147.04 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.761 -1.2 . . . . 1.25 107.761 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 181' ' ' THR . 9.9 m -129.11 -29.19 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 113.251 0.834 . . . . 1.3899999999999999 113.251 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.61 46.35 3.66 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 120.344 -0.931 . . . . 0.96999999999999997 111.97 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 65.8 p -66.78 -12.88 60.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.965 -1.315 . . . . 1.3500000000000001 111.229 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.85 -94.42 0.68 Allowed Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.038 -1.077 . . . . 1.0700000000000001 110.49 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -129.52 31.21 4.82 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.522 -0.987 . . . . 1.9199999999999999 112.144 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.86 -33.34 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.617 -1.302 . . . . 1.3300000000000001 110.474 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 80.5 p -56.33 -28.22 58.24 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.076 -1.015 . . . . 1.4199999999999999 111.171 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 26.4 t -92.26 0.69 57.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.101 -1.0 . . . . 2.1200000000000001 112.214 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -120.33 -4.19 9.94 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.545 0.943 . . . . 2.6899999999999999 113.545 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.3 149.42 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.227 -0.92 . . . . 1.29 109.285 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -117.62 149.61 40.39 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.535 -0.913 . . . . 2.6899999999999999 108.535 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 38.4 p-10 -50.47 141.33 12.34 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.384 -0.926 . . . . 2.79 110.366 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 8.8 t0 81.49 4.06 1.41 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 114.219 1.192 . . . . 2.3500000000000001 114.219 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -66.7 145.62 55.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.883 -1.136 . . . . 1.97 108.252 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -88.13 119.53 28.6 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.328 -1.36 . . . . 2.9700000000000002 107.328 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 85.2 mt -128.66 150.3 50.3 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.506 0.669 . . . . 1.25 110.155 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 56.5 mt -115.09 122.17 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 106.675 -1.602 . . . . 1.22 106.675 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.0 tp -98.99 115.8 29.77 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 106.754 -1.572 . . . . 1.24 106.754 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 9.3 m-20 -95.47 -24.39 16.68 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.414 -0.914 . . . . 2.0499999999999998 112.606 -177.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.405 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 39.21 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.652 0.739 . . . . 1.25 112.176 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.7 t -111.38 -61.29 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.654 -0.869 . . . . 1.4299999999999999 108.654 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -91.13 9.55 30.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.145 0.974 . . . . 3.0299999999999998 110.159 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.93 51.35 3.77 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 114.921 -1.036 . . . . 2.25 111.986 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -153.17 152.79 31.64 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.798 1.285 . . . . 2.52 110.497 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.0 t -117.38 140.79 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.527 -0.916 . . . . 1.29 108.527 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -100.78 132.82 45.99 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.85 -1.156 . . . . 1.3400000000000001 108.56 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.1 t -109.79 129.55 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.419 -0.956 . . . . 1.3400000000000001 108.419 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.445 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER 56.38 48.17 3.35 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 113.734 1.013 . . . . 2.1800000000000002 113.734 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 58.7 Cg_endo -70.61 150.54 63.18 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.292 1.995 . . . . 0.93999999999999995 111.138 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.7 m -72.93 153.74 40.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.984 -1.073 . . . . 2.3999999999999999 109.027 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 31.6 p-10 -59.82 -33.38 71.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.93 . . . . 3.3300000000000001 110.441 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 97.7 mt-10 -60.12 -39.78 87.45 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.294 -0.879 . . . . 3.1699999999999999 110.161 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.86 -38.93 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.898 . . . . 1.6899999999999999 109.883 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.52 -45.04 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.897 -0.721 . . . . 1.6000000000000001 110.627 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -59.88 -42.08 92.97 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.022 -1.071 . . . . 2.7000000000000002 110.193 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -62.23 -41.15 98.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -0.922 . . . . 2.96 110.328 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.0 mtp -71.42 -40.27 70.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.256 -0.902 . . . . 1.6299999999999999 110.507 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -59.85 -40.9 90.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 3.27 110.08 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.81 -57.87 4.2 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.961 -1.087 . . . . 2.23 111.055 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 97.4 t -60.03 -41.26 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.726 -1.234 . . . . 2.79 111.042 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -62.97 -50.16 71.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.888 -1.132 . . . . 4.2599999999999998 110.832 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -63.37 -37.27 86.62 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.173 -0.954 . . . . 1.8799999999999999 110.93 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -59.89 -29.19 68.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.424 -1.423 . . . . 3.3799999999999999 110.631 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.47 -41.22 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 119.449 -0.901 . . . . 2.8799999999999999 109.421 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.79 -39.46 81.14 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.047 -0.661 . . . . 2.75 110.645 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.5 t -70.06 -44.35 69.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.037 -1.039 . . . . 3.4199999999999999 110.048 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -64.29 -33.54 76.06 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.614 -0.678 . . . . 3.5699999999999998 110.074 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.88 -33.74 76.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -0.822 . . . . 4.6100000000000003 110.861 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.39 97.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.983 -1.073 . . . . 4.4500000000000002 110.123 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.73 -17.54 61.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 5.9699999999999998 111.048 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.2 tp -67.27 -25.63 66.15 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.572 0.701 . . . . 6.4500000000000002 110.914 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.26 -13.83 62.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.265 -0.897 . . . . 6.6600000000000001 112.359 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -82.28 -5.47 58.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.095 -1.003 . . . . 8.5399999999999991 112.206 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 62.0 mt -87.35 39.3 0.86 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.256 -0.903 . . . . 8.0700000000000003 112.382 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -81.49 8.19 10.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.406 -0.809 . . . . 9.7200000000000006 112.184 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -91.61 11.88 22.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.211 -0.931 . . . . 10.119999999999999 112.029 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.462 -0.94 . . . . 11.9 108.462 179.223 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.151 0.5 . . . . 3.5299999999999998 110.274 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mt 48.29 74.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.849 -1.157 . . . . 1.5700000000000001 112.904 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.0 m -100.01 119.13 37.78 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.832 -1.544 . . . . 1.4399999999999999 106.832 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.85 -141.35 9.92 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.615 -0.994 . . . . 1.01 110.615 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 94.3 mt -97.71 -1.91 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.558 -0.966 . . . . 1.6299999999999999 113.008 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp 52.06 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.846 -1.159 . . . . 1.5800000000000001 112.265 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.23 -46.95 12.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.245 -0.909 . . . . 1.3400000000000001 111.193 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -143.4 145.33 31.5 Favored Pre-proline 0 N--CA 1.5 2.048 0 N-CA-C 107.784 -1.191 . . . . 1.8600000000000001 107.784 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.82 150.22 26.96 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.26 1.973 . . . . 1.01 112.309 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 149.81 170.82 17.65 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 108.946 -1.662 . . . . 0.81000000000000005 108.946 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.4 mt -128.31 133.5 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 120.961 -1.317 . . . . 1.3700000000000001 107.828 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.08 145.16 47.66 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.663 -0.866 . . . . 1.1399999999999999 108.663 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.7 m-85 -117.39 141.04 48.81 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.302 -0.874 . . . . 0.87 109.051 177.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.21 168.17 36.01 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.474 -1.822 . . . . 0.56999999999999995 110.096 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -76.59 160.52 29.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.861 -0.788 . . . . 2.3500000000000001 109.943 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.98 126.23 31.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.077 -1.015 . . . . 1.21 108.38 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.1 tp -108.07 102.77 11.91 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 105.0 -2.222 . . . . 1.3999999999999999 105.0 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.5 tp -90.58 138.06 31.86 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.602 -1.258 . . . . 1.4399999999999999 107.602 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.9 mt -100.01 117.45 34.31 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.739 -1.578 . . . . 1.45 106.739 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -111.93 140.08 46.89 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.27 -1.011 . . . . 2.5 108.27 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.517 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 71.5 tt0 -123.82 139.82 53.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 2.6600000000000001 108.802 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.85 133.54 34.74 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.982 -1.118 . . . . 2.3199999999999998 107.982 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -62.19 143.01 57.34 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.633 -0.877 . . . . 2.1099999999999999 108.633 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.3 mt -95.23 135.44 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.121 -0.987 . . . . 1.29 108.363 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.71 129.93 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.349 -0.982 . . . . 1.4099999999999999 108.349 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.94 139.74 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.487 -0.931 . . . . 1.3100000000000001 108.487 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -91.26 119.04 30.99 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.333 -1.358 . . . . 1.3400000000000001 107.333 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.525 ' HG2' HH11 ' A' ' 28' ' ' ARG . 1.0 OUTLIER -95.89 11.72 32.79 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.94 -1.1 . . . . 3.48 112.369 -179.657 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.5 150.64 47.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 2.52 110.966 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -89.29 131.3 35.45 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.103 -1.073 . . . . 2.6299999999999999 108.103 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -94.29 165.4 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.04 . . . . 1.3100000000000001 110.278 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.9 p -92.56 166.08 12.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.584 -0.697 . . . . 1.24 109.724 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.84 -22.53 37.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 1.49 111.85 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -67.2 -36.24 81.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.004 -1.06 . . . . 2.2799999999999998 110.87 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -92.43 -9.36 41.89 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.048 -1.032 . . . . 2.0499999999999998 113.187 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.27 -43.72 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.936 -1.102 . . . . 1.3400000000000001 110.044 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -58.51 -39.97 81.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.096 -1.002 . . . . 1.54 110.574 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -61.37 -39.9 92.32 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.445 -0.784 . . . . 2.8500000000000001 110.028 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -61.06 -40.35 93.34 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 1.3100000000000001 110.373 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.5 t -60.71 -41.61 88.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.047 -1.033 . . . . 1.3799999999999999 110.024 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -60.72 -48.96 79.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.122 -0.986 . . . . 1.5 110.268 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -61.78 -43.21 99.3 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.552 -0.859 . . . . 2.7799999999999998 109.979 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -73.37 -53.21 11.31 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.508 -0.745 . . . . 1.0600000000000001 109.748 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 40' ' ' VAL . 44.8 tp -59.6 -47.2 86.49 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.477 -0.889 . . . . 1.3999999999999999 109.938 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.4 t -69.31 -34.41 74.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 1.3200000000000001 110.011 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.17 -41.82 92.96 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.177 -1.569 . . . . 0.69999999999999996 109.177 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 40.7 ttm-85 -58.73 -34.07 70.96 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.438 -0.905 . . . . 3.4399999999999999 109.053 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.34 -49.68 76.63 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.915 0.864 . . . . 1.3600000000000001 110.182 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.557 ' NZ ' ' OE1' ' A' ' 53' ' ' GLN . 26.9 ttpp -80.94 -42.37 21.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 2.8300000000000001 111.136 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.6 92.18 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.746 -0.781 . . . . 1.23 110.093 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.2 t -60.11 -41.4 92.51 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.206 -0.934 . . . . 1.9199999999999999 109.39 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 -48.4 62.52 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.554 -0.716 . . . . 1.25 110.63 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.557 ' OE1' ' NZ ' ' A' ' 49' ' ' LYS . 27.9 mt-30 -62.34 -49.29 76.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 1.97 110.593 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.86 -37.28 86.22 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.084 -1.01 . . . . 2.1800000000000002 109.766 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -59.25 -40.65 86.64 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.652 -0.655 . . . . 1.1899999999999999 110.648 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -62.4 -40.33 96.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.924 -1.11 . . . . 1.3400000000000001 110.058 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.67 -39.85 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 1.23 110.513 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -50.14 -42.99 51.75 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.348 -0.845 . . . . 1.5600000000000001 111.259 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.6 -36.12 78.25 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.03 -1.044 . . . . 1.3 110.276 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.448 ' O ' ' OG1' ' A' ' 64' ' ' THR . 43.7 mtpt -61.13 -37.91 84.48 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.945 -1.102 . . . . 2.3199999999999998 108.984 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.29 86.8 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.793 -0.763 . . . . 1.1399999999999999 109.613 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.17 -34.75 40.39 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.332 -1.413 . . . . 0.68999999999999995 110.398 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -82.32 -20.08 38.08 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.254 -1.145 . . . . 1.48 111.308 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 38.2 m -86.37 -51.33 6.29 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.356 -0.84 . . . . 1.52 110.428 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.96 -19.66 13.66 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.92 0.711 . . . . 1.3100000000000001 112.92 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.17 163.69 13.6 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 111.466 -0.653 . . . . 0.84999999999999998 111.466 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -56.32 -22.48 30.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.794 -0.827 . . . . 3.8599999999999999 112.603 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -58.21 -35.07 71.11 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.033 -1.042 . . . . 2.3500000000000001 111.631 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -86.61 -11.95 49.97 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.824 -1.172 . . . . 2.2599999999999998 113.07 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.75 -30.76 69.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.773 -1.204 . . . . 1.45 111.26 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.74 85.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.983 -1.073 . . . . 1.25 111.241 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 mt -68.02 -48.01 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.823 -1.173 . . . . 1.26 110.13 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -69.87 -32.47 70.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.375 -0.828 . . . . 0.82999999999999996 110.539 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.36 -37.44 80.71 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.054 -1.029 . . . . 1.1899999999999999 110.075 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.22 -38.32 91.77 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 120.281 -0.962 . . . . 0.57999999999999996 110.827 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -59.6 -45.89 90.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.902 -1.352 . . . . 2.0499999999999998 110.599 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 77' ' ' ILE . 94.1 mt -60.31 -38.84 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.863 -1.148 . . . . 1.21 110.488 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.2 ttt -59.55 -39.89 85.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.49 -0.756 . . . . 2.29 110.626 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 tp -59.19 -48.76 80.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.386 -0.926 . . . . 1.21 109.953 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.446 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 61.3 tp -60.91 -45.92 92.73 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.653 0.739 . . . . 1.1399999999999999 110.754 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.11 11.87 7.33 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.225 0.824 . . . . 1.4199999999999999 113.225 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -63.96 123.83 19.99 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.798 -0.816 . . . . 1.27 108.798 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -65.52 -18.09 65.06 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.742 0.782 . . . . 1.3500000000000001 110.819 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.71 -56.88 4.08 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.452 0.644 . . . . 2.2200000000000002 110.046 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.29 -40.18 89.56 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.006 -0.678 . . . . 1.22 110.64 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -58.55 -49.96 75.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.132 -0.98 . . . . 1.29 110.969 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -62.81 -38.03 89.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 2.1699999999999999 110.443 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -65.92 -48.92 69.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 1.3 110.458 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.9 mt -55.98 -42.93 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.058 -1.026 . . . . 1.1699999999999999 109.653 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.0 mt -61.73 -44.0 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.435 -0.79 . . . . 1.3999999999999999 110.316 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.8 -44.29 97.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 1.3300000000000001 110.942 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.01 -44.63 94.45 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.912 -1.117 . . . . 1.48 110.463 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.0 mt -60.61 -48.39 88.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.267 -0.895 . . . . 1.28 110.712 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -81.56 -33.55 31.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.407 -0.808 . . . . 2.6000000000000001 111.714 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 91' ' ' ALA . 54.2 t0 -82.93 -40.18 20.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.091 -1.006 . . . . 1.51 111.457 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -103.09 7.13 38.89 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.241 -0.912 . . . . 2.48 112.263 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.5 m80 51.3 44.62 28.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 1.6100000000000001 111.953 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.9 mtt -102.93 153.73 19.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.417 -0.802 . . . . 1.8999999999999999 109.425 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.414 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 43.2 p -70.54 160.71 31.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 1.3200000000000001 109.506 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.6 92.9 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.93 -1.106 . . . . 1.1499999999999999 110.874 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 24.2 p-10 -69.42 -38.27 77.8 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.985 -1.072 . . . . 2.25 110.024 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.74 -51.2 43.9 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.052 -1.059 . . . . 1.22 111.388 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.69 90.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 1.1899999999999999 111.049 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.32 -41.81 85.37 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.352 -0.842 . . . . 1.2 110.613 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.56 -38.74 85.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.414 -0.804 . . . . 2.1000000000000001 111.173 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -58.06 -48.42 80.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.881 -1.137 . . . . 1.3 111.087 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.04 -43.64 96.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.882 -1.136 . . . . 1.27 110.772 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 108' ' ' ILE . 39.8 mm -62.71 -35.26 69.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.605 -0.684 . . . . 1.1899999999999999 110.318 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -57.44 -39.81 77.07 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.876 -0.73 . . . . 2.1099999999999999 111.207 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.73 -35.61 11.39 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 118.842 -1.647 . . . . 0.88 112.693 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -61.12 -41.2 96.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.497 -1.59 . . . . 1.99 110.145 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.6 -50.91 22.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.932 0.872 . . . . 1.28 110.471 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.501 ' HG ' ' N ' ' A' ' 114' ' ' ALA . 55.9 p -62.34 -37.85 87.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.862 . . . . 2.2200000000000002 110.814 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.501 ' N ' ' HG ' ' A' ' 113' ' ' SER . . . -62.86 -40.77 98.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 1.45 110.943 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.59 -30.18 70.41 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.637 -1.289 . . . . 1.47 110.892 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -67.34 -22.09 65.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.83 -1.169 . . . . 2.04 110.93 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.5 -11.79 60.81 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.103 -1.039 . . . . 1.73 111.0 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 75.8 mt -87.16 144.91 26.63 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.282 -0.636 . . . . 1.79 109.282 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -100.19 39.73 1.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.344 -0.847 . . . . 2.8799999999999999 111.58 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -113.57 135.8 53.51 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 108.261 -1.014 . . . . 1.5800000000000001 108.261 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -57.67 -40.15 78.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.499 -0.75 . . . . 3.04 111.198 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -72.81 -51.14 20.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.731 -1.231 . . . . 1.29 110.714 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 23.9 mt -59.29 -41.28 88.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.26 -0.9 . . . . 1.6000000000000001 110.541 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -64.12 -46.7 83.01 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.209 -0.996 . . . . 2.7599999999999998 109.793 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -60.17 -33.45 72.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.49 -0.884 . . . . 2.1499999999999999 109.561 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.522 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 29.7 ttt-85 -60.79 -29.66 69.58 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.306 1.05 . . . . 2.8100000000000001 108.935 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.78 -49.47 77.6 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.825 0.821 . . . . 1.3899999999999999 109.396 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.19 -45.81 86.73 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.722 -0.791 . . . . 1.4099999999999999 109.774 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.02 -36.85 82.79 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.632 -0.668 . . . . 1.3899999999999999 110.168 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.522 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 48.3 t -69.41 -40.04 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 1.1899999999999999 110.037 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -57.9 -38.46 75.88 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.44 -0.904 . . . . 3.6299999999999999 110.041 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -59.95 -39.57 86.03 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.594 0.711 . . . . 1.28 109.87 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.6 -36.96 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.216 -0.928 . . . . 1.1799999999999999 109.937 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.81 -56.93 22.24 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 120.009 -1.091 . . . . 0.51000000000000001 111.353 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -59.07 -39.72 82.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.153 -1.204 . . . . 3.1699999999999999 110.256 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -60.12 -44.81 94.62 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.775 -1.17 . . . . 2.8500000000000001 109.57 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.98 -43.89 94.84 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.433 -0.792 . . . . 1.6499999999999999 110.176 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.63 -44.87 93.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.447 -0.783 . . . . 1.2 110.365 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.517 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 98.8 mtt180 -60.13 -33.19 71.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.893 . . . . 2.7999999999999998 111.071 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -76.38 -42.95 42.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.098 -1.001 . . . . 2.1499999999999999 110.725 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.72 -40.17 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 1.21 110.105 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.87 -11.27 45.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.076 -1.015 . . . . 1.3400000000000001 111.757 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.6 21.67 71.66 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.73 -1.224 . . . . 0.91000000000000003 112.91 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -62.73 147.41 49.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.806 -0.82 . . . . 1.51 109.139 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -67.0 147.05 53.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.303 -0.873 . . . . 2.8799999999999999 108.905 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.9 mt -105.74 149.16 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.419 -0.956 . . . . 1.6200000000000001 108.419 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.401 HD11 ' H ' ' A' ' 147' ' ' ILE . 4.4 mp -77.65 119.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.157 -0.964 . . . . 2.1099999999999999 108.727 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -99.51 96.5 7.71 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.66 -1.607 . . . . 1.6200000000000001 106.66 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.7 mt -77.36 -12.44 59.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.903 . . . . 1.3999999999999999 111.628 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.5 p -81.7 3.0 27.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.138 -0.977 . . . . 2.0499999999999998 112.072 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.68 18.46 14.27 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.67 -0.644 . . . . 1.3500000000000001 112.579 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.8 mt -71.97 138.95 20.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.52 -0.738 . . . . 1.4199999999999999 109.271 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -118.54 -15.79 9.55 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.834 0.826 . . . . 2.9900000000000002 112.629 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -114.33 138.66 50.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.974 -1.121 . . . . 1.54 107.974 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -72.66 121.98 20.69 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.33 -0.989 . . . . 1.3799999999999999 108.33 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.6 m -144.49 174.95 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.033 -0.728 . . . . 1.28 109.033 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.6 mt -89.45 142.15 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.793 -1.192 . . . . 1.1599999999999999 109.088 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 31.5 tp -94.49 123.05 37.67 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.29 -1.004 . . . . 1.3100000000000001 108.29 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.65 129.64 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.705 -1.22 . . . . 1.25 107.705 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.32 154.68 21.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.149 -0.97 . . . . 1.26 108.826 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.93 -37.31 86.53 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.541 -1.349 . . . . 1.6000000000000001 109.458 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -173.3 147.86 1.57 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.166 -0.679 . . . . 2.4199999999999999 109.166 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.1 mt -115.93 143.25 45.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.489 -0.757 . . . . 1.3500000000000001 109.21 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.7 p -89.45 147.43 38.04 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.162 -0.961 . . . . 1.3200000000000001 108.881 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -40.49 -42.48 3.91 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.892 1.728 . . . . 0.69999999999999996 113.673 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.8 m -61.32 -50.25 73.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.017 -1.052 . . . . 1.1200000000000001 110.295 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -61.42 -39.67 91.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 1.21 109.772 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.6 p -68.75 -39.69 80.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.608 -0.682 . . . . 1.1899999999999999 110.458 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.41 79.38 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.928 -0.709 . . . . 1.24 110.531 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -93.71 -1.03 55.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.902 . . . . 1.6899999999999999 112.727 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.84 148.6 38.81 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.262 -1.014 . . . . 1.3400000000000001 108.262 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -96.4 114.81 26.51 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.839 -1.541 . . . . 2.77 106.839 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 7.5 mp -73.37 -20.39 60.77 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.433 0.635 . . . . 2.0899999999999999 111.77 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -80.42 -21.85 41.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 2.6699999999999999 112.037 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -100.23 -6.08 26.6 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 113.198 0.814 . . . . 2.5800000000000001 113.198 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.26 129.52 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.616 -1.254 . . . . 1.1799999999999999 107.616 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.5 -6.29 54.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 2.1800000000000002 112.635 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.53 164.79 33.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.788 -1.725 . . . . 0.48999999999999999 108.788 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -122.72 127.48 49.28 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.402 -1.333 . . . . 0.64000000000000001 107.402 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.9 mt -127.36 127.64 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.802 -1.555 . . . . 1.21 106.802 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.5 p -140.43 166.27 25.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.865 -1.147 . . . . 1.3799999999999999 109.486 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.429 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 1.5 m-20 -104.4 43.25 1.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.746 -0.596 . . . . 2.3700000000000001 110.341 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.8 140.52 32.05 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.082 -1.011 . . . . 1.52 108.906 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -48.14 -16.86 0.54 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 120.289 -0.957 . . . . 1.8 112.322 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 83.98 -12.5 53.38 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.008 -1.289 . . . . 2.04 113.331 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.444 ' O ' ' OG1' ' A' ' 187' ' ' THR . 48.7 ttt180 -74.54 117.84 16.82 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.905 -1.146 . . . . 5.0 107.905 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 22.4 p 48.69 35.59 6.52 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.474 -0.891 . . . . 3.02 111.968 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.604 ' HG ' ' HG1' ' A' ' 190' ' ' THR . 41.1 t -83.59 130.31 34.99 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.14 -1.059 . . . . 2.1099999999999999 108.14 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -59.96 -39.14 84.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 1.24 110.651 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.604 ' HG1' ' HG ' ' A' ' 188' ' ' SER . 57.5 p -60.03 -40.34 88.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 2.1499999999999999 110.546 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.0 t -60.08 -36.86 78.3 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.167 -0.958 . . . . 2.02 110.12 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.2 mm -60.48 -38.87 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.735 -0.603 . . . . 2.1200000000000001 110.814 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 75.1 mtp -61.01 -45.36 95.12 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.616 1.198 . . . . 1.3600000000000001 109.157 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.02 -50.47 73.61 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.462 -0.79 . . . . 1.29 110.823 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -59.65 -44.84 93.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 3.5600000000000001 111.179 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.9 m -70.2 -40.85 74.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.863 . . . . 1.1799999999999999 110.543 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.3 mt -90.89 -7.0 53.41 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.071 0.939 . . . . 1.3400000000000001 112.242 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 194' ' ' ALA . 93.7 mt-10 53.67 9.71 0.2 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.929 1.085 . . . . 1.45 113.929 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.38 147.91 90.43 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 120.844 -1.16 . . . . 1.25 107.972 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.79 137.28 60.14 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.374 1.383 . . . . 0.78000000000000003 110.07 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.67 166.2 24.78 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.225 -1.39 . . . . 1.2 109.839 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 35.9 mt -148.16 151.07 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.872 -1.159 . . . . 1.25 107.872 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.7 m -134.82 -26.63 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.845 -1.159 . . . . 1.3899999999999999 112.027 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.19 42.4 2.85 Favored Glycine 0 N--CA 1.49 2.258 0 O-C-N 120.985 -1.072 . . . . 0.96999999999999997 111.432 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 69.8 p -64.04 -24.15 67.6 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.925 -1.338 . . . . 1.3500000000000001 111.233 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.86 -90.05 1.48 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 120.042 -1.075 . . . . 1.0700000000000001 110.596 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.7 t -130.83 32.3 4.37 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.291 -1.123 . . . . 1.9199999999999999 113.04 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.9 t -56.29 -32.76 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.255 -1.528 . . . . 1.3300000000000001 110.439 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.6 p -59.04 -25.42 63.69 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.058 -1.026 . . . . 1.4199999999999999 111.215 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.8 m -92.96 1.89 57.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 2.1200000000000001 112.063 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -125.66 -5.72 6.97 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.441 0.904 . . . . 2.6899999999999999 113.441 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.6 t -118.83 148.03 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.424 -0.798 . . . . 1.29 109.515 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -120.42 150.45 40.77 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.998 -1.112 . . . . 2.6899999999999999 107.998 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 26.2 t-20 -51.32 141.29 15.39 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.233 -0.917 . . . . 2.79 110.562 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 80.93 -3.81 1.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.028 1.121 . . . . 2.3500000000000001 114.028 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -61.68 146.01 50.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.814 -1.179 . . . . 1.97 108.284 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -87.32 118.18 26.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.529 -1.286 . . . . 2.9700000000000002 107.529 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.92 147.64 50.86 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.454 -0.779 . . . . 1.25 109.552 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 13.7 mt -119.14 130.06 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.186 -1.413 . . . . 1.22 107.186 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 54.1 tp -98.5 122.88 42.25 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.732 -1.211 . . . . 1.24 107.732 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 223' ' ' VAL . 43.8 t0 -94.03 -29.58 15.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.785 -1.197 . . . . 2.0499999999999998 112.385 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.412 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 38.62 18.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.92 0.711 . . . . 1.25 112.92 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -109.68 -60.49 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.059 -1.025 . . . . 1.4299999999999999 109.222 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -93.74 11.15 30.14 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.949 0.88 . . . . 3.0299999999999998 110.018 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 63.32 53.16 2.25 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.657 -0.702 . . . . 2.25 112.205 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -149.04 154.84 39.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.482 -0.761 . . . . 2.52 109.515 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.6 135.85 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.595 -1.261 . . . . 1.29 107.595 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -102.83 130.51 49.85 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.118 -0.988 . . . . 1.3400000000000001 108.97 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.14 127.81 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.682 -1.229 . . . . 1.3400000000000001 107.682 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 50.1 53.16 13.76 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 113.428 0.899 . . . . 2.1800000000000002 113.428 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 151.15 79.64 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 123.028 2.486 . . . . 0.93999999999999995 111.085 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 67.3 p -73.97 155.29 38.78 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.739 -0.837 . . . . 2.3999999999999999 108.739 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -60.26 -37.94 81.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 3.3300000000000001 110.714 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -50.83 -44.28 59.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.056 -1.027 . . . . 3.1699999999999999 110.445 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.24 -39.93 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.189 -0.944 . . . . 1.6899999999999999 110.64 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.76 -49.16 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.897 -0.721 . . . . 1.6000000000000001 110.962 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.41 -39.64 84.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.922 -1.111 . . . . 2.7000000000000002 110.777 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -61.1 -44.85 96.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 2.96 110.761 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 55.3 mtm -75.1 -37.8 61.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.819 -1.175 . . . . 1.6299999999999999 111.301 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -58.63 -40.26 82.86 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.962 -1.087 . . . . 3.27 111.161 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.56 -53.38 16.29 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.735 -1.228 . . . . 2.23 110.638 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.68 -48.49 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.911 -1.118 . . . . 2.79 111.166 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -59.69 -49.86 76.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.714 -1.241 . . . . 4.2599999999999998 111.442 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.9 -31.11 70.61 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.663 -1.215 . . . . 1.8799999999999999 110.208 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -64.3 -29.9 70.97 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.119 -1.032 . . . . 3.3799999999999999 110.119 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.79 -42.52 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.387 0.613 . . . . 2.8799999999999999 110.403 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.66 94.54 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.595 -0.842 . . . . 2.75 110.248 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.2 t -69.63 -41.07 76.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 3.4199999999999999 110.368 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -63.95 -36.85 85.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.485 -0.76 . . . . 3.5699999999999998 110.039 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -66.79 -30.31 70.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.012 . . . . 4.6100000000000003 111.42 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -62.34 -35.19 78.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.027 -1.045 . . . . 4.4500000000000002 110.913 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -69.55 -27.68 65.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.173 -0.954 . . . . 5.9699999999999998 111.353 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.36 -28.91 70.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.426 -0.796 . . . . 6.4500000000000002 111.659 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -66.88 -14.17 62.45 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.092 -1.005 . . . . 6.6600000000000001 112.69 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -78.8 -9.31 59.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.829 -1.169 . . . . 8.5399999999999991 112.569 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.86 2.69 48.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.752 -1.217 . . . . 8.0700000000000003 112.267 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -84.56 -3.45 58.45 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.161 -0.962 . . . . 9.7200000000000006 113.17 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -92.65 -29.39 16.13 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.782 -1.199 . . . . 10.119999999999999 113.368 -177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.864 -1.065 . . . . 11.9 109.326 -177.319 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mtp . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 108.897 -0.779 . . . . 3.5299999999999998 108.897 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mt -103.62 120.67 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.305 -1.739 . . . . 1.5700000000000001 106.305 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.4 m -101.11 123.45 45.28 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.663 -1.236 . . . . 1.4399999999999999 107.663 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.35 -159.4 11.76 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 108.708 -1.757 . . . . 1.01 108.708 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.461 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 95.0 mt -99.19 2.32 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.439 -1.036 . . . . 1.6299999999999999 112.744 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 48.61 94.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.636 -1.29 . . . . 1.5800000000000001 112.171 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.84 -40.48 17.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.471 -1.393 . . . . 1.3400000000000001 111.49 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -148.27 144.29 18.55 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 107.465 -1.309 . . . . 1.8600000000000001 107.465 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.11 142.31 27.36 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.574 2.183 . . . . 1.01 112.192 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.416 ' O ' ' CB ' ' A' ' 222' ' ' ALA . . . 157.55 171.31 23.39 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.36 -1.496 . . . . 0.81000000000000005 109.36 178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -134.21 133.7 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.819 -1.401 . . . . 1.3700000000000001 107.574 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.09 156.8 45.93 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.141 0.972 . . . . 1.1399999999999999 109.664 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.422 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 13.2 m-85 -120.99 140.21 52.22 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.93 -1.137 . . . . 0.87 107.93 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.21 166.62 36.22 Favored Glycine 0 N--CA 1.499 2.841 0 C-N-CA 119.044 -1.551 . . . . 0.56999999999999995 109.901 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -80.09 157.84 26.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.297 -1.12 . . . . 2.3500000000000001 109.668 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -85.76 128.68 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.149 -1.056 . . . . 1.21 108.149 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.5 tp -107.24 105.47 15.46 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 105.327 -2.101 . . . . 1.3999999999999999 105.327 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.6 tp -93.32 135.43 34.54 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.036 -1.098 . . . . 1.4399999999999999 108.036 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.9 mt -99.54 118.1 35.38 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.584 -1.635 . . . . 1.45 106.584 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -110.56 123.74 50.52 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.782 -1.562 . . . . 2.5 106.782 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -131.38 158.25 41.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.946 -1.096 . . . . 2.6600000000000001 108.701 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -84.95 138.79 32.27 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.782 -0.822 . . . . 2.3199999999999998 108.782 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.41 156.33 36.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.948 . . . . 2.1099999999999999 109.496 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.7 mt -86.24 133.91 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.035 -1.041 . . . . 1.29 108.444 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -110.38 130.71 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.815 -1.18 . . . . 1.4099999999999999 107.815 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.8 mt -94.66 134.34 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.647 -0.871 . . . . 1.3100000000000001 108.647 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -92.41 120.5 32.97 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.086 -1.079 . . . . 1.3400000000000001 108.086 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.523 ' HG2' HH11 ' A' ' 28' ' ' ARG . 1.7 mmt-85 -93.56 16.98 12.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.007 -1.058 . . . . 3.48 112.43 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -60.33 140.14 57.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.014 -1.054 . . . . 2.52 109.81 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -87.65 132.51 34.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.839 -1.163 . . . . 2.6299999999999999 108.004 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 pt -96.89 165.55 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 1.3100000000000001 110.584 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.7 p -97.91 170.45 8.95 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.241 -0.912 . . . . 1.24 109.507 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.1 66.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.394 -0.816 . . . . 1.49 111.454 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.64 -33.47 74.07 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.436 -0.79 . . . . 2.2799999999999998 110.648 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -90.95 -7.57 51.7 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.738 -1.226 . . . . 2.0499999999999998 112.502 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.48 -42.67 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 1.3400000000000001 110.183 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -58.11 -39.91 79.88 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.307 -0.871 . . . . 1.54 111.136 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -63.44 -43.92 96.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.734 -0.604 . . . . 2.8500000000000001 111.233 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -60.67 -40.15 91.03 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.803 -1.186 . . . . 1.3100000000000001 110.189 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.6 t -60.68 -40.83 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.108 -0.995 . . . . 1.3799999999999999 109.963 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -61.59 -44.86 96.24 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.447 -0.783 . . . . 1.5 110.223 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 42' ' ' ARG . 43.5 mtt-85 -62.11 -40.05 94.59 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.33 -0.856 . . . . 2.7799999999999998 110.152 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -70.53 -57.17 5.05 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.36 -0.837 . . . . 1.0600000000000001 110.235 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.79 -47.4 85.84 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.914 -1.115 . . . . 1.3999999999999999 109.582 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 t -69.33 -37.46 77.73 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.399 -0.92 . . . . 1.3200000000000001 109.814 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.05 -43.28 93.26 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.053 -1.546 . . . . 0.69999999999999996 109.681 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -59.87 -30.66 69.14 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.167 0.984 . . . . 3.4399999999999999 109.476 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.79 90.15 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.427 -0.796 . . . . 1.3600000000000001 110.348 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -80.22 -49.77 11.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.371 -0.932 . . . . 2.8300000000000001 110.699 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.91 76.8 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.468 -0.77 . . . . 1.23 110.279 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.4 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 94.7 p -60.09 -40.35 89.31 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.136 0.97 . . . . 1.9199999999999999 109.178 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -47.53 44.42 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.834 0.826 . . . . 1.25 110.733 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -64.5 -48.31 75.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.521 -1.362 . . . . 1.97 110.958 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.18 -37.98 89.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.726 -0.789 . . . . 2.1800000000000002 109.842 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 51' ' ' SER . 17.5 mm-40 -59.81 -40.33 88.04 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.275 -0.57 . . . . 1.1899999999999999 110.272 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.1 m -63.76 -42.24 97.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.234 -0.916 . . . . 1.3400000000000001 110.343 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 99.5 mt -59.97 -37.3 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.716 0.77 . . . . 1.23 110.268 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -50.4 -44.24 54.91 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.46 -0.775 . . . . 1.5600000000000001 110.753 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -69.12 -33.71 73.9 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.156 -0.965 . . . . 1.3 110.225 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.411 ' O ' ' OG1' ' A' ' 64' ' ' THR . 49.5 mttp -64.22 -40.28 95.72 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.185 -1.406 . . . . 2.3199999999999998 109.526 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.75 -30.16 71.16 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.856 -0.738 . . . . 1.1399999999999999 110.151 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.12 -34.18 18.5 Favored Glycine 0 N--CA 1.484 1.872 0 C-N-CA 119.559 -1.305 . . . . 0.68999999999999995 110.893 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -81.7 -20.41 39.49 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.358 -1.083 . . . . 1.48 111.199 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 19.5 m -90.16 -51.98 5.18 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 120.941 0.401 . . . . 1.52 110.842 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -107.83 -9.12 15.81 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 113.616 0.969 . . . . 1.3100000000000001 113.616 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.09 167.01 23.12 Favored Glycine 0 N--CA 1.502 3.09 0 O-C-N 121.24 -0.913 . . . . 0.84999999999999998 112.764 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.96 -21.94 59.34 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.785 -0.833 . . . . 3.8599999999999999 112.131 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -57.7 -40.05 78.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.959 -1.088 . . . . 2.3500000000000001 110.905 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -87.07 -25.48 24.15 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.43 -0.908 . . . . 2.2599999999999998 111.459 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -60.65 -38.0 83.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.904 -0.497 . . . . 1.45 111.405 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.12 90.35 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.242 -0.911 . . . . 1.25 112.055 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -64.77 -41.72 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.339 -1.476 . . . . 1.26 110.381 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -69.44 -32.09 70.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.603 -1.311 . . . . 0.82999999999999996 110.428 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -59.44 -39.73 84.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.783 -1.198 . . . . 1.1899999999999999 109.909 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.74 97.95 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.894 -0.883 . . . . 0.57999999999999996 110.894 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -59.77 -41.2 90.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.906 -1.349 . . . . 2.0499999999999998 110.633 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 77' ' ' ILE . 85.4 mt -60.29 -38.16 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.807 -1.183 . . . . 1.21 110.658 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.7 ttp -58.85 -39.78 82.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.917 . . . . 2.29 110.528 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.65 -48.26 81.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.917 -1.115 . . . . 1.21 110.629 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.2 tp -59.92 -40.92 90.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.493 -0.755 . . . . 1.1399999999999999 110.435 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -86.06 6.09 30.58 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.022 -0.671 . . . . 1.4199999999999999 112.508 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -60.33 121.82 12.98 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.917 -1.114 . . . . 1.27 109.348 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -68.0 -17.63 64.48 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 121.145 -0.972 . . . . 1.3500000000000001 110.792 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -74.14 -46.7 40.8 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.787 -1.165 . . . . 2.2200000000000002 110.419 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.0 -35.47 80.82 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.209 -0.996 . . . . 1.22 110.023 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -58.69 -45.09 90.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.166 -0.959 . . . . 1.29 110.798 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -63.98 -41.6 97.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.926 -1.109 . . . . 2.1699999999999999 110.78 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -67.98 -49.53 61.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.737 -1.227 . . . . 1.3 110.506 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.12 -43.49 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 118.978 -1.089 . . . . 1.1699999999999999 110.372 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.52 ' CG2' ' HZ3' ' A' ' 94' ' ' LYS . 52.2 mt -62.17 -43.85 98.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.107 -0.996 . . . . 1.3999999999999999 110.54 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -60.36 -41.13 93.07 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.251 -0.906 . . . . 1.3300000000000001 110.894 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.31 -44.28 95.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.162 -0.961 . . . . 1.48 110.606 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.71 -49.2 83.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.266 -0.896 . . . . 1.28 110.322 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.52 ' HZ3' ' CG2' ' A' ' 90' ' ' ILE . 20.5 mtmm -82.43 -28.59 31.25 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.603 -1.31 . . . . 2.6000000000000001 112.182 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 91' ' ' ALA . 47.9 t0 -79.16 -45.66 19.5 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 120.242 -1.536 . . . . 1.51 111.293 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -104.62 7.59 35.04 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.752 -1.218 . . . . 2.48 111.884 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.8 m80 54.26 50.15 17.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 1.6100000000000001 112.291 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 73.2 mtm -105.88 161.0 14.83 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.722 -1.236 . . . . 1.8999999999999999 109.502 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.1 p -72.75 158.89 34.71 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.846 0.832 . . . . 1.3200000000000001 109.368 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.68 87.99 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.148 -0.97 . . . . 1.1499999999999999 110.658 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -67.34 -40.75 85.88 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.805 -1.184 . . . . 2.25 110.069 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.43 39.8 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.207 -0.997 . . . . 1.22 110.816 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.13 96.52 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.661 0.743 . . . . 1.1899999999999999 110.338 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.43 93.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.648 -0.658 . . . . 1.2 111.08 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.75 -38.97 83.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.307 -0.871 . . . . 2.1000000000000001 111.335 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.14 -48.28 82.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.091 -1.006 . . . . 1.3 111.19 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.56 -43.22 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.658 -1.217 . . . . 1.27 110.225 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.61 -33.08 53.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.799 -0.563 . . . . 1.1899999999999999 110.697 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -59.53 -40.21 86.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.351 -0.54 . . . . 2.1099999999999999 110.745 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.92 -30.52 25.89 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.018 -1.563 . . . . 0.88 113.128 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -61.37 -40.43 94.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.216 -1.755 . . . . 1.99 109.69 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.23 -45.72 59.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.064 0.935 . . . . 1.28 109.718 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.2 m -60.36 -39.24 86.5 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.346 0.593 . . . . 2.2200000000000002 110.049 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.83 -46.51 89.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.416 -0.803 . . . . 1.45 110.866 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.03 -26.89 67.73 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.506 -1.371 . . . . 1.47 110.87 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -66.22 -26.45 67.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.875 . . . . 2.04 111.572 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -70.65 -13.48 62.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.943 -1.103 . . . . 1.73 111.48 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 78.8 mt -88.72 140.2 29.69 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.838 0.828 . . . . 1.79 109.383 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -94.85 41.44 1.09 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.816 -1.178 . . . . 2.8799999999999999 111.258 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -111.87 133.42 54.08 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.07 0.938 . . . . 1.5800000000000001 108.903 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.59 -29.2 69.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.708 -0.62 . . . . 3.04 111.348 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.03 -60.32 2.38 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.655 -1.278 . . . . 1.29 110.703 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.78 -38.2 90.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 1.6000000000000001 110.801 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -63.38 -50.88 68.15 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.779 -1.201 . . . . 2.7599999999999998 110.093 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.67 -32.17 71.38 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.094 -1.042 . . . . 2.1499999999999999 109.602 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -65.89 -26.97 67.86 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.778 0.799 . . . . 2.8100000000000001 109.485 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.88 -47.88 83.38 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.599 -0.84 . . . . 1.3899999999999999 108.998 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.81 -43.92 91.57 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.306 -0.957 . . . . 1.4099999999999999 110.017 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -64.29 -31.38 72.56 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.422 0.629 . . . . 1.3899999999999999 110.446 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.3 t -68.7 -39.19 79.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 C-N-CA 119.942 -0.703 . . . . 1.1899999999999999 109.961 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -59.32 -38.01 79.2 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.73 -1.188 . . . . 3.6299999999999999 109.285 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -59.92 -38.94 83.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.881 -0.512 . . . . 1.28 110.602 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.7 mt -60.33 -40.0 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.975 -1.078 . . . . 1.1799999999999999 110.148 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.12 -46.96 93.28 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.475 -1.05 . . . . 0.51000000000000001 110.475 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -59.99 -41.08 91.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.966 -1.314 . . . . 3.1699999999999999 110.658 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -60.07 -42.7 95.13 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.315 -0.865 . . . . 2.8500000000000001 110.18 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.41 -40.41 94.3 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.174 0.988 . . . . 1.6499999999999999 109.881 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.0 mt -61.66 -40.67 95.76 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.353 -0.842 . . . . 1.2 110.746 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -61.34 -38.2 86.05 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.509 -0.745 . . . . 2.7999999999999998 111.316 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -74.4 -42.6 58.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.954 -1.091 . . . . 2.1499999999999999 110.993 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.21 -38.95 79.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.013 -1.054 . . . . 1.21 110.553 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.35 -3.08 59.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.829 -1.169 . . . . 1.3400000000000001 111.793 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.83 23.03 78.64 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.613 -1.28 . . . . 0.91000000000000003 113.577 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.5 tp -61.97 150.04 38.99 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 122.053 -0.675 . . . . 1.51 109.746 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -66.93 157.27 33.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.503 -0.748 . . . . 2.8799999999999999 110.16 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.4 mt -101.18 139.5 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.46 -0.941 . . . . 1.6200000000000001 108.46 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.3 mp -79.49 120.51 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.797 -1.186 . . . . 2.1099999999999999 107.797 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -98.62 93.41 6.1 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.881 -1.525 . . . . 1.6200000000000001 106.881 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.6 mt -75.39 -21.29 58.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.898 . . . . 1.3999999999999999 111.599 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 150' ' ' SER . 2.5 t -82.77 10.24 8.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.169 -0.957 . . . . 2.0499999999999998 112.101 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.95 18.52 14.49 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.269 -0.894 . . . . 1.3500000000000001 112.435 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.542 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 23.8 mt -75.28 141.03 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.203 -0.935 . . . . 1.4199999999999999 110.015 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -117.62 -13.67 10.24 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.361 -0.837 . . . . 2.9900000000000002 112.795 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -117.03 141.95 47.59 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.612 -0.884 . . . . 1.54 108.612 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -77.04 122.83 25.49 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.271 -1.011 . . . . 1.3799999999999999 108.271 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.2 m -147.31 178.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.226 -0.657 . . . . 1.28 109.226 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.4 mt -87.4 143.92 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.683 -0.858 . . . . 1.1599999999999999 108.683 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 34.7 tp -97.57 126.1 42.67 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.912 -1.118 . . . . 1.3100000000000001 108.367 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.0 t -126.43 129.23 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.126 -1.065 . . . . 1.25 108.126 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.17 159.91 32.23 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.272 -0.893 . . . . 1.26 108.601 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.18 93.34 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.539 -1.264 . . . . 1.6000000000000001 109.97 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 46.8 p-10 -173.96 150.02 1.57 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.304 -0.628 . . . . 2.4199999999999999 109.304 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.2 mt -115.41 141.54 47.91 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.346 -0.846 . . . . 1.3500000000000001 109.276 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.9 p -93.92 150.7 38.98 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.162 -0.961 . . . . 1.3200000000000001 108.455 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -39.25 -44.97 2.91 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.772 1.648 . . . . 0.69999999999999996 113.243 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.3 m -59.58 -49.41 77.86 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.168 -0.957 . . . . 1.1200000000000001 110.306 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.34 -40.4 94.1 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.743 -0.783 . . . . 1.21 110.001 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.9 p -67.58 -37.12 82.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.815 0.817 . . . . 1.1899999999999999 110.222 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.18 -39.84 87.9 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.519 -0.738 . . . . 1.24 110.54 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -94.21 0.22 55.57 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.094 -1.004 . . . . 1.6899999999999999 113.105 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.89 149.21 41.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.738 -1.226 . . . . 1.3400000000000001 108.498 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -94.45 114.71 26.77 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 106.812 -1.551 . . . . 2.77 106.812 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 10.6 mp -80.79 -10.41 59.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.552 -0.718 . . . . 2.0899999999999999 112.435 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -83.45 -23.25 32.33 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.984 -1.073 . . . . 2.6699999999999999 111.954 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 152' ' ' ILE . 90.7 mttt -105.41 4.16 30.44 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.22 -0.925 . . . . 2.5800000000000001 112.777 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.9 t -108.85 128.63 64.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.929 -1.137 . . . . 1.1799999999999999 107.929 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.412 ' CD2' ' O ' ' A' ' 177' ' ' LEU . 2.0 tt -92.93 -6.31 48.83 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.208 1.004 . . . . 2.1800000000000002 111.53 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.39 168.28 37.51 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.746 -1.741 . . . . 0.48999999999999999 108.746 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -124.04 128.85 49.95 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.559 -1.274 . . . . 0.64000000000000001 107.559 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.9 mt -130.77 129.86 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.968 -1.864 . . . . 1.21 105.968 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.2 p -140.94 176.1 9.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.167 -0.958 . . . . 1.3799999999999999 109.981 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.447 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 2.8 m-20 -110.38 45.13 1.15 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.892 -0.505 . . . . 2.3700000000000001 110.757 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.5 138.4 34.98 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.164 -0.96 . . . . 1.52 108.924 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -81.02 4.6 69.98 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.807 -0.711 . . . . 1.8 112.826 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 111.93 -28.44 9.35 Favored Glycine 0 N--CA 1.504 3.212 0 O-C-N 121.309 -1.112 . . . . 2.04 112.038 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -58.86 -30.08 67.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.742 -1.446 . . . . 5.0 110.347 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 57.0 p -124.23 54.05 1.38 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.934 0.873 . . . . 3.02 109.132 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.7 p -79.53 26.75 0.29 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.371 -0.831 . . . . 2.1099999999999999 112.946 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -49.49 -40.82 38.8 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.143 -1.023 . . . . 1.24 110.161 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.6 p -62.11 -40.8 97.12 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.366 -0.934 . . . . 2.1499999999999999 109.389 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.64 ' HG ' ' N ' ' A' ' 192' ' ' ILE . 27.9 p -60.87 -35.25 76.13 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 119.668 -0.813 . . . . 2.02 109.863 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.64 ' N ' ' HG ' ' A' ' 191' ' ' SER . 77.1 mt -58.79 -39.61 77.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.461 -0.895 . . . . 2.1200000000000001 109.934 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.8 mtp -60.93 -44.23 97.51 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.781 1.276 . . . . 1.3600000000000001 109.126 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.1 -43.97 95.19 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.966 -1.015 . . . . 1.29 110.532 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.444 ' HG2' HH11 ' A' ' 195' ' ' ARG . 28.7 mtt-85 -60.04 -44.2 94.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.995 -1.066 . . . . 3.5600000000000001 110.09 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 35.3 m -68.48 -39.07 81.49 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.099 0.952 . . . . 1.1799999999999999 109.646 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.77 -4.07 56.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.068 -1.02 . . . . 1.3400000000000001 112.659 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.0 mt-10 53.61 9.87 0.2 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.212 1.19 . . . . 1.45 114.212 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.489 ' O ' ' OG ' ' A' ' 8' ' ' SER . 32.7 mt -72.12 150.06 92.21 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 120.581 -1.324 . . . . 1.25 108.378 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.0 143.51 99.77 Favored 'Trans proline' 0 N--CA 1.511 2.554 0 C-N-CA 121.623 1.549 . . . . 0.78000000000000003 110.11 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.92 160.91 31.47 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 117.683 -1.607 . . . . 1.2 109.701 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.0 mt -148.32 149.72 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.088 -1.079 . . . . 1.25 108.088 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 181' ' ' THR . 19.7 m -133.93 -29.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 C-N-CA 119.281 -0.967 . . . . 1.3899999999999999 112.78 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.39 35.65 1.55 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.76 -1.209 . . . . 0.96999999999999997 113.907 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 35.2 p -56.98 -25.49 58.33 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.234 -1.157 . . . . 1.3500000000000001 111.227 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.45 -91.4 1.72 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.032 -1.227 . . . . 1.0700000000000001 110.032 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.8 p -129.31 29.97 5.05 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.295 -1.121 . . . . 1.9199999999999999 112.683 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.2 t -56.56 -35.09 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.246 -1.534 . . . . 1.3300000000000001 110.764 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 45.4 p -60.58 -21.43 62.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.038 . . . . 1.4199999999999999 111.491 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 67.5 m -97.2 1.74 50.14 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.568 0.699 . . . . 2.1200000000000001 111.997 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -126.08 -0.96 7.13 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.227 0.825 . . . . 2.6899999999999999 113.227 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 56.0 t -126.02 155.43 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.139 -0.975 . . . . 1.29 110.182 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -115.7 157.69 23.89 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.06 -1.089 . . . . 2.6899999999999999 108.06 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 32.2 p-10 -58.86 144.18 45.24 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.56 -1.256 . . . . 2.79 109.922 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER 81.39 -3.05 1.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.081 1.141 . . . . 2.3500000000000001 114.081 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 40.0 t0 -61.61 149.96 37.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.882 -1.136 . . . . 1.97 109.129 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.514 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 37.0 t80 -88.58 124.39 33.99 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.412 -1.329 . . . . 2.9700000000000002 107.412 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.5 mt -130.3 149.36 52.03 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.331 -0.856 . . . . 1.25 109.307 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.7 mt -112.75 123.4 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.064 -1.828 . . . . 1.22 106.064 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 49.2 tp -98.72 119.48 37.54 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.087 -1.82 . . . . 1.24 106.087 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 27.4 t0 -93.78 -25.18 17.51 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.086 -1.009 . . . . 2.0499999999999998 112.836 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 10' ' ' GLY . . . 38.64 14.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.153 0.797 . . . . 1.25 113.153 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 37.1 t -111.18 -62.31 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.119 -0.988 . . . . 1.4299999999999999 109.258 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -90.27 9.14 29.85 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.398 1.094 . . . . 3.0299999999999998 110.987 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.18 49.71 3.25 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.436 -0.802 . . . . 2.25 111.645 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -146.93 148.77 32.11 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.635 -1.29 . . . . 2.52 109.734 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.0 t -117.32 139.29 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.216 -1.031 . . . . 1.29 108.216 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -99.26 134.95 41.38 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.118 -1.067 . . . . 1.3400000000000001 108.118 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.71 129.93 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.755 -0.832 . . . . 1.3400000000000001 108.755 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.431 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 42.4 t-20 49.1 50.29 8.93 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.01 0.744 . . . . 2.1800000000000002 113.01 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.5 Cg_endo -62.26 149.95 88.75 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.342 2.028 . . . . 0.93999999999999995 110.883 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 6.0 m -74.53 156.06 37.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.252 -0.905 . . . . 2.3999999999999999 109.151 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -59.35 -38.42 80.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 3.3300000000000001 110.218 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -58.83 -41.05 85.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.231 -0.918 . . . . 3.1699999999999999 110.367 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.66 -41.09 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.13 0.967 . . . . 1.6899999999999999 109.892 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 85.1 mt -60.03 -47.99 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 1.6000000000000001 110.391 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -59.28 -42.52 91.46 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.458 -0.897 . . . . 2.7000000000000002 110.26 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -61.37 -41.54 97.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 2.96 110.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 81.6 mtp -71.48 -37.79 71.28 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.09 -1.006 . . . . 1.6299999999999999 111.201 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -53.67 -43.51 68.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.635 -1.29 . . . . 3.27 110.321 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.1 -52.16 18.07 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.057 -1.057 . . . . 2.23 110.105 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.81 -43.69 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.573 -0.704 . . . . 2.79 110.918 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -58.43 -51.98 67.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.017 -1.052 . . . . 4.2599999999999998 110.678 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.51 -31.91 73.21 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.545 -0.862 . . . . 1.8799999999999999 110.26 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -60.2 -31.09 69.82 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.198 -1.001 . . . . 3.3799999999999999 109.16 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.31 -39.93 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-O 122.033 0.92 . . . . 2.8799999999999999 109.879 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.04 79.39 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.808 -0.757 . . . . 2.75 110.372 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.4 m -69.24 -30.12 68.19 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.089 0.471 . . . . 3.4199999999999999 110.961 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.17 -40.0 92.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 3.5699999999999998 110.39 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -67.48 -30.57 70.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 4.6100000000000003 110.674 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.06 71.24 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.504 -0.747 . . . . 4.4500000000000002 111.142 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -66.33 -31.93 73.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.934 -1.104 . . . . 5.9699999999999998 110.62 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 31.7 tp -62.23 -36.27 81.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.098 -1.001 . . . . 6.4500000000000002 109.759 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -72.35 -19.11 61.69 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.763 0.792 . . . . 6.6600000000000001 111.296 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -82.92 5.31 22.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.826 -1.171 . . . . 8.5399999999999991 112.257 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.39 -9.91 59.05 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.221 -0.924 . . . . 8.0700000000000003 111.495 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -82.03 -2.53 52.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 9.7200000000000006 112.054 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -95.15 -11.36 28.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.456 -0.778 . . . . 10.119999999999999 112.543 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 118.144 -0.931 . . . . 11.9 109.004 -177.986 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.494 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.2 mpt? . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.435 0.636 . . . . 3.5299999999999998 109.745 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.9 mt 40.9 66.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.506 -0.746 . . . . 1.5700000000000001 111.914 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 m -95.57 113.58 25.24 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.614 -1.624 . . . . 1.4399999999999999 106.614 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.66 -149.16 25.21 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.111 -1.196 . . . . 1.01 110.111 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 93.2 mt -96.65 -0.93 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -1.04 . . . . 1.6299999999999999 112.864 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 tp 49.49 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.064 -1.022 . . . . 1.5800000000000001 112.725 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.77 -43.51 12.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.072 -1.018 . . . . 1.3400000000000001 111.168 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 t -145.76 136.08 12.04 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.138 -1.06 . . . . 1.8600000000000001 108.138 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.43 149.79 45.24 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.38 2.053 . . . . 1.01 112.249 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.418 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 152.25 164.34 12.26 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.554 -1.819 . . . . 0.81000000000000005 108.554 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.0 mt -120.89 133.92 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.285 -1.127 . . . . 1.3700000000000001 108.273 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.23 149.99 43.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.318 -0.864 . . . . 1.1399999999999999 109.129 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.3 m-85 -121.25 140.39 52.11 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.179 -1.045 . . . . 0.87 108.179 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.2 166.99 35.96 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 118.998 -1.573 . . . . 0.56999999999999995 109.419 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -78.13 158.33 29.13 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.65 -0.912 . . . . 2.3500000000000001 108.98 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -82.75 131.9 35.19 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.886 -1.134 . . . . 1.21 109.206 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.8 tp -113.67 102.7 10.51 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 105.609 -1.997 . . . . 1.3999999999999999 105.609 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 tp -90.67 137.15 32.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.913 -1.117 . . . . 1.4399999999999999 108.116 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.3 mt -102.57 119.47 38.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.469 -1.678 . . . . 1.45 106.469 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -110.68 135.06 51.87 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.674 -1.232 . . . . 2.5 107.674 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -126.28 137.49 53.51 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.404 -0.962 . . . . 2.6600000000000001 108.404 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -82.73 135.47 34.99 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.794 -1.187 . . . . 2.3199999999999998 107.794 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -62.22 149.21 42.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.579 -0.701 . . . . 2.1099999999999999 109.186 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.94 134.78 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.72 -0.845 . . . . 1.29 108.72 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -107.48 129.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.626 -1.25 . . . . 1.4099999999999999 107.626 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.0 mt -93.78 140.29 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 1.3100000000000001 109.201 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -88.18 121.22 30.32 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.838 -1.171 . . . . 1.3400000000000001 107.838 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -95.02 16.16 16.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 3.48 112.213 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -65.14 142.68 58.27 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.071 -1.018 . . . . 2.52 109.027 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -88.88 134.85 33.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.886 -1.153 . . . . 2.6299999999999999 107.886 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 pt -98.15 165.02 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.3 -0.875 . . . . 1.3100000000000001 110.313 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.467 ' H ' ' HG ' ' A' ' 32' ' ' SER . 4.5 p -99.29 168.79 9.8 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.298 0.57 . . . . 1.24 109.702 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.89 -27.9 46.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.249 -0.907 . . . . 1.49 112.642 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 35' ' ' GLN . 37.1 p-10 -70.07 -31.84 69.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.222 -0.924 . . . . 2.2799999999999998 110.825 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.562 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 73.0 mt-30 -92.31 -7.9 46.64 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.612 -1.305 . . . . 2.0499999999999998 112.792 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.18 -43.15 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.892 . . . . 1.3400000000000001 110.833 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -57.94 -39.16 77.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.075 -1.016 . . . . 1.54 110.828 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.78 -43.29 99.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.987 -1.071 . . . . 2.8500000000000001 111.147 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.96 -39.6 92.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.778 -1.201 . . . . 1.3100000000000001 110.937 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.2 t -60.72 -42.43 92.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.192 -0.943 . . . . 1.3799999999999999 110.366 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -61.77 -45.15 95.13 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.585 -0.846 . . . . 1.5 109.962 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.2 mtt-85 -61.61 -42.01 98.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.875 -1.141 . . . . 2.7799999999999998 109.663 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -71.68 -55.71 7.18 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.507 -0.745 . . . . 1.0600000000000001 109.829 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.9 tp -58.09 -47.6 82.73 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.445 -0.902 . . . . 1.3999999999999999 109.643 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.4 t -68.13 -36.3 79.49 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.441 -0.787 . . . . 1.3200000000000001 109.702 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.66 -40.23 87.78 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.582 -1.407 . . . . 0.69999999999999996 109.582 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -58.86 -34.25 71.38 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 122.076 0.941 . . . . 3.4399999999999999 109.205 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.97 79.51 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.934 0.873 . . . . 1.3600000000000001 109.863 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -81.38 -45.62 15.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -0.822 . . . . 2.8300000000000001 110.949 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.67 86.04 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.644 -0.822 . . . . 1.23 110.397 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 t -59.94 -40.28 88.44 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.105 0.955 . . . . 1.9199999999999999 109.127 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.57 -44.78 81.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.953 -0.567 . . . . 1.25 110.219 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -62.41 -52.11 64.88 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.997 -1.081 . . . . 1.97 110.162 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.84 -40.87 94.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.171 -0.955 . . . . 2.1800000000000002 110.153 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -59.99 -40.0 87.65 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.685 -0.634 . . . . 1.1899999999999999 110.583 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -64.83 -41.8 95.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.9 -1.125 . . . . 1.3400000000000001 110.615 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.43 -38.89 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.227 -0.921 . . . . 1.23 110.798 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -51.42 -44.5 62.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.244 -0.91 . . . . 1.5600000000000001 110.538 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -68.96 -38.21 79.27 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.987 -1.071 . . . . 1.3 110.086 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -62.07 -38.95 90.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.314 -0.955 . . . . 2.3199999999999998 109.641 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.28 -31.47 70.01 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.206 0.527 . . . . 1.1399999999999999 109.748 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.93 -37.68 12.63 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.584 -1.293 . . . . 0.68999999999999995 111.017 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.51 -23.99 36.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.773 -1.427 . . . . 1.48 111.119 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.6 m -87.13 -50.58 6.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 1.52 110.68 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.04 -8.7 16.45 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.194 1.183 . . . . 1.3100000000000001 114.194 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.73 164.93 23.37 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 121.249 -0.907 . . . . 0.84999999999999998 112.734 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -55.11 -13.91 1.4 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.85 -0.794 . . . . 3.8599999999999999 112.925 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -58.75 -37.4 76.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.101 -1.0 . . . . 2.3500000000000001 111.236 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -85.34 -19.18 31.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.816 -1.177 . . . . 2.2599999999999998 112.693 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -59.61 -39.64 84.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.733 -1.229 . . . . 1.45 111.047 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.0 -41.23 91.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 1.25 110.945 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.92 -47.3 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.62 -1.3 . . . . 1.26 110.119 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -69.88 -31.97 70.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.82999999999999996 110.662 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -58.81 -38.61 79.02 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 1.1899999999999999 109.731 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.82 -36.03 73.8 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 110.261 -1.135 . . . . 0.57999999999999996 110.261 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -59.18 -46.49 88.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.167 -1.196 . . . . 2.0499999999999998 110.72 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.73 -39.77 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 1.21 109.956 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.0 ttp -59.13 -39.63 82.94 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.93 -0.708 . . . . 2.29 109.911 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 tp -57.57 -50.08 74.27 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.888 -1.125 . . . . 1.21 110.676 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.89 -40.47 93.2 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.715 0.769 . . . . 1.1399999999999999 109.953 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -86.65 7.42 26.6 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 112.445 0.535 . . . . 1.4199999999999999 112.445 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 57.7 t0 -60.87 120.7 10.68 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.875 -1.14 . . . . 1.27 108.502 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -64.86 -19.81 66.08 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.711 0.767 . . . . 1.3500000000000001 110.876 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.445 ' OE1' ' OD1' ' A' ' 82' ' ' ASP . 21.7 mp0 -77.63 -52.99 8.1 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.357 -0.839 . . . . 2.2200000000000002 110.327 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.87 -40.16 87.68 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.508 -0.877 . . . . 1.22 110.444 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -57.1 -49.48 75.76 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.279 -0.888 . . . . 1.29 110.597 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -62.33 -36.94 83.74 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.355 -0.841 . . . . 2.1699999999999999 110.589 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -67.83 -47.63 68.48 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.352 -0.939 . . . . 1.3 110.682 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.9 mt -57.45 -42.05 79.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.281 -0.887 . . . . 1.1699999999999999 110.044 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 90' ' ' ILE . 78.8 mt -62.48 -41.73 93.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 121.405 0.622 . . . . 1.3999999999999999 110.101 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.56 98.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.67 -0.644 . . . . 1.3300000000000001 111.226 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.69 -42.81 93.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.884 -1.135 . . . . 1.48 110.575 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.47 -50.33 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 1.28 110.351 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.56 -38.71 65.12 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.218 -0.926 . . . . 2.6000000000000001 111.862 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -81.67 -44.93 16.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.709 -1.244 . . . . 1.51 112.169 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -100.49 10.14 41.61 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.976 -1.078 . . . . 2.48 112.166 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.6 m80 49.14 50.59 17.71 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.728 -1.232 . . . . 1.6100000000000001 111.304 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -104.45 151.76 23.16 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.461 -0.774 . . . . 1.8999999999999999 109.747 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.9 p -72.82 167.56 20.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 1.3200000000000001 110.24 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.37 86.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 1.1499999999999999 110.334 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -67.12 -40.21 86.79 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.074 -1.016 . . . . 2.25 110.408 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.37 -49.72 58.19 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.232 -0.987 . . . . 1.22 111.128 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.71 98.22 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.265 -0.897 . . . . 1.1899999999999999 110.299 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.86 97.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.25 -0.906 . . . . 1.2 111.09 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -60.48 -40.08 89.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.015 . . . . 2.1000000000000001 111.272 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -59.91 -48.97 79.51 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.728 -1.233 . . . . 1.3 111.063 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.52 -46.53 96.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.004 -1.06 . . . . 1.27 110.13 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.16 -32.39 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.711 -0.618 . . . . 1.1899999999999999 110.316 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -55.99 -41.09 74.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.486 -0.758 . . . . 2.1099999999999999 110.77 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.38 -34.86 10.0 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.098 -1.525 . . . . 0.88 112.378 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -62.13 -44.34 96.86 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.701 -1.47 . . . . 1.99 110.179 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.29 -52.36 19.29 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.772 0.796 . . . . 1.28 110.695 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.8 p -60.07 -37.57 80.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.514 -0.741 . . . . 2.2200000000000002 110.48 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.51 -44.33 97.27 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.017 -0.673 . . . . 1.45 110.501 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.2 mt -61.75 -29.96 70.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.576 -1.327 . . . . 1.47 110.528 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -67.12 -22.4 65.8 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.339 -0.851 . . . . 2.04 111.411 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -73.18 -15.35 61.45 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.318 -0.864 . . . . 1.73 111.245 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.0 mt -84.54 141.59 30.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.431 -0.793 . . . . 1.79 108.896 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -94.92 39.46 1.1 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.077 -1.014 . . . . 2.8799999999999999 112.086 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -112.0 136.82 50.84 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.119 -1.067 . . . . 1.5800000000000001 108.119 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -59.77 -37.13 78.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.339 -0.851 . . . . 3.04 110.768 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -70.58 -57.84 4.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.79 -1.194 . . . . 1.29 110.188 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 23.1 mt -59.9 -39.9 86.94 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.16 -0.962 . . . . 1.6000000000000001 110.335 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -62.53 -51.17 68.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.997 -1.064 . . . . 2.7599999999999998 110.119 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.31 -30.59 71.7 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.751 -0.78 . . . . 2.1499999999999999 109.816 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -65.22 -28.91 69.7 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.026 -1.07 . . . . 2.8100000000000001 109.155 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.83 80.16 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.813 0.816 . . . . 1.3899999999999999 109.413 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.55 95.18 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.513 -0.875 . . . . 1.4099999999999999 109.692 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -64.95 -36.99 86.17 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.292 0.568 . . . . 1.3899999999999999 110.303 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.9 -40.49 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 1.1899999999999999 109.802 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -59.88 -38.08 81.18 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.894 0.854 . . . . 3.6299999999999999 109.552 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -59.48 -38.99 82.27 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.287 0.565 . . . . 1.28 110.274 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.9 mt -61.46 -40.27 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.271 -0.893 . . . . 1.1799999999999999 109.977 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.4 48.68 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.94 -1.124 . . . . 0.51000000000000001 110.341 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -59.1 -45.99 89.45 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 120.994 -1.297 . . . . 3.1699999999999999 110.087 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.432 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 58.6 mtm180 -62.32 -40.73 97.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.827 -1.17 . . . . 2.8500000000000001 109.998 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.61 -42.97 99.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 1.6499999999999999 110.153 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.27 -45.41 93.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 1.2 110.17 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -59.78 -33.93 72.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.556 -0.715 . . . . 2.7999999999999998 111.025 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -75.18 -40.45 59.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.207 -0.933 . . . . 2.1499999999999999 110.72 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.03 -39.96 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 1.21 110.292 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.3 mt -88.68 -6.18 57.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 1.3400000000000001 111.942 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.72 71.01 Favored Glycine 0 N--CA 1.479 1.544 0 C-N-CA 119.304 -1.427 . . . . 0.91000000000000003 112.932 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.2 tp -61.08 151.83 29.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 122.012 -0.699 . . . . 1.51 110.522 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -61.22 145.71 50.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.36 -0.837 . . . . 2.8799999999999999 109.1 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.9 mt -111.3 139.94 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.536 -0.913 . . . . 1.6200000000000001 108.536 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 147' ' ' ILE . 13.8 mm -79.53 121.85 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.223 -1.029 . . . . 2.1099999999999999 108.223 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -97.4 95.52 7.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.37 -1.715 . . . . 1.6200000000000001 106.37 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.46 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 76.8 mt -75.51 -23.26 56.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.629 -0.669 . . . . 1.3999999999999999 111.332 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.4 ' OG ' ' OD1' ' A' ' 172' ' ' ASN . 5.7 t -79.53 -0.68 34.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.176 -0.952 . . . . 2.0499999999999998 112.334 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.08 22.84 8.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.737 -0.602 . . . . 1.3500000000000001 112.46 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.46 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 11.3 mt -72.05 137.36 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.695 . . . . 1.4199999999999999 109.543 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -112.47 -19.43 12.14 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.714 0.769 . . . . 2.9900000000000002 112.828 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -117.44 138.95 51.5 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.53 -1.285 . . . . 1.54 107.53 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.35 122.02 21.37 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.001 -1.111 . . . . 1.3799999999999999 108.001 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.8 m -145.63 177.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.438 -0.788 . . . . 1.28 109.291 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.3 mt -88.26 140.97 14.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.517 -0.74 . . . . 1.1599999999999999 109.341 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.4 tp -94.12 124.17 37.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.969 -1.082 . . . . 1.3100000000000001 108.143 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.8 t -125.36 130.21 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.131 -1.063 . . . . 1.25 108.131 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.63 152.41 21.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.454 -0.779 . . . . 1.26 109.226 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.24 82.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.495 -1.378 . . . . 1.6000000000000001 109.738 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 49.6 t0 -172.72 146.48 1.64 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.03 -0.729 . . . . 2.4199999999999999 109.03 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.423 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 83.6 mt -119.35 141.27 49.18 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.406 -0.809 . . . . 1.3500000000000001 109.304 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 65.7 p -91.59 152.41 43.41 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 120.848 -1.158 . . . . 1.3200000000000001 108.364 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -41.6 -39.12 4.56 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.081 1.854 . . . . 0.69999999999999996 113.848 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.432 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 27.4 m -59.91 -47.06 87.29 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 1.1200000000000001 110.184 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -67.6 -40.52 84.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.793 . . . . 1.21 109.948 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.524 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 26.9 p -68.42 -37.91 80.74 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.917 -0.713 . . . . 1.1899999999999999 110.223 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.55 82.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.945 . . . . 1.24 110.526 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -93.18 -2.67 55.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.054 . . . . 1.6899999999999999 112.792 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.37 146.23 51.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.05 -1.031 . . . . 1.3400000000000001 108.434 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.4 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 5.1 m120 -96.42 118.86 33.82 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.786 -1.561 . . . . 2.77 106.786 177.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.3 mm? -76.85 -14.55 59.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.446 -0.784 . . . . 2.0899999999999999 111.451 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -80.05 -27.35 39.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.535 -0.728 . . . . 2.6699999999999999 111.807 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -100.83 1.19 39.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.149 -0.969 . . . . 2.5800000000000001 113.204 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.14 129.97 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.584 -0.895 . . . . 1.1799999999999999 108.584 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.26 -11.32 43.91 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.359 -0.838 . . . . 2.1800000000000002 112.455 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.57 177.1 42.54 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.141 -1.584 . . . . 0.48999999999999999 109.141 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -133.45 132.66 41.35 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 107.784 -1.191 . . . . 0.64000000000000001 107.784 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 77.5 mt -134.37 111.2 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 105.824 -1.917 . . . . 1.21 105.824 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 54.2 p -130.32 171.99 12.33 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.679 -1.263 . . . . 1.3799999999999999 110.292 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -101.17 52.1 0.85 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.973 -0.558 . . . . 2.3700000000000001 110.222 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -101.16 140.0 36.05 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.693 -0.854 . . . . 1.52 108.693 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.42 -30.24 18.6 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 120.301 -0.952 . . . . 1.8 111.123 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.27 -17.37 59.44 Favored Glycine 0 N--CA 1.49 2.239 0 O-C-N 121.174 -1.191 . . . . 2.04 112.945 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 -60.09 -38.38 82.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.399 -1.059 . . . . 5.0 110.311 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.5 p -146.94 37.92 0.98 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.369 -0.832 . . . . 3.02 111.454 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.441 ' HG ' ' H ' ' A' ' 191' ' ' SER . 18.2 p -82.85 124.18 30.07 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.385 -0.968 . . . . 2.1099999999999999 108.385 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.524 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 49.2 t60 -59.87 -38.61 82.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.405 -0.81 . . . . 1.24 110.545 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.3 p -54.13 -40.37 67.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 2.1499999999999999 110.587 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.441 ' H ' ' HG ' ' A' ' 188' ' ' SER . 23.2 t -59.62 -39.6 84.82 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.034 -1.041 . . . . 2.02 109.71 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 33.6 mm -60.08 -39.22 79.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.583 -0.698 . . . . 2.1200000000000001 110.394 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.5 mtp -62.51 -40.08 95.59 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.403 1.097 . . . . 1.3600000000000001 109.786 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -56.2 -48.93 75.44 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.815 -0.63 . . . . 1.29 110.749 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -60.16 -42.55 95.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.011 -1.056 . . . . 3.5600000000000001 110.605 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 64.9 m -69.96 -40.03 75.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.932 -1.105 . . . . 1.1799999999999999 110.347 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 26.7 mt -91.12 -7.98 50.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 1.3400000000000001 112.448 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 194' ' ' ALA . 48.3 mt-10 53.33 7.99 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.804 1.038 . . . . 1.45 113.804 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.26 150.48 92.0 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.933 . . . . 1.25 108.646 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.04 144.17 90.61 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.285 1.323 . . . . 0.78000000000000003 109.263 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.73 162.26 34.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.119 -1.613 . . . . 1.2 110.075 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.2 mt -147.31 152.41 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.028 -1.101 . . . . 1.25 108.028 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.6 m -135.42 -32.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 121.288 -0.883 . . . . 1.3899999999999999 112.702 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.84 41.42 2.37 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 120.098 -1.049 . . . . 0.96999999999999997 111.399 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.472 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 43.2 p -64.14 -17.17 63.22 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.453 -1.028 . . . . 1.3500000000000001 111.508 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.69 -95.81 0.91 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.945 -1.122 . . . . 1.0700000000000001 110.345 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 88.8 p -127.25 30.8 5.34 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.849 -0.795 . . . . 1.9199999999999999 112.146 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 72.7 t -58.91 -33.15 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.389 -1.444 . . . . 1.3300000000000001 110.116 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 38.5 p -56.48 -24.04 43.35 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.71 -0.796 . . . . 1.4199999999999999 111.407 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.2 p -92.98 0.74 57.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.866 . . . . 2.1200000000000001 112.001 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -123.55 -7.74 8.03 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.562 0.696 . . . . 2.6899999999999999 112.218 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 15.3 t -114.12 140.91 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.068 -0.716 . . . . 1.29 109.068 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -115.96 150.0 37.87 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.331 -0.988 . . . . 2.6899999999999999 108.331 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.498 HD21 ' CG ' ' A' ' 215' ' ' ASP . 1.8 p-10 -52.1 141.08 19.22 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.28 -0.887 . . . . 2.79 110.279 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.498 ' CG ' HD21 ' A' ' 214' ' ' ASN . 1.2 m-20 80.27 -0.75 1.99 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.948 1.092 . . . . 2.3500000000000001 113.948 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -64.77 149.02 50.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.78 -1.2 . . . . 1.97 108.745 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -87.33 116.01 25.13 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.381 -1.34 . . . . 2.9700000000000002 107.381 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.2 mt -128.38 144.73 51.17 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.513 0.673 . . . . 1.25 109.714 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 20.1 mt -115.81 128.61 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.698 -1.593 . . . . 1.22 106.698 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 48.9 tp -99.3 119.67 38.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 106.725 -1.584 . . . . 1.24 106.725 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.6 t0 -94.46 -28.66 15.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.926 -1.109 . . . . 2.0499999999999998 112.333 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.418 ' HB2' ' N ' ' A' ' 10' ' ' GLY . . . 38.61 17.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.005 0.743 . . . . 1.25 113.005 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' A' ' 221' ' ' ASP . 32.1 t -107.33 -58.54 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -0.929 . . . . 1.4299999999999999 108.948 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -92.15 11.23 26.22 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.888 0.851 . . . . 3.0299999999999998 110.545 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 62.51 50.79 3.47 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.616 -0.72 . . . . 2.25 112.504 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -153.41 159.24 42.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.025 . . . . 2.52 109.945 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.0 t -116.43 141.65 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.127 -0.694 . . . . 1.29 109.127 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -103.5 132.08 50.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.024 -1.047 . . . . 1.3400000000000001 108.758 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.63 129.63 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 107.717 -1.216 . . . . 1.3400000000000001 107.717 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.435 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 54.0 t30 48.9 50.67 9.54 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 2.1800000000000002 112.912 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 25.2 Cg_endo -64.13 154.26 71.64 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.42 2.08 . . . . 0.93999999999999995 110.541 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.6 m -74.55 156.51 36.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.074 -1.016 . . . . 2.3999999999999999 109.489 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -58.74 -35.76 73.22 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.018 . . . . 3.3300000000000001 110.774 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -59.57 -40.19 86.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 3.1699999999999999 110.015 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 96.8 t -69.64 -39.53 78.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.56 -0.713 . . . . 1.6899999999999999 110.236 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.3 mt -57.48 -43.93 83.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.64 -0.662 . . . . 1.6000000000000001 110.613 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.46 -43.31 93.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.873 -1.142 . . . . 2.7000000000000002 110.317 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -63.64 -44.36 94.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.101 -1.0 . . . . 2.96 111.126 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.9 mtp -68.75 -37.75 79.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.007 -1.058 . . . . 1.6299999999999999 110.874 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -59.05 -39.41 81.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.471 -0.768 . . . . 3.27 110.917 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.17 -43.41 67.53 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.158 -0.964 . . . . 2.23 111.086 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 99.6 t -60.26 -49.35 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.498 -1.376 . . . . 2.79 110.898 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.46 -50.32 71.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.742 -1.224 . . . . 4.2599999999999998 110.475 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.76 -34.41 77.82 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.483 -0.887 . . . . 1.8799999999999999 110.436 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -60.49 -29.41 69.06 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.914 -1.116 . . . . 3.3799999999999999 110.418 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.5 -44.82 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.752 0.787 . . . . 2.8799999999999999 110.155 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.27 -42.49 95.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.499 -0.751 . . . . 2.75 110.466 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.9 t -71.77 -34.31 69.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.469 -0.769 . . . . 3.4199999999999999 110.64 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.07 -39.62 94.47 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.28 -0.888 . . . . 3.5699999999999998 110.975 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.74 -31.42 72.06 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.798 -1.189 . . . . 4.6100000000000003 110.804 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.99 85.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 4.4500000000000002 110.622 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.43 -27.16 65.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 5.9699999999999998 111.74 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.19 -29.88 70.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.823 -1.173 . . . . 6.4500000000000002 111.192 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -68.37 -31.22 70.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -0.863 . . . . 6.6600000000000001 110.84 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -83.57 -12.7 55.8 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.191 -0.943 . . . . 8.5399999999999991 112.311 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -87.08 40.24 0.9 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.229 -0.92 . . . . 8.0700000000000003 112.159 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -90.03 22.47 3.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.866 -1.146 . . . . 9.7200000000000006 112.275 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -85.07 -61.64 1.73 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.449 -0.782 . . . . 10.119999999999999 109.54 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 117.93 -1.033 . . . . 11.9 109.609 -178.482 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.5 mtp . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.675 -0.491 . . . . 3.5299999999999998 109.675 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.1 mt -97.73 111.26 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.806 -1.553 . . . . 1.5700000000000001 106.806 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.6 m -104.71 125.46 50.83 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.989 -1.115 . . . . 1.4399999999999999 107.989 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.8 -154.57 18.45 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.252 -1.939 . . . . 1.01 108.252 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 73.0 mt -96.07 -2.08 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -1.003 . . . . 1.6299999999999999 112.808 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 tp 49.57 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 1.5800000000000001 112.583 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.96 -42.92 13.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.991 -1.068 . . . . 1.3400000000000001 111.242 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -145.7 141.3 16.65 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 107.893 -1.151 . . . . 1.8600000000000001 107.893 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.05 147.83 30.61 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.233 1.956 . . . . 1.01 112.333 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.94 166.74 15.67 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.818 -1.713 . . . . 0.81000000000000005 108.818 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -127.46 138.04 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.09 -1.241 . . . . 1.3700000000000001 108.004 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.48 160.06 40.93 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.964 0.888 . . . . 1.1399999999999999 109.466 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 11.9 m-85 -129.66 139.94 51.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.168 -1.419 . . . . 0.87 107.168 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.69 169.2 38.4 Favored Glycine 0 N--CA 1.5 2.903 0 C-N-CA 119.04 -1.552 . . . . 0.56999999999999995 110.077 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -77.31 158.42 30.19 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.606 -0.887 . . . . 2.3500000000000001 108.606 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.09 128.28 35.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.167 -0.958 . . . . 1.21 108.613 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 tp -108.43 105.68 15.45 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 105.124 -2.176 . . . . 1.3999999999999999 105.124 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.0 tp -94.73 132.6 39.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.107 -0.996 . . . . 1.4399999999999999 108.774 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.9 mt -101.78 118.16 36.36 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.161 -1.792 . . . . 1.45 106.161 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -107.27 130.22 54.78 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.961 -1.125 . . . . 2.5 107.961 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -128.46 140.71 51.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.453 -0.779 . . . . 2.6600000000000001 109.178 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.51 137.66 35.55 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.17 -1.048 . . . . 2.3199999999999998 108.17 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -65.57 150.8 47.81 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.208 -0.933 . . . . 2.1099999999999999 110.141 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.5 mt -89.11 134.05 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.89 -1.152 . . . . 1.29 107.89 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.22 130.23 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.928 -1.138 . . . . 1.4099999999999999 107.928 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 26' ' ' ILE . 67.9 mt -94.88 130.92 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.548 -0.908 . . . . 1.3100000000000001 108.548 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -92.74 127.01 38.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.232 -1.025 . . . . 1.3400000000000001 108.232 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.431 HH11 ' HG3' ' A' ' 28' ' ' ARG . 23.4 mmm-85 -99.31 17.39 20.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.529 -0.732 . . . . 3.48 112.277 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -61.95 144.49 54.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.783 -1.198 . . . . 2.52 109.467 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -90.66 131.93 36.07 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.606 -0.886 . . . . 2.6299999999999999 108.606 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 pt -99.24 168.05 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.315 -0.866 . . . . 1.3100000000000001 110.239 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.5 p -94.6 162.73 13.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.565 -0.71 . . . . 1.24 109.825 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.37 -21.11 22.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 1.49 111.667 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.76 -38.41 76.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.058 -1.026 . . . . 2.2799999999999998 110.597 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -88.4 -6.35 57.73 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.104 -0.997 . . . . 2.0499999999999998 111.932 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.07 -41.21 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.049 -1.032 . . . . 1.3400000000000001 110.59 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -57.58 -40.08 78.22 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.907 -1.121 . . . . 1.54 110.736 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -63.2 -40.84 98.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 2.8500000000000001 111.265 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.3 -39.76 88.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.779 -1.201 . . . . 1.3100000000000001 110.875 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.2 -41.72 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.94 . . . . 1.3799999999999999 110.43 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -61.75 -42.6 99.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.021 -1.049 . . . . 1.5 110.071 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.48 ' NH2' ' O ' ' A' ' 141' ' ' ILE . 55.4 mtp180 -61.82 -42.54 99.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 2.7799999999999998 110.371 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -73.11 -51.08 19.33 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.014 -1.054 . . . . 1.0600000000000001 110.162 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.45 -47.86 82.18 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.112 -1.435 . . . . 1.3999999999999999 110.238 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 t -69.63 -42.56 74.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.419 -0.8 . . . . 1.3200000000000001 110.469 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.81 -41.83 84.35 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.178 -1.487 . . . . 0.69999999999999996 109.395 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.53 HH22 ' CD ' ' A' ' 86' ' ' GLU . 17.7 ttm180 -57.45 -32.73 67.21 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.227 1.013 . . . . 3.4399999999999999 109.473 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.28 -42.43 81.64 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.806 0.813 . . . . 1.3600000000000001 109.669 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.664 ' HZ2' ' ND2' ' A' ' 140' ' ' ASN . 26.1 ttpp -79.75 -43.93 21.65 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.729 0.776 . . . . 2.8300000000000001 110.223 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.17 88.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.334 -0.854 . . . . 1.23 109.929 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 t -59.57 -41.76 90.94 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.068 0.937 . . . . 1.9199999999999999 109.289 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.48 -45.23 80.37 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.965 -0.562 . . . . 1.25 110.063 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -64.85 -50.2 67.58 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.052 -1.059 . . . . 1.97 110.181 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.67 -37.61 84.71 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.658 -0.817 . . . . 2.1800000000000002 110.2 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -60.19 -42.81 95.85 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.551 -0.718 . . . . 1.1899999999999999 110.822 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.5 m -65.01 -44.2 90.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.019 -1.051 . . . . 1.3400000000000001 110.42 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.15 -36.76 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.54 -0.725 . . . . 1.23 110.674 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -50.81 -44.94 59.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.155 -0.965 . . . . 1.5600000000000001 110.561 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -68.3 -37.49 80.69 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.135 -0.978 . . . . 1.3 110.16 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' O ' ' OG1' ' A' ' 64' ' ' THR . 24.7 mtpp -61.49 -39.02 89.43 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.427 -1.309 . . . . 2.3199999999999998 108.932 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.98 -38.76 87.11 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.799 -0.761 . . . . 1.1399999999999999 109.261 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.94 -40.04 58.01 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 119.692 -1.242 . . . . 0.68999999999999995 110.505 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -79.64 -20.15 47.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.427 -1.043 . . . . 1.48 110.437 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 87.9 m -82.74 -53.31 6.01 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 120.217 -0.593 . . . . 1.52 110.458 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -106.19 -16.06 14.69 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.289 -0.882 . . . . 1.3100000000000001 112.693 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.95 167.77 16.3 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 111.459 -0.656 . . . . 0.84999999999999998 111.459 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.3 -25.86 62.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.407 -1.054 . . . . 3.8599999999999999 112.23 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.07 -40.06 73.01 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.895 -1.128 . . . . 2.3500000000000001 111.182 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -89.36 -16.45 31.0 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.924 -1.11 . . . . 2.2599999999999998 112.3 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.62 -39.0 86.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 1.45 110.702 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.17 78.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.72 -0.613 . . . . 1.25 111.495 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.01 -41.52 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.847 -1.158 . . . . 1.26 110.521 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -70.26 -31.44 68.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.917 -1.115 . . . . 0.82999999999999996 110.498 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.43 -39.98 92.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.309 -0.87 . . . . 1.1899999999999999 110.021 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.44 96.25 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.799 -1.32 . . . . 0.57999999999999996 109.799 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -57.81 -40.13 79.21 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.367 -1.078 . . . . 2.0499999999999998 110.495 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.5 mt -61.44 -40.39 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 1.21 110.236 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.6 ttm -59.5 -41.12 89.14 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.259 -0.901 . . . . 2.29 110.381 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.3 tp -57.52 -49.1 77.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.81 . . . . 1.21 110.309 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.02 -45.12 93.85 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.86 0.838 . . . . 1.1399999999999999 110.175 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -87.46 8.03 26.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.464 -0.773 . . . . 1.4199999999999999 113.026 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 55.2 t0 -62.22 123.47 18.28 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.764 -1.21 . . . . 1.27 109.151 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -66.48 -18.54 65.42 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.406 -0.809 . . . . 1.3500000000000001 111.168 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' OE1' ' OD1' ' A' ' 82' ' ' ASP . 10.8 mp0 -77.68 -52.4 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.689 -0.804 . . . . 2.2200000000000002 110.099 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.5 mt -60.92 -35.2 76.07 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.101 -0.999 . . . . 1.22 110.287 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.53 ' CD ' HH22 ' A' ' 47' ' ' ARG . 80.8 tt0 -59.14 -47.6 84.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.821 . . . . 1.29 110.402 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -61.72 -35.54 78.34 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.629 -0.669 . . . . 2.1699999999999999 110.12 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.07 -49.09 71.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 1.3 110.313 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.3 mt -58.64 -43.93 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.06 -1.025 . . . . 1.1699999999999999 109.779 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.01 -40.9 87.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.65 -0.656 . . . . 1.3999999999999999 110.146 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.91 -42.32 93.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.33 -0.857 . . . . 1.3300000000000001 110.424 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.39 -44.03 97.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.285 -0.884 . . . . 1.48 110.013 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.8 mt -63.56 -49.21 83.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.363 -0.835 . . . . 1.28 110.039 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -78.12 -37.2 46.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.496 -0.752 . . . . 2.6000000000000001 111.658 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 91' ' ' ALA . 53.0 t0 -81.81 -40.96 21.79 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.573 -1.329 . . . . 1.51 111.996 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -105.58 7.76 32.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.457 -0.777 . . . . 2.48 112.687 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.7 m80 49.65 49.79 19.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.563 -1.336 . . . . 1.6100000000000001 111.504 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 67.1 mtt -104.45 156.75 17.67 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.049 0.928 . . . . 1.8999999999999999 109.967 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.439 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 81.3 p -72.59 161.75 30.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.783 -0.573 . . . . 1.3200000000000001 110.02 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.55 86.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 1.1499999999999999 110.302 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.28 -40.07 89.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.118 -0.989 . . . . 2.25 109.868 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.439 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -70.2 -48.83 55.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.559 -0.713 . . . . 1.22 111.08 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.93 92.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.167 -0.958 . . . . 1.1899999999999999 110.227 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.17 95.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.579 -0.701 . . . . 1.2 110.661 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -60.29 -39.87 88.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.204 -0.935 . . . . 2.1000000000000001 111.275 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -58.05 -48.92 78.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.729 -1.232 . . . . 1.3 110.912 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.77 -45.61 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.892 -1.13 . . . . 1.27 109.867 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.3 mm -62.22 -31.72 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.645 -0.659 . . . . 1.1899999999999999 110.348 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -57.33 -41.09 79.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 2.1099999999999999 110.572 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.16 -34.64 9.52 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.368 -1.396 . . . . 0.88 112.624 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -60.69 -42.37 97.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.261 -1.729 . . . . 1.99 110.153 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.07 -55.55 6.35 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.451 -0.781 . . . . 1.28 110.727 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.8 m -60.61 -37.95 83.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 2.2200000000000002 110.886 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.51 96.37 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.897 -1.127 . . . . 1.45 111.079 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.31 -30.22 70.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.873 -1.131 . . . . 1.47 110.918 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -66.53 -20.82 66.12 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.168 -1.013 . . . . 2.04 110.954 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -71.91 -15.18 62.09 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.838 0.827 . . . . 1.73 110.828 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 50.0 mt -86.74 145.16 26.76 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.246 -0.65 . . . . 1.79 109.246 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -103.02 39.7 1.51 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.337 -0.852 . . . . 2.8799999999999999 111.461 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -113.04 136.27 52.87 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.135 -1.061 . . . . 1.5800000000000001 108.135 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -56.63 -38.07 71.59 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.444 0.64 . . . . 3.04 110.796 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -72.16 -52.79 14.99 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.827 -1.171 . . . . 1.29 110.312 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 19.3 mt -63.58 -39.72 95.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.168 -0.958 . . . . 1.6000000000000001 110.497 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -65.65 -47.54 75.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.93 . . . . 2.7599999999999998 110.502 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -61.47 -31.34 71.3 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.407 -0.917 . . . . 2.1499999999999999 110.248 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -65.71 -27.7 68.52 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 118.995 -1.082 . . . . 2.8100000000000001 109.528 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.84 -49.16 78.77 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.786 0.803 . . . . 1.3899999999999999 109.589 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.23 91.22 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.57 -0.852 . . . . 1.4099999999999999 109.633 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 2.0 m-20 -62.97 -35.47 80.28 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.306 0.574 . . . . 1.3899999999999999 110.214 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.8 t -68.17 -40.47 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.518 -0.739 . . . . 1.1899999999999999 110.639 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -59.72 -38.13 80.81 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.509 -1.277 . . . . 3.6299999999999999 110.076 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.52 ' OD1' ' NE ' ' A' ' 136' ' ' ARG . 54.4 t0 -60.22 -40.05 88.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.608 -0.683 . . . . 1.28 110.186 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.19 -39.64 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.01 -1.056 . . . . 1.1799999999999999 110.399 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.08 -46.9 62.68 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.937 -1.125 . . . . 0.51000000000000001 110.696 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -59.94 -41.31 91.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.123 -1.222 . . . . 3.1699999999999999 110.368 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.52 ' NE ' ' OD1' ' A' ' 132' ' ' ASP . 40.5 mtt-85 -63.32 -42.11 98.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.06 -1.025 . . . . 2.8500000000000001 109.995 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.0 tt -61.06 -45.15 95.92 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.967 0.889 . . . . 1.6499999999999999 109.76 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.98 -42.05 97.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.89 . . . . 1.2 110.522 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.12 -31.71 70.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.933 . . . . 2.7999999999999998 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.664 ' ND2' ' HZ2' ' A' ' 49' ' ' LYS . 24.9 m120 -75.33 -41.67 56.18 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.945 -1.097 . . . . 2.1499999999999999 110.777 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.48 ' O ' ' NH2' ' A' ' 42' ' ' ARG . 98.0 mt -60.02 -37.92 74.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.144 -0.973 . . . . 1.21 110.607 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.0 mt -87.49 -9.18 55.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.378 -0.826 . . . . 1.3400000000000001 111.716 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.26 23.62 65.34 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 120.298 -0.953 . . . . 0.91000000000000003 113.457 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.1 tp -68.34 139.71 55.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.806 -0.82 . . . . 1.51 109.863 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -68.6 150.54 47.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.568 -0.707 . . . . 2.8799999999999999 109.907 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 39.7 mt -108.76 137.7 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.341 -0.985 . . . . 1.6200000000000001 108.341 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 147' ' ' ILE . 13.3 mm -78.31 130.35 36.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.875 -1.141 . . . . 2.1099999999999999 109.016 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -94.47 97.62 10.29 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.625 -1.62 . . . . 1.6200000000000001 106.625 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 51.0 mt -76.98 -15.66 59.58 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.39 0.614 . . . . 1.3999999999999999 111.563 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.4 t -80.97 2.39 27.06 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.59 0.71 . . . . 2.0499999999999998 112.156 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.69 22.7 10.57 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.713 0.768 . . . . 1.3500000000000001 112.069 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 12.5 mt -72.77 135.88 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.427 -0.953 . . . . 1.4199999999999999 108.427 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -121.15 -13.69 8.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 112.927 0.714 . . . . 2.9900000000000002 112.927 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -112.53 136.89 51.51 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.926 -1.138 . . . . 1.54 107.926 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.07 117.68 17.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.376 -0.828 . . . . 1.3799999999999999 109.009 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -148.01 179.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.21 -0.663 . . . . 1.28 109.21 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 49.0 mt -88.13 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.481 -0.933 . . . . 1.1599999999999999 108.481 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.3 tp -94.63 126.82 40.17 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.43 -0.952 . . . . 1.3100000000000001 108.43 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.48 130.66 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.038 -1.097 . . . . 1.25 108.038 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.34 159.51 31.3 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.009 -1.057 . . . . 1.26 108.67 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.14 92.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.692 -1.255 . . . . 1.6000000000000001 109.324 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 50.9 t0 -171.75 154.09 3.53 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.527 -0.916 . . . . 2.4199999999999999 108.527 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 49.6 mt -117.18 139.04 51.26 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.446 -0.946 . . . . 1.3500000000000001 108.446 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.7 p -92.06 146.29 32.49 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.158 -0.964 . . . . 1.3200000000000001 108.41 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -38.97 -44.63 2.51 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.169 1.913 . . . . 0.69999999999999996 113.812 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 16.2 m -60.34 -47.84 84.32 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.629 -1.294 . . . . 1.1200000000000001 109.954 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -63.17 -37.8 88.67 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.657 0.742 . . . . 1.21 110.167 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.651 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 46.0 p -67.87 -39.05 83.79 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.547 -0.721 . . . . 1.1899999999999999 110.192 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.19 86.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.533 -0.73 . . . . 1.24 110.744 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.79 -3.31 56.3 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.149 -0.97 . . . . 1.6899999999999999 113.046 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.37 156.35 26.15 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.402 -0.811 . . . . 1.3400000000000001 109.587 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -94.9 110.2 22.12 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.503 -1.666 . . . . 2.77 106.503 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.1 mt -71.33 -24.91 62.21 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.748 0.785 . . . . 2.0899999999999999 111.408 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -85.66 -18.66 32.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.492 -0.755 . . . . 2.6699999999999999 112.446 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -100.64 -2.73 31.97 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.297 -0.877 . . . . 2.5800000000000001 112.767 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.69 130.09 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.689 -1.226 . . . . 1.1799999999999999 107.689 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.419 ' CD2' ' O ' ' A' ' 177' ' ' LEU . 1.8 tt -85.61 -9.89 56.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.031 -1.043 . . . . 2.1800000000000002 111.702 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.37 173.41 38.98 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.485 -1.446 . . . . 0.48999999999999999 109.485 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.9 OUTLIER -130.64 131.31 44.83 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.622 -1.251 . . . . 0.64000000000000001 107.622 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 87.5 mt -134.49 109.11 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 106.093 -1.818 . . . . 1.21 106.093 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 203' ' ' VAL . 73.6 p -134.26 174.58 10.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.678 -1.264 . . . . 1.3799999999999999 110.415 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 206' ' ' GLY . 11.8 t0 -103.85 65.83 0.83 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.639 -0.71 . . . . 2.3700000000000001 109.375 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -101.85 145.82 28.67 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.195 -0.941 . . . . 1.52 109.053 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.46 -8.63 59.95 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.855 -1.164 . . . . 1.8 112.807 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 83.42 -21.52 8.62 Favored Glycine 0 N--CA 1.492 2.411 0 O-C-N 121.511 -0.994 . . . . 2.04 114.183 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -59.95 -37.14 78.67 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.055 -1.262 . . . . 5.0 109.855 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 20.2 p -146.72 41.99 1.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.557 -0.714 . . . . 3.02 110.505 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.402 ' OG ' ' OG ' ' A' ' 191' ' ' SER . 27.9 p -85.33 103.46 14.27 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.07 -1.455 . . . . 2.1099999999999999 107.07 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.651 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 46.6 t60 -59.98 -30.46 69.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.838 . . . . 1.24 110.528 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.0 m -56.45 -40.51 74.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.539 -0.726 . . . . 2.1499999999999999 110.039 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.402 ' OG ' ' OG ' ' A' ' 188' ' ' SER . 49.1 m -59.78 -39.98 86.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 2.02 109.948 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.504 ' CD1' ' N ' ' A' ' 192' ' ' ILE . 1.6 mp -60.23 -38.89 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.815 . . . . 2.1200000000000001 110.418 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 68.3 mtp -62.38 -42.96 99.82 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 122.062 0.934 . . . . 1.3600000000000001 109.529 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.5 -48.74 79.69 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.726 -0.67 . . . . 1.29 111.673 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 195' ' ' ARG . 30.2 mtt-85 -60.78 -44.4 96.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.14 . . . . 3.5600000000000001 110.653 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 28.8 m -69.45 -39.54 77.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.887 . . . . 1.1799999999999999 110.435 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.4 -4.9 53.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 1.3400000000000001 112.987 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 194' ' ' ALA . 75.3 mt-10 54.6 12.5 0.56 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.115 1.154 . . . . 1.45 114.115 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 72.9 mt -73.77 158.4 86.15 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.05 -1.032 . . . . 1.25 108.495 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -65.32 142.71 73.98 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.973 1.115 . . . . 0.78000000000000003 110.557 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.96 163.87 33.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 119.928 -1.733 . . . . 1.2 110.431 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.0 mt -149.88 149.74 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 107.465 -1.309 . . . . 1.25 107.465 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 5.5 m -135.82 -26.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.755 -1.216 . . . . 1.3899999999999999 112.54 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.15 35.04 1.49 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.309 -1.424 . . . . 0.96999999999999997 113.113 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 47.5 p -56.06 -27.62 54.19 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.421 -1.046 . . . . 1.3500000000000001 111.45 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 77.12 -90.78 1.0 Allowed Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.133 -1.032 . . . . 1.0700000000000001 110.815 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.2 p -125.06 27.6 6.64 Favored 'General case' 0 N--CA 1.512 2.652 0 O-C-N 121.341 -1.094 . . . . 1.9199999999999999 112.669 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.11 -34.76 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.232 -1.543 . . . . 1.3300000000000001 110.075 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.9 p -58.34 -17.97 23.96 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.26 -0.976 . . . . 1.4199999999999999 111.86 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.8 p -92.63 -0.98 57.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.137 -0.977 . . . . 2.1200000000000001 112.006 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -129.13 5.19 5.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 112.595 0.591 . . . . 2.6899999999999999 112.595 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.87 141.32 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.732 -0.605 . . . . 1.29 109.39 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -120.35 155.21 33.84 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.371 -0.974 . . . . 2.6899999999999999 108.371 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 16.6 p30 -53.8 142.79 22.77 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.083 -1.011 . . . . 2.79 110.547 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.6 t0 80.19 0.25 2.01 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.504 1.298 . . . . 2.3500000000000001 114.504 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.12 146.67 54.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.795 -1.191 . . . . 1.97 108.78 177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -88.74 120.7 30.38 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.458 -1.312 . . . . 2.9700000000000002 107.458 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 49.6 mt -128.94 149.04 50.96 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.404 -0.81 . . . . 1.25 110.018 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 57.4 mt -116.03 126.95 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.878 -1.527 . . . . 1.22 106.878 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 65.1 tp -99.22 120.11 38.98 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.306 -1.368 . . . . 1.24 107.306 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 223' ' ' VAL . 49.7 t0 -93.89 -28.97 15.54 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.012 -1.055 . . . . 2.0499999999999998 112.826 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 38.77 18.37 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.186 0.809 . . . . 1.25 113.186 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.8 t -111.45 -58.84 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-O 122.197 0.999 . . . . 1.4299999999999999 108.922 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -96.47 9.8 40.24 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.412 1.101 . . . . 3.0299999999999998 110.188 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 61.92 50.05 4.38 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.785 -1.098 . . . . 2.25 111.665 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -145.28 148.04 33.02 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.345 1.069 . . . . 2.52 109.749 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 80.9 t -117.2 140.77 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 115.503 -0.772 . . . . 1.29 109.285 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -100.03 130.59 46.21 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.171 -1.048 . . . . 1.3400000000000001 108.171 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.3 t -109.83 131.48 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.579 0.704 . . . . 1.3400000000000001 109.166 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.413 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 24.6 t30 52.96 51.65 9.47 Favored Pre-proline 0 N--CA 1.497 1.877 0 N-CA-C 113.345 0.869 . . . . 2.1800000000000002 113.345 177.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 61.9 Cg_endo -70.23 151.66 66.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.784 2.323 . . . . 0.93999999999999995 111.441 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.0 m -72.23 156.46 39.11 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.964 -1.085 . . . . 2.3999999999999999 108.747 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -59.8 -39.43 84.95 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.89 -1.131 . . . . 3.3300000000000001 109.935 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.65 -39.72 85.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.482 -0.761 . . . . 3.1699999999999999 110.278 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 87.9 t -69.71 -38.58 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.461 -0.775 . . . . 1.6899999999999999 110.216 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 236' ' ' ILE . 73.5 mt -59.29 -46.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.042 -1.036 . . . . 1.6000000000000001 110.15 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.03 -40.22 88.57 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.175 -0.953 . . . . 2.7000000000000002 110.208 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -62.17 -41.57 98.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 2.96 110.808 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 74.9 mtp -70.81 -31.39 68.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 1.6299999999999999 110.372 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -40.64 85.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 3.27 110.063 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.6 -45.33 45.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.297 -0.877 . . . . 2.23 110.827 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 87.5 t -59.61 -46.35 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 2.79 110.828 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.484 ' CA ' ' OE1' ' A' ' 243' ' ' GLN . 0.4 OUTLIER -62.86 -51.93 65.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.019 -1.051 . . . . 4.2599999999999998 109.871 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.14 -31.88 71.59 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.216 -0.993 . . . . 1.8799999999999999 109.838 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -60.74 -31.1 70.43 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.097 -1.041 . . . . 3.3799999999999999 109.364 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.7 -43.88 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.87 0.843 . . . . 2.8799999999999999 109.918 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.1 94.76 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.023 -1.071 . . . . 2.75 109.567 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.2 t -73.28 -24.85 60.48 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.664 0.745 . . . . 3.4199999999999999 110.63 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -60.58 -37.77 82.43 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.815 -0.553 . . . . 3.5699999999999998 110.534 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -62.63 -41.54 99.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 4.6100000000000003 110.373 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -71.02 -42.64 69.28 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.886 0.851 . . . . 4.4500000000000002 110.574 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -82.94 5.2 22.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.579 -0.701 . . . . 5.9699999999999998 112.739 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.1 -36.12 74.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.924 -1.11 . . . . 6.4500000000000002 110.415 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.73 -19.55 65.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.848 -1.158 . . . . 6.6600000000000001 111.409 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -84.74 -5.91 59.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.474 -0.767 . . . . 8.5399999999999991 112.69 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.86 -3.72 58.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.903 -1.123 . . . . 8.0700000000000003 111.688 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -87.33 -122.67 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.193 -1.04 . . . . 9.7200000000000006 108.193 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.03 11.58 38.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.476 -0.765 . . . . 10.119999999999999 112.478 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 117.965 -1.017 . . . . 11.9 109.274 179.698 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mmm . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.077 -0.712 . . . . 3.5299999999999998 109.077 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.0 mt -97.14 117.34 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.455 -1.683 . . . . 1.5700000000000001 106.455 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 m -104.38 128.45 52.23 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.097 -1.075 . . . . 1.4399999999999999 108.097 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.04 -160.45 16.79 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.904 -1.678 . . . . 1.01 108.904 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 96.6 mt -93.31 -1.11 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.292 -1.122 . . . . 1.6299999999999999 112.772 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 50.72 96.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.102 -0.999 . . . . 1.5800000000000001 112.688 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.92 -42.33 13.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 1.3400000000000001 111.547 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -145.35 144.85 24.37 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.046 -1.094 . . . . 1.8600000000000001 108.046 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.81 147.44 27.43 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.59 2.193 . . . . 1.01 112.218 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 151.29 167.77 15.16 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 109.261 -1.536 . . . . 0.81000000000000005 109.261 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 11' ' ' ILE . 83.7 mt -125.91 132.49 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.243 -1.151 . . . . 1.3700000000000001 107.909 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.53 151.59 46.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 1.1399999999999999 109.286 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.609 ' CE1' ' NH2' ' A' ' 240' ' ' ARG . 1.8 m-85 -122.24 144.52 48.93 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.259 -1.015 . . . . 0.87 108.259 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.92 167.45 34.22 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 118.362 -1.875 . . . . 0.56999999999999995 110.197 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -78.1 157.68 29.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.429 -1.042 . . . . 2.3500000000000001 108.938 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.96 124.64 31.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.975 -1.078 . . . . 1.21 108.151 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.3 tp -100.46 104.49 15.89 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.024 -2.213 . . . . 1.3999999999999999 105.024 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -91.02 135.78 33.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.215 -1.031 . . . . 1.4399999999999999 108.215 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.3 mt -97.27 120.1 37.01 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.438 -1.319 . . . . 1.45 107.438 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -109.11 134.67 51.4 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.249 -1.019 . . . . 2.5 108.249 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.563 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 37.2 tt0 -117.98 140.36 49.85 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.224 -0.658 . . . . 2.6600000000000001 109.224 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -81.98 131.28 35.25 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.718 -1.216 . . . . 2.3199999999999998 107.718 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.09 145.02 56.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 2.1099999999999999 108.74 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.67 135.19 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.91 -1.118 . . . . 1.29 108.636 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.6 t -103.44 129.8 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.967 -1.123 . . . . 1.4099999999999999 107.967 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -99.0 136.97 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.646 -0.872 . . . . 1.3100000000000001 108.646 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -90.62 122.46 33.43 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.828 -1.175 . . . . 1.3400000000000001 107.828 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' A' ' 28' ' ' ARG . 20.6 mmm-85 -93.52 15.72 15.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.315 -0.865 . . . . 3.48 112.319 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -71.47 143.25 50.1 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.408 -0.807 . . . . 2.52 109.527 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.75 141.7 31.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.649 -0.657 . . . . 2.6299999999999999 109.425 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.2 pt -98.3 168.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.197 -0.939 . . . . 1.3100000000000001 110.622 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.8 p -102.37 162.3 13.03 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.983 -0.747 . . . . 1.24 108.983 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.45 -18.55 1.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.086 -1.009 . . . . 1.49 112.379 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -69.85 -39.99 76.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 2.2799999999999998 110.754 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -93.13 -8.91 41.27 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.873 -1.142 . . . . 2.0499999999999998 112.949 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -56.29 -50.48 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.168 -0.957 . . . . 1.3400000000000001 110.781 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.85 -39.44 85.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.542 -0.724 . . . . 1.54 110.674 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -62.2 -41.29 98.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.831 . . . . 2.8500000000000001 110.896 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.53 -37.62 81.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.742 -1.224 . . . . 1.3100000000000001 110.449 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.41 -41.78 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.169 -0.957 . . . . 1.3799999999999999 110.028 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -62.13 -43.58 98.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 1.5 109.745 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.434 ' HG2' HH11 ' A' ' 42' ' ' ARG . 34.0 mtt-85 -61.8 -44.05 97.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.524 -0.735 . . . . 2.7799999999999998 110.063 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -70.78 -52.16 22.38 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.346 -0.846 . . . . 1.0600000000000001 109.896 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.08 -46.44 89.56 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.394 -0.922 . . . . 1.3999999999999999 109.846 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 t -69.19 -34.89 75.6 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.243 0.544 . . . . 1.3200000000000001 110.364 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.44 -47.95 87.79 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.685 -1.245 . . . . 0.69999999999999996 110.17 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -56.91 -32.02 65.5 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.363 -1.08 . . . . 3.4399999999999999 109.183 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.38 -42.06 69.93 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.522 0.677 . . . . 1.3600000000000001 109.968 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -78.49 -42.02 30.85 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.688 -0.805 . . . . 2.8300000000000001 110.14 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.77 95.95 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.669 0.747 . . . . 1.23 110.368 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.1 p -60.01 -39.81 87.06 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.994 0.902 . . . . 1.9199999999999999 109.666 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.57 67.97 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 120.073 -0.651 . . . . 1.25 110.31 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -61.18 -48.57 80.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.273 -0.892 . . . . 1.97 110.382 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.8 -40.37 96.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -0.92 . . . . 2.1800000000000002 109.821 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -60.55 -41.24 94.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.542 -0.724 . . . . 1.1899999999999999 110.428 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 m -65.65 -42.86 90.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.0 -1.062 . . . . 1.3400000000000001 110.409 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.2 -30.73 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.658 . . . . 1.23 110.611 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -52.61 -46.29 66.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.709 -0.619 . . . . 1.5600000000000001 110.619 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 m -68.82 -37.2 79.05 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.21 -0.931 . . . . 1.3 109.791 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -61.73 -38.35 87.58 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.427 -0.909 . . . . 2.3199999999999998 109.386 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.19 74.86 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.822 -0.751 . . . . 1.1399999999999999 109.977 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.97 -34.57 21.03 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.379 -1.391 . . . . 0.68999999999999995 110.917 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.44 -18.05 43.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.783 -1.422 . . . . 1.48 111.545 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.0 m -87.91 -52.57 5.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.912 -0.493 . . . . 1.52 110.344 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -107.27 -15.28 14.69 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.435 -0.791 . . . . 1.3100000000000001 112.97 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.91 164.88 14.71 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.537 -0.727 . . . . 0.84999999999999998 111.567 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -58.16 -17.94 22.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.629 -0.924 . . . . 3.8599999999999999 113.113 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.91 -39.43 85.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.995 -1.065 . . . . 2.3500000000000001 110.769 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -86.8 -23.63 25.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.953 -1.092 . . . . 2.2599999999999998 111.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -59.84 -39.98 86.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.725 -0.609 . . . . 1.45 111.598 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.44 -36.77 81.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.162 -0.961 . . . . 1.25 111.352 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 57.8 mt -63.38 -41.65 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.73 -1.232 . . . . 1.26 110.843 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -70.59 -30.94 67.75 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.933 -1.104 . . . . 0.82999999999999996 110.631 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.51 -38.73 85.32 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.195 -0.94 . . . . 1.1899999999999999 109.91 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.3 -44.67 90.22 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 120.298 -0.953 . . . . 0.57999999999999996 110.891 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -59.73 -40.79 89.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.874 -1.368 . . . . 2.0499999999999998 110.723 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.6 mt -59.83 -39.43 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.107 -0.995 . . . . 1.21 110.772 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.21 -39.77 83.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.111 -0.993 . . . . 2.29 110.633 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.5 tp -58.36 -45.89 87.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.14 -0.975 . . . . 1.21 110.235 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.51 -39.83 89.2 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.585 -0.846 . . . . 1.1399999999999999 110.248 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -86.93 11.02 14.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 1.4199999999999999 112.304 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -66.47 120.96 14.26 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.978 -1.076 . . . . 1.27 108.536 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.87 -16.8 64.17 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.367 -0.833 . . . . 1.3500000000000001 110.918 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -73.42 -47.89 38.13 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.548 -0.861 . . . . 2.2200000000000002 110.447 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.86 -37.29 86.83 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.429 -0.908 . . . . 1.22 110.229 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.74 -45.53 93.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.338 -0.851 . . . . 1.29 110.915 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.7 -36.98 85.62 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.014 -1.054 . . . . 2.1699999999999999 110.925 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.7 -48.48 63.77 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.735 -1.228 . . . . 1.3 110.404 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -57.44 -47.71 84.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.444 -0.902 . . . . 1.1699999999999999 110.243 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.87 -39.61 80.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.785 -0.572 . . . . 1.3999999999999999 110.415 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.53 91.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 1.3300000000000001 110.644 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.15 -43.68 98.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 1.48 110.284 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.1 mt -61.0 -45.95 97.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 1.28 110.648 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -82.31 -36.43 26.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -0.757 . . . . 2.6000000000000001 111.908 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -84.49 -39.36 18.97 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.62 -1.3 . . . . 1.51 111.627 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -105.26 10.37 33.65 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.969 -1.082 . . . . 2.48 111.939 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.4 m80 48.48 51.39 15.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 1.6100000000000001 111.588 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.2 mtt -109.5 154.34 22.81 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.703 0.763 . . . . 1.8999999999999999 109.722 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.1 p -71.81 158.64 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.132 -0.692 . . . . 1.3200000000000001 109.132 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.27 89.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.403 -0.811 . . . . 1.1499999999999999 110.754 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -67.42 -43.06 82.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.755 -1.215 . . . . 2.25 109.51 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.06 -48.31 58.4 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.656 0.741 . . . . 1.22 110.845 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.48 -46.85 87.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.138 -0.976 . . . . 1.1899999999999999 110.47 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.29 94.96 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.497 0.665 . . . . 1.2 110.411 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.85 -39.33 84.82 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.032 -1.043 . . . . 2.1000000000000001 110.334 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.42 -49.92 75.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.878 -1.139 . . . . 1.3 111.099 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.25 -49.0 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.059 . . . . 1.27 110.004 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.45 -30.82 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.676 -0.64 . . . . 1.1899999999999999 110.699 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -59.45 -40.37 86.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 2.1099999999999999 110.276 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.28 -28.0 31.74 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.204 -1.474 . . . . 0.88 113.108 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -60.29 -39.73 87.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.056 -1.85 . . . . 1.99 110.045 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.63 -46.69 52.82 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.554 -0.716 . . . . 1.28 110.299 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.3 p -62.83 -40.21 96.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.419 -0.801 . . . . 2.2200000000000002 110.433 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.39 -40.65 97.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 1.45 110.508 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.88 -29.61 70.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.04 -1.037 . . . . 1.47 111.111 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.09 -21.36 64.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.906 -1.121 . . . . 2.04 111.053 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -73.81 -12.48 60.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.215 -0.928 . . . . 1.73 110.788 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.6 mt -84.84 144.89 28.13 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.485 -0.759 . . . . 1.79 109.065 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -101.46 46.91 0.92 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.171 -0.956 . . . . 2.8799999999999999 111.591 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -122.28 138.75 54.39 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.057 -1.027 . . . . 1.5800000000000001 108.589 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.8 -38.67 82.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 3.04 110.973 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -71.93 -47.02 55.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.957 -1.089 . . . . 1.29 110.525 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.67 -36.76 84.89 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.46 -0.896 . . . . 1.6000000000000001 110.103 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -60.47 -46.53 89.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.819 -1.152 . . . . 2.7599999999999998 109.644 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -61.95 -30.84 71.19 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.367 -0.933 . . . . 2.1499999999999999 109.651 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -61.86 -30.12 70.64 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.291 -0.964 . . . . 2.8100000000000001 108.9 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.21 73.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.785 0.802 . . . . 1.3899999999999999 109.574 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.89 -43.36 71.95 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.622 0.725 . . . . 1.4099999999999999 110.319 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -64.5 -34.15 77.56 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.497 -0.752 . . . . 1.3899999999999999 110.528 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.01 -39.96 82.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.252 -0.905 . . . . 1.1899999999999999 110.033 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 131' ' ' ARG . 27.4 ttt-85 -56.18 -39.92 73.14 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.251 -1.379 . . . . 3.6299999999999999 109.469 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -60.05 -42.59 94.79 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.575 0.702 . . . . 1.28 110.235 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.32 -38.94 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 1.1799999999999999 110.166 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.59 -43.74 23.02 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.852 -1.166 . . . . 0.51000000000000001 110.832 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -58.33 -40.76 83.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.293 -1.122 . . . . 3.1699999999999999 110.592 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -62.33 -41.55 98.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.959 -1.088 . . . . 2.8500000000000001 109.969 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.64 -39.59 84.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.611 -0.681 . . . . 1.6499999999999999 109.964 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.3 mt -59.73 -40.09 86.86 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.453 -0.779 . . . . 1.2 110.473 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.563 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 63.1 mtt-85 -60.66 -38.6 85.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.016 -1.053 . . . . 2.7999999999999998 111.062 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -71.65 -41.81 68.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 2.1499999999999999 110.87 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.3 -39.62 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.016 -1.053 . . . . 1.21 110.216 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.2 -8.93 56.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.123 -0.986 . . . . 1.3400000000000001 112.199 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.27 21.29 78.07 Favored Glycine 0 N--CA 1.48 1.617 0 C-N-CA 119.703 -1.237 . . . . 0.91000000000000003 113.282 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 tp -69.2 149.94 48.02 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.78 -0.835 . . . . 1.51 110.543 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -67.85 150.92 47.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.369 -0.832 . . . . 2.8799999999999999 110.913 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.9 mt -101.74 139.96 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.368 -0.975 . . . . 1.6200000000000001 108.368 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.514 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.3 mp -78.56 124.42 36.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.297 -1.001 . . . . 2.1099999999999999 108.297 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -99.6 100.03 10.97 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.317 -1.735 . . . . 1.6200000000000001 106.317 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.518 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 71.6 mt -78.54 -4.99 51.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.545 -0.722 . . . . 1.3999999999999999 112.321 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.2 p -86.99 9.18 20.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.145 -0.972 . . . . 2.0499999999999998 112.366 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.66 18.42 14.33 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 114.151 1.167 . . . . 1.3500000000000001 114.151 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.518 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 3.1 mp -71.35 141.12 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 119.909 -1.744 . . . . 1.4199999999999999 109.498 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -118.84 -13.52 9.51 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.045 0.926 . . . . 2.9900000000000002 112.429 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -117.38 145.04 44.34 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.555 -0.906 . . . . 1.54 108.555 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -76.26 121.78 23.44 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.673 -0.862 . . . . 1.3799999999999999 108.673 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.4 m -147.48 176.31 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.434 -0.791 . . . . 1.28 108.973 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.9 mt -88.65 142.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.524 -0.735 . . . . 1.1599999999999999 109.339 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.5 tp -94.85 126.73 40.38 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.594 -0.891 . . . . 1.3100000000000001 108.594 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.89 131.02 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.648 -0.871 . . . . 1.25 108.648 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.98 154.56 19.87 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.646 -0.872 . . . . 1.26 108.646 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.22 -36.02 78.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.393 -1.442 . . . . 1.6000000000000001 109.477 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 55.9 t0 -172.75 151.22 2.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.43 -0.952 . . . . 2.4199999999999999 108.43 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 70.1 mt -113.06 140.22 48.04 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.371 -0.831 . . . . 1.3500000000000001 108.926 177.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.5 p -94.82 152.81 39.97 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.221 -0.925 . . . . 1.3200000000000001 108.754 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -42.91 -42.28 9.08 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.806 1.671 . . . . 0.69999999999999996 113.295 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.9 m -62.24 -50.44 71.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.987 -1.071 . . . . 1.1200000000000001 109.744 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.28 -40.5 90.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.503 -0.748 . . . . 1.21 110.25 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 78.3 p -67.86 -40.09 83.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.53 -0.731 . . . . 1.1899999999999999 110.754 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.13 86.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 1.24 110.743 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -95.32 1.1 54.28 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.204 -0.935 . . . . 1.6899999999999999 112.691 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.83 150.15 29.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.451 -0.781 . . . . 1.3400000000000001 109.902 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.595 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.6 OUTLIER -91.99 107.02 18.91 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.274 -1.75 . . . . 2.77 106.274 177.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.4 mt -81.15 -9.16 59.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.788 . . . . 2.0899999999999999 112.535 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -77.59 -35.51 52.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.039 -1.038 . . . . 2.6699999999999999 110.572 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -101.36 2.87 40.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.235 -0.915 . . . . 2.5800000000000001 113.01 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.0 t -101.0 120.01 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 106.807 -1.553 . . . . 1.1799999999999999 106.807 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.2 tp -90.93 -9.51 45.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.097 -1.002 . . . . 2.1800000000000002 112.04 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.66 169.26 40.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.035 -1.626 . . . . 0.48999999999999999 109.035 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.1 m-85 -128.02 129.79 47.28 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.384 -1.068 . . . . 0.64000000000000001 108.2 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.4 mt -128.85 108.75 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 105.857 -1.905 . . . . 1.21 105.857 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 203' ' ' VAL . 76.4 p -130.82 171.76 12.78 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.905 -1.122 . . . . 1.3799999999999999 110.153 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.445 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 33.3 t0 -102.54 59.15 0.8 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.724 -0.61 . . . . 2.3700000000000001 110.453 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.94 120.5 42.47 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.371 -1.715 . . . . 1.52 106.371 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.72 17.91 49.95 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 120.918 -1.114 . . . . 1.8 113.133 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -91.8 120.42 6.04 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.36 -2.296 . . . . 2.04 107.36 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -59.06 -31.38 68.81 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.199 -1.177 . . . . 5.0 109.558 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 81.2 p -108.44 41.51 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.462 0.649 . . . . 3.02 109.993 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 52.0 m -70.25 158.73 35.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.957 -1.09 . . . . 2.1099999999999999 109.171 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -59.84 -39.6 85.69 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.36 -0.838 . . . . 1.24 111.082 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.9 m -58.47 -40.99 84.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.633 -1.292 . . . . 2.1499999999999999 110.228 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.2 m -61.39 -37.04 81.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 2.02 110.447 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.73 -39.32 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.509 -0.745 . . . . 2.1200000000000001 110.666 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 68.8 mtp -62.92 -41.15 99.37 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.08 0.943 . . . . 1.3600000000000001 109.486 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.92 -45.43 94.67 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.931 -0.577 . . . . 1.29 111.091 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -60.37 -43.37 96.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.982 -1.074 . . . . 3.5600000000000001 110.674 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.2 m -69.45 -39.13 77.97 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.211 -0.93 . . . . 1.1799999999999999 110.187 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.45 -7.48 50.48 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.871 0.844 . . . . 1.3400000000000001 112.531 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 53.12 7.16 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.996 1.109 . . . . 1.45 113.996 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.91 149.67 92.61 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 120.959 -1.088 . . . . 1.25 108.385 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.13 144.95 88.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.534 1.49 . . . . 0.78000000000000003 109.738 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.62 161.41 35.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.366 -1.458 . . . . 1.2 109.673 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.6 mt -149.94 149.55 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.756 -1.202 . . . . 1.25 107.756 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.8 m -133.41 -25.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.123 -0.986 . . . . 1.3899999999999999 112.324 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.68 43.0 2.07 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 120.226 -0.987 . . . . 0.96999999999999997 111.837 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 43.8 p -63.08 -15.63 57.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.322 -1.105 . . . . 1.3500000000000001 111.573 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.445 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 72.12 -93.82 0.6 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.868 -1.293 . . . . 1.0700000000000001 109.868 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 85.2 p -129.95 33.4 4.4 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.35 -1.088 . . . . 1.9199999999999999 112.022 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.67 -35.79 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.023 -1.673 . . . . 1.3300000000000001 110.482 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.1 p -60.33 -24.76 65.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 1.4199999999999999 111.73 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.8 p -96.57 9.0 42.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 2.1200000000000001 112.149 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -132.59 -4.27 3.31 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.728 -0.607 . . . . 2.6899999999999999 112.409 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.06 157.59 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.275 -0.89 . . . . 1.29 109.854 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -122.25 160.25 25.64 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.069 -1.086 . . . . 2.6899999999999999 108.069 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 51.5 p-10 -57.03 142.12 43.23 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.093 -1.004 . . . . 2.79 110.53 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.0 OUTLIER 80.32 7.49 1.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.79 1.404 . . . . 2.3500000000000001 114.79 179.387 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.8 t0 -67.21 149.38 50.53 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.308 -0.997 . . . . 1.97 108.308 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.433 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.3 t80 -89.64 115.04 26.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.331 -1.359 . . . . 2.9700000000000002 107.331 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 78.5 mt -124.96 148.15 48.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -0.755 . . . . 1.25 109.365 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.3 mt -119.09 126.35 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.15 -1.796 . . . . 1.22 106.15 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 66.2 tp -100.91 119.04 38.13 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.425 -1.694 . . . . 1.24 106.425 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.0 p-10 -94.73 -21.33 18.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.027 -1.046 . . . . 2.0499999999999998 112.459 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.425 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 37.93 18.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.376 0.608 . . . . 1.25 112.477 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.601 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.4 t -112.26 -62.83 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 1.4299999999999999 109.389 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -89.68 7.25 37.64 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.314 1.054 . . . . 3.0299999999999998 110.226 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 39.6 t30 63.86 50.58 2.56 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.023 -0.989 . . . . 2.25 112.1 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 74.6 mt-30 -147.16 152.38 38.33 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.352 1.072 . . . . 2.52 110.187 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.9 t -115.65 139.92 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.989 -1.115 . . . . 1.29 107.989 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -104.98 133.17 50.21 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.164 -0.96 . . . . 1.3400000000000001 108.775 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.85 130.89 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.16 -1.052 . . . . 1.3400000000000001 108.16 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.461 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 57.7 t30 54.39 49.04 5.12 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 113.578 0.955 . . . . 2.1800000000000002 113.578 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 52.9 Cg_endo -68.95 149.67 72.25 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.607 2.204 . . . . 0.93999999999999995 110.994 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.1 p -78.33 165.47 23.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.035 -1.041 . . . . 2.3999999999999999 110.497 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -60.77 -36.34 78.7 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.946 -1.096 . . . . 3.3300000000000001 110.455 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.58 -39.91 85.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.004 -1.06 . . . . 3.1699999999999999 111.138 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.17 -40.37 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 1.6899999999999999 110.243 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 74.9 mt -59.42 -43.96 91.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.327 -0.858 . . . . 1.6000000000000001 110.916 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.02 -40.31 88.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.21 -0.931 . . . . 2.7000000000000002 110.573 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -62.49 -45.35 93.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.51 -0.744 . . . . 2.96 110.722 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 77.8 mtp -71.63 -39.46 70.41 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.364 -0.835 . . . . 1.6299999999999999 110.883 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.609 ' NH2' ' CE1' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -56.84 -41.87 78.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 3.27 110.634 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.3 -45.86 62.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.02 -1.05 . . . . 2.23 111.662 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.6 -47.96 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.293 -1.504 . . . . 2.79 111.396 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -62.24 -49.76 74.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.738 -1.226 . . . . 4.2599999999999998 110.867 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.06 -35.52 81.01 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.569 -0.707 . . . . 1.8799999999999999 111.353 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -62.1 -29.84 70.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.696 -1.253 . . . . 3.3799999999999999 110.155 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 64.0 t -67.47 -41.06 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.961 -0.695 . . . . 2.8799999999999999 110.06 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.07 -40.04 88.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 2.75 110.899 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.6 t -69.28 -41.03 77.37 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.936 -1.103 . . . . 3.4199999999999999 110.791 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -62.8 -39.51 94.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.873 . . . . 3.5699999999999998 110.619 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -63.84 -32.76 74.38 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.229 -0.919 . . . . 4.6100000000000003 110.597 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.46 72.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.194 -0.942 . . . . 4.4500000000000002 110.693 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.05 -42.91 75.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.84 -1.162 . . . . 5.9699999999999998 110.815 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 253' ' ' LEU . 3.6 mm? -71.21 -38.1 72.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.093 -1.004 . . . . 6.4500000000000002 111.258 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -73.23 -2.21 20.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.06 -1.025 . . . . 6.6600000000000001 112.899 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -82.99 -8.91 59.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.723 -1.236 . . . . 8.5399999999999991 112.682 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 81.6 mt -90.32 -76.3 0.43 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.749 -1.219 . . . . 8.0700000000000003 109.917 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -123.21 -126.51 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.838 -1.171 . . . . 9.7200000000000006 107.838 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -98.01 19.06 14.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.459 -0.776 . . . . 10.119999999999999 111.622 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 259' ' ' ARG . 19.9 ttt-85 . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 118.103 -0.951 . . . . 11.9 109.955 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.401 -0.592 . . . . 3.5299999999999998 109.401 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.4 mt -92.54 115.04 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.495 -1.668 . . . . 1.5700000000000001 106.495 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.7 m -104.14 121.56 43.49 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.719 -1.215 . . . . 1.4399999999999999 107.719 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 225' ' ' ASN . . . -117.78 -164.17 13.1 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.868 -1.693 . . . . 1.01 108.868 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 96.1 mt -96.34 1.56 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 120.872 -1.37 . . . . 1.6299999999999999 112.708 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ILE . 18.9 tp 49.33 100.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.012 -1.075 . . . . 1.5800000000000001 111.678 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.33 -45.24 13.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.255 -1.528 . . . . 1.3400000000000001 111.249 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -148.57 149.04 30.18 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.275 -1.009 . . . . 1.8600000000000001 108.275 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.53 148.93 43.28 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 123.01 2.473 . . . . 1.01 112.104 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 147.89 119.68 1.1 Allowed Glycine 0 N--CA 1.507 3.413 0 N-CA-C 110.323 -1.111 . . . . 0.81000000000000005 110.323 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.445 ' CG2' ' OE1' ' A' ' 243' ' ' GLN . 53.3 mt -90.64 135.78 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.893 -1.357 . . . . 1.3700000000000001 108.818 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.74 157.64 45.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.854 -0.795 . . . . 1.1399999999999999 108.854 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 243' ' ' GLN . 7.8 m-85 -118.74 140.01 50.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.93 -1.137 . . . . 0.87 107.93 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.77 163.26 31.49 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 118.597 -1.763 . . . . 0.56999999999999995 110.057 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -78.8 157.74 28.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.67 -0.9 . . . . 2.3500000000000001 108.996 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.53 130.42 35.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.002 -1.061 . . . . 1.21 108.394 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -110.87 101.4 10.0 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.729 -1.952 . . . . 1.3999999999999999 105.729 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.4 tp -87.78 135.26 33.46 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.408 -1.33 . . . . 1.4399999999999999 107.408 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.0 mt -101.02 114.56 28.6 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 106.481 -1.674 . . . . 1.45 106.481 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -108.51 138.02 45.51 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.885 -1.154 . . . . 2.5 107.885 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 52.1 mp0 -123.09 149.35 44.58 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.462 -0.774 . . . . 2.6600000000000001 109.463 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -83.82 130.6 34.93 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.784 -1.191 . . . . 2.3199999999999998 107.784 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -63.22 146.88 52.46 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.149 -0.969 . . . . 2.1099999999999999 108.96 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.6 mt -92.16 135.41 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 108.115 -1.069 . . . . 1.29 108.115 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -106.43 127.94 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.099 -1.074 . . . . 1.4099999999999999 108.099 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -101.57 136.26 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.043 -1.095 . . . . 1.3100000000000001 108.043 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -89.47 125.24 35.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.73 -1.231 . . . . 1.3400000000000001 107.766 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.3 mmt-85 -93.54 11.15 29.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.998 -1.064 . . . . 3.48 112.358 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -67.53 143.7 56.01 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.058 -1.026 . . . . 2.52 108.991 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -88.86 136.95 32.74 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.08 -1.082 . . . . 2.6299999999999999 108.08 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.18 166.72 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.277 -0.89 . . . . 1.3100000000000001 110.303 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.7 p -93.89 163.69 13.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 1.24 109.666 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.83 -21.17 6.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.46 -0.775 . . . . 1.49 112.04 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -69.95 -41.92 73.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.063 -1.023 . . . . 2.2799999999999998 111.049 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -86.56 -2.68 58.69 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.438 -1.414 . . . . 2.0499999999999998 112.224 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -60.96 -45.39 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 1.3400000000000001 110.938 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.72 -39.66 85.4 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.644 -1.285 . . . . 1.54 110.528 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.539 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 10.4 mp0 -60.34 -41.07 92.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.106 -0.497 . . . . 2.8500000000000001 110.947 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.59 -38.47 84.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.575 -1.328 . . . . 1.3100000000000001 110.626 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.5 t -59.82 -41.64 86.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.939 -1.101 . . . . 1.3799999999999999 110.729 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -63.42 -49.81 72.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.719 -1.238 . . . . 1.5 110.206 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.37 -38.88 88.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.595 -0.691 . . . . 2.7799999999999998 110.329 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -75.5 -55.87 5.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.657 0.741 . . . . 1.0600000000000001 109.902 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.63 -46.99 85.89 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.693 -0.803 . . . . 1.3999999999999999 110.561 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.4 t -67.32 -41.88 84.57 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.19 -0.944 . . . . 1.3200000000000001 110.131 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.15 87.6 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 119.088 -1.53 . . . . 0.69999999999999996 109.965 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.6 ttt-85 -58.2 -31.35 67.22 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.744 -0.857 . . . . 3.4399999999999999 109.794 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.61 -40.89 80.14 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.881 0.848 . . . . 1.3600000000000001 109.792 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -78.12 -41.91 33.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 2.8300000000000001 110.112 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.21 93.16 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.272 -0.892 . . . . 1.23 109.939 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 p -60.5 -38.24 83.67 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.465 1.126 . . . . 1.9199999999999999 109.268 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.84 -47.04 64.21 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.68 -0.691 . . . . 1.25 110.419 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.04 -48.4 71.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.248 -0.908 . . . . 1.97 110.546 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.8 -39.18 90.8 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.343 -0.848 . . . . 2.1800000000000002 109.572 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -60.18 -41.56 93.17 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.686 -0.634 . . . . 1.1899999999999999 110.478 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.6 m -62.91 -40.63 98.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.026 -1.046 . . . . 1.3400000000000001 110.272 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.4 mt -60.6 -36.02 67.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.471 -0.768 . . . . 1.23 110.325 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -53.79 -42.92 68.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 1.5600000000000001 111.027 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -70.0 -33.39 71.98 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.835 -1.166 . . . . 1.3 110.557 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -64.89 -39.92 94.3 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.886 -1.125 . . . . 2.3199999999999998 109.515 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.39 80.96 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.756 -0.59 . . . . 1.1399999999999999 109.968 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.7 -36.1 34.1 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.651 -1.261 . . . . 0.68999999999999995 110.583 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -79.91 -28.18 39.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.876 -1.367 . . . . 1.48 110.984 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 79.6 m -86.77 -47.74 8.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.368 -0.832 . . . . 1.52 110.942 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -107.93 -11.16 15.39 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 113.343 0.868 . . . . 1.3100000000000001 113.343 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.67 159.63 24.79 Favored Glycine 0 N--CA 1.5 2.949 0 C-N-CA 120.658 -0.782 . . . . 0.84999999999999998 113.29 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -52.33 -18.87 1.77 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.743 -0.857 . . . . 3.8599999999999999 112.921 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.17 -38.57 76.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 2.3500000000000001 111.522 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -82.37 -21.63 35.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.903 -1.123 . . . . 2.2599999999999998 112.05 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -59.74 -31.47 69.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 1.45 111.098 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.79 88.82 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.13 -0.981 . . . . 1.25 110.519 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.0 mt -67.01 -44.71 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.633 -1.292 . . . . 1.26 110.145 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -70.85 -28.8 64.85 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.321 -0.862 . . . . 0.82999999999999996 110.925 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -61.87 -37.99 86.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.883 . . . . 1.1899999999999999 110.153 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.11 -38.98 73.34 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 119.693 -1.242 . . . . 0.57999999999999996 110.486 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -59.68 -42.55 93.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.094 -1.239 . . . . 2.0499999999999998 110.3 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.2 mt -62.44 -38.97 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.351 -0.843 . . . . 1.21 110.091 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.9 ttm -59.99 -39.99 87.62 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.549 -0.861 . . . . 2.29 110.263 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.66 -51.49 69.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.199 -0.938 . . . . 1.21 110.89 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.7 tp -60.52 -41.58 94.68 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.913 -0.715 . . . . 1.1399999999999999 110.057 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -87.24 1.17 53.98 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.086 0.773 . . . . 1.4199999999999999 113.086 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -60.28 123.53 17.52 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.426 -1.421 . . . . 1.27 108.577 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.18 -17.26 64.76 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.694 0.759 . . . . 1.3500000000000001 111.064 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -76.36 -54.19 7.1 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.875 -0.73 . . . . 2.2200000000000002 110.227 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.9 mt -62.27 -38.38 89.12 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.152 -0.619 . . . . 1.22 110.722 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.38 -49.91 75.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.075 -1.016 . . . . 1.29 111.213 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.25 -37.57 83.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.811 -1.181 . . . . 2.1699999999999999 110.577 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.2 -47.79 78.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.146 -0.971 . . . . 1.3 110.18 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.0 mt -57.68 -47.08 86.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 120.999 -1.063 . . . . 1.1699999999999999 110.015 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 90' ' ' ILE . 96.5 mt -62.26 -41.92 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.66 0.743 . . . . 1.3999999999999999 110.857 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.34 -42.44 91.52 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.226 -0.921 . . . . 1.3300000000000001 110.866 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.69 -42.42 97.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.972 -1.08 . . . . 1.48 110.161 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.44 -50.35 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 1.28 110.572 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -76.16 -35.15 59.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 2.6000000000000001 111.903 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -81.89 -43.78 17.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.733 -1.229 . . . . 1.51 112.043 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -102.08 7.11 41.23 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.233 -0.917 . . . . 2.48 112.862 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 50.72 49.59 20.63 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 1.6100000000000001 111.887 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.3 mtt -102.99 155.95 18.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.387 -0.821 . . . . 1.8999999999999999 109.34 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.8 p -72.17 159.53 33.96 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.76 0.79 . . . . 1.3200000000000001 109.6 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.89 88.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.937 -1.102 . . . . 1.1499999999999999 110.416 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -68.52 -39.17 81.3 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.176 -0.953 . . . . 2.25 110.618 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.8 -51.76 24.81 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.273 -0.892 . . . . 1.22 111.214 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.48 94.79 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.827 -1.171 . . . . 1.1899999999999999 110.994 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.15 98.94 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.379 -0.826 . . . . 1.2 110.9 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -60.42 -39.82 88.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.916 -1.115 . . . . 2.1000000000000001 111.003 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -59.03 -49.38 78.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.801 -1.187 . . . . 1.3 110.684 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.57 -41.89 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.252 -0.905 . . . . 1.27 110.231 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -63.29 -32.47 56.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.301 -0.874 . . . . 1.1899999999999999 110.03 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.85 -41.11 86.21 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.611 -0.68 . . . . 2.1099999999999999 110.927 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.21 -31.55 19.49 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.422 -1.371 . . . . 0.88 112.898 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -61.44 -40.45 94.5 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 119.421 1.61 . . . . 1.99 109.958 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.56 -50.6 24.48 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.938 0.875 . . . . 1.28 110.364 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 60.9 p -61.48 -37.22 82.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.394 -0.816 . . . . 2.2200000000000002 110.775 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.1 -45.22 93.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.379 -0.826 . . . . 1.45 110.92 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.22 -28.27 69.25 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.083 -1.011 . . . . 1.47 111.21 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -66.67 -22.27 66.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.856 . . . . 2.04 110.731 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -71.61 -15.72 62.26 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.378 -0.826 . . . . 1.73 111.245 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.7 mt -86.28 138.93 31.47 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.685 -1.228 . . . . 1.79 107.685 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -97.8 39.41 1.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.341 -0.849 . . . . 2.8799999999999999 111.617 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -112.23 137.18 50.7 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.557 -0.905 . . . . 1.5800000000000001 108.557 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.9 -36.72 72.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 3.04 111.167 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.15 -56.48 5.5 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.838 -1.164 . . . . 1.29 110.41 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.4 mt -62.29 -42.08 99.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 1.6000000000000001 110.785 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.03 -47.47 84.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.993 -1.067 . . . . 2.7599999999999998 110.456 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -60.28 -32.53 71.26 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.328 -0.949 . . . . 2.1499999999999999 109.968 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -64.76 -29.12 70.09 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.187 -1.005 . . . . 2.8100000000000001 109.552 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.93 87.02 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.763 0.792 . . . . 1.3899999999999999 109.829 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.41 -42.74 78.56 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.543 0.687 . . . . 1.4099999999999999 110.449 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.04 -33.34 75.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.577 -0.702 . . . . 1.3899999999999999 110.729 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 52.7 t -69.31 -38.56 77.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.439 -0.788 . . . . 1.1899999999999999 110.529 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 131' ' ' ARG . 34.3 ttt-85 -59.67 -40.21 87.04 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.864 -1.135 . . . . 3.6299999999999999 109.665 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -61.23 -35.24 76.7 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.649 0.738 . . . . 1.28 110.715 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.3 mt -61.73 -40.13 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.051 -1.031 . . . . 1.1799999999999999 110.47 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.55 -46.77 91.55 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.088 -1.053 . . . . 0.51000000000000001 110.745 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -58.32 -43.71 88.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.944 -1.327 . . . . 3.1699999999999999 110.59 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 51.6 mtt-85 -60.63 -44.1 96.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.929 -1.107 . . . . 2.8500000000000001 110.577 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.1 -44.21 97.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.067 -1.021 . . . . 1.6499999999999999 110.083 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.46 -41.13 96.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.876 . . . . 1.2 110.702 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -61.52 -34.76 76.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.907 . . . . 2.7999999999999998 110.563 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -73.97 -40.4 63.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 2.1499999999999999 110.989 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.67 -38.5 78.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.23 -0.919 . . . . 1.21 110.615 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.5 mt -87.95 -7.92 56.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.931 -1.105 . . . . 1.3400000000000001 112.587 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.16 18.88 79.06 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 120.077 -1.059 . . . . 0.91000000000000003 113.046 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -62.31 146.75 50.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.983 . . . . 1.51 109.406 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -67.22 147.88 52.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.974 -1.079 . . . . 2.8799999999999999 109.176 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.8 mt -109.63 136.22 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.097 -1.002 . . . . 1.6200000000000001 108.306 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.2 mp -78.0 130.09 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.48 -0.763 . . . . 2.1099999999999999 108.949 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -97.46 99.97 11.39 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.287 -1.745 . . . . 1.6200000000000001 106.287 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.8 mt -70.8 -21.08 62.52 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 116.145 -0.479 . . . . 1.3999999999999999 111.48 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.8 m -80.71 3.33 22.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.922 . . . . 2.0499999999999998 111.821 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.72 19.41 12.51 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.445 -0.784 . . . . 1.3500000000000001 112.507 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.5 mt -71.81 141.44 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 1.4199999999999999 109.689 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -117.54 -14.34 10.28 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.84 0.829 . . . . 2.9900000000000002 113.049 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -114.75 138.04 51.21 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.239 -1.022 . . . . 1.54 108.239 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.62 123.32 22.98 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.408 -0.96 . . . . 1.3799999999999999 108.408 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.1 m -145.95 176.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.391 -0.818 . . . . 1.28 109.273 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mt -87.27 140.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.758 -1.214 . . . . 1.1599999999999999 108.426 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.9 tp -95.3 121.06 36.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.869 -1.145 . . . . 1.3100000000000001 108.158 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.3 t -123.3 132.29 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 108.369 -0.975 . . . . 1.25 108.369 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.4 160.51 32.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 1.26 108.561 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.64 77.63 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.826 -1.171 . . . . 1.6000000000000001 109.208 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 p-10 -172.4 155.49 3.5 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.726 -0.842 . . . . 2.4199999999999999 108.726 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 75.1 mt -120.25 137.99 53.91 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.956 -1.127 . . . . 1.3500000000000001 107.956 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 p -96.42 150.9 37.65 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.188 -0.945 . . . . 1.3200000000000001 108.629 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -41.15 -42.74 5.0 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.869 1.713 . . . . 0.69999999999999996 113.102 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 54.7 m -60.59 -50.58 72.94 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.159 -0.963 . . . . 1.1200000000000001 109.892 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -61.97 -40.85 96.98 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.757 -1.177 . . . . 1.21 109.621 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.7 p -68.23 -37.78 81.18 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.49 -0.884 . . . . 1.1899999999999999 110.525 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.47 75.68 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.509 -0.744 . . . . 1.24 110.706 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -93.73 -3.46 52.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.009 -1.057 . . . . 1.6899999999999999 112.815 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.61 149.1 49.54 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.74 -0.837 . . . . 1.3400000000000001 108.74 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -96.83 118.48 33.35 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.721 -1.585 . . . . 2.77 106.721 177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.9 -12.99 60.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 2.0899999999999999 111.852 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -84.66 -26.16 28.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.391 -0.818 . . . . 2.6699999999999999 112.336 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -100.88 2.1 40.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.367 -0.833 . . . . 2.5800000000000001 112.271 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.9 t -111.18 131.21 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 N-CA-C 108.263 -1.014 . . . . 1.1799999999999999 108.263 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.38 -12.35 43.53 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.37 -0.831 . . . . 2.1800000000000002 112.016 -179.511 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.94 -179.42 44.4 Favored Glycine 0 N--CA 1.497 2.745 0 O-C-N 120.46 -1.4 . . . . 0.48999999999999999 109.768 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -130.1 134.01 47.06 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 107.408 -1.331 . . . . 0.64000000000000001 107.408 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 59.0 mt -137.54 106.22 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 105.783 -1.932 . . . . 1.21 105.783 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 203' ' ' VAL . 71.0 p -132.91 177.32 7.74 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.71 -1.244 . . . . 1.3799999999999999 110.844 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 16.4 m-20 -101.4 57.52 0.85 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.534 -0.757 . . . . 2.3700000000000001 109.405 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -109.09 156.62 19.59 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.417 -0.802 . . . . 1.52 109.656 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.4 -88.61 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.224 -0.989 . . . . 1.8 111.658 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 151.27 -65.07 0.37 Allowed Glycine 0 N--CA 1.498 2.833 0 O-C-N 121.211 -1.17 . . . . 2.04 111.953 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' A' ' 186' ' ' ARG . 18.0 ttt-85 -60.59 -42.73 97.3 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.849 -1.383 . . . . 5.0 110.06 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 48.8 p -109.26 21.86 16.57 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.613 -0.679 . . . . 3.02 111.487 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 t -85.71 131.47 34.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.114 -0.991 . . . . 2.1099999999999999 108.591 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -60.35 -39.34 86.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 1.24 110.727 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 35.2 p -58.36 -38.04 76.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 2.1499999999999999 110.54 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.7 m -60.58 -39.75 89.2 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.357 -0.839 . . . . 2.02 110.221 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.81 -39.72 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.126 -0.983 . . . . 2.1200000000000001 110.489 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 71.3 mtp -63.39 -42.58 98.82 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.503 1.145 . . . . 1.3600000000000001 109.341 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.12 -41.16 92.04 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.463 -0.79 . . . . 1.29 110.938 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.5 -44.92 96.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.837 -1.164 . . . . 3.5600000000000001 110.355 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 27.8 m -71.67 -39.54 70.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.9 . . . . 1.1799999999999999 110.416 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.9 mt -91.64 -11.2 37.75 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.818 0.818 . . . . 1.3400000000000001 112.22 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.5 mt-10 49.94 19.09 0.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.67 0.989 . . . . 1.45 113.67 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.67 166.85 32.35 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.064 -1.022 . . . . 1.25 108.435 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.64 140.57 21.26 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.865 1.71 . . . . 0.78000000000000003 110.38 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.23 168.06 23.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 119.915 -1.741 . . . . 1.2 109.859 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 202' ' ' ILE . 92.9 mt -144.01 156.89 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.36 -1.348 . . . . 1.25 107.36 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 181' ' ' THR . 10.2 m -138.15 -30.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 120.99 -1.069 . . . . 1.3899999999999999 112.744 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.79 30.84 0.9 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.014 -1.089 . . . . 0.96999999999999997 113.663 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.431 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 9.8 p -61.34 -27.51 68.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.649 -1.501 . . . . 1.3500000000000001 110.924 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.47 -91.04 0.38 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 120.221 -0.99 . . . . 1.0700000000000001 110.77 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.5 m -121.7 27.11 8.36 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.531 -0.982 . . . . 1.9199999999999999 112.594 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.1 t -58.5 -35.84 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.121 -1.612 . . . . 1.3300000000000001 110.22 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 56.2 p -52.91 -24.62 9.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 1.4199999999999999 111.625 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.2 p -90.96 0.41 57.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.36 -0.837 . . . . 2.1200000000000001 111.789 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -123.56 -3.52 8.31 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 113.079 0.77 . . . . 2.6899999999999999 113.079 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 38.7 t -116.8 149.08 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.574 0.702 . . . . 1.29 109.712 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.468 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 4.1 mptp? -119.41 150.09 40.77 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.123 -1.066 . . . . 2.6899999999999999 108.123 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.421 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.2 p-10 -56.67 143.85 34.61 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.02 -1.072 . . . . 2.79 110.355 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.1 m-20 79.89 -1.61 2.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.796 1.406 . . . . 2.3500000000000001 114.796 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.468 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 80.4 m-20 -63.31 150.72 42.61 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.709 -1.196 . . . . 1.97 109.036 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -89.5 117.36 28.35 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.455 -1.403 . . . . 2.9700000000000002 107.591 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 84.9 mt -126.67 149.8 49.34 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.596 0.713 . . . . 1.25 109.708 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.4 mt -119.21 129.94 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.394 -1.336 . . . . 1.22 107.394 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 49.6 tp -92.73 121.99 34.68 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.293 -1.373 . . . . 1.24 107.293 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 81.1 m-20 -88.33 -30.48 19.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.695 -1.253 . . . . 2.0499999999999998 111.661 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.402 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 40.41 19.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.448 -0.782 . . . . 1.25 112.552 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.1 t -121.84 -59.68 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.922 0.868 . . . . 1.4299999999999999 110.263 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -96.23 10.29 38.31 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.876 0.846 . . . . 3.0299999999999998 110.768 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 4' ' ' GLY . 6.5 t-20 60.82 50.34 5.43 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.579 -0.737 . . . . 2.25 112.021 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.529 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 12.9 pt20 -151.23 158.7 44.23 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.957 0.884 . . . . 2.52 109.638 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 28.0 t -116.37 140.3 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 109.017 -0.734 . . . . 1.29 109.017 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.529 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 47.4 m-85 -99.35 130.83 45.66 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.144 -0.973 . . . . 1.3400000000000001 108.466 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.2 t -109.84 130.02 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.434 -0.791 . . . . 1.3400000000000001 108.921 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.525 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 4.5 t-20 61.11 43.71 0.69 Allowed Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 113.792 1.034 . . . . 2.1800000000000002 113.792 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 33.4 Cg_endo -65.53 147.48 86.7 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.208 1.939 . . . . 0.93999999999999995 111.199 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 44.1 p -76.82 157.25 31.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.112 -0.992 . . . . 2.3999999999999999 108.985 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -59.92 -33.22 71.6 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.133 -0.98 . . . . 3.3300000000000001 110.523 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -57.62 -40.45 79.2 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.468 -0.77 . . . . 3.1699999999999999 110.218 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -71.0 -40.84 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.393 -0.817 . . . . 1.6899999999999999 110.064 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 56.4 mt -60.17 -47.54 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 1.6000000000000001 110.662 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -59.26 -40.39 85.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.674 -1.266 . . . . 2.7000000000000002 110.482 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -64.66 -42.12 95.63 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.826 -0.75 . . . . 2.96 110.357 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.1 mtp -70.88 -34.35 71.51 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.272 -0.893 . . . . 1.6299999999999999 110.975 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -57.45 -39.82 77.13 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.198 -0.939 . . . . 3.27 110.389 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.04 -48.42 36.32 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.148 -0.97 . . . . 2.23 110.017 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.87 -45.09 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.81 -0.756 . . . . 2.79 110.625 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 13' ' ' PHE . 37.1 tt0 -56.28 -53.02 62.21 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.607 -1.308 . . . . 4.2599999999999998 111.344 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.62 -35.83 82.27 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.226 -0.921 . . . . 1.8799999999999999 110.406 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -60.44 -30.46 69.66 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.025 -1.07 . . . . 3.3799999999999999 109.424 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.5 t -66.0 -38.31 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.341 -0.849 . . . . 2.8799999999999999 110.254 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.03 85.09 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.314 -0.866 . . . . 2.75 110.047 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.4 t -69.86 -38.23 76.38 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.208 -0.933 . . . . 3.4199999999999999 110.35 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -62.95 -32.46 73.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 3.5699999999999998 110.774 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -61.61 -34.84 76.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.915 . . . . 4.6100000000000003 110.442 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -63.05 -41.8 99.56 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.678 -0.809 . . . . 4.4500000000000002 110.351 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -68.56 -33.39 74.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.889 . . . . 5.9699999999999998 110.496 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 1.3 tt -67.54 -28.37 67.75 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.402 -0.811 . . . . 6.4500000000000002 110.984 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -65.53 -23.29 66.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.117 -0.989 . . . . 6.6600000000000001 111.494 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -78.27 -12.68 60.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.965 -1.084 . . . . 8.5399999999999991 111.679 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.75 0.91 56.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.412 -0.805 . . . . 8.0700000000000003 112.041 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -86.63 -69.57 0.67 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 9.7200000000000006 109.948 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -93.15 -1.94 55.85 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.212 -0.93 . . . . 10.119999999999999 113.25 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.784 -1.103 . . . . 11.9 108.543 -178.442 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 mtt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.237 -0.653 . . . . 3.5299999999999998 109.237 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 2' ' ' ILE . 67.2 mt -94.7 113.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 106.302 -1.74 . . . . 1.5700000000000001 106.302 176.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 m -105.38 124.87 50.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.259 -1.015 . . . . 1.4399999999999999 108.259 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.89 -152.02 16.8 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 108.141 -1.984 . . . . 1.01 108.141 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.9 mt -94.78 -4.87 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.249 -1.148 . . . . 1.6299999999999999 112.926 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 tp 49.7 99.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.086 -1.009 . . . . 1.5800000000000001 112.624 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.65 -53.74 5.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.007 -1.058 . . . . 1.3400000000000001 110.571 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.439 ' HG ' ' N ' ' A' ' 9' ' ' PRO . 0.9 OUTLIER -142.99 148.44 45.38 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 107.746 -1.205 . . . . 1.8600000000000001 107.746 -179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' N ' ' HG ' ' A' ' 8' ' ' SER . 85.2 Cg_endo -74.8 156.52 43.88 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.578 2.186 . . . . 1.01 112.272 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 147.17 122.21 1.33 Allowed Glycine 0 N--CA 1.507 3.418 0 N-CA-C 111.087 -0.805 . . . . 0.81000000000000005 111.087 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 11' ' ' ILE . 84.8 mt -89.64 132.05 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.777 -1.426 . . . . 1.3700000000000001 108.706 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.99 151.49 46.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.256 -0.902 . . . . 1.1399999999999999 108.638 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.7 m-85 -116.7 145.41 43.47 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.279 -0.888 . . . . 0.87 109.219 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.31 167.89 36.86 Favored Glycine 0 N--CA 1.5 2.906 0 C-N-CA 118.938 -1.601 . . . . 0.56999999999999995 110.053 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -78.08 158.89 28.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.752 -0.852 . . . . 2.3500000000000001 109.132 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.37 119.81 25.54 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.029 -1.1 . . . . 1.21 108.029 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -99.93 95.68 7.05 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 105.683 -1.969 . . . . 1.3999999999999999 105.683 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.5 tp -90.67 137.71 32.15 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.454 -1.313 . . . . 1.4399999999999999 107.454 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.5 mt -99.02 111.19 23.66 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.647 -1.612 . . . . 1.45 106.647 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -103.52 128.72 50.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.217 -1.401 . . . . 2.5 107.217 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -130.6 154.34 47.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.926 -0.768 . . . . 2.6600000000000001 108.926 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -80.65 139.39 36.23 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.695 -0.854 . . . . 2.3199999999999998 108.695 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.82 149.88 49.46 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.473 -1.392 . . . . 2.1099999999999999 109.046 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -93.22 131.01 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.602 -0.888 . . . . 1.29 108.602 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.9 t -108.93 130.13 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.272 -1.01 . . . . 1.4099999999999999 108.272 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.0 mt -94.67 133.51 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.456 -0.942 . . . . 1.3100000000000001 108.456 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -89.01 120.83 30.78 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.294 -1.372 . . . . 1.3400000000000001 107.294 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -96.54 15.8 20.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.132 -0.98 . . . . 3.48 112.403 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -70.42 149.89 46.8 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.542 -0.723 . . . . 2.52 109.838 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -90.76 130.35 36.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.669 -1.234 . . . . 2.6299999999999999 107.669 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.9 pt -94.76 164.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.988 . . . . 1.3100000000000001 110.347 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -94.95 166.02 12.16 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.486 -0.759 . . . . 1.24 109.681 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.23 -19.11 7.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 1.49 112.351 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.12 -37.86 81.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 2.2799999999999998 110.696 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -94.52 -6.14 44.42 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.563 -1.336 . . . . 2.0499999999999998 113.105 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.8 t -59.55 -42.12 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.217 -0.927 . . . . 1.3400000000000001 110.758 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -58.41 -39.19 79.05 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.128 -0.982 . . . . 1.54 110.58 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -64.99 -38.79 92.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.403 -0.811 . . . . 2.8500000000000001 111.131 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -59.37 -41.23 88.83 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.619 -1.3 . . . . 1.3100000000000001 110.783 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.17 -40.85 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.98 -1.075 . . . . 1.3799999999999999 110.789 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -62.83 -42.6 99.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.977 -1.077 . . . . 1.5 110.457 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.416 ' HG2' HH11 ' A' ' 42' ' ' ARG . 42.2 mtt-85 -61.36 -40.41 94.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -0.863 . . . . 2.7799999999999998 110.296 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 40.6 t80 -75.32 -55.34 5.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.298 -0.876 . . . . 1.0600000000000001 110.965 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.4 tp -58.07 -47.46 83.11 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.507 -0.877 . . . . 1.3999999999999999 110.459 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 t -68.79 -39.91 79.91 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.822 -0.751 . . . . 1.3200000000000001 109.918 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.29 -42.48 97.35 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.495 -1.442 . . . . 0.69999999999999996 109.495 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' CG ' HH11 ' A' ' 47' ' ' ARG . 2.2 ttt-85 -60.3 -28.76 68.36 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.235 -1.156 . . . . 3.4399999999999999 110.117 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.49 73.58 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.465 0.65 . . . . 1.3600000000000001 110.955 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -83.26 -38.07 22.68 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.134 -0.979 . . . . 2.8300000000000001 111.043 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.9 -42.82 85.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.162 -0.961 . . . . 1.23 109.664 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.4 t -60.47 -41.26 93.82 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.718 -0.845 . . . . 1.9199999999999999 108.718 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.78 -44.86 76.42 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.624 -0.831 . . . . 1.25 110.434 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -62.18 -51.51 67.53 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.366 -0.934 . . . . 1.97 110.668 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.69 -38.25 89.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.136 -0.977 . . . . 2.1800000000000002 109.988 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -59.12 -40.08 84.33 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.594 -0.691 . . . . 1.1899999999999999 110.331 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.6 m -62.26 -45.05 95.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.937 -1.102 . . . . 1.3400000000000001 110.266 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 57' ' ' ILE . 97.8 mt -60.25 -32.31 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.566 -0.709 . . . . 1.23 110.978 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -53.98 -44.58 70.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 1.5600000000000001 110.469 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -68.69 -36.49 78.57 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.276 -0.89 . . . . 1.3 109.709 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -62.27 -40.0 94.78 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.862 -1.135 . . . . 2.3199999999999998 108.853 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.32 75.41 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.06 -0.656 . . . . 1.1399999999999999 110.06 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.66 -34.05 26.09 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.106 -1.045 . . . . 0.68999999999999995 110.883 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.25 -18.05 43.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.007 -1.29 . . . . 1.48 111.321 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.6 m -90.96 -53.8 4.23 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.209 0.528 . . . . 1.52 111.184 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -106.86 -12.65 15.43 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 113.066 0.765 . . . . 1.3100000000000001 113.066 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.8 155.84 10.78 Favored Glycine 0 N--CA 1.501 3.022 0 O-C-N 121.434 -0.791 . . . . 0.84999999999999998 112.338 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -55.78 -20.56 15.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.65 -0.912 . . . . 3.8599999999999999 112.393 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.55 -34.26 66.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.415 -0.803 . . . . 2.3500000000000001 111.165 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -81.17 -19.22 43.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.567 -1.333 . . . . 2.2599999999999998 111.86 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.01 -31.81 70.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.187 -0.946 . . . . 1.45 111.022 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.8 95.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.874 -1.141 . . . . 1.25 110.379 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.1 -45.92 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.38 -0.928 . . . . 1.26 110.056 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -71.47 -31.63 67.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.838 . . . . 0.82999999999999996 110.417 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -60.32 -38.44 83.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 1.1899999999999999 109.847 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.32 -41.85 94.35 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.213 -1.155 . . . . 0.57999999999999996 110.213 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -58.25 -46.27 86.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -1.103 . . . . 2.0499999999999998 110.416 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.74 -39.61 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.976 -1.078 . . . . 1.21 110.179 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.4 ttt -59.85 -39.8 86.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.961 -1.087 . . . . 2.29 110.411 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.19 -49.07 79.27 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.595 0.712 . . . . 1.21 110.774 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.76 -43.64 94.22 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.702 0.763 . . . . 1.1399999999999999 110.241 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -86.25 9.39 17.83 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.338 -0.851 . . . . 1.4199999999999999 112.731 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -64.42 126.5 28.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.389 -0.819 . . . . 1.27 109.007 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.76 -14.18 62.74 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.056 0.932 . . . . 1.3500000000000001 110.647 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -75.8 -54.67 6.57 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.643 -0.66 . . . . 2.2200000000000002 110.137 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 mt -62.0 -40.31 95.24 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.759 -0.776 . . . . 1.22 110.686 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.6 -46.03 81.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.701 -1.25 . . . . 1.29 110.749 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.52 -39.59 91.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.78 . . . . 2.1699999999999999 110.891 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.23 -48.09 66.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.372 -1.455 . . . . 1.3 110.953 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -55.44 -43.05 70.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.112 -1.035 . . . . 1.1699999999999999 110.153 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.3 mt -62.43 -47.51 92.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.68 0.753 . . . . 1.3999999999999999 110.524 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.61 94.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.457 -0.777 . . . . 1.3300000000000001 110.879 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.7 -39.03 87.0 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.674 -1.266 . . . . 1.48 110.239 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.56 -52.77 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 1.28 110.347 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -72.36 -35.13 68.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.502 -0.749 . . . . 2.6000000000000001 112.067 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -80.94 -46.06 15.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.796 -1.19 . . . . 1.51 112.045 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -101.16 9.11 42.3 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.408 -0.807 . . . . 2.48 112.335 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.8 m80 50.54 49.68 20.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.051 -1.031 . . . . 1.6100000000000001 111.45 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.0 mtt -103.92 153.5 20.72 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.73 0.776 . . . . 1.8999999999999999 109.631 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.54 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 81.3 p -72.6 161.43 30.79 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.141 -0.975 . . . . 1.3200000000000001 109.508 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.83 -41.28 86.5 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.1 -1.0 . . . . 1.1499999999999999 110.932 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -67.98 -40.73 83.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -0.901 . . . . 2.25 109.866 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.54 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -69.38 -50.36 46.83 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.475 -0.89 . . . . 1.22 110.932 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.07 96.18 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.888 0.851 . . . . 1.1899999999999999 110.166 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.65 96.04 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.856 -0.611 . . . . 1.2 110.94 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -61.94 -38.88 90.14 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.125 -0.984 . . . . 2.1000000000000001 110.789 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.66 -48.62 80.95 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.677 -1.264 . . . . 1.3 111.462 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.02 -44.12 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.207 -0.933 . . . . 1.27 110.059 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.8 mm -61.58 -31.99 52.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.403 0.62 . . . . 1.1899999999999999 110.211 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -59.07 -41.18 87.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.671 . . . . 2.1099999999999999 110.529 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.36 -31.6 21.85 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.355 -1.403 . . . . 0.88 112.518 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -61.33 -39.38 90.32 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.484 1.642 . . . . 1.99 110.12 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.68 -48.2 27.44 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.893 0.854 . . . . 1.28 110.119 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.1 p -63.76 -36.0 82.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.355 -0.841 . . . . 2.2200000000000002 109.954 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.62 -43.61 98.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 1.45 110.535 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.18 -30.55 71.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.819 -1.176 . . . . 1.47 110.94 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.31 -22.72 66.87 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.29 -0.881 . . . . 2.04 111.038 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -74.44 -10.91 60.03 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.398 -0.921 . . . . 1.73 111.391 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.49 141.95 28.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.597 -0.69 . . . . 1.79 109.412 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -97.76 55.51 1.21 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.577 -0.702 . . . . 2.8799999999999999 111.078 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -131.89 134.11 45.35 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 107.382 -1.34 . . . . 1.5800000000000001 107.382 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -57.53 -39.83 77.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.281 -0.887 . . . . 3.04 110.922 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -70.79 -52.02 23.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.52 -1.363 . . . . 1.29 110.672 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -61.17 -41.03 96.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.021 -1.049 . . . . 1.6000000000000001 109.842 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -61.5 -49.21 77.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.798 -1.189 . . . . 2.7599999999999998 109.762 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -60.37 -31.67 70.56 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.898 0.856 . . . . 2.1499999999999999 110.047 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 ttp180 -66.85 -27.7 67.75 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 122.3 1.048 . . . . 2.8100000000000001 109.477 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.02 83.29 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.883 0.849 . . . . 1.3899999999999999 109.33 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.3 80.12 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.464 0.65 . . . . 1.4099999999999999 110.326 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.26 -35.74 79.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 1.3899999999999999 110.649 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.5 t -67.43 -38.34 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.229 -0.919 . . . . 1.1899999999999999 110.331 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -59.0 -39.68 82.57 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 118.923 -1.111 . . . . 3.6299999999999999 109.496 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.45 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 62.1 t0 -60.26 -37.69 81.22 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.44 0.638 . . . . 1.28 110.527 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.8 mt -60.43 -39.15 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.925 -1.109 . . . . 1.1799999999999999 110.113 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.92 -45.34 88.63 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 120.128 -1.034 . . . . 0.51000000000000001 110.702 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -59.81 -40.0 86.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.146 -1.208 . . . . 3.1699999999999999 110.095 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.45 ' NH2' ' OD2' ' A' ' 132' ' ' ASP . 39.7 mtt-85 -61.25 -42.04 97.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.097 -1.002 . . . . 2.8500000000000001 109.78 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 37.8 tp -60.43 -40.48 91.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.462 -0.773 . . . . 1.6499999999999999 110.129 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.58 -42.61 92.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.143 -0.973 . . . . 1.2 110.399 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.457 ' NH1' ' CD2' ' A' ' 144' ' ' LEU . 54.5 mtt-85 -59.87 -37.58 79.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 2.7999999999999998 110.762 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.4 -41.72 55.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.188 -0.945 . . . . 2.1499999999999999 110.893 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.36 -37.76 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.223 -0.923 . . . . 1.21 110.768 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.4 -7.35 58.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 1.3400000000000001 111.994 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.49 23.19 68.34 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 120.091 -1.052 . . . . 0.91000000000000003 113.227 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.457 ' CD2' ' NH1' ' A' ' 139' ' ' ARG . 5.7 tp -64.49 148.09 51.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.049 -0.723 . . . . 1.51 109.049 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -66.44 148.53 51.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.039 -0.726 . . . . 2.8799999999999999 109.039 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.4 mt -103.31 132.35 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.17 -1.048 . . . . 1.6200000000000001 108.17 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.486 ' H ' ' CD1' ' A' ' 147' ' ' ILE . 2.7 mp -84.02 122.82 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.497 -1.297 . . . . 2.1099999999999999 107.497 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -95.07 97.99 10.34 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 105.958 -1.867 . . . . 1.6200000000000001 105.958 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.4 mt -74.91 -15.05 60.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.931 . . . . 1.3999999999999999 112.005 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.8 m -79.94 -1.58 40.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.119 -0.988 . . . . 2.0499999999999998 112.177 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.5 29.04 4.22 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.661 0.743 . . . . 1.3500000000000001 111.954 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 7.3 mt -72.29 138.41 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.169 -0.957 . . . . 1.4199999999999999 109.006 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -113.81 -18.82 11.72 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.278 1.037 . . . . 2.9900000000000002 112.475 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -114.88 138.09 51.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.809 -1.182 . . . . 1.54 107.809 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.26 122.88 26.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.024 -1.102 . . . . 1.3799999999999999 108.024 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.47 179.98 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.11 -0.994 . . . . 1.28 108.847 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.8 mt -87.45 142.24 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.05 -1.031 . . . . 1.1599999999999999 108.785 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 45.2 tp -96.66 123.36 40.31 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.061 -1.089 . . . . 1.3100000000000001 108.061 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.19 129.64 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.281 -1.377 . . . . 1.25 107.281 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.78 157.12 23.72 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.893 -1.129 . . . . 1.26 108.872 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.32 83.11 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.801 -1.187 . . . . 1.6000000000000001 109.392 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -172.97 148.95 1.82 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.13 -0.693 . . . . 2.4199999999999999 109.13 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.0 mt -111.66 141.22 45.53 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.482 -0.761 . . . . 1.3500000000000001 109.223 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.8 p -92.78 147.86 34.89 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.914 -1.116 . . . . 1.3200000000000001 108.917 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.55 -43.31 6.07 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.824 1.683 . . . . 0.69999999999999996 113.119 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.2 m -60.49 -51.01 71.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.201 -0.937 . . . . 1.1200000000000001 110.251 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -61.56 -39.52 91.42 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.01 -1.056 . . . . 1.21 109.975 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.571 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 48.1 p -65.77 -36.92 84.9 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.852 0.834 . . . . 1.1899999999999999 109.965 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.81 88.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.494 -0.754 . . . . 1.24 111.127 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -94.27 -3.05 51.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -0.789 . . . . 1.6899999999999999 113.083 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.91 148.18 44.39 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.407 -0.96 . . . . 1.3400000000000001 108.407 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -93.75 114.79 27.14 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 106.884 -1.524 . . . . 2.77 106.884 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 3.3 mm? -70.75 -27.89 64.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.234 0.54 . . . . 2.0899999999999999 111.506 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -82.92 -16.89 45.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 2.6699999999999999 112.293 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -100.48 -2.82 32.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.015 -1.053 . . . . 2.5800000000000001 112.8 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.9 t -107.69 130.62 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.22 -1.03 . . . . 1.1799999999999999 108.22 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.14 -7.65 59.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 2.1800000000000002 112.133 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.59 172.64 37.13 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.184 -1.566 . . . . 0.48999999999999999 109.184 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -128.89 127.63 42.19 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 107.57 -1.27 . . . . 0.64000000000000001 107.57 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 56.4 mt -132.33 120.6 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.406 -1.701 . . . . 1.21 106.406 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 203' ' ' VAL . 67.7 p -138.88 169.83 17.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.828 -1.17 . . . . 1.3799999999999999 110.357 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.464 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 36.9 t0 -106.25 62.03 0.65 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.109 -0.7 . . . . 2.3700000000000001 109.109 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -106.49 148.85 27.7 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.804 -0.813 . . . . 1.52 108.804 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.62 -0.51 48.92 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.744 -1.217 . . . . 1.8 112.555 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 89.0 -27.9 7.03 Favored Glycine 0 N--CA 1.496 2.646 0 O-C-N 121.395 -1.062 . . . . 2.04 113.797 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.465 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.6 mtt-85 -60.16 -39.06 85.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.272 . . . . 5.0 110.44 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 49.1 p -133.38 34.52 3.5 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.435 -0.791 . . . . 3.02 111.267 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.9 p -84.03 99.05 10.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.675 -1.602 . . . . 2.1099999999999999 106.675 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.571 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 36.2 t60 -61.36 -32.49 72.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 1.24 110.365 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.3 t -56.3 -39.46 72.78 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.381 -0.824 . . . . 2.1499999999999999 110.18 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.4 p -59.74 -39.0 83.3 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.895 -1.122 . . . . 2.02 109.952 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.77 -40.0 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.647 -0.821 . . . . 2.1200000000000001 110.208 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 51.2 mtp -64.55 -44.92 89.26 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.522 1.153 . . . . 1.3600000000000001 109.119 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.81 -43.58 94.44 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.089 -0.96 . . . . 1.29 111.405 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -59.66 -45.68 91.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.894 -1.129 . . . . 3.5600000000000001 110.533 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.1 m -71.19 -39.3 71.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.881 . . . . 1.1799999999999999 110.327 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.5 mt -92.36 -6.64 49.75 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.155 0.798 . . . . 1.3400000000000001 113.155 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 53.92 13.6 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.745 1.017 . . . . 1.45 113.745 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.65 149.73 95.37 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.925 -1.109 . . . . 1.25 108.767 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.08 137.18 73.97 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.503 1.469 . . . . 0.78000000000000003 109.957 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.09 163.65 25.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.368 -1.458 . . . . 1.2 109.522 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 13.2 mt -149.12 145.46 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.998 -1.112 . . . . 1.25 107.998 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.9 m -125.84 -25.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 O-C-N 121.114 -0.991 . . . . 1.3899999999999999 113.24 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.66 50.46 4.25 Favored Glycine 0 N--CA 1.488 2.125 0 O-C-N 120.842 -1.161 . . . . 0.96999999999999997 111.004 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.9 p -68.05 -11.59 59.27 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.933 -1.334 . . . . 1.3500000000000001 112.219 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.464 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 73.88 -95.99 0.84 Allowed Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.756 -1.338 . . . . 1.0700000000000001 109.756 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 70.8 m -130.31 30.65 4.72 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.336 -1.097 . . . . 1.9199999999999999 112.296 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.72 -39.67 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.446 -1.409 . . . . 1.3300000000000001 110.7 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.7 p -60.68 -19.3 58.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 1.4199999999999999 111.986 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 27.7 t -94.93 -1.95 51.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.121 -0.987 . . . . 2.1200000000000001 112.107 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -128.77 6.85 5.6 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 112.529 0.566 . . . . 2.6899999999999999 112.529 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 35.0 t -118.62 148.15 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.567 0.699 . . . . 1.29 110.036 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -119.32 150.08 40.73 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.035 -1.098 . . . . 2.6899999999999999 108.035 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 45.0 p-10 -50.3 141.53 11.52 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.785 -1.197 . . . . 2.79 110.723 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 t70 80.44 1.81 1.9 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.455 1.28 . . . . 2.3500000000000001 114.455 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -65.2 147.99 52.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.882 -1.136 . . . . 1.97 108.732 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -88.22 120.21 29.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.012 -1.477 . . . . 2.9700000000000002 107.012 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 84.6 mt -129.48 152.59 48.84 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.786 0.803 . . . . 1.25 109.984 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 mt -129.31 134.81 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.607 -1.257 . . . . 1.22 107.607 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 36.0 tp -97.96 125.04 42.7 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.891 -1.151 . . . . 1.24 107.891 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.1 t0 -86.07 -31.2 22.05 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.797 -1.189 . . . . 2.0499999999999998 110.984 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.433 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 39.75 19.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.757 1.021 . . . . 1.25 113.757 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.5 t -115.91 -62.32 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-O 121.985 0.898 . . . . 1.4299999999999999 109.465 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -91.41 13.54 17.24 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.655 0.741 . . . . 3.0299999999999998 110.9 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 63.49 51.34 2.59 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.745 0.646 . . . . 2.25 112.745 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.59 ' NE2' ' CZ ' ' A' ' 228' ' ' TYR . 20.7 pt20 -150.24 161.38 42.53 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.544 1.164 . . . . 2.52 109.948 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.8 t -116.36 138.84 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 108.27 -1.011 . . . . 1.29 108.27 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.59 ' CZ ' ' NE2' ' A' ' 226' ' ' GLN . 51.0 m-85 -105.06 131.04 53.07 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.396 -0.964 . . . . 1.3400000000000001 108.396 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.69 129.26 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 107.577 -1.268 . . . . 1.3400000000000001 107.577 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 46.3 56.48 16.38 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.013 -1.054 . . . . 2.1800000000000002 113.132 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.4 150.93 70.98 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.656 2.237 . . . . 0.93999999999999995 110.901 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.4 p -75.12 163.5 27.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -0.849 . . . . 2.3999999999999999 110.321 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -61.27 -38.74 87.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.753 -1.217 . . . . 3.3300000000000001 110.605 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -59.84 -41.3 91.06 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.15 -0.969 . . . . 3.1699999999999999 110.361 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 84.3 t -70.83 -40.48 76.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.241 -0.912 . . . . 1.6899999999999999 110.237 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt -60.01 -43.85 93.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.151 -0.968 . . . . 1.6000000000000001 110.375 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -59.85 -38.75 82.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 2.7000000000000002 110.955 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -61.18 -47.98 83.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.215 -0.928 . . . . 2.96 111.164 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 24.4 mtm -73.79 -36.18 65.0 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.018 -1.051 . . . . 1.6299999999999999 111.172 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -56.94 -38.54 73.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.177 -0.952 . . . . 3.27 110.043 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.96 -43.53 67.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.391 -0.818 . . . . 2.23 111.244 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.11 -49.95 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.134 -0.979 . . . . 2.79 111.24 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -61.18 -50.75 71.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.474 -1.391 . . . . 4.2599999999999998 110.091 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.23 -32.38 73.04 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.903 -0.719 . . . . 1.8799999999999999 110.778 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.85 -31.15 69.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.878 -1.129 . . . . 3.3799999999999999 109.161 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.76 -44.62 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.972 0.891 . . . . 2.8799999999999999 109.82 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.42 -33.82 71.71 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.288 -0.565 . . . . 2.75 110.269 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.0 t -64.97 -36.39 84.23 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.853 -0.739 . . . . 3.4199999999999999 110.53 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -60.41 -45.73 92.55 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.303 -0.959 . . . . 3.5699999999999998 109.823 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 252' ' ' GLU . 81.1 tttt -71.4 -25.15 62.23 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.702 0.763 . . . . 4.6100000000000003 111.13 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.47 12.81 0.15 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.638 -0.664 . . . . 4.4500000000000002 112.764 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 250' ' ' LYS . 84.4 tt0 -62.19 -27.02 68.68 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.466 -0.771 . . . . 5.9699999999999998 111.335 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 82.4 mt -65.74 -22.76 66.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -0.816 . . . . 6.4500000000000002 110.747 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.98 -0.33 7.31 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.542 0.687 . . . . 6.6600000000000001 112.804 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.41 22.83 1.19 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.735 -1.228 . . . . 8.5399999999999991 113.039 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.5 tp -77.35 -3.2 38.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 8.0700000000000003 112.59 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -83.22 -0.55 49.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.819 -1.175 . . . . 9.7200000000000006 112.172 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -94.33 -1.39 53.92 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.172 -0.955 . . . . 10.119999999999999 112.824 -178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.01 -0.995 . . . . 11.9 109.41 -178.604 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 105.863 -1.902 . . . . 1.07 105.863 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -105.44 120.33 41.33 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.794 -1.188 . . . . 1.24 107.794 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.13 -159.28 24.3 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.686 -1.766 . . . . 1.01 108.686 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.8 mt -96.35 1.68 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.29 -1.124 . . . . 1.11 112.687 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tp 49.91 97.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.846 -1.158 . . . . 0.99 112.213 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -83.5 -46.84 12.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.85 111.234 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -149.16 150.15 31.27 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.994 -1.113 . . . . 1.38 107.994 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.59 150.0 44.81 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.024 2.483 . . . . 0.94 111.803 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.09 121.39 1.36 Allowed Glycine 0 N--CA 1.508 3.453 0 C-N-CA 120.133 -1.032 . . . . 0.81 110.708 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -88.59 135.07 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.839 -1.389 . . . . 0.83 109.061 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.05 153.86 48.13 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.789 -0.819 . . . . 0.53 108.789 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -125.02 140.59 52.77 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.221 -0.924 . . . . 0.77 109.077 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.09 170.15 41.76 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 118.672 -1.728 . . . . 0.51 110.207 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -79.46 158.82 27.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.654 -0.91 . . . . 1.9 109.126 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -83.25 126.86 33.12 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.666 -1.235 . . . . 0.66 107.666 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.0 tp -109.91 103.38 12.15 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 105.04 -2.207 . . . . 0.83 105.04 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.6 tp -88.0 140.02 29.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.011 . . . . 0.86 108.906 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.7 mt -99.04 112.31 24.47 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.414 -1.698 . . . . 0.92 106.414 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -110.18 131.97 54.58 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.816 -1.179 . . . . 2.03 107.816 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -126.91 140.07 52.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.192 -0.942 . . . . 2.66 108.949 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -80.61 137.83 36.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.236 -1.024 . . . . 2.32 108.236 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -62.06 150.54 37.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.236 -0.915 . . . . 2.11 109.953 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.5 mt -90.23 134.85 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.077 -1.014 . . . . 0.73 108.52 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -108.9 131.37 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.463 -0.94 . . . . 0.87 108.463 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.9 mt -94.32 140.35 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.936 -0.764 . . . . 0.81 108.936 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -91.33 123.03 34.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.116 -0.99 . . . . 1.34 108.503 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -100.02 18.34 18.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.457 -0.777 . . . . 2.89 112.046 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -70.43 145.31 51.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.812 -1.18 . . . . 2.09 109.488 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -88.15 129.96 35.17 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.759 -1.2 . . . . 2.19 107.759 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 pt -95.96 167.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.405 -0.809 . . . . 0.75 110.474 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.4 p -95.81 167.7 11.1 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.345 0.593 . . . . 0.91 109.997 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.25 -21.44 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.454 -0.779 . . . . 0.93 111.728 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -69.64 -41.24 75.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 2.28 110.743 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -84.13 -7.39 59.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.029 -1.045 . . . . 1.45 112.204 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.1 t -58.5 -39.77 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.32 -0.863 . . . . 0.81 110.299 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -58.54 -40.19 82.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.008 -1.058 . . . . 1.54 110.208 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -61.81 -40.43 95.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.699 -0.625 . . . . 2.36 110.885 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -59.73 -43.97 93.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.064 -1.022 . . . . 1.31 111.004 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.48 -41.77 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.986 -1.071 . . . . 0.82 110.674 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -60.28 -49.21 78.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.177 -0.952 . . . . 1.5 110.044 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.455 HH11 ' HG2' ' A' ' 42' ' ' ARG . 45.6 mtt-85 -60.25 -38.01 82.18 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.534 -0.729 . . . . 2.23 109.857 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -71.85 -59.44 2.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.596 -0.69 . . . . 0.85 110.232 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.15 -45.45 90.95 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.218 -0.993 . . . . 0.91 110.0 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.519 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.7 t -67.76 -38.81 83.95 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.505 -0.747 . . . . 0.9 110.137 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.08 -41.23 94.46 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.579 -1.409 . . . . 0.69 109.579 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.533 HH22 ' CD ' ' A' ' 86' ' ' GLU . 32.8 ttm180 -59.8 -31.23 69.51 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.469 -1.018 . . . . 2.88 109.206 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.5 -46.33 86.9 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.548 0.69 . . . . 0.85 109.765 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -80.61 -44.08 19.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.81 . . . . 2.35 111.007 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.12 -42.41 94.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.65 110.163 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.1 t -59.86 -38.93 83.55 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.053 -1.029 . . . . 1.45 109.081 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.08 -50.05 44.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.682 -0.69 . . . . 0.63 110.94 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.34 -49.44 77.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.602 -1.311 . . . . 1.34 110.66 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.21 -40.42 93.9 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.396 -0.815 . . . . 1.56 109.381 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.86 -40.5 93.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.602 -0.686 . . . . 1.19 110.25 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 m -66.28 -45.42 80.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.998 -1.064 . . . . 0.72 109.798 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.02 -38.33 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.519 -0.738 . . . . 0.62 110.387 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -51.26 -42.42 61.04 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.794 -0.762 . . . . 1.05 110.328 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -70.28 -35.3 73.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.27 -0.894 . . . . 0.64 110.03 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -61.83 -39.92 93.5 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.179 -1.008 . . . . 1.73 109.074 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.85 -34.74 76.51 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.769 -0.773 . . . . 0.56 109.76 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.27 -36.65 20.29 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.643 -1.265 . . . . 0.69 110.884 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -81.71 -20.26 39.78 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.847 -1.384 . . . . 1.48 111.126 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -88.61 -51.93 5.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.414 -0.804 . . . . 0.98 110.839 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -107.31 -21.05 13.08 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.538 -0.726 . . . . 1.16 112.865 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.03 164.24 12.49 Favored Glycine 0 N--CA 1.504 3.167 0 O-C-N 121.51 -0.744 . . . . 0.85 112.075 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -52.85 -24.85 9.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.692 -0.887 . . . . 3.86 112.288 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.23 -39.56 79.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.838 -1.164 . . . . 2.35 111.137 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -87.13 -22.06 25.59 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.981 -1.074 . . . . 1.67 111.8 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -60.76 -37.62 82.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 1.45 110.754 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.69 -33.75 73.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.251 -0.905 . . . . 0.61 111.299 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.9 mt -65.88 -43.46 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.64 -1.287 . . . . 0.65 110.533 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -69.43 -32.15 70.93 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.319 -0.863 . . . . 0.66 110.706 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -61.56 -38.48 87.65 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.215 -0.928 . . . . 1.19 110.087 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.39 -41.9 99.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.817 -0.913 . . . . 0.53 110.817 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -59.28 -40.46 86.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.246 . . . . 1.27 110.535 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.82 -38.57 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.123 -0.985 . . . . 0.54 110.724 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.2 ttp -58.14 -39.68 79.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.356 -0.84 . . . . 1.74 110.639 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.72 -48.77 80.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.412 -0.805 . . . . 0.55 110.11 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.09 -41.33 92.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.562 -0.711 . . . . 0.47 110.641 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -86.54 9.86 17.12 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 112.984 0.735 . . . . 1.42 112.984 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -68.37 122.29 18.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 1.27 108.258 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.55 -16.35 64.09 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.779 0.799 . . . . 1.35 110.789 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -74.75 -51.18 14.86 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.71 0.766 . . . . 2.22 110.115 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.68 -34.43 77.09 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.771 -0.771 . . . . 0.62 110.313 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.533 ' CD ' HH22 ' A' ' 47' ' ' ARG . 88.9 tt0 -59.98 -47.16 86.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.541 -0.724 . . . . 1.29 110.93 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -63.22 -37.91 89.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.991 -1.068 . . . . 1.52 110.995 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -68.24 -49.46 60.51 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.124 -0.985 . . . . 1.3 110.756 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.1 mt -58.42 -43.94 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.61 110.551 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.0 mt -62.91 -43.78 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.78 110.47 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.71 -40.59 95.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.325 -0.859 . . . . 0.82 111.113 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.57 -42.78 97.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.978 -1.076 . . . . 0.8 110.437 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.15 -50.33 79.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.951 -1.093 . . . . 0.77 110.176 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -78.48 -34.97 47.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.369 -0.832 . . . . 2.12 111.774 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -79.08 -46.85 17.25 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.573 -1.329 . . . . 1.51 111.444 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -100.49 8.09 43.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.08 -1.013 . . . . 1.98 111.857 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.6 m170 49.78 48.92 21.01 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.219 -0.993 . . . . 1.32 111.528 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.2 mtt -103.64 156.84 17.49 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.678 0.752 . . . . 1.38 109.923 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.3 p -73.09 159.19 33.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.519 -0.738 . . . . 0.67 109.296 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.16 79.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.088 -1.007 . . . . 0.52 110.376 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.562 ' OD2' HD21 ' A' ' 142' ' ' LEU . 82.6 m-20 -68.75 -39.82 80.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.942 -1.099 . . . . 2.25 110.135 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.38 -51.06 40.28 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.446 -0.784 . . . . 0.64 111.44 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.72 94.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.555 -0.716 . . . . 0.56 110.636 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.89 -44.91 96.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.569 -0.707 . . . . 0.46 111.332 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -60.31 -39.57 87.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 1.32 110.959 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -55.83 -49.46 73.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.86 -1.15 . . . . 1.3 110.969 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.07 -45.49 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.677 -1.264 . . . . 0.61 109.85 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.42 -30.76 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.626 0.727 . . . . 0.65 110.117 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -59.16 -40.36 85.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.126 -0.984 . . . . 2.11 110.775 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.37 -32.18 20.31 Favored Glycine 0 N--CA 1.5 2.904 0 C-N-CA 119.193 -1.479 . . . . 0.83 112.601 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -60.44 -40.73 92.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.545 -1.562 . . . . 1.28 110.096 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.16 -47.77 48.44 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.608 0.718 . . . . 0.89 110.307 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 m -60.97 -38.08 84.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 1.87 110.545 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.56 97.82 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.186 -0.946 . . . . 1.05 110.854 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.2 mt -65.69 -28.04 68.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 1.02 111.288 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -67.39 -24.27 65.65 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.176 -0.952 . . . . 2.04 111.18 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.17 -11.65 60.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.119 -0.988 . . . . 1.73 111.42 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.441 HD13 HD13 ' A' ' 123' ' ' LEU . 11.3 mt -89.51 138.03 31.81 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.818 -1.179 . . . . 1.37 107.818 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 14.9 t70 -97.56 47.77 1.02 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.277 -0.889 . . . . 2.88 111.772 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -119.92 139.84 51.8 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.416 -0.802 . . . . 1.58 109.023 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -59.98 -39.09 84.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.446 -0.783 . . . . 3.04 110.762 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -70.53 -57.19 5.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.9 110.23 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.441 HD13 HD13 ' A' ' 118' ' ' LEU . 22.9 mt -61.01 -41.51 96.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 1.06 110.498 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -61.46 -49.54 76.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.854 -1.154 . . . . 2.18 109.8 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -59.94 -30.97 69.43 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.054 -1.058 . . . . 2.15 109.545 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 130' ' ' VAL . 51.0 ttt180 -63.39 -29.18 70.52 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.532 -0.867 . . . . 2.33 109.499 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.41 73.29 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.779 0.799 . . . . 0.82 109.92 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.99 -44.53 80.16 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.768 -0.773 . . . . 0.85 110.134 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -63.02 -34.84 78.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.357 -0.839 . . . . 1.39 110.569 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.2 t -67.96 -40.81 83.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.905 -1.122 . . . . 0.56 109.586 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -59.28 -37.39 77.56 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.09 -1.044 . . . . 3.12 109.23 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -59.77 -38.21 81.2 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.212 0.529 . . . . 1.28 110.067 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.7 mt -60.1 -40.24 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.972 . . . . 0.49 110.006 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.89 -43.03 94.59 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.089 -1.204 . . . . 0.46 110.089 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -58.6 -40.1 82.29 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.493 -1.004 . . . . 2.71 110.589 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 136' ' ' ARG . 51.9 mtt-85 -62.34 -42.43 99.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 2.14 110.031 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.6 tp -63.28 -44.41 95.16 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.594 0.711 . . . . 1.05 110.036 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.55 -45.2 95.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.635 0.731 . . . . 0.52 110.345 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.435 HH21 ' HA ' ' A' ' 146' ' ' ILE . 53.2 mtp180 -62.06 -34.5 76.38 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.623 -0.673 . . . . 2.35 110.945 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -76.02 -43.23 45.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.927 -1.108 . . . . 1.39 111.005 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.444 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.2 mt -61.58 -37.14 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.922 -1.111 . . . . 0.68 110.823 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.562 HD21 ' OD2' ' A' ' 101' ' ' ASP . 74.7 mt -88.03 -5.96 58.22 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.013 -1.055 . . . . 0.83 112.372 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.14 27.28 73.13 Favored Glycine 0 N--CA 1.481 1.664 0 C-N-CA 119.869 -1.157 . . . . 0.91 112.844 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.1 tp -62.3 147.37 48.38 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.643 0.735 . . . . 0.95 109.66 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.41 140.21 58.61 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.562 -0.903 . . . . 2.43 108.562 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.435 ' HA ' HH21 ' A' ' 139' ' ' ARG . 54.1 mt -101.34 137.88 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.098 -1.001 . . . . 1.1 108.518 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.85 ' H ' HD12 ' A' ' 147' ' ' ILE . 3.0 mp -82.44 123.76 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.869 -1.16 . . . . 1.58 107.869 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -99.67 97.54 8.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.854 -1.536 . . . . 1.62 106.854 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.1 -17.87 61.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.586 -0.696 . . . . 0.8 111.382 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.8 t -81.58 2.02 31.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.874 . . . . 1.56 112.097 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.91 21.09 14.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.559 -0.713 . . . . 0.84 111.928 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.2 mt -74.3 134.51 29.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.266 -0.896 . . . . 0.82 108.913 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.35 -15.8 13.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.487 -0.758 . . . . 2.31 113.003 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -111.49 130.6 55.67 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.165 -1.421 . . . . 1.54 107.165 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -72.27 123.86 23.86 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.535 -0.913 . . . . 1.38 108.535 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 25.3 m -145.69 179.56 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.482 -0.762 . . . . 0.69 109.462 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.7 mt -89.66 140.23 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.714 -0.847 . . . . 0.53 108.714 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.83 124.88 40.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.973 -1.079 . . . . 0.64 108.54 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.42 130.67 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.258 -1.016 . . . . 0.67 108.258 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.72 150.86 17.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.78 109.002 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.491 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.13 -37.86 84.33 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.915 -1.115 . . . . 1.0 109.544 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 46.9 t0 -171.23 150.28 2.94 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.391 -0.818 . . . . 2.42 108.83 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.465 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 48.2 mt -119.55 141.05 49.59 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.882 -0.784 . . . . 0.75 108.882 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.1 p -87.37 150.91 50.13 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.893 -1.129 . . . . 0.78 108.646 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -43.12 -41.63 9.53 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.787 1.658 . . . . 0.67 113.414 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.6 m -61.95 -49.02 77.81 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.144 -1.022 . . . . 0.7 110.14 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -62.84 -40.14 96.52 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.447 -0.783 . . . . 1.21 110.478 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 71.5 p -69.73 -39.0 77.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.236 -0.915 . . . . 0.6 110.271 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.49 -33.4 73.71 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.469 -0.769 . . . . 0.62 110.503 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -96.06 -2.09 47.42 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.198 -0.939 . . . . 1.16 112.51 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.72 147.73 41.25 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.306 -0.998 . . . . 0.73 108.306 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.59 113.79 25.48 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.993 -1.484 . . . . 2.24 106.993 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.18 -17.27 61.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.778 -0.576 . . . . 1.43 111.431 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -80.69 -24.04 39.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.814 . . . . 2.15 111.902 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -100.84 -6.13 25.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.264 -0.898 . . . . 2.04 113.216 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 178' ' ' GLY . 65.4 t -107.61 129.65 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.182 -1.044 . . . . 0.55 108.182 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 55.1 tp -85.79 -11.21 54.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.261 -0.9 . . . . 1.63 112.35 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.452 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 174.92 178.66 44.96 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.072 -1.611 . . . . 0.47 109.072 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -132.13 132.84 43.62 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.557 -1.275 . . . . 0.54 107.557 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 66.8 mt -137.85 107.04 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 106.076 -1.824 . . . . 0.69 106.076 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 205' ' ' THR . 60.1 p -128.57 169.22 14.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.11 -0.994 . . . . 0.82 109.041 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 12.8 p-10 -98.14 42.74 1.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.288 -0.882 . . . . 2.37 111.223 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.216 0 O-C-N 121.547 -0.721 . . . . 1.11 109.804 -179.697 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.877 -0.786 . . . . 1.69 108.877 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -60.16 -36.53 77.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.463 -0.773 . . . . 1.07 111.019 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.2 p -56.09 -41.79 75.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.324 -0.86 . . . . 1.58 110.237 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.7 t -60.02 -38.53 82.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.44 -0.787 . . . . 1.6 110.179 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.89 -39.48 80.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.669 -0.644 . . . . 1.45 110.913 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.7 mtp -60.39 -44.14 95.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.911 -1.118 . . . . 1.05 109.539 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.07 -47.42 86.44 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.711 -0.677 . . . . 0.72 111.205 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.37 -46.17 90.91 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.762 -1.211 . . . . 3.05 111.351 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.4 m -69.77 -39.78 76.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.987 . . . . 0.89 110.644 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.9 mt -91.98 -9.89 41.34 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.069 0.766 . . . . 0.78 113.069 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.6 mt-10 53.66 12.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.637 0.977 . . . . 1.45 113.637 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.1 mt -71.82 148.91 92.6 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.198 -1.038 . . . . 0.67 108.198 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.67 135.56 62.4 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 121.36 1.373 . . . . 0.64 109.916 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -162.0 167.61 24.18 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 117.642 -1.623 . . . . 0.67 109.791 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 203' ' ' VAL . 84.5 mt -148.44 156.09 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.202 -1.407 . . . . 0.69 107.202 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.466 ' N ' HG22 ' A' ' 202' ' ' ILE . 3.1 m -138.71 -25.98 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 120.825 -1.172 . . . . 0.85 112.098 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.98 45.17 3.47 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.432 -0.889 . . . . 0.92 111.832 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 181' ' ' THR . 32.3 p -64.84 -14.55 59.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.453 -1.028 . . . . 0.95 111.034 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.82 -94.26 0.97 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.273 -1.131 . . . . 1.04 110.273 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 71.9 m -129.38 27.7 5.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.621 -0.929 . . . . 1.57 112.697 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.59 -36.26 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.358 -1.464 . . . . 0.84 110.775 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.2 p -57.51 -25.93 60.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.994 -1.066 . . . . 0.99 111.235 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 36.8 p -93.1 3.81 55.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.605 -0.684 . . . . 1.7 111.733 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -126.26 -9.19 6.42 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.33 0.863 . . . . 2.2 113.33 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 213' ' ' LYS . 51.5 t -119.59 156.33 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.97 -0.752 . . . . 0.84 108.97 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.45 ' N ' HG12 ' A' ' 212' ' ' VAL . 6.2 mmmm -125.99 158.85 34.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.817 -1.179 . . . . 2.2 107.817 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 52.7 p-10 -52.43 149.16 5.94 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 120.75 -1.219 . . . . 2.28 110.459 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.1 t70 80.72 -2.69 1.84 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 114.11 1.152 . . . . 2.35 114.11 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 16' ' ' ALA . 54.8 t0 -66.69 146.47 54.43 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.737 -1.227 . . . . 1.97 108.489 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.459 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 43.3 t80 -88.49 122.16 31.66 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.442 -1.318 . . . . 2.65 107.442 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 85.2 mt -127.3 146.38 50.46 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -0.841 . . . . 0.63 109.674 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.5 mt -115.71 128.78 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.418 -1.697 . . . . 0.62 106.418 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.9 tp -98.5 117.96 34.1 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 106.025 -1.843 . . . . 0.64 106.025 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 223' ' ' VAL . 32.0 t0 -87.0 -26.75 23.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.736 -1.227 . . . . 2.05 112.066 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.54 20.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.842 . . . . 0.84 113.139 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.5 t -119.5 -63.22 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-O 121.769 0.795 . . . . 1.02 109.711 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -99.32 14.34 29.98 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.496 0.665 . . . . 2.51 111.256 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 60.22 54.74 3.89 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.376 0.607 . . . . 1.54 112.233 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.514 ' OE1' ' CZ ' ' A' ' 228' ' ' TYR . 15.7 tt0 -145.72 143.59 29.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.035 -1.041 . . . . 1.95 109.568 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.65 139.26 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.438 -1.319 . . . . 0.71 107.438 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.514 ' CZ ' ' OE1' ' A' ' 226' ' ' GLN . 86.8 m-85 -103.93 134.43 47.22 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.832 -1.168 . . . . 1.01 108.956 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.25 130.59 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.9 -1.148 . . . . 0.82 107.9 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 1.0 OUTLIER 54.52 49.91 6.01 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.185 -0.947 . . . . 1.54 112.95 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 44.8 Cg_endo -68.88 149.38 72.34 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.906 2.404 . . . . 0.94 111.459 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.5 m -78.34 157.64 29.07 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.668 0.747 . . . . 1.8 109.765 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.52 ' HA ' HD12 ' A' ' 236' ' ' ILE . 65.9 t30 -55.68 -40.59 72.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.447 -0.783 . . . . 2.73 110.627 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.05 -39.65 86.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.574 -0.704 . . . . 3.17 110.62 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.67 -37.92 71.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.301 -0.874 . . . . 1.34 110.204 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 233' ' ' ASN . 91.3 mt -59.9 -43.0 91.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.454 -0.779 . . . . 1.2 110.369 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -59.18 -40.35 85.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -0.871 . . . . 2.7 110.462 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -61.4 -46.1 91.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 2.59 110.982 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.1 mtp -72.3 -35.91 68.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.066 -1.021 . . . . 1.38 111.148 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 . . . . . 0 C--N 1.301 -1.518 0 O-C-N 121.09 -1.006 . . . . 2.84 110.774 -179.821 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.0 mt . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 106.233 -1.766 . . . . 1.07 106.233 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.3 m -104.57 127.33 52.27 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.387 -0.968 . . . . 1.24 108.387 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.57 -141.24 11.99 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.494 -1.042 . . . . 1.01 110.494 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 5' ' ' ILE . 56.6 mt -100.51 1.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.241 -1.152 . . . . 1.11 112.467 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tp 49.45 96.73 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.863 -1.148 . . . . 0.99 112.162 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.5 -45.79 10.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.072 -1.017 . . . . 0.85 111.419 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t -147.11 145.9 23.75 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.686 -1.227 . . . . 1.38 107.686 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.71 151.8 46.85 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.565 2.176 . . . . 0.94 112.254 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.53 123.7 1.51 Allowed Glycine 0 N--CA 1.508 3.491 0 N-CA-C 110.94 -0.864 . . . . 0.81 110.94 177.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.7 mt -92.37 131.41 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.767 -1.431 . . . . 0.83 109.348 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.89 140.73 42.54 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.355 -0.98 . . . . 0.53 108.355 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 12.4 m-85 -108.59 136.83 47.53 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.971 -1.122 . . . . 0.77 107.971 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.76 169.05 42.09 Favored Glycine 0 N--CA 1.498 2.81 0 C-N-CA 118.276 -1.916 . . . . 0.51 110.461 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -77.7 159.39 29.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.756 -0.849 . . . . 1.9 108.795 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.477 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -87.83 131.24 34.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.999 -1.063 . . . . 0.66 109.234 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 17' ' ' LEU . 36.4 tp -109.8 103.47 12.28 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.175 -2.157 . . . . 0.83 105.175 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 tp -89.46 132.31 35.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.981 -1.075 . . . . 0.86 108.615 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' A' ' 160' ' ' ALA . 67.3 mt -100.01 121.26 41.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.515 -1.291 . . . . 0.92 107.515 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -110.65 129.4 55.83 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.763 -1.199 . . . . 2.03 107.763 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -111.33 141.54 44.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.398 -0.814 . . . . 2.66 109.22 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.18 127.03 33.25 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.436 -1.32 . . . . 2.32 107.436 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.21 147.04 54.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.046 -1.034 . . . . 2.11 109.156 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.5 mt -95.32 133.35 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.498 -0.927 . . . . 0.73 108.498 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -105.74 129.75 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.969 -1.123 . . . . 0.87 107.969 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 73.5 mt -98.33 137.27 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.152 -0.967 . . . . 0.81 108.671 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -92.31 120.61 33.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.161 -1.052 . . . . 1.34 108.161 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.425 HH11 ' HG3' ' A' ' 28' ' ' ARG . 22.6 mmm-85 -94.96 13.78 23.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.206 -0.934 . . . . 2.89 112.217 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -72.13 143.03 49.13 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.494 -0.754 . . . . 2.09 109.239 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -85.74 140.29 30.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.379 -0.826 . . . . 2.19 109.482 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.26 165.59 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 121.629 0.728 . . . . 0.75 110.41 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.7 p -93.56 167.78 11.46 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.311 0.577 . . . . 0.91 109.801 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.97 -18.66 14.41 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.015 -1.053 . . . . 0.93 112.713 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -68.99 -38.14 79.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.885 . . . . 2.28 110.877 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -92.27 -5.88 51.49 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.548 -1.345 . . . . 1.45 113.086 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.72 -42.89 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.097 -1.002 . . . . 0.81 110.69 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.1 -40.33 85.01 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.841 -1.162 . . . . 1.54 110.527 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.52 -39.42 93.51 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.292 -0.88 . . . . 2.36 111.063 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -59.76 -40.83 89.48 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.893 -1.129 . . . . 1.31 111.148 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.1 -45.0 96.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 120.937 -1.102 . . . . 0.82 110.725 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -61.43 -45.88 92.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.823 -1.173 . . . . 1.5 110.648 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -60.77 -41.35 95.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 2.23 110.176 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -75.09 -55.44 5.73 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.155 -0.966 . . . . 0.85 110.184 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.9 tp -57.38 -47.14 82.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.409 -0.916 . . . . 0.91 110.125 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.5 t -70.22 -38.9 75.35 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.051 0.929 . . . . 0.9 109.785 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.53 -44.9 97.22 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.488 -1.445 . . . . 0.69 109.488 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 43.9 ttp180 -57.49 -31.72 66.28 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.853 -0.793 . . . . 2.88 109.342 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.34 -41.49 80.13 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.774 0.797 . . . . 0.85 109.906 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -77.46 -40.94 41.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.633 -0.667 . . . . 2.35 110.236 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.66 92.15 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.588 -0.845 . . . . 0.65 109.874 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.4 t -60.26 -39.85 88.26 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.041 0.925 . . . . 1.45 109.392 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.2 75.47 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.819 -0.628 . . . . 0.63 110.597 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -66.55 -50.1 64.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.055 -1.028 . . . . 1.34 111.032 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.09 -38.43 91.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 1.56 110.229 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -59.76 -41.0 90.04 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.233 -0.917 . . . . 1.19 110.449 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.1 m -65.59 -43.39 89.84 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.241 -0.912 . . . . 0.72 109.882 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.08 -31.9 49.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.379 -0.826 . . . . 0.62 110.691 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -51.78 -46.64 64.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.745 -1.222 . . . . 1.05 110.477 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -68.63 -34.21 75.36 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.953 -1.092 . . . . 0.64 109.805 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.13 -39.95 96.17 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.356 -1.338 . . . . 1.73 109.136 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.7 75.89 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.832 -0.747 . . . . 0.56 109.548 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.18 -35.74 29.41 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.375 -1.393 . . . . 0.69 110.688 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -80.75 -22.53 40.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.107 -1.231 . . . . 1.48 111.016 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.6 m -84.56 -48.9 9.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.428 -0.795 . . . . 0.98 110.714 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -106.81 -22.62 12.65 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.409 -0.807 . . . . 1.16 112.93 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.37 169.29 14.89 Favored Glycine 0 N--CA 1.501 3.002 0 CA-C-O 121.967 0.76 . . . . 0.85 112.036 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.22 -24.17 40.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.912 -0.758 . . . . 3.86 112.501 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.96 -38.27 78.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.091 -1.006 . . . . 2.35 111.634 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -84.62 -15.84 44.12 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.321 -1.487 . . . . 1.67 113.347 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -60.07 -34.66 73.73 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.1 -1.0 . . . . 1.45 110.69 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.59 86.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.61 111.308 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 mt -65.54 -43.8 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.822 -1.174 . . . . 0.65 110.44 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -70.05 -30.68 68.01 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.225 -0.922 . . . . 0.66 110.583 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.49 -38.95 82.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.248 -0.907 . . . . 1.19 110.511 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.48 -38.73 79.87 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.734 -1.222 . . . . 0.53 110.616 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -58.05 -42.62 85.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.782 -1.422 . . . . 1.27 110.873 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.9 mt -60.4 -41.49 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 0.54 110.375 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.5 ttt -60.38 -39.15 86.22 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.221 -0.924 . . . . 1.74 110.397 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 tp -59.64 -48.43 81.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.796 -1.19 . . . . 0.55 110.729 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.61 -41.64 95.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.355 -0.841 . . . . 0.47 110.247 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -87.09 9.99 18.05 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.376 0.608 . . . . 1.42 112.213 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.99 122.17 16.37 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.858 -1.151 . . . . 1.27 108.624 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.86 -17.69 65.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.512 -0.743 . . . . 1.35 111.07 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -76.46 -53.65 7.82 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.664 0.745 . . . . 2.22 110.365 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.89 -39.52 85.62 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.593 -0.843 . . . . 0.62 110.389 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.521 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 86.3 tt0 -59.9 -45.87 91.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.718 -1.239 . . . . 1.29 110.965 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -60.58 -39.98 90.0 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.966 -1.084 . . . . 1.52 110.839 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.42 -48.49 77.56 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.335 -0.853 . . . . 1.3 110.111 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.8 mt -58.61 -43.27 87.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 118.974 -1.09 . . . . 0.61 109.61 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.4 mt -61.35 -45.08 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.535 -0.728 . . . . 0.78 110.316 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.36 -44.93 96.33 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.271 0.558 . . . . 0.82 110.929 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.91 -43.34 94.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.574 -1.329 . . . . 0.8 110.337 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.2 mt -62.33 -49.99 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.137 -0.977 . . . . 0.77 110.723 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -78.79 -36.32 42.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.609 -0.682 . . . . 2.12 111.563 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -79.93 -46.11 17.34 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 120.789 -1.194 . . . . 1.51 111.838 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -102.24 10.66 39.11 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.097 -1.002 . . . . 1.98 112.066 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.3 m80 51.26 51.5 16.8 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.306 -0.871 . . . . 1.32 112.452 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.6 mtp -104.32 158.27 16.57 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 120.91 -1.119 . . . . 1.38 109.289 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 66.7 p -72.83 158.43 35.56 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.282 -0.886 . . . . 0.67 109.466 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.11 -42.04 84.86 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.224 -0.922 . . . . 0.52 110.17 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.528 ' OD2' HD21 ' A' ' 142' ' ' LEU . 88.9 m-20 -68.78 -38.82 80.29 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.976 -1.078 . . . . 2.25 110.207 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.91 -48.59 57.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.5 -0.88 . . . . 0.64 111.536 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.32 -47.58 84.86 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.221 -0.924 . . . . 0.56 110.967 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.59 95.78 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.475 -0.766 . . . . 0.46 110.82 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -61.49 -37.67 84.51 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.558 -0.714 . . . . 1.32 110.718 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.09 -49.3 78.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.859 -1.151 . . . . 1.3 111.399 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.36 -46.25 95.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.622 -1.299 . . . . 0.61 110.097 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.43 -33.78 58.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.451 0.643 . . . . 0.65 110.437 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -57.53 -41.59 81.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -0.828 . . . . 2.11 110.786 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.65 -28.01 27.97 Favored Glycine 0 N--CA 1.5 2.94 0 C-N-CA 119.176 -1.487 . . . . 0.83 113.084 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -62.38 -39.58 93.67 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.253 -1.734 . . . . 1.28 109.747 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.13 -53.63 12.16 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.57 0.7 . . . . 0.89 111.425 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.7 p -60.41 -39.6 88.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 1.87 110.502 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.59 97.5 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.112 -0.993 . . . . 1.05 110.622 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.33 -29.0 69.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.966 -1.084 . . . . 1.02 111.202 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -68.22 -20.26 64.82 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.458 -0.776 . . . . 2.04 111.346 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -73.06 -12.34 60.88 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.331 -0.947 . . . . 1.73 110.766 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 20.1 mt -85.91 147.3 26.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.566 -0.708 . . . . 1.37 109.098 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -103.12 39.14 1.61 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.149 -0.969 . . . . 2.88 111.826 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.422 ' CB ' HD12 ' A' ' 123' ' ' LEU . 7.1 t0 -113.54 139.21 49.17 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 108.733 -0.839 . . . . 1.58 108.733 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.8 -37.74 79.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.795 -1.191 . . . . 3.04 110.812 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -72.42 -46.19 56.23 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.539 -1.351 . . . . 0.9 110.667 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.422 HD12 ' CB ' ' A' ' 120' ' ' ASP . 43.7 mt -64.33 -40.86 96.73 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.014 -1.054 . . . . 1.06 109.823 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -61.17 -46.66 89.59 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.164 -0.96 . . . . 2.18 110.256 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.0 -31.93 71.52 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.177 -0.952 . . . . 2.15 109.641 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.78 -29.19 70.52 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.854 -1.138 . . . . 2.33 109.722 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.37 -49.14 78.75 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.857 0.837 . . . . 0.82 109.852 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.53 -44.65 70.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.62 0.724 . . . . 0.85 110.663 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -63.52 -33.76 76.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.422 -0.799 . . . . 1.39 110.875 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.3 t -69.74 -42.24 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.224 -0.99 . . . . 0.56 110.203 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -59.21 -38.29 79.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.96 -1.088 . . . . 3.12 109.456 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -59.52 -39.59 84.39 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.707 -0.621 . . . . 1.28 110.213 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.04 -40.71 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.081 -1.012 . . . . 0.49 110.322 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.83 -39.93 85.28 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.948 -1.261 . . . . 0.46 109.948 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.33 -45.39 91.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.714 -0.874 . . . . 2.71 109.968 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.431 HH11 ' HG2' ' A' ' 136' ' ' ARG . 51.5 mtt-85 -62.77 -42.68 99.8 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.49 -0.884 . . . . 2.14 109.875 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.02 -41.3 91.87 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.673 -0.642 . . . . 1.05 109.954 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.2 mt -60.36 -42.06 94.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.81 . . . . 0.52 110.226 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.428 ' NH1' HD23 ' A' ' 144' ' ' LEU . 47.9 mtt-85 -61.08 -32.13 71.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 2.35 110.53 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -75.99 -41.55 50.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.244 -0.91 . . . . 1.39 110.933 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.43 HG21 ' OD1' ' A' ' 101' ' ' ASP . 91.9 mt -60.17 -39.18 79.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.961 -1.087 . . . . 0.68 110.274 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.528 HD21 ' OD2' ' A' ' 101' ' ' ASP . 85.1 mt -86.72 -7.61 58.14 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.348 -0.845 . . . . 0.83 112.666 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.82 20.04 77.26 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.11 -1.519 . . . . 0.91 112.724 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.428 HD23 ' NH1' ' A' ' 139' ' ' ARG . 35.9 tp -65.94 149.1 50.75 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.957 -0.731 . . . . 0.95 109.709 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -66.84 149.37 50.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.262 -0.899 . . . . 2.43 109.753 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.0 mt -107.64 141.03 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.229 -1.026 . . . . 1.1 108.229 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.58 ' H ' HD12 ' A' ' 147' ' ' ILE . 5.0 mp -78.98 123.88 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.601 -0.888 . . . . 1.58 108.601 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -96.84 95.67 8.02 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.796 -1.557 . . . . 1.62 106.796 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.42 -15.8 59.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.439 -0.788 . . . . 0.8 111.683 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.6 m -80.76 1.72 29.17 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.244 -0.91 . . . . 1.56 112.514 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.86 19.03 14.48 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 112.774 0.657 . . . . 0.84 112.774 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.8 mt -74.1 139.47 19.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.266 -0.896 . . . . 0.82 109.353 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -122.24 -8.78 8.68 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.458 0.646 . . . . 2.31 112.199 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -111.07 138.49 47.43 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.885 -1.154 . . . . 1.54 107.885 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.88 116.39 20.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.09 -1.078 . . . . 1.38 108.09 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.3 176.7 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.992 -0.744 . . . . 0.69 108.992 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.2 mt -84.21 140.29 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.364 -0.976 . . . . 0.53 108.364 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 19' ' ' LEU . 27.9 tp -96.53 128.32 43.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.486 -0.931 . . . . 0.64 108.486 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.2 130.12 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.075 -1.083 . . . . 0.67 108.075 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.442 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -160.57 159.68 30.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.234 -0.916 . . . . 0.78 108.92 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -62.43 -41.14 98.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.316 -1.49 . . . . 1.0 109.717 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -174.21 150.94 1.58 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.755 -0.832 . . . . 2.42 108.755 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.13 140.8 48.92 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.176 -0.675 . . . . 0.75 109.176 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.7 p -90.98 151.18 43.02 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.675 -1.266 . . . . 0.78 108.471 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -39.67 -37.77 1.51 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.077 1.851 . . . . 0.67 113.512 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.4 m -63.6 -51.4 65.45 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.154 -0.966 . . . . 0.7 109.916 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.95 -39.24 94.03 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.539 -0.726 . . . . 1.21 110.237 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 32.1 p -68.16 -40.28 82.39 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.348 0.595 . . . . 0.6 110.442 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.68 81.56 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.177 -0.952 . . . . 0.62 110.4 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -94.04 -1.61 54.18 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.94 -1.1 . . . . 1.16 112.855 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.26 149.22 33.98 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.697 -0.853 . . . . 0.73 108.697 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -96.48 114.26 25.91 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.885 -1.524 . . . . 2.24 106.885 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 82.4 mt -72.05 -17.02 62.05 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.173 0.511 . . . . 1.43 111.55 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -84.72 -22.19 29.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.654 -0.654 . . . . 2.15 112.034 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -99.51 -4.22 31.75 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.24 -0.913 . . . . 2.04 112.923 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 178' ' ' GLY . 61.1 t -112.92 129.86 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 107.599 -1.26 . . . . 0.55 107.599 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.2 tp -89.1 -8.53 53.66 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.899 -1.126 . . . . 1.63 111.827 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.473 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.22 171.21 39.03 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.995 -1.642 . . . . 0.47 108.995 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.0 136.2 49.15 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.283 -1.127 . . . . 0.54 108.147 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.473 HG22 HG21 ' A' ' 205' ' ' THR . 86.2 mt -135.54 115.75 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 106.358 -1.719 . . . . 0.69 106.358 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 205' ' ' THR . 81.6 p -131.0 169.5 15.75 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.784 -1.198 . . . . 0.82 109.897 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 39.0 p-10 -103.24 43.62 1.07 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.586 -0.696 . . . . 2.37 110.721 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 2.263 0 O-C-N 120.866 -1.146 . . . . 1.11 110.068 179.641 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.9 p . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 107.967 -1.124 . . . . 1.69 107.967 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -61.07 -38.53 86.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.688 -0.633 . . . . 1.07 110.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.1 p -51.99 -43.66 63.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.056 -1.028 . . . . 1.58 110.405 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.9 m -60.12 -37.81 81.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.767 0.794 . . . . 1.6 110.405 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.7 mm -59.52 -38.58 76.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.525 -0.735 . . . . 1.45 110.8 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 77.2 mtp -63.17 -43.0 99.49 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.226 1.012 . . . . 1.05 108.883 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.79 -48.99 78.15 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.598 -0.728 . . . . 0.72 111.335 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.28 -46.78 88.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.014 -1.054 . . . . 3.05 111.146 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 42.7 m -69.85 -41.36 74.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.178 -0.951 . . . . 0.89 110.294 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.27 -1.6 57.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.415 -0.803 . . . . 0.78 111.991 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 194' ' ' ALA . 54.9 mt-10 54.04 9.75 0.24 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.723 1.009 . . . . 1.45 113.723 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.19 164.94 52.78 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.984 -1.072 . . . . 0.67 108.304 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -82.06 144.04 13.18 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.851 1.701 . . . . 0.64 110.397 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.48 168.28 25.44 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 117.733 -1.587 . . . . 0.67 109.499 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.562 ' CD1' HD11 ' A' ' 220' ' ' LEU . 17.4 mt -148.85 145.9 17.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.159 -1.423 . . . . 0.69 107.159 176.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.98 -25.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 120.899 -1.125 . . . . 0.85 113.523 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.14 46.16 3.57 Favored Glycine 0 N--CA 1.492 2.403 0 O-C-N 120.99 -1.069 . . . . 0.92 111.644 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.473 HG21 HG22 ' A' ' 180' ' ' ILE . 60.5 p -67.59 -12.48 60.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.375 -1.073 . . . . 0.95 111.803 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.48 -95.54 0.98 Allowed Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.301 -1.12 . . . . 1.04 110.301 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.9 p -128.41 29.28 5.34 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.389 -1.065 . . . . 1.57 112.344 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 72.4 t -58.49 -38.03 67.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.567 -1.333 . . . . 0.84 110.707 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.7 p -55.48 -24.94 34.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 0.99 111.58 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.4 t -94.34 3.93 54.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.875 . . . . 1.7 111.988 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -127.66 1.13 6.14 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.675 0.621 . . . . 2.2 112.675 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 16.1 t -116.23 150.2 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.889 0.852 . . . . 0.84 109.611 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -116.07 167.16 11.23 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.939 -0.763 . . . . 2.2 108.939 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 68.5 m-80 -68.05 140.33 56.29 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.74 -1.184 . . . . 2.28 108.814 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.0 m-20 78.0 4.71 2.84 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.171 1.175 . . . . 2.35 114.171 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -63.38 147.88 49.97 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.075 -1.083 . . . . 1.97 108.075 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -89.01 120.16 30.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.588 -1.32 . . . . 2.65 107.484 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.477 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 80.2 mt -127.9 146.99 50.46 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.664 0.745 . . . . 0.63 109.697 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 60.2 mt -119.08 128.2 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.08 -1.452 . . . . 0.62 107.08 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.562 HD11 ' CD1' ' A' ' 202' ' ' ILE . 48.8 tp -100.98 119.96 39.49 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 106.329 -1.73 . . . . 0.64 106.329 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 223' ' ' VAL . 40.2 t0 -87.28 -25.65 23.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.955 -1.091 . . . . 2.05 112.176 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.8 16.84 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 113.652 0.982 . . . . 0.84 113.652 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 221' ' ' ASP . 43.1 t -120.38 -63.31 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.178 -0.951 . . . . 1.02 109.621 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -90.81 7.84 37.8 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.059 0.933 . . . . 2.51 111.175 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 62.3 55.34 2.38 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.692 0.758 . . . . 1.54 112.148 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -147.31 145.17 29.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.353 -0.842 . . . . 1.95 109.562 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 29.9 t -115.95 138.34 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.775 -1.194 . . . . 0.71 107.775 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -105.76 132.7 51.56 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.925 -1.11 . . . . 1.01 108.483 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.94 130.56 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 108.532 -0.914 . . . . 0.82 108.532 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.425 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 41.6 t-20 50.72 51.34 10.38 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 113.462 0.912 . . . . 1.54 113.462 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 36.4 Cg_endo -67.86 150.27 78.41 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.53 2.153 . . . . 0.94 110.507 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.412 ' H ' HG23 ' A' ' 232' ' ' THR . 1.5 p -74.05 159.99 31.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.994 -1.066 . . . . 1.8 109.7 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -61.57 -35.76 78.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.284 -0.885 . . . . 2.73 110.334 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.35 -39.74 84.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.961 -1.087 . . . . 3.17 110.43 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.91 -36.73 70.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.491 -0.756 . . . . 1.34 110.017 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.01 -43.78 93.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.261 -0.9 . . . . 1.2 110.543 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.22 -41.2 88.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.955 -1.091 . . . . 2.7 110.252 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -63.61 -40.03 95.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.447 -0.783 . . . . 2.59 110.502 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 73.2 mtp -70.73 -36.99 73.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.925 . . . . 1.38 110.936 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 120.8 -1.188 . . . . 2.84 110.127 179.877 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 106.568 -1.642 . . . . 1.07 106.568 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.3 m -104.01 122.31 44.98 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.281 -1.007 . . . . 1.24 108.281 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.57 -159.22 18.21 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 108.641 -1.784 . . . . 1.01 108.641 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 5' ' ' ILE . 93.4 mt -97.07 1.06 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.253 -1.145 . . . . 1.11 112.646 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tp 51.42 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.049 . . . . 0.99 112.345 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -83.62 -45.0 13.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.993 -1.067 . . . . 0.85 111.496 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.06 146.48 28.43 Favored Pre-proline 0 N--CA 1.5 2.064 0 N-CA-C 107.447 -1.316 . . . . 1.38 107.447 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.15 146.17 28.43 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.644 2.229 . . . . 0.94 112.144 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.898 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.71 176.43 26.11 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 108.828 -1.709 . . . . 0.81 108.828 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.4 mt -138.05 136.69 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 107.712 -1.218 . . . . 0.83 107.712 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.25 152.85 44.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.392 -0.818 . . . . 0.53 109.19 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -122.16 145.11 48.5 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.354 -0.98 . . . . 0.77 108.354 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.78 167.58 34.3 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.584 -1.769 . . . . 0.51 109.886 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -76.89 159.16 30.25 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.788 -0.831 . . . . 1.9 108.802 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.92 126.94 33.49 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.866 -1.161 . . . . 0.66 107.866 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.89 107.89 19.14 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 104.965 -2.235 . . . . 0.83 104.965 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.8 tp -94.37 138.67 32.06 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.162 -1.051 . . . . 0.86 108.162 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.7 mt -100.69 118.03 36.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 106.768 -1.567 . . . . 0.92 106.768 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -109.96 136.06 49.84 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.043 -1.466 . . . . 2.03 107.043 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -123.94 140.1 53.31 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.847 -1.158 . . . . 2.66 108.34 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -82.91 136.26 34.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.464 -1.31 . . . . 2.32 107.464 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.32 150.03 44.32 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.671 -0.812 . . . . 2.11 109.516 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.3 mt -91.77 134.64 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.314 -0.866 . . . . 0.73 108.752 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.4 t -106.31 130.03 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.496 -1.298 . . . . 0.87 107.496 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 26' ' ' ILE . 19.4 mt -96.34 132.26 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.643 -0.873 . . . . 0.81 108.643 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -91.81 121.62 33.6 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.316 -0.994 . . . . 1.34 108.316 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -100.03 22.01 11.92 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.15 -0.969 . . . . 2.89 112.139 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -65.78 143.65 57.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.889 -1.132 . . . . 2.09 109.073 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -89.32 131.39 35.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.077 -1.082 . . . . 2.19 108.077 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 pt -97.63 167.74 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.75 109.996 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.3 p -97.62 163.68 12.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.531 -0.731 . . . . 0.91 110.109 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.87 -24.09 14.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.93 111.861 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -67.37 -35.97 80.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.953 . . . . 2.28 110.715 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -94.78 -12.81 26.41 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.993 -1.067 . . . . 1.45 112.802 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.19 -46.42 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.895 . . . . 0.81 110.537 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -58.12 -39.38 78.54 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.102 -0.999 . . . . 1.54 110.701 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -62.41 -43.25 99.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.418 -0.801 . . . . 2.36 110.876 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.46 -36.55 78.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.079 -1.013 . . . . 1.31 110.935 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.46 -42.4 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.784 -1.198 . . . . 0.82 110.091 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -61.89 -41.03 97.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.097 -1.002 . . . . 1.5 110.091 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -63.14 -40.95 99.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.512 -0.743 . . . . 2.23 110.168 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -71.94 -56.72 5.17 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.27 -0.894 . . . . 0.85 110.349 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.9 tp -58.92 -47.04 86.45 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.377 -0.929 . . . . 0.91 109.754 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.531 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.0 t -70.27 -42.18 72.45 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.263 -0.975 . . . . 0.9 109.426 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.24 -38.85 88.58 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.145 -1.582 . . . . 0.69 109.145 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -59.79 -33.37 71.63 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 122.103 0.954 . . . . 2.88 108.973 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.35 -42.14 81.44 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.604 0.716 . . . . 0.85 109.642 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -79.46 -43.34 23.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -0.821 . . . . 2.35 110.527 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.78 87.88 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.335 -0.853 . . . . 0.65 109.814 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 m -60.77 -39.81 90.21 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.798 0.808 . . . . 1.45 109.546 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.86 86.98 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.243 0.544 . . . . 0.63 110.475 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.02 -48.77 78.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 1.34 110.575 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.96 -38.56 88.89 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.012 -1.055 . . . . 1.56 109.783 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -60.19 -40.04 88.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.83 -0.544 . . . . 1.19 110.789 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.7 m -61.8 -42.81 99.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.759 -1.213 . . . . 0.72 109.931 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.49 -37.64 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.298 -0.876 . . . . 0.62 110.493 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -50.1 -44.29 51.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.403 -0.811 . . . . 1.05 111.118 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.25 -37.38 74.91 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.123 -0.986 . . . . 0.64 110.109 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -61.68 -38.55 88.21 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.905 -1.118 . . . . 1.73 109.545 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.47 -33.59 76.24 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.918 -0.713 . . . . 0.56 109.621 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.37 -36.82 13.41 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.957 -1.116 . . . . 0.69 111.123 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -81.36 -23.08 37.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.966 -1.314 . . . . 1.48 111.023 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 m -91.4 -51.29 5.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.484 -0.76 . . . . 0.98 110.971 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.12 -8.17 17.59 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.001 1.112 . . . . 1.16 114.001 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.36 170.69 30.63 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.257 -0.902 . . . . 0.85 111.75 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -58.21 -21.98 50.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.98 -0.717 . . . . 3.86 112.15 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -54.34 -41.61 69.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.06 -1.025 . . . . 2.35 110.861 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -89.24 -24.0 22.21 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.161 -0.962 . . . . 1.67 112.031 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -60.01 -39.57 86.27 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.604 -0.685 . . . . 1.45 111.167 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.36 87.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.357 -0.839 . . . . 0.61 111.523 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 mt -65.95 -45.56 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.541 -1.35 . . . . 0.65 110.131 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -68.43 -33.22 73.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.066 -1.021 . . . . 0.66 110.623 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -60.15 -36.13 76.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.233 -0.917 . . . . 1.19 110.321 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.87 -39.66 85.3 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.941 -1.123 . . . . 0.53 110.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -58.98 -42.88 91.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.102 -1.234 . . . . 1.27 110.525 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.9 mt -60.36 -37.54 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.54 110.34 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.5 ttt -59.45 -39.9 85.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.257 -0.902 . . . . 1.74 110.517 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.03 -46.36 88.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.334 -0.854 . . . . 0.55 109.866 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.3 -38.78 88.04 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.817 0.818 . . . . 0.47 110.139 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.86 9.7 18.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.515 -0.74 . . . . 1.42 112.735 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -67.11 121.76 16.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.182 -0.949 . . . . 1.27 108.849 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.75 -15.55 62.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.536 -0.728 . . . . 1.35 111.065 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -76.86 -49.63 15.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.678 0.751 . . . . 2.22 110.431 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.36 -37.26 86.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.755 0.788 . . . . 0.62 110.192 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.91 -47.46 85.66 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.35 -0.844 . . . . 1.29 110.744 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.82 -37.79 85.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.215 -0.928 . . . . 1.52 110.473 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -65.41 -47.72 75.29 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.092 -1.043 . . . . 1.3 110.646 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.35 -44.55 88.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.138 -1.025 . . . . 0.61 110.07 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.87 -39.83 83.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.653 -0.655 . . . . 0.78 110.245 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.05 90.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.531 -0.73 . . . . 0.82 110.878 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.0 -41.74 92.74 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.028 -1.045 . . . . 0.8 110.272 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.5 mt -64.94 -50.01 77.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.776 -0.769 . . . . 0.77 110.494 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -74.77 -38.54 62.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 2.12 111.778 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -78.82 -45.76 20.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.665 -1.272 . . . . 1.51 111.279 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -101.47 8.84 41.89 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.983 -1.073 . . . . 1.98 112.569 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.2 m80 50.25 49.97 19.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.707 -1.246 . . . . 1.32 111.632 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.6 mtt -102.8 154.97 18.66 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.831 0.824 . . . . 1.38 109.716 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.7 p -70.96 161.44 31.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.604 -0.685 . . . . 0.67 109.582 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.87 91.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 0.52 111.042 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 28.6 p-10 -69.13 -39.05 79.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.798 -1.189 . . . . 2.25 110.53 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -69.7 -50.36 44.48 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.432 -0.907 . . . . 0.64 111.46 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.11 90.94 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.948 -1.095 . . . . 0.56 110.472 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.44 90.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.254 -0.904 . . . . 0.46 110.868 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -61.06 -38.75 87.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.737 -1.227 . . . . 1.32 111.003 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -57.68 -49.81 75.28 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.053 -1.029 . . . . 1.3 110.791 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.2 -47.23 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.831 -1.168 . . . . 0.61 110.144 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -62.0 -32.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.358 -0.839 . . . . 0.65 110.497 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -57.78 -40.05 78.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 2.11 110.856 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.06 -33.2 15.47 Favored Glycine 0 N--CA 1.501 3.029 0 C-N-CA 119.152 -1.499 . . . . 0.83 112.452 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -61.66 -42.26 98.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.434 -1.627 . . . . 1.28 110.2 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.9 -53.3 15.57 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.494 0.664 . . . . 0.89 110.821 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.6 m -61.42 -39.92 92.5 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.021 -1.049 . . . . 1.87 111.083 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.43 97.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.993 -1.067 . . . . 1.05 111.318 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 43.9 mt -62.21 -29.99 70.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.953 -1.092 . . . . 1.02 110.613 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.27 -19.67 64.73 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.971 -1.081 . . . . 2.04 111.073 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -74.65 -9.38 58.52 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.965 0.888 . . . . 1.73 110.898 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.485 HD13 HD13 ' A' ' 123' ' ' LEU . 69.2 mt -87.37 149.57 24.4 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.039 -0.726 . . . . 1.37 109.039 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -104.12 38.77 1.77 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.105 -0.997 . . . . 2.88 111.586 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -116.43 138.58 51.25 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.23 -0.919 . . . . 1.58 108.981 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.79 -39.54 85.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.693 -0.629 . . . . 3.04 110.957 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -71.68 -48.12 49.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.64 -1.287 . . . . 0.9 110.38 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.485 HD13 HD13 ' A' ' 118' ' ' LEU . 25.5 mt -64.1 -39.57 94.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 1.06 110.021 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -60.28 -47.98 83.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.906 -1.121 . . . . 2.18 109.518 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.32 -31.28 70.13 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.716 -0.794 . . . . 2.15 109.57 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.536 ' O ' HG23 ' A' ' 130' ' ' VAL . 19.2 ttt-85 -60.5 -31.11 70.17 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.136 -1.026 . . . . 2.33 108.397 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -61.96 -48.85 78.51 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.459 -0.896 . . . . 0.82 109.332 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.01 -46.11 79.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.388 -0.82 . . . . 0.85 110.408 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.38 -34.45 77.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.48 -0.763 . . . . 1.39 110.656 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.0 t -68.23 -39.5 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.56 110.275 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -57.37 -39.69 76.57 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.139 -0.976 . . . . 3.12 110.115 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -61.28 -39.38 90.22 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.624 0.726 . . . . 1.28 110.591 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.27 -39.79 83.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.381 -0.825 . . . . 0.49 110.293 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.92 -48.4 48.55 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.394 -0.908 . . . . 0.46 111.456 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -58.26 -40.64 82.38 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.73 -1.453 . . . . 2.71 110.811 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -61.79 -45.86 92.04 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.677 -1.264 . . . . 2.14 110.326 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.96 -43.78 98.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.486 -0.759 . . . . 1.05 110.376 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.93 -45.53 92.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.831 . . . . 0.52 110.44 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.424 HH22 HD12 ' A' ' 147' ' ' ILE . 57.6 mtp180 -60.54 -35.99 77.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.571 -0.706 . . . . 2.35 110.987 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -74.71 -40.35 61.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 1.39 110.66 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.34 -39.17 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.448 -0.901 . . . . 0.68 110.407 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.28 -7.05 58.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.086 -1.009 . . . . 0.83 112.33 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.85 19.49 77.57 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.812 -1.185 . . . . 0.91 112.478 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.38 147.91 39.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.639 -0.918 . . . . 0.95 109.302 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -67.24 142.92 56.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.401 -0.812 . . . . 2.43 109.185 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.6 mt -108.7 137.72 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.167 -1.049 . . . . 1.1 108.167 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.512 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.2 mp -79.45 130.36 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.015 . . . . 1.58 108.546 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -93.95 96.2 9.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.507 -1.664 . . . . 1.62 106.507 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.5 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 57.3 mt -74.61 -10.56 59.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 0.8 111.951 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 172' ' ' ASN . 27.5 t -89.5 0.74 56.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.909 -1.119 . . . . 1.56 112.424 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -102.43 33.75 3.02 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.102 -0.999 . . . . 0.84 112.884 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.544 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.9 mp -66.29 140.63 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.197 -1.564 . . . . 0.82 108.827 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -109.29 -20.77 12.83 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.08 0.943 . . . . 2.31 111.346 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.437 ' O ' ' CG2' ' A' ' 152' ' ' ILE . 95.7 m-20 -118.89 140.17 50.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.875 -1.157 . . . . 1.54 107.875 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -74.49 124.94 27.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.056 -1.091 . . . . 1.38 108.056 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.6 m -146.88 175.7 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.564 -0.71 . . . . 0.69 109.513 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.1 mt -88.7 141.83 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.951 -0.759 . . . . 0.53 108.951 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.6 tp -96.67 121.39 38.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.64 108.297 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.78 131.56 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.373 -0.973 . . . . 0.67 108.373 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.37 158.2 31.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.78 109.088 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.56 82.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.692 -1.255 . . . . 1.0 109.713 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -171.81 151.07 2.74 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.889 -0.782 . . . . 2.42 108.889 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.0 mt -115.76 142.9 46.14 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.504 -0.747 . . . . 0.75 109.248 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 54.3 p -92.4 148.86 37.28 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 120.984 -1.073 . . . . 0.78 108.878 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -41.28 -41.84 4.98 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.052 1.835 . . . . 0.67 113.354 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.9 m -60.51 -50.37 73.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.938 -1.101 . . . . 0.7 110.235 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -60.68 -40.14 91.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.416 -0.802 . . . . 1.21 109.779 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 48.6 p -66.73 -38.47 86.73 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.568 -0.708 . . . . 0.6 110.278 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.28 82.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.62 111.122 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -96.93 1.05 49.95 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.31 -0.869 . . . . 1.16 113.136 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.27 150.03 36.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.2 -0.938 . . . . 0.73 109.601 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 150' ' ' SER . 6.1 m120 -94.83 116.14 28.36 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 106.877 -1.527 . . . . 2.24 106.877 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.619 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.6 mm? -75.06 -19.43 60.0 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.482 -0.761 . . . . 1.43 111.81 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -85.9 -21.23 28.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 2.15 112.266 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -98.95 -2.86 36.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.126 -0.983 . . . . 2.04 112.598 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.592 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.0 t -109.08 129.32 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 107.979 -1.119 . . . . 0.55 107.979 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.2 tp -86.26 -6.2 59.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.518 -0.739 . . . . 1.63 111.833 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.592 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 167.29 172.74 34.8 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 108.822 -1.711 . . . . 0.47 108.822 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -127.18 131.12 50.75 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.206 -1.173 . . . . 0.54 108.15 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.599 HG22 HG21 ' A' ' 205' ' ' THR . 89.1 mt -135.97 116.07 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 106.164 -1.791 . . . . 0.69 106.164 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 203' ' ' VAL . 62.8 p -138.79 174.99 9.94 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.282 -1.511 . . . . 0.82 110.543 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 44.2 m-20 -97.62 61.73 1.63 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 115.455 -0.793 . . . . 2.37 109.674 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.457 ' HB1' ' OG ' ' A' ' 188' ' ' SER . . . . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 108.72 -0.845 . . . . 1.11 108.72 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.457 ' OG ' ' HB1' ' A' ' 183' ' ' ALA . 67.6 m . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.802 -0.814 . . . . 1.69 108.802 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -60.04 -35.49 75.22 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.181 0.515 . . . . 1.07 111.012 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.9 p -57.67 -41.24 81.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.77 -1.206 . . . . 1.58 110.464 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 50.6 m -60.07 -35.95 76.31 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.016 -1.053 . . . . 1.6 110.172 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.1 mm -59.97 -39.95 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.893 -0.504 . . . . 1.45 111.029 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.5 mtp -61.13 -45.14 95.91 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.009 -1.057 . . . . 1.05 109.62 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -57.91 -48.2 80.57 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.678 -0.692 . . . . 0.72 111.061 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' A' ' 195' ' ' ARG . 41.6 mtt-85 -61.87 -41.01 97.33 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.132 -0.98 . . . . 3.05 110.605 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.5 m -69.62 -41.36 75.79 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.288 -0.883 . . . . 0.89 110.185 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.22 -8.12 49.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 112.574 0.583 . . . . 0.78 112.574 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.1 mt-10 52.97 10.66 0.17 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.085 1.143 . . . . 1.45 114.085 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.7 mt -71.95 149.7 92.52 Favored Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 108.188 -1.041 . . . . 0.67 108.188 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -54.09 132.81 52.18 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.236 1.29 . . . . 0.64 109.903 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.75 162.71 37.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.294 -1.504 . . . . 0.67 109.468 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 203' ' ' VAL . 81.2 mt -148.23 154.5 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.686 -1.228 . . . . 0.69 107.686 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.9 m -137.22 -28.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 121.077 -1.014 . . . . 0.85 112.244 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.75 32.93 0.72 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.822 -1.18 . . . . 0.92 113.5 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.599 HG21 HG22 ' A' ' 180' ' ' ILE . 39.4 p -60.8 -25.27 66.44 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.31 -1.112 . . . . 0.95 110.453 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 76.27 -93.44 0.99 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.818 -1.182 . . . . 1.04 110.541 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.0 p -127.3 32.6 5.02 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.215 -1.168 . . . . 1.57 112.325 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.26 -36.24 67.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 120.682 -1.261 . . . . 0.84 109.911 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.5 p -57.48 -20.19 29.36 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.282 -0.886 . . . . 0.99 111.74 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.4 t -91.16 -3.57 56.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 1.7 111.732 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -122.62 -8.2 8.52 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 112.923 0.712 . . . . 2.2 112.923 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 68.9 t -112.32 148.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.427 0.632 . . . . 0.84 109.649 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -120.09 159.46 24.76 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.012 -1.107 . . . . 2.2 108.012 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.2 p30 -57.61 149.0 22.54 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.409 -1.432 . . . . 2.28 110.507 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 9.0 t0 81.69 -2.44 1.6 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 114.644 1.35 . . . . 2.35 114.644 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -67.61 147.97 52.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.743 -1.223 . . . . 1.97 108.328 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -90.18 122.96 33.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.757 -1.201 . . . . 2.65 107.757 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.0 mt -124.88 143.88 50.61 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.9 0.857 . . . . 0.63 110.199 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.61 122.93 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.125 -1.805 . . . . 0.62 106.125 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.1 tp -98.92 117.77 34.17 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.409 -1.7 . . . . 0.64 106.409 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 223' ' ' VAL . 30.9 t0 -92.76 -26.0 17.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.933 -1.104 . . . . 2.05 112.96 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.59 18.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.863 0.69 . . . . 0.84 112.863 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.2 t -113.49 -60.72 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.956 0.884 . . . . 1.02 109.386 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -95.54 10.55 36.2 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.721 0.772 . . . . 2.51 110.764 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.9 t30 62.21 50.25 3.99 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.446 0.641 . . . . 1.54 111.74 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -147.17 146.6 29.93 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.414 1.102 . . . . 1.95 109.563 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.11 140.25 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.691 -0.855 . . . . 0.71 108.691 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -100.28 132.16 45.81 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.909 -1.119 . . . . 1.01 108.542 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.1 t -110.15 130.18 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.411 -0.959 . . . . 0.82 108.411 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.7 t30 53.12 52.84 10.97 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 114.124 1.157 . . . . 1.54 114.124 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.38 149.6 69.53 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.149 1.899 . . . . 0.94 110.717 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 65.7 p -75.72 157.94 32.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 1.8 109.245 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -60.84 -38.56 85.91 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.788 -0.765 . . . . 2.73 110.24 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 55.8 mp0 -60.28 -39.34 86.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.636 -0.665 . . . . 3.17 110.732 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.48 -40.83 77.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.864 -1.134 . . . . 1.34 110.142 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.4 -43.87 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.437 -0.789 . . . . 1.2 110.082 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -59.72 -41.42 90.8 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.104 -0.997 . . . . 2.7 110.385 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -63.61 -40.58 97.27 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.474 -0.89 . . . . 2.59 110.342 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 84.0 mtp -69.85 -41.01 75.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 1.38 110.648 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 . . . . . 0 C--N 1.3 -1.578 0 O-C-N 120.327 -1.483 . . . . 2.84 110.276 179.806 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.2 mt . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 112.321 0.489 . . . . 1.07 112.321 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 m -93.07 118.22 30.95 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.09 -1.448 . . . . 1.24 107.09 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.4 -146.8 16.69 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.48 -1.048 . . . . 1.01 110.48 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -94.95 -2.88 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.34 -1.094 . . . . 1.11 113.036 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tp 50.8 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.867 -1.146 . . . . 0.99 112.607 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.8 -43.79 13.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.85 110.741 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -147.96 142.42 16.54 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 107.797 -1.186 . . . . 1.38 107.797 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.97 149.39 36.79 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.716 2.277 . . . . 0.94 112.454 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.887 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.43 162.61 11.43 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.143 -1.583 . . . . 0.81 109.143 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -121.9 135.08 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 O-C-N 121.089 -1.242 . . . . 0.83 108.271 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.11 155.5 46.97 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.456 -0.778 . . . . 0.53 109.269 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -127.44 139.58 52.73 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.89 -1.152 . . . . 0.77 107.89 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.46 168.98 35.98 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 118.69 -1.719 . . . . 0.51 110.063 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.441 ' HZ3' HG12 ' A' ' 156' ' ' VAL . 30.2 mtmm -80.03 161.15 25.57 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.451 -1.029 . . . . 1.9 110.216 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.85 131.68 34.49 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.391 -0.966 . . . . 0.66 108.391 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 tp -109.78 101.77 10.61 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 105.405 -2.072 . . . . 0.83 105.405 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.53 133.15 35.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.911 -1.144 . . . . 0.86 107.911 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.7 117.93 35.8 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.394 -1.706 . . . . 0.92 106.394 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -109.32 133.38 53.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.943 -1.132 . . . . 2.03 107.943 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -123.59 140.24 53.19 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.305 -0.872 . . . . 2.66 108.666 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -80.46 136.99 36.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.073 -1.017 . . . . 2.32 108.256 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.2 146.12 51.62 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.281 -0.887 . . . . 2.11 108.955 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.0 mt -93.39 128.84 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.237 -1.023 . . . . 0.73 108.237 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -108.83 130.49 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.726 -1.213 . . . . 0.87 107.726 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.5 mt -95.7 132.14 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.341 -0.85 . . . . 0.81 108.943 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -89.94 120.8 31.47 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.61 -1.256 . . . . 1.34 107.61 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -96.65 17.74 15.79 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.431 -0.793 . . . . 2.89 112.417 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -67.45 146.29 54.14 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.203 -0.935 . . . . 2.09 108.979 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -87.82 134.83 33.61 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.103 -1.073 . . . . 2.19 108.103 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 pt -96.82 165.69 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.458 -0.776 . . . . 0.75 110.329 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -94.27 168.47 10.89 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 0.91 109.541 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.11 -18.97 28.75 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.959 -1.088 . . . . 0.93 112.879 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.09 -35.85 76.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.746 -1.221 . . . . 2.28 110.825 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -94.5 -8.83 37.23 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.969 -1.082 . . . . 1.45 113.221 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.9 -43.79 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.164 -0.96 . . . . 0.81 110.156 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.52 -40.09 81.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.954 -1.091 . . . . 1.54 110.4 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -62.1 -38.09 87.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.683 . . . . 2.36 110.656 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.77 -39.49 85.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 1.31 110.883 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.49 -43.68 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.131 -0.98 . . . . 0.82 110.769 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -62.13 -43.8 98.04 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.113 -0.992 . . . . 1.5 110.461 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -62.7 -38.78 91.79 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.247 -0.908 . . . . 2.23 110.592 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -76.09 -55.56 5.48 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.123 -0.986 . . . . 0.85 110.532 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.68 -48.28 81.62 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.295 -0.962 . . . . 0.91 110.59 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.552 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 10.9 t -69.84 -40.78 75.62 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.74 -0.784 . . . . 0.9 110.435 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.15 -45.73 87.05 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.24 -1.457 . . . . 0.69 109.691 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -58.39 -30.06 66.53 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.036 0.922 . . . . 2.88 109.995 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.66 -46.19 87.73 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.672 0.748 . . . . 0.85 110.018 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -78.95 -41.81 28.42 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 2.35 110.311 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.48 86.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.4 -0.813 . . . . 0.65 109.74 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -60.45 -40.38 90.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.118 -0.989 . . . . 1.45 109.288 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.91 -47.17 69.52 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.926 -0.579 . . . . 0.63 110.894 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.52 -51.38 65.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.084 . . . . 1.34 110.7 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 54' ' ' LEU . 3.0 mm? -61.41 -40.11 93.19 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.563 -0.855 . . . . 1.56 110.023 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -59.7 -41.59 91.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 1.19 110.354 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -66.05 -42.74 89.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.134 -0.979 . . . . 0.72 110.457 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.8 mt -59.89 -39.76 80.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.352 -0.843 . . . . 0.62 110.705 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -49.93 -41.92 47.29 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.09 -1.006 . . . . 1.05 110.87 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -70.21 -38.17 75.23 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.143 -0.973 . . . . 0.64 110.039 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.4 -38.88 88.66 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.721 -1.192 . . . . 1.73 108.945 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.16 72.24 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.52 0.676 . . . . 0.56 109.609 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.24 -33.37 20.46 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.103 -1.046 . . . . 0.69 111.055 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -80.6 -26.83 37.59 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.083 -1.245 . . . . 1.48 111.202 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 m -85.71 -48.61 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.579 -0.701 . . . . 0.98 110.856 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -107.48 -17.99 13.97 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 113.229 0.826 . . . . 1.16 113.229 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.13 155.72 11.48 Favored Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.329 -0.857 . . . . 0.85 112.325 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -50.65 -22.56 2.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.882 -0.776 . . . . 3.86 112.305 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.61 -36.18 71.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 2.35 111.349 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -80.98 -22.39 39.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.853 -1.154 . . . . 1.67 111.935 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -58.87 -33.53 70.58 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.957 -1.09 . . . . 1.45 111.2 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.95 -41.71 83.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 0.61 110.816 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.1 mt -66.65 -44.75 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.86 -1.15 . . . . 0.65 110.125 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -70.24 -31.11 68.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 0.66 110.382 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -61.04 -39.76 91.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.316 -0.865 . . . . 1.19 109.754 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.04 -39.95 96.72 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 120.177 -1.011 . . . . 0.53 110.611 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -59.73 -45.39 92.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -1.092 . . . . 1.27 110.621 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.0 mt -60.45 -39.03 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.411 -0.806 . . . . 0.54 110.545 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.9 ttt -59.61 -39.37 84.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 1.74 110.503 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.14 -49.65 77.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.035 -1.04 . . . . 0.55 109.801 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.86 -39.82 95.1 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.571 0.701 . . . . 0.47 110.687 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -85.31 6.91 24.24 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.074 0.768 . . . . 1.42 113.074 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -69.28 118.1 11.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.697 -1.252 . . . . 1.27 109.074 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.35 -16.9 64.07 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.627 0.727 . . . . 1.35 110.901 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.36 -46.33 41.25 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.358 -0.937 . . . . 2.22 109.966 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -66.2 -38.52 88.19 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.664 -0.815 . . . . 0.62 110.273 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -58.8 -46.1 88.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.5 -0.75 . . . . 1.29 110.903 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -62.73 -37.84 88.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.909 . . . . 1.52 110.545 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.51 -48.65 66.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.013 -1.055 . . . . 1.3 110.653 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.8 mt -57.5 -43.05 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.218 -0.926 . . . . 0.61 110.402 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.9 mt -60.62 -43.31 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.737 -0.602 . . . . 0.78 110.389 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.45 -42.69 99.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.326 -0.859 . . . . 0.82 110.67 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.57 -42.5 98.93 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.16 -0.963 . . . . 0.8 110.537 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.43 -44.62 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 0.77 110.537 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -84.41 -35.16 23.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.398 -0.814 . . . . 2.12 111.713 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 91' ' ' ALA . 51.4 t0 -80.97 -45.39 16.73 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.134 -0.979 . . . . 1.51 111.79 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -101.03 9.55 42.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.245 -0.909 . . . . 1.98 112.45 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.5 m80 49.79 51.67 16.09 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.27 -0.894 . . . . 1.32 112.023 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 85.4 mtp -104.11 154.76 19.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.0 -0.741 . . . . 1.38 109.0 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.412 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 46.4 p -72.6 160.39 32.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.67 110.208 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.46 91.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.52 110.81 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 23.5 p-10 -69.86 -43.64 71.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.9 -1.125 . . . . 2.25 110.427 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.4 -47.6 72.76 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.498 -0.881 . . . . 0.64 111.172 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.12 91.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.359 -0.838 . . . . 0.56 110.075 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.74 96.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.556 -0.715 . . . . 0.46 110.482 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -61.49 -37.72 84.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.191 -0.943 . . . . 1.32 110.892 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -56.92 -49.77 74.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.79 . . . . 1.3 110.788 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.8 t -60.28 -44.48 95.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.922 -1.111 . . . . 0.61 110.33 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.14 -34.53 60.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.562 -0.711 . . . . 0.65 110.37 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -58.5 -40.28 82.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.979 -1.076 . . . . 2.11 110.875 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.87 -34.42 13.23 Favored Glycine 0 N--CA 1.498 2.775 0 C-N-CA 119.236 -1.459 . . . . 0.83 112.174 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -62.2 -41.25 98.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.711 -1.464 . . . . 1.28 109.879 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.94 -51.39 22.3 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.529 -0.732 . . . . 0.89 110.547 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.9 m -60.55 -37.51 81.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 1.87 110.76 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.25 97.67 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.552 -0.718 . . . . 1.05 110.523 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.85 -29.81 70.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.908 -1.12 . . . . 1.02 111.156 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -65.94 -21.02 66.4 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.286 -0.884 . . . . 2.04 111.121 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -71.94 -15.01 62.07 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.167 -0.958 . . . . 1.73 111.012 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 123' ' ' LEU . 55.1 mt -84.6 147.16 27.14 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.193 -0.669 . . . . 1.37 109.193 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 6.6 t0 -100.66 38.41 1.53 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.132 -0.98 . . . . 2.88 112.083 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -113.03 140.08 48.13 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.173 -0.954 . . . . 1.58 108.75 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 27.8 mp0 -58.28 -39.37 79.1 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.358 -0.839 . . . . 3.04 110.92 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -71.82 -52.51 17.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.534 -1.354 . . . . 0.9 110.631 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 118' ' ' LEU . 18.9 mt -60.94 -41.7 96.76 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 1.06 110.658 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -63.42 -49.64 72.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.818 -1.176 . . . . 2.18 109.582 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.82 -30.26 69.98 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.328 -0.949 . . . . 2.15 109.446 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.588 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -61.09 -30.1 70.15 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.924 0.868 . . . . 2.33 108.732 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.44 -50.41 72.9 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.78 0.8 . . . . 0.82 109.432 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.01 -43.89 81.74 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.714 0.769 . . . . 0.85 110.093 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -63.72 -34.0 76.9 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.475 0.655 . . . . 1.39 110.255 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 126' ' ' ARG . 21.1 t -69.01 -41.75 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.56 109.91 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -58.51 -37.34 75.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.886 -1.133 . . . . 3.12 109.584 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -58.79 -39.81 82.19 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.418 0.628 . . . . 1.28 110.464 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.19 -40.11 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.994 -1.066 . . . . 0.49 109.778 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.85 -47.56 89.42 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.343 -1.103 . . . . 0.46 110.343 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -58.27 -40.58 82.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -1.14 . . . . 2.71 110.26 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -64.88 -43.66 92.19 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.403 -0.919 . . . . 2.14 109.359 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.0 tp -59.66 -43.58 93.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.571 -0.705 . . . . 1.05 109.64 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 20.7 mt -60.09 -38.66 83.61 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.322 -0.861 . . . . 0.52 110.576 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -39.84 84.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.063 . . . . 2.35 110.776 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -75.77 -40.64 54.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.794 . . . . 1.39 110.536 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.17 -40.36 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.68 109.572 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.45 -8.96 49.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.393 -0.817 . . . . 0.83 112.224 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.04 18.62 76.42 Favored Glycine 0 N--CA 1.482 1.713 0 C-N-CA 119.689 -1.243 . . . . 0.91 112.617 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.73 144.43 57.25 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.594 -0.945 . . . . 0.95 109.08 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -66.35 149.86 49.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.75 . . . . 2.43 109.818 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.44 145.88 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.678 -0.86 . . . . 1.1 108.678 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.1 mm -76.93 118.84 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.942 -1.099 . . . . 1.58 108.555 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -97.8 98.12 9.56 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.487 -1.672 . . . . 1.62 106.487 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.5 mt -77.13 -17.6 58.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.324 -0.86 . . . . 0.8 111.726 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -80.31 1.11 30.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 1.56 112.476 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.75 28.31 4.81 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.364 -0.835 . . . . 0.84 112.284 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 7.9 mt -73.49 140.08 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.82 109.745 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -111.45 -21.67 11.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.605 0.717 . . . . 2.31 112.231 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -118.14 139.96 50.49 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.369 -0.975 . . . . 1.54 108.369 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.46 125.97 28.44 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.361 -0.977 . . . . 1.38 108.361 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.441 HG12 ' HZ3' ' A' ' 15' ' ' LYS . 30.0 m -146.07 173.94 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 0.69 109.258 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.4 mt -87.96 145.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.683 -0.858 . . . . 0.53 108.683 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.7 tp -95.44 123.81 39.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.916 -1.115 . . . . 0.64 108.736 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.6 t -125.04 128.69 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.279 -1.378 . . . . 0.67 107.279 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.67 154.84 18.7 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.941 -1.1 . . . . 0.78 108.537 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.08 81.93 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.409 -1.432 . . . . 1.0 109.375 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.1 t0 -171.01 153.42 3.8 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.511 -0.922 . . . . 2.42 108.511 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 34.8 mt -114.69 144.59 43.21 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.298 -0.876 . . . . 0.75 109.343 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.9 p -91.03 149.62 40.35 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.741 -1.224 . . . . 0.78 108.826 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.58 -43.27 14.33 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.469 1.446 . . . . 0.67 113.527 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.7 m -61.88 -45.76 92.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.926 -1.109 . . . . 0.7 110.132 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.88 -41.66 97.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.472 -0.768 . . . . 1.21 110.385 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.7 p -67.22 -38.41 85.21 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.453 0.644 . . . . 0.6 110.48 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.95 -37.25 86.3 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.467 -0.771 . . . . 0.62 110.606 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -93.73 -1.97 54.42 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.122 -0.986 . . . . 1.16 112.683 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.55 149.62 34.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.621 -0.881 . . . . 0.73 108.621 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -94.86 109.81 21.76 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.772 -1.566 . . . . 2.24 106.772 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.39 -22.01 64.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.93 -0.481 . . . . 1.43 111.745 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -83.72 -17.34 41.63 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.299 -0.876 . . . . 2.15 112.797 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -101.19 -5.65 25.3 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.196 -0.94 . . . . 2.04 113.229 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.643 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.1 t -108.3 129.99 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.92 -1.141 . . . . 0.55 107.92 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.5 tp -86.28 -3.78 59.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.146 -0.971 . . . . 1.63 111.964 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.643 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.27 166.61 28.59 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.947 -1.661 . . . . 0.47 108.947 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.73 130.01 53.13 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.748 -1.204 . . . . 0.54 107.748 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.413 HG22 HG21 ' A' ' 205' ' ' THR . 92.0 mt -131.07 124.84 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.305 -1.739 . . . . 0.69 106.305 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 205' ' ' THR . 41.7 p -140.92 170.66 15.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.786 -1.196 . . . . 0.82 110.595 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 48.8 t0 -108.38 66.73 0.65 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.743 -0.662 . . . . 2.37 109.375 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.025 0 O-C-N 121.363 -0.835 . . . . 1.11 109.045 179.793 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.7 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 107.46 -1.311 . . . . 1.69 107.46 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -62.7 -36.34 82.65 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.411 -0.806 . . . . 1.07 109.604 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 59.0 m -58.65 -38.94 79.21 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.571 -0.706 . . . . 1.58 110.144 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 64.7 p -58.24 -37.98 75.98 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.196 -0.94 . . . . 1.6 109.73 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.8 mm -60.15 -40.0 82.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.479 -0.763 . . . . 1.45 110.287 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 64.5 mtp -63.82 -42.37 97.67 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.084 -1.01 . . . . 1.05 109.578 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.47 -48.45 81.59 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.574 -0.739 . . . . 0.72 110.92 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 195' ' ' ARG . 36.9 mtt-85 -61.89 -44.11 97.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 3.05 110.608 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.0 m -68.62 -40.81 80.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.89 110.165 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.38 -8.53 47.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.456 -0.778 . . . . 0.78 112.526 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.0 mt-10 55.25 13.79 0.93 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.067 1.136 . . . . 1.45 114.067 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 50.2 mt -71.09 164.46 56.63 Favored Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 108.497 -0.927 . . . . 0.67 108.497 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.87 140.46 38.54 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 121.598 1.532 . . . . 0.64 110.468 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.08 168.34 24.57 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.019 -1.675 . . . . 0.67 109.998 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.5 mt -147.7 152.55 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.866 -1.161 . . . . 0.69 107.866 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.6 m -135.12 -27.63 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 120.968 -1.082 . . . . 0.85 111.409 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.22 46.54 3.22 Favored Glycine 0 N--CA 1.489 2.207 0 O-C-N 120.944 -1.098 . . . . 0.92 111.75 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 181' ' ' THR . 69.3 p -62.9 -16.42 58.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.359 -1.083 . . . . 0.95 111.702 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.459 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 76.03 -94.9 1.02 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.948 -1.261 . . . . 1.04 109.948 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.2 m -129.97 27.6 5.14 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.478 -1.013 . . . . 1.57 112.38 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.2 t -57.96 -40.23 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.536 -1.353 . . . . 0.84 110.536 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.1 p -58.68 -18.88 34.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.923 -1.111 . . . . 0.99 111.77 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.8 t -94.96 -0.59 53.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.412 -0.805 . . . . 1.7 112.227 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -129.86 0.44 4.82 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.698 0.629 . . . . 2.2 112.698 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t -120.09 150.54 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.934 0.873 . . . . 0.84 109.806 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.67 154.74 36.43 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.222 -1.029 . . . . 2.2 108.222 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.9 p-10 -51.38 145.6 8.21 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.103 -0.998 . . . . 2.28 110.172 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.9 t0 81.73 -7.0 1.45 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.264 1.209 . . . . 2.35 114.264 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 19.7 t0 -60.47 145.24 49.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.773 -1.205 . . . . 1.97 108.478 177.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.438 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 14.2 t80 -88.32 123.07 32.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.939 -1.134 . . . . 2.65 107.939 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.488 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 49.6 mt -128.26 149.86 50.3 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.553 -0.717 . . . . 0.63 109.607 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.13 123.0 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.309 -1.737 . . . . 0.62 106.309 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.0 tp -100.86 112.79 25.29 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.927 -1.879 . . . . 0.64 105.927 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 223' ' ' VAL . 41.6 p30 -93.35 -22.85 18.7 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.881 -1.137 . . . . 2.05 112.314 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.91 16.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.996 0.739 . . . . 0.84 112.996 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.598 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.1 t -106.94 -57.75 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.057 -1.027 . . . . 1.02 109.359 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -93.62 9.08 38.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.421 1.105 . . . . 2.51 110.41 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 60.7 t30 61.78 52.56 3.45 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.89 -1.05 . . . . 1.54 112.177 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.443 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 89.6 mt-30 -146.79 150.16 34.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.357 1.075 . . . . 1.95 109.827 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -115.63 139.86 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.864 -1.161 . . . . 0.71 107.864 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -104.21 131.67 51.27 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 108.145 -1.057 . . . . 1.01 108.145 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.1 t -110.31 130.38 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.898 -0.778 . . . . 0.82 108.898 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.458 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 8.9 t-20 53.95 48.12 4.47 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 113.393 0.886 . . . . 1.54 113.393 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 56.2 Cg_endo -68.99 148.51 70.24 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.128 1.886 . . . . 0.94 111.216 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 43.2 p -74.61 162.84 28.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.807 -1.183 . . . . 1.8 110.172 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -59.8 -36.78 77.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 2.73 110.66 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -59.9 -39.42 85.32 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.28 -0.888 . . . . 3.17 110.952 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 87.4 t -70.02 -38.46 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 1.34 110.075 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.518 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 96.1 mt -59.69 -47.5 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.552 -0.717 . . . . 1.2 110.377 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -60.01 -39.64 86.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 2.7 110.792 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -63.06 -45.99 89.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.363 -0.836 . . . . 2.59 110.74 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 72.7 mtp -70.99 -35.69 72.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 1.38 110.647 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.552 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.899 . . . . 2.84 110.377 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.4 mt . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.237 0.542 . . . . 1.07 112.116 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -96.39 111.98 23.88 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.829 -1.545 . . . . 1.24 106.829 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.92 -154.13 29.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.66 -1.376 . . . . 1.01 109.66 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 5' ' ' ILE . 82.2 mt -95.03 -0.62 10.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.321 -1.105 . . . . 1.11 112.273 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 49.63 100.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.939 -1.101 . . . . 0.99 112.511 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.18 -42.19 12.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.144 -0.972 . . . . 0.85 111.983 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 m -145.0 142.78 18.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.875 -1.141 . . . . 1.38 108.007 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.53 148.48 26.25 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.198 1.932 . . . . 0.94 112.357 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.935 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.38 173.22 21.04 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.053 -1.619 . . . . 0.81 109.053 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.0 mt -129.52 137.07 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -1.222 . . . . 0.83 108.272 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.95 154.65 46.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 0.53 109.173 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.0 m-85 -121.03 140.46 51.9 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.437 -0.949 . . . . 0.77 108.437 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.45 162.56 28.33 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.311 -1.9 . . . . 0.51 110.32 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -78.45 158.77 28.57 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.527 -0.916 . . . . 1.9 108.527 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.72 127.45 34.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.003 -1.061 . . . . 0.66 108.539 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.1 tp -103.77 103.5 13.4 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 104.976 -2.231 . . . . 0.83 104.976 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.1 tp -91.46 129.9 37.38 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.335 -1.357 . . . . 0.86 107.335 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.07 119.88 39.39 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.443 -1.317 . . . . 0.92 107.443 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -110.17 132.34 54.26 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.503 -1.295 . . . . 2.03 107.503 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -128.96 155.24 45.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.336 -0.852 . . . . 2.66 109.529 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -85.15 137.76 32.82 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.816 -1.179 . . . . 2.32 107.816 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.2 149.71 49.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.033 -1.042 . . . . 2.11 108.991 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -92.42 128.88 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.293 -1.003 . . . . 0.73 108.293 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.75 130.42 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.941 -1.133 . . . . 0.87 107.941 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.9 mt -96.45 139.35 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.545 -0.909 . . . . 0.81 108.545 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.25 120.6 32.3 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.298 -1.371 . . . . 1.34 107.298 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -96.3 16.84 17.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.811 . . . . 2.89 112.485 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -67.74 143.67 55.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.862 -1.149 . . . . 2.09 108.88 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -88.87 132.28 34.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.134 -1.062 . . . . 2.19 108.134 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.1 pt -98.97 167.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.399 -0.813 . . . . 0.75 110.342 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.9 p -93.1 162.44 14.03 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.641 0.734 . . . . 0.91 109.766 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.87 -17.31 6.1 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.111 -0.993 . . . . 0.93 112.722 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -69.89 -32.65 71.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.012 . . . . 2.28 111.094 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -86.27 0.95 52.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.989 -1.069 . . . . 1.45 112.431 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 t -56.27 -44.6 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.466 -0.771 . . . . 0.81 110.46 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -58.08 -40.77 81.9 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.205 -0.935 . . . . 1.54 110.327 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -64.14 -45.0 90.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.653 -0.655 . . . . 2.36 111.604 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.7 -42.8 99.43 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.812 -1.18 . . . . 1.31 111.068 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.27 -41.88 88.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.162 -0.961 . . . . 0.82 110.228 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -63.13 -45.88 89.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.042 -1.036 . . . . 1.5 110.119 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.405 HH11 ' HG2' ' A' ' 42' ' ' ARG . 54.4 mtt-85 -61.92 -42.3 98.92 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.456 -0.897 . . . . 2.23 109.957 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -71.45 -52.86 16.15 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.4 -0.92 . . . . 0.85 110.165 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.44 -49.28 78.21 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.241 -0.984 . . . . 0.91 110.647 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.1 t -69.97 -45.1 68.09 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.552 0.692 . . . . 0.9 110.346 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.98 -45.71 86.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.295 -1.522 . . . . 0.69 109.295 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -57.37 -31.44 65.78 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.855 0.836 . . . . 2.88 109.775 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.11 -42.57 86.02 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.542 0.687 . . . . 0.85 110.097 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -75.82 -38.61 57.97 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.268 -0.895 . . . . 2.35 110.067 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.76 -38.69 82.51 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.148 -0.97 . . . . 0.65 109.946 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 t -61.02 -38.88 87.64 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.897 0.856 . . . . 1.45 109.422 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.64 -47.57 75.13 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.959 -0.564 . . . . 0.63 110.289 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.9 -49.76 74.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.878 -1.139 . . . . 1.34 110.208 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.66 -39.32 90.96 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.258 -0.901 . . . . 1.56 110.016 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -59.66 -41.26 90.21 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.218 -0.593 . . . . 1.19 110.311 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.9 m -67.05 -44.21 80.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.225 -0.922 . . . . 0.72 110.297 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -59.8 -34.82 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.652 -0.655 . . . . 0.62 110.873 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -51.57 -44.64 62.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.92 -1.112 . . . . 1.05 110.713 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -68.97 -34.63 75.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.042 -1.036 . . . . 0.64 110.124 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -63.76 -39.74 95.01 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.812 -1.155 . . . . 1.73 109.241 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.83 -31.12 72.2 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.163 -0.615 . . . . 0.56 109.88 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.1 -36.27 13.4 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.784 -1.198 . . . . 0.69 110.81 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.31 -24.26 42.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.945 -1.327 . . . . 1.48 110.242 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.8 m -84.55 -51.14 7.1 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.339 -0.85 . . . . 0.98 110.995 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -106.68 -19.93 13.51 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.102 -0.998 . . . . 1.16 113.286 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.61 165.55 14.05 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 121.277 -0.889 . . . . 0.85 112.211 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -53.74 -24.03 13.65 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 112.583 0.586 . . . . 3.86 112.583 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.86 -36.74 70.4 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.017 -1.052 . . . . 2.35 111.653 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -84.92 -15.35 44.77 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.301 -1.499 . . . . 1.67 112.913 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.88 -35.62 77.1 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.047 -1.033 . . . . 1.45 110.811 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.51 -39.24 87.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.357 -0.839 . . . . 0.61 111.222 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 72' ' ' ILE . 14.9 mt -66.6 -48.96 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.971 -1.081 . . . . 0.65 110.564 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -69.91 -30.37 67.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.451 -0.781 . . . . 0.66 110.411 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.86 -38.23 87.48 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.604 -0.839 . . . . 1.19 109.823 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.21 -38.66 92.08 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 110.592 -1.003 . . . . 0.53 110.592 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -60.13 -40.39 89.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 1.27 110.797 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.85 -44.74 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.93 -1.106 . . . . 0.54 110.118 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.4 ttp -60.08 -38.16 82.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -0.891 . . . . 1.74 110.11 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 tp -60.31 -49.94 75.6 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.362 -0.836 . . . . 0.55 110.686 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.38 -40.08 89.58 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.923 -0.711 . . . . 0.47 110.333 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -86.21 5.47 34.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.373 -0.829 . . . . 1.42 112.386 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.18 119.7 11.34 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.856 -1.152 . . . . 1.27 108.924 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.03 -15.65 63.22 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.645 0.736 . . . . 1.35 110.977 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -71.68 -49.55 38.69 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.018 -1.073 . . . . 2.22 110.037 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.84 -38.62 88.9 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.169 -1.012 . . . . 0.62 110.097 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.7 -46.18 89.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 1.29 110.777 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -60.05 -39.54 86.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.082 -1.011 . . . . 1.52 110.578 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -65.63 -47.9 74.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.954 -1.092 . . . . 1.3 110.19 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.2 mt -57.9 -43.06 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.558 -0.714 . . . . 0.61 110.158 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.68 -40.89 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.162 0.506 . . . . 0.78 110.547 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.72 -40.59 88.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.82 110.387 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.52 -45.5 90.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.8 110.097 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.0 mt -62.57 -43.42 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.365 -0.834 . . . . 0.77 110.193 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -82.64 -38.4 23.57 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.37 -0.831 . . . . 2.12 111.932 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 91' ' ' ALA . 49.4 t0 -80.83 -43.28 20.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.909 -1.119 . . . . 1.51 111.882 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.55 8.1 35.35 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.374 -0.829 . . . . 1.98 112.777 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.0 m170 52.46 51.43 16.18 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.868 -1.145 . . . . 1.32 111.58 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.2 mtt -105.12 152.17 23.12 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.37 -0.831 . . . . 1.38 109.265 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.4 p -71.3 161.68 30.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.374 -0.829 . . . . 0.67 110.121 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.18 88.92 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.241 -0.912 . . . . 0.52 110.254 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.557 ' OD2' HD21 ' A' ' 142' ' ' LEU . 89.8 m-20 -68.08 -41.1 82.39 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.212 -0.93 . . . . 2.25 110.34 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.66 -49.83 49.91 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.158 -0.964 . . . . 0.64 111.21 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.38 92.22 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.383 -0.823 . . . . 0.56 110.407 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.77 95.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.65 -0.656 . . . . 0.46 110.894 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -61.49 -40.05 93.16 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.396 -0.815 . . . . 1.32 110.835 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -57.84 -49.57 76.24 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.669 -1.27 . . . . 1.3 111.347 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.7 t -61.11 -44.82 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.95 -1.094 . . . . 0.61 110.161 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 mm -62.78 -33.52 60.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.765 0.793 . . . . 0.65 109.958 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -55.46 -40.89 72.18 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.519 -0.738 . . . . 2.11 110.87 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.29 -32.49 16.59 Favored Glycine 0 N--CA 1.498 2.825 0 C-N-CA 118.98 -1.581 . . . . 0.83 112.571 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -60.34 -41.59 93.92 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.302 -1.705 . . . . 1.28 110.204 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.92 -51.62 17.82 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.328 -0.857 . . . . 0.89 110.966 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.8 p -62.41 -39.4 93.13 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.265 -0.897 . . . . 1.87 110.709 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.72 96.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.404 -0.81 . . . . 1.05 110.913 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 43.8 mt -65.29 -30.89 71.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.891 -1.131 . . . . 1.02 110.5 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.14 -22.33 66.37 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.928 -1.108 . . . . 2.04 111.205 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -71.34 -12.47 61.45 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.765 0.793 . . . . 1.73 110.956 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.85 146.06 27.5 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.874 -0.787 . . . . 1.37 108.874 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -100.3 35.36 2.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.15 -0.969 . . . . 2.88 112.112 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -112.58 139.59 48.04 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 108.269 -1.011 . . . . 1.58 108.269 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.01 -37.64 80.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.429 -0.794 . . . . 3.04 110.772 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -73.22 -49.0 30.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.794 -1.191 . . . . 0.9 110.215 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.2 mt -63.2 -40.67 98.14 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.616 -1.234 . . . . 1.06 109.738 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -60.96 -47.63 85.55 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.788 -1.195 . . . . 2.18 110.097 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.27 -31.4 70.19 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.759 -0.777 . . . . 2.15 109.556 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.512 ' HG2' HH11 ' A' ' 126' ' ' ARG . 9.2 ttt-85 -62.14 -29.67 70.5 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.008 0.908 . . . . 2.33 108.975 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.63 -49.83 75.93 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.054 0.93 . . . . 0.82 109.592 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -41.41 78.83 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.59 0.71 . . . . 0.85 110.415 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.87 -38.49 91.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.559 -0.713 . . . . 1.39 110.25 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 126' ' ' ARG . 46.4 t -69.6 -39.77 78.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.522 -0.736 . . . . 0.56 110.648 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -58.68 -39.77 81.64 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.3 -1.36 . . . . 3.12 110.029 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -59.67 -39.75 85.5 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.166 0.508 . . . . 1.28 110.823 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.99 -39.18 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.336 -0.852 . . . . 0.49 110.625 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -64.71 -44.26 95.12 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.791 -1.195 . . . . 0.46 110.909 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -58.14 -40.61 81.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.271 . . . . 2.71 110.575 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.401 HH21 ' HB2' ' A' ' 166' ' ' SER . 63.0 mtt-85 -61.36 -42.68 99.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.312 -0.867 . . . . 2.14 110.111 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 31.3 tp -60.29 -43.33 96.35 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.439 -0.904 . . . . 1.05 109.506 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.25 -45.92 91.6 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.46 0.648 . . . . 0.52 110.197 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -60.98 -34.86 75.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.461 -0.774 . . . . 2.35 111.08 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -75.81 -41.73 51.92 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.074 -1.016 . . . . 1.39 110.978 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.514 HG21 ' OD1' ' A' ' 101' ' ' ASP . 95.2 mt -62.46 -39.02 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.789 -1.194 . . . . 0.68 110.594 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.557 HD21 ' OD2' ' A' ' 101' ' ' ASP . 61.5 mt -84.64 -8.95 58.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.339 -0.851 . . . . 0.83 111.65 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.55 25.62 67.39 Favored Glycine 0 N--CA 1.479 1.557 0 C-N-CA 119.772 -1.204 . . . . 0.91 113.237 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.74 142.04 58.57 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.727 -0.866 . . . . 0.95 109.33 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -67.94 147.74 52.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 2.43 108.907 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 72.9 mt -107.03 138.13 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.219 -1.03 . . . . 1.1 108.219 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 18.2 mm -78.76 133.98 28.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.25 -0.906 . . . . 1.58 108.862 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -94.51 94.74 8.39 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.657 -1.608 . . . . 1.62 106.657 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 67.1 mt -73.53 -24.35 60.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.574 -0.704 . . . . 0.8 110.865 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.9 m -81.48 7.17 12.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.406 -0.809 . . . . 1.56 112.304 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.42 18.05 17.45 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.792 . . . . 0.84 112.151 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.5 mt -74.73 140.23 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.82 109.807 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -118.97 -12.34 9.56 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.946 0.879 . . . . 2.31 112.427 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -112.7 147.74 36.18 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.728 -0.841 . . . . 1.54 108.728 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -78.27 124.13 27.73 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.188 -1.041 . . . . 1.38 108.188 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.8 m -147.64 172.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.55 -0.719 . . . . 0.69 109.3 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.6 mt -90.74 146.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.535 -0.913 . . . . 0.53 108.535 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.2 tp -95.9 123.79 39.64 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.093 0.949 . . . . 0.64 108.788 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.5 t -124.64 129.96 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.892 -1.151 . . . . 0.67 107.892 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.99 152.87 19.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.006 -1.059 . . . . 0.78 108.835 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.92 -33.76 73.64 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.561 -1.337 . . . . 1.0 109.476 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -171.8 144.74 1.83 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.301 -0.629 . . . . 2.42 109.301 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 75.8 mt -118.39 135.94 54.04 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.057 -1.09 . . . . 0.75 108.057 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.0 p -92.9 150.09 38.81 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.931 -1.105 . . . . 0.78 108.529 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -39.18 -45.37 2.87 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 122.252 1.968 . . . . 0.67 113.781 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.401 ' HB2' HH21 ' A' ' 136' ' ' ARG . 61.2 m -58.46 -47.56 83.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.7 110.409 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.18 -38.4 90.9 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.076 -1.015 . . . . 1.21 110.515 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.3 p -69.3 -39.64 78.17 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.545 -0.722 . . . . 0.6 110.5 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.83 -37.58 79.63 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.262 -0.575 . . . . 0.62 110.66 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -91.42 -0.16 57.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.05 -1.031 . . . . 1.16 112.271 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.6 tp -63.88 150.33 45.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.751 -0.593 . . . . 0.73 109.787 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -95.16 113.79 25.52 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.22 -1.4 . . . . 2.24 107.22 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 36.7 mt -71.79 -17.96 62.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.696 -0.627 . . . . 1.43 111.778 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.91 -21.31 31.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 2.15 112.381 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -101.32 -4.99 26.03 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.907 -1.12 . . . . 2.04 113.436 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.7 t -114.2 128.91 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 107.533 -1.284 . . . . 0.55 107.533 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.2 tp -93.69 -4.89 49.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.507 -0.745 . . . . 1.63 112.609 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.41 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -175.49 170.04 42.95 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.021 -1.632 . . . . 0.47 109.021 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -128.11 128.88 45.68 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.484 -1.302 . . . . 0.54 107.484 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 79.3 mt -131.68 125.13 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 106.413 -1.699 . . . . 0.69 106.413 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 205' ' ' THR . 20.6 p -140.63 172.05 13.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.86 -1.15 . . . . 0.82 110.213 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -98.1 39.33 1.24 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.378 0.608 . . . . 2.37 111.497 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.033 0 O-C-N 121.192 -0.942 . . . . 1.11 109.676 179.596 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 83.6 p . . . . . 0 N--CA 1.492 1.675 0 N-CA-C 107.739 -1.208 . . . . 1.69 107.739 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -60.46 -31.43 70.44 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.07 -1.019 . . . . 1.07 110.608 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.3 p -57.21 -40.61 77.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 1.58 110.391 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.6 t -60.18 -37.25 79.62 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.123 -0.986 . . . . 1.6 109.948 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.4 mt -59.51 -40.13 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.287 -0.965 . . . . 1.45 110.497 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 38.5 mtp -64.56 -44.83 89.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.932 -1.105 . . . . 1.05 109.244 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.17 -44.7 94.83 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.554 -0.748 . . . . 0.72 111.212 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -61.23 -45.07 96.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.778 -1.202 . . . . 3.05 110.664 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.8 m -69.87 -38.98 76.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.036 -1.04 . . . . 0.89 110.766 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -91.75 -8.15 47.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.554 -0.716 . . . . 0.78 112.66 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.8 mt-10 54.14 9.31 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.937 1.088 . . . . 1.45 113.937 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.3 mt -70.08 150.19 96.18 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.621 -0.881 . . . . 0.67 108.621 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.8 144.06 94.27 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 121.146 1.231 . . . . 0.64 109.491 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.79 159.78 35.53 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.175 -1.41 . . . . 0.67 110.214 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.5 mt -147.46 150.2 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.071 -1.085 . . . . 0.69 108.071 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.0 m -135.02 -25.72 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.932 -1.105 . . . . 0.85 111.724 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.22 33.35 2.23 Favored Glycine 0 N--CA 1.488 2.151 0 O-C-N 121.022 -1.049 . . . . 0.92 113.306 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 181' ' ' THR . 2.7 p -60.63 -28.31 68.46 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.95 -1.323 . . . . 0.95 111.037 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.04 -90.67 1.3 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.96 -1.114 . . . . 1.04 110.621 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 27.8 m -123.5 27.13 7.55 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.147 -1.208 . . . . 1.57 112.984 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 68.2 t -57.41 -34.47 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.172 -1.58 . . . . 0.84 110.144 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.2 p -57.61 -23.46 51.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 0.99 111.964 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.2 p -92.88 2.77 56.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.968 -1.082 . . . . 1.7 111.928 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -128.32 1.88 5.71 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.808 0.67 . . . . 2.2 112.808 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.75 151.26 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 109.112 -0.699 . . . . 0.84 109.112 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -120.97 150.13 41.58 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.857 -0.794 . . . . 2.2 108.857 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 42.1 p-10 -52.16 143.59 14.06 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.008 -1.077 . . . . 2.28 110.278 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.4 m-20 78.3 -1.17 2.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.525 1.305 . . . . 2.35 114.525 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.53 144.03 52.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.861 -1.149 . . . . 1.97 108.307 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -89.31 112.96 24.16 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.331 -1.359 . . . . 2.65 107.331 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.493 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 48.7 mt -124.22 143.44 50.52 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.322 0.582 . . . . 0.63 109.645 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.3 mt -109.81 126.76 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 106.58 -1.637 . . . . 0.62 106.58 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 52.3 tp -100.64 119.4 38.51 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.118 -1.808 . . . . 0.64 106.118 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 223' ' ' VAL . 36.9 p-10 -93.67 -20.93 19.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.081 -1.012 . . . . 2.05 112.682 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.935 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.73 13.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.477 0.547 . . . . 0.84 112.477 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.624 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.1 t -109.89 -58.75 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.273 -0.892 . . . . 1.02 109.521 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -91.63 8.33 37.27 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.541 1.163 . . . . 2.51 110.852 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.0 t30 60.87 49.31 6.09 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.108 -0.951 . . . . 1.54 111.786 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -148.45 154.58 40.06 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.226 1.012 . . . . 1.95 109.746 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.4 t -116.45 141.04 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.576 -0.738 . . . . 0.71 109.181 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -101.16 134.94 43.43 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.327 -0.99 . . . . 1.01 108.327 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.28 130.77 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.614 -0.884 . . . . 0.82 108.614 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 51.23 58.31 16.6 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.31 -0.869 . . . . 1.54 112.867 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.93 150.19 60.65 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.387 2.058 . . . . 0.94 110.626 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.7 p -76.23 158.59 31.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.105 -0.997 . . . . 1.8 109.608 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -60.79 -39.35 88.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 2.73 110.993 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.39 -41.47 80.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.067 -1.021 . . . . 3.17 110.696 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.05 -39.31 77.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.806 -1.184 . . . . 1.34 110.075 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 71.0 mt -60.03 -49.45 83.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.387 -0.821 . . . . 1.2 110.883 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.92 -41.53 91.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.097 -1.002 . . . . 2.7 110.543 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -64.41 -44.35 91.52 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.717 -0.793 . . . . 2.59 110.285 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 84.6 mtp -72.4 -37.05 68.78 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.301 -0.874 . . . . 1.38 110.743 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.9 mmm-85 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 120.827 -1.17 . . . . 2.84 110.472 179.817 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 79.2 mt . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 107.219 -1.4 . . . . 1.07 107.219 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 m -106.01 119.91 40.41 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.202 -1.407 . . . . 1.24 107.202 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.97 -153.85 24.45 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.414 -1.874 . . . . 1.01 108.414 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.9 mt -97.64 0.98 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -1.168 . . . . 1.11 112.38 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 49.89 93.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.985 -1.072 . . . . 0.99 111.985 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -89.38 -30.93 18.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.85 111.663 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -150.8 138.25 12.0 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.216 -0.927 . . . . 1.38 108.54 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.18 145.0 21.38 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.341 2.027 . . . . 0.94 112.533 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.911 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.42 177.92 25.69 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 109.084 -1.606 . . . . 0.81 109.084 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.5 mt -132.0 138.66 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.058 -1.26 . . . . 0.83 108.238 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HB1' ' CD2' ' A' ' 177' ' ' LEU . . . -140.37 155.5 46.74 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.233 -0.917 . . . . 0.53 109.09 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.537 ' CD2' ' NH1' ' A' ' 240' ' ' ARG . 25.4 m-85 -129.08 141.26 51.26 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.521 -0.918 . . . . 0.77 108.521 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.81 168.42 34.78 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 118.27 -1.919 . . . . 0.51 110.198 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -77.01 160.3 29.23 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.901 . . . . 1.9 109.846 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.84 121.49 26.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.691 -1.225 . . . . 0.66 107.691 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.4 tp -100.14 98.51 9.21 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.069 -1.826 . . . . 0.83 106.069 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 tp -90.74 134.71 34.22 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.662 -1.236 . . . . 0.86 107.662 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.0 mt -99.77 111.1 23.45 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.752 -1.573 . . . . 0.92 106.752 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -104.31 127.54 51.97 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.989 -1.486 . . . . 2.03 106.989 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.474 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 81.6 tt0 -129.41 144.21 51.15 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.941 -0.762 . . . . 2.66 108.941 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -80.89 136.01 36.0 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.823 -1.177 . . . . 2.32 107.823 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -65.81 149.83 49.54 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.516 -0.74 . . . . 2.11 109.264 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -92.21 130.87 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.843 -1.169 . . . . 0.73 107.843 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.65 129.81 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.153 -1.055 . . . . 0.87 108.153 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.2 mt -95.53 139.74 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.424 -0.798 . . . . 0.81 108.927 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -87.58 123.62 32.65 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.125 -1.065 . . . . 1.34 108.125 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -94.74 14.67 20.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.656 -0.652 . . . . 2.89 112.38 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -77.55 140.58 39.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.281 -0.887 . . . . 2.09 109.275 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -84.69 140.27 31.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.103 -0.998 . . . . 2.19 109.744 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -95.75 175.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.75 109.776 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -98.09 164.33 12.38 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.887 -0.597 . . . . 0.91 109.544 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.14 -23.41 21.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.268 -0.895 . . . . 0.93 112.029 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -68.88 -40.05 79.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.812 -1.18 . . . . 2.28 110.946 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -86.39 -6.2 58.99 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.289 -1.507 . . . . 1.45 112.189 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.19 -41.81 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.968 -1.083 . . . . 0.81 110.456 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -58.24 -39.42 79.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.003 -1.061 . . . . 1.54 110.936 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.2 -39.87 95.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.02 . . . . 2.36 110.967 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -58.96 -40.33 84.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.875 . . . . 1.31 110.724 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.25 -41.71 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.82 110.127 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.57 -44.58 93.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 1.5 109.58 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -62.43 -40.45 96.61 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.401 -0.92 . . . . 2.23 109.925 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.39 -52.84 12.37 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.801 0.81 . . . . 0.85 109.871 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.07 -48.84 80.06 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.255 -0.903 . . . . 0.91 109.96 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.2 t -68.21 -41.05 81.88 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.659 0.743 . . . . 0.9 109.831 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.95 -42.08 85.82 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.34 -1.504 . . . . 0.69 109.34 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.404 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 51.7 ttt180 -58.38 -32.77 68.91 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.689 0.756 . . . . 2.88 109.772 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.61 -50.21 72.66 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.375 0.607 . . . . 0.85 110.819 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -78.05 -38.64 43.99 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.306 -0.872 . . . . 2.35 110.44 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.16 87.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.395 -0.816 . . . . 0.65 110.209 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.5 m -60.45 -40.14 90.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.869 0.843 . . . . 1.45 109.497 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.41 78.1 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.15 -0.62 . . . . 0.63 110.072 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.16 -50.58 72.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 1.34 110.577 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.83 -39.17 93.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.019 . . . . 1.56 110.105 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -59.86 -40.93 90.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.807 -0.558 . . . . 1.19 110.958 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.8 m -64.27 -45.31 88.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.822 -1.174 . . . . 0.72 110.356 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.12 -34.64 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 0.62 110.984 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -52.97 -45.76 67.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.26 -0.9 . . . . 1.05 111.084 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.14 -37.71 81.36 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.148 -0.97 . . . . 0.64 110.182 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -61.35 -39.81 91.95 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.577 -1.249 . . . . 1.73 109.617 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.98 -32.3 73.45 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.625 -0.672 . . . . 0.56 110.558 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.04 -34.58 14.43 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.832 -1.175 . . . . 0.69 111.405 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -81.85 -25.75 34.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.567 -1.549 . . . . 1.48 111.373 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.4 m -86.69 -49.99 7.1 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.408 -0.807 . . . . 0.98 111.125 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.9 -5.25 19.83 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 113.909 1.078 . . . . 1.16 113.909 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.83 161.47 27.75 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.401 -0.904 . . . . 0.85 112.733 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -55.79 -18.88 9.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -1.065 . . . . 3.86 112.82 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -59.07 -40.66 85.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -0.973 . . . . 2.35 110.518 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -85.9 -23.9 26.83 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.213 -0.929 . . . . 1.67 111.465 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.65 -35.44 76.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.638 -0.664 . . . . 1.45 111.356 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.02 83.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.388 -0.82 . . . . 0.61 111.334 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.5 mt -62.02 -40.91 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.65 110.324 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -71.04 -30.29 66.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.302 -0.874 . . . . 0.66 110.546 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -60.91 -39.07 87.96 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.187 -0.945 . . . . 1.19 109.732 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.98 -39.58 93.25 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 110.098 -1.201 . . . . 0.53 110.098 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -59.82 -45.0 93.74 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.433 -1.04 . . . . 1.27 110.355 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.61 -40.91 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 0.54 110.401 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 26.3 ttt -60.14 -39.4 86.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.325 -0.859 . . . . 1.74 110.384 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.5 tp -57.84 -48.25 80.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.151 -0.968 . . . . 0.55 110.221 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.98 -41.76 92.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.239 -0.913 . . . . 0.47 110.413 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -88.13 10.4 19.44 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 112.899 0.703 . . . . 1.42 112.899 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.63 126.32 27.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.891 -1.131 . . . . 1.27 108.818 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.22 -18.72 65.35 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.871 0.843 . . . . 1.35 110.639 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -74.45 -54.99 6.48 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.491 0.662 . . . . 2.22 110.178 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.9 mt -61.1 -37.49 82.95 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.663 -0.648 . . . . 0.62 111.058 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.404 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 30.5 tt0 -60.05 -45.18 93.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 1.29 110.559 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.97 -38.46 91.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 1.52 110.685 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -68.26 -47.87 66.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.035 -1.041 . . . . 1.3 110.922 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.11 -42.48 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.093 -1.004 . . . . 0.61 110.04 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.4 mt -63.51 -43.0 98.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.485 -0.76 . . . . 0.78 110.505 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.29 -42.83 99.69 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.3 -0.875 . . . . 0.82 110.928 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.62 -45.63 93.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.974 -1.079 . . . . 0.8 110.544 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.8 mt -61.88 -43.65 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.041 -1.037 . . . . 0.77 110.339 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -84.75 -31.26 24.09 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.277 -0.89 . . . . 2.12 111.724 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 91' ' ' ALA . 60.6 t0 -82.47 -45.57 14.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.64 -1.287 . . . . 1.51 111.527 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -100.76 4.82 43.33 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.227 -0.92 . . . . 1.98 112.617 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 53.2 50.64 17.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 1.32 111.466 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.33 159.02 15.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.385 -0.822 . . . . 1.38 109.207 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.2 p -71.5 161.02 31.69 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.772 -0.58 . . . . 0.67 109.832 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.28 -45.04 92.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.033 -1.042 . . . . 0.52 110.56 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.591 ' OD2' HD21 ' A' ' 142' ' ' LEU . 91.2 m-20 -68.12 -37.04 80.67 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.226 -0.922 . . . . 2.25 110.121 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.54 -51.71 40.0 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.757 -0.777 . . . . 0.64 111.429 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.63 94.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.117 -0.989 . . . . 0.56 110.408 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.31 95.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.653 -0.654 . . . . 0.46 110.793 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -61.69 -37.87 85.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.124 -0.985 . . . . 1.32 111.496 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -59.23 -49.59 77.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.883 -1.136 . . . . 1.3 111.077 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.68 -45.72 97.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.437 -1.414 . . . . 0.61 110.214 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.1 mm -61.12 -34.76 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.638 -0.664 . . . . 0.65 110.403 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -58.44 -39.16 79.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.095 -1.003 . . . . 2.11 111.226 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.69 -41.3 7.8 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.947 -1.597 . . . . 0.83 112.853 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -60.57 -41.07 93.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.599 -1.53 . . . . 1.28 109.891 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.43 -52.65 20.75 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.399 0.619 . . . . 0.89 110.559 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.0 p -62.53 -36.44 82.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.462 -0.774 . . . . 1.87 110.453 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.3 97.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 1.05 110.722 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.19 -30.11 70.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.938 . . . . 1.02 110.855 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.58 -21.75 65.41 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.011 -1.056 . . . . 2.04 110.989 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -71.37 -14.3 62.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 1.73 111.462 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.401 HD13 HD13 ' A' ' 123' ' ' LEU . 16.2 mt -86.85 146.4 26.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.434 -0.791 . . . . 1.37 109.574 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -99.2 36.08 1.79 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.233 -0.917 . . . . 2.88 112.285 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -113.09 139.6 48.57 Favored 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 108.437 -0.949 . . . . 1.58 108.437 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -60.23 -38.46 83.47 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.329 -0.857 . . . . 3.04 110.89 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -70.23 -53.33 17.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.684 -1.26 . . . . 0.9 109.909 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.401 HD13 HD13 ' A' ' 118' ' ' LEU . 36.1 mt -62.79 -40.31 96.94 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.228 -0.92 . . . . 1.06 109.627 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.64 -50.49 66.88 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.828 0.823 . . . . 2.18 109.918 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.78 -29.11 70.46 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.753 -1.217 . . . . 2.15 109.921 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -61.66 -31.4 71.51 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.368 -0.933 . . . . 2.33 109.111 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.15 78.86 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.643 0.735 . . . . 0.82 109.815 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.61 -43.65 79.94 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.416 -0.914 . . . . 0.85 109.958 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -60.97 -38.6 86.52 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.485 0.659 . . . . 1.39 110.829 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.5 -39.07 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.574 -0.704 . . . . 0.56 110.262 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.417 ' NH1' ' HG3' ' A' ' 131' ' ' ARG . 40.4 ttm-85 -59.04 -40.07 83.91 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.143 -0.973 . . . . 3.12 109.856 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -60.21 -38.75 84.29 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.356 0.598 . . . . 1.28 110.405 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.67 -39.76 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.254 -0.904 . . . . 0.49 110.444 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.86 -47.36 67.04 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.424 -1.07 . . . . 0.46 110.424 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -58.24 -42.1 85.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.21 -1.171 . . . . 2.71 110.078 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 136' ' ' ARG . 60.1 mtt-85 -61.67 -43.23 99.26 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.14 -1.024 . . . . 2.14 110.372 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.31 -43.02 96.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.371 -0.831 . . . . 1.05 109.843 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -41.53 91.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.78 -0.575 . . . . 0.52 110.833 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.474 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 99.5 mtt180 -60.08 -35.58 75.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 2.35 111.329 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -73.56 -41.32 63.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.025 -1.047 . . . . 1.39 110.645 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.3 mt -60.4 -39.26 80.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.092 -1.005 . . . . 0.68 110.228 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.591 HD21 ' OD2' ' A' ' 101' ' ' ASP . 87.9 mt -88.6 -8.54 54.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.474 -0.766 . . . . 0.83 112.039 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.34 25.32 70.93 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 120.363 -0.923 . . . . 0.91 113.59 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.5 tp -70.13 148.62 48.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.634 -0.921 . . . . 0.95 109.956 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -65.46 151.72 45.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.483 -0.761 . . . . 2.43 110.803 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.8 mt -103.32 140.6 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.125 -1.065 . . . . 1.1 108.125 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.6 mm -82.37 120.36 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.817 -1.177 . . . . 1.58 108.138 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -99.36 95.89 7.35 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.165 -1.791 . . . . 1.62 106.165 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.82 -18.38 61.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.504 -0.748 . . . . 0.8 112.053 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.0 m -81.72 8.74 9.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 1.56 112.208 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.04 24.63 9.09 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.239 -0.913 . . . . 0.84 111.655 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.1 mt -74.35 147.24 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.371 -0.83 . . . . 0.82 110.146 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -115.26 -20.12 10.49 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.58 -0.7 . . . . 2.31 112.596 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -119.55 139.92 51.36 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.812 -1.181 . . . . 1.54 107.812 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.71 128.57 36.52 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.602 -0.888 . . . . 1.38 108.602 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -146.28 178.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.477 -0.764 . . . . 0.69 109.426 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.417 HG21 HD12 ' A' ' 180' ' ' ILE . 81.3 mt -91.42 144.75 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.504 -0.925 . . . . 0.53 108.504 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.71 123.65 39.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.889 -1.132 . . . . 0.64 108.366 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.74 130.09 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.156 -1.053 . . . . 0.67 108.156 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.34 154.77 21.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.099 -1.001 . . . . 0.78 108.93 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.7 -31.2 70.48 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.653 -1.28 . . . . 1.0 109.626 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 29.0 p-10 -173.35 150.8 1.91 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.708 -0.849 . . . . 2.42 108.708 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.3 mt -119.39 138.78 52.86 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.332 -0.988 . . . . 0.75 108.332 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.0 p -95.61 152.61 39.29 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 108.507 -0.923 . . . . 0.78 108.507 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -43.68 -39.57 10.23 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.367 1.378 . . . . 0.67 113.367 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.0 m -59.85 -48.88 79.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.923 -1.111 . . . . 0.7 110.042 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.99 -40.33 97.43 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.338 -0.851 . . . . 1.21 109.961 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 31.5 p -68.17 -40.0 82.41 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.857 -0.737 . . . . 0.6 110.055 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.36 78.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.581 -0.7 . . . . 0.62 110.779 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -97.03 -1.43 45.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.207 -0.933 . . . . 1.16 112.881 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.82 150.39 41.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.476 -0.765 . . . . 0.73 109.571 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -96.03 111.04 23.17 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.773 -1.566 . . . . 2.24 106.773 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 31.9 mt -74.57 -15.19 60.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.636 -0.665 . . . . 1.43 111.486 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -81.32 -25.58 36.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 2.15 111.832 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -102.72 -1.96 29.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.27 -0.894 . . . . 2.04 113.325 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.05 127.26 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 107.394 -1.335 . . . . 0.55 107.394 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.429 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 45.1 tp -88.58 -10.84 47.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.104 -0.998 . . . . 1.63 112.244 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.96 174.32 46.72 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.049 -1.621 . . . . 0.47 109.049 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -130.02 131.19 45.76 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.506 -1.294 . . . . 0.54 107.506 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.535 ' CG2' HG21 ' A' ' 205' ' ' THR . 84.6 mt -131.32 129.79 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.156 -1.424 . . . . 0.69 107.156 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 203' ' ' VAL . 82.7 p -140.57 170.55 15.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.886 -1.133 . . . . 0.82 109.702 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.447 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 1.4 m-20 -105.04 44.72 1.01 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.817 -0.552 . . . . 2.37 110.777 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.05 0 O-C-N 121.086 -1.009 . . . . 1.11 109.637 179.317 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 107.296 -1.372 . . . . 1.69 107.296 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -59.55 -34.39 72.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.475 -0.765 . . . . 1.07 110.107 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 191' ' ' SER . 15.2 t -59.67 -39.44 84.48 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.537 -0.727 . . . . 1.58 110.603 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.478 ' N ' HG23 ' A' ' 190' ' ' THR . 22.8 t -57.24 -39.99 76.67 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.16 -0.962 . . . . 1.6 110.072 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.3 -39.62 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.44 -0.787 . . . . 1.45 109.937 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 45.5 mtp -66.27 -40.93 90.44 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.395 1.093 . . . . 1.05 109.414 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.73 -42.22 88.26 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.464 -0.789 . . . . 0.72 110.709 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -60.84 -44.95 96.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.912 -1.118 . . . . 3.05 110.317 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.8 m -70.21 -40.1 74.77 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.199 -0.938 . . . . 0.89 110.225 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.4 mt -91.7 -6.92 51.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.529 -0.732 . . . . 0.78 112.64 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.0 mt-10 52.54 13.45 0.32 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.749 1.018 . . . . 1.45 113.749 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.71 148.11 89.7 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.942 -1.132 . . . . 0.67 107.942 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -54.35 140.5 73.18 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.905 1.737 . . . . 0.64 109.985 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.84 160.5 36.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.249 -1.532 . . . . 0.67 109.86 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.46 ' CD1' HD11 ' A' ' 220' ' ' LEU . 29.6 mt -148.65 151.49 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.676 -1.231 . . . . 0.69 107.676 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.7 m -135.5 -27.58 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 120.956 -1.09 . . . . 0.85 112.014 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.92 42.06 2.8 Favored Glycine 0 N--CA 1.492 2.41 0 O-C-N 121.081 -1.012 . . . . 0.92 112.02 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.535 HG21 ' CG2' ' A' ' 180' ' ' ILE . 74.7 p -65.4 -13.11 57.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.899 -1.353 . . . . 0.95 111.151 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.65 -95.88 1.38 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 110.565 -1.014 . . . . 1.04 110.565 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -129.08 30.96 4.96 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.659 -0.907 . . . . 1.57 112.322 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.2 -36.33 45.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.571 -1.331 . . . . 0.84 110.819 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.1 p -57.77 -24.58 57.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.792 -1.193 . . . . 0.99 111.544 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 18.2 t -92.15 -2.05 56.8 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.797 0.808 . . . . 1.7 111.483 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -122.46 -5.29 8.77 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.561 0.949 . . . . 2.2 113.561 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 34.8 t -120.05 149.07 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.357 -0.839 . . . . 0.84 109.594 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.0 156.9 27.75 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.973 -1.121 . . . . 2.2 107.973 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.506 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 7.3 t30 -51.47 142.84 13.01 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.075 -1.016 . . . . 2.28 110.216 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 83.35 -7.62 1.14 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.109 1.151 . . . . 2.35 114.109 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -58.57 142.15 50.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.507 -1.37 . . . . 1.97 108.91 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -88.74 119.82 29.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.671 -1.268 . . . . 2.65 108.072 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.69 148.85 47.76 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.465 0.65 . . . . 0.63 109.653 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.459 HG21 ' SD ' ' A' ' 239' ' ' MET . 82.6 mt -117.79 124.89 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.226 -1.768 . . . . 0.62 106.226 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.46 HD11 ' CD1' ' A' ' 202' ' ' ILE . 53.6 tp -102.24 116.78 33.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.215 -1.772 . . . . 0.64 106.215 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.3 p-10 -93.15 -22.12 19.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.934 -1.104 . . . . 2.05 112.709 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.17 15.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 112.663 0.616 . . . . 0.84 112.663 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.633 ' N ' ' O ' ' A' ' 221' ' ' ASP . 20.6 t -109.73 -59.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.112 -0.993 . . . . 1.02 109.86 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -93.79 9.91 35.22 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.27 1.033 . . . . 2.51 110.891 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 47.7 t30 61.33 53.1 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.983 -1.008 . . . . 1.54 112.304 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -148.84 148.54 30.02 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.811 -1.181 . . . . 1.95 110.084 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.97 139.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 108.136 -1.061 . . . . 0.71 108.136 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -102.74 133.88 47.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.181 -0.95 . . . . 1.01 108.669 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 53.4 t -110.86 130.8 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.214 -1.032 . . . . 0.82 108.214 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 58.5 t-20 55.63 47.9 3.53 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 113.384 0.883 . . . . 1.54 113.384 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 62.3 Cg_endo -69.82 153.12 69.04 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.559 2.172 . . . . 0.94 110.901 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.6 m -74.19 159.38 32.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 1.8 108.866 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -59.47 -34.01 72.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.114 -0.991 . . . . 2.73 110.691 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -59.96 -41.05 91.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.407 -0.808 . . . . 3.17 110.56 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.96 -39.97 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.288 -0.883 . . . . 1.34 110.192 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.4 mt -60.0 -49.97 81.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.168 -0.957 . . . . 1.2 111.043 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -59.52 -40.66 87.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.98 . . . . 2.7 110.644 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.71 -47.91 84.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.853 . . . . 2.59 110.195 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' MET . . . . . 0.459 ' SD ' HG21 ' A' ' 219' ' ' ILE . 66.1 mtp -70.63 -38.39 73.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 1.38 110.871 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.537 ' NH1' ' CD2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.147 -0.97 . . . . 2.84 110.245 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.3 mt . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 106.386 -1.709 . . . . 1.07 106.386 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m -105.88 125.23 50.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.048 -1.093 . . . . 1.24 108.048 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.46 -154.96 17.46 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.333 -1.907 . . . . 1.01 108.333 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 5' ' ' ILE . 80.3 mt -95.78 1.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.309 -1.113 . . . . 1.11 112.185 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 5' ' ' ILE . 3.8 tp 50.82 101.16 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.085 -1.01 . . . . 0.99 112.357 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -84.38 -47.44 10.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.118 -0.989 . . . . 0.85 111.11 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m -144.58 146.95 34.26 Favored Pre-proline 0 N--CA 1.501 2.093 0 N-CA-C 107.855 -1.165 . . . . 1.38 107.855 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.49 147.71 32.52 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.575 2.183 . . . . 0.94 112.088 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.922 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.08 163.34 11.97 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.343 -1.503 . . . . 0.81 109.343 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.3 mt -125.37 130.53 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.159 -1.2 . . . . 0.83 108.095 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.464 ' HB1' ' CD2' ' A' ' 177' ' ' LEU . . . -139.11 148.92 43.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.242 -0.911 . . . . 0.53 109.016 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 5.8 m-85 -117.49 140.17 49.96 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 108.827 -0.805 . . . . 0.77 108.827 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.77 167.27 35.64 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 118.004 -2.046 . . . . 0.51 110.39 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -77.48 160.36 28.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.827 -0.808 . . . . 1.9 109.669 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.41 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.46 126.46 34.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.835 -1.166 . . . . 0.66 108.152 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.9 tp -104.6 98.93 8.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.081 -1.822 . . . . 0.83 106.081 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 18' ' ' LEU . 17.0 tp -90.55 130.83 36.55 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.753 -1.203 . . . . 0.86 107.753 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 158' ' ' LEU . 77.5 mt -101.77 117.06 34.09 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.861 -1.533 . . . . 0.92 106.861 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -109.5 136.04 49.54 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.993 -1.484 . . . . 2.03 106.993 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -119.69 149.18 42.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.083 -1.011 . . . . 2.66 109.452 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -82.67 134.62 35.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.858 -1.164 . . . . 2.32 107.858 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.19 148.35 50.24 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.671 -0.863 . . . . 2.11 108.671 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.87 130.3 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.282 -1.007 . . . . 0.73 108.282 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -105.35 131.11 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.033 -1.099 . . . . 0.87 108.033 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 77.1 mt -97.86 135.55 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.526 -0.916 . . . . 0.81 108.526 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -91.12 123.02 34.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.858 -1.164 . . . . 1.34 107.858 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -95.06 13.04 26.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.223 -0.923 . . . . 2.89 112.135 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -67.25 149.66 50.11 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.282 -0.886 . . . . 2.09 109.244 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -86.43 140.0 30.39 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.179 -1.045 . . . . 2.19 108.179 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -93.31 171.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.079 -1.013 . . . . 0.75 109.418 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.6 p -108.53 158.62 17.39 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.935 -0.765 . . . . 0.91 108.935 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.82 -26.23 1.56 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.108 -0.995 . . . . 0.93 112.672 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -69.84 -39.87 76.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.161 -0.962 . . . . 2.28 110.167 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -86.47 -11.3 52.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.426 -0.796 . . . . 1.45 111.813 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.15 -47.19 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.438 -0.789 . . . . 0.81 110.472 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.12 -40.08 84.3 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.098 -1.001 . . . . 1.54 110.687 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.46 -44.77 95.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.42 -0.8 . . . . 2.36 110.999 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.05 -39.74 87.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.919 -1.113 . . . . 1.31 111.02 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.04 -41.77 87.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.92 -1.112 . . . . 0.82 110.656 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -61.93 -45.89 91.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.008 -1.057 . . . . 1.5 110.279 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -62.48 -39.67 94.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.308 -0.87 . . . . 2.23 110.165 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -76.22 -54.42 6.83 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.562 -0.711 . . . . 0.85 110.315 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -58.32 -47.78 82.64 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.382 -0.927 . . . . 0.91 109.772 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -68.39 -36.74 79.59 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.738 -0.785 . . . . 0.9 109.891 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.68 -44.09 94.17 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.218 -1.468 . . . . 0.69 109.57 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.4 ttt-85 -60.32 -29.48 68.89 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.194 -1.18 . . . . 2.88 110.328 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.31 -50.24 73.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.85 110.929 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -81.44 -36.07 29.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.909 -1.12 . . . . 2.35 110.341 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.49 89.7 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.268 -0.895 . . . . 0.65 109.683 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 87.4 p -60.77 -39.28 88.24 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.219 1.009 . . . . 1.45 109.055 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -45.3 75.64 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.711 -0.677 . . . . 0.63 110.595 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -65.29 -48.6 72.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.672 -1.268 . . . . 1.34 110.658 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.05 -35.95 81.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.994 -1.066 . . . . 1.56 109.888 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -60.06 -40.24 88.81 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.574 -0.704 . . . . 1.19 110.256 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -62.11 -43.45 98.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.139 -0.976 . . . . 0.72 110.457 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.1 mt -59.94 -35.21 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.438 -0.789 . . . . 0.62 110.726 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -52.64 -41.63 63.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.15 -0.969 . . . . 1.05 110.878 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.76 -36.92 76.19 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.996 -1.065 . . . . 0.64 110.318 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -61.58 -36.81 81.72 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.926 -1.109 . . . . 1.73 109.552 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.12 79.01 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.618 -0.677 . . . . 0.56 110.43 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.24 -36.21 13.22 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.637 -1.268 . . . . 0.69 111.502 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.54 -22.66 43.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.668 -1.489 . . . . 1.48 110.736 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.2 m -90.42 -49.93 6.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.253 -0.904 . . . . 0.98 111.52 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.27 -7.17 16.83 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 113.918 1.081 . . . . 1.16 113.918 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.08 163.46 24.79 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.719 -0.753 . . . . 0.85 112.349 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -54.17 -23.89 16.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.565 -0.962 . . . . 3.86 112.779 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.3 -40.08 70.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.823 -1.173 . . . . 2.35 110.993 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -86.02 -22.99 26.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.674 -1.266 . . . . 1.67 111.488 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -60.56 -40.3 91.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 1.45 111.031 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.25 86.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.486 -0.759 . . . . 0.61 111.443 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -65.82 -44.0 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.754 -1.216 . . . . 0.65 110.921 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -69.95 -32.91 71.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.686 -1.259 . . . . 0.66 110.22 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.2 -38.85 88.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -0.881 . . . . 1.19 110.23 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.13 96.96 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.591 -0.814 . . . . 0.53 111.097 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -58.11 -40.92 82.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.669 -1.489 . . . . 1.27 110.777 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.93 -40.05 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.118 -0.989 . . . . 0.54 110.987 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.8 ttm -58.76 -40.28 83.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.983 -1.073 . . . . 1.74 110.377 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 tp -59.85 -48.6 81.05 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.185 -0.947 . . . . 0.55 110.023 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.97 -39.8 86.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.207 -0.933 . . . . 0.47 110.284 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -84.3 6.78 21.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.216 0.821 . . . . 1.42 113.216 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -66.41 125.33 25.31 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.664 -1.273 . . . . 1.27 108.26 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.97 -16.54 64.1 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.263 -0.898 . . . . 1.35 111.121 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -75.03 -50.29 16.98 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.674 -0.81 . . . . 2.22 110.34 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.8 -36.76 84.21 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.739 -0.784 . . . . 0.62 110.392 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -59.93 -48.8 80.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.367 -0.833 . . . . 1.29 110.705 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -61.85 -38.42 88.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 1.52 110.546 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.23 -47.38 79.88 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.025 -1.047 . . . . 1.3 110.499 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.61 -45.03 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.34 -0.85 . . . . 0.61 110.198 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.34 -40.12 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.683 0.754 . . . . 0.78 110.465 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.43 98.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.152 -0.968 . . . . 0.82 110.965 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.18 -39.16 85.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.015 -1.053 . . . . 0.8 110.612 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.26 -51.52 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.77 110.757 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -75.87 -35.31 59.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.756 . . . . 2.12 111.446 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.43 -46.24 14.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 1.51 111.948 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -100.13 7.84 44.31 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.342 -0.849 . . . . 1.98 112.861 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.9 m80 49.9 48.61 21.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.74 -1.225 . . . . 1.32 111.427 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.9 mtt -109.97 152.02 26.39 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.778 0.799 . . . . 1.38 109.552 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.9 p -70.1 160.27 32.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.515 -0.741 . . . . 0.67 110.018 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.18 92.98 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.46 -0.775 . . . . 0.52 110.419 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD2' HD21 ' A' ' 142' ' ' LEU . 74.8 m-20 -65.86 -43.45 88.38 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.962 -1.086 . . . . 2.25 109.361 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.18 -49.31 51.64 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.921 -0.711 . . . . 0.64 110.862 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.71 -44.47 93.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.56 110.637 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.22 -41.07 87.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.46 110.483 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.3 -38.28 90.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 1.32 111.48 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.62 -49.76 76.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.387 -1.446 . . . . 1.3 111.29 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.68 -46.81 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.918 -1.114 . . . . 0.61 110.112 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.8 mm -62.0 -29.43 46.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.921 0.867 . . . . 0.65 110.681 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.51 -40.33 82.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.551 -0.718 . . . . 2.11 110.996 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.55 -32.04 17.07 Favored Glycine 0 N--CA 1.501 3.004 0 C-N-CA 119.384 -1.389 . . . . 0.83 112.535 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -63.03 -37.54 87.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.363 -1.669 . . . . 1.28 110.169 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.63 -51.21 15.08 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.533 -0.73 . . . . 0.89 111.201 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.9 m -58.32 -38.73 77.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.388 -0.82 . . . . 1.87 111.142 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.09 99.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.303 -0.873 . . . . 1.05 111.025 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.75 -28.81 69.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.967 . . . . 1.02 111.269 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -68.11 -22.27 64.9 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.209 -0.932 . . . . 2.04 111.055 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -73.08 -13.64 61.24 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.963 0.887 . . . . 1.73 111.029 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 123' ' ' LEU . 11.4 mt -91.18 140.53 29.72 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.503 -0.925 . . . . 1.37 108.503 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -99.71 43.55 1.05 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.028 -1.045 . . . . 2.88 112.082 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -112.87 140.51 47.6 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.134 -0.979 . . . . 1.58 108.808 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.24 -40.47 77.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 3.04 111.008 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -73.22 -54.04 9.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.864 -1.148 . . . . 0.9 110.95 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 118' ' ' LEU . 26.7 mt -59.81 -41.3 90.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.897 -1.127 . . . . 1.06 110.475 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -63.65 -50.09 70.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.116 -0.99 . . . . 2.18 109.951 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.44 -31.83 70.8 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.978 -1.076 . . . . 2.15 109.292 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.536 ' HG2' HH11 ' A' ' 126' ' ' ARG . 11.3 ttt-85 -61.32 -29.32 69.81 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.59 -0.844 . . . . 2.33 109.49 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.12 74.81 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.815 0.817 . . . . 0.82 109.448 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.5 -45.72 78.66 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.101 -0.64 . . . . 0.85 110.125 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -62.05 -33.93 75.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.543 -0.723 . . . . 1.39 110.574 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.1 t -68.12 -41.91 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 0.56 110.272 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.443 HH11 ' HG2' ' A' ' 131' ' ' ARG . 28.1 ttt-85 -59.77 -39.49 85.04 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.006 -1.077 . . . . 3.12 109.311 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.482 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 56.8 t0 -58.29 -36.22 72.98 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.734 -0.604 . . . . 1.28 109.896 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.2 mt -60.63 -39.35 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.158 -0.964 . . . . 0.49 110.152 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.75 -44.85 30.21 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.253 -0.975 . . . . 0.46 111.007 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -56.68 -45.27 81.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.316 -1.108 . . . . 2.71 110.401 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.482 ' NH2' ' OD2' ' A' ' 132' ' ' ASP . 42.1 mtt-85 -62.46 -40.76 97.67 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.096 -1.042 . . . . 2.14 109.643 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.521 ' O ' HD13 ' A' ' 137' ' ' LEU . 0.2 OUTLIER -62.23 -43.21 99.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.703 -0.623 . . . . 1.05 110.057 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.23 -44.5 92.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.204 -0.935 . . . . 0.52 110.317 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.1 mtp180 -60.02 -32.63 71.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 2.35 110.723 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -74.09 -41.08 62.23 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.254 -0.903 . . . . 1.39 110.704 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 98.5 mt -60.63 -37.52 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.42 -0.8 . . . . 0.68 110.142 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.498 HD21 ' OD2' ' A' ' 101' ' ' ASP . 66.9 mt -87.06 -7.41 58.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.504 -0.748 . . . . 0.83 112.169 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.1 19.4 78.46 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.808 -1.187 . . . . 0.91 112.613 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.6 tp -61.33 143.29 55.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.94 -0.741 . . . . 0.95 109.63 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -66.44 146.6 54.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 2.43 108.966 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.55 142.24 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.214 -1.032 . . . . 1.1 108.214 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.4 mm -75.73 129.93 36.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.04 -1.096 . . . . 1.58 108.04 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.27 94.67 9.28 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.914 -1.513 . . . . 1.62 106.914 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 54.5 mt -74.19 -23.68 59.25 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.73 0.776 . . . . 0.8 110.515 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.5 m -82.88 6.96 16.69 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.882 0.848 . . . . 1.56 112.019 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.73 23.08 9.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.627 -0.671 . . . . 0.84 112.634 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.7 mt -73.68 138.49 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.32 -0.862 . . . . 0.82 109.148 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -118.02 -18.44 9.43 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.778 0.799 . . . . 2.31 112.725 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -115.36 140.72 48.87 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.432 -0.951 . . . . 1.54 108.432 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -70.98 120.83 17.12 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.041 -1.037 . . . . 1.38 108.483 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.13 175.01 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.568 -0.707 . . . . 0.69 109.305 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 mt -87.49 144.43 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.322 -0.861 . . . . 0.53 108.935 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 19' ' ' LEU . 35.8 tp -97.66 126.97 43.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.996 -1.065 . . . . 0.64 108.24 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.0 131.06 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.268 -1.012 . . . . 0.67 108.268 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.04 147.59 11.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.058 -1.027 . . . . 0.78 109.087 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.06 -32.18 71.82 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.544 -1.347 . . . . 1.0 109.741 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 50.6 p-10 -172.53 150.82 2.31 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.434 -0.95 . . . . 2.42 108.434 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 46.4 mt -118.53 143.07 47.01 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.373 -0.829 . . . . 0.75 109.247 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.0 p -92.19 141.83 25.53 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.112 -0.992 . . . . 0.78 108.673 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.57 -40.28 2.15 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 121.871 1.714 . . . . 0.67 113.706 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.8 m -60.72 -49.99 75.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.1 -1.04 . . . . 0.7 109.704 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.31 -39.91 94.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.504 -0.747 . . . . 1.21 110.168 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 34.5 p -66.87 -38.54 86.51 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.449 0.642 . . . . 0.6 110.561 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.39 88.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.632 -0.668 . . . . 0.62 110.427 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -93.23 0.07 56.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.077 -1.015 . . . . 1.16 112.694 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.46 148.06 43.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.979 -1.076 . . . . 0.73 108.515 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -97.65 119.71 36.71 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.13 -1.434 . . . . 2.24 107.13 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 45.5 mt -78.14 -12.34 59.99 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.929 -0.482 . . . . 1.43 111.601 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -83.0 -23.75 33.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.974 -1.079 . . . . 2.15 111.825 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -101.96 -4.95 25.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.232 -0.917 . . . . 2.04 113.092 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.23 125.95 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.76 -1.2 . . . . 0.55 107.76 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.464 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 37.8 tp -90.96 -8.52 49.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.905 . . . . 1.63 112.197 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 177.4 169.64 38.76 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.978 -1.649 . . . . 0.47 108.978 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -127.82 133.86 49.42 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.005 -1.109 . . . . 0.54 108.005 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 76.9 mt -132.09 109.62 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 106.133 -1.803 . . . . 0.69 106.133 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 205' ' ' THR . 66.5 p -131.26 172.28 12.33 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.917 -1.114 . . . . 0.82 110.347 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.402 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 26.9 t0 -101.53 61.7 0.92 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.563 -0.71 . . . . 2.37 109.958 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.143 0 O-C-N 121.233 -0.917 . . . . 1.11 108.809 -179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 108.041 -1.096 . . . . 1.69 108.041 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -62.68 -37.86 88.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.303 -0.873 . . . . 1.07 110.888 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 87.0 m -59.68 -40.12 86.75 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.405 -0.918 . . . . 1.58 110.586 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.6 t -58.54 -39.73 81.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.231 -0.918 . . . . 1.6 110.049 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.9 mm -60.04 -35.84 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 1.45 110.96 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 65.9 mtp -62.94 -41.2 99.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.02 -1.05 . . . . 1.05 109.951 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.17 -47.2 84.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.997 -0.547 . . . . 0.72 110.588 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.495 HH11 ' HG2' ' A' ' 195' ' ' ARG . 29.0 mtt-85 -60.14 -42.16 94.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 3.05 110.349 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.7 m -69.47 -41.59 75.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.017 -1.052 . . . . 0.89 109.835 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.5 mt -91.0 -8.3 49.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.619 -0.675 . . . . 0.78 112.094 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 48.62 14.54 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.739 1.015 . . . . 1.45 113.739 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.4 mt -74.1 149.18 87.14 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.053 -1.03 . . . . 0.67 108.267 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.07 136.64 53.49 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 121.146 1.231 . . . . 0.64 109.691 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -157.28 159.32 37.46 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 118.133 -1.427 . . . . 0.67 110.148 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 77.0 mt -144.65 144.87 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.64 -1.245 . . . . 0.69 107.64 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 181' ' ' THR . 6.6 m -124.54 -33.94 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 113.608 0.966 . . . . 0.85 113.608 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.76 40.72 1.17 Allowed Glycine 0 N--CA 1.484 1.858 0 C-N-CA 120.308 -0.949 . . . . 0.92 111.792 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 181' ' ' THR . 44.3 p -58.21 -22.54 52.33 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.186 -1.185 . . . . 0.95 111.279 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.402 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 72.31 -89.82 0.52 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.505 -1.038 . . . . 1.04 110.505 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.9 t -129.43 28.47 5.2 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.604 -0.939 . . . . 1.57 112.784 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.12 -37.42 61.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.665 -1.272 . . . . 0.84 110.165 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 39.6 p -52.02 -26.25 10.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.99 111.256 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.3 p -93.2 3.9 54.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 1.7 111.603 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -126.92 -3.62 6.44 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.924 0.713 . . . . 2.2 112.924 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 22.7 t -120.59 149.42 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.682 0.753 . . . . 0.84 109.185 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -124.96 156.97 37.2 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.476 -0.935 . . . . 2.2 108.476 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.576 ' ND2' ' OD1' ' A' ' 215' ' ' ASP . 35.0 t30 -56.48 141.13 43.75 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.83 -1.169 . . . . 2.28 110.674 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.576 ' OD1' ' ND2' ' A' ' 214' ' ' ASN . 1.6 m-20 80.24 2.51 1.95 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.472 1.286 . . . . 2.35 114.472 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.38 145.45 55.69 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.812 -1.18 . . . . 1.97 108.455 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -88.46 116.12 26.46 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.041 -1.466 . . . . 2.65 107.041 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.41 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 88.6 mt -127.32 142.05 51.55 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.463 -0.773 . . . . 0.63 109.695 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.2 mt -109.65 128.34 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.99 -1.485 . . . . 0.62 106.99 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.8 tp -102.75 115.93 31.56 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.292 -1.744 . . . . 0.64 106.292 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 223' ' ' VAL . 21.6 p-10 -94.38 -22.81 18.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.94 -1.1 . . . . 2.05 112.599 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.23 17.85 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 112.859 0.689 . . . . 0.84 112.859 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.3 t -108.92 -59.57 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.122 -0.986 . . . . 1.02 108.959 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.32 11.03 34.04 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.654 0.74 . . . . 2.51 111.157 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 60.71 54.67 3.54 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.417 0.627 . . . . 1.54 112.063 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -150.2 149.52 30.32 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.091 0.948 . . . . 1.95 109.942 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.9 t -116.12 141.23 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 109.175 -0.676 . . . . 0.71 109.175 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.43 130.61 49.26 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.855 -1.153 . . . . 1.01 108.264 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.5 t -109.81 129.35 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.217 -0.927 . . . . 0.82 108.695 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.439 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 10.2 t-20 54.82 50.29 6.2 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 113.701 1.0 . . . . 1.54 113.701 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.0 Cg_endo -68.91 151.92 73.69 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.962 2.441 . . . . 0.94 110.594 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.429 ' OG1' HG23 ' A' ' 235' ' ' VAL . 65.3 p -76.35 161.45 28.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.241 -0.912 . . . . 1.8 110.333 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -60.95 -38.08 84.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.792 -1.192 . . . . 2.73 110.191 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -60.4 -41.38 93.76 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.458 0.647 . . . . 3.17 110.573 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.429 HG23 ' OG1' ' A' ' 232' ' ' THR . 97.7 t -69.82 -40.18 78.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.083 -1.011 . . . . 1.34 110.241 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.02 -43.58 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 1.2 110.545 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -57.87 -41.52 82.63 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.181 -0.95 . . . . 2.7 110.418 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.35 -42.33 98.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.547 -0.721 . . . . 2.59 111.057 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.7 mtp -70.24 -42.53 72.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 1.38 110.874 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.075 -1.016 . . . . 2.84 109.593 -178.826 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.2 mt . . . . . 0 N--CA 1.499 1.982 0 N-CA-C 106.119 -1.808 . . . . 1.07 106.119 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -105.9 120.97 43.1 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 107.665 -1.235 . . . . 1.24 107.665 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.4 -159.03 18.39 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.715 -1.754 . . . . 1.01 108.715 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 5' ' ' ILE . 83.5 mt -94.84 1.11 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -1.189 . . . . 1.11 112.409 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tp 49.02 98.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.99 112.012 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.98 -45.71 12.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.728 -1.233 . . . . 0.85 111.577 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -145.89 145.21 24.24 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.796 -1.187 . . . . 1.38 107.796 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.37 143.84 22.43 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.868 2.378 . . . . 0.94 112.276 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.886 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.95 174.19 25.46 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 108.908 -1.677 . . . . 0.81 108.908 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.2 mt -131.31 133.09 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.316 -1.108 . . . . 0.83 108.054 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.62 155.2 48.53 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.503 -0.748 . . . . 0.53 109.629 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.5 m-85 -125.56 140.36 52.81 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.732 -0.84 . . . . 0.77 108.732 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.42 164.41 30.43 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 118.813 -1.66 . . . . 0.51 109.626 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -75.05 159.1 32.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.579 -0.953 . . . . 1.9 108.773 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -89.06 126.23 35.35 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.975 -1.12 . . . . 0.66 107.975 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.9 tp -103.85 105.91 16.26 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.022 -2.214 . . . . 0.83 105.022 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.5 tp -90.32 133.63 34.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 0.86 108.188 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.6 mt -99.93 120.03 39.16 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.925 -1.509 . . . . 0.92 106.925 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -109.86 142.33 41.32 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.717 -0.846 . . . . 2.03 108.717 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -121.57 141.74 50.79 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.907 -1.12 . . . . 2.66 109.225 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.25 137.28 34.9 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.87 -1.144 . . . . 2.32 108.018 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -62.38 149.19 43.07 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.252 -0.648 . . . . 2.11 109.252 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -93.84 131.91 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.359 -0.978 . . . . 0.73 108.359 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t -106.04 130.35 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.297 -1.001 . . . . 0.87 108.297 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.3 mt -96.24 138.22 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.846 -0.798 . . . . 0.81 108.846 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -90.1 122.86 33.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.206 -1.035 . . . . 1.34 108.206 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.475 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.1 mmt-85 -95.35 14.47 22.34 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.283 -0.886 . . . . 2.89 112.478 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -75.3 140.47 43.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.917 -1.114 . . . . 2.09 109.198 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.55 136.35 32.98 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.875 -1.157 . . . . 2.19 107.875 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 pt -94.93 168.84 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.885 . . . . 0.75 110.482 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.4 p -97.77 165.82 11.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.675 -0.641 . . . . 0.91 109.845 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.03 -27.24 61.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.874 -1.141 . . . . 0.93 111.579 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -68.17 -34.62 76.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.939 -1.1 . . . . 2.28 110.453 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -90.13 -9.48 48.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.978 -1.076 . . . . 1.45 112.492 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.3 t -58.55 -42.14 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.856 -1.152 . . . . 0.81 110.622 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.17 -38.25 79.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 1.54 110.926 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -63.17 -45.0 93.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.909 . . . . 2.36 111.268 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.52 -37.05 82.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.547 -1.346 . . . . 1.31 110.991 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.6 t -60.8 -40.17 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.074 -1.016 . . . . 0.82 110.193 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.64 -39.63 92.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.948 -1.095 . . . . 1.5 110.096 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.71 -40.23 91.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.885 . . . . 2.23 109.893 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -74.03 -58.37 3.34 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.295 -0.878 . . . . 0.85 109.703 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.0 -48.38 75.99 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.05 -1.06 . . . . 0.91 110.204 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.8 t -70.65 -44.55 66.89 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.293 -0.963 . . . . 0.9 110.153 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.09 -46.17 85.7 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.55 -1.31 . . . . 0.69 110.035 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -57.91 -30.25 65.76 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.698 -0.883 . . . . 2.88 109.595 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.52 -46.75 80.4 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.676 0.75 . . . . 0.85 109.629 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.413 ' NZ ' ' OE1' ' A' ' 53' ' ' GLN . 25.4 ttpp -79.89 -40.65 27.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.467 -0.771 . . . . 2.35 110.293 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.85 93.13 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.65 110.056 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.8 m -60.13 -37.6 80.54 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.017 0.913 . . . . 1.45 109.334 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.37 -46.66 69.46 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.776 -0.647 . . . . 0.63 110.179 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.413 ' OE1' ' NZ ' ' A' ' 49' ' ' LYS . 53.7 mt-30 -61.4 -48.56 80.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.855 -1.153 . . . . 1.34 110.13 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.09 -41.36 96.51 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.845 0.831 . . . . 1.56 109.596 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -60.56 -41.22 94.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.468 0.652 . . . . 1.19 109.855 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.1 m -64.35 -41.89 96.51 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.387 -0.821 . . . . 0.72 110.429 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.02 -32.81 55.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.191 -0.943 . . . . 0.62 110.573 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -53.18 -46.56 69.02 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.329 -0.857 . . . . 1.05 110.733 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -68.74 -38.92 80.48 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.202 -0.937 . . . . 0.64 109.48 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -62.9 -40.31 97.15 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.53 -1.268 . . . . 1.73 108.952 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.62 72.82 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.714 -0.794 . . . . 0.56 109.234 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.09 -33.23 26.98 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.155 -1.178 . . . . 0.69 110.155 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -82.1 -24.67 35.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.107 -1.231 . . . . 1.48 111.138 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.1 m -86.29 -46.74 10.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.506 -0.746 . . . . 0.98 110.74 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -105.71 -19.04 13.88 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.373 -0.829 . . . . 1.16 112.657 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.82 152.73 9.09 Favored Glycine 0 N--CA 1.504 3.225 0 O-C-N 121.247 -0.908 . . . . 0.85 111.816 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -52.58 -21.77 4.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.48 -1.012 . . . . 3.86 112.66 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.31 -32.63 71.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.193 -0.942 . . . . 2.35 111.456 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -82.79 -13.73 55.72 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.655 -1.278 . . . . 1.67 112.579 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.41 -32.49 71.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.046 -1.034 . . . . 1.45 111.209 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.56 96.16 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.025 -1.047 . . . . 0.61 111.322 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.7 mt -65.45 -42.52 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.652 -1.28 . . . . 0.65 110.638 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.6 -28.74 66.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.113 -0.992 . . . . 0.66 110.554 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.35 -37.59 81.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.259 -0.901 . . . . 1.19 110.403 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.83 -41.09 74.37 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.26 -0.971 . . . . 0.53 110.899 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -58.63 -43.02 89.59 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.967 -1.313 . . . . 1.27 110.223 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -60.59 -39.97 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.19 -0.944 . . . . 0.54 109.934 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.1 ttp -59.61 -39.56 84.61 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.055 -0.658 . . . . 1.74 110.585 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.33 -49.41 77.93 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.035 -1.041 . . . . 0.55 110.837 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.0 -45.1 93.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 0.47 110.423 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -85.93 14.13 6.53 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.01 -1.056 . . . . 1.42 112.718 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -65.58 127.51 32.17 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.759 -1.213 . . . . 1.27 108.503 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -68.21 -17.18 64.25 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.235 1.017 . . . . 1.35 110.704 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -75.24 -52.83 9.94 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.799 0.809 . . . . 2.22 110.544 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.08 -37.85 84.15 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.794 -0.763 . . . . 0.62 110.225 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -59.21 -49.33 78.26 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.487 -0.758 . . . . 1.29 110.716 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.75 -38.7 86.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.422 -0.798 . . . . 1.52 110.781 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.85 -48.55 73.9 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.479 -0.888 . . . . 1.3 110.142 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.06 -45.57 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.411 -0.916 . . . . 0.61 109.661 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.8 mt -60.7 -43.65 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.144 0.497 . . . . 0.78 110.453 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.43 95.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.964 -1.085 . . . . 0.82 111.058 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.65 -44.06 97.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.011 . . . . 0.8 110.151 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.31 -48.94 86.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.276 -0.89 . . . . 0.77 110.292 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -77.83 -33.41 52.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.373 -0.829 . . . . 2.12 111.44 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -82.74 -47.48 11.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.663 -1.273 . . . . 1.51 112.386 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -102.55 10.72 38.63 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.362 -0.836 . . . . 1.98 112.456 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.8 m80 51.49 49.18 21.49 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.988 -1.07 . . . . 1.32 111.303 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 59.0 mtt -104.57 150.79 24.33 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.387 -0.821 . . . . 1.38 109.701 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.4 p -74.11 165.66 24.76 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.405 -0.809 . . . . 0.67 109.988 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.81 -40.6 80.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.647 -0.658 . . . . 0.52 110.711 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.536 ' OD1' HD22 ' A' ' 138' ' ' LEU . 59.8 t0 -68.1 -42.93 79.56 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.52 -0.738 . . . . 2.25 110.07 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -52.09 28.2 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.111 -0.635 . . . . 0.64 111.225 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.16 -44.24 95.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.874 -1.141 . . . . 0.56 110.905 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.56 88.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.724 -0.61 . . . . 0.46 111.078 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -59.75 -37.26 78.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.614 -1.304 . . . . 1.32 110.562 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -59.28 -48.28 82.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.922 -1.111 . . . . 1.3 110.636 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.4 t -60.89 -47.04 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.788 -1.195 . . . . 0.61 110.875 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.17 -34.06 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.605 0.717 . . . . 0.65 109.833 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -57.55 -42.56 83.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.761 . . . . 2.11 110.803 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.09 -32.34 17.62 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.521 -1.323 . . . . 0.83 112.735 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -62.07 -42.63 99.4 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.167 -1.784 . . . . 1.28 109.828 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.7 -53.31 16.16 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.749 0.785 . . . . 0.89 110.771 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 64.7 m -60.95 -36.04 78.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.702 -0.624 . . . . 1.87 110.659 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.55 -42.15 99.36 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.379 -0.826 . . . . 1.05 110.184 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.2 mt -65.3 -29.66 70.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.793 -1.192 . . . . 1.02 110.967 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.98 -20.01 66.27 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.322 -0.861 . . . . 2.04 110.76 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.74 -12.54 61.05 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.779 0.8 . . . . 1.73 110.82 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 24.7 mt -90.6 139.58 30.57 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.964 -1.124 . . . . 1.37 107.964 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -101.83 43.71 1.05 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.46 -0.775 . . . . 2.88 111.618 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -115.87 142.37 46.86 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.296 -0.878 . . . . 1.58 109.069 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -56.81 -41.53 77.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 3.04 110.101 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -71.9 -55.13 8.06 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.911 -1.118 . . . . 0.9 110.577 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.1 mt -60.13 -40.01 88.26 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.141 -0.974 . . . . 1.06 110.63 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -63.09 -48.71 77.45 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.231 -0.918 . . . . 2.18 109.812 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -60.63 -31.45 70.65 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.896 -0.722 . . . . 2.15 109.922 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.567 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.5 ttt-85 -61.2 -30.5 70.46 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.275 1.036 . . . . 2.33 108.769 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.08 -49.8 75.86 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.839 0.828 . . . . 0.82 110.097 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.24 -44.29 79.81 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.737 0.779 . . . . 0.85 110.281 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.6 -35.71 81.39 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.293 -0.88 . . . . 1.39 110.803 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 126' ' ' ARG . 49.8 t -69.14 -38.74 78.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 120.975 -1.078 . . . . 0.56 110.823 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.519 HH11 ' HG2' ' A' ' 131' ' ' ARG . 1.8 ttt-85 -55.31 -39.97 70.55 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.494 -1.282 . . . . 3.12 109.53 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -61.32 -36.99 81.65 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.577 0.703 . . . . 1.28 110.088 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.51 -39.91 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.915 -1.116 . . . . 0.49 109.941 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.03 -44.07 98.65 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.567 -1.301 . . . . 0.46 109.899 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.36 -40.12 85.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.403 -1.057 . . . . 2.71 110.744 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.455 HH11 ' HG2' ' A' ' 136' ' ' ARG . 53.3 mtt-85 -59.46 -43.11 93.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.118 -0.989 . . . . 2.14 110.328 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.6 tp -65.4 -45.42 84.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.433 -0.792 . . . . 1.05 110.154 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.536 HD22 ' OD1' ' A' ' 101' ' ' ASP . 87.8 mt -63.23 -42.91 99.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.317 -0.864 . . . . 0.52 110.419 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -59.68 -34.84 73.38 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.657 -0.652 . . . . 2.35 110.688 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -74.97 -42.38 57.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 1.39 110.832 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.99 -38.81 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.461 -0.774 . . . . 0.68 110.337 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 43.8 mt -87.15 -6.09 58.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.998 -1.064 . . . . 0.83 112.178 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.6 23.87 77.49 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 119.445 -1.36 . . . . 0.91 113.057 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.83 150.35 33.07 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.864 -0.786 . . . . 0.95 109.901 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -67.79 150.46 48.6 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.545 -0.862 . . . . 2.43 110.043 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.5 mt -105.32 141.83 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.423 -0.798 . . . . 1.1 109.083 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 17.8 mm -76.21 122.03 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 107.75 -1.204 . . . . 1.58 107.75 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -92.98 94.6 8.99 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.481 -1.674 . . . . 1.62 106.481 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.38 -28.17 59.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.594 -0.692 . . . . 0.8 111.18 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 t -81.21 3.32 24.18 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.868 0.842 . . . . 1.56 111.979 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.08 14.62 21.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.443 -0.786 . . . . 0.84 112.755 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.4 mt -72.89 136.69 24.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.069 -1.02 . . . . 0.82 108.715 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -117.27 -15.31 10.42 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.148 0.975 . . . . 2.31 112.297 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -115.41 140.34 49.22 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.747 0.784 . . . . 1.54 109.092 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -70.62 119.53 14.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.461 -0.774 . . . . 1.38 109.029 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.06 174.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.281 -0.887 . . . . 0.69 109.174 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mt -89.25 145.55 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.53 108.843 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.6 tp -98.1 121.55 40.16 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.062 -1.024 . . . . 0.64 108.37 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.1 130.21 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 108.146 -1.057 . . . . 0.67 108.146 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.98 157.92 27.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.808 -1.182 . . . . 0.78 108.654 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.84 -36.88 82.49 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.386 -1.446 . . . . 1.0 109.829 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -172.96 149.7 1.92 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.404 -0.591 . . . . 2.42 109.404 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.8 mt -117.64 141.24 48.6 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.405 -0.809 . . . . 0.75 109.009 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.6 p -94.03 151.23 39.54 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.741 -1.224 . . . . 0.78 108.88 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -41.57 -46.22 6.17 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.251 1.968 . . . . 0.67 113.838 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.0 m -58.88 -49.91 76.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.761 -1.212 . . . . 0.7 110.45 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.26 -38.71 87.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.915 0.864 . . . . 1.21 110.225 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.2 p -70.0 -39.9 75.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.6 110.416 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.84 74.32 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.712 -0.618 . . . . 0.62 110.656 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -93.09 -3.56 53.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 1.16 112.767 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.0 tp -64.62 150.99 45.95 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.291 -0.633 . . . . 0.73 109.291 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -93.95 112.43 24.27 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.636 -1.616 . . . . 2.24 106.636 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.0 mt -70.3 -22.23 62.86 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.769 -0.582 . . . . 1.43 111.704 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -83.35 -15.83 48.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.479 -0.763 . . . . 2.15 112.919 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -102.79 -4.04 25.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.206 -0.934 . . . . 2.04 113.446 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 178' ' ' GLY . 64.3 t -111.14 129.93 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.197 -1.038 . . . . 0.55 108.197 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.5 tp -83.99 -10.04 58.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.327 -0.858 . . . . 1.63 112.263 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.508 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.5 166.98 35.59 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.796 -1.721 . . . . 0.47 108.796 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -126.37 127.49 45.57 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.51 -1.293 . . . . 0.54 107.51 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 61.0 mt -125.34 127.91 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 106.702 -1.592 . . . . 0.69 106.702 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 203' ' ' VAL . 30.2 p -138.57 174.61 10.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.005 -1.06 . . . . 0.82 109.704 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 52.8 t0 -106.32 34.71 3.24 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.375 0.607 . . . . 2.37 110.712 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.222 0 N-CA-C 107.262 -1.384 . . . . 1.11 107.262 178.302 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 108.834 -0.802 . . . . 1.69 108.834 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -58.45 -38.08 76.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 1.07 111.208 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.447 ' H ' HG23 ' A' ' 190' ' ' THR . 3.8 p -56.66 -43.28 80.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.31 -1.494 . . . . 1.58 110.199 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.1 p -61.97 -36.17 80.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.3 -0.875 . . . . 1.6 110.316 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.3 mt -61.46 -36.79 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.142 -0.974 . . . . 1.45 110.759 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 85.3 mtp -62.08 -46.94 86.89 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.653 1.216 . . . . 1.05 109.48 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.5 -51.77 67.26 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.016 -0.993 . . . . 0.72 110.748 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -63.15 -44.88 94.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.277 -0.89 . . . . 3.05 110.759 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.4 m -66.9 -38.13 85.68 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.768 -1.207 . . . . 0.89 110.288 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 25.3 mt -91.45 -0.42 57.62 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.723 0.638 . . . . 0.78 112.723 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 56.23 5.52 0.19 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 114.444 1.275 . . . . 1.45 114.444 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.6 mt -72.26 143.05 85.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.919 -1.113 . . . . 0.67 108.396 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.56 137.07 75.39 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.298 1.332 . . . . 0.64 110.292 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.29 169.39 20.72 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 117.762 -1.575 . . . . 0.67 109.803 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.446 HD12 HD11 ' A' ' 220' ' ' LEU . 58.2 mt -145.72 156.85 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.808 -1.182 . . . . 0.69 107.808 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 181' ' ' THR . 25.5 m -140.47 -29.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.268 -0.895 . . . . 0.85 112.893 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.62 38.44 3.11 Favored Glycine 0 N--CA 1.486 2.025 0 O-C-N 121.293 -0.879 . . . . 0.92 112.058 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.3 p -53.25 -26.55 18.46 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.506 -0.997 . . . . 0.95 111.622 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 88.56 -88.98 1.56 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.82 -0.912 . . . . 1.04 110.82 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 39.7 t -128.45 30.43 5.16 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.189 -1.183 . . . . 1.57 112.285 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 44.7 t -62.01 -38.45 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.435 -1.416 . . . . 0.84 109.991 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.8 p -53.19 -21.37 5.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 0.99 111.308 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.3 t -95.02 0.73 54.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.222 -0.924 . . . . 1.7 111.581 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -126.31 -6.36 6.51 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 113.345 0.869 . . . . 2.2 113.345 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 10.2 t -117.31 145.59 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 122.014 0.911 . . . . 0.84 109.434 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -118.94 155.07 31.97 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.026 -1.102 . . . . 2.2 108.026 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 35.5 p-10 -54.58 140.69 34.12 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.844 -1.16 . . . . 2.28 110.724 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 m-20 78.81 5.89 2.34 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.484 1.29 . . . . 2.35 114.484 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.0 149.23 47.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.746 -1.221 . . . . 1.97 108.388 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -88.86 117.63 27.99 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.29 -1.374 . . . . 2.65 107.29 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 16' ' ' ALA . 84.1 mt -128.58 149.62 50.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.763 0.792 . . . . 0.63 109.498 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.3 mt -115.12 129.86 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.77 -1.567 . . . . 0.62 106.77 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 202' ' ' ILE . 64.4 tp -101.02 117.06 34.28 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.41 -2.07 . . . . 0.64 105.41 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.577 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.8 t0 -90.63 -24.36 20.53 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.078 -1.049 . . . . 2.05 112.574 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.886 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.13 17.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 112.735 0.643 . . . . 0.84 112.735 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' A' ' 221' ' ' ASP . 26.0 t -114.42 -64.59 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.959 0.885 . . . . 1.02 109.135 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -89.73 9.41 27.29 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.139 0.971 . . . . 2.51 110.582 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 52.2 t30 60.34 49.81 6.68 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.67 0.748 . . . . 1.54 111.589 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -147.53 153.03 38.97 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.193 0.996 . . . . 1.95 109.669 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 76.5 t -118.43 140.03 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.507 -0.923 . . . . 0.71 108.507 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.25 132.79 42.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.86 -1.15 . . . . 1.01 107.984 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 44.1 t -109.8 129.68 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 108.474 -0.936 . . . . 0.82 108.474 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.408 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 58.5 t30 47.28 54.57 15.64 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 113.577 0.955 . . . . 1.54 113.577 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 40.5 Cg_endo -67.88 151.89 77.78 Favored 'Trans proline' 0 C--N 1.297 -2.177 0 C-N-CA 122.462 2.108 . . . . 0.94 110.033 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.5 m -74.17 155.32 38.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.823 -0.806 . . . . 1.8 108.823 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -57.58 -39.52 76.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.151 -0.968 . . . . 2.73 110.468 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.45 -38.28 89.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.349 -0.845 . . . . 3.17 110.208 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.44 -37.53 75.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.497 -0.752 . . . . 1.34 110.523 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.26 -44.39 95.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.783 -0.767 . . . . 1.2 110.498 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -58.9 -39.4 81.35 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.482 -0.761 . . . . 2.7 110.034 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -60.53 -40.45 91.55 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.46 -0.775 . . . . 2.59 110.239 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 83.8 mtp -74.74 -41.51 60.0 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.016 -1.053 . . . . 1.38 110.537 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 . . . . . 0 C--N 1.307 -1.264 0 C-N-CA 119.513 -0.875 . . . . 2.84 109.689 -178.908 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.3 mt . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 106.737 -1.579 . . . . 1.07 106.737 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.5 m -105.24 122.0 45.02 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.629 -1.249 . . . . 1.24 107.629 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.41 -157.4 13.37 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.643 -1.783 . . . . 1.01 108.643 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 5' ' ' ILE . 85.1 mt -92.69 -1.46 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.327 -1.102 . . . . 1.11 112.552 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 tp 49.83 102.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.99 112.227 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.14 -44.44 11.5 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.138 -0.976 . . . . 0.85 111.589 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 m -144.32 143.81 23.43 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 107.971 -1.122 . . . . 1.38 107.971 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.78 143.01 23.21 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.996 2.464 . . . . 0.94 112.344 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.942 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.67 168.09 16.28 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 109.236 -1.546 . . . . 0.81 109.236 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.8 mt -124.35 137.51 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.034 -1.274 . . . . 0.83 107.845 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.17 148.36 43.08 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.323 -0.861 . . . . 0.53 109.081 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 7.3 m-85 -118.0 139.87 50.56 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 108.378 -0.971 . . . . 0.77 108.378 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.2 167.77 35.45 Favored Glycine 0 N--CA 1.499 2.862 0 C-N-CA 118.806 -1.664 . . . . 0.51 110.05 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HZ3' HG12 ' A' ' 156' ' ' VAL . 28.1 mtmm -78.84 159.83 27.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -1.126 . . . . 1.9 109.494 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.93 126.69 34.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.705 -1.247 . . . . 0.66 107.994 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.426 HD12 HD22 ' A' ' 214' ' ' ASN . 48.8 tp -103.53 105.25 15.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.569 -2.011 . . . . 0.83 105.569 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.1 tp -92.14 134.47 34.82 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.866 -1.161 . . . . 0.86 107.866 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.1 mt -102.21 116.45 32.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.081 -1.452 . . . . 0.92 107.081 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -109.46 131.54 54.97 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.537 -1.282 . . . . 2.03 107.537 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -126.89 152.64 46.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.381 -0.824 . . . . 2.66 109.664 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -83.47 134.41 34.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.131 -1.063 . . . . 2.32 108.131 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.87 148.84 50.62 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.752 -0.833 . . . . 2.11 108.752 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.69 132.28 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.306 -0.998 . . . . 0.73 108.306 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.6 t -108.76 129.94 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.857 -1.164 . . . . 0.87 107.857 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.3 133.4 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.391 -0.966 . . . . 0.81 108.391 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -93.24 128.97 39.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.096 -1.002 . . . . 1.34 108.325 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -97.31 18.95 14.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.277 -0.889 . . . . 2.89 112.004 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -71.19 149.01 46.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 2.09 109.783 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -92.37 138.05 31.85 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.413 -0.958 . . . . 2.19 108.413 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 pt -97.44 168.41 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.77 . . . . 0.75 109.932 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.4 p -97.71 167.32 11.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.688 -0.632 . . . . 0.91 109.939 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.77 -24.72 58.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.005 -1.059 . . . . 0.93 111.858 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -68.72 -37.97 79.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 2.28 110.905 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -84.98 -7.26 59.22 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.72 -1.237 . . . . 1.45 112.354 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -58.59 -45.01 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.114 -0.991 . . . . 0.81 110.137 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -57.95 -39.78 78.91 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.967 -1.083 . . . . 1.54 110.588 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -63.08 -45.42 92.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.162 -0.961 . . . . 2.36 111.037 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -59.88 -40.33 88.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.928 -1.108 . . . . 1.31 110.777 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.1 t -59.93 -41.24 85.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.22 -0.925 . . . . 0.82 110.689 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -60.1 -47.23 86.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.917 -1.114 . . . . 1.5 110.078 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -61.36 -40.9 96.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.774 -0.771 . . . . 2.23 110.247 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -75.29 -56.12 5.03 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.572 -0.705 . . . . 0.85 110.307 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 tp -58.01 -45.62 86.57 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.548 -0.861 . . . . 0.91 110.375 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 9.2 t -66.36 -37.08 84.5 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.159 -0.963 . . . . 0.9 109.749 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.66 -41.77 93.9 Favored Glycine 0 N--CA 1.483 1.819 0 C-N-CA 119.582 -1.294 . . . . 0.69 109.937 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 46.0 ttt-85 -59.81 -29.77 68.47 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.172 -1.193 . . . . 2.88 109.924 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -62.35 -49.16 76.67 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.607 0.718 . . . . 0.85 110.493 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -38.79 23.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.954 -1.092 . . . . 2.35 110.684 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.38 93.31 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.105 -0.997 . . . . 0.65 110.074 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.7 p -63.55 -40.8 97.95 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.046 -1.034 . . . . 1.45 109.439 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.59 -48.5 66.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.537 -0.465 . . . . 0.63 110.477 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.77 -49.17 76.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.925 -1.109 . . . . 1.34 110.724 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.15 -39.13 88.94 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.858 -1.151 . . . . 1.56 109.971 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -59.84 -41.0 90.44 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.216 -0.594 . . . . 1.19 110.319 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.509 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 18.7 m -68.49 -45.12 73.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.142 -0.974 . . . . 0.72 110.246 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.8 mt -58.34 -33.95 48.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.338 -0.851 . . . . 0.62 110.815 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -53.07 -42.82 66.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.178 -0.952 . . . . 1.05 110.844 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.58 -36.34 76.17 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.021 -1.049 . . . . 0.64 110.051 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.509 ' NZ ' HG22 ' A' ' 56' ' ' THR . 62.4 mttp -62.67 -39.62 94.5 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.75 -1.18 . . . . 1.73 109.447 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.13 -33.97 77.28 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.75 -0.78 . . . . 0.56 109.983 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.15 -36.72 17.18 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.878 -1.153 . . . . 0.69 111.132 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -81.65 -25.41 35.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.06 -1.259 . . . . 1.48 111.189 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.8 m -86.48 -48.33 8.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.557 -0.714 . . . . 0.98 111.042 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -107.94 -9.33 15.71 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.031 1.123 . . . . 1.16 114.031 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.71 166.45 23.45 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.423 -0.894 . . . . 0.85 112.749 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.1 -28.15 50.39 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.702 -0.881 . . . . 3.86 112.409 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -54.44 -40.19 68.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.94 -1.1 . . . . 2.35 110.73 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -85.24 -25.99 26.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.902 -1.124 . . . . 1.67 111.926 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.37 -39.9 84.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.469 -0.769 . . . . 1.45 110.631 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.64 90.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.852 . . . . 0.61 110.89 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.94 -45.68 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.009 -1.057 . . . . 0.65 110.315 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -71.31 -31.0 66.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.66 110.441 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.31 -40.12 89.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.012 -1.055 . . . . 1.19 109.68 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.7 -38.85 93.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.208 -1.157 . . . . 0.53 110.208 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -58.28 -42.07 85.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.227 -1.161 . . . . 1.27 110.489 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.37 -39.34 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.54 110.195 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.3 ttp -59.04 -39.36 81.77 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.178 -0.951 . . . . 1.74 110.491 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.39 -51.39 70.03 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.195 -1.002 . . . . 0.55 110.796 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.76 -38.15 90.03 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.376 -0.827 . . . . 0.47 109.994 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -84.67 4.72 31.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.287 0.847 . . . . 1.42 113.287 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -66.75 123.48 20.24 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.576 -1.328 . . . . 1.27 108.169 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -65.71 -20.19 66.19 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.778 0.799 . . . . 1.35 110.811 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -75.24 -49.46 19.26 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.426 -0.909 . . . . 2.22 110.737 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.2 -40.04 95.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.056 -1.027 . . . . 0.62 110.629 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -60.45 -48.22 82.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.002 -1.061 . . . . 1.29 110.602 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.33 -39.97 92.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.385 -0.822 . . . . 1.52 110.771 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -63.73 -46.5 85.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.022 -1.071 . . . . 1.3 110.256 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.5 mt -58.36 -43.66 86.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.23 -0.919 . . . . 0.61 110.067 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.485 HG22 ' NZ ' ' A' ' 94' ' ' LYS . 66.6 mt -63.24 -44.07 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.467 -0.771 . . . . 0.78 110.61 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.53 -41.28 97.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.82 111.146 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.11 -44.85 96.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.054 -1.028 . . . . 0.8 110.736 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.02 -45.1 99.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.16 -0.963 . . . . 0.77 110.305 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.485 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 22.7 mtmm -83.2 -37.57 23.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 2.12 111.665 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -79.16 -45.33 20.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.821 -1.174 . . . . 1.51 111.453 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -101.55 8.02 42.07 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.187 -0.945 . . . . 1.98 112.272 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 51.85 49.77 20.04 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.329 -0.857 . . . . 1.32 112.097 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.8 mtp -106.78 156.8 18.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.264 -0.897 . . . . 1.38 108.838 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.8 p -72.71 161.18 31.08 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.474 -0.766 . . . . 0.67 110.361 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.62 93.65 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.459 -0.776 . . . . 0.52 110.531 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.46 ' OD1' HG21 ' A' ' 141' ' ' ILE . 97.3 m-20 -68.64 -39.46 80.71 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.069 -1.019 . . . . 2.25 110.392 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.89 -52.34 25.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.186 -1.005 . . . . 0.64 110.84 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.07 92.44 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.1 -1.0 . . . . 0.56 110.519 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.46 96.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.339 -0.851 . . . . 0.46 110.565 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -60.64 -38.86 86.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.166 -0.959 . . . . 1.32 110.738 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -54.95 -49.5 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 1.3 111.158 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.21 -47.28 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.844 -1.16 . . . . 0.61 109.987 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -61.93 -32.35 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.352 0.596 . . . . 0.65 110.568 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -58.51 -40.76 83.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -0.877 . . . . 2.11 111.189 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.41 -37.15 8.31 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.064 -1.541 . . . . 0.83 112.888 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -60.3 -38.89 85.06 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.586 -1.538 . . . . 1.28 110.095 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.61 -51.78 15.66 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.54 0.686 . . . . 0.89 110.89 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.6 p -63.49 -35.77 81.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 1.87 110.606 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.44 96.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.795 . . . . 1.05 110.629 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 80.1 mt -65.79 -29.99 70.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.053 -1.03 . . . . 1.02 110.655 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -67.16 -22.57 65.75 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.353 -0.842 . . . . 2.04 110.933 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -70.32 -16.12 62.96 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.593 -0.843 . . . . 1.73 111.131 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 123' ' ' LEU . 21.8 mt -84.66 144.38 28.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.579 -0.7 . . . . 1.37 109.949 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -97.74 37.36 1.4 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.479 -0.763 . . . . 2.88 111.987 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -113.56 139.22 49.18 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 108.377 -0.972 . . . . 1.58 108.377 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -59.96 -40.64 89.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.484 -0.76 . . . . 3.04 110.775 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.34 -50.9 34.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.788 -1.195 . . . . 0.9 110.177 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 118' ' ' LEU . 35.2 mt -63.23 -42.5 99.25 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.85 -1.14 . . . . 1.06 110.022 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -63.35 -49.01 75.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.787 -1.196 . . . . 2.18 109.266 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -59.94 -31.07 69.51 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.606 -0.838 . . . . 2.15 109.386 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.56 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 17.7 ttt-85 -61.93 -30.44 70.9 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.992 0.901 . . . . 2.33 108.82 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -60.86 -49.37 77.74 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.718 0.771 . . . . 0.82 109.366 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.22 85.59 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.581 -0.848 . . . . 0.85 110.258 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -63.32 -37.41 87.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.552 -0.717 . . . . 1.39 110.417 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.56 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 39.9 t -69.18 -39.7 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 0.56 109.936 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -58.58 -36.55 74.15 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.016 -1.052 . . . . 3.12 109.734 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -59.92 -39.74 86.48 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.455 0.645 . . . . 1.28 110.052 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.1 mt -61.97 -39.55 84.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.438 -0.789 . . . . 0.49 109.509 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.97 -46.8 50.18 Favored Glycine 0 N--CA 1.483 1.773 0 C-N-CA 119.766 -1.207 . . . . 0.46 110.517 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.74 -49.99 71.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -1.155 . . . . 2.71 110.289 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -62.64 -39.25 93.27 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.21 -0.996 . . . . 2.14 109.87 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.33 -39.96 88.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.559 -0.713 . . . . 1.05 110.02 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.47 -44.32 93.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.519 -0.738 . . . . 0.52 110.081 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -60.51 -35.4 75.86 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.102 -0.999 . . . . 2.35 110.26 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -73.06 -40.21 65.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 1.39 110.7 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.46 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.7 mt -60.28 -40.01 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 0.68 109.942 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.459 HD21 ' OD2' ' A' ' 101' ' ' ASP . 91.0 mt -91.01 -3.45 57.23 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.209 -0.932 . . . . 0.83 112.416 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.47 23.23 77.72 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.808 -1.187 . . . . 0.91 113.13 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.9 tp -66.16 149.26 50.58 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.744 -0.856 . . . . 0.95 109.284 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -64.64 144.91 56.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 2.43 109.433 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 53.8 mt -105.46 143.12 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.436 -0.949 . . . . 1.1 108.436 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.587 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.2 mp -77.8 125.03 37.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.09 -1.078 . . . . 1.58 108.09 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -95.89 93.16 6.88 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.585 -1.635 . . . . 1.62 106.585 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.9 mt -78.81 -16.53 57.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 0.8 111.981 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.5 m -80.66 0.76 32.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.338 -0.851 . . . . 1.56 112.572 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.03 19.75 14.58 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.24 -0.913 . . . . 0.84 112.459 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.0 mt -74.86 136.72 24.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.515 0.674 . . . . 0.82 109.3 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -125.17 -2.78 7.58 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.448 0.642 . . . . 2.31 112.51 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -116.86 134.28 54.96 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.248 -1.019 . . . . 1.54 108.248 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.72 119.1 15.4 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.075 -0.713 . . . . 1.38 109.075 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.477 HG12 ' HZ3' ' A' ' 15' ' ' LYS . 27.8 m -147.38 172.27 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.518 -0.739 . . . . 0.69 109.286 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.1 mt -87.33 142.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 0.53 109.093 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 25.6 tp -96.46 123.76 40.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.077 -1.014 . . . . 0.64 108.432 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.68 129.74 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 107.594 -1.261 . . . . 0.67 107.594 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.14 152.53 19.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.033 -1.042 . . . . 0.78 108.95 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.68 -35.46 76.31 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.585 -1.322 . . . . 1.0 109.424 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 64.2 t0 -172.54 147.26 1.83 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.268 -0.641 . . . . 2.42 109.268 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.502 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 82.3 mt -116.23 141.61 47.92 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.179 -0.675 . . . . 0.75 109.179 177.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.5 p -94.08 150.25 38.15 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.159 -0.963 . . . . 0.78 109.152 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -42.02 -44.3 7.23 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.007 1.805 . . . . 0.67 113.719 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.8 m -59.94 -48.25 82.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.883 -1.136 . . . . 0.7 110.055 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.95 -40.69 95.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.225 -0.99 . . . . 1.21 110.126 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 70.7 p -70.22 -39.01 75.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.6 110.401 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.04 -34.35 74.72 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.896 -0.722 . . . . 0.62 110.881 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -95.7 1.37 53.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.074 -1.017 . . . . 1.16 112.521 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.51 152.02 31.3 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.384 -0.822 . . . . 0.73 109.778 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -93.65 110.91 22.51 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.057 -1.831 . . . . 2.24 106.057 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.1 mt -72.26 -21.15 61.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.638 -0.664 . . . . 1.43 112.318 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -82.53 -23.57 34.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.929 -1.107 . . . . 2.15 112.386 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -97.15 -4.98 38.24 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.035 -1.041 . . . . 2.04 113.094 -178.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.2 t -108.34 128.78 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.566 -1.272 . . . . 0.55 107.566 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.1 tp -88.5 -12.05 44.06 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.403 -0.811 . . . . 1.63 112.241 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 179.26 167.72 37.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.639 -1.785 . . . . 0.47 108.639 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -128.01 131.48 49.2 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.255 -1.144 . . . . 0.54 108.458 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.448 ' CG2' HG21 ' A' ' 205' ' ' THR . 76.8 mt -127.12 129.91 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.172 -1.418 . . . . 0.69 107.172 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 203' ' ' VAL . 37.8 p -138.96 169.95 16.86 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.593 -1.317 . . . . 0.82 110.066 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.438 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 4.3 m-20 -101.07 35.5 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.875 -0.515 . . . . 2.37 111.53 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.888 0 O-C-N 120.922 -1.112 . . . . 1.11 108.325 178.59 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.598 0.713 . . . . 1.69 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -57.6 -39.66 77.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -0.875 . . . . 1.07 111.088 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 44.1 p -59.74 -41.4 90.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.068 -1.02 . . . . 1.58 110.498 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 59.9 p -61.15 -35.49 77.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 1.6 110.367 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.03 -39.59 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 1.45 110.852 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 66.0 mtp -62.89 -40.78 98.59 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.233 1.016 . . . . 1.05 109.409 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.44 -48.95 79.67 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.739 -0.664 . . . . 0.72 110.297 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 195' ' ' ARG . 38.7 mtt-85 -61.16 -41.57 97.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.238 -0.914 . . . . 3.05 110.938 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m -70.3 -40.57 74.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.963 -1.086 . . . . 0.89 110.539 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.57 -9.1 48.34 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.043 0.757 . . . . 0.78 113.043 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.5 mt-10 55.63 8.35 0.32 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.794 1.035 . . . . 1.45 113.794 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 56.8 mt -72.56 147.98 90.0 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 0.67 108.267 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.76 136.3 72.89 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 120.982 1.121 . . . . 0.64 110.027 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.31 164.63 34.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.398 -1.439 . . . . 0.67 109.429 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 203' ' ' VAL . 99.1 mt -144.1 160.19 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.335 -1.357 . . . . 0.69 107.335 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.497 ' N ' HG22 ' A' ' 202' ' ' ILE . 15.7 m -139.09 -27.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 120.818 -1.176 . . . . 0.85 112.023 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.75 41.03 3.04 Favored Glycine 0 N--CA 1.492 2.43 0 O-C-N 121.242 -0.911 . . . . 0.92 111.841 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.448 HG21 ' CG2' ' A' ' 180' ' ' ILE . 46.9 p -62.69 -23.72 67.28 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.24 -1.153 . . . . 0.95 111.007 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.04 -92.17 1.78 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.077 -1.059 . . . . 1.04 110.668 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 86.0 p -128.35 30.61 5.16 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.178 -1.189 . . . . 1.57 112.302 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.21 -33.68 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.264 -1.522 . . . . 0.84 110.107 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 26.0 p -58.14 -26.76 63.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.987 -1.071 . . . . 0.99 111.52 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.8 t -93.58 1.82 56.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.301 -0.875 . . . . 1.7 111.999 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -123.95 -0.53 8.43 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 112.911 0.708 . . . . 2.2 112.911 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 11.1 t -120.01 150.87 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.52 -0.737 . . . . 0.84 109.853 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -118.73 157.81 26.77 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.918 -1.142 . . . . 2.2 107.918 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.426 HD22 HD12 ' A' ' 17' ' ' LEU . 12.5 t-20 -59.26 141.2 54.96 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.978 -1.076 . . . . 2.28 110.492 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.3 m-20 80.75 -1.5 1.85 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 114.525 1.306 . . . . 2.35 114.525 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -62.33 148.85 43.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.34 -1.475 . . . . 1.97 108.176 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -88.57 120.84 30.32 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.311 -1.366 . . . . 2.65 107.311 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.8 mt -128.48 146.38 50.83 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.664 0.745 . . . . 0.63 109.905 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.11 126.76 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.617 -1.623 . . . . 0.62 106.617 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 65.5 tp -100.52 119.64 38.81 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.355 -1.721 . . . . 0.64 106.355 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 53.3 t0 -92.25 -26.4 18.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.893 -1.13 . . . . 2.05 112.518 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.942 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.11 13.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.137 0.791 . . . . 0.84 113.137 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.2 t -108.27 -59.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.741 -1.224 . . . . 1.02 109.695 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -92.68 10.12 32.01 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.018 0.913 . . . . 2.51 110.561 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 62.15 53.58 2.89 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.659 -0.7 . . . . 1.54 112.242 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -147.0 149.06 32.4 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.371 1.081 . . . . 1.95 109.645 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.1 t -115.98 133.33 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.444 -1.317 . . . . 0.71 107.444 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.11 132.57 46.5 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.026 -1.047 . . . . 1.01 108.468 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 60.4 t -110.48 129.94 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.365 -0.834 . . . . 0.82 108.763 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.4 t30 54.34 55.2 11.73 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.15 -0.969 . . . . 1.54 113.232 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.09 150.42 60.06 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.582 2.188 . . . . 0.94 111.322 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.5 m -75.2 158.87 32.29 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.254 -0.904 . . . . 1.8 109.313 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.58 ' HA ' HD12 ' A' ' 236' ' ' ILE . 81.8 m-20 -58.75 -39.09 79.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 2.73 110.688 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -58.82 -40.17 83.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -0.937 . . . . 3.17 109.865 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.65 -39.09 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 1.34 110.105 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 233' ' ' ASN . 95.4 mt -57.35 -47.26 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.818 -0.753 . . . . 1.2 110.715 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.92 -40.22 88.12 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.326 -0.859 . . . . 2.7 110.557 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -61.17 -48.12 83.03 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.401 -0.812 . . . . 2.59 111.289 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 81.9 mtp -70.44 -33.1 70.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 1.38 111.092 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 . . . . . 0 C--N 1.303 -1.428 0 O-C-N 120.983 -1.073 . . . . 2.84 110.076 179.295 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.1 mt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.557 0.694 . . . . 1.07 111.962 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.0 m -97.38 116.67 30.02 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.576 -1.639 . . . . 1.24 106.576 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.78 -153.47 30.29 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 120.441 -1.412 . . . . 1.01 109.912 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 5' ' ' ILE . 74.6 mt -94.43 1.01 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.586 -0.949 . . . . 1.11 112.552 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 tp 52.52 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.685 -1.26 . . . . 0.99 112.444 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.54 -35.33 17.01 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.648 -1.283 . . . . 0.85 110.744 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 1.2 p -148.67 140.96 14.85 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.711 -1.243 . . . . 1.38 108.083 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.0 147.88 24.33 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.151 1.901 . . . . 0.94 112.347 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.929 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.56 163.64 11.79 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.265 -1.534 . . . . 0.81 109.265 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.5 mt -121.05 134.33 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.057 -1.261 . . . . 0.83 108.345 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.25 151.85 44.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.193 -0.942 . . . . 0.53 109.416 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 7.9 m-85 -122.06 144.46 48.9 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.431 -0.951 . . . . 0.77 108.431 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.85 166.27 31.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.551 -1.785 . . . . 0.51 110.092 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -77.88 159.68 28.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.329 -1.101 . . . . 1.9 109.204 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -87.53 127.69 35.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.792 -1.188 . . . . 0.66 107.792 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.2 tp -106.11 109.53 21.49 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 105.468 -2.049 . . . . 0.83 105.468 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 18' ' ' LEU . 14.8 tp -95.58 136.27 36.17 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.414 -1.328 . . . . 0.86 107.414 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.8 mt -99.8 118.82 37.09 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.062 -1.459 . . . . 0.92 107.062 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -112.05 136.19 51.72 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.65 -1.241 . . . . 2.03 107.65 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -130.33 151.96 50.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.251 -0.906 . . . . 2.66 109.149 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -80.06 138.35 36.96 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.478 -0.934 . . . . 2.32 108.478 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -63.79 149.33 47.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.454 -0.779 . . . . 2.11 109.002 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.6 mt -92.69 129.97 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.915 -1.116 . . . . 0.73 108.651 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.9 t -105.36 130.01 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.529 -1.285 . . . . 0.87 107.529 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.27 135.03 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.654 -0.869 . . . . 0.81 108.654 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -90.91 122.1 33.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.075 -1.016 . . . . 1.34 108.512 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -95.4 11.8 31.52 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.591 -0.693 . . . . 2.89 112.106 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -66.97 141.54 57.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.88 -1.138 . . . . 2.09 108.885 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -88.9 134.16 34.05 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.138 -1.06 . . . . 2.19 108.138 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -97.78 167.14 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.394 -0.816 . . . . 0.75 110.477 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.6 p -94.67 160.95 14.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.686 -0.633 . . . . 0.91 109.53 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.41 -21.92 11.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.903 -1.123 . . . . 0.93 111.94 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -67.53 -37.24 82.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 2.28 110.753 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -90.25 -8.5 50.85 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.649 -1.282 . . . . 1.45 112.587 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.1 t -58.89 -39.82 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.446 -0.784 . . . . 0.81 110.553 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -56.33 -40.24 74.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.929 -1.107 . . . . 1.54 110.187 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.29 -39.5 94.74 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.432 -0.793 . . . . 2.36 111.045 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.46 -43.54 96.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.025 -1.047 . . . . 1.31 110.707 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.24 -40.85 84.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.23 -0.918 . . . . 0.82 110.501 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -60.58 -45.37 94.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.237 -0.914 . . . . 1.5 110.107 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -61.83 -40.57 95.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.582 -0.699 . . . . 2.23 110.287 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -74.02 -52.84 11.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.094 -1.004 . . . . 0.85 109.934 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.6 tp -61.77 -47.96 82.84 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.554 -0.859 . . . . 0.91 110.09 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.1 t -69.92 -38.06 76.13 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.289 -0.882 . . . . 0.9 109.703 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.89 -40.8 95.71 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.037 -1.625 . . . . 0.69 109.037 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.564 HH22 ' CD ' ' A' ' 86' ' ' GLU . 17.2 ttm180 -59.2 -30.69 68.4 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.737 0.779 . . . . 2.88 109.334 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.29 -49.79 76.5 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.614 0.721 . . . . 0.85 110.365 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -82.7 -38.33 23.51 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.297 -0.877 . . . . 2.35 110.169 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.5 -44.85 95.54 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.84 -0.744 . . . . 0.65 109.905 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.8 t -60.13 -40.21 88.99 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.339 1.066 . . . . 1.45 108.797 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.62 -45.93 88.04 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.648 -0.706 . . . . 0.63 109.771 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -61.46 -50.44 72.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.995 -1.065 . . . . 1.34 110.324 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.26 -39.83 91.81 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.321 -0.862 . . . . 1.56 110.071 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -59.9 -43.11 95.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.887 -0.508 . . . . 1.19 110.619 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 m -63.96 -42.36 97.3 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.789 -1.194 . . . . 0.72 109.948 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.6 -35.2 61.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.68 -0.638 . . . . 0.62 110.337 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -53.03 -41.51 64.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.431 -0.793 . . . . 1.05 110.442 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -70.34 -35.42 73.59 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.376 -0.828 . . . . 0.64 109.691 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.48 -40.9 92.93 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.221 -0.991 . . . . 1.73 109.045 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.08 -36.01 82.18 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 120.178 -0.609 . . . . 0.56 109.47 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.2 -35.07 27.92 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.588 -1.291 . . . . 0.69 110.435 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.36 -16.98 50.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.318 -1.107 . . . . 1.48 111.209 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.6 m -91.24 -54.88 3.74 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.264 0.554 . . . . 0.98 110.381 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 67' ' ' GLU . 61.5 m-85 -107.35 -30.48 8.67 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.11 0.782 . . . . 1.16 113.11 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 61.48 -26.13 0.06 OUTLIER Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.536 -1.316 . . . . 0.85 115.059 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 65' ' ' PHE . 52.5 mt-10 -54.84 -166.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.556 -0.967 . . . . 3.86 109.844 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -66.57 7.29 0.36 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 112.953 0.723 . . . . 2.35 112.953 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -68.6 -24.64 64.6 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.461 -0.774 . . . . 1.67 111.375 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -58.65 -40.21 82.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.021 -1.049 . . . . 1.45 110.687 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.83 -36.56 84.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.869 . . . . 0.61 110.958 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 72' ' ' ILE . 13.3 mt -64.8 -45.91 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.65 110.718 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -69.62 -33.96 73.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.863 -1.148 . . . . 0.66 110.257 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.44 -39.23 90.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.302 -0.874 . . . . 1.19 110.174 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.09 -37.74 95.01 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.664 -0.974 . . . . 0.53 110.664 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -59.84 -41.98 92.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -1.114 . . . . 1.27 110.343 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.8 mt -61.2 -40.96 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.09 . . . . 0.54 110.43 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.3 ttt -59.71 -39.65 85.35 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 120.97 -1.081 . . . . 1.74 110.523 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 tp -58.43 -49.98 75.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.114 -0.991 . . . . 0.55 110.199 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.5 tp -61.67 -42.08 98.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.099 -1.001 . . . . 0.47 109.961 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -86.63 9.08 19.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.482 -0.762 . . . . 1.42 112.564 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.05 121.45 14.19 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.12 -0.988 . . . . 1.27 108.505 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.63 -18.89 65.12 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.455 -0.778 . . . . 1.35 111.067 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.61 -50.63 14.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.51 -0.876 . . . . 2.22 110.41 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.28 -35.39 77.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.208 -0.597 . . . . 0.62 110.684 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.564 ' CD ' HH22 ' A' ' 47' ' ' ARG . 72.5 tt0 -59.77 -47.45 85.62 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.444 -0.785 . . . . 1.29 110.473 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -61.22 -37.48 83.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.35 -0.844 . . . . 1.52 110.756 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -68.44 -48.83 63.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 1.3 110.673 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.5 mt -57.6 -43.51 83.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.179 -0.95 . . . . 0.61 110.242 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.0 mt -60.09 -40.63 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.462 -0.774 . . . . 0.78 110.411 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.42 95.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.563 -0.711 . . . . 0.82 110.685 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.31 -45.61 92.78 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.96 -1.087 . . . . 0.8 110.313 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.28 -49.11 80.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.155 -0.966 . . . . 0.77 110.335 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -73.8 -36.44 65.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.916 -1.115 . . . . 2.12 111.842 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -78.5 -47.77 16.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.833 -1.167 . . . . 1.51 111.469 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -101.48 7.43 42.45 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.422 -0.799 . . . . 1.98 112.846 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.4 m80 52.39 50.1 19.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.824 -1.173 . . . . 1.32 111.661 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtt -102.98 158.1 16.52 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.843 0.83 . . . . 1.38 109.16 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.418 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 66.9 p -74.87 161.9 29.13 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.817 -0.552 . . . . 0.67 109.963 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.87 92.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.993 -1.067 . . . . 0.52 110.395 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.418 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 16.7 p-10 -68.64 -39.83 80.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.018 -1.051 . . . . 2.25 110.26 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.26 -51.36 38.26 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.548 -0.861 . . . . 0.64 111.307 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.09 92.78 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.153 -1.019 . . . . 0.56 110.838 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.37 85.23 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.27 -0.894 . . . . 0.46 110.965 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -61.64 -38.88 89.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.686 -1.259 . . . . 1.32 111.499 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.83 -48.98 79.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.779 -1.201 . . . . 1.3 111.219 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.85 -45.99 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.912 -1.118 . . . . 0.61 110.248 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 mm -61.95 -31.13 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.814 . . . . 0.65 109.91 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -59.8 -41.37 91.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 2.11 110.892 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.59 -34.12 12.24 Favored Glycine 0 N--CA 1.498 2.828 0 C-N-CA 119.084 -1.532 . . . . 0.83 112.478 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -60.9 -39.89 91.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.529 -1.571 . . . . 1.28 110.215 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.49 55.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.378 0.609 . . . . 0.89 110.6 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.5 p -62.6 -40.48 97.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.437 -0.789 . . . . 1.87 110.275 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.96 -41.26 96.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 1.05 111.087 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.6 mt -65.67 -30.67 71.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.772 -1.205 . . . . 1.02 111.084 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -66.66 -21.81 66.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.872 -1.143 . . . . 2.04 111.079 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -73.28 -14.18 61.27 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.192 -0.943 . . . . 1.73 111.57 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.407 HD13 HD13 ' A' ' 123' ' ' LEU . 8.1 mt -84.26 142.54 30.18 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.582 -0.699 . . . . 1.37 109.26 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -100.39 55.23 0.89 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 2.88 110.737 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -129.98 137.86 50.53 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.211 -1.033 . . . . 1.58 108.211 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -58.99 -36.61 75.16 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.134 -0.626 . . . . 3.04 110.816 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -73.9 -52.46 12.87 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.791 -1.193 . . . . 0.9 110.381 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.407 HD13 HD13 ' A' ' 118' ' ' LEU . 23.1 mt -64.07 -43.72 94.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.06 -1.025 . . . . 1.06 110.27 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -61.14 -47.35 86.61 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.641 -1.287 . . . . 2.18 109.857 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -61.77 -29.28 70.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.083 -1.011 . . . . 2.15 110.014 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 130' ' ' VAL . 56.0 ttt180 -65.15 -29.0 69.8 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.537 -0.865 . . . . 2.33 109.365 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.55 -49.83 76.27 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.613 -0.835 . . . . 0.82 109.698 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.23 85.02 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.007 -0.677 . . . . 0.85 110.248 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.54 -38.26 90.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.226 -0.921 . . . . 1.39 110.439 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 126' ' ' ARG . 55.2 t -67.92 -40.18 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.913 -1.117 . . . . 0.56 109.839 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -60.08 -37.8 80.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.892 -1.13 . . . . 3.12 110.21 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.54 ' CG ' HH11 ' A' ' 136' ' ' ARG . 42.1 t0 -59.87 -39.23 84.56 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.209 -0.932 . . . . 1.28 110.535 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.31 -39.43 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.562 -0.711 . . . . 0.49 110.1 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.06 -50.48 45.97 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.89 -1.147 . . . . 0.46 110.603 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -59.42 -47.02 87.04 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.112 -1.228 . . . . 2.71 110.534 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.54 HH11 ' CG ' ' A' ' 132' ' ' ASP . 14.8 mtm-85 -64.58 -39.85 94.47 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.067 -1.053 . . . . 2.14 109.883 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.1 tp -61.24 -39.91 92.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.05 110.15 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 73.2 mt -59.34 -40.26 85.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.52 110.704 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.431 ' HE ' HD23 ' A' ' 144' ' ' LEU . 58.0 mtp180 -61.19 -34.52 75.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.128 -0.983 . . . . 2.35 110.344 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -75.58 -40.73 56.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.021 -1.049 . . . . 1.39 110.587 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 98.1 mt -60.04 -39.48 80.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 120.812 -1.18 . . . . 0.68 110.479 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.88 -7.93 58.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.83 111.659 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.26 22.62 64.88 Favored Glycine 0 N--CA 1.483 1.807 0 C-N-CA 120.104 -1.046 . . . . 0.91 113.367 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.431 HD23 ' HE ' ' A' ' 139' ' ' ARG . 43.6 tp -66.41 145.92 55.14 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.744 -0.857 . . . . 0.95 109.418 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -64.5 148.57 50.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.418 -0.801 . . . . 2.43 109.322 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.2 mt -108.61 140.11 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.47 -0.937 . . . . 1.1 108.47 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 21.2 mm -79.77 129.55 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.972 -1.08 . . . . 1.58 108.754 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -96.95 95.67 7.98 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.149 -1.797 . . . . 1.62 106.149 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.43 -22.19 61.13 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.498 -0.751 . . . . 0.8 111.088 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.5 t -78.13 -0.53 28.62 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.084 0.945 . . . . 1.56 112.316 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.9 25.48 5.29 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.438 -0.789 . . . . 0.84 112.236 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.8 mt -71.05 139.97 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.465 -0.772 . . . . 0.82 109.566 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -115.17 -19.89 10.63 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 2.31 112.949 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -117.27 139.61 50.59 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.885 -1.154 . . . . 1.54 107.885 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.6 126.69 30.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.449 -0.945 . . . . 1.38 108.449 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.7 m -149.5 175.16 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.01 -1.056 . . . . 0.69 109.166 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.9 mt -89.09 142.35 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.53 108.644 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 27.6 tp -96.79 124.02 40.65 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.459 -0.941 . . . . 0.64 108.459 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.1 t -125.02 131.98 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.293 -1.003 . . . . 0.67 108.293 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.48 157.63 19.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.78 108.982 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -64.99 -35.35 80.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.686 -1.259 . . . . 1.0 109.304 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.7 t0 -171.45 152.71 3.32 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.845 -0.798 . . . . 2.42 108.845 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.472 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 66.3 mt -115.09 142.98 45.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.677 -0.86 . . . . 0.75 108.677 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.8 p -92.95 147.18 33.43 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.462 -0.773 . . . . 0.78 108.938 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -40.31 -42.04 3.55 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.511 1.474 . . . . 0.67 113.587 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.1 m -61.6 -48.14 82.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.799 -1.188 . . . . 0.7 110.278 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.13 -39.46 89.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.023 -1.048 . . . . 1.21 110.87 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -68.79 -40.51 79.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.344 -0.847 . . . . 0.6 110.783 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.48 79.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -0.949 . . . . 0.62 110.464 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -93.65 -2.39 54.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.913 -1.117 . . . . 1.16 112.396 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 171' ' ' LEU . 42.6 tp -62.13 146.77 49.58 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.251 -1.018 . . . . 0.73 108.251 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -95.33 116.96 29.48 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.727 -1.582 . . . . 2.24 106.727 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.694 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -73.52 -18.82 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.419 -0.801 . . . . 1.43 111.41 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -82.78 -18.26 41.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.526 -0.734 . . . . 2.15 112.293 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -104.15 -6.12 21.34 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.312 0.856 . . . . 2.04 113.312 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 178' ' ' GLY . 52.2 t -108.54 129.67 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.559 -1.275 . . . . 0.55 107.559 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 29.7 tp -82.89 -8.77 59.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.054 -1.029 . . . . 1.63 112.543 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.547 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.98 177.52 38.77 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.599 -1.8 . . . . 0.47 108.599 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -129.28 135.84 49.3 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.975 -1.309 . . . . 0.54 107.588 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.483 HG22 HG21 ' A' ' 205' ' ' THR . 75.1 mt -138.01 105.15 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.145 -1.798 . . . . 0.69 106.145 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 203' ' ' VAL . 76.7 p -129.68 168.94 15.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.357 -0.84 . . . . 0.82 109.416 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 26.1 p-10 -98.68 47.95 0.98 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.737 -0.602 . . . . 2.37 110.93 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.395 -0.816 . . . . 1.11 110.416 -179.849 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 53.5 m . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 107.717 -1.216 . . . . 1.69 107.717 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -60.63 -35.53 76.41 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.383 -0.823 . . . . 1.07 110.422 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.6 p -56.31 -39.7 73.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.167 -0.958 . . . . 1.58 109.982 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.4 m -59.2 -37.29 77.07 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.934 -0.707 . . . . 1.6 110.098 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -59.9 -38.85 78.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.498 -0.751 . . . . 1.45 110.309 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 69.9 mtp -64.1 -40.21 95.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.671 -1.268 . . . . 1.05 109.457 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.8 -48.92 79.73 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.027 -0.533 . . . . 0.72 111.384 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -59.37 -43.95 92.81 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.19 -0.944 . . . . 3.05 110.432 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.1 m -68.97 -40.18 79.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.339 -0.851 . . . . 0.89 110.226 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.6 mt -91.78 -9.32 43.97 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.811 0.815 . . . . 0.78 112.126 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.8 mt-10 47.46 14.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.472 0.916 . . . . 1.45 113.472 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 59.6 mt -75.41 150.27 84.73 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.953 -1.092 . . . . 0.67 108.538 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -51.49 140.51 44.2 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.393 1.396 . . . . 0.64 109.302 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.442 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -159.05 163.61 36.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.209 -1.557 . . . . 0.67 109.829 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.5 mt -147.17 147.04 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.761 -1.2 . . . . 0.69 107.761 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 181' ' ' THR . 9.9 m -129.11 -29.19 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 113.251 0.834 . . . . 0.85 113.251 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.61 46.35 3.66 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 120.344 -0.931 . . . . 0.92 111.97 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.483 HG21 HG22 ' A' ' 180' ' ' ILE . 65.8 p -66.78 -12.88 60.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.965 -1.315 . . . . 0.95 111.229 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.85 -94.42 0.68 Allowed Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.038 -1.077 . . . . 1.04 110.49 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -129.52 31.21 4.82 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.522 -0.987 . . . . 1.57 112.144 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.86 -33.34 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.617 -1.302 . . . . 0.84 110.474 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 80.5 p -56.33 -28.22 58.24 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.076 -1.015 . . . . 0.99 111.171 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 26.4 t -92.26 0.69 57.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.101 -1.0 . . . . 1.7 112.214 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -120.33 -4.19 9.94 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.545 0.943 . . . . 2.2 113.545 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.3 149.42 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.227 -0.92 . . . . 0.84 109.285 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -117.62 149.61 40.39 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.535 -0.913 . . . . 2.2 108.535 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 38.4 p-10 -50.47 141.33 12.34 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.384 -0.926 . . . . 2.28 110.366 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 8.8 t0 81.49 4.06 1.41 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 114.219 1.192 . . . . 2.35 114.219 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -66.7 145.62 55.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.883 -1.136 . . . . 1.97 108.252 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -88.13 119.53 28.6 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.328 -1.36 . . . . 2.65 107.328 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.445 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 85.2 mt -128.66 150.3 50.3 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.506 0.669 . . . . 0.63 110.155 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 56.5 mt -115.09 122.17 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 106.675 -1.602 . . . . 0.62 106.675 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.479 HD13 HD11 ' A' ' 180' ' ' ILE . 62.0 tp -98.99 115.8 29.77 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 106.754 -1.572 . . . . 0.64 106.754 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 9.3 m-20 -95.47 -24.39 16.68 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.414 -0.914 . . . . 2.05 112.606 -177.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.929 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.21 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.652 0.739 . . . . 0.84 112.176 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.7 t -111.38 -61.29 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.654 -0.869 . . . . 1.02 108.654 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -91.13 9.55 30.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.145 0.974 . . . . 2.51 110.159 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 61.93 51.35 3.77 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 114.921 -1.036 . . . . 1.54 111.986 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -153.17 152.79 31.64 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.798 1.285 . . . . 1.95 110.497 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.0 t -117.38 140.79 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.527 -0.916 . . . . 0.71 108.527 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -100.78 132.82 45.99 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.85 -1.156 . . . . 1.01 108.56 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.1 t -109.79 129.55 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.419 -0.956 . . . . 0.82 108.419 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.445 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER 56.38 48.17 3.35 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 113.734 1.013 . . . . 1.54 113.734 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 58.7 Cg_endo -70.61 150.54 63.18 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.292 1.995 . . . . 0.94 111.138 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.7 m -72.93 153.74 40.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.984 -1.073 . . . . 1.8 109.027 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 31.6 p-10 -59.82 -33.38 71.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.93 . . . . 2.73 110.441 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 97.7 mt-10 -60.12 -39.78 87.45 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.294 -0.879 . . . . 3.17 110.161 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.86 -38.93 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.898 . . . . 1.34 109.883 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.52 -45.04 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.897 -0.721 . . . . 1.2 110.627 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -59.88 -42.08 92.97 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.022 -1.071 . . . . 2.7 110.193 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -62.23 -41.15 98.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -0.922 . . . . 2.59 110.328 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.0 mtp -71.42 -40.27 70.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.256 -0.902 . . . . 1.38 110.507 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 2.84 110.08 -178.813 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mt . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 112.904 0.705 . . . . 1.07 112.904 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.0 m -100.01 119.13 37.78 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.832 -1.544 . . . . 1.24 106.832 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.85 -141.35 9.92 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.615 -0.994 . . . . 1.01 110.615 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 5' ' ' ILE . 94.3 mt -97.71 -1.91 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.558 -0.966 . . . . 1.11 113.008 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp 52.06 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.846 -1.159 . . . . 0.99 112.265 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.23 -46.95 12.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.245 -0.909 . . . . 0.85 111.193 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -143.4 145.33 31.5 Favored Pre-proline 0 N--CA 1.5 2.048 0 N-CA-C 107.784 -1.191 . . . . 1.38 107.784 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.82 150.22 26.96 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.26 1.973 . . . . 0.94 112.309 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.909 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 149.81 170.82 17.65 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 108.946 -1.662 . . . . 0.81 108.946 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.4 mt -128.31 133.5 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 120.961 -1.317 . . . . 0.83 107.828 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.08 145.16 47.66 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.663 -0.866 . . . . 0.53 108.663 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.7 m-85 -117.39 141.04 48.81 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.302 -0.874 . . . . 0.77 109.051 177.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.21 168.17 36.01 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.474 -1.822 . . . . 0.51 110.096 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -76.59 160.52 29.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.861 -0.788 . . . . 1.9 109.943 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.98 126.23 31.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.077 -1.015 . . . . 0.66 108.38 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.1 tp -108.07 102.77 11.91 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 105.0 -2.222 . . . . 0.83 105.0 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.5 tp -90.58 138.06 31.86 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.602 -1.258 . . . . 0.86 107.602 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 160' ' ' ALA . 36.9 mt -100.01 117.45 34.31 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.739 -1.578 . . . . 0.92 106.739 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -111.93 140.08 46.89 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.27 -1.011 . . . . 2.03 108.27 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.517 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 71.5 tt0 -123.82 139.82 53.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 2.66 108.802 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.85 133.54 34.74 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.982 -1.118 . . . . 2.32 107.982 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -62.19 143.01 57.34 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.633 -0.877 . . . . 2.11 108.633 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.3 mt -95.23 135.44 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.121 -0.987 . . . . 0.73 108.363 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.71 129.93 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.349 -0.982 . . . . 0.87 108.349 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.94 139.74 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.487 -0.931 . . . . 0.81 108.487 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -91.26 119.04 30.99 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.333 -1.358 . . . . 1.34 107.333 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.564 HH11 ' HG2' ' A' ' 28' ' ' ARG . 1.0 OUTLIER -95.89 11.72 32.79 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.94 -1.1 . . . . 2.89 112.369 -179.657 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.5 150.64 47.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 2.09 110.966 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -89.29 131.3 35.45 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.103 -1.073 . . . . 2.19 108.103 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -94.29 165.4 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.04 . . . . 0.75 110.278 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.9 p -92.56 166.08 12.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.584 -0.697 . . . . 0.91 109.724 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.84 -22.53 37.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.93 111.85 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -67.2 -36.24 81.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.004 -1.06 . . . . 2.28 110.87 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -92.43 -9.36 41.89 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.048 -1.032 . . . . 1.45 113.187 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.27 -43.72 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.936 -1.102 . . . . 0.81 110.044 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -58.51 -39.97 81.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.096 -1.002 . . . . 1.54 110.574 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -61.37 -39.9 92.32 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.445 -0.784 . . . . 2.36 110.028 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -61.06 -40.35 93.34 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 1.31 110.373 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.71 -41.61 88.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.047 -1.033 . . . . 0.82 110.024 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -60.72 -48.96 79.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.122 -0.986 . . . . 1.5 110.268 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -61.78 -43.21 99.3 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.552 -0.859 . . . . 2.23 109.979 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -73.37 -53.21 11.31 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.508 -0.745 . . . . 0.85 109.748 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.8 tp -59.6 -47.2 86.49 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.477 -0.889 . . . . 0.91 109.938 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.4 t -69.31 -34.41 74.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.9 110.011 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.17 -41.82 92.96 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.177 -1.569 . . . . 0.69 109.177 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 40.7 ttm-85 -58.73 -34.07 70.96 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.438 -0.905 . . . . 2.88 109.053 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.34 -49.68 76.63 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.915 0.864 . . . . 0.85 110.182 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.488 ' NZ ' ' OE1' ' A' ' 53' ' ' GLN . 26.9 ttpp -80.94 -42.37 21.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 2.35 111.136 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.6 92.18 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.746 -0.781 . . . . 0.65 110.093 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.2 t -60.11 -41.4 92.51 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.206 -0.934 . . . . 1.45 109.39 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 -48.4 62.52 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.554 -0.716 . . . . 0.63 110.63 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.488 ' OE1' ' NZ ' ' A' ' 49' ' ' LYS . 27.9 mt-30 -62.34 -49.29 76.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 1.34 110.593 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.86 -37.28 86.22 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.084 -1.01 . . . . 1.56 109.766 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -59.25 -40.65 86.64 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.652 -0.655 . . . . 1.19 110.648 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -62.4 -40.33 96.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.924 -1.11 . . . . 0.72 110.058 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.67 -39.85 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.62 110.513 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -50.14 -42.99 51.75 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.348 -0.845 . . . . 1.05 111.259 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.6 -36.12 78.25 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.03 -1.044 . . . . 0.64 110.276 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -61.13 -37.91 84.48 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.945 -1.102 . . . . 1.73 108.984 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.29 86.8 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.793 -0.763 . . . . 0.56 109.613 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.17 -34.75 40.39 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.332 -1.413 . . . . 0.69 110.398 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -82.32 -20.08 38.08 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.254 -1.145 . . . . 1.48 111.308 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.2 m -86.37 -51.33 6.29 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.356 -0.84 . . . . 0.98 110.428 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.96 -19.66 13.66 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.92 0.711 . . . . 1.16 112.92 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.17 163.69 13.6 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 111.466 -0.653 . . . . 0.85 111.466 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -56.32 -22.48 30.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.794 -0.827 . . . . 3.86 112.603 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -58.21 -35.07 71.11 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.033 -1.042 . . . . 2.35 111.631 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -86.61 -11.95 49.97 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.824 -1.172 . . . . 1.67 113.07 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.75 -30.76 69.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.773 -1.204 . . . . 1.45 111.26 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.74 85.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.983 -1.073 . . . . 0.61 111.241 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 72' ' ' ILE . 15.8 mt -68.02 -48.01 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.823 -1.173 . . . . 0.65 110.13 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -69.87 -32.47 70.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.375 -0.828 . . . . 0.66 110.539 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.36 -37.44 80.71 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.054 -1.029 . . . . 1.19 110.075 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.22 -38.32 91.77 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 120.281 -0.962 . . . . 0.53 110.827 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -59.6 -45.89 90.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.902 -1.352 . . . . 1.27 110.599 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.1 mt -60.31 -38.84 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.863 -1.148 . . . . 0.54 110.488 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.2 ttt -59.55 -39.89 85.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.49 -0.756 . . . . 1.74 110.626 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 tp -59.19 -48.76 80.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.386 -0.926 . . . . 0.55 109.953 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.446 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 61.3 tp -60.91 -45.92 92.73 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.653 0.739 . . . . 0.47 110.754 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.11 11.87 7.33 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.225 0.824 . . . . 1.42 113.225 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -63.96 123.83 19.99 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.798 -0.816 . . . . 1.27 108.798 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -65.52 -18.09 65.06 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.742 0.782 . . . . 1.35 110.819 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.71 -56.88 4.08 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.452 0.644 . . . . 2.22 110.046 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.29 -40.18 89.56 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.006 -0.678 . . . . 0.62 110.64 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -58.55 -49.96 75.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.132 -0.98 . . . . 1.29 110.969 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -62.81 -38.03 89.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 1.52 110.443 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -65.92 -48.92 69.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 1.3 110.458 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.9 mt -55.98 -42.93 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.058 -1.026 . . . . 0.61 109.653 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.0 mt -61.73 -44.0 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.435 -0.79 . . . . 0.78 110.316 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.8 -44.29 97.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.82 110.942 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.01 -44.63 94.45 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.912 -1.117 . . . . 0.8 110.463 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.0 mt -60.61 -48.39 88.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.267 -0.895 . . . . 0.77 110.712 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -81.56 -33.55 31.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.407 -0.808 . . . . 2.12 111.714 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 91' ' ' ALA . 54.2 t0 -82.93 -40.18 20.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.091 -1.006 . . . . 1.51 111.457 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -103.09 7.13 38.89 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.241 -0.912 . . . . 1.98 112.263 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.5 m80 51.3 44.62 28.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 1.32 111.953 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.9 mtt -102.93 153.73 19.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.417 -0.802 . . . . 1.38 109.425 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.407 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 43.2 p -70.54 160.71 31.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.67 109.506 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.6 92.9 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.93 -1.106 . . . . 0.52 110.874 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 24.2 p-10 -69.42 -38.27 77.8 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.985 -1.072 . . . . 2.25 110.024 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.74 -51.2 43.9 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.052 -1.059 . . . . 0.64 111.388 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.69 90.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.56 111.049 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.32 -41.81 85.37 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.352 -0.842 . . . . 0.46 110.613 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.56 -38.74 85.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.414 -0.804 . . . . 1.32 111.173 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -58.06 -48.42 80.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.881 -1.137 . . . . 1.3 111.087 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.04 -43.64 96.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.882 -1.136 . . . . 0.61 110.772 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mm -62.71 -35.26 69.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.605 -0.684 . . . . 0.65 110.318 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -57.44 -39.81 77.07 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.876 -0.73 . . . . 2.11 111.207 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.73 -35.61 11.39 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 118.842 -1.647 . . . . 0.83 112.693 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -61.12 -41.2 96.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.497 -1.59 . . . . 1.28 110.145 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.6 -50.91 22.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.932 0.872 . . . . 0.89 110.471 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.9 p -62.34 -37.85 87.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.862 . . . . 1.87 110.814 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.86 -40.77 98.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 1.05 110.943 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.59 -30.18 70.41 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.637 -1.289 . . . . 1.02 110.892 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -67.34 -22.09 65.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.83 -1.169 . . . . 2.04 110.93 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.5 -11.79 60.81 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.103 -1.039 . . . . 1.73 111.0 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 123' ' ' LEU . 75.8 mt -87.16 144.91 26.63 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.282 -0.636 . . . . 1.37 109.282 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -100.19 39.73 1.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.344 -0.847 . . . . 2.88 111.58 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.48 ' CB ' HD12 ' A' ' 123' ' ' LEU . 7.3 t0 -113.57 135.8 53.51 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 108.261 -1.014 . . . . 1.58 108.261 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -57.67 -40.15 78.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.499 -0.75 . . . . 3.04 111.198 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -72.81 -51.14 20.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.731 -1.231 . . . . 0.9 110.714 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 118' ' ' LEU . 23.9 mt -59.29 -41.28 88.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.26 -0.9 . . . . 1.06 110.541 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 71.5 tttt -64.12 -46.7 83.01 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.209 -0.996 . . . . 2.18 109.793 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -60.17 -33.45 72.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.49 -0.884 . . . . 2.15 109.561 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.522 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 29.7 ttt-85 -60.79 -29.66 69.58 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.306 1.05 . . . . 2.33 108.935 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.78 -49.47 77.6 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.825 0.821 . . . . 0.82 109.396 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.19 -45.81 86.73 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.722 -0.791 . . . . 0.85 109.774 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.02 -36.85 82.79 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.632 -0.668 . . . . 1.39 110.168 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.522 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 48.3 t -69.41 -40.04 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.56 110.037 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -57.9 -38.46 75.88 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.44 -0.904 . . . . 3.12 110.041 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -59.95 -39.57 86.03 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.594 0.711 . . . . 1.28 109.87 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.6 -36.96 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.216 -0.928 . . . . 0.49 109.937 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.81 -56.93 22.24 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 120.009 -1.091 . . . . 0.46 111.353 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -59.07 -39.72 82.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.153 -1.204 . . . . 2.71 110.256 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -60.12 -44.81 94.62 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.775 -1.17 . . . . 2.14 109.57 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.98 -43.89 94.84 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.433 -0.792 . . . . 1.05 110.176 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.63 -44.87 93.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.447 -0.783 . . . . 0.52 110.365 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.517 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 98.8 mtt180 -60.13 -33.19 71.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.893 . . . . 2.35 111.071 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -76.38 -42.95 42.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.098 -1.001 . . . . 1.39 110.725 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.72 -40.17 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.68 110.105 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.87 -11.27 45.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.076 -1.015 . . . . 0.83 111.757 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.6 21.67 71.66 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.73 -1.224 . . . . 0.91 112.91 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -62.73 147.41 49.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.806 -0.82 . . . . 0.95 109.139 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -67.0 147.05 53.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.303 -0.873 . . . . 2.43 108.905 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.9 mt -105.74 149.16 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.419 -0.956 . . . . 1.1 108.419 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.556 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.4 mp -77.65 119.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.157 -0.964 . . . . 1.58 108.727 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -99.51 96.5 7.71 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.66 -1.607 . . . . 1.62 106.66 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.7 mt -77.36 -12.44 59.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.903 . . . . 0.8 111.628 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.5 p -81.7 3.0 27.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.138 -0.977 . . . . 1.56 112.072 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.68 18.46 14.27 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.67 -0.644 . . . . 0.84 112.579 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.8 mt -71.97 138.95 20.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.52 -0.738 . . . . 0.82 109.271 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -118.54 -15.79 9.55 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.834 0.826 . . . . 2.31 112.629 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -114.33 138.66 50.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.974 -1.121 . . . . 1.54 107.974 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -72.66 121.98 20.69 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.33 -0.989 . . . . 1.38 108.33 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.6 m -144.49 174.95 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.033 -0.728 . . . . 0.69 109.033 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.6 mt -89.45 142.15 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.793 -1.192 . . . . 0.53 109.088 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 31.5 tp -94.49 123.05 37.67 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.29 -1.004 . . . . 0.64 108.29 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.65 129.64 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.705 -1.22 . . . . 0.67 107.705 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.32 154.68 21.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.149 -0.97 . . . . 0.78 108.826 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.93 -37.31 86.53 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.541 -1.349 . . . . 1.0 109.458 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -173.3 147.86 1.57 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.166 -0.679 . . . . 2.42 109.166 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.1 mt -115.93 143.25 45.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.489 -0.757 . . . . 0.75 109.21 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.7 p -89.45 147.43 38.04 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.162 -0.961 . . . . 0.78 108.881 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -40.49 -42.48 3.91 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.892 1.728 . . . . 0.67 113.673 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.8 m -61.32 -50.25 73.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.017 -1.052 . . . . 0.7 110.295 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -61.42 -39.67 91.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 1.21 109.772 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.6 p -68.75 -39.69 80.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.608 -0.682 . . . . 0.6 110.458 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.41 79.38 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.928 -0.709 . . . . 0.62 110.531 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -93.71 -1.03 55.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.902 . . . . 1.16 112.727 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.84 148.6 38.81 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.262 -1.014 . . . . 0.73 108.262 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -96.4 114.81 26.51 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.839 -1.541 . . . . 2.24 106.839 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 173' ' ' LEU . 7.5 mp -73.37 -20.39 60.77 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.433 0.635 . . . . 1.43 111.77 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -80.42 -21.85 41.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 2.15 112.037 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -100.23 -6.08 26.6 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 113.198 0.814 . . . . 2.04 113.198 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 178' ' ' GLY . 62.1 t -110.26 129.52 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.616 -1.254 . . . . 0.55 107.616 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.5 -6.29 54.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 1.63 112.635 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.47 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.53 164.79 33.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.788 -1.725 . . . . 0.47 108.788 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -122.72 127.48 49.28 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.402 -1.333 . . . . 0.54 107.402 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.413 HD11 HD13 ' A' ' 220' ' ' LEU . 24.9 mt -127.36 127.64 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.802 -1.555 . . . . 0.69 106.802 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.5 p -140.43 166.27 25.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.865 -1.147 . . . . 0.82 109.486 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.429 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 1.5 m-20 -104.4 43.25 1.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.746 -0.596 . . . . 2.37 110.341 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.94 0 O-C-N 121.082 -1.011 . . . . 1.11 108.906 179.115 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 108.14 -1.059 . . . . 1.69 108.14 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -59.96 -39.14 84.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 1.07 110.651 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 57.5 p -60.03 -40.34 88.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 1.58 110.546 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.0 t -60.08 -36.86 78.3 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.167 -0.958 . . . . 1.6 110.12 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.2 mm -60.48 -38.87 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.735 -0.603 . . . . 1.45 110.814 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 75.1 mtp -61.01 -45.36 95.12 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.616 1.198 . . . . 1.05 109.157 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.02 -50.47 73.61 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.462 -0.79 . . . . 0.72 110.823 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -59.65 -44.84 93.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 3.05 111.179 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.9 m -70.2 -40.85 74.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.863 . . . . 0.89 110.543 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.3 mt -90.89 -7.0 53.41 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.071 0.939 . . . . 0.78 112.242 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 194' ' ' ALA . 93.7 mt-10 53.67 9.71 0.2 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.929 1.085 . . . . 1.45 113.929 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.38 147.91 90.43 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 120.844 -1.16 . . . . 0.67 107.972 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.79 137.28 60.14 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.374 1.383 . . . . 0.64 110.07 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.67 166.2 24.78 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.225 -1.39 . . . . 0.67 109.839 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 35.9 mt -148.16 151.07 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.872 -1.159 . . . . 0.69 107.872 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.7 m -134.82 -26.63 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.845 -1.159 . . . . 0.85 112.027 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.19 42.4 2.85 Favored Glycine 0 N--CA 1.49 2.258 0 O-C-N 120.985 -1.072 . . . . 0.92 111.432 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 69.8 p -64.04 -24.15 67.6 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.925 -1.338 . . . . 0.95 111.233 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.86 -90.05 1.48 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 120.042 -1.075 . . . . 1.04 110.596 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.7 t -130.83 32.3 4.37 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.291 -1.123 . . . . 1.57 113.04 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.9 t -56.29 -32.76 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.255 -1.528 . . . . 0.84 110.439 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.6 p -59.04 -25.42 63.69 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.058 -1.026 . . . . 0.99 111.215 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.8 m -92.96 1.89 57.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 1.7 112.063 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -125.66 -5.72 6.97 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.441 0.904 . . . . 2.2 113.441 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.6 t -118.83 148.03 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.424 -0.798 . . . . 0.84 109.515 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -120.42 150.45 40.77 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.998 -1.112 . . . . 2.2 107.998 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 6.4 t30 -51.32 141.29 15.39 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.233 -0.917 . . . . 2.28 110.562 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 80.93 -3.81 1.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.028 1.121 . . . . 2.35 114.028 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -61.68 146.01 50.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.814 -1.179 . . . . 1.97 108.284 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -87.32 118.18 26.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.529 -1.286 . . . . 2.65 107.529 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.92 147.64 50.86 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.454 -0.779 . . . . 0.63 109.552 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 13.7 mt -119.14 130.06 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.186 -1.413 . . . . 0.62 107.186 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.413 HD13 HD11 ' A' ' 180' ' ' ILE . 54.1 tp -98.5 122.88 42.25 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.732 -1.211 . . . . 0.64 107.732 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 223' ' ' VAL . 43.8 t0 -94.03 -29.58 15.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.785 -1.197 . . . . 2.05 112.385 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.62 18.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.92 0.711 . . . . 0.84 112.92 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -109.68 -60.49 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.059 -1.025 . . . . 1.02 109.222 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -93.74 11.15 30.14 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.949 0.88 . . . . 2.51 110.018 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 63.32 53.16 2.25 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.657 -0.702 . . . . 1.54 112.205 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -149.04 154.84 39.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.482 -0.761 . . . . 1.95 109.515 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.6 135.85 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.595 -1.261 . . . . 0.71 107.595 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -102.83 130.51 49.85 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.118 -0.988 . . . . 1.01 108.97 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.14 127.81 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.682 -1.229 . . . . 0.82 107.682 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 50.1 53.16 13.76 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 113.428 0.899 . . . . 1.54 113.428 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 151.15 79.64 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 123.028 2.486 . . . . 0.94 111.085 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 67.3 p -73.97 155.29 38.78 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.739 -0.837 . . . . 1.8 108.739 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -60.26 -37.94 81.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 2.73 110.714 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -50.83 -44.28 59.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.056 -1.027 . . . . 3.17 110.445 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.24 -39.93 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.189 -0.944 . . . . 1.34 110.64 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.76 -49.16 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.897 -0.721 . . . . 1.2 110.962 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.41 -39.64 84.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.922 -1.111 . . . . 2.7 110.777 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -61.1 -44.85 96.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 2.59 110.761 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 55.3 mtm -75.1 -37.8 61.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.819 -1.175 . . . . 1.38 111.301 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 . . . . . 0 N--CA 1.497 1.9 0 O-C-N 120.962 -1.087 . . . . 2.84 111.161 -179.766 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mt . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 106.305 -1.739 . . . . 1.07 106.305 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.4 m -101.11 123.45 45.28 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.663 -1.236 . . . . 1.24 107.663 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.35 -159.4 11.76 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 108.708 -1.757 . . . . 1.01 108.708 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 5' ' ' ILE . 95.0 mt -99.19 2.32 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.439 -1.036 . . . . 1.11 112.744 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 48.61 94.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.636 -1.29 . . . . 0.99 112.171 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -84.84 -40.48 17.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.471 -1.393 . . . . 0.85 111.49 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.27 144.29 18.55 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 107.465 -1.309 . . . . 1.38 107.465 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.11 142.31 27.36 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.574 2.183 . . . . 0.94 112.192 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.945 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.55 171.31 23.39 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.36 -1.496 . . . . 0.81 109.36 178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -134.21 133.7 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.819 -1.401 . . . . 0.83 107.574 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.09 156.8 45.93 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.141 0.972 . . . . 0.53 109.664 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 13.2 m-85 -120.99 140.21 52.22 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.93 -1.137 . . . . 0.77 107.93 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.21 166.62 36.22 Favored Glycine 0 N--CA 1.499 2.841 0 C-N-CA 119.044 -1.551 . . . . 0.51 109.901 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -80.09 157.84 26.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.297 -1.12 . . . . 1.9 109.668 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.76 128.68 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.149 -1.056 . . . . 0.66 108.149 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.5 tp -107.24 105.47 15.46 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 105.327 -2.101 . . . . 0.83 105.327 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.6 tp -93.32 135.43 34.54 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.036 -1.098 . . . . 0.86 108.036 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.9 mt -99.54 118.1 35.38 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.584 -1.635 . . . . 0.92 106.584 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -110.56 123.74 50.52 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.782 -1.562 . . . . 2.03 106.782 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -131.38 158.25 41.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.946 -1.096 . . . . 2.66 108.701 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -84.95 138.79 32.27 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.782 -0.822 . . . . 2.32 108.782 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.41 156.33 36.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.948 . . . . 2.11 109.496 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.7 mt -86.24 133.91 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.035 -1.041 . . . . 0.73 108.444 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -110.38 130.71 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.815 -1.18 . . . . 0.87 107.815 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.8 mt -94.66 134.34 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.647 -0.871 . . . . 0.81 108.647 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -92.41 120.5 32.97 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.086 -1.079 . . . . 1.34 108.086 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.561 HH11 ' HG2' ' A' ' 28' ' ' ARG . 1.7 mmt-85 -93.56 16.98 12.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.007 -1.058 . . . . 2.89 112.43 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -60.33 140.14 57.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.014 -1.054 . . . . 2.09 109.81 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -87.65 132.51 34.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.839 -1.163 . . . . 2.19 108.004 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 pt -96.89 165.55 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.75 110.584 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.7 p -97.91 170.45 8.95 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.241 -0.912 . . . . 0.91 109.507 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.1 66.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.394 -0.816 . . . . 0.93 111.454 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.64 -33.47 74.07 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.436 -0.79 . . . . 2.28 110.648 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -90.95 -7.57 51.7 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.738 -1.226 . . . . 1.45 112.502 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.48 -42.67 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.81 110.183 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -58.11 -39.91 79.88 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.307 -0.871 . . . . 1.54 111.136 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -63.44 -43.92 96.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.734 -0.604 . . . . 2.36 111.233 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -60.67 -40.15 91.03 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.803 -1.186 . . . . 1.31 110.189 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.6 t -60.68 -40.83 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.108 -0.995 . . . . 0.82 109.963 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -61.59 -44.86 96.24 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.447 -0.783 . . . . 1.5 110.223 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.437 HH11 ' HG2' ' A' ' 42' ' ' ARG . 43.5 mtt-85 -62.11 -40.05 94.59 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.33 -0.856 . . . . 2.23 110.152 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -70.53 -57.17 5.05 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.36 -0.837 . . . . 0.85 110.235 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.79 -47.4 85.84 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.914 -1.115 . . . . 0.91 109.582 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.8 t -69.33 -37.46 77.73 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.399 -0.92 . . . . 0.9 109.814 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.05 -43.28 93.26 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.053 -1.546 . . . . 0.69 109.681 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -59.87 -30.66 69.14 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.167 0.984 . . . . 2.88 109.476 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.38 -41.79 90.15 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.427 -0.796 . . . . 0.85 110.348 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -80.22 -49.77 11.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.371 -0.932 . . . . 2.35 110.699 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.91 76.8 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.468 -0.77 . . . . 0.65 110.279 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.4 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 94.7 p -60.09 -40.35 89.31 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.136 0.97 . . . . 1.45 109.178 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -47.53 44.42 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.834 0.826 . . . . 0.63 110.733 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -64.5 -48.31 75.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.521 -1.362 . . . . 1.34 110.958 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.18 -37.98 89.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.726 -0.789 . . . . 1.56 109.842 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 51' ' ' SER . 17.5 mm-40 -59.81 -40.33 88.04 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.275 -0.57 . . . . 1.19 110.272 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.1 m -63.76 -42.24 97.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.234 -0.916 . . . . 0.72 110.343 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 99.5 mt -59.97 -37.3 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.716 0.77 . . . . 0.62 110.268 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -50.4 -44.24 54.91 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.46 -0.775 . . . . 1.05 110.753 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -69.12 -33.71 73.9 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.156 -0.965 . . . . 0.64 110.225 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -64.22 -40.28 95.72 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.185 -1.406 . . . . 1.73 109.526 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.75 -30.16 71.16 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.856 -0.738 . . . . 0.56 110.151 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.12 -34.18 18.5 Favored Glycine 0 N--CA 1.484 1.872 0 C-N-CA 119.559 -1.305 . . . . 0.69 110.893 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -81.7 -20.41 39.49 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.358 -1.083 . . . . 1.48 111.199 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.5 m -90.16 -51.98 5.18 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 120.941 0.401 . . . . 0.98 110.842 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -107.83 -9.12 15.81 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 113.616 0.969 . . . . 1.16 113.616 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.09 167.01 23.12 Favored Glycine 0 N--CA 1.502 3.09 0 O-C-N 121.24 -0.913 . . . . 0.85 112.764 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.96 -21.94 59.34 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.785 -0.833 . . . . 3.86 112.131 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -57.7 -40.05 78.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.959 -1.088 . . . . 2.35 110.905 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -87.07 -25.48 24.15 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.43 -0.908 . . . . 1.67 111.459 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -60.65 -38.0 83.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.904 -0.497 . . . . 1.45 111.405 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.12 90.35 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.242 -0.911 . . . . 0.61 112.055 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -64.77 -41.72 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.339 -1.476 . . . . 0.65 110.381 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -69.44 -32.09 70.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.603 -1.311 . . . . 0.66 110.428 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -59.44 -39.73 84.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.783 -1.198 . . . . 1.19 109.909 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.74 97.95 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.894 -0.883 . . . . 0.53 110.894 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -59.77 -41.2 90.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.906 -1.349 . . . . 1.27 110.633 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.4 mt -60.29 -38.16 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.807 -1.183 . . . . 0.54 110.658 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.7 ttp -58.85 -39.78 82.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.917 . . . . 1.74 110.528 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.65 -48.26 81.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.917 -1.115 . . . . 0.55 110.629 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.2 tp -59.92 -40.92 90.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.493 -0.755 . . . . 0.47 110.435 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -86.06 6.09 30.58 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.022 -0.671 . . . . 1.42 112.508 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -60.33 121.82 12.98 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.917 -1.114 . . . . 1.27 109.348 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -68.0 -17.63 64.48 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 121.145 -0.972 . . . . 1.35 110.792 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -74.14 -46.7 40.8 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.787 -1.165 . . . . 2.22 110.419 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.0 -35.47 80.82 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.209 -0.996 . . . . 0.62 110.023 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -58.69 -45.09 90.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.166 -0.959 . . . . 1.29 110.798 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -63.98 -41.6 97.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.926 -1.109 . . . . 1.52 110.78 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -67.98 -49.53 61.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.737 -1.227 . . . . 1.3 110.506 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.12 -43.49 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 118.978 -1.089 . . . . 0.61 110.372 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.433 HG22 ' NZ ' ' A' ' 94' ' ' LYS . 52.2 mt -62.17 -43.85 98.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.107 -0.996 . . . . 0.78 110.54 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.36 -41.13 93.07 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.251 -0.906 . . . . 0.82 110.894 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.31 -44.28 95.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.162 -0.961 . . . . 0.8 110.606 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.71 -49.2 83.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.266 -0.896 . . . . 0.77 110.322 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.433 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 20.5 mtmm -82.43 -28.59 31.25 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.603 -1.31 . . . . 2.12 112.182 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -79.16 -45.66 19.5 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 120.242 -1.536 . . . . 1.51 111.293 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -104.62 7.59 35.04 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.752 -1.218 . . . . 1.98 111.884 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.8 m80 54.26 50.15 17.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 1.32 112.291 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 73.2 mtm -105.88 161.0 14.83 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.722 -1.236 . . . . 1.38 109.502 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.1 p -72.75 158.89 34.71 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.846 0.832 . . . . 0.67 109.368 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.68 87.99 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.148 -0.97 . . . . 0.52 110.658 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.55 ' OD2' HD21 ' A' ' 142' ' ' LEU . 98.9 m-20 -67.34 -40.75 85.88 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.805 -1.184 . . . . 2.25 110.069 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.43 39.8 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.207 -0.997 . . . . 0.64 110.816 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.13 96.52 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.661 0.743 . . . . 0.56 110.338 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.43 93.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.648 -0.658 . . . . 0.46 111.08 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.75 -38.97 83.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.307 -0.871 . . . . 1.32 111.335 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.14 -48.28 82.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.091 -1.006 . . . . 1.3 111.19 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.56 -43.22 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.658 -1.217 . . . . 0.61 110.225 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.61 -33.08 53.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.799 -0.563 . . . . 0.65 110.697 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -59.53 -40.21 86.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.351 -0.54 . . . . 2.11 110.745 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.92 -30.52 25.89 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.018 -1.563 . . . . 0.83 113.128 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -61.37 -40.43 94.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.216 -1.755 . . . . 1.28 109.69 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.23 -45.72 59.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.064 0.935 . . . . 0.89 109.718 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.2 m -60.36 -39.24 86.5 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.346 0.593 . . . . 1.87 110.049 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.83 -46.51 89.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.416 -0.803 . . . . 1.05 110.866 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 90.2 mt -66.03 -26.89 67.73 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.506 -1.371 . . . . 1.02 110.87 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -66.22 -26.45 67.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.875 . . . . 2.04 111.572 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -70.65 -13.48 62.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.943 -1.103 . . . . 1.73 111.48 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 78.8 mt -88.72 140.2 29.69 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.838 0.828 . . . . 1.37 109.383 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -94.85 41.44 1.09 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.816 -1.178 . . . . 2.88 111.258 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -111.87 133.42 54.08 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.07 0.938 . . . . 1.58 108.903 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.59 -29.2 69.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.708 -0.62 . . . . 3.04 111.348 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.03 -60.32 2.38 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.655 -1.278 . . . . 0.9 110.703 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.78 -38.2 90.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 1.06 110.801 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -63.38 -50.88 68.15 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.779 -1.201 . . . . 2.18 110.093 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.67 -32.17 71.38 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.094 -1.042 . . . . 2.15 109.602 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.519 ' O ' HG23 ' A' ' 130' ' ' VAL . 37.4 ttp180 -65.89 -26.97 67.86 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.778 0.799 . . . . 2.33 109.485 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -58.88 -47.88 83.38 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.599 -0.84 . . . . 0.82 108.998 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.81 -43.92 91.57 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.306 -0.957 . . . . 0.85 110.017 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -64.29 -31.38 72.56 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.422 0.629 . . . . 1.39 110.446 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 126' ' ' ARG . 32.3 t -68.7 -39.19 79.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 C-N-CA 119.942 -0.703 . . . . 0.56 109.961 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.404 ' NH1' ' HG3' ' A' ' 131' ' ' ARG . 38.1 ttm-85 -59.32 -38.01 79.2 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.73 -1.188 . . . . 3.12 109.285 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -59.92 -38.94 83.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.881 -0.512 . . . . 1.28 110.602 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.7 mt -60.33 -40.0 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.975 -1.078 . . . . 0.49 110.148 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.12 -46.96 93.28 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.475 -1.05 . . . . 0.46 110.475 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -59.99 -41.08 91.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.966 -1.314 . . . . 2.71 110.658 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -60.07 -42.7 95.13 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.315 -0.865 . . . . 2.14 110.18 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.41 -40.41 94.3 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.174 0.988 . . . . 1.05 109.881 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.0 mt -61.66 -40.67 95.76 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.353 -0.842 . . . . 0.52 110.746 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -61.34 -38.2 86.05 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.509 -0.745 . . . . 2.35 111.316 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -74.4 -42.6 58.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.954 -1.091 . . . . 1.39 110.993 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.21 -38.95 79.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.013 -1.054 . . . . 0.68 110.553 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.55 HD21 ' OD2' ' A' ' 101' ' ' ASP . 83.9 mt -87.35 -3.08 59.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.829 -1.169 . . . . 0.83 111.793 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.83 23.03 78.64 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.613 -1.28 . . . . 0.91 113.577 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.5 tp -61.97 150.04 38.99 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 122.053 -0.675 . . . . 0.95 109.746 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -66.93 157.27 33.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.503 -0.748 . . . . 2.43 110.16 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.4 mt -101.18 139.5 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.46 -0.941 . . . . 1.1 108.46 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.761 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.3 mp -79.49 120.51 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.797 -1.186 . . . . 1.58 107.797 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -98.62 93.41 6.1 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.881 -1.525 . . . . 1.62 106.881 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.6 mt -75.39 -21.29 58.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.898 . . . . 0.8 111.599 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.5 t -82.77 10.24 8.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.169 -0.957 . . . . 1.56 112.101 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.95 18.52 14.49 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.269 -0.894 . . . . 0.84 112.435 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.408 ' O ' ' CD ' ' A' ' 175' ' ' LYS . 23.8 mt -75.28 141.03 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.203 -0.935 . . . . 0.82 110.015 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -117.62 -13.67 10.24 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.361 -0.837 . . . . 2.31 112.795 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -117.03 141.95 47.59 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.612 -0.884 . . . . 1.54 108.612 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -77.04 122.83 25.49 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.271 -1.011 . . . . 1.38 108.271 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.2 m -147.31 178.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.226 -0.657 . . . . 0.69 109.226 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.4 mt -87.4 143.92 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.683 -0.858 . . . . 0.53 108.683 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 34.7 tp -97.57 126.1 42.67 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.912 -1.118 . . . . 0.64 108.367 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.0 t -126.43 129.23 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.126 -1.065 . . . . 0.67 108.126 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.17 159.91 32.23 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.272 -0.893 . . . . 0.78 108.601 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.18 93.34 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.539 -1.264 . . . . 1.0 109.97 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 46.8 p-10 -173.96 150.02 1.57 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.304 -0.628 . . . . 2.42 109.304 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.2 mt -115.41 141.54 47.91 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.346 -0.846 . . . . 0.75 109.276 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.9 p -93.92 150.7 38.98 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.162 -0.961 . . . . 0.78 108.455 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -39.25 -44.97 2.91 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.772 1.648 . . . . 0.67 113.243 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.3 m -59.58 -49.41 77.86 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.168 -0.957 . . . . 0.7 110.306 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.34 -40.4 94.1 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.743 -0.783 . . . . 1.21 110.001 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.9 p -67.58 -37.12 82.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.815 0.817 . . . . 0.6 110.222 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.18 -39.84 87.9 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.519 -0.738 . . . . 0.62 110.54 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -94.21 0.22 55.57 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.094 -1.004 . . . . 1.16 113.105 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.89 149.21 41.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.738 -1.226 . . . . 0.73 108.498 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -94.45 114.71 26.77 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 106.812 -1.551 . . . . 2.24 106.812 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 173' ' ' LEU . 10.6 mp -80.79 -10.41 59.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.552 -0.718 . . . . 1.43 112.435 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -83.45 -23.25 32.33 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.984 -1.073 . . . . 2.15 111.954 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.408 ' CD ' ' O ' ' A' ' 152' ' ' ILE . 90.7 mttt -105.41 4.16 30.44 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.22 -0.925 . . . . 2.04 112.777 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.9 t -108.85 128.63 64.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.929 -1.137 . . . . 0.55 107.929 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.713 ' O ' HD23 ' A' ' 177' ' ' LEU . 2.0 tt -92.93 -6.31 48.83 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.208 1.004 . . . . 1.63 111.53 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.39 168.28 37.51 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.746 -1.741 . . . . 0.47 108.746 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -124.04 128.85 49.95 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.559 -1.274 . . . . 0.54 107.559 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.9 mt -130.77 129.86 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.968 -1.864 . . . . 0.69 105.968 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.2 p -140.94 176.1 9.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.167 -0.958 . . . . 0.82 109.981 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.497 ' OD2' HG23 ' A' ' 209' ' ' THR . 2.8 m-20 -110.38 45.13 1.15 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.892 -0.505 . . . . 2.37 110.757 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.005 0 O-C-N 121.164 -0.96 . . . . 1.11 108.924 179.227 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 112.946 0.721 . . . . 1.69 112.946 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -49.49 -40.82 38.8 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.143 -1.023 . . . . 1.07 110.161 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.6 p -62.11 -40.8 97.12 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.366 -0.934 . . . . 1.58 109.389 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.9 p -60.87 -35.25 76.13 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 119.668 -0.813 . . . . 1.6 109.863 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 77.1 mt -58.79 -39.61 77.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.461 -0.895 . . . . 1.45 109.934 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.8 mtp -60.93 -44.23 97.51 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.781 1.276 . . . . 1.05 109.126 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.1 -43.97 95.19 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.966 -1.015 . . . . 0.72 110.532 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' A' ' 195' ' ' ARG . 28.7 mtt-85 -60.04 -44.2 94.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.995 -1.066 . . . . 3.05 110.09 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 35.3 m -68.48 -39.07 81.49 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.099 0.952 . . . . 0.89 109.646 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.77 -4.07 56.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.068 -1.02 . . . . 0.78 112.659 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.0 mt-10 53.61 9.87 0.2 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.212 1.19 . . . . 1.45 114.212 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 32.7 mt -72.12 150.06 92.21 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 120.581 -1.324 . . . . 0.67 108.378 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.0 143.51 99.77 Favored 'Trans proline' 0 N--CA 1.511 2.554 0 C-N-CA 121.623 1.549 . . . . 0.64 110.11 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.92 160.91 31.47 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 117.683 -1.607 . . . . 0.67 109.701 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 220' ' ' LEU . 15.0 mt -148.32 149.72 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.088 -1.079 . . . . 0.69 108.088 177.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 181' ' ' THR . 19.7 m -133.93 -29.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 C-N-CA 119.281 -0.967 . . . . 0.85 112.78 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.39 35.65 1.55 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.76 -1.209 . . . . 0.92 113.907 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 35.2 p -56.98 -25.49 58.33 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.234 -1.157 . . . . 0.95 111.227 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.45 -91.4 1.72 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.032 -1.227 . . . . 1.04 110.032 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.8 p -129.31 29.97 5.05 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.295 -1.121 . . . . 1.57 112.683 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.2 t -56.56 -35.09 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.246 -1.534 . . . . 0.84 110.764 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.497 HG23 ' OD2' ' A' ' 182' ' ' ASP . 45.4 p -60.58 -21.43 62.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.038 . . . . 0.99 111.491 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 67.5 m -97.2 1.74 50.14 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.568 0.699 . . . . 1.7 111.997 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -126.08 -0.96 7.13 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.227 0.825 . . . . 2.2 113.227 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 213' ' ' LYS . 56.0 t -126.02 155.43 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.139 -0.975 . . . . 0.84 110.182 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.412 ' N ' HG12 ' A' ' 212' ' ' VAL . 1.1 mptm? -115.7 157.69 23.89 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.06 -1.089 . . . . 2.2 108.06 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 32.2 p-10 -58.86 144.18 45.24 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.56 -1.256 . . . . 2.28 109.922 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER 81.39 -3.05 1.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.081 1.141 . . . . 2.35 114.081 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 40.0 t0 -61.61 149.96 37.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.882 -1.136 . . . . 1.97 109.129 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.514 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 37.0 t80 -88.58 124.39 33.99 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.412 -1.329 . . . . 2.65 107.412 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.5 mt -130.3 149.36 52.03 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.331 -0.856 . . . . 0.63 109.307 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.7 mt -112.75 123.4 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.064 -1.828 . . . . 0.62 106.064 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.531 HD11 HD12 ' A' ' 202' ' ' ILE . 49.2 tp -98.72 119.48 37.54 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.087 -1.82 . . . . 0.64 106.087 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 27.4 t0 -93.78 -25.18 17.51 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.086 -1.009 . . . . 2.05 112.836 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.945 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.64 14.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.153 0.797 . . . . 0.84 113.153 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 37.1 t -111.18 -62.31 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.119 -0.988 . . . . 1.02 109.258 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -90.27 9.14 29.85 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.398 1.094 . . . . 2.51 110.987 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.18 49.71 3.25 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.436 -0.802 . . . . 1.54 111.645 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -146.93 148.77 32.11 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.635 -1.29 . . . . 1.95 109.734 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.0 t -117.32 139.29 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.216 -1.031 . . . . 0.71 108.216 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -99.26 134.95 41.38 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.118 -1.067 . . . . 1.01 108.118 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.71 129.93 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.755 -0.832 . . . . 0.82 108.755 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.431 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 42.4 t-20 49.1 50.29 8.93 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.01 0.744 . . . . 1.54 113.01 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.5 Cg_endo -62.26 149.95 88.75 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.342 2.028 . . . . 0.94 110.883 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 6.0 m -74.53 156.06 37.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.252 -0.905 . . . . 1.8 109.151 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -59.35 -38.42 80.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 2.73 110.218 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -58.83 -41.05 85.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.231 -0.918 . . . . 3.17 110.367 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.66 -41.09 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.13 0.967 . . . . 1.34 109.892 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 85.1 mt -60.03 -47.99 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 1.2 110.391 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -59.28 -42.52 91.46 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.458 -0.897 . . . . 2.7 110.26 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -61.37 -41.54 97.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 2.59 110.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 81.6 mtp -71.48 -37.79 71.28 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.09 -1.006 . . . . 1.38 111.201 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 120.635 -1.29 . . . . 2.84 110.321 179.517 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.9 mt . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 121.258 0.552 . . . . 1.07 111.914 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 m -95.57 113.58 25.24 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.614 -1.624 . . . . 1.24 106.614 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.66 -149.16 25.21 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.111 -1.196 . . . . 1.01 110.111 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 5' ' ' ILE . 93.2 mt -96.65 -0.93 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -1.04 . . . . 1.11 112.864 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 tp 49.49 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.064 -1.022 . . . . 0.99 112.725 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.77 -43.51 12.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.072 -1.018 . . . . 0.85 111.168 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 t -145.76 136.08 12.04 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.138 -1.06 . . . . 1.38 108.138 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.43 149.79 45.24 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.38 2.053 . . . . 0.94 112.249 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.899 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.25 164.34 12.26 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.554 -1.819 . . . . 0.81 108.554 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.0 mt -120.89 133.92 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.285 -1.127 . . . . 0.83 108.273 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.23 149.99 43.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.318 -0.864 . . . . 0.53 109.129 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.3 m-85 -121.25 140.39 52.11 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.179 -1.045 . . . . 0.77 108.179 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.2 166.99 35.96 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 118.998 -1.573 . . . . 0.51 109.419 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -78.13 158.33 29.13 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.65 -0.912 . . . . 1.9 108.98 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -82.75 131.9 35.19 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.886 -1.134 . . . . 0.66 109.206 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.8 tp -113.67 102.7 10.51 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 105.609 -1.997 . . . . 0.83 105.609 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.6 tp -90.67 137.15 32.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.913 -1.117 . . . . 0.86 108.116 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 158' ' ' LEU . 59.3 mt -102.57 119.47 38.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.469 -1.678 . . . . 0.92 106.469 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -110.68 135.06 51.87 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.674 -1.232 . . . . 2.03 107.674 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -126.28 137.49 53.51 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.404 -0.962 . . . . 2.66 108.404 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -82.73 135.47 34.99 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.794 -1.187 . . . . 2.32 107.794 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -62.22 149.21 42.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.579 -0.701 . . . . 2.11 109.186 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.94 134.78 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.72 -0.845 . . . . 0.73 108.72 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -107.48 129.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.626 -1.25 . . . . 0.87 107.626 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.0 mt -93.78 140.29 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.81 109.201 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -88.18 121.22 30.32 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.838 -1.171 . . . . 1.34 107.838 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -95.02 16.16 16.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 2.89 112.213 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -65.14 142.68 58.27 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.071 -1.018 . . . . 2.09 109.027 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -88.88 134.85 33.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.886 -1.153 . . . . 2.19 107.886 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 pt -98.15 165.02 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.3 -0.875 . . . . 0.75 110.313 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 p -99.29 168.79 9.8 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.298 0.57 . . . . 0.91 109.702 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.89 -27.9 46.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.249 -0.907 . . . . 0.93 112.642 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 35' ' ' GLN . 37.1 p-10 -70.07 -31.84 69.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.222 -0.924 . . . . 2.28 110.825 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.562 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 73.0 mt-30 -92.31 -7.9 46.64 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.612 -1.305 . . . . 1.45 112.792 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.18 -43.15 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.892 . . . . 0.81 110.833 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -57.94 -39.16 77.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.075 -1.016 . . . . 1.54 110.828 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.78 -43.29 99.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.987 -1.071 . . . . 2.36 111.147 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.96 -39.6 92.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.778 -1.201 . . . . 1.31 110.937 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.2 t -60.72 -42.43 92.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.192 -0.943 . . . . 0.82 110.366 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -61.77 -45.15 95.13 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.585 -0.846 . . . . 1.5 109.962 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' A' ' 42' ' ' ARG . 51.2 mtt-85 -61.61 -42.01 98.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.875 -1.141 . . . . 2.23 109.663 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -71.68 -55.71 7.18 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.507 -0.745 . . . . 0.85 109.829 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.9 tp -58.09 -47.6 82.73 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.445 -0.902 . . . . 0.91 109.643 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.4 t -68.13 -36.3 79.49 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.441 -0.787 . . . . 0.9 109.702 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.66 -40.23 87.78 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.582 -1.407 . . . . 0.69 109.582 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -58.86 -34.25 71.38 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 122.076 0.941 . . . . 2.88 109.205 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.98 -48.97 79.51 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.934 0.873 . . . . 0.85 109.863 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -81.38 -45.62 15.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -0.822 . . . . 2.35 110.949 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.67 86.04 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.644 -0.822 . . . . 0.65 110.397 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 t -59.94 -40.28 88.44 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.105 0.955 . . . . 1.45 109.127 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.57 -44.78 81.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.953 -0.567 . . . . 0.63 110.219 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -62.41 -52.11 64.88 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.997 -1.081 . . . . 1.34 110.162 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.84 -40.87 94.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.171 -0.955 . . . . 1.56 110.153 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -59.99 -40.0 87.65 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.685 -0.634 . . . . 1.19 110.583 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -64.83 -41.8 95.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.9 -1.125 . . . . 0.72 110.615 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.43 -38.89 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.227 -0.921 . . . . 0.62 110.798 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -51.42 -44.5 62.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.244 -0.91 . . . . 1.05 110.538 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -68.96 -38.21 79.27 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.987 -1.071 . . . . 0.64 110.086 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -62.07 -38.95 90.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.314 -0.955 . . . . 1.73 109.641 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.28 -31.47 70.01 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.206 0.527 . . . . 0.56 109.748 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.93 -37.68 12.63 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.584 -1.293 . . . . 0.69 111.017 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.51 -23.99 36.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.773 -1.427 . . . . 1.48 111.119 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.6 m -87.13 -50.58 6.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.98 110.68 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.04 -8.7 16.45 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.194 1.183 . . . . 1.16 114.194 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.73 164.93 23.37 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 121.249 -0.907 . . . . 0.85 112.734 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -55.11 -13.91 1.4 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.85 -0.794 . . . . 3.86 112.925 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -58.75 -37.4 76.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.101 -1.0 . . . . 2.35 111.236 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -85.34 -19.18 31.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.816 -1.177 . . . . 1.67 112.693 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -59.61 -39.64 84.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.733 -1.229 . . . . 1.45 111.047 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.0 -41.23 91.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 0.61 110.945 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.92 -47.3 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.62 -1.3 . . . . 0.65 110.119 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -69.88 -31.97 70.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.66 110.662 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -58.81 -38.61 79.02 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 1.19 109.731 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.82 -36.03 73.8 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 110.261 -1.135 . . . . 0.53 110.261 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -59.18 -46.49 88.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.167 -1.196 . . . . 1.27 110.72 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.73 -39.77 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.54 109.956 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.0 ttp -59.13 -39.63 82.94 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.93 -0.708 . . . . 1.74 109.911 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 tp -57.57 -50.08 74.27 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.888 -1.125 . . . . 0.55 110.676 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.89 -40.47 93.2 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.715 0.769 . . . . 0.47 109.953 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -86.65 7.42 26.6 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 112.445 0.535 . . . . 1.42 112.445 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 57.7 t0 -60.87 120.7 10.68 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.875 -1.14 . . . . 1.27 108.502 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -64.86 -19.81 66.08 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.711 0.767 . . . . 1.35 110.876 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.445 ' OE1' ' OD1' ' A' ' 82' ' ' ASP . 21.7 mp0 -77.63 -52.99 8.1 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.357 -0.839 . . . . 2.22 110.327 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.87 -40.16 87.68 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.508 -0.877 . . . . 0.62 110.444 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -57.1 -49.48 75.76 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.279 -0.888 . . . . 1.29 110.597 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -62.33 -36.94 83.74 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.355 -0.841 . . . . 1.52 110.589 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -67.83 -47.63 68.48 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.352 -0.939 . . . . 1.3 110.682 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.9 mt -57.45 -42.05 79.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.281 -0.887 . . . . 0.61 110.044 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.8 mt -62.48 -41.73 93.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 121.405 0.622 . . . . 0.78 110.101 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.56 98.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.67 -0.644 . . . . 0.82 111.226 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.69 -42.81 93.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.884 -1.135 . . . . 0.8 110.575 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.47 -50.33 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 0.77 110.351 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.56 -38.71 65.12 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.218 -0.926 . . . . 2.12 111.862 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -81.67 -44.93 16.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.709 -1.244 . . . . 1.51 112.169 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HB3' ' HZ3' ' A' ' 96' ' ' LYS . 9.0 mmmm -100.49 10.14 41.61 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.976 -1.078 . . . . 1.98 112.166 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.6 m80 49.14 50.59 17.71 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.728 -1.232 . . . . 1.32 111.304 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -104.45 151.76 23.16 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.461 -0.774 . . . . 1.38 109.747 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.9 p -72.82 167.56 20.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.67 110.24 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.37 86.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.52 110.334 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -67.12 -40.21 86.79 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.074 -1.016 . . . . 2.25 110.408 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.37 -49.72 58.19 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.232 -0.987 . . . . 0.64 111.128 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.71 98.22 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.265 -0.897 . . . . 0.56 110.299 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.86 97.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.25 -0.906 . . . . 0.46 111.09 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -60.48 -40.08 89.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.015 . . . . 1.32 111.272 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -59.91 -48.97 79.51 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.728 -1.233 . . . . 1.3 111.063 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.52 -46.53 96.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.004 -1.06 . . . . 0.61 110.13 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.16 -32.39 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.711 -0.618 . . . . 0.65 110.316 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -55.99 -41.09 74.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.486 -0.758 . . . . 2.11 110.77 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.38 -34.86 10.0 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.098 -1.525 . . . . 0.83 112.378 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -62.13 -44.34 96.86 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.701 -1.47 . . . . 1.28 110.179 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.29 -52.36 19.29 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.772 0.796 . . . . 0.89 110.695 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.8 p -60.07 -37.57 80.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.514 -0.741 . . . . 1.87 110.48 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.51 -44.33 97.27 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.017 -0.673 . . . . 1.05 110.501 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.2 mt -61.75 -29.96 70.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.576 -1.327 . . . . 1.02 110.528 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -67.12 -22.4 65.8 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.339 -0.851 . . . . 2.04 111.411 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -73.18 -15.35 61.45 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.318 -0.864 . . . . 1.73 111.245 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.532 HD13 HD13 ' A' ' 123' ' ' LEU . 7.0 mt -84.54 141.59 30.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.431 -0.793 . . . . 1.37 108.896 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -94.92 39.46 1.1 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.077 -1.014 . . . . 2.88 112.086 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -112.0 136.82 50.84 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.119 -1.067 . . . . 1.58 108.119 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -59.77 -37.13 78.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.339 -0.851 . . . . 3.04 110.768 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -70.58 -57.84 4.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.79 -1.194 . . . . 0.9 110.188 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.532 HD13 HD13 ' A' ' 118' ' ' LEU . 23.1 mt -59.9 -39.9 86.94 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.16 -0.962 . . . . 1.06 110.335 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -62.53 -51.17 68.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.997 -1.064 . . . . 2.18 110.119 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.31 -30.59 71.7 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.751 -0.78 . . . . 2.15 109.816 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 130' ' ' VAL . 22.7 ttp180 -65.22 -28.91 69.7 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.026 -1.07 . . . . 2.33 109.155 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.83 80.16 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.813 0.816 . . . . 0.82 109.413 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.55 95.18 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.513 -0.875 . . . . 0.85 109.692 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -64.95 -36.99 86.17 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.292 0.568 . . . . 1.39 110.303 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 126' ' ' ARG . 46.8 t -67.9 -40.49 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 0.56 109.802 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -59.88 -38.08 81.18 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.894 0.854 . . . . 3.12 109.552 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -59.48 -38.99 82.27 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.287 0.565 . . . . 1.28 110.274 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.9 mt -61.46 -40.27 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.271 -0.893 . . . . 0.49 109.977 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.4 48.68 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.94 -1.124 . . . . 0.46 110.341 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -59.1 -45.99 89.45 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 120.994 -1.297 . . . . 2.71 110.087 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.432 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 58.6 mtm180 -62.32 -40.73 97.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.827 -1.17 . . . . 2.14 109.998 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.61 -42.97 99.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 1.05 110.153 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.27 -45.41 93.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.52 110.17 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -59.78 -33.93 72.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.556 -0.715 . . . . 2.35 111.025 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -75.18 -40.45 59.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.207 -0.933 . . . . 1.39 110.72 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.03 -39.96 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.68 110.292 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.3 mt -88.68 -6.18 57.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.83 111.942 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.72 71.01 Favored Glycine 0 N--CA 1.479 1.544 0 C-N-CA 119.304 -1.427 . . . . 0.91 112.932 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.2 tp -61.08 151.83 29.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 122.012 -0.699 . . . . 0.95 110.522 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -61.22 145.71 50.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.36 -0.837 . . . . 2.43 109.1 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.9 mt -111.3 139.94 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.536 -0.913 . . . . 1.1 108.536 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.8 mm -79.53 121.85 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.223 -1.029 . . . . 1.58 108.223 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -97.4 95.52 7.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.37 -1.715 . . . . 1.62 106.37 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.46 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 76.8 mt -75.51 -23.26 56.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.629 -0.669 . . . . 0.8 111.332 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.7 t -79.53 -0.68 34.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.176 -0.952 . . . . 1.56 112.334 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.08 22.84 8.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.737 -0.602 . . . . 0.84 112.46 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.46 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 11.3 mt -72.05 137.36 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.695 . . . . 0.82 109.543 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -112.47 -19.43 12.14 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.714 0.769 . . . . 2.31 112.828 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -117.44 138.95 51.5 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.53 -1.285 . . . . 1.54 107.53 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.35 122.02 21.37 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.001 -1.111 . . . . 1.38 108.001 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.8 m -145.63 177.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.438 -0.788 . . . . 0.69 109.291 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.3 mt -88.26 140.97 14.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.517 -0.74 . . . . 0.53 109.341 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 19' ' ' LEU . 26.4 tp -94.12 124.17 37.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.969 -1.082 . . . . 0.64 108.143 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.8 t -125.36 130.21 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.131 -1.063 . . . . 0.67 108.131 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.63 152.41 21.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.454 -0.779 . . . . 0.78 109.226 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.24 82.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.495 -1.378 . . . . 1.0 109.738 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 49.6 t0 -172.72 146.48 1.64 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.03 -0.729 . . . . 2.42 109.03 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.423 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 83.6 mt -119.35 141.27 49.18 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.406 -0.809 . . . . 0.75 109.304 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 65.7 p -91.59 152.41 43.41 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 120.848 -1.158 . . . . 0.78 108.364 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -41.6 -39.12 4.56 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.081 1.854 . . . . 0.67 113.848 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.432 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 27.4 m -59.91 -47.06 87.29 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.7 110.184 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -67.6 -40.52 84.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.793 . . . . 1.21 109.948 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.9 p -68.42 -37.91 80.74 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.917 -0.713 . . . . 0.6 110.223 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.55 82.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.945 . . . . 0.62 110.526 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -93.18 -2.67 55.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.054 . . . . 1.16 112.792 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.37 146.23 51.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.05 -1.031 . . . . 0.73 108.434 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -96.42 118.86 33.82 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.786 -1.561 . . . . 2.24 106.786 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.72 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.3 mm? -76.85 -14.55 59.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.446 -0.784 . . . . 1.43 111.451 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -80.05 -27.35 39.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.535 -0.728 . . . . 2.15 111.807 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -100.83 1.19 39.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.149 -0.969 . . . . 2.04 113.204 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 178' ' ' GLY . 61.3 t -110.14 129.97 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.584 -0.895 . . . . 0.55 108.584 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.26 -11.32 43.91 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.359 -0.838 . . . . 1.63 112.455 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.411 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 173.57 177.1 42.54 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.141 -1.584 . . . . 0.47 109.141 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -133.45 132.66 41.35 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 107.784 -1.191 . . . . 0.54 107.784 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.41 HG22 HG21 ' A' ' 205' ' ' THR . 77.5 mt -134.37 111.2 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 105.824 -1.917 . . . . 0.69 105.824 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 205' ' ' THR . 54.2 p -130.32 171.99 12.33 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.679 -1.263 . . . . 0.82 110.292 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -101.17 52.1 0.85 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.973 -0.558 . . . . 2.37 110.222 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 108.693 -0.854 . . . . 1.11 108.693 179.301 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 18.2 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 108.385 -0.968 . . . . 1.69 108.385 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -59.87 -38.61 82.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.405 -0.81 . . . . 1.07 110.545 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.3 p -54.13 -40.37 67.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 1.58 110.587 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.2 t -59.62 -39.6 84.82 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.034 -1.041 . . . . 1.6 109.71 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 33.6 mm -60.08 -39.22 79.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.583 -0.698 . . . . 1.45 110.394 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.5 mtp -62.51 -40.08 95.59 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.403 1.097 . . . . 1.05 109.786 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -56.2 -48.93 75.44 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.815 -0.63 . . . . 0.72 110.749 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -60.16 -42.55 95.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.011 -1.056 . . . . 3.05 110.605 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 64.9 m -69.96 -40.03 75.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.932 -1.105 . . . . 0.89 110.347 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 26.7 mt -91.12 -7.98 50.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.78 112.448 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 194' ' ' ALA . 48.3 mt-10 53.33 7.99 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.804 1.038 . . . . 1.45 113.804 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.26 150.48 92.0 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.933 . . . . 0.67 108.646 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.04 144.17 90.61 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.285 1.323 . . . . 0.64 109.263 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.73 162.26 34.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.119 -1.613 . . . . 0.67 110.075 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.2 mt -147.31 152.41 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.028 -1.101 . . . . 0.69 108.028 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.6 m -135.42 -32.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 121.288 -0.883 . . . . 0.85 112.702 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.84 41.42 2.37 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 120.098 -1.049 . . . . 0.92 111.399 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.458 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 43.2 p -64.14 -17.17 63.22 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.453 -1.028 . . . . 0.95 111.508 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.69 -95.81 0.91 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.945 -1.122 . . . . 1.04 110.345 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 88.8 p -127.25 30.8 5.34 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.849 -0.795 . . . . 1.57 112.146 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 72.7 t -58.91 -33.15 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.389 -1.444 . . . . 0.84 110.116 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 38.5 p -56.48 -24.04 43.35 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.71 -0.796 . . . . 0.99 111.407 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.2 p -92.98 0.74 57.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.866 . . . . 1.7 112.001 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -123.55 -7.74 8.03 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.562 0.696 . . . . 2.2 112.218 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 15.3 t -114.12 140.91 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.068 -0.716 . . . . 0.84 109.068 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -115.96 150.0 37.87 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.331 -0.988 . . . . 2.2 108.331 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.0 p30 -52.1 141.08 19.22 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.28 -0.887 . . . . 2.28 110.279 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.2 m-20 80.27 -0.75 1.99 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.948 1.092 . . . . 2.35 113.948 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -64.77 149.02 50.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.78 -1.2 . . . . 1.97 108.745 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -87.33 116.01 25.13 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.381 -1.34 . . . . 2.65 107.381 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.2 mt -128.38 144.73 51.17 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.513 0.673 . . . . 0.63 109.714 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 20.1 mt -115.81 128.61 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.698 -1.593 . . . . 0.62 106.698 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 48.9 tp -99.3 119.67 38.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 106.725 -1.584 . . . . 0.64 106.725 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.6 t0 -94.46 -28.66 15.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.926 -1.109 . . . . 2.05 112.333 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.899 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.61 17.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.005 0.743 . . . . 0.84 113.005 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' A' ' 221' ' ' ASP . 32.1 t -107.33 -58.54 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -0.929 . . . . 1.02 108.948 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -92.15 11.23 26.22 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.888 0.851 . . . . 2.51 110.545 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 60.9 t30 62.51 50.79 3.47 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.616 -0.72 . . . . 1.54 112.504 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -153.41 159.24 42.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.025 . . . . 1.95 109.945 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.0 t -116.43 141.65 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.127 -0.694 . . . . 0.71 109.127 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -103.5 132.08 50.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.024 -1.047 . . . . 1.01 108.758 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.63 129.63 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 107.717 -1.216 . . . . 0.82 107.717 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.435 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 54.0 t30 48.9 50.67 9.54 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 1.54 112.912 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 25.2 Cg_endo -64.13 154.26 71.64 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.42 2.08 . . . . 0.94 110.541 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.6 m -74.55 156.51 36.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.074 -1.016 . . . . 1.8 109.489 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -58.74 -35.76 73.22 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.018 . . . . 2.73 110.774 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -59.57 -40.19 86.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 3.17 110.015 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 96.8 t -69.64 -39.53 78.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.56 -0.713 . . . . 1.34 110.236 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.3 mt -57.48 -43.93 83.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.64 -0.662 . . . . 1.2 110.613 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.46 -43.31 93.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.873 -1.142 . . . . 2.7 110.317 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -63.64 -44.36 94.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.101 -1.0 . . . . 2.59 111.126 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.9 mtp -68.75 -37.75 79.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.007 -1.058 . . . . 1.38 110.874 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.471 -0.768 . . . . 2.84 110.917 179.343 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.1 mt . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 106.806 -1.553 . . . . 1.07 106.806 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.6 m -104.71 125.46 50.83 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.989 -1.115 . . . . 1.24 107.989 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.8 -154.57 18.45 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.252 -1.939 . . . . 1.01 108.252 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 5' ' ' ILE . 73.0 mt -96.07 -2.08 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -1.003 . . . . 1.11 112.808 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 tp 49.57 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.99 112.583 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -85.96 -42.92 13.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.991 -1.068 . . . . 0.85 111.242 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -145.7 141.3 16.65 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 107.893 -1.151 . . . . 1.38 107.893 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.05 147.83 30.61 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.233 1.956 . . . . 0.94 112.333 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.904 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.94 166.74 15.67 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.818 -1.713 . . . . 0.81 108.818 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -127.46 138.04 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.09 -1.241 . . . . 0.83 108.004 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.55 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -141.48 160.06 40.93 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.964 0.888 . . . . 0.53 109.466 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 11.9 m-85 -129.66 139.94 51.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.168 -1.419 . . . . 0.77 107.168 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.69 169.2 38.4 Favored Glycine 0 N--CA 1.5 2.903 0 C-N-CA 119.04 -1.552 . . . . 0.51 110.077 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -77.31 158.42 30.19 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.606 -0.887 . . . . 1.9 108.606 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.646 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -88.09 128.28 35.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.167 -0.958 . . . . 0.66 108.613 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 tp -108.43 105.68 15.45 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 105.124 -2.176 . . . . 0.83 105.124 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.0 tp -94.73 132.6 39.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.107 -0.996 . . . . 0.86 108.774 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.9 mt -101.78 118.16 36.36 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.161 -1.792 . . . . 0.92 106.161 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -107.27 130.22 54.78 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.961 -1.125 . . . . 2.03 107.961 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -128.46 140.71 51.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.453 -0.779 . . . . 2.66 109.178 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.51 137.66 35.55 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.17 -1.048 . . . . 2.32 108.17 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -65.57 150.8 47.81 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.208 -0.933 . . . . 2.11 110.141 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.5 mt -89.11 134.05 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.89 -1.152 . . . . 0.73 107.89 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.22 130.23 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.928 -1.138 . . . . 0.87 107.928 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.88 130.92 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.548 -0.908 . . . . 0.81 108.548 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -92.74 127.01 38.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.232 -1.025 . . . . 1.34 108.232 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 28' ' ' ARG . 23.4 mmm-85 -99.31 17.39 20.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.529 -0.732 . . . . 2.89 112.277 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -61.95 144.49 54.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.783 -1.198 . . . . 2.09 109.467 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -90.66 131.93 36.07 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.606 -0.886 . . . . 2.19 108.606 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 pt -99.24 168.05 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.315 -0.866 . . . . 0.75 110.239 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.5 p -94.6 162.73 13.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.565 -0.71 . . . . 0.91 109.825 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.37 -21.11 22.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.93 111.667 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.76 -38.41 76.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.058 -1.026 . . . . 2.28 110.597 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -88.4 -6.35 57.73 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.104 -0.997 . . . . 1.45 111.932 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.07 -41.21 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.049 -1.032 . . . . 0.81 110.59 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -57.58 -40.08 78.22 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.907 -1.121 . . . . 1.54 110.736 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -63.2 -40.84 98.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 2.36 111.265 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.3 -39.76 88.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.779 -1.201 . . . . 1.31 110.875 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.2 -41.72 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.94 . . . . 0.82 110.43 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -61.75 -42.6 99.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.021 -1.049 . . . . 1.5 110.071 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.48 ' NH2' ' O ' ' A' ' 141' ' ' ILE . 55.4 mtp180 -61.82 -42.54 99.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 2.23 110.371 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -73.11 -51.08 19.33 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.014 -1.054 . . . . 0.85 110.162 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.45 -47.86 82.18 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.112 -1.435 . . . . 0.91 110.238 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.9 t -69.63 -42.56 74.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.419 -0.8 . . . . 0.9 110.469 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.81 -41.83 84.35 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.178 -1.487 . . . . 0.69 109.395 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.553 HH22 ' CD ' ' A' ' 86' ' ' GLU . 17.7 ttm180 -57.45 -32.73 67.21 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.227 1.013 . . . . 2.88 109.473 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.28 -42.43 81.64 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.806 0.813 . . . . 0.85 109.669 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -79.75 -43.93 21.65 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.729 0.776 . . . . 2.35 110.223 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.17 88.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.334 -0.854 . . . . 0.65 109.929 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 t -59.57 -41.76 90.94 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.068 0.937 . . . . 1.45 109.289 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.48 -45.23 80.37 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.965 -0.562 . . . . 0.63 110.063 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -64.85 -50.2 67.58 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.052 -1.059 . . . . 1.34 110.181 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.67 -37.61 84.71 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.658 -0.817 . . . . 1.56 110.2 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -60.19 -42.81 95.85 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.551 -0.718 . . . . 1.19 110.822 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.5 m -65.01 -44.2 90.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.019 -1.051 . . . . 0.72 110.42 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.15 -36.76 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.54 -0.725 . . . . 0.62 110.674 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -50.81 -44.94 59.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.155 -0.965 . . . . 1.05 110.561 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -68.3 -37.49 80.69 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.135 -0.978 . . . . 0.64 110.16 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.405 ' O ' ' OG1' ' A' ' 64' ' ' THR . 24.7 mtpp -61.49 -39.02 89.43 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.427 -1.309 . . . . 1.73 108.932 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.98 -38.76 87.11 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.799 -0.761 . . . . 0.56 109.261 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.94 -40.04 58.01 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 119.692 -1.242 . . . . 0.69 110.505 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -79.64 -20.15 47.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.427 -1.043 . . . . 1.48 110.437 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 87.9 m -82.74 -53.31 6.01 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 120.217 -0.593 . . . . 0.98 110.458 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -106.19 -16.06 14.69 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.289 -0.882 . . . . 1.16 112.693 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.95 167.77 16.3 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 111.459 -0.656 . . . . 0.85 111.459 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.3 -25.86 62.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.407 -1.054 . . . . 3.86 112.23 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.07 -40.06 73.01 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.895 -1.128 . . . . 2.35 111.182 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -89.36 -16.45 31.0 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.924 -1.11 . . . . 1.67 112.3 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.62 -39.0 86.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 1.45 110.702 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.17 78.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.72 -0.613 . . . . 0.61 111.495 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.01 -41.52 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.847 -1.158 . . . . 0.65 110.521 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -70.26 -31.44 68.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.917 -1.115 . . . . 0.66 110.498 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.43 -39.98 92.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.309 -0.87 . . . . 1.19 110.021 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.44 96.25 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.799 -1.32 . . . . 0.53 109.799 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -57.81 -40.13 79.21 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.367 -1.078 . . . . 1.27 110.495 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.5 mt -61.44 -40.39 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.54 110.236 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.6 ttm -59.5 -41.12 89.14 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.259 -0.901 . . . . 1.74 110.381 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.3 tp -57.52 -49.1 77.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.81 . . . . 0.55 110.309 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.02 -45.12 93.85 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.86 0.838 . . . . 0.47 110.175 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -87.46 8.03 26.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.464 -0.773 . . . . 1.42 113.026 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 55.2 t0 -62.22 123.47 18.28 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.764 -1.21 . . . . 1.27 109.151 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -66.48 -18.54 65.42 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.406 -0.809 . . . . 1.35 111.168 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' OE1' ' OD1' ' A' ' 82' ' ' ASP . 10.8 mp0 -77.68 -52.4 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.689 -0.804 . . . . 2.22 110.099 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.5 mt -60.92 -35.2 76.07 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.101 -0.999 . . . . 0.62 110.287 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.553 ' CD ' HH22 ' A' ' 47' ' ' ARG . 80.8 tt0 -59.14 -47.6 84.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.821 . . . . 1.29 110.402 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -61.72 -35.54 78.34 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.629 -0.669 . . . . 1.52 110.12 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.07 -49.09 71.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 1.3 110.313 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.3 mt -58.64 -43.93 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.06 -1.025 . . . . 0.61 109.779 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.01 -40.9 87.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.65 -0.656 . . . . 0.78 110.146 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -42.32 93.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.33 -0.857 . . . . 0.82 110.424 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.39 -44.03 97.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.285 -0.884 . . . . 0.8 110.013 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.8 mt -63.56 -49.21 83.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.363 -0.835 . . . . 0.77 110.039 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -78.12 -37.2 46.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.496 -0.752 . . . . 2.12 111.658 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -81.81 -40.96 21.79 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.573 -1.329 . . . . 1.51 111.996 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -105.58 7.76 32.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.457 -0.777 . . . . 1.98 112.687 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.7 m80 49.65 49.79 19.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.563 -1.336 . . . . 1.32 111.504 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 67.1 mtt -104.45 156.75 17.67 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.049 0.928 . . . . 1.38 109.967 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.3 p -72.59 161.75 30.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.783 -0.573 . . . . 0.67 110.02 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.55 86.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.52 110.302 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.587 ' OD2' HD21 ' A' ' 142' ' ' LEU . 96.2 m-20 -66.28 -40.07 89.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.118 -0.989 . . . . 2.25 109.868 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.2 -48.83 55.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.559 -0.713 . . . . 0.64 111.08 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.93 92.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.167 -0.958 . . . . 0.56 110.227 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.17 95.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.579 -0.701 . . . . 0.46 110.661 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -60.29 -39.87 88.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.204 -0.935 . . . . 1.32 111.275 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -58.05 -48.92 78.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.729 -1.232 . . . . 1.3 110.912 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.77 -45.61 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.892 -1.13 . . . . 0.61 109.867 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.3 mm -62.22 -31.72 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.645 -0.659 . . . . 0.65 110.348 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -57.33 -41.09 79.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 2.11 110.572 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.16 -34.64 9.52 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.368 -1.396 . . . . 0.83 112.624 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -60.69 -42.37 97.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.261 -1.729 . . . . 1.28 110.153 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.07 -55.55 6.35 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.451 -0.781 . . . . 0.89 110.727 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.8 m -60.61 -37.95 83.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 1.87 110.886 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.51 96.37 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.897 -1.127 . . . . 1.05 111.079 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.31 -30.22 70.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.873 -1.131 . . . . 1.02 110.918 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -66.53 -20.82 66.12 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.168 -1.013 . . . . 2.04 110.954 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -71.91 -15.18 62.09 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.838 0.827 . . . . 1.73 110.828 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.489 HD13 HD13 ' A' ' 123' ' ' LEU . 50.0 mt -86.74 145.16 26.76 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.246 -0.65 . . . . 1.37 109.246 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -103.02 39.7 1.51 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.337 -0.852 . . . . 2.88 111.461 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -113.04 136.27 52.87 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.135 -1.061 . . . . 1.58 108.135 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -56.63 -38.07 71.59 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.444 0.64 . . . . 3.04 110.796 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -72.16 -52.79 14.99 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.827 -1.171 . . . . 0.9 110.312 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.489 HD13 HD13 ' A' ' 118' ' ' LEU . 19.3 mt -63.58 -39.72 95.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.168 -0.958 . . . . 1.06 110.497 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -65.65 -47.54 75.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.93 . . . . 2.18 110.502 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -61.47 -31.34 71.3 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.407 -0.917 . . . . 2.15 110.248 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 130' ' ' VAL . 63.3 ttt180 -65.71 -27.7 68.52 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 118.995 -1.082 . . . . 2.33 109.528 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.84 -49.16 78.77 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.786 0.803 . . . . 0.82 109.589 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.23 91.22 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.57 -0.852 . . . . 0.85 109.633 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 2.0 m-20 -62.97 -35.47 80.28 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.306 0.574 . . . . 1.39 110.214 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 126' ' ' ARG . 31.8 t -68.17 -40.47 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.518 -0.739 . . . . 0.56 110.639 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -59.72 -38.13 80.81 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.509 -1.277 . . . . 3.12 110.076 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.52 ' OD1' ' NE ' ' A' ' 136' ' ' ARG . 54.4 t0 -60.22 -40.05 88.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.608 -0.683 . . . . 1.28 110.186 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.19 -39.64 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.01 -1.056 . . . . 0.49 110.399 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.08 -46.9 62.68 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.937 -1.125 . . . . 0.46 110.696 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -59.94 -41.31 91.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.123 -1.222 . . . . 2.71 110.368 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.52 ' NE ' ' OD1' ' A' ' 132' ' ' ASP . 40.5 mtt-85 -63.32 -42.11 98.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.06 -1.025 . . . . 2.14 109.995 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.522 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.0 tt -61.06 -45.15 95.92 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.967 0.889 . . . . 1.05 109.76 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.98 -42.05 97.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.89 . . . . 0.52 110.522 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.12 -31.71 70.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.933 . . . . 2.35 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -75.33 -41.67 56.18 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.945 -1.097 . . . . 1.39 110.777 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.48 ' O ' ' NH2' ' A' ' 42' ' ' ARG . 98.0 mt -60.02 -37.92 74.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.144 -0.973 . . . . 0.68 110.607 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.587 HD21 ' OD2' ' A' ' 101' ' ' ASP . 90.0 mt -87.49 -9.18 55.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.378 -0.826 . . . . 0.83 111.716 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.26 23.62 65.34 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 120.298 -0.953 . . . . 0.91 113.457 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.1 tp -68.34 139.71 55.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.806 -0.82 . . . . 0.95 109.863 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -68.6 150.54 47.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.568 -0.707 . . . . 2.43 109.907 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 39.7 mt -108.76 137.7 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.341 -0.985 . . . . 1.1 108.341 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.3 mm -78.31 130.35 36.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.875 -1.141 . . . . 1.58 109.016 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -94.47 97.62 10.29 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.625 -1.62 . . . . 1.62 106.625 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 51.0 mt -76.98 -15.66 59.58 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.39 0.614 . . . . 0.8 111.563 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.4 t -80.97 2.39 27.06 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.59 0.71 . . . . 1.56 112.156 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.69 22.7 10.57 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.713 0.768 . . . . 0.84 112.069 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 12.5 mt -72.77 135.88 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.427 -0.953 . . . . 0.82 108.427 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -121.15 -13.69 8.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 112.927 0.714 . . . . 2.31 112.927 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -112.53 136.89 51.51 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.926 -1.138 . . . . 1.54 107.926 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.07 117.68 17.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.376 -0.828 . . . . 1.38 109.009 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -148.01 179.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.21 -0.663 . . . . 0.69 109.21 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 49.0 mt -88.13 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.481 -0.933 . . . . 0.53 108.481 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.3 tp -94.63 126.82 40.17 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.43 -0.952 . . . . 0.64 108.43 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.48 130.66 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.038 -1.097 . . . . 0.67 108.038 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.34 159.51 31.3 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.009 -1.057 . . . . 0.78 108.67 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.14 92.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.692 -1.255 . . . . 1.0 109.324 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 50.9 t0 -171.75 154.09 3.53 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.527 -0.916 . . . . 2.42 108.527 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 49.6 mt -117.18 139.04 51.26 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.446 -0.946 . . . . 0.75 108.446 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.7 p -92.06 146.29 32.49 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.158 -0.964 . . . . 0.78 108.41 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -38.97 -44.63 2.51 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.169 1.913 . . . . 0.67 113.812 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 16.2 m -60.34 -47.84 84.32 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.629 -1.294 . . . . 0.7 109.954 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -63.17 -37.8 88.67 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.657 0.742 . . . . 1.21 110.167 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.0 p -67.87 -39.05 83.79 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.547 -0.721 . . . . 0.6 110.192 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.19 86.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.533 -0.73 . . . . 0.62 110.744 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.79 -3.31 56.3 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.149 -0.97 . . . . 1.16 113.046 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 171' ' ' LEU . 41.2 tp -63.37 156.35 26.15 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.402 -0.811 . . . . 0.73 109.587 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -94.9 110.2 22.12 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.503 -1.666 . . . . 2.24 106.503 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.1 mt -71.33 -24.91 62.21 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.748 0.785 . . . . 1.43 111.408 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -85.66 -18.66 32.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.492 -0.755 . . . . 2.15 112.446 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -100.64 -2.73 31.97 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.297 -0.877 . . . . 2.04 112.767 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 178' ' ' GLY . 57.5 t -109.69 130.09 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.689 -1.226 . . . . 0.55 107.689 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.743 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.8 tt -85.61 -9.89 56.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.031 -1.043 . . . . 1.63 111.702 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.37 173.41 38.98 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.485 -1.446 . . . . 0.47 109.485 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.9 OUTLIER -130.64 131.31 44.83 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.622 -1.251 . . . . 0.54 107.622 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.526 HG22 HG21 ' A' ' 205' ' ' THR . 87.5 mt -134.49 109.11 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 106.093 -1.818 . . . . 0.69 106.093 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 203' ' ' VAL . 73.6 p -134.26 174.58 10.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.678 -1.264 . . . . 0.82 110.415 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 206' ' ' GLY . 11.8 t0 -103.85 65.83 0.83 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.639 -0.71 . . . . 2.37 109.375 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.027 0 O-C-N 121.195 -0.941 . . . . 1.11 109.053 179.882 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.9 p . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 107.07 -1.455 . . . . 1.69 107.07 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -59.98 -30.46 69.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.838 . . . . 1.07 110.528 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.0 m -56.45 -40.51 74.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.539 -0.726 . . . . 1.58 110.039 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.1 m -59.78 -39.98 86.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 1.6 109.948 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 192' ' ' ILE . 1.6 mp -60.23 -38.89 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.815 . . . . 1.45 110.418 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 68.3 mtp -62.38 -42.96 99.82 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 122.062 0.934 . . . . 1.05 109.529 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.5 -48.74 79.69 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.726 -0.67 . . . . 0.72 111.673 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 195' ' ' ARG . 30.2 mtt-85 -60.78 -44.4 96.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.14 . . . . 3.05 110.653 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 28.8 m -69.45 -39.54 77.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.887 . . . . 0.89 110.435 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.4 -4.9 53.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.78 112.987 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 194' ' ' ALA . 75.3 mt-10 54.6 12.5 0.56 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.115 1.154 . . . . 1.45 114.115 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 72.9 mt -73.77 158.4 86.15 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.05 -1.032 . . . . 0.67 108.495 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -65.32 142.71 73.98 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.973 1.115 . . . . 0.64 110.557 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.96 163.87 33.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 119.928 -1.733 . . . . 0.67 110.431 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.0 mt -149.88 149.74 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 107.465 -1.309 . . . . 0.69 107.465 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 5.5 m -135.82 -26.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.755 -1.216 . . . . 0.85 112.54 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.15 35.04 1.49 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.309 -1.424 . . . . 0.92 113.113 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.526 HG21 HG22 ' A' ' 180' ' ' ILE . 47.5 p -56.06 -27.62 54.19 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.421 -1.046 . . . . 0.95 111.45 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 77.12 -90.78 1.0 Allowed Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.133 -1.032 . . . . 1.04 110.815 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.2 p -125.06 27.6 6.64 Favored 'General case' 0 N--CA 1.512 2.652 0 O-C-N 121.341 -1.094 . . . . 1.57 112.669 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.11 -34.76 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.232 -1.543 . . . . 0.84 110.075 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.9 p -58.34 -17.97 23.96 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.26 -0.976 . . . . 0.99 111.86 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.8 p -92.63 -0.98 57.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.137 -0.977 . . . . 1.7 112.006 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -129.13 5.19 5.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 112.595 0.591 . . . . 2.2 112.595 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.87 141.32 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.732 -0.605 . . . . 0.84 109.39 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -120.35 155.21 33.84 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.371 -0.974 . . . . 2.2 108.371 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 16.6 p30 -53.8 142.79 22.77 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.083 -1.011 . . . . 2.28 110.547 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.6 t0 80.19 0.25 2.01 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.504 1.298 . . . . 2.35 114.504 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.12 146.67 54.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.795 -1.191 . . . . 1.97 108.78 177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -88.74 120.7 30.38 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.458 -1.312 . . . . 2.65 107.458 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.646 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 49.6 mt -128.94 149.04 50.96 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.404 -0.81 . . . . 0.63 110.018 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.425 HD13 ' SD ' ' A' ' 239' ' ' MET . 57.4 mt -116.03 126.95 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.878 -1.527 . . . . 0.62 106.878 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.416 HD13 HD11 ' A' ' 180' ' ' ILE . 65.1 tp -99.22 120.11 38.98 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.306 -1.368 . . . . 0.64 107.306 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 223' ' ' VAL . 49.7 t0 -93.89 -28.97 15.54 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.012 -1.055 . . . . 2.05 112.826 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.77 18.37 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.186 0.809 . . . . 0.84 113.186 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.8 t -111.45 -58.84 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-O 122.197 0.999 . . . . 1.02 108.922 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -96.47 9.8 40.24 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.412 1.101 . . . . 2.51 110.188 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 61.92 50.05 4.38 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.785 -1.098 . . . . 1.54 111.665 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -145.28 148.04 33.02 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.345 1.069 . . . . 1.95 109.749 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 80.9 t -117.2 140.77 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 115.503 -0.772 . . . . 0.71 109.285 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -100.03 130.59 46.21 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.171 -1.048 . . . . 1.01 108.171 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.3 t -109.83 131.48 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.579 0.704 . . . . 0.82 109.166 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.413 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 24.6 t30 52.96 51.65 9.47 Favored Pre-proline 0 N--CA 1.497 1.877 0 N-CA-C 113.345 0.869 . . . . 1.54 113.345 177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 61.9 Cg_endo -70.23 151.66 66.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.784 2.323 . . . . 0.94 111.441 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.0 m -72.23 156.46 39.11 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.964 -1.085 . . . . 1.8 108.747 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -59.8 -39.43 84.95 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.89 -1.131 . . . . 2.73 109.935 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.65 -39.72 85.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.482 -0.761 . . . . 3.17 110.278 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 87.9 t -69.71 -38.58 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.461 -0.775 . . . . 1.34 110.216 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.29 -46.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.042 -1.036 . . . . 1.2 110.15 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.03 -40.22 88.57 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.175 -0.953 . . . . 2.7 110.208 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -62.17 -41.57 98.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 2.59 110.808 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' MET . . . . . 0.425 ' SD ' HD13 ' A' ' 219' ' ' ILE . 74.9 mtp -70.81 -31.39 68.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 1.38 110.372 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.428 ' CA ' ' HE ' ' A' ' 240' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 2.84 110.063 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 106.455 -1.683 . . . . 1.07 106.455 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 m -104.38 128.45 52.23 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.097 -1.075 . . . . 1.24 108.097 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.04 -160.45 16.79 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.904 -1.678 . . . . 1.01 108.904 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.6 mt -93.31 -1.11 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.292 -1.122 . . . . 1.11 112.772 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 50.72 96.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.102 -0.999 . . . . 0.99 112.688 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.92 -42.33 13.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 0.85 111.547 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -145.35 144.85 24.37 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.046 -1.094 . . . . 1.38 108.046 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.81 147.44 27.43 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.59 2.193 . . . . 0.94 112.218 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.893 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.29 167.77 15.16 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 109.261 -1.536 . . . . 0.81 109.261 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.7 mt -125.91 132.49 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.243 -1.151 . . . . 0.83 107.909 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.53 151.59 46.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 0.53 109.286 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.609 ' CE1' ' NH2' ' A' ' 240' ' ' ARG . 1.8 m-85 -122.24 144.52 48.93 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.259 -1.015 . . . . 0.77 108.259 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.92 167.45 34.22 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 118.362 -1.875 . . . . 0.51 110.197 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -78.1 157.68 29.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.429 -1.042 . . . . 1.9 108.938 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.419 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -83.96 124.64 31.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.975 -1.078 . . . . 0.66 108.151 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.3 tp -100.46 104.49 15.89 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.024 -2.213 . . . . 0.83 105.024 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -91.02 135.78 33.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.215 -1.031 . . . . 0.86 108.215 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.3 mt -97.27 120.1 37.01 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.438 -1.319 . . . . 0.92 107.438 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -109.11 134.67 51.4 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.249 -1.019 . . . . 2.03 108.249 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.563 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 37.2 tt0 -117.98 140.36 49.85 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.224 -0.658 . . . . 2.66 109.224 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -81.98 131.28 35.25 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.718 -1.216 . . . . 2.32 107.718 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.09 145.02 56.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 2.11 108.74 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.67 135.19 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.91 -1.118 . . . . 0.73 108.636 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.6 t -103.44 129.8 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.967 -1.123 . . . . 0.87 107.967 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -99.0 136.97 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.646 -0.872 . . . . 0.81 108.646 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -90.62 122.46 33.43 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.828 -1.175 . . . . 1.34 107.828 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.442 HH11 ' HG3' ' A' ' 28' ' ' ARG . 20.6 mmm-85 -93.52 15.72 15.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.315 -0.865 . . . . 2.89 112.319 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -71.47 143.25 50.1 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.408 -0.807 . . . . 2.09 109.527 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.75 141.7 31.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.649 -0.657 . . . . 2.19 109.425 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.2 pt -98.3 168.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.197 -0.939 . . . . 0.75 110.622 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.8 p -102.37 162.3 13.03 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.983 -0.747 . . . . 0.91 108.983 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.45 -18.55 1.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.086 -1.009 . . . . 0.93 112.379 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -69.85 -39.99 76.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 2.28 110.754 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -93.13 -8.91 41.27 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.873 -1.142 . . . . 1.45 112.949 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -56.29 -50.48 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.168 -0.957 . . . . 0.81 110.781 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.85 -39.44 85.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.542 -0.724 . . . . 1.54 110.674 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -62.2 -41.29 98.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.831 . . . . 2.36 110.896 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.53 -37.62 81.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.742 -1.224 . . . . 1.31 110.449 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.41 -41.78 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.169 -0.957 . . . . 0.82 110.028 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -62.13 -43.58 98.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 1.5 109.745 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.464 HH11 ' HG2' ' A' ' 42' ' ' ARG . 34.0 mtt-85 -61.8 -44.05 97.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.524 -0.735 . . . . 2.23 110.063 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -70.78 -52.16 22.38 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.346 -0.846 . . . . 0.85 109.896 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.08 -46.44 89.56 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.394 -0.922 . . . . 0.91 109.846 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 15.5 t -69.19 -34.89 75.6 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.243 0.544 . . . . 0.9 110.364 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.44 -47.95 87.79 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.685 -1.245 . . . . 0.69 110.17 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -56.91 -32.02 65.5 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.363 -1.08 . . . . 2.88 109.183 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.38 -42.06 69.93 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.522 0.677 . . . . 0.85 109.968 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -78.49 -42.02 30.85 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.688 -0.805 . . . . 2.35 110.14 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.77 95.95 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.669 0.747 . . . . 0.65 110.368 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.1 p -60.01 -39.81 87.06 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.994 0.902 . . . . 1.45 109.666 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.57 67.97 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 120.073 -0.651 . . . . 0.63 110.31 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -61.18 -48.57 80.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.273 -0.892 . . . . 1.34 110.382 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.8 -40.37 96.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -0.92 . . . . 1.56 109.821 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -60.55 -41.24 94.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.542 -0.724 . . . . 1.19 110.428 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.621 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 9.4 m -65.65 -42.86 90.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.0 -1.062 . . . . 0.72 110.409 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.2 -30.73 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.658 . . . . 0.62 110.611 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -52.61 -46.29 66.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.709 -0.619 . . . . 1.05 110.619 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 m -68.82 -37.2 79.05 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.21 -0.931 . . . . 0.64 109.791 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.621 ' NZ ' HG22 ' A' ' 56' ' ' THR . 65.2 mttp -61.73 -38.35 87.58 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.427 -0.909 . . . . 1.73 109.386 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.19 74.86 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.822 -0.751 . . . . 0.56 109.977 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.97 -34.57 21.03 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.379 -1.391 . . . . 0.69 110.917 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.44 -18.05 43.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.783 -1.422 . . . . 1.48 111.545 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.0 m -87.91 -52.57 5.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.912 -0.493 . . . . 0.98 110.344 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -107.27 -15.28 14.69 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.435 -0.791 . . . . 1.16 112.97 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.91 164.88 14.71 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.537 -0.727 . . . . 0.85 111.567 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -58.16 -17.94 22.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.629 -0.924 . . . . 3.86 113.113 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.91 -39.43 85.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.995 -1.065 . . . . 2.35 110.769 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -86.8 -23.63 25.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.953 -1.092 . . . . 1.67 111.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -59.84 -39.98 86.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.725 -0.609 . . . . 1.45 111.598 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.44 -36.77 81.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.162 -0.961 . . . . 0.61 111.352 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 57.8 mt -63.38 -41.65 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.73 -1.232 . . . . 0.65 110.843 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -70.59 -30.94 67.75 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.933 -1.104 . . . . 0.66 110.631 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.51 -38.73 85.32 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.195 -0.94 . . . . 1.19 109.91 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.3 -44.67 90.22 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 120.298 -0.953 . . . . 0.53 110.891 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -59.73 -40.79 89.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.874 -1.368 . . . . 1.27 110.723 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.6 mt -59.83 -39.43 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.107 -0.995 . . . . 0.54 110.772 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.21 -39.77 83.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.111 -0.993 . . . . 1.74 110.633 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.5 tp -58.36 -45.89 87.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.14 -0.975 . . . . 0.55 110.235 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.51 -39.83 89.2 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.585 -0.846 . . . . 0.47 110.248 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -86.93 11.02 14.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 1.42 112.304 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -66.47 120.96 14.26 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.978 -1.076 . . . . 1.27 108.536 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.87 -16.8 64.17 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.367 -0.833 . . . . 1.35 110.918 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -73.42 -47.89 38.13 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.548 -0.861 . . . . 2.22 110.447 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.86 -37.29 86.83 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.429 -0.908 . . . . 0.62 110.229 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.74 -45.53 93.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.338 -0.851 . . . . 1.29 110.915 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.7 -36.98 85.62 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.014 -1.054 . . . . 1.52 110.925 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.7 -48.48 63.77 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.735 -1.228 . . . . 1.3 110.404 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -57.44 -47.71 84.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.444 -0.902 . . . . 0.61 110.243 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.87 -39.61 80.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.785 -0.572 . . . . 0.78 110.415 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.53 91.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 0.82 110.644 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.15 -43.68 98.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.8 110.284 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.1 mt -61.0 -45.95 97.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.77 110.648 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -82.31 -36.43 26.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -0.757 . . . . 2.12 111.908 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -84.49 -39.36 18.97 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.62 -1.3 . . . . 1.51 111.627 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -105.26 10.37 33.65 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.969 -1.082 . . . . 1.98 111.939 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.4 m80 48.48 51.39 15.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 1.32 111.588 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.2 mtt -109.5 154.34 22.81 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.703 0.763 . . . . 1.38 109.722 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.1 p -71.81 158.64 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.132 -0.692 . . . . 0.67 109.132 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.27 89.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.403 -0.811 . . . . 0.52 110.754 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.634 ' OD2' HD21 ' A' ' 142' ' ' LEU . 72.4 m-20 -67.42 -43.06 82.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.755 -1.215 . . . . 2.25 109.51 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.06 -48.31 58.4 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.656 0.741 . . . . 0.64 110.845 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.48 -46.85 87.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.138 -0.976 . . . . 0.56 110.47 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.29 94.96 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.497 0.665 . . . . 0.46 110.411 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.85 -39.33 84.82 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.032 -1.043 . . . . 1.32 110.334 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.42 -49.92 75.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.878 -1.139 . . . . 1.3 111.099 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.25 -49.0 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.059 . . . . 0.61 110.004 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.45 -30.82 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.676 -0.64 . . . . 0.65 110.699 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -59.45 -40.37 86.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 2.11 110.276 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.28 -28.0 31.74 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.204 -1.474 . . . . 0.83 113.108 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -60.29 -39.73 87.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.056 -1.85 . . . . 1.28 110.045 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.63 -46.69 52.82 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.554 -0.716 . . . . 0.89 110.299 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.3 p -62.83 -40.21 96.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.419 -0.801 . . . . 1.87 110.433 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.39 -40.65 97.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 1.05 110.508 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.88 -29.61 70.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.04 -1.037 . . . . 1.02 111.111 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.09 -21.36 64.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.906 -1.121 . . . . 2.04 111.053 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -73.81 -12.48 60.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.215 -0.928 . . . . 1.73 110.788 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.454 HD13 HD13 ' A' ' 123' ' ' LEU . 9.6 mt -84.84 144.89 28.13 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.485 -0.759 . . . . 1.37 109.065 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -101.46 46.91 0.92 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.171 -0.956 . . . . 2.88 111.591 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -122.28 138.75 54.39 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.057 -1.027 . . . . 1.58 108.589 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.8 -38.67 82.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 3.04 110.973 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -71.93 -47.02 55.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.957 -1.089 . . . . 0.9 110.525 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.454 HD13 HD13 ' A' ' 118' ' ' LEU . 39.5 mt -63.67 -36.76 84.89 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.46 -0.896 . . . . 1.06 110.103 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -60.47 -46.53 89.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.819 -1.152 . . . . 2.18 109.644 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -61.95 -30.84 71.19 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.367 -0.933 . . . . 2.15 109.651 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 130' ' ' VAL . 60.7 ttt180 -61.86 -30.12 70.64 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.291 -0.964 . . . . 2.33 108.9 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.21 73.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.785 0.802 . . . . 0.82 109.574 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.89 -43.36 71.95 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.622 0.725 . . . . 0.85 110.319 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -64.5 -34.15 77.56 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.497 -0.752 . . . . 1.39 110.528 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 126' ' ' ARG . 16.3 t -68.01 -39.96 82.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.252 -0.905 . . . . 0.56 110.033 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.435 HH11 ' HG2' ' A' ' 131' ' ' ARG . 27.4 ttt-85 -56.18 -39.92 73.14 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.251 -1.379 . . . . 3.12 109.469 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -60.05 -42.59 94.79 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.575 0.702 . . . . 1.28 110.235 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.32 -38.94 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.49 110.166 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.59 -43.74 23.02 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.852 -1.166 . . . . 0.46 110.832 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -58.33 -40.76 83.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.293 -1.122 . . . . 2.71 110.592 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 136' ' ' ARG . 55.1 mtt-85 -62.33 -41.55 98.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.959 -1.088 . . . . 2.14 109.969 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.64 -39.59 84.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.611 -0.681 . . . . 1.05 109.964 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.3 mt -59.73 -40.09 86.86 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.453 -0.779 . . . . 0.52 110.473 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.563 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 63.1 mtt-85 -60.66 -38.6 85.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.016 -1.053 . . . . 2.35 111.062 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -71.65 -41.81 68.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 1.39 110.87 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.3 -39.62 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.016 -1.053 . . . . 0.68 110.216 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.634 HD21 ' OD2' ' A' ' 101' ' ' ASP . 84.1 mt -87.2 -8.93 56.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.123 -0.986 . . . . 0.83 112.199 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.27 21.29 78.07 Favored Glycine 0 N--CA 1.48 1.617 0 C-N-CA 119.703 -1.237 . . . . 0.91 113.282 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 tp -69.2 149.94 48.02 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.78 -0.835 . . . . 0.95 110.543 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -67.85 150.92 47.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.369 -0.832 . . . . 2.43 110.913 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.9 mt -101.74 139.96 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.368 -0.975 . . . . 1.1 108.368 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.737 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.3 mp -78.56 124.42 36.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.297 -1.001 . . . . 1.58 108.297 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -99.6 100.03 10.97 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.317 -1.735 . . . . 1.62 106.317 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.518 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 71.6 mt -78.54 -4.99 51.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.545 -0.722 . . . . 0.8 112.321 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.2 p -86.99 9.18 20.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.145 -0.972 . . . . 1.56 112.366 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.66 18.42 14.33 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 114.151 1.167 . . . . 0.84 114.151 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.1 mp -71.35 141.12 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 119.909 -1.744 . . . . 0.82 109.498 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -118.84 -13.52 9.51 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.045 0.926 . . . . 2.31 112.429 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -117.38 145.04 44.34 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.555 -0.906 . . . . 1.54 108.555 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -76.26 121.78 23.44 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.673 -0.862 . . . . 1.38 108.673 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.4 m -147.48 176.31 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.434 -0.791 . . . . 0.69 108.973 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.9 mt -88.65 142.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.524 -0.735 . . . . 0.53 109.339 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.5 tp -94.85 126.73 40.38 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.594 -0.891 . . . . 0.64 108.594 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.89 131.02 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.648 -0.871 . . . . 0.67 108.648 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.98 154.56 19.87 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.646 -0.872 . . . . 0.78 108.646 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.22 -36.02 78.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.393 -1.442 . . . . 1.0 109.477 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 55.9 t0 -172.75 151.22 2.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.43 -0.952 . . . . 2.42 108.43 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 70.1 mt -113.06 140.22 48.04 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.371 -0.831 . . . . 0.75 108.926 177.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.5 p -94.82 152.81 39.97 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.221 -0.925 . . . . 0.78 108.754 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -42.91 -42.28 9.08 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.806 1.671 . . . . 0.67 113.295 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.9 m -62.24 -50.44 71.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.987 -1.071 . . . . 0.7 109.744 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.28 -40.5 90.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.503 -0.748 . . . . 1.21 110.25 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 78.3 p -67.86 -40.09 83.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.53 -0.731 . . . . 0.6 110.754 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.13 86.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.62 110.743 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -95.32 1.1 54.28 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.204 -0.935 . . . . 1.16 112.691 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.83 150.15 29.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.451 -0.781 . . . . 0.73 109.902 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.445 ' O ' HG23 ' A' ' 176' ' ' VAL . 5.3 p-10 -91.99 107.02 18.91 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.274 -1.75 . . . . 2.24 106.274 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.4 mt -81.15 -9.16 59.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.788 . . . . 1.43 112.535 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -77.59 -35.51 52.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.039 -1.038 . . . . 2.15 110.572 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -101.36 2.87 40.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.235 -0.915 . . . . 2.04 113.01 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 172' ' ' ASN . 91.0 t -101.0 120.01 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 106.807 -1.553 . . . . 0.55 106.807 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.2 tp -90.93 -9.51 45.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.097 -1.002 . . . . 1.63 112.04 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.66 169.26 40.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.035 -1.626 . . . . 0.47 109.035 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 1.1 m-85 -128.02 129.79 47.28 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.384 -1.068 . . . . 0.54 108.2 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.4 mt -128.85 108.75 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 105.857 -1.905 . . . . 0.69 105.857 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 205' ' ' THR . 76.4 p -130.82 171.76 12.78 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.905 -1.122 . . . . 0.82 110.153 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.445 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 33.3 t0 -102.54 59.15 0.8 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.724 -0.61 . . . . 2.37 110.453 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 106.371 -1.715 . . . . 1.11 106.371 178.311 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 52.0 m . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.171 -0.678 . . . . 1.69 109.171 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -59.84 -39.6 85.69 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.36 -0.838 . . . . 1.07 111.082 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.9 m -58.47 -40.99 84.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.633 -1.292 . . . . 1.58 110.228 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.2 m -61.39 -37.04 81.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 1.6 110.447 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.73 -39.32 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.509 -0.745 . . . . 1.45 110.666 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 68.8 mtp -62.92 -41.15 99.37 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.08 0.943 . . . . 1.05 109.486 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.92 -45.43 94.67 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.931 -0.577 . . . . 0.72 111.091 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -60.37 -43.37 96.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.982 -1.074 . . . . 3.05 110.674 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.2 m -69.45 -39.13 77.97 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.211 -0.93 . . . . 0.89 110.187 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.45 -7.48 50.48 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.871 0.844 . . . . 0.78 112.531 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 53.12 7.16 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.996 1.109 . . . . 1.45 113.996 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.91 149.67 92.61 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 120.959 -1.088 . . . . 0.67 108.385 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.13 144.95 88.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.534 1.49 . . . . 0.64 109.738 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.62 161.41 35.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.366 -1.458 . . . . 0.67 109.673 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.467 ' CD1' HD11 ' A' ' 220' ' ' LEU . 19.6 mt -149.94 149.55 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.756 -1.202 . . . . 0.69 107.756 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.8 m -133.41 -25.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.123 -0.986 . . . . 0.85 112.324 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.68 43.0 2.07 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 120.226 -0.987 . . . . 0.92 111.837 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 181' ' ' THR . 43.8 p -63.08 -15.63 57.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.322 -1.105 . . . . 0.95 111.573 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.445 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 72.12 -93.82 0.6 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.868 -1.293 . . . . 1.04 109.868 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 85.2 p -129.95 33.4 4.4 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.35 -1.088 . . . . 1.57 112.022 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.67 -35.79 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.023 -1.673 . . . . 0.84 110.482 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.1 p -60.33 -24.76 65.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.99 111.73 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.8 p -96.57 9.0 42.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 1.7 112.149 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -132.59 -4.27 3.31 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.728 -0.607 . . . . 2.2 112.409 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 213' ' ' LYS . 42.1 t -121.06 157.59 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.275 -0.89 . . . . 0.84 109.854 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.422 ' N ' HG12 ' A' ' 212' ' ' VAL . 20.9 mmmt -122.25 160.25 25.64 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.069 -1.086 . . . . 2.2 108.069 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 51.5 p-10 -57.03 142.12 43.23 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.093 -1.004 . . . . 2.28 110.53 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.0 OUTLIER 80.32 7.49 1.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.79 1.404 . . . . 2.35 114.79 179.387 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.8 t0 -67.21 149.38 50.53 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.308 -0.997 . . . . 1.97 108.308 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.433 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.3 t80 -89.64 115.04 26.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.331 -1.359 . . . . 2.65 107.331 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.419 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 78.5 mt -124.96 148.15 48.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -0.755 . . . . 0.63 109.365 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.3 mt -119.09 126.35 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.15 -1.796 . . . . 0.62 106.15 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 202' ' ' ILE . 66.2 tp -100.91 119.04 38.13 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.425 -1.694 . . . . 0.64 106.425 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.0 p-10 -94.73 -21.33 18.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.027 -1.046 . . . . 2.05 112.459 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.893 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.93 18.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.376 0.608 . . . . 0.84 112.477 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.601 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.4 t -112.26 -62.83 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 1.02 109.389 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -89.68 7.25 37.64 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.314 1.054 . . . . 2.51 110.226 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 39.6 t30 63.86 50.58 2.56 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.023 -0.989 . . . . 1.54 112.1 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 28.7 mt-30 -147.16 152.38 38.33 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.352 1.072 . . . . 1.95 110.187 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.9 t -115.65 139.92 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.989 -1.115 . . . . 0.71 107.989 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -104.98 133.17 50.21 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.164 -0.96 . . . . 1.01 108.775 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.85 130.89 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.16 -1.052 . . . . 0.82 108.16 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.461 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 57.7 t30 54.39 49.04 5.12 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 113.578 0.955 . . . . 1.54 113.578 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 52.9 Cg_endo -68.95 149.67 72.25 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.607 2.204 . . . . 0.94 110.994 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.1 p -78.33 165.47 23.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.035 -1.041 . . . . 1.8 110.497 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -60.77 -36.34 78.7 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.946 -1.096 . . . . 2.73 110.455 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.58 -39.91 85.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.004 -1.06 . . . . 3.17 111.138 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.17 -40.37 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 1.34 110.243 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 74.9 mt -59.42 -43.96 91.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.327 -0.858 . . . . 1.2 110.916 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.02 -40.31 88.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.21 -0.931 . . . . 2.7 110.573 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -62.49 -45.35 93.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.51 -0.744 . . . . 2.59 110.722 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 77.8 mtp -71.63 -39.46 70.41 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.364 -0.835 . . . . 1.38 110.883 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.609 ' NH2' ' CE1' ' A' ' 13' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 2.84 110.634 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 106.495 -1.668 . . . . 1.07 106.495 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.7 m -104.14 121.56 43.49 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.719 -1.215 . . . . 1.24 107.719 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 225' ' ' ASN . . . -117.78 -164.17 13.1 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.868 -1.693 . . . . 1.01 108.868 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.1 mt -96.34 1.56 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 120.872 -1.37 . . . . 1.11 112.708 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ILE . 18.9 tp 49.33 100.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.012 -1.075 . . . . 0.99 111.678 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.33 -45.24 13.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.255 -1.528 . . . . 0.85 111.249 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -148.57 149.04 30.18 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.275 -1.009 . . . . 1.38 108.275 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.53 148.93 43.28 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 123.01 2.473 . . . . 0.94 112.104 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 147.89 119.68 1.1 Allowed Glycine 0 N--CA 1.507 3.413 0 N-CA-C 110.323 -1.111 . . . . 0.81 110.323 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 53.3 mt -90.64 135.78 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.893 -1.357 . . . . 0.83 108.818 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.42 ' CB ' HD12 ' A' ' 177' ' ' LEU . . . -138.74 157.64 45.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.854 -0.795 . . . . 0.53 108.854 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -118.74 140.01 50.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.93 -1.137 . . . . 0.77 107.93 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.77 163.26 31.49 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 118.597 -1.763 . . . . 0.51 110.057 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -78.8 157.74 28.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.67 -0.9 . . . . 1.9 108.996 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -81.53 130.42 35.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.002 -1.061 . . . . 0.66 108.394 178.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -110.87 101.4 10.0 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.729 -1.952 . . . . 0.83 105.729 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.4 tp -87.78 135.26 33.46 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.408 -1.33 . . . . 0.86 107.408 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.464 HD11 HD11 ' A' ' 158' ' ' LEU . 67.0 mt -101.02 114.56 28.6 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 106.481 -1.674 . . . . 0.92 106.481 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -108.51 138.02 45.51 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.885 -1.154 . . . . 2.03 107.885 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 52.1 mp0 -123.09 149.35 44.58 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.462 -0.774 . . . . 2.66 109.463 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -83.82 130.6 34.93 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.784 -1.191 . . . . 2.32 107.784 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -63.22 146.88 52.46 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.149 -0.969 . . . . 2.11 108.96 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.6 mt -92.16 135.41 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 108.115 -1.069 . . . . 0.73 108.115 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -106.43 127.94 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.099 -1.074 . . . . 0.87 108.099 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -101.57 136.26 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.043 -1.095 . . . . 0.81 108.043 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -89.47 125.24 35.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.73 -1.231 . . . . 1.34 107.766 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.3 mmt-85 -93.54 11.15 29.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.998 -1.064 . . . . 2.89 112.358 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -67.53 143.7 56.01 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.058 -1.026 . . . . 2.09 108.991 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -88.86 136.95 32.74 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.08 -1.082 . . . . 2.19 108.08 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.18 166.72 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.277 -0.89 . . . . 0.75 110.303 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.7 p -93.89 163.69 13.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.91 109.666 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.83 -21.17 6.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.46 -0.775 . . . . 0.93 112.04 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -69.95 -41.92 73.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.063 -1.023 . . . . 2.28 111.049 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -86.56 -2.68 58.69 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.438 -1.414 . . . . 1.45 112.224 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -60.96 -45.39 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 0.81 110.938 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.72 -39.66 85.4 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.644 -1.285 . . . . 1.54 110.528 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.539 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 10.4 mp0 -60.34 -41.07 92.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.106 -0.497 . . . . 2.36 110.947 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.59 -38.47 84.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.575 -1.328 . . . . 1.31 110.626 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.5 t -59.82 -41.64 86.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.939 -1.101 . . . . 0.82 110.729 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -63.42 -49.81 72.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.719 -1.238 . . . . 1.5 110.206 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.37 -38.88 88.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.595 -0.691 . . . . 2.23 110.329 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -75.5 -55.87 5.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.657 0.741 . . . . 0.85 109.902 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.63 -46.99 85.89 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.693 -0.803 . . . . 0.91 110.561 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 15.4 t -67.32 -41.88 84.57 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.19 -0.944 . . . . 0.9 110.131 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.15 87.6 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 119.088 -1.53 . . . . 0.69 109.965 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.6 ttt-85 -58.2 -31.35 67.22 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.744 -0.857 . . . . 2.88 109.794 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.61 -40.89 80.14 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.881 0.848 . . . . 0.85 109.792 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -78.12 -41.91 33.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 2.35 110.112 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.21 93.16 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.272 -0.892 . . . . 0.65 109.939 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 p -60.5 -38.24 83.67 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.465 1.126 . . . . 1.45 109.268 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.84 -47.04 64.21 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.68 -0.691 . . . . 0.63 110.419 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.04 -48.4 71.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.248 -0.908 . . . . 1.34 110.546 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.8 -39.18 90.8 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.343 -0.848 . . . . 1.56 109.572 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -60.18 -41.56 93.17 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.686 -0.634 . . . . 1.19 110.478 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.6 m -62.91 -40.63 98.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.026 -1.046 . . . . 0.72 110.272 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.4 mt -60.6 -36.02 67.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.471 -0.768 . . . . 0.62 110.325 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -53.79 -42.92 68.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 1.05 111.027 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -70.0 -33.39 71.98 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.835 -1.166 . . . . 0.64 110.557 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -64.89 -39.92 94.3 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.886 -1.125 . . . . 1.73 109.515 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.39 80.96 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.756 -0.59 . . . . 0.56 109.968 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.7 -36.1 34.1 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.651 -1.261 . . . . 0.69 110.583 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -79.91 -28.18 39.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.876 -1.367 . . . . 1.48 110.984 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 79.6 m -86.77 -47.74 8.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.368 -0.832 . . . . 0.98 110.942 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -107.93 -11.16 15.39 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 113.343 0.868 . . . . 1.16 113.343 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.67 159.63 24.79 Favored Glycine 0 N--CA 1.5 2.949 0 C-N-CA 120.658 -0.782 . . . . 0.85 113.29 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -52.33 -18.87 1.77 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.743 -0.857 . . . . 3.86 112.921 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.17 -38.57 76.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 2.35 111.522 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -82.37 -21.63 35.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.903 -1.123 . . . . 1.67 112.05 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -59.74 -31.47 69.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 1.45 111.098 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.79 88.82 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.13 -0.981 . . . . 0.61 110.519 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.0 mt -67.01 -44.71 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.633 -1.292 . . . . 0.65 110.145 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -70.85 -28.8 64.85 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.321 -0.862 . . . . 0.66 110.925 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -61.87 -37.99 86.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.883 . . . . 1.19 110.153 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.11 -38.98 73.34 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 119.693 -1.242 . . . . 0.53 110.486 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -59.68 -42.55 93.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.094 -1.239 . . . . 1.27 110.3 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.2 mt -62.44 -38.97 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.351 -0.843 . . . . 0.54 110.091 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.9 ttm -59.99 -39.99 87.62 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.549 -0.861 . . . . 1.74 110.263 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.66 -51.49 69.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.199 -0.938 . . . . 0.55 110.89 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.7 tp -60.52 -41.58 94.68 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.913 -0.715 . . . . 0.47 110.057 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -87.24 1.17 53.98 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.086 0.773 . . . . 1.42 113.086 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -60.28 123.53 17.52 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.426 -1.421 . . . . 1.27 108.577 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.18 -17.26 64.76 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.694 0.759 . . . . 1.35 111.064 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -76.36 -54.19 7.1 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.875 -0.73 . . . . 2.22 110.227 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.9 mt -62.27 -38.38 89.12 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.152 -0.619 . . . . 0.62 110.722 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.38 -49.91 75.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.075 -1.016 . . . . 1.29 111.213 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.25 -37.57 83.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.811 -1.181 . . . . 1.52 110.577 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.2 -47.79 78.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.146 -0.971 . . . . 1.3 110.18 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.0 mt -57.68 -47.08 86.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 120.999 -1.063 . . . . 0.61 110.015 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.26 -41.92 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.66 0.743 . . . . 0.78 110.857 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.34 -42.44 91.52 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.226 -0.921 . . . . 0.82 110.866 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.69 -42.42 97.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.972 -1.08 . . . . 0.8 110.161 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.44 -50.35 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 0.77 110.572 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -76.16 -35.15 59.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 2.12 111.903 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -81.89 -43.78 17.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.733 -1.229 . . . . 1.51 112.043 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -102.08 7.11 41.23 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.233 -0.917 . . . . 1.98 112.862 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 50.72 49.59 20.63 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 1.32 111.887 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.3 mtt -102.99 155.95 18.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.387 -0.821 . . . . 1.38 109.34 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.8 p -72.17 159.53 33.96 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.76 0.79 . . . . 0.67 109.6 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.89 88.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.937 -1.102 . . . . 0.52 110.416 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.512 ' OD2' HD21 ' A' ' 142' ' ' LEU . 93.5 m-20 -68.52 -39.17 81.3 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.176 -0.953 . . . . 2.25 110.618 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.8 -51.76 24.81 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.273 -0.892 . . . . 0.64 111.214 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.48 94.79 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.827 -1.171 . . . . 0.56 110.994 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.15 98.94 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.379 -0.826 . . . . 0.46 110.9 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -60.42 -39.82 88.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.916 -1.115 . . . . 1.32 111.003 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -59.03 -49.38 78.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.801 -1.187 . . . . 1.3 110.684 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.57 -41.89 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.252 -0.905 . . . . 0.61 110.231 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -63.29 -32.47 56.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.301 -0.874 . . . . 0.65 110.03 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.85 -41.11 86.21 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.611 -0.68 . . . . 2.11 110.927 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.21 -31.55 19.49 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.422 -1.371 . . . . 0.83 112.898 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -61.44 -40.45 94.5 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 119.421 1.61 . . . . 1.28 109.958 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.56 -50.6 24.48 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.938 0.875 . . . . 0.89 110.364 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 60.9 p -61.48 -37.22 82.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.394 -0.816 . . . . 1.87 110.775 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.1 -45.22 93.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.379 -0.826 . . . . 1.05 110.92 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.22 -28.27 69.25 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.083 -1.011 . . . . 1.02 111.21 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -66.67 -22.27 66.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.856 . . . . 2.04 110.731 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -71.61 -15.72 62.26 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.378 -0.826 . . . . 1.73 111.245 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 123' ' ' LEU . 22.7 mt -86.28 138.93 31.47 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.685 -1.228 . . . . 1.37 107.685 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -97.8 39.41 1.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.341 -0.849 . . . . 2.88 111.617 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -112.23 137.18 50.7 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.557 -0.905 . . . . 1.58 108.557 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.9 -36.72 72.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 3.04 111.167 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.15 -56.48 5.5 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.838 -1.164 . . . . 0.9 110.41 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 118' ' ' LEU . 38.4 mt -62.29 -42.08 99.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 1.06 110.785 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.03 -47.47 84.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.993 -1.067 . . . . 2.18 110.456 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -60.28 -32.53 71.26 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.328 -0.949 . . . . 2.15 109.968 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.556 ' O ' HG23 ' A' ' 130' ' ' VAL . 21.7 ttp180 -64.76 -29.12 70.09 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.187 -1.005 . . . . 2.33 109.552 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.93 87.02 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.763 0.792 . . . . 0.82 109.829 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.41 -42.74 78.56 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.543 0.687 . . . . 0.85 110.449 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.04 -33.34 75.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.577 -0.702 . . . . 1.39 110.729 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 126' ' ' ARG . 52.7 t -69.31 -38.56 77.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.439 -0.788 . . . . 0.56 110.529 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 131' ' ' ARG . 34.3 ttt-85 -59.67 -40.21 87.04 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.864 -1.135 . . . . 3.12 109.665 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -61.23 -35.24 76.7 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.649 0.738 . . . . 1.28 110.715 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.3 mt -61.73 -40.13 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.051 -1.031 . . . . 0.49 110.47 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.55 -46.77 91.55 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.088 -1.053 . . . . 0.46 110.745 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -58.32 -43.71 88.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.944 -1.327 . . . . 2.71 110.59 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 136' ' ' ARG . 51.6 mtt-85 -60.63 -44.1 96.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.929 -1.107 . . . . 2.14 110.577 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.1 -44.21 97.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.067 -1.021 . . . . 1.05 110.083 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.46 -41.13 96.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.876 . . . . 0.52 110.702 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.403 HH11 ' HG2' ' A' ' 139' ' ' ARG . 46.4 mtt-85 -61.52 -34.76 76.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.907 . . . . 2.35 110.563 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -73.97 -40.4 63.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 1.39 110.989 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.67 -38.5 78.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.23 -0.919 . . . . 0.68 110.615 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.512 HD21 ' OD2' ' A' ' 101' ' ' ASP . 74.5 mt -87.95 -7.92 56.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.931 -1.105 . . . . 0.83 112.587 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.16 18.88 79.06 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 120.077 -1.059 . . . . 0.91 113.046 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -62.31 146.75 50.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.983 . . . . 0.95 109.406 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -67.22 147.88 52.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.974 -1.079 . . . . 2.43 109.176 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.8 mt -109.63 136.22 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.097 -1.002 . . . . 1.1 108.306 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.707 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.2 mp -78.0 130.09 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.48 -0.763 . . . . 1.58 108.949 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -97.46 99.97 11.39 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.287 -1.745 . . . . 1.62 106.287 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.8 mt -70.8 -21.08 62.52 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 116.145 -0.479 . . . . 0.8 111.48 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.8 m -80.71 3.33 22.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.922 . . . . 1.56 111.821 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.72 19.41 12.51 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.445 -0.784 . . . . 0.84 112.507 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.5 mt -71.81 141.44 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.82 109.689 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -117.54 -14.34 10.28 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.84 0.829 . . . . 2.31 113.049 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -114.75 138.04 51.21 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.239 -1.022 . . . . 1.54 108.239 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.62 123.32 22.98 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.408 -0.96 . . . . 1.38 108.408 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.1 m -145.95 176.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.391 -0.818 . . . . 0.69 109.273 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mt -87.27 140.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.758 -1.214 . . . . 0.53 108.426 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.464 HD11 HD11 ' A' ' 19' ' ' LEU . 26.9 tp -95.3 121.06 36.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.869 -1.145 . . . . 0.64 108.158 178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.3 t -123.3 132.29 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 108.369 -0.975 . . . . 0.67 108.369 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -160.4 160.51 32.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 0.78 108.561 178.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.64 77.63 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.826 -1.171 . . . . 1.0 109.208 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 p-10 -172.4 155.49 3.5 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.726 -0.842 . . . . 2.42 108.726 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 75.1 mt -120.25 137.99 53.91 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.956 -1.127 . . . . 0.75 107.956 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 p -96.42 150.9 37.65 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.188 -0.945 . . . . 0.78 108.629 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -41.15 -42.74 5.0 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.869 1.713 . . . . 0.67 113.102 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 54.7 m -60.59 -50.58 72.94 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.159 -0.963 . . . . 0.7 109.892 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -61.97 -40.85 96.98 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.757 -1.177 . . . . 1.21 109.621 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.7 p -68.23 -37.78 81.18 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.49 -0.884 . . . . 0.6 110.525 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.47 75.68 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.509 -0.744 . . . . 0.62 110.706 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -93.73 -3.46 52.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.009 -1.057 . . . . 1.16 112.815 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.61 149.1 49.54 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.74 -0.837 . . . . 0.73 108.74 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -96.83 118.48 33.35 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.721 -1.585 . . . . 2.24 106.721 177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.9 -12.99 60.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 1.43 111.852 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -84.66 -26.16 28.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.391 -0.818 . . . . 2.15 112.336 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -100.88 2.1 40.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.367 -0.833 . . . . 2.04 112.271 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 178' ' ' GLY . 54.9 t -111.18 131.21 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 N-CA-C 108.263 -1.014 . . . . 0.55 108.263 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.565 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.38 -12.35 43.53 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.37 -0.831 . . . . 1.63 112.016 -179.511 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.435 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.94 -179.42 44.4 Favored Glycine 0 N--CA 1.497 2.745 0 O-C-N 120.46 -1.4 . . . . 0.47 109.768 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -130.1 134.01 47.06 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 107.408 -1.331 . . . . 0.54 107.408 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.523 HD11 HD13 ' A' ' 220' ' ' LEU . 59.0 mt -137.54 106.22 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 105.783 -1.932 . . . . 0.69 105.783 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.415 ' C ' ' HG1' ' A' ' 205' ' ' THR . 71.0 p -132.91 177.32 7.74 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.71 -1.244 . . . . 0.82 110.844 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 16.4 m-20 -101.4 57.52 0.85 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.534 -0.757 . . . . 2.37 109.405 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.113 0 O-C-N 121.417 -0.802 . . . . 1.11 109.656 179.746 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 108.591 -0.892 . . . . 1.69 108.591 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -60.35 -39.34 86.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 1.07 110.727 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 35.2 p -58.36 -38.04 76.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 1.58 110.54 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.7 m -60.58 -39.75 89.2 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.357 -0.839 . . . . 1.6 110.221 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.81 -39.72 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.126 -0.983 . . . . 1.45 110.489 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 71.3 mtp -63.39 -42.58 98.82 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.503 1.145 . . . . 1.05 109.341 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.12 -41.16 92.04 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.463 -0.79 . . . . 0.72 110.938 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.5 -44.92 96.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.837 -1.164 . . . . 3.05 110.355 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 27.8 m -71.67 -39.54 70.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.9 . . . . 0.89 110.416 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.9 mt -91.64 -11.2 37.75 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.818 0.818 . . . . 0.78 112.22 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.5 mt-10 49.94 19.09 0.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.67 0.989 . . . . 1.45 113.67 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.67 166.85 32.35 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.064 -1.022 . . . . 0.67 108.435 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.64 140.57 21.26 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.865 1.71 . . . . 0.64 110.38 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.23 168.06 23.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 119.915 -1.741 . . . . 0.67 109.859 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 203' ' ' VAL . 92.9 mt -144.01 156.89 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.36 -1.348 . . . . 0.69 107.36 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.456 ' N ' HG22 ' A' ' 202' ' ' ILE . 10.2 m -138.15 -30.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 120.99 -1.069 . . . . 0.85 112.744 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.79 30.84 0.9 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.014 -1.089 . . . . 0.92 113.663 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.431 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 9.8 p -61.34 -27.51 68.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.649 -1.501 . . . . 0.95 110.924 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.47 -91.04 0.38 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 120.221 -0.99 . . . . 1.04 110.77 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.5 m -121.7 27.11 8.36 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.531 -0.982 . . . . 1.57 112.594 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.1 t -58.5 -35.84 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.121 -1.612 . . . . 0.84 110.22 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.405 HG23 ' OD2' ' A' ' 182' ' ' ASP . 56.2 p -52.91 -24.62 9.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 0.99 111.625 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.2 p -90.96 0.41 57.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.36 -0.837 . . . . 1.7 111.789 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -123.56 -3.52 8.31 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 113.079 0.77 . . . . 2.2 113.079 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 38.7 t -116.8 149.08 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.574 0.702 . . . . 0.84 109.712 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -119.41 150.09 40.77 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.123 -1.066 . . . . 2.2 108.123 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.421 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.2 p-10 -56.67 143.85 34.61 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.02 -1.072 . . . . 2.28 110.355 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.1 m-20 79.89 -1.61 2.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.796 1.406 . . . . 2.35 114.796 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.31 150.72 42.61 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.709 -1.196 . . . . 1.97 109.036 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -89.5 117.36 28.35 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.455 -1.403 . . . . 2.65 107.591 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.9 mt -126.67 149.8 49.34 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.596 0.713 . . . . 0.63 109.708 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.4 mt -119.21 129.94 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.394 -1.336 . . . . 0.62 107.394 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.523 HD13 HD11 ' A' ' 180' ' ' ILE . 49.6 tp -92.73 121.99 34.68 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.293 -1.373 . . . . 0.64 107.293 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 81.1 m-20 -88.33 -30.48 19.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.695 -1.253 . . . . 2.05 111.661 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.41 19.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.448 -0.782 . . . . 0.84 112.552 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.1 t -121.84 -59.68 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.922 0.868 . . . . 1.02 110.263 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -96.23 10.29 38.31 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.876 0.846 . . . . 2.51 110.768 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 4' ' ' GLY . 6.5 t-20 60.82 50.34 5.43 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.579 -0.737 . . . . 1.54 112.021 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -151.23 158.7 44.23 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.957 0.884 . . . . 1.95 109.638 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 28.0 t -116.37 140.3 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 109.017 -0.734 . . . . 0.71 109.017 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.446 ' CE2' ' OD2' ' A' ' 221' ' ' ASP . 47.4 m-85 -99.35 130.83 45.66 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.144 -0.973 . . . . 1.01 108.466 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.2 t -109.84 130.02 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.434 -0.791 . . . . 0.82 108.921 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.525 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 66.7 t30 61.11 43.71 0.69 Allowed Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 113.792 1.034 . . . . 1.54 113.792 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 33.4 Cg_endo -65.53 147.48 86.7 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.208 1.939 . . . . 0.94 111.199 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 44.1 p -76.82 157.25 31.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.112 -0.992 . . . . 1.8 108.985 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -59.92 -33.22 71.6 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.133 -0.98 . . . . 2.73 110.523 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -57.62 -40.45 79.2 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.468 -0.77 . . . . 3.17 110.218 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -71.0 -40.84 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.393 -0.817 . . . . 1.34 110.064 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 56.4 mt -60.17 -47.54 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 1.2 110.662 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -59.26 -40.39 85.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.674 -1.266 . . . . 2.7 110.482 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -64.66 -42.12 95.63 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.826 -0.75 . . . . 2.59 110.357 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.1 mtp -70.88 -34.35 71.51 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.272 -0.893 . . . . 1.38 110.975 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.198 -0.939 . . . . 2.84 110.389 -179.791 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.2 mt . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 106.302 -1.74 . . . . 1.07 106.302 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 m -105.38 124.87 50.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.259 -1.015 . . . . 1.24 108.259 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.89 -152.02 16.8 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 108.141 -1.984 . . . . 1.01 108.141 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.9 mt -94.78 -4.87 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.249 -1.148 . . . . 1.11 112.926 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 tp 49.7 99.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.086 -1.009 . . . . 0.99 112.624 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.65 -53.74 5.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.007 -1.058 . . . . 0.85 110.571 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.99 148.44 45.38 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 107.746 -1.205 . . . . 1.38 107.746 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.8 156.52 43.88 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.578 2.186 . . . . 0.94 112.272 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 147.17 122.21 1.33 Allowed Glycine 0 N--CA 1.507 3.418 0 N-CA-C 111.087 -0.805 . . . . 0.81 111.087 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.8 mt -89.64 132.05 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.777 -1.426 . . . . 0.83 108.706 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.99 151.49 46.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.256 -0.902 . . . . 0.53 108.638 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.7 m-85 -116.7 145.41 43.47 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.279 -0.888 . . . . 0.77 109.219 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.31 167.89 36.86 Favored Glycine 0 N--CA 1.5 2.906 0 C-N-CA 118.938 -1.601 . . . . 0.51 110.053 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -78.08 158.89 28.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.752 -0.852 . . . . 1.9 109.132 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.42 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.37 119.81 25.54 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.029 -1.1 . . . . 0.66 108.029 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -99.93 95.68 7.05 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 105.683 -1.969 . . . . 0.83 105.683 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.5 tp -90.67 137.71 32.15 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.454 -1.313 . . . . 0.86 107.454 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.5 mt -99.02 111.19 23.66 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.647 -1.612 . . . . 0.92 106.647 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -103.52 128.72 50.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.217 -1.401 . . . . 2.03 107.217 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -130.6 154.34 47.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.926 -0.768 . . . . 2.66 108.926 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -80.65 139.39 36.23 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.695 -0.854 . . . . 2.32 108.695 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.82 149.88 49.46 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.473 -1.392 . . . . 2.11 109.046 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -93.22 131.01 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.602 -0.888 . . . . 0.73 108.602 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.9 t -108.93 130.13 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.272 -1.01 . . . . 0.87 108.272 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.0 mt -94.67 133.51 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.456 -0.942 . . . . 0.81 108.456 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -89.01 120.83 30.78 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.294 -1.372 . . . . 1.34 107.294 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -96.54 15.8 20.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.132 -0.98 . . . . 2.89 112.403 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -70.42 149.89 46.8 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.542 -0.723 . . . . 2.09 109.838 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -90.76 130.35 36.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.669 -1.234 . . . . 2.19 107.669 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.9 pt -94.76 164.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.988 . . . . 0.75 110.347 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -94.95 166.02 12.16 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.486 -0.759 . . . . 0.91 109.681 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.23 -19.11 7.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 0.93 112.351 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.12 -37.86 81.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 2.28 110.696 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -94.52 -6.14 44.42 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.563 -1.336 . . . . 1.45 113.105 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.8 t -59.55 -42.12 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.217 -0.927 . . . . 0.81 110.758 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -58.41 -39.19 79.05 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.128 -0.982 . . . . 1.54 110.58 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -64.99 -38.79 92.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.403 -0.811 . . . . 2.36 111.131 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -59.37 -41.23 88.83 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.619 -1.3 . . . . 1.31 110.783 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.17 -40.85 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.98 -1.075 . . . . 0.82 110.789 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -62.83 -42.6 99.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.977 -1.077 . . . . 1.5 110.457 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.453 HH11 ' HG2' ' A' ' 42' ' ' ARG . 42.2 mtt-85 -61.36 -40.41 94.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -0.863 . . . . 2.23 110.296 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 40.6 t80 -75.32 -55.34 5.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.298 -0.876 . . . . 0.85 110.965 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.4 tp -58.07 -47.46 83.11 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.507 -0.877 . . . . 0.91 110.459 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -68.79 -39.91 79.91 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.822 -0.751 . . . . 0.9 109.918 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.29 -42.48 97.35 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.495 -1.442 . . . . 0.69 109.495 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' CG ' HH11 ' A' ' 47' ' ' ARG . 2.2 ttt-85 -60.3 -28.76 68.36 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.235 -1.156 . . . . 2.88 110.117 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.92 -50.49 73.58 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.465 0.65 . . . . 0.85 110.955 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -83.26 -38.07 22.68 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.134 -0.979 . . . . 2.35 111.043 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.9 -42.82 85.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.162 -0.961 . . . . 0.65 109.664 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.4 t -60.47 -41.26 93.82 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.718 -0.845 . . . . 1.45 108.718 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.78 -44.86 76.42 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.624 -0.831 . . . . 0.63 110.434 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -62.18 -51.51 67.53 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.366 -0.934 . . . . 1.34 110.668 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.69 -38.25 89.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.136 -0.977 . . . . 1.56 109.988 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -59.12 -40.08 84.33 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.594 -0.691 . . . . 1.19 110.331 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.6 m -62.26 -45.05 95.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.937 -1.102 . . . . 0.72 110.266 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.25 -32.31 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.566 -0.709 . . . . 0.62 110.978 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -53.98 -44.58 70.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 1.05 110.469 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -68.69 -36.49 78.57 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.276 -0.89 . . . . 0.64 109.709 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -62.27 -40.0 94.78 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.862 -1.135 . . . . 1.73 108.853 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.32 75.41 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.06 -0.656 . . . . 0.56 110.06 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.66 -34.05 26.09 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.106 -1.045 . . . . 0.69 110.883 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.25 -18.05 43.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.007 -1.29 . . . . 1.48 111.321 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.6 m -90.96 -53.8 4.23 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.209 0.528 . . . . 0.98 111.184 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -106.86 -12.65 15.43 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 113.066 0.765 . . . . 1.16 113.066 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.8 155.84 10.78 Favored Glycine 0 N--CA 1.501 3.022 0 O-C-N 121.434 -0.791 . . . . 0.85 112.338 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -55.78 -20.56 15.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.65 -0.912 . . . . 3.86 112.393 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.55 -34.26 66.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.415 -0.803 . . . . 2.35 111.165 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -81.17 -19.22 43.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.567 -1.333 . . . . 1.67 111.86 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.01 -31.81 70.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.187 -0.946 . . . . 1.45 111.022 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.8 95.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.874 -1.141 . . . . 0.61 110.379 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.1 -45.92 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.38 -0.928 . . . . 0.65 110.056 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -71.47 -31.63 67.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.838 . . . . 0.66 110.417 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -60.32 -38.44 83.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 1.19 109.847 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.32 -41.85 94.35 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.213 -1.155 . . . . 0.53 110.213 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -58.25 -46.27 86.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -1.103 . . . . 1.27 110.416 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.74 -39.61 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.976 -1.078 . . . . 0.54 110.179 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.4 ttt -59.85 -39.8 86.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.961 -1.087 . . . . 1.74 110.411 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.19 -49.07 79.27 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.595 0.712 . . . . 0.55 110.774 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.76 -43.64 94.22 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.702 0.763 . . . . 0.47 110.241 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -86.25 9.39 17.83 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.338 -0.851 . . . . 1.42 112.731 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -64.42 126.5 28.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.389 -0.819 . . . . 1.27 109.007 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.76 -14.18 62.74 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.056 0.932 . . . . 1.35 110.647 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -75.8 -54.67 6.57 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.643 -0.66 . . . . 2.22 110.137 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 mt -62.0 -40.31 95.24 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.759 -0.776 . . . . 0.62 110.686 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.6 -46.03 81.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.701 -1.25 . . . . 1.29 110.749 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.52 -39.59 91.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.78 . . . . 1.52 110.891 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.23 -48.09 66.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.372 -1.455 . . . . 1.3 110.953 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -55.44 -43.05 70.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.112 -1.035 . . . . 0.61 110.153 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.3 mt -62.43 -47.51 92.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.68 0.753 . . . . 0.78 110.524 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.61 94.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.457 -0.777 . . . . 0.82 110.879 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.7 -39.03 87.0 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.674 -1.266 . . . . 0.8 110.239 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.56 -52.77 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.77 110.347 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -72.36 -35.13 68.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.502 -0.749 . . . . 2.12 112.067 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -80.94 -46.06 15.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.796 -1.19 . . . . 1.51 112.045 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -101.16 9.11 42.3 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.408 -0.807 . . . . 1.98 112.335 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.8 m80 50.54 49.68 20.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.051 -1.031 . . . . 1.32 111.45 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.0 mtt -103.92 153.5 20.72 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.73 0.776 . . . . 1.38 109.631 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.3 p -72.6 161.43 30.79 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.141 -0.975 . . . . 0.67 109.508 178.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.83 -41.28 86.5 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.1 -1.0 . . . . 0.52 110.932 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.623 ' OD2' HD21 ' A' ' 142' ' ' LEU . 91.3 m-20 -67.98 -40.73 83.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -0.901 . . . . 2.25 109.866 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.38 -50.36 46.83 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.475 -0.89 . . . . 0.64 110.932 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.07 96.18 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.888 0.851 . . . . 0.56 110.166 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.65 96.04 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.856 -0.611 . . . . 0.46 110.94 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -61.94 -38.88 90.14 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.125 -0.984 . . . . 1.32 110.789 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.66 -48.62 80.95 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.677 -1.264 . . . . 1.3 111.462 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.02 -44.12 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.207 -0.933 . . . . 0.61 110.059 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.8 mm -61.58 -31.99 52.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.403 0.62 . . . . 0.65 110.211 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -59.07 -41.18 87.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.671 . . . . 2.11 110.529 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.36 -31.6 21.85 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.355 -1.403 . . . . 0.83 112.518 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -61.33 -39.38 90.32 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.484 1.642 . . . . 1.28 110.12 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.68 -48.2 27.44 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.893 0.854 . . . . 0.89 110.119 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.1 p -63.76 -36.0 82.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.355 -0.841 . . . . 1.87 109.954 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.62 -43.61 98.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 1.05 110.535 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.18 -30.55 71.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.819 -1.176 . . . . 1.02 110.94 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.31 -22.72 66.87 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.29 -0.881 . . . . 2.04 111.038 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -74.44 -10.91 60.03 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.398 -0.921 . . . . 1.73 111.391 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.479 HD13 HD13 ' A' ' 123' ' ' LEU . 7.1 mt -86.49 141.95 28.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.597 -0.69 . . . . 1.37 109.412 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -97.76 55.51 1.21 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.577 -0.702 . . . . 2.88 111.078 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -131.89 134.11 45.35 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 107.382 -1.34 . . . . 1.58 107.382 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -57.53 -39.83 77.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.281 -0.887 . . . . 3.04 110.922 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -70.79 -52.02 23.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.52 -1.363 . . . . 0.9 110.672 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.479 HD13 HD13 ' A' ' 118' ' ' LEU . 39.8 mt -61.17 -41.03 96.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.021 -1.049 . . . . 1.06 109.842 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -61.5 -49.21 77.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.798 -1.189 . . . . 2.18 109.762 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -60.37 -31.67 70.56 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.898 0.856 . . . . 2.15 110.047 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 130' ' ' VAL . 22.3 ttp180 -66.85 -27.7 67.75 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 122.3 1.048 . . . . 2.33 109.477 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.02 83.29 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.883 0.849 . . . . 0.82 109.33 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.3 80.12 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.464 0.65 . . . . 0.85 110.326 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.26 -35.74 79.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 1.39 110.649 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 126' ' ' ARG . 41.5 t -67.43 -38.34 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.229 -0.919 . . . . 0.56 110.331 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -59.0 -39.68 82.57 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 118.923 -1.111 . . . . 3.12 109.496 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.45 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 62.1 t0 -60.26 -37.69 81.22 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.44 0.638 . . . . 1.28 110.527 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.8 mt -60.43 -39.15 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.925 -1.109 . . . . 0.49 110.113 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.92 -45.34 88.63 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 120.128 -1.034 . . . . 0.46 110.702 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -59.81 -40.0 86.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.146 -1.208 . . . . 2.71 110.095 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' A' ' 136' ' ' ARG . 39.7 mtt-85 -61.25 -42.04 97.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.097 -1.002 . . . . 2.14 109.78 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 37.8 tp -60.43 -40.48 91.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.462 -0.773 . . . . 1.05 110.129 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.58 -42.61 92.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.143 -0.973 . . . . 0.52 110.399 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.457 ' NH1' ' CD2' ' A' ' 144' ' ' LEU . 54.5 mtt-85 -59.87 -37.58 79.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 2.35 110.762 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.4 -41.72 55.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.188 -0.945 . . . . 1.39 110.893 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.454 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.6 mt -60.36 -37.76 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.223 -0.923 . . . . 0.68 110.768 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.623 HD21 ' OD2' ' A' ' 101' ' ' ASP . 84.3 mt -86.4 -7.35 58.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.83 111.994 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.49 23.19 68.34 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 120.091 -1.052 . . . . 0.91 113.227 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.457 ' CD2' ' NH1' ' A' ' 139' ' ' ARG . 5.7 tp -64.49 148.09 51.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.049 -0.723 . . . . 0.95 109.049 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -66.44 148.53 51.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.039 -0.726 . . . . 2.43 109.039 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.4 mt -103.31 132.35 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.17 -1.048 . . . . 1.1 108.17 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.888 ' H ' HD12 ' A' ' 147' ' ' ILE . 2.7 mp -84.02 122.82 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.497 -1.297 . . . . 1.58 107.497 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -95.07 97.99 10.34 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 105.958 -1.867 . . . . 1.62 105.958 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.4 mt -74.91 -15.05 60.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.931 . . . . 0.8 112.005 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.8 m -79.94 -1.58 40.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.119 -0.988 . . . . 1.56 112.177 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.5 29.04 4.22 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.661 0.743 . . . . 0.84 111.954 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 7.3 mt -72.29 138.41 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.169 -0.957 . . . . 0.82 109.006 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -113.81 -18.82 11.72 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.278 1.037 . . . . 2.31 112.475 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -114.88 138.09 51.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.809 -1.182 . . . . 1.54 107.809 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.26 122.88 26.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.024 -1.102 . . . . 1.38 108.024 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.47 179.98 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.11 -0.994 . . . . 0.69 108.847 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.8 mt -87.45 142.24 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.05 -1.031 . . . . 0.53 108.785 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 45.2 tp -96.66 123.36 40.31 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.061 -1.089 . . . . 0.64 108.061 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.19 129.64 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.281 -1.377 . . . . 0.67 107.281 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.78 157.12 23.72 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.893 -1.129 . . . . 0.78 108.872 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.32 83.11 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.801 -1.187 . . . . 1.0 109.392 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -172.97 148.95 1.82 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.13 -0.693 . . . . 2.42 109.13 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.0 mt -111.66 141.22 45.53 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.482 -0.761 . . . . 0.75 109.223 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 168' ' ' THR . 5.8 p -92.78 147.86 34.89 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.914 -1.116 . . . . 0.78 108.917 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.55 -43.31 6.07 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.824 1.683 . . . . 0.67 113.119 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.2 m -60.49 -51.01 71.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.201 -0.937 . . . . 0.7 110.251 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -61.56 -39.52 91.42 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.01 -1.056 . . . . 1.21 109.975 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 164' ' ' THR . 48.1 p -65.77 -36.92 84.9 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.852 0.834 . . . . 0.6 109.965 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.81 88.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.494 -0.754 . . . . 0.62 111.127 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -94.27 -3.05 51.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -0.789 . . . . 1.16 113.083 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.91 148.18 44.39 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.407 -0.96 . . . . 0.73 108.407 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -93.75 114.79 27.14 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 106.884 -1.524 . . . . 2.24 106.884 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 173' ' ' LEU . 3.3 mm? -70.75 -27.89 64.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.234 0.54 . . . . 1.43 111.506 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -82.92 -16.89 45.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 2.15 112.293 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -100.48 -2.82 32.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.015 -1.053 . . . . 2.04 112.8 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 178' ' ' GLY . 88.9 t -107.69 130.62 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.22 -1.03 . . . . 0.55 108.22 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.14 -7.65 59.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 1.63 112.133 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.618 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.59 172.64 37.13 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.184 -1.566 . . . . 0.47 109.184 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -128.89 127.63 42.19 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 107.57 -1.27 . . . . 0.54 107.57 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 220' ' ' LEU . 56.4 mt -132.33 120.6 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.406 -1.701 . . . . 0.69 106.406 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 203' ' ' VAL . 67.7 p -138.88 169.83 17.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.828 -1.17 . . . . 0.82 110.357 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.464 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 36.9 t0 -106.25 62.03 0.65 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.109 -0.7 . . . . 2.37 109.109 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 108.804 -0.813 . . . . 1.11 108.804 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 188' ' ' SER . 23.9 p . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 106.675 -1.602 . . . . 1.69 106.675 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -61.36 -32.49 72.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 1.07 110.365 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.3 t -56.3 -39.46 72.78 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.381 -0.824 . . . . 1.58 110.18 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.4 p -59.74 -39.0 83.3 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.895 -1.122 . . . . 1.6 109.952 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.77 -40.0 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.647 -0.821 . . . . 1.45 110.208 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 51.2 mtp -64.55 -44.92 89.26 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.522 1.153 . . . . 1.05 109.119 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.81 -43.58 94.44 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.089 -0.96 . . . . 0.72 111.405 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -59.66 -45.68 91.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.894 -1.129 . . . . 3.05 110.533 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.1 m -71.19 -39.3 71.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.881 . . . . 0.89 110.327 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.449 HD13 HD12 ' A' ' 173' ' ' LEU . 16.5 mt -92.36 -6.64 49.75 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.155 0.798 . . . . 0.78 113.155 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 53.92 13.6 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.745 1.017 . . . . 1.45 113.745 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.65 149.73 95.37 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.925 -1.109 . . . . 0.67 108.767 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.08 137.18 73.97 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.503 1.469 . . . . 0.64 109.957 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.09 163.65 25.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.368 -1.458 . . . . 0.67 109.522 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 220' ' ' LEU . 13.2 mt -149.12 145.46 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.998 -1.112 . . . . 0.69 107.998 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.9 m -125.84 -25.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 O-C-N 121.114 -0.991 . . . . 0.85 113.24 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.66 50.46 4.25 Favored Glycine 0 N--CA 1.488 2.125 0 O-C-N 120.842 -1.161 . . . . 0.92 111.004 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 181' ' ' THR . 69.9 p -68.05 -11.59 59.27 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.933 -1.334 . . . . 0.95 112.219 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.464 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 73.88 -95.99 0.84 Allowed Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.756 -1.338 . . . . 1.04 109.756 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 70.8 m -130.31 30.65 4.72 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.336 -1.097 . . . . 1.57 112.296 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.72 -39.67 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.446 -1.409 . . . . 0.84 110.7 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.7 p -60.68 -19.3 58.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 0.99 111.986 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 27.7 t -94.93 -1.95 51.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.121 -0.987 . . . . 1.7 112.107 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -128.77 6.85 5.6 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 112.529 0.566 . . . . 2.2 112.529 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 35.0 t -118.62 148.15 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.567 0.699 . . . . 0.84 110.036 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -119.32 150.08 40.73 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.035 -1.098 . . . . 2.2 108.035 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 45.0 p-10 -50.3 141.53 11.52 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.785 -1.197 . . . . 2.28 110.723 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 t70 80.44 1.81 1.9 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.455 1.28 . . . . 2.35 114.455 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -65.2 147.99 52.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.882 -1.136 . . . . 1.97 108.732 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -88.22 120.21 29.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.012 -1.477 . . . . 2.65 107.012 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.6 mt -129.48 152.59 48.84 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.786 0.803 . . . . 0.63 109.984 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 mt -129.31 134.81 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.607 -1.257 . . . . 0.62 107.607 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.659 HD11 HD12 ' A' ' 202' ' ' ILE . 36.0 tp -97.96 125.04 42.7 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.891 -1.151 . . . . 0.64 107.891 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.1 t0 -86.07 -31.2 22.05 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.797 -1.189 . . . . 2.05 110.984 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.75 19.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.757 1.021 . . . . 0.84 113.757 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.5 t -115.91 -62.32 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-O 121.985 0.898 . . . . 1.02 109.465 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -91.41 13.54 17.24 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.655 0.741 . . . . 2.51 110.9 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 63.49 51.34 2.59 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.745 0.646 . . . . 1.54 112.745 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.44 ' OE1' ' CZ ' ' A' ' 228' ' ' TYR . 6.5 pt20 -150.24 161.38 42.53 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.544 1.164 . . . . 1.95 109.948 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.8 t -116.36 138.84 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 108.27 -1.011 . . . . 0.71 108.27 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.44 ' CZ ' ' OE1' ' A' ' 226' ' ' GLN . 51.0 m-85 -105.06 131.04 53.07 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.396 -0.964 . . . . 1.01 108.396 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.69 129.26 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 107.577 -1.268 . . . . 0.82 107.577 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 46.3 56.48 16.38 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.013 -1.054 . . . . 1.54 113.132 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.4 150.93 70.98 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.656 2.237 . . . . 0.94 110.901 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.4 p -75.12 163.5 27.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -0.849 . . . . 1.8 110.321 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -61.27 -38.74 87.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.753 -1.217 . . . . 2.73 110.605 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -59.84 -41.3 91.06 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.15 -0.969 . . . . 3.17 110.361 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 84.3 t -70.83 -40.48 76.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.241 -0.912 . . . . 1.34 110.237 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt -60.01 -43.85 93.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.151 -0.968 . . . . 1.2 110.375 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -59.85 -38.75 82.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 2.7 110.955 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -61.18 -47.98 83.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.215 -0.928 . . . . 2.59 111.164 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 24.4 mtm -73.79 -36.18 65.0 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.018 -1.051 . . . . 1.38 111.172 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 . . . . . 0 C--N 1.298 -1.64 0 O-C-N 121.177 -0.952 . . . . 2.84 110.043 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 mmt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.236 0.541 . . . . 3.07 109.576 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.6 mt -100.28 107.02 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 105.863 -1.902 . . . . 1.07 105.863 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -105.44 120.33 41.33 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.794 -1.188 . . . . 1.24 107.794 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.13 -159.28 24.3 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.686 -1.766 . . . . 1.01 108.686 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.8 mt -96.35 1.68 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.29 -1.124 . . . . 1.11 112.687 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tp 49.91 97.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.846 -1.158 . . . . 0.99 112.213 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -83.5 -46.84 12.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.85 111.234 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -149.16 150.15 31.27 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.994 -1.113 . . . . 1.38 107.994 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.59 150.0 44.81 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.024 2.483 . . . . 0.94 111.803 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.09 121.39 1.36 Allowed Glycine 0 N--CA 1.508 3.453 0 C-N-CA 120.133 -1.032 . . . . 0.81 110.708 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -88.59 135.07 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.839 -1.389 . . . . 0.83 109.061 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.05 153.86 48.13 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.789 -0.819 . . . . 0.53 108.789 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -125.02 140.59 52.77 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.221 -0.924 . . . . 0.77 109.077 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.09 170.15 41.76 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 118.672 -1.728 . . . . 0.51 110.207 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -79.46 158.82 27.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.654 -0.91 . . . . 1.9 109.126 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -83.25 126.86 33.12 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.666 -1.235 . . . . 0.66 107.666 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.0 tp -109.91 103.38 12.15 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 105.04 -2.207 . . . . 0.83 105.04 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.6 tp -88.0 140.02 29.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.011 . . . . 0.86 108.906 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.7 mt -99.04 112.31 24.47 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.414 -1.698 . . . . 0.92 106.414 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -110.18 131.97 54.58 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.816 -1.179 . . . . 2.03 107.816 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -126.91 140.07 52.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.192 -0.942 . . . . 2.66 108.949 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -80.61 137.83 36.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.236 -1.024 . . . . 2.32 108.236 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -62.06 150.54 37.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.236 -0.915 . . . . 2.11 109.953 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.5 mt -90.23 134.85 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.077 -1.014 . . . . 0.73 108.52 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -108.9 131.37 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.463 -0.94 . . . . 0.87 108.463 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.9 mt -94.32 140.35 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.936 -0.764 . . . . 0.81 108.936 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -91.33 123.03 34.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.116 -0.99 . . . . 1.34 108.503 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -100.02 18.34 18.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.457 -0.777 . . . . 2.89 112.046 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -70.43 145.31 51.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.812 -1.18 . . . . 2.09 109.488 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -88.15 129.96 35.17 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.759 -1.2 . . . . 2.19 107.759 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 pt -95.96 167.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.405 -0.809 . . . . 0.75 110.474 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.4 p -95.81 167.7 11.1 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.345 0.593 . . . . 0.91 109.997 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.25 -21.44 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.454 -0.779 . . . . 0.93 111.728 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -69.64 -41.24 75.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 2.28 110.743 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -84.13 -7.39 59.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.029 -1.045 . . . . 1.45 112.204 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.1 t -58.5 -39.77 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.32 -0.863 . . . . 0.81 110.299 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -58.54 -40.19 82.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.008 -1.058 . . . . 1.54 110.208 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -61.81 -40.43 95.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.699 -0.625 . . . . 2.36 110.885 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -59.73 -43.97 93.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.064 -1.022 . . . . 1.31 111.004 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.48 -41.77 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.986 -1.071 . . . . 0.82 110.674 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -60.28 -49.21 78.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.177 -0.952 . . . . 1.5 110.044 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.455 HH11 ' HG2' ' A' ' 42' ' ' ARG . 45.6 mtt-85 -60.25 -38.01 82.18 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.534 -0.729 . . . . 2.23 109.857 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -71.85 -59.44 2.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.596 -0.69 . . . . 0.85 110.232 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.15 -45.45 90.95 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.218 -0.993 . . . . 0.91 110.0 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.519 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.7 t -67.76 -38.81 83.95 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.505 -0.747 . . . . 0.9 110.137 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.08 -41.23 94.46 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.579 -1.409 . . . . 0.69 109.579 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.533 HH22 ' CD ' ' A' ' 86' ' ' GLU . 32.8 ttm180 -59.8 -31.23 69.51 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.469 -1.018 . . . . 2.88 109.206 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.5 -46.33 86.9 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.548 0.69 . . . . 0.85 109.765 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -80.61 -44.08 19.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.81 . . . . 2.35 111.007 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.12 -42.41 94.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.65 110.163 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.1 t -59.86 -38.93 83.55 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.053 -1.029 . . . . 1.45 109.081 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.08 -50.05 44.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.682 -0.69 . . . . 0.63 110.94 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.34 -49.44 77.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.602 -1.311 . . . . 1.34 110.66 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.21 -40.42 93.9 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.396 -0.815 . . . . 1.56 109.381 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.86 -40.5 93.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.602 -0.686 . . . . 1.19 110.25 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 m -66.28 -45.42 80.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.998 -1.064 . . . . 0.72 109.798 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.02 -38.33 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.519 -0.738 . . . . 0.62 110.387 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -51.26 -42.42 61.04 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.794 -0.762 . . . . 1.05 110.328 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -70.28 -35.3 73.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.27 -0.894 . . . . 0.64 110.03 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -61.83 -39.92 93.5 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.179 -1.008 . . . . 1.73 109.074 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.85 -34.74 76.51 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.769 -0.773 . . . . 0.56 109.76 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.27 -36.65 20.29 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.643 -1.265 . . . . 0.69 110.884 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -81.71 -20.26 39.78 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.847 -1.384 . . . . 1.48 111.126 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -88.61 -51.93 5.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.414 -0.804 . . . . 0.98 110.839 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -107.31 -21.05 13.08 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.538 -0.726 . . . . 1.16 112.865 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.03 164.24 12.49 Favored Glycine 0 N--CA 1.504 3.167 0 O-C-N 121.51 -0.744 . . . . 0.85 112.075 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -52.85 -24.85 9.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.692 -0.887 . . . . 3.86 112.288 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.23 -39.56 79.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.838 -1.164 . . . . 2.35 111.137 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -87.13 -22.06 25.59 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.981 -1.074 . . . . 1.67 111.8 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -60.76 -37.62 82.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 1.45 110.754 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.69 -33.75 73.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.251 -0.905 . . . . 0.61 111.299 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.9 mt -65.88 -43.46 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.64 -1.287 . . . . 0.65 110.533 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -69.43 -32.15 70.93 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.319 -0.863 . . . . 0.66 110.706 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -61.56 -38.48 87.65 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.215 -0.928 . . . . 1.19 110.087 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.39 -41.9 99.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.817 -0.913 . . . . 0.53 110.817 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -59.28 -40.46 86.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.246 . . . . 1.27 110.535 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.82 -38.57 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.123 -0.985 . . . . 0.54 110.724 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.2 ttp -58.14 -39.68 79.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.356 -0.84 . . . . 1.74 110.639 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.72 -48.77 80.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.412 -0.805 . . . . 0.55 110.11 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.09 -41.33 92.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.562 -0.711 . . . . 0.47 110.641 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -86.54 9.86 17.12 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 112.984 0.735 . . . . 1.42 112.984 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -68.37 122.29 18.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 1.27 108.258 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.55 -16.35 64.09 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.779 0.799 . . . . 1.35 110.789 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -74.75 -51.18 14.86 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.71 0.766 . . . . 2.22 110.115 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.68 -34.43 77.09 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.771 -0.771 . . . . 0.62 110.313 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.533 ' CD ' HH22 ' A' ' 47' ' ' ARG . 88.9 tt0 -59.98 -47.16 86.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.541 -0.724 . . . . 1.29 110.93 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -63.22 -37.91 89.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.991 -1.068 . . . . 1.52 110.995 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -68.24 -49.46 60.51 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.124 -0.985 . . . . 1.3 110.756 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.1 mt -58.42 -43.94 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.61 110.551 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.0 mt -62.91 -43.78 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.78 110.47 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.71 -40.59 95.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.325 -0.859 . . . . 0.82 111.113 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.57 -42.78 97.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.978 -1.076 . . . . 0.8 110.437 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.15 -50.33 79.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.951 -1.093 . . . . 0.77 110.176 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -78.48 -34.97 47.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.369 -0.832 . . . . 2.12 111.774 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -79.08 -46.85 17.25 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.573 -1.329 . . . . 1.51 111.444 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -100.49 8.09 43.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.08 -1.013 . . . . 1.98 111.857 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.6 m170 49.78 48.92 21.01 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.219 -0.993 . . . . 1.32 111.528 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.2 mtt -103.64 156.84 17.49 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.678 0.752 . . . . 1.38 109.923 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.3 p -73.09 159.19 33.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.519 -0.738 . . . . 0.67 109.296 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.16 79.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.088 -1.007 . . . . 0.52 110.376 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.562 ' OD2' HD21 ' A' ' 142' ' ' LEU . 82.6 m-20 -68.75 -39.82 80.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.942 -1.099 . . . . 2.25 110.135 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.38 -51.06 40.28 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.446 -0.784 . . . . 0.64 111.44 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.72 94.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.555 -0.716 . . . . 0.56 110.636 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.89 -44.91 96.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.569 -0.707 . . . . 0.46 111.332 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -60.31 -39.57 87.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 1.32 110.959 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -55.83 -49.46 73.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.86 -1.15 . . . . 1.3 110.969 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.07 -45.49 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.677 -1.264 . . . . 0.61 109.85 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.42 -30.76 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.626 0.727 . . . . 0.65 110.117 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -59.16 -40.36 85.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.126 -0.984 . . . . 2.11 110.775 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.37 -32.18 20.31 Favored Glycine 0 N--CA 1.5 2.904 0 C-N-CA 119.193 -1.479 . . . . 0.83 112.601 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -60.44 -40.73 92.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.545 -1.562 . . . . 1.28 110.096 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.16 -47.77 48.44 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.608 0.718 . . . . 0.89 110.307 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 m -60.97 -38.08 84.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 1.87 110.545 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.56 97.82 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.186 -0.946 . . . . 1.05 110.854 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.2 mt -65.69 -28.04 68.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 1.02 111.288 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -67.39 -24.27 65.65 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.176 -0.952 . . . . 2.04 111.18 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.17 -11.65 60.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.119 -0.988 . . . . 1.73 111.42 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.441 HD13 HD13 ' A' ' 123' ' ' LEU . 11.3 mt -89.51 138.03 31.81 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.818 -1.179 . . . . 1.37 107.818 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 14.9 t70 -97.56 47.77 1.02 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.277 -0.889 . . . . 2.88 111.772 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -119.92 139.84 51.8 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.416 -0.802 . . . . 1.58 109.023 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -59.98 -39.09 84.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.446 -0.783 . . . . 3.04 110.762 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -70.53 -57.19 5.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.9 110.23 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.441 HD13 HD13 ' A' ' 118' ' ' LEU . 22.9 mt -61.01 -41.51 96.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 1.06 110.498 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -61.46 -49.54 76.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.854 -1.154 . . . . 2.18 109.8 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -59.94 -30.97 69.43 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.054 -1.058 . . . . 2.15 109.545 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 130' ' ' VAL . 51.0 ttt180 -63.39 -29.18 70.52 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.532 -0.867 . . . . 2.33 109.499 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.41 73.29 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.779 0.799 . . . . 0.82 109.92 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.99 -44.53 80.16 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.768 -0.773 . . . . 0.85 110.134 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -63.02 -34.84 78.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.357 -0.839 . . . . 1.39 110.569 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.2 t -67.96 -40.81 83.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.905 -1.122 . . . . 0.56 109.586 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -59.28 -37.39 77.56 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.09 -1.044 . . . . 3.12 109.23 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -59.77 -38.21 81.2 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.212 0.529 . . . . 1.28 110.067 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.7 mt -60.1 -40.24 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.972 . . . . 0.49 110.006 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.89 -43.03 94.59 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.089 -1.204 . . . . 0.46 110.089 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -58.6 -40.1 82.29 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.493 -1.004 . . . . 2.71 110.589 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 136' ' ' ARG . 51.9 mtt-85 -62.34 -42.43 99.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 2.14 110.031 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.6 tp -63.28 -44.41 95.16 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.594 0.711 . . . . 1.05 110.036 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.55 -45.2 95.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.635 0.731 . . . . 0.52 110.345 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.435 HH21 ' HA ' ' A' ' 146' ' ' ILE . 53.2 mtp180 -62.06 -34.5 76.38 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.623 -0.673 . . . . 2.35 110.945 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -76.02 -43.23 45.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.927 -1.108 . . . . 1.39 111.005 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.444 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.2 mt -61.58 -37.14 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.922 -1.111 . . . . 0.68 110.823 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.562 HD21 ' OD2' ' A' ' 101' ' ' ASP . 74.7 mt -88.03 -5.96 58.22 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.013 -1.055 . . . . 0.83 112.372 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.14 27.28 73.13 Favored Glycine 0 N--CA 1.481 1.664 0 C-N-CA 119.869 -1.157 . . . . 0.91 112.844 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.1 tp -62.3 147.37 48.38 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.643 0.735 . . . . 0.95 109.66 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.41 140.21 58.61 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.562 -0.903 . . . . 2.43 108.562 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.435 ' HA ' HH21 ' A' ' 139' ' ' ARG . 54.1 mt -101.34 137.88 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.098 -1.001 . . . . 1.1 108.518 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.85 ' H ' HD12 ' A' ' 147' ' ' ILE . 3.0 mp -82.44 123.76 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.869 -1.16 . . . . 1.58 107.869 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -99.67 97.54 8.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.854 -1.536 . . . . 1.62 106.854 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.1 -17.87 61.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.586 -0.696 . . . . 0.8 111.382 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.8 t -81.58 2.02 31.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.874 . . . . 1.56 112.097 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.91 21.09 14.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.559 -0.713 . . . . 0.84 111.928 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.2 mt -74.3 134.51 29.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.266 -0.896 . . . . 0.82 108.913 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.35 -15.8 13.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.487 -0.758 . . . . 2.31 113.003 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -111.49 130.6 55.67 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.165 -1.421 . . . . 1.54 107.165 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -72.27 123.86 23.86 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.535 -0.913 . . . . 1.38 108.535 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 25.3 m -145.69 179.56 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.482 -0.762 . . . . 0.69 109.462 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.7 mt -89.66 140.23 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.714 -0.847 . . . . 0.53 108.714 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.83 124.88 40.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.973 -1.079 . . . . 0.64 108.54 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.42 130.67 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.258 -1.016 . . . . 0.67 108.258 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.72 150.86 17.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.78 109.002 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.491 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.13 -37.86 84.33 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.915 -1.115 . . . . 1.0 109.544 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 46.9 t0 -171.23 150.28 2.94 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.391 -0.818 . . . . 2.42 108.83 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.465 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 48.2 mt -119.55 141.05 49.59 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.882 -0.784 . . . . 0.75 108.882 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.1 p -87.37 150.91 50.13 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.893 -1.129 . . . . 0.78 108.646 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -43.12 -41.63 9.53 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.787 1.658 . . . . 0.67 113.414 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.6 m -61.95 -49.02 77.81 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.144 -1.022 . . . . 0.7 110.14 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -62.84 -40.14 96.52 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.447 -0.783 . . . . 1.21 110.478 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 71.5 p -69.73 -39.0 77.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.236 -0.915 . . . . 0.6 110.271 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.49 -33.4 73.71 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.469 -0.769 . . . . 0.62 110.503 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -96.06 -2.09 47.42 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.198 -0.939 . . . . 1.16 112.51 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.72 147.73 41.25 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.306 -0.998 . . . . 0.73 108.306 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.59 113.79 25.48 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.993 -1.484 . . . . 2.24 106.993 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.18 -17.27 61.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.778 -0.576 . . . . 1.43 111.431 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -80.69 -24.04 39.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.814 . . . . 2.15 111.902 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -100.84 -6.13 25.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.264 -0.898 . . . . 2.04 113.216 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 178' ' ' GLY . 65.4 t -107.61 129.65 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.182 -1.044 . . . . 0.55 108.182 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 55.1 tp -85.79 -11.21 54.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.261 -0.9 . . . . 1.63 112.35 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.452 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 174.92 178.66 44.96 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.072 -1.611 . . . . 0.47 109.072 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -132.13 132.84 43.62 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.557 -1.275 . . . . 0.54 107.557 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 66.8 mt -137.85 107.04 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 106.076 -1.824 . . . . 0.69 106.076 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 205' ' ' THR . 60.1 p -128.57 169.22 14.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.11 -0.994 . . . . 0.82 109.041 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 12.8 p-10 -98.14 42.74 1.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.288 -0.882 . . . . 2.37 111.223 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.22 66.68 0.79 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.547 -0.721 . . . . 1.11 109.804 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.15 95.39 1.29 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 107.676 -2.17 . . . . 1.67 107.676 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -160.97 145.07 10.52 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.234 -1.546 . . . . 1.54 109.234 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -58.43 -28.54 65.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.028 -1.278 . . . . 4.48 110.757 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.6 p -87.99 10.24 19.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.711 -0.618 . . . . 2.63 111.75 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.7 m -78.65 116.94 19.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 1.69 108.877 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -60.16 -36.53 77.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.463 -0.773 . . . . 1.07 111.019 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.2 p -56.09 -41.79 75.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.324 -0.86 . . . . 1.58 110.237 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.7 t -60.02 -38.53 82.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.44 -0.787 . . . . 1.6 110.179 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.89 -39.48 80.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.669 -0.644 . . . . 1.45 110.913 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.7 mtp -60.39 -44.14 95.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.911 -1.118 . . . . 1.05 109.539 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.07 -47.42 86.44 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.711 -0.677 . . . . 0.72 111.205 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.37 -46.17 90.91 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.762 -1.211 . . . . 3.05 111.351 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.4 m -69.77 -39.78 76.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.987 . . . . 0.89 110.644 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.9 mt -91.98 -9.89 41.34 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.069 0.766 . . . . 0.78 113.069 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.6 mt-10 53.66 12.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.637 0.977 . . . . 1.45 113.637 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.1 mt -71.82 148.91 92.6 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.198 -1.038 . . . . 0.67 108.198 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.67 135.56 62.4 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 121.36 1.373 . . . . 0.64 109.916 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -162.0 167.61 24.18 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 117.642 -1.623 . . . . 0.67 109.791 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 203' ' ' VAL . 84.5 mt -148.44 156.09 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.202 -1.407 . . . . 0.69 107.202 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.466 ' N ' HG22 ' A' ' 202' ' ' ILE . 3.1 m -138.71 -25.98 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 120.825 -1.172 . . . . 0.85 112.098 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.98 45.17 3.47 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.432 -0.889 . . . . 0.92 111.832 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 181' ' ' THR . 32.3 p -64.84 -14.55 59.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.453 -1.028 . . . . 0.95 111.034 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.82 -94.26 0.97 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.273 -1.131 . . . . 1.04 110.273 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 71.9 m -129.38 27.7 5.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.621 -0.929 . . . . 1.57 112.697 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.59 -36.26 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.358 -1.464 . . . . 0.84 110.775 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.2 p -57.51 -25.93 60.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.994 -1.066 . . . . 0.99 111.235 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 36.8 p -93.1 3.81 55.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.605 -0.684 . . . . 1.7 111.733 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -126.26 -9.19 6.42 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.33 0.863 . . . . 2.2 113.33 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 213' ' ' LYS . 51.5 t -119.59 156.33 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.97 -0.752 . . . . 0.84 108.97 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.45 ' N ' HG12 ' A' ' 212' ' ' VAL . 6.2 mmmm -125.99 158.85 34.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.817 -1.179 . . . . 2.2 107.817 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 52.7 p-10 -52.43 149.16 5.94 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 120.75 -1.219 . . . . 2.28 110.459 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.1 t70 80.72 -2.69 1.84 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 114.11 1.152 . . . . 2.35 114.11 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 16' ' ' ALA . 54.8 t0 -66.69 146.47 54.43 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.737 -1.227 . . . . 1.97 108.489 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.459 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 43.3 t80 -88.49 122.16 31.66 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.442 -1.318 . . . . 2.65 107.442 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 85.2 mt -127.3 146.38 50.46 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -0.841 . . . . 0.63 109.674 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.5 mt -115.71 128.78 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.418 -1.697 . . . . 0.62 106.418 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.9 tp -98.5 117.96 34.1 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 106.025 -1.843 . . . . 0.64 106.025 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 223' ' ' VAL . 32.0 t0 -87.0 -26.75 23.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.736 -1.227 . . . . 2.05 112.066 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.54 20.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.842 . . . . 0.84 113.139 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.5 t -119.5 -63.22 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-O 121.769 0.795 . . . . 1.02 109.711 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -99.32 14.34 29.98 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.496 0.665 . . . . 2.51 111.256 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 60.22 54.74 3.89 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.376 0.607 . . . . 1.54 112.233 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.514 ' OE1' ' CZ ' ' A' ' 228' ' ' TYR . 15.7 tt0 -145.72 143.59 29.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.035 -1.041 . . . . 1.95 109.568 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.65 139.26 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.438 -1.319 . . . . 0.71 107.438 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.514 ' CZ ' ' OE1' ' A' ' 226' ' ' GLN . 86.8 m-85 -103.93 134.43 47.22 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.832 -1.168 . . . . 1.01 108.956 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.25 130.59 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.9 -1.148 . . . . 0.82 107.9 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 1.0 OUTLIER 54.52 49.91 6.01 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.185 -0.947 . . . . 1.54 112.95 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 44.8 Cg_endo -68.88 149.38 72.34 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.906 2.404 . . . . 0.94 111.459 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.5 m -78.34 157.64 29.07 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.668 0.747 . . . . 1.8 109.765 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.52 ' HA ' HD12 ' A' ' 236' ' ' ILE . 65.9 t30 -55.68 -40.59 72.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.447 -0.783 . . . . 2.73 110.627 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.05 -39.65 86.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.574 -0.704 . . . . 3.17 110.62 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.67 -37.92 71.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.301 -0.874 . . . . 1.34 110.204 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 233' ' ' ASN . 91.3 mt -59.9 -43.0 91.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.454 -0.779 . . . . 1.2 110.369 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -59.18 -40.35 85.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -0.871 . . . . 2.7 110.462 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -61.4 -46.1 91.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 2.59 110.982 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.1 mtp -72.3 -35.91 68.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.066 -1.021 . . . . 1.38 111.148 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -59.36 -39.21 82.52 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.09 -1.006 . . . . 2.84 110.774 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -69.47 -43.11 73.88 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.357 -0.839 . . . . 1.88 111.461 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 91.0 t -56.37 -53.21 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.667 -1.271 . . . . 2.4 112.46 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -62.81 -48.63 78.27 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.466 -1.396 . . . . 3.52 109.953 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.38 -39.22 89.86 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.699 -0.625 . . . . 1.88 111.207 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -60.76 -28.77 68.97 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.438 -1.414 . . . . 3.01 110.63 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.51 -42.94 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.469 -0.769 . . . . 2.45 110.66 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.69 89.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.274 -0.891 . . . . 2.75 110.39 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.3 t -69.16 -35.74 76.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.2 -0.937 . . . . 3.16 110.594 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.37 -32.78 73.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.09 -1.006 . . . . 3.57 110.756 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -63.03 -40.2 97.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.979 -1.076 . . . . 4.3 110.572 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.02 83.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -0.958 . . . . 4.45 110.484 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -69.03 -30.52 68.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.879 . . . . 5.97 111.063 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.12 -32.09 71.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.06 -1.025 . . . . 6.18 110.565 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -63.73 -32.1 73.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.089 . . . . 6.66 110.773 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -83.36 -11.09 58.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.859 -1.151 . . . . 8.2 112.739 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 93.1 mt -86.83 -0.97 57.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.279 -0.888 . . . . 8.07 112.399 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -85.31 -11.04 55.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 9.45 112.34 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -96.36 -8.37 32.73 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.366 -0.834 . . . . 10.12 113.098 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.973 -1.013 . . . . 11.49 108.692 -178.638 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.325 0.583 . . . . 3.07 109.889 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.0 mt -142.79 110.9 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.233 -1.766 . . . . 1.07 106.233 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.3 m -104.57 127.33 52.27 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.387 -0.968 . . . . 1.24 108.387 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.57 -141.24 11.99 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.494 -1.042 . . . . 1.01 110.494 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 5' ' ' ILE . 56.6 mt -100.51 1.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.241 -1.152 . . . . 1.11 112.467 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tp 49.45 96.73 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.863 -1.148 . . . . 0.99 112.162 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.5 -45.79 10.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.072 -1.017 . . . . 0.85 111.419 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t -147.11 145.9 23.75 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.686 -1.227 . . . . 1.38 107.686 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.71 151.8 46.85 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.565 2.176 . . . . 0.94 112.254 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.53 123.7 1.51 Allowed Glycine 0 N--CA 1.508 3.491 0 N-CA-C 110.94 -0.864 . . . . 0.81 110.94 177.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.7 mt -92.37 131.41 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.767 -1.431 . . . . 0.83 109.348 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.89 140.73 42.54 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.355 -0.98 . . . . 0.53 108.355 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 12.4 m-85 -108.59 136.83 47.53 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.971 -1.122 . . . . 0.77 107.971 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.76 169.05 42.09 Favored Glycine 0 N--CA 1.498 2.81 0 C-N-CA 118.276 -1.916 . . . . 0.51 110.461 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -77.7 159.39 29.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.756 -0.849 . . . . 1.9 108.795 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.477 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -87.83 131.24 34.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.999 -1.063 . . . . 0.66 109.234 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 17' ' ' LEU . 36.4 tp -109.8 103.47 12.28 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.175 -2.157 . . . . 0.83 105.175 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 tp -89.46 132.31 35.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.981 -1.075 . . . . 0.86 108.615 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' A' ' 160' ' ' ALA . 67.3 mt -100.01 121.26 41.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.515 -1.291 . . . . 0.92 107.515 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -110.65 129.4 55.83 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.763 -1.199 . . . . 2.03 107.763 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -111.33 141.54 44.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.398 -0.814 . . . . 2.66 109.22 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.18 127.03 33.25 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.436 -1.32 . . . . 2.32 107.436 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.21 147.04 54.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.046 -1.034 . . . . 2.11 109.156 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.5 mt -95.32 133.35 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.498 -0.927 . . . . 0.73 108.498 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -105.74 129.75 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.969 -1.123 . . . . 0.87 107.969 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 73.5 mt -98.33 137.27 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.152 -0.967 . . . . 0.81 108.671 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -92.31 120.61 33.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.161 -1.052 . . . . 1.34 108.161 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.425 HH11 ' HG3' ' A' ' 28' ' ' ARG . 22.6 mmm-85 -94.96 13.78 23.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.206 -0.934 . . . . 2.89 112.217 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -72.13 143.03 49.13 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.494 -0.754 . . . . 2.09 109.239 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -85.74 140.29 30.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.379 -0.826 . . . . 2.19 109.482 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.26 165.59 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 121.629 0.728 . . . . 0.75 110.41 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.7 p -93.56 167.78 11.46 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.311 0.577 . . . . 0.91 109.801 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.97 -18.66 14.41 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.015 -1.053 . . . . 0.93 112.713 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -68.99 -38.14 79.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.885 . . . . 2.28 110.877 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -92.27 -5.88 51.49 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.548 -1.345 . . . . 1.45 113.086 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.72 -42.89 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.097 -1.002 . . . . 0.81 110.69 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.1 -40.33 85.01 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.841 -1.162 . . . . 1.54 110.527 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.52 -39.42 93.51 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.292 -0.88 . . . . 2.36 111.063 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -59.76 -40.83 89.48 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.893 -1.129 . . . . 1.31 111.148 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.1 -45.0 96.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 120.937 -1.102 . . . . 0.82 110.725 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -61.43 -45.88 92.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.823 -1.173 . . . . 1.5 110.648 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -60.77 -41.35 95.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 2.23 110.176 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -75.09 -55.44 5.73 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.155 -0.966 . . . . 0.85 110.184 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.9 tp -57.38 -47.14 82.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.409 -0.916 . . . . 0.91 110.125 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.5 t -70.22 -38.9 75.35 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.051 0.929 . . . . 0.9 109.785 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.53 -44.9 97.22 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.488 -1.445 . . . . 0.69 109.488 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 43.9 ttp180 -57.49 -31.72 66.28 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.853 -0.793 . . . . 2.88 109.342 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.34 -41.49 80.13 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.774 0.797 . . . . 0.85 109.906 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -77.46 -40.94 41.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.633 -0.667 . . . . 2.35 110.236 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.66 92.15 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.588 -0.845 . . . . 0.65 109.874 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.4 t -60.26 -39.85 88.26 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.041 0.925 . . . . 1.45 109.392 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.2 75.47 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.819 -0.628 . . . . 0.63 110.597 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -66.55 -50.1 64.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.055 -1.028 . . . . 1.34 111.032 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.09 -38.43 91.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 1.56 110.229 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -59.76 -41.0 90.04 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.233 -0.917 . . . . 1.19 110.449 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.1 m -65.59 -43.39 89.84 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.241 -0.912 . . . . 0.72 109.882 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.08 -31.9 49.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.379 -0.826 . . . . 0.62 110.691 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -51.78 -46.64 64.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.745 -1.222 . . . . 1.05 110.477 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -68.63 -34.21 75.36 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.953 -1.092 . . . . 0.64 109.805 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.13 -39.95 96.17 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.356 -1.338 . . . . 1.73 109.136 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.7 75.89 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.832 -0.747 . . . . 0.56 109.548 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.18 -35.74 29.41 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.375 -1.393 . . . . 0.69 110.688 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -80.75 -22.53 40.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.107 -1.231 . . . . 1.48 111.016 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.6 m -84.56 -48.9 9.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.428 -0.795 . . . . 0.98 110.714 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -106.81 -22.62 12.65 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.409 -0.807 . . . . 1.16 112.93 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.37 169.29 14.89 Favored Glycine 0 N--CA 1.501 3.002 0 CA-C-O 121.967 0.76 . . . . 0.85 112.036 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.22 -24.17 40.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.912 -0.758 . . . . 3.86 112.501 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.96 -38.27 78.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.091 -1.006 . . . . 2.35 111.634 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -84.62 -15.84 44.12 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.321 -1.487 . . . . 1.67 113.347 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -60.07 -34.66 73.73 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.1 -1.0 . . . . 1.45 110.69 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.59 86.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.61 111.308 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 mt -65.54 -43.8 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.822 -1.174 . . . . 0.65 110.44 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -70.05 -30.68 68.01 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.225 -0.922 . . . . 0.66 110.583 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.49 -38.95 82.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.248 -0.907 . . . . 1.19 110.511 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.48 -38.73 79.87 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.734 -1.222 . . . . 0.53 110.616 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -58.05 -42.62 85.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.782 -1.422 . . . . 1.27 110.873 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.9 mt -60.4 -41.49 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 0.54 110.375 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.5 ttt -60.38 -39.15 86.22 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.221 -0.924 . . . . 1.74 110.397 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 tp -59.64 -48.43 81.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.796 -1.19 . . . . 0.55 110.729 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.61 -41.64 95.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.355 -0.841 . . . . 0.47 110.247 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -87.09 9.99 18.05 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.376 0.608 . . . . 1.42 112.213 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.99 122.17 16.37 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.858 -1.151 . . . . 1.27 108.624 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.86 -17.69 65.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.512 -0.743 . . . . 1.35 111.07 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -76.46 -53.65 7.82 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.664 0.745 . . . . 2.22 110.365 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.89 -39.52 85.62 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.593 -0.843 . . . . 0.62 110.389 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.521 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 86.3 tt0 -59.9 -45.87 91.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.718 -1.239 . . . . 1.29 110.965 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -60.58 -39.98 90.0 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.966 -1.084 . . . . 1.52 110.839 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.42 -48.49 77.56 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.335 -0.853 . . . . 1.3 110.111 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.8 mt -58.61 -43.27 87.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 118.974 -1.09 . . . . 0.61 109.61 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.4 mt -61.35 -45.08 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.535 -0.728 . . . . 0.78 110.316 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.36 -44.93 96.33 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.271 0.558 . . . . 0.82 110.929 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.91 -43.34 94.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.574 -1.329 . . . . 0.8 110.337 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.2 mt -62.33 -49.99 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.137 -0.977 . . . . 0.77 110.723 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -78.79 -36.32 42.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.609 -0.682 . . . . 2.12 111.563 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -79.93 -46.11 17.34 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 120.789 -1.194 . . . . 1.51 111.838 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -102.24 10.66 39.11 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.097 -1.002 . . . . 1.98 112.066 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.3 m80 51.26 51.5 16.8 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.306 -0.871 . . . . 1.32 112.452 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.6 mtp -104.32 158.27 16.57 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 120.91 -1.119 . . . . 1.38 109.289 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 66.7 p -72.83 158.43 35.56 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.282 -0.886 . . . . 0.67 109.466 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.11 -42.04 84.86 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.224 -0.922 . . . . 0.52 110.17 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.528 ' OD2' HD21 ' A' ' 142' ' ' LEU . 88.9 m-20 -68.78 -38.82 80.29 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.976 -1.078 . . . . 2.25 110.207 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.91 -48.59 57.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.5 -0.88 . . . . 0.64 111.536 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.32 -47.58 84.86 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.221 -0.924 . . . . 0.56 110.967 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.59 95.78 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.475 -0.766 . . . . 0.46 110.82 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -61.49 -37.67 84.51 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.558 -0.714 . . . . 1.32 110.718 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.09 -49.3 78.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.859 -1.151 . . . . 1.3 111.399 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.36 -46.25 95.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.622 -1.299 . . . . 0.61 110.097 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.43 -33.78 58.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.451 0.643 . . . . 0.65 110.437 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -57.53 -41.59 81.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -0.828 . . . . 2.11 110.786 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.65 -28.01 27.97 Favored Glycine 0 N--CA 1.5 2.94 0 C-N-CA 119.176 -1.487 . . . . 0.83 113.084 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -62.38 -39.58 93.67 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.253 -1.734 . . . . 1.28 109.747 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.13 -53.63 12.16 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.57 0.7 . . . . 0.89 111.425 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.7 p -60.41 -39.6 88.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 1.87 110.502 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.59 97.5 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.112 -0.993 . . . . 1.05 110.622 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.33 -29.0 69.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.966 -1.084 . . . . 1.02 111.202 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -68.22 -20.26 64.82 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.458 -0.776 . . . . 2.04 111.346 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -73.06 -12.34 60.88 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.331 -0.947 . . . . 1.73 110.766 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 20.1 mt -85.91 147.3 26.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.566 -0.708 . . . . 1.37 109.098 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -103.12 39.14 1.61 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.149 -0.969 . . . . 2.88 111.826 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.422 ' CB ' HD12 ' A' ' 123' ' ' LEU . 7.1 t0 -113.54 139.21 49.17 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 108.733 -0.839 . . . . 1.58 108.733 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.8 -37.74 79.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.795 -1.191 . . . . 3.04 110.812 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -72.42 -46.19 56.23 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.539 -1.351 . . . . 0.9 110.667 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.422 HD12 ' CB ' ' A' ' 120' ' ' ASP . 43.7 mt -64.33 -40.86 96.73 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.014 -1.054 . . . . 1.06 109.823 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -61.17 -46.66 89.59 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.164 -0.96 . . . . 2.18 110.256 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.0 -31.93 71.52 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.177 -0.952 . . . . 2.15 109.641 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.78 -29.19 70.52 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.854 -1.138 . . . . 2.33 109.722 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.37 -49.14 78.75 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.857 0.837 . . . . 0.82 109.852 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.53 -44.65 70.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.62 0.724 . . . . 0.85 110.663 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -63.52 -33.76 76.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.422 -0.799 . . . . 1.39 110.875 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.3 t -69.74 -42.24 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.224 -0.99 . . . . 0.56 110.203 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -59.21 -38.29 79.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.96 -1.088 . . . . 3.12 109.456 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -59.52 -39.59 84.39 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.707 -0.621 . . . . 1.28 110.213 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.04 -40.71 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.081 -1.012 . . . . 0.49 110.322 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.83 -39.93 85.28 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.948 -1.261 . . . . 0.46 109.948 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.33 -45.39 91.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.714 -0.874 . . . . 2.71 109.968 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.431 HH11 ' HG2' ' A' ' 136' ' ' ARG . 51.5 mtt-85 -62.77 -42.68 99.8 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.49 -0.884 . . . . 2.14 109.875 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.02 -41.3 91.87 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.673 -0.642 . . . . 1.05 109.954 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.2 mt -60.36 -42.06 94.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.81 . . . . 0.52 110.226 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.428 ' NH1' HD23 ' A' ' 144' ' ' LEU . 47.9 mtt-85 -61.08 -32.13 71.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 2.35 110.53 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -75.99 -41.55 50.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.244 -0.91 . . . . 1.39 110.933 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.43 HG21 ' OD1' ' A' ' 101' ' ' ASP . 91.9 mt -60.17 -39.18 79.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.961 -1.087 . . . . 0.68 110.274 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.528 HD21 ' OD2' ' A' ' 101' ' ' ASP . 85.1 mt -86.72 -7.61 58.14 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.348 -0.845 . . . . 0.83 112.666 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.82 20.04 77.26 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.11 -1.519 . . . . 0.91 112.724 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.428 HD23 ' NH1' ' A' ' 139' ' ' ARG . 35.9 tp -65.94 149.1 50.75 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.957 -0.731 . . . . 0.95 109.709 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -66.84 149.37 50.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.262 -0.899 . . . . 2.43 109.753 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.0 mt -107.64 141.03 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.229 -1.026 . . . . 1.1 108.229 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.58 ' H ' HD12 ' A' ' 147' ' ' ILE . 5.0 mp -78.98 123.88 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.601 -0.888 . . . . 1.58 108.601 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -96.84 95.67 8.02 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.796 -1.557 . . . . 1.62 106.796 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.42 -15.8 59.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.439 -0.788 . . . . 0.8 111.683 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.6 m -80.76 1.72 29.17 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.244 -0.91 . . . . 1.56 112.514 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.86 19.03 14.48 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 112.774 0.657 . . . . 0.84 112.774 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.8 mt -74.1 139.47 19.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.266 -0.896 . . . . 0.82 109.353 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -122.24 -8.78 8.68 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.458 0.646 . . . . 2.31 112.199 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -111.07 138.49 47.43 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.885 -1.154 . . . . 1.54 107.885 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.88 116.39 20.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.09 -1.078 . . . . 1.38 108.09 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.3 176.7 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.992 -0.744 . . . . 0.69 108.992 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.2 mt -84.21 140.29 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.364 -0.976 . . . . 0.53 108.364 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 19' ' ' LEU . 27.9 tp -96.53 128.32 43.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.486 -0.931 . . . . 0.64 108.486 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.2 130.12 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.075 -1.083 . . . . 0.67 108.075 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.442 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -160.57 159.68 30.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.234 -0.916 . . . . 0.78 108.92 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -62.43 -41.14 98.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.316 -1.49 . . . . 1.0 109.717 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -174.21 150.94 1.58 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.755 -0.832 . . . . 2.42 108.755 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.13 140.8 48.92 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.176 -0.675 . . . . 0.75 109.176 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.7 p -90.98 151.18 43.02 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.675 -1.266 . . . . 0.78 108.471 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -39.67 -37.77 1.51 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.077 1.851 . . . . 0.67 113.512 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.4 m -63.6 -51.4 65.45 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.154 -0.966 . . . . 0.7 109.916 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.95 -39.24 94.03 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.539 -0.726 . . . . 1.21 110.237 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 32.1 p -68.16 -40.28 82.39 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.348 0.595 . . . . 0.6 110.442 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.68 81.56 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.177 -0.952 . . . . 0.62 110.4 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -94.04 -1.61 54.18 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.94 -1.1 . . . . 1.16 112.855 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.26 149.22 33.98 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.697 -0.853 . . . . 0.73 108.697 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -96.48 114.26 25.91 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.885 -1.524 . . . . 2.24 106.885 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 82.4 mt -72.05 -17.02 62.05 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.173 0.511 . . . . 1.43 111.55 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -84.72 -22.19 29.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.654 -0.654 . . . . 2.15 112.034 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -99.51 -4.22 31.75 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.24 -0.913 . . . . 2.04 112.923 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 178' ' ' GLY . 61.1 t -112.92 129.86 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 107.599 -1.26 . . . . 0.55 107.599 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.2 tp -89.1 -8.53 53.66 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.899 -1.126 . . . . 1.63 111.827 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.473 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.22 171.21 39.03 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.995 -1.642 . . . . 0.47 108.995 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.0 136.2 49.15 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.283 -1.127 . . . . 0.54 108.147 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.473 HG22 HG21 ' A' ' 205' ' ' THR . 86.2 mt -135.54 115.75 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 106.358 -1.719 . . . . 0.69 106.358 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 205' ' ' THR . 81.6 p -131.0 169.5 15.75 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.784 -1.198 . . . . 0.82 109.897 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 39.0 p-10 -103.24 43.62 1.07 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.586 -0.696 . . . . 2.37 110.721 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -103.52 163.13 12.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.866 -1.146 . . . . 1.11 110.068 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 183' ' ' ALA . . . -47.73 -96.49 0.01 OUTLIER Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.699 -1.239 . . . . 1.67 111.522 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 153.81 -46.11 0.56 Allowed Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.828 -1.395 . . . . 1.54 112.895 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -56.66 -40.13 74.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.742 -1.446 . . . . 4.48 110.474 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.9 p -121.41 23.22 10.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.888 -0.507 . . . . 2.63 111.204 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.9 p -87.88 128.6 35.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.967 -1.124 . . . . 1.69 107.967 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -61.07 -38.53 86.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.688 -0.633 . . . . 1.07 110.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.1 p -51.99 -43.66 63.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.056 -1.028 . . . . 1.58 110.405 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.9 m -60.12 -37.81 81.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.767 0.794 . . . . 1.6 110.405 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.7 mm -59.52 -38.58 76.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.525 -0.735 . . . . 1.45 110.8 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 77.2 mtp -63.17 -43.0 99.49 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.226 1.012 . . . . 1.05 108.883 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.79 -48.99 78.15 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.598 -0.728 . . . . 0.72 111.335 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.28 -46.78 88.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.014 -1.054 . . . . 3.05 111.146 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 42.7 m -69.85 -41.36 74.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.178 -0.951 . . . . 0.89 110.294 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.27 -1.6 57.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.415 -0.803 . . . . 0.78 111.991 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 194' ' ' ALA . 54.9 mt-10 54.04 9.75 0.24 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.723 1.009 . . . . 1.45 113.723 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.19 164.94 52.78 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.984 -1.072 . . . . 0.67 108.304 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -82.06 144.04 13.18 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.851 1.701 . . . . 0.64 110.397 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.48 168.28 25.44 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 117.733 -1.587 . . . . 0.67 109.499 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.562 ' CD1' HD11 ' A' ' 220' ' ' LEU . 17.4 mt -148.85 145.9 17.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.159 -1.423 . . . . 0.69 107.159 176.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.98 -25.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 120.899 -1.125 . . . . 0.85 113.523 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.14 46.16 3.57 Favored Glycine 0 N--CA 1.492 2.403 0 O-C-N 120.99 -1.069 . . . . 0.92 111.644 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.473 HG21 HG22 ' A' ' 180' ' ' ILE . 60.5 p -67.59 -12.48 60.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.375 -1.073 . . . . 0.95 111.803 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.48 -95.54 0.98 Allowed Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.301 -1.12 . . . . 1.04 110.301 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.9 p -128.41 29.28 5.34 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.389 -1.065 . . . . 1.57 112.344 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 72.4 t -58.49 -38.03 67.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.567 -1.333 . . . . 0.84 110.707 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.7 p -55.48 -24.94 34.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 0.99 111.58 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.4 t -94.34 3.93 54.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.875 . . . . 1.7 111.988 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -127.66 1.13 6.14 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.675 0.621 . . . . 2.2 112.675 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 16.1 t -116.23 150.2 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.889 0.852 . . . . 0.84 109.611 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -116.07 167.16 11.23 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.939 -0.763 . . . . 2.2 108.939 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 68.5 m-80 -68.05 140.33 56.29 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.74 -1.184 . . . . 2.28 108.814 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.0 m-20 78.0 4.71 2.84 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.171 1.175 . . . . 2.35 114.171 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -63.38 147.88 49.97 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.075 -1.083 . . . . 1.97 108.075 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -89.01 120.16 30.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.588 -1.32 . . . . 2.65 107.484 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.477 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 80.2 mt -127.9 146.99 50.46 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.664 0.745 . . . . 0.63 109.697 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 60.2 mt -119.08 128.2 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.08 -1.452 . . . . 0.62 107.08 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.562 HD11 ' CD1' ' A' ' 202' ' ' ILE . 48.8 tp -100.98 119.96 39.49 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 106.329 -1.73 . . . . 0.64 106.329 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 223' ' ' VAL . 40.2 t0 -87.28 -25.65 23.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.955 -1.091 . . . . 2.05 112.176 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.8 16.84 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 113.652 0.982 . . . . 0.84 113.652 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 221' ' ' ASP . 43.1 t -120.38 -63.31 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.178 -0.951 . . . . 1.02 109.621 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -90.81 7.84 37.8 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.059 0.933 . . . . 2.51 111.175 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 62.3 55.34 2.38 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.692 0.758 . . . . 1.54 112.148 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -147.31 145.17 29.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.353 -0.842 . . . . 1.95 109.562 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 29.9 t -115.95 138.34 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.775 -1.194 . . . . 0.71 107.775 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -105.76 132.7 51.56 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.925 -1.11 . . . . 1.01 108.483 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.94 130.56 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 108.532 -0.914 . . . . 0.82 108.532 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.425 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 41.6 t-20 50.72 51.34 10.38 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 113.462 0.912 . . . . 1.54 113.462 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 36.4 Cg_endo -67.86 150.27 78.41 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.53 2.153 . . . . 0.94 110.507 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.412 ' H ' HG23 ' A' ' 232' ' ' THR . 1.5 p -74.05 159.99 31.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.994 -1.066 . . . . 1.8 109.7 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -61.57 -35.76 78.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.284 -0.885 . . . . 2.73 110.334 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.35 -39.74 84.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.961 -1.087 . . . . 3.17 110.43 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.91 -36.73 70.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.491 -0.756 . . . . 1.34 110.017 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.01 -43.78 93.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.261 -0.9 . . . . 1.2 110.543 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.22 -41.2 88.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.955 -1.091 . . . . 2.7 110.252 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -63.61 -40.03 95.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.447 -0.783 . . . . 2.59 110.502 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 73.2 mtp -70.73 -36.99 73.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.925 . . . . 1.38 110.936 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -57.56 -39.87 77.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.8 -1.188 . . . . 2.84 110.127 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.15 -56.91 5.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.239 -0.913 . . . . 1.88 110.077 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.78 -42.57 92.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.294 -0.879 . . . . 2.4 110.701 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -58.33 -51.98 67.5 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.901 -1.119 . . . . 3.52 111.055 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.97 -30.95 71.97 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.366 -0.934 . . . . 1.88 109.478 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -60.57 -30.69 69.96 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.298 -0.961 . . . . 3.01 108.754 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 82.7 t -60.13 -41.82 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 122.312 1.053 . . . . 2.45 108.676 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.04 -39.06 68.75 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.001 -1.079 . . . . 2.75 108.773 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 29.4 t -71.0 -19.44 62.52 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.513 0.673 . . . . 3.16 110.569 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.48 -40.59 91.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.345 -0.847 . . . . 3.57 109.283 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -64.72 -29.39 70.37 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.677 1.227 . . . . 4.3 109.629 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.03 37.18 0.43 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.849 -1.069 . . . . 4.45 111.886 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -58.35 -28.45 65.11 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.408 -0.917 . . . . 5.97 111.124 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.654 ' N ' HD12 ' A' ' 253' ' ' LEU . 8.1 mp -66.02 -29.72 70.14 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.445 -0.902 . . . . 6.18 110.367 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -73.66 -3.51 28.63 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.85 0.685 . . . . 6.66 112.85 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.92 -3.14 43.35 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.859 -1.151 . . . . 8.2 112.47 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 256' ' ' LEU . 3.5 mm? -80.39 -1.74 42.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.438 -0.789 . . . . 8.07 111.741 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -94.27 19.64 9.18 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.887 -0.508 . . . . 9.45 112.131 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.25 10.48 22.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.289 -0.882 . . . . 10.12 112.202 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 118.123 -0.941 . . . . 11.49 109.327 178.777 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.805 -0.443 . . . . 3.07 109.805 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 80.9 mt -99.08 117.16 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 106.568 -1.642 . . . . 1.07 106.568 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.3 m -104.01 122.31 44.98 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.281 -1.007 . . . . 1.24 108.281 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.57 -159.22 18.21 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 108.641 -1.784 . . . . 1.01 108.641 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 5' ' ' ILE . 93.4 mt -97.07 1.06 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.253 -1.145 . . . . 1.11 112.646 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tp 51.42 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.049 . . . . 0.99 112.345 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -83.62 -45.0 13.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.993 -1.067 . . . . 0.85 111.496 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.06 146.48 28.43 Favored Pre-proline 0 N--CA 1.5 2.064 0 N-CA-C 107.447 -1.316 . . . . 1.38 107.447 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.15 146.17 28.43 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.644 2.229 . . . . 0.94 112.144 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.898 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.71 176.43 26.11 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 108.828 -1.709 . . . . 0.81 108.828 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.4 mt -138.05 136.69 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 107.712 -1.218 . . . . 0.83 107.712 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.25 152.85 44.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.392 -0.818 . . . . 0.53 109.19 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -122.16 145.11 48.5 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.354 -0.98 . . . . 0.77 108.354 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.78 167.58 34.3 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.584 -1.769 . . . . 0.51 109.886 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -76.89 159.16 30.25 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.788 -0.831 . . . . 1.9 108.802 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.92 126.94 33.49 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.866 -1.161 . . . . 0.66 107.866 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.89 107.89 19.14 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 104.965 -2.235 . . . . 0.83 104.965 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.8 tp -94.37 138.67 32.06 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.162 -1.051 . . . . 0.86 108.162 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.7 mt -100.69 118.03 36.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 106.768 -1.567 . . . . 0.92 106.768 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -109.96 136.06 49.84 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.043 -1.466 . . . . 2.03 107.043 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -123.94 140.1 53.31 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.847 -1.158 . . . . 2.66 108.34 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -82.91 136.26 34.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.464 -1.31 . . . . 2.32 107.464 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.32 150.03 44.32 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.671 -0.812 . . . . 2.11 109.516 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.3 mt -91.77 134.64 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.314 -0.866 . . . . 0.73 108.752 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.4 t -106.31 130.03 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.496 -1.298 . . . . 0.87 107.496 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 26' ' ' ILE . 19.4 mt -96.34 132.26 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.643 -0.873 . . . . 0.81 108.643 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -91.81 121.62 33.6 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.316 -0.994 . . . . 1.34 108.316 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -100.03 22.01 11.92 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.15 -0.969 . . . . 2.89 112.139 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -65.78 143.65 57.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.889 -1.132 . . . . 2.09 109.073 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -89.32 131.39 35.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.077 -1.082 . . . . 2.19 108.077 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 pt -97.63 167.74 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.75 109.996 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.3 p -97.62 163.68 12.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.531 -0.731 . . . . 0.91 110.109 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.87 -24.09 14.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.93 111.861 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -67.37 -35.97 80.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.953 . . . . 2.28 110.715 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -94.78 -12.81 26.41 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.993 -1.067 . . . . 1.45 112.802 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.19 -46.42 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.895 . . . . 0.81 110.537 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -58.12 -39.38 78.54 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.102 -0.999 . . . . 1.54 110.701 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -62.41 -43.25 99.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.418 -0.801 . . . . 2.36 110.876 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.46 -36.55 78.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.079 -1.013 . . . . 1.31 110.935 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.46 -42.4 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.784 -1.198 . . . . 0.82 110.091 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -61.89 -41.03 97.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.097 -1.002 . . . . 1.5 110.091 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -63.14 -40.95 99.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.512 -0.743 . . . . 2.23 110.168 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -71.94 -56.72 5.17 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.27 -0.894 . . . . 0.85 110.349 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.9 tp -58.92 -47.04 86.45 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.377 -0.929 . . . . 0.91 109.754 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.531 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.0 t -70.27 -42.18 72.45 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.263 -0.975 . . . . 0.9 109.426 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.24 -38.85 88.58 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.145 -1.582 . . . . 0.69 109.145 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -59.79 -33.37 71.63 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 122.103 0.954 . . . . 2.88 108.973 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.35 -42.14 81.44 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.604 0.716 . . . . 0.85 109.642 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -79.46 -43.34 23.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -0.821 . . . . 2.35 110.527 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.78 87.88 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.335 -0.853 . . . . 0.65 109.814 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 m -60.77 -39.81 90.21 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.798 0.808 . . . . 1.45 109.546 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.86 86.98 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.243 0.544 . . . . 0.63 110.475 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.02 -48.77 78.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 1.34 110.575 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.96 -38.56 88.89 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.012 -1.055 . . . . 1.56 109.783 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -60.19 -40.04 88.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.83 -0.544 . . . . 1.19 110.789 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.7 m -61.8 -42.81 99.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.759 -1.213 . . . . 0.72 109.931 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.49 -37.64 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.298 -0.876 . . . . 0.62 110.493 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -50.1 -44.29 51.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.403 -0.811 . . . . 1.05 111.118 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.25 -37.38 74.91 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.123 -0.986 . . . . 0.64 110.109 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -61.68 -38.55 88.21 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.905 -1.118 . . . . 1.73 109.545 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.47 -33.59 76.24 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.918 -0.713 . . . . 0.56 109.621 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.37 -36.82 13.41 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.957 -1.116 . . . . 0.69 111.123 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -81.36 -23.08 37.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.966 -1.314 . . . . 1.48 111.023 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 m -91.4 -51.29 5.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.484 -0.76 . . . . 0.98 110.971 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.12 -8.17 17.59 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.001 1.112 . . . . 1.16 114.001 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.36 170.69 30.63 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.257 -0.902 . . . . 0.85 111.75 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -58.21 -21.98 50.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.98 -0.717 . . . . 3.86 112.15 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -54.34 -41.61 69.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.06 -1.025 . . . . 2.35 110.861 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -89.24 -24.0 22.21 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.161 -0.962 . . . . 1.67 112.031 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -60.01 -39.57 86.27 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.604 -0.685 . . . . 1.45 111.167 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.36 87.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.357 -0.839 . . . . 0.61 111.523 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 mt -65.95 -45.56 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.541 -1.35 . . . . 0.65 110.131 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -68.43 -33.22 73.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.066 -1.021 . . . . 0.66 110.623 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -60.15 -36.13 76.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.233 -0.917 . . . . 1.19 110.321 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.87 -39.66 85.3 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.941 -1.123 . . . . 0.53 110.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -58.98 -42.88 91.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.102 -1.234 . . . . 1.27 110.525 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.9 mt -60.36 -37.54 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.54 110.34 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.5 ttt -59.45 -39.9 85.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.257 -0.902 . . . . 1.74 110.517 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.03 -46.36 88.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.334 -0.854 . . . . 0.55 109.866 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.3 -38.78 88.04 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.817 0.818 . . . . 0.47 110.139 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.86 9.7 18.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.515 -0.74 . . . . 1.42 112.735 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -67.11 121.76 16.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.182 -0.949 . . . . 1.27 108.849 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.75 -15.55 62.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.536 -0.728 . . . . 1.35 111.065 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -76.86 -49.63 15.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.678 0.751 . . . . 2.22 110.431 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.36 -37.26 86.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.755 0.788 . . . . 0.62 110.192 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.91 -47.46 85.66 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.35 -0.844 . . . . 1.29 110.744 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.82 -37.79 85.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.215 -0.928 . . . . 1.52 110.473 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -65.41 -47.72 75.29 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.092 -1.043 . . . . 1.3 110.646 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.35 -44.55 88.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.138 -1.025 . . . . 0.61 110.07 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.87 -39.83 83.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.653 -0.655 . . . . 0.78 110.245 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.05 90.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.531 -0.73 . . . . 0.82 110.878 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.0 -41.74 92.74 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.028 -1.045 . . . . 0.8 110.272 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.5 mt -64.94 -50.01 77.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.776 -0.769 . . . . 0.77 110.494 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -74.77 -38.54 62.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 2.12 111.778 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -78.82 -45.76 20.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.665 -1.272 . . . . 1.51 111.279 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -101.47 8.84 41.89 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.983 -1.073 . . . . 1.98 112.569 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.2 m80 50.25 49.97 19.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.707 -1.246 . . . . 1.32 111.632 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.6 mtt -102.8 154.97 18.66 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.831 0.824 . . . . 1.38 109.716 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.7 p -70.96 161.44 31.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.604 -0.685 . . . . 0.67 109.582 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.87 91.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 0.52 111.042 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 28.6 p-10 -69.13 -39.05 79.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.798 -1.189 . . . . 2.25 110.53 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -69.7 -50.36 44.48 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.432 -0.907 . . . . 0.64 111.46 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.11 90.94 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.948 -1.095 . . . . 0.56 110.472 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.44 90.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.254 -0.904 . . . . 0.46 110.868 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -61.06 -38.75 87.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.737 -1.227 . . . . 1.32 111.003 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -57.68 -49.81 75.28 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.053 -1.029 . . . . 1.3 110.791 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.2 -47.23 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.831 -1.168 . . . . 0.61 110.144 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -62.0 -32.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.358 -0.839 . . . . 0.65 110.497 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -57.78 -40.05 78.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 2.11 110.856 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.06 -33.2 15.47 Favored Glycine 0 N--CA 1.501 3.029 0 C-N-CA 119.152 -1.499 . . . . 0.83 112.452 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -61.66 -42.26 98.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.434 -1.627 . . . . 1.28 110.2 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.9 -53.3 15.57 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.494 0.664 . . . . 0.89 110.821 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.6 m -61.42 -39.92 92.5 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.021 -1.049 . . . . 1.87 111.083 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.43 97.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.993 -1.067 . . . . 1.05 111.318 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 43.9 mt -62.21 -29.99 70.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.953 -1.092 . . . . 1.02 110.613 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.27 -19.67 64.73 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.971 -1.081 . . . . 2.04 111.073 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -74.65 -9.38 58.52 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.965 0.888 . . . . 1.73 110.898 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.485 HD13 HD13 ' A' ' 123' ' ' LEU . 69.2 mt -87.37 149.57 24.4 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.039 -0.726 . . . . 1.37 109.039 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -104.12 38.77 1.77 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.105 -0.997 . . . . 2.88 111.586 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -116.43 138.58 51.25 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.23 -0.919 . . . . 1.58 108.981 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.79 -39.54 85.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.693 -0.629 . . . . 3.04 110.957 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -71.68 -48.12 49.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.64 -1.287 . . . . 0.9 110.38 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.485 HD13 HD13 ' A' ' 118' ' ' LEU . 25.5 mt -64.1 -39.57 94.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 1.06 110.021 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -60.28 -47.98 83.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.906 -1.121 . . . . 2.18 109.518 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.32 -31.28 70.13 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.716 -0.794 . . . . 2.15 109.57 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.536 ' O ' HG23 ' A' ' 130' ' ' VAL . 19.2 ttt-85 -60.5 -31.11 70.17 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.136 -1.026 . . . . 2.33 108.397 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -61.96 -48.85 78.51 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.459 -0.896 . . . . 0.82 109.332 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.01 -46.11 79.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.388 -0.82 . . . . 0.85 110.408 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.38 -34.45 77.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.48 -0.763 . . . . 1.39 110.656 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.0 t -68.23 -39.5 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.56 110.275 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -57.37 -39.69 76.57 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.139 -0.976 . . . . 3.12 110.115 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -61.28 -39.38 90.22 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.624 0.726 . . . . 1.28 110.591 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.27 -39.79 83.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.381 -0.825 . . . . 0.49 110.293 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.92 -48.4 48.55 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.394 -0.908 . . . . 0.46 111.456 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -58.26 -40.64 82.38 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.73 -1.453 . . . . 2.71 110.811 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -61.79 -45.86 92.04 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.677 -1.264 . . . . 2.14 110.326 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.96 -43.78 98.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.486 -0.759 . . . . 1.05 110.376 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.93 -45.53 92.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.831 . . . . 0.52 110.44 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.424 HH22 HD12 ' A' ' 147' ' ' ILE . 57.6 mtp180 -60.54 -35.99 77.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.571 -0.706 . . . . 2.35 110.987 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -74.71 -40.35 61.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 1.39 110.66 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.34 -39.17 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.448 -0.901 . . . . 0.68 110.407 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.28 -7.05 58.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.086 -1.009 . . . . 0.83 112.33 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.85 19.49 77.57 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.812 -1.185 . . . . 0.91 112.478 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.38 147.91 39.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.639 -0.918 . . . . 0.95 109.302 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -67.24 142.92 56.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.401 -0.812 . . . . 2.43 109.185 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.6 mt -108.7 137.72 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.167 -1.049 . . . . 1.1 108.167 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.512 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.2 mp -79.45 130.36 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.015 . . . . 1.58 108.546 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -93.95 96.2 9.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.507 -1.664 . . . . 1.62 106.507 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.5 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 57.3 mt -74.61 -10.56 59.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 0.8 111.951 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 172' ' ' ASN . 27.5 t -89.5 0.74 56.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.909 -1.119 . . . . 1.56 112.424 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -102.43 33.75 3.02 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.102 -0.999 . . . . 0.84 112.884 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.544 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.9 mp -66.29 140.63 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.197 -1.564 . . . . 0.82 108.827 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -109.29 -20.77 12.83 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.08 0.943 . . . . 2.31 111.346 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.437 ' O ' ' CG2' ' A' ' 152' ' ' ILE . 95.7 m-20 -118.89 140.17 50.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.875 -1.157 . . . . 1.54 107.875 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -74.49 124.94 27.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.056 -1.091 . . . . 1.38 108.056 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.6 m -146.88 175.7 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.564 -0.71 . . . . 0.69 109.513 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.1 mt -88.7 141.83 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.951 -0.759 . . . . 0.53 108.951 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.6 tp -96.67 121.39 38.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.64 108.297 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.78 131.56 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.373 -0.973 . . . . 0.67 108.373 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.37 158.2 31.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.78 109.088 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.56 82.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.692 -1.255 . . . . 1.0 109.713 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -171.81 151.07 2.74 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.889 -0.782 . . . . 2.42 108.889 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.0 mt -115.76 142.9 46.14 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.504 -0.747 . . . . 0.75 109.248 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 54.3 p -92.4 148.86 37.28 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 120.984 -1.073 . . . . 0.78 108.878 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -41.28 -41.84 4.98 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.052 1.835 . . . . 0.67 113.354 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.9 m -60.51 -50.37 73.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.938 -1.101 . . . . 0.7 110.235 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -60.68 -40.14 91.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.416 -0.802 . . . . 1.21 109.779 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 48.6 p -66.73 -38.47 86.73 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.568 -0.708 . . . . 0.6 110.278 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.28 82.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.62 111.122 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -96.93 1.05 49.95 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.31 -0.869 . . . . 1.16 113.136 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.27 150.03 36.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.2 -0.938 . . . . 0.73 109.601 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 150' ' ' SER . 6.1 m120 -94.83 116.14 28.36 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 106.877 -1.527 . . . . 2.24 106.877 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.619 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.6 mm? -75.06 -19.43 60.0 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.482 -0.761 . . . . 1.43 111.81 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -85.9 -21.23 28.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 2.15 112.266 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -98.95 -2.86 36.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.126 -0.983 . . . . 2.04 112.598 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.592 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.0 t -109.08 129.32 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 107.979 -1.119 . . . . 0.55 107.979 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.2 tp -86.26 -6.2 59.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.518 -0.739 . . . . 1.63 111.833 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.592 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 167.29 172.74 34.8 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 108.822 -1.711 . . . . 0.47 108.822 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -127.18 131.12 50.75 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.206 -1.173 . . . . 0.54 108.15 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.599 HG22 HG21 ' A' ' 205' ' ' THR . 89.1 mt -135.97 116.07 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 106.164 -1.791 . . . . 0.69 106.164 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 203' ' ' VAL . 62.8 p -138.79 174.99 9.94 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.282 -1.511 . . . . 0.82 110.543 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 44.2 m-20 -97.62 61.73 1.63 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 115.455 -0.793 . . . . 2.37 109.674 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.457 ' HB1' ' OG ' ' A' ' 188' ' ' SER . . . -106.88 141.66 37.74 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.72 -0.845 . . . . 1.11 108.72 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -58.58 -35.9 82.77 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.637 -1.268 . . . . 1.67 110.899 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 93.2 -12.78 69.12 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 121.066 -1.255 . . . . 1.54 113.717 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -61.44 -40.98 96.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.812 -1.404 . . . . 4.48 109.887 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 40.9 p -152.6 36.95 0.51 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 2.63 111.89 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.457 ' OG ' ' HB1' ' A' ' 183' ' ' ALA . 67.6 m -83.74 132.04 34.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 1.69 108.802 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -60.04 -35.49 75.22 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.181 0.515 . . . . 1.07 111.012 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.9 p -57.67 -41.24 81.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.77 -1.206 . . . . 1.58 110.464 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 50.6 m -60.07 -35.95 76.31 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.016 -1.053 . . . . 1.6 110.172 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.1 mm -59.97 -39.95 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.893 -0.504 . . . . 1.45 111.029 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.5 mtp -61.13 -45.14 95.91 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.009 -1.057 . . . . 1.05 109.62 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -57.91 -48.2 80.57 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.678 -0.692 . . . . 0.72 111.061 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' A' ' 195' ' ' ARG . 41.6 mtt-85 -61.87 -41.01 97.33 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.132 -0.98 . . . . 3.05 110.605 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.5 m -69.62 -41.36 75.79 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.288 -0.883 . . . . 0.89 110.185 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.22 -8.12 49.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 112.574 0.583 . . . . 0.78 112.574 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.1 mt-10 52.97 10.66 0.17 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.085 1.143 . . . . 1.45 114.085 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.7 mt -71.95 149.7 92.52 Favored Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 108.188 -1.041 . . . . 0.67 108.188 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -54.09 132.81 52.18 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.236 1.29 . . . . 0.64 109.903 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.75 162.71 37.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.294 -1.504 . . . . 0.67 109.468 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 203' ' ' VAL . 81.2 mt -148.23 154.5 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.686 -1.228 . . . . 0.69 107.686 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.9 m -137.22 -28.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 121.077 -1.014 . . . . 0.85 112.244 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.75 32.93 0.72 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.822 -1.18 . . . . 0.92 113.5 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.599 HG21 HG22 ' A' ' 180' ' ' ILE . 39.4 p -60.8 -25.27 66.44 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.31 -1.112 . . . . 0.95 110.453 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 76.27 -93.44 0.99 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.818 -1.182 . . . . 1.04 110.541 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.0 p -127.3 32.6 5.02 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.215 -1.168 . . . . 1.57 112.325 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.26 -36.24 67.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 120.682 -1.261 . . . . 0.84 109.911 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.5 p -57.48 -20.19 29.36 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.282 -0.886 . . . . 0.99 111.74 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.4 t -91.16 -3.57 56.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 1.7 111.732 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -122.62 -8.2 8.52 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 112.923 0.712 . . . . 2.2 112.923 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 68.9 t -112.32 148.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.427 0.632 . . . . 0.84 109.649 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -120.09 159.46 24.76 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.012 -1.107 . . . . 2.2 108.012 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.2 p30 -57.61 149.0 22.54 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.409 -1.432 . . . . 2.28 110.507 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 9.0 t0 81.69 -2.44 1.6 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 114.644 1.35 . . . . 2.35 114.644 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -67.61 147.97 52.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.743 -1.223 . . . . 1.97 108.328 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -90.18 122.96 33.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.757 -1.201 . . . . 2.65 107.757 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.0 mt -124.88 143.88 50.61 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.9 0.857 . . . . 0.63 110.199 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.61 122.93 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.125 -1.805 . . . . 0.62 106.125 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.1 tp -98.92 117.77 34.17 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.409 -1.7 . . . . 0.64 106.409 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 223' ' ' VAL . 30.9 t0 -92.76 -26.0 17.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.933 -1.104 . . . . 2.05 112.96 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.59 18.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.863 0.69 . . . . 0.84 112.863 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.2 t -113.49 -60.72 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.956 0.884 . . . . 1.02 109.386 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -95.54 10.55 36.2 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.721 0.772 . . . . 2.51 110.764 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.9 t30 62.21 50.25 3.99 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.446 0.641 . . . . 1.54 111.74 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -147.17 146.6 29.93 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.414 1.102 . . . . 1.95 109.563 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.11 140.25 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.691 -0.855 . . . . 0.71 108.691 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -100.28 132.16 45.81 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.909 -1.119 . . . . 1.01 108.542 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.1 t -110.15 130.18 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.411 -0.959 . . . . 0.82 108.411 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.7 t30 53.12 52.84 10.97 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 114.124 1.157 . . . . 1.54 114.124 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.38 149.6 69.53 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.149 1.899 . . . . 0.94 110.717 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 65.7 p -75.72 157.94 32.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 1.8 109.245 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -60.84 -38.56 85.91 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.788 -0.765 . . . . 2.73 110.24 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 55.8 mp0 -60.28 -39.34 86.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.636 -0.665 . . . . 3.17 110.732 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.48 -40.83 77.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.864 -1.134 . . . . 1.34 110.142 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.4 -43.87 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.437 -0.789 . . . . 1.2 110.082 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -59.72 -41.42 90.8 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.104 -0.997 . . . . 2.7 110.385 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -63.61 -40.58 97.27 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.474 -0.89 . . . . 2.59 110.342 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.488 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 84.0 mtp -69.85 -41.01 75.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 1.38 110.648 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -53.28 -44.68 68.47 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.327 -1.483 . . . . 2.84 110.276 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.84 -59.63 2.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 1.88 110.514 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.69 -46.01 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.276 -0.89 . . . . 2.4 111.921 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 239' ' ' MET . 4.2 tp60 -59.32 -43.24 92.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.712 -1.243 . . . . 3.52 110.861 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -60.46 -35.87 76.91 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.489 -1.284 . . . . 1.88 109.94 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -60.55 -28.74 68.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.776 -1.17 . . . . 3.01 110.213 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 99.7 t -60.31 -41.66 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 118.981 -1.088 . . . . 2.45 109.186 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.92 82.8 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.478 -0.889 . . . . 2.75 109.705 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 7.7 t -70.82 -27.56 63.97 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.577 0.703 . . . . 3.16 110.887 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -59.78 -38.88 83.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.78 . . . . 3.57 110.3 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 252' ' ' GLU . 93.3 mttt -66.48 -29.32 69.4 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.898 0.856 . . . . 4.3 110.674 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -74.52 28.55 0.08 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.763 0.792 . . . . 4.45 111.88 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 250' ' ' LYS . 85.3 tt0 -59.88 -24.55 64.36 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.695 -0.628 . . . . 5.97 111.388 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.27 -35.15 73.21 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.398 -0.921 . . . . 6.18 109.592 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -74.94 -0.31 18.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.717 -0.614 . . . . 6.66 112.466 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -76.1 -7.69 55.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.222 -0.924 . . . . 8.2 112.529 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 47.9 mt -80.31 -4.24 52.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.994 -1.067 . . . . 8.07 112.256 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -85.18 -3.85 58.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.133 -0.979 . . . . 9.45 112.181 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -94.5 -59.09 2.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.985 -1.072 . . . . 10.12 111.049 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 118.205 -0.902 . . . . 11.49 109.985 -179.168 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 mmt . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.492 -0.558 . . . . 3.07 109.492 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.2 mt 48.36 71.36 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.315 -0.866 . . . . 1.07 112.321 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 m -93.07 118.22 30.95 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.09 -1.448 . . . . 1.24 107.09 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.4 -146.8 16.69 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.48 -1.048 . . . . 1.01 110.48 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -94.95 -2.88 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.34 -1.094 . . . . 1.11 113.036 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tp 50.8 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.867 -1.146 . . . . 0.99 112.607 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.8 -43.79 13.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.85 110.741 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -147.96 142.42 16.54 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 107.797 -1.186 . . . . 1.38 107.797 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.97 149.39 36.79 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.716 2.277 . . . . 0.94 112.454 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.887 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.43 162.61 11.43 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.143 -1.583 . . . . 0.81 109.143 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -121.9 135.08 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 O-C-N 121.089 -1.242 . . . . 0.83 108.271 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.11 155.5 46.97 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.456 -0.778 . . . . 0.53 109.269 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -127.44 139.58 52.73 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.89 -1.152 . . . . 0.77 107.89 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.46 168.98 35.98 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 118.69 -1.719 . . . . 0.51 110.063 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.441 ' HZ3' HG12 ' A' ' 156' ' ' VAL . 30.2 mtmm -80.03 161.15 25.57 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.451 -1.029 . . . . 1.9 110.216 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.85 131.68 34.49 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.391 -0.966 . . . . 0.66 108.391 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 tp -109.78 101.77 10.61 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 105.405 -2.072 . . . . 0.83 105.405 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.53 133.15 35.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.911 -1.144 . . . . 0.86 107.911 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.7 117.93 35.8 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.394 -1.706 . . . . 0.92 106.394 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -109.32 133.38 53.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.943 -1.132 . . . . 2.03 107.943 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -123.59 140.24 53.19 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.305 -0.872 . . . . 2.66 108.666 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -80.46 136.99 36.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.073 -1.017 . . . . 2.32 108.256 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.2 146.12 51.62 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.281 -0.887 . . . . 2.11 108.955 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.0 mt -93.39 128.84 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.237 -1.023 . . . . 0.73 108.237 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -108.83 130.49 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.726 -1.213 . . . . 0.87 107.726 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.5 mt -95.7 132.14 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.341 -0.85 . . . . 0.81 108.943 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -89.94 120.8 31.47 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.61 -1.256 . . . . 1.34 107.61 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -96.65 17.74 15.79 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.431 -0.793 . . . . 2.89 112.417 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -67.45 146.29 54.14 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.203 -0.935 . . . . 2.09 108.979 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -87.82 134.83 33.61 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.103 -1.073 . . . . 2.19 108.103 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 pt -96.82 165.69 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.458 -0.776 . . . . 0.75 110.329 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -94.27 168.47 10.89 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 0.91 109.541 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.11 -18.97 28.75 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.959 -1.088 . . . . 0.93 112.879 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.09 -35.85 76.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.746 -1.221 . . . . 2.28 110.825 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -94.5 -8.83 37.23 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.969 -1.082 . . . . 1.45 113.221 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.9 -43.79 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.164 -0.96 . . . . 0.81 110.156 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.52 -40.09 81.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.954 -1.091 . . . . 1.54 110.4 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -62.1 -38.09 87.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.683 . . . . 2.36 110.656 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.77 -39.49 85.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 1.31 110.883 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.49 -43.68 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.131 -0.98 . . . . 0.82 110.769 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -62.13 -43.8 98.04 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.113 -0.992 . . . . 1.5 110.461 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -62.7 -38.78 91.79 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.247 -0.908 . . . . 2.23 110.592 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -76.09 -55.56 5.48 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.123 -0.986 . . . . 0.85 110.532 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.68 -48.28 81.62 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.295 -0.962 . . . . 0.91 110.59 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.552 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 10.9 t -69.84 -40.78 75.62 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.74 -0.784 . . . . 0.9 110.435 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.15 -45.73 87.05 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.24 -1.457 . . . . 0.69 109.691 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -58.39 -30.06 66.53 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.036 0.922 . . . . 2.88 109.995 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.66 -46.19 87.73 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.672 0.748 . . . . 0.85 110.018 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -78.95 -41.81 28.42 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 2.35 110.311 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.48 86.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.4 -0.813 . . . . 0.65 109.74 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -60.45 -40.38 90.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.118 -0.989 . . . . 1.45 109.288 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.91 -47.17 69.52 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.926 -0.579 . . . . 0.63 110.894 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.52 -51.38 65.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.084 . . . . 1.34 110.7 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 54' ' ' LEU . 3.0 mm? -61.41 -40.11 93.19 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.563 -0.855 . . . . 1.56 110.023 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -59.7 -41.59 91.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 1.19 110.354 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -66.05 -42.74 89.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.134 -0.979 . . . . 0.72 110.457 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.8 mt -59.89 -39.76 80.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.352 -0.843 . . . . 0.62 110.705 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -49.93 -41.92 47.29 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.09 -1.006 . . . . 1.05 110.87 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -70.21 -38.17 75.23 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.143 -0.973 . . . . 0.64 110.039 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.4 -38.88 88.66 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.721 -1.192 . . . . 1.73 108.945 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.16 72.24 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.52 0.676 . . . . 0.56 109.609 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.24 -33.37 20.46 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.103 -1.046 . . . . 0.69 111.055 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -80.6 -26.83 37.59 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.083 -1.245 . . . . 1.48 111.202 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 m -85.71 -48.61 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.579 -0.701 . . . . 0.98 110.856 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -107.48 -17.99 13.97 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 113.229 0.826 . . . . 1.16 113.229 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.13 155.72 11.48 Favored Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.329 -0.857 . . . . 0.85 112.325 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -50.65 -22.56 2.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.882 -0.776 . . . . 3.86 112.305 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.61 -36.18 71.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 2.35 111.349 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -80.98 -22.39 39.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.853 -1.154 . . . . 1.67 111.935 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -58.87 -33.53 70.58 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.957 -1.09 . . . . 1.45 111.2 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.95 -41.71 83.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 0.61 110.816 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.1 mt -66.65 -44.75 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.86 -1.15 . . . . 0.65 110.125 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -70.24 -31.11 68.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 0.66 110.382 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -61.04 -39.76 91.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.316 -0.865 . . . . 1.19 109.754 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.04 -39.95 96.72 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 120.177 -1.011 . . . . 0.53 110.611 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -59.73 -45.39 92.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -1.092 . . . . 1.27 110.621 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.0 mt -60.45 -39.03 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.411 -0.806 . . . . 0.54 110.545 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.9 ttt -59.61 -39.37 84.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 1.74 110.503 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.14 -49.65 77.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.035 -1.04 . . . . 0.55 109.801 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.86 -39.82 95.1 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.571 0.701 . . . . 0.47 110.687 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -85.31 6.91 24.24 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.074 0.768 . . . . 1.42 113.074 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -69.28 118.1 11.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.697 -1.252 . . . . 1.27 109.074 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.35 -16.9 64.07 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.627 0.727 . . . . 1.35 110.901 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.36 -46.33 41.25 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.358 -0.937 . . . . 2.22 109.966 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -66.2 -38.52 88.19 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.664 -0.815 . . . . 0.62 110.273 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -58.8 -46.1 88.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.5 -0.75 . . . . 1.29 110.903 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -62.73 -37.84 88.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.909 . . . . 1.52 110.545 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.51 -48.65 66.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.013 -1.055 . . . . 1.3 110.653 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.8 mt -57.5 -43.05 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.218 -0.926 . . . . 0.61 110.402 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.9 mt -60.62 -43.31 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.737 -0.602 . . . . 0.78 110.389 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.45 -42.69 99.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.326 -0.859 . . . . 0.82 110.67 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.57 -42.5 98.93 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.16 -0.963 . . . . 0.8 110.537 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.43 -44.62 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 0.77 110.537 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -84.41 -35.16 23.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.398 -0.814 . . . . 2.12 111.713 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 91' ' ' ALA . 51.4 t0 -80.97 -45.39 16.73 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.134 -0.979 . . . . 1.51 111.79 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -101.03 9.55 42.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.245 -0.909 . . . . 1.98 112.45 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.5 m80 49.79 51.67 16.09 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.27 -0.894 . . . . 1.32 112.023 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 85.4 mtp -104.11 154.76 19.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.0 -0.741 . . . . 1.38 109.0 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.412 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 46.4 p -72.6 160.39 32.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.67 110.208 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.46 91.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.52 110.81 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 23.5 p-10 -69.86 -43.64 71.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.9 -1.125 . . . . 2.25 110.427 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.4 -47.6 72.76 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.498 -0.881 . . . . 0.64 111.172 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.12 91.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.359 -0.838 . . . . 0.56 110.075 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.74 96.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.556 -0.715 . . . . 0.46 110.482 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -61.49 -37.72 84.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.191 -0.943 . . . . 1.32 110.892 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -56.92 -49.77 74.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.79 . . . . 1.3 110.788 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.8 t -60.28 -44.48 95.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.922 -1.111 . . . . 0.61 110.33 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.14 -34.53 60.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.562 -0.711 . . . . 0.65 110.37 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -58.5 -40.28 82.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.979 -1.076 . . . . 2.11 110.875 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.87 -34.42 13.23 Favored Glycine 0 N--CA 1.498 2.775 0 C-N-CA 119.236 -1.459 . . . . 0.83 112.174 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -62.2 -41.25 98.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.711 -1.464 . . . . 1.28 109.879 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.94 -51.39 22.3 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.529 -0.732 . . . . 0.89 110.547 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.9 m -60.55 -37.51 81.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 1.87 110.76 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.25 97.67 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.552 -0.718 . . . . 1.05 110.523 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.85 -29.81 70.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.908 -1.12 . . . . 1.02 111.156 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -65.94 -21.02 66.4 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.286 -0.884 . . . . 2.04 111.121 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -71.94 -15.01 62.07 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.167 -0.958 . . . . 1.73 111.012 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 123' ' ' LEU . 55.1 mt -84.6 147.16 27.14 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.193 -0.669 . . . . 1.37 109.193 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 6.6 t0 -100.66 38.41 1.53 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.132 -0.98 . . . . 2.88 112.083 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -113.03 140.08 48.13 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.173 -0.954 . . . . 1.58 108.75 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 27.8 mp0 -58.28 -39.37 79.1 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.358 -0.839 . . . . 3.04 110.92 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -71.82 -52.51 17.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.534 -1.354 . . . . 0.9 110.631 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 118' ' ' LEU . 18.9 mt -60.94 -41.7 96.76 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 1.06 110.658 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -63.42 -49.64 72.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.818 -1.176 . . . . 2.18 109.582 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.82 -30.26 69.98 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.328 -0.949 . . . . 2.15 109.446 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.588 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -61.09 -30.1 70.15 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.924 0.868 . . . . 2.33 108.732 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.44 -50.41 72.9 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.78 0.8 . . . . 0.82 109.432 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.01 -43.89 81.74 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.714 0.769 . . . . 0.85 110.093 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -63.72 -34.0 76.9 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.475 0.655 . . . . 1.39 110.255 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 126' ' ' ARG . 21.1 t -69.01 -41.75 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.56 109.91 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -58.51 -37.34 75.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.886 -1.133 . . . . 3.12 109.584 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -58.79 -39.81 82.19 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.418 0.628 . . . . 1.28 110.464 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.19 -40.11 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.994 -1.066 . . . . 0.49 109.778 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.85 -47.56 89.42 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.343 -1.103 . . . . 0.46 110.343 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -58.27 -40.58 82.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -1.14 . . . . 2.71 110.26 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -64.88 -43.66 92.19 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.403 -0.919 . . . . 2.14 109.359 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.0 tp -59.66 -43.58 93.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.571 -0.705 . . . . 1.05 109.64 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 20.7 mt -60.09 -38.66 83.61 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.322 -0.861 . . . . 0.52 110.576 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -39.84 84.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.063 . . . . 2.35 110.776 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -75.77 -40.64 54.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.794 . . . . 1.39 110.536 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.17 -40.36 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.68 109.572 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.45 -8.96 49.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.393 -0.817 . . . . 0.83 112.224 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.04 18.62 76.42 Favored Glycine 0 N--CA 1.482 1.713 0 C-N-CA 119.689 -1.243 . . . . 0.91 112.617 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.73 144.43 57.25 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.594 -0.945 . . . . 0.95 109.08 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -66.35 149.86 49.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.75 . . . . 2.43 109.818 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.44 145.88 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.678 -0.86 . . . . 1.1 108.678 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.1 mm -76.93 118.84 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.942 -1.099 . . . . 1.58 108.555 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -97.8 98.12 9.56 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.487 -1.672 . . . . 1.62 106.487 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.5 mt -77.13 -17.6 58.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.324 -0.86 . . . . 0.8 111.726 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -80.31 1.11 30.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 1.56 112.476 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.75 28.31 4.81 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.364 -0.835 . . . . 0.84 112.284 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 7.9 mt -73.49 140.08 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.82 109.745 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -111.45 -21.67 11.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.605 0.717 . . . . 2.31 112.231 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -118.14 139.96 50.49 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.369 -0.975 . . . . 1.54 108.369 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.46 125.97 28.44 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.361 -0.977 . . . . 1.38 108.361 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.441 HG12 ' HZ3' ' A' ' 15' ' ' LYS . 30.0 m -146.07 173.94 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 0.69 109.258 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.4 mt -87.96 145.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.683 -0.858 . . . . 0.53 108.683 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.7 tp -95.44 123.81 39.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.916 -1.115 . . . . 0.64 108.736 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.6 t -125.04 128.69 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.279 -1.378 . . . . 0.67 107.279 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.67 154.84 18.7 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.941 -1.1 . . . . 0.78 108.537 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.08 81.93 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.409 -1.432 . . . . 1.0 109.375 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.1 t0 -171.01 153.42 3.8 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.511 -0.922 . . . . 2.42 108.511 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 34.8 mt -114.69 144.59 43.21 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.298 -0.876 . . . . 0.75 109.343 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.9 p -91.03 149.62 40.35 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.741 -1.224 . . . . 0.78 108.826 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.58 -43.27 14.33 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.469 1.446 . . . . 0.67 113.527 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.7 m -61.88 -45.76 92.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.926 -1.109 . . . . 0.7 110.132 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.88 -41.66 97.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.472 -0.768 . . . . 1.21 110.385 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.7 p -67.22 -38.41 85.21 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.453 0.644 . . . . 0.6 110.48 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.95 -37.25 86.3 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.467 -0.771 . . . . 0.62 110.606 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -93.73 -1.97 54.42 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.122 -0.986 . . . . 1.16 112.683 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.55 149.62 34.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.621 -0.881 . . . . 0.73 108.621 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -94.86 109.81 21.76 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.772 -1.566 . . . . 2.24 106.772 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.39 -22.01 64.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.93 -0.481 . . . . 1.43 111.745 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -83.72 -17.34 41.63 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.299 -0.876 . . . . 2.15 112.797 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -101.19 -5.65 25.3 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.196 -0.94 . . . . 2.04 113.229 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.643 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.1 t -108.3 129.99 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.92 -1.141 . . . . 0.55 107.92 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.5 tp -86.28 -3.78 59.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.146 -0.971 . . . . 1.63 111.964 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.643 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.27 166.61 28.59 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.947 -1.661 . . . . 0.47 108.947 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.73 130.01 53.13 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.748 -1.204 . . . . 0.54 107.748 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.413 HG22 HG21 ' A' ' 205' ' ' THR . 92.0 mt -131.07 124.84 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.305 -1.739 . . . . 0.69 106.305 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 205' ' ' THR . 41.7 p -140.92 170.66 15.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.786 -1.196 . . . . 0.82 110.595 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 48.8 t0 -108.38 66.73 0.65 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.743 -0.662 . . . . 2.37 109.375 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.08 142.67 36.38 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.363 -0.835 . . . . 1.11 109.045 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.34 2.36 37.72 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.377 -0.916 . . . . 1.67 113.284 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 86.7 -20.02 25.97 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 120.988 -1.301 . . . . 1.54 114.864 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -58.94 -40.59 85.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.035 -1.274 . . . . 4.48 110.177 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.7 p -149.31 58.27 1.02 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.53 -0.731 . . . . 2.63 110.135 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.7 p -87.17 101.01 13.08 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.46 -1.311 . . . . 1.69 107.46 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -62.7 -36.34 82.65 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.411 -0.806 . . . . 1.07 109.604 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 59.0 m -58.65 -38.94 79.21 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.571 -0.706 . . . . 1.58 110.144 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 64.7 p -58.24 -37.98 75.98 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.196 -0.94 . . . . 1.6 109.73 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.8 mm -60.15 -40.0 82.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.479 -0.763 . . . . 1.45 110.287 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 64.5 mtp -63.82 -42.37 97.67 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.084 -1.01 . . . . 1.05 109.578 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.47 -48.45 81.59 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.574 -0.739 . . . . 0.72 110.92 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 195' ' ' ARG . 36.9 mtt-85 -61.89 -44.11 97.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 3.05 110.608 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.0 m -68.62 -40.81 80.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.89 110.165 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.38 -8.53 47.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.456 -0.778 . . . . 0.78 112.526 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.0 mt-10 55.25 13.79 0.93 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.067 1.136 . . . . 1.45 114.067 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 50.2 mt -71.09 164.46 56.63 Favored Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 108.497 -0.927 . . . . 0.67 108.497 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.87 140.46 38.54 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 121.598 1.532 . . . . 0.64 110.468 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.08 168.34 24.57 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.019 -1.675 . . . . 0.67 109.998 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.5 mt -147.7 152.55 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.866 -1.161 . . . . 0.69 107.866 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.6 m -135.12 -27.63 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 120.968 -1.082 . . . . 0.85 111.409 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.22 46.54 3.22 Favored Glycine 0 N--CA 1.489 2.207 0 O-C-N 120.944 -1.098 . . . . 0.92 111.75 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 181' ' ' THR . 69.3 p -62.9 -16.42 58.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.359 -1.083 . . . . 0.95 111.702 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.459 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 76.03 -94.9 1.02 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.948 -1.261 . . . . 1.04 109.948 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.2 m -129.97 27.6 5.14 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.478 -1.013 . . . . 1.57 112.38 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.2 t -57.96 -40.23 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.536 -1.353 . . . . 0.84 110.536 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.1 p -58.68 -18.88 34.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.923 -1.111 . . . . 0.99 111.77 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.8 t -94.96 -0.59 53.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.412 -0.805 . . . . 1.7 112.227 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -129.86 0.44 4.82 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.698 0.629 . . . . 2.2 112.698 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t -120.09 150.54 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.934 0.873 . . . . 0.84 109.806 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.67 154.74 36.43 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.222 -1.029 . . . . 2.2 108.222 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.9 p-10 -51.38 145.6 8.21 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.103 -0.998 . . . . 2.28 110.172 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.9 t0 81.73 -7.0 1.45 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.264 1.209 . . . . 2.35 114.264 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 19.7 t0 -60.47 145.24 49.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.773 -1.205 . . . . 1.97 108.478 177.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.438 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 14.2 t80 -88.32 123.07 32.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.939 -1.134 . . . . 2.65 107.939 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.488 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 49.6 mt -128.26 149.86 50.3 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.553 -0.717 . . . . 0.63 109.607 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.13 123.0 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.309 -1.737 . . . . 0.62 106.309 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.0 tp -100.86 112.79 25.29 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.927 -1.879 . . . . 0.64 105.927 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 223' ' ' VAL . 41.6 p30 -93.35 -22.85 18.7 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.881 -1.137 . . . . 2.05 112.314 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.91 16.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.996 0.739 . . . . 0.84 112.996 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.598 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.1 t -106.94 -57.75 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.057 -1.027 . . . . 1.02 109.359 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -93.62 9.08 38.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.421 1.105 . . . . 2.51 110.41 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 60.7 t30 61.78 52.56 3.45 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.89 -1.05 . . . . 1.54 112.177 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.443 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 89.6 mt-30 -146.79 150.16 34.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.357 1.075 . . . . 1.95 109.827 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -115.63 139.86 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.864 -1.161 . . . . 0.71 107.864 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -104.21 131.67 51.27 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 108.145 -1.057 . . . . 1.01 108.145 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.1 t -110.31 130.38 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.898 -0.778 . . . . 0.82 108.898 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.458 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 8.9 t-20 53.95 48.12 4.47 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 113.393 0.886 . . . . 1.54 113.393 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 56.2 Cg_endo -68.99 148.51 70.24 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.128 1.886 . . . . 0.94 111.216 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 43.2 p -74.61 162.84 28.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.807 -1.183 . . . . 1.8 110.172 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -59.8 -36.78 77.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 2.73 110.66 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -59.9 -39.42 85.32 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.28 -0.888 . . . . 3.17 110.952 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 87.4 t -70.02 -38.46 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 1.34 110.075 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.518 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 96.1 mt -59.69 -47.5 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.552 -0.717 . . . . 1.2 110.377 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -60.01 -39.64 86.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 2.7 110.792 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -63.06 -45.99 89.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.363 -0.836 . . . . 2.59 110.74 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 72.7 mtp -70.99 -35.69 72.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 1.38 110.647 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.552 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -57.1 -40.19 76.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.899 . . . . 2.84 110.377 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.29 -54.43 7.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.273 -0.892 . . . . 1.88 110.673 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.473 ' O ' HG23 ' A' ' 246' ' ' VAL . 85.2 t -59.53 -42.13 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.351 -0.843 . . . . 2.4 111.092 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -59.17 -49.95 75.92 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.963 -1.086 . . . . 3.52 111.103 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -66.78 -39.12 87.69 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.128 -0.982 . . . . 1.88 110.868 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -61.04 -29.74 69.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.811 -1.181 . . . . 3.01 110.377 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 242' ' ' VAL . 49.8 t -61.13 -43.3 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.423 -0.911 . . . . 2.45 109.488 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.62 92.85 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.426 -0.796 . . . . 2.75 110.132 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 p -69.95 -33.0 71.55 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.4 -0.812 . . . . 3.16 110.477 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -62.68 -31.02 71.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 3.57 110.396 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -60.14 -34.6 73.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.487 -0.758 . . . . 4.3 110.47 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.03 -29.25 69.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.922 . . . . 4.45 110.91 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -70.8 -10.25 59.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.203 -0.935 . . . . 5.97 112.242 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 46.5 tp -63.55 -29.69 70.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.901 -1.125 . . . . 6.18 110.865 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.459 ' O ' ' NZ ' ' A' ' 257' ' ' LYS . . . -68.78 -10.34 56.09 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 6.66 111.947 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -83.11 9.9 9.37 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.575 -0.703 . . . . 8.2 112.082 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 13.2 tp -79.67 -4.04 49.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.024 . . . . 8.07 112.164 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 254' ' ' ALA . 31.7 mtmm -80.21 -0.52 36.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.16 -0.963 . . . . 9.45 112.104 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -93.45 10.7 31.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.43 -0.794 . . . . 10.12 112.474 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 259' ' ' ARG . 27.2 ttt-85 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 11.49 109.222 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.072 -0.714 . . . . 3.07 109.072 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.4 mt 41.85 69.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.203 -0.936 . . . . 1.07 112.116 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -96.39 111.98 23.88 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.829 -1.545 . . . . 1.24 106.829 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.92 -154.13 29.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.66 -1.376 . . . . 1.01 109.66 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 5' ' ' ILE . 82.2 mt -95.03 -0.62 10.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.321 -1.105 . . . . 1.11 112.273 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 49.63 100.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.939 -1.101 . . . . 0.99 112.511 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.18 -42.19 12.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.144 -0.972 . . . . 0.85 111.983 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 m -145.0 142.78 18.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.875 -1.141 . . . . 1.38 108.007 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.53 148.48 26.25 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.198 1.932 . . . . 0.94 112.357 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.935 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.38 173.22 21.04 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.053 -1.619 . . . . 0.81 109.053 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.42 HD12 ' HG2' ' A' ' 243' ' ' GLN . 83.0 mt -129.52 137.07 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -1.222 . . . . 0.83 108.272 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.95 154.65 46.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 0.53 109.173 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.0 m-85 -121.03 140.46 51.9 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.437 -0.949 . . . . 0.77 108.437 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.45 162.56 28.33 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.311 -1.9 . . . . 0.51 110.32 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -78.45 158.77 28.57 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.527 -0.916 . . . . 1.9 108.527 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.72 127.45 34.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.003 -1.061 . . . . 0.66 108.539 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.1 tp -103.77 103.5 13.4 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 104.976 -2.231 . . . . 0.83 104.976 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.1 tp -91.46 129.9 37.38 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.335 -1.357 . . . . 0.86 107.335 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.07 119.88 39.39 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.443 -1.317 . . . . 0.92 107.443 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -110.17 132.34 54.26 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.503 -1.295 . . . . 2.03 107.503 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -128.96 155.24 45.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.336 -0.852 . . . . 2.66 109.529 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -85.15 137.76 32.82 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.816 -1.179 . . . . 2.32 107.816 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.2 149.71 49.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.033 -1.042 . . . . 2.11 108.991 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -92.42 128.88 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.293 -1.003 . . . . 0.73 108.293 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.75 130.42 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.941 -1.133 . . . . 0.87 107.941 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.9 mt -96.45 139.35 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.545 -0.909 . . . . 0.81 108.545 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.25 120.6 32.3 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.298 -1.371 . . . . 1.34 107.298 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -96.3 16.84 17.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.811 . . . . 2.89 112.485 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -67.74 143.67 55.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.862 -1.149 . . . . 2.09 108.88 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -88.87 132.28 34.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.134 -1.062 . . . . 2.19 108.134 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.1 pt -98.97 167.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.399 -0.813 . . . . 0.75 110.342 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.9 p -93.1 162.44 14.03 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.641 0.734 . . . . 0.91 109.766 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.87 -17.31 6.1 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.111 -0.993 . . . . 0.93 112.722 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -69.89 -32.65 71.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.012 . . . . 2.28 111.094 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -86.27 0.95 52.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.989 -1.069 . . . . 1.45 112.431 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 t -56.27 -44.6 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.466 -0.771 . . . . 0.81 110.46 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -58.08 -40.77 81.9 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.205 -0.935 . . . . 1.54 110.327 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -64.14 -45.0 90.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.653 -0.655 . . . . 2.36 111.604 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.7 -42.8 99.43 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.812 -1.18 . . . . 1.31 111.068 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.27 -41.88 88.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.162 -0.961 . . . . 0.82 110.228 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -63.13 -45.88 89.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.042 -1.036 . . . . 1.5 110.119 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.405 HH11 ' HG2' ' A' ' 42' ' ' ARG . 54.4 mtt-85 -61.92 -42.3 98.92 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.456 -0.897 . . . . 2.23 109.957 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -71.45 -52.86 16.15 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.4 -0.92 . . . . 0.85 110.165 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.44 -49.28 78.21 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.241 -0.984 . . . . 0.91 110.647 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.1 t -69.97 -45.1 68.09 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.552 0.692 . . . . 0.9 110.346 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.98 -45.71 86.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.295 -1.522 . . . . 0.69 109.295 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -57.37 -31.44 65.78 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.855 0.836 . . . . 2.88 109.775 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.11 -42.57 86.02 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.542 0.687 . . . . 0.85 110.097 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -75.82 -38.61 57.97 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.268 -0.895 . . . . 2.35 110.067 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.76 -38.69 82.51 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.148 -0.97 . . . . 0.65 109.946 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 t -61.02 -38.88 87.64 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.897 0.856 . . . . 1.45 109.422 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.64 -47.57 75.13 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.959 -0.564 . . . . 0.63 110.289 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.9 -49.76 74.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.878 -1.139 . . . . 1.34 110.208 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.66 -39.32 90.96 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.258 -0.901 . . . . 1.56 110.016 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -59.66 -41.26 90.21 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.218 -0.593 . . . . 1.19 110.311 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.9 m -67.05 -44.21 80.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.225 -0.922 . . . . 0.72 110.297 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -59.8 -34.82 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.652 -0.655 . . . . 0.62 110.873 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -51.57 -44.64 62.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.92 -1.112 . . . . 1.05 110.713 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -68.97 -34.63 75.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.042 -1.036 . . . . 0.64 110.124 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -63.76 -39.74 95.01 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.812 -1.155 . . . . 1.73 109.241 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.83 -31.12 72.2 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.163 -0.615 . . . . 0.56 109.88 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.1 -36.27 13.4 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.784 -1.198 . . . . 0.69 110.81 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.31 -24.26 42.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.945 -1.327 . . . . 1.48 110.242 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.8 m -84.55 -51.14 7.1 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.339 -0.85 . . . . 0.98 110.995 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -106.68 -19.93 13.51 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.102 -0.998 . . . . 1.16 113.286 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.61 165.55 14.05 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 121.277 -0.889 . . . . 0.85 112.211 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -53.74 -24.03 13.65 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 112.583 0.586 . . . . 3.86 112.583 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.86 -36.74 70.4 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.017 -1.052 . . . . 2.35 111.653 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -84.92 -15.35 44.77 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.301 -1.499 . . . . 1.67 112.913 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.88 -35.62 77.1 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.047 -1.033 . . . . 1.45 110.811 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.51 -39.24 87.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.357 -0.839 . . . . 0.61 111.222 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 72' ' ' ILE . 14.9 mt -66.6 -48.96 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.971 -1.081 . . . . 0.65 110.564 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -69.91 -30.37 67.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.451 -0.781 . . . . 0.66 110.411 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.86 -38.23 87.48 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.604 -0.839 . . . . 1.19 109.823 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.21 -38.66 92.08 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 110.592 -1.003 . . . . 0.53 110.592 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -60.13 -40.39 89.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 1.27 110.797 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.85 -44.74 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.93 -1.106 . . . . 0.54 110.118 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.4 ttp -60.08 -38.16 82.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -0.891 . . . . 1.74 110.11 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 tp -60.31 -49.94 75.6 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.362 -0.836 . . . . 0.55 110.686 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.38 -40.08 89.58 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.923 -0.711 . . . . 0.47 110.333 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -86.21 5.47 34.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.373 -0.829 . . . . 1.42 112.386 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.18 119.7 11.34 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.856 -1.152 . . . . 1.27 108.924 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.03 -15.65 63.22 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.645 0.736 . . . . 1.35 110.977 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -71.68 -49.55 38.69 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.018 -1.073 . . . . 2.22 110.037 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.84 -38.62 88.9 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.169 -1.012 . . . . 0.62 110.097 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.7 -46.18 89.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 1.29 110.777 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -60.05 -39.54 86.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.082 -1.011 . . . . 1.52 110.578 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -65.63 -47.9 74.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.954 -1.092 . . . . 1.3 110.19 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.2 mt -57.9 -43.06 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.558 -0.714 . . . . 0.61 110.158 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.68 -40.89 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.162 0.506 . . . . 0.78 110.547 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.72 -40.59 88.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.82 110.387 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.52 -45.5 90.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.8 110.097 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.0 mt -62.57 -43.42 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.365 -0.834 . . . . 0.77 110.193 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -82.64 -38.4 23.57 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.37 -0.831 . . . . 2.12 111.932 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 91' ' ' ALA . 49.4 t0 -80.83 -43.28 20.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.909 -1.119 . . . . 1.51 111.882 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.55 8.1 35.35 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.374 -0.829 . . . . 1.98 112.777 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.0 m170 52.46 51.43 16.18 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.868 -1.145 . . . . 1.32 111.58 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.2 mtt -105.12 152.17 23.12 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.37 -0.831 . . . . 1.38 109.265 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.4 p -71.3 161.68 30.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.374 -0.829 . . . . 0.67 110.121 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.18 88.92 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.241 -0.912 . . . . 0.52 110.254 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.557 ' OD2' HD21 ' A' ' 142' ' ' LEU . 89.8 m-20 -68.08 -41.1 82.39 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.212 -0.93 . . . . 2.25 110.34 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.66 -49.83 49.91 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.158 -0.964 . . . . 0.64 111.21 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.38 92.22 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.383 -0.823 . . . . 0.56 110.407 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.77 95.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.65 -0.656 . . . . 0.46 110.894 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -61.49 -40.05 93.16 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.396 -0.815 . . . . 1.32 110.835 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -57.84 -49.57 76.24 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.669 -1.27 . . . . 1.3 111.347 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.7 t -61.11 -44.82 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.95 -1.094 . . . . 0.61 110.161 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 mm -62.78 -33.52 60.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.765 0.793 . . . . 0.65 109.958 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -55.46 -40.89 72.18 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.519 -0.738 . . . . 2.11 110.87 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.29 -32.49 16.59 Favored Glycine 0 N--CA 1.498 2.825 0 C-N-CA 118.98 -1.581 . . . . 0.83 112.571 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -60.34 -41.59 93.92 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.302 -1.705 . . . . 1.28 110.204 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.92 -51.62 17.82 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.328 -0.857 . . . . 0.89 110.966 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.8 p -62.41 -39.4 93.13 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.265 -0.897 . . . . 1.87 110.709 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.72 96.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.404 -0.81 . . . . 1.05 110.913 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 43.8 mt -65.29 -30.89 71.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.891 -1.131 . . . . 1.02 110.5 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.14 -22.33 66.37 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.928 -1.108 . . . . 2.04 111.205 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -71.34 -12.47 61.45 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.765 0.793 . . . . 1.73 110.956 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.85 146.06 27.5 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.874 -0.787 . . . . 1.37 108.874 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -100.3 35.36 2.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.15 -0.969 . . . . 2.88 112.112 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -112.58 139.59 48.04 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 108.269 -1.011 . . . . 1.58 108.269 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.01 -37.64 80.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.429 -0.794 . . . . 3.04 110.772 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -73.22 -49.0 30.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.794 -1.191 . . . . 0.9 110.215 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.2 mt -63.2 -40.67 98.14 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.616 -1.234 . . . . 1.06 109.738 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -60.96 -47.63 85.55 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.788 -1.195 . . . . 2.18 110.097 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.27 -31.4 70.19 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.759 -0.777 . . . . 2.15 109.556 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.512 ' HG2' HH11 ' A' ' 126' ' ' ARG . 9.2 ttt-85 -62.14 -29.67 70.5 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.008 0.908 . . . . 2.33 108.975 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.63 -49.83 75.93 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.054 0.93 . . . . 0.82 109.592 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -41.41 78.83 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.59 0.71 . . . . 0.85 110.415 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.87 -38.49 91.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.559 -0.713 . . . . 1.39 110.25 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 126' ' ' ARG . 46.4 t -69.6 -39.77 78.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.522 -0.736 . . . . 0.56 110.648 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -58.68 -39.77 81.64 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.3 -1.36 . . . . 3.12 110.029 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -59.67 -39.75 85.5 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.166 0.508 . . . . 1.28 110.823 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.99 -39.18 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.336 -0.852 . . . . 0.49 110.625 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -64.71 -44.26 95.12 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.791 -1.195 . . . . 0.46 110.909 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -58.14 -40.61 81.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.271 . . . . 2.71 110.575 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.401 HH21 ' HB2' ' A' ' 166' ' ' SER . 63.0 mtt-85 -61.36 -42.68 99.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.312 -0.867 . . . . 2.14 110.111 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 31.3 tp -60.29 -43.33 96.35 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.439 -0.904 . . . . 1.05 109.506 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.25 -45.92 91.6 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.46 0.648 . . . . 0.52 110.197 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -60.98 -34.86 75.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.461 -0.774 . . . . 2.35 111.08 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -75.81 -41.73 51.92 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.074 -1.016 . . . . 1.39 110.978 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.514 HG21 ' OD1' ' A' ' 101' ' ' ASP . 95.2 mt -62.46 -39.02 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.789 -1.194 . . . . 0.68 110.594 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.557 HD21 ' OD2' ' A' ' 101' ' ' ASP . 61.5 mt -84.64 -8.95 58.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.339 -0.851 . . . . 0.83 111.65 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.55 25.62 67.39 Favored Glycine 0 N--CA 1.479 1.557 0 C-N-CA 119.772 -1.204 . . . . 0.91 113.237 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.74 142.04 58.57 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.727 -0.866 . . . . 0.95 109.33 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -67.94 147.74 52.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 2.43 108.907 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 72.9 mt -107.03 138.13 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.219 -1.03 . . . . 1.1 108.219 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 18.2 mm -78.76 133.98 28.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.25 -0.906 . . . . 1.58 108.862 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -94.51 94.74 8.39 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.657 -1.608 . . . . 1.62 106.657 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 67.1 mt -73.53 -24.35 60.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.574 -0.704 . . . . 0.8 110.865 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.9 m -81.48 7.17 12.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.406 -0.809 . . . . 1.56 112.304 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.42 18.05 17.45 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.792 . . . . 0.84 112.151 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.5 mt -74.73 140.23 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.82 109.807 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -118.97 -12.34 9.56 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.946 0.879 . . . . 2.31 112.427 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -112.7 147.74 36.18 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.728 -0.841 . . . . 1.54 108.728 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -78.27 124.13 27.73 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.188 -1.041 . . . . 1.38 108.188 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.8 m -147.64 172.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.55 -0.719 . . . . 0.69 109.3 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.6 mt -90.74 146.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.535 -0.913 . . . . 0.53 108.535 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.2 tp -95.9 123.79 39.64 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.093 0.949 . . . . 0.64 108.788 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.5 t -124.64 129.96 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.892 -1.151 . . . . 0.67 107.892 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.99 152.87 19.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.006 -1.059 . . . . 0.78 108.835 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.92 -33.76 73.64 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.561 -1.337 . . . . 1.0 109.476 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -171.8 144.74 1.83 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.301 -0.629 . . . . 2.42 109.301 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 75.8 mt -118.39 135.94 54.04 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.057 -1.09 . . . . 0.75 108.057 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.0 p -92.9 150.09 38.81 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.931 -1.105 . . . . 0.78 108.529 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -39.18 -45.37 2.87 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 122.252 1.968 . . . . 0.67 113.781 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.401 ' HB2' HH21 ' A' ' 136' ' ' ARG . 61.2 m -58.46 -47.56 83.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.7 110.409 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.18 -38.4 90.9 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.076 -1.015 . . . . 1.21 110.515 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.3 p -69.3 -39.64 78.17 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.545 -0.722 . . . . 0.6 110.5 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.83 -37.58 79.63 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.262 -0.575 . . . . 0.62 110.66 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -91.42 -0.16 57.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.05 -1.031 . . . . 1.16 112.271 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.6 tp -63.88 150.33 45.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.751 -0.593 . . . . 0.73 109.787 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -95.16 113.79 25.52 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.22 -1.4 . . . . 2.24 107.22 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 36.7 mt -71.79 -17.96 62.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.696 -0.627 . . . . 1.43 111.778 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.91 -21.31 31.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 2.15 112.381 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -101.32 -4.99 26.03 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.907 -1.12 . . . . 2.04 113.436 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.7 t -114.2 128.91 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 107.533 -1.284 . . . . 0.55 107.533 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.2 tp -93.69 -4.89 49.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.507 -0.745 . . . . 1.63 112.609 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.41 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -175.49 170.04 42.95 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.021 -1.632 . . . . 0.47 109.021 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -128.11 128.88 45.68 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.484 -1.302 . . . . 0.54 107.484 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 79.3 mt -131.68 125.13 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 106.413 -1.699 . . . . 0.69 106.413 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 205' ' ' THR . 20.6 p -140.63 172.05 13.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.86 -1.15 . . . . 0.82 110.213 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -98.1 39.33 1.24 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.378 0.608 . . . . 2.37 111.497 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -95.59 141.49 29.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.192 -0.942 . . . . 1.11 109.676 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.79 2.33 25.16 Favored Glycine 0 N--CA 1.487 2.036 0 C-N-CA 120.052 -1.07 . . . . 1.67 113.473 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 88.97 -9.23 77.54 Favored Glycine 0 N--CA 1.491 2.341 0 O-C-N 121.148 -1.207 . . . . 1.54 114.036 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.444 ' O ' ' OG1' ' A' ' 187' ' ' THR . 46.2 ttp180 -77.25 116.71 18.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.902 -1.352 . . . . 4.48 107.841 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 16.6 p 48.66 40.29 15.39 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.97 -1.081 . . . . 2.63 111.601 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 83.6 p -85.21 115.05 22.77 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.739 -1.208 . . . . 1.69 107.739 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -60.46 -31.43 70.44 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.07 -1.019 . . . . 1.07 110.608 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.3 p -57.21 -40.61 77.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 1.58 110.391 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.6 t -60.18 -37.25 79.62 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.123 -0.986 . . . . 1.6 109.948 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.4 mt -59.51 -40.13 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.287 -0.965 . . . . 1.45 110.497 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 38.5 mtp -64.56 -44.83 89.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.932 -1.105 . . . . 1.05 109.244 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.17 -44.7 94.83 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.554 -0.748 . . . . 0.72 111.212 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -61.23 -45.07 96.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.778 -1.202 . . . . 3.05 110.664 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.8 m -69.87 -38.98 76.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.036 -1.04 . . . . 0.89 110.766 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -91.75 -8.15 47.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.554 -0.716 . . . . 0.78 112.66 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.8 mt-10 54.14 9.31 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.937 1.088 . . . . 1.45 113.937 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.3 mt -70.08 150.19 96.18 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.621 -0.881 . . . . 0.67 108.621 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.8 144.06 94.27 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 121.146 1.231 . . . . 0.64 109.491 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.79 159.78 35.53 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.175 -1.41 . . . . 0.67 110.214 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.5 mt -147.46 150.2 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.071 -1.085 . . . . 0.69 108.071 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.0 m -135.02 -25.72 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.932 -1.105 . . . . 0.85 111.724 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.22 33.35 2.23 Favored Glycine 0 N--CA 1.488 2.151 0 O-C-N 121.022 -1.049 . . . . 0.92 113.306 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 181' ' ' THR . 2.7 p -60.63 -28.31 68.46 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.95 -1.323 . . . . 0.95 111.037 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.04 -90.67 1.3 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.96 -1.114 . . . . 1.04 110.621 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 27.8 m -123.5 27.13 7.55 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.147 -1.208 . . . . 1.57 112.984 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 68.2 t -57.41 -34.47 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.172 -1.58 . . . . 0.84 110.144 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.2 p -57.61 -23.46 51.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 0.99 111.964 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.2 p -92.88 2.77 56.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.968 -1.082 . . . . 1.7 111.928 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -128.32 1.88 5.71 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.808 0.67 . . . . 2.2 112.808 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.75 151.26 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 109.112 -0.699 . . . . 0.84 109.112 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -120.97 150.13 41.58 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.857 -0.794 . . . . 2.2 108.857 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 42.1 p-10 -52.16 143.59 14.06 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.008 -1.077 . . . . 2.28 110.278 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.4 m-20 78.3 -1.17 2.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.525 1.305 . . . . 2.35 114.525 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.53 144.03 52.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.861 -1.149 . . . . 1.97 108.307 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -89.31 112.96 24.16 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.331 -1.359 . . . . 2.65 107.331 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.493 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 48.7 mt -124.22 143.44 50.52 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.322 0.582 . . . . 0.63 109.645 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.3 mt -109.81 126.76 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 106.58 -1.637 . . . . 0.62 106.58 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 52.3 tp -100.64 119.4 38.51 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.118 -1.808 . . . . 0.64 106.118 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 223' ' ' VAL . 36.9 p-10 -93.67 -20.93 19.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.081 -1.012 . . . . 2.05 112.682 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.935 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.73 13.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.477 0.547 . . . . 0.84 112.477 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.624 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.1 t -109.89 -58.75 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.273 -0.892 . . . . 1.02 109.521 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -91.63 8.33 37.27 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.541 1.163 . . . . 2.51 110.852 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.0 t30 60.87 49.31 6.09 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.108 -0.951 . . . . 1.54 111.786 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -148.45 154.58 40.06 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.226 1.012 . . . . 1.95 109.746 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.4 t -116.45 141.04 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.576 -0.738 . . . . 0.71 109.181 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -101.16 134.94 43.43 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.327 -0.99 . . . . 1.01 108.327 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.28 130.77 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.614 -0.884 . . . . 0.82 108.614 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 51.23 58.31 16.6 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.31 -0.869 . . . . 1.54 112.867 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.93 150.19 60.65 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.387 2.058 . . . . 0.94 110.626 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.7 p -76.23 158.59 31.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.105 -0.997 . . . . 1.8 109.608 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -60.79 -39.35 88.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 2.73 110.993 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.39 -41.47 80.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.067 -1.021 . . . . 3.17 110.696 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.05 -39.31 77.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.806 -1.184 . . . . 1.34 110.075 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 71.0 mt -60.03 -49.45 83.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.387 -0.821 . . . . 1.2 110.883 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.92 -41.53 91.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.097 -1.002 . . . . 2.7 110.543 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -64.41 -44.35 91.52 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.717 -0.793 . . . . 2.59 110.285 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 84.6 mtp -72.4 -37.05 68.78 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.301 -0.874 . . . . 1.38 110.743 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.9 mmm-85 -57.57 -40.62 79.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.827 -1.17 . . . . 2.84 110.472 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.85 -56.11 5.36 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.267 -0.896 . . . . 1.88 110.634 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.27 -40.02 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.361 -0.837 . . . . 2.4 111.135 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.42 ' HG2' HD12 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -57.93 -50.17 74.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.67 -1.269 . . . . 3.52 111.083 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -64.66 -33.43 75.92 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.696 -0.801 . . . . 1.88 110.68 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -60.59 -31.24 70.4 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.348 -0.941 . . . . 3.01 109.817 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.14 -41.85 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.854 0.835 . . . . 2.45 109.835 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.37 89.73 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.679 0.752 . . . . 2.75 110.57 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.1 m -71.15 -34.32 70.87 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.628 -0.67 . . . . 3.16 110.849 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -66.39 -46.26 77.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.875 -1.141 . . . . 3.57 110.999 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -72.13 -28.92 63.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.005 -1.06 . . . . 4.3 111.422 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.92 71.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.423 -0.798 . . . . 4.45 111.236 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.58 -55.64 7.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.239 -0.913 . . . . 5.97 110.62 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.89 -26.87 62.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 6.18 111.793 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.71 -34.77 77.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.111 -0.993 . . . . 6.66 111.359 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -84.77 -14.04 49.4 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.727 -1.233 . . . . 8.2 113.003 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.2 0.27 56.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.85 -1.156 . . . . 8.07 112.194 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -84.18 -4.49 58.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.065 -1.022 . . . . 9.45 112.4 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -91.26 4.37 52.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.441 -0.787 . . . . 10.12 112.621 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 . . . . . 0 N--CA 1.496 1.825 0 N-CA-C 108.43 -0.952 . . . . 11.49 108.43 -179.184 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 mtt . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 108.949 -0.76 . . . . 3.07 108.949 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 79.2 mt -99.11 111.21 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.219 -1.4 . . . . 1.07 107.219 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 m -106.01 119.91 40.41 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.202 -1.407 . . . . 1.24 107.202 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.97 -153.85 24.45 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.414 -1.874 . . . . 1.01 108.414 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.9 mt -97.64 0.98 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -1.168 . . . . 1.11 112.38 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 49.89 93.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.985 -1.072 . . . . 0.99 111.985 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -89.38 -30.93 18.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.85 111.663 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -150.8 138.25 12.0 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.216 -0.927 . . . . 1.38 108.54 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.18 145.0 21.38 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.341 2.027 . . . . 0.94 112.533 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.911 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.42 177.92 25.69 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 109.084 -1.606 . . . . 0.81 109.084 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.5 mt -132.0 138.66 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.058 -1.26 . . . . 0.83 108.238 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HB1' ' CD2' ' A' ' 177' ' ' LEU . . . -140.37 155.5 46.74 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.233 -0.917 . . . . 0.53 109.09 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.537 ' CD2' ' NH1' ' A' ' 240' ' ' ARG . 25.4 m-85 -129.08 141.26 51.26 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.521 -0.918 . . . . 0.77 108.521 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.81 168.42 34.78 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 118.27 -1.919 . . . . 0.51 110.198 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -77.01 160.3 29.23 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.901 . . . . 1.9 109.846 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.84 121.49 26.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.691 -1.225 . . . . 0.66 107.691 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.4 tp -100.14 98.51 9.21 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.069 -1.826 . . . . 0.83 106.069 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 tp -90.74 134.71 34.22 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.662 -1.236 . . . . 0.86 107.662 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.0 mt -99.77 111.1 23.45 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.752 -1.573 . . . . 0.92 106.752 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -104.31 127.54 51.97 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.989 -1.486 . . . . 2.03 106.989 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.474 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 81.6 tt0 -129.41 144.21 51.15 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.941 -0.762 . . . . 2.66 108.941 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -80.89 136.01 36.0 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.823 -1.177 . . . . 2.32 107.823 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -65.81 149.83 49.54 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.516 -0.74 . . . . 2.11 109.264 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -92.21 130.87 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.843 -1.169 . . . . 0.73 107.843 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.65 129.81 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.153 -1.055 . . . . 0.87 108.153 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.2 mt -95.53 139.74 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.424 -0.798 . . . . 0.81 108.927 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -87.58 123.62 32.65 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.125 -1.065 . . . . 1.34 108.125 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -94.74 14.67 20.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.656 -0.652 . . . . 2.89 112.38 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -77.55 140.58 39.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.281 -0.887 . . . . 2.09 109.275 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -84.69 140.27 31.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.103 -0.998 . . . . 2.19 109.744 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -95.75 175.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.75 109.776 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -98.09 164.33 12.38 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.887 -0.597 . . . . 0.91 109.544 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.14 -23.41 21.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.268 -0.895 . . . . 0.93 112.029 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -68.88 -40.05 79.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.812 -1.18 . . . . 2.28 110.946 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -86.39 -6.2 58.99 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.289 -1.507 . . . . 1.45 112.189 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.19 -41.81 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.968 -1.083 . . . . 0.81 110.456 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -58.24 -39.42 79.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.003 -1.061 . . . . 1.54 110.936 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.2 -39.87 95.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.02 . . . . 2.36 110.967 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -58.96 -40.33 84.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.875 . . . . 1.31 110.724 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.25 -41.71 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.82 110.127 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.57 -44.58 93.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 1.5 109.58 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -62.43 -40.45 96.61 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.401 -0.92 . . . . 2.23 109.925 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.39 -52.84 12.37 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.801 0.81 . . . . 0.85 109.871 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.07 -48.84 80.06 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.255 -0.903 . . . . 0.91 109.96 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.2 t -68.21 -41.05 81.88 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.659 0.743 . . . . 0.9 109.831 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.95 -42.08 85.82 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.34 -1.504 . . . . 0.69 109.34 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.404 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 51.7 ttt180 -58.38 -32.77 68.91 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.689 0.756 . . . . 2.88 109.772 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.61 -50.21 72.66 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.375 0.607 . . . . 0.85 110.819 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -78.05 -38.64 43.99 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.306 -0.872 . . . . 2.35 110.44 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.16 87.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.395 -0.816 . . . . 0.65 110.209 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.5 m -60.45 -40.14 90.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.869 0.843 . . . . 1.45 109.497 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.41 78.1 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.15 -0.62 . . . . 0.63 110.072 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.16 -50.58 72.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 1.34 110.577 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.83 -39.17 93.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.019 . . . . 1.56 110.105 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -59.86 -40.93 90.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.807 -0.558 . . . . 1.19 110.958 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.8 m -64.27 -45.31 88.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.822 -1.174 . . . . 0.72 110.356 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.12 -34.64 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 0.62 110.984 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -52.97 -45.76 67.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.26 -0.9 . . . . 1.05 111.084 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.14 -37.71 81.36 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.148 -0.97 . . . . 0.64 110.182 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -61.35 -39.81 91.95 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.577 -1.249 . . . . 1.73 109.617 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.98 -32.3 73.45 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.625 -0.672 . . . . 0.56 110.558 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.04 -34.58 14.43 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.832 -1.175 . . . . 0.69 111.405 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -81.85 -25.75 34.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.567 -1.549 . . . . 1.48 111.373 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.4 m -86.69 -49.99 7.1 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.408 -0.807 . . . . 0.98 111.125 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.9 -5.25 19.83 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 113.909 1.078 . . . . 1.16 113.909 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.83 161.47 27.75 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.401 -0.904 . . . . 0.85 112.733 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -55.79 -18.88 9.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -1.065 . . . . 3.86 112.82 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -59.07 -40.66 85.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -0.973 . . . . 2.35 110.518 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -85.9 -23.9 26.83 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.213 -0.929 . . . . 1.67 111.465 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.65 -35.44 76.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.638 -0.664 . . . . 1.45 111.356 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.02 83.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.388 -0.82 . . . . 0.61 111.334 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.5 mt -62.02 -40.91 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.65 110.324 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -71.04 -30.29 66.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.302 -0.874 . . . . 0.66 110.546 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -60.91 -39.07 87.96 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.187 -0.945 . . . . 1.19 109.732 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.98 -39.58 93.25 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 110.098 -1.201 . . . . 0.53 110.098 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -59.82 -45.0 93.74 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.433 -1.04 . . . . 1.27 110.355 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.61 -40.91 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 0.54 110.401 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 26.3 ttt -60.14 -39.4 86.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.325 -0.859 . . . . 1.74 110.384 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.5 tp -57.84 -48.25 80.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.151 -0.968 . . . . 0.55 110.221 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.98 -41.76 92.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.239 -0.913 . . . . 0.47 110.413 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -88.13 10.4 19.44 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 112.899 0.703 . . . . 1.42 112.899 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.63 126.32 27.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.891 -1.131 . . . . 1.27 108.818 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.22 -18.72 65.35 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.871 0.843 . . . . 1.35 110.639 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -74.45 -54.99 6.48 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.491 0.662 . . . . 2.22 110.178 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.9 mt -61.1 -37.49 82.95 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.663 -0.648 . . . . 0.62 111.058 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.404 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 30.5 tt0 -60.05 -45.18 93.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 1.29 110.559 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.97 -38.46 91.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 1.52 110.685 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -68.26 -47.87 66.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.035 -1.041 . . . . 1.3 110.922 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.11 -42.48 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.093 -1.004 . . . . 0.61 110.04 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.4 mt -63.51 -43.0 98.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.485 -0.76 . . . . 0.78 110.505 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.29 -42.83 99.69 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.3 -0.875 . . . . 0.82 110.928 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.62 -45.63 93.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.974 -1.079 . . . . 0.8 110.544 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.8 mt -61.88 -43.65 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.041 -1.037 . . . . 0.77 110.339 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -84.75 -31.26 24.09 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.277 -0.89 . . . . 2.12 111.724 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 91' ' ' ALA . 60.6 t0 -82.47 -45.57 14.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.64 -1.287 . . . . 1.51 111.527 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -100.76 4.82 43.33 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.227 -0.92 . . . . 1.98 112.617 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 53.2 50.64 17.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 1.32 111.466 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.33 159.02 15.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.385 -0.822 . . . . 1.38 109.207 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.2 p -71.5 161.02 31.69 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.772 -0.58 . . . . 0.67 109.832 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.28 -45.04 92.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.033 -1.042 . . . . 0.52 110.56 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.591 ' OD2' HD21 ' A' ' 142' ' ' LEU . 91.2 m-20 -68.12 -37.04 80.67 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.226 -0.922 . . . . 2.25 110.121 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.54 -51.71 40.0 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.757 -0.777 . . . . 0.64 111.429 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.63 94.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.117 -0.989 . . . . 0.56 110.408 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.31 95.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.653 -0.654 . . . . 0.46 110.793 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -61.69 -37.87 85.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.124 -0.985 . . . . 1.32 111.496 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -59.23 -49.59 77.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.883 -1.136 . . . . 1.3 111.077 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.68 -45.72 97.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.437 -1.414 . . . . 0.61 110.214 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.1 mm -61.12 -34.76 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.638 -0.664 . . . . 0.65 110.403 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -58.44 -39.16 79.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.095 -1.003 . . . . 2.11 111.226 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.69 -41.3 7.8 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.947 -1.597 . . . . 0.83 112.853 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -60.57 -41.07 93.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.599 -1.53 . . . . 1.28 109.891 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.43 -52.65 20.75 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.399 0.619 . . . . 0.89 110.559 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.0 p -62.53 -36.44 82.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.462 -0.774 . . . . 1.87 110.453 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.3 97.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 1.05 110.722 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.19 -30.11 70.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.938 . . . . 1.02 110.855 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.58 -21.75 65.41 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.011 -1.056 . . . . 2.04 110.989 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -71.37 -14.3 62.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 1.73 111.462 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.401 HD13 HD13 ' A' ' 123' ' ' LEU . 16.2 mt -86.85 146.4 26.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.434 -0.791 . . . . 1.37 109.574 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -99.2 36.08 1.79 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.233 -0.917 . . . . 2.88 112.285 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -113.09 139.6 48.57 Favored 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 108.437 -0.949 . . . . 1.58 108.437 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -60.23 -38.46 83.47 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.329 -0.857 . . . . 3.04 110.89 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -70.23 -53.33 17.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.684 -1.26 . . . . 0.9 109.909 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.401 HD13 HD13 ' A' ' 118' ' ' LEU . 36.1 mt -62.79 -40.31 96.94 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.228 -0.92 . . . . 1.06 109.627 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.64 -50.49 66.88 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.828 0.823 . . . . 2.18 109.918 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.78 -29.11 70.46 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.753 -1.217 . . . . 2.15 109.921 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -61.66 -31.4 71.51 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.368 -0.933 . . . . 2.33 109.111 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.15 78.86 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.643 0.735 . . . . 0.82 109.815 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.61 -43.65 79.94 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.416 -0.914 . . . . 0.85 109.958 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -60.97 -38.6 86.52 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.485 0.659 . . . . 1.39 110.829 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.5 -39.07 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.574 -0.704 . . . . 0.56 110.262 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.417 ' NH1' ' HG3' ' A' ' 131' ' ' ARG . 40.4 ttm-85 -59.04 -40.07 83.91 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.143 -0.973 . . . . 3.12 109.856 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -60.21 -38.75 84.29 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.356 0.598 . . . . 1.28 110.405 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.67 -39.76 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.254 -0.904 . . . . 0.49 110.444 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.86 -47.36 67.04 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.424 -1.07 . . . . 0.46 110.424 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -58.24 -42.1 85.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.21 -1.171 . . . . 2.71 110.078 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 136' ' ' ARG . 60.1 mtt-85 -61.67 -43.23 99.26 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.14 -1.024 . . . . 2.14 110.372 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.31 -43.02 96.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.371 -0.831 . . . . 1.05 109.843 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -41.53 91.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.78 -0.575 . . . . 0.52 110.833 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.474 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 99.5 mtt180 -60.08 -35.58 75.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 2.35 111.329 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -73.56 -41.32 63.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.025 -1.047 . . . . 1.39 110.645 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.3 mt -60.4 -39.26 80.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.092 -1.005 . . . . 0.68 110.228 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.591 HD21 ' OD2' ' A' ' 101' ' ' ASP . 87.9 mt -88.6 -8.54 54.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.474 -0.766 . . . . 0.83 112.039 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.34 25.32 70.93 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 120.363 -0.923 . . . . 0.91 113.59 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.5 tp -70.13 148.62 48.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.634 -0.921 . . . . 0.95 109.956 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -65.46 151.72 45.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.483 -0.761 . . . . 2.43 110.803 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.8 mt -103.32 140.6 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.125 -1.065 . . . . 1.1 108.125 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.6 mm -82.37 120.36 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.817 -1.177 . . . . 1.58 108.138 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -99.36 95.89 7.35 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.165 -1.791 . . . . 1.62 106.165 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.82 -18.38 61.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.504 -0.748 . . . . 0.8 112.053 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.0 m -81.72 8.74 9.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 1.56 112.208 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.04 24.63 9.09 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.239 -0.913 . . . . 0.84 111.655 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.1 mt -74.35 147.24 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.371 -0.83 . . . . 0.82 110.146 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -115.26 -20.12 10.49 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.58 -0.7 . . . . 2.31 112.596 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -119.55 139.92 51.36 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.812 -1.181 . . . . 1.54 107.812 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.71 128.57 36.52 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.602 -0.888 . . . . 1.38 108.602 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -146.28 178.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.477 -0.764 . . . . 0.69 109.426 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.417 HG21 HD12 ' A' ' 180' ' ' ILE . 81.3 mt -91.42 144.75 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.504 -0.925 . . . . 0.53 108.504 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.71 123.65 39.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.889 -1.132 . . . . 0.64 108.366 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.74 130.09 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.156 -1.053 . . . . 0.67 108.156 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.34 154.77 21.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.099 -1.001 . . . . 0.78 108.93 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.7 -31.2 70.48 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.653 -1.28 . . . . 1.0 109.626 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 29.0 p-10 -173.35 150.8 1.91 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.708 -0.849 . . . . 2.42 108.708 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.3 mt -119.39 138.78 52.86 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.332 -0.988 . . . . 0.75 108.332 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.0 p -95.61 152.61 39.29 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 108.507 -0.923 . . . . 0.78 108.507 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -43.68 -39.57 10.23 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.367 1.378 . . . . 0.67 113.367 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.0 m -59.85 -48.88 79.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.923 -1.111 . . . . 0.7 110.042 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.99 -40.33 97.43 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.338 -0.851 . . . . 1.21 109.961 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 31.5 p -68.17 -40.0 82.41 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.857 -0.737 . . . . 0.6 110.055 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.36 78.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.581 -0.7 . . . . 0.62 110.779 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -97.03 -1.43 45.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.207 -0.933 . . . . 1.16 112.881 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.82 150.39 41.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.476 -0.765 . . . . 0.73 109.571 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -96.03 111.04 23.17 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.773 -1.566 . . . . 2.24 106.773 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 31.9 mt -74.57 -15.19 60.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.636 -0.665 . . . . 1.43 111.486 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -81.32 -25.58 36.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 2.15 111.832 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -102.72 -1.96 29.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.27 -0.894 . . . . 2.04 113.325 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.05 127.26 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 107.394 -1.335 . . . . 0.55 107.394 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.429 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 45.1 tp -88.58 -10.84 47.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.104 -0.998 . . . . 1.63 112.244 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.96 174.32 46.72 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.049 -1.621 . . . . 0.47 109.049 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -130.02 131.19 45.76 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.506 -1.294 . . . . 0.54 107.506 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.535 ' CG2' HG21 ' A' ' 205' ' ' THR . 84.6 mt -131.32 129.79 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.156 -1.424 . . . . 0.69 107.156 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 203' ' ' VAL . 82.7 p -140.57 170.55 15.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.886 -1.133 . . . . 0.82 109.702 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.447 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 1.4 m-20 -105.04 44.72 1.01 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.817 -0.552 . . . . 2.37 110.777 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -104.39 155.0 19.15 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.086 -1.009 . . . . 1.11 109.637 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.22 -8.39 74.55 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.924 -1.131 . . . . 1.67 112.311 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.76 -18.43 56.9 Favored Glycine 0 N--CA 1.497 2.707 0 O-C-N 121.4 -1.059 . . . . 1.54 113.385 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -59.78 -39.86 86.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.059 -1.259 . . . . 4.48 110.526 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.0 p -129.59 31.19 4.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.805 -0.559 . . . . 2.63 111.023 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 90.7 p -83.16 98.64 9.46 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.296 -1.372 . . . . 1.69 107.296 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -59.55 -34.39 72.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.475 -0.765 . . . . 1.07 110.107 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 191' ' ' SER . 15.2 t -59.67 -39.44 84.48 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.537 -0.727 . . . . 1.58 110.603 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.478 ' N ' HG23 ' A' ' 190' ' ' THR . 22.8 t -57.24 -39.99 76.67 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.16 -0.962 . . . . 1.6 110.072 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.3 -39.62 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.44 -0.787 . . . . 1.45 109.937 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 45.5 mtp -66.27 -40.93 90.44 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.395 1.093 . . . . 1.05 109.414 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.73 -42.22 88.26 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.464 -0.789 . . . . 0.72 110.709 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -60.84 -44.95 96.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.912 -1.118 . . . . 3.05 110.317 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.8 m -70.21 -40.1 74.77 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.199 -0.938 . . . . 0.89 110.225 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.4 mt -91.7 -6.92 51.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.529 -0.732 . . . . 0.78 112.64 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.0 mt-10 52.54 13.45 0.32 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.749 1.018 . . . . 1.45 113.749 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.71 148.11 89.7 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.942 -1.132 . . . . 0.67 107.942 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -54.35 140.5 73.18 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.905 1.737 . . . . 0.64 109.985 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.84 160.5 36.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.249 -1.532 . . . . 0.67 109.86 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.46 ' CD1' HD11 ' A' ' 220' ' ' LEU . 29.6 mt -148.65 151.49 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.676 -1.231 . . . . 0.69 107.676 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.7 m -135.5 -27.58 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 120.956 -1.09 . . . . 0.85 112.014 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.92 42.06 2.8 Favored Glycine 0 N--CA 1.492 2.41 0 O-C-N 121.081 -1.012 . . . . 0.92 112.02 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.535 HG21 ' CG2' ' A' ' 180' ' ' ILE . 74.7 p -65.4 -13.11 57.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.899 -1.353 . . . . 0.95 111.151 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.65 -95.88 1.38 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 110.565 -1.014 . . . . 1.04 110.565 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -129.08 30.96 4.96 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.659 -0.907 . . . . 1.57 112.322 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.2 -36.33 45.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.571 -1.331 . . . . 0.84 110.819 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.1 p -57.77 -24.58 57.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.792 -1.193 . . . . 0.99 111.544 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 18.2 t -92.15 -2.05 56.8 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.797 0.808 . . . . 1.7 111.483 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -122.46 -5.29 8.77 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.561 0.949 . . . . 2.2 113.561 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 34.8 t -120.05 149.07 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.357 -0.839 . . . . 0.84 109.594 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.0 156.9 27.75 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.973 -1.121 . . . . 2.2 107.973 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.506 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 7.3 t30 -51.47 142.84 13.01 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.075 -1.016 . . . . 2.28 110.216 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 83.35 -7.62 1.14 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.109 1.151 . . . . 2.35 114.109 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -58.57 142.15 50.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.507 -1.37 . . . . 1.97 108.91 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -88.74 119.82 29.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.671 -1.268 . . . . 2.65 108.072 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.69 148.85 47.76 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.465 0.65 . . . . 0.63 109.653 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.459 HG21 ' SD ' ' A' ' 239' ' ' MET . 82.6 mt -117.79 124.89 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.226 -1.768 . . . . 0.62 106.226 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.46 HD11 ' CD1' ' A' ' 202' ' ' ILE . 53.6 tp -102.24 116.78 33.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.215 -1.772 . . . . 0.64 106.215 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.3 p-10 -93.15 -22.12 19.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.934 -1.104 . . . . 2.05 112.709 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.17 15.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 112.663 0.616 . . . . 0.84 112.663 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.633 ' N ' ' O ' ' A' ' 221' ' ' ASP . 20.6 t -109.73 -59.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.112 -0.993 . . . . 1.02 109.86 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -93.79 9.91 35.22 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.27 1.033 . . . . 2.51 110.891 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 47.7 t30 61.33 53.1 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.983 -1.008 . . . . 1.54 112.304 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -148.84 148.54 30.02 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.811 -1.181 . . . . 1.95 110.084 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.97 139.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 108.136 -1.061 . . . . 0.71 108.136 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -102.74 133.88 47.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.181 -0.95 . . . . 1.01 108.669 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 53.4 t -110.86 130.8 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.214 -1.032 . . . . 0.82 108.214 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 58.5 t-20 55.63 47.9 3.53 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 113.384 0.883 . . . . 1.54 113.384 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 62.3 Cg_endo -69.82 153.12 69.04 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.559 2.172 . . . . 0.94 110.901 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.6 m -74.19 159.38 32.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 1.8 108.866 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -59.47 -34.01 72.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.114 -0.991 . . . . 2.73 110.691 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -59.96 -41.05 91.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.407 -0.808 . . . . 3.17 110.56 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.96 -39.97 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.288 -0.883 . . . . 1.34 110.192 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.4 mt -60.0 -49.97 81.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.168 -0.957 . . . . 1.2 111.043 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -59.52 -40.66 87.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.98 . . . . 2.7 110.644 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.71 -47.91 84.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.853 . . . . 2.59 110.195 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.459 ' SD ' HG21 ' A' ' 219' ' ' ILE . 66.1 mtp -70.63 -38.39 73.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 1.38 110.871 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.537 ' NH1' ' CD2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -56.2 -41.36 75.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.147 -0.97 . . . . 2.84 110.245 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.81 -42.99 69.53 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.288 -0.882 . . . . 1.88 111.194 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 246' ' ' VAL . 95.3 t -59.54 -48.82 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.964 -1.085 . . . . 2.4 110.764 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -63.52 -49.91 71.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.424 -1.422 . . . . 3.52 110.097 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.13 -37.84 86.7 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.756 -0.59 . . . . 1.88 111.083 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -61.46 -30.07 70.36 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.839 -1.144 . . . . 3.01 110.178 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 242' ' ' VAL . 55.1 t -63.87 -47.3 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.196 -1.002 . . . . 2.45 109.953 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.57 89.06 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.236 -0.986 . . . . 2.75 110.247 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.4 t -71.55 -44.46 64.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 3.16 111.454 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.64 -36.18 82.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.313 -0.867 . . . . 3.57 110.589 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -63.78 -36.78 85.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.519 -0.738 . . . . 4.3 110.726 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.02 -49.37 58.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 4.45 110.749 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -70.78 -33.03 70.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.541 -0.724 . . . . 5.97 111.205 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 46.5 tp -67.89 -28.75 67.78 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.98 -1.075 . . . . 6.18 111.675 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -72.84 -5.38 37.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.89 -1.132 . . . . 6.66 112.944 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -85.53 34.82 0.59 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.965 -1.085 . . . . 8.2 112.689 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 14.6 mt -80.16 -1.78 41.81 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.809 -1.182 . . . . 8.07 112.233 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -87.27 0.75 54.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.202 -0.936 . . . . 9.45 112.648 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.69 -3.87 58.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.931 . . . . 10.12 112.792 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 117.982 -1.008 . . . . 11.49 109.86 -178.012 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.337 0.589 . . . . 3.07 110.098 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.3 mt -98.13 110.48 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.386 -1.709 . . . . 1.07 106.386 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m -105.88 125.23 50.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.048 -1.093 . . . . 1.24 108.048 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.46 -154.96 17.46 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.333 -1.907 . . . . 1.01 108.333 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 5' ' ' ILE . 80.3 mt -95.78 1.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.309 -1.113 . . . . 1.11 112.185 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 5' ' ' ILE . 3.8 tp 50.82 101.16 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.085 -1.01 . . . . 0.99 112.357 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -84.38 -47.44 10.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.118 -0.989 . . . . 0.85 111.11 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m -144.58 146.95 34.26 Favored Pre-proline 0 N--CA 1.501 2.093 0 N-CA-C 107.855 -1.165 . . . . 1.38 107.855 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.49 147.71 32.52 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.575 2.183 . . . . 0.94 112.088 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.922 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.08 163.34 11.97 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.343 -1.503 . . . . 0.81 109.343 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.3 mt -125.37 130.53 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.159 -1.2 . . . . 0.83 108.095 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.464 ' HB1' ' CD2' ' A' ' 177' ' ' LEU . . . -139.11 148.92 43.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.242 -0.911 . . . . 0.53 109.016 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 5.8 m-85 -117.49 140.17 49.96 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 108.827 -0.805 . . . . 0.77 108.827 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.77 167.27 35.64 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 118.004 -2.046 . . . . 0.51 110.39 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -77.48 160.36 28.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.827 -0.808 . . . . 1.9 109.669 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.41 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.46 126.46 34.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.835 -1.166 . . . . 0.66 108.152 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.9 tp -104.6 98.93 8.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.081 -1.822 . . . . 0.83 106.081 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 18' ' ' LEU . 17.0 tp -90.55 130.83 36.55 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.753 -1.203 . . . . 0.86 107.753 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 158' ' ' LEU . 77.5 mt -101.77 117.06 34.09 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.861 -1.533 . . . . 0.92 106.861 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -109.5 136.04 49.54 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.993 -1.484 . . . . 2.03 106.993 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -119.69 149.18 42.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.083 -1.011 . . . . 2.66 109.452 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -82.67 134.62 35.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.858 -1.164 . . . . 2.32 107.858 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.19 148.35 50.24 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.671 -0.863 . . . . 2.11 108.671 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.87 130.3 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.282 -1.007 . . . . 0.73 108.282 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -105.35 131.11 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.033 -1.099 . . . . 0.87 108.033 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 77.1 mt -97.86 135.55 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.526 -0.916 . . . . 0.81 108.526 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -91.12 123.02 34.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.858 -1.164 . . . . 1.34 107.858 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -95.06 13.04 26.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.223 -0.923 . . . . 2.89 112.135 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -67.25 149.66 50.11 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.282 -0.886 . . . . 2.09 109.244 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -86.43 140.0 30.39 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.179 -1.045 . . . . 2.19 108.179 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -93.31 171.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.079 -1.013 . . . . 0.75 109.418 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.6 p -108.53 158.62 17.39 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.935 -0.765 . . . . 0.91 108.935 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.82 -26.23 1.56 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.108 -0.995 . . . . 0.93 112.672 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -69.84 -39.87 76.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.161 -0.962 . . . . 2.28 110.167 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -86.47 -11.3 52.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.426 -0.796 . . . . 1.45 111.813 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.15 -47.19 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.438 -0.789 . . . . 0.81 110.472 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.12 -40.08 84.3 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.098 -1.001 . . . . 1.54 110.687 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.46 -44.77 95.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.42 -0.8 . . . . 2.36 110.999 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.05 -39.74 87.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.919 -1.113 . . . . 1.31 111.02 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.04 -41.77 87.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.92 -1.112 . . . . 0.82 110.656 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -61.93 -45.89 91.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.008 -1.057 . . . . 1.5 110.279 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -62.48 -39.67 94.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.308 -0.87 . . . . 2.23 110.165 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -76.22 -54.42 6.83 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.562 -0.711 . . . . 0.85 110.315 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -58.32 -47.78 82.64 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.382 -0.927 . . . . 0.91 109.772 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -68.39 -36.74 79.59 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.738 -0.785 . . . . 0.9 109.891 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.68 -44.09 94.17 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.218 -1.468 . . . . 0.69 109.57 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.4 ttt-85 -60.32 -29.48 68.89 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.194 -1.18 . . . . 2.88 110.328 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.31 -50.24 73.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.85 110.929 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -81.44 -36.07 29.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.909 -1.12 . . . . 2.35 110.341 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.49 89.7 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.268 -0.895 . . . . 0.65 109.683 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 87.4 p -60.77 -39.28 88.24 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.219 1.009 . . . . 1.45 109.055 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -45.3 75.64 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.711 -0.677 . . . . 0.63 110.595 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -65.29 -48.6 72.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.672 -1.268 . . . . 1.34 110.658 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.05 -35.95 81.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.994 -1.066 . . . . 1.56 109.888 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -60.06 -40.24 88.81 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.574 -0.704 . . . . 1.19 110.256 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -62.11 -43.45 98.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.139 -0.976 . . . . 0.72 110.457 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.1 mt -59.94 -35.21 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.438 -0.789 . . . . 0.62 110.726 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -52.64 -41.63 63.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.15 -0.969 . . . . 1.05 110.878 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.76 -36.92 76.19 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.996 -1.065 . . . . 0.64 110.318 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -61.58 -36.81 81.72 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.926 -1.109 . . . . 1.73 109.552 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.12 79.01 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.618 -0.677 . . . . 0.56 110.43 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.24 -36.21 13.22 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.637 -1.268 . . . . 0.69 111.502 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.54 -22.66 43.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.668 -1.489 . . . . 1.48 110.736 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.2 m -90.42 -49.93 6.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.253 -0.904 . . . . 0.98 111.52 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.27 -7.17 16.83 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 113.918 1.081 . . . . 1.16 113.918 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.08 163.46 24.79 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.719 -0.753 . . . . 0.85 112.349 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -54.17 -23.89 16.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.565 -0.962 . . . . 3.86 112.779 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.3 -40.08 70.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.823 -1.173 . . . . 2.35 110.993 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -86.02 -22.99 26.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.674 -1.266 . . . . 1.67 111.488 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -60.56 -40.3 91.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 1.45 111.031 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.25 86.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.486 -0.759 . . . . 0.61 111.443 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -65.82 -44.0 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.754 -1.216 . . . . 0.65 110.921 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -69.95 -32.91 71.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.686 -1.259 . . . . 0.66 110.22 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.2 -38.85 88.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -0.881 . . . . 1.19 110.23 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.13 96.96 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.591 -0.814 . . . . 0.53 111.097 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -58.11 -40.92 82.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.669 -1.489 . . . . 1.27 110.777 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.93 -40.05 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.118 -0.989 . . . . 0.54 110.987 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.8 ttm -58.76 -40.28 83.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.983 -1.073 . . . . 1.74 110.377 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 tp -59.85 -48.6 81.05 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.185 -0.947 . . . . 0.55 110.023 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.97 -39.8 86.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.207 -0.933 . . . . 0.47 110.284 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -84.3 6.78 21.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.216 0.821 . . . . 1.42 113.216 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -66.41 125.33 25.31 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.664 -1.273 . . . . 1.27 108.26 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.97 -16.54 64.1 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.263 -0.898 . . . . 1.35 111.121 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -75.03 -50.29 16.98 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.674 -0.81 . . . . 2.22 110.34 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.8 -36.76 84.21 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.739 -0.784 . . . . 0.62 110.392 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -59.93 -48.8 80.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.367 -0.833 . . . . 1.29 110.705 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -61.85 -38.42 88.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 1.52 110.546 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.23 -47.38 79.88 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.025 -1.047 . . . . 1.3 110.499 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.61 -45.03 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.34 -0.85 . . . . 0.61 110.198 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.34 -40.12 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.683 0.754 . . . . 0.78 110.465 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.43 98.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.152 -0.968 . . . . 0.82 110.965 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.18 -39.16 85.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.015 -1.053 . . . . 0.8 110.612 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.26 -51.52 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.77 110.757 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -75.87 -35.31 59.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.756 . . . . 2.12 111.446 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.43 -46.24 14.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 1.51 111.948 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -100.13 7.84 44.31 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.342 -0.849 . . . . 1.98 112.861 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.9 m80 49.9 48.61 21.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.74 -1.225 . . . . 1.32 111.427 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.9 mtt -109.97 152.02 26.39 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.778 0.799 . . . . 1.38 109.552 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.9 p -70.1 160.27 32.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.515 -0.741 . . . . 0.67 110.018 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.18 92.98 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.46 -0.775 . . . . 0.52 110.419 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD2' HD21 ' A' ' 142' ' ' LEU . 74.8 m-20 -65.86 -43.45 88.38 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.962 -1.086 . . . . 2.25 109.361 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.18 -49.31 51.64 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.921 -0.711 . . . . 0.64 110.862 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.71 -44.47 93.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.56 110.637 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.22 -41.07 87.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.46 110.483 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.3 -38.28 90.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 1.32 111.48 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.62 -49.76 76.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.387 -1.446 . . . . 1.3 111.29 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.68 -46.81 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.918 -1.114 . . . . 0.61 110.112 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.8 mm -62.0 -29.43 46.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.921 0.867 . . . . 0.65 110.681 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.51 -40.33 82.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.551 -0.718 . . . . 2.11 110.996 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.55 -32.04 17.07 Favored Glycine 0 N--CA 1.501 3.004 0 C-N-CA 119.384 -1.389 . . . . 0.83 112.535 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -63.03 -37.54 87.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.363 -1.669 . . . . 1.28 110.169 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.63 -51.21 15.08 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.533 -0.73 . . . . 0.89 111.201 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.9 m -58.32 -38.73 77.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.388 -0.82 . . . . 1.87 111.142 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.09 99.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.303 -0.873 . . . . 1.05 111.025 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.75 -28.81 69.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.967 . . . . 1.02 111.269 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -68.11 -22.27 64.9 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.209 -0.932 . . . . 2.04 111.055 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -73.08 -13.64 61.24 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.963 0.887 . . . . 1.73 111.029 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 123' ' ' LEU . 11.4 mt -91.18 140.53 29.72 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.503 -0.925 . . . . 1.37 108.503 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -99.71 43.55 1.05 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.028 -1.045 . . . . 2.88 112.082 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -112.87 140.51 47.6 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.134 -0.979 . . . . 1.58 108.808 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.24 -40.47 77.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 3.04 111.008 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -73.22 -54.04 9.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.864 -1.148 . . . . 0.9 110.95 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 118' ' ' LEU . 26.7 mt -59.81 -41.3 90.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.897 -1.127 . . . . 1.06 110.475 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -63.65 -50.09 70.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.116 -0.99 . . . . 2.18 109.951 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.44 -31.83 70.8 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.978 -1.076 . . . . 2.15 109.292 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.536 ' HG2' HH11 ' A' ' 126' ' ' ARG . 11.3 ttt-85 -61.32 -29.32 69.81 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.59 -0.844 . . . . 2.33 109.49 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.12 74.81 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.815 0.817 . . . . 0.82 109.448 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.5 -45.72 78.66 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.101 -0.64 . . . . 0.85 110.125 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -62.05 -33.93 75.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.543 -0.723 . . . . 1.39 110.574 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.1 t -68.12 -41.91 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 0.56 110.272 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.443 HH11 ' HG2' ' A' ' 131' ' ' ARG . 28.1 ttt-85 -59.77 -39.49 85.04 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.006 -1.077 . . . . 3.12 109.311 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.482 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 56.8 t0 -58.29 -36.22 72.98 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.734 -0.604 . . . . 1.28 109.896 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.2 mt -60.63 -39.35 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.158 -0.964 . . . . 0.49 110.152 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.75 -44.85 30.21 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.253 -0.975 . . . . 0.46 111.007 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -56.68 -45.27 81.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.316 -1.108 . . . . 2.71 110.401 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.482 ' NH2' ' OD2' ' A' ' 132' ' ' ASP . 42.1 mtt-85 -62.46 -40.76 97.67 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.096 -1.042 . . . . 2.14 109.643 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.521 ' O ' HD13 ' A' ' 137' ' ' LEU . 0.2 OUTLIER -62.23 -43.21 99.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.703 -0.623 . . . . 1.05 110.057 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.23 -44.5 92.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.204 -0.935 . . . . 0.52 110.317 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.1 mtp180 -60.02 -32.63 71.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 2.35 110.723 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -74.09 -41.08 62.23 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.254 -0.903 . . . . 1.39 110.704 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 98.5 mt -60.63 -37.52 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.42 -0.8 . . . . 0.68 110.142 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.498 HD21 ' OD2' ' A' ' 101' ' ' ASP . 66.9 mt -87.06 -7.41 58.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.504 -0.748 . . . . 0.83 112.169 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.1 19.4 78.46 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.808 -1.187 . . . . 0.91 112.613 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.6 tp -61.33 143.29 55.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.94 -0.741 . . . . 0.95 109.63 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -66.44 146.6 54.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 2.43 108.966 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.55 142.24 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.214 -1.032 . . . . 1.1 108.214 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.4 mm -75.73 129.93 36.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.04 -1.096 . . . . 1.58 108.04 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.27 94.67 9.28 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.914 -1.513 . . . . 1.62 106.914 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 54.5 mt -74.19 -23.68 59.25 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.73 0.776 . . . . 0.8 110.515 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.5 m -82.88 6.96 16.69 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.882 0.848 . . . . 1.56 112.019 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.73 23.08 9.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.627 -0.671 . . . . 0.84 112.634 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.7 mt -73.68 138.49 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.32 -0.862 . . . . 0.82 109.148 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -118.02 -18.44 9.43 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.778 0.799 . . . . 2.31 112.725 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -115.36 140.72 48.87 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.432 -0.951 . . . . 1.54 108.432 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -70.98 120.83 17.12 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.041 -1.037 . . . . 1.38 108.483 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.13 175.01 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.568 -0.707 . . . . 0.69 109.305 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 mt -87.49 144.43 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.322 -0.861 . . . . 0.53 108.935 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 19' ' ' LEU . 35.8 tp -97.66 126.97 43.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.996 -1.065 . . . . 0.64 108.24 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.0 131.06 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.268 -1.012 . . . . 0.67 108.268 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.04 147.59 11.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.058 -1.027 . . . . 0.78 109.087 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.06 -32.18 71.82 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.544 -1.347 . . . . 1.0 109.741 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 50.6 p-10 -172.53 150.82 2.31 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.434 -0.95 . . . . 2.42 108.434 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 46.4 mt -118.53 143.07 47.01 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.373 -0.829 . . . . 0.75 109.247 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.0 p -92.19 141.83 25.53 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.112 -0.992 . . . . 0.78 108.673 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.57 -40.28 2.15 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 121.871 1.714 . . . . 0.67 113.706 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.8 m -60.72 -49.99 75.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.1 -1.04 . . . . 0.7 109.704 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.31 -39.91 94.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.504 -0.747 . . . . 1.21 110.168 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 34.5 p -66.87 -38.54 86.51 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.449 0.642 . . . . 0.6 110.561 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.39 88.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.632 -0.668 . . . . 0.62 110.427 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -93.23 0.07 56.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.077 -1.015 . . . . 1.16 112.694 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.46 148.06 43.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.979 -1.076 . . . . 0.73 108.515 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -97.65 119.71 36.71 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.13 -1.434 . . . . 2.24 107.13 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 45.5 mt -78.14 -12.34 59.99 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.929 -0.482 . . . . 1.43 111.601 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -83.0 -23.75 33.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.974 -1.079 . . . . 2.15 111.825 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -101.96 -4.95 25.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.232 -0.917 . . . . 2.04 113.092 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.23 125.95 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.76 -1.2 . . . . 0.55 107.76 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.464 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 37.8 tp -90.96 -8.52 49.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.905 . . . . 1.63 112.197 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 177.4 169.64 38.76 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.978 -1.649 . . . . 0.47 108.978 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -127.82 133.86 49.42 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.005 -1.109 . . . . 0.54 108.005 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 76.9 mt -132.09 109.62 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 106.133 -1.803 . . . . 0.69 106.133 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 205' ' ' THR . 66.5 p -131.26 172.28 12.33 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.917 -1.114 . . . . 0.82 110.347 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.402 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 26.9 t0 -101.53 61.7 0.92 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.563 -0.71 . . . . 2.37 109.958 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.55 139.66 37.85 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.233 -0.917 . . . . 1.11 108.809 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.47 0.3 26.72 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.921 -1.133 . . . . 1.67 112.857 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 81.01 -14.87 24.7 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.093 -1.239 . . . . 1.54 113.837 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.409 ' HG2' ' NH1' ' A' ' 186' ' ' ARG . 42.9 ttt-85 -76.09 113.15 13.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.022 -1.281 . . . . 4.48 108.168 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 73.5 p 49.53 40.23 18.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 2.63 111.753 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.8 t -85.13 114.34 22.18 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.041 -1.096 . . . . 1.69 108.041 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -62.68 -37.86 88.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.303 -0.873 . . . . 1.07 110.888 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 87.0 m -59.68 -40.12 86.75 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.405 -0.918 . . . . 1.58 110.586 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.6 t -58.54 -39.73 81.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.231 -0.918 . . . . 1.6 110.049 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.9 mm -60.04 -35.84 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 1.45 110.96 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 65.9 mtp -62.94 -41.2 99.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.02 -1.05 . . . . 1.05 109.951 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.17 -47.2 84.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.997 -0.547 . . . . 0.72 110.588 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.495 HH11 ' HG2' ' A' ' 195' ' ' ARG . 29.0 mtt-85 -60.14 -42.16 94.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 3.05 110.349 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.7 m -69.47 -41.59 75.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.017 -1.052 . . . . 0.89 109.835 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.5 mt -91.0 -8.3 49.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.619 -0.675 . . . . 0.78 112.094 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 48.62 14.54 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.739 1.015 . . . . 1.45 113.739 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.4 mt -74.1 149.18 87.14 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.053 -1.03 . . . . 0.67 108.267 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.07 136.64 53.49 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 121.146 1.231 . . . . 0.64 109.691 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -157.28 159.32 37.46 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 118.133 -1.427 . . . . 0.67 110.148 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 77.0 mt -144.65 144.87 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.64 -1.245 . . . . 0.69 107.64 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 181' ' ' THR . 6.6 m -124.54 -33.94 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 113.608 0.966 . . . . 0.85 113.608 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.76 40.72 1.17 Allowed Glycine 0 N--CA 1.484 1.858 0 C-N-CA 120.308 -0.949 . . . . 0.92 111.792 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 181' ' ' THR . 44.3 p -58.21 -22.54 52.33 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.186 -1.185 . . . . 0.95 111.279 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.402 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 72.31 -89.82 0.52 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.505 -1.038 . . . . 1.04 110.505 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.9 t -129.43 28.47 5.2 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.604 -0.939 . . . . 1.57 112.784 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.12 -37.42 61.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.665 -1.272 . . . . 0.84 110.165 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 39.6 p -52.02 -26.25 10.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.99 111.256 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.3 p -93.2 3.9 54.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 1.7 111.603 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -126.92 -3.62 6.44 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.924 0.713 . . . . 2.2 112.924 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 22.7 t -120.59 149.42 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.682 0.753 . . . . 0.84 109.185 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -124.96 156.97 37.2 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.476 -0.935 . . . . 2.2 108.476 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.576 ' ND2' ' OD1' ' A' ' 215' ' ' ASP . 35.0 t30 -56.48 141.13 43.75 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.83 -1.169 . . . . 2.28 110.674 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.576 ' OD1' ' ND2' ' A' ' 214' ' ' ASN . 1.6 m-20 80.24 2.51 1.95 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.472 1.286 . . . . 2.35 114.472 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.38 145.45 55.69 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.812 -1.18 . . . . 1.97 108.455 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -88.46 116.12 26.46 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.041 -1.466 . . . . 2.65 107.041 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.41 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 88.6 mt -127.32 142.05 51.55 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.463 -0.773 . . . . 0.63 109.695 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.2 mt -109.65 128.34 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.99 -1.485 . . . . 0.62 106.99 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.8 tp -102.75 115.93 31.56 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.292 -1.744 . . . . 0.64 106.292 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 223' ' ' VAL . 21.6 p-10 -94.38 -22.81 18.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.94 -1.1 . . . . 2.05 112.599 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.23 17.85 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 112.859 0.689 . . . . 0.84 112.859 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.3 t -108.92 -59.57 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.122 -0.986 . . . . 1.02 108.959 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.32 11.03 34.04 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.654 0.74 . . . . 2.51 111.157 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 60.71 54.67 3.54 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.417 0.627 . . . . 1.54 112.063 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -150.2 149.52 30.32 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.091 0.948 . . . . 1.95 109.942 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.9 t -116.12 141.23 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 109.175 -0.676 . . . . 0.71 109.175 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.43 130.61 49.26 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.855 -1.153 . . . . 1.01 108.264 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.5 t -109.81 129.35 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.217 -0.927 . . . . 0.82 108.695 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.439 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 10.2 t-20 54.82 50.29 6.2 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 113.701 1.0 . . . . 1.54 113.701 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.0 Cg_endo -68.91 151.92 73.69 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.962 2.441 . . . . 0.94 110.594 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.429 ' OG1' HG23 ' A' ' 235' ' ' VAL . 65.3 p -76.35 161.45 28.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.241 -0.912 . . . . 1.8 110.333 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -60.95 -38.08 84.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.792 -1.192 . . . . 2.73 110.191 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -60.4 -41.38 93.76 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.458 0.647 . . . . 3.17 110.573 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.429 HG23 ' OG1' ' A' ' 232' ' ' THR . 97.7 t -69.82 -40.18 78.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.083 -1.011 . . . . 1.34 110.241 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.02 -43.58 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 1.2 110.545 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -57.87 -41.52 82.63 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.181 -0.95 . . . . 2.7 110.418 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.35 -42.33 98.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.547 -0.721 . . . . 2.59 111.057 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.7 mtp -70.24 -42.53 72.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 1.38 110.874 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -57.83 -40.75 80.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.075 -1.016 . . . . 2.84 109.593 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.6 -56.66 4.73 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.633 -0.667 . . . . 1.88 110.821 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 67.6 t -59.77 -40.95 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 2.4 111.32 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.71 -49.64 76.96 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.739 -1.226 . . . . 3.52 110.4 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.01 -33.87 76.71 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.604 -0.838 . . . . 1.88 110.7 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.27 -30.32 69.37 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.25 -1.38 . . . . 3.01 109.604 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.83 -48.9 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.358 -0.937 . . . . 2.45 109.704 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.4 85.82 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.691 0.757 . . . . 2.75 110.123 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.9 t -69.23 -31.06 69.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.704 -0.623 . . . . 3.16 110.4 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.449 ' OE2' ' OE1' ' A' ' 252' ' ' GLU . 49.3 tp10 -59.92 -39.21 84.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -0.82 . . . . 3.57 110.64 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -62.18 -39.82 93.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.095 -1.003 . . . . 4.3 110.413 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.91 2.43 17.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.339 -0.851 . . . . 4.45 112.858 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.449 ' OE1' ' OE2' ' A' ' 249' ' ' GLU . 70.4 tt0 -70.17 -12.67 61.76 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 112.703 0.631 . . . . 5.97 112.703 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 253' ' ' LEU . 1.8 pt? -63.67 -27.06 68.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.259 -1.525 . . . . 6.18 111.512 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -74.44 -8.05 55.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.383 -0.823 . . . . 6.66 112.52 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -81.76 -1.95 49.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.535 -0.728 . . . . 8.2 112.49 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 39.8 mt -80.22 -14.04 58.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.858 -1.151 . . . . 8.07 111.995 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -92.2 -14.69 28.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 9.45 112.758 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -105.97 56.39 0.67 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.535 -0.728 . . . . 10.12 110.063 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 117.948 -1.025 . . . . 11.49 109.422 179.823 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.793 -0.447 . . . . 3.07 109.793 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.2 mt -97.78 107.6 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 106.119 -1.808 . . . . 1.07 106.119 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -105.9 120.97 43.1 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 107.665 -1.235 . . . . 1.24 107.665 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.4 -159.03 18.39 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.715 -1.754 . . . . 1.01 108.715 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 5' ' ' ILE . 83.5 mt -94.84 1.11 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -1.189 . . . . 1.11 112.409 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tp 49.02 98.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.99 112.012 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.98 -45.71 12.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.728 -1.233 . . . . 0.85 111.577 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -145.89 145.21 24.24 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.796 -1.187 . . . . 1.38 107.796 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.37 143.84 22.43 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.868 2.378 . . . . 0.94 112.276 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.886 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.95 174.19 25.46 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 108.908 -1.677 . . . . 0.81 108.908 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.2 mt -131.31 133.09 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.316 -1.108 . . . . 0.83 108.054 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.62 155.2 48.53 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.503 -0.748 . . . . 0.53 109.629 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.5 m-85 -125.56 140.36 52.81 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.732 -0.84 . . . . 0.77 108.732 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.42 164.41 30.43 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 118.813 -1.66 . . . . 0.51 109.626 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -75.05 159.1 32.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.579 -0.953 . . . . 1.9 108.773 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -89.06 126.23 35.35 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.975 -1.12 . . . . 0.66 107.975 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.9 tp -103.85 105.91 16.26 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.022 -2.214 . . . . 0.83 105.022 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.5 tp -90.32 133.63 34.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 0.86 108.188 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.6 mt -99.93 120.03 39.16 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.925 -1.509 . . . . 0.92 106.925 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -109.86 142.33 41.32 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.717 -0.846 . . . . 2.03 108.717 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -121.57 141.74 50.79 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.907 -1.12 . . . . 2.66 109.225 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.25 137.28 34.9 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.87 -1.144 . . . . 2.32 108.018 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -62.38 149.19 43.07 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.252 -0.648 . . . . 2.11 109.252 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -93.84 131.91 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.359 -0.978 . . . . 0.73 108.359 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t -106.04 130.35 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.297 -1.001 . . . . 0.87 108.297 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.3 mt -96.24 138.22 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.846 -0.798 . . . . 0.81 108.846 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -90.1 122.86 33.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.206 -1.035 . . . . 1.34 108.206 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.475 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.1 mmt-85 -95.35 14.47 22.34 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.283 -0.886 . . . . 2.89 112.478 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -75.3 140.47 43.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.917 -1.114 . . . . 2.09 109.198 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.55 136.35 32.98 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.875 -1.157 . . . . 2.19 107.875 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 pt -94.93 168.84 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.885 . . . . 0.75 110.482 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.4 p -97.77 165.82 11.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.675 -0.641 . . . . 0.91 109.845 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.03 -27.24 61.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.874 -1.141 . . . . 0.93 111.579 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -68.17 -34.62 76.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.939 -1.1 . . . . 2.28 110.453 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -90.13 -9.48 48.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.978 -1.076 . . . . 1.45 112.492 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.3 t -58.55 -42.14 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.856 -1.152 . . . . 0.81 110.622 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.17 -38.25 79.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 1.54 110.926 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -63.17 -45.0 93.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.909 . . . . 2.36 111.268 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.52 -37.05 82.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.547 -1.346 . . . . 1.31 110.991 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.6 t -60.8 -40.17 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.074 -1.016 . . . . 0.82 110.193 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.64 -39.63 92.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.948 -1.095 . . . . 1.5 110.096 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.71 -40.23 91.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.885 . . . . 2.23 109.893 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -74.03 -58.37 3.34 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.295 -0.878 . . . . 0.85 109.703 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.0 -48.38 75.99 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.05 -1.06 . . . . 0.91 110.204 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.8 t -70.65 -44.55 66.89 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.293 -0.963 . . . . 0.9 110.153 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.09 -46.17 85.7 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.55 -1.31 . . . . 0.69 110.035 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -57.91 -30.25 65.76 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.698 -0.883 . . . . 2.88 109.595 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.52 -46.75 80.4 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.676 0.75 . . . . 0.85 109.629 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' NZ ' ' OE1' ' A' ' 53' ' ' GLN . 25.4 ttpp -79.89 -40.65 27.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.467 -0.771 . . . . 2.35 110.293 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.85 93.13 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.65 110.056 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.8 m -60.13 -37.6 80.54 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.017 0.913 . . . . 1.45 109.334 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.37 -46.66 69.46 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.776 -0.647 . . . . 0.63 110.179 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.413 ' OE1' ' NZ ' ' A' ' 49' ' ' LYS . 53.7 mt-30 -61.4 -48.56 80.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.855 -1.153 . . . . 1.34 110.13 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.09 -41.36 96.51 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.845 0.831 . . . . 1.56 109.596 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -60.56 -41.22 94.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.468 0.652 . . . . 1.19 109.855 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.1 m -64.35 -41.89 96.51 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.387 -0.821 . . . . 0.72 110.429 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.02 -32.81 55.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.191 -0.943 . . . . 0.62 110.573 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -53.18 -46.56 69.02 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.329 -0.857 . . . . 1.05 110.733 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -68.74 -38.92 80.48 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.202 -0.937 . . . . 0.64 109.48 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -62.9 -40.31 97.15 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.53 -1.268 . . . . 1.73 108.952 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.62 72.82 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.714 -0.794 . . . . 0.56 109.234 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.09 -33.23 26.98 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.155 -1.178 . . . . 0.69 110.155 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -82.1 -24.67 35.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.107 -1.231 . . . . 1.48 111.138 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.1 m -86.29 -46.74 10.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.506 -0.746 . . . . 0.98 110.74 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -105.71 -19.04 13.88 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.373 -0.829 . . . . 1.16 112.657 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.82 152.73 9.09 Favored Glycine 0 N--CA 1.504 3.225 0 O-C-N 121.247 -0.908 . . . . 0.85 111.816 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -52.58 -21.77 4.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.48 -1.012 . . . . 3.86 112.66 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.31 -32.63 71.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.193 -0.942 . . . . 2.35 111.456 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -82.79 -13.73 55.72 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.655 -1.278 . . . . 1.67 112.579 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.41 -32.49 71.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.046 -1.034 . . . . 1.45 111.209 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.56 96.16 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.025 -1.047 . . . . 0.61 111.322 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.7 mt -65.45 -42.52 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.652 -1.28 . . . . 0.65 110.638 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.6 -28.74 66.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.113 -0.992 . . . . 0.66 110.554 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.35 -37.59 81.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.259 -0.901 . . . . 1.19 110.403 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.83 -41.09 74.37 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.26 -0.971 . . . . 0.53 110.899 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -58.63 -43.02 89.59 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.967 -1.313 . . . . 1.27 110.223 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -60.59 -39.97 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.19 -0.944 . . . . 0.54 109.934 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.1 ttp -59.61 -39.56 84.61 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.055 -0.658 . . . . 1.74 110.585 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.33 -49.41 77.93 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.035 -1.041 . . . . 0.55 110.837 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.0 -45.1 93.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 0.47 110.423 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -85.93 14.13 6.53 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.01 -1.056 . . . . 1.42 112.718 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -65.58 127.51 32.17 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.759 -1.213 . . . . 1.27 108.503 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -68.21 -17.18 64.25 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.235 1.017 . . . . 1.35 110.704 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -75.24 -52.83 9.94 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.799 0.809 . . . . 2.22 110.544 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.08 -37.85 84.15 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.794 -0.763 . . . . 0.62 110.225 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -59.21 -49.33 78.26 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.487 -0.758 . . . . 1.29 110.716 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.75 -38.7 86.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.422 -0.798 . . . . 1.52 110.781 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.85 -48.55 73.9 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.479 -0.888 . . . . 1.3 110.142 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.06 -45.57 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.411 -0.916 . . . . 0.61 109.661 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.8 mt -60.7 -43.65 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.144 0.497 . . . . 0.78 110.453 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.43 95.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.964 -1.085 . . . . 0.82 111.058 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.65 -44.06 97.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.011 . . . . 0.8 110.151 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.31 -48.94 86.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.276 -0.89 . . . . 0.77 110.292 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -77.83 -33.41 52.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.373 -0.829 . . . . 2.12 111.44 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -82.74 -47.48 11.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.663 -1.273 . . . . 1.51 112.386 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -102.55 10.72 38.63 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.362 -0.836 . . . . 1.98 112.456 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.8 m80 51.49 49.18 21.49 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.988 -1.07 . . . . 1.32 111.303 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 59.0 mtt -104.57 150.79 24.33 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.387 -0.821 . . . . 1.38 109.701 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.4 p -74.11 165.66 24.76 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.405 -0.809 . . . . 0.67 109.988 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.81 -40.6 80.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.647 -0.658 . . . . 0.52 110.711 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.536 ' OD1' HD22 ' A' ' 138' ' ' LEU . 59.8 t0 -68.1 -42.93 79.56 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.52 -0.738 . . . . 2.25 110.07 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -52.09 28.2 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.111 -0.635 . . . . 0.64 111.225 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.16 -44.24 95.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.874 -1.141 . . . . 0.56 110.905 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.56 88.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.724 -0.61 . . . . 0.46 111.078 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -59.75 -37.26 78.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.614 -1.304 . . . . 1.32 110.562 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -59.28 -48.28 82.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.922 -1.111 . . . . 1.3 110.636 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.4 t -60.89 -47.04 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.788 -1.195 . . . . 0.61 110.875 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.17 -34.06 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.605 0.717 . . . . 0.65 109.833 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -57.55 -42.56 83.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.761 . . . . 2.11 110.803 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.09 -32.34 17.62 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.521 -1.323 . . . . 0.83 112.735 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -62.07 -42.63 99.4 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.167 -1.784 . . . . 1.28 109.828 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.7 -53.31 16.16 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.749 0.785 . . . . 0.89 110.771 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 64.7 m -60.95 -36.04 78.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.702 -0.624 . . . . 1.87 110.659 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.55 -42.15 99.36 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.379 -0.826 . . . . 1.05 110.184 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.2 mt -65.3 -29.66 70.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.793 -1.192 . . . . 1.02 110.967 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.98 -20.01 66.27 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.322 -0.861 . . . . 2.04 110.76 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.74 -12.54 61.05 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.779 0.8 . . . . 1.73 110.82 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 24.7 mt -90.6 139.58 30.57 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.964 -1.124 . . . . 1.37 107.964 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -101.83 43.71 1.05 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.46 -0.775 . . . . 2.88 111.618 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -115.87 142.37 46.86 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.296 -0.878 . . . . 1.58 109.069 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -56.81 -41.53 77.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 3.04 110.101 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -71.9 -55.13 8.06 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.911 -1.118 . . . . 0.9 110.577 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.1 mt -60.13 -40.01 88.26 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.141 -0.974 . . . . 1.06 110.63 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -63.09 -48.71 77.45 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.231 -0.918 . . . . 2.18 109.812 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -60.63 -31.45 70.65 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.896 -0.722 . . . . 2.15 109.922 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.567 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.5 ttt-85 -61.2 -30.5 70.46 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.275 1.036 . . . . 2.33 108.769 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.08 -49.8 75.86 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.839 0.828 . . . . 0.82 110.097 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.24 -44.29 79.81 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.737 0.779 . . . . 0.85 110.281 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.6 -35.71 81.39 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.293 -0.88 . . . . 1.39 110.803 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 126' ' ' ARG . 49.8 t -69.14 -38.74 78.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 120.975 -1.078 . . . . 0.56 110.823 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.519 HH11 ' HG2' ' A' ' 131' ' ' ARG . 1.8 ttt-85 -55.31 -39.97 70.55 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.494 -1.282 . . . . 3.12 109.53 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -61.32 -36.99 81.65 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.577 0.703 . . . . 1.28 110.088 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.51 -39.91 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.915 -1.116 . . . . 0.49 109.941 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.03 -44.07 98.65 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.567 -1.301 . . . . 0.46 109.899 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.36 -40.12 85.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.403 -1.057 . . . . 2.71 110.744 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.455 HH11 ' HG2' ' A' ' 136' ' ' ARG . 53.3 mtt-85 -59.46 -43.11 93.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.118 -0.989 . . . . 2.14 110.328 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.6 tp -65.4 -45.42 84.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.433 -0.792 . . . . 1.05 110.154 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.536 HD22 ' OD1' ' A' ' 101' ' ' ASP . 87.8 mt -63.23 -42.91 99.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.317 -0.864 . . . . 0.52 110.419 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -59.68 -34.84 73.38 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.657 -0.652 . . . . 2.35 110.688 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -74.97 -42.38 57.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 1.39 110.832 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.99 -38.81 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.461 -0.774 . . . . 0.68 110.337 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 43.8 mt -87.15 -6.09 58.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.998 -1.064 . . . . 0.83 112.178 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.6 23.87 77.49 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 119.445 -1.36 . . . . 0.91 113.057 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.83 150.35 33.07 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.864 -0.786 . . . . 0.95 109.901 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -67.79 150.46 48.6 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.545 -0.862 . . . . 2.43 110.043 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.5 mt -105.32 141.83 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.423 -0.798 . . . . 1.1 109.083 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 17.8 mm -76.21 122.03 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 107.75 -1.204 . . . . 1.58 107.75 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -92.98 94.6 8.99 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.481 -1.674 . . . . 1.62 106.481 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.38 -28.17 59.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.594 -0.692 . . . . 0.8 111.18 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 t -81.21 3.32 24.18 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.868 0.842 . . . . 1.56 111.979 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.08 14.62 21.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.443 -0.786 . . . . 0.84 112.755 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.4 mt -72.89 136.69 24.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.069 -1.02 . . . . 0.82 108.715 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -117.27 -15.31 10.42 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.148 0.975 . . . . 2.31 112.297 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -115.41 140.34 49.22 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.747 0.784 . . . . 1.54 109.092 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -70.62 119.53 14.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.461 -0.774 . . . . 1.38 109.029 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.06 174.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.281 -0.887 . . . . 0.69 109.174 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mt -89.25 145.55 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.53 108.843 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.6 tp -98.1 121.55 40.16 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.062 -1.024 . . . . 0.64 108.37 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.1 130.21 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 108.146 -1.057 . . . . 0.67 108.146 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.98 157.92 27.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.808 -1.182 . . . . 0.78 108.654 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.84 -36.88 82.49 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.386 -1.446 . . . . 1.0 109.829 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -172.96 149.7 1.92 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.404 -0.591 . . . . 2.42 109.404 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.8 mt -117.64 141.24 48.6 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.405 -0.809 . . . . 0.75 109.009 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.6 p -94.03 151.23 39.54 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.741 -1.224 . . . . 0.78 108.88 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -41.57 -46.22 6.17 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.251 1.968 . . . . 0.67 113.838 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.0 m -58.88 -49.91 76.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.761 -1.212 . . . . 0.7 110.45 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.26 -38.71 87.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.915 0.864 . . . . 1.21 110.225 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.2 p -70.0 -39.9 75.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.6 110.416 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.84 74.32 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.712 -0.618 . . . . 0.62 110.656 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -93.09 -3.56 53.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 1.16 112.767 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.0 tp -64.62 150.99 45.95 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.291 -0.633 . . . . 0.73 109.291 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -93.95 112.43 24.27 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.636 -1.616 . . . . 2.24 106.636 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.0 mt -70.3 -22.23 62.86 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.769 -0.582 . . . . 1.43 111.704 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -83.35 -15.83 48.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.479 -0.763 . . . . 2.15 112.919 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -102.79 -4.04 25.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.206 -0.934 . . . . 2.04 113.446 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 178' ' ' GLY . 64.3 t -111.14 129.93 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.197 -1.038 . . . . 0.55 108.197 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.5 tp -83.99 -10.04 58.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.327 -0.858 . . . . 1.63 112.263 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.508 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.5 166.98 35.59 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.796 -1.721 . . . . 0.47 108.796 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -126.37 127.49 45.57 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.51 -1.293 . . . . 0.54 107.51 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 61.0 mt -125.34 127.91 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 106.702 -1.592 . . . . 0.69 106.702 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 203' ' ' VAL . 30.2 p -138.57 174.61 10.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.005 -1.06 . . . . 0.82 109.704 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 52.8 t0 -106.32 34.71 3.24 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.375 0.607 . . . . 2.37 110.712 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -105.31 96.24 6.38 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 107.262 -1.384 . . . . 1.11 107.262 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -84.95 30.35 3.94 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 121.004 -1.06 . . . . 1.67 112.793 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.93 131.97 10.99 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.892 -1.683 . . . . 1.54 108.892 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -57.26 -31.96 66.11 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.467 -1.02 . . . . 4.48 109.78 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 60.2 p -97.29 28.75 3.5 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.565 0.58 . . . . 2.63 112.565 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.4 t -74.75 131.57 40.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.893 -1.13 . . . . 1.69 108.834 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -58.45 -38.08 76.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 1.07 111.208 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.447 ' H ' HG23 ' A' ' 190' ' ' THR . 3.8 p -56.66 -43.28 80.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.31 -1.494 . . . . 1.58 110.199 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.1 p -61.97 -36.17 80.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.3 -0.875 . . . . 1.6 110.316 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.3 mt -61.46 -36.79 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.142 -0.974 . . . . 1.45 110.759 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 85.3 mtp -62.08 -46.94 86.89 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.653 1.216 . . . . 1.05 109.48 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.5 -51.77 67.26 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.016 -0.993 . . . . 0.72 110.748 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -63.15 -44.88 94.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.277 -0.89 . . . . 3.05 110.759 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.4 m -66.9 -38.13 85.68 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.768 -1.207 . . . . 0.89 110.288 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 25.3 mt -91.45 -0.42 57.62 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.723 0.638 . . . . 0.78 112.723 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 56.23 5.52 0.19 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 114.444 1.275 . . . . 1.45 114.444 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.6 mt -72.26 143.05 85.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.919 -1.113 . . . . 0.67 108.396 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.56 137.07 75.39 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.298 1.332 . . . . 0.64 110.292 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.29 169.39 20.72 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 117.762 -1.575 . . . . 0.67 109.803 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.446 HD12 HD11 ' A' ' 220' ' ' LEU . 58.2 mt -145.72 156.85 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.808 -1.182 . . . . 0.69 107.808 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 181' ' ' THR . 25.5 m -140.47 -29.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.268 -0.895 . . . . 0.85 112.893 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.62 38.44 3.11 Favored Glycine 0 N--CA 1.486 2.025 0 O-C-N 121.293 -0.879 . . . . 0.92 112.058 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.3 p -53.25 -26.55 18.46 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.506 -0.997 . . . . 0.95 111.622 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 88.56 -88.98 1.56 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.82 -0.912 . . . . 1.04 110.82 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 39.7 t -128.45 30.43 5.16 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.189 -1.183 . . . . 1.57 112.285 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 44.7 t -62.01 -38.45 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.435 -1.416 . . . . 0.84 109.991 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.8 p -53.19 -21.37 5.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 0.99 111.308 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.3 t -95.02 0.73 54.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.222 -0.924 . . . . 1.7 111.581 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -126.31 -6.36 6.51 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 113.345 0.869 . . . . 2.2 113.345 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 10.2 t -117.31 145.59 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 122.014 0.911 . . . . 0.84 109.434 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -118.94 155.07 31.97 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.026 -1.102 . . . . 2.2 108.026 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 35.5 p-10 -54.58 140.69 34.12 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.844 -1.16 . . . . 2.28 110.724 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 m-20 78.81 5.89 2.34 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.484 1.29 . . . . 2.35 114.484 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.0 149.23 47.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.746 -1.221 . . . . 1.97 108.388 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -88.86 117.63 27.99 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.29 -1.374 . . . . 2.65 107.29 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 16' ' ' ALA . 84.1 mt -128.58 149.62 50.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.763 0.792 . . . . 0.63 109.498 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.3 mt -115.12 129.86 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.77 -1.567 . . . . 0.62 106.77 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 202' ' ' ILE . 64.4 tp -101.02 117.06 34.28 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.41 -2.07 . . . . 0.64 105.41 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.577 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.8 t0 -90.63 -24.36 20.53 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.078 -1.049 . . . . 2.05 112.574 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.886 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.13 17.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 112.735 0.643 . . . . 0.84 112.735 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' A' ' 221' ' ' ASP . 26.0 t -114.42 -64.59 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.959 0.885 . . . . 1.02 109.135 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -89.73 9.41 27.29 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.139 0.971 . . . . 2.51 110.582 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 52.2 t30 60.34 49.81 6.68 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.67 0.748 . . . . 1.54 111.589 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -147.53 153.03 38.97 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.193 0.996 . . . . 1.95 109.669 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 76.5 t -118.43 140.03 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.507 -0.923 . . . . 0.71 108.507 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.25 132.79 42.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.86 -1.15 . . . . 1.01 107.984 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 44.1 t -109.8 129.68 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 108.474 -0.936 . . . . 0.82 108.474 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.408 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 58.5 t30 47.28 54.57 15.64 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 113.577 0.955 . . . . 1.54 113.577 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 40.5 Cg_endo -67.88 151.89 77.78 Favored 'Trans proline' 0 C--N 1.297 -2.177 0 C-N-CA 122.462 2.108 . . . . 0.94 110.033 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.5 m -74.17 155.32 38.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.823 -0.806 . . . . 1.8 108.823 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -57.58 -39.52 76.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.151 -0.968 . . . . 2.73 110.468 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.45 -38.28 89.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.349 -0.845 . . . . 3.17 110.208 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.44 -37.53 75.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.497 -0.752 . . . . 1.34 110.523 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.26 -44.39 95.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.783 -0.767 . . . . 1.2 110.498 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -58.9 -39.4 81.35 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.482 -0.761 . . . . 2.7 110.034 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -60.53 -40.45 91.55 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.46 -0.775 . . . . 2.59 110.239 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 83.8 mtp -74.74 -41.51 60.0 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.016 -1.053 . . . . 1.38 110.537 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -58.27 -37.85 75.8 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.513 -0.875 . . . . 2.84 109.689 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.22 -56.6 5.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 1.88 110.623 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.55 -43.2 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.057 -1.027 . . . . 2.4 110.99 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -51.82 64.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.649 -1.282 . . . . 3.52 110.756 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.88 -32.23 73.63 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.56 -0.713 . . . . 1.88 110.878 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -61.54 -30.15 70.46 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.525 -1.27 . . . . 3.01 109.471 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.77 -50.02 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 118.463 -1.295 . . . . 2.45 109.129 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.15 90.03 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.813 -0.755 . . . . 2.75 110.2 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 18.1 t -65.56 -35.75 81.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.687 -0.633 . . . . 3.16 110.835 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -61.12 -40.7 94.77 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.721 -1.237 . . . . 3.57 110.132 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -67.51 -37.42 82.77 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.158 0.98 . . . . 4.3 109.849 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.25 -6.96 38.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.624 -0.673 . . . . 4.45 112.44 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -61.53 -30.45 70.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 5.97 111.018 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 31.3 tp -60.41 -38.75 85.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.118 -0.989 . . . . 6.18 110.264 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -71.34 -19.77 62.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.469 -0.769 . . . . 6.66 111.872 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -86.5 9.1 19.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.414 -0.804 . . . . 8.2 112.324 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.29 -20.07 57.68 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.325 -0.859 . . . . 8.07 111.371 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -88.29 9.8 21.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.245 -0.91 . . . . 9.45 112.196 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -97.26 24.45 6.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.071 -1.018 . . . . 10.12 112.283 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 118.0 -1.0 . . . . 11.49 109.9 -179.513 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.883 -0.414 . . . . 3.07 109.883 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.3 mt -98.57 114.72 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 106.737 -1.579 . . . . 1.07 106.737 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.5 m -105.24 122.0 45.02 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.629 -1.249 . . . . 1.24 107.629 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.41 -157.4 13.37 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.643 -1.783 . . . . 1.01 108.643 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 5' ' ' ILE . 85.1 mt -92.69 -1.46 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.327 -1.102 . . . . 1.11 112.552 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 tp 49.83 102.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.99 112.227 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.14 -44.44 11.5 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.138 -0.976 . . . . 0.85 111.589 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 m -144.32 143.81 23.43 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 107.971 -1.122 . . . . 1.38 107.971 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.78 143.01 23.21 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.996 2.464 . . . . 0.94 112.344 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.942 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.67 168.09 16.28 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 109.236 -1.546 . . . . 0.81 109.236 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.8 mt -124.35 137.51 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.034 -1.274 . . . . 0.83 107.845 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.17 148.36 43.08 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.323 -0.861 . . . . 0.53 109.081 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 7.3 m-85 -118.0 139.87 50.56 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 108.378 -0.971 . . . . 0.77 108.378 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.2 167.77 35.45 Favored Glycine 0 N--CA 1.499 2.862 0 C-N-CA 118.806 -1.664 . . . . 0.51 110.05 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HZ3' HG12 ' A' ' 156' ' ' VAL . 28.1 mtmm -78.84 159.83 27.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -1.126 . . . . 1.9 109.494 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.93 126.69 34.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.705 -1.247 . . . . 0.66 107.994 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.426 HD12 HD22 ' A' ' 214' ' ' ASN . 48.8 tp -103.53 105.25 15.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.569 -2.011 . . . . 0.83 105.569 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.1 tp -92.14 134.47 34.82 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.866 -1.161 . . . . 0.86 107.866 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.1 mt -102.21 116.45 32.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.081 -1.452 . . . . 0.92 107.081 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -109.46 131.54 54.97 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.537 -1.282 . . . . 2.03 107.537 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -126.89 152.64 46.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.381 -0.824 . . . . 2.66 109.664 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -83.47 134.41 34.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.131 -1.063 . . . . 2.32 108.131 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.87 148.84 50.62 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.752 -0.833 . . . . 2.11 108.752 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.69 132.28 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.306 -0.998 . . . . 0.73 108.306 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.6 t -108.76 129.94 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.857 -1.164 . . . . 0.87 107.857 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.3 133.4 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.391 -0.966 . . . . 0.81 108.391 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -93.24 128.97 39.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.096 -1.002 . . . . 1.34 108.325 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -97.31 18.95 14.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.277 -0.889 . . . . 2.89 112.004 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -71.19 149.01 46.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 2.09 109.783 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -92.37 138.05 31.85 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.413 -0.958 . . . . 2.19 108.413 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 pt -97.44 168.41 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.77 . . . . 0.75 109.932 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.4 p -97.71 167.32 11.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.688 -0.632 . . . . 0.91 109.939 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.77 -24.72 58.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.005 -1.059 . . . . 0.93 111.858 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -68.72 -37.97 79.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 2.28 110.905 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -84.98 -7.26 59.22 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.72 -1.237 . . . . 1.45 112.354 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -58.59 -45.01 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.114 -0.991 . . . . 0.81 110.137 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -57.95 -39.78 78.91 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.967 -1.083 . . . . 1.54 110.588 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -63.08 -45.42 92.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.162 -0.961 . . . . 2.36 111.037 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -59.88 -40.33 88.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.928 -1.108 . . . . 1.31 110.777 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.1 t -59.93 -41.24 85.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.22 -0.925 . . . . 0.82 110.689 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -60.1 -47.23 86.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.917 -1.114 . . . . 1.5 110.078 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -61.36 -40.9 96.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.774 -0.771 . . . . 2.23 110.247 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -75.29 -56.12 5.03 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.572 -0.705 . . . . 0.85 110.307 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 tp -58.01 -45.62 86.57 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.548 -0.861 . . . . 0.91 110.375 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 9.2 t -66.36 -37.08 84.5 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.159 -0.963 . . . . 0.9 109.749 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.66 -41.77 93.9 Favored Glycine 0 N--CA 1.483 1.819 0 C-N-CA 119.582 -1.294 . . . . 0.69 109.937 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 46.0 ttt-85 -59.81 -29.77 68.47 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.172 -1.193 . . . . 2.88 109.924 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -62.35 -49.16 76.67 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.607 0.718 . . . . 0.85 110.493 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -38.79 23.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.954 -1.092 . . . . 2.35 110.684 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.38 93.31 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.105 -0.997 . . . . 0.65 110.074 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.7 p -63.55 -40.8 97.95 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.046 -1.034 . . . . 1.45 109.439 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.59 -48.5 66.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.537 -0.465 . . . . 0.63 110.477 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.77 -49.17 76.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.925 -1.109 . . . . 1.34 110.724 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.15 -39.13 88.94 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.858 -1.151 . . . . 1.56 109.971 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -59.84 -41.0 90.44 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.216 -0.594 . . . . 1.19 110.319 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.509 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 18.7 m -68.49 -45.12 73.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.142 -0.974 . . . . 0.72 110.246 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.8 mt -58.34 -33.95 48.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.338 -0.851 . . . . 0.62 110.815 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -53.07 -42.82 66.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.178 -0.952 . . . . 1.05 110.844 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.58 -36.34 76.17 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.021 -1.049 . . . . 0.64 110.051 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' NZ ' HG22 ' A' ' 56' ' ' THR . 62.4 mttp -62.67 -39.62 94.5 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.75 -1.18 . . . . 1.73 109.447 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.13 -33.97 77.28 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.75 -0.78 . . . . 0.56 109.983 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.15 -36.72 17.18 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.878 -1.153 . . . . 0.69 111.132 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -81.65 -25.41 35.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.06 -1.259 . . . . 1.48 111.189 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.8 m -86.48 -48.33 8.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.557 -0.714 . . . . 0.98 111.042 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -107.94 -9.33 15.71 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.031 1.123 . . . . 1.16 114.031 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.71 166.45 23.45 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.423 -0.894 . . . . 0.85 112.749 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.1 -28.15 50.39 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.702 -0.881 . . . . 3.86 112.409 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -54.44 -40.19 68.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.94 -1.1 . . . . 2.35 110.73 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -85.24 -25.99 26.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.902 -1.124 . . . . 1.67 111.926 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.37 -39.9 84.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.469 -0.769 . . . . 1.45 110.631 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.64 90.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.852 . . . . 0.61 110.89 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.94 -45.68 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.009 -1.057 . . . . 0.65 110.315 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -71.31 -31.0 66.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.66 110.441 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.31 -40.12 89.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.012 -1.055 . . . . 1.19 109.68 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.7 -38.85 93.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.208 -1.157 . . . . 0.53 110.208 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -58.28 -42.07 85.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.227 -1.161 . . . . 1.27 110.489 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.37 -39.34 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.54 110.195 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.3 ttp -59.04 -39.36 81.77 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.178 -0.951 . . . . 1.74 110.491 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.39 -51.39 70.03 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.195 -1.002 . . . . 0.55 110.796 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.76 -38.15 90.03 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.376 -0.827 . . . . 0.47 109.994 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -84.67 4.72 31.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.287 0.847 . . . . 1.42 113.287 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -66.75 123.48 20.24 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.576 -1.328 . . . . 1.27 108.169 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -65.71 -20.19 66.19 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.778 0.799 . . . . 1.35 110.811 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -75.24 -49.46 19.26 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.426 -0.909 . . . . 2.22 110.737 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.2 -40.04 95.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.056 -1.027 . . . . 0.62 110.629 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -60.45 -48.22 82.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.002 -1.061 . . . . 1.29 110.602 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.33 -39.97 92.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.385 -0.822 . . . . 1.52 110.771 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -63.73 -46.5 85.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.022 -1.071 . . . . 1.3 110.256 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.5 mt -58.36 -43.66 86.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.23 -0.919 . . . . 0.61 110.067 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.485 HG22 ' NZ ' ' A' ' 94' ' ' LYS . 66.6 mt -63.24 -44.07 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.467 -0.771 . . . . 0.78 110.61 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.53 -41.28 97.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.82 111.146 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.11 -44.85 96.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.054 -1.028 . . . . 0.8 110.736 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.02 -45.1 99.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.16 -0.963 . . . . 0.77 110.305 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.485 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 22.7 mtmm -83.2 -37.57 23.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 2.12 111.665 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -79.16 -45.33 20.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.821 -1.174 . . . . 1.51 111.453 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -101.55 8.02 42.07 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.187 -0.945 . . . . 1.98 112.272 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 51.85 49.77 20.04 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.329 -0.857 . . . . 1.32 112.097 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.8 mtp -106.78 156.8 18.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.264 -0.897 . . . . 1.38 108.838 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.8 p -72.71 161.18 31.08 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.474 -0.766 . . . . 0.67 110.361 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.62 93.65 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.459 -0.776 . . . . 0.52 110.531 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.46 ' OD1' HG21 ' A' ' 141' ' ' ILE . 97.3 m-20 -68.64 -39.46 80.71 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.069 -1.019 . . . . 2.25 110.392 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.89 -52.34 25.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.186 -1.005 . . . . 0.64 110.84 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.07 92.44 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.1 -1.0 . . . . 0.56 110.519 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.46 96.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.339 -0.851 . . . . 0.46 110.565 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -60.64 -38.86 86.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.166 -0.959 . . . . 1.32 110.738 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -54.95 -49.5 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 1.3 111.158 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.21 -47.28 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.844 -1.16 . . . . 0.61 109.987 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -61.93 -32.35 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.352 0.596 . . . . 0.65 110.568 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -58.51 -40.76 83.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -0.877 . . . . 2.11 111.189 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.41 -37.15 8.31 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.064 -1.541 . . . . 0.83 112.888 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -60.3 -38.89 85.06 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.586 -1.538 . . . . 1.28 110.095 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.61 -51.78 15.66 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.54 0.686 . . . . 0.89 110.89 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.6 p -63.49 -35.77 81.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 1.87 110.606 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.44 96.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.795 . . . . 1.05 110.629 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 80.1 mt -65.79 -29.99 70.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.053 -1.03 . . . . 1.02 110.655 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -67.16 -22.57 65.75 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.353 -0.842 . . . . 2.04 110.933 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -70.32 -16.12 62.96 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.593 -0.843 . . . . 1.73 111.131 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 123' ' ' LEU . 21.8 mt -84.66 144.38 28.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.579 -0.7 . . . . 1.37 109.949 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -97.74 37.36 1.4 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.479 -0.763 . . . . 2.88 111.987 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -113.56 139.22 49.18 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 108.377 -0.972 . . . . 1.58 108.377 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -59.96 -40.64 89.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.484 -0.76 . . . . 3.04 110.775 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.34 -50.9 34.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.788 -1.195 . . . . 0.9 110.177 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 118' ' ' LEU . 35.2 mt -63.23 -42.5 99.25 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.85 -1.14 . . . . 1.06 110.022 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -63.35 -49.01 75.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.787 -1.196 . . . . 2.18 109.266 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -59.94 -31.07 69.51 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.606 -0.838 . . . . 2.15 109.386 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.56 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 17.7 ttt-85 -61.93 -30.44 70.9 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.992 0.901 . . . . 2.33 108.82 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -60.86 -49.37 77.74 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.718 0.771 . . . . 0.82 109.366 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.22 85.59 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.581 -0.848 . . . . 0.85 110.258 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -63.32 -37.41 87.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.552 -0.717 . . . . 1.39 110.417 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.56 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 39.9 t -69.18 -39.7 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 0.56 109.936 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -58.58 -36.55 74.15 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.016 -1.052 . . . . 3.12 109.734 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -59.92 -39.74 86.48 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.455 0.645 . . . . 1.28 110.052 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.1 mt -61.97 -39.55 84.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.438 -0.789 . . . . 0.49 109.509 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.97 -46.8 50.18 Favored Glycine 0 N--CA 1.483 1.773 0 C-N-CA 119.766 -1.207 . . . . 0.46 110.517 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.74 -49.99 71.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -1.155 . . . . 2.71 110.289 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -62.64 -39.25 93.27 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.21 -0.996 . . . . 2.14 109.87 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.33 -39.96 88.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.559 -0.713 . . . . 1.05 110.02 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.47 -44.32 93.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.519 -0.738 . . . . 0.52 110.081 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -60.51 -35.4 75.86 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.102 -0.999 . . . . 2.35 110.26 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -73.06 -40.21 65.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 1.39 110.7 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.46 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.7 mt -60.28 -40.01 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 0.68 109.942 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.459 HD21 ' OD2' ' A' ' 101' ' ' ASP . 91.0 mt -91.01 -3.45 57.23 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.209 -0.932 . . . . 0.83 112.416 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.47 23.23 77.72 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.808 -1.187 . . . . 0.91 113.13 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.9 tp -66.16 149.26 50.58 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.744 -0.856 . . . . 0.95 109.284 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -64.64 144.91 56.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 2.43 109.433 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 53.8 mt -105.46 143.12 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.436 -0.949 . . . . 1.1 108.436 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.587 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.2 mp -77.8 125.03 37.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.09 -1.078 . . . . 1.58 108.09 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -95.89 93.16 6.88 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.585 -1.635 . . . . 1.62 106.585 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.9 mt -78.81 -16.53 57.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 0.8 111.981 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.5 m -80.66 0.76 32.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.338 -0.851 . . . . 1.56 112.572 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.03 19.75 14.58 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.24 -0.913 . . . . 0.84 112.459 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.0 mt -74.86 136.72 24.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.515 0.674 . . . . 0.82 109.3 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -125.17 -2.78 7.58 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.448 0.642 . . . . 2.31 112.51 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -116.86 134.28 54.96 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.248 -1.019 . . . . 1.54 108.248 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.72 119.1 15.4 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.075 -0.713 . . . . 1.38 109.075 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.477 HG12 ' HZ3' ' A' ' 15' ' ' LYS . 27.8 m -147.38 172.27 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.518 -0.739 . . . . 0.69 109.286 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.1 mt -87.33 142.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 0.53 109.093 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 25.6 tp -96.46 123.76 40.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.077 -1.014 . . . . 0.64 108.432 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.68 129.74 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 107.594 -1.261 . . . . 0.67 107.594 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.14 152.53 19.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.033 -1.042 . . . . 0.78 108.95 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.68 -35.46 76.31 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.585 -1.322 . . . . 1.0 109.424 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 64.2 t0 -172.54 147.26 1.83 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.268 -0.641 . . . . 2.42 109.268 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.502 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 82.3 mt -116.23 141.61 47.92 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.179 -0.675 . . . . 0.75 109.179 177.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.5 p -94.08 150.25 38.15 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.159 -0.963 . . . . 0.78 109.152 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -42.02 -44.3 7.23 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.007 1.805 . . . . 0.67 113.719 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.8 m -59.94 -48.25 82.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.883 -1.136 . . . . 0.7 110.055 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.95 -40.69 95.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.225 -0.99 . . . . 1.21 110.126 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 70.7 p -70.22 -39.01 75.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.6 110.401 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.04 -34.35 74.72 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.896 -0.722 . . . . 0.62 110.881 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -95.7 1.37 53.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.074 -1.017 . . . . 1.16 112.521 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.51 152.02 31.3 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.384 -0.822 . . . . 0.73 109.778 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -93.65 110.91 22.51 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.057 -1.831 . . . . 2.24 106.057 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.1 mt -72.26 -21.15 61.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.638 -0.664 . . . . 1.43 112.318 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -82.53 -23.57 34.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.929 -1.107 . . . . 2.15 112.386 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -97.15 -4.98 38.24 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.035 -1.041 . . . . 2.04 113.094 -178.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.2 t -108.34 128.78 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.566 -1.272 . . . . 0.55 107.566 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.1 tp -88.5 -12.05 44.06 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.403 -0.811 . . . . 1.63 112.241 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 179.26 167.72 37.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.639 -1.785 . . . . 0.47 108.639 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -128.01 131.48 49.2 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.255 -1.144 . . . . 0.54 108.458 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.448 ' CG2' HG21 ' A' ' 205' ' ' THR . 76.8 mt -127.12 129.91 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.172 -1.418 . . . . 0.69 107.172 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 203' ' ' VAL . 37.8 p -138.96 169.95 16.86 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.593 -1.317 . . . . 0.82 110.066 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.438 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 4.3 m-20 -101.07 35.5 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.875 -0.515 . . . . 2.37 111.53 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -99.88 121.71 41.73 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.922 -1.112 . . . . 1.11 108.325 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.38 19.42 43.76 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.255 -0.974 . . . . 1.67 112.189 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -82.54 118.78 4.7 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.148 -1.981 . . . . 1.54 108.148 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -57.98 -29.95 65.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.986 -1.302 . . . . 4.48 109.747 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 63.9 p -108.4 38.76 2.14 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.414 0.626 . . . . 2.63 110.195 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.6 t -70.22 150.69 46.17 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.598 0.713 . . . . 1.69 109.416 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -57.6 -39.66 77.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -0.875 . . . . 1.07 111.088 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 44.1 p -59.74 -41.4 90.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.068 -1.02 . . . . 1.58 110.498 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 59.9 p -61.15 -35.49 77.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 1.6 110.367 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.03 -39.59 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 1.45 110.852 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 66.0 mtp -62.89 -40.78 98.59 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.233 1.016 . . . . 1.05 109.409 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.44 -48.95 79.67 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.739 -0.664 . . . . 0.72 110.297 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 195' ' ' ARG . 38.7 mtt-85 -61.16 -41.57 97.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.238 -0.914 . . . . 3.05 110.938 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m -70.3 -40.57 74.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.963 -1.086 . . . . 0.89 110.539 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.57 -9.1 48.34 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.043 0.757 . . . . 0.78 113.043 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.5 mt-10 55.63 8.35 0.32 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.794 1.035 . . . . 1.45 113.794 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 56.8 mt -72.56 147.98 90.0 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 0.67 108.267 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.76 136.3 72.89 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 120.982 1.121 . . . . 0.64 110.027 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.31 164.63 34.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.398 -1.439 . . . . 0.67 109.429 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 203' ' ' VAL . 99.1 mt -144.1 160.19 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.335 -1.357 . . . . 0.69 107.335 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.497 ' N ' HG22 ' A' ' 202' ' ' ILE . 15.7 m -139.09 -27.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 120.818 -1.176 . . . . 0.85 112.023 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.75 41.03 3.04 Favored Glycine 0 N--CA 1.492 2.43 0 O-C-N 121.242 -0.911 . . . . 0.92 111.841 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.448 HG21 ' CG2' ' A' ' 180' ' ' ILE . 46.9 p -62.69 -23.72 67.28 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.24 -1.153 . . . . 0.95 111.007 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.04 -92.17 1.78 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.077 -1.059 . . . . 1.04 110.668 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 86.0 p -128.35 30.61 5.16 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.178 -1.189 . . . . 1.57 112.302 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.21 -33.68 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.264 -1.522 . . . . 0.84 110.107 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 26.0 p -58.14 -26.76 63.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.987 -1.071 . . . . 0.99 111.52 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.8 t -93.58 1.82 56.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.301 -0.875 . . . . 1.7 111.999 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -123.95 -0.53 8.43 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 112.911 0.708 . . . . 2.2 112.911 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 11.1 t -120.01 150.87 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.52 -0.737 . . . . 0.84 109.853 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -118.73 157.81 26.77 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.918 -1.142 . . . . 2.2 107.918 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.426 HD22 HD12 ' A' ' 17' ' ' LEU . 12.5 t-20 -59.26 141.2 54.96 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.978 -1.076 . . . . 2.28 110.492 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.3 m-20 80.75 -1.5 1.85 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 114.525 1.306 . . . . 2.35 114.525 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -62.33 148.85 43.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.34 -1.475 . . . . 1.97 108.176 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -88.57 120.84 30.32 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.311 -1.366 . . . . 2.65 107.311 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.8 mt -128.48 146.38 50.83 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.664 0.745 . . . . 0.63 109.905 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.11 126.76 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.617 -1.623 . . . . 0.62 106.617 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 65.5 tp -100.52 119.64 38.81 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.355 -1.721 . . . . 0.64 106.355 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 53.3 t0 -92.25 -26.4 18.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.893 -1.13 . . . . 2.05 112.518 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.942 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.11 13.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.137 0.791 . . . . 0.84 113.137 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.2 t -108.27 -59.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.741 -1.224 . . . . 1.02 109.695 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -92.68 10.12 32.01 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.018 0.913 . . . . 2.51 110.561 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 62.15 53.58 2.89 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.659 -0.7 . . . . 1.54 112.242 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -147.0 149.06 32.4 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.371 1.081 . . . . 1.95 109.645 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.1 t -115.98 133.33 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.444 -1.317 . . . . 0.71 107.444 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.11 132.57 46.5 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.026 -1.047 . . . . 1.01 108.468 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 60.4 t -110.48 129.94 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.365 -0.834 . . . . 0.82 108.763 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.4 t30 54.34 55.2 11.73 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.15 -0.969 . . . . 1.54 113.232 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.09 150.42 60.06 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.582 2.188 . . . . 0.94 111.322 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.5 m -75.2 158.87 32.29 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.254 -0.904 . . . . 1.8 109.313 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.58 ' HA ' HD12 ' A' ' 236' ' ' ILE . 81.8 m-20 -58.75 -39.09 79.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 2.73 110.688 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -58.82 -40.17 83.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -0.937 . . . . 3.17 109.865 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.65 -39.09 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 1.34 110.105 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 233' ' ' ASN . 95.4 mt -57.35 -47.26 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.818 -0.753 . . . . 1.2 110.715 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.92 -40.22 88.12 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.326 -0.859 . . . . 2.7 110.557 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -61.17 -48.12 83.03 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.401 -0.812 . . . . 2.59 111.289 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 81.9 mtp -70.44 -33.1 70.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 1.38 111.092 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -58.05 -40.4 80.83 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.983 -1.073 . . . . 2.84 110.076 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.11 -36.97 66.85 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.418 -0.801 . . . . 1.88 110.676 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 246' ' ' VAL . 82.5 t -58.86 -49.7 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.206 -0.934 . . . . 2.4 111.097 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.427 ' OE1' ' N ' ' A' ' 244' ' ' GLU . 20.9 tm0? -61.58 -52.09 65.83 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.775 -1.203 . . . . 3.52 110.362 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.427 ' N ' ' OE1' ' A' ' 243' ' ' GLN . 85.8 mt-10 -62.23 -34.42 76.48 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.715 -0.794 . . . . 1.88 110.125 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -62.81 -30.02 71.16 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.373 -0.931 . . . . 3.01 110.024 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 242' ' ' VAL . 91.7 t -61.42 -44.92 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.251 -0.98 . . . . 2.45 109.875 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.28 96.55 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.069 -1.052 . . . . 2.75 109.901 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.3 t -72.41 -30.42 64.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.586 -0.696 . . . . 3.16 110.805 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.46 -40.0 89.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.055 -1.028 . . . . 3.57 110.921 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -65.0 -39.81 94.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.843 -1.161 . . . . 4.3 110.424 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.86 -26.3 63.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.201 -0.937 . . . . 4.45 111.273 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -69.07 -48.86 61.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.113 -0.992 . . . . 5.97 110.624 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 3.1 pp -71.08 -22.85 62.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.1 -1.0 . . . . 6.18 111.622 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -70.37 -20.31 62.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 6.66 111.707 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -77.64 -46.27 22.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.135 -0.978 . . . . 8.2 110.981 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.3 56.75 2.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.997 -1.065 . . . . 8.07 110.771 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -84.6 -8.95 58.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.942 -1.099 . . . . 9.45 112.058 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -93.76 9.57 36.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.581 -0.699 . . . . 10.12 112.548 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 118.046 -0.978 . . . . 11.49 110.361 -179.389 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.671 -0.492 . . . . 3.07 109.671 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 1' ' ' MET . 40.1 mt 41.2 68.17 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.837 . . . . 1.07 111.962 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.0 m -97.38 116.67 30.02 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.576 -1.639 . . . . 1.24 106.576 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.78 -153.47 30.29 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 120.441 -1.412 . . . . 1.01 109.912 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 5' ' ' ILE . 74.6 mt -94.43 1.01 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.586 -0.949 . . . . 1.11 112.552 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 tp 52.52 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.685 -1.26 . . . . 0.99 112.444 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.54 -35.33 17.01 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.648 -1.283 . . . . 0.85 110.744 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 1.2 p -148.67 140.96 14.85 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.711 -1.243 . . . . 1.38 108.083 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.0 147.88 24.33 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.151 1.901 . . . . 0.94 112.347 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.929 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.56 163.64 11.79 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.265 -1.534 . . . . 0.81 109.265 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.5 mt -121.05 134.33 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.057 -1.261 . . . . 0.83 108.345 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.25 151.85 44.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.193 -0.942 . . . . 0.53 109.416 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 7.9 m-85 -122.06 144.46 48.9 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.431 -0.951 . . . . 0.77 108.431 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.85 166.27 31.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.551 -1.785 . . . . 0.51 110.092 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -77.88 159.68 28.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.329 -1.101 . . . . 1.9 109.204 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -87.53 127.69 35.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.792 -1.188 . . . . 0.66 107.792 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.2 tp -106.11 109.53 21.49 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 105.468 -2.049 . . . . 0.83 105.468 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 18' ' ' LEU . 14.8 tp -95.58 136.27 36.17 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.414 -1.328 . . . . 0.86 107.414 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.8 mt -99.8 118.82 37.09 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.062 -1.459 . . . . 0.92 107.062 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -112.05 136.19 51.72 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.65 -1.241 . . . . 2.03 107.65 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -130.33 151.96 50.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.251 -0.906 . . . . 2.66 109.149 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -80.06 138.35 36.96 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.478 -0.934 . . . . 2.32 108.478 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -63.79 149.33 47.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.454 -0.779 . . . . 2.11 109.002 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.6 mt -92.69 129.97 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.915 -1.116 . . . . 0.73 108.651 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.9 t -105.36 130.01 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.529 -1.285 . . . . 0.87 107.529 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.27 135.03 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.654 -0.869 . . . . 0.81 108.654 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -90.91 122.1 33.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.075 -1.016 . . . . 1.34 108.512 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -95.4 11.8 31.52 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.591 -0.693 . . . . 2.89 112.106 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -66.97 141.54 57.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.88 -1.138 . . . . 2.09 108.885 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -88.9 134.16 34.05 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.138 -1.06 . . . . 2.19 108.138 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -97.78 167.14 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.394 -0.816 . . . . 0.75 110.477 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.6 p -94.67 160.95 14.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.686 -0.633 . . . . 0.91 109.53 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.41 -21.92 11.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.903 -1.123 . . . . 0.93 111.94 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -67.53 -37.24 82.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 2.28 110.753 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -90.25 -8.5 50.85 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.649 -1.282 . . . . 1.45 112.587 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.1 t -58.89 -39.82 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.446 -0.784 . . . . 0.81 110.553 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -56.33 -40.24 74.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.929 -1.107 . . . . 1.54 110.187 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.29 -39.5 94.74 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.432 -0.793 . . . . 2.36 111.045 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.46 -43.54 96.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.025 -1.047 . . . . 1.31 110.707 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.24 -40.85 84.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.23 -0.918 . . . . 0.82 110.501 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -60.58 -45.37 94.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.237 -0.914 . . . . 1.5 110.107 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -61.83 -40.57 95.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.582 -0.699 . . . . 2.23 110.287 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -74.02 -52.84 11.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.094 -1.004 . . . . 0.85 109.934 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.6 tp -61.77 -47.96 82.84 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.554 -0.859 . . . . 0.91 110.09 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.1 t -69.92 -38.06 76.13 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.289 -0.882 . . . . 0.9 109.703 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.89 -40.8 95.71 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.037 -1.625 . . . . 0.69 109.037 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.564 HH22 ' CD ' ' A' ' 86' ' ' GLU . 17.2 ttm180 -59.2 -30.69 68.4 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.737 0.779 . . . . 2.88 109.334 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.29 -49.79 76.5 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.614 0.721 . . . . 0.85 110.365 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -82.7 -38.33 23.51 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.297 -0.877 . . . . 2.35 110.169 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.5 -44.85 95.54 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.84 -0.744 . . . . 0.65 109.905 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.8 t -60.13 -40.21 88.99 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.339 1.066 . . . . 1.45 108.797 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.62 -45.93 88.04 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.648 -0.706 . . . . 0.63 109.771 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -61.46 -50.44 72.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.995 -1.065 . . . . 1.34 110.324 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.26 -39.83 91.81 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.321 -0.862 . . . . 1.56 110.071 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -59.9 -43.11 95.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.887 -0.508 . . . . 1.19 110.619 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 m -63.96 -42.36 97.3 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.789 -1.194 . . . . 0.72 109.948 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.6 -35.2 61.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.68 -0.638 . . . . 0.62 110.337 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -53.03 -41.51 64.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.431 -0.793 . . . . 1.05 110.442 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -70.34 -35.42 73.59 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.376 -0.828 . . . . 0.64 109.691 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.48 -40.9 92.93 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.221 -0.991 . . . . 1.73 109.045 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.08 -36.01 82.18 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 120.178 -0.609 . . . . 0.56 109.47 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.2 -35.07 27.92 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.588 -1.291 . . . . 0.69 110.435 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.36 -16.98 50.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.318 -1.107 . . . . 1.48 111.209 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.6 m -91.24 -54.88 3.74 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.264 0.554 . . . . 0.98 110.381 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 67' ' ' GLU . 61.5 m-85 -107.35 -30.48 8.67 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.11 0.782 . . . . 1.16 113.11 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 61.48 -26.13 0.06 OUTLIER Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.536 -1.316 . . . . 0.85 115.059 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 65' ' ' PHE . 52.5 mt-10 -54.84 -166.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.556 -0.967 . . . . 3.86 109.844 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -66.57 7.29 0.36 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 112.953 0.723 . . . . 2.35 112.953 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -68.6 -24.64 64.6 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.461 -0.774 . . . . 1.67 111.375 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -58.65 -40.21 82.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.021 -1.049 . . . . 1.45 110.687 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.83 -36.56 84.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.869 . . . . 0.61 110.958 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 72' ' ' ILE . 13.3 mt -64.8 -45.91 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.65 110.718 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -69.62 -33.96 73.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.863 -1.148 . . . . 0.66 110.257 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.44 -39.23 90.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.302 -0.874 . . . . 1.19 110.174 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.09 -37.74 95.01 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.664 -0.974 . . . . 0.53 110.664 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -59.84 -41.98 92.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -1.114 . . . . 1.27 110.343 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.8 mt -61.2 -40.96 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.09 . . . . 0.54 110.43 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.3 ttt -59.71 -39.65 85.35 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 120.97 -1.081 . . . . 1.74 110.523 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 tp -58.43 -49.98 75.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.114 -0.991 . . . . 0.55 110.199 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.5 tp -61.67 -42.08 98.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.099 -1.001 . . . . 0.47 109.961 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -86.63 9.08 19.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.482 -0.762 . . . . 1.42 112.564 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.05 121.45 14.19 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.12 -0.988 . . . . 1.27 108.505 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.63 -18.89 65.12 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.455 -0.778 . . . . 1.35 111.067 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.61 -50.63 14.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.51 -0.876 . . . . 2.22 110.41 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.28 -35.39 77.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.208 -0.597 . . . . 0.62 110.684 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.564 ' CD ' HH22 ' A' ' 47' ' ' ARG . 72.5 tt0 -59.77 -47.45 85.62 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.444 -0.785 . . . . 1.29 110.473 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -61.22 -37.48 83.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.35 -0.844 . . . . 1.52 110.756 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -68.44 -48.83 63.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 1.3 110.673 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.5 mt -57.6 -43.51 83.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.179 -0.95 . . . . 0.61 110.242 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.0 mt -60.09 -40.63 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.462 -0.774 . . . . 0.78 110.411 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.42 95.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.563 -0.711 . . . . 0.82 110.685 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.31 -45.61 92.78 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.96 -1.087 . . . . 0.8 110.313 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.28 -49.11 80.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.155 -0.966 . . . . 0.77 110.335 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -73.8 -36.44 65.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.916 -1.115 . . . . 2.12 111.842 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -78.5 -47.77 16.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.833 -1.167 . . . . 1.51 111.469 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -101.48 7.43 42.45 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.422 -0.799 . . . . 1.98 112.846 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.4 m80 52.39 50.1 19.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.824 -1.173 . . . . 1.32 111.661 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtt -102.98 158.1 16.52 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.843 0.83 . . . . 1.38 109.16 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.418 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 66.9 p -74.87 161.9 29.13 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.817 -0.552 . . . . 0.67 109.963 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.87 92.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.993 -1.067 . . . . 0.52 110.395 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.418 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 16.7 p-10 -68.64 -39.83 80.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.018 -1.051 . . . . 2.25 110.26 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.26 -51.36 38.26 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.548 -0.861 . . . . 0.64 111.307 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.09 92.78 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.153 -1.019 . . . . 0.56 110.838 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.37 85.23 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.27 -0.894 . . . . 0.46 110.965 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -61.64 -38.88 89.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.686 -1.259 . . . . 1.32 111.499 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.83 -48.98 79.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.779 -1.201 . . . . 1.3 111.219 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.85 -45.99 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.912 -1.118 . . . . 0.61 110.248 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 mm -61.95 -31.13 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.814 . . . . 0.65 109.91 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -59.8 -41.37 91.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 2.11 110.892 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.59 -34.12 12.24 Favored Glycine 0 N--CA 1.498 2.828 0 C-N-CA 119.084 -1.532 . . . . 0.83 112.478 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -60.9 -39.89 91.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.529 -1.571 . . . . 1.28 110.215 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.49 55.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.378 0.609 . . . . 0.89 110.6 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.5 p -62.6 -40.48 97.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.437 -0.789 . . . . 1.87 110.275 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.96 -41.26 96.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 1.05 111.087 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.6 mt -65.67 -30.67 71.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.772 -1.205 . . . . 1.02 111.084 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -66.66 -21.81 66.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.872 -1.143 . . . . 2.04 111.079 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -73.28 -14.18 61.27 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.192 -0.943 . . . . 1.73 111.57 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.407 HD13 HD13 ' A' ' 123' ' ' LEU . 8.1 mt -84.26 142.54 30.18 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.582 -0.699 . . . . 1.37 109.26 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -100.39 55.23 0.89 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 2.88 110.737 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -129.98 137.86 50.53 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.211 -1.033 . . . . 1.58 108.211 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -58.99 -36.61 75.16 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.134 -0.626 . . . . 3.04 110.816 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -73.9 -52.46 12.87 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.791 -1.193 . . . . 0.9 110.381 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.407 HD13 HD13 ' A' ' 118' ' ' LEU . 23.1 mt -64.07 -43.72 94.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.06 -1.025 . . . . 1.06 110.27 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -61.14 -47.35 86.61 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.641 -1.287 . . . . 2.18 109.857 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -61.77 -29.28 70.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.083 -1.011 . . . . 2.15 110.014 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 130' ' ' VAL . 56.0 ttt180 -65.15 -29.0 69.8 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.537 -0.865 . . . . 2.33 109.365 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.55 -49.83 76.27 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.613 -0.835 . . . . 0.82 109.698 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.23 85.02 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.007 -0.677 . . . . 0.85 110.248 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.54 -38.26 90.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.226 -0.921 . . . . 1.39 110.439 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 126' ' ' ARG . 55.2 t -67.92 -40.18 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.913 -1.117 . . . . 0.56 109.839 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -60.08 -37.8 80.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.892 -1.13 . . . . 3.12 110.21 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.54 ' CG ' HH11 ' A' ' 136' ' ' ARG . 42.1 t0 -59.87 -39.23 84.56 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.209 -0.932 . . . . 1.28 110.535 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.31 -39.43 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.562 -0.711 . . . . 0.49 110.1 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.06 -50.48 45.97 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.89 -1.147 . . . . 0.46 110.603 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -59.42 -47.02 87.04 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.112 -1.228 . . . . 2.71 110.534 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.54 HH11 ' CG ' ' A' ' 132' ' ' ASP . 14.8 mtm-85 -64.58 -39.85 94.47 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.067 -1.053 . . . . 2.14 109.883 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.1 tp -61.24 -39.91 92.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.05 110.15 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 73.2 mt -59.34 -40.26 85.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.52 110.704 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.431 ' HE ' HD23 ' A' ' 144' ' ' LEU . 58.0 mtp180 -61.19 -34.52 75.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.128 -0.983 . . . . 2.35 110.344 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -75.58 -40.73 56.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.021 -1.049 . . . . 1.39 110.587 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 98.1 mt -60.04 -39.48 80.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 120.812 -1.18 . . . . 0.68 110.479 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.88 -7.93 58.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.83 111.659 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.26 22.62 64.88 Favored Glycine 0 N--CA 1.483 1.807 0 C-N-CA 120.104 -1.046 . . . . 0.91 113.367 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.431 HD23 ' HE ' ' A' ' 139' ' ' ARG . 43.6 tp -66.41 145.92 55.14 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.744 -0.857 . . . . 0.95 109.418 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -64.5 148.57 50.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.418 -0.801 . . . . 2.43 109.322 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.2 mt -108.61 140.11 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.47 -0.937 . . . . 1.1 108.47 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 21.2 mm -79.77 129.55 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.972 -1.08 . . . . 1.58 108.754 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -96.95 95.67 7.98 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.149 -1.797 . . . . 1.62 106.149 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.43 -22.19 61.13 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.498 -0.751 . . . . 0.8 111.088 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.5 t -78.13 -0.53 28.62 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.084 0.945 . . . . 1.56 112.316 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.9 25.48 5.29 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.438 -0.789 . . . . 0.84 112.236 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.8 mt -71.05 139.97 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.465 -0.772 . . . . 0.82 109.566 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -115.17 -19.89 10.63 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 2.31 112.949 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -117.27 139.61 50.59 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.885 -1.154 . . . . 1.54 107.885 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.6 126.69 30.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.449 -0.945 . . . . 1.38 108.449 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.7 m -149.5 175.16 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.01 -1.056 . . . . 0.69 109.166 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.9 mt -89.09 142.35 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.53 108.644 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 27.6 tp -96.79 124.02 40.65 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.459 -0.941 . . . . 0.64 108.459 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.1 t -125.02 131.98 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.293 -1.003 . . . . 0.67 108.293 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.48 157.63 19.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.78 108.982 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -64.99 -35.35 80.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.686 -1.259 . . . . 1.0 109.304 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.7 t0 -171.45 152.71 3.32 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.845 -0.798 . . . . 2.42 108.845 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.472 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 66.3 mt -115.09 142.98 45.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.677 -0.86 . . . . 0.75 108.677 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.8 p -92.95 147.18 33.43 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.462 -0.773 . . . . 0.78 108.938 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -40.31 -42.04 3.55 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.511 1.474 . . . . 0.67 113.587 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.1 m -61.6 -48.14 82.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.799 -1.188 . . . . 0.7 110.278 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.13 -39.46 89.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.023 -1.048 . . . . 1.21 110.87 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -68.79 -40.51 79.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.344 -0.847 . . . . 0.6 110.783 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.48 79.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -0.949 . . . . 0.62 110.464 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -93.65 -2.39 54.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.913 -1.117 . . . . 1.16 112.396 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 171' ' ' LEU . 42.6 tp -62.13 146.77 49.58 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.251 -1.018 . . . . 0.73 108.251 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -95.33 116.96 29.48 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.727 -1.582 . . . . 2.24 106.727 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.694 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -73.52 -18.82 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.419 -0.801 . . . . 1.43 111.41 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -82.78 -18.26 41.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.526 -0.734 . . . . 2.15 112.293 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -104.15 -6.12 21.34 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.312 0.856 . . . . 2.04 113.312 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 178' ' ' GLY . 52.2 t -108.54 129.67 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.559 -1.275 . . . . 0.55 107.559 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 29.7 tp -82.89 -8.77 59.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.054 -1.029 . . . . 1.63 112.543 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.547 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.98 177.52 38.77 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.599 -1.8 . . . . 0.47 108.599 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -129.28 135.84 49.3 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.975 -1.309 . . . . 0.54 107.588 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.483 HG22 HG21 ' A' ' 205' ' ' THR . 75.1 mt -138.01 105.15 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.145 -1.798 . . . . 0.69 106.145 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 203' ' ' VAL . 76.7 p -129.68 168.94 15.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.357 -0.84 . . . . 0.82 109.416 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 26.1 p-10 -98.68 47.95 0.98 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.737 -0.602 . . . . 2.37 110.93 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.403 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -99.34 164.54 12.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.395 -0.816 . . . . 1.11 110.416 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 183' ' ' ALA . . . -54.23 -100.6 0.01 OUTLIER Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.298 -1.521 . . . . 1.67 109.298 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 164.93 -58.87 0.25 Allowed Glycine 0 N--CA 1.492 2.427 0 O-C-N 121.095 -1.238 . . . . 1.54 112.596 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -57.51 -45.43 84.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -1.094 . . . . 4.48 110.231 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.3 p -109.22 17.78 21.21 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.529 -0.732 . . . . 2.63 112.238 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 53.5 m -88.03 126.83 35.3 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.717 -1.216 . . . . 1.69 107.717 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -60.63 -35.53 76.41 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.383 -0.823 . . . . 1.07 110.422 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.6 p -56.31 -39.7 73.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.167 -0.958 . . . . 1.58 109.982 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.4 m -59.2 -37.29 77.07 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.934 -0.707 . . . . 1.6 110.098 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -59.9 -38.85 78.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.498 -0.751 . . . . 1.45 110.309 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 69.9 mtp -64.1 -40.21 95.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.671 -1.268 . . . . 1.05 109.457 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.8 -48.92 79.73 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.027 -0.533 . . . . 0.72 111.384 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -59.37 -43.95 92.81 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.19 -0.944 . . . . 3.05 110.432 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.1 m -68.97 -40.18 79.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.339 -0.851 . . . . 0.89 110.226 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.6 mt -91.78 -9.32 43.97 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.811 0.815 . . . . 0.78 112.126 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.8 mt-10 47.46 14.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.472 0.916 . . . . 1.45 113.472 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 59.6 mt -75.41 150.27 84.73 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.953 -1.092 . . . . 0.67 108.538 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -51.49 140.51 44.2 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.393 1.396 . . . . 0.64 109.302 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.442 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -159.05 163.61 36.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.209 -1.557 . . . . 0.67 109.829 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.5 mt -147.17 147.04 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.761 -1.2 . . . . 0.69 107.761 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 181' ' ' THR . 9.9 m -129.11 -29.19 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 113.251 0.834 . . . . 0.85 113.251 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.61 46.35 3.66 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 120.344 -0.931 . . . . 0.92 111.97 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.483 HG21 HG22 ' A' ' 180' ' ' ILE . 65.8 p -66.78 -12.88 60.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.965 -1.315 . . . . 0.95 111.229 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.85 -94.42 0.68 Allowed Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.038 -1.077 . . . . 1.04 110.49 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -129.52 31.21 4.82 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.522 -0.987 . . . . 1.57 112.144 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.86 -33.34 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.617 -1.302 . . . . 0.84 110.474 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 80.5 p -56.33 -28.22 58.24 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.076 -1.015 . . . . 0.99 111.171 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 26.4 t -92.26 0.69 57.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.101 -1.0 . . . . 1.7 112.214 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -120.33 -4.19 9.94 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.545 0.943 . . . . 2.2 113.545 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.3 149.42 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.227 -0.92 . . . . 0.84 109.285 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -117.62 149.61 40.39 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.535 -0.913 . . . . 2.2 108.535 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 38.4 p-10 -50.47 141.33 12.34 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.384 -0.926 . . . . 2.28 110.366 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 8.8 t0 81.49 4.06 1.41 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 114.219 1.192 . . . . 2.35 114.219 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -66.7 145.62 55.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.883 -1.136 . . . . 1.97 108.252 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -88.13 119.53 28.6 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.328 -1.36 . . . . 2.65 107.328 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.445 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 85.2 mt -128.66 150.3 50.3 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.506 0.669 . . . . 0.63 110.155 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 56.5 mt -115.09 122.17 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 106.675 -1.602 . . . . 0.62 106.675 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.479 HD13 HD11 ' A' ' 180' ' ' ILE . 62.0 tp -98.99 115.8 29.77 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 106.754 -1.572 . . . . 0.64 106.754 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 9.3 m-20 -95.47 -24.39 16.68 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.414 -0.914 . . . . 2.05 112.606 -177.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.929 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.21 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.652 0.739 . . . . 0.84 112.176 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.7 t -111.38 -61.29 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.654 -0.869 . . . . 1.02 108.654 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -91.13 9.55 30.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.145 0.974 . . . . 2.51 110.159 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 61.93 51.35 3.77 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 114.921 -1.036 . . . . 1.54 111.986 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -153.17 152.79 31.64 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.798 1.285 . . . . 1.95 110.497 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.0 t -117.38 140.79 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.527 -0.916 . . . . 0.71 108.527 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -100.78 132.82 45.99 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.85 -1.156 . . . . 1.01 108.56 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.1 t -109.79 129.55 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.419 -0.956 . . . . 0.82 108.419 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.445 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER 56.38 48.17 3.35 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 113.734 1.013 . . . . 1.54 113.734 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 58.7 Cg_endo -70.61 150.54 63.18 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.292 1.995 . . . . 0.94 111.138 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.7 m -72.93 153.74 40.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.984 -1.073 . . . . 1.8 109.027 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 31.6 p-10 -59.82 -33.38 71.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.93 . . . . 2.73 110.441 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 97.7 mt-10 -60.12 -39.78 87.45 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.294 -0.879 . . . . 3.17 110.161 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.86 -38.93 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.898 . . . . 1.34 109.883 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.52 -45.04 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.897 -0.721 . . . . 1.2 110.627 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -59.88 -42.08 92.97 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.022 -1.071 . . . . 2.7 110.193 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -62.23 -41.15 98.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -0.922 . . . . 2.59 110.328 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.0 mtp -71.42 -40.27 70.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.256 -0.902 . . . . 1.38 110.507 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -59.85 -40.9 90.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 2.84 110.08 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.81 -57.87 4.2 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.961 -1.087 . . . . 1.88 111.055 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 97.4 t -60.03 -41.26 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.726 -1.234 . . . . 2.4 111.042 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -62.97 -50.16 71.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.888 -1.132 . . . . 3.52 110.832 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -63.37 -37.27 86.62 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.173 -0.954 . . . . 1.88 110.93 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -59.89 -29.19 68.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.424 -1.423 . . . . 3.01 110.631 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.47 -41.22 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 119.449 -0.901 . . . . 2.45 109.421 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.79 -39.46 81.14 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.047 -0.661 . . . . 2.75 110.645 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.5 t -70.06 -44.35 69.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.037 -1.039 . . . . 3.16 110.048 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -64.29 -33.54 76.06 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.614 -0.678 . . . . 3.57 110.074 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.88 -33.74 76.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -0.822 . . . . 4.3 110.861 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.39 97.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.983 -1.073 . . . . 4.45 110.123 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.73 -17.54 61.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 5.97 111.048 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.2 tp -67.27 -25.63 66.15 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.572 0.701 . . . . 6.18 110.914 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.26 -13.83 62.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.265 -0.897 . . . . 6.66 112.359 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -82.28 -5.47 58.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.095 -1.003 . . . . 8.2 112.206 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 62.0 mt -87.35 39.3 0.86 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.256 -0.903 . . . . 8.07 112.382 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -81.49 8.19 10.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.406 -0.809 . . . . 9.45 112.184 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -91.61 11.88 22.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.211 -0.931 . . . . 10.12 112.029 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.462 -0.94 . . . . 11.49 108.462 179.223 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.151 0.5 . . . . 3.07 110.274 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mt 48.29 74.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.849 -1.157 . . . . 1.07 112.904 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.0 m -100.01 119.13 37.78 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.832 -1.544 . . . . 1.24 106.832 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.85 -141.35 9.92 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.615 -0.994 . . . . 1.01 110.615 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 5' ' ' ILE . 94.3 mt -97.71 -1.91 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.558 -0.966 . . . . 1.11 113.008 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp 52.06 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.846 -1.159 . . . . 0.99 112.265 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.23 -46.95 12.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.245 -0.909 . . . . 0.85 111.193 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -143.4 145.33 31.5 Favored Pre-proline 0 N--CA 1.5 2.048 0 N-CA-C 107.784 -1.191 . . . . 1.38 107.784 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.82 150.22 26.96 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.26 1.973 . . . . 0.94 112.309 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.909 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 149.81 170.82 17.65 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 108.946 -1.662 . . . . 0.81 108.946 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.573 HD12 ' OE1' ' A' ' 243' ' ' GLN . 7.4 mt -128.31 133.5 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 120.961 -1.317 . . . . 0.83 107.828 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.08 145.16 47.66 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.663 -0.866 . . . . 0.53 108.663 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.7 m-85 -117.39 141.04 48.81 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.302 -0.874 . . . . 0.77 109.051 177.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.21 168.17 36.01 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.474 -1.822 . . . . 0.51 110.096 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -76.59 160.52 29.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.861 -0.788 . . . . 1.9 109.943 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.98 126.23 31.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.077 -1.015 . . . . 0.66 108.38 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.1 tp -108.07 102.77 11.91 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 105.0 -2.222 . . . . 0.83 105.0 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.5 tp -90.58 138.06 31.86 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.602 -1.258 . . . . 0.86 107.602 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 160' ' ' ALA . 36.9 mt -100.01 117.45 34.31 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.739 -1.578 . . . . 0.92 106.739 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -111.93 140.08 46.89 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.27 -1.011 . . . . 2.03 108.27 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.517 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 71.5 tt0 -123.82 139.82 53.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 2.66 108.802 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.85 133.54 34.74 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.982 -1.118 . . . . 2.32 107.982 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -62.19 143.01 57.34 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.633 -0.877 . . . . 2.11 108.633 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.3 mt -95.23 135.44 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.121 -0.987 . . . . 0.73 108.363 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.71 129.93 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.349 -0.982 . . . . 0.87 108.349 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.94 139.74 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.487 -0.931 . . . . 0.81 108.487 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -91.26 119.04 30.99 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.333 -1.358 . . . . 1.34 107.333 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.564 HH11 ' HG2' ' A' ' 28' ' ' ARG . 1.0 OUTLIER -95.89 11.72 32.79 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.94 -1.1 . . . . 2.89 112.369 -179.657 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.5 150.64 47.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 2.09 110.966 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -89.29 131.3 35.45 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.103 -1.073 . . . . 2.19 108.103 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -94.29 165.4 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.04 . . . . 0.75 110.278 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.9 p -92.56 166.08 12.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.584 -0.697 . . . . 0.91 109.724 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.84 -22.53 37.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.93 111.85 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -67.2 -36.24 81.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.004 -1.06 . . . . 2.28 110.87 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -92.43 -9.36 41.89 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.048 -1.032 . . . . 1.45 113.187 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.27 -43.72 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.936 -1.102 . . . . 0.81 110.044 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -58.51 -39.97 81.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.096 -1.002 . . . . 1.54 110.574 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -61.37 -39.9 92.32 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.445 -0.784 . . . . 2.36 110.028 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -61.06 -40.35 93.34 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 1.31 110.373 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.71 -41.61 88.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.047 -1.033 . . . . 0.82 110.024 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -60.72 -48.96 79.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.122 -0.986 . . . . 1.5 110.268 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -61.78 -43.21 99.3 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.552 -0.859 . . . . 2.23 109.979 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -73.37 -53.21 11.31 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.508 -0.745 . . . . 0.85 109.748 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.8 tp -59.6 -47.2 86.49 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.477 -0.889 . . . . 0.91 109.938 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.4 t -69.31 -34.41 74.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.9 110.011 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.17 -41.82 92.96 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.177 -1.569 . . . . 0.69 109.177 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 40.7 ttm-85 -58.73 -34.07 70.96 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.438 -0.905 . . . . 2.88 109.053 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.34 -49.68 76.63 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.915 0.864 . . . . 0.85 110.182 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.488 ' NZ ' ' OE1' ' A' ' 53' ' ' GLN . 26.9 ttpp -80.94 -42.37 21.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 2.35 111.136 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.6 92.18 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.746 -0.781 . . . . 0.65 110.093 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.2 t -60.11 -41.4 92.51 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.206 -0.934 . . . . 1.45 109.39 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 -48.4 62.52 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.554 -0.716 . . . . 0.63 110.63 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.488 ' OE1' ' NZ ' ' A' ' 49' ' ' LYS . 27.9 mt-30 -62.34 -49.29 76.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 1.34 110.593 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.86 -37.28 86.22 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.084 -1.01 . . . . 1.56 109.766 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -59.25 -40.65 86.64 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.652 -0.655 . . . . 1.19 110.648 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -62.4 -40.33 96.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.924 -1.11 . . . . 0.72 110.058 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.67 -39.85 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.62 110.513 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -50.14 -42.99 51.75 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.348 -0.845 . . . . 1.05 111.259 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.6 -36.12 78.25 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.03 -1.044 . . . . 0.64 110.276 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -61.13 -37.91 84.48 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.945 -1.102 . . . . 1.73 108.984 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.29 86.8 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.793 -0.763 . . . . 0.56 109.613 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.17 -34.75 40.39 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.332 -1.413 . . . . 0.69 110.398 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -82.32 -20.08 38.08 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.254 -1.145 . . . . 1.48 111.308 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.2 m -86.37 -51.33 6.29 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.356 -0.84 . . . . 0.98 110.428 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.96 -19.66 13.66 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.92 0.711 . . . . 1.16 112.92 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.17 163.69 13.6 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 111.466 -0.653 . . . . 0.85 111.466 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -56.32 -22.48 30.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.794 -0.827 . . . . 3.86 112.603 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -58.21 -35.07 71.11 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.033 -1.042 . . . . 2.35 111.631 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -86.61 -11.95 49.97 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.824 -1.172 . . . . 1.67 113.07 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.75 -30.76 69.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.773 -1.204 . . . . 1.45 111.26 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.74 85.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.983 -1.073 . . . . 0.61 111.241 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 72' ' ' ILE . 15.8 mt -68.02 -48.01 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.823 -1.173 . . . . 0.65 110.13 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -69.87 -32.47 70.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.375 -0.828 . . . . 0.66 110.539 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.36 -37.44 80.71 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.054 -1.029 . . . . 1.19 110.075 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.22 -38.32 91.77 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 120.281 -0.962 . . . . 0.53 110.827 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -59.6 -45.89 90.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.902 -1.352 . . . . 1.27 110.599 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.1 mt -60.31 -38.84 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.863 -1.148 . . . . 0.54 110.488 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.2 ttt -59.55 -39.89 85.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.49 -0.756 . . . . 1.74 110.626 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 tp -59.19 -48.76 80.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.386 -0.926 . . . . 0.55 109.953 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.446 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 61.3 tp -60.91 -45.92 92.73 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.653 0.739 . . . . 0.47 110.754 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.11 11.87 7.33 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.225 0.824 . . . . 1.42 113.225 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -63.96 123.83 19.99 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.798 -0.816 . . . . 1.27 108.798 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -65.52 -18.09 65.06 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.742 0.782 . . . . 1.35 110.819 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.71 -56.88 4.08 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.452 0.644 . . . . 2.22 110.046 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.29 -40.18 89.56 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.006 -0.678 . . . . 0.62 110.64 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -58.55 -49.96 75.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.132 -0.98 . . . . 1.29 110.969 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -62.81 -38.03 89.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 1.52 110.443 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -65.92 -48.92 69.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 1.3 110.458 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.9 mt -55.98 -42.93 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.058 -1.026 . . . . 0.61 109.653 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.0 mt -61.73 -44.0 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.435 -0.79 . . . . 0.78 110.316 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.8 -44.29 97.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.82 110.942 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.01 -44.63 94.45 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.912 -1.117 . . . . 0.8 110.463 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.0 mt -60.61 -48.39 88.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.267 -0.895 . . . . 0.77 110.712 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -81.56 -33.55 31.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.407 -0.808 . . . . 2.12 111.714 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 91' ' ' ALA . 54.2 t0 -82.93 -40.18 20.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.091 -1.006 . . . . 1.51 111.457 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -103.09 7.13 38.89 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.241 -0.912 . . . . 1.98 112.263 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.5 m80 51.3 44.62 28.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 1.32 111.953 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.9 mtt -102.93 153.73 19.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.417 -0.802 . . . . 1.38 109.425 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.407 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 43.2 p -70.54 160.71 31.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.67 109.506 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.6 92.9 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.93 -1.106 . . . . 0.52 110.874 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 24.2 p-10 -69.42 -38.27 77.8 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.985 -1.072 . . . . 2.25 110.024 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.74 -51.2 43.9 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.052 -1.059 . . . . 0.64 111.388 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.69 90.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.56 111.049 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.32 -41.81 85.37 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.352 -0.842 . . . . 0.46 110.613 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.56 -38.74 85.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.414 -0.804 . . . . 1.32 111.173 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -58.06 -48.42 80.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.881 -1.137 . . . . 1.3 111.087 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.04 -43.64 96.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.882 -1.136 . . . . 0.61 110.772 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mm -62.71 -35.26 69.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.605 -0.684 . . . . 0.65 110.318 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -57.44 -39.81 77.07 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.876 -0.73 . . . . 2.11 111.207 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.73 -35.61 11.39 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 118.842 -1.647 . . . . 0.83 112.693 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -61.12 -41.2 96.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.497 -1.59 . . . . 1.28 110.145 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.6 -50.91 22.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.932 0.872 . . . . 0.89 110.471 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.9 p -62.34 -37.85 87.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.862 . . . . 1.87 110.814 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.86 -40.77 98.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 1.05 110.943 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.59 -30.18 70.41 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.637 -1.289 . . . . 1.02 110.892 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -67.34 -22.09 65.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.83 -1.169 . . . . 2.04 110.93 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.5 -11.79 60.81 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.103 -1.039 . . . . 1.73 111.0 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 123' ' ' LEU . 75.8 mt -87.16 144.91 26.63 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.282 -0.636 . . . . 1.37 109.282 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -100.19 39.73 1.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.344 -0.847 . . . . 2.88 111.58 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.48 ' CB ' HD12 ' A' ' 123' ' ' LEU . 7.3 t0 -113.57 135.8 53.51 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 108.261 -1.014 . . . . 1.58 108.261 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -57.67 -40.15 78.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.499 -0.75 . . . . 3.04 111.198 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -72.81 -51.14 20.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.731 -1.231 . . . . 0.9 110.714 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 118' ' ' LEU . 23.9 mt -59.29 -41.28 88.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.26 -0.9 . . . . 1.06 110.541 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 71.5 tttt -64.12 -46.7 83.01 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.209 -0.996 . . . . 2.18 109.793 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -60.17 -33.45 72.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.49 -0.884 . . . . 2.15 109.561 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.522 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 29.7 ttt-85 -60.79 -29.66 69.58 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.306 1.05 . . . . 2.33 108.935 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.78 -49.47 77.6 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.825 0.821 . . . . 0.82 109.396 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.19 -45.81 86.73 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.722 -0.791 . . . . 0.85 109.774 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.02 -36.85 82.79 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.632 -0.668 . . . . 1.39 110.168 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.522 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 48.3 t -69.41 -40.04 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.56 110.037 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -57.9 -38.46 75.88 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.44 -0.904 . . . . 3.12 110.041 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -59.95 -39.57 86.03 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.594 0.711 . . . . 1.28 109.87 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.6 -36.96 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.216 -0.928 . . . . 0.49 109.937 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.81 -56.93 22.24 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 120.009 -1.091 . . . . 0.46 111.353 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -59.07 -39.72 82.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.153 -1.204 . . . . 2.71 110.256 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -60.12 -44.81 94.62 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.775 -1.17 . . . . 2.14 109.57 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.98 -43.89 94.84 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.433 -0.792 . . . . 1.05 110.176 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.63 -44.87 93.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.447 -0.783 . . . . 0.52 110.365 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.517 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 98.8 mtt180 -60.13 -33.19 71.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.893 . . . . 2.35 111.071 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -76.38 -42.95 42.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.098 -1.001 . . . . 1.39 110.725 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.72 -40.17 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.68 110.105 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.87 -11.27 45.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.076 -1.015 . . . . 0.83 111.757 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.6 21.67 71.66 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.73 -1.224 . . . . 0.91 112.91 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -62.73 147.41 49.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.806 -0.82 . . . . 0.95 109.139 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -67.0 147.05 53.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.303 -0.873 . . . . 2.43 108.905 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.9 mt -105.74 149.16 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.419 -0.956 . . . . 1.1 108.419 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.556 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.4 mp -77.65 119.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.157 -0.964 . . . . 1.58 108.727 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -99.51 96.5 7.71 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.66 -1.607 . . . . 1.62 106.66 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.7 mt -77.36 -12.44 59.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.903 . . . . 0.8 111.628 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.5 p -81.7 3.0 27.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.138 -0.977 . . . . 1.56 112.072 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.68 18.46 14.27 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.67 -0.644 . . . . 0.84 112.579 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.8 mt -71.97 138.95 20.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.52 -0.738 . . . . 0.82 109.271 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -118.54 -15.79 9.55 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.834 0.826 . . . . 2.31 112.629 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -114.33 138.66 50.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.974 -1.121 . . . . 1.54 107.974 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -72.66 121.98 20.69 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.33 -0.989 . . . . 1.38 108.33 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.6 m -144.49 174.95 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.033 -0.728 . . . . 0.69 109.033 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.6 mt -89.45 142.15 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.793 -1.192 . . . . 0.53 109.088 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 31.5 tp -94.49 123.05 37.67 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.29 -1.004 . . . . 0.64 108.29 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.65 129.64 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.705 -1.22 . . . . 0.67 107.705 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.32 154.68 21.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.149 -0.97 . . . . 0.78 108.826 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.93 -37.31 86.53 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.541 -1.349 . . . . 1.0 109.458 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -173.3 147.86 1.57 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.166 -0.679 . . . . 2.42 109.166 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.1 mt -115.93 143.25 45.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.489 -0.757 . . . . 0.75 109.21 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.7 p -89.45 147.43 38.04 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.162 -0.961 . . . . 0.78 108.881 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -40.49 -42.48 3.91 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.892 1.728 . . . . 0.67 113.673 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.8 m -61.32 -50.25 73.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.017 -1.052 . . . . 0.7 110.295 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -61.42 -39.67 91.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 1.21 109.772 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.6 p -68.75 -39.69 80.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.608 -0.682 . . . . 0.6 110.458 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.41 79.38 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.928 -0.709 . . . . 0.62 110.531 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -93.71 -1.03 55.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.902 . . . . 1.16 112.727 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.84 148.6 38.81 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.262 -1.014 . . . . 0.73 108.262 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -96.4 114.81 26.51 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.839 -1.541 . . . . 2.24 106.839 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 173' ' ' LEU . 7.5 mp -73.37 -20.39 60.77 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.433 0.635 . . . . 1.43 111.77 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -80.42 -21.85 41.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 2.15 112.037 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -100.23 -6.08 26.6 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 113.198 0.814 . . . . 2.04 113.198 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 178' ' ' GLY . 62.1 t -110.26 129.52 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.616 -1.254 . . . . 0.55 107.616 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.5 -6.29 54.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 1.63 112.635 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.47 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.53 164.79 33.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.788 -1.725 . . . . 0.47 108.788 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -122.72 127.48 49.28 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.402 -1.333 . . . . 0.54 107.402 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.413 HD11 HD13 ' A' ' 220' ' ' LEU . 24.9 mt -127.36 127.64 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.802 -1.555 . . . . 0.69 106.802 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.5 p -140.43 166.27 25.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.865 -1.147 . . . . 0.82 109.486 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.429 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 1.5 m-20 -104.4 43.25 1.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.746 -0.596 . . . . 2.37 110.341 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.8 140.52 32.05 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.082 -1.011 . . . . 1.11 108.906 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -48.14 -16.86 0.54 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 120.289 -0.957 . . . . 1.67 112.322 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 83.98 -12.5 53.38 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.008 -1.289 . . . . 1.54 113.331 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.443 ' O ' ' OG1' ' A' ' 187' ' ' THR . 48.7 ttt180 -74.54 117.84 16.82 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.905 -1.146 . . . . 4.48 107.905 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 22.4 p 48.69 35.59 6.52 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.474 -0.891 . . . . 2.63 111.968 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.1 t -83.59 130.31 34.99 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.14 -1.059 . . . . 1.69 108.14 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -59.96 -39.14 84.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 1.07 110.651 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 57.5 p -60.03 -40.34 88.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 1.58 110.546 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.0 t -60.08 -36.86 78.3 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.167 -0.958 . . . . 1.6 110.12 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.2 mm -60.48 -38.87 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.735 -0.603 . . . . 1.45 110.814 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 75.1 mtp -61.01 -45.36 95.12 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.616 1.198 . . . . 1.05 109.157 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.02 -50.47 73.61 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.462 -0.79 . . . . 0.72 110.823 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -59.65 -44.84 93.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 3.05 111.179 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.9 m -70.2 -40.85 74.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.863 . . . . 0.89 110.543 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.3 mt -90.89 -7.0 53.41 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.071 0.939 . . . . 0.78 112.242 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 194' ' ' ALA . 93.7 mt-10 53.67 9.71 0.2 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.929 1.085 . . . . 1.45 113.929 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.38 147.91 90.43 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 120.844 -1.16 . . . . 0.67 107.972 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.79 137.28 60.14 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.374 1.383 . . . . 0.64 110.07 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.67 166.2 24.78 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.225 -1.39 . . . . 0.67 109.839 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 35.9 mt -148.16 151.07 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.872 -1.159 . . . . 0.69 107.872 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.7 m -134.82 -26.63 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.845 -1.159 . . . . 0.85 112.027 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.19 42.4 2.85 Favored Glycine 0 N--CA 1.49 2.258 0 O-C-N 120.985 -1.072 . . . . 0.92 111.432 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 69.8 p -64.04 -24.15 67.6 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.925 -1.338 . . . . 0.95 111.233 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.86 -90.05 1.48 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 120.042 -1.075 . . . . 1.04 110.596 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.7 t -130.83 32.3 4.37 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.291 -1.123 . . . . 1.57 113.04 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.9 t -56.29 -32.76 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.255 -1.528 . . . . 0.84 110.439 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.6 p -59.04 -25.42 63.69 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.058 -1.026 . . . . 0.99 111.215 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.8 m -92.96 1.89 57.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 1.7 112.063 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -125.66 -5.72 6.97 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.441 0.904 . . . . 2.2 113.441 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.6 t -118.83 148.03 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.424 -0.798 . . . . 0.84 109.515 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -120.42 150.45 40.77 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.998 -1.112 . . . . 2.2 107.998 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 6.4 t30 -51.32 141.29 15.39 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.233 -0.917 . . . . 2.28 110.562 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 80.93 -3.81 1.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.028 1.121 . . . . 2.35 114.028 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -61.68 146.01 50.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.814 -1.179 . . . . 1.97 108.284 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -87.32 118.18 26.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.529 -1.286 . . . . 2.65 107.529 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.92 147.64 50.86 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.454 -0.779 . . . . 0.63 109.552 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 13.7 mt -119.14 130.06 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.186 -1.413 . . . . 0.62 107.186 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.413 HD13 HD11 ' A' ' 180' ' ' ILE . 54.1 tp -98.5 122.88 42.25 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.732 -1.211 . . . . 0.64 107.732 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 223' ' ' VAL . 43.8 t0 -94.03 -29.58 15.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.785 -1.197 . . . . 2.05 112.385 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.62 18.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.92 0.711 . . . . 0.84 112.92 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -109.68 -60.49 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.059 -1.025 . . . . 1.02 109.222 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -93.74 11.15 30.14 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.949 0.88 . . . . 2.51 110.018 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 63.32 53.16 2.25 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.657 -0.702 . . . . 1.54 112.205 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -149.04 154.84 39.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.482 -0.761 . . . . 1.95 109.515 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.6 135.85 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.595 -1.261 . . . . 0.71 107.595 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -102.83 130.51 49.85 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.118 -0.988 . . . . 1.01 108.97 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.14 127.81 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.682 -1.229 . . . . 0.82 107.682 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 50.1 53.16 13.76 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 113.428 0.899 . . . . 1.54 113.428 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 151.15 79.64 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 123.028 2.486 . . . . 0.94 111.085 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 67.3 p -73.97 155.29 38.78 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.739 -0.837 . . . . 1.8 108.739 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -60.26 -37.94 81.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 2.73 110.714 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -50.83 -44.28 59.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.056 -1.027 . . . . 3.17 110.445 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.24 -39.93 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.189 -0.944 . . . . 1.34 110.64 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.76 -49.16 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.897 -0.721 . . . . 1.2 110.962 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.41 -39.64 84.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.922 -1.111 . . . . 2.7 110.777 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -61.1 -44.85 96.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 2.59 110.761 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 55.3 mtm -75.1 -37.8 61.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.819 -1.175 . . . . 1.38 111.301 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -58.63 -40.26 82.86 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.962 -1.087 . . . . 2.84 111.161 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.56 -53.38 16.29 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.735 -1.228 . . . . 1.88 110.638 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.68 -48.49 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.911 -1.118 . . . . 2.4 111.166 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.573 ' OE1' HD12 ' A' ' 11' ' ' ILE . 54.3 tp60 -59.69 -49.86 76.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.714 -1.241 . . . . 3.52 111.442 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.9 -31.11 70.61 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.663 -1.215 . . . . 1.88 110.208 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -64.3 -29.9 70.97 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.119 -1.032 . . . . 3.01 110.119 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.79 -42.52 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.387 0.613 . . . . 2.45 110.403 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.66 94.54 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.595 -0.842 . . . . 2.75 110.248 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.2 t -69.63 -41.07 76.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 3.16 110.368 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -63.95 -36.85 85.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.485 -0.76 . . . . 3.57 110.039 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -66.79 -30.31 70.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.012 . . . . 4.3 111.42 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -62.34 -35.19 78.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.027 -1.045 . . . . 4.45 110.913 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -69.55 -27.68 65.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.173 -0.954 . . . . 5.97 111.353 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.36 -28.91 70.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.426 -0.796 . . . . 6.18 111.659 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -66.88 -14.17 62.45 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.092 -1.005 . . . . 6.66 112.69 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -78.8 -9.31 59.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.829 -1.169 . . . . 8.2 112.569 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.86 2.69 48.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.752 -1.217 . . . . 8.07 112.267 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -84.56 -3.45 58.45 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.161 -0.962 . . . . 9.45 113.17 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -92.65 -29.39 16.13 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.782 -1.199 . . . . 10.12 113.368 -177.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.864 -1.065 . . . . 11.49 109.326 -177.319 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mtp . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 108.897 -0.779 . . . . 3.07 108.897 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mt -103.62 120.67 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.305 -1.739 . . . . 1.07 106.305 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.4 m -101.11 123.45 45.28 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.663 -1.236 . . . . 1.24 107.663 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.35 -159.4 11.76 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 108.708 -1.757 . . . . 1.01 108.708 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 5' ' ' ILE . 95.0 mt -99.19 2.32 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.439 -1.036 . . . . 1.11 112.744 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 48.61 94.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.636 -1.29 . . . . 0.99 112.171 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -84.84 -40.48 17.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.471 -1.393 . . . . 0.85 111.49 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.27 144.29 18.55 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 107.465 -1.309 . . . . 1.38 107.465 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.11 142.31 27.36 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.574 2.183 . . . . 0.94 112.192 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.945 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.55 171.31 23.39 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.36 -1.496 . . . . 0.81 109.36 178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.409 HG21 ' HG3' ' A' ' 243' ' ' GLN . 86.9 mt -134.21 133.7 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.819 -1.401 . . . . 0.83 107.574 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.09 156.8 45.93 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.141 0.972 . . . . 0.53 109.664 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 13.2 m-85 -120.99 140.21 52.22 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.93 -1.137 . . . . 0.77 107.93 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.21 166.62 36.22 Favored Glycine 0 N--CA 1.499 2.841 0 C-N-CA 119.044 -1.551 . . . . 0.51 109.901 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -80.09 157.84 26.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.297 -1.12 . . . . 1.9 109.668 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.76 128.68 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.149 -1.056 . . . . 0.66 108.149 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.5 tp -107.24 105.47 15.46 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 105.327 -2.101 . . . . 0.83 105.327 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.6 tp -93.32 135.43 34.54 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.036 -1.098 . . . . 0.86 108.036 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.9 mt -99.54 118.1 35.38 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.584 -1.635 . . . . 0.92 106.584 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -110.56 123.74 50.52 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.782 -1.562 . . . . 2.03 106.782 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -131.38 158.25 41.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.946 -1.096 . . . . 2.66 108.701 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -84.95 138.79 32.27 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.782 -0.822 . . . . 2.32 108.782 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.41 156.33 36.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.948 . . . . 2.11 109.496 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.7 mt -86.24 133.91 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.035 -1.041 . . . . 0.73 108.444 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -110.38 130.71 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.815 -1.18 . . . . 0.87 107.815 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.8 mt -94.66 134.34 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.647 -0.871 . . . . 0.81 108.647 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -92.41 120.5 32.97 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.086 -1.079 . . . . 1.34 108.086 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.561 HH11 ' HG2' ' A' ' 28' ' ' ARG . 1.7 mmt-85 -93.56 16.98 12.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.007 -1.058 . . . . 2.89 112.43 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -60.33 140.14 57.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.014 -1.054 . . . . 2.09 109.81 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -87.65 132.51 34.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.839 -1.163 . . . . 2.19 108.004 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 pt -96.89 165.55 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.75 110.584 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.7 p -97.91 170.45 8.95 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.241 -0.912 . . . . 0.91 109.507 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.1 66.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.394 -0.816 . . . . 0.93 111.454 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.64 -33.47 74.07 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.436 -0.79 . . . . 2.28 110.648 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -90.95 -7.57 51.7 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.738 -1.226 . . . . 1.45 112.502 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.48 -42.67 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.81 110.183 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -58.11 -39.91 79.88 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.307 -0.871 . . . . 1.54 111.136 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -63.44 -43.92 96.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.734 -0.604 . . . . 2.36 111.233 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -60.67 -40.15 91.03 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.803 -1.186 . . . . 1.31 110.189 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.6 t -60.68 -40.83 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.108 -0.995 . . . . 0.82 109.963 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -61.59 -44.86 96.24 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.447 -0.783 . . . . 1.5 110.223 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.437 HH11 ' HG2' ' A' ' 42' ' ' ARG . 43.5 mtt-85 -62.11 -40.05 94.59 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.33 -0.856 . . . . 2.23 110.152 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -70.53 -57.17 5.05 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.36 -0.837 . . . . 0.85 110.235 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.79 -47.4 85.84 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.914 -1.115 . . . . 0.91 109.582 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.8 t -69.33 -37.46 77.73 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.399 -0.92 . . . . 0.9 109.814 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.05 -43.28 93.26 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.053 -1.546 . . . . 0.69 109.681 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -59.87 -30.66 69.14 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.167 0.984 . . . . 2.88 109.476 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.38 -41.79 90.15 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.427 -0.796 . . . . 0.85 110.348 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -80.22 -49.77 11.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.371 -0.932 . . . . 2.35 110.699 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.91 76.8 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.468 -0.77 . . . . 0.65 110.279 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.4 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 94.7 p -60.09 -40.35 89.31 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.136 0.97 . . . . 1.45 109.178 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -47.53 44.42 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.834 0.826 . . . . 0.63 110.733 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -64.5 -48.31 75.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.521 -1.362 . . . . 1.34 110.958 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.18 -37.98 89.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.726 -0.789 . . . . 1.56 109.842 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 51' ' ' SER . 17.5 mm-40 -59.81 -40.33 88.04 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.275 -0.57 . . . . 1.19 110.272 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.1 m -63.76 -42.24 97.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.234 -0.916 . . . . 0.72 110.343 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 99.5 mt -59.97 -37.3 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.716 0.77 . . . . 0.62 110.268 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -50.4 -44.24 54.91 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.46 -0.775 . . . . 1.05 110.753 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -69.12 -33.71 73.9 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.156 -0.965 . . . . 0.64 110.225 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -64.22 -40.28 95.72 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.185 -1.406 . . . . 1.73 109.526 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.75 -30.16 71.16 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.856 -0.738 . . . . 0.56 110.151 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.12 -34.18 18.5 Favored Glycine 0 N--CA 1.484 1.872 0 C-N-CA 119.559 -1.305 . . . . 0.69 110.893 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -81.7 -20.41 39.49 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.358 -1.083 . . . . 1.48 111.199 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.5 m -90.16 -51.98 5.18 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 120.941 0.401 . . . . 0.98 110.842 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -107.83 -9.12 15.81 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 113.616 0.969 . . . . 1.16 113.616 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.09 167.01 23.12 Favored Glycine 0 N--CA 1.502 3.09 0 O-C-N 121.24 -0.913 . . . . 0.85 112.764 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.96 -21.94 59.34 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.785 -0.833 . . . . 3.86 112.131 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -57.7 -40.05 78.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.959 -1.088 . . . . 2.35 110.905 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -87.07 -25.48 24.15 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.43 -0.908 . . . . 1.67 111.459 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -60.65 -38.0 83.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.904 -0.497 . . . . 1.45 111.405 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.12 90.35 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.242 -0.911 . . . . 0.61 112.055 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -64.77 -41.72 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.339 -1.476 . . . . 0.65 110.381 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -69.44 -32.09 70.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.603 -1.311 . . . . 0.66 110.428 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -59.44 -39.73 84.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.783 -1.198 . . . . 1.19 109.909 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.74 97.95 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.894 -0.883 . . . . 0.53 110.894 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -59.77 -41.2 90.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.906 -1.349 . . . . 1.27 110.633 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.4 mt -60.29 -38.16 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.807 -1.183 . . . . 0.54 110.658 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.7 ttp -58.85 -39.78 82.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.917 . . . . 1.74 110.528 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.65 -48.26 81.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.917 -1.115 . . . . 0.55 110.629 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.2 tp -59.92 -40.92 90.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.493 -0.755 . . . . 0.47 110.435 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -86.06 6.09 30.58 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.022 -0.671 . . . . 1.42 112.508 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -60.33 121.82 12.98 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.917 -1.114 . . . . 1.27 109.348 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -68.0 -17.63 64.48 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 121.145 -0.972 . . . . 1.35 110.792 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -74.14 -46.7 40.8 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.787 -1.165 . . . . 2.22 110.419 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.0 -35.47 80.82 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.209 -0.996 . . . . 0.62 110.023 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -58.69 -45.09 90.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.166 -0.959 . . . . 1.29 110.798 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -63.98 -41.6 97.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.926 -1.109 . . . . 1.52 110.78 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -67.98 -49.53 61.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.737 -1.227 . . . . 1.3 110.506 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.12 -43.49 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 118.978 -1.089 . . . . 0.61 110.372 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.433 HG22 ' NZ ' ' A' ' 94' ' ' LYS . 52.2 mt -62.17 -43.85 98.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.107 -0.996 . . . . 0.78 110.54 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.36 -41.13 93.07 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.251 -0.906 . . . . 0.82 110.894 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.31 -44.28 95.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.162 -0.961 . . . . 0.8 110.606 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.71 -49.2 83.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.266 -0.896 . . . . 0.77 110.322 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.433 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 20.5 mtmm -82.43 -28.59 31.25 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.603 -1.31 . . . . 2.12 112.182 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -79.16 -45.66 19.5 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 120.242 -1.536 . . . . 1.51 111.293 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -104.62 7.59 35.04 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.752 -1.218 . . . . 1.98 111.884 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.8 m80 54.26 50.15 17.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 1.32 112.291 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 73.2 mtm -105.88 161.0 14.83 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.722 -1.236 . . . . 1.38 109.502 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.1 p -72.75 158.89 34.71 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.846 0.832 . . . . 0.67 109.368 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.68 87.99 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.148 -0.97 . . . . 0.52 110.658 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.55 ' OD2' HD21 ' A' ' 142' ' ' LEU . 98.9 m-20 -67.34 -40.75 85.88 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.805 -1.184 . . . . 2.25 110.069 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.43 39.8 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.207 -0.997 . . . . 0.64 110.816 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.13 96.52 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.661 0.743 . . . . 0.56 110.338 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.43 93.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.648 -0.658 . . . . 0.46 111.08 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.75 -38.97 83.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.307 -0.871 . . . . 1.32 111.335 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.14 -48.28 82.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.091 -1.006 . . . . 1.3 111.19 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.56 -43.22 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.658 -1.217 . . . . 0.61 110.225 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.61 -33.08 53.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.799 -0.563 . . . . 0.65 110.697 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -59.53 -40.21 86.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.351 -0.54 . . . . 2.11 110.745 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.92 -30.52 25.89 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.018 -1.563 . . . . 0.83 113.128 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -61.37 -40.43 94.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.216 -1.755 . . . . 1.28 109.69 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.23 -45.72 59.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.064 0.935 . . . . 0.89 109.718 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.2 m -60.36 -39.24 86.5 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.346 0.593 . . . . 1.87 110.049 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.83 -46.51 89.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.416 -0.803 . . . . 1.05 110.866 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 90.2 mt -66.03 -26.89 67.73 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.506 -1.371 . . . . 1.02 110.87 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -66.22 -26.45 67.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.875 . . . . 2.04 111.572 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -70.65 -13.48 62.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.943 -1.103 . . . . 1.73 111.48 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 78.8 mt -88.72 140.2 29.69 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.838 0.828 . . . . 1.37 109.383 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -94.85 41.44 1.09 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.816 -1.178 . . . . 2.88 111.258 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -111.87 133.42 54.08 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.07 0.938 . . . . 1.58 108.903 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.59 -29.2 69.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.708 -0.62 . . . . 3.04 111.348 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.03 -60.32 2.38 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.655 -1.278 . . . . 0.9 110.703 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.78 -38.2 90.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 1.06 110.801 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -63.38 -50.88 68.15 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.779 -1.201 . . . . 2.18 110.093 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.67 -32.17 71.38 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.094 -1.042 . . . . 2.15 109.602 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.519 ' O ' HG23 ' A' ' 130' ' ' VAL . 37.4 ttp180 -65.89 -26.97 67.86 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.778 0.799 . . . . 2.33 109.485 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -58.88 -47.88 83.38 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.599 -0.84 . . . . 0.82 108.998 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.81 -43.92 91.57 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.306 -0.957 . . . . 0.85 110.017 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -64.29 -31.38 72.56 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.422 0.629 . . . . 1.39 110.446 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 126' ' ' ARG . 32.3 t -68.7 -39.19 79.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 C-N-CA 119.942 -0.703 . . . . 0.56 109.961 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.404 ' NH1' ' HG3' ' A' ' 131' ' ' ARG . 38.1 ttm-85 -59.32 -38.01 79.2 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.73 -1.188 . . . . 3.12 109.285 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -59.92 -38.94 83.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.881 -0.512 . . . . 1.28 110.602 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.7 mt -60.33 -40.0 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.975 -1.078 . . . . 0.49 110.148 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.12 -46.96 93.28 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.475 -1.05 . . . . 0.46 110.475 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -59.99 -41.08 91.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.966 -1.314 . . . . 2.71 110.658 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -60.07 -42.7 95.13 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.315 -0.865 . . . . 2.14 110.18 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.41 -40.41 94.3 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.174 0.988 . . . . 1.05 109.881 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.0 mt -61.66 -40.67 95.76 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.353 -0.842 . . . . 0.52 110.746 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -61.34 -38.2 86.05 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.509 -0.745 . . . . 2.35 111.316 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -74.4 -42.6 58.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.954 -1.091 . . . . 1.39 110.993 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.21 -38.95 79.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.013 -1.054 . . . . 0.68 110.553 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.55 HD21 ' OD2' ' A' ' 101' ' ' ASP . 83.9 mt -87.35 -3.08 59.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.829 -1.169 . . . . 0.83 111.793 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.83 23.03 78.64 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.613 -1.28 . . . . 0.91 113.577 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.5 tp -61.97 150.04 38.99 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 122.053 -0.675 . . . . 0.95 109.746 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -66.93 157.27 33.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.503 -0.748 . . . . 2.43 110.16 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.4 mt -101.18 139.5 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.46 -0.941 . . . . 1.1 108.46 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.761 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.3 mp -79.49 120.51 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.797 -1.186 . . . . 1.58 107.797 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -98.62 93.41 6.1 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.881 -1.525 . . . . 1.62 106.881 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.6 mt -75.39 -21.29 58.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.898 . . . . 0.8 111.599 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.5 t -82.77 10.24 8.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.169 -0.957 . . . . 1.56 112.101 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.95 18.52 14.49 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.269 -0.894 . . . . 0.84 112.435 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.408 ' O ' ' CD ' ' A' ' 175' ' ' LYS . 23.8 mt -75.28 141.03 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.203 -0.935 . . . . 0.82 110.015 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -117.62 -13.67 10.24 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.361 -0.837 . . . . 2.31 112.795 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -117.03 141.95 47.59 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.612 -0.884 . . . . 1.54 108.612 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -77.04 122.83 25.49 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.271 -1.011 . . . . 1.38 108.271 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.2 m -147.31 178.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.226 -0.657 . . . . 0.69 109.226 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.4 mt -87.4 143.92 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.683 -0.858 . . . . 0.53 108.683 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 34.7 tp -97.57 126.1 42.67 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.912 -1.118 . . . . 0.64 108.367 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.0 t -126.43 129.23 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.126 -1.065 . . . . 0.67 108.126 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.17 159.91 32.23 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.272 -0.893 . . . . 0.78 108.601 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.18 93.34 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.539 -1.264 . . . . 1.0 109.97 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 46.8 p-10 -173.96 150.02 1.57 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.304 -0.628 . . . . 2.42 109.304 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.2 mt -115.41 141.54 47.91 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.346 -0.846 . . . . 0.75 109.276 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.9 p -93.92 150.7 38.98 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.162 -0.961 . . . . 0.78 108.455 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -39.25 -44.97 2.91 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.772 1.648 . . . . 0.67 113.243 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.3 m -59.58 -49.41 77.86 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.168 -0.957 . . . . 0.7 110.306 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.34 -40.4 94.1 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.743 -0.783 . . . . 1.21 110.001 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.9 p -67.58 -37.12 82.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.815 0.817 . . . . 0.6 110.222 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.18 -39.84 87.9 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.519 -0.738 . . . . 0.62 110.54 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -94.21 0.22 55.57 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.094 -1.004 . . . . 1.16 113.105 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.89 149.21 41.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.738 -1.226 . . . . 0.73 108.498 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -94.45 114.71 26.77 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 106.812 -1.551 . . . . 2.24 106.812 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 173' ' ' LEU . 10.6 mp -80.79 -10.41 59.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.552 -0.718 . . . . 1.43 112.435 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -83.45 -23.25 32.33 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.984 -1.073 . . . . 2.15 111.954 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.408 ' CD ' ' O ' ' A' ' 152' ' ' ILE . 90.7 mttt -105.41 4.16 30.44 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.22 -0.925 . . . . 2.04 112.777 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.9 t -108.85 128.63 64.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.929 -1.137 . . . . 0.55 107.929 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.713 ' O ' HD23 ' A' ' 177' ' ' LEU . 2.0 tt -92.93 -6.31 48.83 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.208 1.004 . . . . 1.63 111.53 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.39 168.28 37.51 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.746 -1.741 . . . . 0.47 108.746 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -124.04 128.85 49.95 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.559 -1.274 . . . . 0.54 107.559 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.9 mt -130.77 129.86 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.968 -1.864 . . . . 0.69 105.968 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.2 p -140.94 176.1 9.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.167 -0.958 . . . . 0.82 109.981 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.497 ' OD2' HG23 ' A' ' 209' ' ' THR . 2.8 m-20 -110.38 45.13 1.15 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.892 -0.505 . . . . 2.37 110.757 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.5 138.4 34.98 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.164 -0.96 . . . . 1.11 108.924 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -81.02 4.6 69.98 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.807 -0.711 . . . . 1.67 112.826 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 111.93 -28.44 9.35 Favored Glycine 0 N--CA 1.504 3.212 0 O-C-N 121.309 -1.112 . . . . 1.54 112.038 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -58.86 -30.08 67.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.742 -1.446 . . . . 4.48 110.347 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 57.0 p -124.23 54.05 1.38 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.934 0.873 . . . . 2.63 109.132 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.7 p -79.53 26.75 0.29 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.371 -0.831 . . . . 1.69 112.946 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -49.49 -40.82 38.8 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.143 -1.023 . . . . 1.07 110.161 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.6 p -62.11 -40.8 97.12 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.366 -0.934 . . . . 1.58 109.389 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.9 p -60.87 -35.25 76.13 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 119.668 -0.813 . . . . 1.6 109.863 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 77.1 mt -58.79 -39.61 77.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.461 -0.895 . . . . 1.45 109.934 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.8 mtp -60.93 -44.23 97.51 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.781 1.276 . . . . 1.05 109.126 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.1 -43.97 95.19 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.966 -1.015 . . . . 0.72 110.532 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' A' ' 195' ' ' ARG . 28.7 mtt-85 -60.04 -44.2 94.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.995 -1.066 . . . . 3.05 110.09 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 35.3 m -68.48 -39.07 81.49 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.099 0.952 . . . . 0.89 109.646 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.77 -4.07 56.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.068 -1.02 . . . . 0.78 112.659 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.0 mt-10 53.61 9.87 0.2 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.212 1.19 . . . . 1.45 114.212 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 32.7 mt -72.12 150.06 92.21 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 120.581 -1.324 . . . . 0.67 108.378 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.0 143.51 99.77 Favored 'Trans proline' 0 N--CA 1.511 2.554 0 C-N-CA 121.623 1.549 . . . . 0.64 110.11 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.92 160.91 31.47 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 117.683 -1.607 . . . . 0.67 109.701 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 220' ' ' LEU . 15.0 mt -148.32 149.72 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.088 -1.079 . . . . 0.69 108.088 177.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 181' ' ' THR . 19.7 m -133.93 -29.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 C-N-CA 119.281 -0.967 . . . . 0.85 112.78 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.39 35.65 1.55 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.76 -1.209 . . . . 0.92 113.907 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 35.2 p -56.98 -25.49 58.33 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.234 -1.157 . . . . 0.95 111.227 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.45 -91.4 1.72 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.032 -1.227 . . . . 1.04 110.032 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.8 p -129.31 29.97 5.05 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.295 -1.121 . . . . 1.57 112.683 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.2 t -56.56 -35.09 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.246 -1.534 . . . . 0.84 110.764 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.497 HG23 ' OD2' ' A' ' 182' ' ' ASP . 45.4 p -60.58 -21.43 62.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.038 . . . . 0.99 111.491 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 67.5 m -97.2 1.74 50.14 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.568 0.699 . . . . 1.7 111.997 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -126.08 -0.96 7.13 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.227 0.825 . . . . 2.2 113.227 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 213' ' ' LYS . 56.0 t -126.02 155.43 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.139 -0.975 . . . . 0.84 110.182 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.412 ' N ' HG12 ' A' ' 212' ' ' VAL . 1.1 mptm? -115.7 157.69 23.89 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.06 -1.089 . . . . 2.2 108.06 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 32.2 p-10 -58.86 144.18 45.24 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.56 -1.256 . . . . 2.28 109.922 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER 81.39 -3.05 1.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.081 1.141 . . . . 2.35 114.081 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 40.0 t0 -61.61 149.96 37.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.882 -1.136 . . . . 1.97 109.129 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.514 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 37.0 t80 -88.58 124.39 33.99 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.412 -1.329 . . . . 2.65 107.412 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.5 mt -130.3 149.36 52.03 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.331 -0.856 . . . . 0.63 109.307 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.7 mt -112.75 123.4 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.064 -1.828 . . . . 0.62 106.064 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.531 HD11 HD12 ' A' ' 202' ' ' ILE . 49.2 tp -98.72 119.48 37.54 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.087 -1.82 . . . . 0.64 106.087 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 27.4 t0 -93.78 -25.18 17.51 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.086 -1.009 . . . . 2.05 112.836 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.945 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.64 14.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.153 0.797 . . . . 0.84 113.153 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 37.1 t -111.18 -62.31 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.119 -0.988 . . . . 1.02 109.258 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -90.27 9.14 29.85 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.398 1.094 . . . . 2.51 110.987 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.18 49.71 3.25 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.436 -0.802 . . . . 1.54 111.645 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -146.93 148.77 32.11 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.635 -1.29 . . . . 1.95 109.734 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.0 t -117.32 139.29 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.216 -1.031 . . . . 0.71 108.216 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -99.26 134.95 41.38 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.118 -1.067 . . . . 1.01 108.118 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.71 129.93 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.755 -0.832 . . . . 0.82 108.755 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.431 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 42.4 t-20 49.1 50.29 8.93 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.01 0.744 . . . . 1.54 113.01 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.5 Cg_endo -62.26 149.95 88.75 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.342 2.028 . . . . 0.94 110.883 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 6.0 m -74.53 156.06 37.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.252 -0.905 . . . . 1.8 109.151 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -59.35 -38.42 80.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 2.73 110.218 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -58.83 -41.05 85.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.231 -0.918 . . . . 3.17 110.367 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.66 -41.09 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.13 0.967 . . . . 1.34 109.892 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 85.1 mt -60.03 -47.99 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 1.2 110.391 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -59.28 -42.52 91.46 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.458 -0.897 . . . . 2.7 110.26 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -61.37 -41.54 97.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 2.59 110.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 81.6 mtp -71.48 -37.79 71.28 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.09 -1.006 . . . . 1.38 111.201 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -53.67 -43.51 68.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.635 -1.29 . . . . 2.84 110.321 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.1 -52.16 18.07 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.057 -1.057 . . . . 1.88 110.105 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.81 -43.69 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.573 -0.704 . . . . 2.4 110.918 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.409 ' HG3' HG21 ' A' ' 11' ' ' ILE . 3.5 tm0? -58.43 -51.98 67.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.017 -1.052 . . . . 3.52 110.678 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.51 -31.91 73.21 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.545 -0.862 . . . . 1.88 110.26 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -60.2 -31.09 69.82 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.198 -1.001 . . . . 3.01 109.16 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.31 -39.93 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-O 122.033 0.92 . . . . 2.45 109.879 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.04 79.39 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.808 -0.757 . . . . 2.75 110.372 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.4 m -69.24 -30.12 68.19 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.089 0.471 . . . . 3.16 110.961 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.17 -40.0 92.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 3.57 110.39 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -67.48 -30.57 70.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 4.3 110.674 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.06 71.24 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.504 -0.747 . . . . 4.45 111.142 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -66.33 -31.93 73.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.934 -1.104 . . . . 5.97 110.62 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 31.7 tp -62.23 -36.27 81.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.098 -1.001 . . . . 6.18 109.759 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -72.35 -19.11 61.69 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.763 0.792 . . . . 6.66 111.296 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -82.92 5.31 22.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.826 -1.171 . . . . 8.2 112.257 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.39 -9.91 59.05 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.221 -0.924 . . . . 8.07 111.495 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -82.03 -2.53 52.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 9.45 112.054 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -95.15 -11.36 28.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.456 -0.778 . . . . 10.12 112.543 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 118.144 -0.931 . . . . 11.49 109.004 -177.986 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.2 mpt? . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.435 0.636 . . . . 3.07 109.745 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.9 mt 40.9 66.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.506 -0.746 . . . . 1.07 111.914 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 m -95.57 113.58 25.24 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.614 -1.624 . . . . 1.24 106.614 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.66 -149.16 25.21 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.111 -1.196 . . . . 1.01 110.111 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 5' ' ' ILE . 93.2 mt -96.65 -0.93 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -1.04 . . . . 1.11 112.864 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 tp 49.49 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.064 -1.022 . . . . 0.99 112.725 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.77 -43.51 12.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.072 -1.018 . . . . 0.85 111.168 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 t -145.76 136.08 12.04 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.138 -1.06 . . . . 1.38 108.138 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.43 149.79 45.24 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.38 2.053 . . . . 0.94 112.249 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.899 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.25 164.34 12.26 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.554 -1.819 . . . . 0.81 108.554 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.0 mt -120.89 133.92 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.285 -1.127 . . . . 0.83 108.273 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.23 149.99 43.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.318 -0.864 . . . . 0.53 109.129 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.3 m-85 -121.25 140.39 52.11 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.179 -1.045 . . . . 0.77 108.179 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.2 166.99 35.96 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 118.998 -1.573 . . . . 0.51 109.419 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -78.13 158.33 29.13 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.65 -0.912 . . . . 1.9 108.98 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -82.75 131.9 35.19 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.886 -1.134 . . . . 0.66 109.206 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.8 tp -113.67 102.7 10.51 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 105.609 -1.997 . . . . 0.83 105.609 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.6 tp -90.67 137.15 32.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.913 -1.117 . . . . 0.86 108.116 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 158' ' ' LEU . 59.3 mt -102.57 119.47 38.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.469 -1.678 . . . . 0.92 106.469 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -110.68 135.06 51.87 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.674 -1.232 . . . . 2.03 107.674 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -126.28 137.49 53.51 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.404 -0.962 . . . . 2.66 108.404 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -82.73 135.47 34.99 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.794 -1.187 . . . . 2.32 107.794 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -62.22 149.21 42.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.579 -0.701 . . . . 2.11 109.186 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.94 134.78 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.72 -0.845 . . . . 0.73 108.72 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -107.48 129.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.626 -1.25 . . . . 0.87 107.626 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.0 mt -93.78 140.29 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.81 109.201 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -88.18 121.22 30.32 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.838 -1.171 . . . . 1.34 107.838 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -95.02 16.16 16.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 2.89 112.213 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -65.14 142.68 58.27 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.071 -1.018 . . . . 2.09 109.027 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -88.88 134.85 33.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.886 -1.153 . . . . 2.19 107.886 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 pt -98.15 165.02 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.3 -0.875 . . . . 0.75 110.313 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 p -99.29 168.79 9.8 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.298 0.57 . . . . 0.91 109.702 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.89 -27.9 46.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.249 -0.907 . . . . 0.93 112.642 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 35' ' ' GLN . 37.1 p-10 -70.07 -31.84 69.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.222 -0.924 . . . . 2.28 110.825 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.562 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 73.0 mt-30 -92.31 -7.9 46.64 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.612 -1.305 . . . . 1.45 112.792 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.18 -43.15 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.892 . . . . 0.81 110.833 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -57.94 -39.16 77.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.075 -1.016 . . . . 1.54 110.828 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.78 -43.29 99.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.987 -1.071 . . . . 2.36 111.147 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.96 -39.6 92.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.778 -1.201 . . . . 1.31 110.937 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.2 t -60.72 -42.43 92.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.192 -0.943 . . . . 0.82 110.366 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -61.77 -45.15 95.13 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.585 -0.846 . . . . 1.5 109.962 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' A' ' 42' ' ' ARG . 51.2 mtt-85 -61.61 -42.01 98.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.875 -1.141 . . . . 2.23 109.663 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -71.68 -55.71 7.18 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.507 -0.745 . . . . 0.85 109.829 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.9 tp -58.09 -47.6 82.73 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.445 -0.902 . . . . 0.91 109.643 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.4 t -68.13 -36.3 79.49 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.441 -0.787 . . . . 0.9 109.702 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.66 -40.23 87.78 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.582 -1.407 . . . . 0.69 109.582 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -58.86 -34.25 71.38 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 122.076 0.941 . . . . 2.88 109.205 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.98 -48.97 79.51 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.934 0.873 . . . . 0.85 109.863 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -81.38 -45.62 15.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -0.822 . . . . 2.35 110.949 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.67 86.04 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.644 -0.822 . . . . 0.65 110.397 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 t -59.94 -40.28 88.44 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.105 0.955 . . . . 1.45 109.127 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.57 -44.78 81.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.953 -0.567 . . . . 0.63 110.219 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -62.41 -52.11 64.88 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.997 -1.081 . . . . 1.34 110.162 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.84 -40.87 94.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.171 -0.955 . . . . 1.56 110.153 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -59.99 -40.0 87.65 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.685 -0.634 . . . . 1.19 110.583 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -64.83 -41.8 95.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.9 -1.125 . . . . 0.72 110.615 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.43 -38.89 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.227 -0.921 . . . . 0.62 110.798 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -51.42 -44.5 62.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.244 -0.91 . . . . 1.05 110.538 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -68.96 -38.21 79.27 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.987 -1.071 . . . . 0.64 110.086 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -62.07 -38.95 90.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.314 -0.955 . . . . 1.73 109.641 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.28 -31.47 70.01 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.206 0.527 . . . . 0.56 109.748 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.93 -37.68 12.63 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.584 -1.293 . . . . 0.69 111.017 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.51 -23.99 36.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.773 -1.427 . . . . 1.48 111.119 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.6 m -87.13 -50.58 6.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.98 110.68 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.04 -8.7 16.45 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.194 1.183 . . . . 1.16 114.194 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.73 164.93 23.37 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 121.249 -0.907 . . . . 0.85 112.734 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -55.11 -13.91 1.4 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.85 -0.794 . . . . 3.86 112.925 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -58.75 -37.4 76.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.101 -1.0 . . . . 2.35 111.236 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -85.34 -19.18 31.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.816 -1.177 . . . . 1.67 112.693 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -59.61 -39.64 84.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.733 -1.229 . . . . 1.45 111.047 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.0 -41.23 91.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 0.61 110.945 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.92 -47.3 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.62 -1.3 . . . . 0.65 110.119 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -69.88 -31.97 70.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.66 110.662 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -58.81 -38.61 79.02 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 1.19 109.731 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.82 -36.03 73.8 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 110.261 -1.135 . . . . 0.53 110.261 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -59.18 -46.49 88.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.167 -1.196 . . . . 1.27 110.72 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.73 -39.77 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.54 109.956 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.0 ttp -59.13 -39.63 82.94 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.93 -0.708 . . . . 1.74 109.911 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 tp -57.57 -50.08 74.27 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.888 -1.125 . . . . 0.55 110.676 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.89 -40.47 93.2 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.715 0.769 . . . . 0.47 109.953 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -86.65 7.42 26.6 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 112.445 0.535 . . . . 1.42 112.445 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 57.7 t0 -60.87 120.7 10.68 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.875 -1.14 . . . . 1.27 108.502 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -64.86 -19.81 66.08 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.711 0.767 . . . . 1.35 110.876 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.445 ' OE1' ' OD1' ' A' ' 82' ' ' ASP . 21.7 mp0 -77.63 -52.99 8.1 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.357 -0.839 . . . . 2.22 110.327 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.87 -40.16 87.68 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.508 -0.877 . . . . 0.62 110.444 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -57.1 -49.48 75.76 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.279 -0.888 . . . . 1.29 110.597 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -62.33 -36.94 83.74 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.355 -0.841 . . . . 1.52 110.589 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -67.83 -47.63 68.48 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.352 -0.939 . . . . 1.3 110.682 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.9 mt -57.45 -42.05 79.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.281 -0.887 . . . . 0.61 110.044 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.8 mt -62.48 -41.73 93.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 121.405 0.622 . . . . 0.78 110.101 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.56 98.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.67 -0.644 . . . . 0.82 111.226 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.69 -42.81 93.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.884 -1.135 . . . . 0.8 110.575 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.47 -50.33 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 0.77 110.351 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.56 -38.71 65.12 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.218 -0.926 . . . . 2.12 111.862 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -81.67 -44.93 16.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.709 -1.244 . . . . 1.51 112.169 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HB3' ' HZ3' ' A' ' 96' ' ' LYS . 9.0 mmmm -100.49 10.14 41.61 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.976 -1.078 . . . . 1.98 112.166 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.6 m80 49.14 50.59 17.71 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.728 -1.232 . . . . 1.32 111.304 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -104.45 151.76 23.16 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.461 -0.774 . . . . 1.38 109.747 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.9 p -72.82 167.56 20.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.67 110.24 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.37 86.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.52 110.334 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -67.12 -40.21 86.79 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.074 -1.016 . . . . 2.25 110.408 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.37 -49.72 58.19 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.232 -0.987 . . . . 0.64 111.128 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.71 98.22 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.265 -0.897 . . . . 0.56 110.299 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.86 97.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.25 -0.906 . . . . 0.46 111.09 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -60.48 -40.08 89.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.015 . . . . 1.32 111.272 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -59.91 -48.97 79.51 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.728 -1.233 . . . . 1.3 111.063 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.52 -46.53 96.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.004 -1.06 . . . . 0.61 110.13 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.16 -32.39 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.711 -0.618 . . . . 0.65 110.316 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -55.99 -41.09 74.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.486 -0.758 . . . . 2.11 110.77 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.38 -34.86 10.0 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.098 -1.525 . . . . 0.83 112.378 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -62.13 -44.34 96.86 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.701 -1.47 . . . . 1.28 110.179 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.29 -52.36 19.29 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.772 0.796 . . . . 0.89 110.695 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.8 p -60.07 -37.57 80.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.514 -0.741 . . . . 1.87 110.48 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.51 -44.33 97.27 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.017 -0.673 . . . . 1.05 110.501 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.2 mt -61.75 -29.96 70.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.576 -1.327 . . . . 1.02 110.528 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -67.12 -22.4 65.8 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.339 -0.851 . . . . 2.04 111.411 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -73.18 -15.35 61.45 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.318 -0.864 . . . . 1.73 111.245 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.532 HD13 HD13 ' A' ' 123' ' ' LEU . 7.0 mt -84.54 141.59 30.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.431 -0.793 . . . . 1.37 108.896 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -94.92 39.46 1.1 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.077 -1.014 . . . . 2.88 112.086 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -112.0 136.82 50.84 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.119 -1.067 . . . . 1.58 108.119 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -59.77 -37.13 78.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.339 -0.851 . . . . 3.04 110.768 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -70.58 -57.84 4.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.79 -1.194 . . . . 0.9 110.188 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.532 HD13 HD13 ' A' ' 118' ' ' LEU . 23.1 mt -59.9 -39.9 86.94 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.16 -0.962 . . . . 1.06 110.335 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -62.53 -51.17 68.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.997 -1.064 . . . . 2.18 110.119 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.31 -30.59 71.7 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.751 -0.78 . . . . 2.15 109.816 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 130' ' ' VAL . 22.7 ttp180 -65.22 -28.91 69.7 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.026 -1.07 . . . . 2.33 109.155 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.83 80.16 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.813 0.816 . . . . 0.82 109.413 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.55 95.18 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.513 -0.875 . . . . 0.85 109.692 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -64.95 -36.99 86.17 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.292 0.568 . . . . 1.39 110.303 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 126' ' ' ARG . 46.8 t -67.9 -40.49 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 0.56 109.802 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -59.88 -38.08 81.18 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.894 0.854 . . . . 3.12 109.552 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -59.48 -38.99 82.27 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.287 0.565 . . . . 1.28 110.274 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.9 mt -61.46 -40.27 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.271 -0.893 . . . . 0.49 109.977 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.4 48.68 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.94 -1.124 . . . . 0.46 110.341 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -59.1 -45.99 89.45 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 120.994 -1.297 . . . . 2.71 110.087 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.432 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 58.6 mtm180 -62.32 -40.73 97.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.827 -1.17 . . . . 2.14 109.998 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.61 -42.97 99.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 1.05 110.153 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.27 -45.41 93.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.52 110.17 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -59.78 -33.93 72.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.556 -0.715 . . . . 2.35 111.025 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -75.18 -40.45 59.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.207 -0.933 . . . . 1.39 110.72 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.03 -39.96 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.68 110.292 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.3 mt -88.68 -6.18 57.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.83 111.942 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.72 71.01 Favored Glycine 0 N--CA 1.479 1.544 0 C-N-CA 119.304 -1.427 . . . . 0.91 112.932 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.2 tp -61.08 151.83 29.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 122.012 -0.699 . . . . 0.95 110.522 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -61.22 145.71 50.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.36 -0.837 . . . . 2.43 109.1 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.9 mt -111.3 139.94 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.536 -0.913 . . . . 1.1 108.536 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.8 mm -79.53 121.85 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.223 -1.029 . . . . 1.58 108.223 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -97.4 95.52 7.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.37 -1.715 . . . . 1.62 106.37 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.46 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 76.8 mt -75.51 -23.26 56.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.629 -0.669 . . . . 0.8 111.332 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.7 t -79.53 -0.68 34.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.176 -0.952 . . . . 1.56 112.334 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.08 22.84 8.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.737 -0.602 . . . . 0.84 112.46 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.46 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 11.3 mt -72.05 137.36 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.695 . . . . 0.82 109.543 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -112.47 -19.43 12.14 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.714 0.769 . . . . 2.31 112.828 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -117.44 138.95 51.5 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.53 -1.285 . . . . 1.54 107.53 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.35 122.02 21.37 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.001 -1.111 . . . . 1.38 108.001 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.8 m -145.63 177.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.438 -0.788 . . . . 0.69 109.291 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.3 mt -88.26 140.97 14.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.517 -0.74 . . . . 0.53 109.341 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 19' ' ' LEU . 26.4 tp -94.12 124.17 37.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.969 -1.082 . . . . 0.64 108.143 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.8 t -125.36 130.21 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.131 -1.063 . . . . 0.67 108.131 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.63 152.41 21.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.454 -0.779 . . . . 0.78 109.226 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.24 82.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.495 -1.378 . . . . 1.0 109.738 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 49.6 t0 -172.72 146.48 1.64 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.03 -0.729 . . . . 2.42 109.03 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.423 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 83.6 mt -119.35 141.27 49.18 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.406 -0.809 . . . . 0.75 109.304 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 65.7 p -91.59 152.41 43.41 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 120.848 -1.158 . . . . 0.78 108.364 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -41.6 -39.12 4.56 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.081 1.854 . . . . 0.67 113.848 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.432 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 27.4 m -59.91 -47.06 87.29 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.7 110.184 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -67.6 -40.52 84.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.793 . . . . 1.21 109.948 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.9 p -68.42 -37.91 80.74 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.917 -0.713 . . . . 0.6 110.223 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.55 82.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.945 . . . . 0.62 110.526 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -93.18 -2.67 55.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.054 . . . . 1.16 112.792 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.37 146.23 51.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.05 -1.031 . . . . 0.73 108.434 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -96.42 118.86 33.82 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.786 -1.561 . . . . 2.24 106.786 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.72 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.3 mm? -76.85 -14.55 59.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.446 -0.784 . . . . 1.43 111.451 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -80.05 -27.35 39.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.535 -0.728 . . . . 2.15 111.807 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -100.83 1.19 39.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.149 -0.969 . . . . 2.04 113.204 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 178' ' ' GLY . 61.3 t -110.14 129.97 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.584 -0.895 . . . . 0.55 108.584 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.26 -11.32 43.91 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.359 -0.838 . . . . 1.63 112.455 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.411 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 173.57 177.1 42.54 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.141 -1.584 . . . . 0.47 109.141 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -133.45 132.66 41.35 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 107.784 -1.191 . . . . 0.54 107.784 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.41 HG22 HG21 ' A' ' 205' ' ' THR . 77.5 mt -134.37 111.2 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 105.824 -1.917 . . . . 0.69 105.824 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 205' ' ' THR . 54.2 p -130.32 171.99 12.33 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.679 -1.263 . . . . 0.82 110.292 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -101.17 52.1 0.85 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.973 -0.558 . . . . 2.37 110.222 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -101.16 140.0 36.05 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.693 -0.854 . . . . 1.11 108.693 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.42 -30.24 18.6 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 120.301 -0.952 . . . . 1.67 111.123 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.27 -17.37 59.44 Favored Glycine 0 N--CA 1.49 2.239 0 O-C-N 121.174 -1.191 . . . . 1.54 112.945 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 -60.09 -38.38 82.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.399 -1.059 . . . . 4.48 110.311 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.5 p -146.94 37.92 0.98 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.369 -0.832 . . . . 2.63 111.454 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 18.2 p -82.85 124.18 30.07 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.385 -0.968 . . . . 1.69 108.385 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -59.87 -38.61 82.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.405 -0.81 . . . . 1.07 110.545 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.3 p -54.13 -40.37 67.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 1.58 110.587 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.2 t -59.62 -39.6 84.82 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.034 -1.041 . . . . 1.6 109.71 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 33.6 mm -60.08 -39.22 79.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.583 -0.698 . . . . 1.45 110.394 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.5 mtp -62.51 -40.08 95.59 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.403 1.097 . . . . 1.05 109.786 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -56.2 -48.93 75.44 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.815 -0.63 . . . . 0.72 110.749 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -60.16 -42.55 95.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.011 -1.056 . . . . 3.05 110.605 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 64.9 m -69.96 -40.03 75.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.932 -1.105 . . . . 0.89 110.347 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 26.7 mt -91.12 -7.98 50.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.78 112.448 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 194' ' ' ALA . 48.3 mt-10 53.33 7.99 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.804 1.038 . . . . 1.45 113.804 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.26 150.48 92.0 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.933 . . . . 0.67 108.646 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.04 144.17 90.61 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.285 1.323 . . . . 0.64 109.263 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.73 162.26 34.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.119 -1.613 . . . . 0.67 110.075 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.2 mt -147.31 152.41 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.028 -1.101 . . . . 0.69 108.028 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.6 m -135.42 -32.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 121.288 -0.883 . . . . 0.85 112.702 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.84 41.42 2.37 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 120.098 -1.049 . . . . 0.92 111.399 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.458 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 43.2 p -64.14 -17.17 63.22 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.453 -1.028 . . . . 0.95 111.508 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.69 -95.81 0.91 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.945 -1.122 . . . . 1.04 110.345 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 88.8 p -127.25 30.8 5.34 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.849 -0.795 . . . . 1.57 112.146 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 72.7 t -58.91 -33.15 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.389 -1.444 . . . . 0.84 110.116 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 38.5 p -56.48 -24.04 43.35 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.71 -0.796 . . . . 0.99 111.407 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.2 p -92.98 0.74 57.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.866 . . . . 1.7 112.001 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -123.55 -7.74 8.03 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.562 0.696 . . . . 2.2 112.218 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 15.3 t -114.12 140.91 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.068 -0.716 . . . . 0.84 109.068 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -115.96 150.0 37.87 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.331 -0.988 . . . . 2.2 108.331 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.0 p30 -52.1 141.08 19.22 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.28 -0.887 . . . . 2.28 110.279 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.2 m-20 80.27 -0.75 1.99 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.948 1.092 . . . . 2.35 113.948 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -64.77 149.02 50.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.78 -1.2 . . . . 1.97 108.745 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -87.33 116.01 25.13 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.381 -1.34 . . . . 2.65 107.381 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.2 mt -128.38 144.73 51.17 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.513 0.673 . . . . 0.63 109.714 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 20.1 mt -115.81 128.61 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.698 -1.593 . . . . 0.62 106.698 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 48.9 tp -99.3 119.67 38.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 106.725 -1.584 . . . . 0.64 106.725 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.6 t0 -94.46 -28.66 15.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.926 -1.109 . . . . 2.05 112.333 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.899 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.61 17.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.005 0.743 . . . . 0.84 113.005 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' A' ' 221' ' ' ASP . 32.1 t -107.33 -58.54 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -0.929 . . . . 1.02 108.948 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -92.15 11.23 26.22 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.888 0.851 . . . . 2.51 110.545 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 60.9 t30 62.51 50.79 3.47 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.616 -0.72 . . . . 1.54 112.504 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -153.41 159.24 42.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.025 . . . . 1.95 109.945 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.0 t -116.43 141.65 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.127 -0.694 . . . . 0.71 109.127 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -103.5 132.08 50.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.024 -1.047 . . . . 1.01 108.758 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.63 129.63 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 107.717 -1.216 . . . . 0.82 107.717 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.435 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 54.0 t30 48.9 50.67 9.54 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 1.54 112.912 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 25.2 Cg_endo -64.13 154.26 71.64 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.42 2.08 . . . . 0.94 110.541 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.6 m -74.55 156.51 36.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.074 -1.016 . . . . 1.8 109.489 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -58.74 -35.76 73.22 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.018 . . . . 2.73 110.774 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -59.57 -40.19 86.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 3.17 110.015 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 96.8 t -69.64 -39.53 78.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.56 -0.713 . . . . 1.34 110.236 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.3 mt -57.48 -43.93 83.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.64 -0.662 . . . . 1.2 110.613 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.46 -43.31 93.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.873 -1.142 . . . . 2.7 110.317 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -63.64 -44.36 94.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.101 -1.0 . . . . 2.59 111.126 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.9 mtp -68.75 -37.75 79.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.007 -1.058 . . . . 1.38 110.874 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -59.05 -39.41 81.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.471 -0.768 . . . . 2.84 110.917 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.17 -43.41 67.53 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.158 -0.964 . . . . 1.88 111.086 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 99.6 t -60.26 -49.35 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.498 -1.376 . . . . 2.4 110.898 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.46 -50.32 71.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.742 -1.224 . . . . 3.52 110.475 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.76 -34.41 77.82 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.483 -0.887 . . . . 1.88 110.436 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -60.49 -29.41 69.06 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.914 -1.116 . . . . 3.01 110.418 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.5 -44.82 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.752 0.787 . . . . 2.45 110.155 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.27 -42.49 95.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.499 -0.751 . . . . 2.75 110.466 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.9 t -71.77 -34.31 69.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.469 -0.769 . . . . 3.16 110.64 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.07 -39.62 94.47 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.28 -0.888 . . . . 3.57 110.975 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.74 -31.42 72.06 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.798 -1.189 . . . . 4.3 110.804 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.99 85.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 4.45 110.622 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.43 -27.16 65.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 5.97 111.74 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.19 -29.88 70.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.823 -1.173 . . . . 6.18 111.192 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -68.37 -31.22 70.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -0.863 . . . . 6.66 110.84 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -83.57 -12.7 55.8 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.191 -0.943 . . . . 8.2 112.311 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -87.08 40.24 0.9 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.229 -0.92 . . . . 8.07 112.159 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -90.03 22.47 3.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.866 -1.146 . . . . 9.45 112.275 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -85.07 -61.64 1.73 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.449 -0.782 . . . . 10.12 109.54 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 117.93 -1.033 . . . . 11.49 109.609 -178.482 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.5 mtp . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.675 -0.491 . . . . 3.07 109.675 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.1 mt -97.73 111.26 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.806 -1.553 . . . . 1.07 106.806 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.6 m -104.71 125.46 50.83 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.989 -1.115 . . . . 1.24 107.989 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.8 -154.57 18.45 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.252 -1.939 . . . . 1.01 108.252 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 5' ' ' ILE . 73.0 mt -96.07 -2.08 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -1.003 . . . . 1.11 112.808 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 tp 49.57 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.99 112.583 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -85.96 -42.92 13.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.991 -1.068 . . . . 0.85 111.242 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -145.7 141.3 16.65 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 107.893 -1.151 . . . . 1.38 107.893 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.05 147.83 30.61 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.233 1.956 . . . . 0.94 112.333 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.904 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.94 166.74 15.67 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.818 -1.713 . . . . 0.81 108.818 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -127.46 138.04 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.09 -1.241 . . . . 0.83 108.004 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.55 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -141.48 160.06 40.93 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.964 0.888 . . . . 0.53 109.466 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 11.9 m-85 -129.66 139.94 51.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.168 -1.419 . . . . 0.77 107.168 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.69 169.2 38.4 Favored Glycine 0 N--CA 1.5 2.903 0 C-N-CA 119.04 -1.552 . . . . 0.51 110.077 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -77.31 158.42 30.19 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.606 -0.887 . . . . 1.9 108.606 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.646 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -88.09 128.28 35.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.167 -0.958 . . . . 0.66 108.613 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 tp -108.43 105.68 15.45 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 105.124 -2.176 . . . . 0.83 105.124 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.0 tp -94.73 132.6 39.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.107 -0.996 . . . . 0.86 108.774 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.9 mt -101.78 118.16 36.36 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.161 -1.792 . . . . 0.92 106.161 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -107.27 130.22 54.78 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.961 -1.125 . . . . 2.03 107.961 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -128.46 140.71 51.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.453 -0.779 . . . . 2.66 109.178 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.51 137.66 35.55 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.17 -1.048 . . . . 2.32 108.17 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -65.57 150.8 47.81 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.208 -0.933 . . . . 2.11 110.141 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.5 mt -89.11 134.05 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.89 -1.152 . . . . 0.73 107.89 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.22 130.23 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.928 -1.138 . . . . 0.87 107.928 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.88 130.92 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.548 -0.908 . . . . 0.81 108.548 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -92.74 127.01 38.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.232 -1.025 . . . . 1.34 108.232 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 28' ' ' ARG . 23.4 mmm-85 -99.31 17.39 20.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.529 -0.732 . . . . 2.89 112.277 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -61.95 144.49 54.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.783 -1.198 . . . . 2.09 109.467 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -90.66 131.93 36.07 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.606 -0.886 . . . . 2.19 108.606 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 pt -99.24 168.05 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.315 -0.866 . . . . 0.75 110.239 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.5 p -94.6 162.73 13.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.565 -0.71 . . . . 0.91 109.825 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.37 -21.11 22.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.93 111.667 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.76 -38.41 76.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.058 -1.026 . . . . 2.28 110.597 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -88.4 -6.35 57.73 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.104 -0.997 . . . . 1.45 111.932 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.07 -41.21 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.049 -1.032 . . . . 0.81 110.59 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -57.58 -40.08 78.22 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.907 -1.121 . . . . 1.54 110.736 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -63.2 -40.84 98.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 2.36 111.265 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.3 -39.76 88.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.779 -1.201 . . . . 1.31 110.875 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.2 -41.72 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.94 . . . . 0.82 110.43 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -61.75 -42.6 99.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.021 -1.049 . . . . 1.5 110.071 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.48 ' NH2' ' O ' ' A' ' 141' ' ' ILE . 55.4 mtp180 -61.82 -42.54 99.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 2.23 110.371 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -73.11 -51.08 19.33 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.014 -1.054 . . . . 0.85 110.162 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.45 -47.86 82.18 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.112 -1.435 . . . . 0.91 110.238 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.9 t -69.63 -42.56 74.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.419 -0.8 . . . . 0.9 110.469 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.81 -41.83 84.35 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.178 -1.487 . . . . 0.69 109.395 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.553 HH22 ' CD ' ' A' ' 86' ' ' GLU . 17.7 ttm180 -57.45 -32.73 67.21 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.227 1.013 . . . . 2.88 109.473 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.28 -42.43 81.64 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.806 0.813 . . . . 0.85 109.669 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -79.75 -43.93 21.65 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.729 0.776 . . . . 2.35 110.223 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.17 88.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.334 -0.854 . . . . 0.65 109.929 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 t -59.57 -41.76 90.94 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.068 0.937 . . . . 1.45 109.289 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.48 -45.23 80.37 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.965 -0.562 . . . . 0.63 110.063 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -64.85 -50.2 67.58 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.052 -1.059 . . . . 1.34 110.181 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.67 -37.61 84.71 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.658 -0.817 . . . . 1.56 110.2 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -60.19 -42.81 95.85 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.551 -0.718 . . . . 1.19 110.822 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.5 m -65.01 -44.2 90.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.019 -1.051 . . . . 0.72 110.42 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.15 -36.76 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.54 -0.725 . . . . 0.62 110.674 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -50.81 -44.94 59.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.155 -0.965 . . . . 1.05 110.561 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -68.3 -37.49 80.69 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.135 -0.978 . . . . 0.64 110.16 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.405 ' O ' ' OG1' ' A' ' 64' ' ' THR . 24.7 mtpp -61.49 -39.02 89.43 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.427 -1.309 . . . . 1.73 108.932 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.98 -38.76 87.11 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.799 -0.761 . . . . 0.56 109.261 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.94 -40.04 58.01 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 119.692 -1.242 . . . . 0.69 110.505 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -79.64 -20.15 47.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.427 -1.043 . . . . 1.48 110.437 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 87.9 m -82.74 -53.31 6.01 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 120.217 -0.593 . . . . 0.98 110.458 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -106.19 -16.06 14.69 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.289 -0.882 . . . . 1.16 112.693 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.95 167.77 16.3 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 111.459 -0.656 . . . . 0.85 111.459 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.3 -25.86 62.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.407 -1.054 . . . . 3.86 112.23 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.07 -40.06 73.01 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.895 -1.128 . . . . 2.35 111.182 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -89.36 -16.45 31.0 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.924 -1.11 . . . . 1.67 112.3 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.62 -39.0 86.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 1.45 110.702 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.17 78.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.72 -0.613 . . . . 0.61 111.495 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.01 -41.52 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.847 -1.158 . . . . 0.65 110.521 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -70.26 -31.44 68.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.917 -1.115 . . . . 0.66 110.498 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.43 -39.98 92.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.309 -0.87 . . . . 1.19 110.021 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.44 96.25 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.799 -1.32 . . . . 0.53 109.799 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -57.81 -40.13 79.21 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.367 -1.078 . . . . 1.27 110.495 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.5 mt -61.44 -40.39 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.54 110.236 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.6 ttm -59.5 -41.12 89.14 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.259 -0.901 . . . . 1.74 110.381 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.3 tp -57.52 -49.1 77.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.81 . . . . 0.55 110.309 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.02 -45.12 93.85 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.86 0.838 . . . . 0.47 110.175 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -87.46 8.03 26.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.464 -0.773 . . . . 1.42 113.026 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 55.2 t0 -62.22 123.47 18.28 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.764 -1.21 . . . . 1.27 109.151 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -66.48 -18.54 65.42 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.406 -0.809 . . . . 1.35 111.168 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' OE1' ' OD1' ' A' ' 82' ' ' ASP . 10.8 mp0 -77.68 -52.4 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.689 -0.804 . . . . 2.22 110.099 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.5 mt -60.92 -35.2 76.07 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.101 -0.999 . . . . 0.62 110.287 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.553 ' CD ' HH22 ' A' ' 47' ' ' ARG . 80.8 tt0 -59.14 -47.6 84.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.821 . . . . 1.29 110.402 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -61.72 -35.54 78.34 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.629 -0.669 . . . . 1.52 110.12 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.07 -49.09 71.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 1.3 110.313 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.3 mt -58.64 -43.93 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.06 -1.025 . . . . 0.61 109.779 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.01 -40.9 87.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.65 -0.656 . . . . 0.78 110.146 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -42.32 93.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.33 -0.857 . . . . 0.82 110.424 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.39 -44.03 97.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.285 -0.884 . . . . 0.8 110.013 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.8 mt -63.56 -49.21 83.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.363 -0.835 . . . . 0.77 110.039 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -78.12 -37.2 46.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.496 -0.752 . . . . 2.12 111.658 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -81.81 -40.96 21.79 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.573 -1.329 . . . . 1.51 111.996 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -105.58 7.76 32.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.457 -0.777 . . . . 1.98 112.687 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.7 m80 49.65 49.79 19.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.563 -1.336 . . . . 1.32 111.504 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 67.1 mtt -104.45 156.75 17.67 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.049 0.928 . . . . 1.38 109.967 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.3 p -72.59 161.75 30.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.783 -0.573 . . . . 0.67 110.02 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.55 86.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.52 110.302 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.587 ' OD2' HD21 ' A' ' 142' ' ' LEU . 96.2 m-20 -66.28 -40.07 89.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.118 -0.989 . . . . 2.25 109.868 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.2 -48.83 55.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.559 -0.713 . . . . 0.64 111.08 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.93 92.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.167 -0.958 . . . . 0.56 110.227 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.17 95.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.579 -0.701 . . . . 0.46 110.661 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -60.29 -39.87 88.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.204 -0.935 . . . . 1.32 111.275 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -58.05 -48.92 78.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.729 -1.232 . . . . 1.3 110.912 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.77 -45.61 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.892 -1.13 . . . . 0.61 109.867 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.3 mm -62.22 -31.72 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.645 -0.659 . . . . 0.65 110.348 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -57.33 -41.09 79.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 2.11 110.572 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.16 -34.64 9.52 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.368 -1.396 . . . . 0.83 112.624 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -60.69 -42.37 97.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.261 -1.729 . . . . 1.28 110.153 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.07 -55.55 6.35 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.451 -0.781 . . . . 0.89 110.727 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.8 m -60.61 -37.95 83.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 1.87 110.886 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.51 96.37 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.897 -1.127 . . . . 1.05 111.079 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.31 -30.22 70.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.873 -1.131 . . . . 1.02 110.918 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -66.53 -20.82 66.12 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.168 -1.013 . . . . 2.04 110.954 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -71.91 -15.18 62.09 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.838 0.827 . . . . 1.73 110.828 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.489 HD13 HD13 ' A' ' 123' ' ' LEU . 50.0 mt -86.74 145.16 26.76 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.246 -0.65 . . . . 1.37 109.246 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -103.02 39.7 1.51 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.337 -0.852 . . . . 2.88 111.461 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -113.04 136.27 52.87 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.135 -1.061 . . . . 1.58 108.135 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -56.63 -38.07 71.59 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.444 0.64 . . . . 3.04 110.796 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -72.16 -52.79 14.99 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.827 -1.171 . . . . 0.9 110.312 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.489 HD13 HD13 ' A' ' 118' ' ' LEU . 19.3 mt -63.58 -39.72 95.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.168 -0.958 . . . . 1.06 110.497 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -65.65 -47.54 75.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.93 . . . . 2.18 110.502 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -61.47 -31.34 71.3 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.407 -0.917 . . . . 2.15 110.248 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 130' ' ' VAL . 63.3 ttt180 -65.71 -27.7 68.52 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 118.995 -1.082 . . . . 2.33 109.528 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.84 -49.16 78.77 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.786 0.803 . . . . 0.82 109.589 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.23 91.22 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.57 -0.852 . . . . 0.85 109.633 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 2.0 m-20 -62.97 -35.47 80.28 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.306 0.574 . . . . 1.39 110.214 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 126' ' ' ARG . 31.8 t -68.17 -40.47 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.518 -0.739 . . . . 0.56 110.639 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -59.72 -38.13 80.81 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.509 -1.277 . . . . 3.12 110.076 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.52 ' OD1' ' NE ' ' A' ' 136' ' ' ARG . 54.4 t0 -60.22 -40.05 88.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.608 -0.683 . . . . 1.28 110.186 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.19 -39.64 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.01 -1.056 . . . . 0.49 110.399 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.08 -46.9 62.68 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.937 -1.125 . . . . 0.46 110.696 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -59.94 -41.31 91.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.123 -1.222 . . . . 2.71 110.368 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.52 ' NE ' ' OD1' ' A' ' 132' ' ' ASP . 40.5 mtt-85 -63.32 -42.11 98.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.06 -1.025 . . . . 2.14 109.995 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.522 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.0 tt -61.06 -45.15 95.92 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.967 0.889 . . . . 1.05 109.76 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.98 -42.05 97.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.89 . . . . 0.52 110.522 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.12 -31.71 70.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.933 . . . . 2.35 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -75.33 -41.67 56.18 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.945 -1.097 . . . . 1.39 110.777 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.48 ' O ' ' NH2' ' A' ' 42' ' ' ARG . 98.0 mt -60.02 -37.92 74.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.144 -0.973 . . . . 0.68 110.607 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.587 HD21 ' OD2' ' A' ' 101' ' ' ASP . 90.0 mt -87.49 -9.18 55.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.378 -0.826 . . . . 0.83 111.716 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.26 23.62 65.34 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 120.298 -0.953 . . . . 0.91 113.457 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.1 tp -68.34 139.71 55.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.806 -0.82 . . . . 0.95 109.863 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -68.6 150.54 47.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.568 -0.707 . . . . 2.43 109.907 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 39.7 mt -108.76 137.7 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.341 -0.985 . . . . 1.1 108.341 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.3 mm -78.31 130.35 36.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.875 -1.141 . . . . 1.58 109.016 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -94.47 97.62 10.29 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.625 -1.62 . . . . 1.62 106.625 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 51.0 mt -76.98 -15.66 59.58 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.39 0.614 . . . . 0.8 111.563 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.4 t -80.97 2.39 27.06 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.59 0.71 . . . . 1.56 112.156 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.69 22.7 10.57 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.713 0.768 . . . . 0.84 112.069 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 12.5 mt -72.77 135.88 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.427 -0.953 . . . . 0.82 108.427 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -121.15 -13.69 8.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 112.927 0.714 . . . . 2.31 112.927 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -112.53 136.89 51.51 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.926 -1.138 . . . . 1.54 107.926 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.07 117.68 17.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.376 -0.828 . . . . 1.38 109.009 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -148.01 179.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.21 -0.663 . . . . 0.69 109.21 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 49.0 mt -88.13 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.481 -0.933 . . . . 0.53 108.481 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.3 tp -94.63 126.82 40.17 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.43 -0.952 . . . . 0.64 108.43 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.48 130.66 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.038 -1.097 . . . . 0.67 108.038 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.34 159.51 31.3 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.009 -1.057 . . . . 0.78 108.67 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.14 92.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.692 -1.255 . . . . 1.0 109.324 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 50.9 t0 -171.75 154.09 3.53 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.527 -0.916 . . . . 2.42 108.527 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 49.6 mt -117.18 139.04 51.26 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.446 -0.946 . . . . 0.75 108.446 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.7 p -92.06 146.29 32.49 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.158 -0.964 . . . . 0.78 108.41 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -38.97 -44.63 2.51 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.169 1.913 . . . . 0.67 113.812 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 16.2 m -60.34 -47.84 84.32 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.629 -1.294 . . . . 0.7 109.954 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -63.17 -37.8 88.67 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.657 0.742 . . . . 1.21 110.167 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.0 p -67.87 -39.05 83.79 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.547 -0.721 . . . . 0.6 110.192 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.19 86.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.533 -0.73 . . . . 0.62 110.744 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.79 -3.31 56.3 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.149 -0.97 . . . . 1.16 113.046 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 171' ' ' LEU . 41.2 tp -63.37 156.35 26.15 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.402 -0.811 . . . . 0.73 109.587 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -94.9 110.2 22.12 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.503 -1.666 . . . . 2.24 106.503 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.1 mt -71.33 -24.91 62.21 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.748 0.785 . . . . 1.43 111.408 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -85.66 -18.66 32.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.492 -0.755 . . . . 2.15 112.446 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -100.64 -2.73 31.97 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.297 -0.877 . . . . 2.04 112.767 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 178' ' ' GLY . 57.5 t -109.69 130.09 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.689 -1.226 . . . . 0.55 107.689 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.743 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.8 tt -85.61 -9.89 56.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.031 -1.043 . . . . 1.63 111.702 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.37 173.41 38.98 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.485 -1.446 . . . . 0.47 109.485 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.9 OUTLIER -130.64 131.31 44.83 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.622 -1.251 . . . . 0.54 107.622 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.526 HG22 HG21 ' A' ' 205' ' ' THR . 87.5 mt -134.49 109.11 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 106.093 -1.818 . . . . 0.69 106.093 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 203' ' ' VAL . 73.6 p -134.26 174.58 10.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.678 -1.264 . . . . 0.82 110.415 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 206' ' ' GLY . 11.8 t0 -103.85 65.83 0.83 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.639 -0.71 . . . . 2.37 109.375 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -101.85 145.82 28.67 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.195 -0.941 . . . . 1.11 109.053 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.46 -8.63 59.95 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.855 -1.164 . . . . 1.67 112.807 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 83.42 -21.52 8.62 Favored Glycine 0 N--CA 1.492 2.411 0 O-C-N 121.511 -0.994 . . . . 1.54 114.183 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -59.95 -37.14 78.67 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.055 -1.262 . . . . 4.48 109.855 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 20.2 p -146.72 41.99 1.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.557 -0.714 . . . . 2.63 110.505 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.9 p -85.33 103.46 14.27 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.07 -1.455 . . . . 1.69 107.07 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -59.98 -30.46 69.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.838 . . . . 1.07 110.528 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.0 m -56.45 -40.51 74.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.539 -0.726 . . . . 1.58 110.039 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.1 m -59.78 -39.98 86.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 1.6 109.948 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 192' ' ' ILE . 1.6 mp -60.23 -38.89 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.815 . . . . 1.45 110.418 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 68.3 mtp -62.38 -42.96 99.82 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 122.062 0.934 . . . . 1.05 109.529 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.5 -48.74 79.69 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.726 -0.67 . . . . 0.72 111.673 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 195' ' ' ARG . 30.2 mtt-85 -60.78 -44.4 96.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.14 . . . . 3.05 110.653 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 28.8 m -69.45 -39.54 77.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.887 . . . . 0.89 110.435 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.4 -4.9 53.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.78 112.987 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 194' ' ' ALA . 75.3 mt-10 54.6 12.5 0.56 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.115 1.154 . . . . 1.45 114.115 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 72.9 mt -73.77 158.4 86.15 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.05 -1.032 . . . . 0.67 108.495 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -65.32 142.71 73.98 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.973 1.115 . . . . 0.64 110.557 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.96 163.87 33.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 119.928 -1.733 . . . . 0.67 110.431 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.0 mt -149.88 149.74 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 107.465 -1.309 . . . . 0.69 107.465 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 5.5 m -135.82 -26.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.755 -1.216 . . . . 0.85 112.54 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.15 35.04 1.49 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.309 -1.424 . . . . 0.92 113.113 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.526 HG21 HG22 ' A' ' 180' ' ' ILE . 47.5 p -56.06 -27.62 54.19 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.421 -1.046 . . . . 0.95 111.45 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 77.12 -90.78 1.0 Allowed Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.133 -1.032 . . . . 1.04 110.815 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.2 p -125.06 27.6 6.64 Favored 'General case' 0 N--CA 1.512 2.652 0 O-C-N 121.341 -1.094 . . . . 1.57 112.669 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.11 -34.76 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.232 -1.543 . . . . 0.84 110.075 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.9 p -58.34 -17.97 23.96 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.26 -0.976 . . . . 0.99 111.86 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.8 p -92.63 -0.98 57.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.137 -0.977 . . . . 1.7 112.006 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -129.13 5.19 5.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 112.595 0.591 . . . . 2.2 112.595 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.87 141.32 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.732 -0.605 . . . . 0.84 109.39 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -120.35 155.21 33.84 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.371 -0.974 . . . . 2.2 108.371 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 16.6 p30 -53.8 142.79 22.77 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.083 -1.011 . . . . 2.28 110.547 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.6 t0 80.19 0.25 2.01 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.504 1.298 . . . . 2.35 114.504 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.12 146.67 54.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.795 -1.191 . . . . 1.97 108.78 177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -88.74 120.7 30.38 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.458 -1.312 . . . . 2.65 107.458 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.646 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 49.6 mt -128.94 149.04 50.96 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.404 -0.81 . . . . 0.63 110.018 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.425 HD13 ' SD ' ' A' ' 239' ' ' MET . 57.4 mt -116.03 126.95 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.878 -1.527 . . . . 0.62 106.878 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.416 HD13 HD11 ' A' ' 180' ' ' ILE . 65.1 tp -99.22 120.11 38.98 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.306 -1.368 . . . . 0.64 107.306 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 223' ' ' VAL . 49.7 t0 -93.89 -28.97 15.54 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.012 -1.055 . . . . 2.05 112.826 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.77 18.37 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.186 0.809 . . . . 0.84 113.186 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.8 t -111.45 -58.84 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-O 122.197 0.999 . . . . 1.02 108.922 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -96.47 9.8 40.24 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.412 1.101 . . . . 2.51 110.188 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 61.92 50.05 4.38 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.785 -1.098 . . . . 1.54 111.665 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -145.28 148.04 33.02 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.345 1.069 . . . . 1.95 109.749 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 80.9 t -117.2 140.77 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 115.503 -0.772 . . . . 0.71 109.285 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -100.03 130.59 46.21 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.171 -1.048 . . . . 1.01 108.171 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.3 t -109.83 131.48 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.579 0.704 . . . . 0.82 109.166 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.413 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 24.6 t30 52.96 51.65 9.47 Favored Pre-proline 0 N--CA 1.497 1.877 0 N-CA-C 113.345 0.869 . . . . 1.54 113.345 177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 61.9 Cg_endo -70.23 151.66 66.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.784 2.323 . . . . 0.94 111.441 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.0 m -72.23 156.46 39.11 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.964 -1.085 . . . . 1.8 108.747 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -59.8 -39.43 84.95 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.89 -1.131 . . . . 2.73 109.935 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.65 -39.72 85.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.482 -0.761 . . . . 3.17 110.278 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 87.9 t -69.71 -38.58 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.461 -0.775 . . . . 1.34 110.216 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.29 -46.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.042 -1.036 . . . . 1.2 110.15 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.03 -40.22 88.57 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.175 -0.953 . . . . 2.7 110.208 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -62.17 -41.57 98.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 2.59 110.808 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.425 ' SD ' HD13 ' A' ' 219' ' ' ILE . 74.9 mtp -70.81 -31.39 68.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 1.38 110.372 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.428 ' CA ' ' HE ' ' A' ' 240' ' ' ARG . 0.0 OUTLIER -58.95 -40.64 85.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 2.84 110.063 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.6 -45.33 45.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.297 -0.877 . . . . 1.88 110.827 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 87.5 t -59.61 -46.35 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 2.4 110.828 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.484 ' CA ' ' OE1' ' A' ' 243' ' ' GLN . 0.4 OUTLIER -62.86 -51.93 65.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.019 -1.051 . . . . 3.52 109.871 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.14 -31.88 71.59 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.216 -0.993 . . . . 1.88 109.838 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -60.74 -31.1 70.43 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.097 -1.041 . . . . 3.01 109.364 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.7 -43.88 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.87 0.843 . . . . 2.45 109.918 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.1 94.76 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.023 -1.071 . . . . 2.75 109.567 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.2 t -73.28 -24.85 60.48 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.664 0.745 . . . . 3.16 110.63 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -60.58 -37.77 82.43 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.815 -0.553 . . . . 3.57 110.534 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -62.63 -41.54 99.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 4.3 110.373 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -71.02 -42.64 69.28 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.886 0.851 . . . . 4.45 110.574 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -82.94 5.2 22.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.579 -0.701 . . . . 5.97 112.739 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -59.1 -36.12 74.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.924 -1.11 . . . . 6.18 110.415 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.73 -19.55 65.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.848 -1.158 . . . . 6.66 111.409 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -84.74 -5.91 59.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.474 -0.767 . . . . 8.2 112.69 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.86 -3.72 58.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.903 -1.123 . . . . 8.07 111.688 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -87.33 -122.67 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.193 -1.04 . . . . 9.45 108.193 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.03 11.58 38.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.476 -0.765 . . . . 10.12 112.478 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 117.965 -1.017 . . . . 11.49 109.274 179.698 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mmm . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.077 -0.712 . . . . 3.07 109.077 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.0 mt -97.14 117.34 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.455 -1.683 . . . . 1.07 106.455 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 m -104.38 128.45 52.23 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.097 -1.075 . . . . 1.24 108.097 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.04 -160.45 16.79 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.904 -1.678 . . . . 1.01 108.904 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.6 mt -93.31 -1.11 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.292 -1.122 . . . . 1.11 112.772 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 50.72 96.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.102 -0.999 . . . . 0.99 112.688 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.92 -42.33 13.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 0.85 111.547 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -145.35 144.85 24.37 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.046 -1.094 . . . . 1.38 108.046 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.81 147.44 27.43 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.59 2.193 . . . . 0.94 112.218 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.893 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.29 167.77 15.16 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 109.261 -1.536 . . . . 0.81 109.261 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.7 mt -125.91 132.49 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.243 -1.151 . . . . 0.83 107.909 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.53 151.59 46.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 0.53 109.286 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.609 ' CE1' ' NH2' ' A' ' 240' ' ' ARG . 1.8 m-85 -122.24 144.52 48.93 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.259 -1.015 . . . . 0.77 108.259 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.92 167.45 34.22 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 118.362 -1.875 . . . . 0.51 110.197 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -78.1 157.68 29.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.429 -1.042 . . . . 1.9 108.938 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.419 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -83.96 124.64 31.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.975 -1.078 . . . . 0.66 108.151 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.3 tp -100.46 104.49 15.89 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.024 -2.213 . . . . 0.83 105.024 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -91.02 135.78 33.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.215 -1.031 . . . . 0.86 108.215 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.3 mt -97.27 120.1 37.01 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.438 -1.319 . . . . 0.92 107.438 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -109.11 134.67 51.4 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.249 -1.019 . . . . 2.03 108.249 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.563 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 37.2 tt0 -117.98 140.36 49.85 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.224 -0.658 . . . . 2.66 109.224 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -81.98 131.28 35.25 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.718 -1.216 . . . . 2.32 107.718 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.09 145.02 56.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 2.11 108.74 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.67 135.19 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.91 -1.118 . . . . 0.73 108.636 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.6 t -103.44 129.8 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.967 -1.123 . . . . 0.87 107.967 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -99.0 136.97 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.646 -0.872 . . . . 0.81 108.646 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -90.62 122.46 33.43 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.828 -1.175 . . . . 1.34 107.828 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.442 HH11 ' HG3' ' A' ' 28' ' ' ARG . 20.6 mmm-85 -93.52 15.72 15.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.315 -0.865 . . . . 2.89 112.319 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -71.47 143.25 50.1 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.408 -0.807 . . . . 2.09 109.527 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.75 141.7 31.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.649 -0.657 . . . . 2.19 109.425 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.2 pt -98.3 168.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.197 -0.939 . . . . 0.75 110.622 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.8 p -102.37 162.3 13.03 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.983 -0.747 . . . . 0.91 108.983 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.45 -18.55 1.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.086 -1.009 . . . . 0.93 112.379 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -69.85 -39.99 76.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 2.28 110.754 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -93.13 -8.91 41.27 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.873 -1.142 . . . . 1.45 112.949 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -56.29 -50.48 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.168 -0.957 . . . . 0.81 110.781 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.85 -39.44 85.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.542 -0.724 . . . . 1.54 110.674 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -62.2 -41.29 98.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.831 . . . . 2.36 110.896 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.53 -37.62 81.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.742 -1.224 . . . . 1.31 110.449 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.41 -41.78 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.169 -0.957 . . . . 0.82 110.028 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -62.13 -43.58 98.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 1.5 109.745 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.464 HH11 ' HG2' ' A' ' 42' ' ' ARG . 34.0 mtt-85 -61.8 -44.05 97.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.524 -0.735 . . . . 2.23 110.063 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -70.78 -52.16 22.38 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.346 -0.846 . . . . 0.85 109.896 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.08 -46.44 89.56 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.394 -0.922 . . . . 0.91 109.846 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 15.5 t -69.19 -34.89 75.6 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.243 0.544 . . . . 0.9 110.364 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.44 -47.95 87.79 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.685 -1.245 . . . . 0.69 110.17 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -56.91 -32.02 65.5 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.363 -1.08 . . . . 2.88 109.183 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.38 -42.06 69.93 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.522 0.677 . . . . 0.85 109.968 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -78.49 -42.02 30.85 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.688 -0.805 . . . . 2.35 110.14 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.77 95.95 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.669 0.747 . . . . 0.65 110.368 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.1 p -60.01 -39.81 87.06 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.994 0.902 . . . . 1.45 109.666 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.57 67.97 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 120.073 -0.651 . . . . 0.63 110.31 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -61.18 -48.57 80.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.273 -0.892 . . . . 1.34 110.382 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.8 -40.37 96.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -0.92 . . . . 1.56 109.821 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -60.55 -41.24 94.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.542 -0.724 . . . . 1.19 110.428 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.621 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 9.4 m -65.65 -42.86 90.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.0 -1.062 . . . . 0.72 110.409 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.2 -30.73 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.658 . . . . 0.62 110.611 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -52.61 -46.29 66.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.709 -0.619 . . . . 1.05 110.619 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 m -68.82 -37.2 79.05 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.21 -0.931 . . . . 0.64 109.791 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.621 ' NZ ' HG22 ' A' ' 56' ' ' THR . 65.2 mttp -61.73 -38.35 87.58 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.427 -0.909 . . . . 1.73 109.386 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.19 74.86 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.822 -0.751 . . . . 0.56 109.977 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.97 -34.57 21.03 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.379 -1.391 . . . . 0.69 110.917 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.44 -18.05 43.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.783 -1.422 . . . . 1.48 111.545 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.0 m -87.91 -52.57 5.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.912 -0.493 . . . . 0.98 110.344 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -107.27 -15.28 14.69 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.435 -0.791 . . . . 1.16 112.97 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.91 164.88 14.71 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.537 -0.727 . . . . 0.85 111.567 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -58.16 -17.94 22.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.629 -0.924 . . . . 3.86 113.113 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.91 -39.43 85.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.995 -1.065 . . . . 2.35 110.769 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -86.8 -23.63 25.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.953 -1.092 . . . . 1.67 111.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -59.84 -39.98 86.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.725 -0.609 . . . . 1.45 111.598 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.44 -36.77 81.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.162 -0.961 . . . . 0.61 111.352 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 57.8 mt -63.38 -41.65 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.73 -1.232 . . . . 0.65 110.843 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -70.59 -30.94 67.75 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.933 -1.104 . . . . 0.66 110.631 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.51 -38.73 85.32 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.195 -0.94 . . . . 1.19 109.91 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.3 -44.67 90.22 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 120.298 -0.953 . . . . 0.53 110.891 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -59.73 -40.79 89.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.874 -1.368 . . . . 1.27 110.723 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.6 mt -59.83 -39.43 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.107 -0.995 . . . . 0.54 110.772 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.21 -39.77 83.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.111 -0.993 . . . . 1.74 110.633 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.5 tp -58.36 -45.89 87.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.14 -0.975 . . . . 0.55 110.235 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.51 -39.83 89.2 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.585 -0.846 . . . . 0.47 110.248 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -86.93 11.02 14.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 1.42 112.304 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -66.47 120.96 14.26 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.978 -1.076 . . . . 1.27 108.536 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.87 -16.8 64.17 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.367 -0.833 . . . . 1.35 110.918 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -73.42 -47.89 38.13 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.548 -0.861 . . . . 2.22 110.447 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.86 -37.29 86.83 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.429 -0.908 . . . . 0.62 110.229 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.74 -45.53 93.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.338 -0.851 . . . . 1.29 110.915 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.7 -36.98 85.62 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.014 -1.054 . . . . 1.52 110.925 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.7 -48.48 63.77 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.735 -1.228 . . . . 1.3 110.404 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -57.44 -47.71 84.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.444 -0.902 . . . . 0.61 110.243 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.87 -39.61 80.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.785 -0.572 . . . . 0.78 110.415 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.53 91.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 0.82 110.644 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.15 -43.68 98.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.8 110.284 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.1 mt -61.0 -45.95 97.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.77 110.648 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -82.31 -36.43 26.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -0.757 . . . . 2.12 111.908 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -84.49 -39.36 18.97 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.62 -1.3 . . . . 1.51 111.627 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -105.26 10.37 33.65 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.969 -1.082 . . . . 1.98 111.939 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.4 m80 48.48 51.39 15.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 1.32 111.588 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.2 mtt -109.5 154.34 22.81 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.703 0.763 . . . . 1.38 109.722 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.1 p -71.81 158.64 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.132 -0.692 . . . . 0.67 109.132 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.27 89.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.403 -0.811 . . . . 0.52 110.754 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.634 ' OD2' HD21 ' A' ' 142' ' ' LEU . 72.4 m-20 -67.42 -43.06 82.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.755 -1.215 . . . . 2.25 109.51 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.06 -48.31 58.4 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.656 0.741 . . . . 0.64 110.845 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.48 -46.85 87.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.138 -0.976 . . . . 0.56 110.47 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.29 94.96 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.497 0.665 . . . . 0.46 110.411 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.85 -39.33 84.82 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.032 -1.043 . . . . 1.32 110.334 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.42 -49.92 75.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.878 -1.139 . . . . 1.3 111.099 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.25 -49.0 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.059 . . . . 0.61 110.004 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.45 -30.82 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.676 -0.64 . . . . 0.65 110.699 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -59.45 -40.37 86.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 2.11 110.276 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.28 -28.0 31.74 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.204 -1.474 . . . . 0.83 113.108 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -60.29 -39.73 87.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.056 -1.85 . . . . 1.28 110.045 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.63 -46.69 52.82 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.554 -0.716 . . . . 0.89 110.299 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.3 p -62.83 -40.21 96.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.419 -0.801 . . . . 1.87 110.433 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.39 -40.65 97.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 1.05 110.508 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.88 -29.61 70.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.04 -1.037 . . . . 1.02 111.111 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.09 -21.36 64.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.906 -1.121 . . . . 2.04 111.053 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -73.81 -12.48 60.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.215 -0.928 . . . . 1.73 110.788 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.454 HD13 HD13 ' A' ' 123' ' ' LEU . 9.6 mt -84.84 144.89 28.13 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.485 -0.759 . . . . 1.37 109.065 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -101.46 46.91 0.92 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.171 -0.956 . . . . 2.88 111.591 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -122.28 138.75 54.39 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.057 -1.027 . . . . 1.58 108.589 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.8 -38.67 82.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 3.04 110.973 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -71.93 -47.02 55.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.957 -1.089 . . . . 0.9 110.525 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.454 HD13 HD13 ' A' ' 118' ' ' LEU . 39.5 mt -63.67 -36.76 84.89 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.46 -0.896 . . . . 1.06 110.103 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -60.47 -46.53 89.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.819 -1.152 . . . . 2.18 109.644 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -61.95 -30.84 71.19 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.367 -0.933 . . . . 2.15 109.651 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 130' ' ' VAL . 60.7 ttt180 -61.86 -30.12 70.64 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.291 -0.964 . . . . 2.33 108.9 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.21 73.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.785 0.802 . . . . 0.82 109.574 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.89 -43.36 71.95 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.622 0.725 . . . . 0.85 110.319 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -64.5 -34.15 77.56 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.497 -0.752 . . . . 1.39 110.528 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 126' ' ' ARG . 16.3 t -68.01 -39.96 82.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.252 -0.905 . . . . 0.56 110.033 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.435 HH11 ' HG2' ' A' ' 131' ' ' ARG . 27.4 ttt-85 -56.18 -39.92 73.14 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.251 -1.379 . . . . 3.12 109.469 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -60.05 -42.59 94.79 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.575 0.702 . . . . 1.28 110.235 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.32 -38.94 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.49 110.166 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.59 -43.74 23.02 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.852 -1.166 . . . . 0.46 110.832 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -58.33 -40.76 83.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.293 -1.122 . . . . 2.71 110.592 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 136' ' ' ARG . 55.1 mtt-85 -62.33 -41.55 98.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.959 -1.088 . . . . 2.14 109.969 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.64 -39.59 84.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.611 -0.681 . . . . 1.05 109.964 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.3 mt -59.73 -40.09 86.86 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.453 -0.779 . . . . 0.52 110.473 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.563 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 63.1 mtt-85 -60.66 -38.6 85.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.016 -1.053 . . . . 2.35 111.062 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -71.65 -41.81 68.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 1.39 110.87 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.3 -39.62 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.016 -1.053 . . . . 0.68 110.216 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.634 HD21 ' OD2' ' A' ' 101' ' ' ASP . 84.1 mt -87.2 -8.93 56.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.123 -0.986 . . . . 0.83 112.199 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.27 21.29 78.07 Favored Glycine 0 N--CA 1.48 1.617 0 C-N-CA 119.703 -1.237 . . . . 0.91 113.282 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 tp -69.2 149.94 48.02 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.78 -0.835 . . . . 0.95 110.543 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -67.85 150.92 47.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.369 -0.832 . . . . 2.43 110.913 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.9 mt -101.74 139.96 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.368 -0.975 . . . . 1.1 108.368 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.737 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.3 mp -78.56 124.42 36.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.297 -1.001 . . . . 1.58 108.297 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -99.6 100.03 10.97 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.317 -1.735 . . . . 1.62 106.317 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.518 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 71.6 mt -78.54 -4.99 51.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.545 -0.722 . . . . 0.8 112.321 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.2 p -86.99 9.18 20.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.145 -0.972 . . . . 1.56 112.366 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.66 18.42 14.33 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 114.151 1.167 . . . . 0.84 114.151 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.1 mp -71.35 141.12 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 119.909 -1.744 . . . . 0.82 109.498 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -118.84 -13.52 9.51 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.045 0.926 . . . . 2.31 112.429 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -117.38 145.04 44.34 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.555 -0.906 . . . . 1.54 108.555 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -76.26 121.78 23.44 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.673 -0.862 . . . . 1.38 108.673 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.4 m -147.48 176.31 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.434 -0.791 . . . . 0.69 108.973 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.9 mt -88.65 142.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.524 -0.735 . . . . 0.53 109.339 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.5 tp -94.85 126.73 40.38 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.594 -0.891 . . . . 0.64 108.594 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.89 131.02 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.648 -0.871 . . . . 0.67 108.648 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.98 154.56 19.87 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.646 -0.872 . . . . 0.78 108.646 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.22 -36.02 78.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.393 -1.442 . . . . 1.0 109.477 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 55.9 t0 -172.75 151.22 2.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.43 -0.952 . . . . 2.42 108.43 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 70.1 mt -113.06 140.22 48.04 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.371 -0.831 . . . . 0.75 108.926 177.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.5 p -94.82 152.81 39.97 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.221 -0.925 . . . . 0.78 108.754 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -42.91 -42.28 9.08 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.806 1.671 . . . . 0.67 113.295 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.9 m -62.24 -50.44 71.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.987 -1.071 . . . . 0.7 109.744 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.28 -40.5 90.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.503 -0.748 . . . . 1.21 110.25 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 78.3 p -67.86 -40.09 83.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.53 -0.731 . . . . 0.6 110.754 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.13 86.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.62 110.743 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -95.32 1.1 54.28 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.204 -0.935 . . . . 1.16 112.691 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.83 150.15 29.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.451 -0.781 . . . . 0.73 109.902 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.445 ' O ' HG23 ' A' ' 176' ' ' VAL . 5.3 p-10 -91.99 107.02 18.91 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.274 -1.75 . . . . 2.24 106.274 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.4 mt -81.15 -9.16 59.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.788 . . . . 1.43 112.535 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -77.59 -35.51 52.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.039 -1.038 . . . . 2.15 110.572 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -101.36 2.87 40.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.235 -0.915 . . . . 2.04 113.01 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 172' ' ' ASN . 91.0 t -101.0 120.01 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 106.807 -1.553 . . . . 0.55 106.807 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.2 tp -90.93 -9.51 45.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.097 -1.002 . . . . 1.63 112.04 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.66 169.26 40.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.035 -1.626 . . . . 0.47 109.035 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 1.1 m-85 -128.02 129.79 47.28 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.384 -1.068 . . . . 0.54 108.2 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.4 mt -128.85 108.75 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 105.857 -1.905 . . . . 0.69 105.857 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 205' ' ' THR . 76.4 p -130.82 171.76 12.78 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.905 -1.122 . . . . 0.82 110.153 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.445 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 33.3 t0 -102.54 59.15 0.8 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.724 -0.61 . . . . 2.37 110.453 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.94 120.5 42.47 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.371 -1.715 . . . . 1.11 106.371 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.72 17.91 49.95 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 120.918 -1.114 . . . . 1.67 113.133 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -91.8 120.42 6.04 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.36 -2.296 . . . . 1.54 107.36 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -59.06 -31.38 68.81 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.199 -1.177 . . . . 4.48 109.558 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 81.2 p -108.44 41.51 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.462 0.649 . . . . 2.63 109.993 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 52.0 m -70.25 158.73 35.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.957 -1.09 . . . . 1.69 109.171 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -59.84 -39.6 85.69 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.36 -0.838 . . . . 1.07 111.082 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.9 m -58.47 -40.99 84.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.633 -1.292 . . . . 1.58 110.228 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.2 m -61.39 -37.04 81.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 1.6 110.447 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.73 -39.32 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.509 -0.745 . . . . 1.45 110.666 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 68.8 mtp -62.92 -41.15 99.37 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.08 0.943 . . . . 1.05 109.486 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.92 -45.43 94.67 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.931 -0.577 . . . . 0.72 111.091 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -60.37 -43.37 96.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.982 -1.074 . . . . 3.05 110.674 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.2 m -69.45 -39.13 77.97 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.211 -0.93 . . . . 0.89 110.187 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.45 -7.48 50.48 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.871 0.844 . . . . 0.78 112.531 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 53.12 7.16 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.996 1.109 . . . . 1.45 113.996 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.91 149.67 92.61 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 120.959 -1.088 . . . . 0.67 108.385 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.13 144.95 88.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.534 1.49 . . . . 0.64 109.738 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.62 161.41 35.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.366 -1.458 . . . . 0.67 109.673 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.467 ' CD1' HD11 ' A' ' 220' ' ' LEU . 19.6 mt -149.94 149.55 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.756 -1.202 . . . . 0.69 107.756 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.8 m -133.41 -25.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.123 -0.986 . . . . 0.85 112.324 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.68 43.0 2.07 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 120.226 -0.987 . . . . 0.92 111.837 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 181' ' ' THR . 43.8 p -63.08 -15.63 57.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.322 -1.105 . . . . 0.95 111.573 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.445 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 72.12 -93.82 0.6 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.868 -1.293 . . . . 1.04 109.868 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 85.2 p -129.95 33.4 4.4 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.35 -1.088 . . . . 1.57 112.022 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.67 -35.79 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.023 -1.673 . . . . 0.84 110.482 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.1 p -60.33 -24.76 65.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.99 111.73 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.8 p -96.57 9.0 42.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 1.7 112.149 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -132.59 -4.27 3.31 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.728 -0.607 . . . . 2.2 112.409 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 213' ' ' LYS . 42.1 t -121.06 157.59 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.275 -0.89 . . . . 0.84 109.854 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.422 ' N ' HG12 ' A' ' 212' ' ' VAL . 20.9 mmmt -122.25 160.25 25.64 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.069 -1.086 . . . . 2.2 108.069 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 51.5 p-10 -57.03 142.12 43.23 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.093 -1.004 . . . . 2.28 110.53 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.0 OUTLIER 80.32 7.49 1.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.79 1.404 . . . . 2.35 114.79 179.387 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.8 t0 -67.21 149.38 50.53 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.308 -0.997 . . . . 1.97 108.308 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.433 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.3 t80 -89.64 115.04 26.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.331 -1.359 . . . . 2.65 107.331 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.419 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 78.5 mt -124.96 148.15 48.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -0.755 . . . . 0.63 109.365 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.3 mt -119.09 126.35 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.15 -1.796 . . . . 0.62 106.15 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 202' ' ' ILE . 66.2 tp -100.91 119.04 38.13 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.425 -1.694 . . . . 0.64 106.425 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.0 p-10 -94.73 -21.33 18.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.027 -1.046 . . . . 2.05 112.459 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.893 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.93 18.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.376 0.608 . . . . 0.84 112.477 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.601 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.4 t -112.26 -62.83 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 1.02 109.389 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -89.68 7.25 37.64 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.314 1.054 . . . . 2.51 110.226 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 39.6 t30 63.86 50.58 2.56 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.023 -0.989 . . . . 1.54 112.1 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 28.7 mt-30 -147.16 152.38 38.33 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.352 1.072 . . . . 1.95 110.187 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.9 t -115.65 139.92 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.989 -1.115 . . . . 0.71 107.989 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -104.98 133.17 50.21 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.164 -0.96 . . . . 1.01 108.775 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.85 130.89 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.16 -1.052 . . . . 0.82 108.16 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.461 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 57.7 t30 54.39 49.04 5.12 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 113.578 0.955 . . . . 1.54 113.578 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 52.9 Cg_endo -68.95 149.67 72.25 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.607 2.204 . . . . 0.94 110.994 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.1 p -78.33 165.47 23.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.035 -1.041 . . . . 1.8 110.497 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -60.77 -36.34 78.7 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.946 -1.096 . . . . 2.73 110.455 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.58 -39.91 85.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.004 -1.06 . . . . 3.17 111.138 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.17 -40.37 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 1.34 110.243 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 74.9 mt -59.42 -43.96 91.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.327 -0.858 . . . . 1.2 110.916 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.02 -40.31 88.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.21 -0.931 . . . . 2.7 110.573 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -62.49 -45.35 93.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.51 -0.744 . . . . 2.59 110.722 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 77.8 mtp -71.63 -39.46 70.41 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.364 -0.835 . . . . 1.38 110.883 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.609 ' NH2' ' CE1' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -56.84 -41.87 78.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 2.84 110.634 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.3 -45.86 62.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.02 -1.05 . . . . 1.88 111.662 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.6 -47.96 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.293 -1.504 . . . . 2.4 111.396 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -62.24 -49.76 74.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.738 -1.226 . . . . 3.52 110.867 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.06 -35.52 81.01 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.569 -0.707 . . . . 1.88 111.353 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -62.1 -29.84 70.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.696 -1.253 . . . . 3.01 110.155 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 64.0 t -67.47 -41.06 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.961 -0.695 . . . . 2.45 110.06 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.07 -40.04 88.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 2.75 110.899 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.6 t -69.28 -41.03 77.37 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.936 -1.103 . . . . 3.16 110.791 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -62.8 -39.51 94.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.873 . . . . 3.57 110.619 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -63.84 -32.76 74.38 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.229 -0.919 . . . . 4.3 110.597 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.46 72.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.194 -0.942 . . . . 4.45 110.693 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.05 -42.91 75.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.84 -1.162 . . . . 5.97 110.815 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 253' ' ' LEU . 3.6 mm? -71.21 -38.1 72.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.093 -1.004 . . . . 6.18 111.258 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -73.23 -2.21 20.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.06 -1.025 . . . . 6.66 112.899 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -82.99 -8.91 59.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.723 -1.236 . . . . 8.2 112.682 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 81.6 mt -90.32 -76.3 0.43 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.749 -1.219 . . . . 8.07 109.917 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -123.21 -126.51 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.838 -1.171 . . . . 9.45 107.838 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -98.01 19.06 14.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.459 -0.776 . . . . 10.12 111.622 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.49 HH11 ' HG2' ' A' ' 259' ' ' ARG . 19.9 ttt-85 . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 118.103 -0.951 . . . . 11.49 109.955 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.401 -0.592 . . . . 3.07 109.401 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.4 mt -92.54 115.04 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.495 -1.668 . . . . 1.07 106.495 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.7 m -104.14 121.56 43.49 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.719 -1.215 . . . . 1.24 107.719 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 225' ' ' ASN . . . -117.78 -164.17 13.1 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.868 -1.693 . . . . 1.01 108.868 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.1 mt -96.34 1.56 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 120.872 -1.37 . . . . 1.11 112.708 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ILE . 18.9 tp 49.33 100.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.012 -1.075 . . . . 0.99 111.678 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.33 -45.24 13.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.255 -1.528 . . . . 0.85 111.249 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -148.57 149.04 30.18 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.275 -1.009 . . . . 1.38 108.275 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.53 148.93 43.28 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 123.01 2.473 . . . . 0.94 112.104 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 147.89 119.68 1.1 Allowed Glycine 0 N--CA 1.507 3.413 0 N-CA-C 110.323 -1.111 . . . . 0.81 110.323 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.445 ' CG2' ' OE1' ' A' ' 243' ' ' GLN . 53.3 mt -90.64 135.78 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.893 -1.357 . . . . 0.83 108.818 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.42 ' CB ' HD12 ' A' ' 177' ' ' LEU . . . -138.74 157.64 45.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.854 -0.795 . . . . 0.53 108.854 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 243' ' ' GLN . 7.8 m-85 -118.74 140.01 50.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.93 -1.137 . . . . 0.77 107.93 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.77 163.26 31.49 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 118.597 -1.763 . . . . 0.51 110.057 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -78.8 157.74 28.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.67 -0.9 . . . . 1.9 108.996 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -81.53 130.42 35.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.002 -1.061 . . . . 0.66 108.394 178.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -110.87 101.4 10.0 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.729 -1.952 . . . . 0.83 105.729 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.4 tp -87.78 135.26 33.46 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.408 -1.33 . . . . 0.86 107.408 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.464 HD11 HD11 ' A' ' 158' ' ' LEU . 67.0 mt -101.02 114.56 28.6 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 106.481 -1.674 . . . . 0.92 106.481 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -108.51 138.02 45.51 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.885 -1.154 . . . . 2.03 107.885 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 52.1 mp0 -123.09 149.35 44.58 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.462 -0.774 . . . . 2.66 109.463 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -83.82 130.6 34.93 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.784 -1.191 . . . . 2.32 107.784 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -63.22 146.88 52.46 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.149 -0.969 . . . . 2.11 108.96 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.6 mt -92.16 135.41 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 108.115 -1.069 . . . . 0.73 108.115 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -106.43 127.94 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.099 -1.074 . . . . 0.87 108.099 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -101.57 136.26 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.043 -1.095 . . . . 0.81 108.043 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -89.47 125.24 35.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.73 -1.231 . . . . 1.34 107.766 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.3 mmt-85 -93.54 11.15 29.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.998 -1.064 . . . . 2.89 112.358 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -67.53 143.7 56.01 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.058 -1.026 . . . . 2.09 108.991 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -88.86 136.95 32.74 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.08 -1.082 . . . . 2.19 108.08 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.18 166.72 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.277 -0.89 . . . . 0.75 110.303 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.7 p -93.89 163.69 13.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.91 109.666 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.83 -21.17 6.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.46 -0.775 . . . . 0.93 112.04 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -69.95 -41.92 73.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.063 -1.023 . . . . 2.28 111.049 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -86.56 -2.68 58.69 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.438 -1.414 . . . . 1.45 112.224 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -60.96 -45.39 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 0.81 110.938 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.72 -39.66 85.4 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.644 -1.285 . . . . 1.54 110.528 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.539 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 10.4 mp0 -60.34 -41.07 92.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.106 -0.497 . . . . 2.36 110.947 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.59 -38.47 84.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.575 -1.328 . . . . 1.31 110.626 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.5 t -59.82 -41.64 86.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.939 -1.101 . . . . 0.82 110.729 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -63.42 -49.81 72.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.719 -1.238 . . . . 1.5 110.206 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.37 -38.88 88.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.595 -0.691 . . . . 2.23 110.329 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -75.5 -55.87 5.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.657 0.741 . . . . 0.85 109.902 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.63 -46.99 85.89 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.693 -0.803 . . . . 0.91 110.561 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 15.4 t -67.32 -41.88 84.57 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.19 -0.944 . . . . 0.9 110.131 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.15 87.6 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 119.088 -1.53 . . . . 0.69 109.965 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.6 ttt-85 -58.2 -31.35 67.22 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.744 -0.857 . . . . 2.88 109.794 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.61 -40.89 80.14 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.881 0.848 . . . . 0.85 109.792 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -78.12 -41.91 33.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 2.35 110.112 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.21 93.16 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.272 -0.892 . . . . 0.65 109.939 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 p -60.5 -38.24 83.67 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.465 1.126 . . . . 1.45 109.268 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.84 -47.04 64.21 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.68 -0.691 . . . . 0.63 110.419 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.04 -48.4 71.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.248 -0.908 . . . . 1.34 110.546 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.8 -39.18 90.8 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.343 -0.848 . . . . 1.56 109.572 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -60.18 -41.56 93.17 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.686 -0.634 . . . . 1.19 110.478 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.6 m -62.91 -40.63 98.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.026 -1.046 . . . . 0.72 110.272 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.4 mt -60.6 -36.02 67.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.471 -0.768 . . . . 0.62 110.325 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -53.79 -42.92 68.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 1.05 111.027 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -70.0 -33.39 71.98 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.835 -1.166 . . . . 0.64 110.557 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -64.89 -39.92 94.3 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.886 -1.125 . . . . 1.73 109.515 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.39 80.96 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.756 -0.59 . . . . 0.56 109.968 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.7 -36.1 34.1 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.651 -1.261 . . . . 0.69 110.583 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -79.91 -28.18 39.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.876 -1.367 . . . . 1.48 110.984 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 79.6 m -86.77 -47.74 8.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.368 -0.832 . . . . 0.98 110.942 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -107.93 -11.16 15.39 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 113.343 0.868 . . . . 1.16 113.343 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.67 159.63 24.79 Favored Glycine 0 N--CA 1.5 2.949 0 C-N-CA 120.658 -0.782 . . . . 0.85 113.29 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -52.33 -18.87 1.77 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.743 -0.857 . . . . 3.86 112.921 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.17 -38.57 76.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 2.35 111.522 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -82.37 -21.63 35.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.903 -1.123 . . . . 1.67 112.05 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -59.74 -31.47 69.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 1.45 111.098 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.79 88.82 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.13 -0.981 . . . . 0.61 110.519 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.0 mt -67.01 -44.71 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.633 -1.292 . . . . 0.65 110.145 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -70.85 -28.8 64.85 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.321 -0.862 . . . . 0.66 110.925 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -61.87 -37.99 86.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.883 . . . . 1.19 110.153 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.11 -38.98 73.34 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 119.693 -1.242 . . . . 0.53 110.486 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -59.68 -42.55 93.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.094 -1.239 . . . . 1.27 110.3 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.2 mt -62.44 -38.97 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.351 -0.843 . . . . 0.54 110.091 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.9 ttm -59.99 -39.99 87.62 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.549 -0.861 . . . . 1.74 110.263 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.66 -51.49 69.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.199 -0.938 . . . . 0.55 110.89 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.7 tp -60.52 -41.58 94.68 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.913 -0.715 . . . . 0.47 110.057 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -87.24 1.17 53.98 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.086 0.773 . . . . 1.42 113.086 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -60.28 123.53 17.52 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.426 -1.421 . . . . 1.27 108.577 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.18 -17.26 64.76 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.694 0.759 . . . . 1.35 111.064 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -76.36 -54.19 7.1 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.875 -0.73 . . . . 2.22 110.227 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.9 mt -62.27 -38.38 89.12 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.152 -0.619 . . . . 0.62 110.722 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.38 -49.91 75.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.075 -1.016 . . . . 1.29 111.213 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.25 -37.57 83.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.811 -1.181 . . . . 1.52 110.577 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.2 -47.79 78.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.146 -0.971 . . . . 1.3 110.18 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.0 mt -57.68 -47.08 86.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 120.999 -1.063 . . . . 0.61 110.015 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.26 -41.92 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.66 0.743 . . . . 0.78 110.857 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.34 -42.44 91.52 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.226 -0.921 . . . . 0.82 110.866 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.69 -42.42 97.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.972 -1.08 . . . . 0.8 110.161 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.44 -50.35 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 0.77 110.572 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -76.16 -35.15 59.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 2.12 111.903 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -81.89 -43.78 17.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.733 -1.229 . . . . 1.51 112.043 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -102.08 7.11 41.23 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.233 -0.917 . . . . 1.98 112.862 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 50.72 49.59 20.63 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 1.32 111.887 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.3 mtt -102.99 155.95 18.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.387 -0.821 . . . . 1.38 109.34 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.8 p -72.17 159.53 33.96 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.76 0.79 . . . . 0.67 109.6 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.89 88.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.937 -1.102 . . . . 0.52 110.416 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.512 ' OD2' HD21 ' A' ' 142' ' ' LEU . 93.5 m-20 -68.52 -39.17 81.3 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.176 -0.953 . . . . 2.25 110.618 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.8 -51.76 24.81 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.273 -0.892 . . . . 0.64 111.214 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.48 94.79 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.827 -1.171 . . . . 0.56 110.994 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.15 98.94 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.379 -0.826 . . . . 0.46 110.9 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -60.42 -39.82 88.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.916 -1.115 . . . . 1.32 111.003 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -59.03 -49.38 78.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.801 -1.187 . . . . 1.3 110.684 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.57 -41.89 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.252 -0.905 . . . . 0.61 110.231 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -63.29 -32.47 56.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.301 -0.874 . . . . 0.65 110.03 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.85 -41.11 86.21 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.611 -0.68 . . . . 2.11 110.927 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.21 -31.55 19.49 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.422 -1.371 . . . . 0.83 112.898 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -61.44 -40.45 94.5 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 119.421 1.61 . . . . 1.28 109.958 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.56 -50.6 24.48 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.938 0.875 . . . . 0.89 110.364 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 60.9 p -61.48 -37.22 82.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.394 -0.816 . . . . 1.87 110.775 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.1 -45.22 93.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.379 -0.826 . . . . 1.05 110.92 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.22 -28.27 69.25 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.083 -1.011 . . . . 1.02 111.21 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -66.67 -22.27 66.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.856 . . . . 2.04 110.731 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -71.61 -15.72 62.26 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.378 -0.826 . . . . 1.73 111.245 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 123' ' ' LEU . 22.7 mt -86.28 138.93 31.47 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.685 -1.228 . . . . 1.37 107.685 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -97.8 39.41 1.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.341 -0.849 . . . . 2.88 111.617 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -112.23 137.18 50.7 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.557 -0.905 . . . . 1.58 108.557 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.9 -36.72 72.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 3.04 111.167 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.15 -56.48 5.5 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.838 -1.164 . . . . 0.9 110.41 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 118' ' ' LEU . 38.4 mt -62.29 -42.08 99.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 1.06 110.785 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.03 -47.47 84.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.993 -1.067 . . . . 2.18 110.456 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -60.28 -32.53 71.26 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.328 -0.949 . . . . 2.15 109.968 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.556 ' O ' HG23 ' A' ' 130' ' ' VAL . 21.7 ttp180 -64.76 -29.12 70.09 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.187 -1.005 . . . . 2.33 109.552 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.93 87.02 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.763 0.792 . . . . 0.82 109.829 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.41 -42.74 78.56 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.543 0.687 . . . . 0.85 110.449 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.04 -33.34 75.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.577 -0.702 . . . . 1.39 110.729 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 126' ' ' ARG . 52.7 t -69.31 -38.56 77.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.439 -0.788 . . . . 0.56 110.529 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 131' ' ' ARG . 34.3 ttt-85 -59.67 -40.21 87.04 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.864 -1.135 . . . . 3.12 109.665 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -61.23 -35.24 76.7 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.649 0.738 . . . . 1.28 110.715 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.3 mt -61.73 -40.13 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.051 -1.031 . . . . 0.49 110.47 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.55 -46.77 91.55 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.088 -1.053 . . . . 0.46 110.745 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -58.32 -43.71 88.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.944 -1.327 . . . . 2.71 110.59 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 136' ' ' ARG . 51.6 mtt-85 -60.63 -44.1 96.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.929 -1.107 . . . . 2.14 110.577 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.1 -44.21 97.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.067 -1.021 . . . . 1.05 110.083 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.46 -41.13 96.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.876 . . . . 0.52 110.702 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.403 HH11 ' HG2' ' A' ' 139' ' ' ARG . 46.4 mtt-85 -61.52 -34.76 76.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.907 . . . . 2.35 110.563 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -73.97 -40.4 63.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 1.39 110.989 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.67 -38.5 78.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.23 -0.919 . . . . 0.68 110.615 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.512 HD21 ' OD2' ' A' ' 101' ' ' ASP . 74.5 mt -87.95 -7.92 56.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.931 -1.105 . . . . 0.83 112.587 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.16 18.88 79.06 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 120.077 -1.059 . . . . 0.91 113.046 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -62.31 146.75 50.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.983 . . . . 0.95 109.406 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -67.22 147.88 52.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.974 -1.079 . . . . 2.43 109.176 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.8 mt -109.63 136.22 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.097 -1.002 . . . . 1.1 108.306 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.707 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.2 mp -78.0 130.09 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.48 -0.763 . . . . 1.58 108.949 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -97.46 99.97 11.39 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.287 -1.745 . . . . 1.62 106.287 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.8 mt -70.8 -21.08 62.52 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 116.145 -0.479 . . . . 0.8 111.48 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.8 m -80.71 3.33 22.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.922 . . . . 1.56 111.821 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.72 19.41 12.51 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.445 -0.784 . . . . 0.84 112.507 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.5 mt -71.81 141.44 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.82 109.689 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -117.54 -14.34 10.28 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.84 0.829 . . . . 2.31 113.049 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -114.75 138.04 51.21 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.239 -1.022 . . . . 1.54 108.239 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.62 123.32 22.98 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.408 -0.96 . . . . 1.38 108.408 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.1 m -145.95 176.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.391 -0.818 . . . . 0.69 109.273 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mt -87.27 140.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.758 -1.214 . . . . 0.53 108.426 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.464 HD11 HD11 ' A' ' 19' ' ' LEU . 26.9 tp -95.3 121.06 36.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.869 -1.145 . . . . 0.64 108.158 178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.3 t -123.3 132.29 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 108.369 -0.975 . . . . 0.67 108.369 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -160.4 160.51 32.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 0.78 108.561 178.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.64 77.63 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.826 -1.171 . . . . 1.0 109.208 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 p-10 -172.4 155.49 3.5 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.726 -0.842 . . . . 2.42 108.726 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 75.1 mt -120.25 137.99 53.91 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.956 -1.127 . . . . 0.75 107.956 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 p -96.42 150.9 37.65 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.188 -0.945 . . . . 0.78 108.629 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -41.15 -42.74 5.0 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.869 1.713 . . . . 0.67 113.102 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 54.7 m -60.59 -50.58 72.94 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.159 -0.963 . . . . 0.7 109.892 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -61.97 -40.85 96.98 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.757 -1.177 . . . . 1.21 109.621 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.7 p -68.23 -37.78 81.18 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.49 -0.884 . . . . 0.6 110.525 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.47 75.68 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.509 -0.744 . . . . 0.62 110.706 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -93.73 -3.46 52.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.009 -1.057 . . . . 1.16 112.815 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.61 149.1 49.54 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.74 -0.837 . . . . 0.73 108.74 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -96.83 118.48 33.35 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.721 -1.585 . . . . 2.24 106.721 177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.9 -12.99 60.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 1.43 111.852 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -84.66 -26.16 28.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.391 -0.818 . . . . 2.15 112.336 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -100.88 2.1 40.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.367 -0.833 . . . . 2.04 112.271 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 178' ' ' GLY . 54.9 t -111.18 131.21 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 N-CA-C 108.263 -1.014 . . . . 0.55 108.263 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.565 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.38 -12.35 43.53 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.37 -0.831 . . . . 1.63 112.016 -179.511 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.435 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.94 -179.42 44.4 Favored Glycine 0 N--CA 1.497 2.745 0 O-C-N 120.46 -1.4 . . . . 0.47 109.768 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -130.1 134.01 47.06 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 107.408 -1.331 . . . . 0.54 107.408 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.523 HD11 HD13 ' A' ' 220' ' ' LEU . 59.0 mt -137.54 106.22 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 105.783 -1.932 . . . . 0.69 105.783 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.415 ' C ' ' HG1' ' A' ' 205' ' ' THR . 71.0 p -132.91 177.32 7.74 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.71 -1.244 . . . . 0.82 110.844 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 16.4 m-20 -101.4 57.52 0.85 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.534 -0.757 . . . . 2.37 109.405 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -109.09 156.62 19.59 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.417 -0.802 . . . . 1.11 109.656 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.4 -88.61 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.224 -0.989 . . . . 1.67 111.658 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 151.27 -65.07 0.37 Allowed Glycine 0 N--CA 1.498 2.833 0 O-C-N 121.211 -1.17 . . . . 1.54 111.953 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 186' ' ' ARG . 18.0 ttt-85 -60.59 -42.73 97.3 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.849 -1.383 . . . . 4.48 110.06 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 48.8 p -109.26 21.86 16.57 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.613 -0.679 . . . . 2.63 111.487 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 t -85.71 131.47 34.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.114 -0.991 . . . . 1.69 108.591 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -60.35 -39.34 86.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 1.07 110.727 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 35.2 p -58.36 -38.04 76.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 1.58 110.54 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.7 m -60.58 -39.75 89.2 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.357 -0.839 . . . . 1.6 110.221 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.81 -39.72 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.126 -0.983 . . . . 1.45 110.489 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 71.3 mtp -63.39 -42.58 98.82 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.503 1.145 . . . . 1.05 109.341 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.12 -41.16 92.04 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.463 -0.79 . . . . 0.72 110.938 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.5 -44.92 96.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.837 -1.164 . . . . 3.05 110.355 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 27.8 m -71.67 -39.54 70.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.9 . . . . 0.89 110.416 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.9 mt -91.64 -11.2 37.75 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.818 0.818 . . . . 0.78 112.22 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.5 mt-10 49.94 19.09 0.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.67 0.989 . . . . 1.45 113.67 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.67 166.85 32.35 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.064 -1.022 . . . . 0.67 108.435 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.64 140.57 21.26 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.865 1.71 . . . . 0.64 110.38 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.23 168.06 23.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 119.915 -1.741 . . . . 0.67 109.859 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 203' ' ' VAL . 92.9 mt -144.01 156.89 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.36 -1.348 . . . . 0.69 107.36 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.456 ' N ' HG22 ' A' ' 202' ' ' ILE . 10.2 m -138.15 -30.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 120.99 -1.069 . . . . 0.85 112.744 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.79 30.84 0.9 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.014 -1.089 . . . . 0.92 113.663 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.431 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 9.8 p -61.34 -27.51 68.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.649 -1.501 . . . . 0.95 110.924 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.47 -91.04 0.38 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 120.221 -0.99 . . . . 1.04 110.77 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.5 m -121.7 27.11 8.36 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.531 -0.982 . . . . 1.57 112.594 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.1 t -58.5 -35.84 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.121 -1.612 . . . . 0.84 110.22 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.405 HG23 ' OD2' ' A' ' 182' ' ' ASP . 56.2 p -52.91 -24.62 9.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 0.99 111.625 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.2 p -90.96 0.41 57.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.36 -0.837 . . . . 1.7 111.789 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -123.56 -3.52 8.31 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 113.079 0.77 . . . . 2.2 113.079 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 38.7 t -116.8 149.08 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.574 0.702 . . . . 0.84 109.712 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -119.41 150.09 40.77 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.123 -1.066 . . . . 2.2 108.123 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.421 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.2 p-10 -56.67 143.85 34.61 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.02 -1.072 . . . . 2.28 110.355 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.1 m-20 79.89 -1.61 2.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.796 1.406 . . . . 2.35 114.796 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.31 150.72 42.61 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.709 -1.196 . . . . 1.97 109.036 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -89.5 117.36 28.35 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.455 -1.403 . . . . 2.65 107.591 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.9 mt -126.67 149.8 49.34 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.596 0.713 . . . . 0.63 109.708 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.4 mt -119.21 129.94 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.394 -1.336 . . . . 0.62 107.394 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.523 HD13 HD11 ' A' ' 180' ' ' ILE . 49.6 tp -92.73 121.99 34.68 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.293 -1.373 . . . . 0.64 107.293 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 81.1 m-20 -88.33 -30.48 19.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.695 -1.253 . . . . 2.05 111.661 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.41 19.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.448 -0.782 . . . . 0.84 112.552 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.1 t -121.84 -59.68 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.922 0.868 . . . . 1.02 110.263 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -96.23 10.29 38.31 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.876 0.846 . . . . 2.51 110.768 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 4' ' ' GLY . 6.5 t-20 60.82 50.34 5.43 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.579 -0.737 . . . . 1.54 112.021 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -151.23 158.7 44.23 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.957 0.884 . . . . 1.95 109.638 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 28.0 t -116.37 140.3 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 109.017 -0.734 . . . . 0.71 109.017 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.446 ' CE2' ' OD2' ' A' ' 221' ' ' ASP . 47.4 m-85 -99.35 130.83 45.66 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.144 -0.973 . . . . 1.01 108.466 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.2 t -109.84 130.02 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.434 -0.791 . . . . 0.82 108.921 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.525 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 66.7 t30 61.11 43.71 0.69 Allowed Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 113.792 1.034 . . . . 1.54 113.792 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 33.4 Cg_endo -65.53 147.48 86.7 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.208 1.939 . . . . 0.94 111.199 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 44.1 p -76.82 157.25 31.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.112 -0.992 . . . . 1.8 108.985 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -59.92 -33.22 71.6 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.133 -0.98 . . . . 2.73 110.523 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -57.62 -40.45 79.2 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.468 -0.77 . . . . 3.17 110.218 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -71.0 -40.84 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.393 -0.817 . . . . 1.34 110.064 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 56.4 mt -60.17 -47.54 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 1.2 110.662 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -59.26 -40.39 85.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.674 -1.266 . . . . 2.7 110.482 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -64.66 -42.12 95.63 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.826 -0.75 . . . . 2.59 110.357 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.1 mtp -70.88 -34.35 71.51 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.272 -0.893 . . . . 1.38 110.975 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -57.45 -39.82 77.13 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.198 -0.939 . . . . 2.84 110.389 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.04 -48.42 36.32 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.148 -0.97 . . . . 1.88 110.017 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.87 -45.09 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.81 -0.756 . . . . 2.4 110.625 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 13' ' ' PHE . 37.1 tt0 -56.28 -53.02 62.21 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.607 -1.308 . . . . 3.52 111.344 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.62 -35.83 82.27 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.226 -0.921 . . . . 1.88 110.406 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -60.44 -30.46 69.66 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.025 -1.07 . . . . 3.01 109.424 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.5 t -66.0 -38.31 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.341 -0.849 . . . . 2.45 110.254 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.03 85.09 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.314 -0.866 . . . . 2.75 110.047 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.4 t -69.86 -38.23 76.38 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.208 -0.933 . . . . 3.16 110.35 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -62.95 -32.46 73.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 3.57 110.774 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -61.61 -34.84 76.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.915 . . . . 4.3 110.442 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -63.05 -41.8 99.56 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.678 -0.809 . . . . 4.45 110.351 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -68.56 -33.39 74.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.889 . . . . 5.97 110.496 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.621 ' O ' HD23 ' A' ' 253' ' ' LEU . 1.3 tt -67.54 -28.37 67.75 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.402 -0.811 . . . . 6.18 110.984 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -65.53 -23.29 66.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.117 -0.989 . . . . 6.66 111.494 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -78.27 -12.68 60.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.965 -1.084 . . . . 8.2 111.679 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.75 0.91 56.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.412 -0.805 . . . . 8.07 112.041 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -86.63 -69.57 0.67 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 9.45 109.948 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -93.15 -1.94 55.85 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.212 -0.93 . . . . 10.12 113.25 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.784 -1.103 . . . . 11.49 108.543 -178.442 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 mtt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.237 -0.653 . . . . 3.07 109.237 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.2 mt -94.7 113.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 106.302 -1.74 . . . . 1.07 106.302 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 m -105.38 124.87 50.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.259 -1.015 . . . . 1.24 108.259 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.89 -152.02 16.8 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 108.141 -1.984 . . . . 1.01 108.141 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.9 mt -94.78 -4.87 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.249 -1.148 . . . . 1.11 112.926 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 tp 49.7 99.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.086 -1.009 . . . . 0.99 112.624 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.65 -53.74 5.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.007 -1.058 . . . . 0.85 110.571 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.99 148.44 45.38 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 107.746 -1.205 . . . . 1.38 107.746 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.8 156.52 43.88 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.578 2.186 . . . . 0.94 112.272 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 147.17 122.21 1.33 Allowed Glycine 0 N--CA 1.507 3.418 0 N-CA-C 111.087 -0.805 . . . . 0.81 111.087 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.8 mt -89.64 132.05 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.777 -1.426 . . . . 0.83 108.706 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.99 151.49 46.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.256 -0.902 . . . . 0.53 108.638 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.7 m-85 -116.7 145.41 43.47 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.279 -0.888 . . . . 0.77 109.219 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.31 167.89 36.86 Favored Glycine 0 N--CA 1.5 2.906 0 C-N-CA 118.938 -1.601 . . . . 0.51 110.053 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -78.08 158.89 28.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.752 -0.852 . . . . 1.9 109.132 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.42 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.37 119.81 25.54 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.029 -1.1 . . . . 0.66 108.029 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -99.93 95.68 7.05 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 105.683 -1.969 . . . . 0.83 105.683 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.5 tp -90.67 137.71 32.15 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.454 -1.313 . . . . 0.86 107.454 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.5 mt -99.02 111.19 23.66 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.647 -1.612 . . . . 0.92 106.647 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -103.52 128.72 50.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.217 -1.401 . . . . 2.03 107.217 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -130.6 154.34 47.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.926 -0.768 . . . . 2.66 108.926 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -80.65 139.39 36.23 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.695 -0.854 . . . . 2.32 108.695 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.82 149.88 49.46 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.473 -1.392 . . . . 2.11 109.046 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -93.22 131.01 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.602 -0.888 . . . . 0.73 108.602 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.9 t -108.93 130.13 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.272 -1.01 . . . . 0.87 108.272 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.0 mt -94.67 133.51 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.456 -0.942 . . . . 0.81 108.456 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -89.01 120.83 30.78 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.294 -1.372 . . . . 1.34 107.294 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -96.54 15.8 20.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.132 -0.98 . . . . 2.89 112.403 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -70.42 149.89 46.8 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.542 -0.723 . . . . 2.09 109.838 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -90.76 130.35 36.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.669 -1.234 . . . . 2.19 107.669 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.9 pt -94.76 164.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.988 . . . . 0.75 110.347 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -94.95 166.02 12.16 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.486 -0.759 . . . . 0.91 109.681 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.23 -19.11 7.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 0.93 112.351 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.12 -37.86 81.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 2.28 110.696 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -94.52 -6.14 44.42 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.563 -1.336 . . . . 1.45 113.105 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.8 t -59.55 -42.12 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.217 -0.927 . . . . 0.81 110.758 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -58.41 -39.19 79.05 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.128 -0.982 . . . . 1.54 110.58 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -64.99 -38.79 92.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.403 -0.811 . . . . 2.36 111.131 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -59.37 -41.23 88.83 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.619 -1.3 . . . . 1.31 110.783 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.17 -40.85 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.98 -1.075 . . . . 0.82 110.789 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -62.83 -42.6 99.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.977 -1.077 . . . . 1.5 110.457 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.453 HH11 ' HG2' ' A' ' 42' ' ' ARG . 42.2 mtt-85 -61.36 -40.41 94.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -0.863 . . . . 2.23 110.296 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 40.6 t80 -75.32 -55.34 5.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.298 -0.876 . . . . 0.85 110.965 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.4 tp -58.07 -47.46 83.11 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.507 -0.877 . . . . 0.91 110.459 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -68.79 -39.91 79.91 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.822 -0.751 . . . . 0.9 109.918 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.29 -42.48 97.35 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.495 -1.442 . . . . 0.69 109.495 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' CG ' HH11 ' A' ' 47' ' ' ARG . 2.2 ttt-85 -60.3 -28.76 68.36 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.235 -1.156 . . . . 2.88 110.117 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.92 -50.49 73.58 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.465 0.65 . . . . 0.85 110.955 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -83.26 -38.07 22.68 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.134 -0.979 . . . . 2.35 111.043 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.9 -42.82 85.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.162 -0.961 . . . . 0.65 109.664 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.4 t -60.47 -41.26 93.82 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.718 -0.845 . . . . 1.45 108.718 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.78 -44.86 76.42 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.624 -0.831 . . . . 0.63 110.434 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -62.18 -51.51 67.53 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.366 -0.934 . . . . 1.34 110.668 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.69 -38.25 89.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.136 -0.977 . . . . 1.56 109.988 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -59.12 -40.08 84.33 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.594 -0.691 . . . . 1.19 110.331 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.6 m -62.26 -45.05 95.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.937 -1.102 . . . . 0.72 110.266 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.25 -32.31 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.566 -0.709 . . . . 0.62 110.978 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -53.98 -44.58 70.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 1.05 110.469 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -68.69 -36.49 78.57 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.276 -0.89 . . . . 0.64 109.709 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -62.27 -40.0 94.78 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.862 -1.135 . . . . 1.73 108.853 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.32 75.41 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.06 -0.656 . . . . 0.56 110.06 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.66 -34.05 26.09 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.106 -1.045 . . . . 0.69 110.883 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.25 -18.05 43.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.007 -1.29 . . . . 1.48 111.321 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.6 m -90.96 -53.8 4.23 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.209 0.528 . . . . 0.98 111.184 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -106.86 -12.65 15.43 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 113.066 0.765 . . . . 1.16 113.066 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.8 155.84 10.78 Favored Glycine 0 N--CA 1.501 3.022 0 O-C-N 121.434 -0.791 . . . . 0.85 112.338 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -55.78 -20.56 15.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.65 -0.912 . . . . 3.86 112.393 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.55 -34.26 66.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.415 -0.803 . . . . 2.35 111.165 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -81.17 -19.22 43.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.567 -1.333 . . . . 1.67 111.86 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.01 -31.81 70.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.187 -0.946 . . . . 1.45 111.022 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.8 95.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.874 -1.141 . . . . 0.61 110.379 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.1 -45.92 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.38 -0.928 . . . . 0.65 110.056 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -71.47 -31.63 67.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.838 . . . . 0.66 110.417 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -60.32 -38.44 83.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 1.19 109.847 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.32 -41.85 94.35 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.213 -1.155 . . . . 0.53 110.213 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -58.25 -46.27 86.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -1.103 . . . . 1.27 110.416 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.74 -39.61 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.976 -1.078 . . . . 0.54 110.179 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.4 ttt -59.85 -39.8 86.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.961 -1.087 . . . . 1.74 110.411 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.19 -49.07 79.27 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.595 0.712 . . . . 0.55 110.774 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.76 -43.64 94.22 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.702 0.763 . . . . 0.47 110.241 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -86.25 9.39 17.83 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.338 -0.851 . . . . 1.42 112.731 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -64.42 126.5 28.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.389 -0.819 . . . . 1.27 109.007 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.76 -14.18 62.74 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.056 0.932 . . . . 1.35 110.647 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -75.8 -54.67 6.57 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.643 -0.66 . . . . 2.22 110.137 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 mt -62.0 -40.31 95.24 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.759 -0.776 . . . . 0.62 110.686 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.6 -46.03 81.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.701 -1.25 . . . . 1.29 110.749 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.52 -39.59 91.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.78 . . . . 1.52 110.891 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.23 -48.09 66.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.372 -1.455 . . . . 1.3 110.953 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -55.44 -43.05 70.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.112 -1.035 . . . . 0.61 110.153 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.3 mt -62.43 -47.51 92.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.68 0.753 . . . . 0.78 110.524 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.61 94.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.457 -0.777 . . . . 0.82 110.879 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.7 -39.03 87.0 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.674 -1.266 . . . . 0.8 110.239 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.56 -52.77 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.77 110.347 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -72.36 -35.13 68.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.502 -0.749 . . . . 2.12 112.067 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -80.94 -46.06 15.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.796 -1.19 . . . . 1.51 112.045 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -101.16 9.11 42.3 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.408 -0.807 . . . . 1.98 112.335 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.8 m80 50.54 49.68 20.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.051 -1.031 . . . . 1.32 111.45 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.0 mtt -103.92 153.5 20.72 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.73 0.776 . . . . 1.38 109.631 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.3 p -72.6 161.43 30.79 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.141 -0.975 . . . . 0.67 109.508 178.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.83 -41.28 86.5 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.1 -1.0 . . . . 0.52 110.932 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.623 ' OD2' HD21 ' A' ' 142' ' ' LEU . 91.3 m-20 -67.98 -40.73 83.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -0.901 . . . . 2.25 109.866 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.38 -50.36 46.83 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.475 -0.89 . . . . 0.64 110.932 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.07 96.18 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.888 0.851 . . . . 0.56 110.166 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.65 96.04 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.856 -0.611 . . . . 0.46 110.94 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -61.94 -38.88 90.14 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.125 -0.984 . . . . 1.32 110.789 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.66 -48.62 80.95 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.677 -1.264 . . . . 1.3 111.462 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.02 -44.12 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.207 -0.933 . . . . 0.61 110.059 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.8 mm -61.58 -31.99 52.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.403 0.62 . . . . 0.65 110.211 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -59.07 -41.18 87.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.671 . . . . 2.11 110.529 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.36 -31.6 21.85 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.355 -1.403 . . . . 0.83 112.518 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -61.33 -39.38 90.32 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.484 1.642 . . . . 1.28 110.12 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.68 -48.2 27.44 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.893 0.854 . . . . 0.89 110.119 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.1 p -63.76 -36.0 82.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.355 -0.841 . . . . 1.87 109.954 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.62 -43.61 98.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 1.05 110.535 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.18 -30.55 71.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.819 -1.176 . . . . 1.02 110.94 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.31 -22.72 66.87 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.29 -0.881 . . . . 2.04 111.038 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -74.44 -10.91 60.03 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.398 -0.921 . . . . 1.73 111.391 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.479 HD13 HD13 ' A' ' 123' ' ' LEU . 7.1 mt -86.49 141.95 28.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.597 -0.69 . . . . 1.37 109.412 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -97.76 55.51 1.21 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.577 -0.702 . . . . 2.88 111.078 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -131.89 134.11 45.35 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 107.382 -1.34 . . . . 1.58 107.382 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -57.53 -39.83 77.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.281 -0.887 . . . . 3.04 110.922 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -70.79 -52.02 23.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.52 -1.363 . . . . 0.9 110.672 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.479 HD13 HD13 ' A' ' 118' ' ' LEU . 39.8 mt -61.17 -41.03 96.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.021 -1.049 . . . . 1.06 109.842 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -61.5 -49.21 77.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.798 -1.189 . . . . 2.18 109.762 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -60.37 -31.67 70.56 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.898 0.856 . . . . 2.15 110.047 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 130' ' ' VAL . 22.3 ttp180 -66.85 -27.7 67.75 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 122.3 1.048 . . . . 2.33 109.477 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.02 83.29 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.883 0.849 . . . . 0.82 109.33 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.3 80.12 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.464 0.65 . . . . 0.85 110.326 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.26 -35.74 79.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 1.39 110.649 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 126' ' ' ARG . 41.5 t -67.43 -38.34 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.229 -0.919 . . . . 0.56 110.331 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -59.0 -39.68 82.57 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 118.923 -1.111 . . . . 3.12 109.496 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.45 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 62.1 t0 -60.26 -37.69 81.22 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.44 0.638 . . . . 1.28 110.527 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.8 mt -60.43 -39.15 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.925 -1.109 . . . . 0.49 110.113 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.92 -45.34 88.63 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 120.128 -1.034 . . . . 0.46 110.702 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -59.81 -40.0 86.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.146 -1.208 . . . . 2.71 110.095 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' A' ' 136' ' ' ARG . 39.7 mtt-85 -61.25 -42.04 97.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.097 -1.002 . . . . 2.14 109.78 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 37.8 tp -60.43 -40.48 91.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.462 -0.773 . . . . 1.05 110.129 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.58 -42.61 92.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.143 -0.973 . . . . 0.52 110.399 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.457 ' NH1' ' CD2' ' A' ' 144' ' ' LEU . 54.5 mtt-85 -59.87 -37.58 79.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 2.35 110.762 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.4 -41.72 55.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.188 -0.945 . . . . 1.39 110.893 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.454 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.6 mt -60.36 -37.76 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.223 -0.923 . . . . 0.68 110.768 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.623 HD21 ' OD2' ' A' ' 101' ' ' ASP . 84.3 mt -86.4 -7.35 58.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.83 111.994 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.49 23.19 68.34 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 120.091 -1.052 . . . . 0.91 113.227 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.457 ' CD2' ' NH1' ' A' ' 139' ' ' ARG . 5.7 tp -64.49 148.09 51.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.049 -0.723 . . . . 0.95 109.049 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -66.44 148.53 51.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.039 -0.726 . . . . 2.43 109.039 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.4 mt -103.31 132.35 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.17 -1.048 . . . . 1.1 108.17 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.888 ' H ' HD12 ' A' ' 147' ' ' ILE . 2.7 mp -84.02 122.82 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.497 -1.297 . . . . 1.58 107.497 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -95.07 97.99 10.34 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 105.958 -1.867 . . . . 1.62 105.958 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.4 mt -74.91 -15.05 60.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.931 . . . . 0.8 112.005 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.8 m -79.94 -1.58 40.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.119 -0.988 . . . . 1.56 112.177 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.5 29.04 4.22 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.661 0.743 . . . . 0.84 111.954 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 7.3 mt -72.29 138.41 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.169 -0.957 . . . . 0.82 109.006 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -113.81 -18.82 11.72 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.278 1.037 . . . . 2.31 112.475 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -114.88 138.09 51.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.809 -1.182 . . . . 1.54 107.809 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.26 122.88 26.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.024 -1.102 . . . . 1.38 108.024 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.47 179.98 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.11 -0.994 . . . . 0.69 108.847 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.8 mt -87.45 142.24 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.05 -1.031 . . . . 0.53 108.785 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 45.2 tp -96.66 123.36 40.31 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.061 -1.089 . . . . 0.64 108.061 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.19 129.64 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.281 -1.377 . . . . 0.67 107.281 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.78 157.12 23.72 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.893 -1.129 . . . . 0.78 108.872 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.32 83.11 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.801 -1.187 . . . . 1.0 109.392 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -172.97 148.95 1.82 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.13 -0.693 . . . . 2.42 109.13 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.0 mt -111.66 141.22 45.53 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.482 -0.761 . . . . 0.75 109.223 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 168' ' ' THR . 5.8 p -92.78 147.86 34.89 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.914 -1.116 . . . . 0.78 108.917 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.55 -43.31 6.07 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.824 1.683 . . . . 0.67 113.119 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.2 m -60.49 -51.01 71.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.201 -0.937 . . . . 0.7 110.251 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -61.56 -39.52 91.42 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.01 -1.056 . . . . 1.21 109.975 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 164' ' ' THR . 48.1 p -65.77 -36.92 84.9 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.852 0.834 . . . . 0.6 109.965 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.81 88.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.494 -0.754 . . . . 0.62 111.127 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -94.27 -3.05 51.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -0.789 . . . . 1.16 113.083 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.91 148.18 44.39 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.407 -0.96 . . . . 0.73 108.407 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -93.75 114.79 27.14 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 106.884 -1.524 . . . . 2.24 106.884 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 173' ' ' LEU . 3.3 mm? -70.75 -27.89 64.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.234 0.54 . . . . 1.43 111.506 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -82.92 -16.89 45.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 2.15 112.293 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -100.48 -2.82 32.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.015 -1.053 . . . . 2.04 112.8 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 178' ' ' GLY . 88.9 t -107.69 130.62 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.22 -1.03 . . . . 0.55 108.22 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.14 -7.65 59.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 1.63 112.133 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.618 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.59 172.64 37.13 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.184 -1.566 . . . . 0.47 109.184 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -128.89 127.63 42.19 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 107.57 -1.27 . . . . 0.54 107.57 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 220' ' ' LEU . 56.4 mt -132.33 120.6 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.406 -1.701 . . . . 0.69 106.406 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 203' ' ' VAL . 67.7 p -138.88 169.83 17.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.828 -1.17 . . . . 0.82 110.357 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.464 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 36.9 t0 -106.25 62.03 0.65 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.109 -0.7 . . . . 2.37 109.109 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -106.49 148.85 27.7 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.804 -0.813 . . . . 1.11 108.804 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.62 -0.51 48.92 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.744 -1.217 . . . . 1.67 112.555 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 89.0 -27.9 7.03 Favored Glycine 0 N--CA 1.496 2.646 0 O-C-N 121.395 -1.062 . . . . 1.54 113.797 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.6 mtt-85 -60.16 -39.06 85.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.272 . . . . 4.48 110.44 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 49.1 p -133.38 34.52 3.5 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.435 -0.791 . . . . 2.63 111.267 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 188' ' ' SER . 23.9 p -84.03 99.05 10.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.675 -1.602 . . . . 1.69 106.675 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -61.36 -32.49 72.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 1.07 110.365 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.3 t -56.3 -39.46 72.78 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.381 -0.824 . . . . 1.58 110.18 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.4 p -59.74 -39.0 83.3 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.895 -1.122 . . . . 1.6 109.952 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.77 -40.0 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.647 -0.821 . . . . 1.45 110.208 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 51.2 mtp -64.55 -44.92 89.26 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.522 1.153 . . . . 1.05 109.119 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.81 -43.58 94.44 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.089 -0.96 . . . . 0.72 111.405 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -59.66 -45.68 91.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.894 -1.129 . . . . 3.05 110.533 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.1 m -71.19 -39.3 71.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.881 . . . . 0.89 110.327 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.449 HD13 HD12 ' A' ' 173' ' ' LEU . 16.5 mt -92.36 -6.64 49.75 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.155 0.798 . . . . 0.78 113.155 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 53.92 13.6 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.745 1.017 . . . . 1.45 113.745 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.65 149.73 95.37 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.925 -1.109 . . . . 0.67 108.767 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.08 137.18 73.97 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.503 1.469 . . . . 0.64 109.957 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.09 163.65 25.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.368 -1.458 . . . . 0.67 109.522 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 220' ' ' LEU . 13.2 mt -149.12 145.46 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.998 -1.112 . . . . 0.69 107.998 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.9 m -125.84 -25.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 O-C-N 121.114 -0.991 . . . . 0.85 113.24 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.66 50.46 4.25 Favored Glycine 0 N--CA 1.488 2.125 0 O-C-N 120.842 -1.161 . . . . 0.92 111.004 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 181' ' ' THR . 69.9 p -68.05 -11.59 59.27 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.933 -1.334 . . . . 0.95 112.219 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.464 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 73.88 -95.99 0.84 Allowed Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.756 -1.338 . . . . 1.04 109.756 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 70.8 m -130.31 30.65 4.72 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.336 -1.097 . . . . 1.57 112.296 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.72 -39.67 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.446 -1.409 . . . . 0.84 110.7 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.7 p -60.68 -19.3 58.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 0.99 111.986 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 27.7 t -94.93 -1.95 51.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.121 -0.987 . . . . 1.7 112.107 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -128.77 6.85 5.6 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 112.529 0.566 . . . . 2.2 112.529 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 35.0 t -118.62 148.15 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.567 0.699 . . . . 0.84 110.036 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -119.32 150.08 40.73 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.035 -1.098 . . . . 2.2 108.035 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 45.0 p-10 -50.3 141.53 11.52 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.785 -1.197 . . . . 2.28 110.723 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 t70 80.44 1.81 1.9 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.455 1.28 . . . . 2.35 114.455 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -65.2 147.99 52.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.882 -1.136 . . . . 1.97 108.732 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -88.22 120.21 29.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.012 -1.477 . . . . 2.65 107.012 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.6 mt -129.48 152.59 48.84 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.786 0.803 . . . . 0.63 109.984 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 mt -129.31 134.81 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.607 -1.257 . . . . 0.62 107.607 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.659 HD11 HD12 ' A' ' 202' ' ' ILE . 36.0 tp -97.96 125.04 42.7 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.891 -1.151 . . . . 0.64 107.891 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.1 t0 -86.07 -31.2 22.05 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.797 -1.189 . . . . 2.05 110.984 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.75 19.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.757 1.021 . . . . 0.84 113.757 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.5 t -115.91 -62.32 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-O 121.985 0.898 . . . . 1.02 109.465 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -91.41 13.54 17.24 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.655 0.741 . . . . 2.51 110.9 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 63.49 51.34 2.59 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.745 0.646 . . . . 1.54 112.745 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.44 ' OE1' ' CZ ' ' A' ' 228' ' ' TYR . 6.5 pt20 -150.24 161.38 42.53 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.544 1.164 . . . . 1.95 109.948 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.8 t -116.36 138.84 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 108.27 -1.011 . . . . 0.71 108.27 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.44 ' CZ ' ' OE1' ' A' ' 226' ' ' GLN . 51.0 m-85 -105.06 131.04 53.07 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.396 -0.964 . . . . 1.01 108.396 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.69 129.26 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 107.577 -1.268 . . . . 0.82 107.577 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 46.3 56.48 16.38 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.013 -1.054 . . . . 1.54 113.132 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.4 150.93 70.98 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.656 2.237 . . . . 0.94 110.901 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.4 p -75.12 163.5 27.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -0.849 . . . . 1.8 110.321 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -61.27 -38.74 87.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.753 -1.217 . . . . 2.73 110.605 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -59.84 -41.3 91.06 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.15 -0.969 . . . . 3.17 110.361 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 84.3 t -70.83 -40.48 76.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.241 -0.912 . . . . 1.34 110.237 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt -60.01 -43.85 93.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.151 -0.968 . . . . 1.2 110.375 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -59.85 -38.75 82.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 2.7 110.955 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -61.18 -47.98 83.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.215 -0.928 . . . . 2.59 111.164 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 24.4 mtm -73.79 -36.18 65.0 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.018 -1.051 . . . . 1.38 111.172 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -56.94 -38.54 73.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.177 -0.952 . . . . 2.84 110.043 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.96 -43.53 67.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.391 -0.818 . . . . 1.88 111.244 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.11 -49.95 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.134 -0.979 . . . . 2.4 111.24 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -61.18 -50.75 71.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.474 -1.391 . . . . 3.52 110.091 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.23 -32.38 73.04 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.903 -0.719 . . . . 1.88 110.778 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.85 -31.15 69.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.878 -1.129 . . . . 3.01 109.161 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.76 -44.62 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.972 0.891 . . . . 2.45 109.82 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.42 -33.82 71.71 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.288 -0.565 . . . . 2.75 110.269 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.0 t -64.97 -36.39 84.23 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.853 -0.739 . . . . 3.16 110.53 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -60.41 -45.73 92.55 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.303 -0.959 . . . . 3.57 109.823 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -71.4 -25.15 62.23 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.702 0.763 . . . . 4.3 111.13 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.47 12.81 0.15 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.638 -0.664 . . . . 4.45 112.764 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.19 -27.02 68.68 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.466 -0.771 . . . . 5.97 111.335 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 82.4 mt -65.74 -22.76 66.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -0.816 . . . . 6.18 110.747 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.98 -0.33 7.31 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.542 0.687 . . . . 6.66 112.804 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.41 22.83 1.19 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.735 -1.228 . . . . 8.2 113.039 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.5 tp -77.35 -3.2 38.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 8.07 112.59 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -83.22 -0.55 49.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.819 -1.175 . . . . 9.45 112.172 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -94.33 -1.39 53.92 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.172 -0.955 . . . . 10.12 112.824 -178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.01 -0.995 . . . . 11.49 109.41 -178.604 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 105.863 -1.902 . . . . 1.0700000000000001 105.863 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -105.44 120.33 41.33 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.794 -1.188 . . . . 1.24 107.794 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.587 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -104.13 -159.28 24.3 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.686 -1.766 . . . . 1.01 108.686 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.8 mt -96.35 1.68 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.29 -1.124 . . . . 1.1100000000000001 112.687 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tp 49.91 97.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.846 -1.158 . . . . 0.98999999999999999 112.213 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -83.5 -46.84 12.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.84999999999999998 111.234 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -149.16 150.15 31.27 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.994 -1.113 . . . . 1.3799999999999999 107.994 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.59 150.0 44.81 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.024 2.483 . . . . 0.93999999999999995 111.803 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.09 121.39 1.36 Allowed Glycine 0 N--CA 1.508 3.453 0 C-N-CA 120.133 -1.032 . . . . 0.81000000000000005 110.708 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -88.59 135.07 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.839 -1.389 . . . . 0.82999999999999996 109.061 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.05 153.86 48.13 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.789 -0.819 . . . . 0.53000000000000003 108.789 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -125.02 140.59 52.77 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.221 -0.924 . . . . 0.77000000000000002 109.077 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.09 170.15 41.76 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 118.672 -1.728 . . . . 0.51000000000000001 110.207 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -79.46 158.82 27.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.654 -0.91 . . . . 1.8999999999999999 109.126 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -83.25 126.86 33.12 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.666 -1.235 . . . . 0.66000000000000003 107.666 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.0 tp -109.91 103.38 12.15 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 105.04 -2.207 . . . . 0.82999999999999996 105.04 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.6 tp -88.0 140.02 29.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.011 . . . . 0.85999999999999999 108.906 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.7 mt -99.04 112.31 24.47 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.414 -1.698 . . . . 0.92000000000000004 106.414 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -110.18 131.97 54.58 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.816 -1.179 . . . . 2.0299999999999998 107.816 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -126.91 140.07 52.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.192 -0.942 . . . . 2.6600000000000001 108.949 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -80.61 137.83 36.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.236 -1.024 . . . . 2.3199999999999998 108.236 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -62.06 150.54 37.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.236 -0.915 . . . . 2.1099999999999999 109.953 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.5 mt -90.23 134.85 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.077 -1.014 . . . . 0.72999999999999998 108.52 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -108.9 131.37 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.463 -0.94 . . . . 0.87 108.463 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.9 mt -94.32 140.35 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.936 -0.764 . . . . 0.81000000000000005 108.936 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -91.33 123.03 34.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.116 -0.99 . . . . 1.3400000000000001 108.503 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -100.02 18.34 18.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.457 -0.777 . . . . 2.8900000000000001 112.046 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -70.43 145.31 51.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.812 -1.18 . . . . 2.0899999999999999 109.488 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -88.15 129.96 35.17 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.759 -1.2 . . . . 2.1899999999999999 107.759 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 pt -95.96 167.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.405 -0.809 . . . . 0.75 110.474 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.4 p -95.81 167.7 11.1 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.345 0.593 . . . . 0.91000000000000003 109.997 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.25 -21.44 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.454 -0.779 . . . . 0.93000000000000005 111.728 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -69.64 -41.24 75.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 2.2799999999999998 110.743 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -84.13 -7.39 59.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.029 -1.045 . . . . 1.45 112.204 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.1 t -58.5 -39.77 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.32 -0.863 . . . . 0.81000000000000005 110.299 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -58.54 -40.19 82.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.008 -1.058 . . . . 1.54 110.208 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -61.81 -40.43 95.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.699 -0.625 . . . . 2.3599999999999999 110.885 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -59.73 -43.97 93.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.064 -1.022 . . . . 1.3100000000000001 111.004 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.48 -41.77 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.986 -1.071 . . . . 0.81999999999999995 110.674 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -60.28 -49.21 78.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.177 -0.952 . . . . 1.5 110.044 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 42' ' ' ARG . 45.6 mtt-85 -60.25 -38.01 82.18 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.534 -0.729 . . . . 2.23 109.857 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -71.85 -59.44 2.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.596 -0.69 . . . . 0.84999999999999998 110.232 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.15 -45.45 90.95 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.218 -0.993 . . . . 0.91000000000000003 110.0 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.519 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.7 t -67.76 -38.81 83.95 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.505 -0.747 . . . . 0.90000000000000002 110.137 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.08 -41.23 94.46 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.579 -1.409 . . . . 0.68999999999999995 109.579 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.533 HH22 ' CD ' ' A' ' 86' ' ' GLU . 32.8 ttm180 -59.8 -31.23 69.51 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.469 -1.018 . . . . 2.8799999999999999 109.206 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.5 -46.33 86.9 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.548 0.69 . . . . 0.84999999999999998 109.765 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -80.61 -44.08 19.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.81 . . . . 2.3500000000000001 111.007 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.12 -42.41 94.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.65000000000000002 110.163 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.1 t -59.86 -38.93 83.55 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.053 -1.029 . . . . 1.45 109.081 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.08 -50.05 44.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.682 -0.69 . . . . 0.63 110.94 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.34 -49.44 77.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.602 -1.311 . . . . 1.3400000000000001 110.66 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.21 -40.42 93.9 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.396 -0.815 . . . . 1.5600000000000001 109.381 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.86 -40.5 93.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.602 -0.686 . . . . 1.1899999999999999 110.25 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 m -66.28 -45.42 80.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.998 -1.064 . . . . 0.71999999999999997 109.798 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.02 -38.33 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.519 -0.738 . . . . 0.62 110.387 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -51.26 -42.42 61.04 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.794 -0.762 . . . . 1.05 110.328 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -70.28 -35.3 73.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.27 -0.894 . . . . 0.64000000000000001 110.03 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -61.83 -39.92 93.5 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.179 -1.008 . . . . 1.73 109.074 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.85 -34.74 76.51 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.769 -0.773 . . . . 0.56000000000000005 109.76 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.27 -36.65 20.29 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.643 -1.265 . . . . 0.68999999999999995 110.884 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -81.71 -20.26 39.78 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.847 -1.384 . . . . 1.48 111.126 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -88.61 -51.93 5.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.414 -0.804 . . . . 0.97999999999999998 110.839 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -107.31 -21.05 13.08 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.538 -0.726 . . . . 1.1599999999999999 112.865 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.03 164.24 12.49 Favored Glycine 0 N--CA 1.504 3.167 0 O-C-N 121.51 -0.744 . . . . 0.84999999999999998 112.075 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -52.85 -24.85 9.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.692 -0.887 . . . . 3.8599999999999999 112.288 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.23 -39.56 79.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.838 -1.164 . . . . 2.3500000000000001 111.137 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -87.13 -22.06 25.59 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.981 -1.074 . . . . 1.6699999999999999 111.8 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -60.76 -37.62 82.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 1.45 110.754 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.69 -33.75 73.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.251 -0.905 . . . . 0.60999999999999999 111.299 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.9 mt -65.88 -43.46 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.64 -1.287 . . . . 0.65000000000000002 110.533 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -69.43 -32.15 70.93 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.319 -0.863 . . . . 0.66000000000000003 110.706 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -61.56 -38.48 87.65 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.215 -0.928 . . . . 1.1899999999999999 110.087 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.39 -41.9 99.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.817 -0.913 . . . . 0.53000000000000003 110.817 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -59.28 -40.46 86.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.246 . . . . 1.27 110.535 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.82 -38.57 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.123 -0.985 . . . . 0.54000000000000004 110.724 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.2 ttp -58.14 -39.68 79.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.356 -0.84 . . . . 1.74 110.639 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.72 -48.77 80.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.412 -0.805 . . . . 0.55000000000000004 110.11 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.09 -41.33 92.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.562 -0.711 . . . . 0.46999999999999997 110.641 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -86.54 9.86 17.12 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 112.984 0.735 . . . . 1.4199999999999999 112.984 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -68.37 122.29 18.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 1.27 108.258 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.55 -16.35 64.09 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.779 0.799 . . . . 1.3500000000000001 110.789 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -74.75 -51.18 14.86 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.71 0.766 . . . . 2.2200000000000002 110.115 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.68 -34.43 77.09 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.771 -0.771 . . . . 0.62 110.313 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.533 ' CD ' HH22 ' A' ' 47' ' ' ARG . 88.9 tt0 -59.98 -47.16 86.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.541 -0.724 . . . . 1.29 110.93 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -63.22 -37.91 89.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.991 -1.068 . . . . 1.52 110.995 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -68.24 -49.46 60.51 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.124 -0.985 . . . . 1.3 110.756 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.1 mt -58.42 -43.94 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.60999999999999999 110.551 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.0 mt -62.91 -43.78 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.78000000000000003 110.47 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.71 -40.59 95.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.325 -0.859 . . . . 0.81999999999999995 111.113 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.57 -42.78 97.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.978 -1.076 . . . . 0.80000000000000004 110.437 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.15 -50.33 79.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.951 -1.093 . . . . 0.77000000000000002 110.176 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -78.48 -34.97 47.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.369 -0.832 . . . . 2.1200000000000001 111.774 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -79.08 -46.85 17.25 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.573 -1.329 . . . . 1.51 111.444 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -100.49 8.09 43.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.08 -1.013 . . . . 1.98 111.857 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.6 m170 49.78 48.92 21.01 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.219 -0.993 . . . . 1.3200000000000001 111.528 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.2 mtt -103.64 156.84 17.49 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.678 0.752 . . . . 1.3799999999999999 109.923 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.3 p -73.09 159.19 33.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.519 -0.738 . . . . 0.67000000000000004 109.296 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.16 79.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.088 -1.007 . . . . 0.52000000000000002 110.376 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.562 ' OD2' HD21 ' A' ' 142' ' ' LEU . 82.6 m-20 -68.75 -39.82 80.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.942 -1.099 . . . . 2.25 110.135 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.38 -51.06 40.28 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.446 -0.784 . . . . 0.64000000000000001 111.44 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.72 94.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.555 -0.716 . . . . 0.56000000000000005 110.636 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.89 -44.91 96.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.569 -0.707 . . . . 0.46000000000000002 111.332 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -60.31 -39.57 87.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 1.3200000000000001 110.959 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -55.83 -49.46 73.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.86 -1.15 . . . . 1.3 110.969 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.07 -45.49 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.677 -1.264 . . . . 0.60999999999999999 109.85 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.42 -30.76 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.626 0.727 . . . . 0.65000000000000002 110.117 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -59.16 -40.36 85.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.126 -0.984 . . . . 2.1099999999999999 110.775 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.37 -32.18 20.31 Favored Glycine 0 N--CA 1.5 2.904 0 C-N-CA 119.193 -1.479 . . . . 0.82999999999999996 112.601 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -60.44 -40.73 92.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.545 -1.562 . . . . 1.28 110.096 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.16 -47.77 48.44 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.608 0.718 . . . . 0.89000000000000001 110.307 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 m -60.97 -38.08 84.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 1.8700000000000001 110.545 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.56 97.82 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.186 -0.946 . . . . 1.05 110.854 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.2 mt -65.69 -28.04 68.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 1.02 111.288 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -67.39 -24.27 65.65 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.176 -0.952 . . . . 2.04 111.18 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.17 -11.65 60.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.119 -0.988 . . . . 1.73 111.42 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.441 HD13 HD13 ' A' ' 123' ' ' LEU . 11.3 mt -89.51 138.03 31.81 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.818 -1.179 . . . . 1.3700000000000001 107.818 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 14.9 t70 -97.56 47.77 1.02 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.277 -0.889 . . . . 2.8799999999999999 111.772 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -119.92 139.84 51.8 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.416 -0.802 . . . . 1.5800000000000001 109.023 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -59.98 -39.09 84.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.446 -0.783 . . . . 3.04 110.762 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -70.53 -57.19 5.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.90000000000000002 110.23 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.441 HD13 HD13 ' A' ' 118' ' ' LEU . 22.9 mt -61.01 -41.51 96.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 1.0600000000000001 110.498 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -61.46 -49.54 76.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.854 -1.154 . . . . 2.1800000000000002 109.8 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -59.94 -30.97 69.43 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.054 -1.058 . . . . 2.1499999999999999 109.545 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 130' ' ' VAL . 51.0 ttt180 -63.39 -29.18 70.52 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.532 -0.867 . . . . 2.3300000000000001 109.499 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.41 73.29 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.779 0.799 . . . . 0.81999999999999995 109.92 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.99 -44.53 80.16 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.768 -0.773 . . . . 0.84999999999999998 110.134 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -63.02 -34.84 78.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.357 -0.839 . . . . 1.3899999999999999 110.569 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.2 t -67.96 -40.81 83.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.905 -1.122 . . . . 0.56000000000000005 109.586 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -59.28 -37.39 77.56 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.09 -1.044 . . . . 3.1200000000000001 109.23 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -59.77 -38.21 81.2 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.212 0.529 . . . . 1.28 110.067 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.7 mt -60.1 -40.24 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.972 . . . . 0.48999999999999999 110.006 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.89 -43.03 94.59 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.089 -1.204 . . . . 0.46000000000000002 110.089 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -58.6 -40.1 82.29 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.493 -1.004 . . . . 2.71 110.589 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 136' ' ' ARG . 51.9 mtt-85 -62.34 -42.43 99.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 2.1400000000000001 110.031 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.6 tp -63.28 -44.41 95.16 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.594 0.711 . . . . 1.05 110.036 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.55 -45.2 95.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.635 0.731 . . . . 0.52000000000000002 110.345 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.435 HH21 ' HA ' ' A' ' 146' ' ' ILE . 53.2 mtp180 -62.06 -34.5 76.38 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.623 -0.673 . . . . 2.3500000000000001 110.945 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -76.02 -43.23 45.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.927 -1.108 . . . . 1.3899999999999999 111.005 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.444 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.2 mt -61.58 -37.14 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.922 -1.111 . . . . 0.68000000000000005 110.823 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.562 HD21 ' OD2' ' A' ' 101' ' ' ASP . 74.7 mt -88.03 -5.96 58.22 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.013 -1.055 . . . . 0.82999999999999996 112.372 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.14 27.28 73.13 Favored Glycine 0 N--CA 1.481 1.664 0 C-N-CA 119.869 -1.157 . . . . 0.91000000000000003 112.844 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.1 tp -62.3 147.37 48.38 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.643 0.735 . . . . 0.94999999999999996 109.66 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.41 140.21 58.61 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.562 -0.903 . . . . 2.4300000000000002 108.562 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.435 ' HA ' HH21 ' A' ' 139' ' ' ARG . 54.1 mt -101.34 137.88 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.098 -1.001 . . . . 1.1000000000000001 108.518 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.85 HD12 ' H ' ' A' ' 147' ' ' ILE . 3.0 mp -82.44 123.76 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.869 -1.16 . . . . 1.5800000000000001 107.869 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -99.67 97.54 8.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.854 -1.536 . . . . 1.6200000000000001 106.854 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.1 -17.87 61.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.586 -0.696 . . . . 0.80000000000000004 111.382 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.8 t -81.58 2.02 31.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.874 . . . . 1.5600000000000001 112.097 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.91 21.09 14.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.559 -0.713 . . . . 0.83999999999999997 111.928 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.2 mt -74.3 134.51 29.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.266 -0.896 . . . . 0.81999999999999995 108.913 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.35 -15.8 13.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.487 -0.758 . . . . 2.3100000000000001 113.003 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -111.49 130.6 55.67 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.165 -1.421 . . . . 1.54 107.165 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -72.27 123.86 23.86 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.535 -0.913 . . . . 1.3799999999999999 108.535 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 25.3 m -145.69 179.56 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.482 -0.762 . . . . 0.68999999999999995 109.462 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.7 mt -89.66 140.23 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.714 -0.847 . . . . 0.53000000000000003 108.714 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.83 124.88 40.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.973 -1.079 . . . . 0.64000000000000001 108.54 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.42 130.67 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.258 -1.016 . . . . 0.67000000000000004 108.258 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.72 150.86 17.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.78000000000000003 109.002 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.491 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.13 -37.86 84.33 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.915 -1.115 . . . . 1.0 109.544 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 46.9 t0 -171.23 150.28 2.94 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.391 -0.818 . . . . 2.4199999999999999 108.83 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.465 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 48.2 mt -119.55 141.05 49.59 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.882 -0.784 . . . . 0.75 108.882 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.1 p -87.37 150.91 50.13 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.893 -1.129 . . . . 0.78000000000000003 108.646 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -43.12 -41.63 9.53 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.787 1.658 . . . . 0.67000000000000004 113.414 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.6 m -61.95 -49.02 77.81 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.144 -1.022 . . . . 0.69999999999999996 110.14 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -62.84 -40.14 96.52 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.447 -0.783 . . . . 1.21 110.478 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 71.5 p -69.73 -39.0 77.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.236 -0.915 . . . . 0.59999999999999998 110.271 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.49 -33.4 73.71 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.469 -0.769 . . . . 0.62 110.503 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -96.06 -2.09 47.42 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.198 -0.939 . . . . 1.1599999999999999 112.51 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.72 147.73 41.25 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.306 -0.998 . . . . 0.72999999999999998 108.306 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.59 113.79 25.48 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.993 -1.484 . . . . 2.2400000000000002 106.993 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.18 -17.27 61.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.778 -0.576 . . . . 1.4299999999999999 111.431 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -80.69 -24.04 39.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.814 . . . . 2.1499999999999999 111.902 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -100.84 -6.13 25.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.264 -0.898 . . . . 2.04 113.216 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 178' ' ' GLY . 65.4 t -107.61 129.65 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.182 -1.044 . . . . 0.55000000000000004 108.182 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 55.1 tp -85.79 -11.21 54.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.261 -0.9 . . . . 1.6299999999999999 112.35 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.452 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 174.92 178.66 44.96 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.072 -1.611 . . . . 0.46999999999999997 109.072 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -132.13 132.84 43.62 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.557 -1.275 . . . . 0.54000000000000004 107.557 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 66.8 mt -137.85 107.04 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 106.076 -1.824 . . . . 0.68999999999999995 106.076 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 205' ' ' THR . 60.1 p -128.57 169.22 14.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.11 -0.994 . . . . 0.81999999999999995 109.041 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 12.8 p-10 -98.14 42.74 1.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.288 -0.882 . . . . 2.3700000000000001 111.223 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.216 0 O-C-N 121.547 -0.721 . . . . 1.1100000000000001 109.804 -179.697 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.877 -0.786 . . . . 1.6899999999999999 108.877 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -60.16 -36.53 77.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.463 -0.773 . . . . 1.0700000000000001 111.019 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.2 p -56.09 -41.79 75.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.324 -0.86 . . . . 1.5800000000000001 110.237 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.7 t -60.02 -38.53 82.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.44 -0.787 . . . . 1.6000000000000001 110.179 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.89 -39.48 80.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.669 -0.644 . . . . 1.45 110.913 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.7 mtp -60.39 -44.14 95.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.911 -1.118 . . . . 1.05 109.539 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.07 -47.42 86.44 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.711 -0.677 . . . . 0.71999999999999997 111.205 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.37 -46.17 90.91 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.762 -1.211 . . . . 3.0499999999999998 111.351 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.4 m -69.77 -39.78 76.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.987 . . . . 0.89000000000000001 110.644 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.9 mt -91.98 -9.89 41.34 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.069 0.766 . . . . 0.78000000000000003 113.069 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.6 mt-10 53.66 12.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.637 0.977 . . . . 1.45 113.637 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.1 mt -71.82 148.91 92.6 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.198 -1.038 . . . . 0.67000000000000004 108.198 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.67 135.56 62.4 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 121.36 1.373 . . . . 0.64000000000000001 109.916 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -162.0 167.61 24.18 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 117.642 -1.623 . . . . 0.67000000000000004 109.791 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 203' ' ' VAL . 84.5 mt -148.44 156.09 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.202 -1.407 . . . . 0.68999999999999995 107.202 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.466 ' N ' HG22 ' A' ' 202' ' ' ILE . 3.1 m -138.71 -25.98 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 120.825 -1.172 . . . . 0.84999999999999998 112.098 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.98 45.17 3.47 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.432 -0.889 . . . . 0.92000000000000004 111.832 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 181' ' ' THR . 32.3 p -64.84 -14.55 59.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.453 -1.028 . . . . 0.94999999999999996 111.034 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.82 -94.26 0.97 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.273 -1.131 . . . . 1.04 110.273 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 71.9 m -129.38 27.7 5.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.621 -0.929 . . . . 1.5700000000000001 112.697 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.59 -36.26 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.358 -1.464 . . . . 0.83999999999999997 110.775 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.2 p -57.51 -25.93 60.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.994 -1.066 . . . . 0.98999999999999999 111.235 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 36.8 p -93.1 3.81 55.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.605 -0.684 . . . . 1.7 111.733 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -126.26 -9.19 6.42 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.33 0.863 . . . . 2.2000000000000002 113.33 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 213' ' ' LYS . 51.5 t -119.59 156.33 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.97 -0.752 . . . . 0.83999999999999997 108.97 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.45 ' N ' HG12 ' A' ' 212' ' ' VAL . 6.2 mmmm -125.99 158.85 34.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.817 -1.179 . . . . 2.2000000000000002 107.817 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 52.7 p-10 -52.43 149.16 5.94 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 120.75 -1.219 . . . . 2.2799999999999998 110.459 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.1 t70 80.72 -2.69 1.84 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 114.11 1.152 . . . . 2.3500000000000001 114.11 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 16' ' ' ALA . 54.8 t0 -66.69 146.47 54.43 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.737 -1.227 . . . . 1.97 108.489 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.459 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 43.3 t80 -88.49 122.16 31.66 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.442 -1.318 . . . . 2.6499999999999999 107.442 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 85.2 mt -127.3 146.38 50.46 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -0.841 . . . . 0.63 109.674 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.5 mt -115.71 128.78 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.418 -1.697 . . . . 0.62 106.418 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.9 tp -98.5 117.96 34.1 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 106.025 -1.843 . . . . 0.64000000000000001 106.025 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 223' ' ' VAL . 32.0 t0 -87.0 -26.75 23.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.736 -1.227 . . . . 2.0499999999999998 112.066 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.54 20.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.842 . . . . 0.83999999999999997 113.139 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.5 t -119.5 -63.22 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-O 121.769 0.795 . . . . 1.02 109.711 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -99.32 14.34 29.98 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.496 0.665 . . . . 2.5099999999999998 111.256 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.587 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 60.22 54.74 3.89 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.376 0.607 . . . . 1.54 112.233 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.514 ' OE1' ' CZ ' ' A' ' 228' ' ' TYR . 15.7 tt0 -145.72 143.59 29.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.035 -1.041 . . . . 1.95 109.568 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.65 139.26 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.438 -1.319 . . . . 0.70999999999999996 107.438 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.514 ' CZ ' ' OE1' ' A' ' 226' ' ' GLN . 86.8 m-85 -103.93 134.43 47.22 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.832 -1.168 . . . . 1.01 108.956 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.25 130.59 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.9 -1.148 . . . . 0.81999999999999995 107.9 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 1.0 OUTLIER 54.52 49.91 6.01 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.185 -0.947 . . . . 1.54 112.95 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 44.8 Cg_endo -68.88 149.38 72.34 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.906 2.404 . . . . 0.93999999999999995 111.459 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.5 m -78.34 157.64 29.07 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.668 0.747 . . . . 1.8 109.765 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.52 ' HA ' HD12 ' A' ' 236' ' ' ILE . 65.9 t30 -55.68 -40.59 72.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.447 -0.783 . . . . 2.73 110.627 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.05 -39.65 86.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.574 -0.704 . . . . 3.1699999999999999 110.62 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.67 -37.92 71.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.301 -0.874 . . . . 1.3400000000000001 110.204 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 233' ' ' ASN . 91.3 mt -59.9 -43.0 91.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.454 -0.779 . . . . 1.2 110.369 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -59.18 -40.35 85.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -0.871 . . . . 2.7000000000000002 110.462 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -61.4 -46.1 91.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 2.5899999999999999 110.982 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.1 mtp -72.3 -35.91 68.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.066 -1.021 . . . . 1.3799999999999999 111.148 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 . . . . . 0 C--N 1.301 -1.518 0 O-C-N 121.09 -1.006 . . . . 2.8399999999999999 110.774 -179.821 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.0 mt . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 106.233 -1.766 . . . . 1.0700000000000001 106.233 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.3 m -104.57 127.33 52.27 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.387 -0.968 . . . . 1.24 108.387 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.57 -141.24 11.99 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.494 -1.042 . . . . 1.01 110.494 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 5' ' ' ILE . 56.6 mt -100.51 1.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.241 -1.152 . . . . 1.1100000000000001 112.467 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tp 49.45 96.73 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.863 -1.148 . . . . 0.98999999999999999 112.162 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.5 -45.79 10.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.072 -1.017 . . . . 0.84999999999999998 111.419 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t -147.11 145.9 23.75 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.686 -1.227 . . . . 1.3799999999999999 107.686 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.71 151.8 46.85 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.565 2.176 . . . . 0.93999999999999995 112.254 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.53 123.7 1.51 Allowed Glycine 0 N--CA 1.508 3.491 0 N-CA-C 110.94 -0.864 . . . . 0.81000000000000005 110.94 177.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.7 mt -92.37 131.41 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.767 -1.431 . . . . 0.82999999999999996 109.348 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.89 140.73 42.54 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.355 -0.98 . . . . 0.53000000000000003 108.355 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 12.4 m-85 -108.59 136.83 47.53 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.971 -1.122 . . . . 0.77000000000000002 107.971 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.76 169.05 42.09 Favored Glycine 0 N--CA 1.498 2.81 0 C-N-CA 118.276 -1.916 . . . . 0.51000000000000001 110.461 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -77.7 159.39 29.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.756 -0.849 . . . . 1.8999999999999999 108.795 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.477 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -87.83 131.24 34.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.999 -1.063 . . . . 0.66000000000000003 109.234 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 17' ' ' LEU . 36.4 tp -109.8 103.47 12.28 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.175 -2.157 . . . . 0.82999999999999996 105.175 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 tp -89.46 132.31 35.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.981 -1.075 . . . . 0.85999999999999999 108.615 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' A' ' 160' ' ' ALA . 67.3 mt -100.01 121.26 41.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.515 -1.291 . . . . 0.92000000000000004 107.515 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -110.65 129.4 55.83 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.763 -1.199 . . . . 2.0299999999999998 107.763 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -111.33 141.54 44.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.398 -0.814 . . . . 2.6600000000000001 109.22 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.18 127.03 33.25 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.436 -1.32 . . . . 2.3199999999999998 107.436 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.21 147.04 54.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.046 -1.034 . . . . 2.1099999999999999 109.156 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.5 mt -95.32 133.35 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.498 -0.927 . . . . 0.72999999999999998 108.498 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -105.74 129.75 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.969 -1.123 . . . . 0.87 107.969 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 73.5 mt -98.33 137.27 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.152 -0.967 . . . . 0.81000000000000005 108.671 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -92.31 120.61 33.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.161 -1.052 . . . . 1.3400000000000001 108.161 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.425 HH11 ' HG3' ' A' ' 28' ' ' ARG . 22.6 mmm-85 -94.96 13.78 23.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.206 -0.934 . . . . 2.8900000000000001 112.217 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -72.13 143.03 49.13 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.494 -0.754 . . . . 2.0899999999999999 109.239 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -85.74 140.29 30.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.379 -0.826 . . . . 2.1899999999999999 109.482 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.26 165.59 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 121.629 0.728 . . . . 0.75 110.41 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.7 p -93.56 167.78 11.46 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.311 0.577 . . . . 0.91000000000000003 109.801 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.97 -18.66 14.41 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.015 -1.053 . . . . 0.93000000000000005 112.713 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -68.99 -38.14 79.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.885 . . . . 2.2799999999999998 110.877 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -92.27 -5.88 51.49 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.548 -1.345 . . . . 1.45 113.086 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.72 -42.89 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.097 -1.002 . . . . 0.81000000000000005 110.69 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.1 -40.33 85.01 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.841 -1.162 . . . . 1.54 110.527 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.52 -39.42 93.51 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.292 -0.88 . . . . 2.3599999999999999 111.063 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -59.76 -40.83 89.48 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.893 -1.129 . . . . 1.3100000000000001 111.148 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.1 -45.0 96.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 120.937 -1.102 . . . . 0.81999999999999995 110.725 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -61.43 -45.88 92.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.823 -1.173 . . . . 1.5 110.648 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -60.77 -41.35 95.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 2.23 110.176 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -75.09 -55.44 5.73 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.155 -0.966 . . . . 0.84999999999999998 110.184 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.9 tp -57.38 -47.14 82.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.409 -0.916 . . . . 0.91000000000000003 110.125 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.5 t -70.22 -38.9 75.35 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.051 0.929 . . . . 0.90000000000000002 109.785 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.53 -44.9 97.22 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.488 -1.445 . . . . 0.68999999999999995 109.488 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 43.9 ttp180 -57.49 -31.72 66.28 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.853 -0.793 . . . . 2.8799999999999999 109.342 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.34 -41.49 80.13 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.774 0.797 . . . . 0.84999999999999998 109.906 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -77.46 -40.94 41.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.633 -0.667 . . . . 2.3500000000000001 110.236 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.66 92.15 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.588 -0.845 . . . . 0.65000000000000002 109.874 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.4 t -60.26 -39.85 88.26 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.041 0.925 . . . . 1.45 109.392 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.2 75.47 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.819 -0.628 . . . . 0.63 110.597 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -66.55 -50.1 64.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.055 -1.028 . . . . 1.3400000000000001 111.032 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.09 -38.43 91.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 1.5600000000000001 110.229 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -59.76 -41.0 90.04 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.233 -0.917 . . . . 1.1899999999999999 110.449 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.1 m -65.59 -43.39 89.84 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.241 -0.912 . . . . 0.71999999999999997 109.882 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.08 -31.9 49.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.379 -0.826 . . . . 0.62 110.691 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -51.78 -46.64 64.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.745 -1.222 . . . . 1.05 110.477 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -68.63 -34.21 75.36 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.953 -1.092 . . . . 0.64000000000000001 109.805 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.13 -39.95 96.17 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.356 -1.338 . . . . 1.73 109.136 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.7 75.89 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.832 -0.747 . . . . 0.56000000000000005 109.548 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.18 -35.74 29.41 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.375 -1.393 . . . . 0.68999999999999995 110.688 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -80.75 -22.53 40.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.107 -1.231 . . . . 1.48 111.016 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.6 m -84.56 -48.9 9.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.428 -0.795 . . . . 0.97999999999999998 110.714 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -106.81 -22.62 12.65 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.409 -0.807 . . . . 1.1599999999999999 112.93 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.37 169.29 14.89 Favored Glycine 0 N--CA 1.501 3.002 0 CA-C-O 121.967 0.76 . . . . 0.84999999999999998 112.036 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.22 -24.17 40.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.912 -0.758 . . . . 3.8599999999999999 112.501 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.96 -38.27 78.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.091 -1.006 . . . . 2.3500000000000001 111.634 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -84.62 -15.84 44.12 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.321 -1.487 . . . . 1.6699999999999999 113.347 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -60.07 -34.66 73.73 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.1 -1.0 . . . . 1.45 110.69 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.59 86.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.60999999999999999 111.308 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 mt -65.54 -43.8 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.822 -1.174 . . . . 0.65000000000000002 110.44 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -70.05 -30.68 68.01 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.225 -0.922 . . . . 0.66000000000000003 110.583 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.49 -38.95 82.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.248 -0.907 . . . . 1.1899999999999999 110.511 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.48 -38.73 79.87 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.734 -1.222 . . . . 0.53000000000000003 110.616 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -58.05 -42.62 85.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.782 -1.422 . . . . 1.27 110.873 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.9 mt -60.4 -41.49 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 0.54000000000000004 110.375 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.5 ttt -60.38 -39.15 86.22 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.221 -0.924 . . . . 1.74 110.397 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 tp -59.64 -48.43 81.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.796 -1.19 . . . . 0.55000000000000004 110.729 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.61 -41.64 95.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.355 -0.841 . . . . 0.46999999999999997 110.247 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -87.09 9.99 18.05 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.376 0.608 . . . . 1.4199999999999999 112.213 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.99 122.17 16.37 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.858 -1.151 . . . . 1.27 108.624 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.86 -17.69 65.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.512 -0.743 . . . . 1.3500000000000001 111.07 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -76.46 -53.65 7.82 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.664 0.745 . . . . 2.2200000000000002 110.365 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.89 -39.52 85.62 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.593 -0.843 . . . . 0.62 110.389 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.521 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 86.3 tt0 -59.9 -45.87 91.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.718 -1.239 . . . . 1.29 110.965 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -60.58 -39.98 90.0 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.966 -1.084 . . . . 1.52 110.839 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.42 -48.49 77.56 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.335 -0.853 . . . . 1.3 110.111 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.8 mt -58.61 -43.27 87.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 118.974 -1.09 . . . . 0.60999999999999999 109.61 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.4 mt -61.35 -45.08 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.535 -0.728 . . . . 0.78000000000000003 110.316 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.36 -44.93 96.33 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.271 0.558 . . . . 0.81999999999999995 110.929 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.91 -43.34 94.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.574 -1.329 . . . . 0.80000000000000004 110.337 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.2 mt -62.33 -49.99 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.137 -0.977 . . . . 0.77000000000000002 110.723 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -78.79 -36.32 42.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.609 -0.682 . . . . 2.1200000000000001 111.563 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -79.93 -46.11 17.34 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 120.789 -1.194 . . . . 1.51 111.838 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -102.24 10.66 39.11 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.097 -1.002 . . . . 1.98 112.066 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.3 m80 51.26 51.5 16.8 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.306 -0.871 . . . . 1.3200000000000001 112.452 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.6 mtp -104.32 158.27 16.57 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 120.91 -1.119 . . . . 1.3799999999999999 109.289 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 66.7 p -72.83 158.43 35.56 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.282 -0.886 . . . . 0.67000000000000004 109.466 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.11 -42.04 84.86 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.224 -0.922 . . . . 0.52000000000000002 110.17 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.528 ' OD2' HD21 ' A' ' 142' ' ' LEU . 88.9 m-20 -68.78 -38.82 80.29 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.976 -1.078 . . . . 2.25 110.207 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.91 -48.59 57.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.5 -0.88 . . . . 0.64000000000000001 111.536 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.32 -47.58 84.86 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.221 -0.924 . . . . 0.56000000000000005 110.967 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.59 95.78 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.475 -0.766 . . . . 0.46000000000000002 110.82 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -61.49 -37.67 84.51 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.558 -0.714 . . . . 1.3200000000000001 110.718 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.09 -49.3 78.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.859 -1.151 . . . . 1.3 111.399 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.36 -46.25 95.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.622 -1.299 . . . . 0.60999999999999999 110.097 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.43 -33.78 58.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.451 0.643 . . . . 0.65000000000000002 110.437 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -57.53 -41.59 81.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -0.828 . . . . 2.1099999999999999 110.786 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.65 -28.01 27.97 Favored Glycine 0 N--CA 1.5 2.94 0 C-N-CA 119.176 -1.487 . . . . 0.82999999999999996 113.084 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -62.38 -39.58 93.67 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.253 -1.734 . . . . 1.28 109.747 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.13 -53.63 12.16 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.57 0.7 . . . . 0.89000000000000001 111.425 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.7 p -60.41 -39.6 88.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 1.8700000000000001 110.502 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.59 97.5 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.112 -0.993 . . . . 1.05 110.622 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.33 -29.0 69.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.966 -1.084 . . . . 1.02 111.202 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -68.22 -20.26 64.82 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.458 -0.776 . . . . 2.04 111.346 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -73.06 -12.34 60.88 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.331 -0.947 . . . . 1.73 110.766 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 20.1 mt -85.91 147.3 26.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.566 -0.708 . . . . 1.3700000000000001 109.098 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -103.12 39.14 1.61 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.149 -0.969 . . . . 2.8799999999999999 111.826 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.422 ' CB ' HD12 ' A' ' 123' ' ' LEU . 7.1 t0 -113.54 139.21 49.17 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 108.733 -0.839 . . . . 1.5800000000000001 108.733 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.8 -37.74 79.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.795 -1.191 . . . . 3.04 110.812 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -72.42 -46.19 56.23 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.539 -1.351 . . . . 0.90000000000000002 110.667 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.422 HD12 ' CB ' ' A' ' 120' ' ' ASP . 43.7 mt -64.33 -40.86 96.73 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.014 -1.054 . . . . 1.0600000000000001 109.823 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -61.17 -46.66 89.59 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.164 -0.96 . . . . 2.1800000000000002 110.256 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.0 -31.93 71.52 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.177 -0.952 . . . . 2.1499999999999999 109.641 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.78 -29.19 70.52 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.854 -1.138 . . . . 2.3300000000000001 109.722 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.37 -49.14 78.75 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.857 0.837 . . . . 0.81999999999999995 109.852 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.53 -44.65 70.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.62 0.724 . . . . 0.84999999999999998 110.663 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -63.52 -33.76 76.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.422 -0.799 . . . . 1.3899999999999999 110.875 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.3 t -69.74 -42.24 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.224 -0.99 . . . . 0.56000000000000005 110.203 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -59.21 -38.29 79.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.96 -1.088 . . . . 3.1200000000000001 109.456 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -59.52 -39.59 84.39 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.707 -0.621 . . . . 1.28 110.213 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.04 -40.71 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.081 -1.012 . . . . 0.48999999999999999 110.322 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.83 -39.93 85.28 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.948 -1.261 . . . . 0.46000000000000002 109.948 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.33 -45.39 91.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.714 -0.874 . . . . 2.71 109.968 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.431 ' HG2' HH11 ' A' ' 136' ' ' ARG . 51.5 mtt-85 -62.77 -42.68 99.8 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.49 -0.884 . . . . 2.1400000000000001 109.875 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.02 -41.3 91.87 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.673 -0.642 . . . . 1.05 109.954 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.2 mt -60.36 -42.06 94.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.81 . . . . 0.52000000000000002 110.226 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.428 ' NH1' HD23 ' A' ' 144' ' ' LEU . 47.9 mtt-85 -61.08 -32.13 71.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 2.3500000000000001 110.53 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -75.99 -41.55 50.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.244 -0.91 . . . . 1.3899999999999999 110.933 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.43 HG21 ' OD1' ' A' ' 101' ' ' ASP . 91.9 mt -60.17 -39.18 79.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.961 -1.087 . . . . 0.68000000000000005 110.274 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.528 HD21 ' OD2' ' A' ' 101' ' ' ASP . 85.1 mt -86.72 -7.61 58.14 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.348 -0.845 . . . . 0.82999999999999996 112.666 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.82 20.04 77.26 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.11 -1.519 . . . . 0.91000000000000003 112.724 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.428 HD23 ' NH1' ' A' ' 139' ' ' ARG . 35.9 tp -65.94 149.1 50.75 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.957 -0.731 . . . . 0.94999999999999996 109.709 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -66.84 149.37 50.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.262 -0.899 . . . . 2.4300000000000002 109.753 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.0 mt -107.64 141.03 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.229 -1.026 . . . . 1.1000000000000001 108.229 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.58 HD12 ' H ' ' A' ' 147' ' ' ILE . 5.0 mp -78.98 123.88 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.601 -0.888 . . . . 1.5800000000000001 108.601 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -96.84 95.67 8.02 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.796 -1.557 . . . . 1.6200000000000001 106.796 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.42 -15.8 59.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.439 -0.788 . . . . 0.80000000000000004 111.683 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.6 m -80.76 1.72 29.17 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.244 -0.91 . . . . 1.5600000000000001 112.514 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.86 19.03 14.48 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 112.774 0.657 . . . . 0.83999999999999997 112.774 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.8 mt -74.1 139.47 19.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.266 -0.896 . . . . 0.81999999999999995 109.353 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -122.24 -8.78 8.68 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.458 0.646 . . . . 2.3100000000000001 112.199 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -111.07 138.49 47.43 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.885 -1.154 . . . . 1.54 107.885 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.88 116.39 20.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.09 -1.078 . . . . 1.3799999999999999 108.09 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.3 176.7 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.992 -0.744 . . . . 0.68999999999999995 108.992 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.2 mt -84.21 140.29 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.364 -0.976 . . . . 0.53000000000000003 108.364 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 19' ' ' LEU . 27.9 tp -96.53 128.32 43.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.486 -0.931 . . . . 0.64000000000000001 108.486 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.2 130.12 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.075 -1.083 . . . . 0.67000000000000004 108.075 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.442 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -160.57 159.68 30.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.234 -0.916 . . . . 0.78000000000000003 108.92 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -62.43 -41.14 98.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.316 -1.49 . . . . 1.0 109.717 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -174.21 150.94 1.58 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.755 -0.832 . . . . 2.4199999999999999 108.755 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.13 140.8 48.92 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.176 -0.675 . . . . 0.75 109.176 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.7 p -90.98 151.18 43.02 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.675 -1.266 . . . . 0.78000000000000003 108.471 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -39.67 -37.77 1.51 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.077 1.851 . . . . 0.67000000000000004 113.512 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.4 m -63.6 -51.4 65.45 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.154 -0.966 . . . . 0.69999999999999996 109.916 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.95 -39.24 94.03 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.539 -0.726 . . . . 1.21 110.237 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 32.1 p -68.16 -40.28 82.39 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.348 0.595 . . . . 0.59999999999999998 110.442 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.68 81.56 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.177 -0.952 . . . . 0.62 110.4 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -94.04 -1.61 54.18 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.94 -1.1 . . . . 1.1599999999999999 112.855 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.26 149.22 33.98 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.697 -0.853 . . . . 0.72999999999999998 108.697 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -96.48 114.26 25.91 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.885 -1.524 . . . . 2.2400000000000002 106.885 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 82.4 mt -72.05 -17.02 62.05 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.173 0.511 . . . . 1.4299999999999999 111.55 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -84.72 -22.19 29.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.654 -0.654 . . . . 2.1499999999999999 112.034 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -99.51 -4.22 31.75 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.24 -0.913 . . . . 2.04 112.923 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 178' ' ' GLY . 61.1 t -112.92 129.86 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 107.599 -1.26 . . . . 0.55000000000000004 107.599 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.2 tp -89.1 -8.53 53.66 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.899 -1.126 . . . . 1.6299999999999999 111.827 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.473 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.22 171.21 39.03 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.995 -1.642 . . . . 0.46999999999999997 108.995 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.0 136.2 49.15 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.283 -1.127 . . . . 0.54000000000000004 108.147 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.473 HG22 HG21 ' A' ' 205' ' ' THR . 86.2 mt -135.54 115.75 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 106.358 -1.719 . . . . 0.68999999999999995 106.358 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 205' ' ' THR . 81.6 p -131.0 169.5 15.75 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.784 -1.198 . . . . 0.81999999999999995 109.897 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 39.0 p-10 -103.24 43.62 1.07 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.586 -0.696 . . . . 2.3700000000000001 110.721 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 2.263 0 O-C-N 120.866 -1.146 . . . . 1.1100000000000001 110.068 179.641 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.9 p . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 107.967 -1.124 . . . . 1.6899999999999999 107.967 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -61.07 -38.53 86.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.688 -0.633 . . . . 1.0700000000000001 110.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.1 p -51.99 -43.66 63.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.056 -1.028 . . . . 1.5800000000000001 110.405 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.9 m -60.12 -37.81 81.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.767 0.794 . . . . 1.6000000000000001 110.405 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.7 mm -59.52 -38.58 76.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.525 -0.735 . . . . 1.45 110.8 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 77.2 mtp -63.17 -43.0 99.49 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.226 1.012 . . . . 1.05 108.883 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.79 -48.99 78.15 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.598 -0.728 . . . . 0.71999999999999997 111.335 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.28 -46.78 88.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.014 -1.054 . . . . 3.0499999999999998 111.146 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 42.7 m -69.85 -41.36 74.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.178 -0.951 . . . . 0.89000000000000001 110.294 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.27 -1.6 57.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.415 -0.803 . . . . 0.78000000000000003 111.991 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 194' ' ' ALA . 54.9 mt-10 54.04 9.75 0.24 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.723 1.009 . . . . 1.45 113.723 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.19 164.94 52.78 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.984 -1.072 . . . . 0.67000000000000004 108.304 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -82.06 144.04 13.18 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.851 1.701 . . . . 0.64000000000000001 110.397 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.48 168.28 25.44 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 117.733 -1.587 . . . . 0.67000000000000004 109.499 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.562 ' CD1' HD11 ' A' ' 220' ' ' LEU . 17.4 mt -148.85 145.9 17.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.159 -1.423 . . . . 0.68999999999999995 107.159 176.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.98 -25.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 120.899 -1.125 . . . . 0.84999999999999998 113.523 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.14 46.16 3.57 Favored Glycine 0 N--CA 1.492 2.403 0 O-C-N 120.99 -1.069 . . . . 0.92000000000000004 111.644 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.473 HG21 HG22 ' A' ' 180' ' ' ILE . 60.5 p -67.59 -12.48 60.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.375 -1.073 . . . . 0.94999999999999996 111.803 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.48 -95.54 0.98 Allowed Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.301 -1.12 . . . . 1.04 110.301 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.9 p -128.41 29.28 5.34 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.389 -1.065 . . . . 1.5700000000000001 112.344 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 72.4 t -58.49 -38.03 67.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.567 -1.333 . . . . 0.83999999999999997 110.707 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.7 p -55.48 -24.94 34.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 0.98999999999999999 111.58 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.4 t -94.34 3.93 54.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.875 . . . . 1.7 111.988 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -127.66 1.13 6.14 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.675 0.621 . . . . 2.2000000000000002 112.675 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 16.1 t -116.23 150.2 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.889 0.852 . . . . 0.83999999999999997 109.611 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -116.07 167.16 11.23 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.939 -0.763 . . . . 2.2000000000000002 108.939 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 68.5 m-80 -68.05 140.33 56.29 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.74 -1.184 . . . . 2.2799999999999998 108.814 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.0 m-20 78.0 4.71 2.84 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.171 1.175 . . . . 2.3500000000000001 114.171 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -63.38 147.88 49.97 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.075 -1.083 . . . . 1.97 108.075 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -89.01 120.16 30.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.588 -1.32 . . . . 2.6499999999999999 107.484 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.477 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 80.2 mt -127.9 146.99 50.46 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.664 0.745 . . . . 0.63 109.697 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 60.2 mt -119.08 128.2 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.08 -1.452 . . . . 0.62 107.08 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.562 HD11 ' CD1' ' A' ' 202' ' ' ILE . 48.8 tp -100.98 119.96 39.49 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 106.329 -1.73 . . . . 0.64000000000000001 106.329 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 223' ' ' VAL . 40.2 t0 -87.28 -25.65 23.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.955 -1.091 . . . . 2.0499999999999998 112.176 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.8 16.84 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 113.652 0.982 . . . . 0.83999999999999997 113.652 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 221' ' ' ASP . 43.1 t -120.38 -63.31 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.178 -0.951 . . . . 1.02 109.621 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -90.81 7.84 37.8 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.059 0.933 . . . . 2.5099999999999998 111.175 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 62.3 55.34 2.38 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.692 0.758 . . . . 1.54 112.148 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -147.31 145.17 29.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.353 -0.842 . . . . 1.95 109.562 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 29.9 t -115.95 138.34 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.775 -1.194 . . . . 0.70999999999999996 107.775 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -105.76 132.7 51.56 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.925 -1.11 . . . . 1.01 108.483 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.94 130.56 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 108.532 -0.914 . . . . 0.81999999999999995 108.532 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.425 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 41.6 t-20 50.72 51.34 10.38 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 113.462 0.912 . . . . 1.54 113.462 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 36.4 Cg_endo -67.86 150.27 78.41 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.53 2.153 . . . . 0.93999999999999995 110.507 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.412 ' H ' HG23 ' A' ' 232' ' ' THR . 1.5 p -74.05 159.99 31.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.994 -1.066 . . . . 1.8 109.7 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -61.57 -35.76 78.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.284 -0.885 . . . . 2.73 110.334 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.35 -39.74 84.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.961 -1.087 . . . . 3.1699999999999999 110.43 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.91 -36.73 70.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.491 -0.756 . . . . 1.3400000000000001 110.017 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.01 -43.78 93.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.261 -0.9 . . . . 1.2 110.543 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.22 -41.2 88.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.955 -1.091 . . . . 2.7000000000000002 110.252 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -63.61 -40.03 95.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.447 -0.783 . . . . 2.5899999999999999 110.502 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 73.2 mtp -70.73 -36.99 73.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.925 . . . . 1.3799999999999999 110.936 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 120.8 -1.188 . . . . 2.8399999999999999 110.127 179.877 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 106.568 -1.642 . . . . 1.0700000000000001 106.568 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.3 m -104.01 122.31 44.98 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.281 -1.007 . . . . 1.24 108.281 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.401 ' H ' ' ND2' ' A' ' 225' ' ' ASN . . . -109.57 -159.22 18.21 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 108.641 -1.784 . . . . 1.01 108.641 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 5' ' ' ILE . 93.4 mt -97.07 1.06 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.253 -1.145 . . . . 1.1100000000000001 112.646 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tp 51.42 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.049 . . . . 0.98999999999999999 112.345 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -83.62 -45.0 13.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.993 -1.067 . . . . 0.84999999999999998 111.496 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.06 146.48 28.43 Favored Pre-proline 0 N--CA 1.5 2.064 0 N-CA-C 107.447 -1.316 . . . . 1.3799999999999999 107.447 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.15 146.17 28.43 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.644 2.229 . . . . 0.93999999999999995 112.144 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.898 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.71 176.43 26.11 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 108.828 -1.709 . . . . 0.81000000000000005 108.828 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.4 mt -138.05 136.69 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 107.712 -1.218 . . . . 0.82999999999999996 107.712 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.25 152.85 44.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.392 -0.818 . . . . 0.53000000000000003 109.19 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -122.16 145.11 48.5 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.354 -0.98 . . . . 0.77000000000000002 108.354 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.78 167.58 34.3 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.584 -1.769 . . . . 0.51000000000000001 109.886 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -76.89 159.16 30.25 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.788 -0.831 . . . . 1.8999999999999999 108.802 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.92 126.94 33.49 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.866 -1.161 . . . . 0.66000000000000003 107.866 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.89 107.89 19.14 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 104.965 -2.235 . . . . 0.82999999999999996 104.965 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.8 tp -94.37 138.67 32.06 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.162 -1.051 . . . . 0.85999999999999999 108.162 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.7 mt -100.69 118.03 36.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 106.768 -1.567 . . . . 0.92000000000000004 106.768 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -109.96 136.06 49.84 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.043 -1.466 . . . . 2.0299999999999998 107.043 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -123.94 140.1 53.31 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.847 -1.158 . . . . 2.6600000000000001 108.34 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -82.91 136.26 34.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.464 -1.31 . . . . 2.3199999999999998 107.464 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.32 150.03 44.32 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.671 -0.812 . . . . 2.1099999999999999 109.516 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.3 mt -91.77 134.64 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.314 -0.866 . . . . 0.72999999999999998 108.752 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.4 t -106.31 130.03 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.496 -1.298 . . . . 0.87 107.496 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 26' ' ' ILE . 19.4 mt -96.34 132.26 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.643 -0.873 . . . . 0.81000000000000005 108.643 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -91.81 121.62 33.6 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.316 -0.994 . . . . 1.3400000000000001 108.316 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -100.03 22.01 11.92 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.15 -0.969 . . . . 2.8900000000000001 112.139 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -65.78 143.65 57.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.889 -1.132 . . . . 2.0899999999999999 109.073 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -89.32 131.39 35.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.077 -1.082 . . . . 2.1899999999999999 108.077 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 pt -97.63 167.74 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.75 109.996 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.3 p -97.62 163.68 12.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.531 -0.731 . . . . 0.91000000000000003 110.109 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.87 -24.09 14.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.93000000000000005 111.861 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -67.37 -35.97 80.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.953 . . . . 2.2799999999999998 110.715 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -94.78 -12.81 26.41 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.993 -1.067 . . . . 1.45 112.802 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.19 -46.42 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.895 . . . . 0.81000000000000005 110.537 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -58.12 -39.38 78.54 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.102 -0.999 . . . . 1.54 110.701 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -62.41 -43.25 99.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.418 -0.801 . . . . 2.3599999999999999 110.876 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.46 -36.55 78.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.079 -1.013 . . . . 1.3100000000000001 110.935 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.46 -42.4 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.784 -1.198 . . . . 0.81999999999999995 110.091 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -61.89 -41.03 97.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.097 -1.002 . . . . 1.5 110.091 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -63.14 -40.95 99.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.512 -0.743 . . . . 2.23 110.168 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -71.94 -56.72 5.17 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.27 -0.894 . . . . 0.84999999999999998 110.349 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.9 tp -58.92 -47.04 86.45 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.377 -0.929 . . . . 0.91000000000000003 109.754 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.531 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.0 t -70.27 -42.18 72.45 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.263 -0.975 . . . . 0.90000000000000002 109.426 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.24 -38.85 88.58 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.145 -1.582 . . . . 0.68999999999999995 109.145 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -59.79 -33.37 71.63 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 122.103 0.954 . . . . 2.8799999999999999 108.973 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.35 -42.14 81.44 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.604 0.716 . . . . 0.84999999999999998 109.642 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -79.46 -43.34 23.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -0.821 . . . . 2.3500000000000001 110.527 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.78 87.88 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.335 -0.853 . . . . 0.65000000000000002 109.814 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 m -60.77 -39.81 90.21 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.798 0.808 . . . . 1.45 109.546 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.86 86.98 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.243 0.544 . . . . 0.63 110.475 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.02 -48.77 78.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 1.3400000000000001 110.575 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.96 -38.56 88.89 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.012 -1.055 . . . . 1.5600000000000001 109.783 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -60.19 -40.04 88.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.83 -0.544 . . . . 1.1899999999999999 110.789 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.7 m -61.8 -42.81 99.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.759 -1.213 . . . . 0.71999999999999997 109.931 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.49 -37.64 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.298 -0.876 . . . . 0.62 110.493 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -50.1 -44.29 51.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.403 -0.811 . . . . 1.05 111.118 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.25 -37.38 74.91 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.123 -0.986 . . . . 0.64000000000000001 110.109 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -61.68 -38.55 88.21 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.905 -1.118 . . . . 1.73 109.545 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.47 -33.59 76.24 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.918 -0.713 . . . . 0.56000000000000005 109.621 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.37 -36.82 13.41 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.957 -1.116 . . . . 0.68999999999999995 111.123 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -81.36 -23.08 37.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.966 -1.314 . . . . 1.48 111.023 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 m -91.4 -51.29 5.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.484 -0.76 . . . . 0.97999999999999998 110.971 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.12 -8.17 17.59 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.001 1.112 . . . . 1.1599999999999999 114.001 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.36 170.69 30.63 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.257 -0.902 . . . . 0.84999999999999998 111.75 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -58.21 -21.98 50.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.98 -0.717 . . . . 3.8599999999999999 112.15 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -54.34 -41.61 69.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.06 -1.025 . . . . 2.3500000000000001 110.861 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -89.24 -24.0 22.21 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.161 -0.962 . . . . 1.6699999999999999 112.031 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -60.01 -39.57 86.27 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.604 -0.685 . . . . 1.45 111.167 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.36 87.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.357 -0.839 . . . . 0.60999999999999999 111.523 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 mt -65.95 -45.56 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.541 -1.35 . . . . 0.65000000000000002 110.131 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -68.43 -33.22 73.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.066 -1.021 . . . . 0.66000000000000003 110.623 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -60.15 -36.13 76.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.233 -0.917 . . . . 1.1899999999999999 110.321 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.87 -39.66 85.3 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.941 -1.123 . . . . 0.53000000000000003 110.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -58.98 -42.88 91.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.102 -1.234 . . . . 1.27 110.525 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.9 mt -60.36 -37.54 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.54000000000000004 110.34 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.5 ttt -59.45 -39.9 85.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.257 -0.902 . . . . 1.74 110.517 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.03 -46.36 88.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.334 -0.854 . . . . 0.55000000000000004 109.866 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.3 -38.78 88.04 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.817 0.818 . . . . 0.46999999999999997 110.139 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.86 9.7 18.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.515 -0.74 . . . . 1.4199999999999999 112.735 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -67.11 121.76 16.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.182 -0.949 . . . . 1.27 108.849 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.75 -15.55 62.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.536 -0.728 . . . . 1.3500000000000001 111.065 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -76.86 -49.63 15.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.678 0.751 . . . . 2.2200000000000002 110.431 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.36 -37.26 86.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.755 0.788 . . . . 0.62 110.192 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.91 -47.46 85.66 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.35 -0.844 . . . . 1.29 110.744 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.82 -37.79 85.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.215 -0.928 . . . . 1.52 110.473 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -65.41 -47.72 75.29 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.092 -1.043 . . . . 1.3 110.646 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.35 -44.55 88.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.138 -1.025 . . . . 0.60999999999999999 110.07 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.87 -39.83 83.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.653 -0.655 . . . . 0.78000000000000003 110.245 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.05 90.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.531 -0.73 . . . . 0.81999999999999995 110.878 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.0 -41.74 92.74 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.028 -1.045 . . . . 0.80000000000000004 110.272 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.5 mt -64.94 -50.01 77.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.776 -0.769 . . . . 0.77000000000000002 110.494 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -74.77 -38.54 62.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 2.1200000000000001 111.778 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -78.82 -45.76 20.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.665 -1.272 . . . . 1.51 111.279 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -101.47 8.84 41.89 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.983 -1.073 . . . . 1.98 112.569 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.2 m80 50.25 49.97 19.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.707 -1.246 . . . . 1.3200000000000001 111.632 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.6 mtt -102.8 154.97 18.66 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.831 0.824 . . . . 1.3799999999999999 109.716 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.7 p -70.96 161.44 31.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.604 -0.685 . . . . 0.67000000000000004 109.582 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.87 91.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 0.52000000000000002 111.042 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 28.6 p-10 -69.13 -39.05 79.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.798 -1.189 . . . . 2.25 110.53 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -69.7 -50.36 44.48 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.432 -0.907 . . . . 0.64000000000000001 111.46 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.11 90.94 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.948 -1.095 . . . . 0.56000000000000005 110.472 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.44 90.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.254 -0.904 . . . . 0.46000000000000002 110.868 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -61.06 -38.75 87.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.737 -1.227 . . . . 1.3200000000000001 111.003 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -57.68 -49.81 75.28 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.053 -1.029 . . . . 1.3 110.791 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.2 -47.23 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.831 -1.168 . . . . 0.60999999999999999 110.144 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -62.0 -32.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.358 -0.839 . . . . 0.65000000000000002 110.497 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -57.78 -40.05 78.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 2.1099999999999999 110.856 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.06 -33.2 15.47 Favored Glycine 0 N--CA 1.501 3.029 0 C-N-CA 119.152 -1.499 . . . . 0.82999999999999996 112.452 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -61.66 -42.26 98.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.434 -1.627 . . . . 1.28 110.2 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.9 -53.3 15.57 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.494 0.664 . . . . 0.89000000000000001 110.821 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.6 m -61.42 -39.92 92.5 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.021 -1.049 . . . . 1.8700000000000001 111.083 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.43 97.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.993 -1.067 . . . . 1.05 111.318 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 43.9 mt -62.21 -29.99 70.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.953 -1.092 . . . . 1.02 110.613 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.27 -19.67 64.73 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.971 -1.081 . . . . 2.04 111.073 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -74.65 -9.38 58.52 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.965 0.888 . . . . 1.73 110.898 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.485 HD13 HD13 ' A' ' 123' ' ' LEU . 69.2 mt -87.37 149.57 24.4 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.039 -0.726 . . . . 1.3700000000000001 109.039 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -104.12 38.77 1.77 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.105 -0.997 . . . . 2.8799999999999999 111.586 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -116.43 138.58 51.25 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.23 -0.919 . . . . 1.5800000000000001 108.981 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.79 -39.54 85.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.693 -0.629 . . . . 3.04 110.957 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -71.68 -48.12 49.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.64 -1.287 . . . . 0.90000000000000002 110.38 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.485 HD13 HD13 ' A' ' 118' ' ' LEU . 25.5 mt -64.1 -39.57 94.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 1.0600000000000001 110.021 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -60.28 -47.98 83.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.906 -1.121 . . . . 2.1800000000000002 109.518 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.32 -31.28 70.13 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.716 -0.794 . . . . 2.1499999999999999 109.57 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.536 ' O ' HG23 ' A' ' 130' ' ' VAL . 19.2 ttt-85 -60.5 -31.11 70.17 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.136 -1.026 . . . . 2.3300000000000001 108.397 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -61.96 -48.85 78.51 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.459 -0.896 . . . . 0.81999999999999995 109.332 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.01 -46.11 79.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.388 -0.82 . . . . 0.84999999999999998 110.408 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.38 -34.45 77.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.48 -0.763 . . . . 1.3899999999999999 110.656 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.0 t -68.23 -39.5 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.56000000000000005 110.275 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -57.37 -39.69 76.57 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.139 -0.976 . . . . 3.1200000000000001 110.115 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -61.28 -39.38 90.22 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.624 0.726 . . . . 1.28 110.591 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.27 -39.79 83.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.381 -0.825 . . . . 0.48999999999999999 110.293 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.92 -48.4 48.55 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.394 -0.908 . . . . 0.46000000000000002 111.456 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -58.26 -40.64 82.38 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.73 -1.453 . . . . 2.71 110.811 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -61.79 -45.86 92.04 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.677 -1.264 . . . . 2.1400000000000001 110.326 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.96 -43.78 98.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.486 -0.759 . . . . 1.05 110.376 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.93 -45.53 92.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.831 . . . . 0.52000000000000002 110.44 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.424 HH22 HD12 ' A' ' 147' ' ' ILE . 57.6 mtp180 -60.54 -35.99 77.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.571 -0.706 . . . . 2.3500000000000001 110.987 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -74.71 -40.35 61.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 1.3899999999999999 110.66 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.34 -39.17 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.448 -0.901 . . . . 0.68000000000000005 110.407 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.28 -7.05 58.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.086 -1.009 . . . . 0.82999999999999996 112.33 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.85 19.49 77.57 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.812 -1.185 . . . . 0.91000000000000003 112.478 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.38 147.91 39.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.639 -0.918 . . . . 0.94999999999999996 109.302 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -67.24 142.92 56.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.401 -0.812 . . . . 2.4300000000000002 109.185 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.6 mt -108.7 137.72 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.167 -1.049 . . . . 1.1000000000000001 108.167 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.512 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.2 mp -79.45 130.36 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.015 . . . . 1.5800000000000001 108.546 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -93.95 96.2 9.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.507 -1.664 . . . . 1.6200000000000001 106.507 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.5 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 57.3 mt -74.61 -10.56 59.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 0.80000000000000004 111.951 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 172' ' ' ASN . 27.5 t -89.5 0.74 56.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.909 -1.119 . . . . 1.5600000000000001 112.424 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -102.43 33.75 3.02 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.102 -0.999 . . . . 0.83999999999999997 112.884 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 152' ' ' ILE . 1.9 mp -66.29 140.63 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.197 -1.564 . . . . 0.81999999999999995 108.827 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -109.29 -20.77 12.83 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.08 0.943 . . . . 2.3100000000000001 111.346 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.437 ' O ' ' CG2' ' A' ' 152' ' ' ILE . 95.7 m-20 -118.89 140.17 50.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.875 -1.157 . . . . 1.54 107.875 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -74.49 124.94 27.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.056 -1.091 . . . . 1.3799999999999999 108.056 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.6 m -146.88 175.7 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.564 -0.71 . . . . 0.68999999999999995 109.513 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.1 mt -88.7 141.83 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.951 -0.759 . . . . 0.53000000000000003 108.951 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.6 tp -96.67 121.39 38.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.64000000000000001 108.297 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.78 131.56 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.373 -0.973 . . . . 0.67000000000000004 108.373 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.37 158.2 31.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.78000000000000003 109.088 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.56 82.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.692 -1.255 . . . . 1.0 109.713 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -171.81 151.07 2.74 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.889 -0.782 . . . . 2.4199999999999999 108.889 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.0 mt -115.76 142.9 46.14 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.504 -0.747 . . . . 0.75 109.248 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 54.3 p -92.4 148.86 37.28 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 120.984 -1.073 . . . . 0.78000000000000003 108.878 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -41.28 -41.84 4.98 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.052 1.835 . . . . 0.67000000000000004 113.354 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.9 m -60.51 -50.37 73.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.938 -1.101 . . . . 0.69999999999999996 110.235 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -60.68 -40.14 91.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.416 -0.802 . . . . 1.21 109.779 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 48.6 p -66.73 -38.47 86.73 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.568 -0.708 . . . . 0.59999999999999998 110.278 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.28 82.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.62 111.122 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -96.93 1.05 49.95 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.31 -0.869 . . . . 1.1599999999999999 113.136 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.27 150.03 36.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.2 -0.938 . . . . 0.72999999999999998 109.601 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 150' ' ' SER . 6.1 m120 -94.83 116.14 28.36 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 106.877 -1.527 . . . . 2.2400000000000002 106.877 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.619 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.6 mm? -75.06 -19.43 60.0 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.482 -0.761 . . . . 1.4299999999999999 111.81 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -85.9 -21.23 28.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 2.1499999999999999 112.266 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -98.95 -2.86 36.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.126 -0.983 . . . . 2.04 112.598 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.592 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.0 t -109.08 129.32 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 107.979 -1.119 . . . . 0.55000000000000004 107.979 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.2 tp -86.26 -6.2 59.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.518 -0.739 . . . . 1.6299999999999999 111.833 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.592 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 167.29 172.74 34.8 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 108.822 -1.711 . . . . 0.46999999999999997 108.822 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -127.18 131.12 50.75 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.206 -1.173 . . . . 0.54000000000000004 108.15 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.599 HG22 HG21 ' A' ' 205' ' ' THR . 89.1 mt -135.97 116.07 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 106.164 -1.791 . . . . 0.68999999999999995 106.164 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 203' ' ' VAL . 62.8 p -138.79 174.99 9.94 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.282 -1.511 . . . . 0.81999999999999995 110.543 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 44.2 m-20 -97.62 61.73 1.63 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 115.455 -0.793 . . . . 2.3700000000000001 109.674 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.457 ' HB1' ' OG ' ' A' ' 188' ' ' SER . . . . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 108.72 -0.845 . . . . 1.1100000000000001 108.72 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.457 ' OG ' ' HB1' ' A' ' 183' ' ' ALA . 67.6 m . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.802 -0.814 . . . . 1.6899999999999999 108.802 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -60.04 -35.49 75.22 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.181 0.515 . . . . 1.0700000000000001 111.012 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.9 p -57.67 -41.24 81.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.77 -1.206 . . . . 1.5800000000000001 110.464 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 50.6 m -60.07 -35.95 76.31 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.016 -1.053 . . . . 1.6000000000000001 110.172 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.1 mm -59.97 -39.95 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.893 -0.504 . . . . 1.45 111.029 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.5 mtp -61.13 -45.14 95.91 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.009 -1.057 . . . . 1.05 109.62 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -57.91 -48.2 80.57 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.678 -0.692 . . . . 0.71999999999999997 111.061 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 195' ' ' ARG . 41.6 mtt-85 -61.87 -41.01 97.33 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.132 -0.98 . . . . 3.0499999999999998 110.605 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.5 m -69.62 -41.36 75.79 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.288 -0.883 . . . . 0.89000000000000001 110.185 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.22 -8.12 49.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 112.574 0.583 . . . . 0.78000000000000003 112.574 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.1 mt-10 52.97 10.66 0.17 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.085 1.143 . . . . 1.45 114.085 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.7 mt -71.95 149.7 92.52 Favored Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 108.188 -1.041 . . . . 0.67000000000000004 108.188 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -54.09 132.81 52.18 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.236 1.29 . . . . 0.64000000000000001 109.903 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.75 162.71 37.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.294 -1.504 . . . . 0.67000000000000004 109.468 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 203' ' ' VAL . 81.2 mt -148.23 154.5 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.686 -1.228 . . . . 0.68999999999999995 107.686 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.9 m -137.22 -28.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 121.077 -1.014 . . . . 0.84999999999999998 112.244 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.75 32.93 0.72 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.822 -1.18 . . . . 0.92000000000000004 113.5 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.599 HG21 HG22 ' A' ' 180' ' ' ILE . 39.4 p -60.8 -25.27 66.44 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.31 -1.112 . . . . 0.94999999999999996 110.453 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 76.27 -93.44 0.99 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.818 -1.182 . . . . 1.04 110.541 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.0 p -127.3 32.6 5.02 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.215 -1.168 . . . . 1.5700000000000001 112.325 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.26 -36.24 67.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 120.682 -1.261 . . . . 0.83999999999999997 109.911 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.5 p -57.48 -20.19 29.36 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.282 -0.886 . . . . 0.98999999999999999 111.74 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.4 t -91.16 -3.57 56.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 1.7 111.732 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -122.62 -8.2 8.52 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 112.923 0.712 . . . . 2.2000000000000002 112.923 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 68.9 t -112.32 148.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.427 0.632 . . . . 0.83999999999999997 109.649 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -120.09 159.46 24.76 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.012 -1.107 . . . . 2.2000000000000002 108.012 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.2 p30 -57.61 149.0 22.54 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.409 -1.432 . . . . 2.2799999999999998 110.507 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 9.0 t0 81.69 -2.44 1.6 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 114.644 1.35 . . . . 2.3500000000000001 114.644 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -67.61 147.97 52.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.743 -1.223 . . . . 1.97 108.328 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -90.18 122.96 33.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.757 -1.201 . . . . 2.6499999999999999 107.757 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.0 mt -124.88 143.88 50.61 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.9 0.857 . . . . 0.63 110.199 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.61 122.93 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.125 -1.805 . . . . 0.62 106.125 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.1 tp -98.92 117.77 34.17 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.409 -1.7 . . . . 0.64000000000000001 106.409 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 223' ' ' VAL . 30.9 t0 -92.76 -26.0 17.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.933 -1.104 . . . . 2.0499999999999998 112.96 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.59 18.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.863 0.69 . . . . 0.83999999999999997 112.863 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.2 t -113.49 -60.72 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.956 0.884 . . . . 1.02 109.386 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -95.54 10.55 36.2 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.721 0.772 . . . . 2.5099999999999998 110.764 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 4' ' ' GLY . 1.7 t-20 62.21 50.25 3.99 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.446 0.641 . . . . 1.54 111.74 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -147.17 146.6 29.93 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.414 1.102 . . . . 1.95 109.563 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.11 140.25 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.691 -0.855 . . . . 0.70999999999999996 108.691 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -100.28 132.16 45.81 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.909 -1.119 . . . . 1.01 108.542 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.1 t -110.15 130.18 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.411 -0.959 . . . . 0.81999999999999995 108.411 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.7 t30 53.12 52.84 10.97 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 114.124 1.157 . . . . 1.54 114.124 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.38 149.6 69.53 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.149 1.899 . . . . 0.93999999999999995 110.717 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 65.7 p -75.72 157.94 32.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 1.8 109.245 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -60.84 -38.56 85.91 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.788 -0.765 . . . . 2.73 110.24 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 55.8 mp0 -60.28 -39.34 86.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.636 -0.665 . . . . 3.1699999999999999 110.732 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.48 -40.83 77.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.864 -1.134 . . . . 1.3400000000000001 110.142 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.4 -43.87 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.437 -0.789 . . . . 1.2 110.082 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -59.72 -41.42 90.8 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.104 -0.997 . . . . 2.7000000000000002 110.385 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -63.61 -40.58 97.27 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.474 -0.89 . . . . 2.5899999999999999 110.342 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 84.0 mtp -69.85 -41.01 75.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 1.3799999999999999 110.648 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 . . . . . 0 C--N 1.3 -1.578 0 O-C-N 120.327 -1.483 . . . . 2.8399999999999999 110.276 179.806 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.2 mt . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 112.321 0.489 . . . . 1.0700000000000001 112.321 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 m -93.07 118.22 30.95 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.09 -1.448 . . . . 1.24 107.09 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.4 -146.8 16.69 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.48 -1.048 . . . . 1.01 110.48 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -94.95 -2.88 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.34 -1.094 . . . . 1.1100000000000001 113.036 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tp 50.8 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.867 -1.146 . . . . 0.98999999999999999 112.607 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.8 -43.79 13.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.84999999999999998 110.741 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -147.96 142.42 16.54 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 107.797 -1.186 . . . . 1.3799999999999999 107.797 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.97 149.39 36.79 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.716 2.277 . . . . 0.93999999999999995 112.454 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.887 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.43 162.61 11.43 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.143 -1.583 . . . . 0.81000000000000005 109.143 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -121.9 135.08 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 O-C-N 121.089 -1.242 . . . . 0.82999999999999996 108.271 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.11 155.5 46.97 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.456 -0.778 . . . . 0.53000000000000003 109.269 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -127.44 139.58 52.73 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.89 -1.152 . . . . 0.77000000000000002 107.89 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.46 168.98 35.98 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 118.69 -1.719 . . . . 0.51000000000000001 110.063 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.441 ' HZ3' HG12 ' A' ' 156' ' ' VAL . 30.2 mtmm -80.03 161.15 25.57 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.451 -1.029 . . . . 1.8999999999999999 110.216 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.85 131.68 34.49 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.391 -0.966 . . . . 0.66000000000000003 108.391 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 tp -109.78 101.77 10.61 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 105.405 -2.072 . . . . 0.82999999999999996 105.405 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.53 133.15 35.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.911 -1.144 . . . . 0.85999999999999999 107.911 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.7 117.93 35.8 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.394 -1.706 . . . . 0.92000000000000004 106.394 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -109.32 133.38 53.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.943 -1.132 . . . . 2.0299999999999998 107.943 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -123.59 140.24 53.19 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.305 -0.872 . . . . 2.6600000000000001 108.666 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -80.46 136.99 36.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.073 -1.017 . . . . 2.3199999999999998 108.256 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.2 146.12 51.62 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.281 -0.887 . . . . 2.1099999999999999 108.955 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.0 mt -93.39 128.84 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.237 -1.023 . . . . 0.72999999999999998 108.237 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -108.83 130.49 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.726 -1.213 . . . . 0.87 107.726 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.5 mt -95.7 132.14 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.341 -0.85 . . . . 0.81000000000000005 108.943 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -89.94 120.8 31.47 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.61 -1.256 . . . . 1.3400000000000001 107.61 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -96.65 17.74 15.79 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.431 -0.793 . . . . 2.8900000000000001 112.417 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -67.45 146.29 54.14 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.203 -0.935 . . . . 2.0899999999999999 108.979 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -87.82 134.83 33.61 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.103 -1.073 . . . . 2.1899999999999999 108.103 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 pt -96.82 165.69 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.458 -0.776 . . . . 0.75 110.329 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -94.27 168.47 10.89 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 0.91000000000000003 109.541 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.11 -18.97 28.75 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.959 -1.088 . . . . 0.93000000000000005 112.879 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.09 -35.85 76.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.746 -1.221 . . . . 2.2799999999999998 110.825 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -94.5 -8.83 37.23 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.969 -1.082 . . . . 1.45 113.221 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.9 -43.79 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.164 -0.96 . . . . 0.81000000000000005 110.156 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.52 -40.09 81.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.954 -1.091 . . . . 1.54 110.4 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -62.1 -38.09 87.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.683 . . . . 2.3599999999999999 110.656 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.77 -39.49 85.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 1.3100000000000001 110.883 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.49 -43.68 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.131 -0.98 . . . . 0.81999999999999995 110.769 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -62.13 -43.8 98.04 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.113 -0.992 . . . . 1.5 110.461 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -62.7 -38.78 91.79 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.247 -0.908 . . . . 2.23 110.592 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -76.09 -55.56 5.48 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.123 -0.986 . . . . 0.84999999999999998 110.532 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.68 -48.28 81.62 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.295 -0.962 . . . . 0.91000000000000003 110.59 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.552 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 10.9 t -69.84 -40.78 75.62 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.74 -0.784 . . . . 0.90000000000000002 110.435 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.15 -45.73 87.05 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.24 -1.457 . . . . 0.68999999999999995 109.691 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -58.39 -30.06 66.53 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.036 0.922 . . . . 2.8799999999999999 109.995 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.66 -46.19 87.73 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.672 0.748 . . . . 0.84999999999999998 110.018 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -78.95 -41.81 28.42 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 2.3500000000000001 110.311 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.48 86.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.4 -0.813 . . . . 0.65000000000000002 109.74 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -60.45 -40.38 90.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.118 -0.989 . . . . 1.45 109.288 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.91 -47.17 69.52 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.926 -0.579 . . . . 0.63 110.894 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.52 -51.38 65.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.084 . . . . 1.3400000000000001 110.7 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 54' ' ' LEU . 3.0 mm? -61.41 -40.11 93.19 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.563 -0.855 . . . . 1.5600000000000001 110.023 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -59.7 -41.59 91.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 1.1899999999999999 110.354 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -66.05 -42.74 89.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.134 -0.979 . . . . 0.71999999999999997 110.457 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.8 mt -59.89 -39.76 80.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.352 -0.843 . . . . 0.62 110.705 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -49.93 -41.92 47.29 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.09 -1.006 . . . . 1.05 110.87 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -70.21 -38.17 75.23 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.143 -0.973 . . . . 0.64000000000000001 110.039 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.4 -38.88 88.66 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.721 -1.192 . . . . 1.73 108.945 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.16 72.24 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.52 0.676 . . . . 0.56000000000000005 109.609 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.24 -33.37 20.46 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.103 -1.046 . . . . 0.68999999999999995 111.055 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -80.6 -26.83 37.59 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.083 -1.245 . . . . 1.48 111.202 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 m -85.71 -48.61 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.579 -0.701 . . . . 0.97999999999999998 110.856 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -107.48 -17.99 13.97 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 113.229 0.826 . . . . 1.1599999999999999 113.229 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.13 155.72 11.48 Favored Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.329 -0.857 . . . . 0.84999999999999998 112.325 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -50.65 -22.56 2.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.882 -0.776 . . . . 3.8599999999999999 112.305 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.61 -36.18 71.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 2.3500000000000001 111.349 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -80.98 -22.39 39.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.853 -1.154 . . . . 1.6699999999999999 111.935 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -58.87 -33.53 70.58 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.957 -1.09 . . . . 1.45 111.2 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.95 -41.71 83.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 0.60999999999999999 110.816 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.1 mt -66.65 -44.75 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.86 -1.15 . . . . 0.65000000000000002 110.125 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -70.24 -31.11 68.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 0.66000000000000003 110.382 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -61.04 -39.76 91.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.316 -0.865 . . . . 1.1899999999999999 109.754 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.04 -39.95 96.72 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 120.177 -1.011 . . . . 0.53000000000000003 110.611 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -59.73 -45.39 92.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -1.092 . . . . 1.27 110.621 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.0 mt -60.45 -39.03 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.411 -0.806 . . . . 0.54000000000000004 110.545 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.9 ttt -59.61 -39.37 84.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 1.74 110.503 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.14 -49.65 77.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.035 -1.04 . . . . 0.55000000000000004 109.801 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.86 -39.82 95.1 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.571 0.701 . . . . 0.46999999999999997 110.687 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -85.31 6.91 24.24 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.074 0.768 . . . . 1.4199999999999999 113.074 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -69.28 118.1 11.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.697 -1.252 . . . . 1.27 109.074 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.35 -16.9 64.07 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.627 0.727 . . . . 1.3500000000000001 110.901 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.36 -46.33 41.25 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.358 -0.937 . . . . 2.2200000000000002 109.966 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -66.2 -38.52 88.19 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.664 -0.815 . . . . 0.62 110.273 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -58.8 -46.1 88.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.5 -0.75 . . . . 1.29 110.903 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -62.73 -37.84 88.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.909 . . . . 1.52 110.545 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.51 -48.65 66.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.013 -1.055 . . . . 1.3 110.653 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.8 mt -57.5 -43.05 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.218 -0.926 . . . . 0.60999999999999999 110.402 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.9 mt -60.62 -43.31 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.737 -0.602 . . . . 0.78000000000000003 110.389 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.45 -42.69 99.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.326 -0.859 . . . . 0.81999999999999995 110.67 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.57 -42.5 98.93 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.16 -0.963 . . . . 0.80000000000000004 110.537 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.43 -44.62 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 0.77000000000000002 110.537 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -84.41 -35.16 23.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.398 -0.814 . . . . 2.1200000000000001 111.713 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 91' ' ' ALA . 51.4 t0 -80.97 -45.39 16.73 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.134 -0.979 . . . . 1.51 111.79 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -101.03 9.55 42.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.245 -0.909 . . . . 1.98 112.45 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.5 m80 49.79 51.67 16.09 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.27 -0.894 . . . . 1.3200000000000001 112.023 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 85.4 mtp -104.11 154.76 19.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.0 -0.741 . . . . 1.3799999999999999 109.0 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.412 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 46.4 p -72.6 160.39 32.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.67000000000000004 110.208 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.46 91.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.52000000000000002 110.81 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 23.5 p-10 -69.86 -43.64 71.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.9 -1.125 . . . . 2.25 110.427 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.4 -47.6 72.76 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.498 -0.881 . . . . 0.64000000000000001 111.172 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.12 91.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.359 -0.838 . . . . 0.56000000000000005 110.075 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.74 96.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.556 -0.715 . . . . 0.46000000000000002 110.482 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -61.49 -37.72 84.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.191 -0.943 . . . . 1.3200000000000001 110.892 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -56.92 -49.77 74.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.79 . . . . 1.3 110.788 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.8 t -60.28 -44.48 95.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.922 -1.111 . . . . 0.60999999999999999 110.33 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.14 -34.53 60.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.562 -0.711 . . . . 0.65000000000000002 110.37 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -58.5 -40.28 82.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.979 -1.076 . . . . 2.1099999999999999 110.875 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.87 -34.42 13.23 Favored Glycine 0 N--CA 1.498 2.775 0 C-N-CA 119.236 -1.459 . . . . 0.82999999999999996 112.174 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -62.2 -41.25 98.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.711 -1.464 . . . . 1.28 109.879 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.94 -51.39 22.3 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.529 -0.732 . . . . 0.89000000000000001 110.547 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.9 m -60.55 -37.51 81.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 1.8700000000000001 110.76 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.25 97.67 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.552 -0.718 . . . . 1.05 110.523 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.85 -29.81 70.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.908 -1.12 . . . . 1.02 111.156 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -65.94 -21.02 66.4 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.286 -0.884 . . . . 2.04 111.121 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -71.94 -15.01 62.07 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.167 -0.958 . . . . 1.73 111.012 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 123' ' ' LEU . 55.1 mt -84.6 147.16 27.14 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.193 -0.669 . . . . 1.3700000000000001 109.193 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 6.6 t0 -100.66 38.41 1.53 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.132 -0.98 . . . . 2.8799999999999999 112.083 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -113.03 140.08 48.13 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.173 -0.954 . . . . 1.5800000000000001 108.75 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.48 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 27.8 mp0 -58.28 -39.37 79.1 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.358 -0.839 . . . . 3.04 110.92 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -71.82 -52.51 17.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.534 -1.354 . . . . 0.90000000000000002 110.631 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 118' ' ' LEU . 18.9 mt -60.94 -41.7 96.76 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 1.0600000000000001 110.658 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -63.42 -49.64 72.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.818 -1.176 . . . . 2.1800000000000002 109.582 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.82 -30.26 69.98 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.328 -0.949 . . . . 2.1499999999999999 109.446 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.588 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -61.09 -30.1 70.15 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.924 0.868 . . . . 2.3300000000000001 108.732 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.44 -50.41 72.9 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.78 0.8 . . . . 0.81999999999999995 109.432 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.01 -43.89 81.74 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.714 0.769 . . . . 0.84999999999999998 110.093 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -63.72 -34.0 76.9 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.475 0.655 . . . . 1.3899999999999999 110.255 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 126' ' ' ARG . 21.1 t -69.01 -41.75 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.56000000000000005 109.91 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -58.51 -37.34 75.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.886 -1.133 . . . . 3.1200000000000001 109.584 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -58.79 -39.81 82.19 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.418 0.628 . . . . 1.28 110.464 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.19 -40.11 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.994 -1.066 . . . . 0.48999999999999999 109.778 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.85 -47.56 89.42 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.343 -1.103 . . . . 0.46000000000000002 110.343 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -58.27 -40.58 82.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -1.14 . . . . 2.71 110.26 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -64.88 -43.66 92.19 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.403 -0.919 . . . . 2.1400000000000001 109.359 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.0 tp -59.66 -43.58 93.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.571 -0.705 . . . . 1.05 109.64 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 20.7 mt -60.09 -38.66 83.61 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.322 -0.861 . . . . 0.52000000000000002 110.576 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -39.84 84.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.063 . . . . 2.3500000000000001 110.776 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -75.77 -40.64 54.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.794 . . . . 1.3899999999999999 110.536 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.17 -40.36 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.68000000000000005 109.572 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.45 -8.96 49.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.393 -0.817 . . . . 0.82999999999999996 112.224 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.04 18.62 76.42 Favored Glycine 0 N--CA 1.482 1.713 0 C-N-CA 119.689 -1.243 . . . . 0.91000000000000003 112.617 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.73 144.43 57.25 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.594 -0.945 . . . . 0.94999999999999996 109.08 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -66.35 149.86 49.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.75 . . . . 2.4300000000000002 109.818 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.44 145.88 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.678 -0.86 . . . . 1.1000000000000001 108.678 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.1 mm -76.93 118.84 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.942 -1.099 . . . . 1.5800000000000001 108.555 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -97.8 98.12 9.56 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.487 -1.672 . . . . 1.6200000000000001 106.487 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.5 mt -77.13 -17.6 58.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.324 -0.86 . . . . 0.80000000000000004 111.726 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -80.31 1.11 30.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 1.5600000000000001 112.476 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.75 28.31 4.81 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.364 -0.835 . . . . 0.83999999999999997 112.284 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 7.9 mt -73.49 140.08 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.81999999999999995 109.745 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -111.45 -21.67 11.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.605 0.717 . . . . 2.3100000000000001 112.231 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -118.14 139.96 50.49 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.369 -0.975 . . . . 1.54 108.369 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.46 125.97 28.44 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.361 -0.977 . . . . 1.3799999999999999 108.361 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.441 HG12 ' HZ3' ' A' ' 15' ' ' LYS . 30.0 m -146.07 173.94 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 0.68999999999999995 109.258 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.4 mt -87.96 145.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.683 -0.858 . . . . 0.53000000000000003 108.683 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.7 tp -95.44 123.81 39.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.916 -1.115 . . . . 0.64000000000000001 108.736 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.6 t -125.04 128.69 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.279 -1.378 . . . . 0.67000000000000004 107.279 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.67 154.84 18.7 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.941 -1.1 . . . . 0.78000000000000003 108.537 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.08 81.93 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.409 -1.432 . . . . 1.0 109.375 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.1 t0 -171.01 153.42 3.8 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.511 -0.922 . . . . 2.4199999999999999 108.511 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 34.8 mt -114.69 144.59 43.21 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.298 -0.876 . . . . 0.75 109.343 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.9 p -91.03 149.62 40.35 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.741 -1.224 . . . . 0.78000000000000003 108.826 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.58 -43.27 14.33 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.469 1.446 . . . . 0.67000000000000004 113.527 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.7 m -61.88 -45.76 92.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.926 -1.109 . . . . 0.69999999999999996 110.132 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.88 -41.66 97.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.472 -0.768 . . . . 1.21 110.385 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.7 p -67.22 -38.41 85.21 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.453 0.644 . . . . 0.59999999999999998 110.48 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.95 -37.25 86.3 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.467 -0.771 . . . . 0.62 110.606 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -93.73 -1.97 54.42 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.122 -0.986 . . . . 1.1599999999999999 112.683 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.55 149.62 34.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.621 -0.881 . . . . 0.72999999999999998 108.621 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -94.86 109.81 21.76 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.772 -1.566 . . . . 2.2400000000000002 106.772 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.39 -22.01 64.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.93 -0.481 . . . . 1.4299999999999999 111.745 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -83.72 -17.34 41.63 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.299 -0.876 . . . . 2.1499999999999999 112.797 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -101.19 -5.65 25.3 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.196 -0.94 . . . . 2.04 113.229 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.643 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.1 t -108.3 129.99 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.92 -1.141 . . . . 0.55000000000000004 107.92 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.5 tp -86.28 -3.78 59.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.146 -0.971 . . . . 1.6299999999999999 111.964 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.643 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.27 166.61 28.59 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.947 -1.661 . . . . 0.46999999999999997 108.947 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.73 130.01 53.13 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.748 -1.204 . . . . 0.54000000000000004 107.748 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.413 HG22 HG21 ' A' ' 205' ' ' THR . 92.0 mt -131.07 124.84 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.305 -1.739 . . . . 0.68999999999999995 106.305 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 205' ' ' THR . 41.7 p -140.92 170.66 15.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.786 -1.196 . . . . 0.81999999999999995 110.595 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 48.8 t0 -108.38 66.73 0.65 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.743 -0.662 . . . . 2.3700000000000001 109.375 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.025 0 O-C-N 121.363 -0.835 . . . . 1.1100000000000001 109.045 179.793 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.7 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 107.46 -1.311 . . . . 1.6899999999999999 107.46 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -62.7 -36.34 82.65 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.411 -0.806 . . . . 1.0700000000000001 109.604 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 59.0 m -58.65 -38.94 79.21 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.571 -0.706 . . . . 1.5800000000000001 110.144 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 64.7 p -58.24 -37.98 75.98 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.196 -0.94 . . . . 1.6000000000000001 109.73 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.8 mm -60.15 -40.0 82.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.479 -0.763 . . . . 1.45 110.287 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 64.5 mtp -63.82 -42.37 97.67 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.084 -1.01 . . . . 1.05 109.578 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.47 -48.45 81.59 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.574 -0.739 . . . . 0.71999999999999997 110.92 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.423 ' HG2' HH11 ' A' ' 195' ' ' ARG . 36.9 mtt-85 -61.89 -44.11 97.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 3.0499999999999998 110.608 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.0 m -68.62 -40.81 80.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.89000000000000001 110.165 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.38 -8.53 47.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.456 -0.778 . . . . 0.78000000000000003 112.526 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.0 mt-10 55.25 13.79 0.93 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.067 1.136 . . . . 1.45 114.067 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 50.2 mt -71.09 164.46 56.63 Favored Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 108.497 -0.927 . . . . 0.67000000000000004 108.497 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.87 140.46 38.54 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 121.598 1.532 . . . . 0.64000000000000001 110.468 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.08 168.34 24.57 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.019 -1.675 . . . . 0.67000000000000004 109.998 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.5 mt -147.7 152.55 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.866 -1.161 . . . . 0.68999999999999995 107.866 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.6 m -135.12 -27.63 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 120.968 -1.082 . . . . 0.84999999999999998 111.409 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.22 46.54 3.22 Favored Glycine 0 N--CA 1.489 2.207 0 O-C-N 120.944 -1.098 . . . . 0.92000000000000004 111.75 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 181' ' ' THR . 69.3 p -62.9 -16.42 58.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.359 -1.083 . . . . 0.94999999999999996 111.702 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.459 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 76.03 -94.9 1.02 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.948 -1.261 . . . . 1.04 109.948 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.2 m -129.97 27.6 5.14 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.478 -1.013 . . . . 1.5700000000000001 112.38 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.2 t -57.96 -40.23 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.536 -1.353 . . . . 0.83999999999999997 110.536 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.1 p -58.68 -18.88 34.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.923 -1.111 . . . . 0.98999999999999999 111.77 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.8 t -94.96 -0.59 53.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.412 -0.805 . . . . 1.7 112.227 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -129.86 0.44 4.82 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.698 0.629 . . . . 2.2000000000000002 112.698 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t -120.09 150.54 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.934 0.873 . . . . 0.83999999999999997 109.806 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.67 154.74 36.43 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.222 -1.029 . . . . 2.2000000000000002 108.222 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.9 p-10 -51.38 145.6 8.21 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.103 -0.998 . . . . 2.2799999999999998 110.172 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.9 t0 81.73 -7.0 1.45 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.264 1.209 . . . . 2.3500000000000001 114.264 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 19.7 t0 -60.47 145.24 49.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.773 -1.205 . . . . 1.97 108.478 177.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.438 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 14.2 t80 -88.32 123.07 32.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.939 -1.134 . . . . 2.6499999999999999 107.939 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.488 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 49.6 mt -128.26 149.86 50.3 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.553 -0.717 . . . . 0.63 109.607 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.13 123.0 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.309 -1.737 . . . . 0.62 106.309 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.0 tp -100.86 112.79 25.29 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.927 -1.879 . . . . 0.64000000000000001 105.927 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 223' ' ' VAL . 41.6 p30 -93.35 -22.85 18.7 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.881 -1.137 . . . . 2.0499999999999998 112.314 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.91 16.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.996 0.739 . . . . 0.83999999999999997 112.996 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.598 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.1 t -106.94 -57.75 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.057 -1.027 . . . . 1.02 109.359 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -93.62 9.08 38.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.421 1.105 . . . . 2.5099999999999998 110.41 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.78 52.56 3.45 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.89 -1.05 . . . . 1.54 112.177 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.443 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 89.6 mt-30 -146.79 150.16 34.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.357 1.075 . . . . 1.95 109.827 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -115.63 139.86 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.864 -1.161 . . . . 0.70999999999999996 107.864 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -104.21 131.67 51.27 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 108.145 -1.057 . . . . 1.01 108.145 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.1 t -110.31 130.38 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.898 -0.778 . . . . 0.81999999999999995 108.898 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.458 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 8.9 t-20 53.95 48.12 4.47 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 113.393 0.886 . . . . 1.54 113.393 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 56.2 Cg_endo -68.99 148.51 70.24 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.128 1.886 . . . . 0.93999999999999995 111.216 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 43.2 p -74.61 162.84 28.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.807 -1.183 . . . . 1.8 110.172 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -59.8 -36.78 77.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 2.73 110.66 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -59.9 -39.42 85.32 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.28 -0.888 . . . . 3.1699999999999999 110.952 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 87.4 t -70.02 -38.46 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 1.3400000000000001 110.075 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.518 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 96.1 mt -59.69 -47.5 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.552 -0.717 . . . . 1.2 110.377 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -60.01 -39.64 86.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 2.7000000000000002 110.792 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -63.06 -45.99 89.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.363 -0.836 . . . . 2.5899999999999999 110.74 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 72.7 mtp -70.99 -35.69 72.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 1.3799999999999999 110.647 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.552 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.899 . . . . 2.8399999999999999 110.377 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.4 mt . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.237 0.542 . . . . 1.0700000000000001 112.116 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -96.39 111.98 23.88 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.829 -1.545 . . . . 1.24 106.829 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.92 -154.13 29.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.66 -1.376 . . . . 1.01 109.66 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 5' ' ' ILE . 82.2 mt -95.03 -0.62 10.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.321 -1.105 . . . . 1.1100000000000001 112.273 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 49.63 100.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.939 -1.101 . . . . 0.98999999999999999 112.511 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.18 -42.19 12.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.144 -0.972 . . . . 0.84999999999999998 111.983 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 m -145.0 142.78 18.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.875 -1.141 . . . . 1.3799999999999999 108.007 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.53 148.48 26.25 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.198 1.932 . . . . 0.93999999999999995 112.357 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.935 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.38 173.22 21.04 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.053 -1.619 . . . . 0.81000000000000005 109.053 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.0 mt -129.52 137.07 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -1.222 . . . . 0.82999999999999996 108.272 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.95 154.65 46.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 0.53000000000000003 109.173 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.0 m-85 -121.03 140.46 51.9 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.437 -0.949 . . . . 0.77000000000000002 108.437 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.45 162.56 28.33 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.311 -1.9 . . . . 0.51000000000000001 110.32 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -78.45 158.77 28.57 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.527 -0.916 . . . . 1.8999999999999999 108.527 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.72 127.45 34.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.003 -1.061 . . . . 0.66000000000000003 108.539 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.1 tp -103.77 103.5 13.4 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 104.976 -2.231 . . . . 0.82999999999999996 104.976 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.1 tp -91.46 129.9 37.38 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.335 -1.357 . . . . 0.85999999999999999 107.335 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.07 119.88 39.39 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.443 -1.317 . . . . 0.92000000000000004 107.443 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -110.17 132.34 54.26 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.503 -1.295 . . . . 2.0299999999999998 107.503 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -128.96 155.24 45.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.336 -0.852 . . . . 2.6600000000000001 109.529 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -85.15 137.76 32.82 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.816 -1.179 . . . . 2.3199999999999998 107.816 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.2 149.71 49.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.033 -1.042 . . . . 2.1099999999999999 108.991 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -92.42 128.88 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.293 -1.003 . . . . 0.72999999999999998 108.293 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.75 130.42 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.941 -1.133 . . . . 0.87 107.941 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.9 mt -96.45 139.35 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.545 -0.909 . . . . 0.81000000000000005 108.545 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.25 120.6 32.3 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.298 -1.371 . . . . 1.3400000000000001 107.298 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -96.3 16.84 17.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.811 . . . . 2.8900000000000001 112.485 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -67.74 143.67 55.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.862 -1.149 . . . . 2.0899999999999999 108.88 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -88.87 132.28 34.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.134 -1.062 . . . . 2.1899999999999999 108.134 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.1 pt -98.97 167.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.399 -0.813 . . . . 0.75 110.342 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.9 p -93.1 162.44 14.03 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.641 0.734 . . . . 0.91000000000000003 109.766 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.87 -17.31 6.1 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.111 -0.993 . . . . 0.93000000000000005 112.722 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -69.89 -32.65 71.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.012 . . . . 2.2799999999999998 111.094 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -86.27 0.95 52.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.989 -1.069 . . . . 1.45 112.431 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 t -56.27 -44.6 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.466 -0.771 . . . . 0.81000000000000005 110.46 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -58.08 -40.77 81.9 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.205 -0.935 . . . . 1.54 110.327 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -64.14 -45.0 90.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.653 -0.655 . . . . 2.3599999999999999 111.604 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.7 -42.8 99.43 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.812 -1.18 . . . . 1.3100000000000001 111.068 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.27 -41.88 88.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.162 -0.961 . . . . 0.81999999999999995 110.228 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -63.13 -45.88 89.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.042 -1.036 . . . . 1.5 110.119 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.405 ' HG2' HH11 ' A' ' 42' ' ' ARG . 54.4 mtt-85 -61.92 -42.3 98.92 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.456 -0.897 . . . . 2.23 109.957 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -71.45 -52.86 16.15 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.4 -0.92 . . . . 0.84999999999999998 110.165 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.44 -49.28 78.21 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.241 -0.984 . . . . 0.91000000000000003 110.647 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.1 t -69.97 -45.1 68.09 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.552 0.692 . . . . 0.90000000000000002 110.346 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.98 -45.71 86.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.295 -1.522 . . . . 0.68999999999999995 109.295 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -57.37 -31.44 65.78 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.855 0.836 . . . . 2.8799999999999999 109.775 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.11 -42.57 86.02 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.542 0.687 . . . . 0.84999999999999998 110.097 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -75.82 -38.61 57.97 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.268 -0.895 . . . . 2.3500000000000001 110.067 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.76 -38.69 82.51 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.148 -0.97 . . . . 0.65000000000000002 109.946 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 t -61.02 -38.88 87.64 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.897 0.856 . . . . 1.45 109.422 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.64 -47.57 75.13 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.959 -0.564 . . . . 0.63 110.289 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.9 -49.76 74.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.878 -1.139 . . . . 1.3400000000000001 110.208 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.66 -39.32 90.96 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.258 -0.901 . . . . 1.5600000000000001 110.016 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -59.66 -41.26 90.21 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.218 -0.593 . . . . 1.1899999999999999 110.311 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.9 m -67.05 -44.21 80.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.225 -0.922 . . . . 0.71999999999999997 110.297 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -59.8 -34.82 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.652 -0.655 . . . . 0.62 110.873 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -51.57 -44.64 62.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.92 -1.112 . . . . 1.05 110.713 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -68.97 -34.63 75.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.042 -1.036 . . . . 0.64000000000000001 110.124 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -63.76 -39.74 95.01 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.812 -1.155 . . . . 1.73 109.241 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.83 -31.12 72.2 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.163 -0.615 . . . . 0.56000000000000005 109.88 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.1 -36.27 13.4 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.784 -1.198 . . . . 0.68999999999999995 110.81 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.31 -24.26 42.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.945 -1.327 . . . . 1.48 110.242 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.8 m -84.55 -51.14 7.1 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.339 -0.85 . . . . 0.97999999999999998 110.995 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -106.68 -19.93 13.51 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.102 -0.998 . . . . 1.1599999999999999 113.286 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.61 165.55 14.05 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 121.277 -0.889 . . . . 0.84999999999999998 112.211 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -53.74 -24.03 13.65 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 112.583 0.586 . . . . 3.8599999999999999 112.583 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.86 -36.74 70.4 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.017 -1.052 . . . . 2.3500000000000001 111.653 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -84.92 -15.35 44.77 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.301 -1.499 . . . . 1.6699999999999999 112.913 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.88 -35.62 77.1 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.047 -1.033 . . . . 1.45 110.811 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.51 -39.24 87.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.357 -0.839 . . . . 0.60999999999999999 111.222 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 72' ' ' ILE . 14.9 mt -66.6 -48.96 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.971 -1.081 . . . . 0.65000000000000002 110.564 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -69.91 -30.37 67.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.451 -0.781 . . . . 0.66000000000000003 110.411 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.86 -38.23 87.48 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.604 -0.839 . . . . 1.1899999999999999 109.823 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.21 -38.66 92.08 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 110.592 -1.003 . . . . 0.53000000000000003 110.592 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -60.13 -40.39 89.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 1.27 110.797 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.85 -44.74 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.93 -1.106 . . . . 0.54000000000000004 110.118 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.4 ttp -60.08 -38.16 82.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -0.891 . . . . 1.74 110.11 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 tp -60.31 -49.94 75.6 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.362 -0.836 . . . . 0.55000000000000004 110.686 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.38 -40.08 89.58 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.923 -0.711 . . . . 0.46999999999999997 110.333 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -86.21 5.47 34.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.373 -0.829 . . . . 1.4199999999999999 112.386 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.18 119.7 11.34 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.856 -1.152 . . . . 1.27 108.924 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.03 -15.65 63.22 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.645 0.736 . . . . 1.3500000000000001 110.977 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -71.68 -49.55 38.69 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.018 -1.073 . . . . 2.2200000000000002 110.037 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.84 -38.62 88.9 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.169 -1.012 . . . . 0.62 110.097 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.7 -46.18 89.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 1.29 110.777 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -60.05 -39.54 86.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.082 -1.011 . . . . 1.52 110.578 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -65.63 -47.9 74.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.954 -1.092 . . . . 1.3 110.19 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.2 mt -57.9 -43.06 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.558 -0.714 . . . . 0.60999999999999999 110.158 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.68 -40.89 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.162 0.506 . . . . 0.78000000000000003 110.547 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.72 -40.59 88.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.81999999999999995 110.387 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.52 -45.5 90.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.80000000000000004 110.097 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.0 mt -62.57 -43.42 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.365 -0.834 . . . . 0.77000000000000002 110.193 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -82.64 -38.4 23.57 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.37 -0.831 . . . . 2.1200000000000001 111.932 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 91' ' ' ALA . 49.4 t0 -80.83 -43.28 20.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.909 -1.119 . . . . 1.51 111.882 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.55 8.1 35.35 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.374 -0.829 . . . . 1.98 112.777 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.0 m170 52.46 51.43 16.18 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.868 -1.145 . . . . 1.3200000000000001 111.58 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.2 mtt -105.12 152.17 23.12 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.37 -0.831 . . . . 1.3799999999999999 109.265 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.4 p -71.3 161.68 30.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.374 -0.829 . . . . 0.67000000000000004 110.121 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.18 88.92 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.241 -0.912 . . . . 0.52000000000000002 110.254 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.557 ' OD2' HD21 ' A' ' 142' ' ' LEU . 89.8 m-20 -68.08 -41.1 82.39 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.212 -0.93 . . . . 2.25 110.34 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.66 -49.83 49.91 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.158 -0.964 . . . . 0.64000000000000001 111.21 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.38 92.22 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.383 -0.823 . . . . 0.56000000000000005 110.407 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.77 95.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.65 -0.656 . . . . 0.46000000000000002 110.894 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -61.49 -40.05 93.16 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.396 -0.815 . . . . 1.3200000000000001 110.835 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -57.84 -49.57 76.24 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.669 -1.27 . . . . 1.3 111.347 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.7 t -61.11 -44.82 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.95 -1.094 . . . . 0.60999999999999999 110.161 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 mm -62.78 -33.52 60.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.765 0.793 . . . . 0.65000000000000002 109.958 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -55.46 -40.89 72.18 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.519 -0.738 . . . . 2.1099999999999999 110.87 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.29 -32.49 16.59 Favored Glycine 0 N--CA 1.498 2.825 0 C-N-CA 118.98 -1.581 . . . . 0.82999999999999996 112.571 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -60.34 -41.59 93.92 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.302 -1.705 . . . . 1.28 110.204 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.92 -51.62 17.82 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.328 -0.857 . . . . 0.89000000000000001 110.966 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.8 p -62.41 -39.4 93.13 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.265 -0.897 . . . . 1.8700000000000001 110.709 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.72 96.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.404 -0.81 . . . . 1.05 110.913 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 43.8 mt -65.29 -30.89 71.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.891 -1.131 . . . . 1.02 110.5 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.14 -22.33 66.37 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.928 -1.108 . . . . 2.04 111.205 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -71.34 -12.47 61.45 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.765 0.793 . . . . 1.73 110.956 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.85 146.06 27.5 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.874 -0.787 . . . . 1.3700000000000001 108.874 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -100.3 35.36 2.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.15 -0.969 . . . . 2.8799999999999999 112.112 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -112.58 139.59 48.04 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 108.269 -1.011 . . . . 1.5800000000000001 108.269 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.01 -37.64 80.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.429 -0.794 . . . . 3.04 110.772 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -73.22 -49.0 30.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.794 -1.191 . . . . 0.90000000000000002 110.215 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.2 mt -63.2 -40.67 98.14 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.616 -1.234 . . . . 1.0600000000000001 109.738 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -60.96 -47.63 85.55 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.788 -1.195 . . . . 2.1800000000000002 110.097 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.27 -31.4 70.19 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.759 -0.777 . . . . 2.1499999999999999 109.556 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.512 ' HG2' HH11 ' A' ' 126' ' ' ARG . 9.2 ttt-85 -62.14 -29.67 70.5 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.008 0.908 . . . . 2.3300000000000001 108.975 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.63 -49.83 75.93 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.054 0.93 . . . . 0.81999999999999995 109.592 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -41.41 78.83 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.59 0.71 . . . . 0.84999999999999998 110.415 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.87 -38.49 91.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.559 -0.713 . . . . 1.3899999999999999 110.25 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 126' ' ' ARG . 46.4 t -69.6 -39.77 78.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.522 -0.736 . . . . 0.56000000000000005 110.648 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -58.68 -39.77 81.64 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.3 -1.36 . . . . 3.1200000000000001 110.029 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -59.67 -39.75 85.5 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.166 0.508 . . . . 1.28 110.823 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.99 -39.18 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.336 -0.852 . . . . 0.48999999999999999 110.625 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -64.71 -44.26 95.12 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.791 -1.195 . . . . 0.46000000000000002 110.909 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -58.14 -40.61 81.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.271 . . . . 2.71 110.575 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.401 HH21 ' HB2' ' A' ' 166' ' ' SER . 63.0 mtt-85 -61.36 -42.68 99.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.312 -0.867 . . . . 2.1400000000000001 110.111 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 31.3 tp -60.29 -43.33 96.35 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.439 -0.904 . . . . 1.05 109.506 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.25 -45.92 91.6 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.46 0.648 . . . . 0.52000000000000002 110.197 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -60.98 -34.86 75.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.461 -0.774 . . . . 2.3500000000000001 111.08 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -75.81 -41.73 51.92 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.074 -1.016 . . . . 1.3899999999999999 110.978 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.514 HG21 ' OD1' ' A' ' 101' ' ' ASP . 95.2 mt -62.46 -39.02 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.789 -1.194 . . . . 0.68000000000000005 110.594 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.557 HD21 ' OD2' ' A' ' 101' ' ' ASP . 61.5 mt -84.64 -8.95 58.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.339 -0.851 . . . . 0.82999999999999996 111.65 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.55 25.62 67.39 Favored Glycine 0 N--CA 1.479 1.557 0 C-N-CA 119.772 -1.204 . . . . 0.91000000000000003 113.237 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.74 142.04 58.57 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.727 -0.866 . . . . 0.94999999999999996 109.33 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -67.94 147.74 52.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 2.4300000000000002 108.907 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 72.9 mt -107.03 138.13 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.219 -1.03 . . . . 1.1000000000000001 108.219 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 18.2 mm -78.76 133.98 28.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.25 -0.906 . . . . 1.5800000000000001 108.862 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -94.51 94.74 8.39 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.657 -1.608 . . . . 1.6200000000000001 106.657 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 67.1 mt -73.53 -24.35 60.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.574 -0.704 . . . . 0.80000000000000004 110.865 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.9 m -81.48 7.17 12.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.406 -0.809 . . . . 1.5600000000000001 112.304 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.42 18.05 17.45 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.792 . . . . 0.83999999999999997 112.151 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.5 mt -74.73 140.23 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.81999999999999995 109.807 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -118.97 -12.34 9.56 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.946 0.879 . . . . 2.3100000000000001 112.427 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -112.7 147.74 36.18 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.728 -0.841 . . . . 1.54 108.728 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -78.27 124.13 27.73 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.188 -1.041 . . . . 1.3799999999999999 108.188 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.8 m -147.64 172.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.55 -0.719 . . . . 0.68999999999999995 109.3 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.6 mt -90.74 146.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.535 -0.913 . . . . 0.53000000000000003 108.535 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.2 tp -95.9 123.79 39.64 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.093 0.949 . . . . 0.64000000000000001 108.788 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.5 t -124.64 129.96 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.892 -1.151 . . . . 0.67000000000000004 107.892 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.99 152.87 19.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.006 -1.059 . . . . 0.78000000000000003 108.835 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.92 -33.76 73.64 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.561 -1.337 . . . . 1.0 109.476 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -171.8 144.74 1.83 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.301 -0.629 . . . . 2.4199999999999999 109.301 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 75.8 mt -118.39 135.94 54.04 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.057 -1.09 . . . . 0.75 108.057 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.0 p -92.9 150.09 38.81 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.931 -1.105 . . . . 0.78000000000000003 108.529 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -39.18 -45.37 2.87 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 122.252 1.968 . . . . 0.67000000000000004 113.781 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.401 ' HB2' HH21 ' A' ' 136' ' ' ARG . 61.2 m -58.46 -47.56 83.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.69999999999999996 110.409 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.18 -38.4 90.9 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.076 -1.015 . . . . 1.21 110.515 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.3 p -69.3 -39.64 78.17 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.545 -0.722 . . . . 0.59999999999999998 110.5 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.83 -37.58 79.63 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.262 -0.575 . . . . 0.62 110.66 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -91.42 -0.16 57.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.05 -1.031 . . . . 1.1599999999999999 112.271 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.6 tp -63.88 150.33 45.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.751 -0.593 . . . . 0.72999999999999998 109.787 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -95.16 113.79 25.52 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.22 -1.4 . . . . 2.2400000000000002 107.22 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 36.7 mt -71.79 -17.96 62.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.696 -0.627 . . . . 1.4299999999999999 111.778 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.91 -21.31 31.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 2.1499999999999999 112.381 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -101.32 -4.99 26.03 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.907 -1.12 . . . . 2.04 113.436 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.7 t -114.2 128.91 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 107.533 -1.284 . . . . 0.55000000000000004 107.533 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.2 tp -93.69 -4.89 49.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.507 -0.745 . . . . 1.6299999999999999 112.609 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.41 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -175.49 170.04 42.95 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.021 -1.632 . . . . 0.46999999999999997 109.021 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -128.11 128.88 45.68 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.484 -1.302 . . . . 0.54000000000000004 107.484 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 79.3 mt -131.68 125.13 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 106.413 -1.699 . . . . 0.68999999999999995 106.413 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 205' ' ' THR . 20.6 p -140.63 172.05 13.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.86 -1.15 . . . . 0.81999999999999995 110.213 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -98.1 39.33 1.24 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.378 0.608 . . . . 2.3700000000000001 111.497 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.033 0 O-C-N 121.192 -0.942 . . . . 1.1100000000000001 109.676 179.596 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 83.6 p . . . . . 0 N--CA 1.492 1.675 0 N-CA-C 107.739 -1.208 . . . . 1.6899999999999999 107.739 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -60.46 -31.43 70.44 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.07 -1.019 . . . . 1.0700000000000001 110.608 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.3 p -57.21 -40.61 77.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 1.5800000000000001 110.391 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.6 t -60.18 -37.25 79.62 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.123 -0.986 . . . . 1.6000000000000001 109.948 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.4 mt -59.51 -40.13 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.287 -0.965 . . . . 1.45 110.497 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 38.5 mtp -64.56 -44.83 89.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.932 -1.105 . . . . 1.05 109.244 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.17 -44.7 94.83 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.554 -0.748 . . . . 0.71999999999999997 111.212 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -61.23 -45.07 96.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.778 -1.202 . . . . 3.0499999999999998 110.664 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.8 m -69.87 -38.98 76.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.036 -1.04 . . . . 0.89000000000000001 110.766 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -91.75 -8.15 47.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.554 -0.716 . . . . 0.78000000000000003 112.66 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.8 mt-10 54.14 9.31 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.937 1.088 . . . . 1.45 113.937 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.3 mt -70.08 150.19 96.18 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.621 -0.881 . . . . 0.67000000000000004 108.621 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.8 144.06 94.27 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 121.146 1.231 . . . . 0.64000000000000001 109.491 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.79 159.78 35.53 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.175 -1.41 . . . . 0.67000000000000004 110.214 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.5 mt -147.46 150.2 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.071 -1.085 . . . . 0.68999999999999995 108.071 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.0 m -135.02 -25.72 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.932 -1.105 . . . . 0.84999999999999998 111.724 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.22 33.35 2.23 Favored Glycine 0 N--CA 1.488 2.151 0 O-C-N 121.022 -1.049 . . . . 0.92000000000000004 113.306 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 181' ' ' THR . 2.7 p -60.63 -28.31 68.46 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.95 -1.323 . . . . 0.94999999999999996 111.037 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.04 -90.67 1.3 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.96 -1.114 . . . . 1.04 110.621 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 27.8 m -123.5 27.13 7.55 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.147 -1.208 . . . . 1.5700000000000001 112.984 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 68.2 t -57.41 -34.47 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.172 -1.58 . . . . 0.83999999999999997 110.144 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.2 p -57.61 -23.46 51.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 0.98999999999999999 111.964 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.2 p -92.88 2.77 56.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.968 -1.082 . . . . 1.7 111.928 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -128.32 1.88 5.71 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.808 0.67 . . . . 2.2000000000000002 112.808 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.75 151.26 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 109.112 -0.699 . . . . 0.83999999999999997 109.112 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -120.97 150.13 41.58 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.857 -0.794 . . . . 2.2000000000000002 108.857 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 42.1 p-10 -52.16 143.59 14.06 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.008 -1.077 . . . . 2.2799999999999998 110.278 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.4 m-20 78.3 -1.17 2.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.525 1.305 . . . . 2.3500000000000001 114.525 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.53 144.03 52.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.861 -1.149 . . . . 1.97 108.307 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -89.31 112.96 24.16 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.331 -1.359 . . . . 2.6499999999999999 107.331 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.493 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 48.7 mt -124.22 143.44 50.52 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.322 0.582 . . . . 0.63 109.645 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.3 mt -109.81 126.76 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 106.58 -1.637 . . . . 0.62 106.58 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 52.3 tp -100.64 119.4 38.51 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.118 -1.808 . . . . 0.64000000000000001 106.118 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 223' ' ' VAL . 36.9 p-10 -93.67 -20.93 19.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.081 -1.012 . . . . 2.0499999999999998 112.682 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.935 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.73 13.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.477 0.547 . . . . 0.83999999999999997 112.477 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.624 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.1 t -109.89 -58.75 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.273 -0.892 . . . . 1.02 109.521 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -91.63 8.33 37.27 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.541 1.163 . . . . 2.5099999999999998 110.852 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.0 t30 60.87 49.31 6.09 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.108 -0.951 . . . . 1.54 111.786 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -148.45 154.58 40.06 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.226 1.012 . . . . 1.95 109.746 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.4 t -116.45 141.04 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.576 -0.738 . . . . 0.70999999999999996 109.181 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -101.16 134.94 43.43 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.327 -0.99 . . . . 1.01 108.327 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.28 130.77 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.614 -0.884 . . . . 0.81999999999999995 108.614 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 51.23 58.31 16.6 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.31 -0.869 . . . . 1.54 112.867 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.93 150.19 60.65 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.387 2.058 . . . . 0.93999999999999995 110.626 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.7 p -76.23 158.59 31.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.105 -0.997 . . . . 1.8 109.608 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -60.79 -39.35 88.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 2.73 110.993 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.39 -41.47 80.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.067 -1.021 . . . . 3.1699999999999999 110.696 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.05 -39.31 77.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.806 -1.184 . . . . 1.3400000000000001 110.075 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 71.0 mt -60.03 -49.45 83.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.387 -0.821 . . . . 1.2 110.883 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.92 -41.53 91.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.097 -1.002 . . . . 2.7000000000000002 110.543 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -64.41 -44.35 91.52 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.717 -0.793 . . . . 2.5899999999999999 110.285 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 84.6 mtp -72.4 -37.05 68.78 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.301 -0.874 . . . . 1.3799999999999999 110.743 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.9 mmm-85 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 120.827 -1.17 . . . . 2.8399999999999999 110.472 179.817 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 79.2 mt . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 107.219 -1.4 . . . . 1.0700000000000001 107.219 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 m -106.01 119.91 40.41 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.202 -1.407 . . . . 1.24 107.202 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.46 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -102.97 -153.85 24.45 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.414 -1.874 . . . . 1.01 108.414 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.9 mt -97.64 0.98 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -1.168 . . . . 1.1100000000000001 112.38 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 49.89 93.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.985 -1.072 . . . . 0.98999999999999999 111.985 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -89.38 -30.93 18.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.84999999999999998 111.663 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -150.8 138.25 12.0 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.216 -0.927 . . . . 1.3799999999999999 108.54 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.18 145.0 21.38 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.341 2.027 . . . . 0.93999999999999995 112.533 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.911 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.42 177.92 25.69 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 109.084 -1.606 . . . . 0.81000000000000005 109.084 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.5 mt -132.0 138.66 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.058 -1.26 . . . . 0.82999999999999996 108.238 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HB1' ' CD2' ' A' ' 177' ' ' LEU . . . -140.37 155.5 46.74 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.233 -0.917 . . . . 0.53000000000000003 109.09 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.537 ' CD2' ' NH1' ' A' ' 240' ' ' ARG . 25.4 m-85 -129.08 141.26 51.26 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.521 -0.918 . . . . 0.77000000000000002 108.521 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.81 168.42 34.78 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 118.27 -1.919 . . . . 0.51000000000000001 110.198 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -77.01 160.3 29.23 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.901 . . . . 1.8999999999999999 109.846 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.84 121.49 26.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.691 -1.225 . . . . 0.66000000000000003 107.691 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.401 HD12 HD21 ' A' ' 214' ' ' ASN . 31.4 tp -100.14 98.51 9.21 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.069 -1.826 . . . . 0.82999999999999996 106.069 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 tp -90.74 134.71 34.22 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.662 -1.236 . . . . 0.85999999999999999 107.662 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.0 mt -99.77 111.1 23.45 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.752 -1.573 . . . . 0.92000000000000004 106.752 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -104.31 127.54 51.97 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.989 -1.486 . . . . 2.0299999999999998 106.989 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.474 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 81.6 tt0 -129.41 144.21 51.15 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.941 -0.762 . . . . 2.6600000000000001 108.941 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -80.89 136.01 36.0 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.823 -1.177 . . . . 2.3199999999999998 107.823 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -65.81 149.83 49.54 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.516 -0.74 . . . . 2.1099999999999999 109.264 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -92.21 130.87 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.843 -1.169 . . . . 0.72999999999999998 107.843 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.65 129.81 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.153 -1.055 . . . . 0.87 108.153 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.2 mt -95.53 139.74 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.424 -0.798 . . . . 0.81000000000000005 108.927 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -87.58 123.62 32.65 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.125 -1.065 . . . . 1.3400000000000001 108.125 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -94.74 14.67 20.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.656 -0.652 . . . . 2.8900000000000001 112.38 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -77.55 140.58 39.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.281 -0.887 . . . . 2.0899999999999999 109.275 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -84.69 140.27 31.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.103 -0.998 . . . . 2.1899999999999999 109.744 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -95.75 175.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.75 109.776 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -98.09 164.33 12.38 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.887 -0.597 . . . . 0.91000000000000003 109.544 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.14 -23.41 21.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.268 -0.895 . . . . 0.93000000000000005 112.029 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -68.88 -40.05 79.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.812 -1.18 . . . . 2.2799999999999998 110.946 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -86.39 -6.2 58.99 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.289 -1.507 . . . . 1.45 112.189 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.19 -41.81 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.968 -1.083 . . . . 0.81000000000000005 110.456 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -58.24 -39.42 79.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.003 -1.061 . . . . 1.54 110.936 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.2 -39.87 95.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.02 . . . . 2.3599999999999999 110.967 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -58.96 -40.33 84.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.875 . . . . 1.3100000000000001 110.724 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.25 -41.71 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.81999999999999995 110.127 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.57 -44.58 93.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 1.5 109.58 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -62.43 -40.45 96.61 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.401 -0.92 . . . . 2.23 109.925 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.39 -52.84 12.37 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.801 0.81 . . . . 0.84999999999999998 109.871 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.07 -48.84 80.06 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.255 -0.903 . . . . 0.91000000000000003 109.96 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.2 t -68.21 -41.05 81.88 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.659 0.743 . . . . 0.90000000000000002 109.831 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.95 -42.08 85.82 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.34 -1.504 . . . . 0.68999999999999995 109.34 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.404 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 51.7 ttt180 -58.38 -32.77 68.91 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.689 0.756 . . . . 2.8799999999999999 109.772 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.61 -50.21 72.66 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.375 0.607 . . . . 0.84999999999999998 110.819 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -78.05 -38.64 43.99 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.306 -0.872 . . . . 2.3500000000000001 110.44 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.16 87.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.395 -0.816 . . . . 0.65000000000000002 110.209 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.5 m -60.45 -40.14 90.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.869 0.843 . . . . 1.45 109.497 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.41 78.1 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.15 -0.62 . . . . 0.63 110.072 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.16 -50.58 72.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 1.3400000000000001 110.577 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.83 -39.17 93.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.019 . . . . 1.5600000000000001 110.105 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -59.86 -40.93 90.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.807 -0.558 . . . . 1.1899999999999999 110.958 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.8 m -64.27 -45.31 88.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.822 -1.174 . . . . 0.71999999999999997 110.356 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.12 -34.64 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 0.62 110.984 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -52.97 -45.76 67.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.26 -0.9 . . . . 1.05 111.084 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.14 -37.71 81.36 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.148 -0.97 . . . . 0.64000000000000001 110.182 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -61.35 -39.81 91.95 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.577 -1.249 . . . . 1.73 109.617 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.98 -32.3 73.45 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.625 -0.672 . . . . 0.56000000000000005 110.558 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.04 -34.58 14.43 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.832 -1.175 . . . . 0.68999999999999995 111.405 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -81.85 -25.75 34.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.567 -1.549 . . . . 1.48 111.373 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.4 m -86.69 -49.99 7.1 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.408 -0.807 . . . . 0.97999999999999998 111.125 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.9 -5.25 19.83 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 113.909 1.078 . . . . 1.1599999999999999 113.909 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.83 161.47 27.75 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.401 -0.904 . . . . 0.84999999999999998 112.733 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -55.79 -18.88 9.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -1.065 . . . . 3.8599999999999999 112.82 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -59.07 -40.66 85.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -0.973 . . . . 2.3500000000000001 110.518 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -85.9 -23.9 26.83 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.213 -0.929 . . . . 1.6699999999999999 111.465 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.65 -35.44 76.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.638 -0.664 . . . . 1.45 111.356 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.02 83.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.388 -0.82 . . . . 0.60999999999999999 111.334 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.5 mt -62.02 -40.91 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.65000000000000002 110.324 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -71.04 -30.29 66.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.302 -0.874 . . . . 0.66000000000000003 110.546 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -60.91 -39.07 87.96 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.187 -0.945 . . . . 1.1899999999999999 109.732 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.98 -39.58 93.25 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 110.098 -1.201 . . . . 0.53000000000000003 110.098 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -59.82 -45.0 93.74 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.433 -1.04 . . . . 1.27 110.355 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.61 -40.91 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 0.54000000000000004 110.401 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 26.3 ttt -60.14 -39.4 86.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.325 -0.859 . . . . 1.74 110.384 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.5 tp -57.84 -48.25 80.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.151 -0.968 . . . . 0.55000000000000004 110.221 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.98 -41.76 92.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.239 -0.913 . . . . 0.46999999999999997 110.413 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -88.13 10.4 19.44 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 112.899 0.703 . . . . 1.4199999999999999 112.899 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.63 126.32 27.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.891 -1.131 . . . . 1.27 108.818 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.22 -18.72 65.35 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.871 0.843 . . . . 1.3500000000000001 110.639 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -74.45 -54.99 6.48 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.491 0.662 . . . . 2.2200000000000002 110.178 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.9 mt -61.1 -37.49 82.95 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.663 -0.648 . . . . 0.62 111.058 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.404 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 30.5 tt0 -60.05 -45.18 93.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 1.29 110.559 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.97 -38.46 91.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 1.52 110.685 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -68.26 -47.87 66.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.035 -1.041 . . . . 1.3 110.922 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.11 -42.48 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.093 -1.004 . . . . 0.60999999999999999 110.04 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.4 mt -63.51 -43.0 98.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.485 -0.76 . . . . 0.78000000000000003 110.505 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.29 -42.83 99.69 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.3 -0.875 . . . . 0.81999999999999995 110.928 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.62 -45.63 93.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.974 -1.079 . . . . 0.80000000000000004 110.544 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.8 mt -61.88 -43.65 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.041 -1.037 . . . . 0.77000000000000002 110.339 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -84.75 -31.26 24.09 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.277 -0.89 . . . . 2.1200000000000001 111.724 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 91' ' ' ALA . 60.6 t0 -82.47 -45.57 14.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.64 -1.287 . . . . 1.51 111.527 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -100.76 4.82 43.33 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.227 -0.92 . . . . 1.98 112.617 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 53.2 50.64 17.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 1.3200000000000001 111.466 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.33 159.02 15.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.385 -0.822 . . . . 1.3799999999999999 109.207 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.2 p -71.5 161.02 31.69 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.772 -0.58 . . . . 0.67000000000000004 109.832 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.28 -45.04 92.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.033 -1.042 . . . . 0.52000000000000002 110.56 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.591 ' OD2' HD21 ' A' ' 142' ' ' LEU . 91.2 m-20 -68.12 -37.04 80.67 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.226 -0.922 . . . . 2.25 110.121 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.54 -51.71 40.0 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.757 -0.777 . . . . 0.64000000000000001 111.429 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.63 94.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.117 -0.989 . . . . 0.56000000000000005 110.408 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.31 95.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.653 -0.654 . . . . 0.46000000000000002 110.793 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -61.69 -37.87 85.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.124 -0.985 . . . . 1.3200000000000001 111.496 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -59.23 -49.59 77.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.883 -1.136 . . . . 1.3 111.077 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.68 -45.72 97.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.437 -1.414 . . . . 0.60999999999999999 110.214 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.1 mm -61.12 -34.76 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.638 -0.664 . . . . 0.65000000000000002 110.403 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -58.44 -39.16 79.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.095 -1.003 . . . . 2.1099999999999999 111.226 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.69 -41.3 7.8 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.947 -1.597 . . . . 0.82999999999999996 112.853 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -60.57 -41.07 93.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.599 -1.53 . . . . 1.28 109.891 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.43 -52.65 20.75 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.399 0.619 . . . . 0.89000000000000001 110.559 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.0 p -62.53 -36.44 82.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.462 -0.774 . . . . 1.8700000000000001 110.453 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.3 97.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 1.05 110.722 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.19 -30.11 70.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.938 . . . . 1.02 110.855 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.58 -21.75 65.41 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.011 -1.056 . . . . 2.04 110.989 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -71.37 -14.3 62.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 1.73 111.462 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.401 HD13 HD13 ' A' ' 123' ' ' LEU . 16.2 mt -86.85 146.4 26.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.434 -0.791 . . . . 1.3700000000000001 109.574 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -99.2 36.08 1.79 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.233 -0.917 . . . . 2.8799999999999999 112.285 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -113.09 139.6 48.57 Favored 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 108.437 -0.949 . . . . 1.5800000000000001 108.437 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -60.23 -38.46 83.47 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.329 -0.857 . . . . 3.04 110.89 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -70.23 -53.33 17.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.684 -1.26 . . . . 0.90000000000000002 109.909 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.401 HD13 HD13 ' A' ' 118' ' ' LEU . 36.1 mt -62.79 -40.31 96.94 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 109.627 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.64 -50.49 66.88 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.828 0.823 . . . . 2.1800000000000002 109.918 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.78 -29.11 70.46 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.753 -1.217 . . . . 2.1499999999999999 109.921 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -61.66 -31.4 71.51 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.368 -0.933 . . . . 2.3300000000000001 109.111 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.15 78.86 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.643 0.735 . . . . 0.81999999999999995 109.815 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.61 -43.65 79.94 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.416 -0.914 . . . . 0.84999999999999998 109.958 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -60.97 -38.6 86.52 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.485 0.659 . . . . 1.3899999999999999 110.829 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.5 -39.07 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.574 -0.704 . . . . 0.56000000000000005 110.262 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.417 ' NH1' ' HG3' ' A' ' 131' ' ' ARG . 40.4 ttm-85 -59.04 -40.07 83.91 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.143 -0.973 . . . . 3.1200000000000001 109.856 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -60.21 -38.75 84.29 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.356 0.598 . . . . 1.28 110.405 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.67 -39.76 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.254 -0.904 . . . . 0.48999999999999999 110.444 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.86 -47.36 67.04 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.424 -1.07 . . . . 0.46000000000000002 110.424 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -58.24 -42.1 85.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.21 -1.171 . . . . 2.71 110.078 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HG2' HH11 ' A' ' 136' ' ' ARG . 60.1 mtt-85 -61.67 -43.23 99.26 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.14 -1.024 . . . . 2.1400000000000001 110.372 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.31 -43.02 96.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.371 -0.831 . . . . 1.05 109.843 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -41.53 91.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.78 -0.575 . . . . 0.52000000000000002 110.833 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.474 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 99.5 mtt180 -60.08 -35.58 75.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 2.3500000000000001 111.329 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -73.56 -41.32 63.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.025 -1.047 . . . . 1.3899999999999999 110.645 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.3 mt -60.4 -39.26 80.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.092 -1.005 . . . . 0.68000000000000005 110.228 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.591 HD21 ' OD2' ' A' ' 101' ' ' ASP . 87.9 mt -88.6 -8.54 54.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.474 -0.766 . . . . 0.82999999999999996 112.039 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.34 25.32 70.93 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 120.363 -0.923 . . . . 0.91000000000000003 113.59 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.5 tp -70.13 148.62 48.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.634 -0.921 . . . . 0.94999999999999996 109.956 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -65.46 151.72 45.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.483 -0.761 . . . . 2.4300000000000002 110.803 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.8 mt -103.32 140.6 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.125 -1.065 . . . . 1.1000000000000001 108.125 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.6 mm -82.37 120.36 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.817 -1.177 . . . . 1.5800000000000001 108.138 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -99.36 95.89 7.35 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.165 -1.791 . . . . 1.6200000000000001 106.165 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.82 -18.38 61.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.504 -0.748 . . . . 0.80000000000000004 112.053 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.0 m -81.72 8.74 9.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 1.5600000000000001 112.208 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.04 24.63 9.09 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.239 -0.913 . . . . 0.83999999999999997 111.655 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.1 mt -74.35 147.24 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.371 -0.83 . . . . 0.81999999999999995 110.146 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -115.26 -20.12 10.49 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.58 -0.7 . . . . 2.3100000000000001 112.596 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -119.55 139.92 51.36 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.812 -1.181 . . . . 1.54 107.812 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.71 128.57 36.52 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.602 -0.888 . . . . 1.3799999999999999 108.602 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -146.28 178.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.477 -0.764 . . . . 0.68999999999999995 109.426 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.417 HG21 HD12 ' A' ' 180' ' ' ILE . 81.3 mt -91.42 144.75 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.504 -0.925 . . . . 0.53000000000000003 108.504 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.71 123.65 39.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.889 -1.132 . . . . 0.64000000000000001 108.366 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.74 130.09 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.156 -1.053 . . . . 0.67000000000000004 108.156 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.34 154.77 21.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.099 -1.001 . . . . 0.78000000000000003 108.93 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.7 -31.2 70.48 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.653 -1.28 . . . . 1.0 109.626 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 29.0 p-10 -173.35 150.8 1.91 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.708 -0.849 . . . . 2.4199999999999999 108.708 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.3 mt -119.39 138.78 52.86 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.332 -0.988 . . . . 0.75 108.332 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.0 p -95.61 152.61 39.29 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 108.507 -0.923 . . . . 0.78000000000000003 108.507 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -43.68 -39.57 10.23 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.367 1.378 . . . . 0.67000000000000004 113.367 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.0 m -59.85 -48.88 79.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.923 -1.111 . . . . 0.69999999999999996 110.042 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.99 -40.33 97.43 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.338 -0.851 . . . . 1.21 109.961 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 31.5 p -68.17 -40.0 82.41 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.857 -0.737 . . . . 0.59999999999999998 110.055 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.36 78.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.581 -0.7 . . . . 0.62 110.779 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -97.03 -1.43 45.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.207 -0.933 . . . . 1.1599999999999999 112.881 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.82 150.39 41.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.476 -0.765 . . . . 0.72999999999999998 109.571 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -96.03 111.04 23.17 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.773 -1.566 . . . . 2.2400000000000002 106.773 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 31.9 mt -74.57 -15.19 60.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.636 -0.665 . . . . 1.4299999999999999 111.486 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -81.32 -25.58 36.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 2.1499999999999999 111.832 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -102.72 -1.96 29.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.27 -0.894 . . . . 2.04 113.325 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.05 127.26 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 107.394 -1.335 . . . . 0.55000000000000004 107.394 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.429 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 45.1 tp -88.58 -10.84 47.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.104 -0.998 . . . . 1.6299999999999999 112.244 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.96 174.32 46.72 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.049 -1.621 . . . . 0.46999999999999997 109.049 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -130.02 131.19 45.76 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.506 -1.294 . . . . 0.54000000000000004 107.506 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.535 ' CG2' HG21 ' A' ' 205' ' ' THR . 84.6 mt -131.32 129.79 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.156 -1.424 . . . . 0.68999999999999995 107.156 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 203' ' ' VAL . 82.7 p -140.57 170.55 15.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.886 -1.133 . . . . 0.81999999999999995 109.702 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.447 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 1.4 m-20 -105.04 44.72 1.01 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.817 -0.552 . . . . 2.3700000000000001 110.777 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.05 0 O-C-N 121.086 -1.009 . . . . 1.1100000000000001 109.637 179.317 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 107.296 -1.372 . . . . 1.6899999999999999 107.296 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -59.55 -34.39 72.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.475 -0.765 . . . . 1.0700000000000001 110.107 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 191' ' ' SER . 15.2 t -59.67 -39.44 84.48 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.537 -0.727 . . . . 1.5800000000000001 110.603 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.478 ' N ' HG23 ' A' ' 190' ' ' THR . 22.8 t -57.24 -39.99 76.67 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.16 -0.962 . . . . 1.6000000000000001 110.072 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.3 -39.62 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.44 -0.787 . . . . 1.45 109.937 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 45.5 mtp -66.27 -40.93 90.44 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.395 1.093 . . . . 1.05 109.414 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.73 -42.22 88.26 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.464 -0.789 . . . . 0.71999999999999997 110.709 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -60.84 -44.95 96.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.912 -1.118 . . . . 3.0499999999999998 110.317 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.8 m -70.21 -40.1 74.77 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.199 -0.938 . . . . 0.89000000000000001 110.225 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.4 mt -91.7 -6.92 51.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.529 -0.732 . . . . 0.78000000000000003 112.64 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.0 mt-10 52.54 13.45 0.32 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.749 1.018 . . . . 1.45 113.749 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.71 148.11 89.7 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.942 -1.132 . . . . 0.67000000000000004 107.942 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -54.35 140.5 73.18 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.905 1.737 . . . . 0.64000000000000001 109.985 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.84 160.5 36.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.249 -1.532 . . . . 0.67000000000000004 109.86 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.46 ' CD1' HD11 ' A' ' 220' ' ' LEU . 29.6 mt -148.65 151.49 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.676 -1.231 . . . . 0.68999999999999995 107.676 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.7 m -135.5 -27.58 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 120.956 -1.09 . . . . 0.84999999999999998 112.014 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.92 42.06 2.8 Favored Glycine 0 N--CA 1.492 2.41 0 O-C-N 121.081 -1.012 . . . . 0.92000000000000004 112.02 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.535 HG21 ' CG2' ' A' ' 180' ' ' ILE . 74.7 p -65.4 -13.11 57.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.899 -1.353 . . . . 0.94999999999999996 111.151 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.65 -95.88 1.38 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 110.565 -1.014 . . . . 1.04 110.565 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -129.08 30.96 4.96 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.659 -0.907 . . . . 1.5700000000000001 112.322 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.2 -36.33 45.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.571 -1.331 . . . . 0.83999999999999997 110.819 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.1 p -57.77 -24.58 57.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.792 -1.193 . . . . 0.98999999999999999 111.544 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 18.2 t -92.15 -2.05 56.8 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.797 0.808 . . . . 1.7 111.483 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -122.46 -5.29 8.77 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.561 0.949 . . . . 2.2000000000000002 113.561 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 34.8 t -120.05 149.07 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.357 -0.839 . . . . 0.83999999999999997 109.594 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.0 156.9 27.75 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.973 -1.121 . . . . 2.2000000000000002 107.973 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.506 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 22.2 t-20 -51.47 142.84 13.01 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.075 -1.016 . . . . 2.2799999999999998 110.216 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 83.35 -7.62 1.14 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.109 1.151 . . . . 2.3500000000000001 114.109 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -58.57 142.15 50.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.507 -1.37 . . . . 1.97 108.91 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -88.74 119.82 29.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.671 -1.268 . . . . 2.6499999999999999 108.072 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.69 148.85 47.76 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.465 0.65 . . . . 0.63 109.653 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.459 HG21 ' SD ' ' A' ' 239' ' ' MET . 82.6 mt -117.79 124.89 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.226 -1.768 . . . . 0.62 106.226 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.46 HD11 ' CD1' ' A' ' 202' ' ' ILE . 53.6 tp -102.24 116.78 33.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.215 -1.772 . . . . 0.64000000000000001 106.215 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.3 p-10 -93.15 -22.12 19.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.934 -1.104 . . . . 2.0499999999999998 112.709 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.17 15.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 112.663 0.616 . . . . 0.83999999999999997 112.663 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.633 ' N ' ' O ' ' A' ' 221' ' ' ASP . 20.6 t -109.73 -59.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.112 -0.993 . . . . 1.02 109.86 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -93.79 9.91 35.22 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.27 1.033 . . . . 2.5099999999999998 110.891 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.46 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 61.33 53.1 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.983 -1.008 . . . . 1.54 112.304 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -148.84 148.54 30.02 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.811 -1.181 . . . . 1.95 110.084 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.97 139.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 108.136 -1.061 . . . . 0.70999999999999996 108.136 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -102.74 133.88 47.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.181 -0.95 . . . . 1.01 108.669 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 53.4 t -110.86 130.8 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.214 -1.032 . . . . 0.81999999999999995 108.214 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.503 HD22 ' C ' ' A' ' 230' ' ' ASN . 0.6 OUTLIER 55.63 47.9 3.53 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 113.384 0.883 . . . . 1.54 113.384 178.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 62.3 Cg_endo -69.82 153.12 69.04 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.559 2.172 . . . . 0.93999999999999995 110.901 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.6 m -74.19 159.38 32.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 1.8 108.866 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -59.47 -34.01 72.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.114 -0.991 . . . . 2.73 110.691 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -59.96 -41.05 91.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.407 -0.808 . . . . 3.1699999999999999 110.56 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.96 -39.97 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.288 -0.883 . . . . 1.3400000000000001 110.192 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.4 mt -60.0 -49.97 81.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.168 -0.957 . . . . 1.2 111.043 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -59.52 -40.66 87.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.98 . . . . 2.7000000000000002 110.644 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.71 -47.91 84.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.853 . . . . 2.5899999999999999 110.195 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . 0.459 ' SD ' HG21 ' A' ' 219' ' ' ILE . 66.1 mtp -70.63 -38.39 73.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 1.3799999999999999 110.871 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.537 ' NH1' ' CD2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.147 -0.97 . . . . 2.8399999999999999 110.245 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.3 mt . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 106.386 -1.709 . . . . 1.0700000000000001 106.386 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m -105.88 125.23 50.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.048 -1.093 . . . . 1.24 108.048 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.46 -154.96 17.46 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.333 -1.907 . . . . 1.01 108.333 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 5' ' ' ILE . 80.3 mt -95.78 1.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.309 -1.113 . . . . 1.1100000000000001 112.185 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 5' ' ' ILE . 3.8 tp 50.82 101.16 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.085 -1.01 . . . . 0.98999999999999999 112.357 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -84.38 -47.44 10.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.118 -0.989 . . . . 0.84999999999999998 111.11 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m -144.58 146.95 34.26 Favored Pre-proline 0 N--CA 1.501 2.093 0 N-CA-C 107.855 -1.165 . . . . 1.3799999999999999 107.855 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.49 147.71 32.52 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.575 2.183 . . . . 0.93999999999999995 112.088 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.922 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.08 163.34 11.97 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.343 -1.503 . . . . 0.81000000000000005 109.343 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.3 mt -125.37 130.53 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.159 -1.2 . . . . 0.82999999999999996 108.095 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.464 ' HB1' ' CD2' ' A' ' 177' ' ' LEU . . . -139.11 148.92 43.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.242 -0.911 . . . . 0.53000000000000003 109.016 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 5.8 m-85 -117.49 140.17 49.96 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 108.827 -0.805 . . . . 0.77000000000000002 108.827 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.77 167.27 35.64 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 118.004 -2.046 . . . . 0.51000000000000001 110.39 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -77.48 160.36 28.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.827 -0.808 . . . . 1.8999999999999999 109.669 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.41 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.46 126.46 34.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.835 -1.166 . . . . 0.66000000000000003 108.152 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.9 tp -104.6 98.93 8.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.081 -1.822 . . . . 0.82999999999999996 106.081 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 18' ' ' LEU . 17.0 tp -90.55 130.83 36.55 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.753 -1.203 . . . . 0.85999999999999999 107.753 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 158' ' ' LEU . 77.5 mt -101.77 117.06 34.09 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.861 -1.533 . . . . 0.92000000000000004 106.861 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -109.5 136.04 49.54 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.993 -1.484 . . . . 2.0299999999999998 106.993 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -119.69 149.18 42.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.083 -1.011 . . . . 2.6600000000000001 109.452 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -82.67 134.62 35.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.858 -1.164 . . . . 2.3199999999999998 107.858 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.19 148.35 50.24 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.671 -0.863 . . . . 2.1099999999999999 108.671 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.87 130.3 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.282 -1.007 . . . . 0.72999999999999998 108.282 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -105.35 131.11 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.033 -1.099 . . . . 0.87 108.033 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 77.1 mt -97.86 135.55 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.526 -0.916 . . . . 0.81000000000000005 108.526 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -91.12 123.02 34.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.858 -1.164 . . . . 1.3400000000000001 107.858 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -95.06 13.04 26.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.223 -0.923 . . . . 2.8900000000000001 112.135 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -67.25 149.66 50.11 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.282 -0.886 . . . . 2.0899999999999999 109.244 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -86.43 140.0 30.39 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.179 -1.045 . . . . 2.1899999999999999 108.179 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -93.31 171.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.079 -1.013 . . . . 0.75 109.418 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.6 p -108.53 158.62 17.39 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.935 -0.765 . . . . 0.91000000000000003 108.935 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.82 -26.23 1.56 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.108 -0.995 . . . . 0.93000000000000005 112.672 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -69.84 -39.87 76.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.161 -0.962 . . . . 2.2799999999999998 110.167 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -86.47 -11.3 52.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.426 -0.796 . . . . 1.45 111.813 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.15 -47.19 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.438 -0.789 . . . . 0.81000000000000005 110.472 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.12 -40.08 84.3 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.098 -1.001 . . . . 1.54 110.687 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.46 -44.77 95.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.42 -0.8 . . . . 2.3599999999999999 110.999 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.05 -39.74 87.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.919 -1.113 . . . . 1.3100000000000001 111.02 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.04 -41.77 87.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.92 -1.112 . . . . 0.81999999999999995 110.656 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -61.93 -45.89 91.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.008 -1.057 . . . . 1.5 110.279 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -62.48 -39.67 94.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.308 -0.87 . . . . 2.23 110.165 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -76.22 -54.42 6.83 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.562 -0.711 . . . . 0.84999999999999998 110.315 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -58.32 -47.78 82.64 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.382 -0.927 . . . . 0.91000000000000003 109.772 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -68.39 -36.74 79.59 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.738 -0.785 . . . . 0.90000000000000002 109.891 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.68 -44.09 94.17 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.218 -1.468 . . . . 0.68999999999999995 109.57 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.4 ttt-85 -60.32 -29.48 68.89 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.194 -1.18 . . . . 2.8799999999999999 110.328 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.31 -50.24 73.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.84999999999999998 110.929 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -81.44 -36.07 29.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.909 -1.12 . . . . 2.3500000000000001 110.341 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.49 89.7 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.268 -0.895 . . . . 0.65000000000000002 109.683 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 87.4 p -60.77 -39.28 88.24 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.219 1.009 . . . . 1.45 109.055 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -45.3 75.64 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.711 -0.677 . . . . 0.63 110.595 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.29 -48.6 72.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.672 -1.268 . . . . 1.3400000000000001 110.658 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.05 -35.95 81.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.994 -1.066 . . . . 1.5600000000000001 109.888 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -60.06 -40.24 88.81 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.574 -0.704 . . . . 1.1899999999999999 110.256 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -62.11 -43.45 98.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.139 -0.976 . . . . 0.71999999999999997 110.457 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.1 mt -59.94 -35.21 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.438 -0.789 . . . . 0.62 110.726 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -52.64 -41.63 63.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.15 -0.969 . . . . 1.05 110.878 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.76 -36.92 76.19 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.996 -1.065 . . . . 0.64000000000000001 110.318 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -61.58 -36.81 81.72 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.926 -1.109 . . . . 1.73 109.552 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.12 79.01 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.618 -0.677 . . . . 0.56000000000000005 110.43 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.24 -36.21 13.22 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.637 -1.268 . . . . 0.68999999999999995 111.502 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.54 -22.66 43.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.668 -1.489 . . . . 1.48 110.736 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.2 m -90.42 -49.93 6.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.253 -0.904 . . . . 0.97999999999999998 111.52 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.27 -7.17 16.83 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 113.918 1.081 . . . . 1.1599999999999999 113.918 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.08 163.46 24.79 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.719 -0.753 . . . . 0.84999999999999998 112.349 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -54.17 -23.89 16.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.565 -0.962 . . . . 3.8599999999999999 112.779 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.3 -40.08 70.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.823 -1.173 . . . . 2.3500000000000001 110.993 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -86.02 -22.99 26.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.674 -1.266 . . . . 1.6699999999999999 111.488 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -60.56 -40.3 91.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 1.45 111.031 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.25 86.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.486 -0.759 . . . . 0.60999999999999999 111.443 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -65.82 -44.0 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.754 -1.216 . . . . 0.65000000000000002 110.921 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -69.95 -32.91 71.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.686 -1.259 . . . . 0.66000000000000003 110.22 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.2 -38.85 88.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -0.881 . . . . 1.1899999999999999 110.23 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.13 96.96 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.591 -0.814 . . . . 0.53000000000000003 111.097 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -58.11 -40.92 82.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.669 -1.489 . . . . 1.27 110.777 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.93 -40.05 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.118 -0.989 . . . . 0.54000000000000004 110.987 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.8 ttm -58.76 -40.28 83.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.983 -1.073 . . . . 1.74 110.377 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 tp -59.85 -48.6 81.05 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.185 -0.947 . . . . 0.55000000000000004 110.023 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.97 -39.8 86.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.207 -0.933 . . . . 0.46999999999999997 110.284 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -84.3 6.78 21.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.216 0.821 . . . . 1.4199999999999999 113.216 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -66.41 125.33 25.31 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.664 -1.273 . . . . 1.27 108.26 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.97 -16.54 64.1 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.263 -0.898 . . . . 1.3500000000000001 111.121 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -75.03 -50.29 16.98 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.674 -0.81 . . . . 2.2200000000000002 110.34 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.8 -36.76 84.21 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.739 -0.784 . . . . 0.62 110.392 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -59.93 -48.8 80.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.367 -0.833 . . . . 1.29 110.705 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -61.85 -38.42 88.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 1.52 110.546 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.23 -47.38 79.88 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.025 -1.047 . . . . 1.3 110.499 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.61 -45.03 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.34 -0.85 . . . . 0.60999999999999999 110.198 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.34 -40.12 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.683 0.754 . . . . 0.78000000000000003 110.465 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.43 98.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.152 -0.968 . . . . 0.81999999999999995 110.965 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.18 -39.16 85.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.015 -1.053 . . . . 0.80000000000000004 110.612 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.26 -51.52 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.77000000000000002 110.757 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -75.87 -35.31 59.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.756 . . . . 2.1200000000000001 111.446 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.43 -46.24 14.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 1.51 111.948 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -100.13 7.84 44.31 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.342 -0.849 . . . . 1.98 112.861 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.9 m80 49.9 48.61 21.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.74 -1.225 . . . . 1.3200000000000001 111.427 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.9 mtt -109.97 152.02 26.39 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.778 0.799 . . . . 1.3799999999999999 109.552 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.9 p -70.1 160.27 32.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.515 -0.741 . . . . 0.67000000000000004 110.018 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.18 92.98 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.46 -0.775 . . . . 0.52000000000000002 110.419 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD2' HD21 ' A' ' 142' ' ' LEU . 74.8 m-20 -65.86 -43.45 88.38 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.962 -1.086 . . . . 2.25 109.361 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.18 -49.31 51.64 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.921 -0.711 . . . . 0.64000000000000001 110.862 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.71 -44.47 93.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.56000000000000005 110.637 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.22 -41.07 87.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.46000000000000002 110.483 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.3 -38.28 90.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 1.3200000000000001 111.48 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.62 -49.76 76.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.387 -1.446 . . . . 1.3 111.29 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.68 -46.81 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.918 -1.114 . . . . 0.60999999999999999 110.112 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.8 mm -62.0 -29.43 46.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.921 0.867 . . . . 0.65000000000000002 110.681 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.51 -40.33 82.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.551 -0.718 . . . . 2.1099999999999999 110.996 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.55 -32.04 17.07 Favored Glycine 0 N--CA 1.501 3.004 0 C-N-CA 119.384 -1.389 . . . . 0.82999999999999996 112.535 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -63.03 -37.54 87.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.363 -1.669 . . . . 1.28 110.169 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.63 -51.21 15.08 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.533 -0.73 . . . . 0.89000000000000001 111.201 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.9 m -58.32 -38.73 77.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.388 -0.82 . . . . 1.8700000000000001 111.142 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.09 99.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.303 -0.873 . . . . 1.05 111.025 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.75 -28.81 69.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.967 . . . . 1.02 111.269 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -68.11 -22.27 64.9 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.209 -0.932 . . . . 2.04 111.055 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -73.08 -13.64 61.24 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.963 0.887 . . . . 1.73 111.029 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 123' ' ' LEU . 11.4 mt -91.18 140.53 29.72 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.503 -0.925 . . . . 1.3700000000000001 108.503 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -99.71 43.55 1.05 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.028 -1.045 . . . . 2.8799999999999999 112.082 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -112.87 140.51 47.6 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.134 -0.979 . . . . 1.5800000000000001 108.808 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.24 -40.47 77.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 3.04 111.008 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -73.22 -54.04 9.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.864 -1.148 . . . . 0.90000000000000002 110.95 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 118' ' ' LEU . 26.7 mt -59.81 -41.3 90.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.897 -1.127 . . . . 1.0600000000000001 110.475 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -63.65 -50.09 70.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.116 -0.99 . . . . 2.1800000000000002 109.951 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.44 -31.83 70.8 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.978 -1.076 . . . . 2.1499999999999999 109.292 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.536 ' HG2' HH11 ' A' ' 126' ' ' ARG . 11.3 ttt-85 -61.32 -29.32 69.81 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.59 -0.844 . . . . 2.3300000000000001 109.49 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.12 74.81 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.815 0.817 . . . . 0.81999999999999995 109.448 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.5 -45.72 78.66 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.101 -0.64 . . . . 0.84999999999999998 110.125 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -62.05 -33.93 75.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.543 -0.723 . . . . 1.3899999999999999 110.574 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.1 t -68.12 -41.91 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 0.56000000000000005 110.272 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 131' ' ' ARG . 28.1 ttt-85 -59.77 -39.49 85.04 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.006 -1.077 . . . . 3.1200000000000001 109.311 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.482 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 56.8 t0 -58.29 -36.22 72.98 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.734 -0.604 . . . . 1.28 109.896 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.2 mt -60.63 -39.35 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.158 -0.964 . . . . 0.48999999999999999 110.152 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.75 -44.85 30.21 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.253 -0.975 . . . . 0.46000000000000002 111.007 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -56.68 -45.27 81.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.316 -1.108 . . . . 2.71 110.401 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.482 ' NH2' ' OD2' ' A' ' 132' ' ' ASP . 42.1 mtt-85 -62.46 -40.76 97.67 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.096 -1.042 . . . . 2.1400000000000001 109.643 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -62.23 -43.21 99.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.703 -0.623 . . . . 1.05 110.057 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.23 -44.5 92.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.204 -0.935 . . . . 0.52000000000000002 110.317 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.1 mtp180 -60.02 -32.63 71.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 2.3500000000000001 110.723 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -74.09 -41.08 62.23 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.254 -0.903 . . . . 1.3899999999999999 110.704 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 98.5 mt -60.63 -37.52 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.42 -0.8 . . . . 0.68000000000000005 110.142 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.498 HD21 ' OD2' ' A' ' 101' ' ' ASP . 66.9 mt -87.06 -7.41 58.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.504 -0.748 . . . . 0.82999999999999996 112.169 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.1 19.4 78.46 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.808 -1.187 . . . . 0.91000000000000003 112.613 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.6 tp -61.33 143.29 55.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.94 -0.741 . . . . 0.94999999999999996 109.63 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -66.44 146.6 54.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 2.4300000000000002 108.966 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.55 142.24 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.214 -1.032 . . . . 1.1000000000000001 108.214 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.4 mm -75.73 129.93 36.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.04 -1.096 . . . . 1.5800000000000001 108.04 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.27 94.67 9.28 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.914 -1.513 . . . . 1.6200000000000001 106.914 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 54.5 mt -74.19 -23.68 59.25 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.73 0.776 . . . . 0.80000000000000004 110.515 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.5 m -82.88 6.96 16.69 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.882 0.848 . . . . 1.5600000000000001 112.019 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.73 23.08 9.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.627 -0.671 . . . . 0.83999999999999997 112.634 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.7 mt -73.68 138.49 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.32 -0.862 . . . . 0.81999999999999995 109.148 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -118.02 -18.44 9.43 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.778 0.799 . . . . 2.3100000000000001 112.725 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -115.36 140.72 48.87 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.432 -0.951 . . . . 1.54 108.432 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -70.98 120.83 17.12 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.041 -1.037 . . . . 1.3799999999999999 108.483 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.13 175.01 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.568 -0.707 . . . . 0.68999999999999995 109.305 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 mt -87.49 144.43 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.322 -0.861 . . . . 0.53000000000000003 108.935 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 19' ' ' LEU . 35.8 tp -97.66 126.97 43.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.996 -1.065 . . . . 0.64000000000000001 108.24 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.0 131.06 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.268 -1.012 . . . . 0.67000000000000004 108.268 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.04 147.59 11.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.058 -1.027 . . . . 0.78000000000000003 109.087 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.06 -32.18 71.82 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.544 -1.347 . . . . 1.0 109.741 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 50.6 p-10 -172.53 150.82 2.31 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.434 -0.95 . . . . 2.4199999999999999 108.434 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 46.4 mt -118.53 143.07 47.01 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.373 -0.829 . . . . 0.75 109.247 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.0 p -92.19 141.83 25.53 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.112 -0.992 . . . . 0.78000000000000003 108.673 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.57 -40.28 2.15 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 121.871 1.714 . . . . 0.67000000000000004 113.706 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.8 m -60.72 -49.99 75.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.1 -1.04 . . . . 0.69999999999999996 109.704 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.31 -39.91 94.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.504 -0.747 . . . . 1.21 110.168 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 34.5 p -66.87 -38.54 86.51 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.449 0.642 . . . . 0.59999999999999998 110.561 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.39 88.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.632 -0.668 . . . . 0.62 110.427 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -93.23 0.07 56.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.077 -1.015 . . . . 1.1599999999999999 112.694 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.46 148.06 43.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.979 -1.076 . . . . 0.72999999999999998 108.515 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -97.65 119.71 36.71 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.13 -1.434 . . . . 2.2400000000000002 107.13 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 45.5 mt -78.14 -12.34 59.99 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.929 -0.482 . . . . 1.4299999999999999 111.601 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -83.0 -23.75 33.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.974 -1.079 . . . . 2.1499999999999999 111.825 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -101.96 -4.95 25.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.232 -0.917 . . . . 2.04 113.092 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.23 125.95 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.76 -1.2 . . . . 0.55000000000000004 107.76 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.464 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 37.8 tp -90.96 -8.52 49.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.905 . . . . 1.6299999999999999 112.197 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 177.4 169.64 38.76 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.978 -1.649 . . . . 0.46999999999999997 108.978 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -127.82 133.86 49.42 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.005 -1.109 . . . . 0.54000000000000004 108.005 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 76.9 mt -132.09 109.62 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 106.133 -1.803 . . . . 0.68999999999999995 106.133 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 205' ' ' THR . 66.5 p -131.26 172.28 12.33 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.917 -1.114 . . . . 0.81999999999999995 110.347 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.402 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 26.9 t0 -101.53 61.7 0.92 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.563 -0.71 . . . . 2.3700000000000001 109.958 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.143 0 O-C-N 121.233 -0.917 . . . . 1.1100000000000001 108.809 -179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 108.041 -1.096 . . . . 1.6899999999999999 108.041 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -62.68 -37.86 88.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.303 -0.873 . . . . 1.0700000000000001 110.888 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 87.0 m -59.68 -40.12 86.75 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.405 -0.918 . . . . 1.5800000000000001 110.586 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.6 t -58.54 -39.73 81.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.231 -0.918 . . . . 1.6000000000000001 110.049 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.9 mm -60.04 -35.84 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 1.45 110.96 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 65.9 mtp -62.94 -41.2 99.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.02 -1.05 . . . . 1.05 109.951 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.17 -47.2 84.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.997 -0.547 . . . . 0.71999999999999997 110.588 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.495 ' HG2' HH11 ' A' ' 195' ' ' ARG . 29.0 mtt-85 -60.14 -42.16 94.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 3.0499999999999998 110.349 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.7 m -69.47 -41.59 75.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.017 -1.052 . . . . 0.89000000000000001 109.835 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.5 mt -91.0 -8.3 49.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.619 -0.675 . . . . 0.78000000000000003 112.094 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 48.62 14.54 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.739 1.015 . . . . 1.45 113.739 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.4 mt -74.1 149.18 87.14 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.053 -1.03 . . . . 0.67000000000000004 108.267 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.07 136.64 53.49 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 121.146 1.231 . . . . 0.64000000000000001 109.691 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -157.28 159.32 37.46 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 118.133 -1.427 . . . . 0.67000000000000004 110.148 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 77.0 mt -144.65 144.87 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.64 -1.245 . . . . 0.68999999999999995 107.64 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 181' ' ' THR . 6.6 m -124.54 -33.94 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 113.608 0.966 . . . . 0.84999999999999998 113.608 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.76 40.72 1.17 Allowed Glycine 0 N--CA 1.484 1.858 0 C-N-CA 120.308 -0.949 . . . . 0.92000000000000004 111.792 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 181' ' ' THR . 44.3 p -58.21 -22.54 52.33 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.186 -1.185 . . . . 0.94999999999999996 111.279 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.402 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 72.31 -89.82 0.52 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.505 -1.038 . . . . 1.04 110.505 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.9 t -129.43 28.47 5.2 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.604 -0.939 . . . . 1.5700000000000001 112.784 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.12 -37.42 61.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.665 -1.272 . . . . 0.83999999999999997 110.165 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 39.6 p -52.02 -26.25 10.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.98999999999999999 111.256 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.3 p -93.2 3.9 54.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 1.7 111.603 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -126.92 -3.62 6.44 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.924 0.713 . . . . 2.2000000000000002 112.924 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 22.7 t -120.59 149.42 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.682 0.753 . . . . 0.83999999999999997 109.185 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -124.96 156.97 37.2 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.476 -0.935 . . . . 2.2000000000000002 108.476 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 9.8 t-20 -56.48 141.13 43.75 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.83 -1.169 . . . . 2.2799999999999998 110.674 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.6 m-20 80.24 2.51 1.95 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.472 1.286 . . . . 2.3500000000000001 114.472 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.38 145.45 55.69 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.812 -1.18 . . . . 1.97 108.455 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -88.46 116.12 26.46 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.041 -1.466 . . . . 2.6499999999999999 107.041 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.41 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 88.6 mt -127.32 142.05 51.55 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.463 -0.773 . . . . 0.63 109.695 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.2 mt -109.65 128.34 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.99 -1.485 . . . . 0.62 106.99 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.8 tp -102.75 115.93 31.56 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.292 -1.744 . . . . 0.64000000000000001 106.292 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 223' ' ' VAL . 21.6 p-10 -94.38 -22.81 18.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.94 -1.1 . . . . 2.0499999999999998 112.599 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.23 17.85 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 112.859 0.689 . . . . 0.83999999999999997 112.859 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.3 t -108.92 -59.57 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.122 -0.986 . . . . 1.02 108.959 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.32 11.03 34.04 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.654 0.74 . . . . 2.5099999999999998 111.157 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 60.71 54.67 3.54 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.417 0.627 . . . . 1.54 112.063 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -150.2 149.52 30.32 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.091 0.948 . . . . 1.95 109.942 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.9 t -116.12 141.23 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 109.175 -0.676 . . . . 0.70999999999999996 109.175 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.43 130.61 49.26 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.855 -1.153 . . . . 1.01 108.264 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.5 t -109.81 129.35 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.217 -0.927 . . . . 0.81999999999999995 108.695 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.439 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 10.2 t-20 54.82 50.29 6.2 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 113.701 1.0 . . . . 1.54 113.701 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.0 Cg_endo -68.91 151.92 73.69 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.962 2.441 . . . . 0.93999999999999995 110.594 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.429 ' OG1' HG23 ' A' ' 235' ' ' VAL . 65.3 p -76.35 161.45 28.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.241 -0.912 . . . . 1.8 110.333 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -60.95 -38.08 84.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.792 -1.192 . . . . 2.73 110.191 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -60.4 -41.38 93.76 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.458 0.647 . . . . 3.1699999999999999 110.573 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.429 HG23 ' OG1' ' A' ' 232' ' ' THR . 97.7 t -69.82 -40.18 78.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.083 -1.011 . . . . 1.3400000000000001 110.241 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.02 -43.58 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 1.2 110.545 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -57.87 -41.52 82.63 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.181 -0.95 . . . . 2.7000000000000002 110.418 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.35 -42.33 98.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.547 -0.721 . . . . 2.5899999999999999 111.057 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.7 mtp -70.24 -42.53 72.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 1.3799999999999999 110.874 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.075 -1.016 . . . . 2.8399999999999999 109.593 -178.826 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.2 mt . . . . . 0 N--CA 1.499 1.982 0 N-CA-C 106.119 -1.808 . . . . 1.0700000000000001 106.119 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -105.9 120.97 43.1 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 107.665 -1.235 . . . . 1.24 107.665 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.4 -159.03 18.39 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.715 -1.754 . . . . 1.01 108.715 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 5' ' ' ILE . 83.5 mt -94.84 1.11 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -1.189 . . . . 1.1100000000000001 112.409 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tp 49.02 98.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.98999999999999999 112.012 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.98 -45.71 12.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.728 -1.233 . . . . 0.84999999999999998 111.577 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -145.89 145.21 24.24 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.796 -1.187 . . . . 1.3799999999999999 107.796 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.37 143.84 22.43 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.868 2.378 . . . . 0.93999999999999995 112.276 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.886 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.95 174.19 25.46 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 108.908 -1.677 . . . . 0.81000000000000005 108.908 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.2 mt -131.31 133.09 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.316 -1.108 . . . . 0.82999999999999996 108.054 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.62 155.2 48.53 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.503 -0.748 . . . . 0.53000000000000003 109.629 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.5 m-85 -125.56 140.36 52.81 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.732 -0.84 . . . . 0.77000000000000002 108.732 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.42 164.41 30.43 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 118.813 -1.66 . . . . 0.51000000000000001 109.626 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -75.05 159.1 32.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.579 -0.953 . . . . 1.8999999999999999 108.773 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -89.06 126.23 35.35 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.975 -1.12 . . . . 0.66000000000000003 107.975 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.9 tp -103.85 105.91 16.26 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.022 -2.214 . . . . 0.82999999999999996 105.022 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.5 tp -90.32 133.63 34.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 0.85999999999999999 108.188 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.6 mt -99.93 120.03 39.16 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.925 -1.509 . . . . 0.92000000000000004 106.925 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -109.86 142.33 41.32 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.717 -0.846 . . . . 2.0299999999999998 108.717 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -121.57 141.74 50.79 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.907 -1.12 . . . . 2.6600000000000001 109.225 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.25 137.28 34.9 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.87 -1.144 . . . . 2.3199999999999998 108.018 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -62.38 149.19 43.07 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.252 -0.648 . . . . 2.1099999999999999 109.252 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -93.84 131.91 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.359 -0.978 . . . . 0.72999999999999998 108.359 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t -106.04 130.35 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.297 -1.001 . . . . 0.87 108.297 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.3 mt -96.24 138.22 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.846 -0.798 . . . . 0.81000000000000005 108.846 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -90.1 122.86 33.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.206 -1.035 . . . . 1.3400000000000001 108.206 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.1 mmt-85 -95.35 14.47 22.34 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.283 -0.886 . . . . 2.8900000000000001 112.478 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -75.3 140.47 43.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.917 -1.114 . . . . 2.0899999999999999 109.198 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.55 136.35 32.98 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.875 -1.157 . . . . 2.1899999999999999 107.875 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 pt -94.93 168.84 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.885 . . . . 0.75 110.482 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.4 p -97.77 165.82 11.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.675 -0.641 . . . . 0.91000000000000003 109.845 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.03 -27.24 61.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.874 -1.141 . . . . 0.93000000000000005 111.579 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -68.17 -34.62 76.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.939 -1.1 . . . . 2.2799999999999998 110.453 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -90.13 -9.48 48.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.978 -1.076 . . . . 1.45 112.492 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.3 t -58.55 -42.14 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.856 -1.152 . . . . 0.81000000000000005 110.622 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.17 -38.25 79.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 1.54 110.926 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -63.17 -45.0 93.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.909 . . . . 2.3599999999999999 111.268 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.52 -37.05 82.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.547 -1.346 . . . . 1.3100000000000001 110.991 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.6 t -60.8 -40.17 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.074 -1.016 . . . . 0.81999999999999995 110.193 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.64 -39.63 92.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.948 -1.095 . . . . 1.5 110.096 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.71 -40.23 91.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.885 . . . . 2.23 109.893 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -74.03 -58.37 3.34 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.295 -0.878 . . . . 0.84999999999999998 109.703 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.0 -48.38 75.99 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.05 -1.06 . . . . 0.91000000000000003 110.204 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.8 t -70.65 -44.55 66.89 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.293 -0.963 . . . . 0.90000000000000002 110.153 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.09 -46.17 85.7 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.55 -1.31 . . . . 0.68999999999999995 110.035 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -57.91 -30.25 65.76 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.698 -0.883 . . . . 2.8799999999999999 109.595 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.52 -46.75 80.4 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.676 0.75 . . . . 0.84999999999999998 109.629 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.565 ' NZ ' ' NE2' ' A' ' 53' ' ' GLN . 25.4 ttpp -79.89 -40.65 27.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.467 -0.771 . . . . 2.3500000000000001 110.293 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.85 93.13 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.65000000000000002 110.056 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.8 m -60.13 -37.6 80.54 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.017 0.913 . . . . 1.45 109.334 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.37 -46.66 69.46 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.776 -0.647 . . . . 0.63 110.179 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.565 ' NE2' ' NZ ' ' A' ' 49' ' ' LYS . 45.5 mt-30 -61.4 -48.56 80.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.855 -1.153 . . . . 1.3400000000000001 110.13 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.09 -41.36 96.51 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.845 0.831 . . . . 1.5600000000000001 109.596 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -60.56 -41.22 94.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.468 0.652 . . . . 1.1899999999999999 109.855 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.1 m -64.35 -41.89 96.51 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.387 -0.821 . . . . 0.71999999999999997 110.429 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.02 -32.81 55.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.191 -0.943 . . . . 0.62 110.573 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -53.18 -46.56 69.02 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.329 -0.857 . . . . 1.05 110.733 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -68.74 -38.92 80.48 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.202 -0.937 . . . . 0.64000000000000001 109.48 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -62.9 -40.31 97.15 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.53 -1.268 . . . . 1.73 108.952 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.62 72.82 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.714 -0.794 . . . . 0.56000000000000005 109.234 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.09 -33.23 26.98 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.155 -1.178 . . . . 0.68999999999999995 110.155 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -82.1 -24.67 35.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.107 -1.231 . . . . 1.48 111.138 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.1 m -86.29 -46.74 10.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.506 -0.746 . . . . 0.97999999999999998 110.74 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -105.71 -19.04 13.88 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.373 -0.829 . . . . 1.1599999999999999 112.657 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.82 152.73 9.09 Favored Glycine 0 N--CA 1.504 3.225 0 O-C-N 121.247 -0.908 . . . . 0.84999999999999998 111.816 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -52.58 -21.77 4.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.48 -1.012 . . . . 3.8599999999999999 112.66 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.31 -32.63 71.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.193 -0.942 . . . . 2.3500000000000001 111.456 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -82.79 -13.73 55.72 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.655 -1.278 . . . . 1.6699999999999999 112.579 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.41 -32.49 71.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.046 -1.034 . . . . 1.45 111.209 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.56 96.16 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.025 -1.047 . . . . 0.60999999999999999 111.322 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.7 mt -65.45 -42.52 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.652 -1.28 . . . . 0.65000000000000002 110.638 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.6 -28.74 66.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.113 -0.992 . . . . 0.66000000000000003 110.554 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.35 -37.59 81.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.259 -0.901 . . . . 1.1899999999999999 110.403 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.83 -41.09 74.37 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.26 -0.971 . . . . 0.53000000000000003 110.899 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -58.63 -43.02 89.59 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.967 -1.313 . . . . 1.27 110.223 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -60.59 -39.97 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.19 -0.944 . . . . 0.54000000000000004 109.934 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.1 ttp -59.61 -39.56 84.61 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.055 -0.658 . . . . 1.74 110.585 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.33 -49.41 77.93 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.035 -1.041 . . . . 0.55000000000000004 110.837 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.0 -45.1 93.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 0.46999999999999997 110.423 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -85.93 14.13 6.53 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.01 -1.056 . . . . 1.4199999999999999 112.718 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -65.58 127.51 32.17 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.759 -1.213 . . . . 1.27 108.503 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -68.21 -17.18 64.25 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.235 1.017 . . . . 1.3500000000000001 110.704 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -75.24 -52.83 9.94 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.799 0.809 . . . . 2.2200000000000002 110.544 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.08 -37.85 84.15 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.794 -0.763 . . . . 0.62 110.225 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -59.21 -49.33 78.26 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.487 -0.758 . . . . 1.29 110.716 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -60.75 -38.7 86.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.422 -0.798 . . . . 1.52 110.781 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.85 -48.55 73.9 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.479 -0.888 . . . . 1.3 110.142 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.06 -45.57 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.411 -0.916 . . . . 0.60999999999999999 109.661 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.8 mt -60.7 -43.65 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.144 0.497 . . . . 0.78000000000000003 110.453 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.43 95.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.964 -1.085 . . . . 0.81999999999999995 111.058 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.65 -44.06 97.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.011 . . . . 0.80000000000000004 110.151 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.31 -48.94 86.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.276 -0.89 . . . . 0.77000000000000002 110.292 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -77.83 -33.41 52.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.373 -0.829 . . . . 2.1200000000000001 111.44 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -82.74 -47.48 11.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.663 -1.273 . . . . 1.51 112.386 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -102.55 10.72 38.63 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.362 -0.836 . . . . 1.98 112.456 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.8 m80 51.49 49.18 21.49 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.988 -1.07 . . . . 1.3200000000000001 111.303 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 59.0 mtt -104.57 150.79 24.33 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.387 -0.821 . . . . 1.3799999999999999 109.701 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.4 p -74.11 165.66 24.76 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.405 -0.809 . . . . 0.67000000000000004 109.988 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.81 -40.6 80.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.647 -0.658 . . . . 0.52000000000000002 110.711 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.536 ' OD1' HD22 ' A' ' 138' ' ' LEU . 59.8 t0 -68.1 -42.93 79.56 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.52 -0.738 . . . . 2.25 110.07 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -52.09 28.2 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.111 -0.635 . . . . 0.64000000000000001 111.225 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.16 -44.24 95.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.874 -1.141 . . . . 0.56000000000000005 110.905 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.56 88.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.724 -0.61 . . . . 0.46000000000000002 111.078 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -59.75 -37.26 78.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.614 -1.304 . . . . 1.3200000000000001 110.562 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -59.28 -48.28 82.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.922 -1.111 . . . . 1.3 110.636 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.4 t -60.89 -47.04 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.788 -1.195 . . . . 0.60999999999999999 110.875 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.17 -34.06 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.605 0.717 . . . . 0.65000000000000002 109.833 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -57.55 -42.56 83.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.761 . . . . 2.1099999999999999 110.803 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.09 -32.34 17.62 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.521 -1.323 . . . . 0.82999999999999996 112.735 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -62.07 -42.63 99.4 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.167 -1.784 . . . . 1.28 109.828 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.7 -53.31 16.16 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.749 0.785 . . . . 0.89000000000000001 110.771 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 64.7 m -60.95 -36.04 78.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.702 -0.624 . . . . 1.8700000000000001 110.659 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.55 -42.15 99.36 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.379 -0.826 . . . . 1.05 110.184 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.2 mt -65.3 -29.66 70.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.793 -1.192 . . . . 1.02 110.967 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.98 -20.01 66.27 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.322 -0.861 . . . . 2.04 110.76 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.74 -12.54 61.05 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.779 0.8 . . . . 1.73 110.82 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 24.7 mt -90.6 139.58 30.57 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.964 -1.124 . . . . 1.3700000000000001 107.964 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -101.83 43.71 1.05 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.46 -0.775 . . . . 2.8799999999999999 111.618 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -115.87 142.37 46.86 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.296 -0.878 . . . . 1.5800000000000001 109.069 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -56.81 -41.53 77.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 3.04 110.101 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -71.9 -55.13 8.06 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.911 -1.118 . . . . 0.90000000000000002 110.577 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.1 mt -60.13 -40.01 88.26 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.141 -0.974 . . . . 1.0600000000000001 110.63 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -63.09 -48.71 77.45 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.231 -0.918 . . . . 2.1800000000000002 109.812 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -60.63 -31.45 70.65 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.896 -0.722 . . . . 2.1499999999999999 109.922 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.567 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.5 ttt-85 -61.2 -30.5 70.46 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.275 1.036 . . . . 2.3300000000000001 108.769 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.08 -49.8 75.86 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.839 0.828 . . . . 0.81999999999999995 110.097 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.24 -44.29 79.81 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.737 0.779 . . . . 0.84999999999999998 110.281 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.6 -35.71 81.39 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.293 -0.88 . . . . 1.3899999999999999 110.803 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 126' ' ' ARG . 49.8 t -69.14 -38.74 78.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 120.975 -1.078 . . . . 0.56000000000000005 110.823 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.519 ' HG2' HH11 ' A' ' 131' ' ' ARG . 1.8 ttt-85 -55.31 -39.97 70.55 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.494 -1.282 . . . . 3.1200000000000001 109.53 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -61.32 -36.99 81.65 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.577 0.703 . . . . 1.28 110.088 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.51 -39.91 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.915 -1.116 . . . . 0.48999999999999999 109.941 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.03 -44.07 98.65 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.567 -1.301 . . . . 0.46000000000000002 109.899 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.36 -40.12 85.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.403 -1.057 . . . . 2.71 110.744 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 136' ' ' ARG . 53.3 mtt-85 -59.46 -43.11 93.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.118 -0.989 . . . . 2.1400000000000001 110.328 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.6 tp -65.4 -45.42 84.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.433 -0.792 . . . . 1.05 110.154 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.536 HD22 ' OD1' ' A' ' 101' ' ' ASP . 87.8 mt -63.23 -42.91 99.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.317 -0.864 . . . . 0.52000000000000002 110.419 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -59.68 -34.84 73.38 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.657 -0.652 . . . . 2.3500000000000001 110.688 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -74.97 -42.38 57.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 1.3899999999999999 110.832 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.99 -38.81 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.461 -0.774 . . . . 0.68000000000000005 110.337 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 43.8 mt -87.15 -6.09 58.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.998 -1.064 . . . . 0.82999999999999996 112.178 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.6 23.87 77.49 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 119.445 -1.36 . . . . 0.91000000000000003 113.057 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.83 150.35 33.07 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.864 -0.786 . . . . 0.94999999999999996 109.901 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -67.79 150.46 48.6 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.545 -0.862 . . . . 2.4300000000000002 110.043 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.5 mt -105.32 141.83 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.423 -0.798 . . . . 1.1000000000000001 109.083 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 17.8 mm -76.21 122.03 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 107.75 -1.204 . . . . 1.5800000000000001 107.75 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -92.98 94.6 8.99 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.481 -1.674 . . . . 1.6200000000000001 106.481 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.38 -28.17 59.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.594 -0.692 . . . . 0.80000000000000004 111.18 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 t -81.21 3.32 24.18 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.868 0.842 . . . . 1.5600000000000001 111.979 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.08 14.62 21.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.443 -0.786 . . . . 0.83999999999999997 112.755 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.4 mt -72.89 136.69 24.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.069 -1.02 . . . . 0.81999999999999995 108.715 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -117.27 -15.31 10.42 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.148 0.975 . . . . 2.3100000000000001 112.297 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -115.41 140.34 49.22 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.747 0.784 . . . . 1.54 109.092 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -70.62 119.53 14.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.461 -0.774 . . . . 1.3799999999999999 109.029 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.06 174.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.281 -0.887 . . . . 0.68999999999999995 109.174 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mt -89.25 145.55 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.53000000000000003 108.843 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.6 tp -98.1 121.55 40.16 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.062 -1.024 . . . . 0.64000000000000001 108.37 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.1 130.21 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 108.146 -1.057 . . . . 0.67000000000000004 108.146 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.98 157.92 27.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.808 -1.182 . . . . 0.78000000000000003 108.654 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.84 -36.88 82.49 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.386 -1.446 . . . . 1.0 109.829 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -172.96 149.7 1.92 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.404 -0.591 . . . . 2.4199999999999999 109.404 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.8 mt -117.64 141.24 48.6 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.405 -0.809 . . . . 0.75 109.009 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.6 p -94.03 151.23 39.54 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.741 -1.224 . . . . 0.78000000000000003 108.88 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -41.57 -46.22 6.17 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.251 1.968 . . . . 0.67000000000000004 113.838 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.0 m -58.88 -49.91 76.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.761 -1.212 . . . . 0.69999999999999996 110.45 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.26 -38.71 87.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.915 0.864 . . . . 1.21 110.225 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.2 p -70.0 -39.9 75.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.59999999999999998 110.416 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.84 74.32 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.712 -0.618 . . . . 0.62 110.656 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -93.09 -3.56 53.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 1.1599999999999999 112.767 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.0 tp -64.62 150.99 45.95 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.291 -0.633 . . . . 0.72999999999999998 109.291 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -93.95 112.43 24.27 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.636 -1.616 . . . . 2.2400000000000002 106.636 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.0 mt -70.3 -22.23 62.86 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.769 -0.582 . . . . 1.4299999999999999 111.704 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -83.35 -15.83 48.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.479 -0.763 . . . . 2.1499999999999999 112.919 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -102.79 -4.04 25.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.206 -0.934 . . . . 2.04 113.446 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 178' ' ' GLY . 64.3 t -111.14 129.93 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.197 -1.038 . . . . 0.55000000000000004 108.197 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.5 tp -83.99 -10.04 58.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.327 -0.858 . . . . 1.6299999999999999 112.263 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.508 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.5 166.98 35.59 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.796 -1.721 . . . . 0.46999999999999997 108.796 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -126.37 127.49 45.57 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.51 -1.293 . . . . 0.54000000000000004 107.51 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 61.0 mt -125.34 127.91 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 106.702 -1.592 . . . . 0.68999999999999995 106.702 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 203' ' ' VAL . 30.2 p -138.57 174.61 10.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.005 -1.06 . . . . 0.81999999999999995 109.704 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 52.8 t0 -106.32 34.71 3.24 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.375 0.607 . . . . 2.3700000000000001 110.712 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.222 0 N-CA-C 107.262 -1.384 . . . . 1.1100000000000001 107.262 178.302 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 108.834 -0.802 . . . . 1.6899999999999999 108.834 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -58.45 -38.08 76.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 1.0700000000000001 111.208 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.447 ' H ' HG23 ' A' ' 190' ' ' THR . 3.8 p -56.66 -43.28 80.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.31 -1.494 . . . . 1.5800000000000001 110.199 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.1 p -61.97 -36.17 80.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.3 -0.875 . . . . 1.6000000000000001 110.316 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.3 mt -61.46 -36.79 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.142 -0.974 . . . . 1.45 110.759 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 85.3 mtp -62.08 -46.94 86.89 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.653 1.216 . . . . 1.05 109.48 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.5 -51.77 67.26 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.016 -0.993 . . . . 0.71999999999999997 110.748 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -63.15 -44.88 94.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.277 -0.89 . . . . 3.0499999999999998 110.759 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.4 m -66.9 -38.13 85.68 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.768 -1.207 . . . . 0.89000000000000001 110.288 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 25.3 mt -91.45 -0.42 57.62 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.723 0.638 . . . . 0.78000000000000003 112.723 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 56.23 5.52 0.19 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 114.444 1.275 . . . . 1.45 114.444 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.6 mt -72.26 143.05 85.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.919 -1.113 . . . . 0.67000000000000004 108.396 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.56 137.07 75.39 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.298 1.332 . . . . 0.64000000000000001 110.292 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.29 169.39 20.72 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 117.762 -1.575 . . . . 0.67000000000000004 109.803 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.446 HD12 HD11 ' A' ' 220' ' ' LEU . 58.2 mt -145.72 156.85 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.808 -1.182 . . . . 0.68999999999999995 107.808 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 181' ' ' THR . 25.5 m -140.47 -29.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.268 -0.895 . . . . 0.84999999999999998 112.893 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.62 38.44 3.11 Favored Glycine 0 N--CA 1.486 2.025 0 O-C-N 121.293 -0.879 . . . . 0.92000000000000004 112.058 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.3 p -53.25 -26.55 18.46 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.506 -0.997 . . . . 0.94999999999999996 111.622 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 88.56 -88.98 1.56 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.82 -0.912 . . . . 1.04 110.82 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 39.7 t -128.45 30.43 5.16 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.189 -1.183 . . . . 1.5700000000000001 112.285 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 44.7 t -62.01 -38.45 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.435 -1.416 . . . . 0.83999999999999997 109.991 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.8 p -53.19 -21.37 5.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 0.98999999999999999 111.308 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.3 t -95.02 0.73 54.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.222 -0.924 . . . . 1.7 111.581 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -126.31 -6.36 6.51 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 113.345 0.869 . . . . 2.2000000000000002 113.345 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 10.2 t -117.31 145.59 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 122.014 0.911 . . . . 0.83999999999999997 109.434 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -118.94 155.07 31.97 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.026 -1.102 . . . . 2.2000000000000002 108.026 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 35.5 p-10 -54.58 140.69 34.12 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.844 -1.16 . . . . 2.2799999999999998 110.724 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 m-20 78.81 5.89 2.34 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.484 1.29 . . . . 2.3500000000000001 114.484 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.0 149.23 47.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.746 -1.221 . . . . 1.97 108.388 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -88.86 117.63 27.99 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.29 -1.374 . . . . 2.6499999999999999 107.29 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 16' ' ' ALA . 84.1 mt -128.58 149.62 50.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.763 0.792 . . . . 0.63 109.498 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.3 mt -115.12 129.86 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.77 -1.567 . . . . 0.62 106.77 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 202' ' ' ILE . 64.4 tp -101.02 117.06 34.28 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.41 -2.07 . . . . 0.64000000000000001 105.41 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.577 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.8 t0 -90.63 -24.36 20.53 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.078 -1.049 . . . . 2.0499999999999998 112.574 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.886 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.13 17.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 112.735 0.643 . . . . 0.83999999999999997 112.735 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' A' ' 221' ' ' ASP . 26.0 t -114.42 -64.59 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.959 0.885 . . . . 1.02 109.135 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -89.73 9.41 27.29 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.139 0.971 . . . . 2.5099999999999998 110.582 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 52.2 t30 60.34 49.81 6.68 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.67 0.748 . . . . 1.54 111.589 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -147.53 153.03 38.97 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.193 0.996 . . . . 1.95 109.669 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 76.5 t -118.43 140.03 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.507 -0.923 . . . . 0.70999999999999996 108.507 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.25 132.79 42.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.86 -1.15 . . . . 1.01 107.984 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 44.1 t -109.8 129.68 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 108.474 -0.936 . . . . 0.81999999999999995 108.474 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.408 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 58.5 t30 47.28 54.57 15.64 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 113.577 0.955 . . . . 1.54 113.577 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 40.5 Cg_endo -67.88 151.89 77.78 Favored 'Trans proline' 0 C--N 1.297 -2.177 0 C-N-CA 122.462 2.108 . . . . 0.93999999999999995 110.033 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.5 m -74.17 155.32 38.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.823 -0.806 . . . . 1.8 108.823 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -57.58 -39.52 76.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.151 -0.968 . . . . 2.73 110.468 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.45 -38.28 89.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.349 -0.845 . . . . 3.1699999999999999 110.208 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.44 -37.53 75.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.497 -0.752 . . . . 1.3400000000000001 110.523 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.26 -44.39 95.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.783 -0.767 . . . . 1.2 110.498 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -58.9 -39.4 81.35 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.482 -0.761 . . . . 2.7000000000000002 110.034 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -60.53 -40.45 91.55 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.46 -0.775 . . . . 2.5899999999999999 110.239 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 83.8 mtp -74.74 -41.51 60.0 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.016 -1.053 . . . . 1.3799999999999999 110.537 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 . . . . . 0 C--N 1.307 -1.264 0 C-N-CA 119.513 -0.875 . . . . 2.8399999999999999 109.689 -178.908 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.3 mt . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 106.737 -1.579 . . . . 1.0700000000000001 106.737 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.5 m -105.24 122.0 45.02 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.629 -1.249 . . . . 1.24 107.629 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.41 -157.4 13.37 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.643 -1.783 . . . . 1.01 108.643 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 5' ' ' ILE . 85.1 mt -92.69 -1.46 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.327 -1.102 . . . . 1.1100000000000001 112.552 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 tp 49.83 102.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.98999999999999999 112.227 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.14 -44.44 11.5 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.138 -0.976 . . . . 0.84999999999999998 111.589 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 m -144.32 143.81 23.43 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 107.971 -1.122 . . . . 1.3799999999999999 107.971 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.78 143.01 23.21 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.996 2.464 . . . . 0.93999999999999995 112.344 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.942 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.67 168.09 16.28 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 109.236 -1.546 . . . . 0.81000000000000005 109.236 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.8 mt -124.35 137.51 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.034 -1.274 . . . . 0.82999999999999996 107.845 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.17 148.36 43.08 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.323 -0.861 . . . . 0.53000000000000003 109.081 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.3 m-85 -118.0 139.87 50.56 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 108.378 -0.971 . . . . 0.77000000000000002 108.378 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.2 167.77 35.45 Favored Glycine 0 N--CA 1.499 2.862 0 C-N-CA 118.806 -1.664 . . . . 0.51000000000000001 110.05 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HZ3' HG12 ' A' ' 156' ' ' VAL . 28.1 mtmm -78.84 159.83 27.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -1.126 . . . . 1.8999999999999999 109.494 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.93 126.69 34.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.705 -1.247 . . . . 0.66000000000000003 107.994 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.8 tp -103.53 105.25 15.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.569 -2.011 . . . . 0.82999999999999996 105.569 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.1 tp -92.14 134.47 34.82 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.866 -1.161 . . . . 0.85999999999999999 107.866 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.1 mt -102.21 116.45 32.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.081 -1.452 . . . . 0.92000000000000004 107.081 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -109.46 131.54 54.97 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.537 -1.282 . . . . 2.0299999999999998 107.537 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -126.89 152.64 46.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.381 -0.824 . . . . 2.6600000000000001 109.664 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -83.47 134.41 34.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.131 -1.063 . . . . 2.3199999999999998 108.131 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.87 148.84 50.62 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.752 -0.833 . . . . 2.1099999999999999 108.752 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.69 132.28 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.306 -0.998 . . . . 0.72999999999999998 108.306 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.6 t -108.76 129.94 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.857 -1.164 . . . . 0.87 107.857 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.3 133.4 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.391 -0.966 . . . . 0.81000000000000005 108.391 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -93.24 128.97 39.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.096 -1.002 . . . . 1.3400000000000001 108.325 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -97.31 18.95 14.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.277 -0.889 . . . . 2.8900000000000001 112.004 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -71.19 149.01 46.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 2.0899999999999999 109.783 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -92.37 138.05 31.85 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.413 -0.958 . . . . 2.1899999999999999 108.413 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 pt -97.44 168.41 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.77 . . . . 0.75 109.932 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.4 p -97.71 167.32 11.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.688 -0.632 . . . . 0.91000000000000003 109.939 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.77 -24.72 58.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.005 -1.059 . . . . 0.93000000000000005 111.858 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -68.72 -37.97 79.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 2.2799999999999998 110.905 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -84.98 -7.26 59.22 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.72 -1.237 . . . . 1.45 112.354 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -58.59 -45.01 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.114 -0.991 . . . . 0.81000000000000005 110.137 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -57.95 -39.78 78.91 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.967 -1.083 . . . . 1.54 110.588 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -63.08 -45.42 92.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.162 -0.961 . . . . 2.3599999999999999 111.037 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -59.88 -40.33 88.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.928 -1.108 . . . . 1.3100000000000001 110.777 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.1 t -59.93 -41.24 85.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.22 -0.925 . . . . 0.81999999999999995 110.689 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -60.1 -47.23 86.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.917 -1.114 . . . . 1.5 110.078 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -61.36 -40.9 96.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.774 -0.771 . . . . 2.23 110.247 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -75.29 -56.12 5.03 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.572 -0.705 . . . . 0.84999999999999998 110.307 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 tp -58.01 -45.62 86.57 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.548 -0.861 . . . . 0.91000000000000003 110.375 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 9.2 t -66.36 -37.08 84.5 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.159 -0.963 . . . . 0.90000000000000002 109.749 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.66 -41.77 93.9 Favored Glycine 0 N--CA 1.483 1.819 0 C-N-CA 119.582 -1.294 . . . . 0.68999999999999995 109.937 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 46.0 ttt-85 -59.81 -29.77 68.47 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.172 -1.193 . . . . 2.8799999999999999 109.924 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -62.35 -49.16 76.67 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.607 0.718 . . . . 0.84999999999999998 110.493 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -38.79 23.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.954 -1.092 . . . . 2.3500000000000001 110.684 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.38 93.31 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.105 -0.997 . . . . 0.65000000000000002 110.074 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.7 p -63.55 -40.8 97.95 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.046 -1.034 . . . . 1.45 109.439 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.59 -48.5 66.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.537 -0.465 . . . . 0.63 110.477 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.77 -49.17 76.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.925 -1.109 . . . . 1.3400000000000001 110.724 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.15 -39.13 88.94 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.858 -1.151 . . . . 1.5600000000000001 109.971 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -59.84 -41.0 90.44 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.216 -0.594 . . . . 1.1899999999999999 110.319 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.509 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 18.7 m -68.49 -45.12 73.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.142 -0.974 . . . . 0.71999999999999997 110.246 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.8 mt -58.34 -33.95 48.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.338 -0.851 . . . . 0.62 110.815 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -53.07 -42.82 66.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.178 -0.952 . . . . 1.05 110.844 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.58 -36.34 76.17 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.021 -1.049 . . . . 0.64000000000000001 110.051 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.509 ' NZ ' HG22 ' A' ' 56' ' ' THR . 62.4 mttp -62.67 -39.62 94.5 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.75 -1.18 . . . . 1.73 109.447 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.13 -33.97 77.28 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.75 -0.78 . . . . 0.56000000000000005 109.983 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.15 -36.72 17.18 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.878 -1.153 . . . . 0.68999999999999995 111.132 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -81.65 -25.41 35.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.06 -1.259 . . . . 1.48 111.189 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.8 m -86.48 -48.33 8.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.557 -0.714 . . . . 0.97999999999999998 111.042 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -107.94 -9.33 15.71 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.031 1.123 . . . . 1.1599999999999999 114.031 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.71 166.45 23.45 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.423 -0.894 . . . . 0.84999999999999998 112.749 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.1 -28.15 50.39 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.702 -0.881 . . . . 3.8599999999999999 112.409 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -54.44 -40.19 68.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.94 -1.1 . . . . 2.3500000000000001 110.73 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -85.24 -25.99 26.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.902 -1.124 . . . . 1.6699999999999999 111.926 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.37 -39.9 84.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.469 -0.769 . . . . 1.45 110.631 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.64 90.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.852 . . . . 0.60999999999999999 110.89 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.94 -45.68 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.009 -1.057 . . . . 0.65000000000000002 110.315 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -71.31 -31.0 66.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.66000000000000003 110.441 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.31 -40.12 89.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.012 -1.055 . . . . 1.1899999999999999 109.68 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.7 -38.85 93.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.208 -1.157 . . . . 0.53000000000000003 110.208 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -58.28 -42.07 85.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.227 -1.161 . . . . 1.27 110.489 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.37 -39.34 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.54000000000000004 110.195 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.3 ttp -59.04 -39.36 81.77 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.178 -0.951 . . . . 1.74 110.491 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.39 -51.39 70.03 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.195 -1.002 . . . . 0.55000000000000004 110.796 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.76 -38.15 90.03 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.376 -0.827 . . . . 0.46999999999999997 109.994 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -84.67 4.72 31.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.287 0.847 . . . . 1.4199999999999999 113.287 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -66.75 123.48 20.24 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.576 -1.328 . . . . 1.27 108.169 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -65.71 -20.19 66.19 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.778 0.799 . . . . 1.3500000000000001 110.811 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -75.24 -49.46 19.26 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.426 -0.909 . . . . 2.2200000000000002 110.737 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.2 -40.04 95.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.056 -1.027 . . . . 0.62 110.629 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -60.45 -48.22 82.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.002 -1.061 . . . . 1.29 110.602 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.33 -39.97 92.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.385 -0.822 . . . . 1.52 110.771 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -63.73 -46.5 85.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.022 -1.071 . . . . 1.3 110.256 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.5 mt -58.36 -43.66 86.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.23 -0.919 . . . . 0.60999999999999999 110.067 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.485 HG22 ' NZ ' ' A' ' 94' ' ' LYS . 66.6 mt -63.24 -44.07 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.467 -0.771 . . . . 0.78000000000000003 110.61 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.53 -41.28 97.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.81999999999999995 111.146 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.11 -44.85 96.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.054 -1.028 . . . . 0.80000000000000004 110.736 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.02 -45.1 99.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.16 -0.963 . . . . 0.77000000000000002 110.305 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.485 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 22.7 mtmm -83.2 -37.57 23.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 2.1200000000000001 111.665 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -79.16 -45.33 20.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.821 -1.174 . . . . 1.51 111.453 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -101.55 8.02 42.07 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.187 -0.945 . . . . 1.98 112.272 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 51.85 49.77 20.04 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.329 -0.857 . . . . 1.3200000000000001 112.097 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.8 mtp -106.78 156.8 18.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.264 -0.897 . . . . 1.3799999999999999 108.838 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.8 p -72.71 161.18 31.08 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.474 -0.766 . . . . 0.67000000000000004 110.361 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.62 93.65 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.459 -0.776 . . . . 0.52000000000000002 110.531 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.46 ' OD1' HG21 ' A' ' 141' ' ' ILE . 97.3 m-20 -68.64 -39.46 80.71 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.069 -1.019 . . . . 2.25 110.392 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.89 -52.34 25.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.186 -1.005 . . . . 0.64000000000000001 110.84 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.07 92.44 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.1 -1.0 . . . . 0.56000000000000005 110.519 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.46 96.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.339 -0.851 . . . . 0.46000000000000002 110.565 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -60.64 -38.86 86.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.166 -0.959 . . . . 1.3200000000000001 110.738 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -54.95 -49.5 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 1.3 111.158 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.21 -47.28 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.844 -1.16 . . . . 0.60999999999999999 109.987 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -61.93 -32.35 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.352 0.596 . . . . 0.65000000000000002 110.568 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -58.51 -40.76 83.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -0.877 . . . . 2.1099999999999999 111.189 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.41 -37.15 8.31 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.064 -1.541 . . . . 0.82999999999999996 112.888 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -60.3 -38.89 85.06 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.586 -1.538 . . . . 1.28 110.095 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.61 -51.78 15.66 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.54 0.686 . . . . 0.89000000000000001 110.89 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.6 p -63.49 -35.77 81.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 1.8700000000000001 110.606 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.44 96.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.795 . . . . 1.05 110.629 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 80.1 mt -65.79 -29.99 70.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.053 -1.03 . . . . 1.02 110.655 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -67.16 -22.57 65.75 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.353 -0.842 . . . . 2.04 110.933 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -70.32 -16.12 62.96 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.593 -0.843 . . . . 1.73 111.131 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 123' ' ' LEU . 21.8 mt -84.66 144.38 28.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.579 -0.7 . . . . 1.3700000000000001 109.949 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -97.74 37.36 1.4 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.479 -0.763 . . . . 2.8799999999999999 111.987 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -113.56 139.22 49.18 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 108.377 -0.972 . . . . 1.5800000000000001 108.377 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -59.96 -40.64 89.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.484 -0.76 . . . . 3.04 110.775 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.34 -50.9 34.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.788 -1.195 . . . . 0.90000000000000002 110.177 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 118' ' ' LEU . 35.2 mt -63.23 -42.5 99.25 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.85 -1.14 . . . . 1.0600000000000001 110.022 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -63.35 -49.01 75.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.787 -1.196 . . . . 2.1800000000000002 109.266 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -59.94 -31.07 69.51 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.606 -0.838 . . . . 2.1499999999999999 109.386 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.56 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 17.7 ttt-85 -61.93 -30.44 70.9 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.992 0.901 . . . . 2.3300000000000001 108.82 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -60.86 -49.37 77.74 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.718 0.771 . . . . 0.81999999999999995 109.366 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.22 85.59 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.581 -0.848 . . . . 0.84999999999999998 110.258 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -63.32 -37.41 87.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.552 -0.717 . . . . 1.3899999999999999 110.417 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.56 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 39.9 t -69.18 -39.7 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 0.56000000000000005 109.936 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -58.58 -36.55 74.15 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.016 -1.052 . . . . 3.1200000000000001 109.734 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -59.92 -39.74 86.48 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.455 0.645 . . . . 1.28 110.052 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.1 mt -61.97 -39.55 84.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.438 -0.789 . . . . 0.48999999999999999 109.509 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.97 -46.8 50.18 Favored Glycine 0 N--CA 1.483 1.773 0 C-N-CA 119.766 -1.207 . . . . 0.46000000000000002 110.517 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.74 -49.99 71.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -1.155 . . . . 2.71 110.289 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -62.64 -39.25 93.27 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.21 -0.996 . . . . 2.1400000000000001 109.87 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.33 -39.96 88.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.559 -0.713 . . . . 1.05 110.02 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.47 -44.32 93.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.519 -0.738 . . . . 0.52000000000000002 110.081 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -60.51 -35.4 75.86 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.102 -0.999 . . . . 2.3500000000000001 110.26 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -73.06 -40.21 65.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 1.3899999999999999 110.7 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.46 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.7 mt -60.28 -40.01 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 0.68000000000000005 109.942 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.459 HD21 ' OD2' ' A' ' 101' ' ' ASP . 91.0 mt -91.01 -3.45 57.23 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.209 -0.932 . . . . 0.82999999999999996 112.416 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.47 23.23 77.72 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.808 -1.187 . . . . 0.91000000000000003 113.13 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.9 tp -66.16 149.26 50.58 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.744 -0.856 . . . . 0.94999999999999996 109.284 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -64.64 144.91 56.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 2.4300000000000002 109.433 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 53.8 mt -105.46 143.12 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.436 -0.949 . . . . 1.1000000000000001 108.436 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.587 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.2 mp -77.8 125.03 37.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.09 -1.078 . . . . 1.5800000000000001 108.09 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -95.89 93.16 6.88 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.585 -1.635 . . . . 1.6200000000000001 106.585 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.9 mt -78.81 -16.53 57.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 0.80000000000000004 111.981 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.5 m -80.66 0.76 32.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.338 -0.851 . . . . 1.5600000000000001 112.572 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.03 19.75 14.58 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.24 -0.913 . . . . 0.83999999999999997 112.459 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.0 mt -74.86 136.72 24.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.515 0.674 . . . . 0.81999999999999995 109.3 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -125.17 -2.78 7.58 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.448 0.642 . . . . 2.3100000000000001 112.51 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -116.86 134.28 54.96 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.248 -1.019 . . . . 1.54 108.248 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.72 119.1 15.4 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.075 -0.713 . . . . 1.3799999999999999 109.075 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.477 HG12 ' HZ3' ' A' ' 15' ' ' LYS . 27.8 m -147.38 172.27 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.518 -0.739 . . . . 0.68999999999999995 109.286 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.1 mt -87.33 142.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 0.53000000000000003 109.093 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 25.6 tp -96.46 123.76 40.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.077 -1.014 . . . . 0.64000000000000001 108.432 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.68 129.74 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 107.594 -1.261 . . . . 0.67000000000000004 107.594 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.14 152.53 19.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.033 -1.042 . . . . 0.78000000000000003 108.95 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.68 -35.46 76.31 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.585 -1.322 . . . . 1.0 109.424 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 64.2 t0 -172.54 147.26 1.83 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.268 -0.641 . . . . 2.4199999999999999 109.268 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.502 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 82.3 mt -116.23 141.61 47.92 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.179 -0.675 . . . . 0.75 109.179 177.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.5 p -94.08 150.25 38.15 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.159 -0.963 . . . . 0.78000000000000003 109.152 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -42.02 -44.3 7.23 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.007 1.805 . . . . 0.67000000000000004 113.719 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.8 m -59.94 -48.25 82.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.883 -1.136 . . . . 0.69999999999999996 110.055 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.95 -40.69 95.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.225 -0.99 . . . . 1.21 110.126 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 70.7 p -70.22 -39.01 75.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.59999999999999998 110.401 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.04 -34.35 74.72 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.896 -0.722 . . . . 0.62 110.881 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -95.7 1.37 53.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.074 -1.017 . . . . 1.1599999999999999 112.521 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.51 152.02 31.3 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.384 -0.822 . . . . 0.72999999999999998 109.778 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.454 HD22 ' H ' ' A' ' 175' ' ' LYS . 0.4 OUTLIER -93.65 110.91 22.51 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.057 -1.831 . . . . 2.2400000000000002 106.057 177.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.1 mt -72.26 -21.15 61.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.638 -0.664 . . . . 1.4299999999999999 112.318 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.412 ' HB2' HD21 ' A' ' 172' ' ' ASN . 88.6 mttt -82.53 -23.57 34.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.929 -1.107 . . . . 2.1499999999999999 112.386 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.454 ' H ' HD22 ' A' ' 172' ' ' ASN . 44.2 mmtm -97.15 -4.98 38.24 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.035 -1.041 . . . . 2.04 113.094 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.2 t -108.34 128.78 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.566 -1.272 . . . . 0.55000000000000004 107.566 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.1 tp -88.5 -12.05 44.06 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.403 -0.811 . . . . 1.6299999999999999 112.241 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 179.26 167.72 37.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.639 -1.785 . . . . 0.46999999999999997 108.639 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -128.01 131.48 49.2 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.255 -1.144 . . . . 0.54000000000000004 108.458 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.448 ' CG2' HG21 ' A' ' 205' ' ' THR . 76.8 mt -127.12 129.91 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.172 -1.418 . . . . 0.68999999999999995 107.172 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 203' ' ' VAL . 37.8 p -138.96 169.95 16.86 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.593 -1.317 . . . . 0.81999999999999995 110.066 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.438 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 4.3 m-20 -101.07 35.5 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.875 -0.515 . . . . 2.3700000000000001 111.53 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.888 0 O-C-N 120.922 -1.112 . . . . 1.1100000000000001 108.325 178.59 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.598 0.713 . . . . 1.6899999999999999 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -57.6 -39.66 77.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -0.875 . . . . 1.0700000000000001 111.088 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 44.1 p -59.74 -41.4 90.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.068 -1.02 . . . . 1.5800000000000001 110.498 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 59.9 p -61.15 -35.49 77.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 1.6000000000000001 110.367 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.03 -39.59 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 1.45 110.852 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 66.0 mtp -62.89 -40.78 98.59 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.233 1.016 . . . . 1.05 109.409 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.44 -48.95 79.67 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.739 -0.664 . . . . 0.71999999999999997 110.297 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.428 ' HG2' HH11 ' A' ' 195' ' ' ARG . 38.7 mtt-85 -61.16 -41.57 97.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.238 -0.914 . . . . 3.0499999999999998 110.938 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m -70.3 -40.57 74.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.963 -1.086 . . . . 0.89000000000000001 110.539 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.57 -9.1 48.34 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.043 0.757 . . . . 0.78000000000000003 113.043 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.5 mt-10 55.63 8.35 0.32 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.794 1.035 . . . . 1.45 113.794 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 56.8 mt -72.56 147.98 90.0 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 0.67000000000000004 108.267 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.76 136.3 72.89 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 120.982 1.121 . . . . 0.64000000000000001 110.027 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.31 164.63 34.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.398 -1.439 . . . . 0.67000000000000004 109.429 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 203' ' ' VAL . 99.1 mt -144.1 160.19 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.335 -1.357 . . . . 0.68999999999999995 107.335 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.497 ' N ' HG22 ' A' ' 202' ' ' ILE . 15.7 m -139.09 -27.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 120.818 -1.176 . . . . 0.84999999999999998 112.023 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.75 41.03 3.04 Favored Glycine 0 N--CA 1.492 2.43 0 O-C-N 121.242 -0.911 . . . . 0.92000000000000004 111.841 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.448 HG21 ' CG2' ' A' ' 180' ' ' ILE . 46.9 p -62.69 -23.72 67.28 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.24 -1.153 . . . . 0.94999999999999996 111.007 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.04 -92.17 1.78 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.077 -1.059 . . . . 1.04 110.668 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 86.0 p -128.35 30.61 5.16 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.178 -1.189 . . . . 1.5700000000000001 112.302 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.21 -33.68 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.264 -1.522 . . . . 0.83999999999999997 110.107 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 26.0 p -58.14 -26.76 63.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.987 -1.071 . . . . 0.98999999999999999 111.52 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.8 t -93.58 1.82 56.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.301 -0.875 . . . . 1.7 111.999 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -123.95 -0.53 8.43 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 112.911 0.708 . . . . 2.2000000000000002 112.911 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 11.1 t -120.01 150.87 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.52 -0.737 . . . . 0.83999999999999997 109.853 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -118.73 157.81 26.77 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.918 -1.142 . . . . 2.2000000000000002 107.918 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.632 HD22 ' N ' ' A' ' 215' ' ' ASP . 0.2 OUTLIER -59.26 141.2 54.96 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.978 -1.076 . . . . 2.2799999999999998 110.492 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.632 ' N ' HD22 ' A' ' 214' ' ' ASN . 3.3 m-20 80.75 -1.5 1.85 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 114.525 1.306 . . . . 2.3500000000000001 114.525 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -62.33 148.85 43.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.34 -1.475 . . . . 1.97 108.176 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -88.57 120.84 30.32 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.311 -1.366 . . . . 2.6499999999999999 107.311 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.8 mt -128.48 146.38 50.83 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.664 0.745 . . . . 0.63 109.905 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.11 126.76 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.617 -1.623 . . . . 0.62 106.617 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 65.5 tp -100.52 119.64 38.81 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.355 -1.721 . . . . 0.64000000000000001 106.355 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 53.3 t0 -92.25 -26.4 18.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.893 -1.13 . . . . 2.0499999999999998 112.518 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.942 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.11 13.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.137 0.791 . . . . 0.83999999999999997 113.137 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.2 t -108.27 -59.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.741 -1.224 . . . . 1.02 109.695 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -92.68 10.12 32.01 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.018 0.913 . . . . 2.5099999999999998 110.561 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 62.15 53.58 2.89 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.659 -0.7 . . . . 1.54 112.242 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -147.0 149.06 32.4 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.371 1.081 . . . . 1.95 109.645 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.1 t -115.98 133.33 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.444 -1.317 . . . . 0.70999999999999996 107.444 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.11 132.57 46.5 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.026 -1.047 . . . . 1.01 108.468 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 60.4 t -110.48 129.94 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.365 -0.834 . . . . 0.81999999999999995 108.763 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.4 t30 54.34 55.2 11.73 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.15 -0.969 . . . . 1.54 113.232 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.09 150.42 60.06 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.582 2.188 . . . . 0.93999999999999995 111.322 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.5 m -75.2 158.87 32.29 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.254 -0.904 . . . . 1.8 109.313 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.58 ' HA ' HD12 ' A' ' 236' ' ' ILE . 81.8 m-20 -58.75 -39.09 79.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 2.73 110.688 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -58.82 -40.17 83.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -0.937 . . . . 3.1699999999999999 109.865 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.65 -39.09 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 1.3400000000000001 110.105 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 233' ' ' ASN . 95.4 mt -57.35 -47.26 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.818 -0.753 . . . . 1.2 110.715 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.92 -40.22 88.12 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.326 -0.859 . . . . 2.7000000000000002 110.557 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -61.17 -48.12 83.03 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.401 -0.812 . . . . 2.5899999999999999 111.289 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 81.9 mtp -70.44 -33.1 70.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 1.3799999999999999 111.092 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 . . . . . 0 C--N 1.303 -1.428 0 O-C-N 120.983 -1.073 . . . . 2.8399999999999999 110.076 179.295 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.1 mt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.557 0.694 . . . . 1.0700000000000001 111.962 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.0 m -97.38 116.67 30.02 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.576 -1.639 . . . . 1.24 106.576 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.46 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -93.78 -153.47 30.29 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 120.441 -1.412 . . . . 1.01 109.912 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 5' ' ' ILE . 74.6 mt -94.43 1.01 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.586 -0.949 . . . . 1.1100000000000001 112.552 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 tp 52.52 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.685 -1.26 . . . . 0.98999999999999999 112.444 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.54 -35.33 17.01 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.648 -1.283 . . . . 0.84999999999999998 110.744 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 1.2 p -148.67 140.96 14.85 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.711 -1.243 . . . . 1.3799999999999999 108.083 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.0 147.88 24.33 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.151 1.901 . . . . 0.93999999999999995 112.347 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.929 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.56 163.64 11.79 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.265 -1.534 . . . . 0.81000000000000005 109.265 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.5 mt -121.05 134.33 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.057 -1.261 . . . . 0.82999999999999996 108.345 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.25 151.85 44.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.193 -0.942 . . . . 0.53000000000000003 109.416 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.9 m-85 -122.06 144.46 48.9 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.431 -0.951 . . . . 0.77000000000000002 108.431 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.85 166.27 31.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.551 -1.785 . . . . 0.51000000000000001 110.092 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -77.88 159.68 28.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.329 -1.101 . . . . 1.8999999999999999 109.204 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -87.53 127.69 35.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.792 -1.188 . . . . 0.66000000000000003 107.792 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.2 tp -106.11 109.53 21.49 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 105.468 -2.049 . . . . 0.82999999999999996 105.468 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 18' ' ' LEU . 14.8 tp -95.58 136.27 36.17 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.414 -1.328 . . . . 0.85999999999999999 107.414 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.8 mt -99.8 118.82 37.09 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.062 -1.459 . . . . 0.92000000000000004 107.062 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -112.05 136.19 51.72 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.65 -1.241 . . . . 2.0299999999999998 107.65 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -130.33 151.96 50.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.251 -0.906 . . . . 2.6600000000000001 109.149 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -80.06 138.35 36.96 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.478 -0.934 . . . . 2.3199999999999998 108.478 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -63.79 149.33 47.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.454 -0.779 . . . . 2.1099999999999999 109.002 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.6 mt -92.69 129.97 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.915 -1.116 . . . . 0.72999999999999998 108.651 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.9 t -105.36 130.01 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.529 -1.285 . . . . 0.87 107.529 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.27 135.03 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.654 -0.869 . . . . 0.81000000000000005 108.654 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -90.91 122.1 33.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.075 -1.016 . . . . 1.3400000000000001 108.512 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -95.4 11.8 31.52 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.591 -0.693 . . . . 2.8900000000000001 112.106 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -66.97 141.54 57.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.88 -1.138 . . . . 2.0899999999999999 108.885 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -88.9 134.16 34.05 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.138 -1.06 . . . . 2.1899999999999999 108.138 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -97.78 167.14 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.394 -0.816 . . . . 0.75 110.477 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.6 p -94.67 160.95 14.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.686 -0.633 . . . . 0.91000000000000003 109.53 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.41 -21.92 11.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.903 -1.123 . . . . 0.93000000000000005 111.94 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -67.53 -37.24 82.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 2.2799999999999998 110.753 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -90.25 -8.5 50.85 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.649 -1.282 . . . . 1.45 112.587 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.1 t -58.89 -39.82 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.446 -0.784 . . . . 0.81000000000000005 110.553 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -56.33 -40.24 74.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.929 -1.107 . . . . 1.54 110.187 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.29 -39.5 94.74 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.432 -0.793 . . . . 2.3599999999999999 111.045 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.46 -43.54 96.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.025 -1.047 . . . . 1.3100000000000001 110.707 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.24 -40.85 84.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.23 -0.918 . . . . 0.81999999999999995 110.501 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -60.58 -45.37 94.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.237 -0.914 . . . . 1.5 110.107 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -61.83 -40.57 95.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.582 -0.699 . . . . 2.23 110.287 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -74.02 -52.84 11.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.094 -1.004 . . . . 0.84999999999999998 109.934 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.6 tp -61.77 -47.96 82.84 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.554 -0.859 . . . . 0.91000000000000003 110.09 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.1 t -69.92 -38.06 76.13 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.289 -0.882 . . . . 0.90000000000000002 109.703 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.89 -40.8 95.71 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.037 -1.625 . . . . 0.68999999999999995 109.037 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.564 HH22 ' CD ' ' A' ' 86' ' ' GLU . 17.2 ttm180 -59.2 -30.69 68.4 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.737 0.779 . . . . 2.8799999999999999 109.334 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.29 -49.79 76.5 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.614 0.721 . . . . 0.84999999999999998 110.365 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -82.7 -38.33 23.51 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.297 -0.877 . . . . 2.3500000000000001 110.169 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.5 -44.85 95.54 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.84 -0.744 . . . . 0.65000000000000002 109.905 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.8 t -60.13 -40.21 88.99 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.339 1.066 . . . . 1.45 108.797 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.62 -45.93 88.04 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.648 -0.706 . . . . 0.63 109.771 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -61.46 -50.44 72.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.995 -1.065 . . . . 1.3400000000000001 110.324 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.26 -39.83 91.81 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.321 -0.862 . . . . 1.5600000000000001 110.071 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -59.9 -43.11 95.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.887 -0.508 . . . . 1.1899999999999999 110.619 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 m -63.96 -42.36 97.3 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.789 -1.194 . . . . 0.71999999999999997 109.948 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.6 -35.2 61.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.68 -0.638 . . . . 0.62 110.337 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -53.03 -41.51 64.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.431 -0.793 . . . . 1.05 110.442 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -70.34 -35.42 73.59 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.376 -0.828 . . . . 0.64000000000000001 109.691 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.48 -40.9 92.93 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.221 -0.991 . . . . 1.73 109.045 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.08 -36.01 82.18 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 120.178 -0.609 . . . . 0.56000000000000005 109.47 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.2 -35.07 27.92 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.588 -1.291 . . . . 0.68999999999999995 110.435 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.36 -16.98 50.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.318 -1.107 . . . . 1.48 111.209 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.6 m -91.24 -54.88 3.74 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.264 0.554 . . . . 0.97999999999999998 110.381 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 67' ' ' GLU . 61.5 m-85 -107.35 -30.48 8.67 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.11 0.782 . . . . 1.1599999999999999 113.11 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 61.48 -26.13 0.06 OUTLIER Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.536 -1.316 . . . . 0.84999999999999998 115.059 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 65' ' ' PHE . 52.5 mt-10 -54.84 -166.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.556 -0.967 . . . . 3.8599999999999999 109.844 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -66.57 7.29 0.36 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 112.953 0.723 . . . . 2.3500000000000001 112.953 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -68.6 -24.64 64.6 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.461 -0.774 . . . . 1.6699999999999999 111.375 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -58.65 -40.21 82.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.021 -1.049 . . . . 1.45 110.687 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.83 -36.56 84.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.869 . . . . 0.60999999999999999 110.958 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 72' ' ' ILE . 13.3 mt -64.8 -45.91 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.65000000000000002 110.718 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -69.62 -33.96 73.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.863 -1.148 . . . . 0.66000000000000003 110.257 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.44 -39.23 90.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.302 -0.874 . . . . 1.1899999999999999 110.174 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.09 -37.74 95.01 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.664 -0.974 . . . . 0.53000000000000003 110.664 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -59.84 -41.98 92.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -1.114 . . . . 1.27 110.343 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.8 mt -61.2 -40.96 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.09 . . . . 0.54000000000000004 110.43 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.3 ttt -59.71 -39.65 85.35 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 120.97 -1.081 . . . . 1.74 110.523 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 tp -58.43 -49.98 75.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.114 -0.991 . . . . 0.55000000000000004 110.199 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.5 tp -61.67 -42.08 98.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.099 -1.001 . . . . 0.46999999999999997 109.961 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -86.63 9.08 19.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.482 -0.762 . . . . 1.4199999999999999 112.564 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.05 121.45 14.19 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.12 -0.988 . . . . 1.27 108.505 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.63 -18.89 65.12 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.455 -0.778 . . . . 1.3500000000000001 111.067 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.61 -50.63 14.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.51 -0.876 . . . . 2.2200000000000002 110.41 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.28 -35.39 77.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.208 -0.597 . . . . 0.62 110.684 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.564 ' CD ' HH22 ' A' ' 47' ' ' ARG . 72.5 tt0 -59.77 -47.45 85.62 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.444 -0.785 . . . . 1.29 110.473 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -61.22 -37.48 83.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.35 -0.844 . . . . 1.52 110.756 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -68.44 -48.83 63.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 1.3 110.673 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.5 mt -57.6 -43.51 83.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.179 -0.95 . . . . 0.60999999999999999 110.242 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.0 mt -60.09 -40.63 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.462 -0.774 . . . . 0.78000000000000003 110.411 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.42 95.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.563 -0.711 . . . . 0.81999999999999995 110.685 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.31 -45.61 92.78 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.96 -1.087 . . . . 0.80000000000000004 110.313 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.28 -49.11 80.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.155 -0.966 . . . . 0.77000000000000002 110.335 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -73.8 -36.44 65.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.916 -1.115 . . . . 2.1200000000000001 111.842 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -78.5 -47.77 16.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.833 -1.167 . . . . 1.51 111.469 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -101.48 7.43 42.45 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.422 -0.799 . . . . 1.98 112.846 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.4 m80 52.39 50.1 19.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.824 -1.173 . . . . 1.3200000000000001 111.661 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtt -102.98 158.1 16.52 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.843 0.83 . . . . 1.3799999999999999 109.16 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.418 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 66.9 p -74.87 161.9 29.13 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.817 -0.552 . . . . 0.67000000000000004 109.963 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.87 92.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.993 -1.067 . . . . 0.52000000000000002 110.395 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.418 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 16.7 p-10 -68.64 -39.83 80.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.018 -1.051 . . . . 2.25 110.26 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.26 -51.36 38.26 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.548 -0.861 . . . . 0.64000000000000001 111.307 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.09 92.78 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.153 -1.019 . . . . 0.56000000000000005 110.838 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.37 85.23 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.27 -0.894 . . . . 0.46000000000000002 110.965 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -61.64 -38.88 89.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.686 -1.259 . . . . 1.3200000000000001 111.499 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.83 -48.98 79.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.779 -1.201 . . . . 1.3 111.219 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.85 -45.99 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.912 -1.118 . . . . 0.60999999999999999 110.248 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 mm -61.95 -31.13 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.814 . . . . 0.65000000000000002 109.91 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -59.8 -41.37 91.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 2.1099999999999999 110.892 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.59 -34.12 12.24 Favored Glycine 0 N--CA 1.498 2.828 0 C-N-CA 119.084 -1.532 . . . . 0.82999999999999996 112.478 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -60.9 -39.89 91.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.529 -1.571 . . . . 1.28 110.215 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.49 55.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.378 0.609 . . . . 0.89000000000000001 110.6 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.5 p -62.6 -40.48 97.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.437 -0.789 . . . . 1.8700000000000001 110.275 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.96 -41.26 96.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 1.05 111.087 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.6 mt -65.67 -30.67 71.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.772 -1.205 . . . . 1.02 111.084 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -66.66 -21.81 66.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.872 -1.143 . . . . 2.04 111.079 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -73.28 -14.18 61.27 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.192 -0.943 . . . . 1.73 111.57 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.407 HD13 HD13 ' A' ' 123' ' ' LEU . 8.1 mt -84.26 142.54 30.18 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.582 -0.699 . . . . 1.3700000000000001 109.26 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -100.39 55.23 0.89 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 2.8799999999999999 110.737 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -129.98 137.86 50.53 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.211 -1.033 . . . . 1.5800000000000001 108.211 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -58.99 -36.61 75.16 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.134 -0.626 . . . . 3.04 110.816 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -73.9 -52.46 12.87 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.791 -1.193 . . . . 0.90000000000000002 110.381 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.407 HD13 HD13 ' A' ' 118' ' ' LEU . 23.1 mt -64.07 -43.72 94.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.06 -1.025 . . . . 1.0600000000000001 110.27 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -61.14 -47.35 86.61 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.641 -1.287 . . . . 2.1800000000000002 109.857 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -61.77 -29.28 70.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.083 -1.011 . . . . 2.1499999999999999 110.014 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 130' ' ' VAL . 56.0 ttt180 -65.15 -29.0 69.8 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.537 -0.865 . . . . 2.3300000000000001 109.365 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.55 -49.83 76.27 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.613 -0.835 . . . . 0.81999999999999995 109.698 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.23 85.02 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.007 -0.677 . . . . 0.84999999999999998 110.248 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.54 -38.26 90.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.226 -0.921 . . . . 1.3899999999999999 110.439 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 126' ' ' ARG . 55.2 t -67.92 -40.18 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.913 -1.117 . . . . 0.56000000000000005 109.839 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -60.08 -37.8 80.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.892 -1.13 . . . . 3.1200000000000001 110.21 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.54 ' CG ' HH11 ' A' ' 136' ' ' ARG . 42.1 t0 -59.87 -39.23 84.56 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.209 -0.932 . . . . 1.28 110.535 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.31 -39.43 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.562 -0.711 . . . . 0.48999999999999999 110.1 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.06 -50.48 45.97 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.89 -1.147 . . . . 0.46000000000000002 110.603 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -59.42 -47.02 87.04 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.112 -1.228 . . . . 2.71 110.534 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.54 HH11 ' CG ' ' A' ' 132' ' ' ASP . 14.8 mtm-85 -64.58 -39.85 94.47 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.067 -1.053 . . . . 2.1400000000000001 109.883 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.1 tp -61.24 -39.91 92.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.05 110.15 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 73.2 mt -59.34 -40.26 85.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.52000000000000002 110.704 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.431 ' HE ' HD23 ' A' ' 144' ' ' LEU . 58.0 mtp180 -61.19 -34.52 75.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.128 -0.983 . . . . 2.3500000000000001 110.344 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.405 HD21 HD11 ' A' ' 146' ' ' ILE . 31.3 m120 -75.58 -40.73 56.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.021 -1.049 . . . . 1.3899999999999999 110.587 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 98.1 mt -60.04 -39.48 80.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 120.812 -1.18 . . . . 0.68000000000000005 110.479 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.88 -7.93 58.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.82999999999999996 111.659 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.26 22.62 64.88 Favored Glycine 0 N--CA 1.483 1.807 0 C-N-CA 120.104 -1.046 . . . . 0.91000000000000003 113.367 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.431 HD23 ' HE ' ' A' ' 139' ' ' ARG . 43.6 tp -66.41 145.92 55.14 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.744 -0.857 . . . . 0.94999999999999996 109.418 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -64.5 148.57 50.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.418 -0.801 . . . . 2.4300000000000002 109.322 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.405 HD11 HD21 ' A' ' 140' ' ' ASN . 59.2 mt -108.61 140.11 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.47 -0.937 . . . . 1.1000000000000001 108.47 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 21.2 mm -79.77 129.55 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.972 -1.08 . . . . 1.5800000000000001 108.754 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -96.95 95.67 7.98 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.149 -1.797 . . . . 1.6200000000000001 106.149 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.43 -22.19 61.13 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.498 -0.751 . . . . 0.80000000000000004 111.088 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.5 t -78.13 -0.53 28.62 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.084 0.945 . . . . 1.5600000000000001 112.316 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.9 25.48 5.29 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.438 -0.789 . . . . 0.83999999999999997 112.236 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.8 mt -71.05 139.97 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.465 -0.772 . . . . 0.81999999999999995 109.566 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -115.17 -19.89 10.63 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 2.3100000000000001 112.949 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -117.27 139.61 50.59 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.885 -1.154 . . . . 1.54 107.885 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.6 126.69 30.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.449 -0.945 . . . . 1.3799999999999999 108.449 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.7 m -149.5 175.16 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.01 -1.056 . . . . 0.68999999999999995 109.166 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.9 mt -89.09 142.35 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.53000000000000003 108.644 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 27.6 tp -96.79 124.02 40.65 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.459 -0.941 . . . . 0.64000000000000001 108.459 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.1 t -125.02 131.98 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.293 -1.003 . . . . 0.67000000000000004 108.293 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.48 157.63 19.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.78000000000000003 108.982 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -64.99 -35.35 80.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.686 -1.259 . . . . 1.0 109.304 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.7 t0 -171.45 152.71 3.32 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.845 -0.798 . . . . 2.4199999999999999 108.845 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.472 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 66.3 mt -115.09 142.98 45.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.677 -0.86 . . . . 0.75 108.677 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.8 p -92.95 147.18 33.43 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.462 -0.773 . . . . 0.78000000000000003 108.938 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -40.31 -42.04 3.55 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.511 1.474 . . . . 0.67000000000000004 113.587 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.1 m -61.6 -48.14 82.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.799 -1.188 . . . . 0.69999999999999996 110.278 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.13 -39.46 89.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.023 -1.048 . . . . 1.21 110.87 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -68.79 -40.51 79.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.344 -0.847 . . . . 0.59999999999999998 110.783 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.48 79.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -0.949 . . . . 0.62 110.464 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -93.65 -2.39 54.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.913 -1.117 . . . . 1.1599999999999999 112.396 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 171' ' ' LEU . 42.6 tp -62.13 146.77 49.58 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.251 -1.018 . . . . 0.72999999999999998 108.251 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -95.33 116.96 29.48 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.727 -1.582 . . . . 2.2400000000000002 106.727 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.694 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -73.52 -18.82 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.419 -0.801 . . . . 1.4299999999999999 111.41 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -82.78 -18.26 41.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.526 -0.734 . . . . 2.1499999999999999 112.293 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -104.15 -6.12 21.34 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.312 0.856 . . . . 2.04 113.312 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 178' ' ' GLY . 52.2 t -108.54 129.67 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.559 -1.275 . . . . 0.55000000000000004 107.559 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 29.7 tp -82.89 -8.77 59.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.054 -1.029 . . . . 1.6299999999999999 112.543 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.547 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.98 177.52 38.77 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.599 -1.8 . . . . 0.46999999999999997 108.599 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -129.28 135.84 49.3 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.975 -1.309 . . . . 0.54000000000000004 107.588 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.483 HG22 HG21 ' A' ' 205' ' ' THR . 75.1 mt -138.01 105.15 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.145 -1.798 . . . . 0.68999999999999995 106.145 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 203' ' ' VAL . 76.7 p -129.68 168.94 15.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.357 -0.84 . . . . 0.81999999999999995 109.416 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 26.1 p-10 -98.68 47.95 0.98 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.737 -0.602 . . . . 2.3700000000000001 110.93 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.395 -0.816 . . . . 1.1100000000000001 110.416 -179.849 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 53.5 m . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 107.717 -1.216 . . . . 1.6899999999999999 107.717 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -60.63 -35.53 76.41 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.383 -0.823 . . . . 1.0700000000000001 110.422 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.6 p -56.31 -39.7 73.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.167 -0.958 . . . . 1.5800000000000001 109.982 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.4 m -59.2 -37.29 77.07 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.934 -0.707 . . . . 1.6000000000000001 110.098 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -59.9 -38.85 78.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.498 -0.751 . . . . 1.45 110.309 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 69.9 mtp -64.1 -40.21 95.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.671 -1.268 . . . . 1.05 109.457 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.8 -48.92 79.73 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.027 -0.533 . . . . 0.71999999999999997 111.384 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -59.37 -43.95 92.81 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.19 -0.944 . . . . 3.0499999999999998 110.432 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.1 m -68.97 -40.18 79.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.339 -0.851 . . . . 0.89000000000000001 110.226 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.6 mt -91.78 -9.32 43.97 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.811 0.815 . . . . 0.78000000000000003 112.126 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.8 mt-10 47.46 14.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.472 0.916 . . . . 1.45 113.472 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 59.6 mt -75.41 150.27 84.73 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.953 -1.092 . . . . 0.67000000000000004 108.538 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -51.49 140.51 44.2 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.393 1.396 . . . . 0.64000000000000001 109.302 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.442 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -159.05 163.61 36.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.209 -1.557 . . . . 0.67000000000000004 109.829 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.5 mt -147.17 147.04 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.761 -1.2 . . . . 0.68999999999999995 107.761 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 181' ' ' THR . 9.9 m -129.11 -29.19 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 113.251 0.834 . . . . 0.84999999999999998 113.251 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.61 46.35 3.66 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 120.344 -0.931 . . . . 0.92000000000000004 111.97 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.483 HG21 HG22 ' A' ' 180' ' ' ILE . 65.8 p -66.78 -12.88 60.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.965 -1.315 . . . . 0.94999999999999996 111.229 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.85 -94.42 0.68 Allowed Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.038 -1.077 . . . . 1.04 110.49 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -129.52 31.21 4.82 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.522 -0.987 . . . . 1.5700000000000001 112.144 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.86 -33.34 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.617 -1.302 . . . . 0.83999999999999997 110.474 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 80.5 p -56.33 -28.22 58.24 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.076 -1.015 . . . . 0.98999999999999999 111.171 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 26.4 t -92.26 0.69 57.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.101 -1.0 . . . . 1.7 112.214 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -120.33 -4.19 9.94 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.545 0.943 . . . . 2.2000000000000002 113.545 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.3 149.42 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.227 -0.92 . . . . 0.83999999999999997 109.285 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -117.62 149.61 40.39 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.535 -0.913 . . . . 2.2000000000000002 108.535 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 38.4 p-10 -50.47 141.33 12.34 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.384 -0.926 . . . . 2.2799999999999998 110.366 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 8.8 t0 81.49 4.06 1.41 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 114.219 1.192 . . . . 2.3500000000000001 114.219 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -66.7 145.62 55.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.883 -1.136 . . . . 1.97 108.252 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -88.13 119.53 28.6 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.328 -1.36 . . . . 2.6499999999999999 107.328 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.445 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 85.2 mt -128.66 150.3 50.3 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.506 0.669 . . . . 0.63 110.155 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 56.5 mt -115.09 122.17 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 106.675 -1.602 . . . . 0.62 106.675 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.479 HD13 HD11 ' A' ' 180' ' ' ILE . 62.0 tp -98.99 115.8 29.77 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 106.754 -1.572 . . . . 0.64000000000000001 106.754 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 9.3 m-20 -95.47 -24.39 16.68 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.414 -0.914 . . . . 2.0499999999999998 112.606 -177.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.929 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.21 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.652 0.739 . . . . 0.83999999999999997 112.176 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.7 t -111.38 -61.29 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.654 -0.869 . . . . 1.02 108.654 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -91.13 9.55 30.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.145 0.974 . . . . 2.5099999999999998 110.159 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.46 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 61.93 51.35 3.77 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 114.921 -1.036 . . . . 1.54 111.986 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -153.17 152.79 31.64 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.798 1.285 . . . . 1.95 110.497 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.0 t -117.38 140.79 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.527 -0.916 . . . . 0.70999999999999996 108.527 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -100.78 132.82 45.99 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.85 -1.156 . . . . 1.01 108.56 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.1 t -109.79 129.55 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.419 -0.956 . . . . 0.81999999999999995 108.419 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.445 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER 56.38 48.17 3.35 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 113.734 1.013 . . . . 1.54 113.734 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 58.7 Cg_endo -70.61 150.54 63.18 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.292 1.995 . . . . 0.93999999999999995 111.138 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.7 m -72.93 153.74 40.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.984 -1.073 . . . . 1.8 109.027 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 31.6 p-10 -59.82 -33.38 71.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.93 . . . . 2.73 110.441 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 97.7 mt-10 -60.12 -39.78 87.45 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.294 -0.879 . . . . 3.1699999999999999 110.161 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.86 -38.93 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.898 . . . . 1.3400000000000001 109.883 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.52 -45.04 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.897 -0.721 . . . . 1.2 110.627 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -59.88 -42.08 92.97 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.022 -1.071 . . . . 2.7000000000000002 110.193 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -62.23 -41.15 98.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -0.922 . . . . 2.5899999999999999 110.328 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.0 mtp -71.42 -40.27 70.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.256 -0.902 . . . . 1.3799999999999999 110.507 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 2.8399999999999999 110.08 -178.813 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mt . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 112.904 0.705 . . . . 1.0700000000000001 112.904 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.0 m -100.01 119.13 37.78 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.832 -1.544 . . . . 1.24 106.832 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.85 -141.35 9.92 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.615 -0.994 . . . . 1.01 110.615 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 5' ' ' ILE . 94.3 mt -97.71 -1.91 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.558 -0.966 . . . . 1.1100000000000001 113.008 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp 52.06 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.846 -1.159 . . . . 0.98999999999999999 112.265 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.23 -46.95 12.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.245 -0.909 . . . . 0.84999999999999998 111.193 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -143.4 145.33 31.5 Favored Pre-proline 0 N--CA 1.5 2.048 0 N-CA-C 107.784 -1.191 . . . . 1.3799999999999999 107.784 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.82 150.22 26.96 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.26 1.973 . . . . 0.93999999999999995 112.309 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.909 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 149.81 170.82 17.65 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 108.946 -1.662 . . . . 0.81000000000000005 108.946 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.4 mt -128.31 133.5 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 120.961 -1.317 . . . . 0.82999999999999996 107.828 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.08 145.16 47.66 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.663 -0.866 . . . . 0.53000000000000003 108.663 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.7 m-85 -117.39 141.04 48.81 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.302 -0.874 . . . . 0.77000000000000002 109.051 177.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.21 168.17 36.01 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.474 -1.822 . . . . 0.51000000000000001 110.096 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -76.59 160.52 29.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.861 -0.788 . . . . 1.8999999999999999 109.943 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.98 126.23 31.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.077 -1.015 . . . . 0.66000000000000003 108.38 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.468 HD12 HD21 ' A' ' 214' ' ' ASN . 63.1 tp -108.07 102.77 11.91 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 105.0 -2.222 . . . . 0.82999999999999996 105.0 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.418 ' H ' HD22 ' A' ' 214' ' ' ASN . 14.5 tp -90.58 138.06 31.86 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.602 -1.258 . . . . 0.85999999999999999 107.602 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 160' ' ' ALA . 36.9 mt -100.01 117.45 34.31 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.739 -1.578 . . . . 0.92000000000000004 106.739 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -111.93 140.08 46.89 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.27 -1.011 . . . . 2.0299999999999998 108.27 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.517 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 71.5 tt0 -123.82 139.82 53.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 2.6600000000000001 108.802 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.85 133.54 34.74 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.982 -1.118 . . . . 2.3199999999999998 107.982 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -62.19 143.01 57.34 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.633 -0.877 . . . . 2.1099999999999999 108.633 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.3 mt -95.23 135.44 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.121 -0.987 . . . . 0.72999999999999998 108.363 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.71 129.93 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.349 -0.982 . . . . 0.87 108.349 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.94 139.74 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.487 -0.931 . . . . 0.81000000000000005 108.487 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -91.26 119.04 30.99 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.333 -1.358 . . . . 1.3400000000000001 107.333 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.564 ' HG2' HH11 ' A' ' 28' ' ' ARG . 1.0 OUTLIER -95.89 11.72 32.79 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.94 -1.1 . . . . 2.8900000000000001 112.369 -179.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.5 150.64 47.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 2.0899999999999999 110.966 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -89.29 131.3 35.45 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.103 -1.073 . . . . 2.1899999999999999 108.103 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -94.29 165.4 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.04 . . . . 0.75 110.278 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.9 p -92.56 166.08 12.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.584 -0.697 . . . . 0.91000000000000003 109.724 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.84 -22.53 37.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.93000000000000005 111.85 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -67.2 -36.24 81.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.004 -1.06 . . . . 2.2799999999999998 110.87 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -92.43 -9.36 41.89 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.048 -1.032 . . . . 1.45 113.187 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.27 -43.72 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.936 -1.102 . . . . 0.81000000000000005 110.044 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -58.51 -39.97 81.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.096 -1.002 . . . . 1.54 110.574 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -61.37 -39.9 92.32 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.445 -0.784 . . . . 2.3599999999999999 110.028 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -61.06 -40.35 93.34 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 1.3100000000000001 110.373 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.71 -41.61 88.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.047 -1.033 . . . . 0.81999999999999995 110.024 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -60.72 -48.96 79.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.122 -0.986 . . . . 1.5 110.268 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -61.78 -43.21 99.3 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.552 -0.859 . . . . 2.23 109.979 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -73.37 -53.21 11.31 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.508 -0.745 . . . . 0.84999999999999998 109.748 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.8 tp -59.6 -47.2 86.49 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.477 -0.889 . . . . 0.91000000000000003 109.938 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.4 t -69.31 -34.41 74.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.90000000000000002 110.011 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.17 -41.82 92.96 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.177 -1.569 . . . . 0.68999999999999995 109.177 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 40.7 ttm-85 -58.73 -34.07 70.96 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.438 -0.905 . . . . 2.8799999999999999 109.053 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.34 -49.68 76.63 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.915 0.864 . . . . 0.84999999999999998 110.182 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.488 ' NZ ' ' OE1' ' A' ' 53' ' ' GLN . 26.9 ttpp -80.94 -42.37 21.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 2.3500000000000001 111.136 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.6 92.18 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.746 -0.781 . . . . 0.65000000000000002 110.093 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.2 t -60.11 -41.4 92.51 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.206 -0.934 . . . . 1.45 109.39 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 -48.4 62.52 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.554 -0.716 . . . . 0.63 110.63 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.488 ' OE1' ' NZ ' ' A' ' 49' ' ' LYS . 27.9 mt-30 -62.34 -49.29 76.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 1.3400000000000001 110.593 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.86 -37.28 86.22 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.084 -1.01 . . . . 1.5600000000000001 109.766 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -59.25 -40.65 86.64 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.652 -0.655 . . . . 1.1899999999999999 110.648 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -62.4 -40.33 96.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.924 -1.11 . . . . 0.71999999999999997 110.058 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.67 -39.85 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.62 110.513 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -50.14 -42.99 51.75 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.348 -0.845 . . . . 1.05 111.259 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.6 -36.12 78.25 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.03 -1.044 . . . . 0.64000000000000001 110.276 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -61.13 -37.91 84.48 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.945 -1.102 . . . . 1.73 108.984 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.29 86.8 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.793 -0.763 . . . . 0.56000000000000005 109.613 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.17 -34.75 40.39 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.332 -1.413 . . . . 0.68999999999999995 110.398 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -82.32 -20.08 38.08 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.254 -1.145 . . . . 1.48 111.308 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.2 m -86.37 -51.33 6.29 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.356 -0.84 . . . . 0.97999999999999998 110.428 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.96 -19.66 13.66 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.92 0.711 . . . . 1.1599999999999999 112.92 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.17 163.69 13.6 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 111.466 -0.653 . . . . 0.84999999999999998 111.466 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -56.32 -22.48 30.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.794 -0.827 . . . . 3.8599999999999999 112.603 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -58.21 -35.07 71.11 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.033 -1.042 . . . . 2.3500000000000001 111.631 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -86.61 -11.95 49.97 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.824 -1.172 . . . . 1.6699999999999999 113.07 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.75 -30.76 69.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.773 -1.204 . . . . 1.45 111.26 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.74 85.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.983 -1.073 . . . . 0.60999999999999999 111.241 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 72' ' ' ILE . 15.8 mt -68.02 -48.01 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.823 -1.173 . . . . 0.65000000000000002 110.13 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -69.87 -32.47 70.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.375 -0.828 . . . . 0.66000000000000003 110.539 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.36 -37.44 80.71 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.054 -1.029 . . . . 1.1899999999999999 110.075 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.22 -38.32 91.77 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 120.281 -0.962 . . . . 0.53000000000000003 110.827 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -59.6 -45.89 90.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.902 -1.352 . . . . 1.27 110.599 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.1 mt -60.31 -38.84 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.863 -1.148 . . . . 0.54000000000000004 110.488 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.2 ttt -59.55 -39.89 85.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.49 -0.756 . . . . 1.74 110.626 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 tp -59.19 -48.76 80.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.386 -0.926 . . . . 0.55000000000000004 109.953 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.446 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 61.3 tp -60.91 -45.92 92.73 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.653 0.739 . . . . 0.46999999999999997 110.754 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.11 11.87 7.33 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.225 0.824 . . . . 1.4199999999999999 113.225 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -63.96 123.83 19.99 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.798 -0.816 . . . . 1.27 108.798 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -65.52 -18.09 65.06 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.742 0.782 . . . . 1.3500000000000001 110.819 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.71 -56.88 4.08 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.452 0.644 . . . . 2.2200000000000002 110.046 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.29 -40.18 89.56 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.006 -0.678 . . . . 0.62 110.64 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -58.55 -49.96 75.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.132 -0.98 . . . . 1.29 110.969 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -62.81 -38.03 89.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 1.52 110.443 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -65.92 -48.92 69.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 1.3 110.458 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.9 mt -55.98 -42.93 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.058 -1.026 . . . . 0.60999999999999999 109.653 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.0 mt -61.73 -44.0 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.435 -0.79 . . . . 0.78000000000000003 110.316 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.8 -44.29 97.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.81999999999999995 110.942 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.01 -44.63 94.45 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.912 -1.117 . . . . 0.80000000000000004 110.463 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.0 mt -60.61 -48.39 88.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.267 -0.895 . . . . 0.77000000000000002 110.712 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -81.56 -33.55 31.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.407 -0.808 . . . . 2.1200000000000001 111.714 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 91' ' ' ALA . 54.2 t0 -82.93 -40.18 20.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.091 -1.006 . . . . 1.51 111.457 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -103.09 7.13 38.89 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.241 -0.912 . . . . 1.98 112.263 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.5 m80 51.3 44.62 28.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 1.3200000000000001 111.953 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.9 mtt -102.93 153.73 19.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.417 -0.802 . . . . 1.3799999999999999 109.425 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.407 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 43.2 p -70.54 160.71 31.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.67000000000000004 109.506 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.6 92.9 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.93 -1.106 . . . . 0.52000000000000002 110.874 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 24.2 p-10 -69.42 -38.27 77.8 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.985 -1.072 . . . . 2.25 110.024 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.74 -51.2 43.9 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.052 -1.059 . . . . 0.64000000000000001 111.388 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.69 90.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.56000000000000005 111.049 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.32 -41.81 85.37 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.352 -0.842 . . . . 0.46000000000000002 110.613 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.56 -38.74 85.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.414 -0.804 . . . . 1.3200000000000001 111.173 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -58.06 -48.42 80.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.881 -1.137 . . . . 1.3 111.087 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.04 -43.64 96.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.882 -1.136 . . . . 0.60999999999999999 110.772 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mm -62.71 -35.26 69.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.605 -0.684 . . . . 0.65000000000000002 110.318 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -57.44 -39.81 77.07 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.876 -0.73 . . . . 2.1099999999999999 111.207 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.73 -35.61 11.39 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 118.842 -1.647 . . . . 0.82999999999999996 112.693 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -61.12 -41.2 96.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.497 -1.59 . . . . 1.28 110.145 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.6 -50.91 22.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.932 0.872 . . . . 0.89000000000000001 110.471 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.9 p -62.34 -37.85 87.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.862 . . . . 1.8700000000000001 110.814 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.86 -40.77 98.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 1.05 110.943 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.59 -30.18 70.41 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.637 -1.289 . . . . 1.02 110.892 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -67.34 -22.09 65.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.83 -1.169 . . . . 2.04 110.93 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.5 -11.79 60.81 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.103 -1.039 . . . . 1.73 111.0 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 123' ' ' LEU . 75.8 mt -87.16 144.91 26.63 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.282 -0.636 . . . . 1.3700000000000001 109.282 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -100.19 39.73 1.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.344 -0.847 . . . . 2.8799999999999999 111.58 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.48 ' CB ' HD12 ' A' ' 123' ' ' LEU . 7.3 t0 -113.57 135.8 53.51 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 108.261 -1.014 . . . . 1.5800000000000001 108.261 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -57.67 -40.15 78.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.499 -0.75 . . . . 3.04 111.198 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -72.81 -51.14 20.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.731 -1.231 . . . . 0.90000000000000002 110.714 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 118' ' ' LEU . 23.9 mt -59.29 -41.28 88.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.26 -0.9 . . . . 1.0600000000000001 110.541 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 71.5 tttt -64.12 -46.7 83.01 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.209 -0.996 . . . . 2.1800000000000002 109.793 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -60.17 -33.45 72.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.49 -0.884 . . . . 2.1499999999999999 109.561 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.522 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 29.7 ttt-85 -60.79 -29.66 69.58 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.306 1.05 . . . . 2.3300000000000001 108.935 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.78 -49.47 77.6 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.825 0.821 . . . . 0.81999999999999995 109.396 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.19 -45.81 86.73 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.722 -0.791 . . . . 0.84999999999999998 109.774 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.02 -36.85 82.79 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.632 -0.668 . . . . 1.3899999999999999 110.168 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.522 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 48.3 t -69.41 -40.04 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.56000000000000005 110.037 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -57.9 -38.46 75.88 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.44 -0.904 . . . . 3.1200000000000001 110.041 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -59.95 -39.57 86.03 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.594 0.711 . . . . 1.28 109.87 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.6 -36.96 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.216 -0.928 . . . . 0.48999999999999999 109.937 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.81 -56.93 22.24 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 120.009 -1.091 . . . . 0.46000000000000002 111.353 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -59.07 -39.72 82.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.153 -1.204 . . . . 2.71 110.256 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -60.12 -44.81 94.62 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.775 -1.17 . . . . 2.1400000000000001 109.57 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.98 -43.89 94.84 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.433 -0.792 . . . . 1.05 110.176 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.63 -44.87 93.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.447 -0.783 . . . . 0.52000000000000002 110.365 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.517 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 98.8 mtt180 -60.13 -33.19 71.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.893 . . . . 2.3500000000000001 111.071 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -76.38 -42.95 42.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.098 -1.001 . . . . 1.3899999999999999 110.725 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.72 -40.17 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.68000000000000005 110.105 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.87 -11.27 45.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.076 -1.015 . . . . 0.82999999999999996 111.757 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.6 21.67 71.66 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.73 -1.224 . . . . 0.91000000000000003 112.91 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -62.73 147.41 49.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.806 -0.82 . . . . 0.94999999999999996 109.139 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -67.0 147.05 53.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.303 -0.873 . . . . 2.4300000000000002 108.905 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.9 mt -105.74 149.16 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.419 -0.956 . . . . 1.1000000000000001 108.419 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.556 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.4 mp -77.65 119.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.157 -0.964 . . . . 1.5800000000000001 108.727 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -99.51 96.5 7.71 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.66 -1.607 . . . . 1.6200000000000001 106.66 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.7 mt -77.36 -12.44 59.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.903 . . . . 0.80000000000000004 111.628 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.5 p -81.7 3.0 27.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.138 -0.977 . . . . 1.5600000000000001 112.072 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.68 18.46 14.27 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.67 -0.644 . . . . 0.83999999999999997 112.579 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.8 mt -71.97 138.95 20.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.52 -0.738 . . . . 0.81999999999999995 109.271 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -118.54 -15.79 9.55 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.834 0.826 . . . . 2.3100000000000001 112.629 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -114.33 138.66 50.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.974 -1.121 . . . . 1.54 107.974 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -72.66 121.98 20.69 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.33 -0.989 . . . . 1.3799999999999999 108.33 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.6 m -144.49 174.95 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.033 -0.728 . . . . 0.68999999999999995 109.033 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.6 mt -89.45 142.15 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.793 -1.192 . . . . 0.53000000000000003 109.088 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 31.5 tp -94.49 123.05 37.67 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.29 -1.004 . . . . 0.64000000000000001 108.29 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.65 129.64 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.705 -1.22 . . . . 0.67000000000000004 107.705 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.32 154.68 21.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.149 -0.97 . . . . 0.78000000000000003 108.826 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.93 -37.31 86.53 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.541 -1.349 . . . . 1.0 109.458 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -173.3 147.86 1.57 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.166 -0.679 . . . . 2.4199999999999999 109.166 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.1 mt -115.93 143.25 45.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.489 -0.757 . . . . 0.75 109.21 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.7 p -89.45 147.43 38.04 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.162 -0.961 . . . . 0.78000000000000003 108.881 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -40.49 -42.48 3.91 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.892 1.728 . . . . 0.67000000000000004 113.673 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.8 m -61.32 -50.25 73.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.017 -1.052 . . . . 0.69999999999999996 110.295 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -61.42 -39.67 91.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 1.21 109.772 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.6 p -68.75 -39.69 80.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.608 -0.682 . . . . 0.59999999999999998 110.458 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.41 79.38 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.928 -0.709 . . . . 0.62 110.531 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -93.71 -1.03 55.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.902 . . . . 1.1599999999999999 112.727 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.84 148.6 38.81 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.262 -1.014 . . . . 0.72999999999999998 108.262 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -96.4 114.81 26.51 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.839 -1.541 . . . . 2.2400000000000002 106.839 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 173' ' ' LEU . 7.5 mp -73.37 -20.39 60.77 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.433 0.635 . . . . 1.4299999999999999 111.77 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -80.42 -21.85 41.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 2.1499999999999999 112.037 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -100.23 -6.08 26.6 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 113.198 0.814 . . . . 2.04 113.198 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 178' ' ' GLY . 62.1 t -110.26 129.52 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.616 -1.254 . . . . 0.55000000000000004 107.616 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.5 -6.29 54.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 1.6299999999999999 112.635 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.47 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.53 164.79 33.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.788 -1.725 . . . . 0.46999999999999997 108.788 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -122.72 127.48 49.28 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.402 -1.333 . . . . 0.54000000000000004 107.402 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.413 HD11 HD13 ' A' ' 220' ' ' LEU . 24.9 mt -127.36 127.64 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.802 -1.555 . . . . 0.68999999999999995 106.802 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.5 p -140.43 166.27 25.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.865 -1.147 . . . . 0.81999999999999995 109.486 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.429 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 1.5 m-20 -104.4 43.25 1.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.746 -0.596 . . . . 2.3700000000000001 110.341 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.94 0 O-C-N 121.082 -1.011 . . . . 1.1100000000000001 108.906 179.115 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 108.14 -1.059 . . . . 1.6899999999999999 108.14 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -59.96 -39.14 84.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 1.0700000000000001 110.651 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 57.5 p -60.03 -40.34 88.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 1.5800000000000001 110.546 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.0 t -60.08 -36.86 78.3 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.167 -0.958 . . . . 1.6000000000000001 110.12 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.2 mm -60.48 -38.87 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.735 -0.603 . . . . 1.45 110.814 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 75.1 mtp -61.01 -45.36 95.12 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.616 1.198 . . . . 1.05 109.157 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.02 -50.47 73.61 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.462 -0.79 . . . . 0.71999999999999997 110.823 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -59.65 -44.84 93.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 3.0499999999999998 111.179 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.9 m -70.2 -40.85 74.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.863 . . . . 0.89000000000000001 110.543 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.3 mt -90.89 -7.0 53.41 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.071 0.939 . . . . 0.78000000000000003 112.242 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 194' ' ' ALA . 93.7 mt-10 53.67 9.71 0.2 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.929 1.085 . . . . 1.45 113.929 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.38 147.91 90.43 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 120.844 -1.16 . . . . 0.67000000000000004 107.972 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.79 137.28 60.14 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.374 1.383 . . . . 0.64000000000000001 110.07 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.67 166.2 24.78 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.225 -1.39 . . . . 0.67000000000000004 109.839 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 35.9 mt -148.16 151.07 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.872 -1.159 . . . . 0.68999999999999995 107.872 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.7 m -134.82 -26.63 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.845 -1.159 . . . . 0.84999999999999998 112.027 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.19 42.4 2.85 Favored Glycine 0 N--CA 1.49 2.258 0 O-C-N 120.985 -1.072 . . . . 0.92000000000000004 111.432 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 69.8 p -64.04 -24.15 67.6 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.925 -1.338 . . . . 0.94999999999999996 111.233 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.86 -90.05 1.48 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 120.042 -1.075 . . . . 1.04 110.596 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.7 t -130.83 32.3 4.37 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.291 -1.123 . . . . 1.5700000000000001 113.04 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.9 t -56.29 -32.76 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.255 -1.528 . . . . 0.83999999999999997 110.439 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.6 p -59.04 -25.42 63.69 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.058 -1.026 . . . . 0.98999999999999999 111.215 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.8 m -92.96 1.89 57.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 1.7 112.063 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -125.66 -5.72 6.97 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.441 0.904 . . . . 2.2000000000000002 113.441 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.6 t -118.83 148.03 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.424 -0.798 . . . . 0.83999999999999997 109.515 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -120.42 150.45 40.77 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.998 -1.112 . . . . 2.2000000000000002 107.998 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.468 HD21 HD12 ' A' ' 17' ' ' LEU . 26.2 t-20 -51.32 141.29 15.39 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.233 -0.917 . . . . 2.2799999999999998 110.562 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 80.93 -3.81 1.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.028 1.121 . . . . 2.3500000000000001 114.028 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -61.68 146.01 50.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.814 -1.179 . . . . 1.97 108.284 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -87.32 118.18 26.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.529 -1.286 . . . . 2.6499999999999999 107.529 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.92 147.64 50.86 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.454 -0.779 . . . . 0.63 109.552 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 13.7 mt -119.14 130.06 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.186 -1.413 . . . . 0.62 107.186 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.413 HD13 HD11 ' A' ' 180' ' ' ILE . 54.1 tp -98.5 122.88 42.25 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.732 -1.211 . . . . 0.64000000000000001 107.732 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 223' ' ' VAL . 43.8 t0 -94.03 -29.58 15.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.785 -1.197 . . . . 2.0499999999999998 112.385 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.62 18.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.92 0.711 . . . . 0.83999999999999997 112.92 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -109.68 -60.49 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.059 -1.025 . . . . 1.02 109.222 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -93.74 11.15 30.14 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.949 0.88 . . . . 2.5099999999999998 110.018 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 63.32 53.16 2.25 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.657 -0.702 . . . . 1.54 112.205 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -149.04 154.84 39.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.482 -0.761 . . . . 1.95 109.515 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.6 135.85 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.595 -1.261 . . . . 0.70999999999999996 107.595 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -102.83 130.51 49.85 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.118 -0.988 . . . . 1.01 108.97 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.14 127.81 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.682 -1.229 . . . . 0.81999999999999995 107.682 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 50.1 53.16 13.76 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 113.428 0.899 . . . . 1.54 113.428 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 151.15 79.64 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 123.028 2.486 . . . . 0.93999999999999995 111.085 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 67.3 p -73.97 155.29 38.78 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.739 -0.837 . . . . 1.8 108.739 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -60.26 -37.94 81.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 2.73 110.714 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -50.83 -44.28 59.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.056 -1.027 . . . . 3.1699999999999999 110.445 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.24 -39.93 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.189 -0.944 . . . . 1.3400000000000001 110.64 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.76 -49.16 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.897 -0.721 . . . . 1.2 110.962 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.41 -39.64 84.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.922 -1.111 . . . . 2.7000000000000002 110.777 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -61.1 -44.85 96.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 2.5899999999999999 110.761 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 55.3 mtm -75.1 -37.8 61.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.819 -1.175 . . . . 1.3799999999999999 111.301 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 . . . . . 0 N--CA 1.497 1.9 0 O-C-N 120.962 -1.087 . . . . 2.8399999999999999 111.161 -179.766 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mt . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 106.305 -1.739 . . . . 1.0700000000000001 106.305 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.4 m -101.11 123.45 45.28 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.663 -1.236 . . . . 1.24 107.663 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.35 -159.4 11.76 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 108.708 -1.757 . . . . 1.01 108.708 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 5' ' ' ILE . 95.0 mt -99.19 2.32 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.439 -1.036 . . . . 1.1100000000000001 112.744 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 48.61 94.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.636 -1.29 . . . . 0.98999999999999999 112.171 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -84.84 -40.48 17.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.471 -1.393 . . . . 0.84999999999999998 111.49 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.27 144.29 18.55 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 107.465 -1.309 . . . . 1.3799999999999999 107.465 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.11 142.31 27.36 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.574 2.183 . . . . 0.93999999999999995 112.192 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.945 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.55 171.31 23.39 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.36 -1.496 . . . . 0.81000000000000005 109.36 178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -134.21 133.7 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.819 -1.401 . . . . 0.82999999999999996 107.574 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.09 156.8 45.93 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.141 0.972 . . . . 0.53000000000000003 109.664 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.422 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 13.2 m-85 -120.99 140.21 52.22 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.93 -1.137 . . . . 0.77000000000000002 107.93 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.21 166.62 36.22 Favored Glycine 0 N--CA 1.499 2.841 0 C-N-CA 119.044 -1.551 . . . . 0.51000000000000001 109.901 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -80.09 157.84 26.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.297 -1.12 . . . . 1.8999999999999999 109.668 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.76 128.68 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.149 -1.056 . . . . 0.66000000000000003 108.149 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.5 tp -107.24 105.47 15.46 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 105.327 -2.101 . . . . 0.82999999999999996 105.327 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.6 tp -93.32 135.43 34.54 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.036 -1.098 . . . . 0.85999999999999999 108.036 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.9 mt -99.54 118.1 35.38 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.584 -1.635 . . . . 0.92000000000000004 106.584 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -110.56 123.74 50.52 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.782 -1.562 . . . . 2.0299999999999998 106.782 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -131.38 158.25 41.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.946 -1.096 . . . . 2.6600000000000001 108.701 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -84.95 138.79 32.27 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.782 -0.822 . . . . 2.3199999999999998 108.782 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.41 156.33 36.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.948 . . . . 2.1099999999999999 109.496 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.7 mt -86.24 133.91 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.035 -1.041 . . . . 0.72999999999999998 108.444 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -110.38 130.71 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.815 -1.18 . . . . 0.87 107.815 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.8 mt -94.66 134.34 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.647 -0.871 . . . . 0.81000000000000005 108.647 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -92.41 120.5 32.97 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.086 -1.079 . . . . 1.3400000000000001 108.086 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.561 ' HG2' HH11 ' A' ' 28' ' ' ARG . 1.7 mmt-85 -93.56 16.98 12.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.007 -1.058 . . . . 2.8900000000000001 112.43 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -60.33 140.14 57.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.014 -1.054 . . . . 2.0899999999999999 109.81 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -87.65 132.51 34.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.839 -1.163 . . . . 2.1899999999999999 108.004 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 pt -96.89 165.55 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.75 110.584 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.7 p -97.91 170.45 8.95 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.241 -0.912 . . . . 0.91000000000000003 109.507 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.1 66.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.394 -0.816 . . . . 0.93000000000000005 111.454 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.64 -33.47 74.07 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.436 -0.79 . . . . 2.2799999999999998 110.648 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -90.95 -7.57 51.7 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.738 -1.226 . . . . 1.45 112.502 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.48 -42.67 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.81000000000000005 110.183 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -58.11 -39.91 79.88 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.307 -0.871 . . . . 1.54 111.136 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -63.44 -43.92 96.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.734 -0.604 . . . . 2.3599999999999999 111.233 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -60.67 -40.15 91.03 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.803 -1.186 . . . . 1.3100000000000001 110.189 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.6 t -60.68 -40.83 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.108 -0.995 . . . . 0.81999999999999995 109.963 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -61.59 -44.86 96.24 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.447 -0.783 . . . . 1.5 110.223 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 42' ' ' ARG . 43.5 mtt-85 -62.11 -40.05 94.59 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.33 -0.856 . . . . 2.23 110.152 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -70.53 -57.17 5.05 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.36 -0.837 . . . . 0.84999999999999998 110.235 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.79 -47.4 85.84 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.914 -1.115 . . . . 0.91000000000000003 109.582 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.8 t -69.33 -37.46 77.73 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.399 -0.92 . . . . 0.90000000000000002 109.814 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.05 -43.28 93.26 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.053 -1.546 . . . . 0.68999999999999995 109.681 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -59.87 -30.66 69.14 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.167 0.984 . . . . 2.8799999999999999 109.476 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.38 -41.79 90.15 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.427 -0.796 . . . . 0.84999999999999998 110.348 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -80.22 -49.77 11.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.371 -0.932 . . . . 2.3500000000000001 110.699 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.91 76.8 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.468 -0.77 . . . . 0.65000000000000002 110.279 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.4 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 94.7 p -60.09 -40.35 89.31 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.136 0.97 . . . . 1.45 109.178 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -47.53 44.42 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.834 0.826 . . . . 0.63 110.733 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -64.5 -48.31 75.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.521 -1.362 . . . . 1.3400000000000001 110.958 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.18 -37.98 89.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.726 -0.789 . . . . 1.5600000000000001 109.842 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 51' ' ' SER . 17.5 mm-40 -59.81 -40.33 88.04 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.275 -0.57 . . . . 1.1899999999999999 110.272 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.1 m -63.76 -42.24 97.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.234 -0.916 . . . . 0.71999999999999997 110.343 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 99.5 mt -59.97 -37.3 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.716 0.77 . . . . 0.62 110.268 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -50.4 -44.24 54.91 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.46 -0.775 . . . . 1.05 110.753 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -69.12 -33.71 73.9 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.156 -0.965 . . . . 0.64000000000000001 110.225 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -64.22 -40.28 95.72 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.185 -1.406 . . . . 1.73 109.526 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.75 -30.16 71.16 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.856 -0.738 . . . . 0.56000000000000005 110.151 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.12 -34.18 18.5 Favored Glycine 0 N--CA 1.484 1.872 0 C-N-CA 119.559 -1.305 . . . . 0.68999999999999995 110.893 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -81.7 -20.41 39.49 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.358 -1.083 . . . . 1.48 111.199 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.5 m -90.16 -51.98 5.18 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 120.941 0.401 . . . . 0.97999999999999998 110.842 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -107.83 -9.12 15.81 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 113.616 0.969 . . . . 1.1599999999999999 113.616 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.09 167.01 23.12 Favored Glycine 0 N--CA 1.502 3.09 0 O-C-N 121.24 -0.913 . . . . 0.84999999999999998 112.764 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.96 -21.94 59.34 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.785 -0.833 . . . . 3.8599999999999999 112.131 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -57.7 -40.05 78.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.959 -1.088 . . . . 2.3500000000000001 110.905 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -87.07 -25.48 24.15 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.43 -0.908 . . . . 1.6699999999999999 111.459 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -60.65 -38.0 83.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.904 -0.497 . . . . 1.45 111.405 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.12 90.35 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.242 -0.911 . . . . 0.60999999999999999 112.055 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -64.77 -41.72 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.339 -1.476 . . . . 0.65000000000000002 110.381 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -69.44 -32.09 70.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.603 -1.311 . . . . 0.66000000000000003 110.428 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -59.44 -39.73 84.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.783 -1.198 . . . . 1.1899999999999999 109.909 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.74 97.95 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.894 -0.883 . . . . 0.53000000000000003 110.894 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -59.77 -41.2 90.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.906 -1.349 . . . . 1.27 110.633 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.4 mt -60.29 -38.16 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.807 -1.183 . . . . 0.54000000000000004 110.658 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.7 ttp -58.85 -39.78 82.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.917 . . . . 1.74 110.528 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.65 -48.26 81.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.917 -1.115 . . . . 0.55000000000000004 110.629 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.2 tp -59.92 -40.92 90.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.493 -0.755 . . . . 0.46999999999999997 110.435 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -86.06 6.09 30.58 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.022 -0.671 . . . . 1.4199999999999999 112.508 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -60.33 121.82 12.98 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.917 -1.114 . . . . 1.27 109.348 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -68.0 -17.63 64.48 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 121.145 -0.972 . . . . 1.3500000000000001 110.792 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -74.14 -46.7 40.8 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.787 -1.165 . . . . 2.2200000000000002 110.419 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.0 -35.47 80.82 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.209 -0.996 . . . . 0.62 110.023 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -58.69 -45.09 90.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.166 -0.959 . . . . 1.29 110.798 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -63.98 -41.6 97.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.926 -1.109 . . . . 1.52 110.78 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -67.98 -49.53 61.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.737 -1.227 . . . . 1.3 110.506 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.12 -43.49 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 118.978 -1.089 . . . . 0.60999999999999999 110.372 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.433 HG22 ' NZ ' ' A' ' 94' ' ' LYS . 52.2 mt -62.17 -43.85 98.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.107 -0.996 . . . . 0.78000000000000003 110.54 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.36 -41.13 93.07 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.251 -0.906 . . . . 0.81999999999999995 110.894 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.31 -44.28 95.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.162 -0.961 . . . . 0.80000000000000004 110.606 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.71 -49.2 83.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.266 -0.896 . . . . 0.77000000000000002 110.322 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.433 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 20.5 mtmm -82.43 -28.59 31.25 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.603 -1.31 . . . . 2.1200000000000001 112.182 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -79.16 -45.66 19.5 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 120.242 -1.536 . . . . 1.51 111.293 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -104.62 7.59 35.04 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.752 -1.218 . . . . 1.98 111.884 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.8 m80 54.26 50.15 17.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 1.3200000000000001 112.291 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 73.2 mtm -105.88 161.0 14.83 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.722 -1.236 . . . . 1.3799999999999999 109.502 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.1 p -72.75 158.89 34.71 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.846 0.832 . . . . 0.67000000000000004 109.368 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.68 87.99 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.148 -0.97 . . . . 0.52000000000000002 110.658 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.55 ' OD2' HD21 ' A' ' 142' ' ' LEU . 98.9 m-20 -67.34 -40.75 85.88 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.805 -1.184 . . . . 2.25 110.069 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.43 39.8 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.207 -0.997 . . . . 0.64000000000000001 110.816 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.13 96.52 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.661 0.743 . . . . 0.56000000000000005 110.338 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.43 93.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.648 -0.658 . . . . 0.46000000000000002 111.08 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.75 -38.97 83.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.307 -0.871 . . . . 1.3200000000000001 111.335 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.14 -48.28 82.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.091 -1.006 . . . . 1.3 111.19 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.56 -43.22 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.658 -1.217 . . . . 0.60999999999999999 110.225 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.61 -33.08 53.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.799 -0.563 . . . . 0.65000000000000002 110.697 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -59.53 -40.21 86.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.351 -0.54 . . . . 2.1099999999999999 110.745 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.92 -30.52 25.89 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.018 -1.563 . . . . 0.82999999999999996 113.128 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -61.37 -40.43 94.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.216 -1.755 . . . . 1.28 109.69 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.23 -45.72 59.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.064 0.935 . . . . 0.89000000000000001 109.718 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.2 m -60.36 -39.24 86.5 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.346 0.593 . . . . 1.8700000000000001 110.049 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.83 -46.51 89.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.416 -0.803 . . . . 1.05 110.866 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 90.2 mt -66.03 -26.89 67.73 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.506 -1.371 . . . . 1.02 110.87 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -66.22 -26.45 67.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.875 . . . . 2.04 111.572 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -70.65 -13.48 62.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.943 -1.103 . . . . 1.73 111.48 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 78.8 mt -88.72 140.2 29.69 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.838 0.828 . . . . 1.3700000000000001 109.383 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -94.85 41.44 1.09 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.816 -1.178 . . . . 2.8799999999999999 111.258 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -111.87 133.42 54.08 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.07 0.938 . . . . 1.5800000000000001 108.903 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.59 -29.2 69.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.708 -0.62 . . . . 3.04 111.348 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.03 -60.32 2.38 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.655 -1.278 . . . . 0.90000000000000002 110.703 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.78 -38.2 90.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 1.0600000000000001 110.801 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -63.38 -50.88 68.15 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.779 -1.201 . . . . 2.1800000000000002 110.093 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.67 -32.17 71.38 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.094 -1.042 . . . . 2.1499999999999999 109.602 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.519 ' O ' HG23 ' A' ' 130' ' ' VAL . 37.4 ttp180 -65.89 -26.97 67.86 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.778 0.799 . . . . 2.3300000000000001 109.485 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -58.88 -47.88 83.38 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.599 -0.84 . . . . 0.81999999999999995 108.998 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.81 -43.92 91.57 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.306 -0.957 . . . . 0.84999999999999998 110.017 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -64.29 -31.38 72.56 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.422 0.629 . . . . 1.3899999999999999 110.446 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 126' ' ' ARG . 32.3 t -68.7 -39.19 79.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 C-N-CA 119.942 -0.703 . . . . 0.56000000000000005 109.961 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.404 ' NH1' ' HG3' ' A' ' 131' ' ' ARG . 38.1 ttm-85 -59.32 -38.01 79.2 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.73 -1.188 . . . . 3.1200000000000001 109.285 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -59.92 -38.94 83.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.881 -0.512 . . . . 1.28 110.602 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.7 mt -60.33 -40.0 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.975 -1.078 . . . . 0.48999999999999999 110.148 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.12 -46.96 93.28 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.475 -1.05 . . . . 0.46000000000000002 110.475 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -59.99 -41.08 91.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.966 -1.314 . . . . 2.71 110.658 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -60.07 -42.7 95.13 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.315 -0.865 . . . . 2.1400000000000001 110.18 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.41 -40.41 94.3 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.174 0.988 . . . . 1.05 109.881 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.0 mt -61.66 -40.67 95.76 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.353 -0.842 . . . . 0.52000000000000002 110.746 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -61.34 -38.2 86.05 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.509 -0.745 . . . . 2.3500000000000001 111.316 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -74.4 -42.6 58.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.954 -1.091 . . . . 1.3899999999999999 110.993 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.21 -38.95 79.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.013 -1.054 . . . . 0.68000000000000005 110.553 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.55 HD21 ' OD2' ' A' ' 101' ' ' ASP . 83.9 mt -87.35 -3.08 59.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.829 -1.169 . . . . 0.82999999999999996 111.793 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.83 23.03 78.64 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.613 -1.28 . . . . 0.91000000000000003 113.577 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.5 tp -61.97 150.04 38.99 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 122.053 -0.675 . . . . 0.94999999999999996 109.746 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -66.93 157.27 33.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.503 -0.748 . . . . 2.4300000000000002 110.16 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.4 mt -101.18 139.5 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.46 -0.941 . . . . 1.1000000000000001 108.46 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.761 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.3 mp -79.49 120.51 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.797 -1.186 . . . . 1.5800000000000001 107.797 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -98.62 93.41 6.1 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.881 -1.525 . . . . 1.6200000000000001 106.881 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.6 mt -75.39 -21.29 58.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.898 . . . . 0.80000000000000004 111.599 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.5 t -82.77 10.24 8.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.169 -0.957 . . . . 1.5600000000000001 112.101 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.95 18.52 14.49 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.269 -0.894 . . . . 0.83999999999999997 112.435 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.408 ' O ' ' CD ' ' A' ' 175' ' ' LYS . 23.8 mt -75.28 141.03 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.203 -0.935 . . . . 0.81999999999999995 110.015 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -117.62 -13.67 10.24 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.361 -0.837 . . . . 2.3100000000000001 112.795 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -117.03 141.95 47.59 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.612 -0.884 . . . . 1.54 108.612 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -77.04 122.83 25.49 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.271 -1.011 . . . . 1.3799999999999999 108.271 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.2 m -147.31 178.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.226 -0.657 . . . . 0.68999999999999995 109.226 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.4 mt -87.4 143.92 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.683 -0.858 . . . . 0.53000000000000003 108.683 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 34.7 tp -97.57 126.1 42.67 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.912 -1.118 . . . . 0.64000000000000001 108.367 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.0 t -126.43 129.23 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.126 -1.065 . . . . 0.67000000000000004 108.126 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.17 159.91 32.23 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.272 -0.893 . . . . 0.78000000000000003 108.601 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.18 93.34 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.539 -1.264 . . . . 1.0 109.97 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 46.8 p-10 -173.96 150.02 1.57 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.304 -0.628 . . . . 2.4199999999999999 109.304 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.2 mt -115.41 141.54 47.91 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.346 -0.846 . . . . 0.75 109.276 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.9 p -93.92 150.7 38.98 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.162 -0.961 . . . . 0.78000000000000003 108.455 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -39.25 -44.97 2.91 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.772 1.648 . . . . 0.67000000000000004 113.243 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.3 m -59.58 -49.41 77.86 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.168 -0.957 . . . . 0.69999999999999996 110.306 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.34 -40.4 94.1 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.743 -0.783 . . . . 1.21 110.001 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.9 p -67.58 -37.12 82.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.815 0.817 . . . . 0.59999999999999998 110.222 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.18 -39.84 87.9 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.519 -0.738 . . . . 0.62 110.54 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -94.21 0.22 55.57 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.094 -1.004 . . . . 1.1599999999999999 113.105 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.89 149.21 41.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.738 -1.226 . . . . 0.72999999999999998 108.498 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -94.45 114.71 26.77 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 106.812 -1.551 . . . . 2.2400000000000002 106.812 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 173' ' ' LEU . 10.6 mp -80.79 -10.41 59.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.552 -0.718 . . . . 1.4299999999999999 112.435 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -83.45 -23.25 32.33 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.984 -1.073 . . . . 2.1499999999999999 111.954 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.408 ' CD ' ' O ' ' A' ' 152' ' ' ILE . 90.7 mttt -105.41 4.16 30.44 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.22 -0.925 . . . . 2.04 112.777 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.9 t -108.85 128.63 64.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.929 -1.137 . . . . 0.55000000000000004 107.929 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.713 ' O ' HD23 ' A' ' 177' ' ' LEU . 2.0 tt -92.93 -6.31 48.83 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.208 1.004 . . . . 1.6299999999999999 111.53 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.39 168.28 37.51 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.746 -1.741 . . . . 0.46999999999999997 108.746 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -124.04 128.85 49.95 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.559 -1.274 . . . . 0.54000000000000004 107.559 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.9 mt -130.77 129.86 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.968 -1.864 . . . . 0.68999999999999995 105.968 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.2 p -140.94 176.1 9.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.167 -0.958 . . . . 0.81999999999999995 109.981 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.497 ' OD2' HG23 ' A' ' 209' ' ' THR . 2.8 m-20 -110.38 45.13 1.15 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.892 -0.505 . . . . 2.3700000000000001 110.757 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.005 0 O-C-N 121.164 -0.96 . . . . 1.1100000000000001 108.924 179.227 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 112.946 0.721 . . . . 1.6899999999999999 112.946 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -49.49 -40.82 38.8 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.143 -1.023 . . . . 1.0700000000000001 110.161 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.6 p -62.11 -40.8 97.12 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.366 -0.934 . . . . 1.5800000000000001 109.389 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.9 p -60.87 -35.25 76.13 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 119.668 -0.813 . . . . 1.6000000000000001 109.863 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 77.1 mt -58.79 -39.61 77.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.461 -0.895 . . . . 1.45 109.934 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.8 mtp -60.93 -44.23 97.51 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.781 1.276 . . . . 1.05 109.126 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.1 -43.97 95.19 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.966 -1.015 . . . . 0.71999999999999997 110.532 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.471 ' HG2' HH11 ' A' ' 195' ' ' ARG . 28.7 mtt-85 -60.04 -44.2 94.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.995 -1.066 . . . . 3.0499999999999998 110.09 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 35.3 m -68.48 -39.07 81.49 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.099 0.952 . . . . 0.89000000000000001 109.646 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.77 -4.07 56.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.068 -1.02 . . . . 0.78000000000000003 112.659 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.0 mt-10 53.61 9.87 0.2 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.212 1.19 . . . . 1.45 114.212 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 32.7 mt -72.12 150.06 92.21 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 120.581 -1.324 . . . . 0.67000000000000004 108.378 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.0 143.51 99.77 Favored 'Trans proline' 0 N--CA 1.511 2.554 0 C-N-CA 121.623 1.549 . . . . 0.64000000000000001 110.11 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.92 160.91 31.47 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 117.683 -1.607 . . . . 0.67000000000000004 109.701 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 220' ' ' LEU . 15.0 mt -148.32 149.72 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.088 -1.079 . . . . 0.68999999999999995 108.088 177.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 181' ' ' THR . 19.7 m -133.93 -29.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 C-N-CA 119.281 -0.967 . . . . 0.84999999999999998 112.78 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.39 35.65 1.55 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.76 -1.209 . . . . 0.92000000000000004 113.907 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 35.2 p -56.98 -25.49 58.33 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.234 -1.157 . . . . 0.94999999999999996 111.227 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.45 -91.4 1.72 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.032 -1.227 . . . . 1.04 110.032 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.8 p -129.31 29.97 5.05 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.295 -1.121 . . . . 1.5700000000000001 112.683 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.2 t -56.56 -35.09 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.246 -1.534 . . . . 0.83999999999999997 110.764 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.497 HG23 ' OD2' ' A' ' 182' ' ' ASP . 45.4 p -60.58 -21.43 62.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.038 . . . . 0.98999999999999999 111.491 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 67.5 m -97.2 1.74 50.14 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.568 0.699 . . . . 1.7 111.997 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -126.08 -0.96 7.13 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.227 0.825 . . . . 2.2000000000000002 113.227 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 213' ' ' LYS . 56.0 t -126.02 155.43 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.139 -0.975 . . . . 0.83999999999999997 110.182 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.412 ' N ' HG12 ' A' ' 212' ' ' VAL . 1.1 mptm? -115.7 157.69 23.89 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.06 -1.089 . . . . 2.2000000000000002 108.06 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 32.2 p-10 -58.86 144.18 45.24 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.56 -1.256 . . . . 2.2799999999999998 109.922 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER 81.39 -3.05 1.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.081 1.141 . . . . 2.3500000000000001 114.081 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 40.0 t0 -61.61 149.96 37.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.882 -1.136 . . . . 1.97 109.129 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.514 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 37.0 t80 -88.58 124.39 33.99 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.412 -1.329 . . . . 2.6499999999999999 107.412 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.5 mt -130.3 149.36 52.03 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.331 -0.856 . . . . 0.63 109.307 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.7 mt -112.75 123.4 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.064 -1.828 . . . . 0.62 106.064 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.531 HD11 HD12 ' A' ' 202' ' ' ILE . 49.2 tp -98.72 119.48 37.54 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.087 -1.82 . . . . 0.64000000000000001 106.087 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 27.4 t0 -93.78 -25.18 17.51 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.086 -1.009 . . . . 2.0499999999999998 112.836 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.945 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.64 14.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.153 0.797 . . . . 0.83999999999999997 113.153 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 37.1 t -111.18 -62.31 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.119 -0.988 . . . . 1.02 109.258 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -90.27 9.14 29.85 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.398 1.094 . . . . 2.5099999999999998 110.987 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.18 49.71 3.25 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.436 -0.802 . . . . 1.54 111.645 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -146.93 148.77 32.11 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.635 -1.29 . . . . 1.95 109.734 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.0 t -117.32 139.29 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.216 -1.031 . . . . 0.70999999999999996 108.216 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -99.26 134.95 41.38 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.118 -1.067 . . . . 1.01 108.118 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.71 129.93 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.755 -0.832 . . . . 0.81999999999999995 108.755 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.431 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 42.4 t-20 49.1 50.29 8.93 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.01 0.744 . . . . 1.54 113.01 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.5 Cg_endo -62.26 149.95 88.75 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.342 2.028 . . . . 0.93999999999999995 110.883 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 6.0 m -74.53 156.06 37.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.252 -0.905 . . . . 1.8 109.151 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -59.35 -38.42 80.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 2.73 110.218 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -58.83 -41.05 85.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.231 -0.918 . . . . 3.1699999999999999 110.367 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.66 -41.09 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.13 0.967 . . . . 1.3400000000000001 109.892 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 85.1 mt -60.03 -47.99 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 1.2 110.391 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -59.28 -42.52 91.46 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.458 -0.897 . . . . 2.7000000000000002 110.26 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -61.37 -41.54 97.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 2.5899999999999999 110.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 81.6 mtp -71.48 -37.79 71.28 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.09 -1.006 . . . . 1.3799999999999999 111.201 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 120.635 -1.29 . . . . 2.8399999999999999 110.321 179.517 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.9 mt . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 121.258 0.552 . . . . 1.0700000000000001 111.914 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 m -95.57 113.58 25.24 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.614 -1.624 . . . . 1.24 106.614 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.66 -149.16 25.21 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.111 -1.196 . . . . 1.01 110.111 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 5' ' ' ILE . 93.2 mt -96.65 -0.93 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -1.04 . . . . 1.1100000000000001 112.864 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 tp 49.49 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.064 -1.022 . . . . 0.98999999999999999 112.725 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.77 -43.51 12.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.072 -1.018 . . . . 0.84999999999999998 111.168 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 t -145.76 136.08 12.04 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.138 -1.06 . . . . 1.3799999999999999 108.138 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.43 149.79 45.24 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.38 2.053 . . . . 0.93999999999999995 112.249 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.899 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.25 164.34 12.26 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.554 -1.819 . . . . 0.81000000000000005 108.554 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.0 mt -120.89 133.92 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.285 -1.127 . . . . 0.82999999999999996 108.273 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.23 149.99 43.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.318 -0.864 . . . . 0.53000000000000003 109.129 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.3 m-85 -121.25 140.39 52.11 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.179 -1.045 . . . . 0.77000000000000002 108.179 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.2 166.99 35.96 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 118.998 -1.573 . . . . 0.51000000000000001 109.419 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -78.13 158.33 29.13 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.65 -0.912 . . . . 1.8999999999999999 108.98 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -82.75 131.9 35.19 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.886 -1.134 . . . . 0.66000000000000003 109.206 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.8 tp -113.67 102.7 10.51 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 105.609 -1.997 . . . . 0.82999999999999996 105.609 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.6 tp -90.67 137.15 32.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.913 -1.117 . . . . 0.85999999999999999 108.116 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 158' ' ' LEU . 59.3 mt -102.57 119.47 38.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.469 -1.678 . . . . 0.92000000000000004 106.469 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -110.68 135.06 51.87 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.674 -1.232 . . . . 2.0299999999999998 107.674 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -126.28 137.49 53.51 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.404 -0.962 . . . . 2.6600000000000001 108.404 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -82.73 135.47 34.99 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.794 -1.187 . . . . 2.3199999999999998 107.794 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -62.22 149.21 42.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.579 -0.701 . . . . 2.1099999999999999 109.186 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.94 134.78 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.72 -0.845 . . . . 0.72999999999999998 108.72 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -107.48 129.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.626 -1.25 . . . . 0.87 107.626 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.0 mt -93.78 140.29 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.81000000000000005 109.201 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -88.18 121.22 30.32 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.838 -1.171 . . . . 1.3400000000000001 107.838 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -95.02 16.16 16.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 2.8900000000000001 112.213 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -65.14 142.68 58.27 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.071 -1.018 . . . . 2.0899999999999999 109.027 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -88.88 134.85 33.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.886 -1.153 . . . . 2.1899999999999999 107.886 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 pt -98.15 165.02 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.3 -0.875 . . . . 0.75 110.313 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 p -99.29 168.79 9.8 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.298 0.57 . . . . 0.91000000000000003 109.702 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.89 -27.9 46.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.249 -0.907 . . . . 0.93000000000000005 112.642 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 35' ' ' GLN . 37.1 p-10 -70.07 -31.84 69.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.222 -0.924 . . . . 2.2799999999999998 110.825 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.562 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 73.0 mt-30 -92.31 -7.9 46.64 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.612 -1.305 . . . . 1.45 112.792 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.18 -43.15 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.892 . . . . 0.81000000000000005 110.833 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -57.94 -39.16 77.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.075 -1.016 . . . . 1.54 110.828 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.78 -43.29 99.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.987 -1.071 . . . . 2.3599999999999999 111.147 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.96 -39.6 92.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.778 -1.201 . . . . 1.3100000000000001 110.937 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.2 t -60.72 -42.43 92.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.192 -0.943 . . . . 0.81999999999999995 110.366 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -61.77 -45.15 95.13 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.585 -0.846 . . . . 1.5 109.962 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' A' ' 42' ' ' ARG . 51.2 mtt-85 -61.61 -42.01 98.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.875 -1.141 . . . . 2.23 109.663 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -71.68 -55.71 7.18 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.507 -0.745 . . . . 0.84999999999999998 109.829 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.9 tp -58.09 -47.6 82.73 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.445 -0.902 . . . . 0.91000000000000003 109.643 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.4 t -68.13 -36.3 79.49 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.441 -0.787 . . . . 0.90000000000000002 109.702 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.66 -40.23 87.78 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.582 -1.407 . . . . 0.68999999999999995 109.582 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -58.86 -34.25 71.38 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 122.076 0.941 . . . . 2.8799999999999999 109.205 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.98 -48.97 79.51 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.934 0.873 . . . . 0.84999999999999998 109.863 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -81.38 -45.62 15.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -0.822 . . . . 2.3500000000000001 110.949 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.67 86.04 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.644 -0.822 . . . . 0.65000000000000002 110.397 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 t -59.94 -40.28 88.44 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.105 0.955 . . . . 1.45 109.127 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.57 -44.78 81.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.953 -0.567 . . . . 0.63 110.219 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -62.41 -52.11 64.88 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.997 -1.081 . . . . 1.3400000000000001 110.162 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.84 -40.87 94.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.171 -0.955 . . . . 1.5600000000000001 110.153 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -59.99 -40.0 87.65 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.685 -0.634 . . . . 1.1899999999999999 110.583 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -64.83 -41.8 95.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.9 -1.125 . . . . 0.71999999999999997 110.615 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.43 -38.89 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.227 -0.921 . . . . 0.62 110.798 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -51.42 -44.5 62.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.244 -0.91 . . . . 1.05 110.538 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -68.96 -38.21 79.27 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.987 -1.071 . . . . 0.64000000000000001 110.086 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -62.07 -38.95 90.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.314 -0.955 . . . . 1.73 109.641 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.28 -31.47 70.01 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.206 0.527 . . . . 0.56000000000000005 109.748 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.93 -37.68 12.63 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.584 -1.293 . . . . 0.68999999999999995 111.017 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.51 -23.99 36.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.773 -1.427 . . . . 1.48 111.119 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.6 m -87.13 -50.58 6.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.97999999999999998 110.68 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.04 -8.7 16.45 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.194 1.183 . . . . 1.1599999999999999 114.194 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.73 164.93 23.37 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 121.249 -0.907 . . . . 0.84999999999999998 112.734 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -55.11 -13.91 1.4 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.85 -0.794 . . . . 3.8599999999999999 112.925 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -58.75 -37.4 76.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.101 -1.0 . . . . 2.3500000000000001 111.236 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -85.34 -19.18 31.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.816 -1.177 . . . . 1.6699999999999999 112.693 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -59.61 -39.64 84.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.733 -1.229 . . . . 1.45 111.047 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.0 -41.23 91.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 0.60999999999999999 110.945 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.92 -47.3 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.62 -1.3 . . . . 0.65000000000000002 110.119 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -69.88 -31.97 70.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.66000000000000003 110.662 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -58.81 -38.61 79.02 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 1.1899999999999999 109.731 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.82 -36.03 73.8 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 110.261 -1.135 . . . . 0.53000000000000003 110.261 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -59.18 -46.49 88.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.167 -1.196 . . . . 1.27 110.72 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.73 -39.77 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.54000000000000004 109.956 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.0 ttp -59.13 -39.63 82.94 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.93 -0.708 . . . . 1.74 109.911 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 tp -57.57 -50.08 74.27 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.888 -1.125 . . . . 0.55000000000000004 110.676 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.89 -40.47 93.2 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.715 0.769 . . . . 0.46999999999999997 109.953 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -86.65 7.42 26.6 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 112.445 0.535 . . . . 1.4199999999999999 112.445 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 57.7 t0 -60.87 120.7 10.68 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.875 -1.14 . . . . 1.27 108.502 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -64.86 -19.81 66.08 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.711 0.767 . . . . 1.3500000000000001 110.876 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.445 ' OE1' ' OD1' ' A' ' 82' ' ' ASP . 21.7 mp0 -77.63 -52.99 8.1 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.357 -0.839 . . . . 2.2200000000000002 110.327 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.87 -40.16 87.68 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.508 -0.877 . . . . 0.62 110.444 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -57.1 -49.48 75.76 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.279 -0.888 . . . . 1.29 110.597 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -62.33 -36.94 83.74 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.355 -0.841 . . . . 1.52 110.589 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -67.83 -47.63 68.48 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.352 -0.939 . . . . 1.3 110.682 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.9 mt -57.45 -42.05 79.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.281 -0.887 . . . . 0.60999999999999999 110.044 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.8 mt -62.48 -41.73 93.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 121.405 0.622 . . . . 0.78000000000000003 110.101 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.56 98.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.67 -0.644 . . . . 0.81999999999999995 111.226 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.69 -42.81 93.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.884 -1.135 . . . . 0.80000000000000004 110.575 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.47 -50.33 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 0.77000000000000002 110.351 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.56 -38.71 65.12 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.218 -0.926 . . . . 2.1200000000000001 111.862 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -81.67 -44.93 16.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.709 -1.244 . . . . 1.51 112.169 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HB3' ' HZ3' ' A' ' 96' ' ' LYS . 9.0 mmmm -100.49 10.14 41.61 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.976 -1.078 . . . . 1.98 112.166 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.6 m80 49.14 50.59 17.71 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.728 -1.232 . . . . 1.3200000000000001 111.304 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -104.45 151.76 23.16 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.461 -0.774 . . . . 1.3799999999999999 109.747 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.9 p -72.82 167.56 20.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.67000000000000004 110.24 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.37 86.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.52000000000000002 110.334 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -67.12 -40.21 86.79 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.074 -1.016 . . . . 2.25 110.408 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.37 -49.72 58.19 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.232 -0.987 . . . . 0.64000000000000001 111.128 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.71 98.22 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.265 -0.897 . . . . 0.56000000000000005 110.299 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.86 97.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.25 -0.906 . . . . 0.46000000000000002 111.09 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -60.48 -40.08 89.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.015 . . . . 1.3200000000000001 111.272 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -59.91 -48.97 79.51 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.728 -1.233 . . . . 1.3 111.063 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.52 -46.53 96.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.004 -1.06 . . . . 0.60999999999999999 110.13 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.16 -32.39 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.711 -0.618 . . . . 0.65000000000000002 110.316 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -55.99 -41.09 74.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.486 -0.758 . . . . 2.1099999999999999 110.77 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.38 -34.86 10.0 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.098 -1.525 . . . . 0.82999999999999996 112.378 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -62.13 -44.34 96.86 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.701 -1.47 . . . . 1.28 110.179 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.29 -52.36 19.29 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.772 0.796 . . . . 0.89000000000000001 110.695 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.8 p -60.07 -37.57 80.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.514 -0.741 . . . . 1.8700000000000001 110.48 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.51 -44.33 97.27 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.017 -0.673 . . . . 1.05 110.501 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.2 mt -61.75 -29.96 70.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.576 -1.327 . . . . 1.02 110.528 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -67.12 -22.4 65.8 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.339 -0.851 . . . . 2.04 111.411 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -73.18 -15.35 61.45 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.318 -0.864 . . . . 1.73 111.245 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.532 HD13 HD13 ' A' ' 123' ' ' LEU . 7.0 mt -84.54 141.59 30.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.431 -0.793 . . . . 1.3700000000000001 108.896 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -94.92 39.46 1.1 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.077 -1.014 . . . . 2.8799999999999999 112.086 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -112.0 136.82 50.84 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.119 -1.067 . . . . 1.5800000000000001 108.119 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -59.77 -37.13 78.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.339 -0.851 . . . . 3.04 110.768 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -70.58 -57.84 4.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.79 -1.194 . . . . 0.90000000000000002 110.188 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.532 HD13 HD13 ' A' ' 118' ' ' LEU . 23.1 mt -59.9 -39.9 86.94 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.16 -0.962 . . . . 1.0600000000000001 110.335 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -62.53 -51.17 68.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.997 -1.064 . . . . 2.1800000000000002 110.119 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.31 -30.59 71.7 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.751 -0.78 . . . . 2.1499999999999999 109.816 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 130' ' ' VAL . 22.7 ttp180 -65.22 -28.91 69.7 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.026 -1.07 . . . . 2.3300000000000001 109.155 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.83 80.16 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.813 0.816 . . . . 0.81999999999999995 109.413 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.55 95.18 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.513 -0.875 . . . . 0.84999999999999998 109.692 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -64.95 -36.99 86.17 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.292 0.568 . . . . 1.3899999999999999 110.303 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 126' ' ' ARG . 46.8 t -67.9 -40.49 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 0.56000000000000005 109.802 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -59.88 -38.08 81.18 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.894 0.854 . . . . 3.1200000000000001 109.552 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -59.48 -38.99 82.27 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.287 0.565 . . . . 1.28 110.274 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.9 mt -61.46 -40.27 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.271 -0.893 . . . . 0.48999999999999999 109.977 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.4 48.68 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.94 -1.124 . . . . 0.46000000000000002 110.341 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -59.1 -45.99 89.45 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 120.994 -1.297 . . . . 2.71 110.087 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.432 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 58.6 mtm180 -62.32 -40.73 97.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.827 -1.17 . . . . 2.1400000000000001 109.998 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.61 -42.97 99.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 1.05 110.153 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.27 -45.41 93.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.52000000000000002 110.17 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -59.78 -33.93 72.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.556 -0.715 . . . . 2.3500000000000001 111.025 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -75.18 -40.45 59.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.207 -0.933 . . . . 1.3899999999999999 110.72 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.03 -39.96 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.68000000000000005 110.292 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.3 mt -88.68 -6.18 57.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.82999999999999996 111.942 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.72 71.01 Favored Glycine 0 N--CA 1.479 1.544 0 C-N-CA 119.304 -1.427 . . . . 0.91000000000000003 112.932 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.2 tp -61.08 151.83 29.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 122.012 -0.699 . . . . 0.94999999999999996 110.522 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -61.22 145.71 50.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.36 -0.837 . . . . 2.4300000000000002 109.1 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.9 mt -111.3 139.94 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.536 -0.913 . . . . 1.1000000000000001 108.536 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.8 mm -79.53 121.85 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.223 -1.029 . . . . 1.5800000000000001 108.223 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -97.4 95.52 7.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.37 -1.715 . . . . 1.6200000000000001 106.37 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.46 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 76.8 mt -75.51 -23.26 56.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.629 -0.669 . . . . 0.80000000000000004 111.332 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.7 t -79.53 -0.68 34.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.176 -0.952 . . . . 1.5600000000000001 112.334 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.08 22.84 8.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.737 -0.602 . . . . 0.83999999999999997 112.46 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.46 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 11.3 mt -72.05 137.36 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.695 . . . . 0.81999999999999995 109.543 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -112.47 -19.43 12.14 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.714 0.769 . . . . 2.3100000000000001 112.828 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -117.44 138.95 51.5 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.53 -1.285 . . . . 1.54 107.53 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.35 122.02 21.37 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.001 -1.111 . . . . 1.3799999999999999 108.001 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.8 m -145.63 177.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.438 -0.788 . . . . 0.68999999999999995 109.291 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.3 mt -88.26 140.97 14.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.517 -0.74 . . . . 0.53000000000000003 109.341 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 19' ' ' LEU . 26.4 tp -94.12 124.17 37.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.969 -1.082 . . . . 0.64000000000000001 108.143 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.8 t -125.36 130.21 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.131 -1.063 . . . . 0.67000000000000004 108.131 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.63 152.41 21.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.454 -0.779 . . . . 0.78000000000000003 109.226 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.24 82.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.495 -1.378 . . . . 1.0 109.738 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 49.6 t0 -172.72 146.48 1.64 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.03 -0.729 . . . . 2.4199999999999999 109.03 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.423 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 83.6 mt -119.35 141.27 49.18 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.406 -0.809 . . . . 0.75 109.304 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 65.7 p -91.59 152.41 43.41 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 120.848 -1.158 . . . . 0.78000000000000003 108.364 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -41.6 -39.12 4.56 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.081 1.854 . . . . 0.67000000000000004 113.848 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.432 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 27.4 m -59.91 -47.06 87.29 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.69999999999999996 110.184 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -67.6 -40.52 84.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.793 . . . . 1.21 109.948 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.9 p -68.42 -37.91 80.74 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.917 -0.713 . . . . 0.59999999999999998 110.223 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.55 82.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.945 . . . . 0.62 110.526 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -93.18 -2.67 55.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.054 . . . . 1.1599999999999999 112.792 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.37 146.23 51.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.05 -1.031 . . . . 0.72999999999999998 108.434 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -96.42 118.86 33.82 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.786 -1.561 . . . . 2.2400000000000002 106.786 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.72 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.3 mm? -76.85 -14.55 59.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.446 -0.784 . . . . 1.4299999999999999 111.451 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -80.05 -27.35 39.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.535 -0.728 . . . . 2.1499999999999999 111.807 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -100.83 1.19 39.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.149 -0.969 . . . . 2.04 113.204 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 178' ' ' GLY . 61.3 t -110.14 129.97 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.584 -0.895 . . . . 0.55000000000000004 108.584 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.26 -11.32 43.91 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.359 -0.838 . . . . 1.6299999999999999 112.455 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.411 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 173.57 177.1 42.54 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.141 -1.584 . . . . 0.46999999999999997 109.141 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -133.45 132.66 41.35 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 107.784 -1.191 . . . . 0.54000000000000004 107.784 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.41 HG22 HG21 ' A' ' 205' ' ' THR . 77.5 mt -134.37 111.2 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 105.824 -1.917 . . . . 0.68999999999999995 105.824 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 205' ' ' THR . 54.2 p -130.32 171.99 12.33 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.679 -1.263 . . . . 0.81999999999999995 110.292 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -101.17 52.1 0.85 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.973 -0.558 . . . . 2.3700000000000001 110.222 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 108.693 -0.854 . . . . 1.1100000000000001 108.693 179.301 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 18.2 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 108.385 -0.968 . . . . 1.6899999999999999 108.385 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -59.87 -38.61 82.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.405 -0.81 . . . . 1.0700000000000001 110.545 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.3 p -54.13 -40.37 67.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 1.5800000000000001 110.587 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.2 t -59.62 -39.6 84.82 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.034 -1.041 . . . . 1.6000000000000001 109.71 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 33.6 mm -60.08 -39.22 79.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.583 -0.698 . . . . 1.45 110.394 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.5 mtp -62.51 -40.08 95.59 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.403 1.097 . . . . 1.05 109.786 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -56.2 -48.93 75.44 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.815 -0.63 . . . . 0.71999999999999997 110.749 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -60.16 -42.55 95.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.011 -1.056 . . . . 3.0499999999999998 110.605 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 64.9 m -69.96 -40.03 75.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.932 -1.105 . . . . 0.89000000000000001 110.347 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 26.7 mt -91.12 -7.98 50.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.78000000000000003 112.448 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 194' ' ' ALA . 48.3 mt-10 53.33 7.99 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.804 1.038 . . . . 1.45 113.804 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.26 150.48 92.0 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.933 . . . . 0.67000000000000004 108.646 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.04 144.17 90.61 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.285 1.323 . . . . 0.64000000000000001 109.263 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.73 162.26 34.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.119 -1.613 . . . . 0.67000000000000004 110.075 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.2 mt -147.31 152.41 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.028 -1.101 . . . . 0.68999999999999995 108.028 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.6 m -135.42 -32.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 121.288 -0.883 . . . . 0.84999999999999998 112.702 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.84 41.42 2.37 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 120.098 -1.049 . . . . 0.92000000000000004 111.399 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.458 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 43.2 p -64.14 -17.17 63.22 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.453 -1.028 . . . . 0.94999999999999996 111.508 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.69 -95.81 0.91 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.945 -1.122 . . . . 1.04 110.345 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 88.8 p -127.25 30.8 5.34 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.849 -0.795 . . . . 1.5700000000000001 112.146 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 72.7 t -58.91 -33.15 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.389 -1.444 . . . . 0.83999999999999997 110.116 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 38.5 p -56.48 -24.04 43.35 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.71 -0.796 . . . . 0.98999999999999999 111.407 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.2 p -92.98 0.74 57.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.866 . . . . 1.7 112.001 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -123.55 -7.74 8.03 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.562 0.696 . . . . 2.2000000000000002 112.218 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 15.3 t -114.12 140.91 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.068 -0.716 . . . . 0.83999999999999997 109.068 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -115.96 150.0 37.87 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.331 -0.988 . . . . 2.2000000000000002 108.331 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.537 HD22 ' CG ' ' A' ' 215' ' ' ASP . 1.8 p-10 -52.1 141.08 19.22 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.28 -0.887 . . . . 2.2799999999999998 110.279 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.537 ' CG ' HD22 ' A' ' 214' ' ' ASN . 1.2 m-20 80.27 -0.75 1.99 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.948 1.092 . . . . 2.3500000000000001 113.948 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -64.77 149.02 50.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.78 -1.2 . . . . 1.97 108.745 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -87.33 116.01 25.13 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.381 -1.34 . . . . 2.6499999999999999 107.381 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.2 mt -128.38 144.73 51.17 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.513 0.673 . . . . 0.63 109.714 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 20.1 mt -115.81 128.61 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.698 -1.593 . . . . 0.62 106.698 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 48.9 tp -99.3 119.67 38.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 106.725 -1.584 . . . . 0.64000000000000001 106.725 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.6 t0 -94.46 -28.66 15.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.926 -1.109 . . . . 2.0499999999999998 112.333 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.899 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.61 17.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.005 0.743 . . . . 0.83999999999999997 113.005 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' A' ' 221' ' ' ASP . 32.1 t -107.33 -58.54 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -0.929 . . . . 1.02 108.948 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.449 ' HB2' HE21 ' A' ' 226' ' ' GLN . 31.8 m120 -92.15 11.23 26.22 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.888 0.851 . . . . 2.5099999999999998 110.545 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 62.51 50.79 3.47 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.616 -0.72 . . . . 1.54 112.504 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.449 HE21 ' HB2' ' A' ' 224' ' ' ASN . 21.6 pt20 -153.41 159.24 42.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.025 . . . . 1.95 109.945 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.0 t -116.43 141.65 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.127 -0.694 . . . . 0.70999999999999996 109.127 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -103.5 132.08 50.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.024 -1.047 . . . . 1.01 108.758 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.63 129.63 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 107.717 -1.216 . . . . 0.81999999999999995 107.717 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.435 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 54.0 t30 48.9 50.67 9.54 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 1.54 112.912 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 25.2 Cg_endo -64.13 154.26 71.64 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.42 2.08 . . . . 0.93999999999999995 110.541 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.6 m -74.55 156.51 36.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.074 -1.016 . . . . 1.8 109.489 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -58.74 -35.76 73.22 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.018 . . . . 2.73 110.774 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -59.57 -40.19 86.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 3.1699999999999999 110.015 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 96.8 t -69.64 -39.53 78.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.56 -0.713 . . . . 1.3400000000000001 110.236 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.3 mt -57.48 -43.93 83.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.64 -0.662 . . . . 1.2 110.613 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.46 -43.31 93.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.873 -1.142 . . . . 2.7000000000000002 110.317 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -63.64 -44.36 94.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.101 -1.0 . . . . 2.5899999999999999 111.126 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.9 mtp -68.75 -37.75 79.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.007 -1.058 . . . . 1.3799999999999999 110.874 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.471 -0.768 . . . . 2.8399999999999999 110.917 179.343 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.1 mt . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 106.806 -1.553 . . . . 1.0700000000000001 106.806 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.6 m -104.71 125.46 50.83 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.989 -1.115 . . . . 1.24 107.989 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.8 -154.57 18.45 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.252 -1.939 . . . . 1.01 108.252 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 5' ' ' ILE . 73.0 mt -96.07 -2.08 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -1.003 . . . . 1.1100000000000001 112.808 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 tp 49.57 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.98999999999999999 112.583 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -85.96 -42.92 13.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.991 -1.068 . . . . 0.84999999999999998 111.242 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -145.7 141.3 16.65 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 107.893 -1.151 . . . . 1.3799999999999999 107.893 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.05 147.83 30.61 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.233 1.956 . . . . 0.93999999999999995 112.333 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.904 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.94 166.74 15.67 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.818 -1.713 . . . . 0.81000000000000005 108.818 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -127.46 138.04 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.09 -1.241 . . . . 0.82999999999999996 108.004 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.55 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -141.48 160.06 40.93 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.964 0.888 . . . . 0.53000000000000003 109.466 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 11.9 m-85 -129.66 139.94 51.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.168 -1.419 . . . . 0.77000000000000002 107.168 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.69 169.2 38.4 Favored Glycine 0 N--CA 1.5 2.903 0 C-N-CA 119.04 -1.552 . . . . 0.51000000000000001 110.077 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -77.31 158.42 30.19 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.606 -0.887 . . . . 1.8999999999999999 108.606 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.646 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -88.09 128.28 35.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.167 -0.958 . . . . 0.66000000000000003 108.613 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 tp -108.43 105.68 15.45 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 105.124 -2.176 . . . . 0.82999999999999996 105.124 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.0 tp -94.73 132.6 39.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.107 -0.996 . . . . 0.85999999999999999 108.774 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.9 mt -101.78 118.16 36.36 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.161 -1.792 . . . . 0.92000000000000004 106.161 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -107.27 130.22 54.78 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.961 -1.125 . . . . 2.0299999999999998 107.961 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -128.46 140.71 51.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.453 -0.779 . . . . 2.6600000000000001 109.178 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.51 137.66 35.55 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.17 -1.048 . . . . 2.3199999999999998 108.17 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -65.57 150.8 47.81 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.208 -0.933 . . . . 2.1099999999999999 110.141 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.5 mt -89.11 134.05 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.89 -1.152 . . . . 0.72999999999999998 107.89 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.22 130.23 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.928 -1.138 . . . . 0.87 107.928 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.88 130.92 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.548 -0.908 . . . . 0.81000000000000005 108.548 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -92.74 127.01 38.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.232 -1.025 . . . . 1.3400000000000001 108.232 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 28' ' ' ARG . 23.4 mmm-85 -99.31 17.39 20.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.529 -0.732 . . . . 2.8900000000000001 112.277 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -61.95 144.49 54.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.783 -1.198 . . . . 2.0899999999999999 109.467 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -90.66 131.93 36.07 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.606 -0.886 . . . . 2.1899999999999999 108.606 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 pt -99.24 168.05 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.315 -0.866 . . . . 0.75 110.239 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.5 p -94.6 162.73 13.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.565 -0.71 . . . . 0.91000000000000003 109.825 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.37 -21.11 22.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.93000000000000005 111.667 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.76 -38.41 76.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.058 -1.026 . . . . 2.2799999999999998 110.597 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -88.4 -6.35 57.73 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.104 -0.997 . . . . 1.45 111.932 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.07 -41.21 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.049 -1.032 . . . . 0.81000000000000005 110.59 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -57.58 -40.08 78.22 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.907 -1.121 . . . . 1.54 110.736 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -63.2 -40.84 98.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 2.3599999999999999 111.265 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.3 -39.76 88.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.779 -1.201 . . . . 1.3100000000000001 110.875 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.2 -41.72 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.94 . . . . 0.81999999999999995 110.43 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -61.75 -42.6 99.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.021 -1.049 . . . . 1.5 110.071 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.48 ' NH2' ' O ' ' A' ' 141' ' ' ILE . 55.4 mtp180 -61.82 -42.54 99.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 2.23 110.371 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -73.11 -51.08 19.33 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.014 -1.054 . . . . 0.84999999999999998 110.162 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.45 -47.86 82.18 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.112 -1.435 . . . . 0.91000000000000003 110.238 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.9 t -69.63 -42.56 74.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.419 -0.8 . . . . 0.90000000000000002 110.469 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.81 -41.83 84.35 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.178 -1.487 . . . . 0.68999999999999995 109.395 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.553 HH22 ' CD ' ' A' ' 86' ' ' GLU . 17.7 ttm180 -57.45 -32.73 67.21 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.227 1.013 . . . . 2.8799999999999999 109.473 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.28 -42.43 81.64 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.806 0.813 . . . . 0.84999999999999998 109.669 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -79.75 -43.93 21.65 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.729 0.776 . . . . 2.3500000000000001 110.223 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.17 88.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.334 -0.854 . . . . 0.65000000000000002 109.929 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 t -59.57 -41.76 90.94 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.068 0.937 . . . . 1.45 109.289 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.48 -45.23 80.37 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.965 -0.562 . . . . 0.63 110.063 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -64.85 -50.2 67.58 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.052 -1.059 . . . . 1.3400000000000001 110.181 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.67 -37.61 84.71 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.658 -0.817 . . . . 1.5600000000000001 110.2 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -60.19 -42.81 95.85 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.551 -0.718 . . . . 1.1899999999999999 110.822 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.5 m -65.01 -44.2 90.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.019 -1.051 . . . . 0.71999999999999997 110.42 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.15 -36.76 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.54 -0.725 . . . . 0.62 110.674 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -50.81 -44.94 59.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.155 -0.965 . . . . 1.05 110.561 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -68.3 -37.49 80.69 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.135 -0.978 . . . . 0.64000000000000001 110.16 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.405 ' O ' ' OG1' ' A' ' 64' ' ' THR . 24.7 mtpp -61.49 -39.02 89.43 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.427 -1.309 . . . . 1.73 108.932 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.98 -38.76 87.11 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.799 -0.761 . . . . 0.56000000000000005 109.261 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.94 -40.04 58.01 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 119.692 -1.242 . . . . 0.68999999999999995 110.505 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -79.64 -20.15 47.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.427 -1.043 . . . . 1.48 110.437 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 87.9 m -82.74 -53.31 6.01 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 120.217 -0.593 . . . . 0.97999999999999998 110.458 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -106.19 -16.06 14.69 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.289 -0.882 . . . . 1.1599999999999999 112.693 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.95 167.77 16.3 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 111.459 -0.656 . . . . 0.84999999999999998 111.459 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.3 -25.86 62.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.407 -1.054 . . . . 3.8599999999999999 112.23 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.07 -40.06 73.01 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.895 -1.128 . . . . 2.3500000000000001 111.182 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -89.36 -16.45 31.0 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.924 -1.11 . . . . 1.6699999999999999 112.3 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.62 -39.0 86.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 1.45 110.702 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.17 78.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.72 -0.613 . . . . 0.60999999999999999 111.495 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.01 -41.52 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.847 -1.158 . . . . 0.65000000000000002 110.521 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -70.26 -31.44 68.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.917 -1.115 . . . . 0.66000000000000003 110.498 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.43 -39.98 92.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.309 -0.87 . . . . 1.1899999999999999 110.021 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.44 96.25 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.799 -1.32 . . . . 0.53000000000000003 109.799 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -57.81 -40.13 79.21 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.367 -1.078 . . . . 1.27 110.495 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.5 mt -61.44 -40.39 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.54000000000000004 110.236 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.6 ttm -59.5 -41.12 89.14 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.259 -0.901 . . . . 1.74 110.381 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.3 tp -57.52 -49.1 77.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.81 . . . . 0.55000000000000004 110.309 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.02 -45.12 93.85 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.86 0.838 . . . . 0.46999999999999997 110.175 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -87.46 8.03 26.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.464 -0.773 . . . . 1.4199999999999999 113.026 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 55.2 t0 -62.22 123.47 18.28 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.764 -1.21 . . . . 1.27 109.151 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -66.48 -18.54 65.42 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.406 -0.809 . . . . 1.3500000000000001 111.168 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' OE1' ' OD1' ' A' ' 82' ' ' ASP . 10.8 mp0 -77.68 -52.4 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.689 -0.804 . . . . 2.2200000000000002 110.099 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.5 mt -60.92 -35.2 76.07 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.101 -0.999 . . . . 0.62 110.287 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.553 ' CD ' HH22 ' A' ' 47' ' ' ARG . 80.8 tt0 -59.14 -47.6 84.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.821 . . . . 1.29 110.402 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -61.72 -35.54 78.34 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.629 -0.669 . . . . 1.52 110.12 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.07 -49.09 71.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 1.3 110.313 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.3 mt -58.64 -43.93 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.06 -1.025 . . . . 0.60999999999999999 109.779 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.01 -40.9 87.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.65 -0.656 . . . . 0.78000000000000003 110.146 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -42.32 93.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.33 -0.857 . . . . 0.81999999999999995 110.424 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.39 -44.03 97.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.285 -0.884 . . . . 0.80000000000000004 110.013 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.8 mt -63.56 -49.21 83.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.363 -0.835 . . . . 0.77000000000000002 110.039 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -78.12 -37.2 46.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.496 -0.752 . . . . 2.1200000000000001 111.658 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -81.81 -40.96 21.79 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.573 -1.329 . . . . 1.51 111.996 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -105.58 7.76 32.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.457 -0.777 . . . . 1.98 112.687 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.7 m80 49.65 49.79 19.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.563 -1.336 . . . . 1.3200000000000001 111.504 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 67.1 mtt -104.45 156.75 17.67 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.049 0.928 . . . . 1.3799999999999999 109.967 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.3 p -72.59 161.75 30.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.783 -0.573 . . . . 0.67000000000000004 110.02 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.55 86.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.52000000000000002 110.302 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.587 ' OD2' HD21 ' A' ' 142' ' ' LEU . 96.2 m-20 -66.28 -40.07 89.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.118 -0.989 . . . . 2.25 109.868 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.2 -48.83 55.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.559 -0.713 . . . . 0.64000000000000001 111.08 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.93 92.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.167 -0.958 . . . . 0.56000000000000005 110.227 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.17 95.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.579 -0.701 . . . . 0.46000000000000002 110.661 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -60.29 -39.87 88.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.204 -0.935 . . . . 1.3200000000000001 111.275 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -58.05 -48.92 78.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.729 -1.232 . . . . 1.3 110.912 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.77 -45.61 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.892 -1.13 . . . . 0.60999999999999999 109.867 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.3 mm -62.22 -31.72 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.645 -0.659 . . . . 0.65000000000000002 110.348 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -57.33 -41.09 79.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 2.1099999999999999 110.572 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.16 -34.64 9.52 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.368 -1.396 . . . . 0.82999999999999996 112.624 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -60.69 -42.37 97.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.261 -1.729 . . . . 1.28 110.153 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.07 -55.55 6.35 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.451 -0.781 . . . . 0.89000000000000001 110.727 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.8 m -60.61 -37.95 83.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 1.8700000000000001 110.886 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.51 96.37 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.897 -1.127 . . . . 1.05 111.079 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.31 -30.22 70.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.873 -1.131 . . . . 1.02 110.918 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -66.53 -20.82 66.12 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.168 -1.013 . . . . 2.04 110.954 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -71.91 -15.18 62.09 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.838 0.827 . . . . 1.73 110.828 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.489 HD13 HD13 ' A' ' 123' ' ' LEU . 50.0 mt -86.74 145.16 26.76 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.246 -0.65 . . . . 1.3700000000000001 109.246 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -103.02 39.7 1.51 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.337 -0.852 . . . . 2.8799999999999999 111.461 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -113.04 136.27 52.87 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.135 -1.061 . . . . 1.5800000000000001 108.135 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -56.63 -38.07 71.59 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.444 0.64 . . . . 3.04 110.796 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -72.16 -52.79 14.99 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.827 -1.171 . . . . 0.90000000000000002 110.312 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.489 HD13 HD13 ' A' ' 118' ' ' LEU . 19.3 mt -63.58 -39.72 95.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.168 -0.958 . . . . 1.0600000000000001 110.497 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -65.65 -47.54 75.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.93 . . . . 2.1800000000000002 110.502 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -61.47 -31.34 71.3 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.407 -0.917 . . . . 2.1499999999999999 110.248 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 130' ' ' VAL . 63.3 ttt180 -65.71 -27.7 68.52 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 118.995 -1.082 . . . . 2.3300000000000001 109.528 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.84 -49.16 78.77 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.786 0.803 . . . . 0.81999999999999995 109.589 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.23 91.22 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.57 -0.852 . . . . 0.84999999999999998 109.633 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 2.0 m-20 -62.97 -35.47 80.28 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.306 0.574 . . . . 1.3899999999999999 110.214 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 126' ' ' ARG . 31.8 t -68.17 -40.47 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.518 -0.739 . . . . 0.56000000000000005 110.639 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -59.72 -38.13 80.81 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.509 -1.277 . . . . 3.1200000000000001 110.076 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.52 ' OD1' ' NE ' ' A' ' 136' ' ' ARG . 54.4 t0 -60.22 -40.05 88.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.608 -0.683 . . . . 1.28 110.186 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.19 -39.64 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.01 -1.056 . . . . 0.48999999999999999 110.399 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.08 -46.9 62.68 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.937 -1.125 . . . . 0.46000000000000002 110.696 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -59.94 -41.31 91.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.123 -1.222 . . . . 2.71 110.368 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.52 ' NE ' ' OD1' ' A' ' 132' ' ' ASP . 40.5 mtt-85 -63.32 -42.11 98.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.06 -1.025 . . . . 2.1400000000000001 109.995 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 137' ' ' LEU . 3.0 tt -61.06 -45.15 95.92 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.967 0.889 . . . . 1.05 109.76 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.98 -42.05 97.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.89 . . . . 0.52000000000000002 110.522 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.12 -31.71 70.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.933 . . . . 2.3500000000000001 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -75.33 -41.67 56.18 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.945 -1.097 . . . . 1.3899999999999999 110.777 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.48 ' O ' ' NH2' ' A' ' 42' ' ' ARG . 98.0 mt -60.02 -37.92 74.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.144 -0.973 . . . . 0.68000000000000005 110.607 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.587 HD21 ' OD2' ' A' ' 101' ' ' ASP . 90.0 mt -87.49 -9.18 55.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.378 -0.826 . . . . 0.82999999999999996 111.716 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.26 23.62 65.34 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 120.298 -0.953 . . . . 0.91000000000000003 113.457 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.1 tp -68.34 139.71 55.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.806 -0.82 . . . . 0.94999999999999996 109.863 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -68.6 150.54 47.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.568 -0.707 . . . . 2.4300000000000002 109.907 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 39.7 mt -108.76 137.7 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.341 -0.985 . . . . 1.1000000000000001 108.341 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.3 mm -78.31 130.35 36.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.875 -1.141 . . . . 1.5800000000000001 109.016 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -94.47 97.62 10.29 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.625 -1.62 . . . . 1.6200000000000001 106.625 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 51.0 mt -76.98 -15.66 59.58 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.39 0.614 . . . . 0.80000000000000004 111.563 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.4 t -80.97 2.39 27.06 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.59 0.71 . . . . 1.5600000000000001 112.156 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.69 22.7 10.57 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.713 0.768 . . . . 0.83999999999999997 112.069 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 12.5 mt -72.77 135.88 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.427 -0.953 . . . . 0.81999999999999995 108.427 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -121.15 -13.69 8.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 112.927 0.714 . . . . 2.3100000000000001 112.927 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -112.53 136.89 51.51 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.926 -1.138 . . . . 1.54 107.926 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.07 117.68 17.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.376 -0.828 . . . . 1.3799999999999999 109.009 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -148.01 179.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.21 -0.663 . . . . 0.68999999999999995 109.21 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 49.0 mt -88.13 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.481 -0.933 . . . . 0.53000000000000003 108.481 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.3 tp -94.63 126.82 40.17 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.43 -0.952 . . . . 0.64000000000000001 108.43 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.48 130.66 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.038 -1.097 . . . . 0.67000000000000004 108.038 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.34 159.51 31.3 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.009 -1.057 . . . . 0.78000000000000003 108.67 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.14 92.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.692 -1.255 . . . . 1.0 109.324 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 50.9 t0 -171.75 154.09 3.53 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.527 -0.916 . . . . 2.4199999999999999 108.527 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 49.6 mt -117.18 139.04 51.26 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.446 -0.946 . . . . 0.75 108.446 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.7 p -92.06 146.29 32.49 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.158 -0.964 . . . . 0.78000000000000003 108.41 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -38.97 -44.63 2.51 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.169 1.913 . . . . 0.67000000000000004 113.812 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 16.2 m -60.34 -47.84 84.32 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.629 -1.294 . . . . 0.69999999999999996 109.954 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -63.17 -37.8 88.67 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.657 0.742 . . . . 1.21 110.167 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.0 p -67.87 -39.05 83.79 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.547 -0.721 . . . . 0.59999999999999998 110.192 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.19 86.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.533 -0.73 . . . . 0.62 110.744 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.79 -3.31 56.3 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.149 -0.97 . . . . 1.1599999999999999 113.046 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 171' ' ' LEU . 41.2 tp -63.37 156.35 26.15 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.402 -0.811 . . . . 0.72999999999999998 109.587 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -94.9 110.2 22.12 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.503 -1.666 . . . . 2.2400000000000002 106.503 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.1 mt -71.33 -24.91 62.21 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.748 0.785 . . . . 1.4299999999999999 111.408 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -85.66 -18.66 32.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.492 -0.755 . . . . 2.1499999999999999 112.446 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -100.64 -2.73 31.97 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.297 -0.877 . . . . 2.04 112.767 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 178' ' ' GLY . 57.5 t -109.69 130.09 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.689 -1.226 . . . . 0.55000000000000004 107.689 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.743 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.8 tt -85.61 -9.89 56.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.031 -1.043 . . . . 1.6299999999999999 111.702 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.37 173.41 38.98 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.485 -1.446 . . . . 0.46999999999999997 109.485 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.9 OUTLIER -130.64 131.31 44.83 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.622 -1.251 . . . . 0.54000000000000004 107.622 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.526 HG22 HG21 ' A' ' 205' ' ' THR . 87.5 mt -134.49 109.11 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 106.093 -1.818 . . . . 0.68999999999999995 106.093 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 203' ' ' VAL . 73.6 p -134.26 174.58 10.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.678 -1.264 . . . . 0.81999999999999995 110.415 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 206' ' ' GLY . 11.8 t0 -103.85 65.83 0.83 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.639 -0.71 . . . . 2.3700000000000001 109.375 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.027 0 O-C-N 121.195 -0.941 . . . . 1.1100000000000001 109.053 179.882 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.9 p . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 107.07 -1.455 . . . . 1.6899999999999999 107.07 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -59.98 -30.46 69.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.838 . . . . 1.0700000000000001 110.528 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.0 m -56.45 -40.51 74.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.539 -0.726 . . . . 1.5800000000000001 110.039 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.1 m -59.78 -39.98 86.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 1.6000000000000001 109.948 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.6 mp -60.23 -38.89 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.815 . . . . 1.45 110.418 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 68.3 mtp -62.38 -42.96 99.82 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 122.062 0.934 . . . . 1.05 109.529 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.5 -48.74 79.69 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.726 -0.67 . . . . 0.71999999999999997 111.673 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' A' ' 195' ' ' ARG . 30.2 mtt-85 -60.78 -44.4 96.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.14 . . . . 3.0499999999999998 110.653 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 28.8 m -69.45 -39.54 77.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.887 . . . . 0.89000000000000001 110.435 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.4 -4.9 53.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.78000000000000003 112.987 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 194' ' ' ALA . 75.3 mt-10 54.6 12.5 0.56 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.115 1.154 . . . . 1.45 114.115 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 72.9 mt -73.77 158.4 86.15 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.05 -1.032 . . . . 0.67000000000000004 108.495 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -65.32 142.71 73.98 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.973 1.115 . . . . 0.64000000000000001 110.557 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.96 163.87 33.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 119.928 -1.733 . . . . 0.67000000000000004 110.431 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.0 mt -149.88 149.74 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 107.465 -1.309 . . . . 0.68999999999999995 107.465 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 5.5 m -135.82 -26.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.755 -1.216 . . . . 0.84999999999999998 112.54 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.15 35.04 1.49 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.309 -1.424 . . . . 0.92000000000000004 113.113 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.526 HG21 HG22 ' A' ' 180' ' ' ILE . 47.5 p -56.06 -27.62 54.19 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.421 -1.046 . . . . 0.94999999999999996 111.45 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 77.12 -90.78 1.0 Allowed Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.133 -1.032 . . . . 1.04 110.815 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.2 p -125.06 27.6 6.64 Favored 'General case' 0 N--CA 1.512 2.652 0 O-C-N 121.341 -1.094 . . . . 1.5700000000000001 112.669 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.11 -34.76 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.232 -1.543 . . . . 0.83999999999999997 110.075 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.9 p -58.34 -17.97 23.96 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.26 -0.976 . . . . 0.98999999999999999 111.86 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.8 p -92.63 -0.98 57.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.137 -0.977 . . . . 1.7 112.006 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -129.13 5.19 5.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 112.595 0.591 . . . . 2.2000000000000002 112.595 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.87 141.32 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.732 -0.605 . . . . 0.83999999999999997 109.39 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -120.35 155.21 33.84 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.371 -0.974 . . . . 2.2000000000000002 108.371 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 16.6 p30 -53.8 142.79 22.77 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.083 -1.011 . . . . 2.2799999999999998 110.547 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.6 t0 80.19 0.25 2.01 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.504 1.298 . . . . 2.3500000000000001 114.504 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.12 146.67 54.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.795 -1.191 . . . . 1.97 108.78 177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -88.74 120.7 30.38 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.458 -1.312 . . . . 2.6499999999999999 107.458 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.646 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 49.6 mt -128.94 149.04 50.96 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.404 -0.81 . . . . 0.63 110.018 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.425 HD13 ' SD ' ' A' ' 239' ' ' MET . 57.4 mt -116.03 126.95 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.878 -1.527 . . . . 0.62 106.878 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.416 HD13 HD11 ' A' ' 180' ' ' ILE . 65.1 tp -99.22 120.11 38.98 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.306 -1.368 . . . . 0.64000000000000001 107.306 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 223' ' ' VAL . 49.7 t0 -93.89 -28.97 15.54 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.012 -1.055 . . . . 2.0499999999999998 112.826 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.77 18.37 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.186 0.809 . . . . 0.83999999999999997 113.186 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.8 t -111.45 -58.84 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-O 122.197 0.999 . . . . 1.02 108.922 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -96.47 9.8 40.24 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.412 1.101 . . . . 2.5099999999999998 110.188 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 61.92 50.05 4.38 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.785 -1.098 . . . . 1.54 111.665 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -145.28 148.04 33.02 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.345 1.069 . . . . 1.95 109.749 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 80.9 t -117.2 140.77 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 115.503 -0.772 . . . . 0.70999999999999996 109.285 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -100.03 130.59 46.21 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.171 -1.048 . . . . 1.01 108.171 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.3 t -109.83 131.48 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.579 0.704 . . . . 0.81999999999999995 109.166 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.413 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 24.6 t30 52.96 51.65 9.47 Favored Pre-proline 0 N--CA 1.497 1.877 0 N-CA-C 113.345 0.869 . . . . 1.54 113.345 177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 61.9 Cg_endo -70.23 151.66 66.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.784 2.323 . . . . 0.93999999999999995 111.441 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.0 m -72.23 156.46 39.11 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.964 -1.085 . . . . 1.8 108.747 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -59.8 -39.43 84.95 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.89 -1.131 . . . . 2.73 109.935 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.65 -39.72 85.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.482 -0.761 . . . . 3.1699999999999999 110.278 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 87.9 t -69.71 -38.58 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.461 -0.775 . . . . 1.3400000000000001 110.216 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.29 -46.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.042 -1.036 . . . . 1.2 110.15 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.03 -40.22 88.57 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.175 -0.953 . . . . 2.7000000000000002 110.208 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -62.17 -41.57 98.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 2.5899999999999999 110.808 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . 0.425 ' SD ' HD13 ' A' ' 219' ' ' ILE . 74.9 mtp -70.81 -31.39 68.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 1.3799999999999999 110.372 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.428 ' CA ' ' HE ' ' A' ' 240' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 2.8399999999999999 110.063 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 106.455 -1.683 . . . . 1.0700000000000001 106.455 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 m -104.38 128.45 52.23 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.097 -1.075 . . . . 1.24 108.097 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.04 -160.45 16.79 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.904 -1.678 . . . . 1.01 108.904 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.6 mt -93.31 -1.11 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.292 -1.122 . . . . 1.1100000000000001 112.772 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 50.72 96.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.102 -0.999 . . . . 0.98999999999999999 112.688 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.92 -42.33 13.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 0.84999999999999998 111.547 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -145.35 144.85 24.37 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.046 -1.094 . . . . 1.3799999999999999 108.046 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.81 147.44 27.43 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.59 2.193 . . . . 0.93999999999999995 112.218 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.893 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.29 167.77 15.16 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 109.261 -1.536 . . . . 0.81000000000000005 109.261 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.7 mt -125.91 132.49 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.243 -1.151 . . . . 0.82999999999999996 107.909 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.53 151.59 46.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 0.53000000000000003 109.286 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.609 ' CE1' ' NH2' ' A' ' 240' ' ' ARG . 1.8 m-85 -122.24 144.52 48.93 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.259 -1.015 . . . . 0.77000000000000002 108.259 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.92 167.45 34.22 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 118.362 -1.875 . . . . 0.51000000000000001 110.197 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -78.1 157.68 29.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.429 -1.042 . . . . 1.8999999999999999 108.938 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.419 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -83.96 124.64 31.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.975 -1.078 . . . . 0.66000000000000003 108.151 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.3 tp -100.46 104.49 15.89 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.024 -2.213 . . . . 0.82999999999999996 105.024 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -91.02 135.78 33.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.215 -1.031 . . . . 0.85999999999999999 108.215 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.3 mt -97.27 120.1 37.01 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.438 -1.319 . . . . 0.92000000000000004 107.438 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -109.11 134.67 51.4 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.249 -1.019 . . . . 2.0299999999999998 108.249 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.563 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 37.2 tt0 -117.98 140.36 49.85 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.224 -0.658 . . . . 2.6600000000000001 109.224 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -81.98 131.28 35.25 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.718 -1.216 . . . . 2.3199999999999998 107.718 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.09 145.02 56.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 2.1099999999999999 108.74 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.67 135.19 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.91 -1.118 . . . . 0.72999999999999998 108.636 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.6 t -103.44 129.8 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.967 -1.123 . . . . 0.87 107.967 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -99.0 136.97 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.646 -0.872 . . . . 0.81000000000000005 108.646 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -90.62 122.46 33.43 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.828 -1.175 . . . . 1.3400000000000001 107.828 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.442 HH11 ' HG3' ' A' ' 28' ' ' ARG . 20.6 mmm-85 -93.52 15.72 15.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.315 -0.865 . . . . 2.8900000000000001 112.319 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -71.47 143.25 50.1 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.408 -0.807 . . . . 2.0899999999999999 109.527 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.75 141.7 31.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.649 -0.657 . . . . 2.1899999999999999 109.425 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.2 pt -98.3 168.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.197 -0.939 . . . . 0.75 110.622 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.8 p -102.37 162.3 13.03 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.983 -0.747 . . . . 0.91000000000000003 108.983 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.45 -18.55 1.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.086 -1.009 . . . . 0.93000000000000005 112.379 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -69.85 -39.99 76.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 2.2799999999999998 110.754 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -93.13 -8.91 41.27 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.873 -1.142 . . . . 1.45 112.949 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -56.29 -50.48 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.168 -0.957 . . . . 0.81000000000000005 110.781 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.85 -39.44 85.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.542 -0.724 . . . . 1.54 110.674 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -62.2 -41.29 98.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.831 . . . . 2.3599999999999999 110.896 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.53 -37.62 81.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.742 -1.224 . . . . 1.3100000000000001 110.449 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.41 -41.78 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.169 -0.957 . . . . 0.81999999999999995 110.028 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -62.13 -43.58 98.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 1.5 109.745 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 42' ' ' ARG . 34.0 mtt-85 -61.8 -44.05 97.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.524 -0.735 . . . . 2.23 110.063 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -70.78 -52.16 22.38 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.346 -0.846 . . . . 0.84999999999999998 109.896 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.08 -46.44 89.56 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.394 -0.922 . . . . 0.91000000000000003 109.846 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 15.5 t -69.19 -34.89 75.6 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.243 0.544 . . . . 0.90000000000000002 110.364 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.44 -47.95 87.79 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.685 -1.245 . . . . 0.68999999999999995 110.17 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -56.91 -32.02 65.5 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.363 -1.08 . . . . 2.8799999999999999 109.183 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.38 -42.06 69.93 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.522 0.677 . . . . 0.84999999999999998 109.968 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -78.49 -42.02 30.85 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.688 -0.805 . . . . 2.3500000000000001 110.14 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.77 95.95 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.669 0.747 . . . . 0.65000000000000002 110.368 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.1 p -60.01 -39.81 87.06 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.994 0.902 . . . . 1.45 109.666 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.57 67.97 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 120.073 -0.651 . . . . 0.63 110.31 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -61.18 -48.57 80.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.273 -0.892 . . . . 1.3400000000000001 110.382 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.8 -40.37 96.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -0.92 . . . . 1.5600000000000001 109.821 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -60.55 -41.24 94.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.542 -0.724 . . . . 1.1899999999999999 110.428 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.621 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 9.4 m -65.65 -42.86 90.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.0 -1.062 . . . . 0.71999999999999997 110.409 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.2 -30.73 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.658 . . . . 0.62 110.611 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -52.61 -46.29 66.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.709 -0.619 . . . . 1.05 110.619 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 m -68.82 -37.2 79.05 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.21 -0.931 . . . . 0.64000000000000001 109.791 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.621 ' NZ ' HG22 ' A' ' 56' ' ' THR . 65.2 mttp -61.73 -38.35 87.58 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.427 -0.909 . . . . 1.73 109.386 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.19 74.86 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.822 -0.751 . . . . 0.56000000000000005 109.977 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.97 -34.57 21.03 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.379 -1.391 . . . . 0.68999999999999995 110.917 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.44 -18.05 43.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.783 -1.422 . . . . 1.48 111.545 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.0 m -87.91 -52.57 5.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.912 -0.493 . . . . 0.97999999999999998 110.344 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -107.27 -15.28 14.69 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.435 -0.791 . . . . 1.1599999999999999 112.97 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.91 164.88 14.71 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.537 -0.727 . . . . 0.84999999999999998 111.567 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -58.16 -17.94 22.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.629 -0.924 . . . . 3.8599999999999999 113.113 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.91 -39.43 85.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.995 -1.065 . . . . 2.3500000000000001 110.769 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -86.8 -23.63 25.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.953 -1.092 . . . . 1.6699999999999999 111.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -59.84 -39.98 86.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.725 -0.609 . . . . 1.45 111.598 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.44 -36.77 81.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.162 -0.961 . . . . 0.60999999999999999 111.352 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 57.8 mt -63.38 -41.65 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.73 -1.232 . . . . 0.65000000000000002 110.843 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -70.59 -30.94 67.75 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.933 -1.104 . . . . 0.66000000000000003 110.631 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.51 -38.73 85.32 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.195 -0.94 . . . . 1.1899999999999999 109.91 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.3 -44.67 90.22 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 120.298 -0.953 . . . . 0.53000000000000003 110.891 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -59.73 -40.79 89.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.874 -1.368 . . . . 1.27 110.723 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.6 mt -59.83 -39.43 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.107 -0.995 . . . . 0.54000000000000004 110.772 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.21 -39.77 83.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.111 -0.993 . . . . 1.74 110.633 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.5 tp -58.36 -45.89 87.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.14 -0.975 . . . . 0.55000000000000004 110.235 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.51 -39.83 89.2 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.585 -0.846 . . . . 0.46999999999999997 110.248 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -86.93 11.02 14.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 1.4199999999999999 112.304 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -66.47 120.96 14.26 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.978 -1.076 . . . . 1.27 108.536 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.87 -16.8 64.17 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.367 -0.833 . . . . 1.3500000000000001 110.918 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -73.42 -47.89 38.13 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.548 -0.861 . . . . 2.2200000000000002 110.447 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.86 -37.29 86.83 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.429 -0.908 . . . . 0.62 110.229 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.74 -45.53 93.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.338 -0.851 . . . . 1.29 110.915 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.7 -36.98 85.62 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.014 -1.054 . . . . 1.52 110.925 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.7 -48.48 63.77 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.735 -1.228 . . . . 1.3 110.404 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -57.44 -47.71 84.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.444 -0.902 . . . . 0.60999999999999999 110.243 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.87 -39.61 80.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.785 -0.572 . . . . 0.78000000000000003 110.415 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.53 91.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 0.81999999999999995 110.644 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.15 -43.68 98.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.80000000000000004 110.284 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.1 mt -61.0 -45.95 97.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.77000000000000002 110.648 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -82.31 -36.43 26.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -0.757 . . . . 2.1200000000000001 111.908 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -84.49 -39.36 18.97 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.62 -1.3 . . . . 1.51 111.627 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -105.26 10.37 33.65 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.969 -1.082 . . . . 1.98 111.939 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.4 m80 48.48 51.39 15.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 1.3200000000000001 111.588 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.2 mtt -109.5 154.34 22.81 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.703 0.763 . . . . 1.3799999999999999 109.722 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.1 p -71.81 158.64 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.132 -0.692 . . . . 0.67000000000000004 109.132 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.27 89.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.403 -0.811 . . . . 0.52000000000000002 110.754 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.634 ' OD2' HD21 ' A' ' 142' ' ' LEU . 72.4 m-20 -67.42 -43.06 82.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.755 -1.215 . . . . 2.25 109.51 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.06 -48.31 58.4 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.656 0.741 . . . . 0.64000000000000001 110.845 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.48 -46.85 87.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.138 -0.976 . . . . 0.56000000000000005 110.47 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.29 94.96 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.497 0.665 . . . . 0.46000000000000002 110.411 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.85 -39.33 84.82 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.032 -1.043 . . . . 1.3200000000000001 110.334 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.42 -49.92 75.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.878 -1.139 . . . . 1.3 111.099 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.25 -49.0 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.059 . . . . 0.60999999999999999 110.004 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.45 -30.82 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.676 -0.64 . . . . 0.65000000000000002 110.699 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -59.45 -40.37 86.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 2.1099999999999999 110.276 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.28 -28.0 31.74 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.204 -1.474 . . . . 0.82999999999999996 113.108 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -60.29 -39.73 87.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.056 -1.85 . . . . 1.28 110.045 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.63 -46.69 52.82 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.554 -0.716 . . . . 0.89000000000000001 110.299 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.3 p -62.83 -40.21 96.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.419 -0.801 . . . . 1.8700000000000001 110.433 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.39 -40.65 97.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 1.05 110.508 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.88 -29.61 70.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.04 -1.037 . . . . 1.02 111.111 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.09 -21.36 64.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.906 -1.121 . . . . 2.04 111.053 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -73.81 -12.48 60.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.215 -0.928 . . . . 1.73 110.788 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.454 HD13 HD13 ' A' ' 123' ' ' LEU . 9.6 mt -84.84 144.89 28.13 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.485 -0.759 . . . . 1.3700000000000001 109.065 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -101.46 46.91 0.92 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.171 -0.956 . . . . 2.8799999999999999 111.591 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -122.28 138.75 54.39 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.057 -1.027 . . . . 1.5800000000000001 108.589 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.8 -38.67 82.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 3.04 110.973 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -71.93 -47.02 55.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.957 -1.089 . . . . 0.90000000000000002 110.525 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.454 HD13 HD13 ' A' ' 118' ' ' LEU . 39.5 mt -63.67 -36.76 84.89 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.46 -0.896 . . . . 1.0600000000000001 110.103 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -60.47 -46.53 89.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.819 -1.152 . . . . 2.1800000000000002 109.644 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -61.95 -30.84 71.19 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.367 -0.933 . . . . 2.1499999999999999 109.651 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 130' ' ' VAL . 60.7 ttt180 -61.86 -30.12 70.64 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.291 -0.964 . . . . 2.3300000000000001 108.9 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.21 73.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.785 0.802 . . . . 0.81999999999999995 109.574 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.89 -43.36 71.95 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.622 0.725 . . . . 0.84999999999999998 110.319 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -64.5 -34.15 77.56 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.497 -0.752 . . . . 1.3899999999999999 110.528 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 126' ' ' ARG . 16.3 t -68.01 -39.96 82.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.252 -0.905 . . . . 0.56000000000000005 110.033 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 131' ' ' ARG . 27.4 ttt-85 -56.18 -39.92 73.14 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.251 -1.379 . . . . 3.1200000000000001 109.469 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -60.05 -42.59 94.79 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.575 0.702 . . . . 1.28 110.235 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.32 -38.94 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.48999999999999999 110.166 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.59 -43.74 23.02 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.852 -1.166 . . . . 0.46000000000000002 110.832 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -58.33 -40.76 83.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.293 -1.122 . . . . 2.71 110.592 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 136' ' ' ARG . 55.1 mtt-85 -62.33 -41.55 98.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.959 -1.088 . . . . 2.1400000000000001 109.969 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.64 -39.59 84.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.611 -0.681 . . . . 1.05 109.964 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.3 mt -59.73 -40.09 86.86 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.453 -0.779 . . . . 0.52000000000000002 110.473 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.563 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 63.1 mtt-85 -60.66 -38.6 85.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.016 -1.053 . . . . 2.3500000000000001 111.062 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -71.65 -41.81 68.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 1.3899999999999999 110.87 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.3 -39.62 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.016 -1.053 . . . . 0.68000000000000005 110.216 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.634 HD21 ' OD2' ' A' ' 101' ' ' ASP . 84.1 mt -87.2 -8.93 56.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.123 -0.986 . . . . 0.82999999999999996 112.199 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.27 21.29 78.07 Favored Glycine 0 N--CA 1.48 1.617 0 C-N-CA 119.703 -1.237 . . . . 0.91000000000000003 113.282 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 tp -69.2 149.94 48.02 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.78 -0.835 . . . . 0.94999999999999996 110.543 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -67.85 150.92 47.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.369 -0.832 . . . . 2.4300000000000002 110.913 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.9 mt -101.74 139.96 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.368 -0.975 . . . . 1.1000000000000001 108.368 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.737 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.3 mp -78.56 124.42 36.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.297 -1.001 . . . . 1.5800000000000001 108.297 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -99.6 100.03 10.97 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.317 -1.735 . . . . 1.6200000000000001 106.317 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.518 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 71.6 mt -78.54 -4.99 51.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.545 -0.722 . . . . 0.80000000000000004 112.321 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.2 p -86.99 9.18 20.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.145 -0.972 . . . . 1.5600000000000001 112.366 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.66 18.42 14.33 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 114.151 1.167 . . . . 0.83999999999999997 114.151 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.1 mp -71.35 141.12 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 119.909 -1.744 . . . . 0.81999999999999995 109.498 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -118.84 -13.52 9.51 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.045 0.926 . . . . 2.3100000000000001 112.429 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -117.38 145.04 44.34 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.555 -0.906 . . . . 1.54 108.555 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -76.26 121.78 23.44 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.673 -0.862 . . . . 1.3799999999999999 108.673 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.4 m -147.48 176.31 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.434 -0.791 . . . . 0.68999999999999995 108.973 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.9 mt -88.65 142.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.524 -0.735 . . . . 0.53000000000000003 109.339 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.5 tp -94.85 126.73 40.38 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.594 -0.891 . . . . 0.64000000000000001 108.594 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.89 131.02 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.648 -0.871 . . . . 0.67000000000000004 108.648 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.98 154.56 19.87 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.646 -0.872 . . . . 0.78000000000000003 108.646 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.22 -36.02 78.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.393 -1.442 . . . . 1.0 109.477 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 55.9 t0 -172.75 151.22 2.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.43 -0.952 . . . . 2.4199999999999999 108.43 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 70.1 mt -113.06 140.22 48.04 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.371 -0.831 . . . . 0.75 108.926 177.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.5 p -94.82 152.81 39.97 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.221 -0.925 . . . . 0.78000000000000003 108.754 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -42.91 -42.28 9.08 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.806 1.671 . . . . 0.67000000000000004 113.295 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.9 m -62.24 -50.44 71.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.987 -1.071 . . . . 0.69999999999999996 109.744 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.28 -40.5 90.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.503 -0.748 . . . . 1.21 110.25 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 78.3 p -67.86 -40.09 83.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.53 -0.731 . . . . 0.59999999999999998 110.754 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.13 86.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.62 110.743 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -95.32 1.1 54.28 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.204 -0.935 . . . . 1.1599999999999999 112.691 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.83 150.15 29.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.451 -0.781 . . . . 0.72999999999999998 109.902 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.661 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.6 OUTLIER -91.99 107.02 18.91 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.274 -1.75 . . . . 2.2400000000000002 106.274 177.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.4 mt -81.15 -9.16 59.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.788 . . . . 1.4299999999999999 112.535 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -77.59 -35.51 52.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.039 -1.038 . . . . 2.1499999999999999 110.572 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -101.36 2.87 40.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.235 -0.915 . . . . 2.04 113.01 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 172' ' ' ASN . 91.0 t -101.0 120.01 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 106.807 -1.553 . . . . 0.55000000000000004 106.807 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.2 tp -90.93 -9.51 45.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.097 -1.002 . . . . 1.6299999999999999 112.04 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.66 169.26 40.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.035 -1.626 . . . . 0.46999999999999997 109.035 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.1 m-85 -128.02 129.79 47.28 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.384 -1.068 . . . . 0.54000000000000004 108.2 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.4 mt -128.85 108.75 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 105.857 -1.905 . . . . 0.68999999999999995 105.857 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 205' ' ' THR . 76.4 p -130.82 171.76 12.78 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.905 -1.122 . . . . 0.81999999999999995 110.153 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.445 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 33.3 t0 -102.54 59.15 0.8 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.724 -0.61 . . . . 2.3700000000000001 110.453 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 106.371 -1.715 . . . . 1.1100000000000001 106.371 178.311 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 52.0 m . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.171 -0.678 . . . . 1.6899999999999999 109.171 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -59.84 -39.6 85.69 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.36 -0.838 . . . . 1.0700000000000001 111.082 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.9 m -58.47 -40.99 84.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.633 -1.292 . . . . 1.5800000000000001 110.228 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.2 m -61.39 -37.04 81.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 1.6000000000000001 110.447 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.73 -39.32 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.509 -0.745 . . . . 1.45 110.666 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 68.8 mtp -62.92 -41.15 99.37 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.08 0.943 . . . . 1.05 109.486 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.92 -45.43 94.67 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.931 -0.577 . . . . 0.71999999999999997 111.091 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -60.37 -43.37 96.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.982 -1.074 . . . . 3.0499999999999998 110.674 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.2 m -69.45 -39.13 77.97 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.211 -0.93 . . . . 0.89000000000000001 110.187 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.45 -7.48 50.48 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.871 0.844 . . . . 0.78000000000000003 112.531 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 53.12 7.16 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.996 1.109 . . . . 1.45 113.996 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.91 149.67 92.61 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 120.959 -1.088 . . . . 0.67000000000000004 108.385 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.13 144.95 88.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.534 1.49 . . . . 0.64000000000000001 109.738 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.62 161.41 35.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.366 -1.458 . . . . 0.67000000000000004 109.673 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.467 ' CD1' HD11 ' A' ' 220' ' ' LEU . 19.6 mt -149.94 149.55 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.756 -1.202 . . . . 0.68999999999999995 107.756 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.8 m -133.41 -25.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.123 -0.986 . . . . 0.84999999999999998 112.324 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.68 43.0 2.07 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 120.226 -0.987 . . . . 0.92000000000000004 111.837 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 181' ' ' THR . 43.8 p -63.08 -15.63 57.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.322 -1.105 . . . . 0.94999999999999996 111.573 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.445 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 72.12 -93.82 0.6 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.868 -1.293 . . . . 1.04 109.868 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 85.2 p -129.95 33.4 4.4 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.35 -1.088 . . . . 1.5700000000000001 112.022 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.67 -35.79 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.023 -1.673 . . . . 0.83999999999999997 110.482 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.1 p -60.33 -24.76 65.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.98999999999999999 111.73 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.8 p -96.57 9.0 42.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 1.7 112.149 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -132.59 -4.27 3.31 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.728 -0.607 . . . . 2.2000000000000002 112.409 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 213' ' ' LYS . 42.1 t -121.06 157.59 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.275 -0.89 . . . . 0.83999999999999997 109.854 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.422 ' N ' HG12 ' A' ' 212' ' ' VAL . 20.9 mmmt -122.25 160.25 25.64 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.069 -1.086 . . . . 2.2000000000000002 108.069 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 51.5 p-10 -57.03 142.12 43.23 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.093 -1.004 . . . . 2.2799999999999998 110.53 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.0 OUTLIER 80.32 7.49 1.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.79 1.404 . . . . 2.3500000000000001 114.79 179.387 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.8 t0 -67.21 149.38 50.53 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.308 -0.997 . . . . 1.97 108.308 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.433 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.3 t80 -89.64 115.04 26.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.331 -1.359 . . . . 2.6499999999999999 107.331 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.419 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 78.5 mt -124.96 148.15 48.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -0.755 . . . . 0.63 109.365 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.3 mt -119.09 126.35 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.15 -1.796 . . . . 0.62 106.15 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 202' ' ' ILE . 66.2 tp -100.91 119.04 38.13 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.425 -1.694 . . . . 0.64000000000000001 106.425 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.0 p-10 -94.73 -21.33 18.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.027 -1.046 . . . . 2.0499999999999998 112.459 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.893 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.93 18.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.376 0.608 . . . . 0.83999999999999997 112.477 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.601 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.4 t -112.26 -62.83 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 1.02 109.389 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -89.68 7.25 37.64 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.314 1.054 . . . . 2.5099999999999998 110.226 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 39.6 t30 63.86 50.58 2.56 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.023 -0.989 . . . . 1.54 112.1 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 74.6 mt-30 -147.16 152.38 38.33 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.352 1.072 . . . . 1.95 110.187 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.9 t -115.65 139.92 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.989 -1.115 . . . . 0.70999999999999996 107.989 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -104.98 133.17 50.21 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.164 -0.96 . . . . 1.01 108.775 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.85 130.89 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.16 -1.052 . . . . 0.81999999999999995 108.16 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.461 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 57.7 t30 54.39 49.04 5.12 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 113.578 0.955 . . . . 1.54 113.578 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 52.9 Cg_endo -68.95 149.67 72.25 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.607 2.204 . . . . 0.93999999999999995 110.994 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.1 p -78.33 165.47 23.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.035 -1.041 . . . . 1.8 110.497 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -60.77 -36.34 78.7 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.946 -1.096 . . . . 2.73 110.455 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.58 -39.91 85.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.004 -1.06 . . . . 3.1699999999999999 111.138 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.17 -40.37 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 1.3400000000000001 110.243 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 74.9 mt -59.42 -43.96 91.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.327 -0.858 . . . . 1.2 110.916 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.02 -40.31 88.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.21 -0.931 . . . . 2.7000000000000002 110.573 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -62.49 -45.35 93.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.51 -0.744 . . . . 2.5899999999999999 110.722 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 77.8 mtp -71.63 -39.46 70.41 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.364 -0.835 . . . . 1.3799999999999999 110.883 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.609 ' NH2' ' CE1' ' A' ' 13' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 2.8399999999999999 110.634 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 106.495 -1.668 . . . . 1.0700000000000001 106.495 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.7 m -104.14 121.56 43.49 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.719 -1.215 . . . . 1.24 107.719 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 225' ' ' ASN . . . -117.78 -164.17 13.1 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.868 -1.693 . . . . 1.01 108.868 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.1 mt -96.34 1.56 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 120.872 -1.37 . . . . 1.1100000000000001 112.708 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ILE . 18.9 tp 49.33 100.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.012 -1.075 . . . . 0.98999999999999999 111.678 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.33 -45.24 13.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.255 -1.528 . . . . 0.84999999999999998 111.249 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -148.57 149.04 30.18 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.275 -1.009 . . . . 1.3799999999999999 108.275 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.53 148.93 43.28 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 123.01 2.473 . . . . 0.93999999999999995 112.104 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 147.89 119.68 1.1 Allowed Glycine 0 N--CA 1.507 3.413 0 N-CA-C 110.323 -1.111 . . . . 0.81000000000000005 110.323 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 53.3 mt -90.64 135.78 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.893 -1.357 . . . . 0.82999999999999996 108.818 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.42 ' CB ' HD12 ' A' ' 177' ' ' LEU . . . -138.74 157.64 45.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.854 -0.795 . . . . 0.53000000000000003 108.854 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -118.74 140.01 50.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.93 -1.137 . . . . 0.77000000000000002 107.93 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.77 163.26 31.49 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 118.597 -1.763 . . . . 0.51000000000000001 110.057 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -78.8 157.74 28.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.67 -0.9 . . . . 1.8999999999999999 108.996 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -81.53 130.42 35.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.002 -1.061 . . . . 0.66000000000000003 108.394 178.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -110.87 101.4 10.0 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.729 -1.952 . . . . 0.82999999999999996 105.729 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.4 tp -87.78 135.26 33.46 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.408 -1.33 . . . . 0.85999999999999999 107.408 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.464 HD11 HD11 ' A' ' 158' ' ' LEU . 67.0 mt -101.02 114.56 28.6 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 106.481 -1.674 . . . . 0.92000000000000004 106.481 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -108.51 138.02 45.51 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.885 -1.154 . . . . 2.0299999999999998 107.885 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 52.1 mp0 -123.09 149.35 44.58 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.462 -0.774 . . . . 2.6600000000000001 109.463 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -83.82 130.6 34.93 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.784 -1.191 . . . . 2.3199999999999998 107.784 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -63.22 146.88 52.46 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.149 -0.969 . . . . 2.1099999999999999 108.96 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.6 mt -92.16 135.41 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 108.115 -1.069 . . . . 0.72999999999999998 108.115 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -106.43 127.94 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.099 -1.074 . . . . 0.87 108.099 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -101.57 136.26 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.043 -1.095 . . . . 0.81000000000000005 108.043 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -89.47 125.24 35.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.73 -1.231 . . . . 1.3400000000000001 107.766 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.489 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.3 mmt-85 -93.54 11.15 29.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.998 -1.064 . . . . 2.8900000000000001 112.358 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -67.53 143.7 56.01 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.058 -1.026 . . . . 2.0899999999999999 108.991 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -88.86 136.95 32.74 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.08 -1.082 . . . . 2.1899999999999999 108.08 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.18 166.72 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.277 -0.89 . . . . 0.75 110.303 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.7 p -93.89 163.69 13.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.91000000000000003 109.666 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.83 -21.17 6.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.46 -0.775 . . . . 0.93000000000000005 112.04 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -69.95 -41.92 73.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.063 -1.023 . . . . 2.2799999999999998 111.049 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -86.56 -2.68 58.69 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.438 -1.414 . . . . 1.45 112.224 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -60.96 -45.39 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 0.81000000000000005 110.938 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.72 -39.66 85.4 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.644 -1.285 . . . . 1.54 110.528 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.539 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 10.4 mp0 -60.34 -41.07 92.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.106 -0.497 . . . . 2.3599999999999999 110.947 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.59 -38.47 84.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.575 -1.328 . . . . 1.3100000000000001 110.626 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.5 t -59.82 -41.64 86.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.939 -1.101 . . . . 0.81999999999999995 110.729 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -63.42 -49.81 72.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.719 -1.238 . . . . 1.5 110.206 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.37 -38.88 88.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.595 -0.691 . . . . 2.23 110.329 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -75.5 -55.87 5.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.657 0.741 . . . . 0.84999999999999998 109.902 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.63 -46.99 85.89 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.693 -0.803 . . . . 0.91000000000000003 110.561 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 15.4 t -67.32 -41.88 84.57 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.19 -0.944 . . . . 0.90000000000000002 110.131 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.15 87.6 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 119.088 -1.53 . . . . 0.68999999999999995 109.965 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.6 ttt-85 -58.2 -31.35 67.22 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.744 -0.857 . . . . 2.8799999999999999 109.794 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.61 -40.89 80.14 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.881 0.848 . . . . 0.84999999999999998 109.792 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -78.12 -41.91 33.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 2.3500000000000001 110.112 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.21 93.16 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.272 -0.892 . . . . 0.65000000000000002 109.939 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 p -60.5 -38.24 83.67 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.465 1.126 . . . . 1.45 109.268 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.84 -47.04 64.21 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.68 -0.691 . . . . 0.63 110.419 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.04 -48.4 71.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.248 -0.908 . . . . 1.3400000000000001 110.546 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.8 -39.18 90.8 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.343 -0.848 . . . . 1.5600000000000001 109.572 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -60.18 -41.56 93.17 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.686 -0.634 . . . . 1.1899999999999999 110.478 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.6 m -62.91 -40.63 98.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.026 -1.046 . . . . 0.71999999999999997 110.272 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.4 mt -60.6 -36.02 67.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.471 -0.768 . . . . 0.62 110.325 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -53.79 -42.92 68.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 1.05 111.027 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -70.0 -33.39 71.98 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.835 -1.166 . . . . 0.64000000000000001 110.557 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -64.89 -39.92 94.3 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.886 -1.125 . . . . 1.73 109.515 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.39 80.96 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.756 -0.59 . . . . 0.56000000000000005 109.968 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.7 -36.1 34.1 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.651 -1.261 . . . . 0.68999999999999995 110.583 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -79.91 -28.18 39.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.876 -1.367 . . . . 1.48 110.984 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 79.6 m -86.77 -47.74 8.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.368 -0.832 . . . . 0.97999999999999998 110.942 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -107.93 -11.16 15.39 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 113.343 0.868 . . . . 1.1599999999999999 113.343 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.67 159.63 24.79 Favored Glycine 0 N--CA 1.5 2.949 0 C-N-CA 120.658 -0.782 . . . . 0.84999999999999998 113.29 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -52.33 -18.87 1.77 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.743 -0.857 . . . . 3.8599999999999999 112.921 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.17 -38.57 76.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 2.3500000000000001 111.522 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -82.37 -21.63 35.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.903 -1.123 . . . . 1.6699999999999999 112.05 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -59.74 -31.47 69.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 1.45 111.098 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.79 88.82 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.13 -0.981 . . . . 0.60999999999999999 110.519 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.0 mt -67.01 -44.71 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.633 -1.292 . . . . 0.65000000000000002 110.145 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -70.85 -28.8 64.85 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.321 -0.862 . . . . 0.66000000000000003 110.925 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -61.87 -37.99 86.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.883 . . . . 1.1899999999999999 110.153 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.11 -38.98 73.34 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 119.693 -1.242 . . . . 0.53000000000000003 110.486 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -59.68 -42.55 93.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.094 -1.239 . . . . 1.27 110.3 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.2 mt -62.44 -38.97 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.351 -0.843 . . . . 0.54000000000000004 110.091 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.9 ttm -59.99 -39.99 87.62 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.549 -0.861 . . . . 1.74 110.263 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.66 -51.49 69.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.199 -0.938 . . . . 0.55000000000000004 110.89 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.7 tp -60.52 -41.58 94.68 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.913 -0.715 . . . . 0.46999999999999997 110.057 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -87.24 1.17 53.98 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.086 0.773 . . . . 1.4199999999999999 113.086 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -60.28 123.53 17.52 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.426 -1.421 . . . . 1.27 108.577 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.18 -17.26 64.76 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.694 0.759 . . . . 1.3500000000000001 111.064 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -76.36 -54.19 7.1 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.875 -0.73 . . . . 2.2200000000000002 110.227 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.9 mt -62.27 -38.38 89.12 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.152 -0.619 . . . . 0.62 110.722 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.38 -49.91 75.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.075 -1.016 . . . . 1.29 111.213 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.25 -37.57 83.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.811 -1.181 . . . . 1.52 110.577 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.2 -47.79 78.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.146 -0.971 . . . . 1.3 110.18 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.0 mt -57.68 -47.08 86.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 120.999 -1.063 . . . . 0.60999999999999999 110.015 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.26 -41.92 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.66 0.743 . . . . 0.78000000000000003 110.857 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.34 -42.44 91.52 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.226 -0.921 . . . . 0.81999999999999995 110.866 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.69 -42.42 97.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.972 -1.08 . . . . 0.80000000000000004 110.161 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.44 -50.35 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 0.77000000000000002 110.572 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -76.16 -35.15 59.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 2.1200000000000001 111.903 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -81.89 -43.78 17.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.733 -1.229 . . . . 1.51 112.043 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -102.08 7.11 41.23 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.233 -0.917 . . . . 1.98 112.862 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 50.72 49.59 20.63 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 1.3200000000000001 111.887 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.3 mtt -102.99 155.95 18.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.387 -0.821 . . . . 1.3799999999999999 109.34 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.8 p -72.17 159.53 33.96 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.76 0.79 . . . . 0.67000000000000004 109.6 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.89 88.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.937 -1.102 . . . . 0.52000000000000002 110.416 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.512 ' OD2' HD21 ' A' ' 142' ' ' LEU . 93.5 m-20 -68.52 -39.17 81.3 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.176 -0.953 . . . . 2.25 110.618 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.8 -51.76 24.81 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.273 -0.892 . . . . 0.64000000000000001 111.214 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.48 94.79 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.827 -1.171 . . . . 0.56000000000000005 110.994 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.15 98.94 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.379 -0.826 . . . . 0.46000000000000002 110.9 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -60.42 -39.82 88.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.916 -1.115 . . . . 1.3200000000000001 111.003 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -59.03 -49.38 78.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.801 -1.187 . . . . 1.3 110.684 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.57 -41.89 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.252 -0.905 . . . . 0.60999999999999999 110.231 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -63.29 -32.47 56.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.301 -0.874 . . . . 0.65000000000000002 110.03 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.85 -41.11 86.21 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.611 -0.68 . . . . 2.1099999999999999 110.927 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.21 -31.55 19.49 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.422 -1.371 . . . . 0.82999999999999996 112.898 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -61.44 -40.45 94.5 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 119.421 1.61 . . . . 1.28 109.958 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.56 -50.6 24.48 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.938 0.875 . . . . 0.89000000000000001 110.364 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 60.9 p -61.48 -37.22 82.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.394 -0.816 . . . . 1.8700000000000001 110.775 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.1 -45.22 93.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.379 -0.826 . . . . 1.05 110.92 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.22 -28.27 69.25 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.083 -1.011 . . . . 1.02 111.21 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -66.67 -22.27 66.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.856 . . . . 2.04 110.731 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -71.61 -15.72 62.26 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.378 -0.826 . . . . 1.73 111.245 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 123' ' ' LEU . 22.7 mt -86.28 138.93 31.47 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.685 -1.228 . . . . 1.3700000000000001 107.685 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -97.8 39.41 1.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.341 -0.849 . . . . 2.8799999999999999 111.617 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -112.23 137.18 50.7 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.557 -0.905 . . . . 1.5800000000000001 108.557 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.9 -36.72 72.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 3.04 111.167 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.15 -56.48 5.5 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.838 -1.164 . . . . 0.90000000000000002 110.41 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 118' ' ' LEU . 38.4 mt -62.29 -42.08 99.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 1.0600000000000001 110.785 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.03 -47.47 84.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.993 -1.067 . . . . 2.1800000000000002 110.456 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -60.28 -32.53 71.26 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.328 -0.949 . . . . 2.1499999999999999 109.968 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.556 ' O ' HG23 ' A' ' 130' ' ' VAL . 21.7 ttp180 -64.76 -29.12 70.09 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.187 -1.005 . . . . 2.3300000000000001 109.552 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.93 87.02 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.763 0.792 . . . . 0.81999999999999995 109.829 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.41 -42.74 78.56 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.543 0.687 . . . . 0.84999999999999998 110.449 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.04 -33.34 75.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.577 -0.702 . . . . 1.3899999999999999 110.729 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 126' ' ' ARG . 52.7 t -69.31 -38.56 77.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.439 -0.788 . . . . 0.56000000000000005 110.529 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.445 ' HG2' HH11 ' A' ' 131' ' ' ARG . 34.3 ttt-85 -59.67 -40.21 87.04 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.864 -1.135 . . . . 3.1200000000000001 109.665 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -61.23 -35.24 76.7 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.649 0.738 . . . . 1.28 110.715 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.3 mt -61.73 -40.13 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.051 -1.031 . . . . 0.48999999999999999 110.47 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.55 -46.77 91.55 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.088 -1.053 . . . . 0.46000000000000002 110.745 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -58.32 -43.71 88.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.944 -1.327 . . . . 2.71 110.59 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.416 ' HG2' HH11 ' A' ' 136' ' ' ARG . 51.6 mtt-85 -60.63 -44.1 96.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.929 -1.107 . . . . 2.1400000000000001 110.577 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.1 -44.21 97.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.067 -1.021 . . . . 1.05 110.083 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.46 -41.13 96.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.876 . . . . 0.52000000000000002 110.702 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.403 HH11 ' HG2' ' A' ' 139' ' ' ARG . 46.4 mtt-85 -61.52 -34.76 76.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.907 . . . . 2.3500000000000001 110.563 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -73.97 -40.4 63.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 1.3899999999999999 110.989 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.67 -38.5 78.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.23 -0.919 . . . . 0.68000000000000005 110.615 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.512 HD21 ' OD2' ' A' ' 101' ' ' ASP . 74.5 mt -87.95 -7.92 56.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.931 -1.105 . . . . 0.82999999999999996 112.587 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.16 18.88 79.06 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 120.077 -1.059 . . . . 0.91000000000000003 113.046 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -62.31 146.75 50.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.983 . . . . 0.94999999999999996 109.406 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -67.22 147.88 52.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.974 -1.079 . . . . 2.4300000000000002 109.176 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.8 mt -109.63 136.22 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.097 -1.002 . . . . 1.1000000000000001 108.306 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.707 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.2 mp -78.0 130.09 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.48 -0.763 . . . . 1.5800000000000001 108.949 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -97.46 99.97 11.39 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.287 -1.745 . . . . 1.6200000000000001 106.287 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.8 mt -70.8 -21.08 62.52 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 116.145 -0.479 . . . . 0.80000000000000004 111.48 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.8 m -80.71 3.33 22.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.922 . . . . 1.5600000000000001 111.821 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.72 19.41 12.51 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.445 -0.784 . . . . 0.83999999999999997 112.507 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.5 mt -71.81 141.44 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.81999999999999995 109.689 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -117.54 -14.34 10.28 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.84 0.829 . . . . 2.3100000000000001 113.049 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -114.75 138.04 51.21 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.239 -1.022 . . . . 1.54 108.239 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.62 123.32 22.98 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.408 -0.96 . . . . 1.3799999999999999 108.408 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.1 m -145.95 176.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.391 -0.818 . . . . 0.68999999999999995 109.273 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mt -87.27 140.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.758 -1.214 . . . . 0.53000000000000003 108.426 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.464 HD11 HD11 ' A' ' 19' ' ' LEU . 26.9 tp -95.3 121.06 36.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.869 -1.145 . . . . 0.64000000000000001 108.158 178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.3 t -123.3 132.29 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 108.369 -0.975 . . . . 0.67000000000000004 108.369 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -160.4 160.51 32.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 0.78000000000000003 108.561 178.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.64 77.63 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.826 -1.171 . . . . 1.0 109.208 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 p-10 -172.4 155.49 3.5 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.726 -0.842 . . . . 2.4199999999999999 108.726 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 75.1 mt -120.25 137.99 53.91 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.956 -1.127 . . . . 0.75 107.956 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 p -96.42 150.9 37.65 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.188 -0.945 . . . . 0.78000000000000003 108.629 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -41.15 -42.74 5.0 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.869 1.713 . . . . 0.67000000000000004 113.102 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 54.7 m -60.59 -50.58 72.94 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.159 -0.963 . . . . 0.69999999999999996 109.892 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -61.97 -40.85 96.98 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.757 -1.177 . . . . 1.21 109.621 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.7 p -68.23 -37.78 81.18 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.49 -0.884 . . . . 0.59999999999999998 110.525 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.47 75.68 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.509 -0.744 . . . . 0.62 110.706 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -93.73 -3.46 52.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.009 -1.057 . . . . 1.1599999999999999 112.815 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.61 149.1 49.54 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.74 -0.837 . . . . 0.72999999999999998 108.74 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -96.83 118.48 33.35 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.721 -1.585 . . . . 2.2400000000000002 106.721 177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.9 -12.99 60.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 1.4299999999999999 111.852 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -84.66 -26.16 28.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.391 -0.818 . . . . 2.1499999999999999 112.336 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -100.88 2.1 40.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.367 -0.833 . . . . 2.04 112.271 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 178' ' ' GLY . 54.9 t -111.18 131.21 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 N-CA-C 108.263 -1.014 . . . . 0.55000000000000004 108.263 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.38 -12.35 43.53 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.37 -0.831 . . . . 1.6299999999999999 112.016 -179.511 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.435 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.94 -179.42 44.4 Favored Glycine 0 N--CA 1.497 2.745 0 O-C-N 120.46 -1.4 . . . . 0.46999999999999997 109.768 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -130.1 134.01 47.06 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 107.408 -1.331 . . . . 0.54000000000000004 107.408 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.523 HD11 HD13 ' A' ' 220' ' ' LEU . 59.0 mt -137.54 106.22 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 105.783 -1.932 . . . . 0.68999999999999995 105.783 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.415 ' C ' ' HG1' ' A' ' 205' ' ' THR . 71.0 p -132.91 177.32 7.74 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.71 -1.244 . . . . 0.81999999999999995 110.844 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 16.4 m-20 -101.4 57.52 0.85 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.534 -0.757 . . . . 2.3700000000000001 109.405 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.113 0 O-C-N 121.417 -0.802 . . . . 1.1100000000000001 109.656 179.746 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 108.591 -0.892 . . . . 1.6899999999999999 108.591 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -60.35 -39.34 86.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 1.0700000000000001 110.727 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 35.2 p -58.36 -38.04 76.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 1.5800000000000001 110.54 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.7 m -60.58 -39.75 89.2 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.357 -0.839 . . . . 1.6000000000000001 110.221 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.81 -39.72 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.126 -0.983 . . . . 1.45 110.489 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 71.3 mtp -63.39 -42.58 98.82 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.503 1.145 . . . . 1.05 109.341 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.12 -41.16 92.04 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.463 -0.79 . . . . 0.71999999999999997 110.938 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.5 -44.92 96.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.837 -1.164 . . . . 3.0499999999999998 110.355 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 27.8 m -71.67 -39.54 70.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.9 . . . . 0.89000000000000001 110.416 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.9 mt -91.64 -11.2 37.75 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.818 0.818 . . . . 0.78000000000000003 112.22 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.5 mt-10 49.94 19.09 0.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.67 0.989 . . . . 1.45 113.67 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.67 166.85 32.35 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.064 -1.022 . . . . 0.67000000000000004 108.435 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.64 140.57 21.26 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.865 1.71 . . . . 0.64000000000000001 110.38 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.23 168.06 23.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 119.915 -1.741 . . . . 0.67000000000000004 109.859 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 203' ' ' VAL . 92.9 mt -144.01 156.89 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.36 -1.348 . . . . 0.68999999999999995 107.36 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.456 ' N ' HG22 ' A' ' 202' ' ' ILE . 10.2 m -138.15 -30.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 120.99 -1.069 . . . . 0.84999999999999998 112.744 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.79 30.84 0.9 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.014 -1.089 . . . . 0.92000000000000004 113.663 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.431 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 9.8 p -61.34 -27.51 68.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.649 -1.501 . . . . 0.94999999999999996 110.924 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.47 -91.04 0.38 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 120.221 -0.99 . . . . 1.04 110.77 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.5 m -121.7 27.11 8.36 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.531 -0.982 . . . . 1.5700000000000001 112.594 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.1 t -58.5 -35.84 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.121 -1.612 . . . . 0.83999999999999997 110.22 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.405 HG23 ' OD2' ' A' ' 182' ' ' ASP . 56.2 p -52.91 -24.62 9.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 0.98999999999999999 111.625 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.2 p -90.96 0.41 57.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.36 -0.837 . . . . 1.7 111.789 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -123.56 -3.52 8.31 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 113.079 0.77 . . . . 2.2000000000000002 113.079 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 38.7 t -116.8 149.08 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.574 0.702 . . . . 0.83999999999999997 109.712 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -119.41 150.09 40.77 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.123 -1.066 . . . . 2.2000000000000002 108.123 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.421 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.2 p-10 -56.67 143.85 34.61 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.02 -1.072 . . . . 2.2799999999999998 110.355 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.1 m-20 79.89 -1.61 2.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.796 1.406 . . . . 2.3500000000000001 114.796 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.31 150.72 42.61 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.709 -1.196 . . . . 1.97 109.036 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -89.5 117.36 28.35 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.455 -1.403 . . . . 2.6499999999999999 107.591 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.9 mt -126.67 149.8 49.34 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.596 0.713 . . . . 0.63 109.708 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.4 mt -119.21 129.94 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.394 -1.336 . . . . 0.62 107.394 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.523 HD13 HD11 ' A' ' 180' ' ' ILE . 49.6 tp -92.73 121.99 34.68 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.293 -1.373 . . . . 0.64000000000000001 107.293 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 81.1 m-20 -88.33 -30.48 19.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.695 -1.253 . . . . 2.0499999999999998 111.661 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.41 19.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.448 -0.782 . . . . 0.83999999999999997 112.552 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.1 t -121.84 -59.68 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.922 0.868 . . . . 1.02 110.263 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -96.23 10.29 38.31 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.876 0.846 . . . . 2.5099999999999998 110.768 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 4' ' ' GLY . 6.5 t-20 60.82 50.34 5.43 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.579 -0.737 . . . . 1.54 112.021 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.529 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 12.9 pt20 -151.23 158.7 44.23 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.957 0.884 . . . . 1.95 109.638 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 28.0 t -116.37 140.3 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 109.017 -0.734 . . . . 0.70999999999999996 109.017 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.529 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 47.4 m-85 -99.35 130.83 45.66 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.144 -0.973 . . . . 1.01 108.466 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.2 t -109.84 130.02 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.434 -0.791 . . . . 0.81999999999999995 108.921 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.525 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 4.5 t-20 61.11 43.71 0.69 Allowed Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 113.792 1.034 . . . . 1.54 113.792 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 33.4 Cg_endo -65.53 147.48 86.7 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.208 1.939 . . . . 0.93999999999999995 111.199 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 44.1 p -76.82 157.25 31.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.112 -0.992 . . . . 1.8 108.985 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -59.92 -33.22 71.6 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.133 -0.98 . . . . 2.73 110.523 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -57.62 -40.45 79.2 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.468 -0.77 . . . . 3.1699999999999999 110.218 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -71.0 -40.84 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.393 -0.817 . . . . 1.3400000000000001 110.064 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 56.4 mt -60.17 -47.54 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 1.2 110.662 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -59.26 -40.39 85.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.674 -1.266 . . . . 2.7000000000000002 110.482 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -64.66 -42.12 95.63 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.826 -0.75 . . . . 2.5899999999999999 110.357 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.1 mtp -70.88 -34.35 71.51 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.272 -0.893 . . . . 1.3799999999999999 110.975 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.198 -0.939 . . . . 2.8399999999999999 110.389 -179.791 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.2 mt . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 106.302 -1.74 . . . . 1.0700000000000001 106.302 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 m -105.38 124.87 50.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.259 -1.015 . . . . 1.24 108.259 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.89 -152.02 16.8 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 108.141 -1.984 . . . . 1.01 108.141 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.9 mt -94.78 -4.87 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.249 -1.148 . . . . 1.1100000000000001 112.926 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 tp 49.7 99.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.086 -1.009 . . . . 0.98999999999999999 112.624 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.65 -53.74 5.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.007 -1.058 . . . . 0.84999999999999998 110.571 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.99 148.44 45.38 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 107.746 -1.205 . . . . 1.3799999999999999 107.746 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.8 156.52 43.88 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.578 2.186 . . . . 0.93999999999999995 112.272 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 147.17 122.21 1.33 Allowed Glycine 0 N--CA 1.507 3.418 0 N-CA-C 111.087 -0.805 . . . . 0.81000000000000005 111.087 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.8 mt -89.64 132.05 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.777 -1.426 . . . . 0.82999999999999996 108.706 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.99 151.49 46.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.256 -0.902 . . . . 0.53000000000000003 108.638 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.7 m-85 -116.7 145.41 43.47 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.279 -0.888 . . . . 0.77000000000000002 109.219 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.31 167.89 36.86 Favored Glycine 0 N--CA 1.5 2.906 0 C-N-CA 118.938 -1.601 . . . . 0.51000000000000001 110.053 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -78.08 158.89 28.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.752 -0.852 . . . . 1.8999999999999999 109.132 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.42 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.37 119.81 25.54 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.029 -1.1 . . . . 0.66000000000000003 108.029 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -99.93 95.68 7.05 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 105.683 -1.969 . . . . 0.82999999999999996 105.683 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.5 tp -90.67 137.71 32.15 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.454 -1.313 . . . . 0.85999999999999999 107.454 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.5 mt -99.02 111.19 23.66 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.647 -1.612 . . . . 0.92000000000000004 106.647 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -103.52 128.72 50.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.217 -1.401 . . . . 2.0299999999999998 107.217 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -130.6 154.34 47.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.926 -0.768 . . . . 2.6600000000000001 108.926 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -80.65 139.39 36.23 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.695 -0.854 . . . . 2.3199999999999998 108.695 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.82 149.88 49.46 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.473 -1.392 . . . . 2.1099999999999999 109.046 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -93.22 131.01 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.602 -0.888 . . . . 0.72999999999999998 108.602 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.9 t -108.93 130.13 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.272 -1.01 . . . . 0.87 108.272 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.0 mt -94.67 133.51 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.456 -0.942 . . . . 0.81000000000000005 108.456 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -89.01 120.83 30.78 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.294 -1.372 . . . . 1.3400000000000001 107.294 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -96.54 15.8 20.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.132 -0.98 . . . . 2.8900000000000001 112.403 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -70.42 149.89 46.8 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.542 -0.723 . . . . 2.0899999999999999 109.838 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -90.76 130.35 36.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.669 -1.234 . . . . 2.1899999999999999 107.669 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.9 pt -94.76 164.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.988 . . . . 0.75 110.347 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -94.95 166.02 12.16 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.486 -0.759 . . . . 0.91000000000000003 109.681 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.23 -19.11 7.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 0.93000000000000005 112.351 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.12 -37.86 81.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 2.2799999999999998 110.696 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -94.52 -6.14 44.42 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.563 -1.336 . . . . 1.45 113.105 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.8 t -59.55 -42.12 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.217 -0.927 . . . . 0.81000000000000005 110.758 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -58.41 -39.19 79.05 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.128 -0.982 . . . . 1.54 110.58 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -64.99 -38.79 92.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.403 -0.811 . . . . 2.3599999999999999 111.131 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -59.37 -41.23 88.83 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.619 -1.3 . . . . 1.3100000000000001 110.783 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.17 -40.85 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.98 -1.075 . . . . 0.81999999999999995 110.789 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -62.83 -42.6 99.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.977 -1.077 . . . . 1.5 110.457 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.453 ' HG2' HH11 ' A' ' 42' ' ' ARG . 42.2 mtt-85 -61.36 -40.41 94.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -0.863 . . . . 2.23 110.296 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 40.6 t80 -75.32 -55.34 5.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.298 -0.876 . . . . 0.84999999999999998 110.965 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.4 tp -58.07 -47.46 83.11 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.507 -0.877 . . . . 0.91000000000000003 110.459 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -68.79 -39.91 79.91 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.822 -0.751 . . . . 0.90000000000000002 109.918 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.29 -42.48 97.35 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.495 -1.442 . . . . 0.68999999999999995 109.495 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' CG ' HH11 ' A' ' 47' ' ' ARG . 2.2 ttt-85 -60.3 -28.76 68.36 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.235 -1.156 . . . . 2.8799999999999999 110.117 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.92 -50.49 73.58 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.465 0.65 . . . . 0.84999999999999998 110.955 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -83.26 -38.07 22.68 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.134 -0.979 . . . . 2.3500000000000001 111.043 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.9 -42.82 85.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.162 -0.961 . . . . 0.65000000000000002 109.664 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.4 t -60.47 -41.26 93.82 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.718 -0.845 . . . . 1.45 108.718 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.78 -44.86 76.42 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.624 -0.831 . . . . 0.63 110.434 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -62.18 -51.51 67.53 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.366 -0.934 . . . . 1.3400000000000001 110.668 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.69 -38.25 89.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.136 -0.977 . . . . 1.5600000000000001 109.988 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -59.12 -40.08 84.33 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.594 -0.691 . . . . 1.1899999999999999 110.331 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.6 m -62.26 -45.05 95.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.937 -1.102 . . . . 0.71999999999999997 110.266 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.25 -32.31 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.566 -0.709 . . . . 0.62 110.978 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -53.98 -44.58 70.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 1.05 110.469 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -68.69 -36.49 78.57 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.276 -0.89 . . . . 0.64000000000000001 109.709 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -62.27 -40.0 94.78 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.862 -1.135 . . . . 1.73 108.853 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.32 75.41 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.06 -0.656 . . . . 0.56000000000000005 110.06 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.66 -34.05 26.09 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.106 -1.045 . . . . 0.68999999999999995 110.883 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.25 -18.05 43.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.007 -1.29 . . . . 1.48 111.321 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.6 m -90.96 -53.8 4.23 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.209 0.528 . . . . 0.97999999999999998 111.184 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -106.86 -12.65 15.43 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 113.066 0.765 . . . . 1.1599999999999999 113.066 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.8 155.84 10.78 Favored Glycine 0 N--CA 1.501 3.022 0 O-C-N 121.434 -0.791 . . . . 0.84999999999999998 112.338 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -55.78 -20.56 15.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.65 -0.912 . . . . 3.8599999999999999 112.393 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.55 -34.26 66.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.415 -0.803 . . . . 2.3500000000000001 111.165 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -81.17 -19.22 43.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.567 -1.333 . . . . 1.6699999999999999 111.86 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.01 -31.81 70.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.187 -0.946 . . . . 1.45 111.022 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.8 95.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.874 -1.141 . . . . 0.60999999999999999 110.379 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.1 -45.92 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.38 -0.928 . . . . 0.65000000000000002 110.056 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -71.47 -31.63 67.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.838 . . . . 0.66000000000000003 110.417 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -60.32 -38.44 83.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 1.1899999999999999 109.847 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.32 -41.85 94.35 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.213 -1.155 . . . . 0.53000000000000003 110.213 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -58.25 -46.27 86.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -1.103 . . . . 1.27 110.416 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.74 -39.61 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.976 -1.078 . . . . 0.54000000000000004 110.179 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.4 ttt -59.85 -39.8 86.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.961 -1.087 . . . . 1.74 110.411 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.19 -49.07 79.27 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.595 0.712 . . . . 0.55000000000000004 110.774 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.76 -43.64 94.22 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.702 0.763 . . . . 0.46999999999999997 110.241 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -86.25 9.39 17.83 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.338 -0.851 . . . . 1.4199999999999999 112.731 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -64.42 126.5 28.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.389 -0.819 . . . . 1.27 109.007 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.76 -14.18 62.74 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.056 0.932 . . . . 1.3500000000000001 110.647 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -75.8 -54.67 6.57 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.643 -0.66 . . . . 2.2200000000000002 110.137 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 mt -62.0 -40.31 95.24 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.759 -0.776 . . . . 0.62 110.686 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.6 -46.03 81.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.701 -1.25 . . . . 1.29 110.749 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.52 -39.59 91.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.78 . . . . 1.52 110.891 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.23 -48.09 66.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.372 -1.455 . . . . 1.3 110.953 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -55.44 -43.05 70.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.112 -1.035 . . . . 0.60999999999999999 110.153 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.3 mt -62.43 -47.51 92.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.68 0.753 . . . . 0.78000000000000003 110.524 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.61 94.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.457 -0.777 . . . . 0.81999999999999995 110.879 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.7 -39.03 87.0 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.674 -1.266 . . . . 0.80000000000000004 110.239 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.56 -52.77 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.77000000000000002 110.347 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -72.36 -35.13 68.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.502 -0.749 . . . . 2.1200000000000001 112.067 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -80.94 -46.06 15.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.796 -1.19 . . . . 1.51 112.045 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -101.16 9.11 42.3 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.408 -0.807 . . . . 1.98 112.335 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.8 m80 50.54 49.68 20.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.051 -1.031 . . . . 1.3200000000000001 111.45 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.0 mtt -103.92 153.5 20.72 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.73 0.776 . . . . 1.3799999999999999 109.631 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.3 p -72.6 161.43 30.79 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.141 -0.975 . . . . 0.67000000000000004 109.508 178.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.83 -41.28 86.5 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.1 -1.0 . . . . 0.52000000000000002 110.932 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.623 ' OD2' HD21 ' A' ' 142' ' ' LEU . 91.3 m-20 -67.98 -40.73 83.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -0.901 . . . . 2.25 109.866 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.38 -50.36 46.83 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.475 -0.89 . . . . 0.64000000000000001 110.932 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.07 96.18 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.888 0.851 . . . . 0.56000000000000005 110.166 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.65 96.04 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.856 -0.611 . . . . 0.46000000000000002 110.94 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -61.94 -38.88 90.14 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.125 -0.984 . . . . 1.3200000000000001 110.789 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.66 -48.62 80.95 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.677 -1.264 . . . . 1.3 111.462 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.02 -44.12 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.207 -0.933 . . . . 0.60999999999999999 110.059 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.8 mm -61.58 -31.99 52.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.403 0.62 . . . . 0.65000000000000002 110.211 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -59.07 -41.18 87.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.671 . . . . 2.1099999999999999 110.529 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.36 -31.6 21.85 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.355 -1.403 . . . . 0.82999999999999996 112.518 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -61.33 -39.38 90.32 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.484 1.642 . . . . 1.28 110.12 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.68 -48.2 27.44 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.893 0.854 . . . . 0.89000000000000001 110.119 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.1 p -63.76 -36.0 82.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.355 -0.841 . . . . 1.8700000000000001 109.954 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.62 -43.61 98.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 1.05 110.535 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.18 -30.55 71.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.819 -1.176 . . . . 1.02 110.94 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.31 -22.72 66.87 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.29 -0.881 . . . . 2.04 111.038 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -74.44 -10.91 60.03 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.398 -0.921 . . . . 1.73 111.391 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.479 HD13 HD13 ' A' ' 123' ' ' LEU . 7.1 mt -86.49 141.95 28.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.597 -0.69 . . . . 1.3700000000000001 109.412 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -97.76 55.51 1.21 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.577 -0.702 . . . . 2.8799999999999999 111.078 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -131.89 134.11 45.35 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 107.382 -1.34 . . . . 1.5800000000000001 107.382 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -57.53 -39.83 77.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.281 -0.887 . . . . 3.04 110.922 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -70.79 -52.02 23.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.52 -1.363 . . . . 0.90000000000000002 110.672 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.479 HD13 HD13 ' A' ' 118' ' ' LEU . 39.8 mt -61.17 -41.03 96.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.021 -1.049 . . . . 1.0600000000000001 109.842 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -61.5 -49.21 77.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.798 -1.189 . . . . 2.1800000000000002 109.762 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -60.37 -31.67 70.56 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.898 0.856 . . . . 2.1499999999999999 110.047 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 130' ' ' VAL . 22.3 ttp180 -66.85 -27.7 67.75 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 122.3 1.048 . . . . 2.3300000000000001 109.477 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.02 83.29 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.883 0.849 . . . . 0.81999999999999995 109.33 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.3 80.12 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.464 0.65 . . . . 0.84999999999999998 110.326 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.26 -35.74 79.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 1.3899999999999999 110.649 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 126' ' ' ARG . 41.5 t -67.43 -38.34 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.229 -0.919 . . . . 0.56000000000000005 110.331 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -59.0 -39.68 82.57 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 118.923 -1.111 . . . . 3.1200000000000001 109.496 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.45 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 62.1 t0 -60.26 -37.69 81.22 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.44 0.638 . . . . 1.28 110.527 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.8 mt -60.43 -39.15 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.925 -1.109 . . . . 0.48999999999999999 110.113 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.92 -45.34 88.63 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 120.128 -1.034 . . . . 0.46000000000000002 110.702 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -59.81 -40.0 86.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.146 -1.208 . . . . 2.71 110.095 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 136' ' ' ARG . 39.7 mtt-85 -61.25 -42.04 97.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.097 -1.002 . . . . 2.1400000000000001 109.78 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 37.8 tp -60.43 -40.48 91.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.462 -0.773 . . . . 1.05 110.129 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.58 -42.61 92.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.143 -0.973 . . . . 0.52000000000000002 110.399 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.457 ' NH1' ' CD2' ' A' ' 144' ' ' LEU . 54.5 mtt-85 -59.87 -37.58 79.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 2.3500000000000001 110.762 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.4 -41.72 55.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.188 -0.945 . . . . 1.3899999999999999 110.893 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.454 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.6 mt -60.36 -37.76 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.223 -0.923 . . . . 0.68000000000000005 110.768 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.623 HD21 ' OD2' ' A' ' 101' ' ' ASP . 84.3 mt -86.4 -7.35 58.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.82999999999999996 111.994 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.49 23.19 68.34 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 120.091 -1.052 . . . . 0.91000000000000003 113.227 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.457 ' CD2' ' NH1' ' A' ' 139' ' ' ARG . 5.7 tp -64.49 148.09 51.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.049 -0.723 . . . . 0.94999999999999996 109.049 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -66.44 148.53 51.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.039 -0.726 . . . . 2.4300000000000002 109.039 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.4 mt -103.31 132.35 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.17 -1.048 . . . . 1.1000000000000001 108.17 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.888 HD12 ' H ' ' A' ' 147' ' ' ILE . 2.7 mp -84.02 122.82 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.497 -1.297 . . . . 1.5800000000000001 107.497 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -95.07 97.99 10.34 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 105.958 -1.867 . . . . 1.6200000000000001 105.958 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.4 mt -74.91 -15.05 60.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.931 . . . . 0.80000000000000004 112.005 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.8 m -79.94 -1.58 40.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.119 -0.988 . . . . 1.5600000000000001 112.177 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.5 29.04 4.22 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.661 0.743 . . . . 0.83999999999999997 111.954 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 7.3 mt -72.29 138.41 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.169 -0.957 . . . . 0.81999999999999995 109.006 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -113.81 -18.82 11.72 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.278 1.037 . . . . 2.3100000000000001 112.475 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -114.88 138.09 51.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.809 -1.182 . . . . 1.54 107.809 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.26 122.88 26.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.024 -1.102 . . . . 1.3799999999999999 108.024 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.47 179.98 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.11 -0.994 . . . . 0.68999999999999995 108.847 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.8 mt -87.45 142.24 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.05 -1.031 . . . . 0.53000000000000003 108.785 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 45.2 tp -96.66 123.36 40.31 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.061 -1.089 . . . . 0.64000000000000001 108.061 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.19 129.64 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.281 -1.377 . . . . 0.67000000000000004 107.281 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.78 157.12 23.72 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.893 -1.129 . . . . 0.78000000000000003 108.872 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.32 83.11 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.801 -1.187 . . . . 1.0 109.392 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -172.97 148.95 1.82 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.13 -0.693 . . . . 2.4199999999999999 109.13 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.0 mt -111.66 141.22 45.53 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.482 -0.761 . . . . 0.75 109.223 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 168' ' ' THR . 5.8 p -92.78 147.86 34.89 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.914 -1.116 . . . . 0.78000000000000003 108.917 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.55 -43.31 6.07 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.824 1.683 . . . . 0.67000000000000004 113.119 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.2 m -60.49 -51.01 71.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.201 -0.937 . . . . 0.69999999999999996 110.251 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -61.56 -39.52 91.42 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.01 -1.056 . . . . 1.21 109.975 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 164' ' ' THR . 48.1 p -65.77 -36.92 84.9 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.852 0.834 . . . . 0.59999999999999998 109.965 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.81 88.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.494 -0.754 . . . . 0.62 111.127 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -94.27 -3.05 51.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -0.789 . . . . 1.1599999999999999 113.083 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.91 148.18 44.39 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.407 -0.96 . . . . 0.72999999999999998 108.407 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -93.75 114.79 27.14 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 106.884 -1.524 . . . . 2.2400000000000002 106.884 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 173' ' ' LEU . 3.3 mm? -70.75 -27.89 64.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.234 0.54 . . . . 1.4299999999999999 111.506 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -82.92 -16.89 45.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 2.1499999999999999 112.293 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -100.48 -2.82 32.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.015 -1.053 . . . . 2.04 112.8 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 178' ' ' GLY . 88.9 t -107.69 130.62 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.22 -1.03 . . . . 0.55000000000000004 108.22 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.14 -7.65 59.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 1.6299999999999999 112.133 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.618 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.59 172.64 37.13 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.184 -1.566 . . . . 0.46999999999999997 109.184 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -128.89 127.63 42.19 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 107.57 -1.27 . . . . 0.54000000000000004 107.57 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 220' ' ' LEU . 56.4 mt -132.33 120.6 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.406 -1.701 . . . . 0.68999999999999995 106.406 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 203' ' ' VAL . 67.7 p -138.88 169.83 17.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.828 -1.17 . . . . 0.81999999999999995 110.357 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.464 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 36.9 t0 -106.25 62.03 0.65 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.109 -0.7 . . . . 2.3700000000000001 109.109 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 108.804 -0.813 . . . . 1.1100000000000001 108.804 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 188' ' ' SER . 23.9 p . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 106.675 -1.602 . . . . 1.6899999999999999 106.675 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -61.36 -32.49 72.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 1.0700000000000001 110.365 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.3 t -56.3 -39.46 72.78 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.381 -0.824 . . . . 1.5800000000000001 110.18 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.4 p -59.74 -39.0 83.3 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.895 -1.122 . . . . 1.6000000000000001 109.952 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.77 -40.0 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.647 -0.821 . . . . 1.45 110.208 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 51.2 mtp -64.55 -44.92 89.26 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.522 1.153 . . . . 1.05 109.119 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.81 -43.58 94.44 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.089 -0.96 . . . . 0.71999999999999997 111.405 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -59.66 -45.68 91.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.894 -1.129 . . . . 3.0499999999999998 110.533 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.1 m -71.19 -39.3 71.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.881 . . . . 0.89000000000000001 110.327 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.449 HD13 HD12 ' A' ' 173' ' ' LEU . 16.5 mt -92.36 -6.64 49.75 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.155 0.798 . . . . 0.78000000000000003 113.155 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 53.92 13.6 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.745 1.017 . . . . 1.45 113.745 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.65 149.73 95.37 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.925 -1.109 . . . . 0.67000000000000004 108.767 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.08 137.18 73.97 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.503 1.469 . . . . 0.64000000000000001 109.957 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.09 163.65 25.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.368 -1.458 . . . . 0.67000000000000004 109.522 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 220' ' ' LEU . 13.2 mt -149.12 145.46 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.998 -1.112 . . . . 0.68999999999999995 107.998 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.9 m -125.84 -25.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 O-C-N 121.114 -0.991 . . . . 0.84999999999999998 113.24 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.66 50.46 4.25 Favored Glycine 0 N--CA 1.488 2.125 0 O-C-N 120.842 -1.161 . . . . 0.92000000000000004 111.004 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 181' ' ' THR . 69.9 p -68.05 -11.59 59.27 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.933 -1.334 . . . . 0.94999999999999996 112.219 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.464 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 73.88 -95.99 0.84 Allowed Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.756 -1.338 . . . . 1.04 109.756 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 70.8 m -130.31 30.65 4.72 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.336 -1.097 . . . . 1.5700000000000001 112.296 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.72 -39.67 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.446 -1.409 . . . . 0.83999999999999997 110.7 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.7 p -60.68 -19.3 58.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 0.98999999999999999 111.986 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 27.7 t -94.93 -1.95 51.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.121 -0.987 . . . . 1.7 112.107 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -128.77 6.85 5.6 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 112.529 0.566 . . . . 2.2000000000000002 112.529 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 35.0 t -118.62 148.15 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.567 0.699 . . . . 0.83999999999999997 110.036 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -119.32 150.08 40.73 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.035 -1.098 . . . . 2.2000000000000002 108.035 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 45.0 p-10 -50.3 141.53 11.52 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.785 -1.197 . . . . 2.2799999999999998 110.723 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 t70 80.44 1.81 1.9 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.455 1.28 . . . . 2.3500000000000001 114.455 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -65.2 147.99 52.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.882 -1.136 . . . . 1.97 108.732 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -88.22 120.21 29.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.012 -1.477 . . . . 2.6499999999999999 107.012 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.6 mt -129.48 152.59 48.84 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.786 0.803 . . . . 0.63 109.984 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 mt -129.31 134.81 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.607 -1.257 . . . . 0.62 107.607 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.659 HD11 HD12 ' A' ' 202' ' ' ILE . 36.0 tp -97.96 125.04 42.7 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.891 -1.151 . . . . 0.64000000000000001 107.891 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.1 t0 -86.07 -31.2 22.05 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.797 -1.189 . . . . 2.0499999999999998 110.984 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.75 19.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.757 1.021 . . . . 0.83999999999999997 113.757 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.5 t -115.91 -62.32 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-O 121.985 0.898 . . . . 1.02 109.465 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -91.41 13.54 17.24 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.655 0.741 . . . . 2.5099999999999998 110.9 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 63.49 51.34 2.59 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.745 0.646 . . . . 1.54 112.745 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.59 ' NE2' ' CZ ' ' A' ' 228' ' ' TYR . 20.7 pt20 -150.24 161.38 42.53 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.544 1.164 . . . . 1.95 109.948 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.8 t -116.36 138.84 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 108.27 -1.011 . . . . 0.70999999999999996 108.27 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.59 ' CZ ' ' NE2' ' A' ' 226' ' ' GLN . 51.0 m-85 -105.06 131.04 53.07 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.396 -0.964 . . . . 1.01 108.396 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.69 129.26 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 107.577 -1.268 . . . . 0.81999999999999995 107.577 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 46.3 56.48 16.38 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.013 -1.054 . . . . 1.54 113.132 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.4 150.93 70.98 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.656 2.237 . . . . 0.93999999999999995 110.901 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.4 p -75.12 163.5 27.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -0.849 . . . . 1.8 110.321 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.427 HD22 ' H ' ' A' ' 233' ' ' ASN . 2.1 p30 -61.27 -38.74 87.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.753 -1.217 . . . . 2.73 110.605 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -59.84 -41.3 91.06 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.15 -0.969 . . . . 3.1699999999999999 110.361 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 84.3 t -70.83 -40.48 76.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.241 -0.912 . . . . 1.3400000000000001 110.237 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt -60.01 -43.85 93.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.151 -0.968 . . . . 1.2 110.375 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -59.85 -38.75 82.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 2.7000000000000002 110.955 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -61.18 -47.98 83.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.215 -0.928 . . . . 2.5899999999999999 111.164 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 24.4 mtm -73.79 -36.18 65.0 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.018 -1.051 . . . . 1.3799999999999999 111.172 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 . . . . . 0 C--N 1.298 -1.64 0 O-C-N 121.177 -0.952 . . . . 2.8399999999999999 110.043 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 mmt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.236 0.541 . . . . 3.0699999999999998 109.576 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.6 mt -100.28 107.02 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 105.863 -1.902 . . . . 1.0700000000000001 105.863 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -105.44 120.33 41.33 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.794 -1.188 . . . . 1.24 107.794 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.587 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -104.13 -159.28 24.3 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.686 -1.766 . . . . 1.01 108.686 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.8 mt -96.35 1.68 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.29 -1.124 . . . . 1.1100000000000001 112.687 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tp 49.91 97.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.846 -1.158 . . . . 0.98999999999999999 112.213 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -83.5 -46.84 12.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.84999999999999998 111.234 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -149.16 150.15 31.27 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.994 -1.113 . . . . 1.3799999999999999 107.994 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.59 150.0 44.81 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.024 2.483 . . . . 0.93999999999999995 111.803 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.09 121.39 1.36 Allowed Glycine 0 N--CA 1.508 3.453 0 C-N-CA 120.133 -1.032 . . . . 0.81000000000000005 110.708 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -88.59 135.07 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.839 -1.389 . . . . 0.82999999999999996 109.061 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.05 153.86 48.13 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.789 -0.819 . . . . 0.53000000000000003 108.789 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -125.02 140.59 52.77 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.221 -0.924 . . . . 0.77000000000000002 109.077 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.09 170.15 41.76 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 118.672 -1.728 . . . . 0.51000000000000001 110.207 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -79.46 158.82 27.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.654 -0.91 . . . . 1.8999999999999999 109.126 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -83.25 126.86 33.12 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.666 -1.235 . . . . 0.66000000000000003 107.666 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.0 tp -109.91 103.38 12.15 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 105.04 -2.207 . . . . 0.82999999999999996 105.04 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.6 tp -88.0 140.02 29.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.011 . . . . 0.85999999999999999 108.906 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.7 mt -99.04 112.31 24.47 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.414 -1.698 . . . . 0.92000000000000004 106.414 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -110.18 131.97 54.58 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.816 -1.179 . . . . 2.0299999999999998 107.816 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -126.91 140.07 52.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.192 -0.942 . . . . 2.6600000000000001 108.949 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -80.61 137.83 36.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.236 -1.024 . . . . 2.3199999999999998 108.236 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -62.06 150.54 37.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.236 -0.915 . . . . 2.1099999999999999 109.953 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.5 mt -90.23 134.85 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.077 -1.014 . . . . 0.72999999999999998 108.52 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -108.9 131.37 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.463 -0.94 . . . . 0.87 108.463 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.9 mt -94.32 140.35 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.936 -0.764 . . . . 0.81000000000000005 108.936 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -91.33 123.03 34.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.116 -0.99 . . . . 1.3400000000000001 108.503 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -100.02 18.34 18.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.457 -0.777 . . . . 2.8900000000000001 112.046 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -70.43 145.31 51.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.812 -1.18 . . . . 2.0899999999999999 109.488 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -88.15 129.96 35.17 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.759 -1.2 . . . . 2.1899999999999999 107.759 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 pt -95.96 167.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.405 -0.809 . . . . 0.75 110.474 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.4 p -95.81 167.7 11.1 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.345 0.593 . . . . 0.91000000000000003 109.997 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.25 -21.44 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.454 -0.779 . . . . 0.93000000000000005 111.728 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -69.64 -41.24 75.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 2.2799999999999998 110.743 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -84.13 -7.39 59.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.029 -1.045 . . . . 1.45 112.204 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.1 t -58.5 -39.77 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.32 -0.863 . . . . 0.81000000000000005 110.299 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -58.54 -40.19 82.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.008 -1.058 . . . . 1.54 110.208 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -61.81 -40.43 95.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.699 -0.625 . . . . 2.3599999999999999 110.885 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -59.73 -43.97 93.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.064 -1.022 . . . . 1.3100000000000001 111.004 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.48 -41.77 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.986 -1.071 . . . . 0.81999999999999995 110.674 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -60.28 -49.21 78.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.177 -0.952 . . . . 1.5 110.044 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 42' ' ' ARG . 45.6 mtt-85 -60.25 -38.01 82.18 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.534 -0.729 . . . . 2.23 109.857 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -71.85 -59.44 2.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.596 -0.69 . . . . 0.84999999999999998 110.232 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.15 -45.45 90.95 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.218 -0.993 . . . . 0.91000000000000003 110.0 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.519 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.7 t -67.76 -38.81 83.95 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.505 -0.747 . . . . 0.90000000000000002 110.137 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.08 -41.23 94.46 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.579 -1.409 . . . . 0.68999999999999995 109.579 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.533 HH22 ' CD ' ' A' ' 86' ' ' GLU . 32.8 ttm180 -59.8 -31.23 69.51 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.469 -1.018 . . . . 2.8799999999999999 109.206 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.5 -46.33 86.9 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.548 0.69 . . . . 0.84999999999999998 109.765 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -80.61 -44.08 19.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.81 . . . . 2.3500000000000001 111.007 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.12 -42.41 94.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.65000000000000002 110.163 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.1 t -59.86 -38.93 83.55 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.053 -1.029 . . . . 1.45 109.081 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.08 -50.05 44.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.682 -0.69 . . . . 0.63 110.94 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.34 -49.44 77.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.602 -1.311 . . . . 1.3400000000000001 110.66 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.21 -40.42 93.9 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.396 -0.815 . . . . 1.5600000000000001 109.381 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -60.86 -40.5 93.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.602 -0.686 . . . . 1.1899999999999999 110.25 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 m -66.28 -45.42 80.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.998 -1.064 . . . . 0.71999999999999997 109.798 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.02 -38.33 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.519 -0.738 . . . . 0.62 110.387 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -51.26 -42.42 61.04 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.794 -0.762 . . . . 1.05 110.328 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -70.28 -35.3 73.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.27 -0.894 . . . . 0.64000000000000001 110.03 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -61.83 -39.92 93.5 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.179 -1.008 . . . . 1.73 109.074 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.85 -34.74 76.51 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.769 -0.773 . . . . 0.56000000000000005 109.76 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.27 -36.65 20.29 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.643 -1.265 . . . . 0.68999999999999995 110.884 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -81.71 -20.26 39.78 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.847 -1.384 . . . . 1.48 111.126 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -88.61 -51.93 5.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.414 -0.804 . . . . 0.97999999999999998 110.839 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -107.31 -21.05 13.08 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.538 -0.726 . . . . 1.1599999999999999 112.865 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.03 164.24 12.49 Favored Glycine 0 N--CA 1.504 3.167 0 O-C-N 121.51 -0.744 . . . . 0.84999999999999998 112.075 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -52.85 -24.85 9.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.692 -0.887 . . . . 3.8599999999999999 112.288 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.23 -39.56 79.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.838 -1.164 . . . . 2.3500000000000001 111.137 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -87.13 -22.06 25.59 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.981 -1.074 . . . . 1.6699999999999999 111.8 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -60.76 -37.62 82.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 1.45 110.754 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.69 -33.75 73.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.251 -0.905 . . . . 0.60999999999999999 111.299 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.9 mt -65.88 -43.46 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.64 -1.287 . . . . 0.65000000000000002 110.533 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -69.43 -32.15 70.93 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.319 -0.863 . . . . 0.66000000000000003 110.706 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -61.56 -38.48 87.65 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.215 -0.928 . . . . 1.1899999999999999 110.087 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.39 -41.9 99.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.817 -0.913 . . . . 0.53000000000000003 110.817 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -59.28 -40.46 86.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.246 . . . . 1.27 110.535 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.82 -38.57 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.123 -0.985 . . . . 0.54000000000000004 110.724 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.2 ttp -58.14 -39.68 79.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.356 -0.84 . . . . 1.74 110.639 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.72 -48.77 80.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.412 -0.805 . . . . 0.55000000000000004 110.11 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.09 -41.33 92.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.562 -0.711 . . . . 0.46999999999999997 110.641 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -86.54 9.86 17.12 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 112.984 0.735 . . . . 1.4199999999999999 112.984 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -68.37 122.29 18.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 1.27 108.258 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.55 -16.35 64.09 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.779 0.799 . . . . 1.3500000000000001 110.789 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -74.75 -51.18 14.86 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.71 0.766 . . . . 2.2200000000000002 110.115 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.68 -34.43 77.09 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.771 -0.771 . . . . 0.62 110.313 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.533 ' CD ' HH22 ' A' ' 47' ' ' ARG . 88.9 tt0 -59.98 -47.16 86.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.541 -0.724 . . . . 1.29 110.93 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -63.22 -37.91 89.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.991 -1.068 . . . . 1.52 110.995 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -68.24 -49.46 60.51 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.124 -0.985 . . . . 1.3 110.756 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.1 mt -58.42 -43.94 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.60999999999999999 110.551 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.0 mt -62.91 -43.78 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.78000000000000003 110.47 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.71 -40.59 95.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.325 -0.859 . . . . 0.81999999999999995 111.113 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.57 -42.78 97.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.978 -1.076 . . . . 0.80000000000000004 110.437 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.15 -50.33 79.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.951 -1.093 . . . . 0.77000000000000002 110.176 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -78.48 -34.97 47.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.369 -0.832 . . . . 2.1200000000000001 111.774 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -79.08 -46.85 17.25 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.573 -1.329 . . . . 1.51 111.444 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -100.49 8.09 43.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.08 -1.013 . . . . 1.98 111.857 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.6 m170 49.78 48.92 21.01 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.219 -0.993 . . . . 1.3200000000000001 111.528 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.2 mtt -103.64 156.84 17.49 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.678 0.752 . . . . 1.3799999999999999 109.923 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.3 p -73.09 159.19 33.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.519 -0.738 . . . . 0.67000000000000004 109.296 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.16 79.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.088 -1.007 . . . . 0.52000000000000002 110.376 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.562 ' OD2' HD21 ' A' ' 142' ' ' LEU . 82.6 m-20 -68.75 -39.82 80.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.942 -1.099 . . . . 2.25 110.135 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.38 -51.06 40.28 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.446 -0.784 . . . . 0.64000000000000001 111.44 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.72 94.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.555 -0.716 . . . . 0.56000000000000005 110.636 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.89 -44.91 96.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.569 -0.707 . . . . 0.46000000000000002 111.332 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -60.31 -39.57 87.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 1.3200000000000001 110.959 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -55.83 -49.46 73.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.86 -1.15 . . . . 1.3 110.969 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.07 -45.49 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.677 -1.264 . . . . 0.60999999999999999 109.85 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.42 -30.76 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.626 0.727 . . . . 0.65000000000000002 110.117 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -59.16 -40.36 85.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.126 -0.984 . . . . 2.1099999999999999 110.775 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.37 -32.18 20.31 Favored Glycine 0 N--CA 1.5 2.904 0 C-N-CA 119.193 -1.479 . . . . 0.82999999999999996 112.601 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -60.44 -40.73 92.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.545 -1.562 . . . . 1.28 110.096 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.16 -47.77 48.44 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.608 0.718 . . . . 0.89000000000000001 110.307 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 m -60.97 -38.08 84.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 1.8700000000000001 110.545 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.56 97.82 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.186 -0.946 . . . . 1.05 110.854 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.2 mt -65.69 -28.04 68.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 1.02 111.288 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -67.39 -24.27 65.65 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.176 -0.952 . . . . 2.04 111.18 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.17 -11.65 60.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.119 -0.988 . . . . 1.73 111.42 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.441 HD13 HD13 ' A' ' 123' ' ' LEU . 11.3 mt -89.51 138.03 31.81 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.818 -1.179 . . . . 1.3700000000000001 107.818 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 14.9 t70 -97.56 47.77 1.02 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.277 -0.889 . . . . 2.8799999999999999 111.772 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -119.92 139.84 51.8 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.416 -0.802 . . . . 1.5800000000000001 109.023 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -59.98 -39.09 84.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.446 -0.783 . . . . 3.04 110.762 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -70.53 -57.19 5.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.90000000000000002 110.23 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.441 HD13 HD13 ' A' ' 118' ' ' LEU . 22.9 mt -61.01 -41.51 96.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 1.0600000000000001 110.498 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -61.46 -49.54 76.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.854 -1.154 . . . . 2.1800000000000002 109.8 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -59.94 -30.97 69.43 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.054 -1.058 . . . . 2.1499999999999999 109.545 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 130' ' ' VAL . 51.0 ttt180 -63.39 -29.18 70.52 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.532 -0.867 . . . . 2.3300000000000001 109.499 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.41 73.29 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.779 0.799 . . . . 0.81999999999999995 109.92 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.99 -44.53 80.16 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.768 -0.773 . . . . 0.84999999999999998 110.134 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -63.02 -34.84 78.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.357 -0.839 . . . . 1.3899999999999999 110.569 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.2 t -67.96 -40.81 83.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.905 -1.122 . . . . 0.56000000000000005 109.586 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -59.28 -37.39 77.56 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.09 -1.044 . . . . 3.1200000000000001 109.23 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -59.77 -38.21 81.2 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.212 0.529 . . . . 1.28 110.067 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.7 mt -60.1 -40.24 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.972 . . . . 0.48999999999999999 110.006 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.89 -43.03 94.59 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.089 -1.204 . . . . 0.46000000000000002 110.089 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -58.6 -40.1 82.29 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.493 -1.004 . . . . 2.71 110.589 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 136' ' ' ARG . 51.9 mtt-85 -62.34 -42.43 99.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 2.1400000000000001 110.031 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.6 tp -63.28 -44.41 95.16 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.594 0.711 . . . . 1.05 110.036 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.55 -45.2 95.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.635 0.731 . . . . 0.52000000000000002 110.345 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.435 HH21 ' HA ' ' A' ' 146' ' ' ILE . 53.2 mtp180 -62.06 -34.5 76.38 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.623 -0.673 . . . . 2.3500000000000001 110.945 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -76.02 -43.23 45.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.927 -1.108 . . . . 1.3899999999999999 111.005 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.444 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.2 mt -61.58 -37.14 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.922 -1.111 . . . . 0.68000000000000005 110.823 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.562 HD21 ' OD2' ' A' ' 101' ' ' ASP . 74.7 mt -88.03 -5.96 58.22 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.013 -1.055 . . . . 0.82999999999999996 112.372 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.14 27.28 73.13 Favored Glycine 0 N--CA 1.481 1.664 0 C-N-CA 119.869 -1.157 . . . . 0.91000000000000003 112.844 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 23.1 tp -62.3 147.37 48.38 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.643 0.735 . . . . 0.94999999999999996 109.66 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.41 140.21 58.61 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.562 -0.903 . . . . 2.4300000000000002 108.562 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.435 ' HA ' HH21 ' A' ' 139' ' ' ARG . 54.1 mt -101.34 137.88 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.098 -1.001 . . . . 1.1000000000000001 108.518 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.85 HD12 ' H ' ' A' ' 147' ' ' ILE . 3.0 mp -82.44 123.76 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.869 -1.16 . . . . 1.5800000000000001 107.869 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -99.67 97.54 8.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.854 -1.536 . . . . 1.6200000000000001 106.854 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.1 -17.87 61.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.586 -0.696 . . . . 0.80000000000000004 111.382 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.8 t -81.58 2.02 31.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.874 . . . . 1.5600000000000001 112.097 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.91 21.09 14.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.559 -0.713 . . . . 0.83999999999999997 111.928 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.2 mt -74.3 134.51 29.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.266 -0.896 . . . . 0.81999999999999995 108.913 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.35 -15.8 13.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.487 -0.758 . . . . 2.3100000000000001 113.003 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -111.49 130.6 55.67 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.165 -1.421 . . . . 1.54 107.165 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -72.27 123.86 23.86 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.535 -0.913 . . . . 1.3799999999999999 108.535 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 25.3 m -145.69 179.56 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.482 -0.762 . . . . 0.68999999999999995 109.462 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.7 mt -89.66 140.23 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.714 -0.847 . . . . 0.53000000000000003 108.714 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.83 124.88 40.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.973 -1.079 . . . . 0.64000000000000001 108.54 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.42 130.67 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.258 -1.016 . . . . 0.67000000000000004 108.258 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.72 150.86 17.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.78000000000000003 109.002 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.491 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -61.13 -37.86 84.33 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.915 -1.115 . . . . 1.0 109.544 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 46.9 t0 -171.23 150.28 2.94 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.391 -0.818 . . . . 2.4199999999999999 108.83 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.465 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 48.2 mt -119.55 141.05 49.59 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.882 -0.784 . . . . 0.75 108.882 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.1 p -87.37 150.91 50.13 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.893 -1.129 . . . . 0.78000000000000003 108.646 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -43.12 -41.63 9.53 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.787 1.658 . . . . 0.67000000000000004 113.414 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.6 m -61.95 -49.02 77.81 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.144 -1.022 . . . . 0.69999999999999996 110.14 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -62.84 -40.14 96.52 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.447 -0.783 . . . . 1.21 110.478 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 71.5 p -69.73 -39.0 77.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.236 -0.915 . . . . 0.59999999999999998 110.271 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.49 -33.4 73.71 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.469 -0.769 . . . . 0.62 110.503 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -96.06 -2.09 47.42 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.198 -0.939 . . . . 1.1599999999999999 112.51 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.72 147.73 41.25 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.306 -0.998 . . . . 0.72999999999999998 108.306 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.59 113.79 25.48 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.993 -1.484 . . . . 2.2400000000000002 106.993 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.18 -17.27 61.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.778 -0.576 . . . . 1.4299999999999999 111.431 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -80.69 -24.04 39.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.814 . . . . 2.1499999999999999 111.902 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -100.84 -6.13 25.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.264 -0.898 . . . . 2.04 113.216 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 178' ' ' GLY . 65.4 t -107.61 129.65 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.182 -1.044 . . . . 0.55000000000000004 108.182 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 55.1 tp -85.79 -11.21 54.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.261 -0.9 . . . . 1.6299999999999999 112.35 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.452 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 174.92 178.66 44.96 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.072 -1.611 . . . . 0.46999999999999997 109.072 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -132.13 132.84 43.62 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.557 -1.275 . . . . 0.54000000000000004 107.557 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 66.8 mt -137.85 107.04 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 106.076 -1.824 . . . . 0.68999999999999995 106.076 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 205' ' ' THR . 60.1 p -128.57 169.22 14.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.11 -0.994 . . . . 0.81999999999999995 109.041 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 12.8 p-10 -98.14 42.74 1.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.288 -0.882 . . . . 2.3700000000000001 111.223 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.22 66.68 0.79 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.547 -0.721 . . . . 1.1100000000000001 109.804 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.15 95.39 1.29 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 107.676 -2.17 . . . . 1.6699999999999999 107.676 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -160.97 145.07 10.52 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.234 -1.546 . . . . 1.54 109.234 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -58.43 -28.54 65.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.028 -1.278 . . . . 4.4800000000000004 110.757 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.6 p -87.99 10.24 19.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.711 -0.618 . . . . 2.6299999999999999 111.75 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.7 m -78.65 116.94 19.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 1.6899999999999999 108.877 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -60.16 -36.53 77.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.463 -0.773 . . . . 1.0700000000000001 111.019 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.2 p -56.09 -41.79 75.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.324 -0.86 . . . . 1.5800000000000001 110.237 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.7 t -60.02 -38.53 82.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.44 -0.787 . . . . 1.6000000000000001 110.179 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.89 -39.48 80.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.669 -0.644 . . . . 1.45 110.913 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.7 mtp -60.39 -44.14 95.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.911 -1.118 . . . . 1.05 109.539 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.07 -47.42 86.44 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.711 -0.677 . . . . 0.71999999999999997 111.205 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.37 -46.17 90.91 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.762 -1.211 . . . . 3.0499999999999998 111.351 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.4 m -69.77 -39.78 76.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.987 . . . . 0.89000000000000001 110.644 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.9 mt -91.98 -9.89 41.34 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.069 0.766 . . . . 0.78000000000000003 113.069 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.6 mt-10 53.66 12.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.637 0.977 . . . . 1.45 113.637 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 24.1 mt -71.82 148.91 92.6 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.198 -1.038 . . . . 0.67000000000000004 108.198 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.67 135.56 62.4 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 121.36 1.373 . . . . 0.64000000000000001 109.916 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -162.0 167.61 24.18 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 117.642 -1.623 . . . . 0.67000000000000004 109.791 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 203' ' ' VAL . 84.5 mt -148.44 156.09 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.202 -1.407 . . . . 0.68999999999999995 107.202 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.466 ' N ' HG22 ' A' ' 202' ' ' ILE . 3.1 m -138.71 -25.98 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 120.825 -1.172 . . . . 0.84999999999999998 112.098 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.98 45.17 3.47 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.432 -0.889 . . . . 0.92000000000000004 111.832 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 181' ' ' THR . 32.3 p -64.84 -14.55 59.75 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.453 -1.028 . . . . 0.94999999999999996 111.034 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.82 -94.26 0.97 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.273 -1.131 . . . . 1.04 110.273 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 71.9 m -129.38 27.7 5.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.621 -0.929 . . . . 1.5700000000000001 112.697 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.59 -36.26 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.358 -1.464 . . . . 0.83999999999999997 110.775 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.2 p -57.51 -25.93 60.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.994 -1.066 . . . . 0.98999999999999999 111.235 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 36.8 p -93.1 3.81 55.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.605 -0.684 . . . . 1.7 111.733 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -126.26 -9.19 6.42 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.33 0.863 . . . . 2.2000000000000002 113.33 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 213' ' ' LYS . 51.5 t -119.59 156.33 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.97 -0.752 . . . . 0.83999999999999997 108.97 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.45 ' N ' HG12 ' A' ' 212' ' ' VAL . 6.2 mmmm -125.99 158.85 34.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.817 -1.179 . . . . 2.2000000000000002 107.817 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 52.7 p-10 -52.43 149.16 5.94 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 120.75 -1.219 . . . . 2.2799999999999998 110.459 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.1 t70 80.72 -2.69 1.84 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 114.11 1.152 . . . . 2.3500000000000001 114.11 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 16' ' ' ALA . 54.8 t0 -66.69 146.47 54.43 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.737 -1.227 . . . . 1.97 108.489 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.459 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 43.3 t80 -88.49 122.16 31.66 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.442 -1.318 . . . . 2.6499999999999999 107.442 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 85.2 mt -127.3 146.38 50.46 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -0.841 . . . . 0.63 109.674 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.5 mt -115.71 128.78 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.418 -1.697 . . . . 0.62 106.418 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.9 tp -98.5 117.96 34.1 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 106.025 -1.843 . . . . 0.64000000000000001 106.025 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 223' ' ' VAL . 32.0 t0 -87.0 -26.75 23.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.736 -1.227 . . . . 2.0499999999999998 112.066 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.54 20.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.842 . . . . 0.83999999999999997 113.139 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.5 t -119.5 -63.22 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-O 121.769 0.795 . . . . 1.02 109.711 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -99.32 14.34 29.98 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.496 0.665 . . . . 2.5099999999999998 111.256 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.587 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 60.22 54.74 3.89 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.376 0.607 . . . . 1.54 112.233 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.514 ' OE1' ' CZ ' ' A' ' 228' ' ' TYR . 15.7 tt0 -145.72 143.59 29.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.035 -1.041 . . . . 1.95 109.568 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.65 139.26 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.438 -1.319 . . . . 0.70999999999999996 107.438 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.514 ' CZ ' ' OE1' ' A' ' 226' ' ' GLN . 86.8 m-85 -103.93 134.43 47.22 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.832 -1.168 . . . . 1.01 108.956 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.25 130.59 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.9 -1.148 . . . . 0.81999999999999995 107.9 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 1.0 OUTLIER 54.52 49.91 6.01 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.185 -0.947 . . . . 1.54 112.95 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 44.8 Cg_endo -68.88 149.38 72.34 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.906 2.404 . . . . 0.93999999999999995 111.459 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.5 m -78.34 157.64 29.07 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.668 0.747 . . . . 1.8 109.765 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.52 ' HA ' HD12 ' A' ' 236' ' ' ILE . 65.9 t30 -55.68 -40.59 72.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.447 -0.783 . . . . 2.73 110.627 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.05 -39.65 86.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.574 -0.704 . . . . 3.1699999999999999 110.62 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.67 -37.92 71.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.301 -0.874 . . . . 1.3400000000000001 110.204 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 233' ' ' ASN . 91.3 mt -59.9 -43.0 91.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.454 -0.779 . . . . 1.2 110.369 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -59.18 -40.35 85.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -0.871 . . . . 2.7000000000000002 110.462 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -61.4 -46.1 91.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 2.5899999999999999 110.982 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.1 mtp -72.3 -35.91 68.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.066 -1.021 . . . . 1.3799999999999999 111.148 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -59.36 -39.21 82.52 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.09 -1.006 . . . . 2.8399999999999999 110.774 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -69.47 -43.11 73.88 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.357 -0.839 . . . . 1.8799999999999999 111.461 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 91.0 t -56.37 -53.21 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.667 -1.271 . . . . 2.3999999999999999 112.46 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -62.81 -48.63 78.27 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.466 -1.396 . . . . 3.52 109.953 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.38 -39.22 89.86 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.699 -0.625 . . . . 1.8799999999999999 111.207 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -60.76 -28.77 68.97 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.438 -1.414 . . . . 3.0099999999999998 110.63 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.51 -42.94 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.469 -0.769 . . . . 2.4500000000000002 110.66 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.69 89.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.274 -0.891 . . . . 2.75 110.39 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.3 t -69.16 -35.74 76.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.2 -0.937 . . . . 3.1600000000000001 110.594 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.37 -32.78 73.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.09 -1.006 . . . . 3.5699999999999998 110.756 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -63.03 -40.2 97.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.979 -1.076 . . . . 4.2999999999999998 110.572 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.02 83.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -0.958 . . . . 4.4500000000000002 110.484 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -69.03 -30.52 68.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.879 . . . . 5.9699999999999998 111.063 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.12 -32.09 71.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.06 -1.025 . . . . 6.1799999999999997 110.565 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -63.73 -32.1 73.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.089 . . . . 6.6600000000000001 110.773 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -83.36 -11.09 58.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.859 -1.151 . . . . 8.1999999999999993 112.739 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 93.1 mt -86.83 -0.97 57.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.279 -0.888 . . . . 8.0700000000000003 112.399 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -85.31 -11.04 55.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 9.4499999999999993 112.34 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -96.36 -8.37 32.73 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.366 -0.834 . . . . 10.119999999999999 113.098 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.973 -1.013 . . . . 11.49 108.692 -178.638 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.325 0.583 . . . . 3.0699999999999998 109.889 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.0 mt -142.79 110.9 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.233 -1.766 . . . . 1.0700000000000001 106.233 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.3 m -104.57 127.33 52.27 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.387 -0.968 . . . . 1.24 108.387 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.57 -141.24 11.99 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.494 -1.042 . . . . 1.01 110.494 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 5' ' ' ILE . 56.6 mt -100.51 1.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.241 -1.152 . . . . 1.1100000000000001 112.467 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tp 49.45 96.73 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.863 -1.148 . . . . 0.98999999999999999 112.162 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.5 -45.79 10.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.072 -1.017 . . . . 0.84999999999999998 111.419 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t -147.11 145.9 23.75 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.686 -1.227 . . . . 1.3799999999999999 107.686 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.71 151.8 46.85 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.565 2.176 . . . . 0.93999999999999995 112.254 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.53 123.7 1.51 Allowed Glycine 0 N--CA 1.508 3.491 0 N-CA-C 110.94 -0.864 . . . . 0.81000000000000005 110.94 177.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.7 mt -92.37 131.41 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.767 -1.431 . . . . 0.82999999999999996 109.348 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.89 140.73 42.54 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.355 -0.98 . . . . 0.53000000000000003 108.355 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 12.4 m-85 -108.59 136.83 47.53 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.971 -1.122 . . . . 0.77000000000000002 107.971 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.76 169.05 42.09 Favored Glycine 0 N--CA 1.498 2.81 0 C-N-CA 118.276 -1.916 . . . . 0.51000000000000001 110.461 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -77.7 159.39 29.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.756 -0.849 . . . . 1.8999999999999999 108.795 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.477 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -87.83 131.24 34.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.999 -1.063 . . . . 0.66000000000000003 109.234 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 17' ' ' LEU . 36.4 tp -109.8 103.47 12.28 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.175 -2.157 . . . . 0.82999999999999996 105.175 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 tp -89.46 132.31 35.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.981 -1.075 . . . . 0.85999999999999999 108.615 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' A' ' 160' ' ' ALA . 67.3 mt -100.01 121.26 41.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.515 -1.291 . . . . 0.92000000000000004 107.515 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -110.65 129.4 55.83 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 107.763 -1.199 . . . . 2.0299999999999998 107.763 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -111.33 141.54 44.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.398 -0.814 . . . . 2.6600000000000001 109.22 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.18 127.03 33.25 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.436 -1.32 . . . . 2.3199999999999998 107.436 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.21 147.04 54.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.046 -1.034 . . . . 2.1099999999999999 109.156 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.5 mt -95.32 133.35 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.498 -0.927 . . . . 0.72999999999999998 108.498 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -105.74 129.75 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.969 -1.123 . . . . 0.87 107.969 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 73.5 mt -98.33 137.27 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.152 -0.967 . . . . 0.81000000000000005 108.671 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -92.31 120.61 33.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.161 -1.052 . . . . 1.3400000000000001 108.161 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.425 HH11 ' HG3' ' A' ' 28' ' ' ARG . 22.6 mmm-85 -94.96 13.78 23.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.206 -0.934 . . . . 2.8900000000000001 112.217 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -72.13 143.03 49.13 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.494 -0.754 . . . . 2.0899999999999999 109.239 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -85.74 140.29 30.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.379 -0.826 . . . . 2.1899999999999999 109.482 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.26 165.59 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 121.629 0.728 . . . . 0.75 110.41 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.7 p -93.56 167.78 11.46 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.311 0.577 . . . . 0.91000000000000003 109.801 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.97 -18.66 14.41 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.015 -1.053 . . . . 0.93000000000000005 112.713 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -68.99 -38.14 79.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.885 . . . . 2.2799999999999998 110.877 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -92.27 -5.88 51.49 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.548 -1.345 . . . . 1.45 113.086 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.72 -42.89 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.097 -1.002 . . . . 0.81000000000000005 110.69 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.1 -40.33 85.01 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.841 -1.162 . . . . 1.54 110.527 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.52 -39.42 93.51 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.292 -0.88 . . . . 2.3599999999999999 111.063 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -59.76 -40.83 89.48 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.893 -1.129 . . . . 1.3100000000000001 111.148 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.1 -45.0 96.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 120.937 -1.102 . . . . 0.81999999999999995 110.725 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -61.43 -45.88 92.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.823 -1.173 . . . . 1.5 110.648 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -60.77 -41.35 95.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 2.23 110.176 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -75.09 -55.44 5.73 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.155 -0.966 . . . . 0.84999999999999998 110.184 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.9 tp -57.38 -47.14 82.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.409 -0.916 . . . . 0.91000000000000003 110.125 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.5 t -70.22 -38.9 75.35 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.051 0.929 . . . . 0.90000000000000002 109.785 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.53 -44.9 97.22 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.488 -1.445 . . . . 0.68999999999999995 109.488 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 43.9 ttp180 -57.49 -31.72 66.28 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.853 -0.793 . . . . 2.8799999999999999 109.342 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.34 -41.49 80.13 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.774 0.797 . . . . 0.84999999999999998 109.906 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -77.46 -40.94 41.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.633 -0.667 . . . . 2.3500000000000001 110.236 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.66 92.15 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.588 -0.845 . . . . 0.65000000000000002 109.874 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.4 t -60.26 -39.85 88.26 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.041 0.925 . . . . 1.45 109.392 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.2 75.47 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.819 -0.628 . . . . 0.63 110.597 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -66.55 -50.1 64.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.055 -1.028 . . . . 1.3400000000000001 111.032 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.09 -38.43 91.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 1.5600000000000001 110.229 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -59.76 -41.0 90.04 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.233 -0.917 . . . . 1.1899999999999999 110.449 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.1 m -65.59 -43.39 89.84 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.241 -0.912 . . . . 0.71999999999999997 109.882 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.08 -31.9 49.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.379 -0.826 . . . . 0.62 110.691 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -51.78 -46.64 64.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.745 -1.222 . . . . 1.05 110.477 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -68.63 -34.21 75.36 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.953 -1.092 . . . . 0.64000000000000001 109.805 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.13 -39.95 96.17 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.356 -1.338 . . . . 1.73 109.136 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.92 -33.7 75.89 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.832 -0.747 . . . . 0.56000000000000005 109.548 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.18 -35.74 29.41 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.375 -1.393 . . . . 0.68999999999999995 110.688 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -80.75 -22.53 40.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.107 -1.231 . . . . 1.48 111.016 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.6 m -84.56 -48.9 9.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.428 -0.795 . . . . 0.97999999999999998 110.714 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -106.81 -22.62 12.65 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.409 -0.807 . . . . 1.1599999999999999 112.93 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.37 169.29 14.89 Favored Glycine 0 N--CA 1.501 3.002 0 CA-C-O 121.967 0.76 . . . . 0.84999999999999998 112.036 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.22 -24.17 40.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.912 -0.758 . . . . 3.8599999999999999 112.501 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.96 -38.27 78.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.091 -1.006 . . . . 2.3500000000000001 111.634 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -84.62 -15.84 44.12 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.321 -1.487 . . . . 1.6699999999999999 113.347 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -60.07 -34.66 73.73 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.1 -1.0 . . . . 1.45 110.69 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.59 86.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.60999999999999999 111.308 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 mt -65.54 -43.8 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.822 -1.174 . . . . 0.65000000000000002 110.44 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -70.05 -30.68 68.01 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.225 -0.922 . . . . 0.66000000000000003 110.583 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -59.49 -38.95 82.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.248 -0.907 . . . . 1.1899999999999999 110.511 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.48 -38.73 79.87 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.734 -1.222 . . . . 0.53000000000000003 110.616 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -58.05 -42.62 85.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.782 -1.422 . . . . 1.27 110.873 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.9 mt -60.4 -41.49 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 0.54000000000000004 110.375 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.5 ttt -60.38 -39.15 86.22 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.221 -0.924 . . . . 1.74 110.397 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 tp -59.64 -48.43 81.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.796 -1.19 . . . . 0.55000000000000004 110.729 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.61 -41.64 95.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.355 -0.841 . . . . 0.46999999999999997 110.247 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -87.09 9.99 18.05 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.376 0.608 . . . . 1.4199999999999999 112.213 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -64.99 122.17 16.37 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.858 -1.151 . . . . 1.27 108.624 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.86 -17.69 65.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.512 -0.743 . . . . 1.3500000000000001 111.07 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -76.46 -53.65 7.82 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.664 0.745 . . . . 2.2200000000000002 110.365 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.89 -39.52 85.62 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.593 -0.843 . . . . 0.62 110.389 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.521 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 86.3 tt0 -59.9 -45.87 91.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.718 -1.239 . . . . 1.29 110.965 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -60.58 -39.98 90.0 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.966 -1.084 . . . . 1.52 110.839 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.42 -48.49 77.56 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.335 -0.853 . . . . 1.3 110.111 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.8 mt -58.61 -43.27 87.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 118.974 -1.09 . . . . 0.60999999999999999 109.61 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.4 mt -61.35 -45.08 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.535 -0.728 . . . . 0.78000000000000003 110.316 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.36 -44.93 96.33 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.271 0.558 . . . . 0.81999999999999995 110.929 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.91 -43.34 94.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.574 -1.329 . . . . 0.80000000000000004 110.337 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.2 mt -62.33 -49.99 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.137 -0.977 . . . . 0.77000000000000002 110.723 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -78.79 -36.32 42.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.609 -0.682 . . . . 2.1200000000000001 111.563 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -79.93 -46.11 17.34 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 120.789 -1.194 . . . . 1.51 111.838 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -102.24 10.66 39.11 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.097 -1.002 . . . . 1.98 112.066 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.3 m80 51.26 51.5 16.8 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.306 -0.871 . . . . 1.3200000000000001 112.452 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.6 mtp -104.32 158.27 16.57 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 120.91 -1.119 . . . . 1.3799999999999999 109.289 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 66.7 p -72.83 158.43 35.56 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.282 -0.886 . . . . 0.67000000000000004 109.466 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.11 -42.04 84.86 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.224 -0.922 . . . . 0.52000000000000002 110.17 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.528 ' OD2' HD21 ' A' ' 142' ' ' LEU . 88.9 m-20 -68.78 -38.82 80.29 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.976 -1.078 . . . . 2.25 110.207 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.91 -48.59 57.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.5 -0.88 . . . . 0.64000000000000001 111.536 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.32 -47.58 84.86 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.221 -0.924 . . . . 0.56000000000000005 110.967 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.59 95.78 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.475 -0.766 . . . . 0.46000000000000002 110.82 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -61.49 -37.67 84.51 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.558 -0.714 . . . . 1.3200000000000001 110.718 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.09 -49.3 78.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.859 -1.151 . . . . 1.3 111.399 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.36 -46.25 95.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.622 -1.299 . . . . 0.60999999999999999 110.097 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -61.43 -33.78 58.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.451 0.643 . . . . 0.65000000000000002 110.437 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -57.53 -41.59 81.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -0.828 . . . . 2.1099999999999999 110.786 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.65 -28.01 27.97 Favored Glycine 0 N--CA 1.5 2.94 0 C-N-CA 119.176 -1.487 . . . . 0.82999999999999996 113.084 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -62.38 -39.58 93.67 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.253 -1.734 . . . . 1.28 109.747 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.13 -53.63 12.16 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.57 0.7 . . . . 0.89000000000000001 111.425 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.7 p -60.41 -39.6 88.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 1.8700000000000001 110.502 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.59 97.5 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.112 -0.993 . . . . 1.05 110.622 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.33 -29.0 69.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.966 -1.084 . . . . 1.02 111.202 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -68.22 -20.26 64.82 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.458 -0.776 . . . . 2.04 111.346 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -73.06 -12.34 60.88 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.331 -0.947 . . . . 1.73 110.766 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 20.1 mt -85.91 147.3 26.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.566 -0.708 . . . . 1.3700000000000001 109.098 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -103.12 39.14 1.61 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.149 -0.969 . . . . 2.8799999999999999 111.826 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.422 ' CB ' HD12 ' A' ' 123' ' ' LEU . 7.1 t0 -113.54 139.21 49.17 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 108.733 -0.839 . . . . 1.5800000000000001 108.733 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.8 -37.74 79.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.795 -1.191 . . . . 3.04 110.812 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -72.42 -46.19 56.23 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.539 -1.351 . . . . 0.90000000000000002 110.667 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.422 HD12 ' CB ' ' A' ' 120' ' ' ASP . 43.7 mt -64.33 -40.86 96.73 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.014 -1.054 . . . . 1.0600000000000001 109.823 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -61.17 -46.66 89.59 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.164 -0.96 . . . . 2.1800000000000002 110.256 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -61.0 -31.93 71.52 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.177 -0.952 . . . . 2.1499999999999999 109.641 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -62.78 -29.19 70.52 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.854 -1.138 . . . . 2.3300000000000001 109.722 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.37 -49.14 78.75 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.857 0.837 . . . . 0.81999999999999995 109.852 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.53 -44.65 70.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.62 0.724 . . . . 0.84999999999999998 110.663 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -63.52 -33.76 76.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.422 -0.799 . . . . 1.3899999999999999 110.875 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.3 t -69.74 -42.24 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.224 -0.99 . . . . 0.56000000000000005 110.203 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -59.21 -38.29 79.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.96 -1.088 . . . . 3.1200000000000001 109.456 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -59.52 -39.59 84.39 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.707 -0.621 . . . . 1.28 110.213 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.04 -40.71 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.081 -1.012 . . . . 0.48999999999999999 110.322 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.83 -39.93 85.28 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.948 -1.261 . . . . 0.46000000000000002 109.948 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.33 -45.39 91.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.714 -0.874 . . . . 2.71 109.968 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.431 ' HG2' HH11 ' A' ' 136' ' ' ARG . 51.5 mtt-85 -62.77 -42.68 99.8 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.49 -0.884 . . . . 2.1400000000000001 109.875 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.02 -41.3 91.87 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.673 -0.642 . . . . 1.05 109.954 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.2 mt -60.36 -42.06 94.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.81 . . . . 0.52000000000000002 110.226 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.428 ' NH1' HD23 ' A' ' 144' ' ' LEU . 47.9 mtt-85 -61.08 -32.13 71.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 2.3500000000000001 110.53 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -75.99 -41.55 50.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.244 -0.91 . . . . 1.3899999999999999 110.933 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.43 HG21 ' OD1' ' A' ' 101' ' ' ASP . 91.9 mt -60.17 -39.18 79.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.961 -1.087 . . . . 0.68000000000000005 110.274 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.528 HD21 ' OD2' ' A' ' 101' ' ' ASP . 85.1 mt -86.72 -7.61 58.14 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.348 -0.845 . . . . 0.82999999999999996 112.666 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.82 20.04 77.26 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.11 -1.519 . . . . 0.91000000000000003 112.724 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.428 HD23 ' NH1' ' A' ' 139' ' ' ARG . 35.9 tp -65.94 149.1 50.75 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.957 -0.731 . . . . 0.94999999999999996 109.709 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -66.84 149.37 50.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.262 -0.899 . . . . 2.4300000000000002 109.753 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.0 mt -107.64 141.03 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.229 -1.026 . . . . 1.1000000000000001 108.229 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.58 HD12 ' H ' ' A' ' 147' ' ' ILE . 5.0 mp -78.98 123.88 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.601 -0.888 . . . . 1.5800000000000001 108.601 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -96.84 95.67 8.02 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.796 -1.557 . . . . 1.6200000000000001 106.796 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.42 -15.8 59.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.439 -0.788 . . . . 0.80000000000000004 111.683 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.6 m -80.76 1.72 29.17 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.244 -0.91 . . . . 1.5600000000000001 112.514 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.86 19.03 14.48 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 112.774 0.657 . . . . 0.83999999999999997 112.774 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.8 mt -74.1 139.47 19.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.266 -0.896 . . . . 0.81999999999999995 109.353 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -122.24 -8.78 8.68 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.458 0.646 . . . . 2.3100000000000001 112.199 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -111.07 138.49 47.43 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.885 -1.154 . . . . 1.54 107.885 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.88 116.39 20.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.09 -1.078 . . . . 1.3799999999999999 108.09 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.3 176.7 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.992 -0.744 . . . . 0.68999999999999995 108.992 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.2 mt -84.21 140.29 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.364 -0.976 . . . . 0.53000000000000003 108.364 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 19' ' ' LEU . 27.9 tp -96.53 128.32 43.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.486 -0.931 . . . . 0.64000000000000001 108.486 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.2 130.12 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.075 -1.083 . . . . 0.67000000000000004 108.075 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.442 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -160.57 159.68 30.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.234 -0.916 . . . . 0.78000000000000003 108.92 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -62.43 -41.14 98.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.316 -1.49 . . . . 1.0 109.717 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -174.21 150.94 1.58 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.755 -0.832 . . . . 2.4199999999999999 108.755 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.13 140.8 48.92 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 109.176 -0.675 . . . . 0.75 109.176 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.7 p -90.98 151.18 43.02 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.675 -1.266 . . . . 0.78000000000000003 108.471 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -39.67 -37.77 1.51 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.077 1.851 . . . . 0.67000000000000004 113.512 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.4 m -63.6 -51.4 65.45 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.154 -0.966 . . . . 0.69999999999999996 109.916 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.95 -39.24 94.03 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.539 -0.726 . . . . 1.21 110.237 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 32.1 p -68.16 -40.28 82.39 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.348 0.595 . . . . 0.59999999999999998 110.442 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.68 81.56 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.177 -0.952 . . . . 0.62 110.4 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -94.04 -1.61 54.18 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.94 -1.1 . . . . 1.1599999999999999 112.855 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.26 149.22 33.98 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.697 -0.853 . . . . 0.72999999999999998 108.697 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -96.48 114.26 25.91 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.885 -1.524 . . . . 2.2400000000000002 106.885 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 82.4 mt -72.05 -17.02 62.05 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.173 0.511 . . . . 1.4299999999999999 111.55 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -84.72 -22.19 29.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.654 -0.654 . . . . 2.1499999999999999 112.034 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -99.51 -4.22 31.75 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.24 -0.913 . . . . 2.04 112.923 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 178' ' ' GLY . 61.1 t -112.92 129.86 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 107.599 -1.26 . . . . 0.55000000000000004 107.599 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.2 tp -89.1 -8.53 53.66 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.899 -1.126 . . . . 1.6299999999999999 111.827 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.473 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.22 171.21 39.03 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.995 -1.642 . . . . 0.46999999999999997 108.995 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.0 136.2 49.15 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.283 -1.127 . . . . 0.54000000000000004 108.147 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.473 HG22 HG21 ' A' ' 205' ' ' THR . 86.2 mt -135.54 115.75 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 106.358 -1.719 . . . . 0.68999999999999995 106.358 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 205' ' ' THR . 81.6 p -131.0 169.5 15.75 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.784 -1.198 . . . . 0.81999999999999995 109.897 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 39.0 p-10 -103.24 43.62 1.07 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.586 -0.696 . . . . 2.3700000000000001 110.721 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -103.52 163.13 12.49 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.866 -1.146 . . . . 1.1100000000000001 110.068 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 183' ' ' ALA . . . -47.73 -96.49 0.01 OUTLIER Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.699 -1.239 . . . . 1.6699999999999999 111.522 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 153.81 -46.11 0.56 Allowed Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.828 -1.395 . . . . 1.54 112.895 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -56.66 -40.13 74.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.742 -1.446 . . . . 4.4800000000000004 110.474 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.9 p -121.41 23.22 10.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.888 -0.507 . . . . 2.6299999999999999 111.204 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.9 p -87.88 128.6 35.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.967 -1.124 . . . . 1.6899999999999999 107.967 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -61.07 -38.53 86.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.688 -0.633 . . . . 1.0700000000000001 110.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.1 p -51.99 -43.66 63.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.056 -1.028 . . . . 1.5800000000000001 110.405 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.9 m -60.12 -37.81 81.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.767 0.794 . . . . 1.6000000000000001 110.405 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.7 mm -59.52 -38.58 76.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.525 -0.735 . . . . 1.45 110.8 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 77.2 mtp -63.17 -43.0 99.49 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.226 1.012 . . . . 1.05 108.883 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.79 -48.99 78.15 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.598 -0.728 . . . . 0.71999999999999997 111.335 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.28 -46.78 88.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.014 -1.054 . . . . 3.0499999999999998 111.146 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 42.7 m -69.85 -41.36 74.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.178 -0.951 . . . . 0.89000000000000001 110.294 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.27 -1.6 57.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.415 -0.803 . . . . 0.78000000000000003 111.991 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 194' ' ' ALA . 54.9 mt-10 54.04 9.75 0.24 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.723 1.009 . . . . 1.45 113.723 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.19 164.94 52.78 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.984 -1.072 . . . . 0.67000000000000004 108.304 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -82.06 144.04 13.18 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.851 1.701 . . . . 0.64000000000000001 110.397 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.48 168.28 25.44 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 117.733 -1.587 . . . . 0.67000000000000004 109.499 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.562 ' CD1' HD11 ' A' ' 220' ' ' LEU . 17.4 mt -148.85 145.9 17.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.159 -1.423 . . . . 0.68999999999999995 107.159 176.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.98 -25.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 120.899 -1.125 . . . . 0.84999999999999998 113.523 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.14 46.16 3.57 Favored Glycine 0 N--CA 1.492 2.403 0 O-C-N 120.99 -1.069 . . . . 0.92000000000000004 111.644 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.473 HG21 HG22 ' A' ' 180' ' ' ILE . 60.5 p -67.59 -12.48 60.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.375 -1.073 . . . . 0.94999999999999996 111.803 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.48 -95.54 0.98 Allowed Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.301 -1.12 . . . . 1.04 110.301 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.9 p -128.41 29.28 5.34 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.389 -1.065 . . . . 1.5700000000000001 112.344 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 72.4 t -58.49 -38.03 67.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.567 -1.333 . . . . 0.83999999999999997 110.707 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.7 p -55.48 -24.94 34.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 0.98999999999999999 111.58 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.4 t -94.34 3.93 54.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.875 . . . . 1.7 111.988 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -127.66 1.13 6.14 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.675 0.621 . . . . 2.2000000000000002 112.675 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 16.1 t -116.23 150.2 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.889 0.852 . . . . 0.83999999999999997 109.611 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -116.07 167.16 11.23 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.939 -0.763 . . . . 2.2000000000000002 108.939 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 68.5 m-80 -68.05 140.33 56.29 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.74 -1.184 . . . . 2.2799999999999998 108.814 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.0 m-20 78.0 4.71 2.84 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.171 1.175 . . . . 2.3500000000000001 114.171 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -63.38 147.88 49.97 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.075 -1.083 . . . . 1.97 108.075 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -89.01 120.16 30.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.588 -1.32 . . . . 2.6499999999999999 107.484 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.477 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 80.2 mt -127.9 146.99 50.46 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.664 0.745 . . . . 0.63 109.697 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 60.2 mt -119.08 128.2 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.08 -1.452 . . . . 0.62 107.08 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.562 HD11 ' CD1' ' A' ' 202' ' ' ILE . 48.8 tp -100.98 119.96 39.49 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 106.329 -1.73 . . . . 0.64000000000000001 106.329 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 223' ' ' VAL . 40.2 t0 -87.28 -25.65 23.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.955 -1.091 . . . . 2.0499999999999998 112.176 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.8 16.84 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 113.652 0.982 . . . . 0.83999999999999997 113.652 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 221' ' ' ASP . 43.1 t -120.38 -63.31 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.178 -0.951 . . . . 1.02 109.621 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -90.81 7.84 37.8 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.059 0.933 . . . . 2.5099999999999998 111.175 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 62.3 55.34 2.38 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.692 0.758 . . . . 1.54 112.148 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -147.31 145.17 29.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.353 -0.842 . . . . 1.95 109.562 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 29.9 t -115.95 138.34 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.775 -1.194 . . . . 0.70999999999999996 107.775 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -105.76 132.7 51.56 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.925 -1.11 . . . . 1.01 108.483 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.94 130.56 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 108.532 -0.914 . . . . 0.81999999999999995 108.532 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.425 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 41.6 t-20 50.72 51.34 10.38 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 113.462 0.912 . . . . 1.54 113.462 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 36.4 Cg_endo -67.86 150.27 78.41 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.53 2.153 . . . . 0.93999999999999995 110.507 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.412 ' H ' HG23 ' A' ' 232' ' ' THR . 1.5 p -74.05 159.99 31.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.994 -1.066 . . . . 1.8 109.7 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -61.57 -35.76 78.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.284 -0.885 . . . . 2.73 110.334 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.35 -39.74 84.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.961 -1.087 . . . . 3.1699999999999999 110.43 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.91 -36.73 70.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.491 -0.756 . . . . 1.3400000000000001 110.017 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.01 -43.78 93.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.261 -0.9 . . . . 1.2 110.543 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.22 -41.2 88.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.955 -1.091 . . . . 2.7000000000000002 110.252 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -63.61 -40.03 95.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.447 -0.783 . . . . 2.5899999999999999 110.502 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 73.2 mtp -70.73 -36.99 73.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.925 . . . . 1.3799999999999999 110.936 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -57.56 -39.87 77.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.8 -1.188 . . . . 2.8399999999999999 110.127 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.15 -56.91 5.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.239 -0.913 . . . . 1.8799999999999999 110.077 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.78 -42.57 92.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.294 -0.879 . . . . 2.3999999999999999 110.701 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -58.33 -51.98 67.5 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.901 -1.119 . . . . 3.52 111.055 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.97 -30.95 71.97 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.366 -0.934 . . . . 1.8799999999999999 109.478 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -60.57 -30.69 69.96 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.298 -0.961 . . . . 3.0099999999999998 108.754 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 82.7 t -60.13 -41.82 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 122.312 1.053 . . . . 2.4500000000000002 108.676 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.04 -39.06 68.75 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.001 -1.079 . . . . 2.75 108.773 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 29.4 t -71.0 -19.44 62.52 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.513 0.673 . . . . 3.1600000000000001 110.569 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.48 -40.59 91.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.345 -0.847 . . . . 3.5699999999999998 109.283 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -64.72 -29.39 70.37 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.677 1.227 . . . . 4.2999999999999998 109.629 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.03 37.18 0.43 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.849 -1.069 . . . . 4.4500000000000002 111.886 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -58.35 -28.45 65.11 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.408 -0.917 . . . . 5.9699999999999998 111.124 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.654 ' N ' HD12 ' A' ' 253' ' ' LEU . 8.1 mp -66.02 -29.72 70.14 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.445 -0.902 . . . . 6.1799999999999997 110.367 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -73.66 -3.51 28.63 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.85 0.685 . . . . 6.6600000000000001 112.85 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.92 -3.14 43.35 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.859 -1.151 . . . . 8.1999999999999993 112.47 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.553 ' N ' HD22 ' A' ' 256' ' ' LEU . 3.5 mm? -80.39 -1.74 42.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.438 -0.789 . . . . 8.0700000000000003 111.741 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -94.27 19.64 9.18 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.887 -0.508 . . . . 9.4499999999999993 112.131 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.25 10.48 22.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.289 -0.882 . . . . 10.119999999999999 112.202 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 118.123 -0.941 . . . . 11.49 109.327 178.777 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.805 -0.443 . . . . 3.0699999999999998 109.805 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 80.9 mt -99.08 117.16 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 106.568 -1.642 . . . . 1.0700000000000001 106.568 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.3 m -104.01 122.31 44.98 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.281 -1.007 . . . . 1.24 108.281 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.401 ' H ' ' ND2' ' A' ' 225' ' ' ASN . . . -109.57 -159.22 18.21 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 108.641 -1.784 . . . . 1.01 108.641 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 5' ' ' ILE . 93.4 mt -97.07 1.06 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.253 -1.145 . . . . 1.1100000000000001 112.646 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tp 51.42 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.049 . . . . 0.98999999999999999 112.345 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -83.62 -45.0 13.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.993 -1.067 . . . . 0.84999999999999998 111.496 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.06 146.48 28.43 Favored Pre-proline 0 N--CA 1.5 2.064 0 N-CA-C 107.447 -1.316 . . . . 1.3799999999999999 107.447 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.15 146.17 28.43 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.644 2.229 . . . . 0.93999999999999995 112.144 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.898 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.71 176.43 26.11 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 108.828 -1.709 . . . . 0.81000000000000005 108.828 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.4 mt -138.05 136.69 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 107.712 -1.218 . . . . 0.82999999999999996 107.712 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.25 152.85 44.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.392 -0.818 . . . . 0.53000000000000003 109.19 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -122.16 145.11 48.5 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.354 -0.98 . . . . 0.77000000000000002 108.354 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.78 167.58 34.3 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.584 -1.769 . . . . 0.51000000000000001 109.886 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -76.89 159.16 30.25 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.788 -0.831 . . . . 1.8999999999999999 108.802 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.92 126.94 33.49 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.866 -1.161 . . . . 0.66000000000000003 107.866 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.89 107.89 19.14 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 104.965 -2.235 . . . . 0.82999999999999996 104.965 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.8 tp -94.37 138.67 32.06 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.162 -1.051 . . . . 0.85999999999999999 108.162 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.7 mt -100.69 118.03 36.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 106.768 -1.567 . . . . 0.92000000000000004 106.768 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -109.96 136.06 49.84 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.043 -1.466 . . . . 2.0299999999999998 107.043 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -123.94 140.1 53.31 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.847 -1.158 . . . . 2.6600000000000001 108.34 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -82.91 136.26 34.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.464 -1.31 . . . . 2.3199999999999998 107.464 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.32 150.03 44.32 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.671 -0.812 . . . . 2.1099999999999999 109.516 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.3 mt -91.77 134.64 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.314 -0.866 . . . . 0.72999999999999998 108.752 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.4 t -106.31 130.03 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.496 -1.298 . . . . 0.87 107.496 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 26' ' ' ILE . 19.4 mt -96.34 132.26 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.643 -0.873 . . . . 0.81000000000000005 108.643 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -91.81 121.62 33.6 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.316 -0.994 . . . . 1.3400000000000001 108.316 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -100.03 22.01 11.92 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.15 -0.969 . . . . 2.8900000000000001 112.139 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -65.78 143.65 57.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.889 -1.132 . . . . 2.0899999999999999 109.073 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -89.32 131.39 35.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.077 -1.082 . . . . 2.1899999999999999 108.077 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 pt -97.63 167.74 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.75 109.996 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.3 p -97.62 163.68 12.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.531 -0.731 . . . . 0.91000000000000003 110.109 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.87 -24.09 14.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.93000000000000005 111.861 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -67.37 -35.97 80.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.953 . . . . 2.2799999999999998 110.715 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -94.78 -12.81 26.41 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.993 -1.067 . . . . 1.45 112.802 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.19 -46.42 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.895 . . . . 0.81000000000000005 110.537 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -58.12 -39.38 78.54 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.102 -0.999 . . . . 1.54 110.701 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -62.41 -43.25 99.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.418 -0.801 . . . . 2.3599999999999999 110.876 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.46 -36.55 78.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.079 -1.013 . . . . 1.3100000000000001 110.935 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.46 -42.4 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.784 -1.198 . . . . 0.81999999999999995 110.091 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -61.89 -41.03 97.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.097 -1.002 . . . . 1.5 110.091 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -63.14 -40.95 99.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.512 -0.743 . . . . 2.23 110.168 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -71.94 -56.72 5.17 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.27 -0.894 . . . . 0.84999999999999998 110.349 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.9 tp -58.92 -47.04 86.45 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.377 -0.929 . . . . 0.91000000000000003 109.754 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.531 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.0 t -70.27 -42.18 72.45 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.263 -0.975 . . . . 0.90000000000000002 109.426 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.24 -38.85 88.58 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.145 -1.582 . . . . 0.68999999999999995 109.145 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -59.79 -33.37 71.63 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 122.103 0.954 . . . . 2.8799999999999999 108.973 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.35 -42.14 81.44 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.604 0.716 . . . . 0.84999999999999998 109.642 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -79.46 -43.34 23.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -0.821 . . . . 2.3500000000000001 110.527 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.78 87.88 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.335 -0.853 . . . . 0.65000000000000002 109.814 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 m -60.77 -39.81 90.21 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.798 0.808 . . . . 1.45 109.546 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.86 86.98 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.243 0.544 . . . . 0.63 110.475 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.02 -48.77 78.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 1.3400000000000001 110.575 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.96 -38.56 88.89 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.012 -1.055 . . . . 1.5600000000000001 109.783 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -60.19 -40.04 88.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.83 -0.544 . . . . 1.1899999999999999 110.789 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.7 m -61.8 -42.81 99.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.759 -1.213 . . . . 0.71999999999999997 109.931 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.49 -37.64 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.298 -0.876 . . . . 0.62 110.493 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -50.1 -44.29 51.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.403 -0.811 . . . . 1.05 111.118 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.25 -37.38 74.91 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.123 -0.986 . . . . 0.64000000000000001 110.109 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -61.68 -38.55 88.21 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.905 -1.118 . . . . 1.73 109.545 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.47 -33.59 76.24 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.918 -0.713 . . . . 0.56000000000000005 109.621 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.37 -36.82 13.41 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.957 -1.116 . . . . 0.68999999999999995 111.123 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -81.36 -23.08 37.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.966 -1.314 . . . . 1.48 111.023 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 m -91.4 -51.29 5.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.484 -0.76 . . . . 0.97999999999999998 110.971 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.12 -8.17 17.59 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.001 1.112 . . . . 1.1599999999999999 114.001 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.36 170.69 30.63 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.257 -0.902 . . . . 0.84999999999999998 111.75 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -58.21 -21.98 50.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.98 -0.717 . . . . 3.8599999999999999 112.15 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -54.34 -41.61 69.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.06 -1.025 . . . . 2.3500000000000001 110.861 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -89.24 -24.0 22.21 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.161 -0.962 . . . . 1.6699999999999999 112.031 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -60.01 -39.57 86.27 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.604 -0.685 . . . . 1.45 111.167 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.36 87.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.357 -0.839 . . . . 0.60999999999999999 111.523 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 mt -65.95 -45.56 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.541 -1.35 . . . . 0.65000000000000002 110.131 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -68.43 -33.22 73.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.066 -1.021 . . . . 0.66000000000000003 110.623 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -60.15 -36.13 76.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.233 -0.917 . . . . 1.1899999999999999 110.321 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.87 -39.66 85.3 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.941 -1.123 . . . . 0.53000000000000003 110.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -58.98 -42.88 91.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.102 -1.234 . . . . 1.27 110.525 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.9 mt -60.36 -37.54 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.54000000000000004 110.34 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.5 ttt -59.45 -39.9 85.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.257 -0.902 . . . . 1.74 110.517 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.03 -46.36 88.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.334 -0.854 . . . . 0.55000000000000004 109.866 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.3 -38.78 88.04 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.817 0.818 . . . . 0.46999999999999997 110.139 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.86 9.7 18.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.515 -0.74 . . . . 1.4199999999999999 112.735 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -67.11 121.76 16.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.182 -0.949 . . . . 1.27 108.849 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.75 -15.55 62.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.536 -0.728 . . . . 1.3500000000000001 111.065 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -76.86 -49.63 15.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.678 0.751 . . . . 2.2200000000000002 110.431 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.36 -37.26 86.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.755 0.788 . . . . 0.62 110.192 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.91 -47.46 85.66 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.35 -0.844 . . . . 1.29 110.744 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.82 -37.79 85.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.215 -0.928 . . . . 1.52 110.473 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -65.41 -47.72 75.29 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.092 -1.043 . . . . 1.3 110.646 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -58.35 -44.55 88.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.138 -1.025 . . . . 0.60999999999999999 110.07 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.87 -39.83 83.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.653 -0.655 . . . . 0.78000000000000003 110.245 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.05 90.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.531 -0.73 . . . . 0.81999999999999995 110.878 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.0 -41.74 92.74 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.028 -1.045 . . . . 0.80000000000000004 110.272 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.5 mt -64.94 -50.01 77.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.776 -0.769 . . . . 0.77000000000000002 110.494 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -74.77 -38.54 62.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 2.1200000000000001 111.778 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -78.82 -45.76 20.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.665 -1.272 . . . . 1.51 111.279 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -101.47 8.84 41.89 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.983 -1.073 . . . . 1.98 112.569 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.2 m80 50.25 49.97 19.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.707 -1.246 . . . . 1.3200000000000001 111.632 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.6 mtt -102.8 154.97 18.66 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.831 0.824 . . . . 1.3799999999999999 109.716 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.7 p -70.96 161.44 31.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.604 -0.685 . . . . 0.67000000000000004 109.582 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.87 91.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 0.52000000000000002 111.042 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 28.6 p-10 -69.13 -39.05 79.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.798 -1.189 . . . . 2.25 110.53 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -69.7 -50.36 44.48 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.432 -0.907 . . . . 0.64000000000000001 111.46 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.11 90.94 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.948 -1.095 . . . . 0.56000000000000005 110.472 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.44 90.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.254 -0.904 . . . . 0.46000000000000002 110.868 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -61.06 -38.75 87.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.737 -1.227 . . . . 1.3200000000000001 111.003 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -57.68 -49.81 75.28 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.053 -1.029 . . . . 1.3 110.791 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.2 -47.23 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.831 -1.168 . . . . 0.60999999999999999 110.144 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -62.0 -32.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.358 -0.839 . . . . 0.65000000000000002 110.497 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -57.78 -40.05 78.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 2.1099999999999999 110.856 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.06 -33.2 15.47 Favored Glycine 0 N--CA 1.501 3.029 0 C-N-CA 119.152 -1.499 . . . . 0.82999999999999996 112.452 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -61.66 -42.26 98.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.434 -1.627 . . . . 1.28 110.2 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.9 -53.3 15.57 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.494 0.664 . . . . 0.89000000000000001 110.821 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.6 m -61.42 -39.92 92.5 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.021 -1.049 . . . . 1.8700000000000001 111.083 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.43 97.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.993 -1.067 . . . . 1.05 111.318 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 43.9 mt -62.21 -29.99 70.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.953 -1.092 . . . . 1.02 110.613 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.27 -19.67 64.73 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.971 -1.081 . . . . 2.04 111.073 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -74.65 -9.38 58.52 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.965 0.888 . . . . 1.73 110.898 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.485 HD13 HD13 ' A' ' 123' ' ' LEU . 69.2 mt -87.37 149.57 24.4 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.039 -0.726 . . . . 1.3700000000000001 109.039 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -104.12 38.77 1.77 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.105 -0.997 . . . . 2.8799999999999999 111.586 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -116.43 138.58 51.25 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.23 -0.919 . . . . 1.5800000000000001 108.981 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.79 -39.54 85.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.693 -0.629 . . . . 3.04 110.957 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -71.68 -48.12 49.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.64 -1.287 . . . . 0.90000000000000002 110.38 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.485 HD13 HD13 ' A' ' 118' ' ' LEU . 25.5 mt -64.1 -39.57 94.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 1.0600000000000001 110.021 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -60.28 -47.98 83.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.906 -1.121 . . . . 2.1800000000000002 109.518 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.32 -31.28 70.13 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.716 -0.794 . . . . 2.1499999999999999 109.57 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.536 ' O ' HG23 ' A' ' 130' ' ' VAL . 19.2 ttt-85 -60.5 -31.11 70.17 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.136 -1.026 . . . . 2.3300000000000001 108.397 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -61.96 -48.85 78.51 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.459 -0.896 . . . . 0.81999999999999995 109.332 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.01 -46.11 79.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.388 -0.82 . . . . 0.84999999999999998 110.408 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.38 -34.45 77.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.48 -0.763 . . . . 1.3899999999999999 110.656 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.0 t -68.23 -39.5 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.56000000000000005 110.275 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -57.37 -39.69 76.57 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.139 -0.976 . . . . 3.1200000000000001 110.115 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -61.28 -39.38 90.22 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.624 0.726 . . . . 1.28 110.591 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.27 -39.79 83.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.381 -0.825 . . . . 0.48999999999999999 110.293 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.92 -48.4 48.55 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.394 -0.908 . . . . 0.46000000000000002 111.456 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -58.26 -40.64 82.38 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.73 -1.453 . . . . 2.71 110.811 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -61.79 -45.86 92.04 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.677 -1.264 . . . . 2.1400000000000001 110.326 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.96 -43.78 98.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.486 -0.759 . . . . 1.05 110.376 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.93 -45.53 92.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.831 . . . . 0.52000000000000002 110.44 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.424 HH22 HD12 ' A' ' 147' ' ' ILE . 57.6 mtp180 -60.54 -35.99 77.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.571 -0.706 . . . . 2.3500000000000001 110.987 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -74.71 -40.35 61.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 1.3899999999999999 110.66 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.34 -39.17 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.448 -0.901 . . . . 0.68000000000000005 110.407 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.28 -7.05 58.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.086 -1.009 . . . . 0.82999999999999996 112.33 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.85 19.49 77.57 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.812 -1.185 . . . . 0.91000000000000003 112.478 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.38 147.91 39.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.639 -0.918 . . . . 0.94999999999999996 109.302 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -67.24 142.92 56.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.401 -0.812 . . . . 2.4300000000000002 109.185 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.6 mt -108.7 137.72 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.167 -1.049 . . . . 1.1000000000000001 108.167 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.512 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.2 mp -79.45 130.36 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.015 . . . . 1.5800000000000001 108.546 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -93.95 96.2 9.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.507 -1.664 . . . . 1.6200000000000001 106.507 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.5 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 57.3 mt -74.61 -10.56 59.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 0.80000000000000004 111.951 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 172' ' ' ASN . 27.5 t -89.5 0.74 56.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.909 -1.119 . . . . 1.5600000000000001 112.424 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -102.43 33.75 3.02 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.102 -0.999 . . . . 0.83999999999999997 112.884 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 152' ' ' ILE . 1.9 mp -66.29 140.63 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.197 -1.564 . . . . 0.81999999999999995 108.827 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -109.29 -20.77 12.83 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.08 0.943 . . . . 2.3100000000000001 111.346 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.437 ' O ' ' CG2' ' A' ' 152' ' ' ILE . 95.7 m-20 -118.89 140.17 50.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.875 -1.157 . . . . 1.54 107.875 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -74.49 124.94 27.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.056 -1.091 . . . . 1.3799999999999999 108.056 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.6 m -146.88 175.7 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.564 -0.71 . . . . 0.68999999999999995 109.513 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.1 mt -88.7 141.83 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.951 -0.759 . . . . 0.53000000000000003 108.951 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.6 tp -96.67 121.39 38.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.64000000000000001 108.297 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.78 131.56 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.373 -0.973 . . . . 0.67000000000000004 108.373 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.37 158.2 31.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.78000000000000003 109.088 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.56 82.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.692 -1.255 . . . . 1.0 109.713 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -171.81 151.07 2.74 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.889 -0.782 . . . . 2.4199999999999999 108.889 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.0 mt -115.76 142.9 46.14 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.504 -0.747 . . . . 0.75 109.248 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 54.3 p -92.4 148.86 37.28 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 120.984 -1.073 . . . . 0.78000000000000003 108.878 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -41.28 -41.84 4.98 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.052 1.835 . . . . 0.67000000000000004 113.354 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.9 m -60.51 -50.37 73.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.938 -1.101 . . . . 0.69999999999999996 110.235 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -60.68 -40.14 91.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.416 -0.802 . . . . 1.21 109.779 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 48.6 p -66.73 -38.47 86.73 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.568 -0.708 . . . . 0.59999999999999998 110.278 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.28 82.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.62 111.122 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -96.93 1.05 49.95 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.31 -0.869 . . . . 1.1599999999999999 113.136 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.27 150.03 36.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.2 -0.938 . . . . 0.72999999999999998 109.601 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 150' ' ' SER . 6.1 m120 -94.83 116.14 28.36 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 106.877 -1.527 . . . . 2.2400000000000002 106.877 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.619 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.6 mm? -75.06 -19.43 60.0 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.482 -0.761 . . . . 1.4299999999999999 111.81 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -85.9 -21.23 28.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 2.1499999999999999 112.266 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -98.95 -2.86 36.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.126 -0.983 . . . . 2.04 112.598 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.592 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.0 t -109.08 129.32 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 107.979 -1.119 . . . . 0.55000000000000004 107.979 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.2 tp -86.26 -6.2 59.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.518 -0.739 . . . . 1.6299999999999999 111.833 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.592 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 167.29 172.74 34.8 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 108.822 -1.711 . . . . 0.46999999999999997 108.822 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -127.18 131.12 50.75 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.206 -1.173 . . . . 0.54000000000000004 108.15 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.599 HG22 HG21 ' A' ' 205' ' ' THR . 89.1 mt -135.97 116.07 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 106.164 -1.791 . . . . 0.68999999999999995 106.164 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 203' ' ' VAL . 62.8 p -138.79 174.99 9.94 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.282 -1.511 . . . . 0.81999999999999995 110.543 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 44.2 m-20 -97.62 61.73 1.63 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 115.455 -0.793 . . . . 2.3700000000000001 109.674 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.457 ' HB1' ' OG ' ' A' ' 188' ' ' SER . . . -106.88 141.66 37.74 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.72 -0.845 . . . . 1.1100000000000001 108.72 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -58.58 -35.9 82.77 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.637 -1.268 . . . . 1.6699999999999999 110.899 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 93.2 -12.78 69.12 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 121.066 -1.255 . . . . 1.54 113.717 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -61.44 -40.98 96.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.812 -1.404 . . . . 4.4800000000000004 109.887 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 40.9 p -152.6 36.95 0.51 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 2.6299999999999999 111.89 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.457 ' OG ' ' HB1' ' A' ' 183' ' ' ALA . 67.6 m -83.74 132.04 34.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 1.6899999999999999 108.802 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -60.04 -35.49 75.22 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.181 0.515 . . . . 1.0700000000000001 111.012 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.9 p -57.67 -41.24 81.12 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.77 -1.206 . . . . 1.5800000000000001 110.464 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 50.6 m -60.07 -35.95 76.31 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.016 -1.053 . . . . 1.6000000000000001 110.172 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.1 mm -59.97 -39.95 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.893 -0.504 . . . . 1.45 111.029 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.5 mtp -61.13 -45.14 95.91 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.009 -1.057 . . . . 1.05 109.62 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -57.91 -48.2 80.57 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.678 -0.692 . . . . 0.71999999999999997 111.061 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 195' ' ' ARG . 41.6 mtt-85 -61.87 -41.01 97.33 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.132 -0.98 . . . . 3.0499999999999998 110.605 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.5 m -69.62 -41.36 75.79 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.288 -0.883 . . . . 0.89000000000000001 110.185 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.22 -8.12 49.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 112.574 0.583 . . . . 0.78000000000000003 112.574 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.1 mt-10 52.97 10.66 0.17 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.085 1.143 . . . . 1.45 114.085 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.7 mt -71.95 149.7 92.52 Favored Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 108.188 -1.041 . . . . 0.67000000000000004 108.188 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -54.09 132.81 52.18 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.236 1.29 . . . . 0.64000000000000001 109.903 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.75 162.71 37.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.294 -1.504 . . . . 0.67000000000000004 109.468 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 203' ' ' VAL . 81.2 mt -148.23 154.5 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.686 -1.228 . . . . 0.68999999999999995 107.686 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.9 m -137.22 -28.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 121.077 -1.014 . . . . 0.84999999999999998 112.244 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.75 32.93 0.72 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.822 -1.18 . . . . 0.92000000000000004 113.5 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.599 HG21 HG22 ' A' ' 180' ' ' ILE . 39.4 p -60.8 -25.27 66.44 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.31 -1.112 . . . . 0.94999999999999996 110.453 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 76.27 -93.44 0.99 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.818 -1.182 . . . . 1.04 110.541 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 95.0 p -127.3 32.6 5.02 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.215 -1.168 . . . . 1.5700000000000001 112.325 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.26 -36.24 67.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 120.682 -1.261 . . . . 0.83999999999999997 109.911 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.5 p -57.48 -20.19 29.36 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.282 -0.886 . . . . 0.98999999999999999 111.74 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.4 t -91.16 -3.57 56.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 1.7 111.732 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -122.62 -8.2 8.52 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 112.923 0.712 . . . . 2.2000000000000002 112.923 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 68.9 t -112.32 148.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.427 0.632 . . . . 0.83999999999999997 109.649 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -120.09 159.46 24.76 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.012 -1.107 . . . . 2.2000000000000002 108.012 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.2 p30 -57.61 149.0 22.54 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.409 -1.432 . . . . 2.2799999999999998 110.507 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 9.0 t0 81.69 -2.44 1.6 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 114.644 1.35 . . . . 2.3500000000000001 114.644 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -67.61 147.97 52.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.743 -1.223 . . . . 1.97 108.328 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -90.18 122.96 33.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.757 -1.201 . . . . 2.6499999999999999 107.757 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.0 mt -124.88 143.88 50.61 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.9 0.857 . . . . 0.63 110.199 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.61 122.93 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.125 -1.805 . . . . 0.62 106.125 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.1 tp -98.92 117.77 34.17 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.409 -1.7 . . . . 0.64000000000000001 106.409 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 223' ' ' VAL . 30.9 t0 -92.76 -26.0 17.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.933 -1.104 . . . . 2.0499999999999998 112.96 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.59 18.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.863 0.69 . . . . 0.83999999999999997 112.863 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.2 t -113.49 -60.72 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.956 0.884 . . . . 1.02 109.386 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -95.54 10.55 36.2 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.721 0.772 . . . . 2.5099999999999998 110.764 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 4' ' ' GLY . 1.7 t-20 62.21 50.25 3.99 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.446 0.641 . . . . 1.54 111.74 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -147.17 146.6 29.93 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.414 1.102 . . . . 1.95 109.563 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.11 140.25 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.691 -0.855 . . . . 0.70999999999999996 108.691 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -100.28 132.16 45.81 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.909 -1.119 . . . . 1.01 108.542 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.1 t -110.15 130.18 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.411 -0.959 . . . . 0.81999999999999995 108.411 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.7 t30 53.12 52.84 10.97 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 114.124 1.157 . . . . 1.54 114.124 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.38 149.6 69.53 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.149 1.899 . . . . 0.93999999999999995 110.717 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 65.7 p -75.72 157.94 32.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 1.8 109.245 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -60.84 -38.56 85.91 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.788 -0.765 . . . . 2.73 110.24 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 55.8 mp0 -60.28 -39.34 86.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.636 -0.665 . . . . 3.1699999999999999 110.732 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.48 -40.83 77.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.864 -1.134 . . . . 1.3400000000000001 110.142 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.4 -43.87 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.437 -0.789 . . . . 1.2 110.082 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -59.72 -41.42 90.8 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.104 -0.997 . . . . 2.7000000000000002 110.385 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -63.61 -40.58 97.27 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.474 -0.89 . . . . 2.5899999999999999 110.342 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.488 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 84.0 mtp -69.85 -41.01 75.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 1.3799999999999999 110.648 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -53.28 -44.68 68.47 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.327 -1.483 . . . . 2.8399999999999999 110.276 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.84 -59.63 2.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 1.8799999999999999 110.514 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.69 -46.01 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.276 -0.89 . . . . 2.3999999999999999 111.921 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 239' ' ' MET . 4.2 tp60 -59.32 -43.24 92.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.712 -1.243 . . . . 3.52 110.861 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -60.46 -35.87 76.91 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.489 -1.284 . . . . 1.8799999999999999 109.94 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -60.55 -28.74 68.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.776 -1.17 . . . . 3.0099999999999998 110.213 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 99.7 t -60.31 -41.66 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 118.981 -1.088 . . . . 2.4500000000000002 109.186 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.92 82.8 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.478 -0.889 . . . . 2.75 109.705 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 7.7 t -70.82 -27.56 63.97 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.577 0.703 . . . . 3.1600000000000001 110.887 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -59.78 -38.88 83.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.78 . . . . 3.5699999999999998 110.3 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 252' ' ' GLU . 93.3 mttt -66.48 -29.32 69.4 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.898 0.856 . . . . 4.2999999999999998 110.674 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -74.52 28.55 0.08 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.763 0.792 . . . . 4.4500000000000002 111.88 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 250' ' ' LYS . 85.3 tt0 -59.88 -24.55 64.36 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.695 -0.628 . . . . 5.9699999999999998 111.388 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.27 -35.15 73.21 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.398 -0.921 . . . . 6.1799999999999997 109.592 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -74.94 -0.31 18.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.717 -0.614 . . . . 6.6600000000000001 112.466 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -76.1 -7.69 55.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.222 -0.924 . . . . 8.1999999999999993 112.529 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 47.9 mt -80.31 -4.24 52.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.994 -1.067 . . . . 8.0700000000000003 112.256 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -85.18 -3.85 58.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.133 -0.979 . . . . 9.4499999999999993 112.181 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -94.5 -59.09 2.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.985 -1.072 . . . . 10.119999999999999 111.049 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 118.205 -0.902 . . . . 11.49 109.985 -179.168 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 mmt . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.492 -0.558 . . . . 3.0699999999999998 109.492 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.2 mt 48.36 71.36 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.315 -0.866 . . . . 1.0700000000000001 112.321 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 m -93.07 118.22 30.95 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.09 -1.448 . . . . 1.24 107.09 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.4 -146.8 16.69 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.48 -1.048 . . . . 1.01 110.48 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -94.95 -2.88 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.34 -1.094 . . . . 1.1100000000000001 113.036 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tp 50.8 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.867 -1.146 . . . . 0.98999999999999999 112.607 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.8 -43.79 13.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.84999999999999998 110.741 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -147.96 142.42 16.54 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 107.797 -1.186 . . . . 1.3799999999999999 107.797 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.97 149.39 36.79 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.716 2.277 . . . . 0.93999999999999995 112.454 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.887 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.43 162.61 11.43 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.143 -1.583 . . . . 0.81000000000000005 109.143 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -121.9 135.08 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 O-C-N 121.089 -1.242 . . . . 0.82999999999999996 108.271 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.11 155.5 46.97 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.456 -0.778 . . . . 0.53000000000000003 109.269 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -127.44 139.58 52.73 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.89 -1.152 . . . . 0.77000000000000002 107.89 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.46 168.98 35.98 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 118.69 -1.719 . . . . 0.51000000000000001 110.063 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.441 ' HZ3' HG12 ' A' ' 156' ' ' VAL . 30.2 mtmm -80.03 161.15 25.57 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.451 -1.029 . . . . 1.8999999999999999 110.216 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.85 131.68 34.49 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.391 -0.966 . . . . 0.66000000000000003 108.391 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 tp -109.78 101.77 10.61 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 105.405 -2.072 . . . . 0.82999999999999996 105.405 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.53 133.15 35.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.911 -1.144 . . . . 0.85999999999999999 107.911 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.7 117.93 35.8 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.394 -1.706 . . . . 0.92000000000000004 106.394 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -109.32 133.38 53.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.943 -1.132 . . . . 2.0299999999999998 107.943 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -123.59 140.24 53.19 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.305 -0.872 . . . . 2.6600000000000001 108.666 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -80.46 136.99 36.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.073 -1.017 . . . . 2.3199999999999998 108.256 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.2 146.12 51.62 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.281 -0.887 . . . . 2.1099999999999999 108.955 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.0 mt -93.39 128.84 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.237 -1.023 . . . . 0.72999999999999998 108.237 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -108.83 130.49 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.726 -1.213 . . . . 0.87 107.726 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.5 mt -95.7 132.14 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.341 -0.85 . . . . 0.81000000000000005 108.943 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -89.94 120.8 31.47 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.61 -1.256 . . . . 1.3400000000000001 107.61 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -96.65 17.74 15.79 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.431 -0.793 . . . . 2.8900000000000001 112.417 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -67.45 146.29 54.14 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.203 -0.935 . . . . 2.0899999999999999 108.979 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -87.82 134.83 33.61 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.103 -1.073 . . . . 2.1899999999999999 108.103 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 pt -96.82 165.69 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.458 -0.776 . . . . 0.75 110.329 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.6 p -94.27 168.47 10.89 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 0.91000000000000003 109.541 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.11 -18.97 28.75 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.959 -1.088 . . . . 0.93000000000000005 112.879 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.09 -35.85 76.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.746 -1.221 . . . . 2.2799999999999998 110.825 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -94.5 -8.83 37.23 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.969 -1.082 . . . . 1.45 113.221 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.9 -43.79 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.164 -0.96 . . . . 0.81000000000000005 110.156 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.52 -40.09 81.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.954 -1.091 . . . . 1.54 110.4 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -62.1 -38.09 87.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.683 . . . . 2.3599999999999999 110.656 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.77 -39.49 85.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 1.3100000000000001 110.883 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.49 -43.68 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.131 -0.98 . . . . 0.81999999999999995 110.769 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -62.13 -43.8 98.04 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.113 -0.992 . . . . 1.5 110.461 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -62.7 -38.78 91.79 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.247 -0.908 . . . . 2.23 110.592 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -76.09 -55.56 5.48 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.123 -0.986 . . . . 0.84999999999999998 110.532 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.68 -48.28 81.62 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.295 -0.962 . . . . 0.91000000000000003 110.59 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.552 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 10.9 t -69.84 -40.78 75.62 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.74 -0.784 . . . . 0.90000000000000002 110.435 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.15 -45.73 87.05 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.24 -1.457 . . . . 0.68999999999999995 109.691 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -58.39 -30.06 66.53 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.036 0.922 . . . . 2.8799999999999999 109.995 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.66 -46.19 87.73 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.672 0.748 . . . . 0.84999999999999998 110.018 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -78.95 -41.81 28.42 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 2.3500000000000001 110.311 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.48 86.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.4 -0.813 . . . . 0.65000000000000002 109.74 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -60.45 -40.38 90.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.118 -0.989 . . . . 1.45 109.288 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.91 -47.17 69.52 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.926 -0.579 . . . . 0.63 110.894 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.52 -51.38 65.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.084 . . . . 1.3400000000000001 110.7 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 54' ' ' LEU . 3.0 mm? -61.41 -40.11 93.19 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.563 -0.855 . . . . 1.5600000000000001 110.023 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -59.7 -41.59 91.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.377 -0.827 . . . . 1.1899999999999999 110.354 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -66.05 -42.74 89.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.134 -0.979 . . . . 0.71999999999999997 110.457 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.8 mt -59.89 -39.76 80.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.352 -0.843 . . . . 0.62 110.705 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -49.93 -41.92 47.29 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.09 -1.006 . . . . 1.05 110.87 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -70.21 -38.17 75.23 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.143 -0.973 . . . . 0.64000000000000001 110.039 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -61.4 -38.88 88.66 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.721 -1.192 . . . . 1.73 108.945 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.16 72.24 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.52 0.676 . . . . 0.56000000000000005 109.609 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.24 -33.37 20.46 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.103 -1.046 . . . . 0.68999999999999995 111.055 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -80.6 -26.83 37.59 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.083 -1.245 . . . . 1.48 111.202 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 m -85.71 -48.61 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.579 -0.701 . . . . 0.97999999999999998 110.856 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -107.48 -17.99 13.97 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 113.229 0.826 . . . . 1.1599999999999999 113.229 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.13 155.72 11.48 Favored Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.329 -0.857 . . . . 0.84999999999999998 112.325 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -50.65 -22.56 2.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.882 -0.776 . . . . 3.8599999999999999 112.305 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.61 -36.18 71.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 2.3500000000000001 111.349 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -80.98 -22.39 39.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.853 -1.154 . . . . 1.6699999999999999 111.935 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -58.87 -33.53 70.58 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.957 -1.09 . . . . 1.45 111.2 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.95 -41.71 83.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 0.60999999999999999 110.816 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.1 mt -66.65 -44.75 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.86 -1.15 . . . . 0.65000000000000002 110.125 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -70.24 -31.11 68.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 0.66000000000000003 110.382 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -61.04 -39.76 91.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.316 -0.865 . . . . 1.1899999999999999 109.754 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.04 -39.95 96.72 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 120.177 -1.011 . . . . 0.53000000000000003 110.611 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -59.73 -45.39 92.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -1.092 . . . . 1.27 110.621 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.0 mt -60.45 -39.03 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.411 -0.806 . . . . 0.54000000000000004 110.545 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.9 ttt -59.61 -39.37 84.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 1.74 110.503 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.14 -49.65 77.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.035 -1.04 . . . . 0.55000000000000004 109.801 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.86 -39.82 95.1 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.571 0.701 . . . . 0.46999999999999997 110.687 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -85.31 6.91 24.24 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.074 0.768 . . . . 1.4199999999999999 113.074 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -69.28 118.1 11.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.697 -1.252 . . . . 1.27 109.074 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.35 -16.9 64.07 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.627 0.727 . . . . 1.3500000000000001 110.901 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.36 -46.33 41.25 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.358 -0.937 . . . . 2.2200000000000002 109.966 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -66.2 -38.52 88.19 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.664 -0.815 . . . . 0.62 110.273 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -58.8 -46.1 88.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.5 -0.75 . . . . 1.29 110.903 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -62.73 -37.84 88.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.909 . . . . 1.52 110.545 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.51 -48.65 66.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.013 -1.055 . . . . 1.3 110.653 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.8 mt -57.5 -43.05 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.218 -0.926 . . . . 0.60999999999999999 110.402 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.9 mt -60.62 -43.31 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.737 -0.602 . . . . 0.78000000000000003 110.389 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.45 -42.69 99.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.326 -0.859 . . . . 0.81999999999999995 110.67 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.57 -42.5 98.93 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.16 -0.963 . . . . 0.80000000000000004 110.537 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.43 -44.62 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 0.77000000000000002 110.537 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -84.41 -35.16 23.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.398 -0.814 . . . . 2.1200000000000001 111.713 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 91' ' ' ALA . 51.4 t0 -80.97 -45.39 16.73 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.134 -0.979 . . . . 1.51 111.79 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -101.03 9.55 42.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.245 -0.909 . . . . 1.98 112.45 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.5 m80 49.79 51.67 16.09 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.27 -0.894 . . . . 1.3200000000000001 112.023 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 85.4 mtp -104.11 154.76 19.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.0 -0.741 . . . . 1.3799999999999999 109.0 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.412 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 46.4 p -72.6 160.39 32.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.67000000000000004 110.208 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.46 91.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.52000000000000002 110.81 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 23.5 p-10 -69.86 -43.64 71.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.9 -1.125 . . . . 2.25 110.427 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.4 -47.6 72.76 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.498 -0.881 . . . . 0.64000000000000001 111.172 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.12 91.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.359 -0.838 . . . . 0.56000000000000005 110.075 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.74 96.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.556 -0.715 . . . . 0.46000000000000002 110.482 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -61.49 -37.72 84.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.191 -0.943 . . . . 1.3200000000000001 110.892 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -56.92 -49.77 74.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.79 . . . . 1.3 110.788 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.8 t -60.28 -44.48 95.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.922 -1.111 . . . . 0.60999999999999999 110.33 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.14 -34.53 60.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.562 -0.711 . . . . 0.65000000000000002 110.37 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -58.5 -40.28 82.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.979 -1.076 . . . . 2.1099999999999999 110.875 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.87 -34.42 13.23 Favored Glycine 0 N--CA 1.498 2.775 0 C-N-CA 119.236 -1.459 . . . . 0.82999999999999996 112.174 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -62.2 -41.25 98.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.711 -1.464 . . . . 1.28 109.879 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.94 -51.39 22.3 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.529 -0.732 . . . . 0.89000000000000001 110.547 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.9 m -60.55 -37.51 81.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 1.8700000000000001 110.76 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.25 97.67 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.552 -0.718 . . . . 1.05 110.523 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.85 -29.81 70.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.908 -1.12 . . . . 1.02 111.156 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -65.94 -21.02 66.4 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.286 -0.884 . . . . 2.04 111.121 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -71.94 -15.01 62.07 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.167 -0.958 . . . . 1.73 111.012 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 123' ' ' LEU . 55.1 mt -84.6 147.16 27.14 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.193 -0.669 . . . . 1.3700000000000001 109.193 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 6.6 t0 -100.66 38.41 1.53 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.132 -0.98 . . . . 2.8799999999999999 112.083 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -113.03 140.08 48.13 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.173 -0.954 . . . . 1.5800000000000001 108.75 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.48 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 27.8 mp0 -58.28 -39.37 79.1 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.358 -0.839 . . . . 3.04 110.92 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -71.82 -52.51 17.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.534 -1.354 . . . . 0.90000000000000002 110.631 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 118' ' ' LEU . 18.9 mt -60.94 -41.7 96.76 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 1.0600000000000001 110.658 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -63.42 -49.64 72.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.818 -1.176 . . . . 2.1800000000000002 109.582 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.82 -30.26 69.98 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.328 -0.949 . . . . 2.1499999999999999 109.446 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.588 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -61.09 -30.1 70.15 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.924 0.868 . . . . 2.3300000000000001 108.732 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.44 -50.41 72.9 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.78 0.8 . . . . 0.81999999999999995 109.432 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.01 -43.89 81.74 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.714 0.769 . . . . 0.84999999999999998 110.093 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -63.72 -34.0 76.9 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.475 0.655 . . . . 1.3899999999999999 110.255 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 126' ' ' ARG . 21.1 t -69.01 -41.75 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.56000000000000005 109.91 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -58.51 -37.34 75.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.886 -1.133 . . . . 3.1200000000000001 109.584 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -58.79 -39.81 82.19 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.418 0.628 . . . . 1.28 110.464 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.19 -40.11 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.994 -1.066 . . . . 0.48999999999999999 109.778 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.85 -47.56 89.42 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.343 -1.103 . . . . 0.46000000000000002 110.343 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -58.27 -40.58 82.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -1.14 . . . . 2.71 110.26 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -64.88 -43.66 92.19 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.403 -0.919 . . . . 2.1400000000000001 109.359 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.0 tp -59.66 -43.58 93.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.571 -0.705 . . . . 1.05 109.64 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 20.7 mt -60.09 -38.66 83.61 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.322 -0.861 . . . . 0.52000000000000002 110.576 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -39.84 84.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.063 . . . . 2.3500000000000001 110.776 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -75.77 -40.64 54.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.794 . . . . 1.3899999999999999 110.536 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.17 -40.36 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.68000000000000005 109.572 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.45 -8.96 49.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.393 -0.817 . . . . 0.82999999999999996 112.224 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.04 18.62 76.42 Favored Glycine 0 N--CA 1.482 1.713 0 C-N-CA 119.689 -1.243 . . . . 0.91000000000000003 112.617 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.73 144.43 57.25 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.594 -0.945 . . . . 0.94999999999999996 109.08 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -66.35 149.86 49.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.75 . . . . 2.4300000000000002 109.818 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.44 145.88 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.678 -0.86 . . . . 1.1000000000000001 108.678 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.1 mm -76.93 118.84 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.942 -1.099 . . . . 1.5800000000000001 108.555 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -97.8 98.12 9.56 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.487 -1.672 . . . . 1.6200000000000001 106.487 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.5 mt -77.13 -17.6 58.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.324 -0.86 . . . . 0.80000000000000004 111.726 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -80.31 1.11 30.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 1.5600000000000001 112.476 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.75 28.31 4.81 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.364 -0.835 . . . . 0.83999999999999997 112.284 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 7.9 mt -73.49 140.08 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.81999999999999995 109.745 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -111.45 -21.67 11.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.605 0.717 . . . . 2.3100000000000001 112.231 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -118.14 139.96 50.49 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.369 -0.975 . . . . 1.54 108.369 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.46 125.97 28.44 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.361 -0.977 . . . . 1.3799999999999999 108.361 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.441 HG12 ' HZ3' ' A' ' 15' ' ' LYS . 30.0 m -146.07 173.94 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 0.68999999999999995 109.258 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.4 mt -87.96 145.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.683 -0.858 . . . . 0.53000000000000003 108.683 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.7 tp -95.44 123.81 39.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.916 -1.115 . . . . 0.64000000000000001 108.736 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.6 t -125.04 128.69 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.279 -1.378 . . . . 0.67000000000000004 107.279 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.67 154.84 18.7 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.941 -1.1 . . . . 0.78000000000000003 108.537 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.08 81.93 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.409 -1.432 . . . . 1.0 109.375 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.1 t0 -171.01 153.42 3.8 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.511 -0.922 . . . . 2.4199999999999999 108.511 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 34.8 mt -114.69 144.59 43.21 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.298 -0.876 . . . . 0.75 109.343 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.9 p -91.03 149.62 40.35 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.741 -1.224 . . . . 0.78000000000000003 108.826 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.58 -43.27 14.33 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.469 1.446 . . . . 0.67000000000000004 113.527 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.7 m -61.88 -45.76 92.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.926 -1.109 . . . . 0.69999999999999996 110.132 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.88 -41.66 97.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.472 -0.768 . . . . 1.21 110.385 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.7 p -67.22 -38.41 85.21 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.453 0.644 . . . . 0.59999999999999998 110.48 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.95 -37.25 86.3 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.467 -0.771 . . . . 0.62 110.606 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -93.73 -1.97 54.42 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.122 -0.986 . . . . 1.1599999999999999 112.683 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.55 149.62 34.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.621 -0.881 . . . . 0.72999999999999998 108.621 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -94.86 109.81 21.76 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.772 -1.566 . . . . 2.2400000000000002 106.772 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.39 -22.01 64.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.93 -0.481 . . . . 1.4299999999999999 111.745 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -83.72 -17.34 41.63 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.299 -0.876 . . . . 2.1499999999999999 112.797 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -101.19 -5.65 25.3 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.196 -0.94 . . . . 2.04 113.229 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.643 HG12 ' H ' ' A' ' 178' ' ' GLY . 59.1 t -108.3 129.99 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.92 -1.141 . . . . 0.55000000000000004 107.92 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.5 tp -86.28 -3.78 59.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.146 -0.971 . . . . 1.6299999999999999 111.964 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.643 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.27 166.61 28.59 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.947 -1.661 . . . . 0.46999999999999997 108.947 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.73 130.01 53.13 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.748 -1.204 . . . . 0.54000000000000004 107.748 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.413 HG22 HG21 ' A' ' 205' ' ' THR . 92.0 mt -131.07 124.84 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.305 -1.739 . . . . 0.68999999999999995 106.305 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 205' ' ' THR . 41.7 p -140.92 170.66 15.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.786 -1.196 . . . . 0.81999999999999995 110.595 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 48.8 t0 -108.38 66.73 0.65 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.743 -0.662 . . . . 2.3700000000000001 109.375 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.08 142.67 36.38 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.363 -0.835 . . . . 1.1100000000000001 109.045 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.34 2.36 37.72 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.377 -0.916 . . . . 1.6699999999999999 113.284 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 86.7 -20.02 25.97 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 120.988 -1.301 . . . . 1.54 114.864 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -58.94 -40.59 85.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.035 -1.274 . . . . 4.4800000000000004 110.177 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.7 p -149.31 58.27 1.02 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.53 -0.731 . . . . 2.6299999999999999 110.135 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.7 p -87.17 101.01 13.08 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.46 -1.311 . . . . 1.6899999999999999 107.46 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -62.7 -36.34 82.65 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.411 -0.806 . . . . 1.0700000000000001 109.604 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 59.0 m -58.65 -38.94 79.21 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.571 -0.706 . . . . 1.5800000000000001 110.144 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 64.7 p -58.24 -37.98 75.98 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.196 -0.94 . . . . 1.6000000000000001 109.73 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.8 mm -60.15 -40.0 82.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.479 -0.763 . . . . 1.45 110.287 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 64.5 mtp -63.82 -42.37 97.67 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.084 -1.01 . . . . 1.05 109.578 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.47 -48.45 81.59 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.574 -0.739 . . . . 0.71999999999999997 110.92 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.423 ' HG2' HH11 ' A' ' 195' ' ' ARG . 36.9 mtt-85 -61.89 -44.11 97.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 3.0499999999999998 110.608 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.0 m -68.62 -40.81 80.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.89000000000000001 110.165 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.38 -8.53 47.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.456 -0.778 . . . . 0.78000000000000003 112.526 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.0 mt-10 55.25 13.79 0.93 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.067 1.136 . . . . 1.45 114.067 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 50.2 mt -71.09 164.46 56.63 Favored Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 108.497 -0.927 . . . . 0.67000000000000004 108.497 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.87 140.46 38.54 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 121.598 1.532 . . . . 0.64000000000000001 110.468 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.08 168.34 24.57 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.019 -1.675 . . . . 0.67000000000000004 109.998 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.5 mt -147.7 152.55 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.866 -1.161 . . . . 0.68999999999999995 107.866 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.6 m -135.12 -27.63 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 120.968 -1.082 . . . . 0.84999999999999998 111.409 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.22 46.54 3.22 Favored Glycine 0 N--CA 1.489 2.207 0 O-C-N 120.944 -1.098 . . . . 0.92000000000000004 111.75 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 181' ' ' THR . 69.3 p -62.9 -16.42 58.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.359 -1.083 . . . . 0.94999999999999996 111.702 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.459 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 76.03 -94.9 1.02 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.948 -1.261 . . . . 1.04 109.948 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.2 m -129.97 27.6 5.14 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.478 -1.013 . . . . 1.5700000000000001 112.38 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.2 t -57.96 -40.23 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.536 -1.353 . . . . 0.83999999999999997 110.536 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.1 p -58.68 -18.88 34.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.923 -1.111 . . . . 0.98999999999999999 111.77 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.8 t -94.96 -0.59 53.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.412 -0.805 . . . . 1.7 112.227 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -129.86 0.44 4.82 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.698 0.629 . . . . 2.2000000000000002 112.698 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t -120.09 150.54 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.934 0.873 . . . . 0.83999999999999997 109.806 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.67 154.74 36.43 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.222 -1.029 . . . . 2.2000000000000002 108.222 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.9 p-10 -51.38 145.6 8.21 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.103 -0.998 . . . . 2.2799999999999998 110.172 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.9 t0 81.73 -7.0 1.45 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.264 1.209 . . . . 2.3500000000000001 114.264 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 19.7 t0 -60.47 145.24 49.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.773 -1.205 . . . . 1.97 108.478 177.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.438 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 14.2 t80 -88.32 123.07 32.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.939 -1.134 . . . . 2.6499999999999999 107.939 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.488 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 49.6 mt -128.26 149.86 50.3 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.553 -0.717 . . . . 0.63 109.607 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.13 123.0 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.309 -1.737 . . . . 0.62 106.309 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.0 tp -100.86 112.79 25.29 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.927 -1.879 . . . . 0.64000000000000001 105.927 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 223' ' ' VAL . 41.6 p30 -93.35 -22.85 18.7 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.881 -1.137 . . . . 2.0499999999999998 112.314 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.91 16.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.996 0.739 . . . . 0.83999999999999997 112.996 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.598 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.1 t -106.94 -57.75 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.057 -1.027 . . . . 1.02 109.359 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -93.62 9.08 38.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.421 1.105 . . . . 2.5099999999999998 110.41 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.78 52.56 3.45 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.89 -1.05 . . . . 1.54 112.177 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.443 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 89.6 mt-30 -146.79 150.16 34.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.357 1.075 . . . . 1.95 109.827 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -115.63 139.86 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.864 -1.161 . . . . 0.70999999999999996 107.864 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -104.21 131.67 51.27 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 108.145 -1.057 . . . . 1.01 108.145 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.1 t -110.31 130.38 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.898 -0.778 . . . . 0.81999999999999995 108.898 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.458 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 8.9 t-20 53.95 48.12 4.47 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 113.393 0.886 . . . . 1.54 113.393 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 56.2 Cg_endo -68.99 148.51 70.24 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.128 1.886 . . . . 0.93999999999999995 111.216 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 43.2 p -74.61 162.84 28.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.807 -1.183 . . . . 1.8 110.172 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -59.8 -36.78 77.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 2.73 110.66 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -59.9 -39.42 85.32 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.28 -0.888 . . . . 3.1699999999999999 110.952 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 87.4 t -70.02 -38.46 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 1.3400000000000001 110.075 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.518 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 96.1 mt -59.69 -47.5 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.552 -0.717 . . . . 1.2 110.377 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -60.01 -39.64 86.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 2.7000000000000002 110.792 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -63.06 -45.99 89.6 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.363 -0.836 . . . . 2.5899999999999999 110.74 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 72.7 mtp -70.99 -35.69 72.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 1.3799999999999999 110.647 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.552 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -57.1 -40.19 76.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.899 . . . . 2.8399999999999999 110.377 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.29 -54.43 7.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.273 -0.892 . . . . 1.8799999999999999 110.673 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.473 ' O ' HG23 ' A' ' 246' ' ' VAL . 85.2 t -59.53 -42.13 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.351 -0.843 . . . . 2.3999999999999999 111.092 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -59.17 -49.95 75.92 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.963 -1.086 . . . . 3.52 111.103 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -66.78 -39.12 87.69 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.128 -0.982 . . . . 1.8799999999999999 110.868 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -61.04 -29.74 69.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.811 -1.181 . . . . 3.0099999999999998 110.377 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 242' ' ' VAL . 49.8 t -61.13 -43.3 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.423 -0.911 . . . . 2.4500000000000002 109.488 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.62 92.85 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.426 -0.796 . . . . 2.75 110.132 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 p -69.95 -33.0 71.55 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.4 -0.812 . . . . 3.1600000000000001 110.477 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -62.68 -31.02 71.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 3.5699999999999998 110.396 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -60.14 -34.6 73.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.487 -0.758 . . . . 4.2999999999999998 110.47 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.03 -29.25 69.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.922 . . . . 4.4500000000000002 110.91 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -70.8 -10.25 59.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.203 -0.935 . . . . 5.9699999999999998 112.242 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 46.5 tp -63.55 -29.69 70.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.901 -1.125 . . . . 6.1799999999999997 110.865 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.459 ' O ' ' NZ ' ' A' ' 257' ' ' LYS . . . -68.78 -10.34 56.09 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 6.6600000000000001 111.947 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -83.11 9.9 9.37 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.575 -0.703 . . . . 8.1999999999999993 112.082 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 13.2 tp -79.67 -4.04 49.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.024 . . . . 8.0700000000000003 112.164 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 254' ' ' ALA . 31.7 mtmm -80.21 -0.52 36.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.16 -0.963 . . . . 9.4499999999999993 112.104 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -93.45 10.7 31.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.43 -0.794 . . . . 10.119999999999999 112.474 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.432 ' HG2' HH11 ' A' ' 259' ' ' ARG . 27.2 ttt-85 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 11.49 109.222 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.072 -0.714 . . . . 3.0699999999999998 109.072 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.4 mt 41.85 69.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.203 -0.936 . . . . 1.0700000000000001 112.116 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -96.39 111.98 23.88 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.829 -1.545 . . . . 1.24 106.829 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.92 -154.13 29.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.66 -1.376 . . . . 1.01 109.66 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 5' ' ' ILE . 82.2 mt -95.03 -0.62 10.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.321 -1.105 . . . . 1.1100000000000001 112.273 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 49.63 100.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.939 -1.101 . . . . 0.98999999999999999 112.511 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.18 -42.19 12.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.144 -0.972 . . . . 0.84999999999999998 111.983 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 m -145.0 142.78 18.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.875 -1.141 . . . . 1.3799999999999999 108.007 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.53 148.48 26.25 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.198 1.932 . . . . 0.93999999999999995 112.357 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.935 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.38 173.22 21.04 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.053 -1.619 . . . . 0.81000000000000005 109.053 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.42 HD12 ' HG2' ' A' ' 243' ' ' GLN . 83.0 mt -129.52 137.07 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -1.222 . . . . 0.82999999999999996 108.272 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.95 154.65 46.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 0.53000000000000003 109.173 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.0 m-85 -121.03 140.46 51.9 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.437 -0.949 . . . . 0.77000000000000002 108.437 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.45 162.56 28.33 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.311 -1.9 . . . . 0.51000000000000001 110.32 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -78.45 158.77 28.57 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.527 -0.916 . . . . 1.8999999999999999 108.527 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.72 127.45 34.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.003 -1.061 . . . . 0.66000000000000003 108.539 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.1 tp -103.77 103.5 13.4 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 104.976 -2.231 . . . . 0.82999999999999996 104.976 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.1 tp -91.46 129.9 37.38 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.335 -1.357 . . . . 0.85999999999999999 107.335 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.07 119.88 39.39 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.443 -1.317 . . . . 0.92000000000000004 107.443 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -110.17 132.34 54.26 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.503 -1.295 . . . . 2.0299999999999998 107.503 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -128.96 155.24 45.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.336 -0.852 . . . . 2.6600000000000001 109.529 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -85.15 137.76 32.82 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.816 -1.179 . . . . 2.3199999999999998 107.816 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.2 149.71 49.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.033 -1.042 . . . . 2.1099999999999999 108.991 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -92.42 128.88 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.293 -1.003 . . . . 0.72999999999999998 108.293 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.75 130.42 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.941 -1.133 . . . . 0.87 107.941 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.9 mt -96.45 139.35 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.545 -0.909 . . . . 0.81000000000000005 108.545 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.25 120.6 32.3 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.298 -1.371 . . . . 1.3400000000000001 107.298 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -96.3 16.84 17.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.811 . . . . 2.8900000000000001 112.485 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -67.74 143.67 55.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.862 -1.149 . . . . 2.0899999999999999 108.88 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -88.87 132.28 34.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.134 -1.062 . . . . 2.1899999999999999 108.134 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.1 pt -98.97 167.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.399 -0.813 . . . . 0.75 110.342 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.9 p -93.1 162.44 14.03 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.641 0.734 . . . . 0.91000000000000003 109.766 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.87 -17.31 6.1 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.111 -0.993 . . . . 0.93000000000000005 112.722 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -69.89 -32.65 71.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.012 . . . . 2.2799999999999998 111.094 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -86.27 0.95 52.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.989 -1.069 . . . . 1.45 112.431 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 t -56.27 -44.6 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.466 -0.771 . . . . 0.81000000000000005 110.46 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -58.08 -40.77 81.9 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.205 -0.935 . . . . 1.54 110.327 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -64.14 -45.0 90.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.653 -0.655 . . . . 2.3599999999999999 111.604 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.7 -42.8 99.43 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.812 -1.18 . . . . 1.3100000000000001 111.068 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.27 -41.88 88.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.162 -0.961 . . . . 0.81999999999999995 110.228 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -63.13 -45.88 89.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.042 -1.036 . . . . 1.5 110.119 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.405 ' HG2' HH11 ' A' ' 42' ' ' ARG . 54.4 mtt-85 -61.92 -42.3 98.92 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.456 -0.897 . . . . 2.23 109.957 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -71.45 -52.86 16.15 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.4 -0.92 . . . . 0.84999999999999998 110.165 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.44 -49.28 78.21 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.241 -0.984 . . . . 0.91000000000000003 110.647 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.1 t -69.97 -45.1 68.09 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.552 0.692 . . . . 0.90000000000000002 110.346 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.98 -45.71 86.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.295 -1.522 . . . . 0.68999999999999995 109.295 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -57.37 -31.44 65.78 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.855 0.836 . . . . 2.8799999999999999 109.775 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.11 -42.57 86.02 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.542 0.687 . . . . 0.84999999999999998 110.097 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -75.82 -38.61 57.97 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.268 -0.895 . . . . 2.3500000000000001 110.067 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.76 -38.69 82.51 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.148 -0.97 . . . . 0.65000000000000002 109.946 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 t -61.02 -38.88 87.64 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.897 0.856 . . . . 1.45 109.422 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.64 -47.57 75.13 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.959 -0.564 . . . . 0.63 110.289 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.9 -49.76 74.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.878 -1.139 . . . . 1.3400000000000001 110.208 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.66 -39.32 90.96 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.258 -0.901 . . . . 1.5600000000000001 110.016 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -59.66 -41.26 90.21 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.218 -0.593 . . . . 1.1899999999999999 110.311 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.9 m -67.05 -44.21 80.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.225 -0.922 . . . . 0.71999999999999997 110.297 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -59.8 -34.82 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.652 -0.655 . . . . 0.62 110.873 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -51.57 -44.64 62.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.92 -1.112 . . . . 1.05 110.713 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -68.97 -34.63 75.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.042 -1.036 . . . . 0.64000000000000001 110.124 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -63.76 -39.74 95.01 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.812 -1.155 . . . . 1.73 109.241 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.83 -31.12 72.2 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.163 -0.615 . . . . 0.56000000000000005 109.88 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.1 -36.27 13.4 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.784 -1.198 . . . . 0.68999999999999995 110.81 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.31 -24.26 42.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.945 -1.327 . . . . 1.48 110.242 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.8 m -84.55 -51.14 7.1 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.339 -0.85 . . . . 0.97999999999999998 110.995 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -106.68 -19.93 13.51 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.102 -0.998 . . . . 1.1599999999999999 113.286 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.61 165.55 14.05 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 121.277 -0.889 . . . . 0.84999999999999998 112.211 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -53.74 -24.03 13.65 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 112.583 0.586 . . . . 3.8599999999999999 112.583 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.86 -36.74 70.4 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.017 -1.052 . . . . 2.3500000000000001 111.653 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -84.92 -15.35 44.77 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.301 -1.499 . . . . 1.6699999999999999 112.913 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.88 -35.62 77.1 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.047 -1.033 . . . . 1.45 110.811 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.51 -39.24 87.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.357 -0.839 . . . . 0.60999999999999999 111.222 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 72' ' ' ILE . 14.9 mt -66.6 -48.96 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.971 -1.081 . . . . 0.65000000000000002 110.564 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -69.91 -30.37 67.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.451 -0.781 . . . . 0.66000000000000003 110.411 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.86 -38.23 87.48 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.604 -0.839 . . . . 1.1899999999999999 109.823 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.21 -38.66 92.08 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 110.592 -1.003 . . . . 0.53000000000000003 110.592 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -60.13 -40.39 89.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 1.27 110.797 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.85 -44.74 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.93 -1.106 . . . . 0.54000000000000004 110.118 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.4 ttp -60.08 -38.16 82.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -0.891 . . . . 1.74 110.11 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 tp -60.31 -49.94 75.6 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.362 -0.836 . . . . 0.55000000000000004 110.686 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.38 -40.08 89.58 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.923 -0.711 . . . . 0.46999999999999997 110.333 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -86.21 5.47 34.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.373 -0.829 . . . . 1.4199999999999999 112.386 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.18 119.7 11.34 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.856 -1.152 . . . . 1.27 108.924 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.03 -15.65 63.22 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.645 0.736 . . . . 1.3500000000000001 110.977 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -71.68 -49.55 38.69 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.018 -1.073 . . . . 2.2200000000000002 110.037 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.84 -38.62 88.9 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.169 -1.012 . . . . 0.62 110.097 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.7 -46.18 89.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 1.29 110.777 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -60.05 -39.54 86.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.082 -1.011 . . . . 1.52 110.578 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -65.63 -47.9 74.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.954 -1.092 . . . . 1.3 110.19 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.2 mt -57.9 -43.06 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.558 -0.714 . . . . 0.60999999999999999 110.158 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.68 -40.89 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.162 0.506 . . . . 0.78000000000000003 110.547 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.72 -40.59 88.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.81999999999999995 110.387 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.52 -45.5 90.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.80000000000000004 110.097 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.0 mt -62.57 -43.42 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.365 -0.834 . . . . 0.77000000000000002 110.193 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -82.64 -38.4 23.57 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.37 -0.831 . . . . 2.1200000000000001 111.932 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 91' ' ' ALA . 49.4 t0 -80.83 -43.28 20.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.909 -1.119 . . . . 1.51 111.882 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.55 8.1 35.35 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.374 -0.829 . . . . 1.98 112.777 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.0 m170 52.46 51.43 16.18 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.868 -1.145 . . . . 1.3200000000000001 111.58 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.2 mtt -105.12 152.17 23.12 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.37 -0.831 . . . . 1.3799999999999999 109.265 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.4 p -71.3 161.68 30.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.374 -0.829 . . . . 0.67000000000000004 110.121 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.18 88.92 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.241 -0.912 . . . . 0.52000000000000002 110.254 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.557 ' OD2' HD21 ' A' ' 142' ' ' LEU . 89.8 m-20 -68.08 -41.1 82.39 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.212 -0.93 . . . . 2.25 110.34 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.66 -49.83 49.91 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.158 -0.964 . . . . 0.64000000000000001 111.21 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.38 92.22 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.383 -0.823 . . . . 0.56000000000000005 110.407 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.77 95.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.65 -0.656 . . . . 0.46000000000000002 110.894 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -61.49 -40.05 93.16 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.396 -0.815 . . . . 1.3200000000000001 110.835 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -57.84 -49.57 76.24 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.669 -1.27 . . . . 1.3 111.347 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.7 t -61.11 -44.82 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.95 -1.094 . . . . 0.60999999999999999 110.161 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 mm -62.78 -33.52 60.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.765 0.793 . . . . 0.65000000000000002 109.958 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -55.46 -40.89 72.18 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.519 -0.738 . . . . 2.1099999999999999 110.87 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.29 -32.49 16.59 Favored Glycine 0 N--CA 1.498 2.825 0 C-N-CA 118.98 -1.581 . . . . 0.82999999999999996 112.571 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -60.34 -41.59 93.92 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.302 -1.705 . . . . 1.28 110.204 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.92 -51.62 17.82 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.328 -0.857 . . . . 0.89000000000000001 110.966 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.8 p -62.41 -39.4 93.13 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.265 -0.897 . . . . 1.8700000000000001 110.709 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.72 96.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.404 -0.81 . . . . 1.05 110.913 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 43.8 mt -65.29 -30.89 71.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.891 -1.131 . . . . 1.02 110.5 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.14 -22.33 66.37 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.928 -1.108 . . . . 2.04 111.205 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -71.34 -12.47 61.45 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.765 0.793 . . . . 1.73 110.956 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.85 146.06 27.5 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.874 -0.787 . . . . 1.3700000000000001 108.874 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -100.3 35.36 2.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.15 -0.969 . . . . 2.8799999999999999 112.112 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -112.58 139.59 48.04 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 108.269 -1.011 . . . . 1.5800000000000001 108.269 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.01 -37.64 80.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.429 -0.794 . . . . 3.04 110.772 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -73.22 -49.0 30.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.794 -1.191 . . . . 0.90000000000000002 110.215 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.2 mt -63.2 -40.67 98.14 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.616 -1.234 . . . . 1.0600000000000001 109.738 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -60.96 -47.63 85.55 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.788 -1.195 . . . . 2.1800000000000002 110.097 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.27 -31.4 70.19 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.759 -0.777 . . . . 2.1499999999999999 109.556 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.512 ' HG2' HH11 ' A' ' 126' ' ' ARG . 9.2 ttt-85 -62.14 -29.67 70.5 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.008 0.908 . . . . 2.3300000000000001 108.975 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.63 -49.83 75.93 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.054 0.93 . . . . 0.81999999999999995 109.592 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -41.41 78.83 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.59 0.71 . . . . 0.84999999999999998 110.415 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.87 -38.49 91.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.559 -0.713 . . . . 1.3899999999999999 110.25 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 126' ' ' ARG . 46.4 t -69.6 -39.77 78.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.522 -0.736 . . . . 0.56000000000000005 110.648 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -58.68 -39.77 81.64 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.3 -1.36 . . . . 3.1200000000000001 110.029 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -59.67 -39.75 85.5 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.166 0.508 . . . . 1.28 110.823 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.99 -39.18 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.336 -0.852 . . . . 0.48999999999999999 110.625 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -64.71 -44.26 95.12 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.791 -1.195 . . . . 0.46000000000000002 110.909 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -58.14 -40.61 81.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.271 . . . . 2.71 110.575 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.401 HH21 ' HB2' ' A' ' 166' ' ' SER . 63.0 mtt-85 -61.36 -42.68 99.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.312 -0.867 . . . . 2.1400000000000001 110.111 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 31.3 tp -60.29 -43.33 96.35 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.439 -0.904 . . . . 1.05 109.506 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.25 -45.92 91.6 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.46 0.648 . . . . 0.52000000000000002 110.197 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -60.98 -34.86 75.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.461 -0.774 . . . . 2.3500000000000001 111.08 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -75.81 -41.73 51.92 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.074 -1.016 . . . . 1.3899999999999999 110.978 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.514 HG21 ' OD1' ' A' ' 101' ' ' ASP . 95.2 mt -62.46 -39.02 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.789 -1.194 . . . . 0.68000000000000005 110.594 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.557 HD21 ' OD2' ' A' ' 101' ' ' ASP . 61.5 mt -84.64 -8.95 58.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.339 -0.851 . . . . 0.82999999999999996 111.65 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.55 25.62 67.39 Favored Glycine 0 N--CA 1.479 1.557 0 C-N-CA 119.772 -1.204 . . . . 0.91000000000000003 113.237 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.74 142.04 58.57 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.727 -0.866 . . . . 0.94999999999999996 109.33 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -67.94 147.74 52.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 2.4300000000000002 108.907 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 72.9 mt -107.03 138.13 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.219 -1.03 . . . . 1.1000000000000001 108.219 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 18.2 mm -78.76 133.98 28.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.25 -0.906 . . . . 1.5800000000000001 108.862 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -94.51 94.74 8.39 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.657 -1.608 . . . . 1.6200000000000001 106.657 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 67.1 mt -73.53 -24.35 60.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.574 -0.704 . . . . 0.80000000000000004 110.865 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.9 m -81.48 7.17 12.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.406 -0.809 . . . . 1.5600000000000001 112.304 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.42 18.05 17.45 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.432 -0.792 . . . . 0.83999999999999997 112.151 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.5 mt -74.73 140.23 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.81999999999999995 109.807 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -118.97 -12.34 9.56 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.946 0.879 . . . . 2.3100000000000001 112.427 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -112.7 147.74 36.18 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.728 -0.841 . . . . 1.54 108.728 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -78.27 124.13 27.73 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.188 -1.041 . . . . 1.3799999999999999 108.188 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.8 m -147.64 172.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.55 -0.719 . . . . 0.68999999999999995 109.3 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.6 mt -90.74 146.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.535 -0.913 . . . . 0.53000000000000003 108.535 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.2 tp -95.9 123.79 39.64 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.093 0.949 . . . . 0.64000000000000001 108.788 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.5 t -124.64 129.96 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.892 -1.151 . . . . 0.67000000000000004 107.892 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.99 152.87 19.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.006 -1.059 . . . . 0.78000000000000003 108.835 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.92 -33.76 73.64 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.561 -1.337 . . . . 1.0 109.476 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -171.8 144.74 1.83 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.301 -0.629 . . . . 2.4199999999999999 109.301 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 75.8 mt -118.39 135.94 54.04 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.057 -1.09 . . . . 0.75 108.057 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.0 p -92.9 150.09 38.81 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.931 -1.105 . . . . 0.78000000000000003 108.529 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -39.18 -45.37 2.87 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 122.252 1.968 . . . . 0.67000000000000004 113.781 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.401 ' HB2' HH21 ' A' ' 136' ' ' ARG . 61.2 m -58.46 -47.56 83.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.69999999999999996 110.409 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.18 -38.4 90.9 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.076 -1.015 . . . . 1.21 110.515 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.3 p -69.3 -39.64 78.17 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.545 -0.722 . . . . 0.59999999999999998 110.5 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.83 -37.58 79.63 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.262 -0.575 . . . . 0.62 110.66 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -91.42 -0.16 57.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.05 -1.031 . . . . 1.1599999999999999 112.271 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.6 tp -63.88 150.33 45.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.751 -0.593 . . . . 0.72999999999999998 109.787 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -95.16 113.79 25.52 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.22 -1.4 . . . . 2.2400000000000002 107.22 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 36.7 mt -71.79 -17.96 62.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.696 -0.627 . . . . 1.4299999999999999 111.778 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.91 -21.31 31.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 2.1499999999999999 112.381 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -101.32 -4.99 26.03 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.907 -1.12 . . . . 2.04 113.436 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.7 t -114.2 128.91 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 107.533 -1.284 . . . . 0.55000000000000004 107.533 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.2 tp -93.69 -4.89 49.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.507 -0.745 . . . . 1.6299999999999999 112.609 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.41 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -175.49 170.04 42.95 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.021 -1.632 . . . . 0.46999999999999997 109.021 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -128.11 128.88 45.68 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.484 -1.302 . . . . 0.54000000000000004 107.484 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 79.3 mt -131.68 125.13 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 106.413 -1.699 . . . . 0.68999999999999995 106.413 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 205' ' ' THR . 20.6 p -140.63 172.05 13.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.86 -1.15 . . . . 0.81999999999999995 110.213 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -98.1 39.33 1.24 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.378 0.608 . . . . 2.3700000000000001 111.497 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -95.59 141.49 29.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.192 -0.942 . . . . 1.1100000000000001 109.676 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.79 2.33 25.16 Favored Glycine 0 N--CA 1.487 2.036 0 C-N-CA 120.052 -1.07 . . . . 1.6699999999999999 113.473 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 88.97 -9.23 77.54 Favored Glycine 0 N--CA 1.491 2.341 0 O-C-N 121.148 -1.207 . . . . 1.54 114.036 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.444 ' O ' ' OG1' ' A' ' 187' ' ' THR . 46.2 ttp180 -77.25 116.71 18.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.902 -1.352 . . . . 4.4800000000000004 107.841 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 16.6 p 48.66 40.29 15.39 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.97 -1.081 . . . . 2.6299999999999999 111.601 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 83.6 p -85.21 115.05 22.77 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.739 -1.208 . . . . 1.6899999999999999 107.739 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -60.46 -31.43 70.44 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.07 -1.019 . . . . 1.0700000000000001 110.608 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.3 p -57.21 -40.61 77.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 1.5800000000000001 110.391 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.6 t -60.18 -37.25 79.62 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.123 -0.986 . . . . 1.6000000000000001 109.948 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.4 mt -59.51 -40.13 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.287 -0.965 . . . . 1.45 110.497 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 38.5 mtp -64.56 -44.83 89.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.932 -1.105 . . . . 1.05 109.244 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.17 -44.7 94.83 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.554 -0.748 . . . . 0.71999999999999997 111.212 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -61.23 -45.07 96.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.778 -1.202 . . . . 3.0499999999999998 110.664 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.8 m -69.87 -38.98 76.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.036 -1.04 . . . . 0.89000000000000001 110.766 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -91.75 -8.15 47.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.554 -0.716 . . . . 0.78000000000000003 112.66 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.8 mt-10 54.14 9.31 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.937 1.088 . . . . 1.45 113.937 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.3 mt -70.08 150.19 96.18 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.621 -0.881 . . . . 0.67000000000000004 108.621 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.8 144.06 94.27 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 121.146 1.231 . . . . 0.64000000000000001 109.491 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.79 159.78 35.53 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.175 -1.41 . . . . 0.67000000000000004 110.214 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.5 mt -147.46 150.2 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.071 -1.085 . . . . 0.68999999999999995 108.071 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.0 m -135.02 -25.72 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.932 -1.105 . . . . 0.84999999999999998 111.724 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.22 33.35 2.23 Favored Glycine 0 N--CA 1.488 2.151 0 O-C-N 121.022 -1.049 . . . . 0.92000000000000004 113.306 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 181' ' ' THR . 2.7 p -60.63 -28.31 68.46 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.95 -1.323 . . . . 0.94999999999999996 111.037 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.04 -90.67 1.3 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.96 -1.114 . . . . 1.04 110.621 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 27.8 m -123.5 27.13 7.55 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.147 -1.208 . . . . 1.5700000000000001 112.984 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 68.2 t -57.41 -34.47 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.172 -1.58 . . . . 0.83999999999999997 110.144 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.2 p -57.61 -23.46 51.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 0.98999999999999999 111.964 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.2 p -92.88 2.77 56.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.968 -1.082 . . . . 1.7 111.928 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -128.32 1.88 5.71 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.808 0.67 . . . . 2.2000000000000002 112.808 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.75 151.26 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 109.112 -0.699 . . . . 0.83999999999999997 109.112 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -120.97 150.13 41.58 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.857 -0.794 . . . . 2.2000000000000002 108.857 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 42.1 p-10 -52.16 143.59 14.06 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.008 -1.077 . . . . 2.2799999999999998 110.278 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.4 m-20 78.3 -1.17 2.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.525 1.305 . . . . 2.3500000000000001 114.525 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.53 144.03 52.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.861 -1.149 . . . . 1.97 108.307 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -89.31 112.96 24.16 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.331 -1.359 . . . . 2.6499999999999999 107.331 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.493 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 48.7 mt -124.22 143.44 50.52 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.322 0.582 . . . . 0.63 109.645 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.3 mt -109.81 126.76 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 106.58 -1.637 . . . . 0.62 106.58 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 52.3 tp -100.64 119.4 38.51 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.118 -1.808 . . . . 0.64000000000000001 106.118 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 223' ' ' VAL . 36.9 p-10 -93.67 -20.93 19.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.081 -1.012 . . . . 2.0499999999999998 112.682 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.935 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.73 13.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.477 0.547 . . . . 0.83999999999999997 112.477 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.624 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.1 t -109.89 -58.75 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.273 -0.892 . . . . 1.02 109.521 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -91.63 8.33 37.27 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.541 1.163 . . . . 2.5099999999999998 110.852 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.0 t30 60.87 49.31 6.09 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.108 -0.951 . . . . 1.54 111.786 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -148.45 154.58 40.06 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.226 1.012 . . . . 1.95 109.746 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.4 t -116.45 141.04 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.576 -0.738 . . . . 0.70999999999999996 109.181 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -101.16 134.94 43.43 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.327 -0.99 . . . . 1.01 108.327 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.28 130.77 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.614 -0.884 . . . . 0.81999999999999995 108.614 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 51.23 58.31 16.6 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.31 -0.869 . . . . 1.54 112.867 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.93 150.19 60.65 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.387 2.058 . . . . 0.93999999999999995 110.626 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.7 p -76.23 158.59 31.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.105 -0.997 . . . . 1.8 109.608 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -60.79 -39.35 88.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 2.73 110.993 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.39 -41.47 80.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.067 -1.021 . . . . 3.1699999999999999 110.696 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.05 -39.31 77.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.806 -1.184 . . . . 1.3400000000000001 110.075 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 71.0 mt -60.03 -49.45 83.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.387 -0.821 . . . . 1.2 110.883 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.92 -41.53 91.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.097 -1.002 . . . . 2.7000000000000002 110.543 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -64.41 -44.35 91.52 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.717 -0.793 . . . . 2.5899999999999999 110.285 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 84.6 mtp -72.4 -37.05 68.78 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.301 -0.874 . . . . 1.3799999999999999 110.743 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.9 mmm-85 -57.57 -40.62 79.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.827 -1.17 . . . . 2.8399999999999999 110.472 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.85 -56.11 5.36 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.267 -0.896 . . . . 1.8799999999999999 110.634 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.27 -40.02 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.361 -0.837 . . . . 2.3999999999999999 111.135 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.42 ' HG2' HD12 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -57.93 -50.17 74.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.67 -1.269 . . . . 3.52 111.083 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -64.66 -33.43 75.92 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.696 -0.801 . . . . 1.8799999999999999 110.68 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -60.59 -31.24 70.4 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.348 -0.941 . . . . 3.0099999999999998 109.817 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.14 -41.85 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.854 0.835 . . . . 2.4500000000000002 109.835 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.37 89.73 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.679 0.752 . . . . 2.75 110.57 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.1 m -71.15 -34.32 70.87 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.628 -0.67 . . . . 3.1600000000000001 110.849 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -66.39 -46.26 77.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.875 -1.141 . . . . 3.5699999999999998 110.999 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -72.13 -28.92 63.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.005 -1.06 . . . . 4.2999999999999998 111.422 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.92 71.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.423 -0.798 . . . . 4.4500000000000002 111.236 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.58 -55.64 7.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.239 -0.913 . . . . 5.9699999999999998 110.62 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.89 -26.87 62.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 6.1799999999999997 111.793 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.71 -34.77 77.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.111 -0.993 . . . . 6.6600000000000001 111.359 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -84.77 -14.04 49.4 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.727 -1.233 . . . . 8.1999999999999993 113.003 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.2 0.27 56.27 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.85 -1.156 . . . . 8.0700000000000003 112.194 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -84.18 -4.49 58.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.065 -1.022 . . . . 9.4499999999999993 112.4 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -91.26 4.37 52.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.441 -0.787 . . . . 10.119999999999999 112.621 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 . . . . . 0 N--CA 1.496 1.825 0 N-CA-C 108.43 -0.952 . . . . 11.49 108.43 -179.184 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 mtt . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 108.949 -0.76 . . . . 3.0699999999999998 108.949 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 79.2 mt -99.11 111.21 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.219 -1.4 . . . . 1.0700000000000001 107.219 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 m -106.01 119.91 40.41 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.202 -1.407 . . . . 1.24 107.202 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.46 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -102.97 -153.85 24.45 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.414 -1.874 . . . . 1.01 108.414 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.9 mt -97.64 0.98 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -1.168 . . . . 1.1100000000000001 112.38 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 49.89 93.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.985 -1.072 . . . . 0.98999999999999999 111.985 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -89.38 -30.93 18.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.84999999999999998 111.663 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -150.8 138.25 12.0 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.216 -0.927 . . . . 1.3799999999999999 108.54 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.18 145.0 21.38 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.341 2.027 . . . . 0.93999999999999995 112.533 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.911 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.42 177.92 25.69 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 109.084 -1.606 . . . . 0.81000000000000005 109.084 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.5 mt -132.0 138.66 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.058 -1.26 . . . . 0.82999999999999996 108.238 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HB1' ' CD2' ' A' ' 177' ' ' LEU . . . -140.37 155.5 46.74 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.233 -0.917 . . . . 0.53000000000000003 109.09 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.537 ' CD2' ' NH1' ' A' ' 240' ' ' ARG . 25.4 m-85 -129.08 141.26 51.26 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.521 -0.918 . . . . 0.77000000000000002 108.521 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.81 168.42 34.78 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 118.27 -1.919 . . . . 0.51000000000000001 110.198 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -77.01 160.3 29.23 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.901 . . . . 1.8999999999999999 109.846 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.84 121.49 26.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.691 -1.225 . . . . 0.66000000000000003 107.691 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.401 HD12 HD21 ' A' ' 214' ' ' ASN . 31.4 tp -100.14 98.51 9.21 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.069 -1.826 . . . . 0.82999999999999996 106.069 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 tp -90.74 134.71 34.22 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.662 -1.236 . . . . 0.85999999999999999 107.662 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.0 mt -99.77 111.1 23.45 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.752 -1.573 . . . . 0.92000000000000004 106.752 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -104.31 127.54 51.97 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.989 -1.486 . . . . 2.0299999999999998 106.989 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.474 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 81.6 tt0 -129.41 144.21 51.15 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.941 -0.762 . . . . 2.6600000000000001 108.941 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -80.89 136.01 36.0 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.823 -1.177 . . . . 2.3199999999999998 107.823 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -65.81 149.83 49.54 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.516 -0.74 . . . . 2.1099999999999999 109.264 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -92.21 130.87 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.843 -1.169 . . . . 0.72999999999999998 107.843 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.65 129.81 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.153 -1.055 . . . . 0.87 108.153 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.2 mt -95.53 139.74 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.424 -0.798 . . . . 0.81000000000000005 108.927 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -87.58 123.62 32.65 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.125 -1.065 . . . . 1.3400000000000001 108.125 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -94.74 14.67 20.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.656 -0.652 . . . . 2.8900000000000001 112.38 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -77.55 140.58 39.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.281 -0.887 . . . . 2.0899999999999999 109.275 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -84.69 140.27 31.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.103 -0.998 . . . . 2.1899999999999999 109.744 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -95.75 175.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.75 109.776 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -98.09 164.33 12.38 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.887 -0.597 . . . . 0.91000000000000003 109.544 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.14 -23.41 21.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.268 -0.895 . . . . 0.93000000000000005 112.029 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -68.88 -40.05 79.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.812 -1.18 . . . . 2.2799999999999998 110.946 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -86.39 -6.2 58.99 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.289 -1.507 . . . . 1.45 112.189 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.19 -41.81 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.968 -1.083 . . . . 0.81000000000000005 110.456 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -58.24 -39.42 79.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.003 -1.061 . . . . 1.54 110.936 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.2 -39.87 95.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.02 . . . . 2.3599999999999999 110.967 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -58.96 -40.33 84.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.875 . . . . 1.3100000000000001 110.724 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.25 -41.71 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.81999999999999995 110.127 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.57 -44.58 93.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 1.5 109.58 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -62.43 -40.45 96.61 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.401 -0.92 . . . . 2.23 109.925 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.39 -52.84 12.37 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.801 0.81 . . . . 0.84999999999999998 109.871 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.07 -48.84 80.06 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.255 -0.903 . . . . 0.91000000000000003 109.96 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.2 t -68.21 -41.05 81.88 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.659 0.743 . . . . 0.90000000000000002 109.831 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.95 -42.08 85.82 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.34 -1.504 . . . . 0.68999999999999995 109.34 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.404 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 51.7 ttt180 -58.38 -32.77 68.91 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.689 0.756 . . . . 2.8799999999999999 109.772 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.61 -50.21 72.66 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.375 0.607 . . . . 0.84999999999999998 110.819 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -78.05 -38.64 43.99 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.306 -0.872 . . . . 2.3500000000000001 110.44 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.16 87.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.395 -0.816 . . . . 0.65000000000000002 110.209 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.5 m -60.45 -40.14 90.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.869 0.843 . . . . 1.45 109.497 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.41 78.1 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.15 -0.62 . . . . 0.63 110.072 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.16 -50.58 72.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 1.3400000000000001 110.577 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.83 -39.17 93.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.019 . . . . 1.5600000000000001 110.105 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -59.86 -40.93 90.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.807 -0.558 . . . . 1.1899999999999999 110.958 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.8 m -64.27 -45.31 88.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.822 -1.174 . . . . 0.71999999999999997 110.356 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.12 -34.64 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 0.62 110.984 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -52.97 -45.76 67.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.26 -0.9 . . . . 1.05 111.084 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.14 -37.71 81.36 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.148 -0.97 . . . . 0.64000000000000001 110.182 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -61.35 -39.81 91.95 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.577 -1.249 . . . . 1.73 109.617 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.98 -32.3 73.45 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.625 -0.672 . . . . 0.56000000000000005 110.558 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.04 -34.58 14.43 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.832 -1.175 . . . . 0.68999999999999995 111.405 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -81.85 -25.75 34.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.567 -1.549 . . . . 1.48 111.373 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.4 m -86.69 -49.99 7.1 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.408 -0.807 . . . . 0.97999999999999998 111.125 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.9 -5.25 19.83 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 113.909 1.078 . . . . 1.1599999999999999 113.909 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.83 161.47 27.75 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.401 -0.904 . . . . 0.84999999999999998 112.733 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -55.79 -18.88 9.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -1.065 . . . . 3.8599999999999999 112.82 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -59.07 -40.66 85.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -0.973 . . . . 2.3500000000000001 110.518 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -85.9 -23.9 26.83 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.213 -0.929 . . . . 1.6699999999999999 111.465 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.65 -35.44 76.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.638 -0.664 . . . . 1.45 111.356 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.02 83.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.388 -0.82 . . . . 0.60999999999999999 111.334 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.5 mt -62.02 -40.91 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.946 . . . . 0.65000000000000002 110.324 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -71.04 -30.29 66.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.302 -0.874 . . . . 0.66000000000000003 110.546 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -60.91 -39.07 87.96 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.187 -0.945 . . . . 1.1899999999999999 109.732 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.98 -39.58 93.25 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 110.098 -1.201 . . . . 0.53000000000000003 110.098 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -59.82 -45.0 93.74 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.433 -1.04 . . . . 1.27 110.355 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.61 -40.91 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 0.54000000000000004 110.401 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 26.3 ttt -60.14 -39.4 86.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.325 -0.859 . . . . 1.74 110.384 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.5 tp -57.84 -48.25 80.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.151 -0.968 . . . . 0.55000000000000004 110.221 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.98 -41.76 92.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.239 -0.913 . . . . 0.46999999999999997 110.413 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -88.13 10.4 19.44 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 112.899 0.703 . . . . 1.4199999999999999 112.899 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.63 126.32 27.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.891 -1.131 . . . . 1.27 108.818 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.22 -18.72 65.35 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.871 0.843 . . . . 1.3500000000000001 110.639 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -74.45 -54.99 6.48 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.491 0.662 . . . . 2.2200000000000002 110.178 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.9 mt -61.1 -37.49 82.95 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.663 -0.648 . . . . 0.62 111.058 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.404 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 30.5 tt0 -60.05 -45.18 93.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 1.29 110.559 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.97 -38.46 91.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 1.52 110.685 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -68.26 -47.87 66.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.035 -1.041 . . . . 1.3 110.922 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.11 -42.48 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.093 -1.004 . . . . 0.60999999999999999 110.04 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.4 mt -63.51 -43.0 98.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.485 -0.76 . . . . 0.78000000000000003 110.505 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -62.29 -42.83 99.69 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.3 -0.875 . . . . 0.81999999999999995 110.928 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.62 -45.63 93.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.974 -1.079 . . . . 0.80000000000000004 110.544 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.8 mt -61.88 -43.65 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.041 -1.037 . . . . 0.77000000000000002 110.339 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -84.75 -31.26 24.09 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.277 -0.89 . . . . 2.1200000000000001 111.724 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 91' ' ' ALA . 60.6 t0 -82.47 -45.57 14.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.64 -1.287 . . . . 1.51 111.527 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -100.76 4.82 43.33 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.227 -0.92 . . . . 1.98 112.617 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 53.2 50.64 17.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 1.3200000000000001 111.466 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.33 159.02 15.62 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.385 -0.822 . . . . 1.3799999999999999 109.207 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.2 p -71.5 161.02 31.69 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.772 -0.58 . . . . 0.67000000000000004 109.832 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.28 -45.04 92.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.033 -1.042 . . . . 0.52000000000000002 110.56 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.591 ' OD2' HD21 ' A' ' 142' ' ' LEU . 91.2 m-20 -68.12 -37.04 80.67 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.226 -0.922 . . . . 2.25 110.121 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.54 -51.71 40.0 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.757 -0.777 . . . . 0.64000000000000001 111.429 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.63 94.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.117 -0.989 . . . . 0.56000000000000005 110.408 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.31 95.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.653 -0.654 . . . . 0.46000000000000002 110.793 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -61.69 -37.87 85.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.124 -0.985 . . . . 1.3200000000000001 111.496 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -59.23 -49.59 77.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.883 -1.136 . . . . 1.3 111.077 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.68 -45.72 97.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.437 -1.414 . . . . 0.60999999999999999 110.214 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.1 mm -61.12 -34.76 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.638 -0.664 . . . . 0.65000000000000002 110.403 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -58.44 -39.16 79.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.095 -1.003 . . . . 2.1099999999999999 111.226 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.69 -41.3 7.8 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.947 -1.597 . . . . 0.82999999999999996 112.853 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -60.57 -41.07 93.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.599 -1.53 . . . . 1.28 109.891 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.43 -52.65 20.75 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.399 0.619 . . . . 0.89000000000000001 110.559 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.0 p -62.53 -36.44 82.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.462 -0.774 . . . . 1.8700000000000001 110.453 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.3 97.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 1.05 110.722 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.19 -30.11 70.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.938 . . . . 1.02 110.855 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.58 -21.75 65.41 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.011 -1.056 . . . . 2.04 110.989 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -71.37 -14.3 62.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 1.73 111.462 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.401 HD13 HD13 ' A' ' 123' ' ' LEU . 16.2 mt -86.85 146.4 26.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.434 -0.791 . . . . 1.3700000000000001 109.574 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -99.2 36.08 1.79 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.233 -0.917 . . . . 2.8799999999999999 112.285 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -113.09 139.6 48.57 Favored 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 108.437 -0.949 . . . . 1.5800000000000001 108.437 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -60.23 -38.46 83.47 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.329 -0.857 . . . . 3.04 110.89 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -70.23 -53.33 17.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.684 -1.26 . . . . 0.90000000000000002 109.909 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.401 HD13 HD13 ' A' ' 118' ' ' LEU . 36.1 mt -62.79 -40.31 96.94 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 109.627 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.64 -50.49 66.88 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.828 0.823 . . . . 2.1800000000000002 109.918 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.78 -29.11 70.46 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.753 -1.217 . . . . 2.1499999999999999 109.921 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -61.66 -31.4 71.51 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.368 -0.933 . . . . 2.3300000000000001 109.111 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.15 78.86 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.643 0.735 . . . . 0.81999999999999995 109.815 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.61 -43.65 79.94 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.416 -0.914 . . . . 0.84999999999999998 109.958 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -60.97 -38.6 86.52 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.485 0.659 . . . . 1.3899999999999999 110.829 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.5 -39.07 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.574 -0.704 . . . . 0.56000000000000005 110.262 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.417 ' NH1' ' HG3' ' A' ' 131' ' ' ARG . 40.4 ttm-85 -59.04 -40.07 83.91 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.143 -0.973 . . . . 3.1200000000000001 109.856 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -60.21 -38.75 84.29 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.356 0.598 . . . . 1.28 110.405 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.67 -39.76 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.254 -0.904 . . . . 0.48999999999999999 110.444 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.86 -47.36 67.04 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.424 -1.07 . . . . 0.46000000000000002 110.424 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -58.24 -42.1 85.61 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.21 -1.171 . . . . 2.71 110.078 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HG2' HH11 ' A' ' 136' ' ' ARG . 60.1 mtt-85 -61.67 -43.23 99.26 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.14 -1.024 . . . . 2.1400000000000001 110.372 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.31 -43.02 96.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.371 -0.831 . . . . 1.05 109.843 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -41.53 91.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.78 -0.575 . . . . 0.52000000000000002 110.833 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.474 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 99.5 mtt180 -60.08 -35.58 75.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 2.3500000000000001 111.329 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -73.56 -41.32 63.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.025 -1.047 . . . . 1.3899999999999999 110.645 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.3 mt -60.4 -39.26 80.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.092 -1.005 . . . . 0.68000000000000005 110.228 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.591 HD21 ' OD2' ' A' ' 101' ' ' ASP . 87.9 mt -88.6 -8.54 54.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.474 -0.766 . . . . 0.82999999999999996 112.039 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.34 25.32 70.93 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 120.363 -0.923 . . . . 0.91000000000000003 113.59 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.5 tp -70.13 148.62 48.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.634 -0.921 . . . . 0.94999999999999996 109.956 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -65.46 151.72 45.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.483 -0.761 . . . . 2.4300000000000002 110.803 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.8 mt -103.32 140.6 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.125 -1.065 . . . . 1.1000000000000001 108.125 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.6 mm -82.37 120.36 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.817 -1.177 . . . . 1.5800000000000001 108.138 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -99.36 95.89 7.35 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.165 -1.791 . . . . 1.6200000000000001 106.165 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.82 -18.38 61.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.504 -0.748 . . . . 0.80000000000000004 112.053 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.0 m -81.72 8.74 9.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 1.5600000000000001 112.208 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.04 24.63 9.09 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.239 -0.913 . . . . 0.83999999999999997 111.655 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.1 mt -74.35 147.24 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.371 -0.83 . . . . 0.81999999999999995 110.146 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -115.26 -20.12 10.49 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.58 -0.7 . . . . 2.3100000000000001 112.596 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -119.55 139.92 51.36 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.812 -1.181 . . . . 1.54 107.812 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.71 128.57 36.52 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.602 -0.888 . . . . 1.3799999999999999 108.602 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -146.28 178.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.477 -0.764 . . . . 0.68999999999999995 109.426 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.417 HG21 HD12 ' A' ' 180' ' ' ILE . 81.3 mt -91.42 144.75 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.504 -0.925 . . . . 0.53000000000000003 108.504 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.71 123.65 39.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.889 -1.132 . . . . 0.64000000000000001 108.366 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.74 130.09 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.156 -1.053 . . . . 0.67000000000000004 108.156 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.34 154.77 21.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.099 -1.001 . . . . 0.78000000000000003 108.93 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.7 -31.2 70.48 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.653 -1.28 . . . . 1.0 109.626 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 29.0 p-10 -173.35 150.8 1.91 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.708 -0.849 . . . . 2.4199999999999999 108.708 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.3 mt -119.39 138.78 52.86 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.332 -0.988 . . . . 0.75 108.332 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.0 p -95.61 152.61 39.29 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 108.507 -0.923 . . . . 0.78000000000000003 108.507 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -43.68 -39.57 10.23 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.367 1.378 . . . . 0.67000000000000004 113.367 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.0 m -59.85 -48.88 79.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.923 -1.111 . . . . 0.69999999999999996 110.042 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.99 -40.33 97.43 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.338 -0.851 . . . . 1.21 109.961 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 31.5 p -68.17 -40.0 82.41 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.857 -0.737 . . . . 0.59999999999999998 110.055 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.36 78.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.581 -0.7 . . . . 0.62 110.779 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -97.03 -1.43 45.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.207 -0.933 . . . . 1.1599999999999999 112.881 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.82 150.39 41.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.476 -0.765 . . . . 0.72999999999999998 109.571 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -96.03 111.04 23.17 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.773 -1.566 . . . . 2.2400000000000002 106.773 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 31.9 mt -74.57 -15.19 60.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.636 -0.665 . . . . 1.4299999999999999 111.486 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -81.32 -25.58 36.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 2.1499999999999999 111.832 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -102.72 -1.96 29.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.27 -0.894 . . . . 2.04 113.325 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.05 127.26 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 107.394 -1.335 . . . . 0.55000000000000004 107.394 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.429 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 45.1 tp -88.58 -10.84 47.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.104 -0.998 . . . . 1.6299999999999999 112.244 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.96 174.32 46.72 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.049 -1.621 . . . . 0.46999999999999997 109.049 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -130.02 131.19 45.76 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.506 -1.294 . . . . 0.54000000000000004 107.506 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.535 ' CG2' HG21 ' A' ' 205' ' ' THR . 84.6 mt -131.32 129.79 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.156 -1.424 . . . . 0.68999999999999995 107.156 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 203' ' ' VAL . 82.7 p -140.57 170.55 15.57 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.886 -1.133 . . . . 0.81999999999999995 109.702 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.447 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 1.4 m-20 -105.04 44.72 1.01 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.817 -0.552 . . . . 2.3700000000000001 110.777 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -104.39 155.0 19.15 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.086 -1.009 . . . . 1.1100000000000001 109.637 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.22 -8.39 74.55 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.924 -1.131 . . . . 1.6699999999999999 112.311 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.76 -18.43 56.9 Favored Glycine 0 N--CA 1.497 2.707 0 O-C-N 121.4 -1.059 . . . . 1.54 113.385 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -59.78 -39.86 86.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.059 -1.259 . . . . 4.4800000000000004 110.526 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.0 p -129.59 31.19 4.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.805 -0.559 . . . . 2.6299999999999999 111.023 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 90.7 p -83.16 98.64 9.46 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.296 -1.372 . . . . 1.6899999999999999 107.296 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -59.55 -34.39 72.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.475 -0.765 . . . . 1.0700000000000001 110.107 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 191' ' ' SER . 15.2 t -59.67 -39.44 84.48 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.537 -0.727 . . . . 1.5800000000000001 110.603 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.478 ' N ' HG23 ' A' ' 190' ' ' THR . 22.8 t -57.24 -39.99 76.67 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.16 -0.962 . . . . 1.6000000000000001 110.072 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.3 -39.62 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.44 -0.787 . . . . 1.45 109.937 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 45.5 mtp -66.27 -40.93 90.44 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.395 1.093 . . . . 1.05 109.414 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.73 -42.22 88.26 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.464 -0.789 . . . . 0.71999999999999997 110.709 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -60.84 -44.95 96.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.912 -1.118 . . . . 3.0499999999999998 110.317 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.8 m -70.21 -40.1 74.77 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.199 -0.938 . . . . 0.89000000000000001 110.225 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.4 mt -91.7 -6.92 51.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.529 -0.732 . . . . 0.78000000000000003 112.64 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.0 mt-10 52.54 13.45 0.32 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.749 1.018 . . . . 1.45 113.749 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.71 148.11 89.7 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.942 -1.132 . . . . 0.67000000000000004 107.942 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -54.35 140.5 73.18 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.905 1.737 . . . . 0.64000000000000001 109.985 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -158.84 160.5 36.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.249 -1.532 . . . . 0.67000000000000004 109.86 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.46 ' CD1' HD11 ' A' ' 220' ' ' LEU . 29.6 mt -148.65 151.49 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.676 -1.231 . . . . 0.68999999999999995 107.676 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.7 m -135.5 -27.58 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 120.956 -1.09 . . . . 0.84999999999999998 112.014 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.92 42.06 2.8 Favored Glycine 0 N--CA 1.492 2.41 0 O-C-N 121.081 -1.012 . . . . 0.92000000000000004 112.02 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.535 HG21 ' CG2' ' A' ' 180' ' ' ILE . 74.7 p -65.4 -13.11 57.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.899 -1.353 . . . . 0.94999999999999996 111.151 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.65 -95.88 1.38 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 110.565 -1.014 . . . . 1.04 110.565 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -129.08 30.96 4.96 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.659 -0.907 . . . . 1.5700000000000001 112.322 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.2 -36.33 45.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.571 -1.331 . . . . 0.83999999999999997 110.819 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.1 p -57.77 -24.58 57.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.792 -1.193 . . . . 0.98999999999999999 111.544 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 18.2 t -92.15 -2.05 56.8 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.797 0.808 . . . . 1.7 111.483 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -122.46 -5.29 8.77 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.561 0.949 . . . . 2.2000000000000002 113.561 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 34.8 t -120.05 149.07 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.357 -0.839 . . . . 0.83999999999999997 109.594 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.0 156.9 27.75 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.973 -1.121 . . . . 2.2000000000000002 107.973 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.506 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 22.2 t-20 -51.47 142.84 13.01 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.075 -1.016 . . . . 2.2799999999999998 110.216 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 83.35 -7.62 1.14 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.109 1.151 . . . . 2.3500000000000001 114.109 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -58.57 142.15 50.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.507 -1.37 . . . . 1.97 108.91 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -88.74 119.82 29.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.671 -1.268 . . . . 2.6499999999999999 108.072 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 72.9 mt -124.69 148.85 47.76 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.465 0.65 . . . . 0.63 109.653 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.459 HG21 ' SD ' ' A' ' 239' ' ' MET . 82.6 mt -117.79 124.89 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.226 -1.768 . . . . 0.62 106.226 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.46 HD11 ' CD1' ' A' ' 202' ' ' ILE . 53.6 tp -102.24 116.78 33.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.215 -1.772 . . . . 0.64000000000000001 106.215 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.3 p-10 -93.15 -22.12 19.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.934 -1.104 . . . . 2.0499999999999998 112.709 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.17 15.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 112.663 0.616 . . . . 0.83999999999999997 112.663 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.633 ' N ' ' O ' ' A' ' 221' ' ' ASP . 20.6 t -109.73 -59.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.112 -0.993 . . . . 1.02 109.86 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -93.79 9.91 35.22 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.27 1.033 . . . . 2.5099999999999998 110.891 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.46 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 61.33 53.1 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.983 -1.008 . . . . 1.54 112.304 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -148.84 148.54 30.02 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.811 -1.181 . . . . 1.95 110.084 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.97 139.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 108.136 -1.061 . . . . 0.70999999999999996 108.136 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -102.74 133.88 47.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.181 -0.95 . . . . 1.01 108.669 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 53.4 t -110.86 130.8 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.214 -1.032 . . . . 0.81999999999999995 108.214 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.503 HD22 ' C ' ' A' ' 230' ' ' ASN . 0.6 OUTLIER 55.63 47.9 3.53 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 113.384 0.883 . . . . 1.54 113.384 178.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 62.3 Cg_endo -69.82 153.12 69.04 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.559 2.172 . . . . 0.93999999999999995 110.901 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.6 m -74.19 159.38 32.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 1.8 108.866 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -59.47 -34.01 72.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.114 -0.991 . . . . 2.73 110.691 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -59.96 -41.05 91.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.407 -0.808 . . . . 3.1699999999999999 110.56 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.96 -39.97 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.288 -0.883 . . . . 1.3400000000000001 110.192 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.4 mt -60.0 -49.97 81.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.168 -0.957 . . . . 1.2 111.043 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -59.52 -40.66 87.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.98 . . . . 2.7000000000000002 110.644 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.71 -47.91 84.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.853 . . . . 2.5899999999999999 110.195 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.459 ' SD ' HG21 ' A' ' 219' ' ' ILE . 66.1 mtp -70.63 -38.39 73.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 1.3799999999999999 110.871 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.537 ' NH1' ' CD2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -56.2 -41.36 75.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.147 -0.97 . . . . 2.8399999999999999 110.245 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.81 -42.99 69.53 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.288 -0.882 . . . . 1.8799999999999999 111.194 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 246' ' ' VAL . 95.3 t -59.54 -48.82 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.964 -1.085 . . . . 2.3999999999999999 110.764 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -63.52 -49.91 71.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.424 -1.422 . . . . 3.52 110.097 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.13 -37.84 86.7 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.756 -0.59 . . . . 1.8799999999999999 111.083 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -61.46 -30.07 70.36 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.839 -1.144 . . . . 3.0099999999999998 110.178 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 242' ' ' VAL . 55.1 t -63.87 -47.3 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.196 -1.002 . . . . 2.4500000000000002 109.953 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.57 89.06 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.236 -0.986 . . . . 2.75 110.247 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.4 t -71.55 -44.46 64.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 3.1600000000000001 111.454 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.64 -36.18 82.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.313 -0.867 . . . . 3.5699999999999998 110.589 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -63.78 -36.78 85.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.519 -0.738 . . . . 4.2999999999999998 110.726 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.02 -49.37 58.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 4.4500000000000002 110.749 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -70.78 -33.03 70.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.541 -0.724 . . . . 5.9699999999999998 111.205 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 46.5 tp -67.89 -28.75 67.78 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.98 -1.075 . . . . 6.1799999999999997 111.675 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -72.84 -5.38 37.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.89 -1.132 . . . . 6.6600000000000001 112.944 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -85.53 34.82 0.59 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.965 -1.085 . . . . 8.1999999999999993 112.689 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 14.6 mt -80.16 -1.78 41.81 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.809 -1.182 . . . . 8.0700000000000003 112.233 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -87.27 0.75 54.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.202 -0.936 . . . . 9.4499999999999993 112.648 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -88.69 -3.87 58.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.931 . . . . 10.119999999999999 112.792 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 117.982 -1.008 . . . . 11.49 109.86 -178.012 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.337 0.589 . . . . 3.0699999999999998 110.098 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.3 mt -98.13 110.48 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.386 -1.709 . . . . 1.0700000000000001 106.386 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m -105.88 125.23 50.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.048 -1.093 . . . . 1.24 108.048 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.46 -154.96 17.46 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.333 -1.907 . . . . 1.01 108.333 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 5' ' ' ILE . 80.3 mt -95.78 1.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.309 -1.113 . . . . 1.1100000000000001 112.185 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 5' ' ' ILE . 3.8 tp 50.82 101.16 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.085 -1.01 . . . . 0.98999999999999999 112.357 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -84.38 -47.44 10.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.118 -0.989 . . . . 0.84999999999999998 111.11 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m -144.58 146.95 34.26 Favored Pre-proline 0 N--CA 1.501 2.093 0 N-CA-C 107.855 -1.165 . . . . 1.3799999999999999 107.855 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.49 147.71 32.52 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.575 2.183 . . . . 0.93999999999999995 112.088 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.922 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.08 163.34 11.97 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.343 -1.503 . . . . 0.81000000000000005 109.343 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.3 mt -125.37 130.53 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.159 -1.2 . . . . 0.82999999999999996 108.095 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.464 ' HB1' ' CD2' ' A' ' 177' ' ' LEU . . . -139.11 148.92 43.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.242 -0.911 . . . . 0.53000000000000003 109.016 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 5.8 m-85 -117.49 140.17 49.96 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 108.827 -0.805 . . . . 0.77000000000000002 108.827 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.77 167.27 35.64 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 118.004 -2.046 . . . . 0.51000000000000001 110.39 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -77.48 160.36 28.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.827 -0.808 . . . . 1.8999999999999999 109.669 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.41 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -86.46 126.46 34.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.835 -1.166 . . . . 0.66000000000000003 108.152 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.9 tp -104.6 98.93 8.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.081 -1.822 . . . . 0.82999999999999996 106.081 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 18' ' ' LEU . 17.0 tp -90.55 130.83 36.55 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.753 -1.203 . . . . 0.85999999999999999 107.753 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 158' ' ' LEU . 77.5 mt -101.77 117.06 34.09 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.861 -1.533 . . . . 0.92000000000000004 106.861 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -109.5 136.04 49.54 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.993 -1.484 . . . . 2.0299999999999998 106.993 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -119.69 149.18 42.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.083 -1.011 . . . . 2.6600000000000001 109.452 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -82.67 134.62 35.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.858 -1.164 . . . . 2.3199999999999998 107.858 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.19 148.35 50.24 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.671 -0.863 . . . . 2.1099999999999999 108.671 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.87 130.3 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.282 -1.007 . . . . 0.72999999999999998 108.282 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -105.35 131.11 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.033 -1.099 . . . . 0.87 108.033 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 77.1 mt -97.86 135.55 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.526 -0.916 . . . . 0.81000000000000005 108.526 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -91.12 123.02 34.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.858 -1.164 . . . . 1.3400000000000001 107.858 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -95.06 13.04 26.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.223 -0.923 . . . . 2.8900000000000001 112.135 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -67.25 149.66 50.11 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.282 -0.886 . . . . 2.0899999999999999 109.244 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -86.43 140.0 30.39 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.179 -1.045 . . . . 2.1899999999999999 108.179 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -93.31 171.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.079 -1.013 . . . . 0.75 109.418 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.6 p -108.53 158.62 17.39 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.935 -0.765 . . . . 0.91000000000000003 108.935 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.82 -26.23 1.56 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.108 -0.995 . . . . 0.93000000000000005 112.672 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -69.84 -39.87 76.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.161 -0.962 . . . . 2.2799999999999998 110.167 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -86.47 -11.3 52.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.426 -0.796 . . . . 1.45 111.813 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.15 -47.19 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.438 -0.789 . . . . 0.81000000000000005 110.472 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.12 -40.08 84.3 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.098 -1.001 . . . . 1.54 110.687 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -62.46 -44.77 95.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.42 -0.8 . . . . 2.3599999999999999 110.999 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.05 -39.74 87.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.919 -1.113 . . . . 1.3100000000000001 111.02 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.04 -41.77 87.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.92 -1.112 . . . . 0.81999999999999995 110.656 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -61.93 -45.89 91.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.008 -1.057 . . . . 1.5 110.279 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -62.48 -39.67 94.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.308 -0.87 . . . . 2.23 110.165 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -76.22 -54.42 6.83 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.562 -0.711 . . . . 0.84999999999999998 110.315 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -58.32 -47.78 82.64 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.382 -0.927 . . . . 0.91000000000000003 109.772 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -68.39 -36.74 79.59 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.738 -0.785 . . . . 0.90000000000000002 109.891 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.68 -44.09 94.17 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.218 -1.468 . . . . 0.68999999999999995 109.57 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.4 ttt-85 -60.32 -29.48 68.89 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.194 -1.18 . . . . 2.8799999999999999 110.328 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.31 -50.24 73.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.84999999999999998 110.929 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -81.44 -36.07 29.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.909 -1.12 . . . . 2.3500000000000001 110.341 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.49 89.7 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.268 -0.895 . . . . 0.65000000000000002 109.683 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 87.4 p -60.77 -39.28 88.24 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.219 1.009 . . . . 1.45 109.055 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -45.3 75.64 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.711 -0.677 . . . . 0.63 110.595 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.29 -48.6 72.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.672 -1.268 . . . . 1.3400000000000001 110.658 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.05 -35.95 81.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.994 -1.066 . . . . 1.5600000000000001 109.888 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -60.06 -40.24 88.81 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.574 -0.704 . . . . 1.1899999999999999 110.256 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -62.11 -43.45 98.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.139 -0.976 . . . . 0.71999999999999997 110.457 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.1 mt -59.94 -35.21 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.438 -0.789 . . . . 0.62 110.726 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -52.64 -41.63 63.94 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.15 -0.969 . . . . 1.05 110.878 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.76 -36.92 76.19 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.996 -1.065 . . . . 0.64000000000000001 110.318 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -61.58 -36.81 81.72 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.926 -1.109 . . . . 1.73 109.552 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.12 79.01 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.618 -0.677 . . . . 0.56000000000000005 110.43 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.24 -36.21 13.22 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.637 -1.268 . . . . 0.68999999999999995 111.502 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.54 -22.66 43.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.668 -1.489 . . . . 1.48 110.736 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.2 m -90.42 -49.93 6.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.253 -0.904 . . . . 0.97999999999999998 111.52 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.27 -7.17 16.83 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 113.918 1.081 . . . . 1.1599999999999999 113.918 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.08 163.46 24.79 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.719 -0.753 . . . . 0.84999999999999998 112.349 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -54.17 -23.89 16.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.565 -0.962 . . . . 3.8599999999999999 112.779 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.3 -40.08 70.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.823 -1.173 . . . . 2.3500000000000001 110.993 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -86.02 -22.99 26.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.674 -1.266 . . . . 1.6699999999999999 111.488 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -60.56 -40.3 91.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 1.45 111.031 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.25 86.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.486 -0.759 . . . . 0.60999999999999999 111.443 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -65.82 -44.0 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.754 -1.216 . . . . 0.65000000000000002 110.921 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -69.95 -32.91 71.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.686 -1.259 . . . . 0.66000000000000003 110.22 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.2 -38.85 88.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -0.881 . . . . 1.1899999999999999 110.23 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.13 96.96 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.591 -0.814 . . . . 0.53000000000000003 111.097 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -58.11 -40.92 82.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.669 -1.489 . . . . 1.27 110.777 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.93 -40.05 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.118 -0.989 . . . . 0.54000000000000004 110.987 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.8 ttm -58.76 -40.28 83.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.983 -1.073 . . . . 1.74 110.377 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 tp -59.85 -48.6 81.05 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.185 -0.947 . . . . 0.55000000000000004 110.023 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.97 -39.8 86.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.207 -0.933 . . . . 0.46999999999999997 110.284 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -84.3 6.78 21.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.216 0.821 . . . . 1.4199999999999999 113.216 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -66.41 125.33 25.31 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.664 -1.273 . . . . 1.27 108.26 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.97 -16.54 64.1 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.263 -0.898 . . . . 1.3500000000000001 111.121 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -75.03 -50.29 16.98 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.674 -0.81 . . . . 2.2200000000000002 110.34 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.8 -36.76 84.21 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.739 -0.784 . . . . 0.62 110.392 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -59.93 -48.8 80.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.367 -0.833 . . . . 1.29 110.705 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -61.85 -38.42 88.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 1.52 110.546 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.23 -47.38 79.88 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.025 -1.047 . . . . 1.3 110.499 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.61 -45.03 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.34 -0.85 . . . . 0.60999999999999999 110.198 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.34 -40.12 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.683 0.754 . . . . 0.78000000000000003 110.465 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.43 98.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.152 -0.968 . . . . 0.81999999999999995 110.965 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.18 -39.16 85.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.015 -1.053 . . . . 0.80000000000000004 110.612 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.26 -51.52 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.77000000000000002 110.757 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -75.87 -35.31 59.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.756 . . . . 2.1200000000000001 111.446 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.43 -46.24 14.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 1.51 111.948 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -100.13 7.84 44.31 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.342 -0.849 . . . . 1.98 112.861 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.9 m80 49.9 48.61 21.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.74 -1.225 . . . . 1.3200000000000001 111.427 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.9 mtt -109.97 152.02 26.39 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.778 0.799 . . . . 1.3799999999999999 109.552 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.9 p -70.1 160.27 32.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.515 -0.741 . . . . 0.67000000000000004 110.018 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.18 92.98 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.46 -0.775 . . . . 0.52000000000000002 110.419 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD2' HD21 ' A' ' 142' ' ' LEU . 74.8 m-20 -65.86 -43.45 88.38 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.962 -1.086 . . . . 2.25 109.361 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.18 -49.31 51.64 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.921 -0.711 . . . . 0.64000000000000001 110.862 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.71 -44.47 93.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.56000000000000005 110.637 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.22 -41.07 87.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.46000000000000002 110.483 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.3 -38.28 90.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 1.3200000000000001 111.48 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.62 -49.76 76.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.387 -1.446 . . . . 1.3 111.29 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.68 -46.81 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.918 -1.114 . . . . 0.60999999999999999 110.112 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.8 mm -62.0 -29.43 46.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.921 0.867 . . . . 0.65000000000000002 110.681 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.51 -40.33 82.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.551 -0.718 . . . . 2.1099999999999999 110.996 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.55 -32.04 17.07 Favored Glycine 0 N--CA 1.501 3.004 0 C-N-CA 119.384 -1.389 . . . . 0.82999999999999996 112.535 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -63.03 -37.54 87.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.363 -1.669 . . . . 1.28 110.169 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.63 -51.21 15.08 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.533 -0.73 . . . . 0.89000000000000001 111.201 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.9 m -58.32 -38.73 77.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.388 -0.82 . . . . 1.8700000000000001 111.142 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.09 99.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.303 -0.873 . . . . 1.05 111.025 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.75 -28.81 69.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.967 . . . . 1.02 111.269 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -68.11 -22.27 64.9 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.209 -0.932 . . . . 2.04 111.055 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -73.08 -13.64 61.24 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.963 0.887 . . . . 1.73 111.029 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 123' ' ' LEU . 11.4 mt -91.18 140.53 29.72 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.503 -0.925 . . . . 1.3700000000000001 108.503 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -99.71 43.55 1.05 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.028 -1.045 . . . . 2.8799999999999999 112.082 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -112.87 140.51 47.6 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.134 -0.979 . . . . 1.5800000000000001 108.808 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.24 -40.47 77.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 3.04 111.008 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -73.22 -54.04 9.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.864 -1.148 . . . . 0.90000000000000002 110.95 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 118' ' ' LEU . 26.7 mt -59.81 -41.3 90.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.897 -1.127 . . . . 1.0600000000000001 110.475 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -63.65 -50.09 70.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.116 -0.99 . . . . 2.1800000000000002 109.951 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.44 -31.83 70.8 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.978 -1.076 . . . . 2.1499999999999999 109.292 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.536 ' HG2' HH11 ' A' ' 126' ' ' ARG . 11.3 ttt-85 -61.32 -29.32 69.81 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.59 -0.844 . . . . 2.3300000000000001 109.49 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.12 74.81 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.815 0.817 . . . . 0.81999999999999995 109.448 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.5 -45.72 78.66 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.101 -0.64 . . . . 0.84999999999999998 110.125 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -62.05 -33.93 75.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.543 -0.723 . . . . 1.3899999999999999 110.574 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 126' ' ' ARG . 25.1 t -68.12 -41.91 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 0.56000000000000005 110.272 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 131' ' ' ARG . 28.1 ttt-85 -59.77 -39.49 85.04 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.006 -1.077 . . . . 3.1200000000000001 109.311 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.482 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 56.8 t0 -58.29 -36.22 72.98 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.734 -0.604 . . . . 1.28 109.896 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.2 mt -60.63 -39.35 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.158 -0.964 . . . . 0.48999999999999999 110.152 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.75 -44.85 30.21 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.253 -0.975 . . . . 0.46000000000000002 111.007 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -56.68 -45.27 81.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.316 -1.108 . . . . 2.71 110.401 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.482 ' NH2' ' OD2' ' A' ' 132' ' ' ASP . 42.1 mtt-85 -62.46 -40.76 97.67 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.096 -1.042 . . . . 2.1400000000000001 109.643 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -62.23 -43.21 99.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.703 -0.623 . . . . 1.05 110.057 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.23 -44.5 92.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.204 -0.935 . . . . 0.52000000000000002 110.317 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.1 mtp180 -60.02 -32.63 71.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 2.3500000000000001 110.723 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -74.09 -41.08 62.23 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.254 -0.903 . . . . 1.3899999999999999 110.704 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 98.5 mt -60.63 -37.52 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.42 -0.8 . . . . 0.68000000000000005 110.142 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.498 HD21 ' OD2' ' A' ' 101' ' ' ASP . 66.9 mt -87.06 -7.41 58.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.504 -0.748 . . . . 0.82999999999999996 112.169 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.1 19.4 78.46 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.808 -1.187 . . . . 0.91000000000000003 112.613 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.6 tp -61.33 143.29 55.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.94 -0.741 . . . . 0.94999999999999996 109.63 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -66.44 146.6 54.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 2.4300000000000002 108.966 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.0 mt -103.55 142.24 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.214 -1.032 . . . . 1.1000000000000001 108.214 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.4 mm -75.73 129.93 36.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.04 -1.096 . . . . 1.5800000000000001 108.04 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.27 94.67 9.28 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.914 -1.513 . . . . 1.6200000000000001 106.914 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 54.5 mt -74.19 -23.68 59.25 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.73 0.776 . . . . 0.80000000000000004 110.515 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.5 m -82.88 6.96 16.69 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.882 0.848 . . . . 1.5600000000000001 112.019 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.73 23.08 9.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.627 -0.671 . . . . 0.83999999999999997 112.634 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.7 mt -73.68 138.49 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.32 -0.862 . . . . 0.81999999999999995 109.148 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -118.02 -18.44 9.43 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.778 0.799 . . . . 2.3100000000000001 112.725 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -115.36 140.72 48.87 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.432 -0.951 . . . . 1.54 108.432 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -70.98 120.83 17.12 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.041 -1.037 . . . . 1.3799999999999999 108.483 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.13 175.01 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.568 -0.707 . . . . 0.68999999999999995 109.305 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 mt -87.49 144.43 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.322 -0.861 . . . . 0.53000000000000003 108.935 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 19' ' ' LEU . 35.8 tp -97.66 126.97 43.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.996 -1.065 . . . . 0.64000000000000001 108.24 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.0 131.06 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.268 -1.012 . . . . 0.67000000000000004 108.268 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.04 147.59 11.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.058 -1.027 . . . . 0.78000000000000003 109.087 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.06 -32.18 71.82 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.544 -1.347 . . . . 1.0 109.741 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 50.6 p-10 -172.53 150.82 2.31 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.434 -0.95 . . . . 2.4199999999999999 108.434 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 46.4 mt -118.53 143.07 47.01 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.373 -0.829 . . . . 0.75 109.247 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.0 p -92.19 141.83 25.53 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.112 -0.992 . . . . 0.78000000000000003 108.673 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.57 -40.28 2.15 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 121.871 1.714 . . . . 0.67000000000000004 113.706 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.8 m -60.72 -49.99 75.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.1 -1.04 . . . . 0.69999999999999996 109.704 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.31 -39.91 94.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.504 -0.747 . . . . 1.21 110.168 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 34.5 p -66.87 -38.54 86.51 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.449 0.642 . . . . 0.59999999999999998 110.561 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.39 88.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.632 -0.668 . . . . 0.62 110.427 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -93.23 0.07 56.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.077 -1.015 . . . . 1.1599999999999999 112.694 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.46 148.06 43.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.979 -1.076 . . . . 0.72999999999999998 108.515 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -97.65 119.71 36.71 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.13 -1.434 . . . . 2.2400000000000002 107.13 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 45.5 mt -78.14 -12.34 59.99 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.929 -0.482 . . . . 1.4299999999999999 111.601 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -83.0 -23.75 33.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.974 -1.079 . . . . 2.1499999999999999 111.825 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -101.96 -4.95 25.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.232 -0.917 . . . . 2.04 113.092 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.23 125.95 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.76 -1.2 . . . . 0.55000000000000004 107.76 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.464 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 37.8 tp -90.96 -8.52 49.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.905 . . . . 1.6299999999999999 112.197 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 177.4 169.64 38.76 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 108.978 -1.649 . . . . 0.46999999999999997 108.978 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -127.82 133.86 49.42 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.005 -1.109 . . . . 0.54000000000000004 108.005 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 76.9 mt -132.09 109.62 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 106.133 -1.803 . . . . 0.68999999999999995 106.133 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 205' ' ' THR . 66.5 p -131.26 172.28 12.33 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.917 -1.114 . . . . 0.81999999999999995 110.347 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.402 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 26.9 t0 -101.53 61.7 0.92 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.563 -0.71 . . . . 2.3700000000000001 109.958 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -102.55 139.66 37.85 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.233 -0.917 . . . . 1.1100000000000001 108.809 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.47 0.3 26.72 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.921 -1.133 . . . . 1.6699999999999999 112.857 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 81.01 -14.87 24.7 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.093 -1.239 . . . . 1.54 113.837 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.409 ' HG2' ' NH1' ' A' ' 186' ' ' ARG . 42.9 ttt-85 -76.09 113.15 13.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.022 -1.281 . . . . 4.4800000000000004 108.168 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 73.5 p 49.53 40.23 18.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 2.6299999999999999 111.753 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.8 t -85.13 114.34 22.18 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.041 -1.096 . . . . 1.6899999999999999 108.041 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -62.68 -37.86 88.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.303 -0.873 . . . . 1.0700000000000001 110.888 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 87.0 m -59.68 -40.12 86.75 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.405 -0.918 . . . . 1.5800000000000001 110.586 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.6 t -58.54 -39.73 81.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.231 -0.918 . . . . 1.6000000000000001 110.049 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.9 mm -60.04 -35.84 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.706 . . . . 1.45 110.96 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 65.9 mtp -62.94 -41.2 99.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.02 -1.05 . . . . 1.05 109.951 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.17 -47.2 84.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.997 -0.547 . . . . 0.71999999999999997 110.588 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.495 ' HG2' HH11 ' A' ' 195' ' ' ARG . 29.0 mtt-85 -60.14 -42.16 94.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 3.0499999999999998 110.349 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.7 m -69.47 -41.59 75.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.017 -1.052 . . . . 0.89000000000000001 109.835 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.5 mt -91.0 -8.3 49.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.619 -0.675 . . . . 0.78000000000000003 112.094 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 48.62 14.54 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.739 1.015 . . . . 1.45 113.739 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.4 mt -74.1 149.18 87.14 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.053 -1.03 . . . . 0.67000000000000004 108.267 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.07 136.64 53.49 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 121.146 1.231 . . . . 0.64000000000000001 109.691 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -157.28 159.32 37.46 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 118.133 -1.427 . . . . 0.67000000000000004 110.148 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 77.0 mt -144.65 144.87 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.64 -1.245 . . . . 0.68999999999999995 107.64 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 181' ' ' THR . 6.6 m -124.54 -33.94 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 113.608 0.966 . . . . 0.84999999999999998 113.608 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.76 40.72 1.17 Allowed Glycine 0 N--CA 1.484 1.858 0 C-N-CA 120.308 -0.949 . . . . 0.92000000000000004 111.792 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 181' ' ' THR . 44.3 p -58.21 -22.54 52.33 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.186 -1.185 . . . . 0.94999999999999996 111.279 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.402 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 72.31 -89.82 0.52 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.505 -1.038 . . . . 1.04 110.505 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.9 t -129.43 28.47 5.2 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.604 -0.939 . . . . 1.5700000000000001 112.784 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.12 -37.42 61.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.665 -1.272 . . . . 0.83999999999999997 110.165 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 39.6 p -52.02 -26.25 10.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.98999999999999999 111.256 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.3 p -93.2 3.9 54.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 1.7 111.603 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -126.92 -3.62 6.44 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.924 0.713 . . . . 2.2000000000000002 112.924 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 22.7 t -120.59 149.42 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.682 0.753 . . . . 0.83999999999999997 109.185 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -124.96 156.97 37.2 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.476 -0.935 . . . . 2.2000000000000002 108.476 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 9.8 t-20 -56.48 141.13 43.75 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.83 -1.169 . . . . 2.2799999999999998 110.674 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.6 m-20 80.24 2.51 1.95 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.472 1.286 . . . . 2.3500000000000001 114.472 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.38 145.45 55.69 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.812 -1.18 . . . . 1.97 108.455 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -88.46 116.12 26.46 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.041 -1.466 . . . . 2.6499999999999999 107.041 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.41 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 88.6 mt -127.32 142.05 51.55 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.463 -0.773 . . . . 0.63 109.695 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.2 mt -109.65 128.34 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.99 -1.485 . . . . 0.62 106.99 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.8 tp -102.75 115.93 31.56 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.292 -1.744 . . . . 0.64000000000000001 106.292 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 223' ' ' VAL . 21.6 p-10 -94.38 -22.81 18.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.94 -1.1 . . . . 2.0499999999999998 112.599 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.23 17.85 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 112.859 0.689 . . . . 0.83999999999999997 112.859 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 221' ' ' ASP . 19.3 t -108.92 -59.57 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.122 -0.986 . . . . 1.02 108.959 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.32 11.03 34.04 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.654 0.74 . . . . 2.5099999999999998 111.157 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 60.71 54.67 3.54 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.417 0.627 . . . . 1.54 112.063 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -150.2 149.52 30.32 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.091 0.948 . . . . 1.95 109.942 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.9 t -116.12 141.23 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 109.175 -0.676 . . . . 0.70999999999999996 109.175 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.43 130.61 49.26 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.855 -1.153 . . . . 1.01 108.264 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.5 t -109.81 129.35 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.217 -0.927 . . . . 0.81999999999999995 108.695 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.439 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 10.2 t-20 54.82 50.29 6.2 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 113.701 1.0 . . . . 1.54 113.701 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 38.0 Cg_endo -68.91 151.92 73.69 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.962 2.441 . . . . 0.93999999999999995 110.594 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.429 ' OG1' HG23 ' A' ' 235' ' ' VAL . 65.3 p -76.35 161.45 28.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.241 -0.912 . . . . 1.8 110.333 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -60.95 -38.08 84.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.792 -1.192 . . . . 2.73 110.191 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -60.4 -41.38 93.76 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.458 0.647 . . . . 3.1699999999999999 110.573 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.429 HG23 ' OG1' ' A' ' 232' ' ' THR . 97.7 t -69.82 -40.18 78.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.083 -1.011 . . . . 1.3400000000000001 110.241 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.02 -43.58 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 1.2 110.545 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -57.87 -41.52 82.63 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.181 -0.95 . . . . 2.7000000000000002 110.418 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.35 -42.33 98.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.547 -0.721 . . . . 2.5899999999999999 111.057 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.7 mtp -70.24 -42.53 72.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 1.3799999999999999 110.874 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -57.83 -40.75 80.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.075 -1.016 . . . . 2.8399999999999999 109.593 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.6 -56.66 4.73 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.633 -0.667 . . . . 1.8799999999999999 110.821 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 67.6 t -59.77 -40.95 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 2.3999999999999999 111.32 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.71 -49.64 76.96 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.739 -1.226 . . . . 3.52 110.4 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.01 -33.87 76.71 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.604 -0.838 . . . . 1.8799999999999999 110.7 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.27 -30.32 69.37 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.25 -1.38 . . . . 3.0099999999999998 109.604 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.83 -48.9 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.358 -0.937 . . . . 2.4500000000000002 109.704 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.4 85.82 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.691 0.757 . . . . 2.75 110.123 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.9 t -69.23 -31.06 69.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.704 -0.623 . . . . 3.1600000000000001 110.4 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.449 ' OE2' ' OE1' ' A' ' 252' ' ' GLU . 49.3 tp10 -59.92 -39.21 84.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -0.82 . . . . 3.5699999999999998 110.64 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -62.18 -39.82 93.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.095 -1.003 . . . . 4.2999999999999998 110.413 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.91 2.43 17.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.339 -0.851 . . . . 4.4500000000000002 112.858 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.449 ' OE1' ' OE2' ' A' ' 249' ' ' GLU . 70.4 tt0 -70.17 -12.67 61.76 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 112.703 0.631 . . . . 5.9699999999999998 112.703 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 253' ' ' LEU . 1.8 pt? -63.67 -27.06 68.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.259 -1.525 . . . . 6.1799999999999997 111.512 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -74.44 -8.05 55.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.383 -0.823 . . . . 6.6600000000000001 112.52 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -81.76 -1.95 49.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.535 -0.728 . . . . 8.1999999999999993 112.49 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 39.8 mt -80.22 -14.04 58.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.858 -1.151 . . . . 8.0700000000000003 111.995 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -92.2 -14.69 28.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 9.4499999999999993 112.758 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -105.97 56.39 0.67 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.535 -0.728 . . . . 10.119999999999999 110.063 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 117.948 -1.025 . . . . 11.49 109.422 179.823 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.793 -0.447 . . . . 3.0699999999999998 109.793 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.2 mt -97.78 107.6 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 106.119 -1.808 . . . . 1.0700000000000001 106.119 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -105.9 120.97 43.1 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 107.665 -1.235 . . . . 1.24 107.665 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.4 -159.03 18.39 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.715 -1.754 . . . . 1.01 108.715 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 5' ' ' ILE . 83.5 mt -94.84 1.11 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -1.189 . . . . 1.1100000000000001 112.409 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tp 49.02 98.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.98999999999999999 112.012 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.98 -45.71 12.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.728 -1.233 . . . . 0.84999999999999998 111.577 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -145.89 145.21 24.24 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.796 -1.187 . . . . 1.3799999999999999 107.796 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.37 143.84 22.43 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.868 2.378 . . . . 0.93999999999999995 112.276 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.886 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.95 174.19 25.46 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 108.908 -1.677 . . . . 0.81000000000000005 108.908 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.2 mt -131.31 133.09 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.316 -1.108 . . . . 0.82999999999999996 108.054 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.62 155.2 48.53 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.503 -0.748 . . . . 0.53000000000000003 109.629 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.5 m-85 -125.56 140.36 52.81 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.732 -0.84 . . . . 0.77000000000000002 108.732 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.42 164.41 30.43 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 118.813 -1.66 . . . . 0.51000000000000001 109.626 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -75.05 159.1 32.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.579 -0.953 . . . . 1.8999999999999999 108.773 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -89.06 126.23 35.35 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.975 -1.12 . . . . 0.66000000000000003 107.975 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.9 tp -103.85 105.91 16.26 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.022 -2.214 . . . . 0.82999999999999996 105.022 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.5 tp -90.32 133.63 34.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 0.85999999999999999 108.188 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.6 mt -99.93 120.03 39.16 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.925 -1.509 . . . . 0.92000000000000004 106.925 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -109.86 142.33 41.32 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.717 -0.846 . . . . 2.0299999999999998 108.717 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -121.57 141.74 50.79 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.907 -1.12 . . . . 2.6600000000000001 109.225 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.25 137.28 34.9 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.87 -1.144 . . . . 2.3199999999999998 108.018 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -62.38 149.19 43.07 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.252 -0.648 . . . . 2.1099999999999999 109.252 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -93.84 131.91 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.359 -0.978 . . . . 0.72999999999999998 108.359 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t -106.04 130.35 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.297 -1.001 . . . . 0.87 108.297 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.3 mt -96.24 138.22 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.846 -0.798 . . . . 0.81000000000000005 108.846 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -90.1 122.86 33.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.206 -1.035 . . . . 1.3400000000000001 108.206 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.1 mmt-85 -95.35 14.47 22.34 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.283 -0.886 . . . . 2.8900000000000001 112.478 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -75.3 140.47 43.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.917 -1.114 . . . . 2.0899999999999999 109.198 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.55 136.35 32.98 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.875 -1.157 . . . . 2.1899999999999999 107.875 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 pt -94.93 168.84 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.885 . . . . 0.75 110.482 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.4 p -97.77 165.82 11.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.675 -0.641 . . . . 0.91000000000000003 109.845 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.03 -27.24 61.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.874 -1.141 . . . . 0.93000000000000005 111.579 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -68.17 -34.62 76.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.939 -1.1 . . . . 2.2799999999999998 110.453 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -90.13 -9.48 48.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.978 -1.076 . . . . 1.45 112.492 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.3 t -58.55 -42.14 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.856 -1.152 . . . . 0.81000000000000005 110.622 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.17 -38.25 79.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 1.54 110.926 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -63.17 -45.0 93.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.909 . . . . 2.3599999999999999 111.268 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.52 -37.05 82.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.547 -1.346 . . . . 1.3100000000000001 110.991 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.6 t -60.8 -40.17 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.074 -1.016 . . . . 0.81999999999999995 110.193 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.64 -39.63 92.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.948 -1.095 . . . . 1.5 110.096 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.71 -40.23 91.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.885 . . . . 2.23 109.893 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -74.03 -58.37 3.34 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.295 -0.878 . . . . 0.84999999999999998 109.703 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.0 -48.38 75.99 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.05 -1.06 . . . . 0.91000000000000003 110.204 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.8 t -70.65 -44.55 66.89 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.293 -0.963 . . . . 0.90000000000000002 110.153 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.09 -46.17 85.7 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.55 -1.31 . . . . 0.68999999999999995 110.035 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -57.91 -30.25 65.76 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.698 -0.883 . . . . 2.8799999999999999 109.595 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.52 -46.75 80.4 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.676 0.75 . . . . 0.84999999999999998 109.629 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.565 ' NZ ' ' NE2' ' A' ' 53' ' ' GLN . 25.4 ttpp -79.89 -40.65 27.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.467 -0.771 . . . . 2.3500000000000001 110.293 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.85 93.13 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.65000000000000002 110.056 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.8 m -60.13 -37.6 80.54 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.017 0.913 . . . . 1.45 109.334 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.37 -46.66 69.46 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.776 -0.647 . . . . 0.63 110.179 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.565 ' NE2' ' NZ ' ' A' ' 49' ' ' LYS . 45.5 mt-30 -61.4 -48.56 80.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.855 -1.153 . . . . 1.3400000000000001 110.13 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.09 -41.36 96.51 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.845 0.831 . . . . 1.5600000000000001 109.596 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -60.56 -41.22 94.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.468 0.652 . . . . 1.1899999999999999 109.855 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.1 m -64.35 -41.89 96.51 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.387 -0.821 . . . . 0.71999999999999997 110.429 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.02 -32.81 55.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.191 -0.943 . . . . 0.62 110.573 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -53.18 -46.56 69.02 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.329 -0.857 . . . . 1.05 110.733 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -68.74 -38.92 80.48 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.202 -0.937 . . . . 0.64000000000000001 109.48 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -62.9 -40.31 97.15 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.53 -1.268 . . . . 1.73 108.952 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.62 72.82 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.714 -0.794 . . . . 0.56000000000000005 109.234 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.09 -33.23 26.98 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.155 -1.178 . . . . 0.68999999999999995 110.155 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -82.1 -24.67 35.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.107 -1.231 . . . . 1.48 111.138 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.1 m -86.29 -46.74 10.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.506 -0.746 . . . . 0.97999999999999998 110.74 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -105.71 -19.04 13.88 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.373 -0.829 . . . . 1.1599999999999999 112.657 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.82 152.73 9.09 Favored Glycine 0 N--CA 1.504 3.225 0 O-C-N 121.247 -0.908 . . . . 0.84999999999999998 111.816 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -52.58 -21.77 4.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.48 -1.012 . . . . 3.8599999999999999 112.66 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.31 -32.63 71.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.193 -0.942 . . . . 2.3500000000000001 111.456 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -82.79 -13.73 55.72 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.655 -1.278 . . . . 1.6699999999999999 112.579 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.41 -32.49 71.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.046 -1.034 . . . . 1.45 111.209 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.56 96.16 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.025 -1.047 . . . . 0.60999999999999999 111.322 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.7 mt -65.45 -42.52 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.652 -1.28 . . . . 0.65000000000000002 110.638 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.6 -28.74 66.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.113 -0.992 . . . . 0.66000000000000003 110.554 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.35 -37.59 81.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.259 -0.901 . . . . 1.1899999999999999 110.403 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.83 -41.09 74.37 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.26 -0.971 . . . . 0.53000000000000003 110.899 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -58.63 -43.02 89.59 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.967 -1.313 . . . . 1.27 110.223 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -60.59 -39.97 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.19 -0.944 . . . . 0.54000000000000004 109.934 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.1 ttp -59.61 -39.56 84.61 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.055 -0.658 . . . . 1.74 110.585 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.33 -49.41 77.93 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.035 -1.041 . . . . 0.55000000000000004 110.837 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.0 -45.1 93.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 0.46999999999999997 110.423 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -85.93 14.13 6.53 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.01 -1.056 . . . . 1.4199999999999999 112.718 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -65.58 127.51 32.17 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.759 -1.213 . . . . 1.27 108.503 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -68.21 -17.18 64.25 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.235 1.017 . . . . 1.3500000000000001 110.704 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -75.24 -52.83 9.94 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.799 0.809 . . . . 2.2200000000000002 110.544 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.08 -37.85 84.15 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.794 -0.763 . . . . 0.62 110.225 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -59.21 -49.33 78.26 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.487 -0.758 . . . . 1.29 110.716 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -60.75 -38.7 86.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.422 -0.798 . . . . 1.52 110.781 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.85 -48.55 73.9 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.479 -0.888 . . . . 1.3 110.142 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.06 -45.57 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.411 -0.916 . . . . 0.60999999999999999 109.661 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.8 mt -60.7 -43.65 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.144 0.497 . . . . 0.78000000000000003 110.453 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.43 95.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.964 -1.085 . . . . 0.81999999999999995 111.058 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.65 -44.06 97.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.011 . . . . 0.80000000000000004 110.151 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.31 -48.94 86.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.276 -0.89 . . . . 0.77000000000000002 110.292 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -77.83 -33.41 52.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.373 -0.829 . . . . 2.1200000000000001 111.44 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -82.74 -47.48 11.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.663 -1.273 . . . . 1.51 112.386 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -102.55 10.72 38.63 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.362 -0.836 . . . . 1.98 112.456 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.8 m80 51.49 49.18 21.49 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.988 -1.07 . . . . 1.3200000000000001 111.303 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 59.0 mtt -104.57 150.79 24.33 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.387 -0.821 . . . . 1.3799999999999999 109.701 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.4 p -74.11 165.66 24.76 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.405 -0.809 . . . . 0.67000000000000004 109.988 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.81 -40.6 80.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.647 -0.658 . . . . 0.52000000000000002 110.711 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.536 ' OD1' HD22 ' A' ' 138' ' ' LEU . 59.8 t0 -68.1 -42.93 79.56 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.52 -0.738 . . . . 2.25 110.07 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -52.09 28.2 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.111 -0.635 . . . . 0.64000000000000001 111.225 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.16 -44.24 95.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.874 -1.141 . . . . 0.56000000000000005 110.905 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.56 88.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.724 -0.61 . . . . 0.46000000000000002 111.078 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -59.75 -37.26 78.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.614 -1.304 . . . . 1.3200000000000001 110.562 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -59.28 -48.28 82.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.922 -1.111 . . . . 1.3 110.636 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.4 t -60.89 -47.04 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.788 -1.195 . . . . 0.60999999999999999 110.875 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.17 -34.06 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.605 0.717 . . . . 0.65000000000000002 109.833 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -57.55 -42.56 83.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.761 . . . . 2.1099999999999999 110.803 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.09 -32.34 17.62 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.521 -1.323 . . . . 0.82999999999999996 112.735 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -62.07 -42.63 99.4 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.167 -1.784 . . . . 1.28 109.828 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.7 -53.31 16.16 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.749 0.785 . . . . 0.89000000000000001 110.771 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 64.7 m -60.95 -36.04 78.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.702 -0.624 . . . . 1.8700000000000001 110.659 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.55 -42.15 99.36 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.379 -0.826 . . . . 1.05 110.184 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.2 mt -65.3 -29.66 70.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.793 -1.192 . . . . 1.02 110.967 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.98 -20.01 66.27 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.322 -0.861 . . . . 2.04 110.76 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.74 -12.54 61.05 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.779 0.8 . . . . 1.73 110.82 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 24.7 mt -90.6 139.58 30.57 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.964 -1.124 . . . . 1.3700000000000001 107.964 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -101.83 43.71 1.05 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.46 -0.775 . . . . 2.8799999999999999 111.618 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -115.87 142.37 46.86 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.296 -0.878 . . . . 1.5800000000000001 109.069 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -56.81 -41.53 77.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 3.04 110.101 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -71.9 -55.13 8.06 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.911 -1.118 . . . . 0.90000000000000002 110.577 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.1 mt -60.13 -40.01 88.26 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.141 -0.974 . . . . 1.0600000000000001 110.63 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -63.09 -48.71 77.45 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.231 -0.918 . . . . 2.1800000000000002 109.812 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -60.63 -31.45 70.65 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.896 -0.722 . . . . 2.1499999999999999 109.922 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.567 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.5 ttt-85 -61.2 -30.5 70.46 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.275 1.036 . . . . 2.3300000000000001 108.769 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.08 -49.8 75.86 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.839 0.828 . . . . 0.81999999999999995 110.097 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.24 -44.29 79.81 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.737 0.779 . . . . 0.84999999999999998 110.281 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.6 -35.71 81.39 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.293 -0.88 . . . . 1.3899999999999999 110.803 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 126' ' ' ARG . 49.8 t -69.14 -38.74 78.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 120.975 -1.078 . . . . 0.56000000000000005 110.823 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.519 ' HG2' HH11 ' A' ' 131' ' ' ARG . 1.8 ttt-85 -55.31 -39.97 70.55 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.494 -1.282 . . . . 3.1200000000000001 109.53 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -61.32 -36.99 81.65 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.577 0.703 . . . . 1.28 110.088 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.51 -39.91 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.915 -1.116 . . . . 0.48999999999999999 109.941 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.03 -44.07 98.65 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.567 -1.301 . . . . 0.46000000000000002 109.899 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.36 -40.12 85.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.403 -1.057 . . . . 2.71 110.744 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 136' ' ' ARG . 53.3 mtt-85 -59.46 -43.11 93.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.118 -0.989 . . . . 2.1400000000000001 110.328 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.6 tp -65.4 -45.42 84.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.433 -0.792 . . . . 1.05 110.154 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.536 HD22 ' OD1' ' A' ' 101' ' ' ASP . 87.8 mt -63.23 -42.91 99.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.317 -0.864 . . . . 0.52000000000000002 110.419 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -59.68 -34.84 73.38 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.657 -0.652 . . . . 2.3500000000000001 110.688 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -74.97 -42.38 57.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 1.3899999999999999 110.832 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.99 -38.81 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.461 -0.774 . . . . 0.68000000000000005 110.337 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 43.8 mt -87.15 -6.09 58.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.998 -1.064 . . . . 0.82999999999999996 112.178 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.6 23.87 77.49 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 119.445 -1.36 . . . . 0.91000000000000003 113.057 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.83 150.35 33.07 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.864 -0.786 . . . . 0.94999999999999996 109.901 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -67.79 150.46 48.6 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.545 -0.862 . . . . 2.4300000000000002 110.043 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 71.5 mt -105.32 141.83 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.423 -0.798 . . . . 1.1000000000000001 109.083 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 17.8 mm -76.21 122.03 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 107.75 -1.204 . . . . 1.5800000000000001 107.75 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -92.98 94.6 8.99 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.481 -1.674 . . . . 1.6200000000000001 106.481 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.38 -28.17 59.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.594 -0.692 . . . . 0.80000000000000004 111.18 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 t -81.21 3.32 24.18 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.868 0.842 . . . . 1.5600000000000001 111.979 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.08 14.62 21.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.443 -0.786 . . . . 0.83999999999999997 112.755 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.4 mt -72.89 136.69 24.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.069 -1.02 . . . . 0.81999999999999995 108.715 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -117.27 -15.31 10.42 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.148 0.975 . . . . 2.3100000000000001 112.297 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -115.41 140.34 49.22 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.747 0.784 . . . . 1.54 109.092 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -70.62 119.53 14.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.461 -0.774 . . . . 1.3799999999999999 109.029 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.06 174.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.281 -0.887 . . . . 0.68999999999999995 109.174 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mt -89.25 145.55 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.53000000000000003 108.843 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.6 tp -98.1 121.55 40.16 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.062 -1.024 . . . . 0.64000000000000001 108.37 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.1 130.21 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 108.146 -1.057 . . . . 0.67000000000000004 108.146 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.98 157.92 27.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.808 -1.182 . . . . 0.78000000000000003 108.654 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.84 -36.88 82.49 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.386 -1.446 . . . . 1.0 109.829 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -172.96 149.7 1.92 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.404 -0.591 . . . . 2.4199999999999999 109.404 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.8 mt -117.64 141.24 48.6 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.405 -0.809 . . . . 0.75 109.009 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.6 p -94.03 151.23 39.54 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.741 -1.224 . . . . 0.78000000000000003 108.88 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -41.57 -46.22 6.17 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.251 1.968 . . . . 0.67000000000000004 113.838 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.0 m -58.88 -49.91 76.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.761 -1.212 . . . . 0.69999999999999996 110.45 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.26 -38.71 87.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.915 0.864 . . . . 1.21 110.225 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.2 p -70.0 -39.9 75.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.59999999999999998 110.416 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.84 74.32 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.712 -0.618 . . . . 0.62 110.656 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -93.09 -3.56 53.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 1.1599999999999999 112.767 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.0 tp -64.62 150.99 45.95 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.291 -0.633 . . . . 0.72999999999999998 109.291 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -93.95 112.43 24.27 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.636 -1.616 . . . . 2.2400000000000002 106.636 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.0 mt -70.3 -22.23 62.86 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.769 -0.582 . . . . 1.4299999999999999 111.704 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -83.35 -15.83 48.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.479 -0.763 . . . . 2.1499999999999999 112.919 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -102.79 -4.04 25.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.206 -0.934 . . . . 2.04 113.446 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 178' ' ' GLY . 64.3 t -111.14 129.93 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.197 -1.038 . . . . 0.55000000000000004 108.197 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.5 tp -83.99 -10.04 58.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.327 -0.858 . . . . 1.6299999999999999 112.263 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.508 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.5 166.98 35.59 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.796 -1.721 . . . . 0.46999999999999997 108.796 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -126.37 127.49 45.57 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.51 -1.293 . . . . 0.54000000000000004 107.51 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 61.0 mt -125.34 127.91 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 106.702 -1.592 . . . . 0.68999999999999995 106.702 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 203' ' ' VAL . 30.2 p -138.57 174.61 10.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.005 -1.06 . . . . 0.81999999999999995 109.704 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 52.8 t0 -106.32 34.71 3.24 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.375 0.607 . . . . 2.3700000000000001 110.712 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -105.31 96.24 6.38 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 107.262 -1.384 . . . . 1.1100000000000001 107.262 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -84.95 30.35 3.94 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 121.004 -1.06 . . . . 1.6699999999999999 112.793 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.93 131.97 10.99 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.892 -1.683 . . . . 1.54 108.892 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -57.26 -31.96 66.11 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.467 -1.02 . . . . 4.4800000000000004 109.78 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 60.2 p -97.29 28.75 3.5 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.565 0.58 . . . . 2.6299999999999999 112.565 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.4 t -74.75 131.57 40.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.893 -1.13 . . . . 1.6899999999999999 108.834 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -58.45 -38.08 76.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 1.0700000000000001 111.208 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.447 ' H ' HG23 ' A' ' 190' ' ' THR . 3.8 p -56.66 -43.28 80.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.31 -1.494 . . . . 1.5800000000000001 110.199 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.1 p -61.97 -36.17 80.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.3 -0.875 . . . . 1.6000000000000001 110.316 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.3 mt -61.46 -36.79 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.142 -0.974 . . . . 1.45 110.759 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 85.3 mtp -62.08 -46.94 86.89 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.653 1.216 . . . . 1.05 109.48 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.5 -51.77 67.26 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.016 -0.993 . . . . 0.71999999999999997 110.748 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -63.15 -44.88 94.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.277 -0.89 . . . . 3.0499999999999998 110.759 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.4 m -66.9 -38.13 85.68 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.768 -1.207 . . . . 0.89000000000000001 110.288 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 25.3 mt -91.45 -0.42 57.62 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.723 0.638 . . . . 0.78000000000000003 112.723 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 56.23 5.52 0.19 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 114.444 1.275 . . . . 1.45 114.444 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 22.6 mt -72.26 143.05 85.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.919 -1.113 . . . . 0.67000000000000004 108.396 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.56 137.07 75.39 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.298 1.332 . . . . 0.64000000000000001 110.292 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.29 169.39 20.72 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 117.762 -1.575 . . . . 0.67000000000000004 109.803 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.446 HD12 HD11 ' A' ' 220' ' ' LEU . 58.2 mt -145.72 156.85 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.808 -1.182 . . . . 0.68999999999999995 107.808 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 181' ' ' THR . 25.5 m -140.47 -29.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.268 -0.895 . . . . 0.84999999999999998 112.893 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.62 38.44 3.11 Favored Glycine 0 N--CA 1.486 2.025 0 O-C-N 121.293 -0.879 . . . . 0.92000000000000004 112.058 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.3 p -53.25 -26.55 18.46 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.506 -0.997 . . . . 0.94999999999999996 111.622 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 88.56 -88.98 1.56 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.82 -0.912 . . . . 1.04 110.82 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 39.7 t -128.45 30.43 5.16 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.189 -1.183 . . . . 1.5700000000000001 112.285 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 44.7 t -62.01 -38.45 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.435 -1.416 . . . . 0.83999999999999997 109.991 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.8 p -53.19 -21.37 5.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 0.98999999999999999 111.308 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.3 t -95.02 0.73 54.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.222 -0.924 . . . . 1.7 111.581 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -126.31 -6.36 6.51 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 113.345 0.869 . . . . 2.2000000000000002 113.345 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 10.2 t -117.31 145.59 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 122.014 0.911 . . . . 0.83999999999999997 109.434 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -118.94 155.07 31.97 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.026 -1.102 . . . . 2.2000000000000002 108.026 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 35.5 p-10 -54.58 140.69 34.12 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.844 -1.16 . . . . 2.2799999999999998 110.724 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 m-20 78.81 5.89 2.34 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.484 1.29 . . . . 2.3500000000000001 114.484 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.0 149.23 47.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.746 -1.221 . . . . 1.97 108.388 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -88.86 117.63 27.99 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.29 -1.374 . . . . 2.6499999999999999 107.29 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 16' ' ' ALA . 84.1 mt -128.58 149.62 50.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.763 0.792 . . . . 0.63 109.498 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.3 mt -115.12 129.86 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.77 -1.567 . . . . 0.62 106.77 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 202' ' ' ILE . 64.4 tp -101.02 117.06 34.28 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.41 -2.07 . . . . 0.64000000000000001 105.41 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.577 ' O ' ' N ' ' A' ' 223' ' ' VAL . 38.8 t0 -90.63 -24.36 20.53 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.078 -1.049 . . . . 2.0499999999999998 112.574 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.886 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.13 17.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 112.735 0.643 . . . . 0.83999999999999997 112.735 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' A' ' 221' ' ' ASP . 26.0 t -114.42 -64.59 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.959 0.885 . . . . 1.02 109.135 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -89.73 9.41 27.29 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.139 0.971 . . . . 2.5099999999999998 110.582 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 52.2 t30 60.34 49.81 6.68 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.67 0.748 . . . . 1.54 111.589 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -147.53 153.03 38.97 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.193 0.996 . . . . 1.95 109.669 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 76.5 t -118.43 140.03 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.507 -0.923 . . . . 0.70999999999999996 108.507 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.25 132.79 42.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.86 -1.15 . . . . 1.01 107.984 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 44.1 t -109.8 129.68 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 108.474 -0.936 . . . . 0.81999999999999995 108.474 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.408 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 58.5 t30 47.28 54.57 15.64 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 113.577 0.955 . . . . 1.54 113.577 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 40.5 Cg_endo -67.88 151.89 77.78 Favored 'Trans proline' 0 C--N 1.297 -2.177 0 C-N-CA 122.462 2.108 . . . . 0.93999999999999995 110.033 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.5 m -74.17 155.32 38.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.823 -0.806 . . . . 1.8 108.823 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -57.58 -39.52 76.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.151 -0.968 . . . . 2.73 110.468 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.45 -38.28 89.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.349 -0.845 . . . . 3.1699999999999999 110.208 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.44 -37.53 75.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.497 -0.752 . . . . 1.3400000000000001 110.523 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 90.0 mt -60.26 -44.39 95.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.783 -0.767 . . . . 1.2 110.498 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -58.9 -39.4 81.35 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.482 -0.761 . . . . 2.7000000000000002 110.034 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -60.53 -40.45 91.55 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.46 -0.775 . . . . 2.5899999999999999 110.239 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 83.8 mtp -74.74 -41.51 60.0 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.016 -1.053 . . . . 1.3799999999999999 110.537 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -58.27 -37.85 75.8 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.513 -0.875 . . . . 2.8399999999999999 109.689 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.577 ' C ' HE21 ' A' ' 245' ' ' GLN . . . -72.22 -56.6 5.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 1.8799999999999999 110.623 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.55 -43.2 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.057 -1.027 . . . . 2.3999999999999999 110.99 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -51.82 64.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.649 -1.282 . . . . 3.52 110.756 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.88 -32.23 73.63 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.56 -0.713 . . . . 1.8799999999999999 110.878 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.577 HE21 ' C ' ' A' ' 241' ' ' ALA . 37.5 mt-30 -61.54 -30.15 70.46 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.525 -1.27 . . . . 3.0099999999999998 109.471 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.77 -50.02 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 118.463 -1.295 . . . . 2.4500000000000002 109.129 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.15 90.03 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.813 -0.755 . . . . 2.75 110.2 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 18.1 t -65.56 -35.75 81.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.687 -0.633 . . . . 3.1600000000000001 110.835 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -61.12 -40.7 94.77 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.721 -1.237 . . . . 3.5699999999999998 110.132 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -67.51 -37.42 82.77 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.158 0.98 . . . . 4.2999999999999998 109.849 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.25 -6.96 38.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.624 -0.673 . . . . 4.4500000000000002 112.44 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -61.53 -30.45 70.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 5.9699999999999998 111.018 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 31.3 tp -60.41 -38.75 85.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.118 -0.989 . . . . 6.1799999999999997 110.264 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -71.34 -19.77 62.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.469 -0.769 . . . . 6.6600000000000001 111.872 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -86.5 9.1 19.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.414 -0.804 . . . . 8.1999999999999993 112.324 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.29 -20.07 57.68 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.325 -0.859 . . . . 8.0700000000000003 111.371 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -88.29 9.8 21.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.245 -0.91 . . . . 9.4499999999999993 112.196 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -97.26 24.45 6.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.071 -1.018 . . . . 10.119999999999999 112.283 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 118.0 -1.0 . . . . 11.49 109.9 -179.513 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.883 -0.414 . . . . 3.0699999999999998 109.883 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.3 mt -98.57 114.72 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 106.737 -1.579 . . . . 1.0700000000000001 106.737 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.5 m -105.24 122.0 45.02 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.629 -1.249 . . . . 1.24 107.629 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.41 -157.4 13.37 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.643 -1.783 . . . . 1.01 108.643 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 5' ' ' ILE . 85.1 mt -92.69 -1.46 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.327 -1.102 . . . . 1.1100000000000001 112.552 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 tp 49.83 102.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.98999999999999999 112.227 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.14 -44.44 11.5 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.138 -0.976 . . . . 0.84999999999999998 111.589 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 m -144.32 143.81 23.43 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 107.971 -1.122 . . . . 1.3799999999999999 107.971 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.78 143.01 23.21 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.996 2.464 . . . . 0.93999999999999995 112.344 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.942 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.67 168.09 16.28 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 109.236 -1.546 . . . . 0.81000000000000005 109.236 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.8 mt -124.35 137.51 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.034 -1.274 . . . . 0.82999999999999996 107.845 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.17 148.36 43.08 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.323 -0.861 . . . . 0.53000000000000003 109.081 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.3 m-85 -118.0 139.87 50.56 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 108.378 -0.971 . . . . 0.77000000000000002 108.378 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.2 167.77 35.45 Favored Glycine 0 N--CA 1.499 2.862 0 C-N-CA 118.806 -1.664 . . . . 0.51000000000000001 110.05 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HZ3' HG12 ' A' ' 156' ' ' VAL . 28.1 mtmm -78.84 159.83 27.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -1.126 . . . . 1.8999999999999999 109.494 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.93 126.69 34.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.705 -1.247 . . . . 0.66000000000000003 107.994 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.8 tp -103.53 105.25 15.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.569 -2.011 . . . . 0.82999999999999996 105.569 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.1 tp -92.14 134.47 34.82 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.866 -1.161 . . . . 0.85999999999999999 107.866 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.1 mt -102.21 116.45 32.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.081 -1.452 . . . . 0.92000000000000004 107.081 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -109.46 131.54 54.97 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.537 -1.282 . . . . 2.0299999999999998 107.537 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -126.89 152.64 46.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.381 -0.824 . . . . 2.6600000000000001 109.664 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -83.47 134.41 34.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.131 -1.063 . . . . 2.3199999999999998 108.131 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.87 148.84 50.62 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.752 -0.833 . . . . 2.1099999999999999 108.752 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.69 132.28 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.306 -0.998 . . . . 0.72999999999999998 108.306 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.6 t -108.76 129.94 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.857 -1.164 . . . . 0.87 107.857 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.3 133.4 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.391 -0.966 . . . . 0.81000000000000005 108.391 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -93.24 128.97 39.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.096 -1.002 . . . . 1.3400000000000001 108.325 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -97.31 18.95 14.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.277 -0.889 . . . . 2.8900000000000001 112.004 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -71.19 149.01 46.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 2.0899999999999999 109.783 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -92.37 138.05 31.85 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.413 -0.958 . . . . 2.1899999999999999 108.413 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 pt -97.44 168.41 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.469 -0.77 . . . . 0.75 109.932 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.4 p -97.71 167.32 11.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.688 -0.632 . . . . 0.91000000000000003 109.939 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.77 -24.72 58.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.005 -1.059 . . . . 0.93000000000000005 111.858 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -68.72 -37.97 79.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 2.2799999999999998 110.905 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -84.98 -7.26 59.22 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.72 -1.237 . . . . 1.45 112.354 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -58.59 -45.01 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.114 -0.991 . . . . 0.81000000000000005 110.137 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -57.95 -39.78 78.91 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.967 -1.083 . . . . 1.54 110.588 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -63.08 -45.42 92.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.162 -0.961 . . . . 2.3599999999999999 111.037 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -59.88 -40.33 88.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.928 -1.108 . . . . 1.3100000000000001 110.777 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.1 t -59.93 -41.24 85.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.22 -0.925 . . . . 0.81999999999999995 110.689 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -60.1 -47.23 86.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.917 -1.114 . . . . 1.5 110.078 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -61.36 -40.9 96.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.774 -0.771 . . . . 2.23 110.247 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -75.29 -56.12 5.03 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.572 -0.705 . . . . 0.84999999999999998 110.307 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 tp -58.01 -45.62 86.57 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.548 -0.861 . . . . 0.91000000000000003 110.375 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 9.2 t -66.36 -37.08 84.5 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.159 -0.963 . . . . 0.90000000000000002 109.749 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.66 -41.77 93.9 Favored Glycine 0 N--CA 1.483 1.819 0 C-N-CA 119.582 -1.294 . . . . 0.68999999999999995 109.937 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 46.0 ttt-85 -59.81 -29.77 68.47 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.172 -1.193 . . . . 2.8799999999999999 109.924 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -62.35 -49.16 76.67 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.607 0.718 . . . . 0.84999999999999998 110.493 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -38.79 23.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.954 -1.092 . . . . 2.3500000000000001 110.684 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.38 93.31 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.105 -0.997 . . . . 0.65000000000000002 110.074 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.7 p -63.55 -40.8 97.95 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.046 -1.034 . . . . 1.45 109.439 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.59 -48.5 66.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.537 -0.465 . . . . 0.63 110.477 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.77 -49.17 76.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.925 -1.109 . . . . 1.3400000000000001 110.724 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.15 -39.13 88.94 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.858 -1.151 . . . . 1.5600000000000001 109.971 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -59.84 -41.0 90.44 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.216 -0.594 . . . . 1.1899999999999999 110.319 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.509 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 18.7 m -68.49 -45.12 73.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.142 -0.974 . . . . 0.71999999999999997 110.246 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.8 mt -58.34 -33.95 48.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.338 -0.851 . . . . 0.62 110.815 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -53.07 -42.82 66.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.178 -0.952 . . . . 1.05 110.844 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.58 -36.34 76.17 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.021 -1.049 . . . . 0.64000000000000001 110.051 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' NZ ' HG22 ' A' ' 56' ' ' THR . 62.4 mttp -62.67 -39.62 94.5 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.75 -1.18 . . . . 1.73 109.447 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.13 -33.97 77.28 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.75 -0.78 . . . . 0.56000000000000005 109.983 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.15 -36.72 17.18 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.878 -1.153 . . . . 0.68999999999999995 111.132 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -81.65 -25.41 35.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.06 -1.259 . . . . 1.48 111.189 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.8 m -86.48 -48.33 8.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.557 -0.714 . . . . 0.97999999999999998 111.042 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -107.94 -9.33 15.71 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.031 1.123 . . . . 1.1599999999999999 114.031 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.71 166.45 23.45 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.423 -0.894 . . . . 0.84999999999999998 112.749 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.1 -28.15 50.39 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.702 -0.881 . . . . 3.8599999999999999 112.409 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -54.44 -40.19 68.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.94 -1.1 . . . . 2.3500000000000001 110.73 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -85.24 -25.99 26.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.902 -1.124 . . . . 1.6699999999999999 111.926 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.37 -39.9 84.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.469 -0.769 . . . . 1.45 110.631 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.64 90.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.852 . . . . 0.60999999999999999 110.89 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.94 -45.68 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.009 -1.057 . . . . 0.65000000000000002 110.315 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -71.31 -31.0 66.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.66000000000000003 110.441 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.31 -40.12 89.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.012 -1.055 . . . . 1.1899999999999999 109.68 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.7 -38.85 93.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.208 -1.157 . . . . 0.53000000000000003 110.208 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -58.28 -42.07 85.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.227 -1.161 . . . . 1.27 110.489 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.37 -39.34 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.54000000000000004 110.195 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.3 ttp -59.04 -39.36 81.77 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.178 -0.951 . . . . 1.74 110.491 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.39 -51.39 70.03 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.195 -1.002 . . . . 0.55000000000000004 110.796 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.76 -38.15 90.03 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.376 -0.827 . . . . 0.46999999999999997 109.994 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -84.67 4.72 31.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.287 0.847 . . . . 1.4199999999999999 113.287 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -66.75 123.48 20.24 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.576 -1.328 . . . . 1.27 108.169 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -65.71 -20.19 66.19 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.778 0.799 . . . . 1.3500000000000001 110.811 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -75.24 -49.46 19.26 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.426 -0.909 . . . . 2.2200000000000002 110.737 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.2 -40.04 95.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.056 -1.027 . . . . 0.62 110.629 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -60.45 -48.22 82.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.002 -1.061 . . . . 1.29 110.602 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.33 -39.97 92.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.385 -0.822 . . . . 1.52 110.771 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -63.73 -46.5 85.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.022 -1.071 . . . . 1.3 110.256 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.5 mt -58.36 -43.66 86.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.23 -0.919 . . . . 0.60999999999999999 110.067 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.485 HG22 ' NZ ' ' A' ' 94' ' ' LYS . 66.6 mt -63.24 -44.07 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.467 -0.771 . . . . 0.78000000000000003 110.61 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.53 -41.28 97.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.81999999999999995 111.146 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.11 -44.85 96.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.054 -1.028 . . . . 0.80000000000000004 110.736 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.02 -45.1 99.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.16 -0.963 . . . . 0.77000000000000002 110.305 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.485 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 22.7 mtmm -83.2 -37.57 23.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 2.1200000000000001 111.665 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -79.16 -45.33 20.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.821 -1.174 . . . . 1.51 111.453 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -101.55 8.02 42.07 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.187 -0.945 . . . . 1.98 112.272 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 51.85 49.77 20.04 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.329 -0.857 . . . . 1.3200000000000001 112.097 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.8 mtp -106.78 156.8 18.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.264 -0.897 . . . . 1.3799999999999999 108.838 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.8 p -72.71 161.18 31.08 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.474 -0.766 . . . . 0.67000000000000004 110.361 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.62 93.65 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.459 -0.776 . . . . 0.52000000000000002 110.531 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.46 ' OD1' HG21 ' A' ' 141' ' ' ILE . 97.3 m-20 -68.64 -39.46 80.71 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.069 -1.019 . . . . 2.25 110.392 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.89 -52.34 25.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.186 -1.005 . . . . 0.64000000000000001 110.84 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.07 92.44 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.1 -1.0 . . . . 0.56000000000000005 110.519 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.46 96.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.339 -0.851 . . . . 0.46000000000000002 110.565 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -60.64 -38.86 86.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.166 -0.959 . . . . 1.3200000000000001 110.738 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -54.95 -49.5 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 1.3 111.158 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.21 -47.28 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.844 -1.16 . . . . 0.60999999999999999 109.987 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -61.93 -32.35 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.352 0.596 . . . . 0.65000000000000002 110.568 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -58.51 -40.76 83.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -0.877 . . . . 2.1099999999999999 111.189 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.41 -37.15 8.31 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.064 -1.541 . . . . 0.82999999999999996 112.888 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -60.3 -38.89 85.06 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.586 -1.538 . . . . 1.28 110.095 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.61 -51.78 15.66 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.54 0.686 . . . . 0.89000000000000001 110.89 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.6 p -63.49 -35.77 81.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 1.8700000000000001 110.606 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.44 96.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.795 . . . . 1.05 110.629 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 80.1 mt -65.79 -29.99 70.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.053 -1.03 . . . . 1.02 110.655 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -67.16 -22.57 65.75 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.353 -0.842 . . . . 2.04 110.933 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -70.32 -16.12 62.96 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.593 -0.843 . . . . 1.73 111.131 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 123' ' ' LEU . 21.8 mt -84.66 144.38 28.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.579 -0.7 . . . . 1.3700000000000001 109.949 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -97.74 37.36 1.4 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.479 -0.763 . . . . 2.8799999999999999 111.987 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -113.56 139.22 49.18 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 108.377 -0.972 . . . . 1.5800000000000001 108.377 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -59.96 -40.64 89.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.484 -0.76 . . . . 3.04 110.775 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.34 -50.9 34.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.788 -1.195 . . . . 0.90000000000000002 110.177 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 118' ' ' LEU . 35.2 mt -63.23 -42.5 99.25 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.85 -1.14 . . . . 1.0600000000000001 110.022 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -63.35 -49.01 75.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.787 -1.196 . . . . 2.1800000000000002 109.266 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -59.94 -31.07 69.51 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.606 -0.838 . . . . 2.1499999999999999 109.386 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.56 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 17.7 ttt-85 -61.93 -30.44 70.9 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.992 0.901 . . . . 2.3300000000000001 108.82 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -60.86 -49.37 77.74 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.718 0.771 . . . . 0.81999999999999995 109.366 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.22 85.59 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.581 -0.848 . . . . 0.84999999999999998 110.258 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -63.32 -37.41 87.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.552 -0.717 . . . . 1.3899999999999999 110.417 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.56 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 39.9 t -69.18 -39.7 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 0.56000000000000005 109.936 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -58.58 -36.55 74.15 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.016 -1.052 . . . . 3.1200000000000001 109.734 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -59.92 -39.74 86.48 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.455 0.645 . . . . 1.28 110.052 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.1 mt -61.97 -39.55 84.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.438 -0.789 . . . . 0.48999999999999999 109.509 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.97 -46.8 50.18 Favored Glycine 0 N--CA 1.483 1.773 0 C-N-CA 119.766 -1.207 . . . . 0.46000000000000002 110.517 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.74 -49.99 71.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -1.155 . . . . 2.71 110.289 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -62.64 -39.25 93.27 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.21 -0.996 . . . . 2.1400000000000001 109.87 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.33 -39.96 88.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.559 -0.713 . . . . 1.05 110.02 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.47 -44.32 93.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.519 -0.738 . . . . 0.52000000000000002 110.081 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -60.51 -35.4 75.86 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.102 -0.999 . . . . 2.3500000000000001 110.26 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -73.06 -40.21 65.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 1.3899999999999999 110.7 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.46 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.7 mt -60.28 -40.01 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 0.68000000000000005 109.942 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.459 HD21 ' OD2' ' A' ' 101' ' ' ASP . 91.0 mt -91.01 -3.45 57.23 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.209 -0.932 . . . . 0.82999999999999996 112.416 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.47 23.23 77.72 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.808 -1.187 . . . . 0.91000000000000003 113.13 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.9 tp -66.16 149.26 50.58 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.744 -0.856 . . . . 0.94999999999999996 109.284 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -64.64 144.91 56.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 2.4300000000000002 109.433 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 53.8 mt -105.46 143.12 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.436 -0.949 . . . . 1.1000000000000001 108.436 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.587 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.2 mp -77.8 125.03 37.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.09 -1.078 . . . . 1.5800000000000001 108.09 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -95.89 93.16 6.88 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.585 -1.635 . . . . 1.6200000000000001 106.585 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.9 mt -78.81 -16.53 57.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 0.80000000000000004 111.981 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.5 m -80.66 0.76 32.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.338 -0.851 . . . . 1.5600000000000001 112.572 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.03 19.75 14.58 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.24 -0.913 . . . . 0.83999999999999997 112.459 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.0 mt -74.86 136.72 24.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.515 0.674 . . . . 0.81999999999999995 109.3 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -125.17 -2.78 7.58 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.448 0.642 . . . . 2.3100000000000001 112.51 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -116.86 134.28 54.96 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.248 -1.019 . . . . 1.54 108.248 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.72 119.1 15.4 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.075 -0.713 . . . . 1.3799999999999999 109.075 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.477 HG12 ' HZ3' ' A' ' 15' ' ' LYS . 27.8 m -147.38 172.27 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.518 -0.739 . . . . 0.68999999999999995 109.286 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.1 mt -87.33 142.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 0.53000000000000003 109.093 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 25.6 tp -96.46 123.76 40.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.077 -1.014 . . . . 0.64000000000000001 108.432 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.68 129.74 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 107.594 -1.261 . . . . 0.67000000000000004 107.594 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.14 152.53 19.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.033 -1.042 . . . . 0.78000000000000003 108.95 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.68 -35.46 76.31 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.585 -1.322 . . . . 1.0 109.424 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 64.2 t0 -172.54 147.26 1.83 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.268 -0.641 . . . . 2.4199999999999999 109.268 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.502 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 82.3 mt -116.23 141.61 47.92 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.179 -0.675 . . . . 0.75 109.179 177.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.5 p -94.08 150.25 38.15 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.159 -0.963 . . . . 0.78000000000000003 109.152 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -42.02 -44.3 7.23 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.007 1.805 . . . . 0.67000000000000004 113.719 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.8 m -59.94 -48.25 82.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.883 -1.136 . . . . 0.69999999999999996 110.055 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.95 -40.69 95.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.225 -0.99 . . . . 1.21 110.126 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 70.7 p -70.22 -39.01 75.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.59999999999999998 110.401 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.04 -34.35 74.72 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.896 -0.722 . . . . 0.62 110.881 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -95.7 1.37 53.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.074 -1.017 . . . . 1.1599999999999999 112.521 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.51 152.02 31.3 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.384 -0.822 . . . . 0.72999999999999998 109.778 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.454 HD22 ' H ' ' A' ' 175' ' ' LYS . 0.4 OUTLIER -93.65 110.91 22.51 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.057 -1.831 . . . . 2.2400000000000002 106.057 177.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.1 mt -72.26 -21.15 61.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.638 -0.664 . . . . 1.4299999999999999 112.318 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.412 ' HB2' HD21 ' A' ' 172' ' ' ASN . 88.6 mttt -82.53 -23.57 34.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.929 -1.107 . . . . 2.1499999999999999 112.386 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.454 ' H ' HD22 ' A' ' 172' ' ' ASN . 44.2 mmtm -97.15 -4.98 38.24 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.035 -1.041 . . . . 2.04 113.094 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.2 t -108.34 128.78 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.566 -1.272 . . . . 0.55000000000000004 107.566 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.1 tp -88.5 -12.05 44.06 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.403 -0.811 . . . . 1.6299999999999999 112.241 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 179.26 167.72 37.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.639 -1.785 . . . . 0.46999999999999997 108.639 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.6 OUTLIER -128.01 131.48 49.2 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.255 -1.144 . . . . 0.54000000000000004 108.458 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.448 ' CG2' HG21 ' A' ' 205' ' ' THR . 76.8 mt -127.12 129.91 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.172 -1.418 . . . . 0.68999999999999995 107.172 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 203' ' ' VAL . 37.8 p -138.96 169.95 16.86 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.593 -1.317 . . . . 0.81999999999999995 110.066 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.438 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 4.3 m-20 -101.07 35.5 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.875 -0.515 . . . . 2.3700000000000001 111.53 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -99.88 121.71 41.73 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.922 -1.112 . . . . 1.1100000000000001 108.325 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.38 19.42 43.76 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.255 -0.974 . . . . 1.6699999999999999 112.189 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -82.54 118.78 4.7 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.148 -1.981 . . . . 1.54 108.148 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -57.98 -29.95 65.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.986 -1.302 . . . . 4.4800000000000004 109.747 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 63.9 p -108.4 38.76 2.14 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.414 0.626 . . . . 2.6299999999999999 110.195 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.6 t -70.22 150.69 46.17 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.598 0.713 . . . . 1.6899999999999999 109.416 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -57.6 -39.66 77.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -0.875 . . . . 1.0700000000000001 111.088 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 44.1 p -59.74 -41.4 90.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.068 -1.02 . . . . 1.5800000000000001 110.498 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 59.9 p -61.15 -35.49 77.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 1.6000000000000001 110.367 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.03 -39.59 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 1.45 110.852 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 66.0 mtp -62.89 -40.78 98.59 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.233 1.016 . . . . 1.05 109.409 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.44 -48.95 79.67 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.739 -0.664 . . . . 0.71999999999999997 110.297 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.428 ' HG2' HH11 ' A' ' 195' ' ' ARG . 38.7 mtt-85 -61.16 -41.57 97.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.238 -0.914 . . . . 3.0499999999999998 110.938 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m -70.3 -40.57 74.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.963 -1.086 . . . . 0.89000000000000001 110.539 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.57 -9.1 48.34 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.043 0.757 . . . . 0.78000000000000003 113.043 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.5 mt-10 55.63 8.35 0.32 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.794 1.035 . . . . 1.45 113.794 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 56.8 mt -72.56 147.98 90.0 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 0.67000000000000004 108.267 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.76 136.3 72.89 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 120.982 1.121 . . . . 0.64000000000000001 110.027 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.31 164.63 34.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.398 -1.439 . . . . 0.67000000000000004 109.429 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 203' ' ' VAL . 99.1 mt -144.1 160.19 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.335 -1.357 . . . . 0.68999999999999995 107.335 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.497 ' N ' HG22 ' A' ' 202' ' ' ILE . 15.7 m -139.09 -27.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 120.818 -1.176 . . . . 0.84999999999999998 112.023 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.75 41.03 3.04 Favored Glycine 0 N--CA 1.492 2.43 0 O-C-N 121.242 -0.911 . . . . 0.92000000000000004 111.841 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.448 HG21 ' CG2' ' A' ' 180' ' ' ILE . 46.9 p -62.69 -23.72 67.28 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.24 -1.153 . . . . 0.94999999999999996 111.007 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.04 -92.17 1.78 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.077 -1.059 . . . . 1.04 110.668 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 86.0 p -128.35 30.61 5.16 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.178 -1.189 . . . . 1.5700000000000001 112.302 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.21 -33.68 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.264 -1.522 . . . . 0.83999999999999997 110.107 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 26.0 p -58.14 -26.76 63.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.987 -1.071 . . . . 0.98999999999999999 111.52 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 25.8 t -93.58 1.82 56.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.301 -0.875 . . . . 1.7 111.999 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -123.95 -0.53 8.43 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 112.911 0.708 . . . . 2.2000000000000002 112.911 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 11.1 t -120.01 150.87 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.52 -0.737 . . . . 0.83999999999999997 109.853 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -118.73 157.81 26.77 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.918 -1.142 . . . . 2.2000000000000002 107.918 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.632 HD22 ' N ' ' A' ' 215' ' ' ASP . 0.2 OUTLIER -59.26 141.2 54.96 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.978 -1.076 . . . . 2.2799999999999998 110.492 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.632 ' N ' HD22 ' A' ' 214' ' ' ASN . 3.3 m-20 80.75 -1.5 1.85 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 114.525 1.306 . . . . 2.3500000000000001 114.525 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -62.33 148.85 43.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.34 -1.475 . . . . 1.97 108.176 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -88.57 120.84 30.32 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.311 -1.366 . . . . 2.6499999999999999 107.311 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.8 mt -128.48 146.38 50.83 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.664 0.745 . . . . 0.63 109.905 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.11 126.76 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.617 -1.623 . . . . 0.62 106.617 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 65.5 tp -100.52 119.64 38.81 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.355 -1.721 . . . . 0.64000000000000001 106.355 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 53.3 t0 -92.25 -26.4 18.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.893 -1.13 . . . . 2.0499999999999998 112.518 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.942 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.11 13.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.137 0.791 . . . . 0.83999999999999997 113.137 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.2 t -108.27 -59.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.741 -1.224 . . . . 1.02 109.695 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -92.68 10.12 32.01 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.018 0.913 . . . . 2.5099999999999998 110.561 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 62.15 53.58 2.89 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.659 -0.7 . . . . 1.54 112.242 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -147.0 149.06 32.4 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.371 1.081 . . . . 1.95 109.645 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.1 t -115.98 133.33 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.444 -1.317 . . . . 0.70999999999999996 107.444 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.11 132.57 46.5 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.026 -1.047 . . . . 1.01 108.468 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 60.4 t -110.48 129.94 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.365 -0.834 . . . . 0.81999999999999995 108.763 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.4 t30 54.34 55.2 11.73 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.15 -0.969 . . . . 1.54 113.232 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.09 150.42 60.06 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.582 2.188 . . . . 0.93999999999999995 111.322 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.5 m -75.2 158.87 32.29 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.254 -0.904 . . . . 1.8 109.313 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.58 ' HA ' HD12 ' A' ' 236' ' ' ILE . 81.8 m-20 -58.75 -39.09 79.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 2.73 110.688 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -58.82 -40.17 83.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -0.937 . . . . 3.1699999999999999 109.865 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.65 -39.09 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 1.3400000000000001 110.105 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 233' ' ' ASN . 95.4 mt -57.35 -47.26 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.818 -0.753 . . . . 1.2 110.715 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.92 -40.22 88.12 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.326 -0.859 . . . . 2.7000000000000002 110.557 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -61.17 -48.12 83.03 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.401 -0.812 . . . . 2.5899999999999999 111.289 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 81.9 mtp -70.44 -33.1 70.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 1.3799999999999999 111.092 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -58.05 -40.4 80.83 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.983 -1.073 . . . . 2.8399999999999999 110.076 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.11 -36.97 66.85 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.418 -0.801 . . . . 1.8799999999999999 110.676 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 246' ' ' VAL . 82.5 t -58.86 -49.7 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.206 -0.934 . . . . 2.3999999999999999 111.097 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.427 ' OE1' ' N ' ' A' ' 244' ' ' GLU . 20.9 tm0? -61.58 -52.09 65.83 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.775 -1.203 . . . . 3.52 110.362 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.427 ' N ' ' OE1' ' A' ' 243' ' ' GLN . 85.8 mt-10 -62.23 -34.42 76.48 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.715 -0.794 . . . . 1.8799999999999999 110.125 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -62.81 -30.02 71.16 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.373 -0.931 . . . . 3.0099999999999998 110.024 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 242' ' ' VAL . 91.7 t -61.42 -44.92 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.251 -0.98 . . . . 2.4500000000000002 109.875 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.28 96.55 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.069 -1.052 . . . . 2.75 109.901 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.3 t -72.41 -30.42 64.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.586 -0.696 . . . . 3.1600000000000001 110.805 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.46 -40.0 89.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.055 -1.028 . . . . 3.5699999999999998 110.921 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -65.0 -39.81 94.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.843 -1.161 . . . . 4.2999999999999998 110.424 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.86 -26.3 63.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.201 -0.937 . . . . 4.4500000000000002 111.273 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -69.07 -48.86 61.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.113 -0.992 . . . . 5.9699999999999998 110.624 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 3.1 pp -71.08 -22.85 62.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.1 -1.0 . . . . 6.1799999999999997 111.622 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -70.37 -20.31 62.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 6.6600000000000001 111.707 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -77.64 -46.27 22.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.135 -0.978 . . . . 8.1999999999999993 110.981 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.3 56.75 2.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.997 -1.065 . . . . 8.0700000000000003 110.771 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -84.6 -8.95 58.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.942 -1.099 . . . . 9.4499999999999993 112.058 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -93.76 9.57 36.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.581 -0.699 . . . . 10.119999999999999 112.548 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 118.046 -0.978 . . . . 11.49 110.361 -179.389 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.671 -0.492 . . . . 3.0699999999999998 109.671 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 1' ' ' MET . 40.1 mt 41.2 68.17 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.837 . . . . 1.0700000000000001 111.962 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.0 m -97.38 116.67 30.02 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.576 -1.639 . . . . 1.24 106.576 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.46 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -93.78 -153.47 30.29 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 120.441 -1.412 . . . . 1.01 109.912 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 5' ' ' ILE . 74.6 mt -94.43 1.01 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.586 -0.949 . . . . 1.1100000000000001 112.552 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 tp 52.52 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.685 -1.26 . . . . 0.98999999999999999 112.444 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.54 -35.33 17.01 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.648 -1.283 . . . . 0.84999999999999998 110.744 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 1.2 p -148.67 140.96 14.85 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.711 -1.243 . . . . 1.3799999999999999 108.083 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.0 147.88 24.33 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.151 1.901 . . . . 0.93999999999999995 112.347 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.929 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.56 163.64 11.79 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.265 -1.534 . . . . 0.81000000000000005 109.265 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.5 mt -121.05 134.33 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.057 -1.261 . . . . 0.82999999999999996 108.345 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.25 151.85 44.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.193 -0.942 . . . . 0.53000000000000003 109.416 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 7.9 m-85 -122.06 144.46 48.9 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.431 -0.951 . . . . 0.77000000000000002 108.431 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.85 166.27 31.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.551 -1.785 . . . . 0.51000000000000001 110.092 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -77.88 159.68 28.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.329 -1.101 . . . . 1.8999999999999999 109.204 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -87.53 127.69 35.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.792 -1.188 . . . . 0.66000000000000003 107.792 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.2 tp -106.11 109.53 21.49 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 105.468 -2.049 . . . . 0.82999999999999996 105.468 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 18' ' ' LEU . 14.8 tp -95.58 136.27 36.17 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.414 -1.328 . . . . 0.85999999999999999 107.414 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.8 mt -99.8 118.82 37.09 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.062 -1.459 . . . . 0.92000000000000004 107.062 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -112.05 136.19 51.72 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.65 -1.241 . . . . 2.0299999999999998 107.65 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -130.33 151.96 50.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.251 -0.906 . . . . 2.6600000000000001 109.149 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -80.06 138.35 36.96 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.478 -0.934 . . . . 2.3199999999999998 108.478 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -63.79 149.33 47.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.454 -0.779 . . . . 2.1099999999999999 109.002 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.6 mt -92.69 129.97 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.915 -1.116 . . . . 0.72999999999999998 108.651 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.9 t -105.36 130.01 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.529 -1.285 . . . . 0.87 107.529 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.27 135.03 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.654 -0.869 . . . . 0.81000000000000005 108.654 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -90.91 122.1 33.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.075 -1.016 . . . . 1.3400000000000001 108.512 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -95.4 11.8 31.52 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.591 -0.693 . . . . 2.8900000000000001 112.106 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -66.97 141.54 57.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.88 -1.138 . . . . 2.0899999999999999 108.885 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -88.9 134.16 34.05 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.138 -1.06 . . . . 2.1899999999999999 108.138 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -97.78 167.14 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.394 -0.816 . . . . 0.75 110.477 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.6 p -94.67 160.95 14.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.686 -0.633 . . . . 0.91000000000000003 109.53 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.41 -21.92 11.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.903 -1.123 . . . . 0.93000000000000005 111.94 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -67.53 -37.24 82.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 2.2799999999999998 110.753 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -90.25 -8.5 50.85 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.649 -1.282 . . . . 1.45 112.587 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.1 t -58.89 -39.82 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.446 -0.784 . . . . 0.81000000000000005 110.553 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -56.33 -40.24 74.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.929 -1.107 . . . . 1.54 110.187 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.29 -39.5 94.74 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.432 -0.793 . . . . 2.3599999999999999 111.045 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.46 -43.54 96.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.025 -1.047 . . . . 1.3100000000000001 110.707 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.24 -40.85 84.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.23 -0.918 . . . . 0.81999999999999995 110.501 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -60.58 -45.37 94.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.237 -0.914 . . . . 1.5 110.107 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -61.83 -40.57 95.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.582 -0.699 . . . . 2.23 110.287 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -74.02 -52.84 11.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.094 -1.004 . . . . 0.84999999999999998 109.934 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.6 tp -61.77 -47.96 82.84 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.554 -0.859 . . . . 0.91000000000000003 110.09 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.1 t -69.92 -38.06 76.13 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.289 -0.882 . . . . 0.90000000000000002 109.703 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.89 -40.8 95.71 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.037 -1.625 . . . . 0.68999999999999995 109.037 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.564 HH22 ' CD ' ' A' ' 86' ' ' GLU . 17.2 ttm180 -59.2 -30.69 68.4 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.737 0.779 . . . . 2.8799999999999999 109.334 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.29 -49.79 76.5 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.614 0.721 . . . . 0.84999999999999998 110.365 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -82.7 -38.33 23.51 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.297 -0.877 . . . . 2.3500000000000001 110.169 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.5 -44.85 95.54 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.84 -0.744 . . . . 0.65000000000000002 109.905 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.8 t -60.13 -40.21 88.99 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 122.339 1.066 . . . . 1.45 108.797 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.62 -45.93 88.04 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.648 -0.706 . . . . 0.63 109.771 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -61.46 -50.44 72.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.995 -1.065 . . . . 1.3400000000000001 110.324 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.26 -39.83 91.81 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.321 -0.862 . . . . 1.5600000000000001 110.071 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -59.9 -43.11 95.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.887 -0.508 . . . . 1.1899999999999999 110.619 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 m -63.96 -42.36 97.3 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.789 -1.194 . . . . 0.71999999999999997 109.948 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.6 -35.2 61.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.68 -0.638 . . . . 0.62 110.337 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -53.03 -41.51 64.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.431 -0.793 . . . . 1.05 110.442 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -70.34 -35.42 73.59 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.376 -0.828 . . . . 0.64000000000000001 109.691 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.48 -40.9 92.93 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.221 -0.991 . . . . 1.73 109.045 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.08 -36.01 82.18 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 120.178 -0.609 . . . . 0.56000000000000005 109.47 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.2 -35.07 27.92 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.588 -1.291 . . . . 0.68999999999999995 110.435 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.36 -16.98 50.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.318 -1.107 . . . . 1.48 111.209 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.6 m -91.24 -54.88 3.74 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.264 0.554 . . . . 0.97999999999999998 110.381 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 67' ' ' GLU . 61.5 m-85 -107.35 -30.48 8.67 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.11 0.782 . . . . 1.1599999999999999 113.11 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 61.48 -26.13 0.06 OUTLIER Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.536 -1.316 . . . . 0.84999999999999998 115.059 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 65' ' ' PHE . 52.5 mt-10 -54.84 -166.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.556 -0.967 . . . . 3.8599999999999999 109.844 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -66.57 7.29 0.36 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 112.953 0.723 . . . . 2.3500000000000001 112.953 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -68.6 -24.64 64.6 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.461 -0.774 . . . . 1.6699999999999999 111.375 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -58.65 -40.21 82.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.021 -1.049 . . . . 1.45 110.687 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.83 -36.56 84.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.31 -0.869 . . . . 0.60999999999999999 110.958 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 72' ' ' ILE . 13.3 mt -64.8 -45.91 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.65000000000000002 110.718 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -69.62 -33.96 73.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.863 -1.148 . . . . 0.66000000000000003 110.257 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.44 -39.23 90.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.302 -0.874 . . . . 1.1899999999999999 110.174 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.09 -37.74 95.01 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.664 -0.974 . . . . 0.53000000000000003 110.664 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -59.84 -41.98 92.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -1.114 . . . . 1.27 110.343 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.8 mt -61.2 -40.96 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.09 . . . . 0.54000000000000004 110.43 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.3 ttt -59.71 -39.65 85.35 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 120.97 -1.081 . . . . 1.74 110.523 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 tp -58.43 -49.98 75.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.114 -0.991 . . . . 0.55000000000000004 110.199 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.5 tp -61.67 -42.08 98.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.099 -1.001 . . . . 0.46999999999999997 109.961 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -86.63 9.08 19.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.482 -0.762 . . . . 1.4199999999999999 112.564 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.05 121.45 14.19 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.12 -0.988 . . . . 1.27 108.505 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.63 -18.89 65.12 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.455 -0.778 . . . . 1.3500000000000001 111.067 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.61 -50.63 14.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.51 -0.876 . . . . 2.2200000000000002 110.41 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.28 -35.39 77.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.208 -0.597 . . . . 0.62 110.684 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.564 ' CD ' HH22 ' A' ' 47' ' ' ARG . 72.5 tt0 -59.77 -47.45 85.62 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.444 -0.785 . . . . 1.29 110.473 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -61.22 -37.48 83.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.35 -0.844 . . . . 1.52 110.756 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -68.44 -48.83 63.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 1.3 110.673 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.5 mt -57.6 -43.51 83.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.179 -0.95 . . . . 0.60999999999999999 110.242 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.0 mt -60.09 -40.63 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.462 -0.774 . . . . 0.78000000000000003 110.411 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.42 95.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.563 -0.711 . . . . 0.81999999999999995 110.685 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.31 -45.61 92.78 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.96 -1.087 . . . . 0.80000000000000004 110.313 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.28 -49.11 80.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.155 -0.966 . . . . 0.77000000000000002 110.335 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -73.8 -36.44 65.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.916 -1.115 . . . . 2.1200000000000001 111.842 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -78.5 -47.77 16.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.833 -1.167 . . . . 1.51 111.469 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -101.48 7.43 42.45 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.422 -0.799 . . . . 1.98 112.846 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.4 m80 52.39 50.1 19.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.824 -1.173 . . . . 1.3200000000000001 111.661 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtt -102.98 158.1 16.52 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.843 0.83 . . . . 1.3799999999999999 109.16 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.418 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 66.9 p -74.87 161.9 29.13 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.817 -0.552 . . . . 0.67000000000000004 109.963 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.87 92.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.993 -1.067 . . . . 0.52000000000000002 110.395 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.418 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 16.7 p-10 -68.64 -39.83 80.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.018 -1.051 . . . . 2.25 110.26 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.26 -51.36 38.26 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.548 -0.861 . . . . 0.64000000000000001 111.307 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.09 92.78 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.153 -1.019 . . . . 0.56000000000000005 110.838 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.37 85.23 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.27 -0.894 . . . . 0.46000000000000002 110.965 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -61.64 -38.88 89.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.686 -1.259 . . . . 1.3200000000000001 111.499 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.83 -48.98 79.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.779 -1.201 . . . . 1.3 111.219 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.85 -45.99 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.912 -1.118 . . . . 0.60999999999999999 110.248 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 mm -61.95 -31.13 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.814 . . . . 0.65000000000000002 109.91 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -59.8 -41.37 91.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 2.1099999999999999 110.892 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.59 -34.12 12.24 Favored Glycine 0 N--CA 1.498 2.828 0 C-N-CA 119.084 -1.532 . . . . 0.82999999999999996 112.478 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -60.9 -39.89 91.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.529 -1.571 . . . . 1.28 110.215 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.49 55.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.378 0.609 . . . . 0.89000000000000001 110.6 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.5 p -62.6 -40.48 97.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.437 -0.789 . . . . 1.8700000000000001 110.275 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.96 -41.26 96.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 1.05 111.087 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.6 mt -65.67 -30.67 71.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.772 -1.205 . . . . 1.02 111.084 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -66.66 -21.81 66.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.872 -1.143 . . . . 2.04 111.079 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -73.28 -14.18 61.27 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.192 -0.943 . . . . 1.73 111.57 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.407 HD13 HD13 ' A' ' 123' ' ' LEU . 8.1 mt -84.26 142.54 30.18 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.582 -0.699 . . . . 1.3700000000000001 109.26 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -100.39 55.23 0.89 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 2.8799999999999999 110.737 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -129.98 137.86 50.53 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.211 -1.033 . . . . 1.5800000000000001 108.211 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -58.99 -36.61 75.16 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.134 -0.626 . . . . 3.04 110.816 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -73.9 -52.46 12.87 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.791 -1.193 . . . . 0.90000000000000002 110.381 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.407 HD13 HD13 ' A' ' 118' ' ' LEU . 23.1 mt -64.07 -43.72 94.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.06 -1.025 . . . . 1.0600000000000001 110.27 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -61.14 -47.35 86.61 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.641 -1.287 . . . . 2.1800000000000002 109.857 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -61.77 -29.28 70.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.083 -1.011 . . . . 2.1499999999999999 110.014 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 130' ' ' VAL . 56.0 ttt180 -65.15 -29.0 69.8 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.537 -0.865 . . . . 2.3300000000000001 109.365 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.55 -49.83 76.27 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.613 -0.835 . . . . 0.81999999999999995 109.698 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.23 85.02 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.007 -0.677 . . . . 0.84999999999999998 110.248 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.54 -38.26 90.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.226 -0.921 . . . . 1.3899999999999999 110.439 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 126' ' ' ARG . 55.2 t -67.92 -40.18 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.913 -1.117 . . . . 0.56000000000000005 109.839 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -60.08 -37.8 80.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.892 -1.13 . . . . 3.1200000000000001 110.21 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.54 ' CG ' HH11 ' A' ' 136' ' ' ARG . 42.1 t0 -59.87 -39.23 84.56 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.209 -0.932 . . . . 1.28 110.535 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.31 -39.43 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.562 -0.711 . . . . 0.48999999999999999 110.1 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.06 -50.48 45.97 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.89 -1.147 . . . . 0.46000000000000002 110.603 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -59.42 -47.02 87.04 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.112 -1.228 . . . . 2.71 110.534 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.54 HH11 ' CG ' ' A' ' 132' ' ' ASP . 14.8 mtm-85 -64.58 -39.85 94.47 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.067 -1.053 . . . . 2.1400000000000001 109.883 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.1 tp -61.24 -39.91 92.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.05 110.15 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 73.2 mt -59.34 -40.26 85.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.52000000000000002 110.704 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.431 ' HE ' HD23 ' A' ' 144' ' ' LEU . 58.0 mtp180 -61.19 -34.52 75.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.128 -0.983 . . . . 2.3500000000000001 110.344 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.405 HD21 HD11 ' A' ' 146' ' ' ILE . 31.3 m120 -75.58 -40.73 56.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.021 -1.049 . . . . 1.3899999999999999 110.587 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 98.1 mt -60.04 -39.48 80.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 120.812 -1.18 . . . . 0.68000000000000005 110.479 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.88 -7.93 58.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.82999999999999996 111.659 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.26 22.62 64.88 Favored Glycine 0 N--CA 1.483 1.807 0 C-N-CA 120.104 -1.046 . . . . 0.91000000000000003 113.367 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.431 HD23 ' HE ' ' A' ' 139' ' ' ARG . 43.6 tp -66.41 145.92 55.14 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.744 -0.857 . . . . 0.94999999999999996 109.418 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -64.5 148.57 50.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.418 -0.801 . . . . 2.4300000000000002 109.322 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.405 HD11 HD21 ' A' ' 140' ' ' ASN . 59.2 mt -108.61 140.11 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.47 -0.937 . . . . 1.1000000000000001 108.47 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 21.2 mm -79.77 129.55 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.972 -1.08 . . . . 1.5800000000000001 108.754 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -96.95 95.67 7.98 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.149 -1.797 . . . . 1.6200000000000001 106.149 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.43 -22.19 61.13 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.498 -0.751 . . . . 0.80000000000000004 111.088 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.5 t -78.13 -0.53 28.62 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.084 0.945 . . . . 1.5600000000000001 112.316 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.9 25.48 5.29 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.438 -0.789 . . . . 0.83999999999999997 112.236 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.8 mt -71.05 139.97 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.465 -0.772 . . . . 0.81999999999999995 109.566 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -115.17 -19.89 10.63 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 2.3100000000000001 112.949 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -117.27 139.61 50.59 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.885 -1.154 . . . . 1.54 107.885 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.6 126.69 30.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.449 -0.945 . . . . 1.3799999999999999 108.449 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.7 m -149.5 175.16 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.01 -1.056 . . . . 0.68999999999999995 109.166 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.9 mt -89.09 142.35 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.53000000000000003 108.644 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 27.6 tp -96.79 124.02 40.65 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.459 -0.941 . . . . 0.64000000000000001 108.459 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.1 t -125.02 131.98 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.293 -1.003 . . . . 0.67000000000000004 108.293 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.48 157.63 19.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.78000000000000003 108.982 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -64.99 -35.35 80.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.686 -1.259 . . . . 1.0 109.304 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 53.7 t0 -171.45 152.71 3.32 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.845 -0.798 . . . . 2.4199999999999999 108.845 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.472 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 66.3 mt -115.09 142.98 45.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.677 -0.86 . . . . 0.75 108.677 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.8 p -92.95 147.18 33.43 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.462 -0.773 . . . . 0.78000000000000003 108.938 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -40.31 -42.04 3.55 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.511 1.474 . . . . 0.67000000000000004 113.587 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.1 m -61.6 -48.14 82.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.799 -1.188 . . . . 0.69999999999999996 110.278 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.13 -39.46 89.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.023 -1.048 . . . . 1.21 110.87 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -68.79 -40.51 79.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.344 -0.847 . . . . 0.59999999999999998 110.783 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.48 79.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -0.949 . . . . 0.62 110.464 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -93.65 -2.39 54.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.913 -1.117 . . . . 1.1599999999999999 112.396 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 171' ' ' LEU . 42.6 tp -62.13 146.77 49.58 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.251 -1.018 . . . . 0.72999999999999998 108.251 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -95.33 116.96 29.48 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.727 -1.582 . . . . 2.2400000000000002 106.727 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.694 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -73.52 -18.82 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.419 -0.801 . . . . 1.4299999999999999 111.41 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -82.78 -18.26 41.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.526 -0.734 . . . . 2.1499999999999999 112.293 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -104.15 -6.12 21.34 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.312 0.856 . . . . 2.04 113.312 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 178' ' ' GLY . 52.2 t -108.54 129.67 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.559 -1.275 . . . . 0.55000000000000004 107.559 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 29.7 tp -82.89 -8.77 59.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.054 -1.029 . . . . 1.6299999999999999 112.543 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.547 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.98 177.52 38.77 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.599 -1.8 . . . . 0.46999999999999997 108.599 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -129.28 135.84 49.3 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.975 -1.309 . . . . 0.54000000000000004 107.588 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.483 HG22 HG21 ' A' ' 205' ' ' THR . 75.1 mt -138.01 105.15 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.145 -1.798 . . . . 0.68999999999999995 106.145 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 203' ' ' VAL . 76.7 p -129.68 168.94 15.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.357 -0.84 . . . . 0.81999999999999995 109.416 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 26.1 p-10 -98.68 47.95 0.98 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.737 -0.602 . . . . 2.3700000000000001 110.93 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.403 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -99.34 164.54 12.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.395 -0.816 . . . . 1.1100000000000001 110.416 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 183' ' ' ALA . . . -54.23 -100.6 0.01 OUTLIER Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.298 -1.521 . . . . 1.6699999999999999 109.298 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 164.93 -58.87 0.25 Allowed Glycine 0 N--CA 1.492 2.427 0 O-C-N 121.095 -1.238 . . . . 1.54 112.596 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -57.51 -45.43 84.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -1.094 . . . . 4.4800000000000004 110.231 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.3 p -109.22 17.78 21.21 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.529 -0.732 . . . . 2.6299999999999999 112.238 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 53.5 m -88.03 126.83 35.3 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.717 -1.216 . . . . 1.6899999999999999 107.717 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -60.63 -35.53 76.41 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.383 -0.823 . . . . 1.0700000000000001 110.422 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.6 p -56.31 -39.7 73.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.167 -0.958 . . . . 1.5800000000000001 109.982 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.4 m -59.2 -37.29 77.07 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.934 -0.707 . . . . 1.6000000000000001 110.098 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -59.9 -38.85 78.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.498 -0.751 . . . . 1.45 110.309 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 69.9 mtp -64.1 -40.21 95.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.671 -1.268 . . . . 1.05 109.457 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.8 -48.92 79.73 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.027 -0.533 . . . . 0.71999999999999997 111.384 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -59.37 -43.95 92.81 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.19 -0.944 . . . . 3.0499999999999998 110.432 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.1 m -68.97 -40.18 79.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.339 -0.851 . . . . 0.89000000000000001 110.226 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.6 mt -91.78 -9.32 43.97 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.811 0.815 . . . . 0.78000000000000003 112.126 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.8 mt-10 47.46 14.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.472 0.916 . . . . 1.45 113.472 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 59.6 mt -75.41 150.27 84.73 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.953 -1.092 . . . . 0.67000000000000004 108.538 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -51.49 140.51 44.2 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.393 1.396 . . . . 0.64000000000000001 109.302 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.442 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -159.05 163.61 36.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.209 -1.557 . . . . 0.67000000000000004 109.829 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.5 mt -147.17 147.04 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.761 -1.2 . . . . 0.68999999999999995 107.761 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 181' ' ' THR . 9.9 m -129.11 -29.19 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 113.251 0.834 . . . . 0.84999999999999998 113.251 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.61 46.35 3.66 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 120.344 -0.931 . . . . 0.92000000000000004 111.97 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.483 HG21 HG22 ' A' ' 180' ' ' ILE . 65.8 p -66.78 -12.88 60.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.965 -1.315 . . . . 0.94999999999999996 111.229 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.85 -94.42 0.68 Allowed Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.038 -1.077 . . . . 1.04 110.49 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -129.52 31.21 4.82 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.522 -0.987 . . . . 1.5700000000000001 112.144 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 85.7 t -59.86 -33.34 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.617 -1.302 . . . . 0.83999999999999997 110.474 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 80.5 p -56.33 -28.22 58.24 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.076 -1.015 . . . . 0.98999999999999999 111.171 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 26.4 t -92.26 0.69 57.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.101 -1.0 . . . . 1.7 112.214 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -120.33 -4.19 9.94 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.545 0.943 . . . . 2.2000000000000002 113.545 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.3 149.42 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.227 -0.92 . . . . 0.83999999999999997 109.285 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -117.62 149.61 40.39 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.535 -0.913 . . . . 2.2000000000000002 108.535 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 38.4 p-10 -50.47 141.33 12.34 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.384 -0.926 . . . . 2.2799999999999998 110.366 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 8.8 t0 81.49 4.06 1.41 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 114.219 1.192 . . . . 2.3500000000000001 114.219 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -66.7 145.62 55.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.883 -1.136 . . . . 1.97 108.252 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -88.13 119.53 28.6 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.328 -1.36 . . . . 2.6499999999999999 107.328 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.445 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 85.2 mt -128.66 150.3 50.3 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.506 0.669 . . . . 0.63 110.155 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 56.5 mt -115.09 122.17 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 106.675 -1.602 . . . . 0.62 106.675 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.479 HD13 HD11 ' A' ' 180' ' ' ILE . 62.0 tp -98.99 115.8 29.77 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 106.754 -1.572 . . . . 0.64000000000000001 106.754 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 9.3 m-20 -95.47 -24.39 16.68 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.414 -0.914 . . . . 2.0499999999999998 112.606 -177.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.929 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.21 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.652 0.739 . . . . 0.83999999999999997 112.176 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 22.7 t -111.38 -61.29 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.654 -0.869 . . . . 1.02 108.654 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -91.13 9.55 30.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.145 0.974 . . . . 2.5099999999999998 110.159 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.46 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 61.93 51.35 3.77 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 114.921 -1.036 . . . . 1.54 111.986 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -153.17 152.79 31.64 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.798 1.285 . . . . 1.95 110.497 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.0 t -117.38 140.79 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.527 -0.916 . . . . 0.70999999999999996 108.527 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -100.78 132.82 45.99 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.85 -1.156 . . . . 1.01 108.56 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.1 t -109.79 129.55 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.419 -0.956 . . . . 0.81999999999999995 108.419 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.445 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER 56.38 48.17 3.35 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 113.734 1.013 . . . . 1.54 113.734 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 58.7 Cg_endo -70.61 150.54 63.18 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.292 1.995 . . . . 0.93999999999999995 111.138 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.7 m -72.93 153.74 40.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.984 -1.073 . . . . 1.8 109.027 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 31.6 p-10 -59.82 -33.38 71.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.93 . . . . 2.73 110.441 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 97.7 mt-10 -60.12 -39.78 87.45 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.294 -0.879 . . . . 3.1699999999999999 110.161 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.86 -38.93 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.898 . . . . 1.3400000000000001 109.883 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.52 -45.04 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.897 -0.721 . . . . 1.2 110.627 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -59.88 -42.08 92.97 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.022 -1.071 . . . . 2.7000000000000002 110.193 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -62.23 -41.15 98.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -0.922 . . . . 2.5899999999999999 110.328 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 75.0 mtp -71.42 -40.27 70.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.256 -0.902 . . . . 1.3799999999999999 110.507 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -59.85 -40.9 90.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 2.8399999999999999 110.08 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.81 -57.87 4.2 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.961 -1.087 . . . . 1.8799999999999999 111.055 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 97.4 t -60.03 -41.26 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.726 -1.234 . . . . 2.3999999999999999 111.042 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -62.97 -50.16 71.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.888 -1.132 . . . . 3.52 110.832 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -63.37 -37.27 86.62 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.173 -0.954 . . . . 1.8799999999999999 110.93 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -59.89 -29.19 68.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.424 -1.423 . . . . 3.0099999999999998 110.631 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.47 -41.22 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 119.449 -0.901 . . . . 2.4500000000000002 109.421 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.79 -39.46 81.14 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.047 -0.661 . . . . 2.75 110.645 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.5 t -70.06 -44.35 69.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.037 -1.039 . . . . 3.1600000000000001 110.048 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -64.29 -33.54 76.06 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.614 -0.678 . . . . 3.5699999999999998 110.074 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -64.88 -33.74 76.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -0.822 . . . . 4.2999999999999998 110.861 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.39 97.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.983 -1.073 . . . . 4.4500000000000002 110.123 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.73 -17.54 61.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 5.9699999999999998 111.048 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.2 tp -67.27 -25.63 66.15 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.572 0.701 . . . . 6.1799999999999997 110.914 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.26 -13.83 62.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.265 -0.897 . . . . 6.6600000000000001 112.359 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -82.28 -5.47 58.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.095 -1.003 . . . . 8.1999999999999993 112.206 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 62.0 mt -87.35 39.3 0.86 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.256 -0.903 . . . . 8.0700000000000003 112.382 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -81.49 8.19 10.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.406 -0.809 . . . . 9.4499999999999993 112.184 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -91.61 11.88 22.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.211 -0.931 . . . . 10.119999999999999 112.029 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.462 -0.94 . . . . 11.49 108.462 179.223 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.151 0.5 . . . . 3.0699999999999998 110.274 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mt 48.29 74.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.849 -1.157 . . . . 1.0700000000000001 112.904 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.0 m -100.01 119.13 37.78 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.832 -1.544 . . . . 1.24 106.832 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.85 -141.35 9.92 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.615 -0.994 . . . . 1.01 110.615 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 5' ' ' ILE . 94.3 mt -97.71 -1.91 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.558 -0.966 . . . . 1.1100000000000001 113.008 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp 52.06 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.846 -1.159 . . . . 0.98999999999999999 112.265 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.23 -46.95 12.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.245 -0.909 . . . . 0.84999999999999998 111.193 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -143.4 145.33 31.5 Favored Pre-proline 0 N--CA 1.5 2.048 0 N-CA-C 107.784 -1.191 . . . . 1.3799999999999999 107.784 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.82 150.22 26.96 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.26 1.973 . . . . 0.93999999999999995 112.309 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.909 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 149.81 170.82 17.65 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 108.946 -1.662 . . . . 0.81000000000000005 108.946 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.573 HD12 ' OE1' ' A' ' 243' ' ' GLN . 7.4 mt -128.31 133.5 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 120.961 -1.317 . . . . 0.82999999999999996 107.828 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.08 145.16 47.66 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.663 -0.866 . . . . 0.53000000000000003 108.663 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.7 m-85 -117.39 141.04 48.81 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.302 -0.874 . . . . 0.77000000000000002 109.051 177.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.21 168.17 36.01 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.474 -1.822 . . . . 0.51000000000000001 110.096 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -76.59 160.52 29.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.861 -0.788 . . . . 1.8999999999999999 109.943 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.98 126.23 31.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.077 -1.015 . . . . 0.66000000000000003 108.38 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.468 HD12 HD21 ' A' ' 214' ' ' ASN . 63.1 tp -108.07 102.77 11.91 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 105.0 -2.222 . . . . 0.82999999999999996 105.0 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.418 ' H ' HD22 ' A' ' 214' ' ' ASN . 14.5 tp -90.58 138.06 31.86 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.602 -1.258 . . . . 0.85999999999999999 107.602 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 160' ' ' ALA . 36.9 mt -100.01 117.45 34.31 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.739 -1.578 . . . . 0.92000000000000004 106.739 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -111.93 140.08 46.89 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.27 -1.011 . . . . 2.0299999999999998 108.27 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.517 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 71.5 tt0 -123.82 139.82 53.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 2.6600000000000001 108.802 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.85 133.54 34.74 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.982 -1.118 . . . . 2.3199999999999998 107.982 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -62.19 143.01 57.34 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.633 -0.877 . . . . 2.1099999999999999 108.633 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.3 mt -95.23 135.44 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.121 -0.987 . . . . 0.72999999999999998 108.363 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.71 129.93 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.349 -0.982 . . . . 0.87 108.349 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.94 139.74 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.487 -0.931 . . . . 0.81000000000000005 108.487 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -91.26 119.04 30.99 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.333 -1.358 . . . . 1.3400000000000001 107.333 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.564 ' HG2' HH11 ' A' ' 28' ' ' ARG . 1.0 OUTLIER -95.89 11.72 32.79 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.94 -1.1 . . . . 2.8900000000000001 112.369 -179.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.5 150.64 47.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 2.0899999999999999 110.966 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -89.29 131.3 35.45 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.103 -1.073 . . . . 2.1899999999999999 108.103 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -94.29 165.4 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.04 . . . . 0.75 110.278 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.9 p -92.56 166.08 12.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.584 -0.697 . . . . 0.91000000000000003 109.724 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.84 -22.53 37.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.93000000000000005 111.85 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -67.2 -36.24 81.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.004 -1.06 . . . . 2.2799999999999998 110.87 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -92.43 -9.36 41.89 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.048 -1.032 . . . . 1.45 113.187 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.27 -43.72 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.936 -1.102 . . . . 0.81000000000000005 110.044 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -58.51 -39.97 81.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.096 -1.002 . . . . 1.54 110.574 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -61.37 -39.9 92.32 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.445 -0.784 . . . . 2.3599999999999999 110.028 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -61.06 -40.35 93.34 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 1.3100000000000001 110.373 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.71 -41.61 88.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.047 -1.033 . . . . 0.81999999999999995 110.024 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -60.72 -48.96 79.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.122 -0.986 . . . . 1.5 110.268 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -61.78 -43.21 99.3 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.552 -0.859 . . . . 2.23 109.979 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -73.37 -53.21 11.31 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.508 -0.745 . . . . 0.84999999999999998 109.748 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.8 tp -59.6 -47.2 86.49 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.477 -0.889 . . . . 0.91000000000000003 109.938 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.4 t -69.31 -34.41 74.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.90000000000000002 110.011 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.17 -41.82 92.96 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.177 -1.569 . . . . 0.68999999999999995 109.177 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 40.7 ttm-85 -58.73 -34.07 70.96 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.438 -0.905 . . . . 2.8799999999999999 109.053 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.34 -49.68 76.63 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.915 0.864 . . . . 0.84999999999999998 110.182 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.488 ' NZ ' ' OE1' ' A' ' 53' ' ' GLN . 26.9 ttpp -80.94 -42.37 21.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 2.3500000000000001 111.136 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.6 92.18 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.746 -0.781 . . . . 0.65000000000000002 110.093 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.2 t -60.11 -41.4 92.51 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.206 -0.934 . . . . 1.45 109.39 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 -48.4 62.52 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.554 -0.716 . . . . 0.63 110.63 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.488 ' OE1' ' NZ ' ' A' ' 49' ' ' LYS . 27.9 mt-30 -62.34 -49.29 76.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 1.3400000000000001 110.593 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.86 -37.28 86.22 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.084 -1.01 . . . . 1.5600000000000001 109.766 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -59.25 -40.65 86.64 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.652 -0.655 . . . . 1.1899999999999999 110.648 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -62.4 -40.33 96.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.924 -1.11 . . . . 0.71999999999999997 110.058 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.67 -39.85 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.62 110.513 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -50.14 -42.99 51.75 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.348 -0.845 . . . . 1.05 111.259 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.6 -36.12 78.25 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.03 -1.044 . . . . 0.64000000000000001 110.276 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -61.13 -37.91 84.48 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.945 -1.102 . . . . 1.73 108.984 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.29 86.8 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.793 -0.763 . . . . 0.56000000000000005 109.613 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.17 -34.75 40.39 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.332 -1.413 . . . . 0.68999999999999995 110.398 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -82.32 -20.08 38.08 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.254 -1.145 . . . . 1.48 111.308 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.2 m -86.37 -51.33 6.29 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.356 -0.84 . . . . 0.97999999999999998 110.428 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.96 -19.66 13.66 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.92 0.711 . . . . 1.1599999999999999 112.92 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.17 163.69 13.6 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 111.466 -0.653 . . . . 0.84999999999999998 111.466 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -56.32 -22.48 30.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.794 -0.827 . . . . 3.8599999999999999 112.603 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -58.21 -35.07 71.11 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.033 -1.042 . . . . 2.3500000000000001 111.631 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -86.61 -11.95 49.97 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.824 -1.172 . . . . 1.6699999999999999 113.07 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.75 -30.76 69.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.773 -1.204 . . . . 1.45 111.26 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.74 85.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.983 -1.073 . . . . 0.60999999999999999 111.241 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 72' ' ' ILE . 15.8 mt -68.02 -48.01 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.823 -1.173 . . . . 0.65000000000000002 110.13 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -69.87 -32.47 70.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.375 -0.828 . . . . 0.66000000000000003 110.539 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.36 -37.44 80.71 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.054 -1.029 . . . . 1.1899999999999999 110.075 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.22 -38.32 91.77 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 120.281 -0.962 . . . . 0.53000000000000003 110.827 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -59.6 -45.89 90.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.902 -1.352 . . . . 1.27 110.599 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.1 mt -60.31 -38.84 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.863 -1.148 . . . . 0.54000000000000004 110.488 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.2 ttt -59.55 -39.89 85.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.49 -0.756 . . . . 1.74 110.626 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 tp -59.19 -48.76 80.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.386 -0.926 . . . . 0.55000000000000004 109.953 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.446 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 61.3 tp -60.91 -45.92 92.73 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.653 0.739 . . . . 0.46999999999999997 110.754 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.11 11.87 7.33 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.225 0.824 . . . . 1.4199999999999999 113.225 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -63.96 123.83 19.99 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.798 -0.816 . . . . 1.27 108.798 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -65.52 -18.09 65.06 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.742 0.782 . . . . 1.3500000000000001 110.819 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.71 -56.88 4.08 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.452 0.644 . . . . 2.2200000000000002 110.046 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.29 -40.18 89.56 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.006 -0.678 . . . . 0.62 110.64 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -58.55 -49.96 75.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.132 -0.98 . . . . 1.29 110.969 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -62.81 -38.03 89.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 1.52 110.443 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -65.92 -48.92 69.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 1.3 110.458 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.9 mt -55.98 -42.93 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.058 -1.026 . . . . 0.60999999999999999 109.653 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.0 mt -61.73 -44.0 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.435 -0.79 . . . . 0.78000000000000003 110.316 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -61.8 -44.29 97.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.81999999999999995 110.942 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.01 -44.63 94.45 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.912 -1.117 . . . . 0.80000000000000004 110.463 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.0 mt -60.61 -48.39 88.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.267 -0.895 . . . . 0.77000000000000002 110.712 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -81.56 -33.55 31.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.407 -0.808 . . . . 2.1200000000000001 111.714 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 91' ' ' ALA . 54.2 t0 -82.93 -40.18 20.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.091 -1.006 . . . . 1.51 111.457 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -103.09 7.13 38.89 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.241 -0.912 . . . . 1.98 112.263 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.5 m80 51.3 44.62 28.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 1.3200000000000001 111.953 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.9 mtt -102.93 153.73 19.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.417 -0.802 . . . . 1.3799999999999999 109.425 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.407 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 43.2 p -70.54 160.71 31.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.67000000000000004 109.506 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.6 92.9 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.93 -1.106 . . . . 0.52000000000000002 110.874 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 24.2 p-10 -69.42 -38.27 77.8 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.985 -1.072 . . . . 2.25 110.024 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.74 -51.2 43.9 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.052 -1.059 . . . . 0.64000000000000001 111.388 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.69 90.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.56000000000000005 111.049 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.32 -41.81 85.37 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.352 -0.842 . . . . 0.46000000000000002 110.613 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.56 -38.74 85.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.414 -0.804 . . . . 1.3200000000000001 111.173 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -58.06 -48.42 80.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.881 -1.137 . . . . 1.3 111.087 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.04 -43.64 96.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.882 -1.136 . . . . 0.60999999999999999 110.772 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mm -62.71 -35.26 69.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.605 -0.684 . . . . 0.65000000000000002 110.318 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -57.44 -39.81 77.07 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.876 -0.73 . . . . 2.1099999999999999 111.207 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.73 -35.61 11.39 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 118.842 -1.647 . . . . 0.82999999999999996 112.693 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -61.12 -41.2 96.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.497 -1.59 . . . . 1.28 110.145 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.6 -50.91 22.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.932 0.872 . . . . 0.89000000000000001 110.471 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.9 p -62.34 -37.85 87.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.862 . . . . 1.8700000000000001 110.814 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.86 -40.77 98.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 1.05 110.943 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.59 -30.18 70.41 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.637 -1.289 . . . . 1.02 110.892 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -67.34 -22.09 65.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.83 -1.169 . . . . 2.04 110.93 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.5 -11.79 60.81 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.103 -1.039 . . . . 1.73 111.0 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 123' ' ' LEU . 75.8 mt -87.16 144.91 26.63 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.282 -0.636 . . . . 1.3700000000000001 109.282 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -100.19 39.73 1.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.344 -0.847 . . . . 2.8799999999999999 111.58 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.48 ' CB ' HD12 ' A' ' 123' ' ' LEU . 7.3 t0 -113.57 135.8 53.51 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 108.261 -1.014 . . . . 1.5800000000000001 108.261 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -57.67 -40.15 78.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.499 -0.75 . . . . 3.04 111.198 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -72.81 -51.14 20.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.731 -1.231 . . . . 0.90000000000000002 110.714 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 118' ' ' LEU . 23.9 mt -59.29 -41.28 88.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.26 -0.9 . . . . 1.0600000000000001 110.541 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 71.5 tttt -64.12 -46.7 83.01 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.209 -0.996 . . . . 2.1800000000000002 109.793 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -60.17 -33.45 72.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.49 -0.884 . . . . 2.1499999999999999 109.561 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.522 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 29.7 ttt-85 -60.79 -29.66 69.58 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.306 1.05 . . . . 2.3300000000000001 108.935 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.78 -49.47 77.6 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.825 0.821 . . . . 0.81999999999999995 109.396 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.19 -45.81 86.73 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.722 -0.791 . . . . 0.84999999999999998 109.774 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.02 -36.85 82.79 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.632 -0.668 . . . . 1.3899999999999999 110.168 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.522 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 48.3 t -69.41 -40.04 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.56000000000000005 110.037 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -57.9 -38.46 75.88 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.44 -0.904 . . . . 3.1200000000000001 110.041 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -59.95 -39.57 86.03 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.594 0.711 . . . . 1.28 109.87 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.6 -36.96 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.216 -0.928 . . . . 0.48999999999999999 109.937 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.81 -56.93 22.24 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 120.009 -1.091 . . . . 0.46000000000000002 111.353 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -59.07 -39.72 82.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.153 -1.204 . . . . 2.71 110.256 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -60.12 -44.81 94.62 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.775 -1.17 . . . . 2.1400000000000001 109.57 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.98 -43.89 94.84 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.433 -0.792 . . . . 1.05 110.176 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.63 -44.87 93.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.447 -0.783 . . . . 0.52000000000000002 110.365 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.517 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 98.8 mtt180 -60.13 -33.19 71.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.893 . . . . 2.3500000000000001 111.071 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -76.38 -42.95 42.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.098 -1.001 . . . . 1.3899999999999999 110.725 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.72 -40.17 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.68000000000000005 110.105 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.87 -11.27 45.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.076 -1.015 . . . . 0.82999999999999996 111.757 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.6 21.67 71.66 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.73 -1.224 . . . . 0.91000000000000003 112.91 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -62.73 147.41 49.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.806 -0.82 . . . . 0.94999999999999996 109.139 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -67.0 147.05 53.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.303 -0.873 . . . . 2.4300000000000002 108.905 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.9 mt -105.74 149.16 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.419 -0.956 . . . . 1.1000000000000001 108.419 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.556 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.4 mp -77.65 119.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.157 -0.964 . . . . 1.5800000000000001 108.727 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -99.51 96.5 7.71 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.66 -1.607 . . . . 1.6200000000000001 106.66 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.7 mt -77.36 -12.44 59.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.903 . . . . 0.80000000000000004 111.628 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.5 p -81.7 3.0 27.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.138 -0.977 . . . . 1.5600000000000001 112.072 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.68 18.46 14.27 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.67 -0.644 . . . . 0.83999999999999997 112.579 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.8 mt -71.97 138.95 20.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.52 -0.738 . . . . 0.81999999999999995 109.271 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -118.54 -15.79 9.55 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.834 0.826 . . . . 2.3100000000000001 112.629 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -114.33 138.66 50.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.974 -1.121 . . . . 1.54 107.974 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -72.66 121.98 20.69 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.33 -0.989 . . . . 1.3799999999999999 108.33 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.6 m -144.49 174.95 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.033 -0.728 . . . . 0.68999999999999995 109.033 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.6 mt -89.45 142.15 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.793 -1.192 . . . . 0.53000000000000003 109.088 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 31.5 tp -94.49 123.05 37.67 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.29 -1.004 . . . . 0.64000000000000001 108.29 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.65 129.64 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.705 -1.22 . . . . 0.67000000000000004 107.705 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.32 154.68 21.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.149 -0.97 . . . . 0.78000000000000003 108.826 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.93 -37.31 86.53 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.541 -1.349 . . . . 1.0 109.458 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -173.3 147.86 1.57 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.166 -0.679 . . . . 2.4199999999999999 109.166 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.1 mt -115.93 143.25 45.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.489 -0.757 . . . . 0.75 109.21 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.7 p -89.45 147.43 38.04 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.162 -0.961 . . . . 0.78000000000000003 108.881 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -40.49 -42.48 3.91 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.892 1.728 . . . . 0.67000000000000004 113.673 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.8 m -61.32 -50.25 73.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.017 -1.052 . . . . 0.69999999999999996 110.295 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -61.42 -39.67 91.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.435 -0.79 . . . . 1.21 109.772 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.6 p -68.75 -39.69 80.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.608 -0.682 . . . . 0.59999999999999998 110.458 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.41 79.38 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.928 -0.709 . . . . 0.62 110.531 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -93.71 -1.03 55.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.902 . . . . 1.1599999999999999 112.727 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.84 148.6 38.81 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.262 -1.014 . . . . 0.72999999999999998 108.262 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -96.4 114.81 26.51 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.839 -1.541 . . . . 2.2400000000000002 106.839 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 173' ' ' LEU . 7.5 mp -73.37 -20.39 60.77 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.433 0.635 . . . . 1.4299999999999999 111.77 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -80.42 -21.85 41.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 2.1499999999999999 112.037 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -100.23 -6.08 26.6 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 113.198 0.814 . . . . 2.04 113.198 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 178' ' ' GLY . 62.1 t -110.26 129.52 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.616 -1.254 . . . . 0.55000000000000004 107.616 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.5 -6.29 54.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 1.6299999999999999 112.635 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.47 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.53 164.79 33.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.788 -1.725 . . . . 0.46999999999999997 108.788 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -122.72 127.48 49.28 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.402 -1.333 . . . . 0.54000000000000004 107.402 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.413 HD11 HD13 ' A' ' 220' ' ' LEU . 24.9 mt -127.36 127.64 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.802 -1.555 . . . . 0.68999999999999995 106.802 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.5 p -140.43 166.27 25.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.865 -1.147 . . . . 0.81999999999999995 109.486 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.429 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 1.5 m-20 -104.4 43.25 1.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.746 -0.596 . . . . 2.3700000000000001 110.341 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.8 140.52 32.05 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.082 -1.011 . . . . 1.1100000000000001 108.906 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -48.14 -16.86 0.54 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 120.289 -0.957 . . . . 1.6699999999999999 112.322 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 83.98 -12.5 53.38 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.008 -1.289 . . . . 1.54 113.331 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.443 ' O ' ' OG1' ' A' ' 187' ' ' THR . 48.7 ttt180 -74.54 117.84 16.82 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.905 -1.146 . . . . 4.4800000000000004 107.905 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 22.4 p 48.69 35.59 6.52 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.474 -0.891 . . . . 2.6299999999999999 111.968 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.1 t -83.59 130.31 34.99 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.14 -1.059 . . . . 1.6899999999999999 108.14 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -59.96 -39.14 84.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 1.0700000000000001 110.651 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 57.5 p -60.03 -40.34 88.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 1.5800000000000001 110.546 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.0 t -60.08 -36.86 78.3 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.167 -0.958 . . . . 1.6000000000000001 110.12 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.2 mm -60.48 -38.87 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.735 -0.603 . . . . 1.45 110.814 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 75.1 mtp -61.01 -45.36 95.12 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.616 1.198 . . . . 1.05 109.157 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.02 -50.47 73.61 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.462 -0.79 . . . . 0.71999999999999997 110.823 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -59.65 -44.84 93.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 3.0499999999999998 111.179 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.9 m -70.2 -40.85 74.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.863 . . . . 0.89000000000000001 110.543 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 18.3 mt -90.89 -7.0 53.41 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.071 0.939 . . . . 0.78000000000000003 112.242 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 194' ' ' ALA . 93.7 mt-10 53.67 9.71 0.2 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.929 1.085 . . . . 1.45 113.929 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.38 147.91 90.43 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 120.844 -1.16 . . . . 0.67000000000000004 107.972 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.79 137.28 60.14 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.374 1.383 . . . . 0.64000000000000001 110.07 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.67 166.2 24.78 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.225 -1.39 . . . . 0.67000000000000004 109.839 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 35.9 mt -148.16 151.07 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.872 -1.159 . . . . 0.68999999999999995 107.872 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.7 m -134.82 -26.63 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.845 -1.159 . . . . 0.84999999999999998 112.027 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.19 42.4 2.85 Favored Glycine 0 N--CA 1.49 2.258 0 O-C-N 120.985 -1.072 . . . . 0.92000000000000004 111.432 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 69.8 p -64.04 -24.15 67.6 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.925 -1.338 . . . . 0.94999999999999996 111.233 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.86 -90.05 1.48 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 120.042 -1.075 . . . . 1.04 110.596 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.7 t -130.83 32.3 4.37 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.291 -1.123 . . . . 1.5700000000000001 113.04 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.9 t -56.29 -32.76 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.255 -1.528 . . . . 0.83999999999999997 110.439 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.6 p -59.04 -25.42 63.69 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.058 -1.026 . . . . 0.98999999999999999 111.215 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.8 m -92.96 1.89 57.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 1.7 112.063 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -125.66 -5.72 6.97 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.441 0.904 . . . . 2.2000000000000002 113.441 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.6 t -118.83 148.03 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.424 -0.798 . . . . 0.83999999999999997 109.515 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -120.42 150.45 40.77 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.998 -1.112 . . . . 2.2000000000000002 107.998 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.468 HD21 HD12 ' A' ' 17' ' ' LEU . 26.2 t-20 -51.32 141.29 15.39 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.233 -0.917 . . . . 2.2799999999999998 110.562 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 80.93 -3.81 1.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.028 1.121 . . . . 2.3500000000000001 114.028 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -61.68 146.01 50.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.814 -1.179 . . . . 1.97 108.284 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -87.32 118.18 26.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.529 -1.286 . . . . 2.6499999999999999 107.529 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.92 147.64 50.86 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.454 -0.779 . . . . 0.63 109.552 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 13.7 mt -119.14 130.06 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.186 -1.413 . . . . 0.62 107.186 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.413 HD13 HD11 ' A' ' 180' ' ' ILE . 54.1 tp -98.5 122.88 42.25 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.732 -1.211 . . . . 0.64000000000000001 107.732 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 223' ' ' VAL . 43.8 t0 -94.03 -29.58 15.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.785 -1.197 . . . . 2.0499999999999998 112.385 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.62 18.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.92 0.711 . . . . 0.83999999999999997 112.92 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -109.68 -60.49 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.059 -1.025 . . . . 1.02 109.222 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -93.74 11.15 30.14 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.949 0.88 . . . . 2.5099999999999998 110.018 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 63.32 53.16 2.25 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.657 -0.702 . . . . 1.54 112.205 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -149.04 154.84 39.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.482 -0.761 . . . . 1.95 109.515 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.6 135.85 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.595 -1.261 . . . . 0.70999999999999996 107.595 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -102.83 130.51 49.85 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.118 -0.988 . . . . 1.01 108.97 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.14 127.81 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.682 -1.229 . . . . 0.81999999999999995 107.682 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 50.1 53.16 13.76 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 113.428 0.899 . . . . 1.54 113.428 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 151.15 79.64 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 123.028 2.486 . . . . 0.93999999999999995 111.085 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 67.3 p -73.97 155.29 38.78 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.739 -0.837 . . . . 1.8 108.739 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -60.26 -37.94 81.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 2.73 110.714 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -50.83 -44.28 59.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.056 -1.027 . . . . 3.1699999999999999 110.445 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.24 -39.93 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.189 -0.944 . . . . 1.3400000000000001 110.64 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.76 -49.16 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.897 -0.721 . . . . 1.2 110.962 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.41 -39.64 84.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.922 -1.111 . . . . 2.7000000000000002 110.777 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -61.1 -44.85 96.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 2.5899999999999999 110.761 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 55.3 mtm -75.1 -37.8 61.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.819 -1.175 . . . . 1.3799999999999999 111.301 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -58.63 -40.26 82.86 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.962 -1.087 . . . . 2.8399999999999999 111.161 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.56 -53.38 16.29 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.735 -1.228 . . . . 1.8799999999999999 110.638 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.68 -48.49 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.911 -1.118 . . . . 2.3999999999999999 111.166 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.573 ' OE1' HD12 ' A' ' 11' ' ' ILE . 54.3 tp60 -59.69 -49.86 76.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.714 -1.241 . . . . 3.52 111.442 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.9 -31.11 70.61 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.663 -1.215 . . . . 1.8799999999999999 110.208 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -64.3 -29.9 70.97 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.119 -1.032 . . . . 3.0099999999999998 110.119 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.79 -42.52 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.387 0.613 . . . . 2.4500000000000002 110.403 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.08 -40.66 94.54 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.595 -0.842 . . . . 2.75 110.248 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.2 t -69.63 -41.07 76.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 3.1600000000000001 110.368 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -63.95 -36.85 85.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.485 -0.76 . . . . 3.5699999999999998 110.039 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -66.79 -30.31 70.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.012 . . . . 4.2999999999999998 111.42 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -62.34 -35.19 78.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.027 -1.045 . . . . 4.4500000000000002 110.913 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -69.55 -27.68 65.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.173 -0.954 . . . . 5.9699999999999998 111.353 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.36 -28.91 70.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.426 -0.796 . . . . 6.1799999999999997 111.659 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -66.88 -14.17 62.45 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.092 -1.005 . . . . 6.6600000000000001 112.69 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -78.8 -9.31 59.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.829 -1.169 . . . . 8.1999999999999993 112.569 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.86 2.69 48.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.752 -1.217 . . . . 8.0700000000000003 112.267 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -84.56 -3.45 58.45 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.161 -0.962 . . . . 9.4499999999999993 113.17 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -92.65 -29.39 16.13 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.782 -1.199 . . . . 10.119999999999999 113.368 -177.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.864 -1.065 . . . . 11.49 109.326 -177.319 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mtp . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 108.897 -0.779 . . . . 3.0699999999999998 108.897 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mt -103.62 120.67 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.305 -1.739 . . . . 1.0700000000000001 106.305 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.4 m -101.11 123.45 45.28 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.663 -1.236 . . . . 1.24 107.663 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.35 -159.4 11.76 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 108.708 -1.757 . . . . 1.01 108.708 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 5' ' ' ILE . 95.0 mt -99.19 2.32 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.439 -1.036 . . . . 1.1100000000000001 112.744 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 48.61 94.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.636 -1.29 . . . . 0.98999999999999999 112.171 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -84.84 -40.48 17.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.471 -1.393 . . . . 0.84999999999999998 111.49 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.27 144.29 18.55 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 107.465 -1.309 . . . . 1.3799999999999999 107.465 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.11 142.31 27.36 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.574 2.183 . . . . 0.93999999999999995 112.192 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.945 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.55 171.31 23.39 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.36 -1.496 . . . . 0.81000000000000005 109.36 178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.409 HG21 ' HG3' ' A' ' 243' ' ' GLN . 86.9 mt -134.21 133.7 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.819 -1.401 . . . . 0.82999999999999996 107.574 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.09 156.8 45.93 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.141 0.972 . . . . 0.53000000000000003 109.664 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.422 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 13.2 m-85 -120.99 140.21 52.22 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.93 -1.137 . . . . 0.77000000000000002 107.93 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.21 166.62 36.22 Favored Glycine 0 N--CA 1.499 2.841 0 C-N-CA 119.044 -1.551 . . . . 0.51000000000000001 109.901 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -80.09 157.84 26.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.297 -1.12 . . . . 1.8999999999999999 109.668 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -85.76 128.68 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.149 -1.056 . . . . 0.66000000000000003 108.149 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.5 tp -107.24 105.47 15.46 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 105.327 -2.101 . . . . 0.82999999999999996 105.327 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.6 tp -93.32 135.43 34.54 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.036 -1.098 . . . . 0.85999999999999999 108.036 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.9 mt -99.54 118.1 35.38 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.584 -1.635 . . . . 0.92000000000000004 106.584 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -110.56 123.74 50.52 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.782 -1.562 . . . . 2.0299999999999998 106.782 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -131.38 158.25 41.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.946 -1.096 . . . . 2.6600000000000001 108.701 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -84.95 138.79 32.27 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.782 -0.822 . . . . 2.3199999999999998 108.782 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.41 156.33 36.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.948 . . . . 2.1099999999999999 109.496 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.7 mt -86.24 133.91 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.035 -1.041 . . . . 0.72999999999999998 108.444 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -110.38 130.71 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.815 -1.18 . . . . 0.87 107.815 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.8 mt -94.66 134.34 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.647 -0.871 . . . . 0.81000000000000005 108.647 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -92.41 120.5 32.97 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.086 -1.079 . . . . 1.3400000000000001 108.086 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.561 ' HG2' HH11 ' A' ' 28' ' ' ARG . 1.7 mmt-85 -93.56 16.98 12.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.007 -1.058 . . . . 2.8900000000000001 112.43 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -60.33 140.14 57.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.014 -1.054 . . . . 2.0899999999999999 109.81 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -87.65 132.51 34.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.839 -1.163 . . . . 2.1899999999999999 108.004 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 pt -96.89 165.55 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.75 110.584 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.7 p -97.91 170.45 8.95 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.241 -0.912 . . . . 0.91000000000000003 109.507 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.1 66.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.394 -0.816 . . . . 0.93000000000000005 111.454 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.64 -33.47 74.07 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.436 -0.79 . . . . 2.2799999999999998 110.648 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -90.95 -7.57 51.7 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.738 -1.226 . . . . 1.45 112.502 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.48 -42.67 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.81000000000000005 110.183 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -58.11 -39.91 79.88 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.307 -0.871 . . . . 1.54 111.136 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -63.44 -43.92 96.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.734 -0.604 . . . . 2.3599999999999999 111.233 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -60.67 -40.15 91.03 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.803 -1.186 . . . . 1.3100000000000001 110.189 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.6 t -60.68 -40.83 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.108 -0.995 . . . . 0.81999999999999995 109.963 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -61.59 -44.86 96.24 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.447 -0.783 . . . . 1.5 110.223 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 42' ' ' ARG . 43.5 mtt-85 -62.11 -40.05 94.59 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.33 -0.856 . . . . 2.23 110.152 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -70.53 -57.17 5.05 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.36 -0.837 . . . . 0.84999999999999998 110.235 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.79 -47.4 85.84 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.914 -1.115 . . . . 0.91000000000000003 109.582 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.8 t -69.33 -37.46 77.73 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.399 -0.92 . . . . 0.90000000000000002 109.814 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.05 -43.28 93.26 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.053 -1.546 . . . . 0.68999999999999995 109.681 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -59.87 -30.66 69.14 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.167 0.984 . . . . 2.8799999999999999 109.476 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.38 -41.79 90.15 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.427 -0.796 . . . . 0.84999999999999998 110.348 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -80.22 -49.77 11.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.371 -0.932 . . . . 2.3500000000000001 110.699 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.91 76.8 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.468 -0.77 . . . . 0.65000000000000002 110.279 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.4 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 94.7 p -60.09 -40.35 89.31 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.136 0.97 . . . . 1.45 109.178 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -47.53 44.42 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.834 0.826 . . . . 0.63 110.733 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -64.5 -48.31 75.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.521 -1.362 . . . . 1.3400000000000001 110.958 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.18 -37.98 89.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.726 -0.789 . . . . 1.5600000000000001 109.842 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 51' ' ' SER . 17.5 mm-40 -59.81 -40.33 88.04 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.275 -0.57 . . . . 1.1899999999999999 110.272 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.1 m -63.76 -42.24 97.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.234 -0.916 . . . . 0.71999999999999997 110.343 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 99.5 mt -59.97 -37.3 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.716 0.77 . . . . 0.62 110.268 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -50.4 -44.24 54.91 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.46 -0.775 . . . . 1.05 110.753 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -69.12 -33.71 73.9 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.156 -0.965 . . . . 0.64000000000000001 110.225 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -64.22 -40.28 95.72 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.185 -1.406 . . . . 1.73 109.526 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.75 -30.16 71.16 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.856 -0.738 . . . . 0.56000000000000005 110.151 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.12 -34.18 18.5 Favored Glycine 0 N--CA 1.484 1.872 0 C-N-CA 119.559 -1.305 . . . . 0.68999999999999995 110.893 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -81.7 -20.41 39.49 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.358 -1.083 . . . . 1.48 111.199 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.5 m -90.16 -51.98 5.18 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 120.941 0.401 . . . . 0.97999999999999998 110.842 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -107.83 -9.12 15.81 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 113.616 0.969 . . . . 1.1599999999999999 113.616 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.09 167.01 23.12 Favored Glycine 0 N--CA 1.502 3.09 0 O-C-N 121.24 -0.913 . . . . 0.84999999999999998 112.764 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.96 -21.94 59.34 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.785 -0.833 . . . . 3.8599999999999999 112.131 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -57.7 -40.05 78.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.959 -1.088 . . . . 2.3500000000000001 110.905 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -87.07 -25.48 24.15 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.43 -0.908 . . . . 1.6699999999999999 111.459 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -60.65 -38.0 83.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.904 -0.497 . . . . 1.45 111.405 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.12 90.35 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.242 -0.911 . . . . 0.60999999999999999 112.055 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -64.77 -41.72 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.339 -1.476 . . . . 0.65000000000000002 110.381 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -69.44 -32.09 70.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.603 -1.311 . . . . 0.66000000000000003 110.428 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -59.44 -39.73 84.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.783 -1.198 . . . . 1.1899999999999999 109.909 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.74 97.95 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.894 -0.883 . . . . 0.53000000000000003 110.894 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -59.77 -41.2 90.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.906 -1.349 . . . . 1.27 110.633 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.4 mt -60.29 -38.16 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.807 -1.183 . . . . 0.54000000000000004 110.658 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.7 ttp -58.85 -39.78 82.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.917 . . . . 1.74 110.528 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.65 -48.26 81.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.917 -1.115 . . . . 0.55000000000000004 110.629 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.2 tp -59.92 -40.92 90.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.493 -0.755 . . . . 0.46999999999999997 110.435 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -86.06 6.09 30.58 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.022 -0.671 . . . . 1.4199999999999999 112.508 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -60.33 121.82 12.98 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.917 -1.114 . . . . 1.27 109.348 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -68.0 -17.63 64.48 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 121.145 -0.972 . . . . 1.3500000000000001 110.792 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -74.14 -46.7 40.8 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.787 -1.165 . . . . 2.2200000000000002 110.419 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.0 -35.47 80.82 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.209 -0.996 . . . . 0.62 110.023 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -58.69 -45.09 90.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.166 -0.959 . . . . 1.29 110.798 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -63.98 -41.6 97.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.926 -1.109 . . . . 1.52 110.78 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -67.98 -49.53 61.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.737 -1.227 . . . . 1.3 110.506 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.12 -43.49 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 118.978 -1.089 . . . . 0.60999999999999999 110.372 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.433 HG22 ' NZ ' ' A' ' 94' ' ' LYS . 52.2 mt -62.17 -43.85 98.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.107 -0.996 . . . . 0.78000000000000003 110.54 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.36 -41.13 93.07 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.251 -0.906 . . . . 0.81999999999999995 110.894 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.31 -44.28 95.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.162 -0.961 . . . . 0.80000000000000004 110.606 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.71 -49.2 83.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.266 -0.896 . . . . 0.77000000000000002 110.322 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.433 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 20.5 mtmm -82.43 -28.59 31.25 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.603 -1.31 . . . . 2.1200000000000001 112.182 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -79.16 -45.66 19.5 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 120.242 -1.536 . . . . 1.51 111.293 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -104.62 7.59 35.04 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.752 -1.218 . . . . 1.98 111.884 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.8 m80 54.26 50.15 17.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 1.3200000000000001 112.291 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 73.2 mtm -105.88 161.0 14.83 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.722 -1.236 . . . . 1.3799999999999999 109.502 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.1 p -72.75 158.89 34.71 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.846 0.832 . . . . 0.67000000000000004 109.368 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.68 87.99 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.148 -0.97 . . . . 0.52000000000000002 110.658 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.55 ' OD2' HD21 ' A' ' 142' ' ' LEU . 98.9 m-20 -67.34 -40.75 85.88 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.805 -1.184 . . . . 2.25 110.069 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.43 39.8 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.207 -0.997 . . . . 0.64000000000000001 110.816 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.13 96.52 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.661 0.743 . . . . 0.56000000000000005 110.338 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.43 93.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.648 -0.658 . . . . 0.46000000000000002 111.08 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.75 -38.97 83.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.307 -0.871 . . . . 1.3200000000000001 111.335 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.14 -48.28 82.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.091 -1.006 . . . . 1.3 111.19 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.56 -43.22 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.658 -1.217 . . . . 0.60999999999999999 110.225 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.1 mm -60.61 -33.08 53.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.799 -0.563 . . . . 0.65000000000000002 110.697 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -59.53 -40.21 86.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.351 -0.54 . . . . 2.1099999999999999 110.745 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.92 -30.52 25.89 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.018 -1.563 . . . . 0.82999999999999996 113.128 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -61.37 -40.43 94.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.216 -1.755 . . . . 1.28 109.69 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.23 -45.72 59.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.064 0.935 . . . . 0.89000000000000001 109.718 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.2 m -60.36 -39.24 86.5 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.346 0.593 . . . . 1.8700000000000001 110.049 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.83 -46.51 89.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.416 -0.803 . . . . 1.05 110.866 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 127' ' ' ALA . 90.2 mt -66.03 -26.89 67.73 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.506 -1.371 . . . . 1.02 110.87 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -66.22 -26.45 67.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.875 . . . . 2.04 111.572 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -70.65 -13.48 62.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.943 -1.103 . . . . 1.73 111.48 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 78.8 mt -88.72 140.2 29.69 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.838 0.828 . . . . 1.3700000000000001 109.383 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -94.85 41.44 1.09 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.816 -1.178 . . . . 2.8799999999999999 111.258 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -111.87 133.42 54.08 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.07 0.938 . . . . 1.5800000000000001 108.903 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.59 -29.2 69.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.708 -0.62 . . . . 3.04 111.348 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.03 -60.32 2.38 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.655 -1.278 . . . . 0.90000000000000002 110.703 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.78 -38.2 90.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 1.0600000000000001 110.801 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -63.38 -50.88 68.15 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.779 -1.201 . . . . 2.1800000000000002 110.093 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.67 -32.17 71.38 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.094 -1.042 . . . . 2.1499999999999999 109.602 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.519 ' O ' HG23 ' A' ' 130' ' ' VAL . 37.4 ttp180 -65.89 -26.97 67.86 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.778 0.799 . . . . 2.3300000000000001 109.485 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 115' ' ' LEU . . . -58.88 -47.88 83.38 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.599 -0.84 . . . . 0.81999999999999995 108.998 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.81 -43.92 91.57 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.306 -0.957 . . . . 0.84999999999999998 110.017 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -64.29 -31.38 72.56 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.422 0.629 . . . . 1.3899999999999999 110.446 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 126' ' ' ARG . 32.3 t -68.7 -39.19 79.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 C-N-CA 119.942 -0.703 . . . . 0.56000000000000005 109.961 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.404 ' NH1' ' HG3' ' A' ' 131' ' ' ARG . 38.1 ttm-85 -59.32 -38.01 79.2 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.73 -1.188 . . . . 3.1200000000000001 109.285 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -59.92 -38.94 83.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.881 -0.512 . . . . 1.28 110.602 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.7 mt -60.33 -40.0 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.975 -1.078 . . . . 0.48999999999999999 110.148 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.12 -46.96 93.28 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.475 -1.05 . . . . 0.46000000000000002 110.475 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -59.99 -41.08 91.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.966 -1.314 . . . . 2.71 110.658 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -60.07 -42.7 95.13 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.315 -0.865 . . . . 2.1400000000000001 110.18 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.41 -40.41 94.3 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.174 0.988 . . . . 1.05 109.881 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.0 mt -61.66 -40.67 95.76 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.353 -0.842 . . . . 0.52000000000000002 110.746 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -61.34 -38.2 86.05 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.509 -0.745 . . . . 2.3500000000000001 111.316 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -74.4 -42.6 58.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.954 -1.091 . . . . 1.3899999999999999 110.993 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.21 -38.95 79.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.013 -1.054 . . . . 0.68000000000000005 110.553 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.55 HD21 ' OD2' ' A' ' 101' ' ' ASP . 83.9 mt -87.35 -3.08 59.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.829 -1.169 . . . . 0.82999999999999996 111.793 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.83 23.03 78.64 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.613 -1.28 . . . . 0.91000000000000003 113.577 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.5 tp -61.97 150.04 38.99 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 122.053 -0.675 . . . . 0.94999999999999996 109.746 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -66.93 157.27 33.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.503 -0.748 . . . . 2.4300000000000002 110.16 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.4 mt -101.18 139.5 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.46 -0.941 . . . . 1.1000000000000001 108.46 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.761 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.3 mp -79.49 120.51 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.797 -1.186 . . . . 1.5800000000000001 107.797 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -98.62 93.41 6.1 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.881 -1.525 . . . . 1.6200000000000001 106.881 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 76.6 mt -75.39 -21.29 58.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.898 . . . . 0.80000000000000004 111.599 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.5 t -82.77 10.24 8.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.169 -0.957 . . . . 1.5600000000000001 112.101 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.95 18.52 14.49 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.269 -0.894 . . . . 0.83999999999999997 112.435 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.408 ' O ' ' CD ' ' A' ' 175' ' ' LYS . 23.8 mt -75.28 141.03 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.203 -0.935 . . . . 0.81999999999999995 110.015 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -117.62 -13.67 10.24 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.361 -0.837 . . . . 2.3100000000000001 112.795 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -117.03 141.95 47.59 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.612 -0.884 . . . . 1.54 108.612 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -77.04 122.83 25.49 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.271 -1.011 . . . . 1.3799999999999999 108.271 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.2 m -147.31 178.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.226 -0.657 . . . . 0.68999999999999995 109.226 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.4 mt -87.4 143.92 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.683 -0.858 . . . . 0.53000000000000003 108.683 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 34.7 tp -97.57 126.1 42.67 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.912 -1.118 . . . . 0.64000000000000001 108.367 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.0 t -126.43 129.23 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.126 -1.065 . . . . 0.67000000000000004 108.126 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.17 159.91 32.23 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.272 -0.893 . . . . 0.78000000000000003 108.601 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.18 93.34 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.539 -1.264 . . . . 1.0 109.97 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 46.8 p-10 -173.96 150.02 1.57 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.304 -0.628 . . . . 2.4199999999999999 109.304 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.2 mt -115.41 141.54 47.91 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.346 -0.846 . . . . 0.75 109.276 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.9 p -93.92 150.7 38.98 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.162 -0.961 . . . . 0.78000000000000003 108.455 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -39.25 -44.97 2.91 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.772 1.648 . . . . 0.67000000000000004 113.243 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.3 m -59.58 -49.41 77.86 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.168 -0.957 . . . . 0.69999999999999996 110.306 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.34 -40.4 94.1 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.743 -0.783 . . . . 1.21 110.001 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.9 p -67.58 -37.12 82.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.815 0.817 . . . . 0.59999999999999998 110.222 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.18 -39.84 87.9 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.519 -0.738 . . . . 0.62 110.54 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -94.21 0.22 55.57 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.094 -1.004 . . . . 1.1599999999999999 113.105 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.89 149.21 41.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.738 -1.226 . . . . 0.72999999999999998 108.498 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -94.45 114.71 26.77 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 106.812 -1.551 . . . . 2.2400000000000002 106.812 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 173' ' ' LEU . 10.6 mp -80.79 -10.41 59.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.552 -0.718 . . . . 1.4299999999999999 112.435 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -83.45 -23.25 32.33 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.984 -1.073 . . . . 2.1499999999999999 111.954 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.408 ' CD ' ' O ' ' A' ' 152' ' ' ILE . 90.7 mttt -105.41 4.16 30.44 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.22 -0.925 . . . . 2.04 112.777 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.9 t -108.85 128.63 64.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.929 -1.137 . . . . 0.55000000000000004 107.929 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.713 ' O ' HD23 ' A' ' 177' ' ' LEU . 2.0 tt -92.93 -6.31 48.83 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.208 1.004 . . . . 1.6299999999999999 111.53 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.39 168.28 37.51 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.746 -1.741 . . . . 0.46999999999999997 108.746 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -124.04 128.85 49.95 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.559 -1.274 . . . . 0.54000000000000004 107.559 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.9 mt -130.77 129.86 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.968 -1.864 . . . . 0.68999999999999995 105.968 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.2 p -140.94 176.1 9.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.167 -0.958 . . . . 0.81999999999999995 109.981 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.497 ' OD2' HG23 ' A' ' 209' ' ' THR . 2.8 m-20 -110.38 45.13 1.15 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.892 -0.505 . . . . 2.3700000000000001 110.757 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -97.5 138.4 34.98 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.164 -0.96 . . . . 1.1100000000000001 108.924 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -81.02 4.6 69.98 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.807 -0.711 . . . . 1.6699999999999999 112.826 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 111.93 -28.44 9.35 Favored Glycine 0 N--CA 1.504 3.212 0 O-C-N 121.309 -1.112 . . . . 1.54 112.038 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -58.86 -30.08 67.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.742 -1.446 . . . . 4.4800000000000004 110.347 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 57.0 p -124.23 54.05 1.38 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.934 0.873 . . . . 2.6299999999999999 109.132 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.7 p -79.53 26.75 0.29 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.371 -0.831 . . . . 1.6899999999999999 112.946 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -49.49 -40.82 38.8 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.143 -1.023 . . . . 1.0700000000000001 110.161 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.6 p -62.11 -40.8 97.12 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.366 -0.934 . . . . 1.5800000000000001 109.389 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.9 p -60.87 -35.25 76.13 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 119.668 -0.813 . . . . 1.6000000000000001 109.863 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 77.1 mt -58.79 -39.61 77.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.461 -0.895 . . . . 1.45 109.934 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.8 mtp -60.93 -44.23 97.51 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.781 1.276 . . . . 1.05 109.126 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.1 -43.97 95.19 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.966 -1.015 . . . . 0.71999999999999997 110.532 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.471 ' HG2' HH11 ' A' ' 195' ' ' ARG . 28.7 mtt-85 -60.04 -44.2 94.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.995 -1.066 . . . . 3.0499999999999998 110.09 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 35.3 m -68.48 -39.07 81.49 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.099 0.952 . . . . 0.89000000000000001 109.646 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.77 -4.07 56.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.068 -1.02 . . . . 0.78000000000000003 112.659 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 194' ' ' ALA . 96.0 mt-10 53.61 9.87 0.2 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.212 1.19 . . . . 1.45 114.212 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 32.7 mt -72.12 150.06 92.21 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 120.581 -1.324 . . . . 0.67000000000000004 108.378 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.0 143.51 99.77 Favored 'Trans proline' 0 N--CA 1.511 2.554 0 C-N-CA 121.623 1.549 . . . . 0.64000000000000001 110.11 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.92 160.91 31.47 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 117.683 -1.607 . . . . 0.67000000000000004 109.701 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 220' ' ' LEU . 15.0 mt -148.32 149.72 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.088 -1.079 . . . . 0.68999999999999995 108.088 177.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 181' ' ' THR . 19.7 m -133.93 -29.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 C-N-CA 119.281 -0.967 . . . . 0.84999999999999998 112.78 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.39 35.65 1.55 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.76 -1.209 . . . . 0.92000000000000004 113.907 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 35.2 p -56.98 -25.49 58.33 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.234 -1.157 . . . . 0.94999999999999996 111.227 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.45 -91.4 1.72 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.032 -1.227 . . . . 1.04 110.032 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.8 p -129.31 29.97 5.05 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.295 -1.121 . . . . 1.5700000000000001 112.683 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.2 t -56.56 -35.09 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.246 -1.534 . . . . 0.83999999999999997 110.764 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.497 HG23 ' OD2' ' A' ' 182' ' ' ASP . 45.4 p -60.58 -21.43 62.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.038 . . . . 0.98999999999999999 111.491 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 67.5 m -97.2 1.74 50.14 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.568 0.699 . . . . 1.7 111.997 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -126.08 -0.96 7.13 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.227 0.825 . . . . 2.2000000000000002 113.227 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 213' ' ' LYS . 56.0 t -126.02 155.43 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.139 -0.975 . . . . 0.83999999999999997 110.182 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.412 ' N ' HG12 ' A' ' 212' ' ' VAL . 1.1 mptm? -115.7 157.69 23.89 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.06 -1.089 . . . . 2.2000000000000002 108.06 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 32.2 p-10 -58.86 144.18 45.24 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.56 -1.256 . . . . 2.2799999999999998 109.922 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER 81.39 -3.05 1.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.081 1.141 . . . . 2.3500000000000001 114.081 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 40.0 t0 -61.61 149.96 37.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.882 -1.136 . . . . 1.97 109.129 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.514 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 37.0 t80 -88.58 124.39 33.99 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.412 -1.329 . . . . 2.6499999999999999 107.412 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.5 mt -130.3 149.36 52.03 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.331 -0.856 . . . . 0.63 109.307 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.7 mt -112.75 123.4 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.064 -1.828 . . . . 0.62 106.064 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.531 HD11 HD12 ' A' ' 202' ' ' ILE . 49.2 tp -98.72 119.48 37.54 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.087 -1.82 . . . . 0.64000000000000001 106.087 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 223' ' ' VAL . 27.4 t0 -93.78 -25.18 17.51 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.086 -1.009 . . . . 2.0499999999999998 112.836 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.945 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.64 14.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.153 0.797 . . . . 0.83999999999999997 113.153 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 221' ' ' ASP . 37.1 t -111.18 -62.31 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.119 -0.988 . . . . 1.02 109.258 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -90.27 9.14 29.85 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.398 1.094 . . . . 2.5099999999999998 110.987 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.18 49.71 3.25 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.436 -0.802 . . . . 1.54 111.645 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -146.93 148.77 32.11 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.635 -1.29 . . . . 1.95 109.734 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 39.0 t -117.32 139.29 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.216 -1.031 . . . . 0.70999999999999996 108.216 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -99.26 134.95 41.38 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.118 -1.067 . . . . 1.01 108.118 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.71 129.93 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.755 -0.832 . . . . 0.81999999999999995 108.755 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.431 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 42.4 t-20 49.1 50.29 8.93 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.01 0.744 . . . . 1.54 113.01 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 30.5 Cg_endo -62.26 149.95 88.75 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.342 2.028 . . . . 0.93999999999999995 110.883 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 6.0 m -74.53 156.06 37.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.252 -0.905 . . . . 1.8 109.151 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -59.35 -38.42 80.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 2.73 110.218 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -58.83 -41.05 85.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.231 -0.918 . . . . 3.1699999999999999 110.367 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.66 -41.09 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.13 0.967 . . . . 1.3400000000000001 109.892 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 85.1 mt -60.03 -47.99 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 1.2 110.391 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -59.28 -42.52 91.46 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.458 -0.897 . . . . 2.7000000000000002 110.26 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -61.37 -41.54 97.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 2.5899999999999999 110.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 81.6 mtp -71.48 -37.79 71.28 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.09 -1.006 . . . . 1.3799999999999999 111.201 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -53.67 -43.51 68.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.635 -1.29 . . . . 2.8399999999999999 110.321 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.1 -52.16 18.07 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.057 -1.057 . . . . 1.8799999999999999 110.105 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.81 -43.69 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.573 -0.704 . . . . 2.3999999999999999 110.918 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.409 ' HG3' HG21 ' A' ' 11' ' ' ILE . 3.5 tm0? -58.43 -51.98 67.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.017 -1.052 . . . . 3.52 110.678 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.51 -31.91 73.21 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.545 -0.862 . . . . 1.8799999999999999 110.26 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -60.2 -31.09 69.82 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.198 -1.001 . . . . 3.0099999999999998 109.16 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.31 -39.93 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-O 122.033 0.92 . . . . 2.4500000000000002 109.879 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.04 79.39 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.808 -0.757 . . . . 2.75 110.372 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.4 m -69.24 -30.12 68.19 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.089 0.471 . . . . 3.1600000000000001 110.961 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.17 -40.0 92.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 3.5699999999999998 110.39 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -67.48 -30.57 70.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 4.2999999999999998 110.674 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.06 71.24 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.504 -0.747 . . . . 4.4500000000000002 111.142 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -66.33 -31.93 73.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.934 -1.104 . . . . 5.9699999999999998 110.62 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 31.7 tp -62.23 -36.27 81.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.098 -1.001 . . . . 6.1799999999999997 109.759 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -72.35 -19.11 61.69 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.763 0.792 . . . . 6.6600000000000001 111.296 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -82.92 5.31 22.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.826 -1.171 . . . . 8.1999999999999993 112.257 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.39 -9.91 59.05 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.221 -0.924 . . . . 8.0700000000000003 111.495 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -82.03 -2.53 52.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 9.4499999999999993 112.054 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -95.15 -11.36 28.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.456 -0.778 . . . . 10.119999999999999 112.543 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 118.144 -0.931 . . . . 11.49 109.004 -177.986 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.2 mpt? . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.435 0.636 . . . . 3.0699999999999998 109.745 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.9 mt 40.9 66.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.506 -0.746 . . . . 1.0700000000000001 111.914 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 m -95.57 113.58 25.24 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.614 -1.624 . . . . 1.24 106.614 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.66 -149.16 25.21 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.111 -1.196 . . . . 1.01 110.111 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 5' ' ' ILE . 93.2 mt -96.65 -0.93 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -1.04 . . . . 1.1100000000000001 112.864 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 tp 49.49 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.064 -1.022 . . . . 0.98999999999999999 112.725 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.77 -43.51 12.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.072 -1.018 . . . . 0.84999999999999998 111.168 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 t -145.76 136.08 12.04 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.138 -1.06 . . . . 1.3799999999999999 108.138 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.43 149.79 45.24 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.38 2.053 . . . . 0.93999999999999995 112.249 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.899 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.25 164.34 12.26 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.554 -1.819 . . . . 0.81000000000000005 108.554 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.0 mt -120.89 133.92 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 O-C-N 121.285 -1.127 . . . . 0.82999999999999996 108.273 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.23 149.99 43.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.318 -0.864 . . . . 0.53000000000000003 109.129 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.3 m-85 -121.25 140.39 52.11 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.179 -1.045 . . . . 0.77000000000000002 108.179 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.2 166.99 35.96 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 118.998 -1.573 . . . . 0.51000000000000001 109.419 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -78.13 158.33 29.13 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.65 -0.912 . . . . 1.8999999999999999 108.98 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -82.75 131.9 35.19 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.886 -1.134 . . . . 0.66000000000000003 109.206 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.8 tp -113.67 102.7 10.51 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 105.609 -1.997 . . . . 0.82999999999999996 105.609 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.6 tp -90.67 137.15 32.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.913 -1.117 . . . . 0.85999999999999999 108.116 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 158' ' ' LEU . 59.3 mt -102.57 119.47 38.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.469 -1.678 . . . . 0.92000000000000004 106.469 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -110.68 135.06 51.87 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.674 -1.232 . . . . 2.0299999999999998 107.674 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -126.28 137.49 53.51 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.404 -0.962 . . . . 2.6600000000000001 108.404 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -82.73 135.47 34.99 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.794 -1.187 . . . . 2.3199999999999998 107.794 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -62.22 149.21 42.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.579 -0.701 . . . . 2.1099999999999999 109.186 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -95.94 134.78 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.72 -0.845 . . . . 0.72999999999999998 108.72 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -107.48 129.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.626 -1.25 . . . . 0.87 107.626 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.0 mt -93.78 140.29 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.81000000000000005 109.201 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -88.18 121.22 30.32 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.838 -1.171 . . . . 1.3400000000000001 107.838 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -95.02 16.16 16.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 2.8900000000000001 112.213 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -65.14 142.68 58.27 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.071 -1.018 . . . . 2.0899999999999999 109.027 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -88.88 134.85 33.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.886 -1.153 . . . . 2.1899999999999999 107.886 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 pt -98.15 165.02 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.3 -0.875 . . . . 0.75 110.313 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 p -99.29 168.79 9.8 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.298 0.57 . . . . 0.91000000000000003 109.702 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.89 -27.9 46.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.249 -0.907 . . . . 0.93000000000000005 112.642 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 35' ' ' GLN . 37.1 p-10 -70.07 -31.84 69.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.222 -0.924 . . . . 2.2799999999999998 110.825 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.562 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 73.0 mt-30 -92.31 -7.9 46.64 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.612 -1.305 . . . . 1.45 112.792 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.18 -43.15 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.892 . . . . 0.81000000000000005 110.833 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -57.94 -39.16 77.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.075 -1.016 . . . . 1.54 110.828 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.78 -43.29 99.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.987 -1.071 . . . . 2.3599999999999999 111.147 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.96 -39.6 92.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.778 -1.201 . . . . 1.3100000000000001 110.937 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.2 t -60.72 -42.43 92.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.192 -0.943 . . . . 0.81999999999999995 110.366 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -61.77 -45.15 95.13 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.585 -0.846 . . . . 1.5 109.962 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' A' ' 42' ' ' ARG . 51.2 mtt-85 -61.61 -42.01 98.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.875 -1.141 . . . . 2.23 109.663 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -71.68 -55.71 7.18 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.507 -0.745 . . . . 0.84999999999999998 109.829 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.9 tp -58.09 -47.6 82.73 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.445 -0.902 . . . . 0.91000000000000003 109.643 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.4 t -68.13 -36.3 79.49 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.441 -0.787 . . . . 0.90000000000000002 109.702 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.66 -40.23 87.78 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.582 -1.407 . . . . 0.68999999999999995 109.582 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -58.86 -34.25 71.38 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 122.076 0.941 . . . . 2.8799999999999999 109.205 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.98 -48.97 79.51 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.934 0.873 . . . . 0.84999999999999998 109.863 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -81.38 -45.62 15.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -0.822 . . . . 2.3500000000000001 110.949 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.67 86.04 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.644 -0.822 . . . . 0.65000000000000002 110.397 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 t -59.94 -40.28 88.44 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.105 0.955 . . . . 1.45 109.127 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.57 -44.78 81.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.953 -0.567 . . . . 0.63 110.219 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -62.41 -52.11 64.88 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.997 -1.081 . . . . 1.3400000000000001 110.162 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.84 -40.87 94.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.171 -0.955 . . . . 1.5600000000000001 110.153 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -59.99 -40.0 87.65 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.685 -0.634 . . . . 1.1899999999999999 110.583 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -64.83 -41.8 95.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.9 -1.125 . . . . 0.71999999999999997 110.615 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.43 -38.89 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.227 -0.921 . . . . 0.62 110.798 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -51.42 -44.5 62.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.244 -0.91 . . . . 1.05 110.538 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -68.96 -38.21 79.27 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.987 -1.071 . . . . 0.64000000000000001 110.086 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -62.07 -38.95 90.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.314 -0.955 . . . . 1.73 109.641 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.28 -31.47 70.01 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.206 0.527 . . . . 0.56000000000000005 109.748 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.93 -37.68 12.63 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.584 -1.293 . . . . 0.68999999999999995 111.017 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.51 -23.99 36.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.773 -1.427 . . . . 1.48 111.119 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.6 m -87.13 -50.58 6.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.97999999999999998 110.68 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.04 -8.7 16.45 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.194 1.183 . . . . 1.1599999999999999 114.194 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.73 164.93 23.37 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 121.249 -0.907 . . . . 0.84999999999999998 112.734 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -55.11 -13.91 1.4 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.85 -0.794 . . . . 3.8599999999999999 112.925 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -58.75 -37.4 76.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.101 -1.0 . . . . 2.3500000000000001 111.236 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -85.34 -19.18 31.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.816 -1.177 . . . . 1.6699999999999999 112.693 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -59.61 -39.64 84.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.733 -1.229 . . . . 1.45 111.047 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.0 -41.23 91.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 0.60999999999999999 110.945 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.92 -47.3 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.62 -1.3 . . . . 0.65000000000000002 110.119 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -69.88 -31.97 70.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.66000000000000003 110.662 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -58.81 -38.61 79.02 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 1.1899999999999999 109.731 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.82 -36.03 73.8 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 110.261 -1.135 . . . . 0.53000000000000003 110.261 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -59.18 -46.49 88.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.167 -1.196 . . . . 1.27 110.72 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.73 -39.77 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.54000000000000004 109.956 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.0 ttp -59.13 -39.63 82.94 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.93 -0.708 . . . . 1.74 109.911 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 tp -57.57 -50.08 74.27 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.888 -1.125 . . . . 0.55000000000000004 110.676 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.89 -40.47 93.2 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.715 0.769 . . . . 0.46999999999999997 109.953 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -86.65 7.42 26.6 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 112.445 0.535 . . . . 1.4199999999999999 112.445 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 57.7 t0 -60.87 120.7 10.68 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.875 -1.14 . . . . 1.27 108.502 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -64.86 -19.81 66.08 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.711 0.767 . . . . 1.3500000000000001 110.876 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.445 ' OE1' ' OD1' ' A' ' 82' ' ' ASP . 21.7 mp0 -77.63 -52.99 8.1 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.357 -0.839 . . . . 2.2200000000000002 110.327 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.87 -40.16 87.68 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.508 -0.877 . . . . 0.62 110.444 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -57.1 -49.48 75.76 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.279 -0.888 . . . . 1.29 110.597 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -62.33 -36.94 83.74 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.355 -0.841 . . . . 1.52 110.589 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -67.83 -47.63 68.48 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.352 -0.939 . . . . 1.3 110.682 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.9 mt -57.45 -42.05 79.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.281 -0.887 . . . . 0.60999999999999999 110.044 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.8 mt -62.48 -41.73 93.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 121.405 0.622 . . . . 0.78000000000000003 110.101 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.56 98.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.67 -0.644 . . . . 0.81999999999999995 111.226 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.69 -42.81 93.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.884 -1.135 . . . . 0.80000000000000004 110.575 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.47 -50.33 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 0.77000000000000002 110.351 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.56 -38.71 65.12 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.218 -0.926 . . . . 2.1200000000000001 111.862 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -81.67 -44.93 16.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.709 -1.244 . . . . 1.51 112.169 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HB3' ' HZ3' ' A' ' 96' ' ' LYS . 9.0 mmmm -100.49 10.14 41.61 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.976 -1.078 . . . . 1.98 112.166 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.6 m80 49.14 50.59 17.71 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.728 -1.232 . . . . 1.3200000000000001 111.304 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.4 mtt -104.45 151.76 23.16 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.461 -0.774 . . . . 1.3799999999999999 109.747 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.9 p -72.82 167.56 20.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.67000000000000004 110.24 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.37 86.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.52000000000000002 110.334 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -67.12 -40.21 86.79 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.074 -1.016 . . . . 2.25 110.408 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.37 -49.72 58.19 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.232 -0.987 . . . . 0.64000000000000001 111.128 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.71 98.22 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.265 -0.897 . . . . 0.56000000000000005 110.299 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.86 97.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.25 -0.906 . . . . 0.46000000000000002 111.09 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -60.48 -40.08 89.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.015 . . . . 1.3200000000000001 111.272 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -59.91 -48.97 79.51 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.728 -1.233 . . . . 1.3 111.063 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.52 -46.53 96.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.004 -1.06 . . . . 0.60999999999999999 110.13 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.16 -32.39 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.711 -0.618 . . . . 0.65000000000000002 110.316 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -55.99 -41.09 74.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.486 -0.758 . . . . 2.1099999999999999 110.77 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.38 -34.86 10.0 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.098 -1.525 . . . . 0.82999999999999996 112.378 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -62.13 -44.34 96.86 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.701 -1.47 . . . . 1.28 110.179 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.29 -52.36 19.29 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.772 0.796 . . . . 0.89000000000000001 110.695 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.8 p -60.07 -37.57 80.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.514 -0.741 . . . . 1.8700000000000001 110.48 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.51 -44.33 97.27 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.017 -0.673 . . . . 1.05 110.501 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.2 mt -61.75 -29.96 70.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.576 -1.327 . . . . 1.02 110.528 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -67.12 -22.4 65.8 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.339 -0.851 . . . . 2.04 111.411 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -73.18 -15.35 61.45 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.318 -0.864 . . . . 1.73 111.245 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.532 HD13 HD13 ' A' ' 123' ' ' LEU . 7.0 mt -84.54 141.59 30.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.431 -0.793 . . . . 1.3700000000000001 108.896 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -94.92 39.46 1.1 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.077 -1.014 . . . . 2.8799999999999999 112.086 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -112.0 136.82 50.84 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.119 -1.067 . . . . 1.5800000000000001 108.119 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -59.77 -37.13 78.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.339 -0.851 . . . . 3.04 110.768 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -70.58 -57.84 4.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.79 -1.194 . . . . 0.90000000000000002 110.188 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.532 HD13 HD13 ' A' ' 118' ' ' LEU . 23.1 mt -59.9 -39.9 86.94 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.16 -0.962 . . . . 1.0600000000000001 110.335 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -62.53 -51.17 68.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.997 -1.064 . . . . 2.1800000000000002 110.119 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.31 -30.59 71.7 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.751 -0.78 . . . . 2.1499999999999999 109.816 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 130' ' ' VAL . 22.7 ttp180 -65.22 -28.91 69.7 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.026 -1.07 . . . . 2.3300000000000001 109.155 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.83 80.16 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.813 0.816 . . . . 0.81999999999999995 109.413 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.55 95.18 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.513 -0.875 . . . . 0.84999999999999998 109.692 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -64.95 -36.99 86.17 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.292 0.568 . . . . 1.3899999999999999 110.303 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 126' ' ' ARG . 46.8 t -67.9 -40.49 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 0.56000000000000005 109.802 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -59.88 -38.08 81.18 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.894 0.854 . . . . 3.1200000000000001 109.552 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -59.48 -38.99 82.27 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.287 0.565 . . . . 1.28 110.274 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.9 mt -61.46 -40.27 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.271 -0.893 . . . . 0.48999999999999999 109.977 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.4 48.68 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.94 -1.124 . . . . 0.46000000000000002 110.341 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -59.1 -45.99 89.45 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 120.994 -1.297 . . . . 2.71 110.087 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.432 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 58.6 mtm180 -62.32 -40.73 97.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.827 -1.17 . . . . 2.1400000000000001 109.998 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.61 -42.97 99.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 1.05 110.153 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.27 -45.41 93.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.52000000000000002 110.17 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -59.78 -33.93 72.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.556 -0.715 . . . . 2.3500000000000001 111.025 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -75.18 -40.45 59.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.207 -0.933 . . . . 1.3899999999999999 110.72 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.03 -39.96 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.68000000000000005 110.292 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.3 mt -88.68 -6.18 57.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.82999999999999996 111.942 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.72 71.01 Favored Glycine 0 N--CA 1.479 1.544 0 C-N-CA 119.304 -1.427 . . . . 0.91000000000000003 112.932 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.2 tp -61.08 151.83 29.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 122.012 -0.699 . . . . 0.94999999999999996 110.522 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -61.22 145.71 50.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.36 -0.837 . . . . 2.4300000000000002 109.1 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.9 mt -111.3 139.94 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.536 -0.913 . . . . 1.1000000000000001 108.536 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.8 mm -79.53 121.85 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.223 -1.029 . . . . 1.5800000000000001 108.223 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -97.4 95.52 7.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.37 -1.715 . . . . 1.6200000000000001 106.37 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.46 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 76.8 mt -75.51 -23.26 56.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.629 -0.669 . . . . 0.80000000000000004 111.332 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.7 t -79.53 -0.68 34.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.176 -0.952 . . . . 1.5600000000000001 112.334 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.08 22.84 8.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.737 -0.602 . . . . 0.83999999999999997 112.46 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.46 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 11.3 mt -72.05 137.36 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.695 . . . . 0.81999999999999995 109.543 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -112.47 -19.43 12.14 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.714 0.769 . . . . 2.3100000000000001 112.828 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -117.44 138.95 51.5 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.53 -1.285 . . . . 1.54 107.53 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.35 122.02 21.37 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.001 -1.111 . . . . 1.3799999999999999 108.001 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.8 m -145.63 177.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.438 -0.788 . . . . 0.68999999999999995 109.291 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.3 mt -88.26 140.97 14.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.517 -0.74 . . . . 0.53000000000000003 109.341 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 19' ' ' LEU . 26.4 tp -94.12 124.17 37.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.969 -1.082 . . . . 0.64000000000000001 108.143 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.8 t -125.36 130.21 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.131 -1.063 . . . . 0.67000000000000004 108.131 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.63 152.41 21.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.454 -0.779 . . . . 0.78000000000000003 109.226 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.24 82.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.495 -1.378 . . . . 1.0 109.738 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 49.6 t0 -172.72 146.48 1.64 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.03 -0.729 . . . . 2.4199999999999999 109.03 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.423 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 83.6 mt -119.35 141.27 49.18 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.406 -0.809 . . . . 0.75 109.304 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 65.7 p -91.59 152.41 43.41 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 120.848 -1.158 . . . . 0.78000000000000003 108.364 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -41.6 -39.12 4.56 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.081 1.854 . . . . 0.67000000000000004 113.848 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.432 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 27.4 m -59.91 -47.06 87.29 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.69999999999999996 110.184 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -67.6 -40.52 84.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.793 . . . . 1.21 109.948 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.9 p -68.42 -37.91 80.74 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.917 -0.713 . . . . 0.59999999999999998 110.223 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.55 82.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.945 . . . . 0.62 110.526 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -93.18 -2.67 55.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.054 . . . . 1.1599999999999999 112.792 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.37 146.23 51.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.05 -1.031 . . . . 0.72999999999999998 108.434 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -96.42 118.86 33.82 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.786 -1.561 . . . . 2.2400000000000002 106.786 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.72 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.3 mm? -76.85 -14.55 59.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.446 -0.784 . . . . 1.4299999999999999 111.451 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -80.05 -27.35 39.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.535 -0.728 . . . . 2.1499999999999999 111.807 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -100.83 1.19 39.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.149 -0.969 . . . . 2.04 113.204 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 178' ' ' GLY . 61.3 t -110.14 129.97 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.584 -0.895 . . . . 0.55000000000000004 108.584 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.26 -11.32 43.91 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.359 -0.838 . . . . 1.6299999999999999 112.455 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.411 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 173.57 177.1 42.54 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.141 -1.584 . . . . 0.46999999999999997 109.141 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -133.45 132.66 41.35 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 107.784 -1.191 . . . . 0.54000000000000004 107.784 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.41 HG22 HG21 ' A' ' 205' ' ' THR . 77.5 mt -134.37 111.2 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 105.824 -1.917 . . . . 0.68999999999999995 105.824 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 205' ' ' THR . 54.2 p -130.32 171.99 12.33 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.679 -1.263 . . . . 0.81999999999999995 110.292 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -101.17 52.1 0.85 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.973 -0.558 . . . . 2.3700000000000001 110.222 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -101.16 140.0 36.05 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.693 -0.854 . . . . 1.1100000000000001 108.693 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.42 -30.24 18.6 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 120.301 -0.952 . . . . 1.6699999999999999 111.123 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 95.27 -17.37 59.44 Favored Glycine 0 N--CA 1.49 2.239 0 O-C-N 121.174 -1.191 . . . . 1.54 112.945 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 -60.09 -38.38 82.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.399 -1.059 . . . . 4.4800000000000004 110.311 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.5 p -146.94 37.92 0.98 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.369 -0.832 . . . . 2.6299999999999999 111.454 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 18.2 p -82.85 124.18 30.07 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.385 -0.968 . . . . 1.6899999999999999 108.385 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -59.87 -38.61 82.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.405 -0.81 . . . . 1.0700000000000001 110.545 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.3 p -54.13 -40.37 67.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 1.5800000000000001 110.587 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.2 t -59.62 -39.6 84.82 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.034 -1.041 . . . . 1.6000000000000001 109.71 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 33.6 mm -60.08 -39.22 79.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.583 -0.698 . . . . 1.45 110.394 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 58.5 mtp -62.51 -40.08 95.59 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.403 1.097 . . . . 1.05 109.786 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -56.2 -48.93 75.44 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.815 -0.63 . . . . 0.71999999999999997 110.749 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -60.16 -42.55 95.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.011 -1.056 . . . . 3.0499999999999998 110.605 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 64.9 m -69.96 -40.03 75.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.932 -1.105 . . . . 0.89000000000000001 110.347 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 26.7 mt -91.12 -7.98 50.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.78000000000000003 112.448 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 194' ' ' ALA . 48.3 mt-10 53.33 7.99 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.804 1.038 . . . . 1.45 113.804 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.26 150.48 92.0 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.933 . . . . 0.67000000000000004 108.646 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.04 144.17 90.61 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.285 1.323 . . . . 0.64000000000000001 109.263 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.73 162.26 34.91 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.119 -1.613 . . . . 0.67000000000000004 110.075 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.2 mt -147.31 152.41 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.028 -1.101 . . . . 0.68999999999999995 108.028 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.6 m -135.42 -32.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 121.288 -0.883 . . . . 0.84999999999999998 112.702 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.84 41.42 2.37 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 120.098 -1.049 . . . . 0.92000000000000004 111.399 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.458 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 43.2 p -64.14 -17.17 63.22 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.453 -1.028 . . . . 0.94999999999999996 111.508 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.69 -95.81 0.91 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.945 -1.122 . . . . 1.04 110.345 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 88.8 p -127.25 30.8 5.34 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.849 -0.795 . . . . 1.5700000000000001 112.146 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 72.7 t -58.91 -33.15 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.389 -1.444 . . . . 0.83999999999999997 110.116 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 38.5 p -56.48 -24.04 43.35 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.71 -0.796 . . . . 0.98999999999999999 111.407 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.2 p -92.98 0.74 57.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.866 . . . . 1.7 112.001 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -123.55 -7.74 8.03 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.562 0.696 . . . . 2.2000000000000002 112.218 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 15.3 t -114.12 140.91 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.068 -0.716 . . . . 0.83999999999999997 109.068 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -115.96 150.0 37.87 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.331 -0.988 . . . . 2.2000000000000002 108.331 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.537 HD22 ' CG ' ' A' ' 215' ' ' ASP . 1.8 p-10 -52.1 141.08 19.22 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.28 -0.887 . . . . 2.2799999999999998 110.279 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.537 ' CG ' HD22 ' A' ' 214' ' ' ASN . 1.2 m-20 80.27 -0.75 1.99 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.948 1.092 . . . . 2.3500000000000001 113.948 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -64.77 149.02 50.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.78 -1.2 . . . . 1.97 108.745 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -87.33 116.01 25.13 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.381 -1.34 . . . . 2.6499999999999999 107.381 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 89.2 mt -128.38 144.73 51.17 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.513 0.673 . . . . 0.63 109.714 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 20.1 mt -115.81 128.61 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.698 -1.593 . . . . 0.62 106.698 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 48.9 tp -99.3 119.67 38.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 106.725 -1.584 . . . . 0.64000000000000001 106.725 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.6 t0 -94.46 -28.66 15.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.926 -1.109 . . . . 2.0499999999999998 112.333 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.899 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.61 17.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.005 0.743 . . . . 0.83999999999999997 113.005 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' A' ' 221' ' ' ASP . 32.1 t -107.33 -58.54 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -0.929 . . . . 1.02 108.948 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.449 ' HB2' HE21 ' A' ' 226' ' ' GLN . 31.8 m120 -92.15 11.23 26.22 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.888 0.851 . . . . 2.5099999999999998 110.545 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 62.51 50.79 3.47 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.616 -0.72 . . . . 1.54 112.504 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.449 HE21 ' HB2' ' A' ' 224' ' ' ASN . 21.6 pt20 -153.41 159.24 42.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.025 . . . . 1.95 109.945 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.0 t -116.43 141.65 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.127 -0.694 . . . . 0.70999999999999996 109.127 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -103.5 132.08 50.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.024 -1.047 . . . . 1.01 108.758 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.63 129.63 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 107.717 -1.216 . . . . 0.81999999999999995 107.717 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.435 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 54.0 t30 48.9 50.67 9.54 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 1.54 112.912 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 25.2 Cg_endo -64.13 154.26 71.64 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.42 2.08 . . . . 0.93999999999999995 110.541 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.6 m -74.55 156.51 36.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.074 -1.016 . . . . 1.8 109.489 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -58.74 -35.76 73.22 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.07 -1.018 . . . . 2.73 110.774 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -59.57 -40.19 86.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 3.1699999999999999 110.015 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 96.8 t -69.64 -39.53 78.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.56 -0.713 . . . . 1.3400000000000001 110.236 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.3 mt -57.48 -43.93 83.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.64 -0.662 . . . . 1.2 110.613 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.46 -43.31 93.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.873 -1.142 . . . . 2.7000000000000002 110.317 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -63.64 -44.36 94.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.101 -1.0 . . . . 2.5899999999999999 111.126 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.9 mtp -68.75 -37.75 79.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.007 -1.058 . . . . 1.3799999999999999 110.874 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -59.05 -39.41 81.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.471 -0.768 . . . . 2.8399999999999999 110.917 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.17 -43.41 67.53 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.158 -0.964 . . . . 1.8799999999999999 111.086 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 99.6 t -60.26 -49.35 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.498 -1.376 . . . . 2.3999999999999999 110.898 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.46 -50.32 71.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.742 -1.224 . . . . 3.52 110.475 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.76 -34.41 77.82 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.483 -0.887 . . . . 1.8799999999999999 110.436 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -60.49 -29.41 69.06 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.914 -1.116 . . . . 3.0099999999999998 110.418 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.5 -44.82 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.752 0.787 . . . . 2.4500000000000002 110.155 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.27 -42.49 95.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.499 -0.751 . . . . 2.75 110.466 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.9 t -71.77 -34.31 69.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.469 -0.769 . . . . 3.1600000000000001 110.64 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.07 -39.62 94.47 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.28 -0.888 . . . . 3.5699999999999998 110.975 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -66.74 -31.42 72.06 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.798 -1.189 . . . . 4.2999999999999998 110.804 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.99 85.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 4.4500000000000002 110.622 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.43 -27.16 65.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 5.9699999999999998 111.74 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.19 -29.88 70.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.823 -1.173 . . . . 6.1799999999999997 111.192 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -68.37 -31.22 70.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -0.863 . . . . 6.6600000000000001 110.84 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -83.57 -12.7 55.8 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.191 -0.943 . . . . 8.1999999999999993 112.311 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -87.08 40.24 0.9 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.229 -0.92 . . . . 8.0700000000000003 112.159 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -90.03 22.47 3.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.866 -1.146 . . . . 9.4499999999999993 112.275 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -85.07 -61.64 1.73 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.449 -0.782 . . . . 10.119999999999999 109.54 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 117.93 -1.033 . . . . 11.49 109.609 -178.482 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.5 mtp . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.675 -0.491 . . . . 3.0699999999999998 109.675 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.1 mt -97.73 111.26 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.806 -1.553 . . . . 1.0700000000000001 106.806 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.6 m -104.71 125.46 50.83 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.989 -1.115 . . . . 1.24 107.989 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.8 -154.57 18.45 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.252 -1.939 . . . . 1.01 108.252 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 5' ' ' ILE . 73.0 mt -96.07 -2.08 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -1.003 . . . . 1.1100000000000001 112.808 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 tp 49.57 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.98999999999999999 112.583 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -85.96 -42.92 13.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.991 -1.068 . . . . 0.84999999999999998 111.242 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -145.7 141.3 16.65 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 107.893 -1.151 . . . . 1.3799999999999999 107.893 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.05 147.83 30.61 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.233 1.956 . . . . 0.93999999999999995 112.333 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.904 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.94 166.74 15.67 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.818 -1.713 . . . . 0.81000000000000005 108.818 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -127.46 138.04 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.09 -1.241 . . . . 0.82999999999999996 108.004 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.55 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -141.48 160.06 40.93 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.964 0.888 . . . . 0.53000000000000003 109.466 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 11.9 m-85 -129.66 139.94 51.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.168 -1.419 . . . . 0.77000000000000002 107.168 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.69 169.2 38.4 Favored Glycine 0 N--CA 1.5 2.903 0 C-N-CA 119.04 -1.552 . . . . 0.51000000000000001 110.077 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -77.31 158.42 30.19 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.606 -0.887 . . . . 1.8999999999999999 108.606 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.646 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -88.09 128.28 35.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.167 -0.958 . . . . 0.66000000000000003 108.613 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 tp -108.43 105.68 15.45 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 105.124 -2.176 . . . . 0.82999999999999996 105.124 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.0 tp -94.73 132.6 39.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.107 -0.996 . . . . 0.85999999999999999 108.774 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.9 mt -101.78 118.16 36.36 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.161 -1.792 . . . . 0.92000000000000004 106.161 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -107.27 130.22 54.78 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.961 -1.125 . . . . 2.0299999999999998 107.961 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -128.46 140.71 51.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.453 -0.779 . . . . 2.6600000000000001 109.178 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.51 137.66 35.55 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.17 -1.048 . . . . 2.3199999999999998 108.17 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -65.57 150.8 47.81 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.208 -0.933 . . . . 2.1099999999999999 110.141 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.5 mt -89.11 134.05 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.89 -1.152 . . . . 0.72999999999999998 107.89 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.22 130.23 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.928 -1.138 . . . . 0.87 107.928 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.88 130.92 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.548 -0.908 . . . . 0.81000000000000005 108.548 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -92.74 127.01 38.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.232 -1.025 . . . . 1.3400000000000001 108.232 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 28' ' ' ARG . 23.4 mmm-85 -99.31 17.39 20.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.529 -0.732 . . . . 2.8900000000000001 112.277 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -61.95 144.49 54.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.783 -1.198 . . . . 2.0899999999999999 109.467 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -90.66 131.93 36.07 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.606 -0.886 . . . . 2.1899999999999999 108.606 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 pt -99.24 168.05 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.315 -0.866 . . . . 0.75 110.239 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.5 p -94.6 162.73 13.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.565 -0.71 . . . . 0.91000000000000003 109.825 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.37 -21.11 22.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.167 -0.958 . . . . 0.93000000000000005 111.667 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.76 -38.41 76.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.058 -1.026 . . . . 2.2799999999999998 110.597 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -88.4 -6.35 57.73 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.104 -0.997 . . . . 1.45 111.932 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.07 -41.21 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.049 -1.032 . . . . 0.81000000000000005 110.59 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -57.58 -40.08 78.22 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.907 -1.121 . . . . 1.54 110.736 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -63.2 -40.84 98.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 2.3599999999999999 111.265 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.3 -39.76 88.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.779 -1.201 . . . . 1.3100000000000001 110.875 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.2 -41.72 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.197 -0.94 . . . . 0.81999999999999995 110.43 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -61.75 -42.6 99.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.021 -1.049 . . . . 1.5 110.071 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.48 ' NH2' ' O ' ' A' ' 141' ' ' ILE . 55.4 mtp180 -61.82 -42.54 99.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 2.23 110.371 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -73.11 -51.08 19.33 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.014 -1.054 . . . . 0.84999999999999998 110.162 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.45 -47.86 82.18 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.112 -1.435 . . . . 0.91000000000000003 110.238 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.9 t -69.63 -42.56 74.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.419 -0.8 . . . . 0.90000000000000002 110.469 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.81 -41.83 84.35 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.178 -1.487 . . . . 0.68999999999999995 109.395 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.553 HH22 ' CD ' ' A' ' 86' ' ' GLU . 17.7 ttm180 -57.45 -32.73 67.21 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.227 1.013 . . . . 2.8799999999999999 109.473 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.28 -42.43 81.64 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.806 0.813 . . . . 0.84999999999999998 109.669 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -79.75 -43.93 21.65 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.729 0.776 . . . . 2.3500000000000001 110.223 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.17 88.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.334 -0.854 . . . . 0.65000000000000002 109.929 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 t -59.57 -41.76 90.94 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.068 0.937 . . . . 1.45 109.289 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.48 -45.23 80.37 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.965 -0.562 . . . . 0.63 110.063 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -64.85 -50.2 67.58 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.052 -1.059 . . . . 1.3400000000000001 110.181 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.67 -37.61 84.71 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.658 -0.817 . . . . 1.5600000000000001 110.2 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -60.19 -42.81 95.85 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.551 -0.718 . . . . 1.1899999999999999 110.822 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.5 m -65.01 -44.2 90.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.019 -1.051 . . . . 0.71999999999999997 110.42 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.15 -36.76 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.54 -0.725 . . . . 0.62 110.674 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -50.81 -44.94 59.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.155 -0.965 . . . . 1.05 110.561 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -68.3 -37.49 80.69 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.135 -0.978 . . . . 0.64000000000000001 110.16 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.405 ' O ' ' OG1' ' A' ' 64' ' ' THR . 24.7 mtpp -61.49 -39.02 89.43 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.427 -1.309 . . . . 1.73 108.932 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.98 -38.76 87.11 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.799 -0.761 . . . . 0.56000000000000005 109.261 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.94 -40.04 58.01 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 119.692 -1.242 . . . . 0.68999999999999995 110.505 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -79.64 -20.15 47.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.427 -1.043 . . . . 1.48 110.437 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 87.9 m -82.74 -53.31 6.01 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 120.217 -0.593 . . . . 0.97999999999999998 110.458 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -106.19 -16.06 14.69 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.289 -0.882 . . . . 1.1599999999999999 112.693 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.95 167.77 16.3 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 111.459 -0.656 . . . . 0.84999999999999998 111.459 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.3 -25.86 62.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.407 -1.054 . . . . 3.8599999999999999 112.23 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.07 -40.06 73.01 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.895 -1.128 . . . . 2.3500000000000001 111.182 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -89.36 -16.45 31.0 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.924 -1.11 . . . . 1.6699999999999999 112.3 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.62 -39.0 86.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 1.45 110.702 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.17 78.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.72 -0.613 . . . . 0.60999999999999999 111.495 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.01 -41.52 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.847 -1.158 . . . . 0.65000000000000002 110.521 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -70.26 -31.44 68.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.917 -1.115 . . . . 0.66000000000000003 110.498 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.43 -39.98 92.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.309 -0.87 . . . . 1.1899999999999999 110.021 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.44 96.25 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.799 -1.32 . . . . 0.53000000000000003 109.799 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -57.81 -40.13 79.21 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.367 -1.078 . . . . 1.27 110.495 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.5 mt -61.44 -40.39 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.54000000000000004 110.236 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.6 ttm -59.5 -41.12 89.14 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.259 -0.901 . . . . 1.74 110.381 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.3 tp -57.52 -49.1 77.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.81 . . . . 0.55000000000000004 110.309 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.02 -45.12 93.85 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.86 0.838 . . . . 0.46999999999999997 110.175 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -87.46 8.03 26.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.464 -0.773 . . . . 1.4199999999999999 113.026 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 55.2 t0 -62.22 123.47 18.28 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.764 -1.21 . . . . 1.27 109.151 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -66.48 -18.54 65.42 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.406 -0.809 . . . . 1.3500000000000001 111.168 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' OE1' ' OD1' ' A' ' 82' ' ' ASP . 10.8 mp0 -77.68 -52.4 9.04 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.689 -0.804 . . . . 2.2200000000000002 110.099 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.5 mt -60.92 -35.2 76.07 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.101 -0.999 . . . . 0.62 110.287 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.553 ' CD ' HH22 ' A' ' 47' ' ' ARG . 80.8 tt0 -59.14 -47.6 84.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.821 . . . . 1.29 110.402 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -61.72 -35.54 78.34 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.629 -0.669 . . . . 1.52 110.12 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.07 -49.09 71.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 1.3 110.313 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.3 mt -58.64 -43.93 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.06 -1.025 . . . . 0.60999999999999999 109.779 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.01 -40.9 87.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.65 -0.656 . . . . 0.78000000000000003 110.146 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -42.32 93.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.33 -0.857 . . . . 0.81999999999999995 110.424 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.39 -44.03 97.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.285 -0.884 . . . . 0.80000000000000004 110.013 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.8 mt -63.56 -49.21 83.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.363 -0.835 . . . . 0.77000000000000002 110.039 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -78.12 -37.2 46.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.496 -0.752 . . . . 2.1200000000000001 111.658 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -81.81 -40.96 21.79 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.573 -1.329 . . . . 1.51 111.996 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -105.58 7.76 32.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.457 -0.777 . . . . 1.98 112.687 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.7 m80 49.65 49.79 19.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.563 -1.336 . . . . 1.3200000000000001 111.504 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 67.1 mtt -104.45 156.75 17.67 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.049 0.928 . . . . 1.3799999999999999 109.967 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.3 p -72.59 161.75 30.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.783 -0.573 . . . . 0.67000000000000004 110.02 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.55 86.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.52000000000000002 110.302 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.587 ' OD2' HD21 ' A' ' 142' ' ' LEU . 96.2 m-20 -66.28 -40.07 89.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.118 -0.989 . . . . 2.25 109.868 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.2 -48.83 55.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.559 -0.713 . . . . 0.64000000000000001 111.08 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.93 92.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.167 -0.958 . . . . 0.56000000000000005 110.227 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.17 95.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.579 -0.701 . . . . 0.46000000000000002 110.661 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -60.29 -39.87 88.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.204 -0.935 . . . . 1.3200000000000001 111.275 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -58.05 -48.92 78.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.729 -1.232 . . . . 1.3 110.912 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.77 -45.61 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.892 -1.13 . . . . 0.60999999999999999 109.867 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.3 mm -62.22 -31.72 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.645 -0.659 . . . . 0.65000000000000002 110.348 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -57.33 -41.09 79.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 2.1099999999999999 110.572 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.16 -34.64 9.52 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.368 -1.396 . . . . 0.82999999999999996 112.624 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -60.69 -42.37 97.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.261 -1.729 . . . . 1.28 110.153 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.07 -55.55 6.35 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.451 -0.781 . . . . 0.89000000000000001 110.727 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.8 m -60.61 -37.95 83.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 1.8700000000000001 110.886 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.51 96.37 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.897 -1.127 . . . . 1.05 111.079 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.31 -30.22 70.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.873 -1.131 . . . . 1.02 110.918 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -66.53 -20.82 66.12 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.168 -1.013 . . . . 2.04 110.954 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -71.91 -15.18 62.09 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.838 0.827 . . . . 1.73 110.828 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.489 HD13 HD13 ' A' ' 123' ' ' LEU . 50.0 mt -86.74 145.16 26.76 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.246 -0.65 . . . . 1.3700000000000001 109.246 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -103.02 39.7 1.51 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.337 -0.852 . . . . 2.8799999999999999 111.461 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -113.04 136.27 52.87 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.135 -1.061 . . . . 1.5800000000000001 108.135 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -56.63 -38.07 71.59 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.444 0.64 . . . . 3.04 110.796 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -72.16 -52.79 14.99 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.827 -1.171 . . . . 0.90000000000000002 110.312 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.489 HD13 HD13 ' A' ' 118' ' ' LEU . 19.3 mt -63.58 -39.72 95.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.168 -0.958 . . . . 1.0600000000000001 110.497 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -65.65 -47.54 75.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -0.93 . . . . 2.1800000000000002 110.502 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -61.47 -31.34 71.3 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.407 -0.917 . . . . 2.1499999999999999 110.248 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 130' ' ' VAL . 63.3 ttt180 -65.71 -27.7 68.52 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 118.995 -1.082 . . . . 2.3300000000000001 109.528 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.84 -49.16 78.77 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.786 0.803 . . . . 0.81999999999999995 109.589 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.41 -43.23 91.22 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.57 -0.852 . . . . 0.84999999999999998 109.633 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 2.0 m-20 -62.97 -35.47 80.28 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.306 0.574 . . . . 1.3899999999999999 110.214 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 126' ' ' ARG . 31.8 t -68.17 -40.47 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.518 -0.739 . . . . 0.56000000000000005 110.639 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -59.72 -38.13 80.81 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.509 -1.277 . . . . 3.1200000000000001 110.076 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.52 ' OD1' ' NE ' ' A' ' 136' ' ' ARG . 54.4 t0 -60.22 -40.05 88.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.608 -0.683 . . . . 1.28 110.186 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.19 -39.64 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.01 -1.056 . . . . 0.48999999999999999 110.399 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.08 -46.9 62.68 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.937 -1.125 . . . . 0.46000000000000002 110.696 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -59.94 -41.31 91.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.123 -1.222 . . . . 2.71 110.368 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.52 ' NE ' ' OD1' ' A' ' 132' ' ' ASP . 40.5 mtt-85 -63.32 -42.11 98.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.06 -1.025 . . . . 2.1400000000000001 109.995 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 137' ' ' LEU . 3.0 tt -61.06 -45.15 95.92 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.967 0.889 . . . . 1.05 109.76 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.98 -42.05 97.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.89 . . . . 0.52000000000000002 110.522 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.12 -31.71 70.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.933 . . . . 2.3500000000000001 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -75.33 -41.67 56.18 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.945 -1.097 . . . . 1.3899999999999999 110.777 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.48 ' O ' ' NH2' ' A' ' 42' ' ' ARG . 98.0 mt -60.02 -37.92 74.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.144 -0.973 . . . . 0.68000000000000005 110.607 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.587 HD21 ' OD2' ' A' ' 101' ' ' ASP . 90.0 mt -87.49 -9.18 55.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.378 -0.826 . . . . 0.82999999999999996 111.716 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.26 23.62 65.34 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 120.298 -0.953 . . . . 0.91000000000000003 113.457 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.1 tp -68.34 139.71 55.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.806 -0.82 . . . . 0.94999999999999996 109.863 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -68.6 150.54 47.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.568 -0.707 . . . . 2.4300000000000002 109.907 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 39.7 mt -108.76 137.7 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.341 -0.985 . . . . 1.1000000000000001 108.341 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.3 mm -78.31 130.35 36.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.875 -1.141 . . . . 1.5800000000000001 109.016 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -94.47 97.62 10.29 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.625 -1.62 . . . . 1.6200000000000001 106.625 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 51.0 mt -76.98 -15.66 59.58 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.39 0.614 . . . . 0.80000000000000004 111.563 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.4 t -80.97 2.39 27.06 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.59 0.71 . . . . 1.5600000000000001 112.156 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.69 22.7 10.57 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.713 0.768 . . . . 0.83999999999999997 112.069 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 12.5 mt -72.77 135.88 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.427 -0.953 . . . . 0.81999999999999995 108.427 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -121.15 -13.69 8.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 112.927 0.714 . . . . 2.3100000000000001 112.927 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -112.53 136.89 51.51 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.926 -1.138 . . . . 1.54 107.926 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.07 117.68 17.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.376 -0.828 . . . . 1.3799999999999999 109.009 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -148.01 179.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.21 -0.663 . . . . 0.68999999999999995 109.21 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 49.0 mt -88.13 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.481 -0.933 . . . . 0.53000000000000003 108.481 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 26.3 tp -94.63 126.82 40.17 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.43 -0.952 . . . . 0.64000000000000001 108.43 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.48 130.66 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.038 -1.097 . . . . 0.67000000000000004 108.038 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.34 159.51 31.3 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.009 -1.057 . . . . 0.78000000000000003 108.67 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.14 92.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.692 -1.255 . . . . 1.0 109.324 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 50.9 t0 -171.75 154.09 3.53 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.527 -0.916 . . . . 2.4199999999999999 108.527 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 49.6 mt -117.18 139.04 51.26 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.446 -0.946 . . . . 0.75 108.446 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.7 p -92.06 146.29 32.49 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.158 -0.964 . . . . 0.78000000000000003 108.41 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -38.97 -44.63 2.51 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.169 1.913 . . . . 0.67000000000000004 113.812 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 16.2 m -60.34 -47.84 84.32 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.629 -1.294 . . . . 0.69999999999999996 109.954 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -63.17 -37.8 88.67 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.657 0.742 . . . . 1.21 110.167 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.0 p -67.87 -39.05 83.79 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.547 -0.721 . . . . 0.59999999999999998 110.192 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.19 86.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.533 -0.73 . . . . 0.62 110.744 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.79 -3.31 56.3 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.149 -0.97 . . . . 1.1599999999999999 113.046 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 171' ' ' LEU . 41.2 tp -63.37 156.35 26.15 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.402 -0.811 . . . . 0.72999999999999998 109.587 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -94.9 110.2 22.12 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.503 -1.666 . . . . 2.2400000000000002 106.503 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.1 mt -71.33 -24.91 62.21 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.748 0.785 . . . . 1.4299999999999999 111.408 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -85.66 -18.66 32.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.492 -0.755 . . . . 2.1499999999999999 112.446 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -100.64 -2.73 31.97 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.297 -0.877 . . . . 2.04 112.767 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 178' ' ' GLY . 57.5 t -109.69 130.09 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.689 -1.226 . . . . 0.55000000000000004 107.689 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.743 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.8 tt -85.61 -9.89 56.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.031 -1.043 . . . . 1.6299999999999999 111.702 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.37 173.41 38.98 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.485 -1.446 . . . . 0.46999999999999997 109.485 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.9 OUTLIER -130.64 131.31 44.83 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.622 -1.251 . . . . 0.54000000000000004 107.622 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.526 HG22 HG21 ' A' ' 205' ' ' THR . 87.5 mt -134.49 109.11 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 106.093 -1.818 . . . . 0.68999999999999995 106.093 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 203' ' ' VAL . 73.6 p -134.26 174.58 10.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.678 -1.264 . . . . 0.81999999999999995 110.415 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 206' ' ' GLY . 11.8 t0 -103.85 65.83 0.83 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.639 -0.71 . . . . 2.3700000000000001 109.375 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -101.85 145.82 28.67 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.195 -0.941 . . . . 1.1100000000000001 109.053 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.46 -8.63 59.95 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.855 -1.164 . . . . 1.6699999999999999 112.807 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 83.42 -21.52 8.62 Favored Glycine 0 N--CA 1.492 2.411 0 O-C-N 121.511 -0.994 . . . . 1.54 114.183 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -59.95 -37.14 78.67 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.055 -1.262 . . . . 4.4800000000000004 109.855 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 20.2 p -146.72 41.99 1.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.557 -0.714 . . . . 2.6299999999999999 110.505 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.9 p -85.33 103.46 14.27 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.07 -1.455 . . . . 1.6899999999999999 107.07 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -59.98 -30.46 69.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.838 . . . . 1.0700000000000001 110.528 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.0 m -56.45 -40.51 74.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.539 -0.726 . . . . 1.5800000000000001 110.039 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.1 m -59.78 -39.98 86.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 1.6000000000000001 109.948 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.6 mp -60.23 -38.89 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.815 . . . . 1.45 110.418 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 68.3 mtp -62.38 -42.96 99.82 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 122.062 0.934 . . . . 1.05 109.529 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -61.5 -48.74 79.69 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.726 -0.67 . . . . 0.71999999999999997 111.673 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' A' ' 195' ' ' ARG . 30.2 mtt-85 -60.78 -44.4 96.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.14 . . . . 3.0499999999999998 110.653 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 28.8 m -69.45 -39.54 77.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.887 . . . . 0.89000000000000001 110.435 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.4 -4.9 53.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.78000000000000003 112.987 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 194' ' ' ALA . 75.3 mt-10 54.6 12.5 0.56 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.115 1.154 . . . . 1.45 114.115 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 72.9 mt -73.77 158.4 86.15 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.05 -1.032 . . . . 0.67000000000000004 108.495 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -65.32 142.71 73.98 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.973 1.115 . . . . 0.64000000000000001 110.557 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.96 163.87 33.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 119.928 -1.733 . . . . 0.67000000000000004 110.431 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.0 mt -149.88 149.74 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 107.465 -1.309 . . . . 0.68999999999999995 107.465 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 181' ' ' THR . 5.5 m -135.82 -26.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.755 -1.216 . . . . 0.84999999999999998 112.54 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.15 35.04 1.49 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.309 -1.424 . . . . 0.92000000000000004 113.113 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.526 HG21 HG22 ' A' ' 180' ' ' ILE . 47.5 p -56.06 -27.62 54.19 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.421 -1.046 . . . . 0.94999999999999996 111.45 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 77.12 -90.78 1.0 Allowed Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.133 -1.032 . . . . 1.04 110.815 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.2 p -125.06 27.6 6.64 Favored 'General case' 0 N--CA 1.512 2.652 0 O-C-N 121.341 -1.094 . . . . 1.5700000000000001 112.669 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.11 -34.76 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.232 -1.543 . . . . 0.83999999999999997 110.075 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.9 p -58.34 -17.97 23.96 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.26 -0.976 . . . . 0.98999999999999999 111.86 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.8 p -92.63 -0.98 57.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.137 -0.977 . . . . 1.7 112.006 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -129.13 5.19 5.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 112.595 0.591 . . . . 2.2000000000000002 112.595 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.87 141.32 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.732 -0.605 . . . . 0.83999999999999997 109.39 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -120.35 155.21 33.84 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.371 -0.974 . . . . 2.2000000000000002 108.371 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 16.6 p30 -53.8 142.79 22.77 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.083 -1.011 . . . . 2.2799999999999998 110.547 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.6 t0 80.19 0.25 2.01 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.504 1.298 . . . . 2.3500000000000001 114.504 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.12 146.67 54.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.795 -1.191 . . . . 1.97 108.78 177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -88.74 120.7 30.38 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.458 -1.312 . . . . 2.6499999999999999 107.458 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.646 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 49.6 mt -128.94 149.04 50.96 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.404 -0.81 . . . . 0.63 110.018 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.425 HD13 ' SD ' ' A' ' 239' ' ' MET . 57.4 mt -116.03 126.95 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.878 -1.527 . . . . 0.62 106.878 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.416 HD13 HD11 ' A' ' 180' ' ' ILE . 65.1 tp -99.22 120.11 38.98 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.306 -1.368 . . . . 0.64000000000000001 107.306 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 223' ' ' VAL . 49.7 t0 -93.89 -28.97 15.54 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.012 -1.055 . . . . 2.0499999999999998 112.826 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.77 18.37 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.186 0.809 . . . . 0.83999999999999997 113.186 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.8 t -111.45 -58.84 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-O 122.197 0.999 . . . . 1.02 108.922 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -96.47 9.8 40.24 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.412 1.101 . . . . 2.5099999999999998 110.188 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 61.92 50.05 4.38 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.785 -1.098 . . . . 1.54 111.665 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -145.28 148.04 33.02 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.345 1.069 . . . . 1.95 109.749 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 80.9 t -117.2 140.77 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 115.503 -0.772 . . . . 0.70999999999999996 109.285 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -100.03 130.59 46.21 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.171 -1.048 . . . . 1.01 108.171 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.3 t -109.83 131.48 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.579 0.704 . . . . 0.81999999999999995 109.166 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.413 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 24.6 t30 52.96 51.65 9.47 Favored Pre-proline 0 N--CA 1.497 1.877 0 N-CA-C 113.345 0.869 . . . . 1.54 113.345 177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 61.9 Cg_endo -70.23 151.66 66.5 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.784 2.323 . . . . 0.93999999999999995 111.441 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.0 m -72.23 156.46 39.11 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.964 -1.085 . . . . 1.8 108.747 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -59.8 -39.43 84.95 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.89 -1.131 . . . . 2.73 109.935 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.65 -39.72 85.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.482 -0.761 . . . . 3.1699999999999999 110.278 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 87.9 t -69.71 -38.58 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.461 -0.775 . . . . 1.3400000000000001 110.216 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.29 -46.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.042 -1.036 . . . . 1.2 110.15 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.03 -40.22 88.57 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.175 -0.953 . . . . 2.7000000000000002 110.208 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -62.17 -41.57 98.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 2.5899999999999999 110.808 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.425 ' SD ' HD13 ' A' ' 219' ' ' ILE . 74.9 mtp -70.81 -31.39 68.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 1.3799999999999999 110.372 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.428 ' CA ' ' HE ' ' A' ' 240' ' ' ARG . 0.0 OUTLIER -58.95 -40.64 85.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 2.8399999999999999 110.063 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.6 -45.33 45.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.297 -0.877 . . . . 1.8799999999999999 110.827 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 87.5 t -59.61 -46.35 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 2.3999999999999999 110.828 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.484 ' CA ' ' OE1' ' A' ' 243' ' ' GLN . 0.4 OUTLIER -62.86 -51.93 65.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.019 -1.051 . . . . 3.52 109.871 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.14 -31.88 71.59 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.216 -0.993 . . . . 1.8799999999999999 109.838 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -60.74 -31.1 70.43 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.097 -1.041 . . . . 3.0099999999999998 109.364 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.7 -43.88 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.87 0.843 . . . . 2.4500000000000002 109.918 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.1 94.76 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.023 -1.071 . . . . 2.75 109.567 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.2 t -73.28 -24.85 60.48 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.664 0.745 . . . . 3.1600000000000001 110.63 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -60.58 -37.77 82.43 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.815 -0.553 . . . . 3.5699999999999998 110.534 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -62.63 -41.54 99.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 4.2999999999999998 110.373 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -71.02 -42.64 69.28 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.886 0.851 . . . . 4.4500000000000002 110.574 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -82.94 5.2 22.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.579 -0.701 . . . . 5.9699999999999998 112.739 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -59.1 -36.12 74.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.924 -1.11 . . . . 6.1799999999999997 110.415 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.73 -19.55 65.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.848 -1.158 . . . . 6.6600000000000001 111.409 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -84.74 -5.91 59.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.474 -0.767 . . . . 8.1999999999999993 112.69 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.86 -3.72 58.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.903 -1.123 . . . . 8.0700000000000003 111.688 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -87.33 -122.67 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.193 -1.04 . . . . 9.4499999999999993 108.193 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.03 11.58 38.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.476 -0.765 . . . . 10.119999999999999 112.478 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 117.965 -1.017 . . . . 11.49 109.274 179.698 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mmm . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.077 -0.712 . . . . 3.0699999999999998 109.077 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.0 mt -97.14 117.34 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.455 -1.683 . . . . 1.0700000000000001 106.455 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 m -104.38 128.45 52.23 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.097 -1.075 . . . . 1.24 108.097 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.04 -160.45 16.79 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.904 -1.678 . . . . 1.01 108.904 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.6 mt -93.31 -1.11 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.292 -1.122 . . . . 1.1100000000000001 112.772 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp 50.72 96.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.102 -0.999 . . . . 0.98999999999999999 112.688 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -86.92 -42.33 13.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 0.84999999999999998 111.547 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -145.35 144.85 24.37 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.046 -1.094 . . . . 1.3799999999999999 108.046 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.81 147.44 27.43 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.59 2.193 . . . . 0.93999999999999995 112.218 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.893 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.29 167.77 15.16 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 109.261 -1.536 . . . . 0.81000000000000005 109.261 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.7 mt -125.91 132.49 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.243 -1.151 . . . . 0.82999999999999996 107.909 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.53 151.59 46.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 0.53000000000000003 109.286 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.609 ' CE1' ' NH2' ' A' ' 240' ' ' ARG . 1.8 m-85 -122.24 144.52 48.93 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.259 -1.015 . . . . 0.77000000000000002 108.259 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.92 167.45 34.22 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 118.362 -1.875 . . . . 0.51000000000000001 110.197 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -78.1 157.68 29.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.429 -1.042 . . . . 1.8999999999999999 108.938 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.419 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -83.96 124.64 31.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.975 -1.078 . . . . 0.66000000000000003 108.151 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.3 tp -100.46 104.49 15.89 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 105.024 -2.213 . . . . 0.82999999999999996 105.024 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -91.02 135.78 33.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.215 -1.031 . . . . 0.85999999999999999 108.215 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.3 mt -97.27 120.1 37.01 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.438 -1.319 . . . . 0.92000000000000004 107.438 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -109.11 134.67 51.4 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.249 -1.019 . . . . 2.0299999999999998 108.249 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.563 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 37.2 tt0 -117.98 140.36 49.85 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.224 -0.658 . . . . 2.6600000000000001 109.224 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -81.98 131.28 35.25 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.718 -1.216 . . . . 2.3199999999999998 107.718 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.09 145.02 56.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 2.1099999999999999 108.74 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.67 135.19 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.91 -1.118 . . . . 0.72999999999999998 108.636 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.6 t -103.44 129.8 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.967 -1.123 . . . . 0.87 107.967 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -99.0 136.97 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.646 -0.872 . . . . 0.81000000000000005 108.646 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -90.62 122.46 33.43 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.828 -1.175 . . . . 1.3400000000000001 107.828 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.442 HH11 ' HG3' ' A' ' 28' ' ' ARG . 20.6 mmm-85 -93.52 15.72 15.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.315 -0.865 . . . . 2.8900000000000001 112.319 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -71.47 143.25 50.1 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.408 -0.807 . . . . 2.0899999999999999 109.527 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.75 141.7 31.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.649 -0.657 . . . . 2.1899999999999999 109.425 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.2 pt -98.3 168.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.197 -0.939 . . . . 0.75 110.622 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.8 p -102.37 162.3 13.03 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.983 -0.747 . . . . 0.91000000000000003 108.983 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.45 -18.55 1.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.086 -1.009 . . . . 0.93000000000000005 112.379 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -69.85 -39.99 76.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 2.2799999999999998 110.754 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -93.13 -8.91 41.27 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.873 -1.142 . . . . 1.45 112.949 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -56.29 -50.48 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.168 -0.957 . . . . 0.81000000000000005 110.781 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.85 -39.44 85.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.542 -0.724 . . . . 1.54 110.674 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -62.2 -41.29 98.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.831 . . . . 2.3599999999999999 110.896 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.53 -37.62 81.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.742 -1.224 . . . . 1.3100000000000001 110.449 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.41 -41.78 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.169 -0.957 . . . . 0.81999999999999995 110.028 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -62.13 -43.58 98.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 1.5 109.745 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 42' ' ' ARG . 34.0 mtt-85 -61.8 -44.05 97.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.524 -0.735 . . . . 2.23 110.063 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -70.78 -52.16 22.38 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.346 -0.846 . . . . 0.84999999999999998 109.896 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.08 -46.44 89.56 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.394 -0.922 . . . . 0.91000000000000003 109.846 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 15.5 t -69.19 -34.89 75.6 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.243 0.544 . . . . 0.90000000000000002 110.364 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.44 -47.95 87.79 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.685 -1.245 . . . . 0.68999999999999995 110.17 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -56.91 -32.02 65.5 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.363 -1.08 . . . . 2.8799999999999999 109.183 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.38 -42.06 69.93 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.522 0.677 . . . . 0.84999999999999998 109.968 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -78.49 -42.02 30.85 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.688 -0.805 . . . . 2.3500000000000001 110.14 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.77 95.95 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.669 0.747 . . . . 0.65000000000000002 110.368 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.1 p -60.01 -39.81 87.06 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.994 0.902 . . . . 1.45 109.666 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.57 67.97 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 120.073 -0.651 . . . . 0.63 110.31 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -61.18 -48.57 80.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.273 -0.892 . . . . 1.3400000000000001 110.382 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.8 -40.37 96.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -0.92 . . . . 1.5600000000000001 109.821 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -60.55 -41.24 94.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.542 -0.724 . . . . 1.1899999999999999 110.428 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.621 HG22 ' NZ ' ' A' ' 60' ' ' LYS . 9.4 m -65.65 -42.86 90.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.0 -1.062 . . . . 0.71999999999999997 110.409 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.2 -30.73 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.658 . . . . 0.62 110.611 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -52.61 -46.29 66.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.709 -0.619 . . . . 1.05 110.619 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 m -68.82 -37.2 79.05 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.21 -0.931 . . . . 0.64000000000000001 109.791 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.621 ' NZ ' HG22 ' A' ' 56' ' ' THR . 65.2 mttp -61.73 -38.35 87.58 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.427 -0.909 . . . . 1.73 109.386 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.19 74.86 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.822 -0.751 . . . . 0.56000000000000005 109.977 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.97 -34.57 21.03 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.379 -1.391 . . . . 0.68999999999999995 110.917 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.44 -18.05 43.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.783 -1.422 . . . . 1.48 111.545 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.0 m -87.91 -52.57 5.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.912 -0.493 . . . . 0.97999999999999998 110.344 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -107.27 -15.28 14.69 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.435 -0.791 . . . . 1.1599999999999999 112.97 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.91 164.88 14.71 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.537 -0.727 . . . . 0.84999999999999998 111.567 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -58.16 -17.94 22.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.629 -0.924 . . . . 3.8599999999999999 113.113 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.91 -39.43 85.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.995 -1.065 . . . . 2.3500000000000001 110.769 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -86.8 -23.63 25.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.953 -1.092 . . . . 1.6699999999999999 111.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -59.84 -39.98 86.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.725 -0.609 . . . . 1.45 111.598 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.44 -36.77 81.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.162 -0.961 . . . . 0.60999999999999999 111.352 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 57.8 mt -63.38 -41.65 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.73 -1.232 . . . . 0.65000000000000002 110.843 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -70.59 -30.94 67.75 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.933 -1.104 . . . . 0.66000000000000003 110.631 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.51 -38.73 85.32 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.195 -0.94 . . . . 1.1899999999999999 109.91 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.3 -44.67 90.22 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 120.298 -0.953 . . . . 0.53000000000000003 110.891 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -59.73 -40.79 89.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.874 -1.368 . . . . 1.27 110.723 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.6 mt -59.83 -39.43 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.107 -0.995 . . . . 0.54000000000000004 110.772 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.21 -39.77 83.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.111 -0.993 . . . . 1.74 110.633 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.5 tp -58.36 -45.89 87.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.14 -0.975 . . . . 0.55000000000000004 110.235 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.51 -39.83 89.2 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.585 -0.846 . . . . 0.46999999999999997 110.248 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -86.93 11.02 14.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 1.4199999999999999 112.304 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -66.47 120.96 14.26 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.978 -1.076 . . . . 1.27 108.536 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.87 -16.8 64.17 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.367 -0.833 . . . . 1.3500000000000001 110.918 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -73.42 -47.89 38.13 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.548 -0.861 . . . . 2.2200000000000002 110.447 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.86 -37.29 86.83 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.429 -0.908 . . . . 0.62 110.229 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.74 -45.53 93.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.338 -0.851 . . . . 1.29 110.915 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.7 -36.98 85.62 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.014 -1.054 . . . . 1.52 110.925 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.7 -48.48 63.77 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.735 -1.228 . . . . 1.3 110.404 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -57.44 -47.71 84.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.444 -0.902 . . . . 0.60999999999999999 110.243 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.87 -39.61 80.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.785 -0.572 . . . . 0.78000000000000003 110.415 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.53 91.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 0.81999999999999995 110.644 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.15 -43.68 98.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.80000000000000004 110.284 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.1 mt -61.0 -45.95 97.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.77000000000000002 110.648 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -82.31 -36.43 26.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -0.757 . . . . 2.1200000000000001 111.908 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -84.49 -39.36 18.97 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.62 -1.3 . . . . 1.51 111.627 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -105.26 10.37 33.65 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.969 -1.082 . . . . 1.98 111.939 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.4 m80 48.48 51.39 15.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 1.3200000000000001 111.588 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.2 mtt -109.5 154.34 22.81 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.703 0.763 . . . . 1.3799999999999999 109.722 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.1 p -71.81 158.64 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.132 -0.692 . . . . 0.67000000000000004 109.132 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.27 89.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.403 -0.811 . . . . 0.52000000000000002 110.754 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.634 ' OD2' HD21 ' A' ' 142' ' ' LEU . 72.4 m-20 -67.42 -43.06 82.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.755 -1.215 . . . . 2.25 109.51 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.06 -48.31 58.4 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.656 0.741 . . . . 0.64000000000000001 110.845 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.48 -46.85 87.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.138 -0.976 . . . . 0.56000000000000005 110.47 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.29 94.96 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.497 0.665 . . . . 0.46000000000000002 110.411 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.85 -39.33 84.82 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.032 -1.043 . . . . 1.3200000000000001 110.334 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.42 -49.92 75.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.878 -1.139 . . . . 1.3 111.099 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.25 -49.0 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.005 -1.059 . . . . 0.60999999999999999 110.004 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.45 -30.82 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.676 -0.64 . . . . 0.65000000000000002 110.699 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -59.45 -40.37 86.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 2.1099999999999999 110.276 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.28 -28.0 31.74 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.204 -1.474 . . . . 0.82999999999999996 113.108 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -60.29 -39.73 87.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.056 -1.85 . . . . 1.28 110.045 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.63 -46.69 52.82 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.554 -0.716 . . . . 0.89000000000000001 110.299 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.3 p -62.83 -40.21 96.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.419 -0.801 . . . . 1.8700000000000001 110.433 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.39 -40.65 97.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 1.05 110.508 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.88 -29.61 70.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.04 -1.037 . . . . 1.02 111.111 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.09 -21.36 64.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.906 -1.121 . . . . 2.04 111.053 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -73.81 -12.48 60.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.215 -0.928 . . . . 1.73 110.788 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.454 HD13 HD13 ' A' ' 123' ' ' LEU . 9.6 mt -84.84 144.89 28.13 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.485 -0.759 . . . . 1.3700000000000001 109.065 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -101.46 46.91 0.92 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.171 -0.956 . . . . 2.8799999999999999 111.591 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -122.28 138.75 54.39 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.057 -1.027 . . . . 1.5800000000000001 108.589 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.8 -38.67 82.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 3.04 110.973 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -71.93 -47.02 55.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.957 -1.089 . . . . 0.90000000000000002 110.525 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.454 HD13 HD13 ' A' ' 118' ' ' LEU . 39.5 mt -63.67 -36.76 84.89 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.46 -0.896 . . . . 1.0600000000000001 110.103 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -60.47 -46.53 89.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.819 -1.152 . . . . 2.1800000000000002 109.644 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -61.95 -30.84 71.19 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.367 -0.933 . . . . 2.1499999999999999 109.651 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 130' ' ' VAL . 60.7 ttt180 -61.86 -30.12 70.64 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.291 -0.964 . . . . 2.3300000000000001 108.9 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.21 73.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.785 0.802 . . . . 0.81999999999999995 109.574 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.89 -43.36 71.95 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.622 0.725 . . . . 0.84999999999999998 110.319 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -64.5 -34.15 77.56 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.497 -0.752 . . . . 1.3899999999999999 110.528 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 126' ' ' ARG . 16.3 t -68.01 -39.96 82.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.252 -0.905 . . . . 0.56000000000000005 110.033 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 131' ' ' ARG . 27.4 ttt-85 -56.18 -39.92 73.14 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.251 -1.379 . . . . 3.1200000000000001 109.469 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -60.05 -42.59 94.79 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.575 0.702 . . . . 1.28 110.235 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.32 -38.94 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.48999999999999999 110.166 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.59 -43.74 23.02 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.852 -1.166 . . . . 0.46000000000000002 110.832 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -58.33 -40.76 83.0 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.293 -1.122 . . . . 2.71 110.592 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 136' ' ' ARG . 55.1 mtt-85 -62.33 -41.55 98.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.959 -1.088 . . . . 2.1400000000000001 109.969 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.64 -39.59 84.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.611 -0.681 . . . . 1.05 109.964 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.3 mt -59.73 -40.09 86.86 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.453 -0.779 . . . . 0.52000000000000002 110.473 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.563 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 63.1 mtt-85 -60.66 -38.6 85.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.016 -1.053 . . . . 2.3500000000000001 111.062 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -71.65 -41.81 68.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 1.3899999999999999 110.87 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.3 -39.62 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.016 -1.053 . . . . 0.68000000000000005 110.216 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.634 HD21 ' OD2' ' A' ' 101' ' ' ASP . 84.1 mt -87.2 -8.93 56.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.123 -0.986 . . . . 0.82999999999999996 112.199 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.27 21.29 78.07 Favored Glycine 0 N--CA 1.48 1.617 0 C-N-CA 119.703 -1.237 . . . . 0.91000000000000003 113.282 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 tp -69.2 149.94 48.02 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.78 -0.835 . . . . 0.94999999999999996 110.543 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -67.85 150.92 47.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.369 -0.832 . . . . 2.4300000000000002 110.913 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.9 mt -101.74 139.96 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.368 -0.975 . . . . 1.1000000000000001 108.368 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.737 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.3 mp -78.56 124.42 36.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.297 -1.001 . . . . 1.5800000000000001 108.297 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -99.6 100.03 10.97 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.317 -1.735 . . . . 1.6200000000000001 106.317 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.518 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 71.6 mt -78.54 -4.99 51.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.545 -0.722 . . . . 0.80000000000000004 112.321 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.2 p -86.99 9.18 20.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.145 -0.972 . . . . 1.5600000000000001 112.366 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.66 18.42 14.33 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 114.151 1.167 . . . . 0.83999999999999997 114.151 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.1 mp -71.35 141.12 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 119.909 -1.744 . . . . 0.81999999999999995 109.498 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -118.84 -13.52 9.51 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.045 0.926 . . . . 2.3100000000000001 112.429 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -117.38 145.04 44.34 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.555 -0.906 . . . . 1.54 108.555 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -76.26 121.78 23.44 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.673 -0.862 . . . . 1.3799999999999999 108.673 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.4 m -147.48 176.31 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.434 -0.791 . . . . 0.68999999999999995 108.973 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.9 mt -88.65 142.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.524 -0.735 . . . . 0.53000000000000003 109.339 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.5 tp -94.85 126.73 40.38 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.594 -0.891 . . . . 0.64000000000000001 108.594 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.89 131.02 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.648 -0.871 . . . . 0.67000000000000004 108.648 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.98 154.56 19.87 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.646 -0.872 . . . . 0.78000000000000003 108.646 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.22 -36.02 78.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.393 -1.442 . . . . 1.0 109.477 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 55.9 t0 -172.75 151.22 2.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.43 -0.952 . . . . 2.4199999999999999 108.43 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 70.1 mt -113.06 140.22 48.04 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.371 -0.831 . . . . 0.75 108.926 177.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.5 p -94.82 152.81 39.97 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.221 -0.925 . . . . 0.78000000000000003 108.754 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -42.91 -42.28 9.08 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.806 1.671 . . . . 0.67000000000000004 113.295 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.9 m -62.24 -50.44 71.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.987 -1.071 . . . . 0.69999999999999996 109.744 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.28 -40.5 90.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.503 -0.748 . . . . 1.21 110.25 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 78.3 p -67.86 -40.09 83.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.53 -0.731 . . . . 0.59999999999999998 110.754 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.13 86.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.62 110.743 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -95.32 1.1 54.28 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.204 -0.935 . . . . 1.1599999999999999 112.691 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.83 150.15 29.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.451 -0.781 . . . . 0.72999999999999998 109.902 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.661 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.6 OUTLIER -91.99 107.02 18.91 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.274 -1.75 . . . . 2.2400000000000002 106.274 177.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.4 mt -81.15 -9.16 59.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.438 -0.788 . . . . 1.4299999999999999 112.535 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -77.59 -35.51 52.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.039 -1.038 . . . . 2.1499999999999999 110.572 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -101.36 2.87 40.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.235 -0.915 . . . . 2.04 113.01 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 172' ' ' ASN . 91.0 t -101.0 120.01 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 106.807 -1.553 . . . . 0.55000000000000004 106.807 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.2 tp -90.93 -9.51 45.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.097 -1.002 . . . . 1.6299999999999999 112.04 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.66 169.26 40.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.035 -1.626 . . . . 0.46999999999999997 109.035 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 179' ' ' PHE . 1.1 m-85 -128.02 129.79 47.28 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.384 -1.068 . . . . 0.54000000000000004 108.2 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.4 mt -128.85 108.75 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 105.857 -1.905 . . . . 0.68999999999999995 105.857 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 205' ' ' THR . 76.4 p -130.82 171.76 12.78 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.905 -1.122 . . . . 0.81999999999999995 110.153 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.445 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 33.3 t0 -102.54 59.15 0.8 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.724 -0.61 . . . . 2.3700000000000001 110.453 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.94 120.5 42.47 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.371 -1.715 . . . . 1.1100000000000001 106.371 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.72 17.91 49.95 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 120.918 -1.114 . . . . 1.6699999999999999 113.133 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -91.8 120.42 6.04 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.36 -2.296 . . . . 1.54 107.36 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -59.06 -31.38 68.81 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.199 -1.177 . . . . 4.4800000000000004 109.558 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 81.2 p -108.44 41.51 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.462 0.649 . . . . 2.6299999999999999 109.993 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 52.0 m -70.25 158.73 35.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.957 -1.09 . . . . 1.6899999999999999 109.171 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -59.84 -39.6 85.69 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.36 -0.838 . . . . 1.0700000000000001 111.082 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.9 m -58.47 -40.99 84.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.633 -1.292 . . . . 1.5800000000000001 110.228 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.2 m -61.39 -37.04 81.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 1.6000000000000001 110.447 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.73 -39.32 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.509 -0.745 . . . . 1.45 110.666 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 68.8 mtp -62.92 -41.15 99.37 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.08 0.943 . . . . 1.05 109.486 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.92 -45.43 94.67 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.931 -0.577 . . . . 0.71999999999999997 111.091 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -60.37 -43.37 96.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.982 -1.074 . . . . 3.0499999999999998 110.674 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.2 m -69.45 -39.13 77.97 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.211 -0.93 . . . . 0.89000000000000001 110.187 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.45 -7.48 50.48 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.871 0.844 . . . . 0.78000000000000003 112.531 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.9 mt-10 53.12 7.16 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.996 1.109 . . . . 1.45 113.996 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.91 149.67 92.61 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 120.959 -1.088 . . . . 0.67000000000000004 108.385 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.13 144.95 88.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.534 1.49 . . . . 0.64000000000000001 109.738 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.62 161.41 35.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.366 -1.458 . . . . 0.67000000000000004 109.673 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.467 ' CD1' HD11 ' A' ' 220' ' ' LEU . 19.6 mt -149.94 149.55 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.756 -1.202 . . . . 0.68999999999999995 107.756 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.8 m -133.41 -25.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.123 -0.986 . . . . 0.84999999999999998 112.324 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.68 43.0 2.07 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 120.226 -0.987 . . . . 0.92000000000000004 111.837 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 181' ' ' THR . 43.8 p -63.08 -15.63 57.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.322 -1.105 . . . . 0.94999999999999996 111.573 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.445 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 72.12 -93.82 0.6 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.868 -1.293 . . . . 1.04 109.868 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 85.2 p -129.95 33.4 4.4 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.35 -1.088 . . . . 1.5700000000000001 112.022 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.67 -35.79 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.023 -1.673 . . . . 0.83999999999999997 110.482 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.1 p -60.33 -24.76 65.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.98999999999999999 111.73 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.8 p -96.57 9.0 42.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 1.7 112.149 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -132.59 -4.27 3.31 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.728 -0.607 . . . . 2.2000000000000002 112.409 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 213' ' ' LYS . 42.1 t -121.06 157.59 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.275 -0.89 . . . . 0.83999999999999997 109.854 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.422 ' N ' HG12 ' A' ' 212' ' ' VAL . 20.9 mmmt -122.25 160.25 25.64 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.069 -1.086 . . . . 2.2000000000000002 108.069 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 51.5 p-10 -57.03 142.12 43.23 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.093 -1.004 . . . . 2.2799999999999998 110.53 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.0 OUTLIER 80.32 7.49 1.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.79 1.404 . . . . 2.3500000000000001 114.79 179.387 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.8 t0 -67.21 149.38 50.53 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.308 -0.997 . . . . 1.97 108.308 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.433 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.3 t80 -89.64 115.04 26.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.331 -1.359 . . . . 2.6499999999999999 107.331 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.419 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 78.5 mt -124.96 148.15 48.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -0.755 . . . . 0.63 109.365 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 58.3 mt -119.09 126.35 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.15 -1.796 . . . . 0.62 106.15 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 202' ' ' ILE . 66.2 tp -100.91 119.04 38.13 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.425 -1.694 . . . . 0.64000000000000001 106.425 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.0 p-10 -94.73 -21.33 18.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.027 -1.046 . . . . 2.0499999999999998 112.459 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.893 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.93 18.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.376 0.608 . . . . 0.83999999999999997 112.477 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.601 ' N ' ' O ' ' A' ' 221' ' ' ASP . 14.4 t -112.26 -62.83 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 1.02 109.389 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -89.68 7.25 37.64 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.314 1.054 . . . . 2.5099999999999998 110.226 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 39.6 t30 63.86 50.58 2.56 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.023 -0.989 . . . . 1.54 112.1 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 74.6 mt-30 -147.16 152.38 38.33 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.352 1.072 . . . . 1.95 110.187 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.9 t -115.65 139.92 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.989 -1.115 . . . . 0.70999999999999996 107.989 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -104.98 133.17 50.21 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.164 -0.96 . . . . 1.01 108.775 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.85 130.89 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.16 -1.052 . . . . 0.81999999999999995 108.16 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.461 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 57.7 t30 54.39 49.04 5.12 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 113.578 0.955 . . . . 1.54 113.578 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 52.9 Cg_endo -68.95 149.67 72.25 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.607 2.204 . . . . 0.93999999999999995 110.994 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.1 p -78.33 165.47 23.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.035 -1.041 . . . . 1.8 110.497 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -60.77 -36.34 78.7 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.946 -1.096 . . . . 2.73 110.455 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.58 -39.91 85.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.004 -1.06 . . . . 3.1699999999999999 111.138 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.17 -40.37 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 1.3400000000000001 110.243 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 74.9 mt -59.42 -43.96 91.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.327 -0.858 . . . . 1.2 110.916 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.02 -40.31 88.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.21 -0.931 . . . . 2.7000000000000002 110.573 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -62.49 -45.35 93.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.51 -0.744 . . . . 2.5899999999999999 110.722 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 77.8 mtp -71.63 -39.46 70.41 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.364 -0.835 . . . . 1.3799999999999999 110.883 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.609 ' NH2' ' CE1' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -56.84 -41.87 78.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 2.8399999999999999 110.634 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.3 -45.86 62.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.02 -1.05 . . . . 1.8799999999999999 111.662 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.6 -47.96 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.293 -1.504 . . . . 2.3999999999999999 111.396 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -62.24 -49.76 74.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.738 -1.226 . . . . 3.52 110.867 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.06 -35.52 81.01 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.569 -0.707 . . . . 1.8799999999999999 111.353 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -62.1 -29.84 70.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.696 -1.253 . . . . 3.0099999999999998 110.155 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 64.0 t -67.47 -41.06 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.961 -0.695 . . . . 2.4500000000000002 110.06 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.07 -40.04 88.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 2.75 110.899 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.6 t -69.28 -41.03 77.37 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.936 -1.103 . . . . 3.1600000000000001 110.791 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -62.8 -39.51 94.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.873 . . . . 3.5699999999999998 110.619 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -63.84 -32.76 74.38 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.229 -0.919 . . . . 4.2999999999999998 110.597 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.46 72.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.194 -0.942 . . . . 4.4500000000000002 110.693 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.05 -42.91 75.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.84 -1.162 . . . . 5.9699999999999998 110.815 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 253' ' ' LEU . 3.6 mm? -71.21 -38.1 72.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.093 -1.004 . . . . 6.1799999999999997 111.258 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -73.23 -2.21 20.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.06 -1.025 . . . . 6.6600000000000001 112.899 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -82.99 -8.91 59.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.723 -1.236 . . . . 8.1999999999999993 112.682 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 81.6 mt -90.32 -76.3 0.43 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.749 -1.219 . . . . 8.0700000000000003 109.917 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -123.21 -126.51 0.26 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.838 -1.171 . . . . 9.4499999999999993 107.838 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -98.01 19.06 14.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.459 -0.776 . . . . 10.119999999999999 111.622 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.49 ' HG2' HH11 ' A' ' 259' ' ' ARG . 19.9 ttt-85 . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 118.103 -0.951 . . . . 11.49 109.955 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.401 -0.592 . . . . 3.0699999999999998 109.401 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.4 mt -92.54 115.04 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.495 -1.668 . . . . 1.0700000000000001 106.495 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.7 m -104.14 121.56 43.49 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.719 -1.215 . . . . 1.24 107.719 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 225' ' ' ASN . . . -117.78 -164.17 13.1 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.868 -1.693 . . . . 1.01 108.868 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.1 mt -96.34 1.56 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 120.872 -1.37 . . . . 1.1100000000000001 112.708 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ILE . 18.9 tp 49.33 100.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.012 -1.075 . . . . 0.98999999999999999 111.678 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.33 -45.24 13.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.255 -1.528 . . . . 0.84999999999999998 111.249 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -148.57 149.04 30.18 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.275 -1.009 . . . . 1.3799999999999999 108.275 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.53 148.93 43.28 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 123.01 2.473 . . . . 0.93999999999999995 112.104 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 147.89 119.68 1.1 Allowed Glycine 0 N--CA 1.507 3.413 0 N-CA-C 110.323 -1.111 . . . . 0.81000000000000005 110.323 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.445 ' CG2' ' OE1' ' A' ' 243' ' ' GLN . 53.3 mt -90.64 135.78 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.893 -1.357 . . . . 0.82999999999999996 108.818 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.42 ' CB ' HD12 ' A' ' 177' ' ' LEU . . . -138.74 157.64 45.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.854 -0.795 . . . . 0.53000000000000003 108.854 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 243' ' ' GLN . 7.8 m-85 -118.74 140.01 50.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.93 -1.137 . . . . 0.77000000000000002 107.93 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.77 163.26 31.49 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 118.597 -1.763 . . . . 0.51000000000000001 110.057 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -78.8 157.74 28.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.67 -0.9 . . . . 1.8999999999999999 108.996 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -81.53 130.42 35.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.002 -1.061 . . . . 0.66000000000000003 108.394 178.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -110.87 101.4 10.0 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.729 -1.952 . . . . 0.82999999999999996 105.729 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.4 tp -87.78 135.26 33.46 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.408 -1.33 . . . . 0.85999999999999999 107.408 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.464 HD11 HD11 ' A' ' 158' ' ' LEU . 67.0 mt -101.02 114.56 28.6 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 106.481 -1.674 . . . . 0.92000000000000004 106.481 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -108.51 138.02 45.51 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.885 -1.154 . . . . 2.0299999999999998 107.885 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 52.1 mp0 -123.09 149.35 44.58 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.462 -0.774 . . . . 2.6600000000000001 109.463 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -83.82 130.6 34.93 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.784 -1.191 . . . . 2.3199999999999998 107.784 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -63.22 146.88 52.46 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.149 -0.969 . . . . 2.1099999999999999 108.96 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.6 mt -92.16 135.41 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 108.115 -1.069 . . . . 0.72999999999999998 108.115 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -106.43 127.94 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.099 -1.074 . . . . 0.87 108.099 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -101.57 136.26 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.043 -1.095 . . . . 0.81000000000000005 108.043 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -89.47 125.24 35.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.73 -1.231 . . . . 1.3400000000000001 107.766 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.489 ' HG2' HH11 ' A' ' 28' ' ' ARG . 4.3 mmt-85 -93.54 11.15 29.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.998 -1.064 . . . . 2.8900000000000001 112.358 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -67.53 143.7 56.01 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.058 -1.026 . . . . 2.0899999999999999 108.991 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -88.86 136.95 32.74 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.08 -1.082 . . . . 2.1899999999999999 108.08 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.18 166.72 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.277 -0.89 . . . . 0.75 110.303 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.7 p -93.89 163.69 13.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.91000000000000003 109.666 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.83 -21.17 6.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.46 -0.775 . . . . 0.93000000000000005 112.04 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -69.95 -41.92 73.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.063 -1.023 . . . . 2.2799999999999998 111.049 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -86.56 -2.68 58.69 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.438 -1.414 . . . . 1.45 112.224 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -60.96 -45.39 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 0.81000000000000005 110.938 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.72 -39.66 85.4 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.644 -1.285 . . . . 1.54 110.528 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.539 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 10.4 mp0 -60.34 -41.07 92.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.106 -0.497 . . . . 2.3599999999999999 110.947 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.59 -38.47 84.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.575 -1.328 . . . . 1.3100000000000001 110.626 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.5 t -59.82 -41.64 86.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.939 -1.101 . . . . 0.81999999999999995 110.729 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -63.42 -49.81 72.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.719 -1.238 . . . . 1.5 110.206 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.37 -38.88 88.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.595 -0.691 . . . . 2.23 110.329 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -75.5 -55.87 5.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.657 0.741 . . . . 0.84999999999999998 109.902 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.63 -46.99 85.89 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.693 -0.803 . . . . 0.91000000000000003 110.561 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 15.4 t -67.32 -41.88 84.57 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.19 -0.944 . . . . 0.90000000000000002 110.131 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.15 87.6 Favored Glycine 0 N--CA 1.486 2.025 0 C-N-CA 119.088 -1.53 . . . . 0.68999999999999995 109.965 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.6 ttt-85 -58.2 -31.35 67.22 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.744 -0.857 . . . . 2.8799999999999999 109.794 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.61 -40.89 80.14 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.881 0.848 . . . . 0.84999999999999998 109.792 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -78.12 -41.91 33.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 2.3500000000000001 110.112 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.21 93.16 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.272 -0.892 . . . . 0.65000000000000002 109.939 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 p -60.5 -38.24 83.67 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.465 1.126 . . . . 1.45 109.268 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.84 -47.04 64.21 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.68 -0.691 . . . . 0.63 110.419 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.04 -48.4 71.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.248 -0.908 . . . . 1.3400000000000001 110.546 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.8 -39.18 90.8 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.343 -0.848 . . . . 1.5600000000000001 109.572 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -60.18 -41.56 93.17 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.686 -0.634 . . . . 1.1899999999999999 110.478 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.6 m -62.91 -40.63 98.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.026 -1.046 . . . . 0.71999999999999997 110.272 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.4 mt -60.6 -36.02 67.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.471 -0.768 . . . . 0.62 110.325 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -53.79 -42.92 68.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 1.05 111.027 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -70.0 -33.39 71.98 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.835 -1.166 . . . . 0.64000000000000001 110.557 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -64.89 -39.92 94.3 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.886 -1.125 . . . . 1.73 109.515 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.39 80.96 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.756 -0.59 . . . . 0.56000000000000005 109.968 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.7 -36.1 34.1 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.651 -1.261 . . . . 0.68999999999999995 110.583 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -79.91 -28.18 39.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.876 -1.367 . . . . 1.48 110.984 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 79.6 m -86.77 -47.74 8.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.368 -0.832 . . . . 0.97999999999999998 110.942 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -107.93 -11.16 15.39 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 113.343 0.868 . . . . 1.1599999999999999 113.343 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.67 159.63 24.79 Favored Glycine 0 N--CA 1.5 2.949 0 C-N-CA 120.658 -0.782 . . . . 0.84999999999999998 113.29 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -52.33 -18.87 1.77 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.743 -0.857 . . . . 3.8599999999999999 112.921 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.17 -38.57 76.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 2.3500000000000001 111.522 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -82.37 -21.63 35.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.903 -1.123 . . . . 1.6699999999999999 112.05 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -59.74 -31.47 69.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 1.45 111.098 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.79 88.82 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.13 -0.981 . . . . 0.60999999999999999 110.519 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.0 mt -67.01 -44.71 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.633 -1.292 . . . . 0.65000000000000002 110.145 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -70.85 -28.8 64.85 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.321 -0.862 . . . . 0.66000000000000003 110.925 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -61.87 -37.99 86.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.883 . . . . 1.1899999999999999 110.153 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.11 -38.98 73.34 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 119.693 -1.242 . . . . 0.53000000000000003 110.486 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -59.68 -42.55 93.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.094 -1.239 . . . . 1.27 110.3 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.2 mt -62.44 -38.97 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.351 -0.843 . . . . 0.54000000000000004 110.091 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.9 ttm -59.99 -39.99 87.62 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.549 -0.861 . . . . 1.74 110.263 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.66 -51.49 69.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.199 -0.938 . . . . 0.55000000000000004 110.89 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.7 tp -60.52 -41.58 94.68 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.913 -0.715 . . . . 0.46999999999999997 110.057 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -87.24 1.17 53.98 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.086 0.773 . . . . 1.4199999999999999 113.086 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -60.28 123.53 17.52 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.426 -1.421 . . . . 1.27 108.577 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.18 -17.26 64.76 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.694 0.759 . . . . 1.3500000000000001 111.064 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -76.36 -54.19 7.1 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.875 -0.73 . . . . 2.2200000000000002 110.227 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.9 mt -62.27 -38.38 89.12 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.152 -0.619 . . . . 0.62 110.722 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -59.38 -49.91 75.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.075 -1.016 . . . . 1.29 111.213 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.25 -37.57 83.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.811 -1.181 . . . . 1.52 110.577 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.2 -47.79 78.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.146 -0.971 . . . . 1.3 110.18 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 94.0 mt -57.68 -47.08 86.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 120.999 -1.063 . . . . 0.60999999999999999 110.015 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.26 -41.92 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.66 0.743 . . . . 0.78000000000000003 110.857 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.34 -42.44 91.52 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.226 -0.921 . . . . 0.81999999999999995 110.866 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.69 -42.42 97.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.972 -1.08 . . . . 0.80000000000000004 110.161 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.44 -50.35 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 0.77000000000000002 110.572 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -76.16 -35.15 59.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 2.1200000000000001 111.903 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -81.89 -43.78 17.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.733 -1.229 . . . . 1.51 112.043 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -102.08 7.11 41.23 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.233 -0.917 . . . . 1.98 112.862 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 50.72 49.59 20.63 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 1.3200000000000001 111.887 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.3 mtt -102.99 155.95 18.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.387 -0.821 . . . . 1.3799999999999999 109.34 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.8 p -72.17 159.53 33.96 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.76 0.79 . . . . 0.67000000000000004 109.6 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.89 88.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.937 -1.102 . . . . 0.52000000000000002 110.416 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.512 ' OD2' HD21 ' A' ' 142' ' ' LEU . 93.5 m-20 -68.52 -39.17 81.3 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.176 -0.953 . . . . 2.25 110.618 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.8 -51.76 24.81 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.273 -0.892 . . . . 0.64000000000000001 111.214 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.48 94.79 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.827 -1.171 . . . . 0.56000000000000005 110.994 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.15 98.94 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.379 -0.826 . . . . 0.46000000000000002 110.9 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -60.42 -39.82 88.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.916 -1.115 . . . . 1.3200000000000001 111.003 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -59.03 -49.38 78.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.801 -1.187 . . . . 1.3 110.684 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.57 -41.89 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.252 -0.905 . . . . 0.60999999999999999 110.231 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -63.29 -32.47 56.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.301 -0.874 . . . . 0.65000000000000002 110.03 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.85 -41.11 86.21 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.611 -0.68 . . . . 2.1099999999999999 110.927 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.21 -31.55 19.49 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.422 -1.371 . . . . 0.82999999999999996 112.898 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -61.44 -40.45 94.5 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 119.421 1.61 . . . . 1.28 109.958 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.56 -50.6 24.48 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.938 0.875 . . . . 0.89000000000000001 110.364 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 60.9 p -61.48 -37.22 82.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.394 -0.816 . . . . 1.8700000000000001 110.775 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.1 -45.22 93.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.379 -0.826 . . . . 1.05 110.92 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.22 -28.27 69.25 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.083 -1.011 . . . . 1.02 111.21 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -66.67 -22.27 66.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.856 . . . . 2.04 110.731 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -71.61 -15.72 62.26 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.378 -0.826 . . . . 1.73 111.245 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 123' ' ' LEU . 22.7 mt -86.28 138.93 31.47 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.685 -1.228 . . . . 1.3700000000000001 107.685 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -97.8 39.41 1.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.341 -0.849 . . . . 2.8799999999999999 111.617 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -112.23 137.18 50.7 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.557 -0.905 . . . . 1.5800000000000001 108.557 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.9 -36.72 72.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 3.04 111.167 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.15 -56.48 5.5 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.838 -1.164 . . . . 0.90000000000000002 110.41 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 118' ' ' LEU . 38.4 mt -62.29 -42.08 99.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 1.0600000000000001 110.785 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.03 -47.47 84.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.993 -1.067 . . . . 2.1800000000000002 110.456 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -60.28 -32.53 71.26 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.328 -0.949 . . . . 2.1499999999999999 109.968 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.556 ' O ' HG23 ' A' ' 130' ' ' VAL . 21.7 ttp180 -64.76 -29.12 70.09 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.187 -1.005 . . . . 2.3300000000000001 109.552 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.93 87.02 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.763 0.792 . . . . 0.81999999999999995 109.829 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.41 -42.74 78.56 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.543 0.687 . . . . 0.84999999999999998 110.449 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.04 -33.34 75.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.577 -0.702 . . . . 1.3899999999999999 110.729 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 126' ' ' ARG . 52.7 t -69.31 -38.56 77.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.439 -0.788 . . . . 0.56000000000000005 110.529 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.445 ' HG2' HH11 ' A' ' 131' ' ' ARG . 34.3 ttt-85 -59.67 -40.21 87.04 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.864 -1.135 . . . . 3.1200000000000001 109.665 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -61.23 -35.24 76.7 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.649 0.738 . . . . 1.28 110.715 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.3 mt -61.73 -40.13 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.051 -1.031 . . . . 0.48999999999999999 110.47 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.55 -46.77 91.55 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.088 -1.053 . . . . 0.46000000000000002 110.745 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -58.32 -43.71 88.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.944 -1.327 . . . . 2.71 110.59 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.416 ' HG2' HH11 ' A' ' 136' ' ' ARG . 51.6 mtt-85 -60.63 -44.1 96.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.929 -1.107 . . . . 2.1400000000000001 110.577 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.1 -44.21 97.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.067 -1.021 . . . . 1.05 110.083 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.46 -41.13 96.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.876 . . . . 0.52000000000000002 110.702 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.403 HH11 ' HG2' ' A' ' 139' ' ' ARG . 46.4 mtt-85 -61.52 -34.76 76.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.907 . . . . 2.3500000000000001 110.563 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -73.97 -40.4 63.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 1.3899999999999999 110.989 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.67 -38.5 78.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.23 -0.919 . . . . 0.68000000000000005 110.615 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.512 HD21 ' OD2' ' A' ' 101' ' ' ASP . 74.5 mt -87.95 -7.92 56.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.931 -1.105 . . . . 0.82999999999999996 112.587 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.16 18.88 79.06 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 120.077 -1.059 . . . . 0.91000000000000003 113.046 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -62.31 146.75 50.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.983 . . . . 0.94999999999999996 109.406 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -67.22 147.88 52.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.974 -1.079 . . . . 2.4300000000000002 109.176 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.8 mt -109.63 136.22 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.097 -1.002 . . . . 1.1000000000000001 108.306 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.707 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.2 mp -78.0 130.09 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.48 -0.763 . . . . 1.5800000000000001 108.949 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -97.46 99.97 11.39 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.287 -1.745 . . . . 1.6200000000000001 106.287 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.8 mt -70.8 -21.08 62.52 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 116.145 -0.479 . . . . 0.80000000000000004 111.48 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.8 m -80.71 3.33 22.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.922 . . . . 1.5600000000000001 111.821 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.72 19.41 12.51 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.445 -0.784 . . . . 0.83999999999999997 112.507 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.5 mt -71.81 141.44 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.81999999999999995 109.689 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -117.54 -14.34 10.28 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.84 0.829 . . . . 2.3100000000000001 113.049 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -114.75 138.04 51.21 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.239 -1.022 . . . . 1.54 108.239 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.62 123.32 22.98 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.408 -0.96 . . . . 1.3799999999999999 108.408 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.1 m -145.95 176.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.391 -0.818 . . . . 0.68999999999999995 109.273 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mt -87.27 140.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.758 -1.214 . . . . 0.53000000000000003 108.426 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.464 HD11 HD11 ' A' ' 19' ' ' LEU . 26.9 tp -95.3 121.06 36.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.869 -1.145 . . . . 0.64000000000000001 108.158 178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.3 t -123.3 132.29 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 108.369 -0.975 . . . . 0.67000000000000004 108.369 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -160.4 160.51 32.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 0.78000000000000003 108.561 178.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.64 77.63 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.826 -1.171 . . . . 1.0 109.208 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 p-10 -172.4 155.49 3.5 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.726 -0.842 . . . . 2.4199999999999999 108.726 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 75.1 mt -120.25 137.99 53.91 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.956 -1.127 . . . . 0.75 107.956 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 p -96.42 150.9 37.65 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.188 -0.945 . . . . 0.78000000000000003 108.629 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -41.15 -42.74 5.0 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.869 1.713 . . . . 0.67000000000000004 113.102 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 54.7 m -60.59 -50.58 72.94 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.159 -0.963 . . . . 0.69999999999999996 109.892 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -61.97 -40.85 96.98 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.757 -1.177 . . . . 1.21 109.621 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.7 p -68.23 -37.78 81.18 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.49 -0.884 . . . . 0.59999999999999998 110.525 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.47 75.68 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.509 -0.744 . . . . 0.62 110.706 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -93.73 -3.46 52.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.009 -1.057 . . . . 1.1599999999999999 112.815 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.61 149.1 49.54 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.74 -0.837 . . . . 0.72999999999999998 108.74 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -96.83 118.48 33.35 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.721 -1.585 . . . . 2.2400000000000002 106.721 177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.9 -12.99 60.03 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 1.4299999999999999 111.852 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -84.66 -26.16 28.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.391 -0.818 . . . . 2.1499999999999999 112.336 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -100.88 2.1 40.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.367 -0.833 . . . . 2.04 112.271 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 178' ' ' GLY . 54.9 t -111.18 131.21 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 N-CA-C 108.263 -1.014 . . . . 0.55000000000000004 108.263 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.38 -12.35 43.53 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.37 -0.831 . . . . 1.6299999999999999 112.016 -179.511 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.435 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.94 -179.42 44.4 Favored Glycine 0 N--CA 1.497 2.745 0 O-C-N 120.46 -1.4 . . . . 0.46999999999999997 109.768 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -130.1 134.01 47.06 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 107.408 -1.331 . . . . 0.54000000000000004 107.408 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.523 HD11 HD13 ' A' ' 220' ' ' LEU . 59.0 mt -137.54 106.22 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 105.783 -1.932 . . . . 0.68999999999999995 105.783 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.415 ' C ' ' HG1' ' A' ' 205' ' ' THR . 71.0 p -132.91 177.32 7.74 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.71 -1.244 . . . . 0.81999999999999995 110.844 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 16.4 m-20 -101.4 57.52 0.85 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.534 -0.757 . . . . 2.3700000000000001 109.405 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -109.09 156.62 19.59 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.417 -0.802 . . . . 1.1100000000000001 109.656 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.4 -88.61 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.224 -0.989 . . . . 1.6699999999999999 111.658 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 151.27 -65.07 0.37 Allowed Glycine 0 N--CA 1.498 2.833 0 O-C-N 121.211 -1.17 . . . . 1.54 111.953 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 186' ' ' ARG . 18.0 ttt-85 -60.59 -42.73 97.3 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.849 -1.383 . . . . 4.4800000000000004 110.06 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 48.8 p -109.26 21.86 16.57 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.613 -0.679 . . . . 2.6299999999999999 111.487 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 t -85.71 131.47 34.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.114 -0.991 . . . . 1.6899999999999999 108.591 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -60.35 -39.34 86.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 1.0700000000000001 110.727 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 35.2 p -58.36 -38.04 76.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 1.5800000000000001 110.54 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.7 m -60.58 -39.75 89.2 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.357 -0.839 . . . . 1.6000000000000001 110.221 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.81 -39.72 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.126 -0.983 . . . . 1.45 110.489 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 71.3 mtp -63.39 -42.58 98.82 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.503 1.145 . . . . 1.05 109.341 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -60.12 -41.16 92.04 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.463 -0.79 . . . . 0.71999999999999997 110.938 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -61.5 -44.92 96.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.837 -1.164 . . . . 3.0499999999999998 110.355 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 27.8 m -71.67 -39.54 70.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.9 . . . . 0.89000000000000001 110.416 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.9 mt -91.64 -11.2 37.75 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.818 0.818 . . . . 0.78000000000000003 112.22 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 194' ' ' ALA . 92.5 mt-10 49.94 19.09 0.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.67 0.989 . . . . 1.45 113.67 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.67 166.85 32.35 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.064 -1.022 . . . . 0.67000000000000004 108.435 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.64 140.57 21.26 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.865 1.71 . . . . 0.64000000000000001 110.38 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.23 168.06 23.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 119.915 -1.741 . . . . 0.67000000000000004 109.859 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 203' ' ' VAL . 92.9 mt -144.01 156.89 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.36 -1.348 . . . . 0.68999999999999995 107.36 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.456 ' N ' HG22 ' A' ' 202' ' ' ILE . 10.2 m -138.15 -30.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 120.99 -1.069 . . . . 0.84999999999999998 112.744 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.79 30.84 0.9 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.014 -1.089 . . . . 0.92000000000000004 113.663 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.431 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 9.8 p -61.34 -27.51 68.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.649 -1.501 . . . . 0.94999999999999996 110.924 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.47 -91.04 0.38 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 120.221 -0.99 . . . . 1.04 110.77 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.5 m -121.7 27.11 8.36 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.531 -0.982 . . . . 1.5700000000000001 112.594 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.1 t -58.5 -35.84 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.121 -1.612 . . . . 0.83999999999999997 110.22 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.405 HG23 ' OD2' ' A' ' 182' ' ' ASP . 56.2 p -52.91 -24.62 9.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 0.98999999999999999 111.625 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.2 p -90.96 0.41 57.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.36 -0.837 . . . . 1.7 111.789 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -123.56 -3.52 8.31 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 113.079 0.77 . . . . 2.2000000000000002 113.079 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 38.7 t -116.8 149.08 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.574 0.702 . . . . 0.83999999999999997 109.712 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -119.41 150.09 40.77 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.123 -1.066 . . . . 2.2000000000000002 108.123 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.421 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.2 p-10 -56.67 143.85 34.61 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.02 -1.072 . . . . 2.2799999999999998 110.355 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.1 m-20 79.89 -1.61 2.08 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.796 1.406 . . . . 2.3500000000000001 114.796 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.31 150.72 42.61 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.709 -1.196 . . . . 1.97 109.036 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -89.5 117.36 28.35 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.455 -1.403 . . . . 2.6499999999999999 107.591 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.9 mt -126.67 149.8 49.34 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.596 0.713 . . . . 0.63 109.708 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.4 mt -119.21 129.94 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.394 -1.336 . . . . 0.62 107.394 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.523 HD13 HD11 ' A' ' 180' ' ' ILE . 49.6 tp -92.73 121.99 34.68 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.293 -1.373 . . . . 0.64000000000000001 107.293 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 81.1 m-20 -88.33 -30.48 19.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.695 -1.253 . . . . 2.0499999999999998 111.661 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.41 19.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.448 -0.782 . . . . 0.83999999999999997 112.552 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.1 t -121.84 -59.68 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.922 0.868 . . . . 1.02 110.263 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -96.23 10.29 38.31 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.876 0.846 . . . . 2.5099999999999998 110.768 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 4' ' ' GLY . 6.5 t-20 60.82 50.34 5.43 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.579 -0.737 . . . . 1.54 112.021 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.529 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 12.9 pt20 -151.23 158.7 44.23 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.957 0.884 . . . . 1.95 109.638 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 28.0 t -116.37 140.3 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 109.017 -0.734 . . . . 0.70999999999999996 109.017 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.529 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 47.4 m-85 -99.35 130.83 45.66 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.144 -0.973 . . . . 1.01 108.466 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.2 t -109.84 130.02 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.434 -0.791 . . . . 0.81999999999999995 108.921 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.525 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 4.5 t-20 61.11 43.71 0.69 Allowed Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 113.792 1.034 . . . . 1.54 113.792 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 33.4 Cg_endo -65.53 147.48 86.7 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.208 1.939 . . . . 0.93999999999999995 111.199 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 44.1 p -76.82 157.25 31.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.112 -0.992 . . . . 1.8 108.985 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -59.92 -33.22 71.6 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.133 -0.98 . . . . 2.73 110.523 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -57.62 -40.45 79.2 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.468 -0.77 . . . . 3.1699999999999999 110.218 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -71.0 -40.84 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.393 -0.817 . . . . 1.3400000000000001 110.064 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 56.4 mt -60.17 -47.54 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 1.2 110.662 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -59.26 -40.39 85.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.674 -1.266 . . . . 2.7000000000000002 110.482 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -64.66 -42.12 95.63 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.826 -0.75 . . . . 2.5899999999999999 110.357 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.1 mtp -70.88 -34.35 71.51 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.272 -0.893 . . . . 1.3799999999999999 110.975 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -57.45 -39.82 77.13 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.198 -0.939 . . . . 2.8399999999999999 110.389 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.04 -48.42 36.32 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.148 -0.97 . . . . 1.8799999999999999 110.017 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.87 -45.09 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.81 -0.756 . . . . 2.3999999999999999 110.625 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 13' ' ' PHE . 37.1 tt0 -56.28 -53.02 62.21 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.607 -1.308 . . . . 3.52 111.344 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.62 -35.83 82.27 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.226 -0.921 . . . . 1.8799999999999999 110.406 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -60.44 -30.46 69.66 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.025 -1.07 . . . . 3.0099999999999998 109.424 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.5 t -66.0 -38.31 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.341 -0.849 . . . . 2.4500000000000002 110.254 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.03 85.09 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.314 -0.866 . . . . 2.75 110.047 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.4 t -69.86 -38.23 76.38 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.208 -0.933 . . . . 3.1600000000000001 110.35 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -62.95 -32.46 73.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 3.5699999999999998 110.774 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -61.61 -34.84 76.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.915 . . . . 4.2999999999999998 110.442 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -63.05 -41.8 99.56 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.678 -0.809 . . . . 4.4500000000000002 110.351 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -68.56 -33.39 74.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.889 . . . . 5.9699999999999998 110.496 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 253' ' ' LEU . 1.3 tt -67.54 -28.37 67.75 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.402 -0.811 . . . . 6.1799999999999997 110.984 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -65.53 -23.29 66.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.117 -0.989 . . . . 6.6600000000000001 111.494 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -78.27 -12.68 60.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.965 -1.084 . . . . 8.1999999999999993 111.679 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.75 0.91 56.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.412 -0.805 . . . . 8.0700000000000003 112.041 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -86.63 -69.57 0.67 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 9.4499999999999993 109.948 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -93.15 -1.94 55.85 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.212 -0.93 . . . . 10.119999999999999 113.25 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.784 -1.103 . . . . 11.49 108.543 -178.442 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 mtt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.237 -0.653 . . . . 3.0699999999999998 109.237 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.2 mt -94.7 113.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 106.302 -1.74 . . . . 1.0700000000000001 106.302 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 m -105.38 124.87 50.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.259 -1.015 . . . . 1.24 108.259 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.89 -152.02 16.8 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 108.141 -1.984 . . . . 1.01 108.141 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.9 mt -94.78 -4.87 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.249 -1.148 . . . . 1.1100000000000001 112.926 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 tp 49.7 99.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.086 -1.009 . . . . 0.98999999999999999 112.624 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.65 -53.74 5.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.007 -1.058 . . . . 0.84999999999999998 110.571 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.99 148.44 45.38 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 107.746 -1.205 . . . . 1.3799999999999999 107.746 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.8 156.52 43.88 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.578 2.186 . . . . 0.93999999999999995 112.272 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 147.17 122.21 1.33 Allowed Glycine 0 N--CA 1.507 3.418 0 N-CA-C 111.087 -0.805 . . . . 0.81000000000000005 111.087 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.8 mt -89.64 132.05 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.777 -1.426 . . . . 0.82999999999999996 108.706 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.99 151.49 46.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.256 -0.902 . . . . 0.53000000000000003 108.638 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.7 m-85 -116.7 145.41 43.47 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.279 -0.888 . . . . 0.77000000000000002 109.219 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.31 167.89 36.86 Favored Glycine 0 N--CA 1.5 2.906 0 C-N-CA 118.938 -1.601 . . . . 0.51000000000000001 110.053 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -78.08 158.89 28.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.752 -0.852 . . . . 1.8999999999999999 109.132 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.42 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -84.37 119.81 25.54 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.029 -1.1 . . . . 0.66000000000000003 108.029 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -99.93 95.68 7.05 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 105.683 -1.969 . . . . 0.82999999999999996 105.683 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.5 tp -90.67 137.71 32.15 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.454 -1.313 . . . . 0.85999999999999999 107.454 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.5 mt -99.02 111.19 23.66 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 106.647 -1.612 . . . . 0.92000000000000004 106.647 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -103.52 128.72 50.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.217 -1.401 . . . . 2.0299999999999998 107.217 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -130.6 154.34 47.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.926 -0.768 . . . . 2.6600000000000001 108.926 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -80.65 139.39 36.23 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.695 -0.854 . . . . 2.3199999999999998 108.695 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.82 149.88 49.46 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.473 -1.392 . . . . 2.1099999999999999 109.046 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -93.22 131.01 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.602 -0.888 . . . . 0.72999999999999998 108.602 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.9 t -108.93 130.13 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.272 -1.01 . . . . 0.87 108.272 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.0 mt -94.67 133.51 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.456 -0.942 . . . . 0.81000000000000005 108.456 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -89.01 120.83 30.78 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.294 -1.372 . . . . 1.3400000000000001 107.294 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -96.54 15.8 20.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.132 -0.98 . . . . 2.8900000000000001 112.403 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -70.42 149.89 46.8 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.542 -0.723 . . . . 2.0899999999999999 109.838 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -90.76 130.35 36.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.669 -1.234 . . . . 2.1899999999999999 107.669 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.9 pt -94.76 164.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.988 . . . . 0.75 110.347 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -94.95 166.02 12.16 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.486 -0.759 . . . . 0.91000000000000003 109.681 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.23 -19.11 7.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 0.93000000000000005 112.351 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.12 -37.86 81.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 2.2799999999999998 110.696 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -94.52 -6.14 44.42 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.563 -1.336 . . . . 1.45 113.105 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.8 t -59.55 -42.12 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.217 -0.927 . . . . 0.81000000000000005 110.758 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -58.41 -39.19 79.05 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.128 -0.982 . . . . 1.54 110.58 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -64.99 -38.79 92.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.403 -0.811 . . . . 2.3599999999999999 111.131 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -59.37 -41.23 88.83 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.619 -1.3 . . . . 1.3100000000000001 110.783 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.17 -40.85 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.98 -1.075 . . . . 0.81999999999999995 110.789 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -62.83 -42.6 99.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.977 -1.077 . . . . 1.5 110.457 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.453 ' HG2' HH11 ' A' ' 42' ' ' ARG . 42.2 mtt-85 -61.36 -40.41 94.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -0.863 . . . . 2.23 110.296 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 40.6 t80 -75.32 -55.34 5.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.298 -0.876 . . . . 0.84999999999999998 110.965 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.4 tp -58.07 -47.46 83.11 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.507 -0.877 . . . . 0.91000000000000003 110.459 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -68.79 -39.91 79.91 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.822 -0.751 . . . . 0.90000000000000002 109.918 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.29 -42.48 97.35 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.495 -1.442 . . . . 0.68999999999999995 109.495 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' CG ' HH11 ' A' ' 47' ' ' ARG . 2.2 ttt-85 -60.3 -28.76 68.36 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.235 -1.156 . . . . 2.8799999999999999 110.117 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.92 -50.49 73.58 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.465 0.65 . . . . 0.84999999999999998 110.955 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -83.26 -38.07 22.68 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.134 -0.979 . . . . 2.3500000000000001 111.043 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.9 -42.82 85.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.162 -0.961 . . . . 0.65000000000000002 109.664 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.4 t -60.47 -41.26 93.82 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.718 -0.845 . . . . 1.45 108.718 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.78 -44.86 76.42 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.624 -0.831 . . . . 0.63 110.434 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -62.18 -51.51 67.53 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.366 -0.934 . . . . 1.3400000000000001 110.668 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.69 -38.25 89.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.136 -0.977 . . . . 1.5600000000000001 109.988 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -59.12 -40.08 84.33 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.594 -0.691 . . . . 1.1899999999999999 110.331 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.6 m -62.26 -45.05 95.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.937 -1.102 . . . . 0.71999999999999997 110.266 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.25 -32.31 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.566 -0.709 . . . . 0.62 110.978 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -53.98 -44.58 70.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 1.05 110.469 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -68.69 -36.49 78.57 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.276 -0.89 . . . . 0.64000000000000001 109.709 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -62.27 -40.0 94.78 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.862 -1.135 . . . . 1.73 108.853 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.32 75.41 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.06 -0.656 . . . . 0.56000000000000005 110.06 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.66 -34.05 26.09 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.106 -1.045 . . . . 0.68999999999999995 110.883 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.25 -18.05 43.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.007 -1.29 . . . . 1.48 111.321 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.6 m -90.96 -53.8 4.23 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.209 0.528 . . . . 0.97999999999999998 111.184 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -106.86 -12.65 15.43 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 113.066 0.765 . . . . 1.1599999999999999 113.066 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.8 155.84 10.78 Favored Glycine 0 N--CA 1.501 3.022 0 O-C-N 121.434 -0.791 . . . . 0.84999999999999998 112.338 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -55.78 -20.56 15.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.65 -0.912 . . . . 3.8599999999999999 112.393 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.55 -34.26 66.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.415 -0.803 . . . . 2.3500000000000001 111.165 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -81.17 -19.22 43.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.567 -1.333 . . . . 1.6699999999999999 111.86 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.01 -31.81 70.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.187 -0.946 . . . . 1.45 111.022 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.8 95.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.874 -1.141 . . . . 0.60999999999999999 110.379 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.1 -45.92 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.38 -0.928 . . . . 0.65000000000000002 110.056 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -71.47 -31.63 67.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.838 . . . . 0.66000000000000003 110.417 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -60.32 -38.44 83.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 1.1899999999999999 109.847 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.32 -41.85 94.35 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.213 -1.155 . . . . 0.53000000000000003 110.213 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -58.25 -46.27 86.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -1.103 . . . . 1.27 110.416 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.74 -39.61 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.976 -1.078 . . . . 0.54000000000000004 110.179 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.4 ttt -59.85 -39.8 86.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.961 -1.087 . . . . 1.74 110.411 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.19 -49.07 79.27 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.595 0.712 . . . . 0.55000000000000004 110.774 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.76 -43.64 94.22 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.702 0.763 . . . . 0.46999999999999997 110.241 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -86.25 9.39 17.83 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.338 -0.851 . . . . 1.4199999999999999 112.731 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -64.42 126.5 28.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.389 -0.819 . . . . 1.27 109.007 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.76 -14.18 62.74 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.056 0.932 . . . . 1.3500000000000001 110.647 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -75.8 -54.67 6.57 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.643 -0.66 . . . . 2.2200000000000002 110.137 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 mt -62.0 -40.31 95.24 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.759 -0.776 . . . . 0.62 110.686 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.6 -46.03 81.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.701 -1.25 . . . . 1.29 110.749 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.52 -39.59 91.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.78 . . . . 1.52 110.891 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.23 -48.09 66.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.372 -1.455 . . . . 1.3 110.953 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -55.44 -43.05 70.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.112 -1.035 . . . . 0.60999999999999999 110.153 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.3 mt -62.43 -47.51 92.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.68 0.753 . . . . 0.78000000000000003 110.524 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.61 94.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.457 -0.777 . . . . 0.81999999999999995 110.879 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.7 -39.03 87.0 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.674 -1.266 . . . . 0.80000000000000004 110.239 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.56 -52.77 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.77000000000000002 110.347 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -72.36 -35.13 68.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.502 -0.749 . . . . 2.1200000000000001 112.067 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -80.94 -46.06 15.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.796 -1.19 . . . . 1.51 112.045 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -101.16 9.11 42.3 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.408 -0.807 . . . . 1.98 112.335 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.8 m80 50.54 49.68 20.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.051 -1.031 . . . . 1.3200000000000001 111.45 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.0 mtt -103.92 153.5 20.72 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.73 0.776 . . . . 1.3799999999999999 109.631 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.3 p -72.6 161.43 30.79 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.141 -0.975 . . . . 0.67000000000000004 109.508 178.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.83 -41.28 86.5 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.1 -1.0 . . . . 0.52000000000000002 110.932 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.623 ' OD2' HD21 ' A' ' 142' ' ' LEU . 91.3 m-20 -67.98 -40.73 83.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -0.901 . . . . 2.25 109.866 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.38 -50.36 46.83 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.475 -0.89 . . . . 0.64000000000000001 110.932 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.07 96.18 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.888 0.851 . . . . 0.56000000000000005 110.166 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.65 96.04 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.856 -0.611 . . . . 0.46000000000000002 110.94 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -61.94 -38.88 90.14 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.125 -0.984 . . . . 1.3200000000000001 110.789 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.66 -48.62 80.95 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.677 -1.264 . . . . 1.3 111.462 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.02 -44.12 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.207 -0.933 . . . . 0.60999999999999999 110.059 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.8 mm -61.58 -31.99 52.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.403 0.62 . . . . 0.65000000000000002 110.211 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -59.07 -41.18 87.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.671 . . . . 2.1099999999999999 110.529 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.36 -31.6 21.85 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.355 -1.403 . . . . 0.82999999999999996 112.518 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -61.33 -39.38 90.32 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.484 1.642 . . . . 1.28 110.12 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.68 -48.2 27.44 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.893 0.854 . . . . 0.89000000000000001 110.119 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.1 p -63.76 -36.0 82.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.355 -0.841 . . . . 1.8700000000000001 109.954 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.62 -43.61 98.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 1.05 110.535 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.18 -30.55 71.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.819 -1.176 . . . . 1.02 110.94 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.31 -22.72 66.87 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.29 -0.881 . . . . 2.04 111.038 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -74.44 -10.91 60.03 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.398 -0.921 . . . . 1.73 111.391 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.479 HD13 HD13 ' A' ' 123' ' ' LEU . 7.1 mt -86.49 141.95 28.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.597 -0.69 . . . . 1.3700000000000001 109.412 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -97.76 55.51 1.21 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.577 -0.702 . . . . 2.8799999999999999 111.078 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -131.89 134.11 45.35 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 107.382 -1.34 . . . . 1.5800000000000001 107.382 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -57.53 -39.83 77.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.281 -0.887 . . . . 3.04 110.922 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -70.79 -52.02 23.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.52 -1.363 . . . . 0.90000000000000002 110.672 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.479 HD13 HD13 ' A' ' 118' ' ' LEU . 39.8 mt -61.17 -41.03 96.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.021 -1.049 . . . . 1.0600000000000001 109.842 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -61.5 -49.21 77.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.798 -1.189 . . . . 2.1800000000000002 109.762 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -60.37 -31.67 70.56 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.898 0.856 . . . . 2.1499999999999999 110.047 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 130' ' ' VAL . 22.3 ttp180 -66.85 -27.7 67.75 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 122.3 1.048 . . . . 2.3300000000000001 109.477 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.02 83.29 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.883 0.849 . . . . 0.81999999999999995 109.33 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.3 80.12 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.464 0.65 . . . . 0.84999999999999998 110.326 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.26 -35.74 79.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 1.3899999999999999 110.649 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 126' ' ' ARG . 41.5 t -67.43 -38.34 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.229 -0.919 . . . . 0.56000000000000005 110.331 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -59.0 -39.68 82.57 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 118.923 -1.111 . . . . 3.1200000000000001 109.496 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.45 ' OD2' ' NH2' ' A' ' 136' ' ' ARG . 62.1 t0 -60.26 -37.69 81.22 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.44 0.638 . . . . 1.28 110.527 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.8 mt -60.43 -39.15 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.925 -1.109 . . . . 0.48999999999999999 110.113 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.92 -45.34 88.63 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 120.128 -1.034 . . . . 0.46000000000000002 110.702 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -59.81 -40.0 86.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.146 -1.208 . . . . 2.71 110.095 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 136' ' ' ARG . 39.7 mtt-85 -61.25 -42.04 97.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.097 -1.002 . . . . 2.1400000000000001 109.78 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 37.8 tp -60.43 -40.48 91.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.462 -0.773 . . . . 1.05 110.129 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.58 -42.61 92.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.143 -0.973 . . . . 0.52000000000000002 110.399 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.457 ' NH1' ' CD2' ' A' ' 144' ' ' LEU . 54.5 mtt-85 -59.87 -37.58 79.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 2.3500000000000001 110.762 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.4 -41.72 55.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.188 -0.945 . . . . 1.3899999999999999 110.893 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.454 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.6 mt -60.36 -37.76 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.223 -0.923 . . . . 0.68000000000000005 110.768 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.623 HD21 ' OD2' ' A' ' 101' ' ' ASP . 84.3 mt -86.4 -7.35 58.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.82999999999999996 111.994 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.49 23.19 68.34 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 120.091 -1.052 . . . . 0.91000000000000003 113.227 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.457 ' CD2' ' NH1' ' A' ' 139' ' ' ARG . 5.7 tp -64.49 148.09 51.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.049 -0.723 . . . . 0.94999999999999996 109.049 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -66.44 148.53 51.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.039 -0.726 . . . . 2.4300000000000002 109.039 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 59.4 mt -103.31 132.35 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.17 -1.048 . . . . 1.1000000000000001 108.17 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.888 HD12 ' H ' ' A' ' 147' ' ' ILE . 2.7 mp -84.02 122.82 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.497 -1.297 . . . . 1.5800000000000001 107.497 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -95.07 97.99 10.34 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 105.958 -1.867 . . . . 1.6200000000000001 105.958 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.4 mt -74.91 -15.05 60.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.931 . . . . 0.80000000000000004 112.005 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.8 m -79.94 -1.58 40.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.119 -0.988 . . . . 1.5600000000000001 112.177 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -99.5 29.04 4.22 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.661 0.743 . . . . 0.83999999999999997 111.954 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 7.3 mt -72.29 138.41 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.169 -0.957 . . . . 0.81999999999999995 109.006 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -113.81 -18.82 11.72 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.278 1.037 . . . . 2.3100000000000001 112.475 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -114.88 138.09 51.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.809 -1.182 . . . . 1.54 107.809 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.26 122.88 26.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.024 -1.102 . . . . 1.3799999999999999 108.024 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.47 179.98 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.11 -0.994 . . . . 0.68999999999999995 108.847 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.8 mt -87.45 142.24 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.05 -1.031 . . . . 0.53000000000000003 108.785 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 45.2 tp -96.66 123.36 40.31 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.061 -1.089 . . . . 0.64000000000000001 108.061 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.19 129.64 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.281 -1.377 . . . . 0.67000000000000004 107.281 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.78 157.12 23.72 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.893 -1.129 . . . . 0.78000000000000003 108.872 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.32 83.11 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.801 -1.187 . . . . 1.0 109.392 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -172.97 148.95 1.82 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.13 -0.693 . . . . 2.4199999999999999 109.13 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.0 mt -111.66 141.22 45.53 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.482 -0.761 . . . . 0.75 109.223 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 168' ' ' THR . 5.8 p -92.78 147.86 34.89 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.914 -1.116 . . . . 0.78000000000000003 108.917 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.55 -43.31 6.07 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.824 1.683 . . . . 0.67000000000000004 113.119 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.2 m -60.49 -51.01 71.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.201 -0.937 . . . . 0.69999999999999996 110.251 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -61.56 -39.52 91.42 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.01 -1.056 . . . . 1.21 109.975 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 164' ' ' THR . 48.1 p -65.77 -36.92 84.9 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.852 0.834 . . . . 0.59999999999999998 109.965 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.81 88.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.494 -0.754 . . . . 0.62 111.127 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -94.27 -3.05 51.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -0.789 . . . . 1.1599999999999999 113.083 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.91 148.18 44.39 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.407 -0.96 . . . . 0.72999999999999998 108.407 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -93.75 114.79 27.14 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 106.884 -1.524 . . . . 2.2400000000000002 106.884 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 173' ' ' LEU . 3.3 mm? -70.75 -27.89 64.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.234 0.54 . . . . 1.4299999999999999 111.506 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -82.92 -16.89 45.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 2.1499999999999999 112.293 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -100.48 -2.82 32.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.015 -1.053 . . . . 2.04 112.8 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 178' ' ' GLY . 88.9 t -107.69 130.62 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.22 -1.03 . . . . 0.55000000000000004 108.22 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.14 -7.65 59.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 1.6299999999999999 112.133 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.618 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.59 172.64 37.13 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.184 -1.566 . . . . 0.46999999999999997 109.184 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -128.89 127.63 42.19 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 107.57 -1.27 . . . . 0.54000000000000004 107.57 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 220' ' ' LEU . 56.4 mt -132.33 120.6 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.406 -1.701 . . . . 0.68999999999999995 106.406 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 203' ' ' VAL . 67.7 p -138.88 169.83 17.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.828 -1.17 . . . . 0.81999999999999995 110.357 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.464 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 36.9 t0 -106.25 62.03 0.65 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.109 -0.7 . . . . 2.3700000000000001 109.109 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -106.49 148.85 27.7 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.804 -0.813 . . . . 1.1100000000000001 108.804 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.62 -0.51 48.92 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.744 -1.217 . . . . 1.6699999999999999 112.555 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 89.0 -27.9 7.03 Favored Glycine 0 N--CA 1.496 2.646 0 O-C-N 121.395 -1.062 . . . . 1.54 113.797 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.6 mtt-85 -60.16 -39.06 85.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.272 . . . . 4.4800000000000004 110.44 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 49.1 p -133.38 34.52 3.5 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.435 -0.791 . . . . 2.6299999999999999 111.267 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 188' ' ' SER . 23.9 p -84.03 99.05 10.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.675 -1.602 . . . . 1.6899999999999999 106.675 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -61.36 -32.49 72.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 1.0700000000000001 110.365 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.3 t -56.3 -39.46 72.78 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.381 -0.824 . . . . 1.5800000000000001 110.18 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.4 p -59.74 -39.0 83.3 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.895 -1.122 . . . . 1.6000000000000001 109.952 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.77 -40.0 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.647 -0.821 . . . . 1.45 110.208 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 51.2 mtp -64.55 -44.92 89.26 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.522 1.153 . . . . 1.05 109.119 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.81 -43.58 94.44 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.089 -0.96 . . . . 0.71999999999999997 111.405 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -59.66 -45.68 91.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.894 -1.129 . . . . 3.0499999999999998 110.533 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.1 m -71.19 -39.3 71.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.881 . . . . 0.89000000000000001 110.327 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.449 HD13 HD12 ' A' ' 173' ' ' LEU . 16.5 mt -92.36 -6.64 49.75 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.155 0.798 . . . . 0.78000000000000003 113.155 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 194' ' ' ALA . 95.3 mt-10 53.92 13.6 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.745 1.017 . . . . 1.45 113.745 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.65 149.73 95.37 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.925 -1.109 . . . . 0.67000000000000004 108.767 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.08 137.18 73.97 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.503 1.469 . . . . 0.64000000000000001 109.957 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.09 163.65 25.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.368 -1.458 . . . . 0.67000000000000004 109.522 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 220' ' ' LEU . 13.2 mt -149.12 145.46 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.998 -1.112 . . . . 0.68999999999999995 107.998 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.9 m -125.84 -25.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 O-C-N 121.114 -0.991 . . . . 0.84999999999999998 113.24 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.66 50.46 4.25 Favored Glycine 0 N--CA 1.488 2.125 0 O-C-N 120.842 -1.161 . . . . 0.92000000000000004 111.004 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 181' ' ' THR . 69.9 p -68.05 -11.59 59.27 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.933 -1.334 . . . . 0.94999999999999996 112.219 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.464 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 73.88 -95.99 0.84 Allowed Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.756 -1.338 . . . . 1.04 109.756 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 70.8 m -130.31 30.65 4.72 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 121.336 -1.097 . . . . 1.5700000000000001 112.296 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.72 -39.67 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.446 -1.409 . . . . 0.83999999999999997 110.7 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 69.7 p -60.68 -19.3 58.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 0.98999999999999999 111.986 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 27.7 t -94.93 -1.95 51.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.121 -0.987 . . . . 1.7 112.107 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -128.77 6.85 5.6 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 112.529 0.566 . . . . 2.2000000000000002 112.529 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 35.0 t -118.62 148.15 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.567 0.699 . . . . 0.83999999999999997 110.036 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -119.32 150.08 40.73 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.035 -1.098 . . . . 2.2000000000000002 108.035 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 45.0 p-10 -50.3 141.53 11.52 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.785 -1.197 . . . . 2.2799999999999998 110.723 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 t70 80.44 1.81 1.9 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.455 1.28 . . . . 2.3500000000000001 114.455 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -65.2 147.99 52.47 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.882 -1.136 . . . . 1.97 108.732 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -88.22 120.21 29.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.012 -1.477 . . . . 2.6499999999999999 107.012 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.6 mt -129.48 152.59 48.84 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.786 0.803 . . . . 0.63 109.984 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 mt -129.31 134.81 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.607 -1.257 . . . . 0.62 107.607 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.659 HD11 HD12 ' A' ' 202' ' ' ILE . 36.0 tp -97.96 125.04 42.7 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.891 -1.151 . . . . 0.64000000000000001 107.891 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.1 t0 -86.07 -31.2 22.05 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.797 -1.189 . . . . 2.0499999999999998 110.984 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.75 19.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.757 1.021 . . . . 0.83999999999999997 113.757 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 24.5 t -115.91 -62.32 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-O 121.985 0.898 . . . . 1.02 109.465 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -91.41 13.54 17.24 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.655 0.741 . . . . 2.5099999999999998 110.9 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 63.49 51.34 2.59 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.745 0.646 . . . . 1.54 112.745 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.59 ' NE2' ' CZ ' ' A' ' 228' ' ' TYR . 20.7 pt20 -150.24 161.38 42.53 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.544 1.164 . . . . 1.95 109.948 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.8 t -116.36 138.84 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 108.27 -1.011 . . . . 0.70999999999999996 108.27 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.59 ' CZ ' ' NE2' ' A' ' 226' ' ' GLN . 51.0 m-85 -105.06 131.04 53.07 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.396 -0.964 . . . . 1.01 108.396 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.69 129.26 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 107.577 -1.268 . . . . 0.81999999999999995 107.577 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 46.3 56.48 16.38 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.013 -1.054 . . . . 1.54 113.132 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.4 150.93 70.98 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.656 2.237 . . . . 0.93999999999999995 110.901 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.4 p -75.12 163.5 27.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -0.849 . . . . 1.8 110.321 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.427 HD22 ' H ' ' A' ' 233' ' ' ASN . 2.1 p30 -61.27 -38.74 87.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.753 -1.217 . . . . 2.73 110.605 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -59.84 -41.3 91.06 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.15 -0.969 . . . . 3.1699999999999999 110.361 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 84.3 t -70.83 -40.48 76.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.241 -0.912 . . . . 1.3400000000000001 110.237 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt -60.01 -43.85 93.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.151 -0.968 . . . . 1.2 110.375 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -59.85 -38.75 82.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 2.7000000000000002 110.955 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -61.18 -47.98 83.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.215 -0.928 . . . . 2.5899999999999999 111.164 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 24.4 mtm -73.79 -36.18 65.0 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.018 -1.051 . . . . 1.3799999999999999 111.172 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -56.94 -38.54 73.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.177 -0.952 . . . . 2.8399999999999999 110.043 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.96 -43.53 67.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.391 -0.818 . . . . 1.8799999999999999 111.244 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.11 -49.95 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.134 -0.979 . . . . 2.3999999999999999 111.24 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -61.18 -50.75 71.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.474 -1.391 . . . . 3.52 110.091 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.23 -32.38 73.04 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.903 -0.719 . . . . 1.8799999999999999 110.778 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.85 -31.15 69.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.878 -1.129 . . . . 3.0099999999999998 109.161 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.76 -44.62 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.972 0.891 . . . . 2.4500000000000002 109.82 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.42 -33.82 71.71 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.288 -0.565 . . . . 2.75 110.269 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.0 t -64.97 -36.39 84.23 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.853 -0.739 . . . . 3.1600000000000001 110.53 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -60.41 -45.73 92.55 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.303 -0.959 . . . . 3.5699999999999998 109.823 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -71.4 -25.15 62.23 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.702 0.763 . . . . 4.2999999999999998 111.13 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.47 12.81 0.15 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.638 -0.664 . . . . 4.4500000000000002 112.764 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.19 -27.02 68.68 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.466 -0.771 . . . . 5.9699999999999998 111.335 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 82.4 mt -65.74 -22.76 66.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -0.816 . . . . 6.1799999999999997 110.747 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.98 -0.33 7.31 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.542 0.687 . . . . 6.6600000000000001 112.804 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.41 22.83 1.19 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.735 -1.228 . . . . 8.1999999999999993 113.039 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.5 tp -77.35 -3.2 38.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 8.0700000000000003 112.59 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -83.22 -0.55 49.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.819 -1.175 . . . . 9.4499999999999993 112.172 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -94.33 -1.39 53.92 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.172 -0.955 . . . . 10.119999999999999 112.824 -178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.01 -0.995 . . . . 11.49 109.41 -178.604 . . . . . . . . 0 0 . 1 stop_ save_